Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647497 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "bone marrow: 44.6" "Group enriched" "Detected in some" 5 "Basal respiratory cells: 33.8;Club cells: 25.8;Respiratory ciliated cells: 101.5" "Cancer enhanced" "Detected in some" "lung cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.8;LHCN-M2: 2.4;U-2 OS: 6.4;U-266/84: 2.9" "Not detected" "Not detected" HPA063601 Approved Vesicles,Centrosome,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "Centrosome, Cytosol" "HPA063601: AB_2685057" "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.0 0.0 0.1 0.1 0.3 44.6 0.6 0.1 0.2 0.3 0.3 0.2 0.2 0.1 1.1 1.2 1.2 0.3 0.0 0.3 0.1 0.9 0.3 1.3 0.1 0.1 0.3 0.0 0.7 0.0 1.2 0.0 0.1 0.0 0.3 0.4 0.9 0.2 0.0 0.9 0.1 0.0 0.0 0.5 0.0 1.6 0.1 0.6 3.0 0.0 1.7 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.0 1.3 0.0 1.2 0.3 0.7 1.4 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.2 0.0 0.1 2.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 6.4 0.3 1.0 1.9 2.9 0.0 0.8 0.3 0.2 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.1 33.8 0.0 0.0 1.2 0.3 10.5 0.0 25.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 10.2 1.8 0.5 0.2 0.0 0.8 0.6 0.4 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.9 0.2 0.0 0.5 0.2 6.1 0.0 0.0 6.1 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 101.5 0.0 0.0 0.1 1.8 3.6 3.7 1.7 0.0 0.0 0.1 0.1 0.5 0.2 AC007906.2 ENSG00000277639 "Novel protein" 16 53035690-53052873 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "choroid plexus: 86.7;fallopian tube: 77.8" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 224.8;Respiratory ciliated cells: 209.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 31.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 8.3;ASC TERT1: 7.0;BEWO: 11.6;HSkMC: 7.1;RPTEC TERT1: 7.5" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 28: BEWO - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.97e-2)" "unprognostic (8.34e-3)" "unprognostic (1.63e-1)" "unprognostic (5.38e-3)" "unprognostic (1.70e-1)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (3.34e-1)" "unprognostic (2.25e-2)" "unprognostic (1.54e-2)" "unprognostic (5.02e-2)" "unprognostic (6.07e-2)" "unprognostic (5.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.02e-2)" "unprognostic (4.46e-3)" 1.0 0.3 1.6 0.4 1.1 0.0 6.0 1.0 0.4 11.2 86.7 4.5 0.6 2.8 1.4 9.0 77.8 10.5 1.4 2.9 2.0 16.5 1.3 9.5 0.1 6.5 10.4 0.3 11.6 0.3 0.3 1.5 3.9 9.4 5.1 0.0 3.5 2.7 1.0 4.7 0.4 0.8 3.4 0.0 0.9 0.2 2.5 0.8 0.3 1.0 1.2 6.8 2.6 1.6 0.1 2.5 4.1 2.1 8.3 7.0 11.6 1.2 0.9 0.1 0.0 0.3 1.7 0.2 2.1 1.7 0.8 0.7 0.0 1.6 0.5 0.2 0.1 0.0 0.1 0.6 1.6 0.0 1.8 7.1 6.2 2.3 0.7 2.3 1.7 0.1 0.1 0.1 3.8 0.1 0.1 0.0 4.6 0.4 0.6 1.0 0.0 0.0 7.5 1.6 0.2 0.0 0.3 0.0 0.1 3.4 0.8 0.1 2.0 2.7 2.7 0.1 0.0 0.0 0.0 0.0 3.3 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 1.0 0.4 2.9 2.0 6.5 10.4 3.9 3.4 2.5 1.6 0.1 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.7 12.7 0.0 0.0 30.3 25.8 0.0 0.1 0.5 0.0 5.9 4.9 0.0 224.8 1.7 0.8 0.0 0.0 0.0 0.0 0.3 3.2 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.4 209.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 AC010255.2 ENSG00000250803 "Zinc finger protein 474-like" 5 122129622-122183949 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 56 "testis: 101.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 7.5" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (8.24e-2)" "unprognostic (3.81e-3)" "unprognostic (3.43e-2)" "unprognostic (1.42e-1)" "unprognostic (8.28e-2)" "unprognostic (1.76e-1)" "unprognostic (4.18e-1)" "unprognostic (5.54e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.4 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 101.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.2 0.2 0.5 0.7 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC013470.2 ENSG00000226690 "Novel protein" 7 12469621-12542222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.0;fallopian tube: 4.7" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 60.6;Respiratory ciliated cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.4" "Region enhanced" "Detected in many" "midbrain: 5.0" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.89e-1)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "unprognostic (1.48e-1)" "unprognostic (8.16e-2)" "unprognostic (1.53e-4)" "unprognostic (1.14e-3)" "unprognostic (3.62e-3)" "unprognostic (7.82e-3)" "unprognostic (3.61e-1)" "unprognostic (8.04e-2)" "unprognostic (8.40e-2)" "unprognostic (1.98e-1)" "unprognostic (2.88e-2)" "unprognostic (2.67e-1)" 0.1 0.1 0.8 0.0 1.0 0.1 0.0 0.6 0.4 0.1 0.8 0.1 0.0 0.3 0.1 0.0 4.7 0.0 0.0 1.1 2.0 0.0 0.0 0.4 0.0 7.0 6.1 0.0 0.2 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.7 1.3 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.8 1.0 0.6 0.4 1.1 2.0 7.0 6.1 4.6 3.1 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 7.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.1 ENSG00000278263 "Novel protein, identical to IGHV4-4" 15 21742364-21742799 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 52.2;lymphoid tissue: 57.9;urinary bladder: 97.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "memory B-cell: 24.0;naive B-cell: 7.7" "Lineage enriched" "Detected in single" 45 "B-cells: 24.0" "Not detected" "Not detected" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "unprognostic (1.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.93e-1)" "prognostic favorable (2.52e-4)" "unprognostic (1.05e-1)" "unprognostic (9.75e-3)" "unprognostic (1.80e-2)" "unprognostic (5.51e-6)" "unprognostic (5.57e-2)" "unprognostic (3.76e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-1)" 1.0 0.0 0.2 27.3 0.1 4.2 5.4 0.0 0.0 3.7 0.0 52.2 22.6 0.2 0.0 3.7 0.5 0.5 2.1 0.1 0.0 0.2 1.0 5.5 5.5 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.4 22.1 0.0 30.1 2.1 0.0 1.1 6.0 0.0 0.0 9.4 22.3 0.1 0.0 7.8 0.7 0.0 57.9 97.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.2 0.0 0.0 7.7 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732539-111120610 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 7.2;lung: 9.3" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 41.9" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 12.1;RPMI-8226: 22.0;RT4: 29.3;U-266/70: 18.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 1.1 0.6 0.4 0.5 0.7 1.5 0.1 0.2 0.4 0.4 0.0 0.5 0.5 0.5 7.2 0.4 0.3 0.6 1.2 0.3 0.1 0.5 0.3 9.3 0.9 0.4 0.4 0.2 1.0 2.9 0.3 0.7 0.3 3.2 0.3 0.7 0.6 0.0 1.3 0.7 0.6 0.1 0.0 0.6 0.5 3.2 0.2 0.3 0.8 0.0 1.2 4.6 0.1 0.5 12.1 0.2 0.3 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.9 0.7 0.3 0.5 0.1 0.3 1.3 0.0 0.1 0.0 0.3 3.5 0.2 0.5 0.5 0.0 0.0 0.3 0.1 1.2 0.0 0.1 0.3 0.0 0.6 1.8 1.8 0.1 4.4 0.9 0.4 4.2 0.0 0.3 0.6 0.2 22.0 0.0 29.3 2.5 1.0 0.3 0.5 0.1 0.6 0.4 1.2 0.3 0.2 1.0 0.2 0.1 18.7 4.8 0.7 0.0 0.1 0.1 0.7 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.9 0.2 0.2 0.2 0.1 0.1 0.4 0.7 0.2 0.4 0.3 0.1 0.4 0.4 0.3 0.0 0.2 0.5 0.3 0.0 41.9 0.0 1.0 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.0 0.1 1.3 0.0 0.2 5.4 0.2 0.1 0.2 1.2 0.0 2.2 0.0 0.0 0.4 0.0 0.8 0.0 5.9 0.0 0.0 0.1 0.0 2.0 0.3 0.0 0.0 0.8 8.1 0.0 0.2 0.0 0.0 0.0 0.1 1.0 1.0 1.3 0.1 2.3 0.0 7.5 0.8 0.0 0.1 0.1 0.3 0.0 0.2 0.3 1.6 2.7 0.0 0.3 0.0 1.1 0.0 0.2 0.8 ACSBG1 "BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352" ENSG00000103740 "Acyl-CoA synthetase bubblegum family member 1" Q96GR2 15 78167468-78245688 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 56.6;skin 1: 14.3" "Cell type enriched" "Detected in some" 5 "Astrocytes: 158.0" "Cancer enriched" "Detected in some" 4 "glioma: 3.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1;SK-MEL-30: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041642, CAB045955, HPA058869" Approved Approved Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 5: NTERA-2 - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840" "unprognostic (1.28e-1)" "unprognostic (1.63e-2)" "unprognostic (1.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-2)" "unprognostic (4.18e-2)" "unprognostic (1.32e-2)" "unprognostic (1.58e-2)" "unprognostic (1.86e-1)" "unprognostic (5.64e-2)" "unprognostic (2.02e-1)" "unprognostic (4.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (4.19e-2)" "unprognostic (1.42e-2)" 0.1 5.5 23.0 0.4 42.6 2.4 1.6 30.5 24.0 0.5 0.0 1.1 0.4 0.2 0.7 0.3 2.8 0.2 0.8 19.6 35.9 0.5 0.4 0.5 0.4 46.0 39.9 0.3 0.2 0.0 0.5 0.1 47.7 0.8 0.1 0.6 0.3 0.2 0.2 14.3 0.5 0.2 45.8 0.3 0.3 3.7 36.6 3.4 0.2 0.0 0.1 0.3 0.5 56.6 0.3 0.0 0.6 0.9 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.5 0.3 0.6 0.3 0.0 0.2 0.6 0.2 0.0 0.1 0.1 0.2 0.0 0.4 0.2 0.4 0.0 0.1 0.2 0.5 3.1 0.2 0.1 0.1 0.4 0.2 0.0 0.4 0.2 0.3 0.1 0.4 1.5 0.3 0.1 0.2 0.4 0.2 0.2 0.1 0.1 0.3 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.3 23.0 42.6 30.5 24.0 19.6 35.9 46.0 39.9 47.7 45.8 36.6 56.6 0.1 0.0 2.0 158.0 0.6 1.1 0.6 0.3 0.6 1.9 0.2 0.1 3.0 0.0 2.7 0.0 4.2 0.2 0.5 0.3 0.0 0.0 1.8 4.4 0.3 0.2 0.0 4.6 0.7 0.0 0.2 0.7 0.5 0.3 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 1.7 0.3 4.0 1.8 2.8 0.1 0.2 1.0 7.5 26.9 0.2 0.0 0.0 0.9 0.3 0.1 0.2 19.1 3.3 0.0 0.3 1.0 2.0 10.0 0.4 0.6 0.4 0.5 1.6 0.1 0.7 ACTA2 ACTSA ENSG00000107796 "Actin alpha 2, smooth muscle" P62736 10 88935074-88991339 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 6678.8;seminal vesicle: 5920.3;smooth muscle: 8099.9" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 1007.7;Peritubular cells: 5290.7;Sertoli cells: 3030.6;Smooth muscle cells: 2394.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 58.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 390.6;fHDF/TERT166: 641.1;HHSteC: 625.8;HSkMC: 345.1;hTERT-RPE1: 743.4;SuSa: 296.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "midbrain: 101.0" "CAB000002, CAB003761, CAB013531, HPA041264, HPA041271" Enhanced Supported "Actin filaments" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Actin filaments" "CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (7.05e-2)" "unprognostic (2.54e-1)" "unprognostic (2.30e-3)" "unprognostic (3.18e-2)" "unprognostic (3.33e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-2)" "unprognostic (1.71e-2)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (1.44e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (1.37e-8)" "unprognostic (1.87e-3)" "unprognostic (2.30e-1)" "unprognostic (7.91e-2)" "unprognostic (2.09e-3)" 1035.2 241.6 54.0 728.1 61.4 3.9 838.4 52.7 121.1 2000.3 61.4 2755.1 248.9 6678.8 1360.1 1509.9 3104.3 906.1 1069.2 53.4 54.6 312.2 161.8 732.8 173.7 59.0 55.9 798.0 91.4 80.6 60.8 771.3 55.3 2642.8 866.4 8.2 414.7 5920.3 202.1 355.7 701.6 8099.9 54.1 452.1 1427.1 263.9 56.1 56.5 312.0 214.0 48.4 3002.5 1367.0 52.9 3.9 19.0 49.3 102.7 198.1 390.6 9.5 109.8 136.8 11.9 45.4 0.0 8.8 7.2 11.5 641.1 8.6 1.4 1.8 25.4 11.3 60.6 11.3 0.4 5.6 119.3 625.8 0.8 3.2 345.1 44.9 73.9 28.5 743.4 11.3 3.0 0.0 7.1 128.8 10.8 1.0 28.3 2.5 0.2 1.2 1.4 0.2 4.6 27.1 5.0 0.7 7.6 10.2 7.9 1.0 296.8 32.4 1.0 27.9 24.0 4.0 30.2 9.3 21.1 1.6 0.6 29.6 10.2 26.1 28.1 12.3 17.5 17.6 8.7 13.8 6.0 14.1 19.8 10.8 1.8 1.5 10.7 11.1 4.0 14.2 0.4 58.7 10.7 54.0 61.4 52.7 121.1 53.4 54.6 59.0 55.9 55.3 54.1 56.1 52.9 65.4 9.6 6.1 5.5 4.4 43.2 23.4 16.5 22.8 1.1 22.7 1007.7 25.1 2.8 5.2 0.0 6.2 16.3 7.3 1.9 1.9 1.8 11.1 11.1 225.4 41.1 0.0 4.0 3.6 0.9 16.8 316.3 10.7 8.2 5.7 448.9 474.0 4.6 37.7 0.0 1.1 2.7 4.1 5.4 67.6 48.8 141.4 12.6 55.2 61.8 4.2 13.4 4.1 1.0 0.3 2.0 3.0 5290.7 3.7 17.5 3.4 9.5 10.9 1.4 3030.6 72.0 2394.6 4.0 13.8 11.1 40.5 23.7 16.5 36.0 5.7 10.4 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598967-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5;choroid plexus: 6.0;fallopian tube: 7.5;testis: 26.1" "Cell type enhanced" "Detected in some" "Early spermatids: 305.4;Endometrial ciliated cells: 57.1;Late spermatids: 74.8;Respiratory ciliated cells: 92.5;Spermatocytes: 68.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HDLM-2: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria No NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria Nucleoplasm "HPA036340: AB_2675071, HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.3 0.1 0.4 6.0 0.3 0.0 0.1 0.2 0.0 7.5 0.0 0.0 0.8 0.8 0.0 0.0 1.4 0.0 5.5 3.8 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 26.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.3 0.1 0.8 0.8 5.5 3.8 2.4 3.0 1.0 1.0 0.0 3.2 1.5 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 0.0 9.5 0.0 4.2 0.0 0.0 0.4 0.0 0.0 305.4 57.1 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.4 2.0 0.0 1.9 74.8 2.8 0.4 0.0 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.3 2.6 0.0 0.1 0.0 0.1 92.5 0.1 0.0 0.0 0.9 68.4 3.3 0.0 0.0 0.0 0.1 0.0 0.7 0.0 ADGRA1 "GPR123, KIAA1828" ENSG00000197177 "Adhesion G protein-coupled receptor A1" Q86SQ6 10 133070929-133131675 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 38.4" "Group enriched" "Detected in some" 4 "Excitatory neurons: 25.2;Hepatic stellate cells: 11.7;Inhibitory neurons: 24.6;Oligodendrocyte precursor cells: 29.1" "Cancer enriched" "Detected in single" 13 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "RH-30: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042773 Approved NA NA "Cluster 65: Brain - Ion transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA042773: AB_10794764" "unprognostic (8.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (1.09e-2)" "unprognostic (7.51e-3)" "unprognostic (2.48e-2)" "unprognostic (3.33e-1)" "unprognostic (1.66e-1)" 0.0 3.8 16.3 0.0 14.2 0.0 0.0 3.3 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 18.8 15.2 0.4 0.2 0.1 0.0 9.8 18.5 0.0 0.1 0.0 2.8 0.0 10.9 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.7 38.4 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 14.2 3.3 27.5 18.8 15.2 9.8 18.5 10.9 4.2 38.4 15.7 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 2.7 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.5 0.0 29.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732392-14778560 "CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 19.4" "Group enriched" "Detected in many" 4 "granulocytes: 47.9;Kupffer cells: 69.4;Macrophages: 73.2;monocytes: 49.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 70.0;eosinophil: 74.7;intermediate monocyte: 46.9;neutrophil: 55.7;non-classical monocyte: 89.9" "Group enriched" "Detected in many" 9 "granulocytes: 74.7;monocytes: 89.9" "Cell line enhanced" "Detected in many" "HEL: 11.8;HMC-1: 18.3;NB-4: 11.5;RPMI-8226: 8.4;U-937: 14.9" "Low region specificity" "Detected in many" HPA055200 Uncertain Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 4.9 1.5 1.0 19.4 1.3 6.9 1.8 1.2 2.1 0.9 1.3 1.4 1.9 0.7 0.7 0.9 0.9 2.5 0.5 1.0 1.5 2.1 2.0 4.2 3.0 2.5 1.6 0.1 0.8 1.1 0.5 1.6 2.2 1.1 1.9 0.6 1.0 2.8 0.6 2.0 2.3 1.6 1.1 15.6 1.5 0.4 1.8 2.4 0.6 0.9 2.2 5.4 0.9 2.4 0.3 1.2 0.1 0.2 0.0 0.3 1.2 0.9 1.3 0.0 0.0 0.2 0.2 0.1 0.1 0.7 2.3 1.9 0.3 0.1 0.0 0.2 0.2 11.8 3.8 0.2 0.5 4.3 18.3 0.9 1.6 4.1 0.6 0.1 0.1 1.0 2.7 0.4 1.3 0.5 1.5 11.5 0.4 0.8 0.2 0.1 1.5 8.4 0.0 0.3 0.0 0.2 2.4 2.0 0.4 0.2 0.3 5.4 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.2 1.1 14.9 0.6 70.0 13.9 74.7 0.2 46.9 0.2 0.2 0.2 0.1 9.3 0.3 0.1 0.2 55.7 3.3 89.9 1.9 0.1 7.3 1.0 1.3 1.2 2.1 1.0 1.5 2.5 1.6 2.2 1.1 1.8 2.4 0.6 3.2 7.7 0.7 1.9 0.0 4.8 0.0 0.6 0.8 1.6 1.5 0.8 0.0 2.5 0.0 0.0 0.2 12.8 0.0 0.0 0.0 2.0 0.7 3.5 1.8 1.2 3.8 0.9 0.0 0.5 1.9 1.1 0.9 47.9 0.1 0.7 0.5 12.8 0.0 1.2 0.1 0.0 69.4 0.0 2.5 0.0 73.2 0.0 0.0 49.2 0.0 2.1 0.5 12.0 0.0 0.2 0.4 2.1 2.4 0.1 0.1 2.2 0.9 0.0 2.0 1.5 0.3 0.5 0.6 0.0 0.4 3.0 0.1 0.1 3.0 ADGRF2 "GPR111, hGPCR35, PGR20" ENSG00000164393 "Adhesion G protein-coupled receptor F2" Q8IZF7 6 47656436-47697797 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 1.0;skin 1: 2.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Early spermatids: 1.0;Endometrial ciliated cells: 1.6;Excitatory neurons: 1.2;Glandular and luminal cells: 1.3;Squamous epithelial cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035507 Uncertain NA NA "Cluster 31: Skin - Epidermis development" "Cluster 44: Endometrium - Transcription" "HPA035507: AB_10601809" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.74e-2)" "unprognostic (5.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (2.51e-4)" "unprognostic (3.05e-2)" "unprognostic (3.86e-2)" "unprognostic (1.20e-1)" "unprognostic (2.24e-1)" "unprognostic (7.99e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.6 0.1 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 ADGRV1 "DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1" ENSG00000164199 "Adhesion G protein-coupled receptor V1" Q8WXG9 5 90529344-91164437 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Hydrolase, Receptor, Transducer" "Deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "adrenal gland: 533.0" "Cell type enriched" "Detected in many" 8 "Astrocytes: 2207.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 15.5;HAP1: 23.0;K-562: 9.8;NTERA-2: 11.6;SCLC-21H: 11.1;SuSa: 15.0;U-266/70: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067503 Approved Approved "Lipid droplets" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Lipid droplets" "HPA067503: AB_2685856" "unprognostic (1.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.69e-2)" "unprognostic (1.38e-1)" "unprognostic (4.01e-2)" "unprognostic (2.61e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-3)" "unprognostic (1.48e-2)" "unprognostic (1.87e-1)" "unprognostic (3.95e-3)" "unprognostic (7.50e-3)" "unprognostic (9.73e-7)" "unprognostic (1.87e-2)" "unprognostic (5.24e-2)" "unprognostic (3.48e-2)" "unprognostic (7.14e-2)" 0.0 533.0 36.9 0.0 47.8 0.6 3.6 12.7 40.3 0.9 22.4 1.0 0.3 0.1 0.7 2.4 0.2 12.3 0.2 39.1 11.6 21.5 42.3 2.1 0.0 9.4 12.8 0.2 1.5 0.8 15.1 4.1 9.4 1.3 1.0 18.2 2.3 0.2 0.2 2.1 0.5 0.0 7.3 0.3 1.1 1.4 18.3 0.8 17.5 0.0 0.4 10.4 1.9 26.1 0.5 2.1 15.5 0.0 0.0 0.1 0.2 0.3 0.1 0.0 0.0 1.7 0.2 0.3 0.4 0.0 0.4 0.2 23.0 0.2 0.0 1.0 4.3 4.1 2.0 1.4 0.0 0.3 0.1 0.0 4.8 0.0 0.1 0.1 0.0 0.1 9.8 2.6 0.0 2.1 0.1 0.2 11.6 2.9 4.2 0.0 0.4 2.1 0.0 0.5 11.1 2.7 3.4 2.2 0.2 15.0 5.9 0.0 0.8 0.4 1.9 0.5 1.1 13.4 4.1 0.6 0.7 0.2 0.0 3.2 0.9 2.8 1.0 0.7 1.7 1.5 1.1 1.4 0.5 2.9 1.7 0.9 4.6 1.1 0.5 1.2 1.6 0.2 36.9 47.8 12.7 40.3 39.1 11.6 9.4 12.8 9.4 7.3 18.3 26.1 0.4 25.6 26.5 2207.3 0.0 0.0 6.1 0.0 1.8 28.0 15.5 7.4 2.4 2.8 5.6 5.5 264.8 3.0 0.4 0.6 1.9 1.9 43.5 3.3 0.3 1.1 7.3 0.0 54.0 4.2 2.6 1.1 4.6 1.9 0.0 6.7 0.0 12.4 0.2 10.1 21.9 0.4 0.0 0.8 0.0 54.8 0.6 0.5 0.0 51.5 1.2 8.9 1.0 40.2 7.4 1.7 1.2 0.4 0.1 2.1 0.1 24.2 7.3 84.4 0.0 0.3 0.4 3.6 4.5 2.9 0.0 4.1 0.6 0.2 1.2 9.0 ADH7 ADH-4 ENSG00000196344 "Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide" P40394 4 99412261-99435737 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 196.3" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 89.0;Club cells: 64.1;Squamous epithelial cells: 209.1" "Cancer enhanced" "Detected in some" "cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC TERT1: 1.0;HaCaT: 1.2" "Not detected" "Not detected" HPA039695 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Plasma membrane, Cytosol" "HPA039695: AB_10795681" "unprognostic (1.02e-2)" "unprognostic (8.64e-2)" "unprognostic (4.86e-2)" "unprognostic (5.66e-3)" "unprognostic (4.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 196.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.2 0.0 0.0 38.1 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 89.0 21.1 0.0 0.0 0.0 0.2 0.0 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 7.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 18.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.6 0.0 0.0 26.2 0.0 0.0 0.0 2.3 0.0 0.0 209.1 0.0 0.0 0.0 0.0 0.0 1.0 AGBL2 "CCP2, FLJ23598" ENSG00000165923 "ATP/GTP binding protein like 2" Q5U5Z8 11 47659591-47715389 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.7;testis: 12.5" "Cell type enhanced" "Detected in many" "Early spermatids: 37.5;Endometrial ciliated cells: 25.7;Respiratory ciliated cells: 77.2;Spermatocytes: 19.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.3;T-47d: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007718 Uncertain NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA007718: AB_1078110" "unprognostic (3.44e-5)" "unprognostic (1.16e-1)" "unprognostic (5.84e-2)" "unprognostic (5.33e-4)" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (9.83e-3)" "unprognostic (4.11e-2)" "unprognostic (5.56e-2)" "unprognostic (1.79e-1)" "unprognostic (8.24e-6)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (9.62e-2)" "unprognostic (1.17e-3)" 0.3 1.3 0.3 0.4 0.2 0.2 0.5 0.7 0.3 1.4 2.6 0.8 0.3 0.6 1.1 0.4 7.7 0.2 0.2 0.3 0.4 1.6 3.0 1.6 0.5 1.2 1.8 1.3 0.8 0.3 1.7 0.2 0.8 1.2 0.2 0.3 0.5 0.4 0.0 0.4 1.2 0.1 1.0 0.9 0.6 12.5 0.2 0.7 1.5 0.0 0.4 1.1 0.6 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.3 0.2 0.6 0.2 2.3 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.3 0.7 0.1 0.1 1.1 0.8 0.3 0.0 0.3 0.6 0.2 0.3 0.2 0.2 0.0 0.8 0.1 0.5 0.3 0.9 0.5 0.2 0.0 0.1 0.0 0.6 0.0 0.2 0.3 1.0 0.8 0.1 0.2 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.3 0.0 0.5 0.4 0.4 0.1 0.3 0.0 0.3 0.5 0.1 0.3 0.2 0.7 0.3 0.3 0.4 1.2 1.8 0.8 1.0 0.2 0.4 0.1 0.0 2.7 2.6 1.3 0.1 1.3 2.6 2.2 0.1 0.9 0.6 0.6 0.0 6.5 7.3 0.0 0.4 0.5 0.7 0.0 0.4 37.5 25.7 1.3 0.1 1.2 0.8 0.6 0.0 0.3 1.2 1.5 0.9 0.0 0.8 0.4 0.8 0.1 0.0 0.6 0.5 2.0 0.6 0.0 8.2 0.3 0.3 0.0 1.0 1.0 0.7 0.0 1.0 0.5 0.3 0.6 1.5 0.4 0.4 2.4 0.2 77.2 0.5 0.0 0.3 1.1 19.3 1.8 0.6 0.0 0.4 1.3 1.3 0.9 0.5 AGBL4 "CCP6, FLJ14442" ENSG00000186094 "ATP/GTP binding protein like 4" Q5VU57 1 48532854-50023954 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.4;retina: 5.9" "Group enriched" "Detected in some" 5 "Excitatory neurons: 1232.8;Inhibitory neurons: 630.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 5.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.1;SCLC-21H: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037994 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA037994: AB_10673036" "unprognostic (3.06e-2)" "unprognostic (2.76e-1)" "unprognostic (2.58e-2)" "unprognostic (3.31e-4)" "unprognostic (3.42e-4)" "unprognostic (1.72e-1)" "unprognostic (3.86e-3)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (5.85e-3)" "unprognostic (3.91e-2)" "unprognostic (1.51e-4)" "unprognostic (5.95e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.85e-1)" 0.4 1.5 2.0 0.1 2.4 0.2 0.4 0.0 5.4 0.2 2.3 0.1 0.0 0.2 0.8 0.1 2.8 0.1 1.4 2.0 0.0 3.9 1.6 0.4 0.1 0.0 0.5 0.3 0.8 2.4 2.4 0.9 0.2 0.1 0.1 5.9 0.1 0.3 0.1 0.3 0.1 0.0 0.0 0.3 0.2 2.4 0.1 0.4 1.1 0.1 0.1 0.0 0.1 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.0 2.4 0.0 5.4 2.0 0.0 0.0 0.5 0.2 0.0 0.1 0.8 0.2 0.0 0.0 166.2 0.0 0.3 1.0 0.3 0.0 4.0 0.4 1.1 2.2 0.0 0.9 3.7 85.5 0.2 0.0 0.4 1.9 0.1 12.6 10.7 0.1 0.4 6.0 0.0 1232.8 0.2 0.1 0.5 0.0 0.2 0.0 0.2 0.4 0.1 0.1 5.0 630.3 0.5 2.0 0.0 0.0 9.1 0.3 0.0 0.0 40.3 0.0 2.4 0.0 142.2 19.2 0.0 0.1 0.7 0.0 0.3 0.0 4.4 10.5 22.6 0.0 0.7 0.3 19.9 10.4 0.0 0.0 0.1 0.0 0.4 0.1 0.2 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184322 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lung: 728.3" "Cell type enriched" "Detected in many" 22 "Alveolar cells type 1: 2394.2" "Cancer enhanced" "Detected in all" "lung cancer: 27.2;thyroid cancer: 20.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" NA NA 5360000 100000 "Cluster 19: Lung - Lung function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favorable (2.74e-6)" 2.2 1.7 0.1 1.1 0.1 0.5 1.6 0.1 0.4 4.4 0.2 3.9 0.6 2.5 1.9 2.1 4.5 0.1 2.7 0.2 0.1 6.4 2.7 728.3 0.6 0.2 0.1 4.8 1.7 0.0 5.0 0.4 0.2 4.9 0.8 0.4 1.6 0.0 1.0 2.0 3.2 0.1 0.1 7.0 2.0 2.2 0.2 0.8 39.2 0.1 0.5 2.9 3.2 0.3 0.1 0.0 0.0 0.3 0.1 0.9 1.5 0.0 0.1 0.0 0.1 0.0 0.2 0.1 1.0 0.2 0.0 1.0 0.1 0.3 0.2 0.2 2.5 0.7 0.0 0.0 0.0 0.3 1.1 0.0 0.1 0.0 0.1 0.2 0.1 3.0 0.0 0.3 0.1 1.3 0.1 0.9 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.5 0.0 0.1 0.0 0.6 0.8 0.1 2.4 2.0 0.9 1.1 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.3 5.4 2394.2 107.9 5.9 4.9 0.9 1.5 2.0 2.8 5.1 1.5 2.9 3.0 4.3 20.9 1.8 0.0 1.1 2.7 1.1 0.0 1.5 0.4 1.1 2.6 4.1 0.0 4.4 0.5 1.0 0.9 3.0 1.5 1.9 17.7 3.1 2.9 2.0 1.3 6.7 0.6 1.3 0.0 5.3 6.5 1.2 1.8 5.3 1.8 4.7 4.8 4.6 2.1 2.5 1.3 1.1 2.7 1.2 3.3 2.6 0.8 0.3 5.6 3.4 6.6 1.2 2.6 0.1 1.2 1.6 1.8 2.2 6.2 1.7 1.2 0.9 AK7 "CFAP75, FAP75, FLJ32864" ENSG00000140057 "Adenylate kinase 7" Q96M32 14 96392128-96489427 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.3" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 97.9;Respiratory ciliated cells: 137.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "basophil: 9.0" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "BEWO: 17.0;CAPAN-2: 15.1;MCF7: 49.5;REH: 35.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003543 Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA003543: AB_1078117" "unprognostic (4.18e-3)" "unprognostic (1.14e-1)" "unprognostic (9.40e-3)" "prognostic favorable (3.18e-4)" "unprognostic (4.98e-5)" "unprognostic (8.41e-2)" "unprognostic (9.81e-3)" "unprognostic (1.29e-1)" "unprognostic (9.02e-2)" "unprognostic (3.65e-4)" "unprognostic (8.64e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.00e-2)" "unprognostic (1.23e-2)" "unprognostic (4.01e-2)" "unprognostic (2.25e-3)" 0.7 2.6 2.0 0.6 3.1 1.5 1.4 1.1 1.7 1.7 13.2 2.1 1.9 2.1 3.9 1.5 24.3 2.6 0.7 2.2 5.2 4.5 1.6 4.2 0.6 6.9 9.4 0.4 2.2 6.9 5.1 0.5 5.6 0.9 1.6 3.0 1.0 1.3 0.3 6.1 1.2 1.1 4.4 3.3 2.8 7.6 5.0 0.5 2.7 0.0 0.4 0.5 1.0 4.2 0.2 4.9 2.0 1.5 0.8 2.6 17.0 0.3 0.6 0.3 0.3 0.5 15.1 0.4 0.3 0.0 0.3 1.9 4.7 0.2 0.1 2.2 0.4 0.4 2.4 0.2 0.8 0.1 0.3 0.2 0.6 2.5 0.1 0.8 0.2 1.4 0.2 0.3 0.3 49.5 0.3 0.3 0.8 2.2 1.0 35.2 0.3 0.4 7.6 0.3 3.1 6.7 1.9 0.6 0.1 1.8 4.2 0.2 0.1 0.4 0.2 0.6 0.2 0.6 2.3 0.2 0.2 0.0 0.7 9.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.1 2.0 3.1 1.1 1.7 2.2 5.2 6.9 9.4 5.6 4.4 5.0 4.2 1.6 6.4 4.1 0.7 0.8 1.8 0.9 3.6 1.8 0.2 0.9 0.3 0.4 4.3 12.3 7.3 2.1 0.7 0.1 1.4 3.9 3.2 18.7 97.9 1.7 1.9 1.2 6.9 2.0 1.1 1.7 0.8 5.1 11.6 0.0 0.1 0.7 2.4 0.2 0.0 2.4 0.3 4.1 0.3 0.4 4.1 0.0 0.5 1.8 0.0 0.0 0.6 0.0 0.5 3.7 0.5 0.1 0.0 0.0 0.5 1.0 3.4 137.1 1.8 0.0 0.4 1.6 25.4 9.1 0.7 3.0 2.9 0.2 1.5 1.2 0.6 AK8 "C9orf98, FLJ32704" ENSG00000165695 "Adenylate kinase 8" Q96MA6 9 132725578-132878777 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 19.3;fallopian tube: 25.8;testis: 15.9" "Cell type enhanced" "Detected in many" "Early spermatids: 102.3;Endometrial ciliated cells: 26.1;Late spermatids: 134.1;monocytes: 49.2;Respiratory ciliated cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 30 "memory B-cell: 6.2;naive B-cell: 4.9;NK-cell: 3.1" "Group enriched" "Detected in many" 30 "B-cells: 6.2;NK-cells: 3.1" "Cell line enhanced" "Detected in some" "MCF7: 3.1;RPTEC TERT1: 3.6;T-47d: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021443, HPA023894" Enhanced NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 3: Monocytes - Immune response regulation" "HPA021443: AB_1845852, HPA023894: AB_1845854" "unprognostic (4.14e-2)" "unprognostic (1.20e-4)" "unprognostic (1.31e-2)" "unprognostic (1.70e-3)" "unprognostic (2.16e-1)" "unprognostic (2.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.18e-1)" "unprognostic (3.43e-1)" "unprognostic (1.71e-1)" "unprognostic (7.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.61e-4)" "unprognostic (9.89e-2)" "unprognostic (3.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.43e-1)" 0.7 1.2 2.2 0.5 2.5 0.1 1.0 1.7 2.3 2.5 5.6 0.5 0.0 1.3 19.3 0.9 25.8 1.3 0.2 2.5 3.1 2.3 0.1 2.1 0.6 4.2 6.8 1.6 0.7 3.1 1.8 0.4 4.5 0.9 0.3 2.7 1.7 2.7 0.0 1.6 0.1 0.7 3.7 0.1 0.8 15.9 3.3 1.5 4.7 0.2 4.3 0.5 0.5 2.5 1.1 0.7 0.3 1.6 0.2 0.4 0.3 0.1 0.1 0.1 0.0 0.3 1.2 0.0 0.3 0.2 0.3 0.2 0.3 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.7 0.0 0.0 1.0 0.5 0.3 0.4 0.4 0.0 0.8 0.0 0.0 0.3 3.1 0.7 0.3 0.1 0.4 0.5 0.0 0.0 0.0 3.6 0.0 0.6 0.6 1.5 0.0 0.2 0.3 2.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 4.9 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.1 2.2 2.5 1.7 2.3 2.5 3.1 4.2 6.8 4.5 3.7 3.3 2.5 0.2 3.2 1.7 9.4 1.5 0.5 0.5 3.9 0.6 0.3 0.8 0.5 1.2 0.0 3.4 3.7 0.0 0.4 0.1 0.3 0.0 2.8 102.3 26.1 1.1 1.1 0.0 0.4 4.9 0.5 0.3 0.8 0.0 1.3 0.0 0.4 0.7 0.0 1.7 0.0 5.1 0.9 2.0 0.3 0.3 134.1 6.2 1.8 1.8 0.0 49.2 0.8 0.0 4.5 5.0 1.2 0.3 4.1 0.0 0.6 0.0 6.0 36.7 1.8 0.0 0.8 2.7 24.3 5.6 0.4 1.6 0.4 0.2 1.0 0.5 0.7 AK9 "AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954" ENSG00000155085 "Adenylate kinase 9" Q5TCS8 6 109492856-109691217 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.6" "HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear membrane" "HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265" "unprognostic (9.68e-3)" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (2.36e-2)" "unprognostic (3.42e-1)" "unprognostic (7.28e-2)" "unprognostic (1.41e-3)" "unprognostic (6.76e-3)" "unprognostic (1.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-4)" "unprognostic (2.58e-1)" "unprognostic (2.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (8.39e-2)" "unprognostic (5.56e-2)" 3.5 3.1 8.1 3.3 9.9 3.7 4.8 13.5 17.2 3.5 10.9 4.6 3.6 4.3 7.6 4.3 7.9 3.5 4.9 6.4 11.0 5.3 3.1 4.1 4.2 8.8 10.7 3.6 3.4 9.2 7.7 3.1 9.5 3.9 4.5 14.1 5.1 3.9 4.8 3.9 3.6 3.9 10.7 4.0 4.5 16.6 8.7 7.6 6.9 3.5 3.6 3.4 3.2 13.4 2.3 1.6 6.6 11.5 6.1 3.7 4.8 3.5 4.3 3.6 4.9 2.6 4.6 4.9 1.7 3.4 7.9 3.7 1.9 3.9 7.6 10.2 4.0 3.8 3.8 2.6 4.8 4.4 2.3 3.1 7.3 6.6 8.6 8.8 4.2 7.2 3.6 4.0 2.7 4.7 4.1 3.2 1.5 5.1 2.5 5.5 3.7 4.7 5.0 4.3 7.8 6.4 4.2 3.9 5.9 3.7 5.1 5.8 5.2 3.1 2.2 5.1 2.3 2.0 1.8 2.8 6.8 5.9 2.0 17.1 2.8 7.1 5.1 1.5 4.4 13.1 4.9 6.2 2.1 10.8 6.2 5.4 5.6 5.6 4.8 3.1 3.9 1.6 8.1 9.9 13.5 17.2 6.4 11.0 8.8 10.7 9.5 10.7 8.7 13.4 13.3 28.9 17.2 21.2 13.6 2.7 7.7 14.7 3.4 18.3 10.4 6.7 18.9 5.7 19.9 9.2 14.6 3.4 8.6 13.1 0.0 9.1 70.9 76.3 5.4 10.0 19.8 4.2 34.8 4.5 1.5 6.0 12.2 7.3 22.1 10.6 8.9 2.1 3.6 20.2 37.0 15.5 14.2 5.3 3.9 41.7 7.5 5.6 5.4 25.3 5.0 12.6 18.6 22.6 46.9 7.4 8.9 6.4 5.5 5.6 22.9 6.8 152.0 50.7 26.3 9.1 6.9 174.3 34.1 4.0 2.6 5.6 10.3 4.7 11.4 7.9 AKAP14 AKAP28 ENSG00000186471 "A-kinase anchoring protein 14" Q86UN6 X 119895837-119920716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 44.0;testis: 83.9" "Group enriched" "Detected in some" 4 "Early spermatids: 485.6;Late spermatids: 1648.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.6;SCLC-21H: 2.4;SuSa: 1.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA060999 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 31: Spermatids - Spermatogenesis" "HPA060999: AB_2684407" "unprognostic (1.36e-2)" "unprognostic (2.36e-2)" "unprognostic (2.82e-2)" "unprognostic (1.25e-3)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (4.16e-1)" "unprognostic (4.68e-2)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (2.72e-1)" "unprognostic (3.73e-2)" "unprognostic (3.17e-1)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" 0.0 0.0 1.0 0.0 1.0 0.2 0.1 1.0 0.8 1.2 16.1 0.1 0.3 0.7 0.1 0.0 44.0 0.0 0.0 1.4 2.2 0.0 0.1 3.2 0.0 3.4 3.7 0.1 0.0 0.0 0.7 0.0 2.5 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.4 0.0 1.4 0.0 0.0 83.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 1.0 0.8 1.4 2.2 3.4 3.7 2.5 1.4 3.7 1.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 18.7 0.0 0.5 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 485.6 133.5 1.1 0.3 0.0 0.0 0.6 0.0 0.3 0.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 22.4 0.0 0.0 1648.3 2.5 0.8 0.0 1.0 0.0 0.2 0.0 1.5 0.2 0.0 0.1 7.2 0.0 0.0 0.1 0.1 224.1 0.1 13.1 0.0 4.9 14.0 2.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 496.1;salivary gland: 128.0;stomach 1: 224.8" "Group enriched" "Detected in many" 4 "Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.4;lung cancer: 60.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "A549: 5094.7;OE19: 6071.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No 52000 "Cluster 22: NK-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 61: Squamous epithelial cells - Keratinization" "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122" "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favorable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 1.7 1.0 0.4 1.3 0.7 0.1 3.2 0.3 0.4 6.7 17.5 4.5 6.2 0.3 0.2 496.1 5.5 10.3 0.3 1.0 0.4 1.3 1.9 10.9 0.5 0.6 2.1 0.4 0.5 0.0 0.9 0.0 0.5 1.9 3.3 0.1 128.0 1.5 1.3 72.6 3.5 0.4 0.9 0.9 224.8 1.6 1.3 0.6 0.5 0.3 33.7 6.2 22.3 0.9 0.1 5094.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 10.7 246.5 0.0 2.7 0.5 2.0 29.3 0.7 12.8 0.0 0.0 0.8 0.1 116.6 1.0 0.3 0.1 0.5 0.0 14.9 0.5 0.4 0.2 0.5 0.0 0.0 0.0 0.0 9.7 0.1 0.3 0.4 6071.6 19.8 0.0 0.0 0.0 0.0 87.0 0.2 0.6 24.8 0.0 0.0 0.2 0.2 0.9 0.6 0.3 0.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.7 0.3 0.4 1.0 0.4 0.6 2.1 0.5 0.9 1.3 0.9 0.7 3.2 5.5 0.0 0.7 44.1 46.8 389.5 274.3 0.0 0.1 1.5 0.4 2.8 150.1 0.0 0.0 0.0 0.0 5.1 0.0 1.4 1.5 12.4 0.2 1.3 1.8 0.0 0.1 0.5 0.0 1.6 437.9 0.8 2.5 0.3 1.4 3.2 0.2 0.0 0.0 4.8 83.4 0.3 1.8 5.2 0.9 1.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 9.5 4.7 1.9 3.2 5.8 3.4 5.0 412.7 0.2 0.0 1.7 20.1 1.7 8.6 342.2 32.0 0.0 0.5 0.2 8.4 64.3 ALG1L ALG1L1 ENSG00000189366 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like" Q6GMV1 3 125929275-125937039 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 10.8;urinary bladder: 9.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 33.6;Club cells: 15.2;Endometrial ciliated cells: 10.5;Ionocytes: 12.2;Respiratory ciliated cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 15.9;CAPAN-2: 14.3;HaCaT: 15.2;MCF7: 30.1;OE19: 19.1;T-47d: 19.7" HPA036108 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA036108: AB_10673344" "unprognostic (7.06e-3)" "unprognostic (1.50e-3)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.40e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-1)" "unprognostic (4.37e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-6)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "prognostic favorable (6.24e-4)" 0.5 1.1 2.5 1.1 2.7 0.3 1.4 2.0 3.0 1.6 1.4 1.4 0.4 1.4 10.8 1.6 2.2 0.8 0.7 2.4 2.6 1.7 1.4 1.0 0.4 2.5 2.4 2.3 1.3 0.6 1.8 1.5 2.5 1.8 0.8 0.6 1.9 0.9 6.7 5.8 0.5 0.5 2.1 0.3 1.5 1.2 2.4 1.1 1.6 2.6 2.7 9.4 1.5 2.5 1.1 0.8 0.4 0.0 0.0 0.2 1.8 0.1 0.0 0.2 0.4 15.9 14.3 4.4 6.8 0.0 0.3 15.2 0.4 0.0 0.8 0.6 3.6 0.8 2.4 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0 4.1 1.2 1.4 0.0 30.1 1.0 0.3 6.4 19.1 3.8 0.1 0.1 7.4 0.0 0.9 2.4 0.9 0.5 0.2 0.7 3.2 19.7 0.4 0.3 0.2 2.2 0.2 0.1 10.9 1.7 5.9 0.2 0.0 1.0 2.5 0.0 0.1 2.0 0.1 1.1 1.6 1.0 2.2 0.0 0.9 1.2 0.7 0.4 3.2 0.0 1.3 2.7 0.9 2.5 2.7 2.0 3.0 2.4 2.6 2.5 2.4 2.5 2.1 2.4 2.5 0.2 0.0 0.5 0.3 0.7 3.3 1.7 33.6 0.6 0.3 2.1 2.4 0.0 0.0 15.2 1.8 0.0 3.5 0.5 0.3 1.9 0.4 1.7 10.5 0.8 0.3 1.8 0.0 1.2 0.4 2.0 1.1 0.0 0.4 1.3 1.4 0.0 0.1 0.3 0.0 1.7 0.2 12.2 0.0 1.2 1.8 1.8 0.1 1.8 0.0 0.2 1.5 2.1 1.0 0.6 0.6 1.4 3.0 0.4 0.5 0.0 1.0 46.0 0.0 0.0 2.7 2.6 1.4 1.6 0.3 5.1 1.4 0.5 2.4 0.4 8.2 ALOX15 15-LOX-1 ENSG00000161905 "Arachidonate 15-lipoxygenase" P16050 17 4630919-4642294 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.2;fallopian tube: 12.7" "Group enriched" "Detected in some" 5 "Club cells: 60.3;Langerhans cells: 72.2;Respiratory ciliated cells: 191.8" "Cancer enhanced" "Detected in many" "cervical cancer: 6.6" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 193 "eosinophil: 602.9" "Lineage enriched" "Detected in many" 193 "granulocytes: 602.9" "Group enriched" "Detected in some" 7 "HMC-1: 15.9;MCF7: 14.7;T-47d: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004962, CAB004963, HPA013859" Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB004962: , CAB004963: , HPA013859: AB_1844758" "unprognostic (5.31e-4)" "unprognostic (1.43e-2)" "unprognostic (2.81e-2)" "unprognostic (8.36e-3)" "unprognostic (2.22e-1)" "unprognostic (8.60e-2)" "unprognostic (2.36e-1)" "unprognostic (2.66e-2)" "unprognostic (1.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.31e-3)" "unprognostic (1.88e-2)" "unprognostic (1.30e-1)" "unprognostic (2.78e-1)" "unprognostic (1.59e-1)" 37.2 0.0 0.6 1.6 2.0 0.5 3.2 0.0 1.3 0.5 0.0 1.6 1.9 0.0 0.4 0.8 12.7 0.6 2.9 0.5 0.5 0.0 0.1 6.6 1.9 0.3 0.2 0.1 0.0 0.0 3.0 0.1 0.3 0.2 1.0 0.0 0.2 0.3 0.0 2.2 3.3 0.6 0.1 1.4 1.0 1.8 0.4 0.8 0.0 0.0 0.6 1.1 0.1 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 14.7 0.0 0.3 1.1 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 602.9 0.0 0.2 0.2 0.1 0.0 0.1 3.1 0.2 0.0 0.1 0.9 0.0 0.1 2.7 0.1 0.4 0.6 2.0 0.0 1.3 0.5 0.5 0.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 1.1 0.0 0.2 1.5 0.0 13.0 0.0 0.0 1.1 0.1 0.9 11.5 60.3 0.0 0.0 1.8 1.3 0.0 0.0 0.0 19.2 3.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 3.6 0.0 0.1 1.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 72.2 2.5 0.0 0.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 191.8 0.0 0.0 0.1 3.9 1.2 1.2 0.0 0.9 7.4 0.3 0.0 0.0 0.3 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280220-85301784 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 3.9;kidney: 6.1" "Cell type enriched" "Detected in some" 5 "Melanocytes: 32.0" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.3 1.0 0.4 0.0 0.0 0.7 3.9 0.0 2.3 0.0 0.0 0.2 0.3 6.1 0.0 0.0 0.0 0.2 0.2 1.6 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.2 1.9 0.9 0.0 1.6 0.0 0.3 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.8 0.0 0.4 0.3 0.2 0.0 6.0 0.0 0.0 0.7 0.7 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 3.6 0.0 10.4 0.5 0.0 0.0 23.3 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 9.3 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 2.7 5.8 0.0 0.0 29.5 4.1 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 2.2 0.2 1.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.3;cervix: 9.2;fallopian tube: 5.3" "Cell type enhanced" "Detected in some" "Astrocytes: 138.4;Excitatory neurons: 27.2;Inhibitory neurons: 86.6;Oligodendrocyte precursor cells: 70.9;Respiratory ciliated cells: 31.0" "Cancer enhanced" "Detected in some" "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 6.8;MOLT-4: 15.4;T-47d: 5.0;U-2197: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 0.7 0.2 5.3 0.0 3.6 0.0 0.3 3.6 1.8 9.2 0.6 0.1 0.1 0.1 0.9 0.2 5.3 0.2 0.0 3.1 8.4 0.1 0.0 0.7 0.0 7.5 11.3 0.0 0.0 0.0 0.3 0.8 6.2 0.2 0.1 0.2 0.2 0.1 0.0 2.2 0.1 0.0 7.7 0.0 0.3 1.7 9.7 0.6 0.1 0.0 0.0 1.0 0.9 3.0 0.0 0.0 0.1 0.0 1.1 0.1 0.3 0.0 2.5 0.1 0.2 0.0 0.0 0.2 0.2 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.1 0.4 15.4 0.0 0.0 0.8 0.6 0.1 0.0 0.0 0.0 0.0 1.0 0.0 1.5 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.3 4.8 0.0 1.3 0.2 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.6 3.6 1.8 3.1 8.4 7.5 11.3 6.2 7.7 9.7 3.0 0.0 0.0 1.1 138.4 0.0 0.5 0.1 0.6 0.0 0.0 0.3 0.1 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 18.7 16.9 1.2 0.3 0.0 0.0 27.2 0.0 0.9 1.1 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 86.6 2.4 0.0 0.0 0.7 8.6 0.6 0.0 1.8 11.2 0.0 0.3 0.0 70.9 3.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 31.0 0.1 6.6 0.0 0.5 6.4 2.7 0.0 0.4 2.9 0.0 0.0 0.1 1.4 ANKK1 X-kinase ENSG00000170209 "Ankyrin repeat and kinase domain containing 1" Q8NFD2 11 113387779-113400416 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 3.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 7.2;Club cells: 2.4;Ionocytes: 6.1;Respiratory ciliated cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.1;RT4: 1.0" "Not detected" "Not detected" HPA012813 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA012813: AB_1844832" "unprognostic (5.63e-3)" "unprognostic (6.67e-3)" "unprognostic (5.09e-3)" "unprognostic (6.27e-3)" "unprognostic (5.56e-4)" "unprognostic (7.02e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.50e-1)" "unprognostic (3.15e-1)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (5.39e-6)" "unprognostic (3.17e-2)" "unprognostic (3.83e-2)" "unprognostic (2.79e-1)" "unprognostic (4.65e-2)" 0.2 0.5 0.6 0.2 2.7 0.1 0.7 0.5 1.0 1.1 2.0 0.3 0.1 0.4 0.3 0.5 2.0 0.0 0.1 0.4 0.7 0.4 0.3 0.6 0.4 1.0 3.1 0.7 0.3 0.1 3.0 0.0 0.7 1.5 0.0 0.6 1.3 0.3 0.3 3.5 0.6 0.0 0.7 0.8 0.2 1.0 1.1 0.1 0.7 0.0 0.2 0.4 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.5 1.0 0.4 0.7 1.0 3.1 0.7 0.7 1.1 0.7 0.2 0.0 0.5 1.6 0.2 0.6 0.8 7.2 0.0 1.2 0.3 1.1 0.4 0.0 2.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 1.9 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.7 0.2 0.2 6.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.5 1.1 0.0 1.1 0.0 0.0 0.5 0.0 0.0 6.0 0.9 0.0 1.3 0.4 0.1 0.1 0.0 0.6 0.0 0.5 0.2 0.0 0.5 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.9" "Cell type enhanced" "Detected in many" "Early spermatids: 187.5;Late spermatids: 213.1;Respiratory ciliated cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.20e-4)" 4.9 4.4 6.4 5.7 7.6 12.5 6.3 6.0 7.3 7.5 6.1 6.0 6.5 5.4 8.7 5.8 24.6 4.7 3.4 5.4 4.9 5.0 6.2 6.9 9.0 8.1 12.3 7.4 8.6 6.2 4.5 3.9 8.0 6.6 5.5 3.8 5.1 5.2 3.5 8.2 7.2 3.0 8.0 8.2 9.6 67.9 7.1 7.1 6.5 2.1 6.7 5.7 6.4 11.1 7.0 15.2 3.2 6.0 2.9 4.1 13.4 3.3 5.0 2.7 3.6 4.9 14.2 7.0 0.6 3.7 4.1 7.6 6.2 7.8 3.2 12.9 5.2 13.9 8.6 13.0 2.4 7.8 12.8 6.6 18.7 2.5 17.7 8.2 2.8 11.0 13.2 8.8 4.6 6.7 7.2 12.8 2.7 12.1 9.0 20.1 9.8 11.1 4.1 15.0 7.5 5.6 2.7 7.2 10.0 3.9 6.2 11.9 3.6 10.0 3.3 4.0 5.9 20.0 5.5 7.0 5.7 11.8 7.9 0.0 2.1 4.5 4.6 1.8 2.7 2.8 2.8 2.9 2.7 4.1 4.1 3.0 0.9 1.3 2.3 1.8 0.9 2.4 6.4 7.6 6.0 7.3 5.4 4.9 8.1 12.3 8.0 8.0 7.1 11.1 3.0 0.0 8.1 23.8 7.2 0.9 1.8 5.3 13.1 3.5 4.3 3.7 2.2 1.5 10.1 3.7 4.2 3.0 8.1 4.8 1.9 2.7 187.5 40.8 3.6 3.5 4.2 6.5 17.0 4.3 1.7 2.8 16.8 4.5 5.7 4.8 2.9 6.4 2.7 3.3 25.4 4.5 6.1 7.6 2.0 213.1 4.1 6.7 0.0 38.4 5.5 2.6 7.2 21.1 42.9 3.2 2.2 3.0 3.4 2.8 5.7 2.9 62.6 4.0 0.0 2.2 3.5 28.8 8.9 5.0 2.3 2.9 8.6 2.9 4.7 2.0 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 34.5;choroid plexus: 10.6" "Cell type enhanced" "Detected in many" "Early spermatids: 34.4;Excitatory neurons: 13.8;Muller glia cells: 22.3;Spermatocytes: 41.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 27.5" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Uncertain "Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 0.4 0.2 16.8 0.0 17.5 0.1 0.1 34.5 30.1 0.2 10.6 0.0 0.0 0.1 0.1 1.9 0.2 0.4 0.0 18.2 13.6 0.0 0.0 0.1 0.1 22.3 15.7 0.0 0.0 0.0 0.4 0.2 21.4 1.2 0.0 1.9 0.1 0.0 0.7 2.2 0.0 0.0 12.7 0.3 0.0 3.9 14.5 0.0 0.2 0.1 0.1 0.7 0.9 17.0 10.0 8.8 0.6 0.1 0.2 1.5 0.9 2.1 2.1 2.7 2.9 2.1 0.2 0.2 0.4 0.3 2.9 2.2 5.9 2.1 3.6 0.1 5.2 10.2 13.1 1.5 0.0 3.5 0.6 0.8 3.6 3.7 9.3 0.7 5.0 0.0 5.5 0.5 3.0 1.7 0.0 27.5 9.1 0.2 4.8 0.0 13.0 2.0 1.6 2.4 0.3 8.5 4.2 0.3 0.4 5.5 7.5 13.4 4.6 1.5 5.8 4.4 3.9 1.5 0.8 0.0 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 17.5 34.5 30.1 18.2 13.6 22.3 15.7 21.4 12.7 14.5 17.0 0.0 0.0 0.0 0.7 0.0 2.0 5.4 2.9 1.2 8.5 0.5 0.9 3.1 4.3 2.8 1.8 0.0 0.0 0.0 0.6 0.0 0.8 34.4 12.1 0.2 0.3 0.0 0.0 13.8 0.5 0.4 0.1 0.0 4.0 0.0 12.1 0.4 0.1 0.2 0.0 9.0 2.0 4.1 0.0 0.3 3.7 0.6 0.2 0.0 1.9 0.0 22.3 0.0 4.0 0.8 0.4 1.7 0.7 0.0 2.5 0.3 0.1 9.8 5.5 0.0 0.5 0.5 41.4 2.1 6.2 3.3 0.0 0.2 0.0 1.3 3.9 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 163.8;Alveolar cells type 1: 218.0;Cone photoreceptor cells: 66.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.7;BJ hTERT+: 16.6;hTCEpi: 16.2;PC-3: 15.5;U-2197: 20.5;U-87 MG: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favorable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favorable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favorable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 17.8 7.2 14.1 3.6 6.4 0.2 15.8 9.1 13.5 12.9 10.7 4.7 1.5 15.7 5.3 9.4 13.8 5.6 6.8 13.5 10.4 3.6 1.9 31.3 20.1 11.6 14.8 14.5 1.0 24.8 8.1 0.1 11.5 8.3 2.2 4.9 7.5 8.8 4.4 4.4 6.6 11.7 6.8 2.6 15.1 3.7 9.4 3.8 3.3 3.9 14.3 6.6 13.0 10.1 2.4 6.7 0.0 0.0 1.6 16.7 0.1 6.6 16.6 2.6 3.3 3.0 0.6 0.0 0.9 3.2 12.9 3.4 0.0 8.7 0.6 0.2 5.9 0.0 4.3 0.2 0.3 0.0 0.5 4.4 16.2 2.6 4.4 2.4 1.7 0.0 0.0 0.4 4.4 0.7 0.0 0.0 1.2 5.7 15.5 0.0 0.4 1.5 4.1 2.4 1.0 8.0 1.7 0.3 0.1 0.3 1.9 0.1 3.9 0.4 2.3 20.5 6.0 0.0 0.0 0.0 21.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 14.1 6.4 9.1 13.5 13.5 10.4 11.6 14.8 11.5 6.8 9.4 10.1 163.8 218.0 38.7 27.4 0.2 5.1 10.1 5.0 5.2 6.0 5.1 16.6 9.7 8.6 6.3 1.8 66.7 0.0 1.1 0.3 5.9 2.5 40.0 10.2 18.7 39.0 1.8 0.4 22.1 1.1 0.0 6.6 25.5 0.8 3.8 9.7 15.4 0.9 2.3 42.1 27.6 1.7 0.0 0.8 3.3 25.2 7.2 3.6 7.2 22.5 0.2 1.3 0.0 8.5 1.3 11.4 1.2 20.3 1.5 5.1 11.5 10.1 1.6 4.3 13.1 12.1 40.6 2.3 2.6 20.1 2.8 0.0 0.8 21.5 2.5 3.6 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173608336-173669851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 6.7;choroid plexus: 14.3;fallopian tube: 12.7;parathyroid gland: 9.3;testis: 11.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Early spermatids: 48.8;Endometrial ciliated cells: 23.7;Late spermatids: 16.8;Respiratory ciliated cells: 31.8;Spermatocytes: 54.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.5;BJ hTERT+: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;GAMG: 1.9;HBF TERT88: 1.9;SH-SY5Y: 5.7" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.2 0.6 2.8 0.0 5.4 0.2 0.1 1.9 2.5 1.3 14.3 0.2 0.0 1.6 0.7 0.0 12.7 0.3 0.4 4.3 2.8 1.3 0.0 1.2 0.0 5.2 6.7 0.7 0.3 9.3 1.8 0.0 3.9 0.8 0.1 2.6 0.0 0.3 0.2 0.0 0.0 1.1 3.3 0.4 0.1 11.0 3.8 0.2 0.5 0.0 0.0 0.1 0.1 4.0 0.0 0.0 5.5 0.0 0.0 0.3 0.1 0.0 2.0 1.7 2.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 5.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.8 5.4 1.9 2.5 4.3 2.8 5.2 6.7 3.9 3.3 3.8 4.0 0.2 0.0 1.7 12.4 0.0 0.3 0.3 1.1 0.0 0.7 0.1 0.4 0.9 0.0 1.5 5.5 37.5 0.2 0.0 0.3 1.9 0.6 48.8 23.7 1.3 1.3 0.0 0.0 4.6 0.5 0.3 0.4 0.0 0.6 0.0 1.1 3.3 0.0 0.1 0.0 4.1 0.0 6.1 0.0 0.0 16.8 1.8 0.2 0.0 2.8 0.0 3.3 0.0 0.5 3.2 0.1 0.0 0.4 0.0 0.2 0.0 0.4 31.8 1.7 0.0 0.1 0.8 54.9 7.9 0.0 0.0 0.1 0.0 5.5 0.4 0.1 ANKRD66 ENSG00000230062 "Ankyrin repeat domain 66" B4E2M5 6 46746917-46759506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "fallopian tube: 40.2" "Group enriched" "Detected in some" 8 "Endometrial ciliated cells: 104.2;Respiratory ciliated cells: 184.4" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.67e-3)" "unprognostic (2.52e-1)" "unprognostic (2.44e-2)" "unprognostic (2.03e-2)" "unprognostic (9.36e-2)" "unprognostic (4.30e-3)" "unprognostic (2.19e-1)" 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.4 0.2 0.8 0.8 0.0 0.0 0.7 0.0 0.0 40.2 0.0 0.0 0.8 1.4 0.0 0.0 3.2 0.0 4.5 5.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.4 0.2 0.8 1.4 4.5 5.1 3.4 3.1 0.9 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 8.5 0.0 0.0 0.0 0.0 0.1 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 184.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 ANKUB1 C3orf16 ENSG00000206199 "Ankyrin repeat and ubiquitin domain containing 1" A6NFN9 3 149761100-149968385 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.1;choroid plexus: 6.9;fallopian tube: 5.9" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 124.3;Respiratory ciliated cells: 118.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 7 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.5" "Cell line enhanced" "Detected in single" "OE19: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053749 Uncertain NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA053749: AB_2682248" "unprognostic (1.71e-2)" "unprognostic (1.89e-4)" "unprognostic (1.01e-1)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-1)" "unprognostic (2.42e-1)" "unprognostic (1.61e-2)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (2.18e-9)" "unprognostic (3.06e-1)" "unprognostic (2.96e-1)" "unprognostic (3.17e-1)" "unprognostic (7.07e-4)" 0.0 0.0 0.8 0.1 0.6 0.3 0.0 0.3 0.3 0.6 6.9 0.0 0.1 0.2 0.0 0.0 5.9 0.0 0.0 0.7 0.5 0.0 0.0 1.1 0.0 2.9 5.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 1.4 0.1 0.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.3 0.3 0.7 0.5 2.9 5.1 2.5 1.4 0.3 1.3 0.0 0.0 1.7 0.3 0.0 0.5 0.8 7.3 0.0 0.0 0.0 0.0 0.2 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 124.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 10.2 1.6 0.3 5.4 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 118.9 0.0 0.0 0.2 1.4 4.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.7 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389821-36453791 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 266.0" "Group enriched" "Detected in many" 5 "Early spermatids: 156.4;Oligodendrocytes: 441.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HBF TERT88: 655.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 70: Brain - Nervous system development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175" "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (5.97e-7)" "prognostic unfavorable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.2 0.7 59.8 5.2 134.5 36.4 2.0 125.1 72.7 1.8 18.4 6.0 4.4 1.8 0.2 10.4 0.9 2.1 0.8 59.3 83.6 0.4 1.2 1.4 6.7 162.3 106.5 0.9 0.6 0.2 0.2 8.9 160.2 0.9 8.0 0.3 1.7 0.4 0.3 13.6 4.3 14.9 99.2 1.2 4.8 12.4 102.3 16.0 0.8 0.3 9.5 3.2 3.2 266.0 476.1 96.5 79.3 61.0 10.7 26.9 85.6 292.5 169.3 344.4 256.0 66.4 142.7 23.9 82.1 148.6 182.8 237.0 63.4 170.7 655.4 16.1 46.0 32.7 104.8 55.8 1.7 47.3 36.7 6.0 7.7 225.3 147.2 40.8 109.3 31.2 69.6 48.8 284.4 71.0 40.0 54.8 88.5 71.9 102.3 29.1 238.2 15.9 76.5 76.5 33.5 39.5 154.1 175.8 26.1 109.6 119.0 53.6 104.5 214.2 239.0 127.6 346.6 20.1 34.2 43.2 72.9 74.9 460.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.3 59.8 134.5 125.1 72.7 59.3 83.6 162.3 106.5 160.2 99.2 102.3 266.0 0.4 0.0 1.1 2.3 1.0 14.1 1.9 8.3 7.4 0.0 1.9 2.0 0.6 0.0 3.2 0.0 0.0 13.8 1.1 2.8 0.0 0.7 156.4 18.9 3.2 1.9 0.0 35.3 3.4 0.2 23.2 6.9 10.2 12.8 0.0 15.4 1.1 0.5 9.8 0.0 5.7 3.4 6.1 1.6 5.9 53.3 1.2 2.7 0.0 0.0 0.0 0.0 0.0 1.5 441.3 0.6 0.1 0.0 8.8 1.6 0.8 0.3 10.4 0.0 0.0 0.4 5.2 20.0 17.7 27.1 9.2 2.9 2.6 1.7 6.0 3.3 ANXA13 ANX13 ENSG00000104537 "Annexin A13" P27216 8 123680794-123737402 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 144.3;intestine: 293.6" "Cell type enhanced" "Detected in some" "Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5" "Group enriched" "Detected in many" 13 "colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A549: 27.8;HDLM-2: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018535, HPA019569, HPA019650, CAB025135" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane" Nucleoplasm "CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856" "unprognostic (6.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" "unprognostic (5.66e-2)" "unprognostic (4.05e-2)" "unprognostic (5.48e-2)" "unprognostic (2.86e-3)" "unprognostic (2.06e-1)" "unprognostic (9.11e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.49e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (4.79e-2)" 0.2 0.0 1.1 1.6 2.6 0.0 0.4 2.6 2.2 0.4 1.1 21.6 293.6 1.5 2.2 0.2 58.4 144.3 0.1 1.1 1.5 7.0 20.2 0.2 0.2 4.1 2.9 0.4 0.4 0.0 0.0 0.0 3.3 0.5 36.1 4.3 0.1 24.3 0.0 0.1 219.5 2.9 3.3 0.0 0.8 4.2 2.1 0.1 0.0 0.0 0.0 0.5 0.1 5.3 0.0 27.8 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 14.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.0 0.0 1.7 1.6 0.0 0.1 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.6 2.6 2.2 1.1 1.5 4.1 2.9 3.3 3.3 2.1 5.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.2 0.1 1.1 0.4 180.1 0.0 0.0 0.0 0.0 0.0 6.2 3.9 1.4 1.1 4.5 3.6 0.2 44.9 2.7 0.9 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.2 0.0 1.0 161.1 0.0 0.0 0.0 1.4 1.2 0.3 0.0 0.0 0.0 0.3 0.0 0.5 1.2 0.1 58.1 0.0 0.0 0.0 125.2 27.6 2.9 10.9 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.4 0.1 38.5 0.1 ANXA3 ANX3 ENSG00000138772 "Annexin A3" P12429 4 78551747-78610451 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Phospholipase A2 inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 337.7" "Cell type enhanced" "Detected in many" "Adipocytes: 322.7;Alveolar cells type 1: 589.7;Ductal cells: 434.5;Exocrine glandular cells: 305.3;Pancreatic endocrine cells: 754.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 320 "neutrophil: 207.7" "Lineage enriched" "Detected in single" 327 "granulocytes: 207.7" "Cell line enhanced" "Detected in many" "A-431: 419.5;CACO-2: 403.5;CAPAN-2: 563.7;EFO-21: 334.7;hTERT-HME1: 566.3;OE19: 502.1;RPTEC TERT1: 477.8" "Low region specificity" "Detected in all" "HPA013398, HPA013431" Enhanced Supported "Plasma membrane" NA NA 6400000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane" "HPA013398: AB_1844861, HPA013431: AB_1844862" "unprognostic (2.66e-1)" "unprognostic (5.65e-3)" "unprognostic (4.92e-3)" "unprognostic (8.67e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-3)" "unprognostic (4.17e-2)" "unprognostic (1.87e-1)" "unprognostic (5.09e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (4.82e-2)" "prognostic favorable (8.48e-6)" "unprognostic (2.23e-1)" "unprognostic (2.02e-2)" "unprognostic (7.20e-2)" "unprognostic (3.30e-2)" 52.9 3.1 16.5 22.7 17.3 337.7 43.8 14.5 28.2 19.6 11.7 27.7 15.8 12.5 3.7 55.2 16.8 17.3 51.2 14.2 21.6 24.9 3.9 144.4 2.4 19.9 16.1 2.5 32.7 34.0 5.9 81.5 20.8 68.0 26.7 1.6 119.5 12.9 28.3 10.0 13.3 20.1 14.6 21.6 90.5 1.9 19.9 7.1 83.7 36.7 12.7 10.2 15.6 14.7 419.5 77.7 1.3 0.9 1.0 0.9 0.6 4.9 0.4 11.0 10.9 403.5 563.7 0.1 334.7 14.4 0.4 161.6 0.1 300.0 16.0 1.4 3.3 36.4 142.0 23.9 45.9 5.9 0.2 2.4 262.6 4.1 566.3 60.1 118.9 9.0 0.7 0.3 1.9 15.9 1.7 0.2 13.0 502.1 55.4 0.0 0.8 0.0 477.8 45.2 0.3 0.3 235.5 58.2 16.6 186.1 9.9 4.3 153.2 0.6 52.6 0.2 93.0 3.1 5.1 2.2 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 207.7 0.1 0.6 0.1 0.0 2.9 16.5 17.3 14.5 28.2 14.2 21.6 19.9 16.1 20.8 14.6 19.9 14.7 322.7 589.7 47.3 0.0 1.1 24.9 81.8 144.9 1.8 0.2 27.6 85.9 8.6 55.8 175.2 38.6 0.0 212.6 1.0 35.4 17.6 434.5 1.1 33.7 4.4 84.6 5.4 3.2 0.9 305.3 106.2 16.9 99.9 58.1 5.1 0.1 23.2 0.6 18.9 0.0 0.3 33.4 122.1 0.3 0.3 0.3 3.1 6.9 5.4 42.2 21.0 1.2 0.0 1.0 0.6 754.2 61.6 0.4 0.6 158.6 11.5 5.5 89.6 0.4 0.0 7.6 18.7 1.1 0.6 21.9 6.7 62.8 2.3 1.3 29.7 46.7 APOBEC4 "C1orf169, FLJ25691, MGC26594, RP1-127C7.4" ENSG00000173627 "Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4" Q8WW27 1 183646275-183653316 "Metabolic proteins, Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 11.6;testis: 10.0" "Cell type enhanced" "Detected in some" "Early spermatids: 131.4;Endometrial ciliated cells: 31.0;Late spermatids: 86.7;Respiratory ciliated cells: 63.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (2.27e-1)" "prognostic favorable (2.65e-4)" "unprognostic (2.61e-1)" "unprognostic (3.84e-2)" "unprognostic (1.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.10e-2)" "unprognostic (4.00e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.1 0.7 0.1 1.0 0.0 0.1 0.2 0.0 0.0 11.6 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 10.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.1 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 11.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 131.4 31.0 0.2 0.1 3.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 86.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.2 0.0 63.3 0.0 0.0 0.0 0.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 AQP9 "HsT17287, SSC1" ENSG00000103569 "Aquaporin 9" O43315 15 58138169-58185911 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 702.7" "Group enriched" "Detected in some" 4 "Hepatocytes: 313.9;Macrophages: 82.1" "Cancer enriched" "Detected in many" 30 "liver cancer: 132.4" "Region enhanced" "Detected in many" "cerebral cortex: 14.4" "Immune cell enriched" "Detected in many" 20 "neutrophil: 1161.4" "Lineage enriched" "Detected in many" 20 "granulocytes: 1161.4" "Cell line enriched" "Detected in some" 29 "U-87 MG: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA074762, CAB075684" Enhanced NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 41: Macrophages - Immune response" "CAB075684: , HPA074762: AB_2732267" "unprognostic (1.91e-1)" "unprognostic (1.92e-1)" "unprognostic (7.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.24e-2)" "unprognostic (4.15e-2)" "unprognostic (1.36e-3)" "unprognostic (2.28e-2)" "unprognostic (3.82e-2)" "unprognostic (2.03e-1)" "unprognostic (4.80e-3)" "unprognostic (6.98e-2)" "prognostic unfavorable (5.72e-11)" "unprognostic (8.78e-2)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (8.39e-2)" 18.2 0.8 0.8 72.9 0.9 67.5 2.4 0.9 14.4 1.3 0.8 0.9 0.2 1.2 43.4 1.2 7.1 5.3 1.7 3.2 0.5 0.9 702.7 22.2 0.6 0.7 1.0 0.5 1.6 5.6 0.3 6.2 4.0 0.9 0.3 0.4 1.1 0.7 0.5 22.0 0.9 6.4 0.6 42.7 1.5 0.3 6.9 1.8 0.6 7.5 0.8 32.6 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 29.7 0.1 0.0 0.2 58.4 1.2 0.1 17.5 0.1 0.5 0.1 0.0 1.8 0.1 0.1 0.0 1161.4 0.3 23.0 0.6 0.3 18.9 0.8 0.9 0.9 14.4 3.2 0.5 0.7 1.0 4.0 0.6 6.9 0.8 0.7 0.0 12.2 0.3 2.3 0.4 0.2 0.0 0.0 0.0 0.1 0.0 1.1 5.7 3.1 0.0 0.0 0.3 0.5 0.0 0.0 0.1 2.1 0.3 0.1 0.7 0.0 13.9 2.4 0.2 0.9 1.9 0.0 1.8 7.6 0.0 7.9 313.9 40.8 0.0 0.8 0.0 0.0 28.5 6.2 1.9 0.3 82.1 0.0 0.0 18.9 0.0 1.0 0.5 0.2 0.5 0.0 0.0 0.7 0.2 0.0 0.3 1.5 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.6 0.8 1.5 0.0 0.0 0.1 ARFGEF3 "BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33" ENSG00000112379 "ARFGEF family member 3" Q5TH69 6 138161939-138344663 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4;salivary gland: 18.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 114.6;Excitatory neurons: 200.9;Inhibitory neurons: 207.8;Oligodendrocyte precursor cells: 173.9;Oligodendrocytes: 378.1" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 14.8;RH-30: 13.4;RT4: 19.4;SK-BR-3: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036350 Uncertain NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA036350: AB_10672084" "prognostic unfavorable (8.20e-4)" "unprognostic (4.31e-2)" "unprognostic (9.91e-3)" "unprognostic (5.91e-2)" "unprognostic (2.20e-2)" "unprognostic (4.53e-2)" "unprognostic (4.30e-3)" "unprognostic (1.21e-2)" "unprognostic (7.41e-2)" "unprognostic (7.82e-2)" "unprognostic (3.46e-2)" "unprognostic (4.93e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (2.38e-1)" "unprognostic (8.87e-2)" "unprognostic (1.69e-2)" 1.2 3.8 13.4 0.7 16.4 0.4 7.9 20.1 17.7 5.0 0.0 4.2 2.2 0.7 0.9 0.4 2.2 1.7 1.0 16.7 13.0 2.1 0.1 6.4 0.2 11.1 17.7 0.1 8.7 15.8 7.0 1.4 14.4 12.0 4.8 2.8 18.0 1.0 0.2 1.2 1.9 0.7 7.5 0.4 10.0 0.6 15.2 0.1 1.9 0.7 0.2 3.4 0.4 28.4 8.0 3.1 0.0 0.6 0.0 0.0 4.7 0.3 0.2 0.2 0.0 0.1 0.4 0.0 3.1 0.3 2.7 2.6 3.8 2.0 0.0 0.0 4.9 0.0 1.5 0.9 0.0 3.0 0.0 0.0 0.9 0.0 0.9 3.5 4.1 2.7 0.0 4.9 0.0 14.8 0.0 0.0 2.7 8.5 3.4 0.6 13.4 2.6 2.6 19.4 6.9 0.0 7.8 22.2 0.9 0.3 4.4 0.0 0.4 0.2 2.2 0.0 7.9 1.7 6.7 0.0 3.2 1.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 16.4 20.1 17.7 16.7 13.0 11.1 17.7 14.4 7.5 15.2 28.4 9.4 16.0 114.6 34.3 0.5 0.0 18.8 0.0 6.2 19.0 39.9 12.6 6.4 14.3 44.6 3.7 0.0 16.5 0.8 2.5 3.9 11.4 83.0 8.6 1.4 11.9 66.7 2.7 200.9 24.7 2.4 4.1 41.3 17.7 2.5 0.1 8.2 0.3 1.4 11.8 207.8 44.2 0.0 0.0 0.0 22.0 0.0 0.5 0.0 36.5 2.0 0.9 0.0 173.9 378.1 14.2 8.4 0.0 0.9 67.6 2.5 0.3 37.2 3.3 0.0 3.5 0.9 4.1 1.1 3.0 0.0 6.2 0.8 0.1 13.2 42.7 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639941 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.2;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040830, HPA066481" Enhanced Approved Nucleoli,Cytosol No Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Nucleoli "HPA040830: AB_10805830, HPA066481: " "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.05e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.7 0.9 2.0 7.9 2.5 24.2 1.7 2.1 2.1 1.5 1.2 7.5 6.1 1.5 1.0 5.3 0.8 1.7 0.7 1.7 1.9 0.6 1.3 1.7 13.5 2.6 3.0 0.6 2.6 1.2 0.7 4.3 2.6 0.6 8.8 0.5 1.2 0.5 0.9 4.4 7.6 4.8 2.5 2.8 3.6 8.6 2.2 26.1 1.3 0.4 14.3 2.8 1.9 3.0 80.8 69.4 73.1 46.2 5.0 13.0 39.6 78.5 50.2 80.0 63.3 52.2 41.5 43.5 23.7 49.9 91.3 56.9 55.3 43.8 110.9 83.5 27.4 132.6 68.9 33.5 2.0 103.8 55.5 4.3 5.5 61.6 50.9 15.2 61.5 94.4 101.0 112.7 95.3 31.7 58.6 39.7 44.6 71.6 44.5 67.8 141.7 38.2 28.4 41.6 64.7 44.5 72.9 46.2 17.6 37.6 63.6 115.8 35.3 102.5 74.1 42.0 87.2 38.3 63.7 123.7 44.4 129.1 91.8 0.1 0.3 0.8 0.5 0.5 0.2 0.3 1.0 0.9 0.4 0.2 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.3 2.0 2.5 2.1 2.1 1.7 1.9 2.6 3.0 2.6 2.5 2.2 3.0 0.7 0.0 2.3 0.3 4.6 4.8 1.1 2.4 2.2 0.2 1.3 1.7 0.9 4.3 1.9 1.8 0.0 9.8 2.9 6.2 0.0 0.8 4.7 3.8 2.6 2.0 0.0 38.7 1.0 0.8 23.7 3.5 8.6 2.8 0.0 21.1 1.8 2.1 9.5 0.0 0.6 7.8 0.0 6.5 4.2 5.0 0.6 3.5 0.0 1.0 3.9 0.1 2.1 0.5 1.4 0.5 2.9 0.4 18.6 1.4 1.1 0.4 1.4 1.0 6.6 1.4 3.3 24.7 22.6 10.5 2.3 3.1 5.4 2.0 14.1 2.1 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.8" "Cell type enhanced" "Detected in many" "Astrocytes: 34.3;Endometrial ciliated cells: 31.4;Excitatory neurons: 41.7;Inhibitory neurons: 33.1;Oligodendrocytes: 30.8;Respiratory ciliated cells: 27.6;Rod photoreceptor cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.6 3.9 4.3 0.8 5.2 0.0 3.4 2.3 9.4 4.9 1.2 4.5 1.7 2.8 0.8 5.0 8.2 0.7 1.9 8.5 2.3 4.9 1.6 2.7 0.3 8.4 5.9 2.6 5.2 1.3 9.9 0.7 5.5 4.2 0.6 3.1 3.5 1.4 0.7 5.2 2.7 0.5 4.7 1.3 2.0 21.8 3.5 0.7 7.5 0.1 0.1 1.9 3.1 9.5 8.3 8.1 3.8 5.8 0.7 0.6 7.2 2.1 0.7 2.6 1.6 5.2 4.8 0.8 5.4 0.8 2.7 7.0 1.8 2.0 0.5 0.0 7.2 0.1 5.8 3.4 1.3 0.0 0.8 0.5 3.2 3.3 1.4 1.3 0.8 0.4 7.7 0.0 1.1 13.4 4.6 0.0 4.0 3.4 11.4 4.3 3.0 3.2 2.1 4.1 10.9 7.7 6.2 2.1 3.8 1.4 9.0 1.2 2.0 1.9 0.1 6.6 4.5 0.0 0.1 0.3 3.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.2 2.3 9.4 8.5 2.3 8.4 5.9 5.5 4.7 3.5 9.5 0.8 3.2 2.3 34.3 0.6 3.7 0.6 1.9 2.2 7.2 5.0 3.3 1.6 0.0 2.8 3.7 20.9 0.6 0.1 7.5 0.0 2.4 3.9 31.4 2.8 1.1 0.0 0.0 41.7 2.5 0.9 1.2 1.1 6.0 0.0 6.0 0.7 1.4 0.5 3.3 33.1 4.2 4.1 0.0 0.4 3.1 2.1 0.2 5.4 1.0 0.0 3.6 0.0 15.6 30.8 1.4 7.9 8.2 0.0 1.0 3.3 1.5 27.6 24.5 6.6 2.5 2.1 8.5 11.2 2.1 3.0 0.5 0.3 3.1 5.2 0.7 ARHGEF26 "DKFZP434D146, SGEF" ENSG00000114790 "Rho guanine nucleotide exchange factor 26" Q96DR7 3 154121003-154257827 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 339.7;Astrocytes: 248.8" "Cancer enhanced" "Detected in all" "prostate cancer: 19.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017722, HPA049195" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 30: Mammary glandular cells - Lactation" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017722: AB_1856800, HPA049195: AB_2680671" "unprognostic (1.41e-1)" "unprognostic (1.43e-3)" "unprognostic (3.55e-1)" "unprognostic (7.99e-3)" "unprognostic (2.82e-1)" "unprognostic (9.42e-3)" "prognostic favorable (9.74e-4)" "unprognostic (7.06e-2)" "unprognostic (1.16e-1)" "unprognostic (6.01e-5)" "unprognostic (1.44e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-1)" "unprognostic (5.53e-3)" "unprognostic (3.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.24e-3)" 8.0 2.1 5.8 1.8 5.7 0.3 6.0 4.1 5.3 5.0 7.7 18.3 7.3 4.3 1.2 7.4 6.2 5.5 3.2 4.6 5.0 1.7 15.5 16.3 0.3 5.9 7.3 3.9 6.0 9.9 1.7 3.4 5.8 3.4 2.6 7.1 3.1 4.8 0.4 6.2 6.6 7.1 5.4 0.8 8.7 5.1 6.1 0.8 3.1 1.4 0.9 5.1 6.4 4.8 8.5 3.7 10.6 6.8 5.1 1.4 0.3 0.3 0.0 3.1 4.3 6.5 0.8 5.0 0.5 0.6 4.9 8.9 6.7 4.4 3.9 0.0 8.8 0.1 2.6 1.5 4.7 1.6 0.2 1.3 0.4 4.0 0.5 1.8 0.6 5.4 0.0 0.0 2.0 8.1 2.0 0.1 6.7 2.4 3.0 0.0 12.9 0.0 0.7 4.1 3.2 1.1 1.7 14.4 1.5 4.6 10.1 0.5 0.0 1.1 5.3 0.1 26.6 4.5 0.7 0.0 2.5 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.7 4.1 5.3 4.6 5.0 5.9 7.3 5.8 5.4 6.1 4.8 5.0 339.7 26.8 248.8 1.7 19.5 9.0 2.7 17.6 11.6 54.2 6.6 1.8 20.0 10.8 3.7 4.2 1.8 4.3 1.5 0.0 2.2 11.9 4.7 4.5 4.3 0.0 2.7 4.2 2.5 1.1 12.0 14.3 2.1 5.1 3.6 8.6 60.8 0.6 5.0 10.1 7.9 6.1 2.5 3.4 3.4 10.5 1.3 3.6 7.5 2.7 58.1 12.3 41.7 5.1 2.0 6.9 18.8 0.7 7.5 21.4 0.1 14.9 47.8 0.0 14.1 3.7 4.7 37.0 11.7 23.7 6.2 4.7 2.5 8.1 5.7 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 7.8;pancreas: 6.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 48.5;Breast glandular cells: 17.9;Respiratory ciliated cells: 31.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.8;RPTEC TERT1: 14.3;SK-BR-3: 8.0;T-47d: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Centrosome "HPA036510: AB_10672357, HPA045484: AB_2679345" "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.0 0.0 0.0 0.3 0.0 0.0 7.8 0.0 0.0 2.5 0.0 2.6 1.9 0.2 5.5 0.1 0.6 3.2 0.0 0.0 0.0 3.9 0.1 3.6 0.0 0.0 0.0 0.0 6.5 0.0 2.0 0.0 0.0 5.7 4.2 0.0 4.9 0.4 0.3 0.5 2.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 8.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 48.5 0.0 0.2 0.0 1.1 1.1 0.0 0.0 17.9 6.1 1.8 4.3 12.6 12.9 0.0 0.2 0.2 9.8 9.8 6.8 1.9 12.6 0.5 0.3 8.4 0.0 0.3 5.8 0.1 0.3 9.2 7.8 0.0 0.0 0.0 0.1 0.1 0.0 0.3 14.8 10.2 0.0 0.2 0.4 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.1 2.4 6.4 0.0 0.1 9.4 4.8 0.5 31.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.4 0.8 ARMC2 "bA787I22.1, DKFZp434P0714" ENSG00000118690 "Armadillo repeat containing 2" Q8NEN0 6 108848416-108974476 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.4" "Cell type enhanced" "Detected in many" "Astrocytes: 80.0;Early spermatids: 117.7;Excitatory neurons: 86.1;Inhibitory neurons: 69.3;Late spermatids: 145.3;Respiratory ciliated cells: 61.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025809, HPA053696" Enhanced Approved Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA025809: AB_1845032, HPA053696: AB_2682233" "unprognostic (4.42e-2)" "unprognostic (9.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (4.00e-4)" "unprognostic (1.13e-2)" "unprognostic (3.74e-2)" "unprognostic (5.71e-2)" "unprognostic (5.19e-5)" "unprognostic (7.55e-2)" "unprognostic (1.55e-3)" "unprognostic (9.38e-2)" "unprognostic (6.44e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" 5.3 3.8 3.8 3.9 7.8 8.8 7.0 0.9 6.8 6.6 31.8 2.9 1.8 7.5 7.6 3.4 20.4 5.2 9.3 3.0 2.3 3.6 2.6 8.6 4.2 2.7 5.9 5.4 2.4 9.4 6.7 6.9 1.2 3.9 4.6 26.7 3.4 4.7 4.0 5.2 3.4 4.1 1.1 5.9 5.0 33.4 7.6 3.8 10.6 1.3 4.2 2.4 2.7 3.6 3.5 2.1 10.1 6.5 4.9 5.9 2.2 2.1 2.9 5.3 7.0 3.2 3.0 5.5 2.6 3.4 8.1 3.0 5.6 4.2 9.1 1.5 4.9 5.1 5.2 3.4 2.6 8.0 2.2 6.8 5.8 6.1 1.7 7.1 5.0 16.6 2.2 8.4 5.5 2.7 7.0 7.3 3.2 3.4 2.6 7.8 8.3 4.3 4.9 4.1 14.0 5.2 7.3 1.8 5.1 5.6 3.7 4.1 2.5 4.4 2.3 3.8 2.9 3.8 5.5 4.7 7.6 5.5 5.6 3.7 2.1 0.6 2.0 3.0 1.8 0.8 1.5 2.2 1.7 1.9 0.9 2.2 6.0 2.9 2.4 2.8 4.7 1.0 3.8 7.8 0.9 6.8 3.0 2.3 2.7 5.9 1.2 1.1 7.6 3.6 2.0 9.6 3.7 80.0 3.4 1.0 1.1 1.9 0.6 2.0 1.2 1.5 6.8 1.5 10.9 0.0 0.0 1.5 2.9 0.3 0.0 1.2 117.7 33.0 2.7 2.2 1.8 2.1 86.1 1.0 2.1 3.0 1.5 1.8 0.0 2.8 0.7 0.3 3.9 1.7 69.3 0.4 4.1 4.4 0.4 145.3 6.8 3.1 5.4 11.2 0.5 1.7 3.1 35.7 24.4 0.7 0.0 10.1 5.9 0.6 0.4 1.8 61.8 4.9 0.0 4.2 4.2 41.5 6.3 1.9 1.4 0.5 5.1 2.5 0.6 0.7 ARMC3 "CT81, FLJ32827" ENSG00000165309 "Armadillo repeat containing 3" Q5W041 10 22928024-23038523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 12.9;choroid plexus: 34.5;fallopian tube: 44.6;testis: 33.6" "Cell type enhanced" "Detected in some" "Early spermatids: 364.4;Endometrial ciliated cells: 169.1;Late spermatids: 90.1;Respiratory ciliated cells: 204.6;Spermatocytes: 70.0" "Group enriched" "Detected in some" 5 "endometrial cancer: 4.0;ovarian cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "CAPAN-2: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037823, HPA037824" Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA037823: AB_2675689, HPA037824: AB_10671634" "unprognostic (8.11e-3)" "unprognostic (5.78e-2)" "unprognostic (6.63e-2)" "unprognostic (7.81e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (5.23e-1)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (7.37e-3)" "unprognostic (4.02e-1)" "unprognostic (3.61e-2)" "unprognostic (2.97e-1)" "unprognostic (6.21e-3)" "unprognostic (9.53e-4)" "unprognostic (1.40e-2)" 0.0 0.0 3.3 0.0 3.9 0.0 0.0 2.4 1.5 1.3 34.5 0.0 0.0 1.5 0.1 0.1 44.6 0.0 0.1 3.0 3.7 0.4 0.0 3.5 0.0 11.4 12.9 0.0 0.3 0.0 1.3 0.0 8.5 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.0 0.0 33.6 4.6 0.1 0.3 0.1 0.0 0.0 0.0 8.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 3.9 2.4 1.5 3.0 3.7 11.4 12.9 8.5 7.7 4.6 8.3 0.0 0.0 1.1 8.1 0.0 0.0 0.0 6.0 0.0 0.0 0.1 0.1 0.3 0.0 22.4 0.0 6.2 0.0 0.1 0.0 0.0 0.4 364.4 169.1 1.4 0.8 0.0 0.0 9.1 0.0 0.0 0.4 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 12.2 0.0 0.0 90.1 3.4 1.5 0.0 2.8 0.0 0.0 0.0 1.5 9.0 0.0 0.0 3.8 0.0 0.3 0.0 1.5 204.6 1.1 0.0 0.0 3.0 70.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ARMC4 "CILD23, DKFZP434P1735, FLJ10376, FLJ10817, gudu" ENSG00000169126 "Armadillo repeat containing 4" Q5T2S8 10 27775186-27999079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 23.1;testis: 40.7" "Cell type enhanced" "Detected in some" "Early spermatids: 277.5;Endometrial ciliated cells: 45.3;Late spermatids: 85.1;Respiratory ciliated cells: 128.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 7.8;BJ: 8.2;fHDF/TERT166: 9.4;RH-30: 25.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037829 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 49: Ciliated cells - Cilium organization" "HPA037829: AB_10670960" "unprognostic (1.03e-2)" "unprognostic (2.87e-1)" "unprognostic (3.48e-2)" "unprognostic (4.43e-3)" "unprognostic (1.64e-1)" "unprognostic (4.28e-2)" "unprognostic (6.23e-2)" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-3)" "unprognostic (7.72e-2)" "unprognostic (2.76e-2)" "unprognostic (1.75e-2)" "unprognostic (6.15e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" 0.3 0.9 1.4 0.3 1.4 0.6 0.2 0.9 1.7 1.2 9.5 1.0 0.2 1.0 0.6 0.4 23.1 0.3 0.2 1.3 1.8 0.3 0.7 2.6 0.1 4.5 4.7 1.6 0.0 0.3 3.2 0.0 3.5 2.4 0.3 0.3 0.0 1.8 0.1 0.1 0.2 0.5 3.5 0.2 0.3 40.7 1.4 0.6 0.4 0.0 0.0 0.6 0.3 2.8 0.1 0.2 7.8 0.0 0.0 0.0 0.1 8.2 2.7 6.0 3.6 0.0 0.3 0.1 0.0 9.4 1.8 0.0 1.2 0.6 4.7 0.3 4.9 0.0 4.6 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 2.2 2.2 1.8 0.0 0.0 1.3 0.0 4.9 0.6 6.8 0.0 5.4 0.1 25.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.4 0.7 1.7 1.0 0.0 3.6 0.4 4.3 0.2 0.0 0.1 1.2 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 0.9 1.7 1.3 1.8 4.5 4.7 3.5 3.5 1.4 2.8 0.2 3.2 3.9 8.8 0.0 0.0 0.1 2.1 0.0 0.0 0.1 0.4 2.7 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 277.5 45.3 0.9 0.6 0.0 0.0 2.2 0.4 0.0 1.1 0.0 0.7 0.0 1.1 0.0 0.0 0.1 0.0 1.2 0.0 2.0 0.0 0.3 85.1 1.2 0.3 0.0 5.6 0.0 0.0 0.0 7.1 0.3 0.0 1.1 1.9 0.0 0.1 0.0 0.1 128.4 0.0 0.0 0.2 1.4 32.4 2.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 ARMH1 "C1orf228, MGC33556, NCRNA00082, p40" ENSG00000198520 "Armadillo like helical domain containing 1" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 8.2;testis: 11.7" "Cell type enhanced" "Detected in some" "B-cells: 5.0;Collecting duct cells: 3.7;Endometrial ciliated cells: 13.1;Granulosa cells: 6.2;Hofbauer cells: 11.3;Macrophages: 5.1;T-cells: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 6.9;MOLT-4: 4.9;NB-4: 7.5;U-937: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 32: U-937 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.4 1.1 1.7 0.2 2.2 2.2 0.7 1.1 2.6 0.8 4.5 0.5 0.2 1.7 3.5 0.5 8.2 0.7 0.2 2.3 1.3 0.9 4.2 1.0 0.6 2.6 4.0 2.6 0.5 1.9 3.3 0.3 2.1 0.8 0.3 4.2 0.7 0.6 0.1 0.8 0.3 0.3 1.8 0.3 0.7 11.7 1.9 0.4 0.6 0.0 0.3 0.3 0.3 2.2 0.2 0.3 1.8 0.1 0.5 2.1 0.5 0.0 0.2 0.5 0.3 0.4 3.8 0.2 0.2 0.8 0.9 0.5 0.0 0.0 0.0 1.0 0.2 0.9 2.6 0.6 0.2 6.9 4.1 1.7 0.2 0.7 0.0 1.3 0.2 0.3 0.1 0.7 0.2 0.0 4.9 7.5 0.1 0.5 0.0 2.7 0.1 2.2 0.7 0.0 1.2 0.8 0.0 1.2 0.9 1.2 0.3 3.6 0.0 0.3 0.3 0.3 0.0 0.3 0.1 0.2 0.3 9.9 0.4 8.7 2.1 6.1 0.2 0.7 0.1 0.6 1.1 0.8 1.0 0.9 1.6 1.5 1.0 0.4 0.0 4.8 0.0 1.4 1.7 2.2 1.1 2.6 2.3 1.3 2.6 4.0 2.1 1.8 1.9 2.2 0.5 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.0 0.0 0.0 3.7 0.0 0.4 1.3 0.0 1.9 0.7 0.0 13.1 0.6 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.7 0.0 6.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 5.2 0.9 0.0 0.0 ARMH2 C6orf229 ENSG00000260286 "Armadillo like helical domain containing 2" H3BNL8 6 24797335-24798917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 13.4" "Cell type enriched" "Detected in single" 9 "Endometrial ciliated cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.0 1.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 13.4 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.1 0.3 0.1 0.7 0.5 0.3 0.5 0.2 0.7 0.5 0.3 2.5 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARX "CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS" ENSG00000004848 "Aristaless related homeobox" Q96QS3 X 25003694-25016420 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.4;ovary: 78.7;skeletal muscle: 26.7" "Group enriched" "Detected in some" 5 "Enteroendocrine cells: 83.7;Inhibitory neurons: 53.2;Leydig cells: 131.7;Peritubular cells: 70.0;Theca cells: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.9;PC-3: 3.9;THP-1: 1.7;U-266/70: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (8.28e-2)" "unprognostic (3.06e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.54e-7)" "unprognostic (9.85e-2)" "unprognostic (7.96e-3)" "unprognostic (1.18e-1)" "unprognostic (2.77e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.06e-6)" "unprognostic (6.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" 0.0 0.1 7.6 0.0 10.1 0.0 0.3 0.0 17.4 0.0 0.0 0.9 3.5 0.0 0.1 0.1 1.1 0.0 0.0 10.1 6.0 0.1 0.0 0.4 0.0 0.0 0.0 78.7 1.4 1.8 0.3 0.0 0.1 0.7 0.9 0.0 0.2 0.0 26.7 0.0 0.7 0.0 0.0 0.2 5.5 7.2 0.4 0.0 0.2 1.9 0.4 0.0 0.2 8.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 3.9 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.1 0.0 0.0 8.3 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 10.1 0.0 17.4 10.1 6.0 0.0 0.0 0.1 0.0 0.4 8.0 0.0 0.0 0.0 14.0 0.3 0.0 2.5 0.5 0.0 0.0 0.3 0.0 0.5 0.0 2.2 0.0 0.0 0.2 0.1 1.9 0.0 0.0 1.2 0.0 0.0 0.1 83.7 0.0 0.2 0.0 2.4 4.7 4.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 53.2 3.6 4.1 0.0 0.0 3.6 131.7 0.2 0.0 3.7 0.0 0.0 0.0 3.5 0.6 0.3 0.8 70.0 0.9 1.3 0.1 0.1 11.3 0.0 0.0 1.5 0.3 0.5 0.3 0.0 0.0 0.1 0.3 66.8 1.9 1.6 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Assembly factor for spindle microtubules" Q8IZT6 1 197084121-197146694 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 10.1;lymphoid tissue: 17.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 99.5;Granulosa cells: 121.1;Plasma cells: 44.8;Spermatocytes: 43.8;Spermatogonia: 44.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB017816 Approved "Plasma membrane,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.2 0.1 0.0 3.0 0.0 10.1 0.4 0.0 0.1 0.2 0.0 1.6 2.1 0.3 0.0 1.5 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.3 5.3 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 1.9 0.0 0.2 0.0 0.0 2.7 1.9 0.7 0.0 0.9 1.1 3.2 0.1 17.0 0.1 0.0 5.1 0.6 0.4 0.2 44.6 22.9 39.1 23.2 1.9 5.5 14.7 35.1 23.2 32.6 25.6 16.7 31.1 45.4 12.5 27.5 13.8 40.2 33.6 12.1 39.1 41.8 25.4 33.1 56.1 12.8 0.4 51.9 20.5 0.6 1.0 26.1 15.2 7.3 31.5 32.9 41.8 50.7 29.0 16.0 40.6 10.3 17.8 24.8 6.4 30.2 55.5 31.7 7.4 11.4 20.4 29.5 50.6 20.6 9.5 20.8 26.9 12.7 28.9 20.9 20.0 34.9 61.2 13.9 21.6 26.8 14.9 11.0 42.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 1.1 1.3 5.8 6.1 1.5 4.0 2.2 0.1 2.4 2.4 1.1 0.0 1.3 1.8 0.0 20.0 7.8 7.7 0.0 0.3 3.9 2.9 6.2 4.3 0.0 99.5 2.0 0.0 14.8 9.8 13.3 8.1 1.3 121.1 6.4 2.2 11.6 0.0 4.8 6.8 4.1 6.4 2.4 4.5 0.6 6.4 0.0 0.0 0.9 0.7 4.1 0.0 1.0 0.5 0.2 1.5 44.8 2.0 0.4 0.4 0.8 0.3 0.0 0.6 7.0 43.8 44.7 27.1 3.4 3.7 9.1 5.7 16.9 2.1 ATG9B "APG9L2, FLJ14885, NOS3AS, SONE" ENSG00000181652 "Autophagy related 9B" Q674R7 7 151012209-151024499 "Metabolic proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 8.3;skin 1: 11.5" "Cell type enhanced" "Detected in many" "Early spermatids: 50.7;Endometrial ciliated cells: 28.6;Late spermatids: 30.3;Respiratory ciliated cells: 25.9;Syncytiotrophoblasts: 115.5" "Cancer enhanced" "Detected in many" "testis cancer: 6.2" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 8.9" "Lineage enriched" "Detected in many" 5 "T-cells: 8.9" "Group enriched" "Detected in some" 5 "BEWO: 13.0;CAPAN-2: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 31: Skin - Epidermis development" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "unprognostic (1.59e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (1.53e-3)" "unprognostic (1.05e-3)" "unprognostic (2.79e-3)" "unprognostic (6.66e-2)" "unprognostic (2.38e-3)" "unprognostic (6.76e-2)" "unprognostic (2.02e-1)" "unprognostic (5.06e-2)" "unprognostic (2.08e-6)" "unprognostic (2.82e-2)" "unprognostic (2.70e-2)" "unprognostic (6.34e-2)" "unprognostic (2.63e-1)" 0.0 0.5 1.1 0.4 1.7 0.2 0.2 0.4 1.0 1.7 0.3 0.0 0.0 0.4 1.1 8.3 1.0 0.2 0.0 0.5 2.1 0.0 0.0 0.2 0.8 2.0 1.7 0.1 0.0 0.0 1.5 4.1 1.1 0.2 0.0 0.8 0.5 0.0 0.2 11.5 0.0 0.0 1.0 0.1 0.1 2.0 2.1 0.3 0.1 0.0 0.8 0.1 1.6 0.4 0.6 0.0 0.7 0.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.1 4.2 0.3 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.6 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.5 0.4 0.6 0.0 1.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 1.1 0.0 1.0 0.9 5.0 1.3 0.0 1.6 8.9 3.4 0.0 0.4 0.1 0.7 5.4 1.4 1.1 1.7 0.4 1.0 0.5 2.1 2.0 1.7 1.1 1.0 2.1 0.4 0.4 0.0 0.0 0.0 2.8 0.0 0.2 1.9 0.6 4.0 0.7 0.9 1.4 1.5 1.6 0.0 0.0 10.2 1.5 0.3 0.0 0.3 50.7 28.6 3.3 1.1 0.0 0.0 2.7 0.2 2.5 0.5 0.0 15.4 14.7 7.8 2.2 0.0 1.9 0.0 7.7 0.0 4.1 0.3 0.4 30.3 0.6 0.8 0.0 0.0 0.3 0.5 1.0 0.5 0.6 3.8 0.0 0.7 0.4 0.3 0.0 0.1 25.9 0.6 0.0 0.0 0.9 19.8 12.7 0.8 0.3 115.5 4.7 0.1 0.2 1.9 ATP11A "ATPIH, ATPIS, KIAA1021" ENSG00000068650 "ATPase phospholipid transporting 11A" P98196 13 112690329-112887168 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035583, HPA035584" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Vesicles "Golgi apparatus" "HPA035583: AB_10671106, HPA035584: AB_10672096" "unprognostic (1.67e-1)" "unprognostic (5.06e-3)" "unprognostic (1.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.58e-2)" "unprognostic (8.84e-2)" "unprognostic (5.87e-3)" "unprognostic (1.80e-2)" "unprognostic (6.97e-2)" "unprognostic (1.54e-3)" "unprognostic (3.93e-2)" "unprognostic (4.23e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.26e-2)" "unprognostic (7.40e-3)" 10.2 10.4 12.3 8.9 22.0 18.2 6.1 18.3 16.8 13.0 5.7 4.4 9.9 10.1 5.8 7.0 8.7 15.0 21.4 9.7 12.5 12.7 10.1 39.5 5.8 25.3 22.2 6.5 12.4 23.1 16.2 10.1 22.9 4.3 3.2 14.9 9.0 3.9 13.1 8.9 8.3 9.1 15.7 8.9 5.3 8.9 21.9 8.2 13.9 17.3 6.1 6.5 5.9 40.2 28.0 14.0 17.5 20.5 8.7 11.7 30.9 13.0 7.6 10.9 8.8 44.5 31.5 14.1 15.5 11.0 14.0 23.2 15.8 10.8 10.5 14.2 14.9 16.3 11.9 23.3 13.6 30.8 25.5 7.9 8.2 13.2 8.0 8.8 29.0 12.6 11.4 2.3 7.7 10.5 14.1 19.4 7.5 31.8 9.9 12.2 7.1 8.1 59.3 6.4 27.8 7.7 12.7 16.3 10.7 22.4 6.2 40.4 19.2 0.0 23.3 14.1 9.9 7.4 15.5 5.9 4.8 28.3 12.2 0.0 1.1 1.7 0.4 1.6 0.3 0.6 0.2 0.2 0.6 1.8 0.3 0.2 3.1 0.0 1.5 0.5 0.0 0.3 12.3 22.0 18.3 16.8 9.7 12.5 25.3 22.2 22.9 15.7 21.9 40.2 25.6 218.0 215.0 22.2 11.3 10.8 3.4 4.9 1.2 42.0 5.2 3.7 42.3 31.5 29.4 16.5 235.6 1.7 7.0 2.4 5.9 32.7 0.9 51.2 24.2 34.2 12.0 3.8 35.0 11.4 32.2 16.5 8.6 176.3 12.0 62.2 27.1 16.5 20.7 13.5 32.5 3.5 14.2 33.6 16.9 1.9 11.1 29.3 10.6 48.7 36.9 11.0 6.2 33.7 138.3 24.3 6.1 4.9 7.7 7.7 10.5 15.7 13.3 44.8 0.0 9.5 12.8 4.0 10.1 6.3 9.7 8.6 8.4 8.7 5.9 3.9 ATP12A "ATP1AL1, H-K-ATPase, HK" ENSG00000075673 "ATPase H+/K+ transporting non-gastric alpha2 subunit" P54707 13 24680408-24712472 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Sodium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 11.2;kidney: 5.4;lymphoid tissue: 14.8;placenta: 5.6;skin 1: 6.2" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 75.6;Club cells: 49.2" "Cancer enhanced" "Detected in many" "testis cancer: 12.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "SuSa: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA039526 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 12: NES - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Actin filaments" Cytosol "HPA039526: AB_10673534" "unprognostic (8.33e-3)" "unprognostic (3.58e-2)" "unprognostic (2.93e-1)" "unprognostic (5.21e-3)" "unprognostic (2.58e-1)" "unprognostic (1.21e-2)" "unprognostic (8.03e-3)" "unprognostic (2.64e-1)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.67e-1)" "unprognostic (6.80e-2)" "unprognostic (8.22e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.6 0.0 5.6 0.0 0.2 2.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 14.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.7 1.0 0.0 0.0 0.0 75.6 0.0 0.0 0.2 0.3 0.4 0.0 49.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 2.2 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.2 8.2 0.0 0.0 0.1 0.3 0.1 0.0 1.0 0.0 0.0 0.0 1.0 0.6 0.1 1.2 0.0 0.0 0.2 0.0 0.1 13.6 0.0 0.0 0.0 1.8 1.0 1.1 0.0 0.0 0.0 0.1 0.0 0.1 1.3 ATP2C2 "KIAA0703, SPCA2" ENSG00000064270 "ATPase secretory pathway Ca2+ transporting 2" O75185 16 84368527-84464187 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.4;skin 1: 26.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA052262, HPA075812" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Focal adhesion sites" "HPA052262: AB_2681776, HPA075812: AB_2686765" "unprognostic (2.28e-2)" "unprognostic (6.13e-2)" "unprognostic (3.34e-2)" "prognostic favorable (6.20e-6)" "unprognostic (2.04e-1)" "unprognostic (2.41e-2)" "unprognostic (8.36e-2)" "unprognostic (1.72e-1)" "unprognostic (9.92e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-2)" "unprognostic (2.16e-1)" "unprognostic (8.37e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (4.32e-4)" "unprognostic (1.39e-1)" 0.0 0.0 1.4 2.4 1.4 11.0 2.5 0.5 1.3 6.4 0.5 30.1 27.3 1.0 0.1 4.7 6.8 4.6 0.0 1.3 1.1 1.8 0.1 10.5 0.0 1.0 0.9 0.0 0.7 3.3 1.0 0.9 1.0 12.5 37.4 0.9 19.6 0.2 0.1 26.0 20.3 0.6 0.6 0.4 5.9 0.4 1.1 0.0 8.9 0.0 0.5 4.0 4.6 0.8 6.2 0.4 0.9 0.1 0.0 0.0 6.4 0.2 0.0 0.0 0.0 5.8 5.2 0.0 0.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 44.4 0.1 0.0 0.0 0.2 0.0 19.3 4.9 0.0 0.0 33.0 0.2 0.9 11.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 1.4 0.5 1.3 1.3 1.1 1.0 0.9 1.0 0.6 1.1 0.8 0.0 32.1 56.2 4.2 0.0 0.6 14.3 39.9 0.6 1.3 20.8 3.2 0.8 5.7 50.0 0.0 0.0 2.0 0.1 44.4 0.0 9.0 3.2 26.8 2.5 0.7 34.2 0.0 8.3 2.5 2.4 0.5 22.4 28.0 8.9 0.0 0.0 0.1 0.3 0.0 1.8 82.3 8.2 0.0 1.2 1.9 0.0 0.6 1.8 1.0 0.0 1.9 0.0 58.8 2.4 4.7 29.2 0.0 0.0 13.8 10.2 1.8 78.2 5.2 0.0 0.1 1.8 0.8 1.0 1.5 1.1 24.1 0.9 0.2 77.1 9.9 ATP6V1F "ATP6S14, VATF, Vma7" ENSG00000128524 "ATPase H+ transporting V1 subunit F" Q16864 7 128862856-128865847 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1054.6;Hofbauer cells: 1132.8;Proximal tubular cells: 1076.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009529, HPA048700, HPA062011" Supported NA NA 26000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 4: Macrophages - Innate immune response" "CAB009529: AB_2290237, HPA048700: AB_2680498, HPA062011: AB_2684656" "unprognostic (1.70e-1)" "unprognostic (1.61e-2)" "unprognostic (2.14e-2)" "unprognostic (3.26e-2)" "unprognostic (2.99e-2)" "unprognostic (8.46e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.28e-3)" "unprognostic (2.70e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (4.06e-1)" "prognostic favorable (2.49e-5)" "unprognostic (2.20e-1)" "unprognostic (2.43e-1)" "unprognostic (1.36e-2)" "unprognostic (7.33e-2)" 133.3 160.7 275.6 106.2 290.1 210.4 122.3 272.7 368.6 126.5 250.2 104.6 74.7 95.3 61.7 223.0 98.3 104.2 183.3 294.8 300.1 307.0 84.2 140.0 139.9 280.1 275.3 89.0 106.8 163.5 141.0 104.6 286.0 103.0 56.6 110.6 129.3 81.6 169.3 170.1 97.0 71.2 269.5 119.6 114.4 212.2 284.3 119.6 84.6 154.7 103.7 123.1 146.6 277.4 305.6 345.1 151.2 323.2 297.6 236.8 86.9 151.2 201.3 246.8 267.2 257.0 179.8 287.6 156.5 175.7 367.7 163.9 224.5 250.1 91.9 312.6 364.2 220.1 211.4 256.4 344.1 227.1 400.8 278.2 340.0 284.7 163.4 188.9 238.1 257.9 534.3 297.3 276.3 403.1 381.0 494.3 201.9 190.6 281.4 168.7 110.1 467.5 315.5 240.3 286.6 197.3 214.1 796.5 363.7 156.6 184.4 284.9 253.0 303.5 65.3 409.5 236.2 333.5 326.9 372.0 600.4 315.5 263.6 370.2 697.1 489.2 244.6 475.1 238.0 343.7 247.6 239.7 508.9 348.5 235.8 238.6 203.1 243.6 324.7 288.3 317.3 886.1 275.6 290.1 272.7 368.6 294.8 300.1 280.1 275.3 286.0 269.5 284.3 277.4 129.3 28.9 62.8 17.3 140.1 237.6 202.5 378.9 136.6 111.4 162.0 190.1 157.6 127.2 230.7 331.1 37.5 171.8 119.8 97.3 1054.6 241.0 574.0 128.6 96.3 163.1 113.2 63.1 27.0 222.2 289.0 155.1 78.5 131.0 275.1 114.0 124.6 112.0 1132.8 545.1 34.6 108.7 585.9 320.6 378.7 898.9 164.4 456.1 254.3 16.9 285.8 230.4 190.5 11.6 26.2 253.9 93.0 127.9 136.8 224.7 212.0 1076.3 200.2 96.4 85.5 69.7 168.9 399.6 102.0 328.4 326.6 401.4 136.3 184.5 98.9 362.7 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 44.1;lymphoid tissue: 60.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "T-reg: 7.9" "Group enriched" "Detected in many" 6 "B-cells: 2.5;T-cells: 7.9" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 1.3;white matter: 4.0" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Midbody "CAB005862: AB_449204, HPA037708: AB_2675623" "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.1 1.2 0.1 14.2 0.2 44.1 1.7 0.2 0.2 3.0 0.1 11.1 12.1 1.6 0.4 18.6 0.6 1.5 0.7 0.1 0.2 0.9 2.0 2.5 36.7 0.1 0.3 0.5 0.6 0.3 0.2 8.2 0.3 0.8 11.0 0.0 2.7 0.3 5.5 9.3 11.6 3.2 0.0 12.0 4.6 1.2 0.4 60.1 0.6 0.0 36.6 3.5 5.9 0.2 196.5 130.9 191.1 93.0 4.2 6.5 73.4 91.7 49.5 186.2 170.6 171.5 57.4 193.3 46.2 37.0 77.0 139.8 140.1 62.6 153.7 84.9 231.3 115.7 78.3 146.1 0.7 62.2 109.2 3.5 2.9 109.4 67.7 18.5 86.5 123.6 73.3 73.4 82.9 92.9 225.1 87.4 119.6 63.9 57.6 149.8 176.1 80.5 41.2 38.2 41.2 59.1 81.7 36.5 61.2 56.5 63.5 41.4 33.9 74.3 75.6 67.6 243.3 53.2 37.7 147.9 35.7 92.9 153.4 0.0 0.4 0.6 0.5 0.3 0.1 1.1 1.3 2.1 0.5 2.5 0.1 0.7 0.9 0.3 0.2 0.2 7.9 0.9 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.3 0.3 0.0 0.4 0.2 0.3 0.0 0.5 0.0 7.6 4.5 1.8 6.1 0.6 0.0 1.8 2.2 1.4 0.0 2.6 0.0 0.0 40.5 1.8 13.2 0.0 0.4 0.1 0.5 1.6 3.1 0.0 59.3 0.0 0.0 89.1 5.7 6.1 2.1 4.5 24.7 6.1 0.7 29.4 0.0 0.0 10.8 0.0 5.7 7.3 0.2 0.6 5.1 1.8 0.0 0.9 0.0 3.1 0.0 0.1 0.3 2.8 0.0 15.4 1.2 1.5 0.1 0.2 0.0 0.0 0.1 4.8 1.6 7.2 11.8 2.4 9.0 4.3 1.0 22.0 2.8 AXDND1 "C1orf125, FLJ32940" ENSG00000162779 "Axonemal dynein light chain domain containing 1" Q5T1B0 1 179365720-179554735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 15.7" "Group enriched" "Detected in some" 4 "Early spermatids: 226.5;Late spermatids: 247.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA071114 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA071114: AB_2686345" "unprognostic (1.67e-2)" "unprognostic (8.37e-2)" "unprognostic (2.81e-2)" "unprognostic (1.05e-1)" "unprognostic (3.34e-1)" "unprognostic (1.73e-1)" "unprognostic (3.78e-4)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (6.99e-3)" "unprognostic (2.09e-2)" "unprognostic (1.31e-1)" "unprognostic (5.17e-3)" "unprognostic (1.92e-1)" "unprognostic (5.48e-2)" "unprognostic (5.04e-2)" "unprognostic (2.25e-1)" 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 15.7 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.4 0.2 0.3 0.2 0.2 0.1 0.0 0.5 8.8 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.3 0.8 0.0 0.8 0.0 2.1 0.1 0.1 16.3 0.0 0.2 226.5 3.1 0.3 0.2 0.0 0.0 3.1 0.2 0.3 0.1 31.6 0.3 0.0 0.2 0.0 0.0 0.1 0.0 3.2 1.5 0.0 0.0 0.0 247.2 1.5 0.5 0.0 1.0 0.0 0.6 0.0 2.0 2.5 0.6 3.8 1.9 0.1 0.1 2.0 0.1 3.2 0.7 0.0 0.0 0.2 50.2 4.3 0.0 0.0 0.1 0.2 0.6 6.1 0.2 AZU1 "AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC" ENSG00000172232 "Azurocidin 1" P20160 19 825097-832018 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "bone marrow: 1578.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4.5;Breast myoepithelial cells: 4.6;Endometrial ciliated cells: 8.9;Erythroid cells: 8.8;Respiratory ciliated cells: 4.5;Skeletal myocytes: 5.7;Spermatogonia: 6.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in some" 15 "THP-1: 659.5" "Not detected" "Not detected" "HPA055851, HPA075964" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 320000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA055851: AB_2682943, HPA075964: " "unprognostic (1.12e-2)" "unprognostic (3.71e-2)" "unprognostic (4.44e-2)" "unprognostic (8.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (3.32e-1)" "unprognostic (4.22e-3)" "unprognostic (2.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-6)" "unprognostic (1.11e-2)" "unprognostic (1.10e-1)" "unprognostic (2.46e-2)" "unprognostic (3.04e-2)" 0.8 0.2 0.4 0.0 0.4 1578.1 1.5 0.2 0.9 0.2 0.2 0.2 0.0 0.5 0.0 0.1 1.4 0.0 2.0 0.4 0.3 0.4 2.8 15.9 0.6 0.3 0.3 0.2 0.2 0.0 0.9 0.9 0.4 0.4 0.0 0.0 2.6 0.0 0.5 0.6 0.2 0.0 0.2 33.1 0.2 2.4 0.4 3.1 0.5 0.0 0.0 0.3 0.2 0.3 1.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 44.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.6 659.5 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.6 0.0 34.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.1 0.4 0.4 0.2 0.9 0.4 0.3 0.3 0.3 0.4 0.2 0.4 0.3 3.5 0.0 0.0 0.0 0.6 0.0 0.1 1.2 0.0 0.0 4.5 4.6 0.7 0.0 0.5 0.0 0.0 0.2 2.8 0.6 0.0 0.1 0.0 8.9 1.2 1.0 0.0 8.8 0.8 0.0 0.3 0.8 0.0 2.3 0.0 0.1 0.0 0.4 3.2 0.0 1.4 0.4 0.0 3.7 0.4 0.7 0.0 3.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.2 0.0 4.5 0.0 0.0 5.7 1.2 0.1 6.4 0.9 0.1 0.0 1.0 0.0 0.6 0.0 B3GALT5 "B3GalT-V, B3T5, beta3Gal-T5, GLCT5" ENSG00000183778 "Beta-1,3-galactosyltransferase 5" Q9Y2C3 21 39556442-39673137 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 37.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 196.4;Intestinal goblet cells: 47.4;Paneth cells: 72.5;Proximal enterocytes: 94.1;Undifferentiated cells: 57.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 23.5;RPTEC TERT1: 27.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 8.6" "HPA054092, HPA054684" Approved "Intracellular and membrane" NA NA "Cluster 9: Intestine - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA054092: AB_2682375, HPA054684: AB_2682573" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "prognostic favorable (6.36e-4)" "unprognostic (9.23e-2)" "unprognostic (4.62e-2)" "unprognostic (4.06e-2)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (3.25e-2)" "unprognostic (7.86e-3)" "unprognostic (1.67e-1)" "unprognostic (6.09e-4)" "unprognostic (1.12e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" 0.0 0.3 2.5 0.9 8.6 0.0 2.6 0.7 3.7 2.2 1.9 22.4 27.3 0.7 1.3 1.6 1.3 5.5 0.0 2.4 4.6 0.2 0.1 0.1 0.0 2.0 2.1 0.3 3.3 0.0 1.8 0.0 1.3 0.4 37.4 0.8 4.5 0.1 0.0 0.8 33.7 0.8 1.3 0.0 5.0 0.4 6.9 1.0 1.2 0.3 2.0 1.3 2.3 0.7 0.0 0.9 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 23.5 0.0 0.2 0.2 2.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.3 0.2 0.6 0.0 2.7 0.1 27.1 1.7 4.6 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.7 0.2 1.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 8.6 0.7 3.7 2.4 4.6 2.0 2.1 1.3 1.3 6.9 0.7 0.1 0.0 0.0 6.5 0.3 0.0 0.5 0.1 0.0 7.4 8.0 8.1 2.2 10.0 5.3 5.5 0.0 0.0 0.2 196.4 0.0 7.5 0.4 0.2 5.9 0.4 28.9 0.0 3.6 4.7 0.0 0.2 13.3 0.2 4.5 0.8 0.0 0.0 0.0 0.0 4.8 47.4 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 1.4 0.0 11.1 1.0 9.2 72.5 0.0 0.0 0.6 94.1 0.1 1.5 0.2 0.0 0.1 0.4 0.1 1.7 0.5 0.0 0.0 0.5 0.0 57.7 9.7 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 459939-563509 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 61.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.2 7.0 0.5 3.2 0.7 2.1 1.3 0.0 1.0 7.4 1.0 18.4 1.0 6.2 2.7 7.5 3.7 2.2 23.9 0.5 0.0 4.6 0.1 5.2 0.1 0.0 0.0 0.4 2.6 16.9 9.3 0.1 0.0 2.0 12.5 0.1 4.8 0.7 1.5 14.8 2.0 2.2 0.0 0.3 61.0 8.0 0.0 2.3 2.3 0.1 0.7 1.4 5.6 0.7 0.0 0.0 0.3 1.2 0.0 0.0 33.5 0.0 0.0 0.0 0.0 8.0 6.6 0.0 0.9 0.0 0.7 3.6 8.0 1.1 0.1 13.2 12.5 0.0 0.0 1.8 0.0 0.1 5.3 0.0 5.3 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.4 0.0 0.1 14.8 10.5 0.6 0.5 5.0 0.0 7.1 6.8 3.8 2.7 0.8 0.3 1.0 4.9 0.8 2.9 0.0 0.0 2.7 0.2 0.9 0.0 0.0 0.0 0.0 9.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 7.0 1.3 0.3 7.5 6.0 3.4 0.0 0.6 2.9 0.6 15.1 1.5 6.2 9.2 0.0 0.0 0.6 81.1 0.0 12.0 26.3 20.4 4.8 0.6 10.3 0.0 32.6 4.8 0.1 1.6 128.0 47.4 0.0 0.1 0.0 0.1 0.7 0.0 5.2 18.6 2.0 0.0 1.1 89.2 0.0 0.5 0.0 2.8 0.6 0.0 0.0 1.0 3.6 16.6 33.4 0.0 0.2 12.7 1.9 0.2 9.1 0.2 0.0 0.2 0.8 2.8 1.3 0.9 17.3 0.0 1.5 1.9 26.1 14.4 BAIAP3 "BAP3, KIAA0734" ENSG00000007516 "BAI1 associated protein 3" O94812 16 1333638-1349441 "Predicted intracellular proteins" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 221.6;pituitary gland: 367.9" "Cell type enhanced" "Detected in many" "Astrocytes: 21.5;Endometrial ciliated cells: 23.5;Enteroendocrine cells: 50.3;Excitatory neurons: 19.2;Respiratory ciliated cells: 45.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 20.2;MCF7: 6.2;RT4: 5.6" "Region enhanced" "Detected in many" "hypothalamus: 123.4" "Low region specificity" "Detected in all" "HPA015627, HPA015979" Uncertain Supported NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA015627: AB_10603678, HPA015979: " "unprognostic (1.37e-2)" "unprognostic (3.93e-2)" "unprognostic (2.44e-2)" "unprognostic (3.92e-3)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (2.25e-1)" "unprognostic (1.06e-1)" "unprognostic (5.60e-2)" "unprognostic (6.75e-3)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.52e-5)" "unprognostic (5.26e-2)" "unprognostic (3.11e-1)" "unprognostic (7.12e-3)" "unprognostic (6.43e-2)" 3.2 19.3 87.5 1.1 86.9 0.9 5.1 2.3 74.9 5.0 11.5 4.0 3.9 1.2 1.9 2.2 31.2 0.5 4.0 60.7 221.6 12.5 8.1 6.1 1.3 59.8 108.9 0.8 8.0 3.6 367.9 1.8 58.8 9.7 0.8 0.7 4.8 2.4 2.7 2.1 13.5 0.1 37.5 6.8 6.0 20.5 181.6 0.3 1.6 1.1 0.7 2.6 2.0 26.4 0.1 2.3 4.0 1.3 0.4 0.0 1.0 0.2 0.1 0.2 0.0 3.6 20.2 0.3 2.7 0.0 0.1 0.1 0.0 0.2 0.0 0.2 1.3 0.1 0.4 1.4 0.3 0.0 2.7 0.0 0.0 0.2 0.1 0.2 0.1 0.3 0.7 0.0 0.0 6.2 0.0 0.8 2.3 1.0 3.4 0.6 0.0 4.0 2.3 5.6 0.5 0.2 0.0 1.8 0.1 1.1 4.3 0.3 0.3 0.0 2.2 0.5 0.0 1.5 0.5 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.3 0.0 0.1 1.6 0.1 0.5 0.0 0.1 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.1 87.5 86.9 2.3 74.9 60.7 221.6 59.8 108.9 58.8 37.5 181.6 26.4 5.6 0.0 0.0 21.5 7.7 0.5 3.3 2.4 1.8 1.6 2.5 1.9 1.3 0.0 4.9 5.5 0.0 0.2 1.9 2.8 0.0 0.7 4.0 23.5 0.9 2.3 50.3 2.7 19.2 0.2 0.3 0.6 4.1 3.7 0.0 2.0 2.9 4.7 0.1 0.0 13.2 3.2 8.2 0.0 0.4 2.0 0.6 0.2 1.8 1.0 0.1 0.8 0.0 1.5 2.3 0.2 0.8 0.0 4.0 2.9 4.0 0.6 45.7 0.6 6.6 0.9 2.7 2.6 1.8 1.6 0.4 1.1 1.7 0.1 2.9 1.9 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375848-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 158.0;salivary gland: 131.4;vagina: 72.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 163.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.8;hippocampal formation: 1.7" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.3 0.0 0.1 1.3 0.3 0.0 14.9 1.1 0.3 24.2 5.5 7.0 17.9 0.1 0.2 158.0 16.7 4.7 0.2 0.3 0.4 5.4 0.0 0.3 0.7 3.0 1.6 0.0 10.3 0.3 1.7 3.6 3.2 4.8 4.9 0.2 131.4 0.6 2.2 34.8 13.0 0.2 1.8 0.0 6.4 2.4 0.4 0.4 0.3 39.3 8.8 0.4 72.2 2.9 23.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 0.0 1.0 20.9 0.0 5.1 0.0 163.7 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.1 0.0 3.9 0.0 6.2 0.0 0.0 0.0 20.6 0.9 0.0 0.0 39.8 0.0 0.3 0.2 0.0 0.0 19.4 0.1 0.4 3.8 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.3 0.3 0.4 3.0 1.6 3.2 1.8 0.4 2.9 0.2 0.0 1.1 0.3 0.5 43.1 128.5 8.7 3.4 0.6 50.4 16.9 0.5 4.3 8.0 0.0 0.0 13.4 0.8 29.4 7.9 23.7 7.2 11.3 0.6 1.2 1.8 0.0 1.8 0.7 5.8 2.7 6.6 4.6 0.0 0.0 0.0 0.2 1.9 0.0 0.3 13.4 0.0 0.3 2.2 1.6 0.0 0.7 10.6 0.0 0.1 0.7 0.0 0.0 0.3 6.2 29.8 0.4 0.9 25.6 34.0 3.4 11.8 0.3 0.0 0.6 1.7 0.1 5.3 136.4 82.5 4.2 1.7 0.0 19.4 84.8 BBOF1 "C14orf45, CCDC176, FBB10" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019349-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.6" "Group enriched" "Detected in many" 4 "Early spermatids: 239.3;Endometrial ciliated cells: 166.4;Late spermatids: 111.3;Respiratory ciliated cells: 177.8;Spermatocytes: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favorable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 4.9 2.8 5.8 2.3 6.3 6.5 7.3 5.5 9.0 6.5 15.9 7.1 2.0 7.1 14.6 5.2 22.5 5.7 4.4 6.3 5.8 9.7 2.2 6.8 1.7 9.7 9.8 5.1 2.8 5.0 10.7 2.4 8.3 5.5 3.5 24.3 3.8 7.1 2.3 3.1 2.4 5.5 8.0 1.4 3.4 38.6 6.2 2.8 13.2 3.3 2.1 5.0 3.1 6.6 5.4 3.1 1.3 8.7 5.7 12.5 1.1 4.6 6.5 4.6 4.3 1.1 3.7 5.3 1.2 5.7 2.0 1.3 1.8 0.8 5.2 0.8 1.0 0.6 3.1 1.2 4.8 2.7 0.3 6.1 4.2 10.3 1.3 7.3 1.7 9.7 2.9 0.9 3.4 4.3 8.5 1.3 0.4 0.5 2.1 3.0 3.4 0.9 7.9 1.4 5.2 3.3 9.0 3.6 2.6 1.3 9.2 0.2 3.8 5.7 4.0 7.6 1.3 1.9 4.9 3.3 16.7 0.3 1.6 1.1 0.0 0.1 1.5 0.0 1.8 0.5 1.4 1.0 0.1 0.6 1.9 1.5 1.0 1.1 0.0 2.4 0.3 1.2 5.8 6.3 5.5 9.0 6.3 5.8 9.7 9.8 8.3 8.0 6.2 6.6 3.8 12.8 8.1 0.0 1.4 0.0 3.8 0.0 4.0 7.8 15.8 8.0 0.0 7.2 30.3 3.7 29.2 1.8 3.9 1.8 15.6 9.0 239.3 166.4 15.1 3.1 2.4 39.6 0.0 3.5 2.6 7.4 2.0 18.2 1.3 4.3 3.6 4.5 2.3 6.7 0.0 2.7 0.0 1.6 0.0 111.3 10.8 3.9 0.0 0.0 0.8 5.7 4.1 0.0 0.0 3.0 0.2 6.0 0.7 2.5 1.0 23.5 177.8 29.9 0.0 4.3 4.0 149.2 14.7 1.3 0.0 1.0 2.3 4.1 0.9 3.4 BCAS1 "AIBC1, NABC1, PMES-2" ENSG00000064787 "Brain enriched myelin associated protein 1" O75363 20 53936777-54070594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 890.2;choroid plexus: 301.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 182.6;Gastric mucus-secreting cells: 202.9;Intestinal goblet cells: 371.4;Oligodendrocyte precursor cells: 538.8;Oligodendrocytes: 718.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 44.2;OE19: 90.0;RT4: 179.5;SK-BR-3: 368.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033558, HPA051816, HPA054745" Enhanced Approved Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (6.20e-2)" "unprognostic (7.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-1)" "unprognostic (3.80e-1)" "unprognostic (1.19e-1)" "unprognostic (5.25e-2)" "unprognostic (2.91e-2)" "unprognostic (4.70e-3)" "unprognostic (3.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (7.77e-3)" 1.2 0.2 506.5 6.4 627.9 0.1 3.4 551.3 890.2 7.3 301.2 69.5 19.0 1.3 2.2 7.2 1.5 8.6 0.4 421.4 525.8 3.3 0.4 2.9 0.6 749.3 660.7 0.4 0.9 0.0 1.0 0.1 649.9 33.4 74.3 0.2 22.3 0.3 0.5 1.4 31.1 2.8 584.8 0.5 159.8 3.4 562.0 0.7 0.3 0.8 6.5 35.7 7.5 724.7 0.0 8.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.0 27.8 0.2 0.0 0.3 4.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 44.2 0.1 0.2 0.2 90.0 0.0 2.3 0.0 1.2 0.0 179.5 0.2 0.1 0.0 368.6 0.4 0.0 12.2 0.0 0.0 0.0 0.1 3.2 0.0 0.9 0.5 1.0 0.9 0.0 0.3 0.3 0.1 0.0 0.2 0.0 1.2 0.6 0.4 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.1 2.1 0.1 506.5 627.9 551.3 890.2 421.4 525.8 749.3 660.7 649.9 584.8 562.0 724.7 0.8 9.6 1.1 1.6 2.8 0.8 6.3 8.5 0.6 0.1 6.2 1.9 2.2 7.2 35.9 3.7 0.0 0.2 0.4 182.6 1.9 2.9 15.6 9.4 11.1 0.4 8.4 0.0 1.6 22.5 0.1 0.8 202.9 11.8 4.5 0.0 0.4 0.1 0.1 0.0 2.5 371.4 18.3 0.0 2.5 16.1 0.3 1.7 16.0 0.0 0.0 0.8 0.0 538.8 718.8 22.9 102.0 0.0 1.0 21.3 12.0 0.1 100.5 0.5 0.0 1.4 2.2 15.4 6.1 0.3 0.3 0.0 1.7 0.4 35.6 56.7 BEST4 VMD2L2 ENSG00000142959 "Bestrophin 4" Q8NFU0 1 44783585-44788170 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 16.4;fallopian tube: 8.3;intestine: 27.4" "Cell type enriched" "Detected in some" 25 "Paneth cells: 1290.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;U-698: 1.8" "Low region specificity" "Detected in many" HPA058564 Uncertain NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 37: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA058564: AB_2683759" "unprognostic (5.76e-2)" "unprognostic (1.22e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-2)" "unprognostic (6.51e-3)" "unprognostic (1.09e-1)" "unprognostic (8.39e-2)" "unprognostic (1.45e-3)" "unprognostic (1.04e-1)" "unprognostic (8.97e-2)" "unprognostic (5.72e-2)" "unprognostic (1.29e-1)" "unprognostic (2.69e-5)" "unprognostic (1.43e-1)" "unprognostic (3.72e-1)" "unprognostic (1.28e-1)" "unprognostic (4.13e-3)" 0.2 1.9 1.2 0.7 1.1 0.7 0.5 2.2 1.3 1.6 16.4 27.4 9.1 0.7 3.0 0.2 8.3 0.2 0.3 0.8 1.7 0.5 0.6 1.9 0.6 1.9 3.3 0.5 0.3 0.3 2.7 0.2 1.5 0.4 16.0 1.1 0.3 0.5 0.4 2.2 8.1 0.5 1.3 0.5 0.4 0.7 1.6 0.5 0.6 0.1 0.4 0.3 0.2 1.0 0.0 0.2 0.3 0.4 0.1 0.1 1.1 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.5 0.1 0.3 0.5 0.1 0.0 0.1 0.3 0.2 0.0 0.8 2.5 0.1 0.0 0.3 0.2 0.3 0.1 0.2 0.6 0.3 0.4 0.1 0.2 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.8 0.3 0.1 0.1 0.1 0.2 0.4 0.0 0.5 0.1 0.1 0.1 0.2 0.4 0.1 1.8 0.4 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.8 0.6 0.7 0.0 0.5 0.2 0.5 0.1 0.3 0.0 0.3 0.6 0.1 1.2 1.1 2.2 1.3 0.8 1.7 1.9 3.3 1.5 1.3 1.6 1.0 0.2 0.0 0.0 0.0 0.8 0.3 0.8 3.4 0.0 0.8 0.4 1.0 0.5 0.0 4.2 5.5 0.0 0.3 0.4 31.2 1.9 0.7 0.0 26.7 0.5 0.2 2.4 0.0 1.9 0.8 0.2 0.6 0.5 1.2 0.0 0.3 0.4 0.0 0.3 0.0 4.3 3.2 0.0 0.0 0.9 0.2 0.9 0.2 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.6 1290.4 0.4 0.4 0.7 6.1 1.0 50.1 0.2 0.0 1.2 0.8 0.7 1.6 0.0 0.6 0.3 1.4 0.4 9.1 0.5 BIRC5 "API4, EPR-1, survivin" ENSG00000089685 "Baculoviral IAP repeat containing 5" O15392 17 78214186-78225636 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Protease inhibitor, Repressor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.9;lymphoid tissue: 41.0;testis: 19.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.7;Early spermatids: 94.1;Erythroid cells: 166.7;Extravillous trophoblasts: 162.0;Spermatocytes: 191.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 14.1" "Lineage enriched" "Detected in many" 6 "T-cells: 14.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002830, CAB004270" Enhanced Supported "Cytokinetic bridge" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Cytokinetic bridge" "CAB004270: AB_628302, HPA002830: AB_1857672" "unprognostic (8.04e-2)" "unprognostic (3.51e-2)" "unprognostic (4.48e-3)" "unprognostic (2.72e-3)" "unprognostic (3.37e-1)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.28e-6)" "prognostic unfavorable (4.49e-4)" "unprognostic (3.56e-3)" "unprognostic (4.53e-3)" "unprognostic (2.87e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" 0.9 1.1 0.3 8.5 0.5 37.9 5.1 0.6 0.6 1.9 0.4 6.7 7.9 1.6 0.0 12.8 0.6 1.1 0.5 0.4 0.4 0.7 2.1 1.9 16.2 0.6 0.6 0.4 0.6 0.2 0.2 6.1 0.5 0.6 8.0 0.1 1.8 0.2 1.1 5.8 7.6 4.3 0.4 5.8 3.7 19.6 1.0 41.0 0.4 0.1 16.3 2.6 3.2 0.8 139.1 126.2 111.3 121.5 6.7 11.3 41.0 103.6 57.5 144.0 94.2 104.0 52.9 140.7 41.5 60.5 108.7 71.9 113.6 66.6 125.2 48.2 157.5 93.2 71.4 123.1 0.8 90.8 67.0 3.9 4.5 79.8 59.2 21.0 103.5 104.3 118.8 116.0 112.6 79.7 195.5 86.2 83.4 96.3 218.0 100.5 180.2 108.4 34.5 50.2 136.8 94.8 80.3 88.6 71.7 54.1 117.5 84.8 39.5 173.1 152.6 76.0 150.4 83.3 72.2 163.3 63.3 37.8 154.4 0.0 0.0 0.0 0.7 0.0 0.1 2.4 4.1 2.8 0.8 0.2 0.0 0.4 0.5 2.4 0.0 0.2 14.1 3.1 0.3 0.5 0.6 0.6 0.4 0.4 0.6 0.6 0.5 0.4 1.0 0.8 1.2 0.0 20.0 0.0 15.9 8.2 3.7 12.2 2.8 0.7 7.7 8.6 2.3 2.8 10.8 0.0 0.0 74.7 3.3 10.7 0.0 2.0 94.1 5.4 5.1 8.8 3.0 166.7 0.4 0.0 162.0 15.1 8.6 6.9 9.5 42.7 12.8 2.7 52.1 0.0 0.2 17.1 10.2 13.7 13.8 68.4 3.1 9.6 1.8 0.0 0.6 0.4 7.2 0.0 0.3 0.4 2.5 0.7 50.2 2.8 3.2 0.1 2.6 0.5 6.6 0.9 15.2 191.1 58.2 31.3 6.5 19.2 10.1 3.4 38.8 6.3 BLK MGC10442 ENSG00000136573 "BLK proto-oncogene, Src family tyrosine kinase" P51451 8 11486894-11564599 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "intestine: 39.1;lymphoid tissue: 46.7" "Cell type enriched" "Detected in some" 11 "B-cells: 116.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "memory B-cell: 183.4;naive B-cell: 131.5" "Lineage enriched" "Detected in many" 5 "B-cells: 183.4" "Cell line enhanced" "Detected in some" "Daudi: 106.6;REH: 29.9;RPMI-8226: 38.5;U-698: 48.6;U-87 MG: 22.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB005093, HPA069571" Approved Uncertain Nucleoplasm NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "CAB005093: AB_2274756, HPA069571: AB_2732137" "unprognostic (6.50e-5)" "unprognostic (4.22e-3)" "unprognostic (5.64e-2)" "unprognostic (1.42e-1)" "unprognostic (3.45e-1)" "unprognostic (5.98e-6)" "unprognostic (1.59e-2)" "unprognostic (8.94e-4)" "unprognostic (1.02e-3)" "unprognostic (9.83e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (9.05e-6)" "unprognostic (5.62e-2)" "unprognostic (5.43e-2)" "unprognostic (2.19e-1)" "unprognostic (1.16e-1)" 0.5 0.1 0.0 9.1 0.0 2.6 0.2 0.0 0.0 0.0 0.0 2.6 0.5 0.1 0.0 1.2 0.2 0.5 0.1 0.0 0.0 1.2 0.7 0.8 29.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.7 0.0 0.7 0.0 0.3 0.0 39.1 0.1 0.0 46.7 2.1 0.1 0.0 2.5 1.2 0.0 27.9 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 29.9 0.0 38.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 5.4 10.2 48.6 22.7 0.0 0.0 0.2 0.1 0.2 2.0 0.0 37.9 183.4 1.4 4.6 0.1 131.5 0.9 0.4 0.7 0.1 0.1 17.5 1.8 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 116.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.1 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 4.0 0.1 0.1 0.0 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "BLM RecQ like helicase" P54132 15 90717346-90816166 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 0.3 0.2 0.9 3.6 1.1 5.7 0.5 2.3 0.9 0.1 0.3 1.4 1.0 0.4 0.4 0.6 0.3 0.3 0.3 0.8 1.1 0.1 0.1 0.4 6.4 1.2 1.4 0.1 0.2 0.0 0.6 1.2 1.1 0.1 1.7 2.4 7.8 0.0 0.5 0.4 1.6 0.4 1.0 1.6 1.1 2.2 0.9 7.9 0.3 0.1 6.2 1.0 0.2 1.0 13.0 14.4 20.4 12.6 0.1 0.9 14.6 9.4 3.2 11.1 13.4 11.7 10.1 35.1 5.9 2.6 14.1 20.4 25.7 7.1 15.1 19.1 20.5 36.4 14.8 3.9 0.0 33.7 17.3 0.3 0.1 10.6 4.7 1.3 7.9 16.9 32.7 9.9 11.0 7.4 28.3 14.5 22.2 24.9 4.2 25.4 39.1 14.7 2.3 18.9 14.6 14.7 8.5 11.5 4.8 18.1 7.2 23.4 3.7 8.6 13.6 9.6 21.0 6.4 30.4 39.5 5.6 25.8 15.7 1.7 0.6 2.6 1.6 0.8 2.6 4.6 1.4 2.1 0.7 2.3 1.0 1.1 0.7 3.1 1.0 0.7 3.2 0.9 0.9 1.1 2.3 0.9 0.8 1.1 1.2 1.4 1.1 1.0 0.9 1.0 0.9 3.2 8.9 1.0 12.9 0.3 0.5 0.5 0.6 3.6 1.3 1.0 7.9 0.0 4.2 0.0 2.1 5.5 6.9 2.2 1.9 1.0 2.7 1.3 1.3 2.0 0.0 18.3 0.7 0.7 6.8 1.8 3.6 1.7 13.3 8.1 2.2 0.6 5.7 0.0 8.6 1.3 0.0 7.7 1.3 1.6 0.0 7.7 0.0 7.5 2.7 1.7 10.3 58.3 2.6 1.2 0.3 0.4 20.6 0.7 0.2 0.0 5.4 7.1 0.0 0.9 1.7 17.1 12.9 2.2 0.6 1.0 10.2 0.7 4.0 0.4 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025806 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA No 7900000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Nuclear bodies, Plasma membrane" Nucleoplasm "CAB025806: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favorable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.18e-5)" 41.6 5.8 15.8 10.4 15.5 0.2 29.8 13.1 12.1 26.0 33.2 49.1 4.9 46.6 10.1 24.9 63.2 19.3 14.3 17.1 15.2 9.7 1.0 6.6 3.6 53.2 30.1 35.2 16.1 2.7 20.8 2.2 23.2 33.8 4.6 3.2 23.8 21.3 6.3 34.9 18.3 32.6 32.3 4.6 19.0 5.0 26.3 5.7 24.6 9.0 3.1 32.5 25.8 23.4 0.0 7.6 27.6 79.2 113.6 6.0 0.9 12.8 41.9 3.2 2.7 0.0 0.0 0.1 7.8 21.8 1.7 0.0 5.6 2.7 1.1 0.0 3.4 0.0 2.3 0.0 0.6 0.3 0.2 19.7 1.8 1.7 0.2 25.7 0.0 0.0 0.1 0.0 0.6 2.1 0.2 1.4 7.0 0.0 6.9 0.2 12.3 0.0 0.7 0.1 8.2 11.7 0.1 0.5 0.3 8.1 3.4 0.4 0.0 4.5 7.3 0.1 4.2 0.0 0.0 0.0 9.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 15.5 13.1 12.1 17.1 15.2 53.2 30.1 23.2 32.3 26.3 23.4 9.6 0.0 0.5 71.8 0.0 21.2 3.1 3.6 112.1 0.6 3.7 17.3 1.1 1.5 0.7 5.5 0.0 4.8 0.2 0.0 0.0 0.1 1.4 12.6 10.5 5.6 1.8 0.0 8.8 0.0 4.3 55.4 0.5 11.7 0.0 5.7 3.3 0.1 0.8 0.0 2.5 0.0 0.0 0.3 5.5 3.3 84.8 1.0 10.6 6.5 0.0 12.2 0.0 24.1 0.7 0.3 0.0 47.8 0.6 3.3 0.0 0.0 0.3 0.5 0.0 18.0 13.5 1.5 3.2 11.5 11.1 1.9 0.8 1.1 0.0 0.9 BPI BPIFD1 ENSG00000101425 "Bactericidal permeability increasing protein" P17213 20 38304150-38337505 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 88 "bone marrow: 1503.7" "Group enriched" "Detected in some" 8 "Early spermatids: 201.8;Late spermatids: 220.6;Proximal tubular cells: 99.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "classical monocyte: 14.5;neutrophil: 7.1" "Group enriched" "Detected in many" 17 "granulocytes: 7.1;monocytes: 14.5" "Cell line enhanced" "Detected in single" "HL-60: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA061284 Enhanced "Secreted to blood" NA NA 7290000 78000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA061284: AB_2684465" "unprognostic (9.30e-4)" "unprognostic (5.49e-2)" "unprognostic (1.97e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.56e-1)" "unprognostic (4.50e-2)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.60e-2)" "unprognostic (1.50e-1)" "unprognostic (8.83e-6)" "unprognostic (2.66e-4)" "unprognostic (9.29e-2)" "unprognostic (2.32e-2)" "unprognostic (9.47e-3)" 0.5 0.2 0.1 0.1 0.2 1503.7 0.6 0.1 0.4 2.6 0.2 0.2 0.0 0.7 1.0 0.1 0.4 0.5 0.5 0.1 0.2 3.4 0.8 3.7 0.3 0.2 0.2 1.7 0.0 0.0 0.6 0.5 0.2 0.4 0.0 0.0 1.4 1.2 0.1 1.8 0.1 0.2 0.2 13.0 0.1 17.1 0.2 3.7 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.1 0.0 0.6 0.0 0.0 9.8 0.1 0.2 0.1 0.4 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 1.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.3 0.4 0.0 0.4 3.7 0.0 0.0 0.0 0.0 9.8 0.0 201.8 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 20.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 220.6 17.7 1.3 1.8 0.0 7.1 0.0 1.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 99.7 0.3 0.0 0.0 0.2 0.4 2.1 1.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 BPIFB1 "bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP" ENSG00000125999 "BPI fold containing family B member 1" Q8TDL5 20 33273480-33309871 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 566.8;salivary gland: 271.3;stomach 1: 512.5" "Cell type enriched" "Detected in many" 5 "Club cells: 5748.4" "Cancer enhanced" "Detected in many" "stomach cancer: 75.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.7;OE19: 3.8;RT4: 2.2;SK-BR-3: 4.3" "Region enriched" "Detected in single" 6 "olfactory bulb: 4.8" "Low region specificity" "Detected in many" HPA024256 Enhanced "Secreted in other tissues" NA NA 2700000 "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA024256: AB_1845664" "unprognostic (2.42e-1)" "unprognostic (5.41e-2)" "unprognostic (3.67e-2)" "unprognostic (3.09e-1)" "unprognostic (6.72e-2)" "unprognostic (3.43e-2)" "unprognostic (9.37e-3)" "unprognostic (1.14e-1)" "unprognostic (2.82e-1)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (1.36e-7)" "unprognostic (3.30e-1)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" 0.1 0.1 0.0 0.0 0.3 0.0 0.9 0.0 0.1 566.8 0.0 0.5 25.6 0.0 0.0 47.1 0.1 3.4 0.0 0.4 0.0 0.0 0.1 112.5 0.2 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 1.2 0.0 0.0 271.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 512.5 3.5 0.0 0.2 0.0 0.0 1.2 8.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 3.8 0.0 0.4 0.0 0.1 0.0 2.2 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 22.7 0.0 0.0 1.3 1.4 614.0 0.0 0.0 2.0 1.3 0.4 2.8 5748.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 63.6 0.4 0.1 1.1 0.0 0.0 0.2 0.2 0.1 3.0 31.1 0.6 3.8 0.0 0.4 0.1 0.2 0.0 0.1 0.0 1021.3 0.0 1.9 82.9 0.3 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.7 0.0 2.0 0.0 0.0 1027.4 0.0 0.0 0.4 305.5 5.8 0.8 11.6 0.4 0.1 1.0 0.0 0.0 95.9 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61679139-61863528 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0" "Group enriched" "Detected in many" 12 "Early spermatids: 186.2;Late spermatids: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 88.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Cluster 26: Non-specific - Mitochondria" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favorable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favorable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 0.3 0.3 0.8 1.7 0.6 7.2 0.9 1.3 0.9 0.4 0.0 1.7 2.0 0.8 0.4 1.5 0.3 0.6 0.1 0.5 0.2 0.3 1.6 0.4 2.8 0.3 0.0 1.1 0.3 0.1 0.0 0.8 0.4 0.4 1.9 0.5 0.4 0.2 0.1 2.0 1.9 0.9 0.0 0.7 0.9 7.0 0.2 5.9 0.3 0.1 3.3 0.7 0.6 0.8 26.6 9.4 25.0 14.1 0.9 2.1 5.5 23.6 13.3 24.6 31.8 9.5 8.0 14.9 5.2 4.9 7.7 9.2 12.8 4.5 33.3 3.8 15.8 15.5 14.4 10.5 0.2 20.3 8.8 0.6 0.4 20.2 5.1 3.4 5.0 14.8 11.6 10.5 14.4 88.9 32.5 6.7 5.3 5.9 7.3 19.7 50.1 7.1 3.0 12.8 10.0 24.2 9.4 3.0 3.3 9.1 8.3 7.3 4.5 36.9 26.5 13.5 26.6 6.3 13.3 16.6 7.3 9.3 8.8 1.0 0.1 0.4 0.1 0.0 0.1 0.5 0.3 0.1 0.1 0.6 0.4 0.2 0.3 0.1 0.1 0.1 1.0 0.1 0.8 0.6 1.3 0.9 0.5 0.2 0.3 0.0 0.4 0.0 0.2 0.8 0.2 0.0 0.5 1.0 1.6 2.3 1.3 0.8 0.6 0.3 1.1 1.8 0.6 0.0 4.0 0.0 0.0 2.0 2.0 1.8 0.0 0.3 186.2 0.7 1.7 0.8 0.0 7.4 4.6 0.2 3.0 2.0 2.0 1.6 0.0 15.5 0.4 3.4 1.7 0.0 3.3 1.8 0.0 0.8 1.1 194.1 1.2 1.0 3.6 2.8 0.6 0.2 1.0 1.5 1.0 0.8 0.1 1.2 4.8 0.4 1.4 0.2 0.8 0.2 0.0 2.5 1.8 12.1 6.0 2.9 0.4 0.3 2.3 2.1 4.7 0.7 BTBD9 "dJ322I12.1, KIAA1880" ENSG00000183826 "BTB domain containing 9" Q96Q07 6 38168451-38640148 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Astrocytes: 191.3;Excitatory neurons: 390.4;Inhibitory neurons: 257.0;Microglial cells: 142.4;Oligodendrocyte precursor cells: 193.5;Oligodendrocytes: 218.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041930 Uncertain Approved Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "HPA041930: AB_10795270" "unprognostic (4.40e-1)" "unprognostic (1.74e-1)" "unprognostic (1.75e-3)" "unprognostic (1.64e-2)" "unprognostic (6.59e-2)" "unprognostic (3.94e-2)" "unprognostic (1.48e-1)" "unprognostic (1.76e-3)" "unprognostic (5.44e-2)" "unprognostic (6.13e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-1)" "prognostic favorable (4.20e-13)" "unprognostic (1.35e-1)" "unprognostic (6.56e-2)" "unprognostic (8.67e-2)" "unprognostic (1.15e-2)" 4.2 4.7 13.1 4.3 13.2 8.3 3.8 1.8 22.6 3.8 10.1 5.1 5.2 5.2 4.4 5.6 8.7 5.8 8.3 18.8 4.2 6.2 3.2 9.2 4.7 3.0 7.8 8.1 3.5 13.7 4.3 4.3 4.1 5.2 5.6 7.1 4.5 4.1 7.8 5.2 7.2 5.0 0.7 4.8 4.7 8.1 7.5 3.7 6.7 6.7 4.4 4.7 3.5 10.7 5.4 4.7 6.8 8.5 4.6 6.7 5.4 5.3 7.4 5.4 6.3 6.2 3.1 3.1 3.7 8.2 7.3 3.5 3.2 6.7 5.9 7.4 7.0 6.9 5.1 2.5 4.0 6.5 13.4 5.2 6.0 7.4 7.9 4.9 9.3 4.8 3.2 5.2 5.6 3.4 4.6 2.7 2.0 4.9 3.6 3.0 4.7 6.1 5.1 12.3 10.2 5.8 4.5 5.7 5.2 4.6 5.8 5.3 7.0 5.6 3.7 6.6 5.5 3.3 2.5 3.7 4.9 4.4 6.6 12.3 1.8 3.2 2.4 2.6 3.3 2.6 2.4 2.2 1.7 3.7 3.0 2.7 4.5 3.3 4.0 2.6 4.1 1.9 13.1 13.2 1.8 22.6 18.8 4.2 3.0 7.8 4.1 0.7 7.5 10.7 3.9 3.2 17.9 191.3 14.2 4.6 2.2 2.9 4.6 11.5 3.6 2.9 11.8 8.6 6.7 9.2 8.4 2.7 7.3 15.5 5.9 4.6 17.5 12.8 5.3 4.1 4.9 1.3 390.4 5.8 1.5 4.6 10.2 8.1 0.0 5.5 7.5 3.0 2.6 5.0 257.0 3.9 6.1 3.5 3.0 24.6 3.1 5.6 1.8 142.4 1.5 5.9 2.1 193.5 218.3 5.5 5.0 3.4 10.4 2.1 13.1 6.8 8.7 5.6 0.0 5.4 6.1 3.1 2.9 4.4 5.8 4.7 11.1 3.7 6.0 3.2 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 26.4" "Group enriched" "Detected in some" 6 "Early spermatids: 61.3;Late spermatids: 80.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.3;Karpas-707: 4.5;U-266/70: 3.1;U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Endoplasmic reticulum, Golgi apparatus" "HPA057157: AB_2683354" "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 5.2 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.7 1.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 26.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.2 3.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.5 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.2 3.1 1.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 1.0 0.5 0.4 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 80.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 10.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221123 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8;lymphoid tissue: 35.7;testis: 22.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008419 Supported Cytosol Yes Yes "Cluster 24: B-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (7.43e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 0.4 0.5 0.1 6.7 0.1 17.8 1.6 0.3 0.2 1.0 7.7 4.6 4.7 1.2 0.3 5.2 0.6 0.6 0.3 0.3 0.1 0.3 0.4 1.0 12.6 0.0 0.1 0.2 0.2 0.2 0.1 3.4 0.1 0.4 6.0 0.1 0.9 0.2 0.0 3.5 4.1 2.1 0.0 3.1 2.4 22.2 0.2 35.7 0.5 0.0 15.0 1.5 1.7 0.0 66.5 32.8 103.0 41.5 2.5 7.1 33.2 60.9 34.2 64.6 55.7 48.1 25.0 59.7 33.5 22.7 59.0 72.6 98.8 33.2 70.5 51.8 52.1 86.4 83.6 45.5 0.2 79.0 45.7 1.6 2.0 39.2 37.1 12.9 47.7 66.5 76.4 61.7 65.6 22.5 62.5 48.9 70.2 55.6 36.8 66.5 83.7 45.2 19.9 33.1 67.1 40.8 38.0 35.9 13.3 45.1 41.9 40.9 27.6 49.3 51.8 49.2 55.5 32.1 58.2 95.6 26.3 87.8 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.1 0.1 0.1 0.3 0.2 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 3.2 1.1 0.3 1.8 0.8 0.3 1.0 1.8 0.7 0.9 2.0 0.8 0.0 1.9 0.0 0.0 5.4 0.6 1.8 0.0 0.4 3.0 0.9 1.4 1.0 0.0 23.5 0.7 0.0 6.7 2.4 5.6 2.1 0.0 12.9 1.1 0.3 5.2 0.0 0.7 2.5 0.0 1.9 1.7 3.3 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.5 0.4 12.6 0.3 0.3 0.1 0.2 0.2 6.6 0.2 1.7 79.2 26.8 6.9 0.3 0.8 1.8 0.8 5.4 0.6 C10orf53 Em:AC069546.1 ENSG00000178645 "Chromosome 10 open reading frame 53" Q8N6V4 10 49679651-49710261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 39.6" "Group enriched" "Detected in some" 10 "Early spermatids: 499.3;Late spermatids: 1522.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037951 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "HPA037951: AB_10671382" "unprognostic (9.09e-2)" 0.0 0.0 0.4 0.0 0.3 0.3 0.0 1.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 39.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.3 1.8 0.8 0.2 0.4 0.7 0.6 0.4 0.1 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 499.3 2.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1522.4 4.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 98.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf16 ENSG00000176029 "Chromosome 11 open reading frame 16" Q9NQ32 11 8920076-8933006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 6.2;fallopian tube: 12.9;lymphoid tissue: 6.2" "Group enriched" "Detected in some" 8 "Endometrial ciliated cells: 40.8;Ionocytes: 28.5;Respiratory ciliated cells: 110.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA040644 Uncertain "Endoplasmic reticulum,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "Endoplasmic reticulum" Vesicles "HPA040644: " "unprognostic (5.32e-3)" "unprognostic (1.03e-2)" "unprognostic (4.09e-3)" "prognostic favorable (3.32e-4)" "unprognostic (1.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.94e-5)" "unprognostic (6.40e-4)" "unprognostic (1.58e-2)" "unprognostic (9.99e-2)" "unprognostic (4.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.71e-1)" "unprognostic (1.13e-3)" 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.3 0.1 1.0 6.2 0.0 0.0 0.3 0.0 0.0 12.9 0.0 0.0 0.3 0.7 0.3 0.0 2.6 0.0 1.3 2.3 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 2.2 0.6 6.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.1 0.3 0.7 1.3 2.3 0.8 1.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.1 0.0 0.0 7.1 5.5 0.0 0.1 0.0 0.0 0.0 0.0 1.6 40.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 28.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 110.8 0.0 0.0 0.0 1.5 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C11orf53 MGC50104 ENSG00000150750 "Chromosome 11 open reading frame 53" Q8IXP5 11 111245726-111286401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 3.4;testis: 5.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "OE19: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA056128, HPA073101" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm Vesicles "HPA056128: AB_2683046, HPA073101: " "unprognostic (3.51e-2)" "unprognostic (3.60e-2)" "unprognostic (4.84e-2)" "unprognostic (5.84e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-3)" "unprognostic (5.60e-3)" "unprognostic (3.09e-1)" "unprognostic (2.50e-1)" "unprognostic (9.95e-2)" "unprognostic (8.66e-2)" "unprognostic (3.52e-2)" 0.9 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.1 0.0 1.4 0.9 0.9 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.6 1.3 0.4 0.7 0.0 0.3 1.0 0.0 2.1 0.0 1.8 0.0 1.2 0.0 0.0 0.0 3.4 5.5 0.0 0.4 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 0.1 0.1 14.3 3.3 0.0 0.0 0.0 0.1 1.5 0.0 1.9 38.1 0.0 1.4 0.0 7.7 0.0 0.1 56.6 0.1 1.9 3.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 3.0 8.2 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.2 0.3 4.0 0.0 9.9 0.0 0.0 0.1 0.6 1.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 4.4 C11orf97 LINC01171 ENSG00000257057 "Chromosome 11 open reading frame 97" A0A1B0GVM6 11 94512461-94532123 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "fallopian tube: 19.1;testis: 18.2" "Group enriched" "Detected in some" 5 "Early spermatids: 239.3;Endometrial ciliated cells: 258.2;Respiratory ciliated cells: 109.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (4.18e-1)" "unprognostic (4.70e-1)" "unprognostic (9.64e-3)" "unprognostic (9.44e-3)" "unprognostic (3.86e-3)" 0.0 0.0 1.4 0.0 2.6 0.3 0.0 0.2 1.7 1.2 4.0 0.0 0.0 0.5 0.1 0.0 19.1 0.1 0.0 1.5 1.1 0.9 1.3 2.5 0.0 2.2 2.5 0.0 0.5 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 18.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.6 0.2 1.7 1.5 1.1 2.2 2.5 1.6 1.9 1.5 1.5 0.0 3.2 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 11.2 0.0 0.0 0.3 0.0 0.1 0.0 0.4 239.3 258.2 1.4 0.6 0.0 0.0 3.4 0.2 0.0 0.5 0.0 3.2 0.0 0.0 0.0 4.5 0.1 0.0 2.0 0.0 0.0 0.0 0.0 34.4 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 18.1 109.3 0.0 0.0 0.0 0.0 37.9 9.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 92.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 16 "hypothalamus: 2.9;thalamus: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 0.3 1.8 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.8 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.5 4.8 0.0 0.0 1.1 0.0 2.7 4.6 0.1 3.0 0.0 0.1 0.1 0.0 0.0 0.3 10.8 2.4 0.1 0.2 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 6.2 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.7 0.0 0.1 0.0 28.3 0.0 0.0 2.0 0.0 23.9 0.3 3.0 0.0 1.4 0.0 6.2 0.0 0.4 1.7 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 12.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.9 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.5 0.0 0.9 0.0 0.1 0.7 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.9 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.0 1.0 0.0 12.3 0.0 1.0 0.7 0.0 0.0 0.7 0.0 0.8 0.0 0.0 1.2 1.1 0.0 10.0 0.2 92.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408495-55418798 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 168.5;Endometrial ciliated cells: 79.4;Respiratory ciliated cells: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.7" "Cell line enhanced" "Detected in many" "hTCEpi: 13.2;SK-MEL-30: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067189 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Cytosol "HPA067189: AB_2685800" "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favorable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 1.3 2.1 2.8 0.5 3.0 0.6 3.2 2.6 3.4 4.3 5.3 4.0 1.8 1.9 6.0 0.8 7.9 3.1 5.6 2.8 3.1 7.2 1.3 2.3 1.1 3.6 3.5 1.2 8.5 4.6 8.9 0.5 3.4 3.3 3.6 7.5 9.0 2.7 6.9 1.4 1.6 2.1 3.1 1.2 6.3 9.0 3.0 1.5 4.0 2.8 1.1 1.6 1.1 2.9 0.9 1.3 2.7 1.7 4.0 5.8 0.4 1.5 2.2 1.2 2.5 0.0 1.5 1.2 4.0 5.1 3.2 1.2 0.0 2.5 0.4 2.5 1.8 1.2 9.3 0.4 7.6 2.8 1.5 1.9 13.2 3.8 1.0 6.9 2.4 0.0 2.3 4.0 5.8 2.1 0.1 7.6 0.7 4.8 3.0 0.5 0.0 10.5 7.0 0.0 7.7 4.3 1.9 3.2 13.0 1.1 6.4 2.7 1.8 2.1 0.9 2.0 0.7 1.8 4.8 1.0 5.9 6.7 1.1 4.7 0.4 1.7 0.2 0.7 0.0 0.9 0.0 0.3 0.3 0.8 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 2.8 3.0 2.6 3.4 2.8 3.1 3.6 3.5 3.4 3.1 3.0 2.9 3.3 3.2 1.1 4.6 3.3 1.3 3.7 13.1 2.2 1.7 8.6 10.8 7.8 5.7 8.0 5.5 0.0 1.1 0.5 6.7 17.6 8.8 168.5 79.4 4.1 3.9 3.6 0.4 4.0 11.0 1.5 3.6 5.1 7.2 4.5 1.9 4.6 1.7 2.9 3.3 2.7 18.8 14.2 1.9 1.9 17.0 4.4 1.0 3.6 1.0 0.8 5.1 0.0 1.0 0.9 6.6 16.8 5.7 2.6 4.8 1.9 22.5 47.5 8.2 6.6 3.2 3.4 23.9 3.6 0.8 1.7 0.0 1.0 4.2 4.8 2.1 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.9" "Cell type enhanced" "Detected in many" "Early spermatids: 94.7;Late spermatids: 112.4;Respiratory ciliated cells: 31.8;Spermatocytes: 32.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 0.5 0.5 1.9 0.4 1.9 0.6 0.8 1.6 2.8 0.7 4.0 0.3 0.2 0.7 1.2 0.3 2.7 0.4 0.3 2.2 2.1 1.0 1.0 0.4 0.1 2.0 2.2 0.4 0.7 0.5 1.8 0.7 2.1 0.9 0.2 1.3 0.4 0.4 0.7 0.1 0.2 0.4 1.9 0.2 0.3 5.9 2.1 0.2 2.8 0.3 0.2 0.6 0.4 2.4 1.2 0.2 0.4 0.2 2.0 0.4 1.1 0.2 1.5 0.8 0.5 0.2 1.7 0.3 0.7 0.3 1.0 0.4 0.4 0.8 1.5 0.3 0.3 0.3 0.9 1.1 1.2 0.4 0.9 0.8 0.6 2.0 1.2 0.9 0.7 0.6 0.8 0.6 0.6 0.9 0.1 2.4 0.5 0.4 0.2 0.9 0.1 0.2 1.4 0.7 0.6 0.5 1.7 0.5 0.3 0.7 0.5 0.6 0.6 0.4 0.2 0.3 0.3 0.6 1.0 0.7 0.7 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 1.6 2.8 2.2 2.1 2.0 2.2 2.1 1.9 2.1 2.4 1.0 0.0 2.3 11.4 0.5 1.9 8.9 6.4 2.2 2.3 5.7 3.2 2.3 4.3 4.6 0.0 4.2 8.2 0.3 0.6 5.9 1.2 94.7 17.3 2.0 1.7 1.2 0.4 12.1 0.4 15.8 2.1 0.5 1.7 0.0 0.3 1.1 3.3 3.3 0.0 9.0 1.7 8.2 0.6 1.0 112.4 8.1 1.5 5.4 1.0 0.3 5.6 1.0 7.1 16.3 0.5 0.6 7.5 0.5 7.5 0.1 3.9 31.8 8.1 0.0 3.1 2.0 32.7 6.8 0.8 2.7 6.3 0.7 0.8 0.8 5.0 C16orf71 "DKFZp686H2240, FLJ43261" ENSG00000166246 "Chromosome 16 open reading frame 71" Q8IYS4 16 4734344-4749396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 22.5;testis: 74.0" "Cell type enhanced" "Detected in some" "Early spermatids: 37.1;Late spermatids: 62.0;Respiratory ciliated cells: 22.6;Spermatocytes: 122.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 4.6;U-2197: 5.0" "Low region specificity" "Detected in all" HPA049468 Enhanced Uncertain "Nuclear speckles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA049468: AB_2680779" "unprognostic (1.24e-2)" "unprognostic (8.87e-2)" "unprognostic (2.39e-1)" "prognostic favorable (7.49e-4)" "unprognostic (7.06e-2)" "unprognostic (2.17e-2)" "unprognostic (5.36e-3)" "unprognostic (2.21e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-2)" "unprognostic (6.79e-3)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-5)" "unprognostic (1.65e-1)" 0.7 1.3 1.0 0.7 1.4 0.2 0.7 2.2 1.6 1.4 9.2 0.8 0.6 1.0 2.7 0.7 22.5 1.4 0.8 1.5 1.4 1.8 1.3 2.8 0.4 4.5 5.7 1.2 1.1 0.9 4.1 0.2 2.6 1.1 0.3 1.7 1.2 0.7 1.0 0.5 0.4 0.8 3.3 0.4 0.8 74.0 1.5 0.6 2.0 1.1 0.4 0.7 0.5 1.6 0.3 2.0 0.4 1.1 2.6 1.1 0.8 1.1 0.9 0.9 1.1 0.9 0.8 0.0 1.0 1.6 2.6 0.9 0.9 1.1 0.2 0.4 0.6 0.2 1.5 0.1 0.8 0.9 0.3 0.3 0.2 3.4 0.9 0.7 0.4 0.8 0.7 0.5 0.9 4.6 0.2 0.8 0.6 1.3 1.0 0.3 0.4 1.4 2.3 0.4 3.0 1.1 1.1 0.9 0.3 0.7 4.0 0.2 0.4 0.7 0.8 5.0 0.5 2.0 1.7 0.5 0.4 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.3 1.1 0.0 0.1 1.0 1.4 2.2 1.6 1.5 1.4 4.5 5.7 2.6 3.3 1.5 1.6 0.1 0.0 1.1 1.0 0.1 0.0 0.2 1.0 0.6 0.9 0.6 0.5 1.2 0.0 3.9 0.0 4.2 0.3 0.2 0.2 0.0 0.6 37.1 15.6 0.6 0.2 0.0 0.0 1.0 0.0 0.1 0.3 3.6 0.6 0.0 0.2 0.0 0.3 0.2 0.0 0.9 0.1 0.0 0.0 0.0 62.0 1.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 1.5 0.0 0.1 0.0 2.4 22.6 1.7 0.0 0.2 0.7 122.1 7.2 0.5 0.0 0.1 0.2 0.3 0.3 0.0 C17orf97 "LIAT1, LOC400566" ENSG00000187624 "Chromosome 17 open reading frame 97" Q6ZQX7 17 410325-431062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 58.8" "Group enriched" "Detected in many" 5 "Early spermatids: 546.2;Late spermatids: 1313.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 7.0;U-2197: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023583 Approved Approved Nucleoli,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 18: U-2197 - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" Nucleoli Cytosol "HPA023583: AB_1853122" "unprognostic (6.62e-2)" "unprognostic (9.12e-3)" "unprognostic (2.64e-1)" "unprognostic (3.07e-3)" "unprognostic (7.73e-2)" "unprognostic (6.51e-2)" "unprognostic (6.91e-2)" "unprognostic (3.17e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-1)" "unprognostic (5.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.98e-3)" "unprognostic (7.70e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-2)" "unprognostic (4.19e-2)" 2.1 5.2 1.2 1.0 1.6 0.7 2.8 0.6 2.4 4.1 2.9 4.0 0.8 3.9 1.8 3.2 8.9 1.8 3.8 1.2 1.0 8.5 2.7 2.8 1.2 1.6 2.6 3.8 2.9 1.9 7.0 0.3 1.3 3.1 1.1 2.7 3.1 2.4 4.7 3.7 2.5 0.6 1.4 1.5 3.0 58.8 1.1 1.9 6.9 0.7 0.6 2.7 2.5 1.2 2.1 3.0 1.4 1.7 0.7 0.6 0.7 1.5 1.0 1.1 0.7 0.0 3.1 0.5 1.1 3.4 0.9 7.0 3.8 0.8 1.1 0.3 0.4 1.5 2.6 0.2 2.5 0.3 0.6 0.7 1.9 2.6 0.3 1.6 1.2 3.4 0.2 0.0 0.7 1.8 5.2 2.7 2.1 6.2 0.9 0.5 0.3 1.9 4.8 1.7 0.4 1.6 1.9 2.6 0.4 2.3 1.6 2.3 1.1 1.4 0.7 9.1 0.6 0.2 0.2 0.0 1.7 0.7 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 1.2 1.6 0.6 2.4 1.2 1.0 1.6 2.6 1.3 1.4 1.1 1.2 1.4 3.2 5.9 2.6 0.8 3.3 3.5 6.5 0.0 4.3 7.7 6.0 6.1 7.2 9.5 20.2 20.9 1.6 0.9 18.4 62.6 13.3 546.2 87.1 6.3 3.3 16.1 5.7 3.3 3.5 0.3 3.5 4.6 8.4 2.5 8.6 2.5 5.3 1.9 1.7 3.1 8.5 14.2 0.0 1.5 1313.1 8.4 2.0 3.6 1.9 3.1 13.5 0.0 0.5 0.9 4.7 6.4 6.4 0.1 4.5 3.8 28.0 55.8 26.4 6.6 3.4 4.6 156.2 12.4 1.8 1.0 0.8 0.8 15.4 10.4 1.6 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304164-38305006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 515.3;skin 1: 331.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "myeloid DC: 22.2" "Lineage enriched" "Detected in many" 10 "dendritic cells: 22.2" "Cell line enhanced" "Detected in many" "A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8" "Not detected" "Not detected" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 460000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "Plasma membrane, Cytosol" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 43.1 5.0 2.8 17.6 3.1 3.6 25.5 2.9 4.4 82.4 2.9 187.5 186.7 6.1 0.6 515.3 91.5 49.5 32.9 2.3 2.6 28.2 1.3 91.3 0.9 3.1 3.0 4.6 8.9 0.5 12.7 7.9 3.4 26.2 104.1 0.1 123.3 18.3 3.9 331.1 189.5 4.0 2.5 10.7 151.5 1.5 3.8 4.1 18.9 4.3 30.8 102.2 224.3 2.5 745.5 1228.0 0.0 0.6 0.0 0.0 1.2 1.0 0.0 0.0 0.0 77.1 767.1 0.0 394.2 0.0 0.7 300.1 0.0 744.6 0.0 0.4 0.5 0.4 244.2 20.0 5.4 0.0 0.2 0.0 799.2 0.3 493.3 3.3 10.2 0.9 0.4 0.5 0.8 220.4 0.1 1.9 0.4 678.3 659.8 0.2 0.2 2.8 469.5 255.2 0.8 0.8 416.6 340.8 0.8 1.6 103.7 2.3 141.6 0.5 201.9 0.7 2.8 0.7 2.4 3.7 0.1 0.2 0.2 2.1 0.6 2.2 0.2 0.0 0.4 0.1 0.5 0.1 22.2 1.4 0.7 0.3 1.0 0.4 0.1 1.8 0.0 18.2 2.8 3.1 2.9 4.4 2.3 2.6 3.1 3.0 3.4 2.5 3.8 2.5 29.1 535.2 172.9 0.0 5.4 225.3 28.4 508.7 436.5 0.0 32.5 25.5 2.4 267.4 418.0 55.2 0.0 8.6 1.7 2060.3 1.9 207.7 0.7 144.3 26.0 18.4 76.1 3.6 0.1 753.8 1.3 44.7 353.7 273.2 38.2 3.7 3.6 0.4 1.3 0.0 0.0 842.0 99.7 1.4 15.1 5.1 4.1 32.9 1.8 0.0 4.9 0.0 0.0 0.0 0.0 2590.4 1697.3 0.0 5.7 35.7 1756.4 51.7 212.5 0.0 0.0 0.4 14.3 1.8 1.9 629.0 348.4 3.1 7.9 0.0 691.9 188.4 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 98.0" "Cell type enhanced" "Detected in many" "Kupffer cells: 90.1;Langerhans cells: 33.4;Macrophages: 59.2;monocytes: 86.7;Plasma cells: 24.7;Spermatocytes: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 20 "classical monocyte: 282.3;eosinophil: 169.4;intermediate monocyte: 312.5;myeloid DC: 162.2;neutrophil: 230.1;non-classical monocyte: 392.8" "Group enriched" "Detected in all" 20 "dendritic cells: 162.2;granulocytes: 230.1;monocytes: 392.8" "Cell line enriched" "Detected in some" 4 "U-937: 50.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 3.6 1.0 3.5 11.2 3.9 98.0 1.2 4.2 4.5 2.1 3.5 1.8 1.7 1.0 2.7 1.0 2.3 2.9 0.9 3.4 4.1 1.2 3.2 6.1 5.2 5.2 4.3 2.0 1.7 0.4 0.8 1.8 5.2 1.3 1.2 0.7 0.9 0.9 2.7 0.5 2.3 3.4 4.6 21.7 1.6 11.1 4.0 3.2 0.5 1.5 3.0 4.6 1.6 6.0 2.4 0.1 0.2 0.4 2.2 1.2 0.2 0.4 0.1 0.4 0.9 0.2 0.4 5.9 0.5 0.0 0.2 0.2 0.3 0.3 0.3 2.7 0.6 0.3 0.0 0.0 1.6 3.9 0.6 6.0 0.7 1.0 0.3 0.1 0.1 0.6 0.3 12.2 0.2 2.2 0.2 9.3 0.5 0.4 0.4 4.5 0.0 3.1 0.0 0.2 0.3 0.1 1.2 0.0 0.9 0.1 0.2 8.7 0.0 0.1 0.0 1.1 0.1 7.3 3.7 1.7 0.0 50.9 0.0 7.8 282.3 169.4 0.6 312.5 1.6 13.0 0.8 0.8 162.2 8.5 4.9 1.5 230.1 8.0 392.8 3.6 2.3 157.7 3.5 3.9 4.2 4.5 3.4 4.1 5.2 4.3 5.2 4.6 4.0 6.0 0.3 0.0 1.8 1.6 10.6 0.8 0.4 2.1 1.2 0.1 0.6 0.5 1.1 0.0 1.7 1.8 2.1 1.0 0.7 0.3 0.0 0.1 3.7 0.9 0.3 1.1 0.0 4.8 0.9 1.3 0.9 1.6 4.1 1.0 2.5 0.3 0.4 1.1 22.3 0.0 0.9 0.6 2.0 90.1 33.4 6.1 0.9 59.2 1.8 0.0 86.7 3.1 4.1 0.0 3.1 0.1 3.5 0.7 24.7 0.3 0.2 0.7 5.1 1.1 6.6 0.5 0.6 28.5 19.2 0.3 0.9 0.7 2.1 0.1 0.6 0.6 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.7;testis: 15.5" "Cell type enhanced" "Detected in some" "Early spermatids: 117.8;Granulosa cells: 23.1;Late spermatids: 94.7;Muller glia cells: 63.0;Respiratory ciliated cells: 53.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 44 "HEL: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA035316 Uncertain "Intermediate filaments" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.6 0.2 2.7 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.3 0.6 0.0 0.0 1.0 0.0 1.3 0.9 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 15.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.2 0.6 0.3 0.6 1.3 0.9 0.5 1.1 0.3 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.2 0.0 9.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 117.8 3.8 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 23.1 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 94.7 1.8 0.2 0.0 0.0 0.0 63.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 53.8 2.1 0.0 0.0 1.4 8.8 0.9 0.0 0.0 0.1 0.0 4.0 0.0 0.0 C1orf158 MGC35194 ENSG00000157330 "Chromosome 1 open reading frame 158" Q8N1D5 1 12746200-12763699 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 18.1;fallopian tube: 26.7;testis: 48.9" "Cell type enhanced" "Detected in some" "Early spermatids: 223.3;Endometrial ciliated cells: 50.3;Late spermatids: 92.8;Respiratory ciliated cells: 88.1;Spermatocytes: 70.7" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028396 Uncertain Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA028396: AB_10603451" "unprognostic (1.11e-2)" "unprognostic (4.94e-3)" "unprognostic (4.62e-1)" "unprognostic (8.00e-2)" "unprognostic (4.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.45e-1)" "unprognostic (3.51e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.9 0.0 1.1 0.3 0.0 1.0 0.4 1.1 18.1 0.0 0.0 0.4 0.1 0.1 26.7 0.0 0.0 0.9 1.0 0.0 0.0 1.9 0.1 4.3 5.9 0.1 0.1 0.0 0.6 0.1 3.4 0.0 0.0 0.1 0.1 0.0 1.2 0.4 0.0 0.0 3.3 0.1 0.1 48.9 1.9 0.0 0.6 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.9 1.1 1.0 0.4 0.9 1.0 4.3 5.9 3.4 3.3 1.9 3.6 0.0 3.2 0.5 0.3 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.3 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 223.3 50.3 0.4 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 92.8 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.1 88.1 0.0 6.6 0.1 1.3 70.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 C1orf189 ENSG00000163263 "Chromosome 1 open reading frame 189" Q5VU69 1 154199085-154206333 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 30.5;testis: 19.7" "Cell type enhanced" "Detected in some" "Early spermatids: 88.7;Endometrial ciliated cells: 30.7;Late spermatids: 19.6;Respiratory ciliated cells: 25.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045779 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Golgi apparatus, Plasma membrane" "HPA045779: AB_2679448" "unprognostic (8.23e-3)" "unprognostic (5.55e-3)" "unprognostic (2.39e-2)" "unprognostic (2.01e-3)" "unprognostic (2.50e-3)" "unprognostic (2.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.24e-2)" "unprognostic (8.78e-3)" "unprognostic (1.36e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (3.75e-2)" "unprognostic (2.06e-1)" "unprognostic (9.79e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.2 0.1 0.3 0.5 0.1 0.4 0.4 1.6 0.6 0.0 0.0 0.5 0.3 0.1 30.5 0.0 0.1 0.3 0.4 0.1 0.3 1.8 0.1 1.6 3.4 0.1 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.1 0.0 0.9 0.0 0.1 19.7 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.4 0.2 0.4 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.5 0.1 0.1 0.5 0.2 0.5 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.3 0.0 0.4 0.2 0.2 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.4 0.4 0.3 0.4 1.6 3.4 1.2 0.9 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.7 30.7 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 25.1 0.0 0.0 0.0 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 106.5;testis: 147.9" "Cell type enhanced" "Detected in some" "Early spermatids: 2151.8;Endometrial ciliated cells: 931.5;Late spermatids: 3412.7;Respiratory ciliated cells: 808.8;Spermatocytes: 514.1" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.1" "Lineage enriched" "Detected in single" 16 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 1.5;SCLC-21H: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: AB_2680849" "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.0 0.1 1.7 0.0 1.9 0.0 0.2 2.1 2.8 2.1 14.0 0.4 0.3 1.1 1.2 0.1 106.5 0.0 0.1 2.3 1.8 0.2 0.0 4.4 0.0 3.3 3.3 0.1 0.9 0.2 2.4 0.0 2.8 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 2.1 0.0 0.3 147.9 2.2 0.3 0.3 0.0 0.0 0.3 0.0 2.3 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 1.9 2.1 2.8 2.3 1.8 3.3 3.3 2.8 2.1 2.2 2.3 0.0 0.0 4.1 0.7 0.2 0.0 0.2 53.9 0.0 0.6 0.8 0.9 3.5 0.0 61.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2151.8 931.5 6.1 1.8 0.0 0.0 1.1 0.2 0.0 0.7 0.0 11.2 3.8 0.0 0.0 0.0 0.1 0.0 1.0 0.4 57.0 0.0 0.3 3412.7 21.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 18.8 0.0 2.4 0.0 0.8 808.8 0.0 6.6 0.2 9.0 514.1 20.2 0.0 0.1 0.0 1.1 0.0 0.2 0.4 C1orf87 "CREF, MGC34837" ENSG00000162598 "Chromosome 1 open reading frame 87" Q8N0U7 1 59987269-60073770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 9.1;fallopian tube: 29.9" "Cell type enhanced" "Detected in some" "Early spermatids: 113.0;Endometrial ciliated cells: 63.0;Late spermatids: 25.4;Respiratory ciliated cells: 101.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031366, HPA031368" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "HPA031366: AB_2673847, HPA031368: AB_10600795" "unprognostic (1.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.83e-2)" "unprognostic (1.92e-2)" "unprognostic (6.69e-2)" "unprognostic (7.11e-2)" "unprognostic (8.95e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" 0.0 0.0 2.2 0.0 2.6 0.0 0.0 0.6 0.9 1.0 3.2 0.0 0.0 0.5 0.0 0.0 29.9 0.0 0.0 1.5 2.3 0.1 0.0 3.2 0.0 8.4 9.1 0.0 0.0 0.6 0.3 0.0 5.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 2.6 0.6 0.9 1.5 2.3 8.4 9.1 5.9 6.2 2.4 2.7 0.0 0.0 1.5 4.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 11.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 113.0 63.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 0.0 25.4 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.7 0.0 0.0 0.0 0.7 11.4 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 C1QTNF8 "CTRP8, UNQ5829" ENSG00000184471 "C1q and TNF related 8" P60827 16 1088226-1096244 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.8;fallopian tube: 1.8;pituitary gland: 2.0" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Endometrial ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056438 Uncertain "Secreted - unknown location" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 49: Ciliated cells - Cilium organization" "HPA056438: AB_2683134" "unprognostic (8.65e-2)" "unprognostic (2.56e-2)" "unprognostic (5.46e-2)" 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.9 0.0 0.0 0.1 0.0 1.9 2.8 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.4 0.5 0.9 1.9 2.8 1.2 2.1 0.8 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1R ENSG00000159403 "Complement C1r" 12 7080214-7092540 "Human disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 1425.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 442.3;Fibroblasts: 684.4;Hepatocytes: 1444.2;Leydig cells: 1142.6;Peritubular cells: 388.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1089.8;ASC TERT1: 546.0;BJ hTERT+: 461.9;BJ hTERT+ SV40 Large T+ RasG12V: 303.4;HSkMC: 672.1" "Low region specificity" "Detected in many" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" "HPA001251: AB_2666252, HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 540.6 203.6 15.8 122.4 15.9 1.1 400.6 15.9 23.3 470.5 21.7 277.3 38.3 353.8 80.8 119.0 526.3 279.1 458.7 15.4 19.6 148.9 1425.6 340.3 72.4 23.4 19.9 644.3 88.0 11.0 63.9 52.4 18.4 205.2 100.9 5.8 158.3 87.0 69.4 177.7 228.1 157.7 18.1 192.1 242.7 46.7 18.1 34.7 223.4 74.2 75.3 468.4 394.3 18.0 1.2 8.9 0.9 9.1 1089.8 546.0 0.4 108.9 461.9 143.0 303.4 1.4 2.4 0.5 4.5 108.8 11.8 2.3 11.8 5.5 18.3 18.3 1.1 0.5 4.1 3.6 226.5 0.8 2.3 672.1 3.2 74.7 4.7 121.0 2.9 0.5 0.3 20.5 21.2 0.1 8.0 0.8 3.1 0.1 0.9 8.6 3.8 0.8 0.9 5.5 0.4 2.3 95.1 3.7 2.8 1.3 0.2 0.2 0.4 38.3 6.3 152.1 0.8 1.1 3.0 0.2 53.1 1.0 5.4 0.0 0.0 0.6 0.3 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.6 0.6 0.5 0.8 0.0 0.0 0.3 0.1 15.8 15.9 15.9 23.3 15.4 19.6 23.4 19.9 18.4 18.1 18.1 18.0 45.4 22.4 90.5 3.6 7.1 54.7 58.8 76.6 33.6 0.3 5.9 30.9 20.8 183.0 22.9 18.4 2.1 4.1 1.8 0.7 3.9 280.8 4.6 13.3 442.3 45.4 0.0 40.6 0.9 44.5 3.7 684.4 16.3 11.6 10.1 24.9 114.9 1444.2 11.2 0.0 0.3 0.7 0.0 40.9 66.9 29.2 1142.6 7.0 53.4 13.1 1.6 16.0 0.0 2.5 0.1 51.1 1.3 388.1 6.2 17.7 0.3 6.1 5.3 1.4 170.9 87.5 140.4 6.8 6.7 5.6 40.1 5.2 11.5 15.2 0.7 11.2 C20orf85 "bA196N14.1, LLC1" ENSG00000124237 "Chromosome 20 open reading frame 85" Q9H1P6 20 58150902-58161150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "fallopian tube: 455.2" "Group enriched" "Detected in some" 6 "Early spermatids: 412.1;Endometrial ciliated cells: 1096.5;Late spermatids: 413.4;Respiratory ciliated cells: 1504.4" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 57.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "basal ganglia: 1.6" "Region enhanced" "Detected in many" "midbrain: 20.0" "HPA058271, HPA065540" Enhanced NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "HPA058271: AB_2683661, HPA065540: AB_2685510" "unprognostic (4.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "unprognostic (6.46e-2)" "unprognostic (3.62e-1)" "unprognostic (2.79e-2)" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 12.9 1.3 0.0 0.0 5.1 0.2 0.0 455.2 0.0 0.0 0.1 1.0 0.1 0.0 25.5 0.0 2.2 3.1 0.3 0.0 0.0 0.4 0.0 1.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.2 0.1 0.1 77.9 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 1.0 2.2 3.1 1.0 2.2 0.9 0.1 0.0 0.0 9.9 0.0 0.0 0.0 0.0 98.3 0.0 0.0 0.0 0.0 0.0 0.0 122.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 412.1 1096.5 6.2 0.9 0.0 0.0 0.1 0.0 0.0 1.2 0.0 11.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 120.1 0.0 0.0 413.4 3.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.1 1504.4 0.0 0.0 0.0 34.5 95.9 3.1 0.0 0.0 0.0 1.2 0.0 0.0 0.3 C20orf96 dJ1103G7.2 ENSG00000196476 "Chromosome 20 open reading frame 96" Q9NUD7 20 270863-290778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 109.6;Endometrial ciliated cells: 89.2;Respiratory ciliated cells: 106.2;Spermatocytes: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048649, HPA056227" Approved Approved "Centriolar satellite" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Centriolar satellite" "HPA048649: AB_2680476, HPA056227: " "unprognostic (1.59e-2)" "unprognostic (4.15e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-1)" "unprognostic (8.21e-2)" "prognostic unfavorable (6.12e-5)" "unprognostic (4.62e-2)" "unprognostic (5.12e-1)" "unprognostic (3.24e-1)" "prognostic favorable (4.12e-5)" "unprognostic (2.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "prognostic favorable (1.05e-4)" 6.6 10.5 13.5 5.3 13.1 8.1 10.2 12.6 13.7 16.8 20.5 11.0 9.6 16.6 20.7 4.4 33.5 8.8 8.3 13.6 13.6 15.1 6.2 10.2 5.4 17.2 20.8 20.3 9.2 8.4 17.3 3.8 17.3 13.9 8.3 11.2 9.8 7.8 3.5 3.6 9.2 10.3 16.6 9.6 9.8 30.1 14.3 6.7 17.1 2.3 4.6 8.9 8.1 13.4 7.5 23.3 23.9 21.1 6.2 6.0 10.6 5.3 6.8 7.7 10.3 4.5 14.3 18.7 3.4 6.4 13.4 6.4 8.9 4.1 8.9 4.7 13.9 12.5 0.2 25.6 17.2 10.3 5.2 8.3 3.5 13.2 1.6 19.4 15.6 23.6 25.9 9.1 6.7 3.7 12.2 39.9 7.9 7.4 10.1 36.9 4.2 15.4 12.1 11.5 2.5 21.3 6.3 9.0 15.3 11.0 15.6 22.7 10.5 7.6 13.1 6.8 4.4 20.7 22.5 12.8 4.2 31.9 7.2 0.0 1.3 0.0 0.6 1.0 0.4 1.6 0.4 0.5 3.0 1.7 0.9 1.2 0.0 1.3 0.7 1.4 0.6 0.8 13.5 13.1 12.6 13.7 13.6 13.6 17.2 20.8 17.3 16.6 14.3 13.4 7.2 3.2 3.6 13.4 4.1 3.7 5.5 9.9 9.1 3.8 21.8 19.2 0.8 11.5 12.5 18.4 6.2 5.1 2.8 5.0 39.2 11.4 109.6 89.2 11.0 10.4 8.4 9.7 5.1 6.9 3.1 9.1 15.8 7.1 14.7 18.6 9.7 3.4 9.1 6.7 4.0 8.1 26.4 3.8 3.3 35.8 10.8 7.7 3.6 4.7 3.7 7.7 4.1 2.0 4.6 8.5 1.9 18.0 10.7 4.9 4.6 23.1 106.2 9.8 6.6 6.5 8.7 60.8 45.1 4.3 1.6 2.7 4.1 9.8 9.3 4.2 C21orf58 ENSG00000160298 "Chromosome 21 open reading frame 58" P58505 21 46300181-46323875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.4;pituitary gland: 20.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "REH: 62.0" "Not detected" "Not detected" "HPA035110, HPA035111" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 14: REH - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nuclear bodies" "HPA035110: AB_10603683, HPA035111: AB_2674468" "unprognostic (2.19e-1)" "unprognostic (6.74e-3)" "unprognostic (2.51e-1)" "unprognostic (6.31e-3)" "unprognostic (1.08e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.74e-3)" "unprognostic (6.14e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (1.38e-1)" "prognostic favorable (4.20e-4)" "unprognostic (1.27e-1)" "unprognostic (1.01e-10)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (6.07e-2)" 1.5 1.7 1.9 3.6 2.4 13.1 2.0 2.6 2.3 3.5 3.0 3.2 4.7 2.0 0.7 3.9 26.4 1.0 1.3 1.8 1.9 1.5 1.7 4.8 6.3 2.8 4.6 2.6 2.5 1.2 20.7 2.0 2.0 2.9 2.6 2.5 2.3 1.5 1.7 5.3 4.4 1.3 1.8 3.4 3.5 7.1 2.5 12.8 2.1 0.7 3.8 2.1 2.7 3.2 26.0 11.6 30.2 19.0 2.9 4.0 16.7 15.7 5.7 10.8 10.5 5.4 18.6 18.6 3.8 4.4 12.5 20.3 8.1 6.7 3.2 19.9 17.8 29.9 35.2 3.1 0.7 8.6 16.6 1.7 1.4 7.7 1.9 4.0 6.8 45.4 17.4 48.1 8.9 10.6 42.7 11.6 13.0 7.2 5.7 62.0 13.6 16.6 3.4 4.8 24.7 15.4 11.7 8.3 3.7 6.4 20.5 17.1 4.7 6.6 18.4 6.6 9.6 19.3 9.3 8.8 11.6 37.1 17.4 4.4 0.2 0.6 0.4 0.1 0.2 0.1 0.5 0.6 0.0 0.9 0.9 0.7 0.3 0.3 0.1 1.0 0.8 0.5 1.9 2.4 2.6 2.3 1.8 1.9 2.8 4.6 2.0 1.8 2.5 3.2 2.1 3.2 2.6 4.2 3.1 0.9 1.6 7.0 2.8 19.5 6.2 8.8 3.0 0.0 16.6 1.8 27.1 7.7 9.4 13.9 0.0 1.7 17.3 141.9 7.7 2.3 69.4 80.2 2.7 1.0 5.9 5.9 11.7 4.5 2.5 21.4 2.2 1.5 4.0 5.0 2.5 12.8 14.2 1.6 1.9 32.5 5.3 6.2 0.0 0.0 1.3 5.9 5.2 1.5 4.2 1.2 4.1 2.6 4.8 2.0 3.0 0.7 164.1 28.2 0.0 2.6 5.5 80.8 45.3 8.5 1.4 1.4 3.7 3.9 16.8 0.9 C22orf15 "FLJ36561, N27C7-3" ENSG00000169314 "Chromosome 22 open reading frame 15" Q8WYQ4 22 23762990-23765863 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "fallopian tube: 18.3" "Cell type enriched" "Detected in some" 5 "Respiratory ciliated cells: 198.2" "Cancer enriched" "Detected in single" 4 "endometrial cancer: 1.7" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 1.2;BJ: 1.2;BJ hTERT+: 2.3;hTERT-RPE1: 3.2;MOLT-4: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted in female reproductive system" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (2.37e-2)" "unprognostic (3.28e-3)" "unprognostic (1.28e-1)" "prognostic favorable (8.53e-5)" "unprognostic (1.86e-2)" "unprognostic (2.07e-2)" "unprognostic (4.38e-2)" "unprognostic (6.14e-2)" "unprognostic (3.60e-2)" "unprognostic (7.70e-2)" "unprognostic (4.58e-2)" "unprognostic (2.60e-1)" "unprognostic (9.79e-2)" "unprognostic (2.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.28e-2)" "unprognostic (3.08e-3)" 0.1 0.0 0.3 0.0 0.2 0.3 0.1 0.2 0.2 0.4 0.5 0.2 0.0 0.2 0.0 0.0 18.3 0.2 0.0 0.3 0.6 0.1 0.0 1.8 0.1 1.1 1.6 0.5 0.0 0.0 1.0 0.2 1.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.8 0.2 0.1 2.8 0.3 1.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.0 1.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.3 0.2 0.1 0.1 0.5 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.3 0.2 0.2 0.2 0.3 0.6 1.1 1.6 1.1 0.8 0.3 0.2 0.0 0.0 1.8 1.3 0.0 0.1 0.0 9.1 0.0 0.5 0.0 0.5 0.1 0.0 15.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.0 35.8 0.2 0.2 0.0 0.4 2.3 0.0 0.0 1.4 0.0 0.3 2.5 0.1 0.7 0.1 0.0 0.0 2.0 0.0 16.2 0.3 0.4 3.5 0.0 0.3 0.0 1.0 0.1 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 198.2 1.9 0.0 0.1 3.5 10.9 4.2 0.0 0.3 0.0 1.0 0.5 0.0 0.1 C22orf23 "EVG1, FLJ32787, LOC84645" ENSG00000128346 "Chromosome 22 open reading frame 23" Q9BZE7 22 37943050-37953669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 95.5" "Group enriched" "Detected in some" 7 "Early spermatids: 292.5;Late spermatids: 312.9;Spermatocytes: 241.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 31.8;U-138 MG: 31.4;U-87 MG: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000650 Approved Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA000650: AB_2732391" "unprognostic (6.09e-3)" "unprognostic (3.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-1)" "unprognostic (7.42e-5)" "unprognostic (1.50e-2)" "unprognostic (2.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.04e-1)" "unprognostic (5.80e-2)" "unprognostic (8.18e-3)" "unprognostic (4.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.82e-2)" "unprognostic (8.46e-2)" 2.9 2.6 3.9 5.6 8.8 3.0 0.8 9.5 5.1 1.7 4.7 3.4 2.9 8.3 1.3 14.0 12.4 6.4 5.1 4.7 7.7 2.3 0.4 5.0 3.6 12.8 10.4 2.5 8.6 1.1 4.8 5.3 11.0 5.0 0.1 3.5 10.3 0.2 5.7 26.0 3.8 0.1 8.2 2.3 9.0 95.5 9.7 0.2 8.2 0.0 0.1 6.2 1.2 16.1 6.6 5.3 11.1 10.3 0.2 0.4 13.7 18.4 0.5 0.5 0.7 6.3 5.9 3.5 5.0 0.4 11.7 31.8 0.4 0.1 0.6 6.7 13.4 2.0 4.6 4.3 0.5 5.4 4.4 0.4 0.2 2.2 0.2 15.4 0.1 2.6 2.3 2.0 0.1 4.1 0.3 3.2 1.6 6.6 4.6 6.0 16.1 1.3 0.1 29.4 5.6 4.0 8.2 3.2 10.3 17.5 3.6 7.3 27.8 31.4 10.2 25.1 10.0 4.6 2.0 1.6 46.9 2.5 18.3 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.8 9.5 5.1 4.7 7.7 12.8 10.4 11.0 8.2 9.7 16.1 0.2 0.0 2.4 1.3 0.0 0.3 0.1 1.8 0.0 0.2 0.3 0.8 0.1 1.5 1.9 0.0 0.0 0.1 0.1 0.1 1.9 0.4 292.5 16.8 0.6 0.6 0.0 0.0 0.5 0.4 0.1 0.5 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 312.9 6.8 0.5 0.0 1.0 0.0 2.2 0.0 1.0 5.6 0.3 0.0 5.3 0.0 0.1 0.0 1.8 37.8 1.2 0.0 0.5 0.4 241.3 5.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 C2orf50 FLJ25143 ENSG00000150873 "Chromosome 2 open reading frame 50" Q96LR7 2 11133128-11151317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.7;fallopian tube: 7.4" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 8.4;Endometrial ciliated cells: 21.5;Excitatory neurons: 9.7;Respiratory ciliated cells: 27.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.0" "HPA062894, HPA067681" Enhanced Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" Cytosol "HPA062894: AB_2684897, HPA067681: " "unprognostic (6.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.53e-4)" "unprognostic (1.92e-3)" "unprognostic (3.35e-2)" "unprognostic (6.19e-2)" "unprognostic (3.55e-1)" "unprognostic (1.31e-1)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (2.00e-2)" "unprognostic (2.45e-1)" "unprognostic (3.97e-4)" "unprognostic (7.03e-2)" "unprognostic (2.92e-1)" "unprognostic (8.25e-3)" "unprognostic (7.36e-2)" 0.1 0.2 1.5 0.2 1.8 0.5 0.2 0.4 1.6 0.4 5.7 0.1 0.3 0.3 0.2 0.1 7.4 0.1 0.0 1.3 1.4 0.2 0.1 0.6 0.3 1.8 1.9 0.3 0.2 0.1 0.7 0.1 0.5 0.2 0.2 1.5 0.3 0.1 0.2 0.4 0.1 0.1 1.0 0.3 0.2 0.3 1.0 0.2 0.2 0.0 0.1 0.1 0.0 1.0 0.1 0.5 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.2 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.3 0.0 0.7 0.1 0.3 0.2 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.3 0.1 0.6 0.2 0.2 0.2 0.1 0.1 1.5 1.8 0.4 1.6 1.3 1.4 1.8 1.9 0.5 1.0 1.0 1.0 0.0 0.0 1.8 0.7 0.5 0.0 0.5 0.5 0.0 0.4 0.4 0.5 0.4 0.0 3.5 0.0 8.4 0.0 0.1 0.0 0.0 0.3 0.2 21.5 0.4 0.0 0.0 0.0 9.7 0.2 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.9 0.0 2.5 0.4 0.2 0.0 1.5 0.0 0.1 0.0 0.2 27.1 3.0 0.0 1.0 0.5 0.5 1.4 0.0 0.0 0.0 0.3 0.9 0.0 0.1 C2orf73 FLJ40298 ENSG00000177994 "Chromosome 2 open reading frame 73" Q8N5S3 2 54330034-54383742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 50.6" "Group enriched" "Detected in some" 8 "Early spermatids: 1101.7;Late spermatids: 600.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-RPE1: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055221, HPA059596" Uncertain NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 34: Spermatids - Unknown function" "HPA055221: AB_2682744, HPA059596: AB_2684077" "unprognostic (1.56e-2)" "unprognostic (7.00e-3)" "unprognostic (1.51e-2)" "unprognostic (1.39e-2)" "unprognostic (5.46e-2)" "unprognostic (2.74e-2)" "unprognostic (6.69e-3)" "unprognostic (2.36e-2)" "unprognostic (1.62e-3)" "unprognostic (7.69e-2)" "unprognostic (3.00e-2)" "unprognostic (5.01e-3)" "unprognostic (1.17e-2)" "unprognostic (8.99e-2)" "unprognostic (3.80e-2)" 0.1 0.6 1.9 0.0 2.1 0.0 0.1 1.6 2.0 0.5 6.4 0.1 0.0 0.3 1.3 0.0 7.6 0.0 0.1 1.9 2.1 0.6 0.0 1.1 0.0 3.8 3.4 0.3 0.6 0.9 1.4 0.0 2.5 0.3 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 3.2 0.1 0.0 50.6 2.0 0.0 1.1 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.1 1.6 2.0 1.9 2.1 3.8 3.4 2.5 3.2 2.0 2.3 0.7 0.0 0.0 13.7 0.0 0.3 0.4 1.8 0.0 0.3 0.5 0.9 0.1 0.0 9.7 3.7 0.0 0.0 0.0 0.0 5.9 0.2 1101.7 36.0 0.6 0.8 0.0 0.0 2.9 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 2.1 0.0 2.0 0.0 0.4 600.3 7.8 0.3 0.0 1.0 0.0 2.4 0.0 1.5 2.1 0.0 0.0 4.1 0.0 0.2 0.0 3.7 56.4 1.7 0.0 0.2 0.8 97.8 7.3 0.0 0.1 0.0 0.0 0.3 0.0 0.2 C2orf81 "hCG40743, LOC388963" ENSG00000284308 "Chromosome 2 open reading frame 81" A6NN90 2 74414176-74421591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.3" "Cell type enhanced" "Detected in many" "Early spermatids: 45.6;Late spermatids: 31.4;Respiratory ciliated cells: 25.7;Spermatocytes: 20.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 15.1;RPMI-8226: 14.5;SCLC-21H: 17.8;SH-SY5Y: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049564, HPA054835" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli fibrillar center" "HPA049564: , HPA054835: AB_2682620" 2.1 1.5 3.4 1.7 3.9 0.5 2.6 3.7 4.7 5.7 10.0 3.1 1.1 4.9 0.8 1.1 17.7 2.4 2.0 4.4 4.2 5.1 0.7 3.8 2.6 6.1 6.3 4.0 2.2 5.5 17.6 0.6 3.7 5.0 0.4 3.0 2.1 2.5 0.7 1.6 2.5 0.9 4.6 3.7 2.1 27.3 3.6 2.2 3.7 0.5 0.8 3.1 2.5 3.5 4.4 8.0 2.4 8.6 2.6 2.2 0.8 0.6 2.6 0.7 0.8 0.2 4.9 10.5 1.8 1.3 2.1 1.6 0.2 2.1 0.8 5.9 0.4 1.1 0.5 0.0 1.3 2.1 2.1 1.3 5.2 1.0 1.0 3.0 0.1 5.6 0.2 1.6 1.3 15.1 2.7 5.5 4.6 2.4 1.7 1.4 0.8 14.5 3.2 1.9 17.8 19.3 2.4 3.9 1.3 0.3 3.7 1.9 0.0 0.9 3.8 2.7 2.2 3.7 7.4 3.4 5.2 2.0 1.8 0.1 1.9 0.0 0.6 2.0 0.3 6.6 0.7 0.8 6.3 5.8 3.3 1.6 0.1 3.0 1.5 13.3 0.7 1.3 3.4 3.9 3.7 4.7 4.4 4.2 6.1 6.3 3.7 4.6 3.6 3.5 1.7 0.0 2.4 0.0 0.8 0.6 1.0 2.9 1.8 0.9 1.9 4.7 1.4 4.3 3.6 3.7 0.0 0.0 2.9 0.7 5.9 3.2 45.6 11.7 1.9 2.1 7.2 0.0 1.1 2.2 0.0 4.1 0.5 3.1 0.0 1.1 4.2 0.0 0.0 3.3 0.9 1.7 4.1 1.9 3.4 31.4 3.4 1.1 3.6 1.0 6.1 6.1 1.0 1.0 0.2 2.6 0.3 7.5 0.2 0.7 0.4 5.9 25.7 3.9 6.6 2.4 3.9 20.1 1.5 0.1 0.9 0.0 0.6 1.2 1.2 0.3 C4orf19 FLJ11017 ENSG00000154274 "Chromosome 4 open reading frame 19" Q8IY42 4 37453925-37623495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.0" "Cell type enhanced" "Detected in many" "Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 8.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.6" "Group enriched" "Detected in some" 5 "OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043458, HPA052894" Enhanced Supported "Cell Junctions" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cell Junctions" "HPA043458: AB_10960696, HPA052894: AB_2681982" "unprognostic (8.83e-2)" "unprognostic (7.86e-2)" "unprognostic (3.00e-3)" "unprognostic (2.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.59e-3)" "unprognostic (5.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.66e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-2)" "prognostic favorable (1.49e-11)" "unprognostic (1.33e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (8.19e-3)" 3.4 0.3 2.7 3.0 2.9 3.8 3.8 5.3 4.3 10.2 5.9 25.5 17.7 6.7 0.2 2.1 2.8 9.2 0.4 3.5 4.2 12.4 36.0 3.7 0.5 4.9 4.9 0.2 24.9 16.0 1.2 7.6 4.2 1.7 23.7 4.6 28.2 6.8 0.2 1.6 19.6 4.0 4.5 0.3 20.7 1.4 4.9 0.2 1.5 0.4 4.3 8.8 2.9 4.1 0.1 0.2 3.2 0.3 0.0 0.0 4.2 0.7 0.0 0.0 0.0 12.6 5.2 0.1 3.0 0.0 0.1 0.4 0.2 0.8 0.1 0.0 0.4 0.0 8.3 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 14.3 0.2 0.2 0.5 64.6 1.7 0.1 7.8 0.2 12.7 81.0 0.9 0.3 0.5 32.6 1.0 4.0 113.1 0.7 0.6 0.4 4.5 0.2 1.6 0.2 0.1 0.5 0.0 6.9 5.6 0.9 1.4 2.1 0.6 0.2 0.4 0.2 0.3 0.4 0.2 0.5 0.5 0.8 8.6 0.8 0.1 1.6 0.7 0.3 2.7 2.9 5.3 4.3 3.5 4.2 4.9 4.9 4.2 4.5 4.9 4.1 0.3 0.0 12.6 45.4 0.7 0.3 7.8 4.9 0.0 0.6 7.1 3.9 0.2 27.1 10.1 11.0 0.0 6.7 0.2 61.3 11.7 25.2 1.2 9.5 0.4 0.9 9.6 0.0 2.3 51.8 4.7 0.3 33.6 5.5 0.0 0.0 0.0 13.1 0.7 0.0 2.4 28.0 4.1 0.0 0.3 2.4 0.0 0.2 3.6 22.5 0.6 5.3 0.0 46.8 1.8 53.6 67.2 0.0 0.0 7.8 52.3 9.2 12.3 1.0 0.0 0.2 0.9 0.3 0.2 0.5 0.0 47.5 0.4 0.1 31.8 19.1 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 24.3;fallopian tube: 13.6;retina: 15.1;testis: 13.3" "Cell type enhanced" "Detected in many" "Early spermatids: 191.3;Endometrial ciliated cells: 50.0;Excitatory neurons: 36.6;Respiratory ciliated cells: 106.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 2.4;hTERT-RPE1: 4.9;U-87 MG: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Uncertain Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.5 0.3 3.2 0.2 4.4 0.3 2.1 3.8 2.9 1.0 24.3 0.3 0.1 1.2 3.8 0.3 13.6 0.9 0.9 3.3 3.6 2.7 0.4 2.0 0.1 7.2 8.2 0.7 0.7 0.6 2.9 0.2 5.5 0.6 0.2 15.1 0.5 0.6 0.1 1.0 0.2 0.3 7.1 0.2 0.3 13.3 3.9 0.2 4.6 0.1 0.2 0.3 0.3 3.9 2.4 0.0 0.2 1.2 0.4 2.3 0.7 0.0 0.1 0.2 0.3 0.3 1.4 0.1 0.4 0.1 0.2 0.2 0.3 0.4 0.5 0.5 0.4 0.0 0.1 0.3 0.5 0.0 0.1 0.5 0.5 0.5 0.2 4.9 0.0 0.5 0.3 0.1 1.8 0.3 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.2 0.7 0.0 1.3 0.6 0.4 0.0 1.5 0.5 0.1 0.4 0.7 0.4 0.1 0.0 0.0 1.0 0.0 0.0 5.9 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.2 0.0 0.0 3.2 4.4 3.8 2.9 3.3 3.6 7.2 8.2 5.5 7.1 3.9 3.9 0.6 3.2 1.5 21.5 2.0 0.6 0.9 8.7 4.6 0.9 2.2 3.9 0.6 1.5 13.2 3.7 10.4 0.1 0.4 0.4 1.9 2.8 191.3 50.0 1.5 1.3 0.0 0.0 36.6 0.6 1.5 2.4 6.6 3.4 0.0 0.3 1.1 0.1 0.2 1.7 26.3 0.0 2.0 0.6 0.4 20.9 0.6 0.7 1.8 4.7 0.1 3.6 0.0 18.6 13.4 1.0 0.0 0.7 9.6 0.6 0.0 3.7 106.6 14.8 0.0 3.0 3.1 12.6 5.0 2.6 0.6 0.3 1.5 0.5 0.0 0.3 C5orf49 LOC134121 ENSG00000215217 "Chromosome 5 open reading frame 49" A4QMS7 5 7830378-7851151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.1;choroid plexus: 27.4;fallopian tube: 75.7;testis: 37.1" "Group enriched" "Detected in many" 11 "Early spermatids: 821.2;Endometrial ciliated cells: 353.9;Late spermatids: 410.2;Respiratory ciliated cells: 502.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043759 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA043759: AB_2678655" "unprognostic (1.55e-1)" "unprognostic (5.82e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-2)" "unprognostic (2.13e-3)" "unprognostic (4.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (7.93e-2)" "unprognostic (7.54e-3)" "unprognostic (1.85e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (2.28e-2)" "unprognostic (2.20e-2)" 0.2 0.5 15.2 0.1 17.0 0.0 0.8 12.3 16.5 4.2 27.4 0.1 0.1 1.4 1.7 0.0 75.7 0.5 0.2 15.9 18.1 3.9 3.3 6.0 0.0 21.9 29.1 1.0 2.7 6.2 10.4 0.1 22.0 3.5 0.0 1.4 0.3 1.3 0.0 0.6 0.1 0.3 19.1 0.1 0.6 37.1 19.7 0.7 0.8 0.0 0.0 0.2 0.8 18.1 0.0 0.2 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 17.0 12.3 16.5 15.9 18.1 21.9 29.1 22.0 19.1 19.7 18.1 0.1 0.0 5.4 2.3 1.0 0.0 2.6 32.0 0.0 0.4 4.7 3.0 0.4 1.5 41.4 9.2 0.0 0.2 0.0 0.0 3.9 5.6 821.2 353.9 4.3 1.2 5.4 0.0 2.8 0.9 2.9 1.7 0.0 5.8 1.3 0.2 0.4 0.8 0.1 1.7 3.5 0.2 46.8 0.0 0.4 410.2 8.7 0.8 3.6 1.0 0.0 2.3 0.0 1.5 0.2 1.6 0.0 3.8 0.0 4.1 0.0 39.9 502.4 3.6 6.6 0.8 13.4 41.1 8.4 0.0 0.6 0.3 0.9 0.1 0.0 1.5 C6 ENSG00000039537 "Complement C6" P13671 5 41142116-41261438 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Complement pathway, Cytolysis, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "liver: 665.9" "Cell type enhanced" "Detected in some" "Cholangiocytes: 127.2;Hepatocytes: 376.9;Late spermatids: 54.8;Leydig cells: 120.2;Respiratory ciliated cells: 58.0" "Group enriched" "Detected in many" 7 "liver cancer: 49.0;pancreatic cancer: 12.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "ASC diff: 4.5;ASC TERT1: 6.2;HSkMC: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA043823, CAB069427" Enhanced "Secreted to blood" NA NA 45000000000 9200000000 "Cluster 62: Liver - Hemostasis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 15: Hepatocytes - Hemostasis" "CAB069427: AB_1614336, HPA043823: AB_10960262" "unprognostic (9.79e-2)" "unprognostic (1.96e-2)" "unprognostic (5.94e-3)" "unprognostic (3.02e-2)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (4.66e-2)" "unprognostic (3.72e-2)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (3.04e-3)" "prognostic favorable (4.31e-4)" "unprognostic (2.69e-4)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" 12.8 1.1 0.2 0.0 0.2 0.0 5.4 0.2 0.1 0.8 1.6 0.8 0.9 0.4 0.9 0.3 43.9 12.0 57.1 0.2 0.6 4.4 665.9 3.2 0.4 0.0 1.7 6.2 42.7 0.1 0.7 2.8 0.2 0.9 0.6 0.0 0.9 0.6 0.6 0.6 1.4 0.9 0.1 0.3 2.2 4.2 0.8 0.6 2.0 0.7 0.5 0.9 0.6 0.6 0.0 0.0 0.0 0.0 4.5 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.2 0.6 0.0 1.7 0.2 0.1 0.8 0.6 0.8 0.0 0.0 0.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.9 127.2 7.5 0.0 0.0 0.0 0.1 0.3 0.0 9.3 11.3 37.5 0.8 0.9 0.0 8.0 1.4 0.4 0.0 6.7 0.0 0.7 0.0 0.1 5.0 376.9 0.0 0.0 2.7 1.0 0.0 9.7 0.3 54.8 120.2 0.2 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.5 1.3 0.4 0.0 0.0 11.6 0.8 58.0 0.0 0.0 0.2 0.4 0.4 0.1 0.0 0.0 0.0 0.4 0.5 0.6 0.0 C6orf118 "bA85G2.1, MGC23884" ENSG00000112539 "Chromosome 6 open reading frame 118" Q5T5N4 6 165279664-165309605 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;choroid plexus: 29.8;fallopian tube: 16.4" "Cell type enhanced" "Detected in some" "Early spermatids: 145.5;Endometrial ciliated cells: 140.4;Late spermatids: 57.6;Respiratory ciliated cells: 243.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 2.7;SCLC-21H: 1.6" "Low region specificity" "Detected in many" "HPA029787, HPA029789" Approved Uncertain Mitochondria NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "HPA029787: AB_10599999, HPA029789: AB_10601002" "unprognostic (2.84e-1)" "unprognostic (3.09e-4)" "unprognostic (2.70e-2)" "unprognostic (7.99e-2)" "unprognostic (5.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.50e-1)" "unprognostic (4.27e-2)" "unprognostic (4.89e-2)" "unprognostic (8.18e-9)" "unprognostic (3.22e-3)" "unprognostic (3.03e-2)" "unprognostic (6.55e-3)" "unprognostic (4.50e-1)" 0.0 0.0 2.7 0.0 2.3 0.0 0.0 0.9 1.1 0.6 29.8 0.0 0.0 0.4 0.0 0.0 16.4 0.0 0.0 4.0 2.6 0.0 0.0 2.1 0.0 8.4 10.6 0.0 0.0 0.0 1.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 7.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.2 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.9 1.1 4.0 2.6 8.4 10.6 5.3 6.4 2.8 3.7 0.0 0.0 1.5 0.3 0.0 0.0 0.2 6.6 0.0 0.0 0.0 0.1 0.4 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 145.5 140.4 1.4 0.1 0.0 0.0 0.4 0.0 0.0 1.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 10.2 0.0 0.0 57.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 243.9 0.0 0.0 0.0 1.8 16.8 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 13.7" "Cell type enhanced" "Detected in many" "Early spermatids: 46.4;Endometrial ciliated cells: 44.9;Late spermatids: 27.3;Respiratory ciliated cells: 37.7;Spermatocytes: 36.1;Spermatogonia: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 6.1;U-266/84: 6.4" "Not detected" "Not detected" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" No No "Cluster 35: T-regs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "Intermediate filaments" "HPA051142: AB_2681359" "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.0 1.8 2.2 0.5 2.2 0.3 1.1 2.3 4.0 0.7 3.1 0.8 3.3 0.5 3.5 0.6 3.3 0.2 0.6 2.2 2.5 4.4 0.7 1.0 0.4 2.6 2.7 1.1 2.2 0.3 2.0 0.2 2.6 2.0 0.3 0.8 0.8 0.5 0.5 1.3 0.7 0.3 2.4 0.7 1.6 13.7 2.3 0.5 0.8 0.2 0.6 0.6 0.5 2.8 1.0 2.0 1.8 1.7 0.6 0.0 3.3 0.3 0.0 0.2 0.4 2.7 1.6 0.2 2.9 0.0 2.8 0.2 1.8 0.0 0.6 1.2 4.5 0.8 0.5 0.5 0.0 1.2 0.5 0.3 2.6 0.7 1.0 0.4 0.0 1.9 3.6 0.3 0.7 6.1 1.5 6.1 1.9 1.4 2.3 1.3 0.4 0.9 0.8 0.5 3.8 2.1 0.8 0.5 3.9 2.3 0.2 1.0 0.7 1.4 0.5 1.0 1.4 2.6 6.4 1.4 2.3 0.9 1.6 0.0 0.2 2.4 0.6 0.5 0.2 0.2 0.7 0.6 0.5 0.3 0.3 0.3 0.3 0.7 0.3 0.4 3.1 0.3 2.2 2.2 2.3 4.0 2.2 2.5 2.6 2.7 2.6 2.4 2.3 2.8 0.7 0.0 2.7 3.3 1.2 1.5 2.0 4.2 0.0 1.6 3.2 3.7 1.3 1.5 2.6 3.7 2.1 2.9 0.2 1.6 5.9 4.1 46.4 44.9 0.9 1.9 3.0 0.0 0.9 6.1 2.3 1.1 2.0 2.5 0.0 0.6 1.4 1.9 1.2 1.7 1.0 1.2 0.0 0.3 1.0 27.3 2.1 0.6 3.6 0.0 1.6 3.3 1.0 0.0 3.5 2.8 2.7 0.0 2.5 2.0 1.3 9.6 37.7 0.9 0.0 1.1 2.1 36.1 20.4 0.6 1.4 1.4 0.4 0.4 1.7 1.0 C7orf57 ENSG00000164746 "Chromosome 7 open reading frame 57" Q8NEG2 7 48035511-48061304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0;choroid plexus: 6.4;fallopian tube: 13.9" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 52.7;Respiratory ciliated cells: 127.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.4;hTERT-HME1: 5.5;U-266/70: 3.2;U-698: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021286 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" "HPA021286: AB_1845760" "unprognostic (1.74e-2)" "unprognostic (4.82e-2)" "unprognostic (3.13e-2)" "unprognostic (1.28e-2)" "unprognostic (2.77e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.37e-1)" "unprognostic (4.98e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-5)" "unprognostic (5.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.42e-3)" "unprognostic (1.20e-1)" 0.0 0.0 0.7 0.0 0.8 0.2 0.1 0.5 0.3 0.4 6.4 0.0 0.1 0.4 0.0 0.8 13.9 0.0 0.1 0.7 0.9 0.1 0.0 2.2 0.0 4.0 3.8 0.0 0.0 0.6 0.2 0.0 2.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 3.7 0.9 0.0 0.2 0.0 0.1 0.0 0.4 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.3 0.0 0.1 0.1 3.4 0.2 0.0 0.5 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.5 0.2 0.3 3.2 0.5 1.9 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.5 0.3 0.7 0.9 4.0 3.8 2.3 2.9 0.9 2.0 0.0 0.0 3.0 0.3 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.1 1.0 0.0 15.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.9 52.7 0.6 0.2 0.0 0.0 0.5 0.0 0.1 0.6 0.0 1.1 2.5 0.0 0.0 0.0 0.1 0.0 0.5 0.0 6.1 0.0 0.4 3.5 0.0 0.3 0.0 0.0 0.0 1.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 127.6 0.9 0.0 0.0 2.7 16.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 C9orf116 "MGC29761, PIERCE1, RbEST47" ENSG00000160345 "Chromosome 9 open reading frame 116" Q5BN46 9 135495181-135501734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 97.2;testis: 62.5" "Group enriched" "Detected in many" 4 "Early spermatids: 520.9;Endometrial ciliated cells: 442.5;Late spermatids: 579.4;Respiratory ciliated cells: 610.3" "Cancer enhanced" "Detected in all" "endometrial cancer: 13.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 41.3;T-47d: 41.9;U-2197: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021439, HPA065287" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "HPA021439: AB_1845799, HPA065287: AB_2732732" "unprognostic (9.02e-2)" "unprognostic (1.36e-2)" "unprognostic (1.93e-1)" "prognostic favorable (3.53e-5)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (4.23e-1)" "unprognostic (2.58e-1)" "unprognostic (5.30e-2)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (4.23e-3)" "unprognostic (3.86e-2)" "unprognostic (8.75e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" 2.6 16.3 11.9 0.8 12.8 0.9 3.1 10.7 13.0 5.5 24.5 2.1 1.0 4.2 25.7 1.9 97.2 2.8 2.0 14.0 13.6 9.5 3.5 9.2 0.7 15.8 19.7 2.8 6.5 6.8 16.9 1.5 15.9 4.2 1.2 10.1 3.4 6.3 1.5 1.8 1.4 1.2 15.4 1.9 3.1 62.5 14.5 0.6 8.1 0.9 1.2 2.7 1.5 13.0 11.0 18.7 8.1 12.7 3.5 7.4 1.6 7.3 5.1 8.7 5.9 7.1 10.9 1.9 9.5 4.9 4.7 7.4 9.1 4.1 7.4 0.5 8.0 0.0 21.0 22.1 9.7 1.5 5.0 5.2 3.2 4.4 1.4 7.1 4.2 8.6 10.3 1.4 4.2 41.3 5.7 1.9 17.1 17.2 21.5 8.7 3.9 6.9 21.0 7.7 7.9 8.3 10.3 4.4 1.2 3.7 41.9 1.8 2.1 5.0 6.5 42.9 2.9 4.7 12.6 1.8 14.7 0.7 1.5 0.0 0.8 0.0 0.5 0.5 1.2 0.2 0.4 0.4 0.3 0.4 0.7 0.5 0.0 0.6 0.1 0.1 0.5 0.3 11.9 12.8 10.7 13.0 14.0 13.6 15.8 19.7 15.9 15.4 14.5 13.0 1.2 9.6 7.8 2.3 1.9 0.9 1.8 39.7 2.2 5.0 11.7 9.8 1.7 15.7 46.3 14.7 14.6 11.5 0.7 0.5 11.7 26.0 520.9 442.5 6.6 2.1 1.2 1.3 2.1 7.8 3.4 5.2 4.6 23.9 1.3 12.0 0.7 1.6 3.6 3.3 2.2 1.0 38.7 1.2 1.4 579.4 8.1 1.3 0.0 0.0 2.0 13.2 0.0 1.0 0.2 6.9 1.7 7.5 3.6 2.4 1.3 58.8 610.3 19.9 0.0 1.4 15.0 133.8 20.0 1.3 0.3 4.5 1.6 41.4 1.7 3.1 C9orf135 ENSG00000204711 "Chromosome 9 open reading frame 135" Q5VTT2 9 69820817-69906227 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 36.8;testis: 15.5" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 77.2;Early spermatids: 192.0;Endometrial ciliated cells: 198.0;Respiratory ciliated cells: 277.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 7.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "naive CD4 T-cell: 1.2;naive CD8 T-cell: 1.7;T-reg: 1.5" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Group enriched" "Detected in some" 5 "HAP1: 11.7;NTERA-2: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021261, HPA021325" Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 5: NTERA-2 - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "HPA021261: AB_1845811, HPA021325: AB_1845812" "unprognostic (1.05e-2)" "unprognostic (4.39e-1)" "unprognostic (1.97e-1)" "unprognostic (1.39e-1)" "unprognostic (1.90e-1)" "unprognostic (5.22e-3)" "unprognostic (5.72e-1)" "unprognostic (3.25e-3)" "unprognostic (4.11e-2)" "unprognostic (2.04e-1)" "unprognostic (7.60e-2)" 0.0 0.4 0.4 0.0 0.4 0.0 0.0 0.2 0.2 0.8 6.5 0.0 0.0 0.5 0.0 0.0 36.8 1.4 0.0 0.5 0.7 1.3 0.0 2.2 0.0 1.6 2.4 0.0 0.5 3.0 7.6 0.0 1.2 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 15.5 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.2 1.7 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.4 0.2 0.2 0.5 0.7 1.6 2.4 1.2 1.7 1.0 0.8 0.0 0.0 2.0 0.0 0.0 0.4 0.0 14.7 0.0 0.1 0.3 0.5 2.5 0.0 30.8 1.8 77.2 0.1 0.0 0.7 17.6 0.7 192.0 198.0 2.1 0.5 1.8 0.0 0.5 0.0 0.0 0.5 0.0 2.4 1.3 0.3 0.0 0.0 0.1 0.0 0.4 0.3 12.2 0.0 1.1 22.0 2.5 0.6 0.0 0.0 0.0 0.6 0.0 0.5 0.3 0.2 0.1 0.7 0.0 0.1 0.0 2.2 277.3 1.5 0.0 0.0 5.7 41.8 1.3 0.0 0.1 0.0 0.5 0.1 0.0 0.3 C9orf24 "bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1" ENSG00000164972 "Chromosome 9 open reading frame 24" Q8NCR6 9 34379019-34397810 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 39.2;choroid plexus: 105.6;fallopian tube: 108.7;testis: 90.6" "Cell type enhanced" "Detected in many" "Early spermatids: 744.6;Endometrial ciliated cells: 841.0;Late spermatids: 3115.3;Respiratory ciliated cells: 1312.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 17.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053008 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Cytosol "HPA053008: AB_2682015" "unprognostic (3.62e-3)" "unprognostic (9.06e-3)" "unprognostic (1.00e-1)" "prognostic favorable (3.23e-5)" "unprognostic (7.66e-2)" "unprognostic (1.21e-2)" "unprognostic (2.40e-1)" "unprognostic (1.25e-1)" "unprognostic (2.72e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.50e-1)" "unprognostic (7.43e-3)" "unprognostic (4.72e-2)" "unprognostic (1.90e-2)" 1.2 0.6 20.6 0.3 26.6 0.0 0.7 19.5 29.8 7.8 105.6 3.2 1.9 0.7 0.0 0.4 108.7 0.3 17.5 20.8 22.8 3.4 0.3 18.4 0.2 35.9 39.2 0.4 0.9 0.1 10.6 0.2 29.8 1.6 0.7 1.2 1.9 0.4 1.4 0.6 5.4 0.5 33.0 0.2 1.4 90.6 22.3 0.3 0.6 1.7 0.3 0.9 0.4 25.5 0.2 0.0 0.4 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.6 0.3 0.0 0.4 1.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.2 0.1 0.2 0.6 0.4 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.8 0.3 0.0 0.2 0.0 0.0 0.4 0.1 20.6 26.6 19.5 29.8 20.8 22.8 35.9 39.2 29.8 33.0 22.3 25.5 0.4 6.4 15.1 11.4 0.3 2.2 3.3 67.3 2.2 1.4 1.6 1.8 37.0 1.5 116.4 7.3 0.0 0.6 0.1 11.3 72.4 1.1 744.6 841.0 6.1 2.1 12.1 0.0 11.3 1.5 0.3 3.5 0.5 9.8 8.8 0.2 1.4 4.1 0.4 0.0 12.6 13.4 81.4 1.0 1.0 3115.3 10.5 2.7 0.0 1.0 0.0 2.2 1.0 4.0 5.4 0.2 7.3 7.2 0.5 4.5 142.5 13.7 1312.6 0.9 32.9 0.5 25.5 21.0 6.9 0.4 1.0 0.5 1.6 0.0 20.5 2.4 C9orf43 MGC17358 ENSG00000157653 "Chromosome 9 open reading frame 43" Q8TAL5 9 113410054-113429690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.6" "Group enriched" "Detected in some" 8 "Early spermatids: 114.2;Late spermatids: 226.0;Spermatocytes: 91.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA021310 Approved Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA021310: AB_1845825" "unprognostic (2.91e-2)" "unprognostic (9.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.18e-1)" "unprognostic (2.63e-1)" "unprognostic (6.58e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (8.90e-2)" "unprognostic (1.97e-2)" "unprognostic (5.96e-3)" "unprognostic (1.51e-1)" "unprognostic (7.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-2)" "unprognostic (1.63e-1)" 0.3 1.5 0.9 0.1 1.0 1.9 0.5 0.9 1.2 0.2 0.8 0.2 0.1 0.2 1.2 0.3 0.7 0.3 0.2 0.9 1.2 1.2 1.5 0.2 0.4 1.3 1.6 0.8 0.8 0.9 1.4 0.2 1.2 0.5 0.2 1.2 0.7 0.4 0.1 0.5 0.2 0.0 1.3 0.4 0.5 45.6 1.1 0.4 0.8 0.3 0.4 0.2 0.2 1.3 0.5 0.4 0.2 0.7 0.6 0.3 0.3 0.2 0.4 0.7 0.5 0.5 0.4 1.3 0.4 0.1 1.4 0.9 0.2 0.6 0.2 1.1 0.2 1.1 0.8 0.2 0.5 0.2 0.1 0.7 1.0 0.8 1.0 0.4 0.6 1.5 0.7 1.2 0.3 1.0 0.5 0.3 0.3 0.6 1.6 0.3 0.2 0.7 0.7 0.2 1.2 0.3 1.2 0.5 0.7 0.5 1.6 0.1 0.0 1.0 0.2 0.6 1.0 0.7 1.5 2.0 0.5 0.4 0.3 0.0 0.1 0.0 0.3 0.3 0.0 0.3 0.1 0.4 0.2 0.1 0.3 0.4 0.4 0.2 0.0 0.3 0.0 0.1 0.9 1.0 0.9 1.2 0.9 1.2 1.3 1.6 1.2 1.3 1.1 1.3 0.4 0.0 0.0 4.9 1.5 0.6 0.6 0.5 1.2 1.7 0.8 0.9 0.1 0.0 1.6 0.0 0.0 0.5 0.3 0.2 1.9 0.3 114.2 3.0 0.7 0.7 0.0 0.8 0.6 0.2 0.4 0.2 0.0 0.6 0.0 0.7 0.0 0.9 0.3 0.0 0.7 0.1 0.0 0.3 0.4 226.0 2.1 0.5 0.0 0.0 0.7 1.8 0.0 0.5 1.8 0.9 0.0 1.5 1.8 0.3 0.1 0.9 6.7 2.8 0.0 0.7 0.3 91.5 17.9 0.7 0.0 0.0 0.4 0.7 0.2 0.6 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662929-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.6;testis: 15.5" "Group enriched" "Detected in some" 10 "Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 88.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "MOLT-4: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.0 0.5 4.2 0.2 4.2 0.0 1.2 3.5 3.9 4.2 5.9 1.2 0.3 3.5 0.5 0.3 26.6 0.8 0.2 4.4 4.6 1.8 0.3 4.1 0.0 6.8 8.9 0.2 0.5 2.9 4.2 0.8 7.2 4.1 0.6 0.9 1.0 2.5 0.1 0.3 0.5 0.7 8.3 1.0 0.5 15.5 4.0 0.1 0.7 0.0 0.1 0.4 0.6 7.8 0.0 0.2 0.1 0.0 0.0 2.5 0.0 0.4 1.7 0.3 0.6 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 1.0 0.9 0.5 0.1 0.0 0.1 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 5.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.2 3.5 3.9 4.4 4.6 6.8 8.9 7.2 8.3 4.0 7.8 1.9 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.0 0.8 0.0 60.4 4.1 0.4 0.0 0.0 0.0 0.2 0.2 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 88.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.2 1.2 0.0 0.0 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "brain: 42.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 188.7;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 34.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;NB-4: 1.0;NTERA-2: 1.1;U-266/70: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.0 1.0 33.5 0.6 30.5 1.2 0.0 0.0 34.6 0.0 0.0 0.1 0.0 0.0 1.5 0.2 0.7 0.0 0.3 42.8 3.4 1.3 0.0 0.1 0.4 4.6 6.2 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.2 9.7 0.4 0.1 1.0 3.8 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 33.5 30.5 0.0 34.6 42.8 3.4 4.6 6.2 0.9 9.7 3.8 1.1 0.0 0.0 0.0 3.6 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.4 0.0 0.0 188.7 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 116.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.5 0.0 0.2 0.0 73.9 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964707-67033398 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 35.1;prostate: 11.7" "Cell type enriched" "Detected in some" 6 "Oligodendrocyte precursor cells: 145.3" "Group enriched" "Detected in many" 5 "breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 6 "SH-SY5Y: 387.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 118.1" "HPA005803, HPA065370" Enhanced Approved Vesicles NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Vesicles "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.5 0.8 26.5 0.1 35.1 0.0 5.3 6.9 26.8 0.4 4.2 0.8 0.2 0.5 0.1 0.2 4.2 0.4 0.2 14.5 17.9 0.2 0.0 5.7 0.0 11.7 16.7 0.1 0.4 1.2 0.3 0.7 15.0 11.7 0.1 0.7 1.7 1.3 0.1 0.5 0.1 1.1 14.3 0.0 1.5 0.2 29.6 0.0 0.1 0.0 0.0 0.4 0.7 9.5 6.4 4.1 15.6 0.0 0.0 0.0 4.4 0.0 0.0 1.4 0.0 4.6 0.2 0.0 0.2 0.0 41.2 64.1 0.1 0.0 0.0 0.0 0.3 0.0 1.8 3.7 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 34.5 0.1 0.3 15.7 7.3 0.0 0.0 0.4 8.7 0.0 11.1 15.8 387.4 3.6 10.4 0.0 38.1 38.5 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 35.1 6.9 26.8 14.5 17.9 11.7 16.7 15.0 14.3 29.6 9.5 0.0 3.2 1.3 0.0 0.0 0.0 1.1 0.3 0.0 0.2 6.4 3.4 1.3 0.0 1.4 0.0 0.0 0.3 0.1 0.6 0.0 0.1 2.6 1.0 0.2 0.1 7.7 0.0 1.8 0.2 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.7 0.0 3.4 0.0 145.3 0.3 0.7 0.2 0.0 0.0 2.6 0.0 0.0 1.9 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.7 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53991637-54012666 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skeletal muscle: 90.7;tongue: 29.9" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 8.3;Horizontal cells: 1.7;Respiratory ciliated cells: 9.1;Skeletal myocytes: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 107 "basophil: 13.3;eosinophil: 8.0" "Lineage enriched" "Detected in single" 133 "granulocytes: 13.3" "Cell line enhanced" "Detected in some" "A549: 12.7;EFO-21: 23.6;HHSteC: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center" Cytosol "HPA056615: AB_2683192" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.1 0.9 0.3 0.2 0.1 0.2 0.2 0.0 0.3 8.8 0.0 0.0 0.6 0.6 0.0 0.0 2.2 0.0 1.0 2.0 0.0 0.0 2.9 1.9 0.0 0.8 0.4 0.0 0.1 1.0 0.0 90.7 0.0 0.2 0.0 1.0 0.1 0.3 2.3 0.4 0.0 0.0 29.9 0.1 0.0 0.0 0.5 0.0 12.7 0.2 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 23.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.6 0.0 0.1 0.1 0.0 0.0 0.0 1.9 3.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.1 1.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.2 0.0 2.8 0.0 0.0 0.0 3.5 0.1 0.2 0.0 0.0 13.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.9 0.6 0.6 1.0 2.0 0.8 1.0 0.4 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.1 0.0 0.0 2.3 0.1 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CAP1 CAP ENSG00000131236 "Cyclase associated actin cytoskeleton regulatory protein 1" Q01518 1 40040233-40072649 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 832.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 1954.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030124 Approved Approved Cytosol NA NA 73000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "HPA030124: AB_10600799" "unprognostic (1.80e-3)" "unprognostic (1.23e-3)" "unprognostic (5.68e-2)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (1.44e-6)" "unprognostic (5.37e-2)" "unprognostic (4.87e-1)" "unprognostic (1.98e-1)" "unprognostic (3.33e-3)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (1.39e-1)" "unprognostic (7.08e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" 175.2 96.8 78.6 275.0 92.3 314.9 137.5 87.6 95.3 131.2 77.8 223.7 143.7 207.2 100.4 196.2 134.2 135.3 82.3 82.6 85.3 130.7 124.4 181.7 266.8 98.0 87.6 87.7 67.8 115.1 62.8 184.2 94.4 105.0 210.4 63.4 117.4 140.1 48.1 120.2 165.0 236.6 89.7 206.1 147.8 75.0 91.5 186.8 106.8 56.0 326.4 231.2 130.4 107.9 435.9 185.1 216.4 134.8 310.6 290.5 338.9 749.8 437.7 398.9 399.9 272.5 440.1 339.5 295.7 598.7 275.7 267.1 265.8 535.7 548.1 461.6 164.9 520.2 188.7 216.8 286.4 326.9 1417.9 297.5 280.6 612.5 345.4 456.5 346.4 185.7 201.6 215.0 621.7 129.2 265.4 194.9 367.7 312.1 207.9 197.0 297.6 198.6 451.3 452.0 107.5 222.9 308.7 366.4 523.8 443.1 170.0 1954.7 628.9 347.3 317.9 188.0 641.4 178.9 381.8 301.0 451.5 353.8 466.9 1371.5 776.8 2592.7 665.8 1097.6 526.2 328.0 473.4 643.9 868.3 325.6 397.1 537.9 1560.4 479.8 1402.6 333.8 701.5 1838.4 78.6 92.3 87.6 95.3 82.6 85.3 98.0 87.6 94.4 89.7 91.5 107.9 132.5 121.8 90.9 17.6 179.0 112.3 149.0 236.2 48.9 40.8 81.8 89.9 15.7 80.1 161.8 114.0 27.1 212.9 206.9 372.1 111.6 364.1 411.3 94.5 109.8 163.2 76.1 73.4 22.3 272.3 439.6 107.9 74.5 182.9 229.1 70.9 167.0 77.0 426.0 42.1 16.7 180.2 142.4 411.6 333.3 480.3 88.0 390.8 99.6 25.3 606.5 160.9 315.1 13.0 30.4 832.7 202.0 176.8 117.1 130.7 159.7 142.1 105.6 49.5 164.3 68.9 207.1 118.0 67.9 97.2 132.8 237.8 238.0 74.8 151.5 221.4 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine Q13938 19 5912339-5916211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 334.8" "Group enriched" "Detected in many" 6 "Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8" "Low region specificity" "Detected in all" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favorable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favorable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 12.2 25.9 37.5 10.9 35.1 10.0 11.6 55.0 30.1 47.2 55.4 16.1 6.9 21.7 4.6 12.9 334.8 11.2 13.5 40.2 69.6 38.3 21.5 49.5 12.2 72.6 105.3 13.8 24.0 3.3 27.9 9.3 85.7 40.4 2.8 2.2 24.9 30.9 4.3 16.2 18.7 2.3 60.9 25.2 37.5 6.4 50.0 5.7 30.8 1.1 4.2 44.2 13.7 66.1 2.2 2.3 0.9 6.3 2.1 3.2 4.0 0.7 0.7 0.3 0.6 1.5 13.8 0.9 4.0 1.5 0.7 2.3 0.1 0.6 0.0 4.7 1.9 0.8 4.8 4.7 2.5 0.8 3.5 4.1 4.2 0.4 0.8 4.0 1.0 4.7 0.7 5.4 0.7 4.4 2.4 4.0 0.7 19.4 12.6 3.1 0.3 4.7 1.8 6.2 1.0 4.9 1.0 65.1 6.6 2.0 4.3 4.7 1.5 0.6 0.4 4.6 17.1 19.8 6.5 1.1 7.7 1.8 2.8 0.4 0.7 0.3 1.7 0.6 0.9 0.9 1.0 1.3 0.8 1.8 0.8 0.7 0.7 1.8 0.4 1.5 1.0 0.8 37.5 35.1 55.0 30.1 40.2 69.6 72.6 105.3 85.7 60.9 50.0 66.1 5.3 12.8 16.5 11.1 3.3 4.8 32.1 122.8 1.8 2.5 8.9 8.8 2.2 0.0 161.5 121.4 4.2 24.3 7.4 5.3 35.2 34.7 6.5 2622.9 48.3 5.5 19.2 0.4 2.6 5.9 22.8 12.9 33.6 330.8 6.3 8.1 0.0 0.0 5.2 6.7 3.2 25.1 197.4 0.0 5.9 5.7 4.7 6.6 10.6 6.5 3.0 7.7 9.2 3.5 12.9 36.9 3.3 4.9 3.8 20.4 4.2 4.5 1557.4 4.2 6.6 3.5 42.7 0.4 0.6 0.9 4.1 20.5 9.2 3.3 9.3 128.6 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 11.8" "Cell type enhanced" "Detected in many" "Astrocytes: 85.5;Excitatory neurons: 133.8;Inhibitory neurons: 95.8;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 102.6;Respiratory ciliated cells: 77.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039542, HPA040004" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome Yes No "Cluster 4: T-regs - Cell cycle regulation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "Nucleoplasm, Vesicles, Centrosome" "HPA039542: , HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 1.0 1.5 1.2 0.3 1.2 0.5 1.4 1.7 4.0 1.2 8.8 1.0 0.6 2.0 3.7 1.3 10.0 1.3 2.3 1.1 3.1 2.7 1.8 2.4 0.3 5.5 4.3 1.6 0.9 3.9 2.5 0.1 2.5 2.0 0.6 11.8 2.4 1.3 1.7 0.9 0.6 0.6 2.7 1.0 1.3 3.8 2.3 0.6 4.0 3.2 0.3 0.7 0.7 2.6 0.7 2.1 0.6 0.1 1.0 0.7 0.0 0.4 0.1 1.1 1.2 0.0 1.0 0.2 1.8 0.3 0.4 0.5 0.0 1.0 0.8 0.7 0.3 0.9 0.4 0.0 0.0 0.1 0.0 0.3 0.5 0.9 0.2 6.8 0.1 0.7 0.2 0.3 1.5 0.0 1.0 0.8 0.3 0.0 0.3 0.0 0.0 0.1 1.5 0.0 1.2 0.6 0.1 0.0 0.6 0.1 0.7 0.3 0.5 1.0 0.5 0.2 0.1 0.1 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.0 1.2 1.2 1.7 4.0 1.1 3.1 5.5 4.3 2.5 2.7 2.3 2.6 3.3 9.6 2.8 85.5 1.7 1.8 2.6 2.9 7.4 1.5 3.1 3.0 8.2 1.5 11.5 5.5 4.2 1.2 0.9 0.4 5.9 1.1 35.8 24.3 2.1 2.3 0.0 4.6 133.8 1.7 0.6 4.8 4.6 0.9 0.0 6.0 3.3 2.4 0.5 1.7 95.8 1.3 2.0 1.6 1.7 14.9 6.2 1.3 0.0 46.9 0.1 6.7 2.1 117.1 102.6 0.6 0.3 7.2 2.5 1.0 0.5 3.5 77.2 22.4 0.0 3.8 3.8 8.5 1.6 4.1 0.6 0.3 1.6 3.3 0.8 0.6 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904288-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "fallopian tube: 110.9" "Cell type enhanced" "Detected in some" "Early spermatids: 167.1;Endometrial ciliated cells: 400.1;Late spermatids: 148.9;Respiratory ciliated cells: 709.5" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 14.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.7;REH: 8.0;U-698: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules No No "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.0 0.0 3.3 0.0 2.8 0.2 0.1 1.9 2.1 2.5 25.4 0.0 0.0 2.0 8.4 0.0 110.9 0.0 0.0 2.1 3.6 0.8 0.0 7.7 0.0 9.9 10.2 0.1 0.5 1.2 13.6 0.0 7.5 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 8.0 0.0 0.1 9.9 4.0 6.6 5.4 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.3 6.2 0.0 0.0 2.2 0.0 1.0 0.1 0.0 0.1 0.0 4.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.0 1.2 2.1 0.0 0.5 0.0 0.0 19.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.8 1.9 2.1 2.1 3.6 9.9 10.2 7.5 8.0 4.0 7.6 0.0 3.2 7.3 0.3 0.0 0.0 0.1 58.0 0.0 0.0 0.2 0.0 0.0 0.0 66.2 1.8 0.0 0.0 0.0 0.0 1.9 0.1 167.1 400.1 2.4 0.5 0.0 0.0 0.4 0.0 0.0 0.8 0.0 4.7 1.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 65.1 0.0 0.0 148.9 0.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.5 0.0 1.6 709.5 0.0 0.0 0.0 19.2 21.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 CATIP "C2orf62, MGC50811" ENSG00000158428 "Ciliogenesis associated TTC17 interacting protein" Q7Z7H3 2 218356857-218368099 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 20.0;testis: 7.3" "Cell type enhanced" "Detected in some" "Distal tubular cells: 11.7;Early spermatids: 13.6;Endometrial ciliated cells: 36.1;Late spermatids: 18.6;Proximal tubular cells: 11.3;Spermatocytes: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "BEWO: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044818 Supported NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 28: BEWO - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA044818: AB_10959301" "unprognostic (7.11e-3)" "unprognostic (2.37e-1)" "unprognostic (3.95e-2)" "unprognostic (1.70e-3)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-2)" "unprognostic (1.69e-2)" "unprognostic (3.44e-1)" "unprognostic (1.95e-3)" "unprognostic (1.46e-1)" "unprognostic (2.72e-1)" "unprognostic (9.93e-2)" "unprognostic (1.19e-1)" 0.1 0.1 0.9 0.0 0.9 0.1 0.0 0.7 0.5 1.3 6.0 0.0 0.0 0.4 4.9 0.0 20.0 0.3 0.0 0.9 1.4 3.4 0.0 2.2 0.0 2.5 3.4 0.1 1.1 1.8 1.3 0.8 2.0 1.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.2 0.1 7.3 1.2 0.0 3.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.9 0.7 0.5 0.9 1.4 2.5 3.4 2.0 2.5 1.2 1.5 0.1 0.0 0.5 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.7 2.8 0.0 5.5 0.0 2.2 0.0 0.0 11.7 1.4 13.6 36.1 0.4 0.2 0.0 0.0 0.9 0.2 1.3 0.1 1.1 0.8 0.0 0.1 0.7 0.1 1.3 0.0 0.6 0.0 0.0 2.7 0.0 18.6 0.6 1.8 0.0 1.0 0.7 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 11.3 0.7 0.1 0.0 0.2 0.2 10.2 0.1 0.0 0.0 4.7 0.1 0.3 0.0 0.1 CATSPERD "MGC39581, TMEM146" ENSG00000174898 "Cation channel sperm associated auxiliary subunit delta" Q86XM0 19 5720637-5778734 "Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 8.7" "Group enriched" "Detected in some" 6 "Early spermatids: 120.2;Endometrial ciliated cells: 67.5;Late spermatids: 165.8;Respiratory ciliated cells: 149.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 62 "HEL: 7.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA024056 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "HPA024056: AB_1858093" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (3.77e-3)" "unprognostic (9.91e-2)" "unprognostic (3.74e-2)" "unprognostic (6.85e-2)" "unprognostic (2.63e-3)" "unprognostic (2.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.50e-1)" "unprognostic (5.95e-8)" "unprognostic (2.54e-2)" "unprognostic (9.92e-2)" "unprognostic (2.83e-1)" "unprognostic (3.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.2 0.2 0.1 0.0 0.1 0.0 2.2 0.7 0.0 0.4 0.2 4.7 0.0 0.0 0.3 0.6 0.5 0.0 6.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 120.2 67.5 0.7 0.5 0.0 0.0 1.3 0.2 0.1 0.4 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 8.2 0.3 0.0 165.8 0.6 0.2 0.0 1.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.4 0.1 0.2 0.0 0.0 149.9 0.0 0.0 0.5 2.0 18.7 1.2 0.0 1.4 0.3 0.1 0.0 0.0 0.1 CCDC113 "DKFZp434N1418, HSPC065" ENSG00000103021 "Coiled-coil domain containing 113" Q9H0I3 16 58231157-58283836 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 31.4;testis: 18.1" "Group enriched" "Detected in many" 5 "Early spermatids: 182.3;Endometrial ciliated cells: 140.3;Late spermatids: 171.8;Respiratory ciliated cells: 194.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 10 "basophil: 6.5" "Lineage enriched" "Detected in single" 27 "granulocytes: 6.5" "Cell line enhanced" "Detected in many" "SiHa: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040759, HPA040869" Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA040759: AB_2677121, HPA040869: AB_2677180" "unprognostic (8.50e-2)" "unprognostic (3.39e-2)" "prognostic favorable (8.65e-4)" "prognostic favorable (7.01e-4)" "unprognostic (2.40e-1)" "unprognostic (4.87e-4)" "unprognostic (2.39e-2)" "unprognostic (5.38e-2)" "unprognostic (3.21e-1)" "unprognostic (4.59e-1)" "unprognostic (2.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.09e-2)" "unprognostic (1.21e-1)" "unprognostic (6.74e-2)" "unprognostic (1.65e-3)" "unprognostic (5.61e-2)" 2.2 2.8 5.5 1.1 5.2 0.3 2.5 2.8 5.2 2.5 10.8 1.4 0.5 2.0 1.8 1.8 31.4 1.7 3.6 5.4 4.5 1.8 1.1 3.8 0.7 7.3 9.6 1.7 1.4 6.8 3.3 0.7 6.0 2.3 1.6 9.5 1.2 1.9 3.1 2.5 0.6 1.6 7.4 0.4 1.7 18.1 4.8 0.4 2.7 2.4 0.6 1.5 0.9 5.6 5.7 4.7 2.1 8.6 4.6 4.9 6.8 3.3 2.1 2.7 0.6 0.6 7.2 0.1 4.3 1.0 2.9 0.8 0.7 3.1 2.6 0.6 1.6 0.1 3.4 0.6 4.6 2.9 0.6 2.6 5.4 0.7 7.4 1.7 0.5 2.7 5.1 0.0 0.6 4.2 0.2 0.8 3.2 0.4 7.0 1.7 0.0 1.1 4.8 1.6 2.2 3.5 28.3 2.3 1.2 0.9 8.0 2.9 0.2 2.8 2.8 1.8 1.0 2.2 1.5 1.5 6.6 1.8 2.0 6.5 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.0 5.5 5.2 2.8 5.2 5.4 4.5 7.3 9.6 6.0 7.4 4.8 5.6 1.4 0.0 2.8 6.2 0.3 0.5 1.4 5.4 3.4 5.7 3.8 4.1 11.2 2.8 19.9 1.8 12.5 0.0 0.1 1.2 3.9 5.5 182.3 140.3 6.7 1.8 1.2 0.0 9.6 3.8 1.9 3.4 0.5 4.5 0.0 2.9 0.4 2.1 0.1 3.3 8.6 1.2 4.1 0.0 0.7 171.8 4.7 0.6 1.8 1.0 0.0 7.7 0.0 4.0 5.8 2.7 0.3 4.1 0.5 1.3 0.1 1.3 194.6 12.1 0.0 3.3 3.4 32.1 8.7 1.0 1.6 1.1 0.6 10.4 1.1 0.8 CCDC114 "CILD20, FLJ32926" ENSG00000105479 "Coiled-coil domain containing 114" Q96M63 19 48296457-48321971 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 12.1;choroid plexus: 28.8;fallopian tube: 25.5;testis: 13.3" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 106.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;U-266/70: 1.7" HPA042524 Approved NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA042524: AB_10795706" "unprognostic (8.55e-2)" "unprognostic (2.40e-2)" "unprognostic (2.70e-5)" "unprognostic (1.54e-2)" "unprognostic (5.09e-4)" "unprognostic (1.16e-1)" "unprognostic (2.33e-2)" "unprognostic (3.02e-2)" "unprognostic (1.46e-1)" "unprognostic (1.82e-1)" "unprognostic (7.93e-2)" "unprognostic (1.30e-1)" "unprognostic (7.50e-3)" "unprognostic (4.35e-2)" "unprognostic (4.25e-2)" "unprognostic (1.30e-1)" "unprognostic (5.15e-2)" 0.0 0.1 1.6 0.0 1.1 0.5 0.1 0.7 0.6 0.7 28.8 0.0 0.0 0.7 0.1 0.0 25.5 0.0 0.1 2.1 1.6 0.2 0.0 3.0 0.1 7.7 12.1 0.8 0.1 0.7 0.4 0.0 4.9 0.1 0.0 0.4 0.0 0.5 0.0 0.5 0.0 0.0 4.4 0.1 0.2 13.3 1.7 0.2 0.5 0.0 0.0 0.0 0.0 2.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.1 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.4 0.0 0.6 0.1 1.0 0.0 0.1 0.0 0.7 0.0 0.5 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.5 0.0 0.6 0.0 0.1 0.0 0.2 1.7 0.8 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.7 0.6 2.1 1.6 7.7 12.1 4.9 4.4 1.7 2.0 0.1 0.0 3.4 0.7 0.1 0.1 0.2 4.7 0.0 0.7 0.6 0.4 0.5 0.0 9.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.9 60.4 0.6 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 1.5 3.8 0.2 0.0 0.2 0.0 1.7 0.4 0.3 6.1 0.0 0.3 6.5 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 106.5 0.6 0.0 0.2 1.4 20.8 2.2 0.1 0.1 0.0 1.0 0.5 0.2 0.1 CCDC13 FLJ25467 ENSG00000244607 "Coiled-coil domain containing 13" Q8IYE1 3 42705756-42773253 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.4;choroid plexus: 2.5;fallopian tube: 2.9;retina: 4.3;testis: 5.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 28.0;Distal tubular cells: 17.6;Early spermatids: 18.1;Endometrial ciliated cells: 23.3;Late spermatids: 18.4;Respiratory ciliated cells: 53.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047429 Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Cluster 49: Ciliated cells - Cilium organization" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA047429: AB_2680043" "unprognostic (3.34e-2)" "unprognostic (3.72e-2)" "unprognostic (2.18e-2)" "unprognostic (1.67e-3)" "unprognostic (2.19e-2)" "unprognostic (5.35e-2)" "unprognostic (4.75e-2)" "unprognostic (8.06e-2)" "unprognostic (4.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.05e-2)" "unprognostic (2.31e-1)" "unprognostic (1.83e-7)" "unprognostic (6.21e-2)" "unprognostic (2.40e-1)" "unprognostic (5.71e-2)" "unprognostic (2.04e-2)" 0.2 0.1 1.0 0.0 1.9 0.0 0.1 1.1 1.4 0.5 2.5 0.3 0.0 0.2 0.3 0.1 2.9 0.0 0.4 1.1 0.9 0.4 0.8 0.8 0.0 1.9 2.1 0.0 0.2 0.0 0.7 0.0 1.6 0.3 0.1 4.3 0.1 0.0 0.3 0.0 0.2 0.0 1.5 0.1 0.3 5.9 1.4 0.0 0.6 0.0 0.0 0.2 0.2 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 1.1 1.4 1.1 0.9 1.9 2.1 1.6 1.5 1.4 2.4 0.3 0.0 0.6 7.2 0.4 1.0 0.4 2.8 0.6 28.0 0.8 0.5 1.2 1.5 5.6 3.7 4.2 0.1 0.3 0.9 17.6 0.9 18.1 23.3 2.1 0.6 0.0 0.0 6.0 0.2 0.5 0.8 0.0 1.1 1.3 0.2 0.4 0.4 2.6 0.0 4.0 0.4 0.0 1.6 2.8 18.4 1.5 1.4 1.8 3.7 2.7 1.8 1.0 2.0 4.6 0.2 2.4 0.7 0.0 1.0 0.0 4.6 53.4 5.4 0.0 0.0 1.7 13.3 3.7 0.1 1.1 0.0 0.5 1.0 0.1 0.7 CCDC138 FLJ32745 ENSG00000163006 "Coiled-coil domain containing 138" Q96M89 2 108786757-108885477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.9" "Cell type enhanced" "Detected in many" "Early spermatids: 154.1;Excitatory neurons: 56.5;Inhibitory neurons: 58.9;Oligodendrocytes: 48.7;Respiratory ciliated cells: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049899, HPA054223" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Cytosol "HPA049899: AB_2680941, HPA054223: AB_2682420" "unprognostic (2.34e-1)" "unprognostic (3.74e-2)" "unprognostic (3.22e-2)" "unprognostic (3.04e-1)" "unprognostic (2.83e-2)" "unprognostic (1.64e-2)" "unprognostic (2.24e-5)" "unprognostic (2.89e-1)" "unprognostic (1.01e-4)" "unprognostic (2.56e-1)" "unprognostic (1.64e-1)" "unprognostic (5.77e-2)" "unprognostic (7.06e-4)" "unprognostic (7.88e-2)" "unprognostic (4.73e-2)" "unprognostic (2.69e-1)" "unprognostic (8.93e-2)" 1.0 0.9 2.0 2.0 1.8 3.5 2.4 4.8 3.1 1.3 2.1 1.9 1.0 2.1 1.3 2.1 4.3 1.8 0.7 2.4 2.3 1.7 2.8 1.3 4.5 2.6 2.4 1.6 1.7 0.7 0.8 1.3 2.4 1.4 2.3 2.3 1.3 0.7 1.0 2.4 1.7 1.5 2.0 1.2 1.8 10.9 2.0 6.4 0.8 0.7 3.8 1.6 1.3 3.0 14.7 6.7 22.4 11.6 1.8 2.0 14.2 6.3 2.0 14.6 10.6 21.8 8.4 35.2 9.2 2.0 7.3 12.2 16.3 8.5 13.0 8.2 21.0 16.3 11.6 18.2 2.2 22.4 2.3 1.4 2.5 17.2 5.1 2.2 7.7 15.0 31.4 15.8 7.5 8.2 32.2 15.3 33.3 8.0 6.9 21.1 21.2 21.3 8.1 11.5 15.7 15.3 13.6 7.3 11.1 13.6 7.8 10.7 4.9 9.2 16.2 6.0 13.5 4.9 12.2 36.4 3.8 17.2 9.3 2.6 0.5 0.8 1.1 1.2 2.2 3.0 1.5 2.3 0.5 3.2 2.2 2.6 0.3 2.0 0.4 4.8 2.4 1.2 2.0 1.8 4.8 3.1 2.4 2.3 2.6 2.4 2.4 2.0 2.0 3.0 2.4 0.0 3.3 14.7 7.9 2.4 3.5 4.5 6.8 7.3 3.6 3.9 1.4 2.8 9.6 1.8 8.4 5.2 13.6 0.9 1.9 3.7 154.1 38.9 7.0 2.7 5.4 5.9 56.5 1.4 5.5 6.3 8.6 7.3 4.5 6.7 1.1 2.4 2.2 6.7 58.9 2.5 2.0 1.6 1.5 34.0 3.7 3.9 1.8 10.3 1.3 1.8 6.2 19.1 48.7 3.3 0.5 1.9 14.4 1.1 0.7 1.7 43.8 7.0 0.0 5.0 3.5 29.5 20.1 7.0 2.8 1.4 5.9 5.5 2.9 2.3 CCDC146 "KIAA1505, MBO2" ENSG00000135205 "Coiled-coil domain containing 146" Q8IYE0 7 77122434-77329533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 34.0" "Cell type enhanced" "Detected in many" "Early spermatids: 308.3;Endometrial ciliated cells: 460.8;Oligodendrocyte precursor cells: 151.3;Respiratory ciliated cells: 417.9;Spermatocytes: 149.4" "Group enriched" "Detected in all" 4 "endometrial cancer: 8.8;ovarian cancer: 13.6;renal cancer: 15.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 14.3;neutrophil: 15.4" "Group enriched" "Detected in many" 4 "granulocytes: 15.4;NK-cells: 5.3;T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA020082, HPA020105" Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA020082: AB_1852410, HPA020105: AB_2072056" "unprognostic (3.07e-3)" "unprognostic (9.94e-3)" "unprognostic (1.56e-1)" "unprognostic (2.54e-3)" "unprognostic (1.85e-1)" "prognostic favorable (7.37e-4)" "unprognostic (1.95e-3)" "unprognostic (8.02e-3)" "unprognostic (4.05e-4)" "unprognostic (1.73e-1)" "unprognostic (4.63e-1)" "unprognostic (4.09e-2)" "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-1)" "unprognostic (2.70e-3)" "unprognostic (5.58e-3)" 2.2 1.1 4.0 2.5 3.7 1.7 2.4 2.0 2.5 4.5 18.3 3.8 2.4 4.6 2.5 3.6 34.0 3.1 1.8 2.7 4.4 4.2 1.8 5.2 3.0 11.5 11.4 3.3 2.5 3.9 3.8 1.9 7.4 3.7 2.7 14.5 4.1 2.3 1.1 9.4 2.8 3.0 7.8 3.7 3.3 21.5 3.9 3.1 7.7 1.6 2.7 3.1 3.9 6.3 0.6 0.9 2.7 1.4 1.7 1.7 0.3 0.7 0.6 0.7 1.1 0.0 4.6 1.4 0.1 0.2 2.6 0.9 0.4 0.8 1.1 1.9 0.3 1.8 1.5 0.8 0.5 1.8 1.3 0.8 1.3 1.2 0.2 2.2 0.6 1.4 0.0 1.4 0.1 0.2 1.5 2.9 0.3 0.6 0.6 4.0 0.4 0.2 2.8 0.5 2.0 1.3 1.0 0.9 0.6 0.8 0.8 0.6 0.9 1.0 0.4 1.4 0.4 2.7 4.5 1.2 2.3 2.7 2.3 0.9 0.6 14.3 4.4 0.9 3.0 1.2 1.9 3.1 0.8 0.2 1.2 2.0 15.4 5.3 0.4 2.0 1.6 0.8 4.0 3.7 2.0 2.5 2.7 4.4 11.5 11.4 7.4 7.8 3.9 6.3 6.9 3.2 9.7 34.0 3.6 7.1 2.6 16.9 6.2 8.6 2.7 4.6 32.0 2.8 56.9 5.5 62.6 1.2 9.3 2.8 21.5 3.2 308.3 460.8 11.1 4.8 1.8 0.4 49.0 1.6 0.7 15.4 6.1 106.0 6.3 6.1 23.6 0.8 1.6 5.0 48.8 1.4 24.4 3.5 7.1 52.4 12.2 4.5 5.4 50.6 2.0 12.1 20.6 151.3 62.8 1.7 5.2 6.4 3.7 5.8 2.9 30.1 417.9 55.1 6.6 15.6 11.6 149.4 10.8 5.5 3.4 2.5 8.6 7.2 4.0 5.4 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171073-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 3.0;testis: 3.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Early spermatids: 39.4;Excitatory neurons: 33.6;Inhibitory neurons: 53.0;Oligodendrocytes: 38.6;Respiratory ciliated cells: 34.1;Rod photoreceptor cells: 30.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.7;HBF TERT88: 1.8;RPTEC TERT1: 1.9;SCLC-21H: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Cluster 41: Basophils - Cellular respiration" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.54e-4)" "unprognostic (6.57e-3)" 0.2 0.3 0.5 0.0 0.6 0.0 1.0 0.9 0.4 0.7 3.0 0.0 0.0 0.4 1.2 0.1 1.8 0.3 0.1 0.5 0.4 2.4 0.1 0.4 0.0 0.9 0.7 0.7 0.2 2.5 1.0 0.0 0.6 0.3 0.0 2.0 0.6 0.4 0.0 0.2 0.0 0.1 0.5 0.0 0.1 3.4 0.5 0.0 1.0 0.0 0.0 0.1 0.2 0.3 0.7 0.0 0.4 0.7 0.0 0.0 0.0 0.5 0.0 0.5 1.1 0.5 2.7 0.0 0.1 0.4 0.2 0.2 0.0 0.1 1.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.9 0.2 2.0 0.1 0.3 0.2 0.2 0.6 1.2 0.1 0.0 0.2 0.4 0.1 0.1 0.3 0.6 0.0 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.9 0.4 0.5 0.4 0.9 0.7 0.6 0.5 0.5 0.3 1.1 0.0 1.5 13.4 0.2 0.0 2.6 4.2 1.2 10.9 3.8 4.6 3.0 0.0 3.0 7.3 56.3 0.0 0.0 0.0 13.7 5.5 39.4 15.2 0.6 1.5 0.0 0.0 33.6 2.0 0.0 0.6 0.0 2.8 0.0 1.3 1.1 1.3 0.1 5.0 53.0 0.0 10.2 0.3 0.0 7.7 0.9 1.0 0.0 5.6 0.8 6.0 0.0 19.6 38.6 2.6 0.0 1.9 0.0 1.2 0.0 6.4 34.1 30.8 6.6 1.6 0.7 22.6 4.0 0.6 0.4 0.0 0.2 1.3 0.1 1.7 CCDC151 "MGC20983, ODA10" ENSG00000198003 "Coiled-coil domain containing 151" A5D8V7 19 11420604-11435782 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 15.0;parathyroid gland: 9.8;testis: 10.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Kupffer cells: 51.6;Muller glia cells: 58.9;Respiratory ciliated cells: 29.6;Spermatocytes: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.0;T-47d: 4.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054626 Enhanced NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 5: Muller glia cells - Visual perception" "HPA054626: AB_2682547" "unprognostic (1.50e-1)" "unprognostic (6.59e-2)" "unprognostic (2.05e-3)" "unprognostic (4.41e-3)" "unprognostic (1.35e-2)" "unprognostic (6.30e-2)" "unprognostic (4.41e-3)" "unprognostic (2.32e-2)" "unprognostic (2.22e-1)" "unprognostic (5.09e-2)" "unprognostic (6.76e-4)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (4.27e-2)" "unprognostic (1.85e-1)" "unprognostic (2.35e-1)" "unprognostic (2.05e-1)" 0.4 2.8 4.6 0.0 4.6 0.0 0.4 4.7 6.5 1.6 15.0 0.3 0.0 0.6 0.3 0.2 8.5 0.0 1.9 5.0 4.7 3.5 0.7 2.3 0.0 6.4 6.8 0.6 0.4 9.8 7.0 0.4 5.7 0.8 0.0 0.9 1.7 0.5 0.1 0.5 0.2 0.0 5.2 2.6 0.4 10.4 4.6 0.0 2.9 0.0 0.0 0.3 0.8 4.9 0.2 0.0 0.6 0.2 0.1 0.2 0.5 0.2 0.1 0.3 0.4 0.0 0.0 0.1 0.2 0.1 1.2 0.1 0.5 0.2 0.0 0.5 0.5 0.2 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.5 0.1 0.4 0.0 0.1 0.2 0.1 1.0 0.2 0.0 0.7 0.3 0.0 2.0 1.3 0.6 0.1 0.1 0.1 4.8 0.2 0.0 0.8 0.1 1.7 0.0 1.7 1.4 0.1 1.8 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.6 4.6 4.7 6.5 5.0 4.7 6.4 6.8 5.7 5.2 4.6 4.9 1.1 0.0 0.0 6.5 5.7 0.9 0.7 1.0 0.6 1.1 0.8 1.3 2.2 1.5 2.6 12.9 0.0 0.5 0.0 0.0 29.4 0.2 12.4 20.3 4.2 2.9 0.0 0.0 2.3 0.2 0.5 3.8 0.5 1.1 4.5 1.6 14.3 1.2 4.7 1.7 1.7 0.5 2.0 51.6 1.7 14.5 2.8 7.8 7.2 1.0 2.6 58.9 0.0 1.0 0.8 0.1 0.0 0.7 0.8 0.1 0.1 1.1 29.6 3.2 6.6 15.2 6.8 22.7 6.6 0.1 0.4 1.2 1.5 1.0 0.0 0.5 CCDC153 LOC283152 ENSG00000248712 "Coiled-coil domain containing 153" Q494R4 11 119189638-119196769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.1" "Group enriched" "Detected in many" 7 "Endometrial ciliated cells: 92.3;Respiratory ciliated cells: 186.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 4.0;neutrophil: 15.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;EFO-21: 4.2;HEL: 5.0;T-47d: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041497 Uncertain Uncertain Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA041497: AB_10794378" "unprognostic (4.66e-2)" "unprognostic (1.86e-2)" "unprognostic (3.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-3)" "unprognostic (5.19e-2)" "unprognostic (9.43e-3)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (2.92e-3)" "unprognostic (1.15e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-3)" "unprognostic (1.98e-3)" 1.1 0.7 1.5 0.5 1.2 2.5 0.7 2.7 1.6 0.9 2.7 0.7 0.3 0.8 0.2 1.0 11.1 1.1 0.3 1.3 1.6 1.3 0.4 1.5 0.3 2.0 1.9 0.2 0.3 2.8 3.3 0.9 1.4 0.4 0.5 1.5 0.5 1.1 0.4 0.7 0.6 0.5 1.7 0.5 1.1 1.8 2.0 0.3 0.8 0.0 0.2 0.4 0.5 1.8 0.6 0.9 0.9 1.0 0.2 0.1 2.8 0.6 1.1 0.4 0.5 1.9 4.8 0.2 4.2 0.2 1.3 0.5 0.3 1.1 0.1 1.1 0.6 5.0 0.4 0.3 0.7 0.6 0.3 0.5 0.7 1.2 0.3 1.4 1.2 0.6 0.7 0.9 0.1 3.4 0.3 0.7 0.3 1.2 1.0 0.7 0.1 0.3 0.4 0.8 1.0 0.2 1.3 0.8 0.7 0.3 8.8 1.4 1.2 0.7 0.5 0.3 0.4 0.4 0.5 0.2 0.3 0.2 0.3 0.5 2.3 4.0 0.3 1.6 0.1 0.3 0.2 0.4 1.7 0.3 0.5 0.4 15.8 0.2 1.6 1.7 0.4 0.8 1.5 1.2 2.7 1.6 1.3 1.6 2.0 1.9 1.4 1.7 2.0 1.8 4.4 0.0 6.1 0.0 0.6 2.8 1.7 14.9 1.8 0.4 2.3 2.2 0.4 1.5 19.8 7.3 0.0 4.3 0.7 5.3 0.0 1.1 3.5 92.3 1.9 3.3 1.8 0.0 0.5 2.0 3.5 2.1 4.6 2.3 0.0 1.5 3.3 1.8 3.6 0.0 0.4 4.2 12.2 4.6 5.5 7.0 0.3 2.7 3.6 1.0 4.5 0.8 1.0 0.0 0.6 1.1 11.3 2.6 3.0 1.0 3.3 4.8 186.9 2.0 6.6 0.7 9.9 5.9 4.0 1.6 2.3 3.3 0.6 0.5 2.9 2.7 CCDC157 ENSG00000187860 "Coiled-coil domain containing 157" Q569K6 22 30356635-30378658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.6" "Cell type enhanced" "Detected in many" "Early spermatids: 118.0;Late spermatids: 142.4;Respiratory ciliated cells: 44.9;Spermatocytes: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042943 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" "HPA042943: AB_10794767" "unprognostic (3.69e-3)" "unprognostic (1.72e-4)" "unprognostic (4.35e-2)" "unprognostic (1.24e-2)" "unprognostic (3.61e-1)" "unprognostic (7.74e-3)" "unprognostic (8.72e-4)" "unprognostic (1.35e-2)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.89e-4)" "unprognostic (2.33e-2)" "unprognostic (2.60e-2)" "unprognostic (4.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.42e-1)" "unprognostic (3.45e-2)" 0.7 1.4 3.9 0.9 3.5 1.8 1.2 2.9 3.8 1.5 7.3 0.9 0.9 1.0 1.8 1.1 7.4 1.2 0.7 3.8 4.1 3.0 0.9 2.2 1.1 4.3 5.9 1.2 1.9 2.2 5.0 0.5 3.3 1.7 0.4 1.9 1.5 0.9 0.6 1.0 1.2 0.4 3.6 1.6 1.1 27.6 5.0 0.8 3.6 0.5 0.7 0.9 1.0 2.7 1.8 2.0 1.8 3.4 1.0 0.6 2.2 0.9 1.1 1.7 1.7 2.6 1.3 1.6 1.1 0.9 2.6 1.9 1.0 1.2 0.9 1.1 4.3 0.9 2.0 1.4 1.1 1.7 1.4 0.6 0.8 3.1 0.5 1.1 1.0 2.3 1.5 1.4 1.4 1.6 2.2 1.8 2.4 1.2 1.0 1.9 1.0 1.4 4.2 1.8 6.1 4.0 2.8 1.1 1.2 1.3 3.3 0.8 1.8 1.8 2.2 1.1 0.8 1.2 0.7 1.2 2.7 1.0 1.4 0.8 0.6 0.8 0.7 0.4 0.8 0.4 0.7 0.8 0.3 0.5 0.4 0.6 2.5 0.7 0.6 0.9 0.7 0.5 3.9 3.5 2.9 3.8 3.8 4.1 4.3 5.9 3.3 3.6 5.0 2.7 2.6 3.2 3.3 2.0 2.6 1.3 2.4 4.2 0.6 6.2 6.6 5.2 0.9 4.3 7.3 9.2 12.5 2.5 7.0 3.0 0.0 5.5 118.0 31.3 3.3 2.8 1.2 0.4 4.2 2.3 2.3 2.6 2.0 5.0 2.5 3.8 5.7 0.9 2.0 6.7 3.1 1.5 8.2 3.8 3.9 142.4 3.7 3.4 0.0 1.0 2.2 4.4 4.1 1.0 0.6 3.0 3.2 2.6 6.6 1.4 1.7 6.9 44.9 28.3 0.0 6.7 3.8 59.3 16.5 1.5 1.7 3.4 4.8 4.5 1.8 1.9 CCDC160 ENSG00000203952 "Coiled-coil domain containing 160" A6NGH7 X 134237047-134246207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 16.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 45.0;Early spermatids: 14.8;Endometrial ciliated cells: 28.1;Respiratory ciliated cells: 36.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 29.7;RPTEC TERT1: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (7.45e-3)" "unprognostic (2.79e-2)" "prognostic favorable (2.31e-4)" "unprognostic (1.98e-1)" "unprognostic (5.11e-4)" "unprognostic (4.22e-2)" "unprognostic (2.07e-2)" "prognostic favorable (7.62e-6)" "unprognostic (3.32e-2)" "unprognostic (4.51e-2)" "prognostic favorable (2.21e-4)" "unprognostic (5.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.44e-3)" 0.2 0.0 2.2 0.1 2.2 0.2 3.9 2.8 2.7 2.9 3.9 0.2 0.0 0.7 1.7 0.4 3.3 1.1 0.1 2.2 2.4 6.0 0.0 0.4 0.5 2.5 2.5 1.3 0.5 5.1 0.6 0.2 2.7 1.8 0.1 1.0 16.5 2.6 1.0 0.3 0.0 0.0 2.1 0.4 1.0 2.0 2.3 0.0 0.2 0.0 0.1 0.5 0.3 2.6 0.0 0.0 29.7 2.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 8.3 2.4 0.0 0.1 0.0 0.3 0.4 2.9 3.7 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.2 2.8 2.7 2.2 2.4 2.5 2.5 2.7 2.1 2.3 2.6 0.2 0.0 0.0 5.5 0.0 0.0 1.0 9.3 0.6 0.3 9.6 9.0 0.5 1.5 10.2 9.2 0.0 0.0 0.0 0.0 45.0 3.2 14.8 28.1 0.5 0.3 0.0 0.0 0.4 0.0 0.3 0.8 0.0 2.5 0.0 0.8 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.6 0.1 1.8 1.0 0.0 6.9 0.0 6.0 5.6 0.2 0.0 0.4 0.0 1.8 0.0 7.7 36.0 0.6 0.0 0.7 0.6 6.7 10.1 2.3 0.0 0.0 0.1 0.1 0.0 1.4 CCDC17 FLJ33084 ENSG00000159588 "Coiled-coil domain containing 17" Q96LX7 1 45620044-45624057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "fallopian tube: 36.0" "Cell type enriched" "Detected in many" 5 "Respiratory ciliated cells: 374.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028338 Enhanced NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "HPA028338: AB_10669641" "unprognostic (3.53e-5)" "unprognostic (7.40e-2)" "unprognostic (3.08e-3)" "unprognostic (3.55e-3)" "unprognostic (3.31e-1)" "unprognostic (9.21e-3)" "unprognostic (6.97e-2)" "unprognostic (1.30e-2)" "unprognostic (8.55e-2)" "unprognostic (1.07e-1)" "unprognostic (4.46e-3)" "unprognostic (2.91e-1)" "unprognostic (8.37e-7)" "unprognostic (1.20e-1)" "unprognostic (1.96e-1)" "unprognostic (2.92e-1)" "unprognostic (5.91e-3)" 0.1 0.1 0.2 0.1 0.3 0.4 0.0 0.2 0.8 2.1 0.2 0.1 0.2 0.1 0.0 0.0 36.0 0.0 0.2 0.2 0.2 0.1 0.1 3.3 0.1 0.7 1.1 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.8 0.2 0.2 0.7 1.1 0.7 0.2 0.2 0.2 3.1 3.2 4.1 1.0 0.4 1.1 0.3 14.2 0.6 0.1 2.4 1.7 1.6 0.0 23.4 0.0 0.0 0.6 2.0 4.6 5.9 0.5 0.0 74.5 1.1 2.1 1.2 0.4 0.1 0.9 0.2 1.9 1.1 3.2 1.3 0.3 1.1 0.9 0.6 0.0 0.1 2.3 10.2 0.6 1.4 0.4 1.2 1.8 0.0 1.0 1.0 0.4 0.0 0.0 1.7 1.3 3.2 2.2 0.3 0.6 4.2 1.1 374.1 0.5 0.0 0.9 5.2 0.8 0.7 0.9 0.6 0.5 0.8 0.7 2.6 0.4 CCDC170 "bA282P11.1, C6orf97, FLJ23305" ENSG00000120262 "Coiled-coil domain containing 170" Q8IYT3 6 151494017-151621193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "fallopian tube: 33.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 236.6;Late spermatids: 82.6;Respiratory ciliated cells: 379.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MCF7: 10.4;T-47d: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027114, HPA027185" Enhanced Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "Cell Junctions" "HPA027114: AB_2732435, HPA027185: AB_2672151" "unprognostic (7.46e-2)" "unprognostic (3.54e-2)" "unprognostic (6.93e-2)" "prognostic favorable (3.64e-4)" "unprognostic (2.13e-1)" "unprognostic (8.79e-3)" "unprognostic (2.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.56e-2)" "unprognostic (1.40e-2)" "unprognostic (3.93e-2)" "unprognostic (2.17e-1)" "unprognostic (5.21e-2)" 3.0 4.2 1.5 1.3 1.4 0.1 3.7 0.9 0.7 3.0 8.0 0.7 2.5 3.6 0.4 0.4 33.4 1.3 0.8 1.3 1.8 0.8 1.3 4.1 1.4 3.6 4.9 5.6 0.1 0.1 0.2 1.4 3.1 0.4 0.6 0.2 0.2 0.4 0.3 0.2 1.1 0.9 3.2 2.2 1.7 2.7 1.7 0.3 5.6 0.1 0.6 1.1 0.5 2.8 0.0 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.1 5.9 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 6.2 0.0 2.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.8 0.1 2.8 0.1 0.0 0.6 1.5 1.4 0.9 0.7 1.3 1.8 3.6 4.9 3.1 3.2 1.7 2.8 1.2 3.2 1.5 7.5 0.4 0.6 0.3 6.5 1.2 0.3 27.3 8.9 0.7 0.0 39.5 0.0 22.9 0.1 0.4 1.1 0.0 0.3 53.0 236.6 23.6 1.2 0.0 0.0 5.5 1.1 0.4 5.2 3.1 14.1 3.8 3.5 1.1 1.5 11.9 0.0 5.9 0.0 12.2 17.5 11.3 82.6 7.2 16.8 0.0 0.0 11.0 2.5 0.0 3.0 0.8 2.7 5.8 0.0 0.1 0.9 0.5 5.8 379.4 1.0 0.0 0.4 6.5 19.1 1.1 0.2 1.0 0.0 1.2 14.0 0.3 0.5 CCDC173 "C2orf77, LOC129881" ENSG00000154479 "Coiled-coil domain containing 173" Q0VFZ6 2 169645425-169694405 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 22.2;testis: 80.2" "Cell type enhanced" "Detected in many" "Early spermatids: 939.2;Endometrial ciliated cells: 118.1;Late spermatids: 133.4;Respiratory ciliated cells: 232.6;Spermatocytes: 460.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042995, HPA048454" Approved NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 36: HEL - Hemostasis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA042995: AB_2678260, HPA048454: AB_2680400" "unprognostic (1.66e-2)" "unprognostic (2.68e-2)" "unprognostic (2.27e-1)" "unprognostic (3.16e-2)" "unprognostic (9.20e-2)" "unprognostic (4.18e-2)" "unprognostic (3.56e-3)" "unprognostic (3.05e-1)" "unprognostic (3.14e-2)" "unprognostic (1.69e-1)" "unprognostic (5.26e-6)" "unprognostic (8.73e-2)" "unprognostic (1.20e-1)" "unprognostic (2.20e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-2)" "unprognostic (1.41e-1)" 0.3 0.3 7.4 0.7 7.8 3.6 1.3 4.4 11.6 1.0 22.2 0.2 0.6 1.2 1.1 0.2 14.9 0.5 0.1 8.7 7.1 0.9 0.4 2.5 0.2 13.7 16.6 0.8 1.4 1.6 2.6 0.1 9.6 0.4 0.4 6.7 0.2 0.8 0.1 0.2 0.4 0.6 11.3 0.1 0.4 80.2 8.1 0.2 3.4 0.0 0.0 0.2 0.2 9.6 0.5 0.8 0.8 0.2 0.0 0.1 0.9 0.4 0.0 0.4 0.1 0.3 0.1 0.1 0.1 0.0 0.7 0.6 0.7 1.0 0.7 0.1 0.5 11.1 0.7 0.3 0.0 1.1 2.5 0.0 0.1 1.4 0.0 0.6 0.0 0.6 2.5 0.1 0.0 1.2 0.2 0.3 0.2 0.3 0.6 0.0 0.0 0.0 0.3 0.5 2.7 0.7 0.1 0.0 0.0 0.3 0.6 0.1 0.0 0.2 0.1 0.7 0.4 0.4 0.3 0.3 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.4 7.8 4.4 11.6 8.7 7.1 13.7 16.6 9.6 11.3 8.1 9.6 1.5 9.6 8.3 12.7 1.6 0.1 2.5 3.8 1.2 13.3 2.2 3.9 0.6 0.0 31.7 1.8 8.4 0.2 4.1 0.1 5.9 0.4 939.2 118.1 3.3 1.2 0.0 0.0 5.8 0.4 2.6 3.5 1.5 2.3 2.5 0.5 1.4 0.8 0.0 0.0 2.3 0.7 8.2 0.3 0.2 133.4 7.5 1.0 1.8 2.8 0.0 7.3 0.0 1.5 0.5 0.1 0.0 6.8 1.9 0.5 0.0 3.2 232.6 13.7 13.1 21.2 1.8 460.3 13.7 0.0 0.0 0.1 3.3 0.1 0.1 0.9 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 18.4" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 8.4;Early spermatids: 11.9;Excitatory neurons: 15.9;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 11.4;Spermatocytes: 17.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "cerebellum: 18.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 18.4 0.5 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 18.4 0.5 0.0 0.2 0.7 0.8 0.8 0.4 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 8.4 0.0 0.0 1.1 0.0 0.0 11.9 5.0 0.1 0.0 0.0 1.7 15.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 1.5 4.8 0.0 0.3 0.0 0.0 0.1 1.5 0.0 5.0 3.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 7.4 11.4 0.0 0.4 0.3 17.7 4.4 0.0 0.0 0.0 0.0 0.1 2.4 0.1 CCDC180 "BDAG1, C9orf174, CFAP76, DKFZp434I2420, FAP76, KIAA1529" ENSG00000197816 "Coiled-coil domain containing 180" 9 97307304-97378751 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "choroid plexus: 11.8;testis: 13.1" "Cell type enhanced" "Detected in many" "Early spermatids: 133.5;Late spermatids: 297.4;Respiratory ciliated cells: 81.2;Spermatocytes: 48.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6;U-266/70: 4.1;U-266/84: 3.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (9.92e-2)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-3)" "unprognostic (2.94e-2)" "unprognostic (3.52e-2)" "unprognostic (2.94e-1)" "unprognostic (1.52e-1)" "unprognostic (5.53e-5)" "unprognostic (2.33e-2)" "unprognostic (7.34e-3)" "unprognostic (1.64e-1)" "unprognostic (2.54e-1)" "unprognostic (1.41e-2)" "unprognostic (7.50e-3)" 0.7 0.8 1.7 0.6 1.9 0.7 1.2 3.7 2.8 1.2 11.8 0.8 0.4 1.7 2.0 0.5 6.4 0.8 0.9 1.9 1.7 0.9 0.5 2.0 0.9 3.9 5.5 2.4 1.1 0.9 1.2 0.5 2.7 1.1 0.8 6.5 0.8 1.1 0.9 0.5 0.6 1.3 2.7 1.1 0.6 13.1 1.9 0.6 1.8 0.8 0.7 0.5 0.4 2.5 0.0 0.4 0.6 0.3 0.4 1.3 0.0 0.1 0.4 0.4 0.3 0.7 0.4 0.0 0.6 0.0 0.3 0.0 0.4 0.0 0.1 2.6 0.3 0.8 0.9 0.3 0.1 1.0 1.3 0.6 0.4 0.0 0.1 1.5 0.0 1.2 0.6 0.4 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.3 0.0 0.4 0.1 1.2 0.6 4.1 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.9 3.7 2.8 1.9 1.7 3.9 5.5 2.7 2.7 1.9 2.5 3.0 0.0 10.5 0.0 3.4 0.4 0.5 1.8 1.2 12.6 1.9 2.3 0.8 1.5 11.7 0.0 20.9 0.2 2.0 0.4 1.9 0.4 133.5 39.0 3.7 2.7 1.2 0.8 0.0 1.4 0.0 2.8 0.5 1.4 9.5 11.4 2.9 0.1 0.5 13.5 0.0 1.2 2.0 0.8 0.9 297.4 1.8 1.6 1.8 0.0 3.4 2.7 4.1 0.0 0.0 0.2 0.5 3.0 5.1 0.4 1.7 15.9 81.2 25.0 0.0 6.7 3.0 48.0 6.0 0.5 0.1 0.4 2.7 5.7 1.2 0.4 CCDC181 "C1orf114, FLJ25846" ENSG00000117477 "Coiled-coil domain containing 181" Q5TID7 1 169394870-169460669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 41.5;testis: 27.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 66.1;Cone photoreceptor cells: 66.7;Early spermatids: 289.9;Late spermatids: 69.3;Respiratory ciliated cells: 109.6;Rod photoreceptor cells: 89.4;Spermatocytes: 201.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Cell line enhanced" "Detected in many" "AF22: 7.1;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.4;SH-SY5Y: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027189, HPA027275, HPA027281, HPA027312" Enhanced Uncertain "Nuclear speckles" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349" "unprognostic (2.45e-1)" "unprognostic (2.20e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-3)" "unprognostic (3.00e-1)" "unprognostic (5.97e-2)" "unprognostic (6.87e-2)" "unprognostic (2.15e-3)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (4.89e-4)" "unprognostic (4.03e-2)" "unprognostic (3.06e-2)" "unprognostic (1.18e-2)" "unprognostic (8.41e-2)" 0.4 2.5 7.4 0.5 7.9 0.5 0.4 8.4 11.9 3.1 14.2 0.7 0.2 3.6 1.9 0.4 12.3 3.6 1.9 7.7 10.3 6.2 0.1 1.8 0.2 8.0 9.0 6.3 3.8 12.1 18.2 0.1 7.6 2.0 0.2 41.5 0.4 2.0 0.2 0.6 0.4 2.0 7.5 0.1 1.6 27.6 8.9 0.4 0.5 0.3 0.1 1.2 1.0 7.1 0.2 0.3 7.1 0.1 0.2 0.2 0.2 0.1 0.0 1.8 3.7 0.1 0.2 0.1 0.1 0.0 7.4 0.1 0.3 0.0 0.3 0.2 1.6 1.8 0.2 0.0 0.0 2.0 0.1 0.7 0.0 0.4 0.0 0.1 0.1 5.7 0.1 0.1 1.3 0.1 4.5 0.0 13.8 0.1 0.0 0.0 5.9 0.1 1.1 0.0 8.4 9.9 0.0 0.3 0.5 3.7 0.0 0.0 0.5 1.4 4.4 0.2 6.4 2.1 2.0 0.0 2.8 0.1 5.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.4 7.9 8.4 11.9 7.7 10.3 8.0 9.0 7.6 7.5 8.9 7.1 0.2 3.2 4.7 6.8 0.0 0.0 0.2 2.7 0.6 66.1 0.8 0.4 6.3 0.0 22.5 9.2 66.7 0.0 0.2 0.1 15.6 1.2 289.9 47.0 1.9 1.5 19.2 2.1 16.2 1.6 0.0 3.1 0.0 1.7 1.3 4.5 0.7 0.0 0.1 25.2 13.1 0.0 6.1 0.0 0.0 69.3 3.1 0.5 0.0 5.6 0.0 23.5 0.0 8.5 3.9 0.7 0.0 10.5 0.0 0.1 0.0 16.2 109.6 89.4 6.6 13.1 3.4 201.8 41.1 0.4 0.0 0.1 0.4 4.0 0.0 0.5 CCDC187 MGC50722 ENSG00000260220 "Coiled-coil domain containing 187" A0A096LP49 9 136249973-136306901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 11.0;pituitary gland: 7.1;testis: 29.6" "Cell type enriched" "Detected in some" 4 "Late spermatids: 446.1" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "RPMI-8226: 10.4;SCLC-21H: 3.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 3.2" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (1.11e-1)" "unprognostic (9.60e-3)" "unprognostic (1.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (4.31e-2)" "unprognostic (6.18e-2)" "unprognostic (1.72e-1)" "unprognostic (2.86e-1)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (5.54e-2)" "unprognostic (8.93e-4)" 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 1.4 0.4 0.0 0.0 0.1 2.8 0.0 11.0 0.0 0.0 0.1 0.7 0.3 0.0 1.9 0.0 0.1 0.3 0.0 0.4 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 29.6 0.4 0.0 4.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 10.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 107.8 49.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 446.1 3.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.0 0.1 22.6 0.0 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 CCDC189 "C16orf93, MGC104706" ENSG00000196118 "Coiled-coil domain containing 189" A1A4V9 16 30757423-30762221 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 18.4" "Group enriched" "Detected in many" 4 "Early spermatids: 208.2;Late spermatids: 318.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 12.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041806, HPA046289, HPA075094" Approved Approved Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: " "unprognostic (5.84e-2)" "unprognostic (3.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.45e-4)" "unprognostic (3.60e-2)" "unprognostic (5.41e-3)" "unprognostic (7.76e-5)" "unprognostic (1.66e-2)" "unprognostic (1.82e-2)" "unprognostic (5.11e-3)" "unprognostic (2.15e-4)" "unprognostic (1.22e-3)" "unprognostic (1.06e-7)" "unprognostic (1.75e-3)" "unprognostic (2.14e-1)" "unprognostic (6.63e-2)" "unprognostic (3.41e-2)" 1.1 5.2 6.7 1.6 6.8 7.9 2.7 5.8 8.7 3.0 12.2 1.9 1.1 1.8 4.3 1.7 10.4 1.6 0.7 7.4 6.7 6.5 1.3 3.9 1.1 6.9 8.1 2.1 3.7 2.3 12.6 0.6 8.9 4.1 1.7 3.5 3.3 1.9 0.3 1.2 1.8 0.7 6.8 2.1 2.0 18.4 6.7 1.7 6.5 0.1 2.1 1.4 1.2 5.9 7.1 5.2 1.1 5.3 1.5 1.7 0.3 2.6 1.2 2.8 2.1 0.3 5.0 0.2 4.3 2.1 1.4 8.2 0.8 4.3 1.2 0.7 9.8 1.9 10.1 2.5 0.3 2.4 1.8 0.4 0.4 5.1 4.4 4.0 2.2 1.8 2.6 1.2 2.2 4.3 2.9 4.6 1.9 2.2 2.5 2.8 1.6 5.2 6.2 0.0 4.2 1.5 3.0 7.7 1.6 1.3 7.5 3.6 1.8 1.3 1.0 2.2 2.6 3.6 2.2 2.1 8.3 7.3 0.4 1.9 1.1 6.0 0.1 1.3 0.9 1.0 0.0 0.2 1.8 0.1 0.0 0.2 0.4 1.9 3.3 12.2 0.1 0.8 6.7 6.8 5.8 8.7 7.4 6.7 6.9 8.1 8.9 6.8 6.7 5.9 0.6 0.0 3.1 0.0 4.3 0.0 4.0 0.0 4.6 1.0 6.8 4.2 0.0 0.0 3.7 7.3 4.2 2.9 16.1 1.6 5.9 3.9 208.2 42.9 2.3 1.4 2.4 14.3 0.0 3.0 1.1 3.5 12.8 4.0 1.3 2.3 0.7 1.1 4.5 0.0 0.0 2.0 0.0 2.2 0.0 318.0 7.5 5.4 0.0 0.0 4.8 3.7 1.0 0.0 0.0 1.9 1.6 4.9 11.9 3.6 1.0 8.6 49.6 15.0 0.0 1.0 1.5 52.7 15.7 2.0 0.0 2.5 2.1 7.0 1.8 3.7 CCDC190 "C1orf110, MGC48998" ENSG00000185860 "Coiled-coil domain containing 190" Q86UF4 1 162824458-162868815 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 2.3;choroid plexus: 1.0;esophagus: 3.3;lung: 1.8" "Cell type enriched" "Detected in some" 4 "Respiratory ciliated cells: 26.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 3.9;hTERT-RPE1: 4.8;HUVEC TERT2: 4.8;LHCN-M2: 7.3;TIME: 16.7;U-2197: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028579, HPA028584, HPA028592" Uncertain Approved Vesicles NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001" "unprognostic (4.29e-1)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (8.33e-3)" "unprognostic (3.04e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (7.41e-5)" "unprognostic (2.64e-1)" "unprognostic (1.52e-1)" "unprognostic (5.26e-1)" "unprognostic (1.70e-1)" 0.1 0.1 0.9 0.0 1.0 0.0 0.0 0.3 1.0 0.1 1.0 0.0 0.0 0.1 0.3 3.3 0.5 0.4 0.5 1.4 2.1 0.0 0.0 1.8 0.0 1.6 2.1 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.5 0.0 0.1 0.3 2.3 0.0 0.1 0.1 0.4 0.1 0.0 2.3 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 3.9 2.4 4.8 4.8 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.4 0.0 8.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.3 1.0 1.4 2.1 1.6 2.1 1.0 0.5 2.3 2.3 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.6 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 26.2 0.0 0.0 0.4 0.5 0.1 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.5 CCDC191 KIAA1407 ENSG00000163617 "Coiled-coil domain containing 191" Q8NCU4 3 113964137-114056594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Endometrial ciliated cells: 68.0;Respiratory ciliated cells: 104.2;Rod photoreceptor cells: 40.4;Spermatocytes: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047833 Approved Approved Mitochondria NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "HPA047833: AB_10961639" "unprognostic (2.59e-2)" "unprognostic (3.93e-2)" "unprognostic (1.86e-1)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (1.42e-2)" "unprognostic (6.57e-2)" "unprognostic (5.91e-2)" "unprognostic (1.08e-1)" "unprognostic (2.90e-1)" "unprognostic (6.33e-2)" "unprognostic (3.64e-2)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.62e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.45e-4)" 2.9 3.3 4.2 3.1 3.9 2.9 4.7 3.1 4.4 4.6 11.7 3.4 1.8 5.3 7.9 2.5 12.1 3.5 1.8 3.8 4.0 7.7 1.9 4.7 4.4 5.7 5.7 4.8 5.1 7.9 10.9 2.1 4.2 5.0 3.2 14.0 3.6 4.8 0.9 7.6 4.0 2.7 4.7 5.6 3.1 9.7 4.0 2.8 8.3 0.8 4.1 3.5 3.3 4.0 3.7 1.9 3.0 2.5 0.8 4.3 0.9 0.8 1.5 1.1 1.8 0.4 4.1 1.0 1.4 1.5 1.0 4.6 0.9 1.6 2.6 0.7 0.7 0.8 0.7 0.3 1.2 1.1 0.5 1.8 4.2 1.5 2.2 2.0 2.2 2.8 0.3 2.1 0.7 1.6 2.3 0.4 0.5 2.4 1.4 1.4 0.6 2.0 4.2 1.8 1.8 2.9 1.5 0.3 1.5 1.5 7.2 0.4 2.4 2.1 0.5 0.9 0.5 3.0 2.6 3.5 2.7 0.6 1.0 0.1 0.8 1.6 0.9 0.8 1.0 8.9 1.8 1.5 0.9 8.3 0.9 1.5 4.4 0.8 0.5 3.7 1.4 0.9 4.2 3.9 3.1 4.4 3.8 4.0 5.7 5.7 4.2 4.7 4.0 4.0 5.2 12.8 14.4 0.0 20.0 0.0 4.0 0.0 4.6 8.9 5.7 7.0 0.0 0.0 16.1 12.9 37.5 1.8 7.9 1.5 13.7 5.4 27.1 68.0 9.5 3.7 4.9 2.1 0.0 3.6 0.5 4.0 9.7 10.6 1.3 9.1 4.6 1.3 3.0 20.2 0.0 2.3 0.0 3.2 0.0 13.1 4.1 3.0 0.0 0.0 2.0 21.6 4.1 0.0 0.0 2.6 1.0 5.3 3.0 1.7 2.4 5.0 104.2 40.4 0.0 6.3 3.5 68.3 13.3 4.3 0.0 0.3 4.5 8.1 2.7 2.8 CCDC24 MGC45441 ENSG00000159214 "Coiled-coil domain containing 24" Q8N4L8 1 43991359-43996528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 36.4;Respiratory ciliated cells: 57.6;Spermatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.0;intermediate monocyte: 2.2;memory B-cell: 3.5;naive B-cell: 2.2;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 5 "B-cells: 3.5;granulocytes: 1.0;monocytes: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA035424, HPA061710" Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "Nucleoli, Cytosol" "HPA035424: AB_2674619, HPA061710: AB_2684591" "prognostic favorable (3.06e-5)" "unprognostic (1.47e-1)" "unprognostic (1.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.65e-2)" "prognostic favorable (3.18e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.92e-2)" "unprognostic (6.38e-2)" "unprognostic (2.81e-1)" "unprognostic (7.00e-3)" "unprognostic (3.00e-1)" "unprognostic (1.74e-2)" "unprognostic (6.91e-2)" "unprognostic (1.51e-1)" "unprognostic (7.84e-2)" "unprognostic (2.15e-3)" 1.6 4.8 11.8 1.3 11.9 0.4 3.3 11.3 15.9 5.9 12.3 3.8 1.9 3.2 1.9 2.1 11.2 3.1 1.3 11.8 12.0 11.8 3.6 2.9 1.4 11.6 11.8 2.4 5.6 6.2 12.9 1.0 11.7 7.2 2.1 6.6 4.4 5.0 0.8 1.1 2.4 1.3 11.8 2.4 3.8 19.1 12.3 0.9 9.1 0.2 1.0 4.1 2.4 11.5 4.7 2.8 1.2 1.4 1.2 0.8 2.7 0.2 1.9 1.4 2.4 1.8 13.4 3.8 5.0 0.5 4.0 4.7 0.7 6.5 1.3 3.9 1.6 1.9 1.7 0.5 1.3 0.6 3.2 0.3 0.6 4.5 0.4 4.3 1.1 1.4 0.8 1.4 2.0 4.0 0.2 1.4 2.7 4.2 2.2 1.3 0.0 0.7 5.5 1.8 2.9 2.6 4.0 2.3 2.6 2.5 6.7 0.1 0.3 2.1 5.9 1.5 0.7 0.5 1.8 0.8 5.3 0.5 1.7 0.0 0.4 1.0 0.3 2.2 0.2 3.5 0.1 0.1 0.4 2.2 0.0 0.0 0.4 0.3 1.8 0.3 0.0 0.2 11.8 11.9 11.3 15.9 11.8 12.0 11.6 11.8 11.7 11.8 12.3 11.5 1.7 3.2 7.2 17.0 2.3 1.1 7.9 26.5 9.1 8.9 13.3 12.1 1.0 12.8 22.0 9.2 6.2 5.6 0.9 11.3 21.5 9.4 20.7 30.9 2.4 2.1 36.4 1.3 17.7 7.2 2.2 2.5 21.9 6.9 2.5 1.6 2.5 2.6 3.3 3.3 10.0 13.6 14.2 2.0 2.2 11.7 2.1 3.6 3.6 1.9 2.7 10.2 0.0 5.0 2.4 6.5 8.3 3.0 1.8 5.7 6.3 11.5 57.6 15.4 0.0 2.9 3.8 50.6 19.9 3.9 0.9 2.5 1.3 3.9 10.2 11.4 CCDC30 "FLJ20972, LOC728621, PFD6L" ENSG00000186409 "Coiled-coil domain containing 30" Q5VVM6 1 42463221-42657190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 13.0" "Cell type enhanced" "Detected in many" "Early spermatids: 81.9;Endometrial ciliated cells: 62.9;Excitatory neurons: 109.2;Inhibitory neurons: 70.3;Respiratory ciliated cells: 109.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036344, HPA036345" Approved NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA036344: AB_10795572, HPA036345: AB_10796213" "unprognostic (3.21e-2)" "unprognostic (8.48e-2)" "unprognostic (3.33e-1)" "unprognostic (4.46e-2)" "unprognostic (2.35e-1)" "unprognostic (5.72e-3)" "unprognostic (6.77e-3)" "unprognostic (7.68e-3)" "unprognostic (4.61e-3)" "unprognostic (1.41e-2)" "unprognostic (3.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (3.06e-2)" "unprognostic (1.13e-1)" "unprognostic (5.70e-3)" "unprognostic (6.95e-3)" 0.8 1.5 3.9 0.7 3.5 1.6 2.3 4.5 4.0 2.4 13.0 0.7 0.6 1.8 5.1 0.7 6.1 1.3 0.7 3.6 5.3 4.7 0.7 1.8 1.0 6.2 5.4 2.2 1.5 3.3 1.6 0.9 2.6 1.5 1.0 3.1 1.4 1.9 1.6 1.7 1.1 1.1 2.6 1.2 0.8 3.9 5.4 1.0 4.9 0.5 0.8 0.8 0.2 3.6 1.4 0.9 2.1 2.2 1.0 1.2 0.7 0.7 0.3 1.1 1.0 0.8 2.5 1.6 1.0 0.2 1.2 0.9 1.0 1.2 1.5 1.3 1.4 1.0 2.0 0.7 1.0 1.3 8.8 0.6 2.3 1.9 0.8 2.0 0.8 1.0 0.9 0.9 0.5 0.8 0.8 1.6 1.3 0.7 0.6 0.7 0.8 0.9 2.7 0.7 2.6 2.1 0.8 1.7 1.5 1.9 1.2 3.2 0.3 1.0 1.0 1.3 1.1 1.1 1.0 0.7 1.9 2.4 1.0 5.8 1.0 2.4 1.0 0.6 1.1 1.0 0.6 0.9 0.7 1.4 1.0 0.8 4.6 1.3 1.7 1.8 1.0 0.4 3.9 3.5 4.5 4.0 3.6 5.3 6.2 5.4 2.6 2.6 5.4 3.6 2.8 6.4 12.9 43.1 2.0 1.3 2.8 2.5 2.2 5.8 5.5 4.2 2.7 5.7 21.1 7.3 8.4 1.6 6.3 3.1 1.9 5.9 81.9 62.9 5.5 3.8 3.0 4.0 109.2 2.4 1.0 5.2 2.0 4.2 8.9 11.8 2.5 0.9 1.2 6.7 70.3 2.0 2.0 2.5 1.7 37.7 5.9 3.0 1.8 33.7 4.5 5.3 5.2 40.2 41.6 1.3 2.9 7.2 1.3 2.3 3.0 9.1 109.1 9.3 6.6 9.0 5.3 42.4 6.6 1.0 1.0 1.8 3.9 7.1 1.3 1.9 CCDC33 "CT61, FLJ32855" ENSG00000140481 "Coiled-coil domain containing 33" Q8N5R6 15 74202705-74336472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 23.6;testis: 20.2" "Group enriched" "Detected in some" 9 "Early spermatids: 54.2;Endometrial ciliated cells: 70.1;Late spermatids: 54.6;Respiratory ciliated cells: 56.7" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.4;ovarian cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 4.4;SCLC-21H: 2.4;SH-SY5Y: 2.9" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 7.4" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.13e-3)" "unprognostic (6.37e-3)" "unprognostic (2.16e-1)" "unprognostic (3.16e-3)" "unprognostic (3.68e-2)" "unprognostic (9.87e-2)" "unprognostic (2.05e-2)" "unprognostic (4.46e-1)" "unprognostic (4.18e-2)" "unprognostic (6.12e-2)" "unprognostic (9.37e-2)" 0.0 0.2 0.6 0.0 0.4 0.0 0.0 0.2 0.0 2.0 0.5 0.0 0.0 0.3 0.1 0.0 23.6 0.0 0.1 0.5 0.6 0.0 0.0 2.6 0.0 2.1 3.4 0.1 0.0 0.0 0.4 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 20.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.4 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.5 0.6 2.1 3.4 1.6 2.3 0.4 0.6 0.2 0.0 1.5 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.3 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 54.2 70.1 1.5 0.2 0.0 0.0 0.6 0.0 0.0 0.5 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.1 0.0 0.0 54.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.6 0.0 0.4 0.0 0.0 0.0 0.4 56.7 0.0 0.0 0.0 1.1 0.6 0.2 0.0 0.0 1.8 0.1 0.2 0.0 0.1 CCDC40 "CFAP172, CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640" ENSG00000141519 "Coiled-coil domain containing 40" Q4G0X9 17 80036632-80100613 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 31.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 58.5;Respiratory ciliated cells: 92.9;Rod photoreceptor cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.1;SH-SY5Y: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022974 Enhanced Approved Microtubules NA NA "Cluster 11: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "HPA022974: AB_1848791" "unprognostic (5.89e-3)" "unprognostic (2.30e-1)" "unprognostic (8.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.04e-5)" "unprognostic (7.38e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.86e-1)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" "unprognostic (4.26e-2)" 2.0 2.3 2.3 0.9 2.2 0.3 2.2 1.8 2.3 2.6 31.4 2.3 0.5 3.2 2.5 0.7 14.8 2.1 3.1 2.2 4.1 7.5 1.7 3.2 0.7 7.4 10.8 1.7 2.6 1.8 6.9 0.6 3.7 3.2 0.5 5.7 2.3 1.6 0.8 1.1 1.6 1.0 4.6 1.2 1.8 8.4 4.8 0.3 4.9 0.5 0.5 1.7 1.2 2.2 2.2 7.0 6.2 6.9 0.8 0.9 1.6 2.0 1.4 1.7 1.8 0.7 3.0 0.3 0.9 1.4 2.9 0.6 1.6 1.5 0.4 0.1 1.3 0.1 3.9 3.5 1.4 0.1 2.2 1.6 2.1 2.1 0.2 3.0 0.9 1.3 0.8 0.0 1.4 2.5 0.1 0.4 2.8 3.0 2.3 1.8 3.3 0.0 3.5 1.4 12.1 8.7 3.1 1.5 1.4 3.3 2.8 0.2 1.1 3.8 2.3 2.5 0.4 2.0 0.7 0.3 0.8 0.2 1.9 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.3 2.2 1.8 2.3 2.2 4.1 7.4 10.8 3.7 4.6 4.8 2.2 0.8 12.8 5.2 16.6 0.6 0.6 2.4 2.5 0.6 4.2 2.9 3.0 3.6 0.0 10.0 7.3 14.6 0.4 0.1 0.3 1.9 2.9 13.6 58.5 4.0 1.4 3.0 0.0 10.7 1.5 1.0 2.3 1.5 4.7 0.0 1.8 1.8 1.2 1.4 11.8 11.7 1.7 8.2 4.3 1.4 7.9 1.2 1.5 0.0 10.3 0.3 4.7 0.0 8.0 1.9 0.9 1.1 3.4 0.1 1.5 0.3 2.1 92.9 28.6 0.0 3.3 3.2 16.0 5.3 0.5 0.3 0.3 0.5 2.4 0.7 1.1 CCDC60 MGC39827 ENSG00000183273 "Coiled-coil domain containing 60" Q8IWA6 12 119334712-119541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 22.9;fallopian tube: 18.3;testis: 11.6" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 28.6;Early spermatids: 155.1;Late spermatids: 74.7;Respiratory ciliated cells: 43.7;Urothelial cells: 32.9" "Cancer enhanced" "Detected in some" "cervical cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (2.96e-1)" "unprognostic (2.05e-2)" "unprognostic (7.73e-3)" "unprognostic (2.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-3)" "unprognostic (1.00e-1)" "unprognostic (2.70e-1)" "unprognostic (1.70e-1)" "unprognostic (2.93e-2)" "unprognostic (3.56e-3)" "unprognostic (3.92e-1)" "unprognostic (4.29e-2)" "unprognostic (4.11e-1)" "unprognostic (2.54e-1)" 0.0 0.0 1.2 0.5 1.0 0.0 0.0 0.2 0.2 5.6 22.9 1.7 0.1 0.4 0.6 1.7 18.3 0.0 0.0 1.2 1.6 0.0 0.0 1.3 0.0 5.1 4.6 0.0 0.0 0.0 0.0 0.5 3.2 3.0 4.6 2.5 1.1 1.6 0.1 0.1 0.1 0.0 3.5 0.0 0.3 11.6 1.3 0.1 0.0 0.0 2.3 3.2 2.4 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.2 0.2 1.2 1.6 5.1 4.6 3.2 3.5 1.3 1.4 0.0 0.0 0.0 1.6 0.2 0.8 28.6 3.1 8.6 0.3 0.0 0.0 0.3 0.0 4.7 0.0 14.6 0.0 0.0 0.3 0.0 0.1 155.1 19.4 0.2 0.1 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.1 10.2 0.0 0.0 74.7 0.9 0.1 0.0 2.8 0.0 0.2 0.0 0.0 1.0 0.1 0.5 0.4 0.0 5.5 0.1 0.0 43.7 1.0 0.0 0.0 1.2 23.1 2.3 5.9 0.0 0.0 0.0 0.1 0.7 32.9 CCDC65 "CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28" ENSG00000139537 "Coiled-coil domain containing 65" Q8IXS2 12 48904110-48931840 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 26.6;testis: 37.3" "Cell type enhanced" "Detected in many" "Early spermatids: 151.1;Endometrial ciliated cells: 92.7;Respiratory ciliated cells: 155.7;Spermatocytes: 85.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 8.7;MAIT T-cell: 9.1;memory CD4 T-cell: 7.5;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.6;naive CD8 T-cell: 6.2;T-reg: 4.8" "Lineage enriched" "Detected in single" 11 "T-cells: 9.1" "Cell line enhanced" "Detected in many" "HeLa: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038520, HPA057573" Uncertain Approved "Vesicles,Centriolar satellite" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "Centriolar satellite" "HPA038520: AB_10672714, HPA057573: AB_2683473" "unprognostic (3.06e-2)" "unprognostic (1.17e-1)" "unprognostic (4.22e-2)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.43e-2)" "unprognostic (2.86e-2)" "unprognostic (5.79e-3)" "unprognostic (3.23e-1)" "unprognostic (9.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.03e-4)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (6.16e-2)" 0.4 0.4 1.5 0.7 2.3 1.4 0.4 0.0 2.8 1.4 3.4 0.4 0.3 1.1 2.8 0.3 26.6 1.2 0.3 3.2 0.3 1.8 0.3 2.9 1.0 1.4 2.3 0.8 0.8 1.4 2.1 0.1 1.3 0.4 0.0 7.1 0.3 0.4 0.4 1.5 0.5 0.1 0.5 1.1 0.4 37.3 1.5 0.2 2.5 0.0 0.3 0.2 0.3 0.3 0.6 2.5 1.1 2.2 0.0 0.0 1.1 0.6 0.0 0.3 1.0 3.1 1.4 0.9 0.8 0.0 0.3 0.7 0.0 0.0 0.4 1.4 1.1 1.4 4.4 1.1 0.1 1.1 1.2 0.0 0.0 0.6 0.0 1.7 0.0 0.7 0.6 0.3 0.0 1.5 0.3 1.5 2.5 0.9 0.6 0.8 0.5 1.0 2.0 1.6 0.6 1.0 0.7 0.9 0.8 1.7 2.3 1.0 1.0 0.8 0.8 0.9 0.5 1.1 1.2 0.8 0.9 0.9 0.2 0.0 0.0 0.0 8.7 0.0 9.1 0.2 7.5 7.3 0.0 0.5 4.6 6.2 0.1 0.8 0.0 0.0 4.8 2.9 1.5 2.3 0.0 2.8 3.2 0.3 1.4 2.3 1.3 0.5 1.5 0.3 0.9 0.0 1.1 2.0 0.6 0.9 0.2 6.2 0.0 1.2 0.4 0.5 0.5 0.0 13.8 0.0 12.5 0.1 6.5 0.0 7.9 1.0 151.1 92.7 3.0 0.6 0.0 2.7 7.2 0.6 0.1 0.8 0.5 4.2 0.0 0.5 0.0 0.5 0.0 0.0 4.0 0.0 12.2 0.0 0.8 22.7 1.5 0.3 1.8 1.0 0.2 2.2 33.0 2.0 0.8 0.3 0.0 2.2 1.0 0.2 0.0 3.4 155.7 11.5 0.0 0.5 3.6 85.9 4.8 0.0 0.1 0.1 7.3 0.5 0.0 0.1 CCDC74A FLJ40345 ENSG00000163040 "Coiled-coil domain containing 74A" Q96AQ1 2 131527675-131533666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 73.5" "Cell type enhanced" "Detected in many" "Early spermatids: 424.4;Late spermatids: 274.9;Respiratory ciliated cells: 166.1;Spermatocytes: 154.2;Theca cells: 211.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 28.6;SCLC-21H: 23.2" HPA060727 Uncertain Vesicles NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA060727: " "prognostic favorable (5.11e-4)" "unprognostic (2.89e-3)" "unprognostic (6.49e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.91e-1)" "unprognostic (1.36e-2)" "unprognostic (2.18e-3)" "unprognostic (1.71e-1)" "unprognostic (2.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.70e-7)" "unprognostic (7.28e-3)" "prognostic favorable (4.92e-4)" "unprognostic (5.96e-2)" "unprognostic (3.53e-2)" 3.3 32.7 10.6 1.2 9.6 0.1 9.6 7.3 11.3 17.6 29.3 6.9 1.1 12.8 8.9 3.0 34.5 7.0 3.5 11.1 12.2 8.9 1.2 6.2 1.3 12.1 12.8 14.8 2.6 20.4 34.7 1.1 10.5 15.8 1.7 2.0 3.1 6.3 0.5 4.9 2.5 3.0 10.5 1.2 3.2 73.5 15.1 5.3 7.3 0.8 0.8 14.5 8.0 8.0 0.0 5.9 6.0 0.3 8.4 20.2 0.5 5.1 8.4 4.6 3.4 0.2 8.9 2.3 3.1 7.9 7.7 4.6 2.6 1.5 1.9 6.1 11.1 0.0 6.2 0.2 1.0 0.2 0.5 6.6 0.6 4.5 0.0 9.0 1.8 12.7 3.4 6.5 4.2 3.8 13.3 3.6 28.6 2.3 3.8 6.4 0.0 2.7 11.8 0.1 23.2 16.9 0.6 0.8 0.9 2.3 8.2 1.3 1.9 1.4 4.3 18.0 3.9 1.3 1.2 0.8 19.0 0.6 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 9.6 7.3 11.3 11.1 12.2 12.1 12.8 10.5 10.5 15.1 8.0 0.8 0.0 0.5 1.6 0.3 5.1 12.2 21.6 14.2 1.0 34.8 28.4 0.5 4.3 15.8 7.3 0.0 0.5 1.1 0.8 7.9 9.4 424.4 88.2 7.6 1.4 7.7 0.0 3.7 0.7 0.4 11.1 1.1 4.7 0.0 30.4 1.4 0.1 0.3 0.0 2.4 0.6 16.2 0.0 5.9 274.9 37.0 0.8 1.8 1.0 0.0 14.2 0.0 1.0 0.5 2.7 0.5 68.4 0.9 7.4 0.1 2.6 166.1 1.1 0.0 2.5 14.2 154.2 18.8 7.2 6.0 0.3 1.2 211.1 2.4 7.2 CCDC74B DKFZp434E2321 ENSG00000152076 "Coiled-coil domain containing 74B" Q96LY2 2 130139287-130145134 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.4" "Cell type enhanced" "Detected in many" "Early spermatids: 322.3;Late spermatids: 129.6;Respiratory ciliated cells: 70.3;Spermatocytes: 142.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.2;SH-SY5Y: 14.8" HPA060727 Uncertain Vesicles NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" Vesicles "HPA060727: " "prognostic favorable (4.46e-4)" "unprognostic (4.75e-3)" "unprognostic (2.67e-1)" "unprognostic (2.76e-3)" "unprognostic (2.81e-1)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (9.43e-2)" "unprognostic (2.99e-1)" "unprognostic (2.10e-1)" "unprognostic (6.43e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.43e-2)" "unprognostic (1.48e-4)" "unprognostic (8.31e-3)" "unprognostic (9.94e-3)" 1.5 1.9 3.5 0.3 3.6 0.0 2.4 2.6 4.3 17.0 7.6 1.6 0.2 8.9 0.8 0.4 14.1 1.4 1.5 4.1 5.4 3.8 0.1 2.8 0.3 6.2 7.2 5.0 0.8 11.1 19.7 0.2 5.1 7.1 0.1 0.6 0.6 2.8 0.2 1.0 0.7 1.2 5.7 0.4 1.5 55.4 6.1 0.6 7.0 0.0 0.2 2.4 3.6 3.9 0.0 1.9 2.8 0.1 2.5 5.4 0.6 2.2 1.1 0.3 0.5 0.9 0.7 0.1 3.5 2.0 3.2 1.0 0.2 0.3 0.4 2.0 5.5 0.0 7.0 0.1 0.3 0.1 0.2 1.1 0.0 0.9 0.0 3.4 0.1 1.3 0.1 1.7 0.8 2.1 0.0 0.0 5.7 0.5 5.9 4.6 0.0 3.2 1.7 0.0 10.2 14.8 1.6 0.1 0.2 0.6 5.9 0.7 0.4 1.1 4.8 5.9 0.5 0.1 0.3 0.0 6.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.6 2.6 4.3 4.1 5.4 6.2 7.2 5.1 5.7 6.1 3.9 0.2 3.2 0.5 1.6 0.1 0.5 3.0 6.3 1.2 0.5 6.1 9.5 0.4 1.5 4.3 5.5 0.0 0.2 0.2 0.1 3.9 1.5 322.3 42.8 9.9 0.2 11.4 0.0 1.6 0.2 0.8 3.6 0.0 2.2 0.0 7.8 0.0 0.0 0.3 3.3 1.1 0.1 2.0 0.0 0.2 129.6 10.2 0.6 0.0 1.0 0.0 6.2 0.0 0.5 0.3 0.0 0.1 12.4 0.1 3.9 0.0 1.2 70.3 0.1 0.0 0.9 3.2 142.7 16.4 0.7 1.1 0.1 0.3 28.8 0.1 0.7 CCDC78 "C16orf25, FLJ34512" ENSG00000162004 "Coiled-coil domain containing 78" A2IDD5 16 722582-726954 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 50.3" "Group enriched" "Detected in some" 11 "Endometrial ciliated cells: 179.7;Respiratory ciliated cells: 240.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.2;U-266/70: 9.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.10e-1)" "unprognostic (6.48e-2)" "unprognostic (2.62e-4)" "unprognostic (1.02e-2)" "unprognostic (1.24e-1)" "unprognostic (2.58e-2)" "unprognostic (3.47e-2)" "unprognostic (2.06e-2)" "unprognostic (9.39e-2)" "unprognostic (1.48e-1)" "unprognostic (7.82e-3)" "unprognostic (6.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.45e-3)" "unprognostic (5.20e-1)" "unprognostic (1.44e-1)" "unprognostic (7.22e-3)" 0.4 1.1 2.6 1.7 3.4 1.4 0.4 4.6 3.9 3.3 3.5 0.2 0.3 1.7 0.1 0.5 50.3 0.9 0.6 3.4 3.0 0.9 0.1 10.0 2.2 7.1 7.6 0.5 1.0 0.7 4.9 0.5 4.7 0.6 0.3 0.8 1.1 0.7 0.5 0.7 1.9 0.1 5.1 2.1 1.1 0.6 2.6 0.9 0.6 0.2 0.8 0.9 0.3 3.3 1.8 3.1 1.1 5.4 1.1 1.2 2.8 1.1 2.2 0.5 0.1 0.8 2.8 2.0 0.4 0.3 1.0 1.7 2.8 1.1 0.1 9.0 2.1 2.3 4.8 1.4 0.8 1.5 1.5 2.5 0.4 0.1 3.3 2.4 0.2 3.7 1.4 2.4 0.8 8.6 0.0 4.5 1.5 1.3 0.8 2.1 0.9 6.6 2.5 1.7 12.2 2.1 0.9 3.6 0.9 0.9 4.5 1.7 0.9 1.5 0.5 0.4 0.3 9.9 4.7 1.9 0.8 3.2 2.6 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.6 3.4 4.6 3.9 3.4 3.0 7.1 7.6 4.7 5.1 2.6 3.3 0.1 0.0 0.0 2.6 1.9 0.0 0.1 17.9 0.0 3.5 0.7 0.6 0.5 0.0 17.7 0.0 0.0 0.0 3.4 0.2 1.9 0.0 0.0 179.7 2.1 0.1 0.0 0.4 1.4 0.2 0.1 0.2 1.1 2.4 0.0 0.0 0.0 0.0 0.9 3.3 1.0 0.0 18.3 0.6 0.0 0.1 0.3 0.5 0.0 1.0 0.1 0.7 2.1 1.0 2.0 0.3 0.0 0.0 0.2 0.6 0.0 0.2 240.7 0.2 0.0 0.0 7.6 0.8 0.9 0.0 0.1 0.0 1.4 0.1 0.1 0.2 CCDC80 "CL2, DRO1, LINC01279, SSG1, TCONS_00006930, URB" ENSG00000091986 "Coiled-coil domain containing 80" Q76M96 3 112596797-112649530 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 450.8;Fibroblasts: 921.6;Late spermatids: 353.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 521.4;fHDF/TERT166: 1281.3;hTERT-RPE1: 2404.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002266 Approved "Secreted to extracellular matrix" NA NA 510000 "Cluster 41: Basophils - Cellular respiration" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA002266: AB_1078423" "unprognostic (1.26e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-2)" "unprognostic (3.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.53e-2)" "unprognostic (2.30e-3)" "unprognostic (1.99e-3)" "unprognostic (8.40e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.86e-5)" "unprognostic (5.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.26e-4)" 244.9 15.0 6.4 83.5 6.9 1.1 218.3 9.6 8.6 305.3 24.4 74.5 8.7 276.5 76.8 92.4 82.2 234.0 218.8 6.8 10.2 17.7 6.6 74.0 18.5 12.2 11.4 62.2 28.7 12.4 10.8 26.0 9.3 67.8 73.4 9.4 34.7 78.7 13.4 79.1 25.1 360.3 11.1 34.8 47.5 42.7 9.2 17.1 87.5 34.9 30.8 194.4 131.8 13.5 26.1 11.0 127.6 5.8 521.4 411.2 6.9 359.0 108.5 118.6 171.8 2.9 2.1 1.2 13.5 1281.3 11.4 33.5 5.3 4.8 123.7 24.3 1.2 0.7 27.7 0.7 109.5 1.0 0.5 409.7 14.4 174.9 11.0 2404.9 27.8 0.6 0.4 1.0 352.7 0.5 0.3 0.7 31.6 0.7 4.2 0.3 14.0 0.6 3.3 0.5 0.4 2.5 53.5 2.3 1.8 23.0 2.1 1.0 141.7 345.6 56.6 66.6 160.1 1.6 0.8 1.2 102.4 0.7 56.8 0.9 0.3 0.2 0.3 0.1 0.3 0.4 0.3 0.3 0.1 0.6 0.4 0.4 0.3 0.3 0.2 0.7 0.2 0.0 6.4 6.9 9.6 8.6 6.8 10.2 12.2 11.4 9.3 11.1 9.2 13.5 104.5 6.4 15.9 13.1 1.5 60.9 4.2 44.7 26.7 1.1 5.9 59.7 22.5 10.0 62.7 5.5 0.0 57.9 1.0 0.3 1.9 23.7 450.8 95.4 93.2 43.9 0.0 0.0 1.0 1.2 101.5 921.6 16.8 18.4 1.3 44.3 53.6 0.9 9.4 0.0 0.3 0.8 30.5 2.2 121.5 353.6 77.0 9.7 144.1 3.7 2.0 101.4 0.0 0.0 0.0 13.5 0.0 34.6 5.8 3.6 0.0 0.1 112.4 2.5 19.7 177.7 198.4 6.9 4.9 11.9 51.7 27.9 9.0 23.0 0.1 1.9 CCDC81 "FLJ16339, FLJ23514" ENSG00000149201 "Coiled-coil domain containing 81" Q6ZN84 11 86374736-86423109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 10.2;fallopian tube: 27.4" "Cell type enhanced" "Detected in many" "Early spermatids: 37.5;Endometrial ciliated cells: 72.7;Extravillous trophoblasts: 35.8;Respiratory ciliated cells: 38.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 3.4;BJ hTERT+: 1.8;HBF TERT88: 1.9;SuSa: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.02e-1)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (2.30e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (7.00e-3)" "unprognostic (8.54e-3)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.14e-4)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" 0.7 0.3 1.5 0.2 1.4 0.2 0.4 1.8 1.4 1.9 10.2 0.5 0.0 1.6 0.5 0.2 27.4 0.4 0.4 1.8 2.3 0.4 0.3 1.4 0.4 4.0 5.5 0.8 0.2 0.1 1.8 0.6 3.9 0.7 0.2 1.0 0.2 0.7 0.8 0.4 0.3 1.1 3.5 0.4 0.4 5.8 2.0 0.8 0.7 0.1 0.3 0.6 0.5 2.4 0.0 0.1 1.1 0.0 0.3 0.1 0.4 3.4 1.8 0.5 0.4 0.4 0.3 0.2 1.3 0.6 0.1 0.2 0.6 0.1 1.9 0.2 0.2 0.3 0.1 0.3 0.1 0.2 0.3 0.0 0.6 0.9 0.3 0.6 0.6 0.2 0.2 0.0 0.4 0.5 0.4 1.0 0.1 0.5 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.2 0.0 2.1 0.2 0.4 0.1 0.8 0.4 0.8 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 1.8 1.4 1.8 2.3 4.0 5.5 3.9 3.5 2.0 2.4 0.1 3.2 0.5 4.6 0.0 0.3 0.2 1.0 0.0 1.8 0.7 0.6 1.1 0.0 5.2 0.0 0.0 4.0 0.2 0.1 0.0 0.1 37.5 72.7 1.0 0.4 0.0 0.0 2.3 0.0 35.8 1.0 0.0 1.3 0.0 0.3 1.8 0.0 2.1 0.0 3.8 0.0 2.0 0.6 0.7 5.1 1.5 0.5 0.0 1.0 0.6 0.4 0.0 2.5 3.5 0.0 0.1 0.7 0.0 0.6 0.1 0.1 38.4 1.0 13.1 0.7 0.9 5.8 0.3 0.0 0.6 2.7 0.2 1.0 0.1 0.2 CCDC96 FLJ90575 ENSG00000173013 "Coiled-coil domain containing 96" Q2M329 4 7040849-7043001 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 65.4" "Cell type enhanced" "Detected in many" "Early spermatids: 76.7;Endometrial ciliated cells: 59.7;Late spermatids: 93.4;Respiratory ciliated cells: 53.4;Spermatocytes: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 5.3" HPA047546 Enhanced NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA047546: AB_2680082" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "unprognostic (7.95e-2)" "prognostic favorable (4.05e-4)" "unprognostic (1.22e-2)" "unprognostic (3.51e-3)" "unprognostic (1.77e-1)" "unprognostic (9.24e-3)" "unprognostic (1.01e-2)" "unprognostic (3.92e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.43e-1)" "prognostic favorable (3.80e-5)" "unprognostic (4.37e-2)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 0.8 2.0 2.0 0.5 2.4 1.3 1.2 2.4 2.1 1.1 6.0 0.8 0.9 0.8 0.7 1.3 10.7 0.8 0.6 2.5 2.1 1.4 0.5 1.7 0.8 3.4 3.7 0.7 1.3 1.0 3.3 0.5 3.0 1.0 0.6 1.8 1.0 1.1 1.1 1.7 0.8 0.6 2.7 0.8 1.1 65.4 2.6 0.7 1.5 0.7 0.6 0.7 0.9 1.9 1.0 2.7 1.4 1.1 1.8 1.2 0.3 2.7 1.6 3.0 1.8 0.9 2.4 0.6 0.7 1.5 3.9 1.2 0.5 1.2 0.9 0.1 0.4 0.6 1.1 0.7 0.9 0.8 1.5 1.1 1.3 1.8 0.2 0.3 1.2 1.9 0.4 0.2 1.9 2.4 1.6 1.0 0.5 0.9 1.6 0.6 0.9 0.1 5.3 1.0 3.8 0.8 2.2 1.0 0.5 1.3 1.0 1.5 1.3 2.5 0.7 1.5 2.1 0.0 0.1 0.5 1.9 0.0 0.8 0.0 0.4 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.5 0.0 0.0 0.5 0.1 0.1 1.0 0.0 0.0 0.1 2.0 2.4 2.4 2.1 2.5 2.1 3.4 3.7 3.0 2.7 2.6 1.9 3.1 0.0 4.8 0.0 1.0 0.6 0.8 2.8 0.6 4.0 3.7 3.2 0.9 0.0 6.9 3.7 12.5 0.6 0.7 2.5 1.9 2.2 76.7 59.7 4.0 2.3 5.4 0.0 0.0 1.1 0.6 1.5 0.5 2.4 0.0 0.6 2.9 0.9 1.2 0.0 0.0 1.9 4.1 2.2 0.9 93.4 3.1 1.7 1.8 0.0 1.1 6.9 0.0 0.0 0.0 1.7 2.7 4.1 0.1 1.2 0.2 4.5 53.4 19.6 0.0 4.6 2.3 30.6 3.6 1.2 1.0 0.5 0.8 2.7 0.8 0.9 CCNA1 CT146 ENSG00000133101 "Cyclin A1" P78396 13 36431520-36442870 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 22.2;testis: 81.3" "Group enriched" "Detected in some" 5 "Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7" "Group enriched" "Detected in many" 4 "endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 103 "basophil: 49.2" "Lineage enriched" "Detected in single" 301 "granulocytes: 49.2" "Cell line enhanced" "Detected in many" "HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA060646, HPA077614" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA060646: AB_2684336, HPA077614: " "unprognostic (1.92e-3)" "unprognostic (1.21e-1)" "unprognostic (4.69e-3)" "unprognostic (1.89e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (1.24e-1)" "unprognostic (4.01e-3)" "unprognostic (1.64e-1)" "unprognostic (4.04e-6)" "unprognostic (7.04e-3)" "unprognostic (2.45e-1)" "unprognostic (1.42e-1)" "unprognostic (2.63e-2)" 0.4 0.9 5.9 0.4 5.9 2.1 0.7 2.3 7.8 5.8 4.1 0.6 0.4 3.7 7.0 0.4 18.0 0.7 0.3 5.5 7.3 0.5 0.1 1.4 0.3 5.3 5.4 0.5 0.1 22.2 8.2 0.0 10.7 0.5 0.1 1.0 0.6 0.1 1.2 0.3 0.3 8.2 4.9 0.6 0.4 81.3 6.1 0.4 0.6 0.4 0.6 0.6 1.1 4.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 15.2 0.1 15.5 1.2 12.9 1.4 0.1 0.0 0.7 0.0 0.4 0.0 0.6 8.0 350.9 0.3 34.1 0.7 2.8 5.5 0.9 1.7 0.0 0.5 0.2 4.4 0.4 71.4 2.5 0.0 8.8 0.0 8.3 0.0 2.3 0.0 2.5 5.8 0.0 8.4 0.2 1.8 0.0 71.5 4.5 0.0 0.0 0.1 2.9 0.8 0.0 0.0 0.3 90.3 0.6 49.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.9 5.9 2.3 7.8 5.5 7.3 5.3 5.4 10.7 4.9 6.1 4.0 0.1 0.0 0.6 0.3 0.3 0.6 0.6 19.1 0.0 0.4 0.5 1.4 0.4 0.0 10.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 162.4 119.1 1.8 0.4 0.0 0.0 3.5 0.0 0.8 1.1 0.0 31.9 5.1 2.2 0.0 0.0 0.2 0.0 3.0 0.0 6.1 0.0 1.8 91.1 3.1 1.1 0.0 0.0 0.0 1.4 0.0 0.5 0.4 0.0 0.0 2.6 0.0 0.7 0.0 0.1 29.3 0.8 6.6 0.5 1.5 285.7 2.4 0.0 0.4 0.3 0.9 0.0 0.1 1.1 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105126-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "T-reg: 22.7" "Lineage enriched" "Detected in many" 6 "T-cells: 22.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.83e-4)" "prognostic unfavorable (4.63e-4)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 1.0 1.1 0.4 12.2 1.1 74.6 2.9 0.7 0.7 2.9 1.1 14.3 14.1 2.6 0.3 16.1 1.1 1.9 0.7 0.6 0.7 1.1 1.4 2.2 33.0 1.3 1.0 0.8 0.7 0.2 0.3 11.4 1.0 1.6 16.8 0.3 2.8 0.4 0.7 9.4 12.0 6.4 0.7 7.1 5.6 69.4 1.1 73.1 1.0 0.4 43.7 3.6 5.6 2.2 132.5 112.1 188.6 47.1 8.5 16.6 97.5 104.8 69.9 165.2 135.6 187.8 81.1 122.1 75.4 71.8 97.2 160.1 181.4 92.6 157.8 124.1 92.4 153.1 127.3 108.1 2.5 118.1 98.6 6.3 12.6 71.4 91.9 32.7 114.1 147.0 163.1 194.5 128.2 96.5 137.9 177.2 138.6 58.5 65.2 157.5 260.0 124.4 53.3 91.9 115.2 75.9 148.9 80.2 97.3 147.9 139.4 120.4 58.5 81.6 134.4 90.5 210.5 84.2 133.2 213.8 53.6 267.1 117.9 0.0 0.1 0.7 0.1 0.0 0.3 2.1 4.6 5.0 3.0 1.7 0.0 0.1 0.8 3.6 0.1 0.1 22.7 2.1 0.4 1.1 0.7 0.7 0.6 0.7 1.3 1.0 1.0 0.7 1.1 2.2 0.3 0.0 0.6 0.0 6.8 4.8 2.8 11.5 1.8 0.2 2.5 3.3 0.5 0.0 3.2 0.0 0.0 67.9 1.6 4.1 0.0 0.7 228.5 5.3 3.1 3.9 3.0 123.6 0.7 0.2 128.3 7.2 7.1 5.9 0.0 29.9 6.1 1.1 29.9 0.0 0.8 10.1 20.3 10.6 3.3 53.5 4.4 7.9 0.0 0.0 2.4 0.2 1.0 0.0 1.4 0.4 1.9 1.9 18.7 2.3 2.1 0.0 1.8 0.3 0.0 1.0 5.7 288.7 32.1 20.3 6.1 16.3 4.4 4.1 23.4 5.0 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811991-29824312 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.8;placenta: 30.8" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1756.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "BEWO: 293.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes "Cluster 43: B-cells - Humoral immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.2 5.7 1.9 4.3 2.1 35.8 0.8 2.8 2.7 1.0 0.9 3.9 3.0 1.4 0.6 4.4 0.9 1.0 2.3 2.0 2.5 1.0 0.7 1.1 6.1 2.0 2.1 0.8 1.8 2.8 0.9 30.8 2.0 1.0 4.7 2.0 1.5 1.4 2.1 4.1 2.5 2.2 1.7 4.2 2.1 12.1 2.5 4.5 1.6 1.8 7.8 3.0 1.8 2.3 15.6 31.8 24.3 34.0 5.2 6.0 293.1 24.7 5.3 10.8 13.2 33.0 31.2 13.3 55.9 11.1 14.0 4.9 28.8 12.8 15.2 41.9 17.7 11.2 30.0 34.5 4.1 44.0 28.7 6.2 7.1 14.8 1.9 3.4 13.3 13.2 45.6 5.8 16.8 24.4 24.5 13.0 40.1 36.2 7.2 36.2 28.6 10.1 8.4 24.6 20.5 17.4 35.4 42.7 3.9 35.4 9.5 32.7 8.0 25.0 92.8 14.9 16.9 24.1 18.2 91.6 13.8 5.6 13.7 0.0 0.0 0.0 0.1 0.5 0.3 0.6 0.1 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.5 0.0 0.3 0.1 1.9 2.1 2.8 2.7 2.0 2.5 2.0 2.1 2.0 1.7 2.5 2.3 3.1 0.0 0.6 0.7 4.8 4.8 1.5 0.3 2.2 2.9 8.2 11.3 3.1 0.0 1.4 0.0 0.0 122.4 3.7 3.5 0.0 0.4 14.6 7.5 4.1 1.9 3.0 30.7 2.9 0.7 1756.5 6.0 5.6 20.1 0.0 4.6 1.4 0.2 43.4 3.3 5.1 3.3 0.0 1.0 2.5 3.6 1.2 4.2 1.8 0.0 0.2 1.7 0.0 2.5 1.3 1.4 2.2 2.2 18.4 2.2 1.0 0.4 0.1 1.1 6.6 4.1 3.4 25.0 17.6 8.5 6.0 115.7 4.5 6.9 4.9 3.5 CCNO "CCNU, FLJ22422, UDG2, UNG2" ENSG00000152669 "Cyclin O" P22674 5 55231152-55233608 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation" Cyclin "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 12.3;pancreas: 10.1;testis: 13.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 39.3;Club cells: 51.4;Collecting duct cells: 33.1;Endometrial ciliated cells: 38.1;Ionocytes: 61.1;Respiratory ciliated cells: 97.2;Spermatocytes: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 5.2;T-47d: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA050090 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA050090: AB_2681011" "unprognostic (3.44e-2)" "unprognostic (5.20e-2)" "unprognostic (5.28e-2)" "prognostic favorable (6.78e-4)" "unprognostic (3.96e-2)" "unprognostic (2.60e-1)" "unprognostic (3.18e-3)" "prognostic favorable (7.60e-4)" "unprognostic (3.54e-2)" "unprognostic (2.10e-1)" "unprognostic (1.92e-1)" "unprognostic (3.09e-1)" "unprognostic (3.03e-2)" "prognostic favorable (5.10e-4)" "unprognostic (1.81e-1)" "unprognostic (9.49e-2)" "unprognostic (8.88e-3)" 0.1 0.4 1.3 0.0 2.8 0.0 0.5 1.1 2.3 1.0 12.3 0.3 0.3 0.2 0.3 1.0 2.1 0.1 0.1 2.2 1.8 1.9 0.2 1.3 0.0 1.7 1.9 0.8 10.1 1.1 5.3 0.1 1.1 2.0 0.0 0.1 1.8 1.2 0.0 1.8 0.5 0.0 1.2 0.0 5.6 13.2 2.0 0.0 5.5 0.0 0.0 1.8 0.4 1.3 2.8 3.2 0.0 1.6 0.2 0.0 5.2 0.0 0.0 0.4 0.5 0.0 3.1 0.0 2.0 0.0 1.0 2.6 0.1 0.0 0.0 0.0 4.1 0.1 3.5 0.3 0.0 0.1 0.7 0.0 0.6 0.0 0.0 0.4 0.0 1.3 0.1 0.0 0.0 2.7 0.0 0.1 0.2 0.4 4.4 1.5 0.3 0.0 1.2 1.0 1.9 0.0 3.5 0.8 1.1 0.0 7.5 0.5 0.2 0.0 2.2 2.8 1.2 2.6 1.5 0.0 1.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.8 1.1 2.3 2.2 1.8 1.7 1.9 1.1 1.2 2.0 1.3 0.2 0.0 1.5 0.7 0.0 1.0 3.7 39.3 5.7 11.9 9.2 5.0 0.5 2.8 51.4 33.1 6.2 0.7 0.3 2.7 0.0 4.2 12.5 38.1 0.5 0.3 0.0 0.0 2.8 28.5 1.9 0.6 13.3 5.4 0.0 0.1 0.0 0.0 0.1 1.7 0.3 3.4 61.1 0.0 0.7 4.4 1.2 0.2 1.8 0.0 0.0 0.1 0.0 0.5 0.1 11.1 2.7 0.4 0.0 7.9 5.7 1.0 97.2 0.5 0.0 0.3 5.1 53.9 21.5 3.3 2.4 0.3 0.2 0.0 4.2 5.9 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383333 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 19.9;fallopian tube: 30.0;salivary gland: 13.5" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 28.5;Endometrial ciliated cells: 53.6;Respiratory ciliated cells: 146.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.2;CAPAN-2: 4.1;HaCaT: 1.9;HBEC3-KT: 2.2;hTCEpi: 2.8;SK-BR-3: 2.6;T-47d: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Plasma membrane" "HPA062915: AB_2684903" "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.1 0.1 0.3 0.0 0.3 0.0 2.5 0.2 0.4 4.9 1.0 0.2 0.0 0.3 0.5 19.9 30.0 0.1 0.0 0.4 0.3 0.9 0.2 5.1 0.0 2.0 1.5 0.0 0.8 0.8 3.4 0.0 0.6 4.1 0.2 0.0 13.5 0.3 0.0 11.1 0.1 0.0 0.8 0.0 0.7 0.5 0.2 0.9 0.4 0.0 1.8 0.0 9.3 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.9 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.1 0.1 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 2.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.4 0.4 0.3 2.0 1.5 0.6 0.8 0.2 0.4 0.2 0.0 3.7 0.0 0.2 2.9 9.6 12.9 28.5 0.0 5.7 14.4 0.9 0.0 10.1 0.0 0.0 0.0 0.3 0.8 0.0 0.1 0.2 53.6 0.5 1.5 0.0 0.0 0.2 0.2 0.1 0.5 0.0 1.0 0.0 0.0 1.1 0.0 0.1 0.0 0.3 0.5 12.2 0.0 0.4 1.6 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.2 3.4 0.0 0.1 146.1 0.0 0.0 0.1 2.8 0.1 1.0 9.3 2.8 0.0 0.4 0.0 0.5 4.4 CD177 "HNA2A, NB1, PRV1" ENSG00000204936 "CD177 molecule" 19 43353686-43363172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 285.9;intestine: 164.6" "Group enriched" "Detected in some" 5 "Distal enterocytes: 632.4;Paneth cells: 314.8" "Cancer enhanced" "Detected in many" "prostate cancer: 27.6" "Group enriched" "Detected in many" 4 "cerebellum: 3.6;cerebral cortex: 7.7;pons: 2.3" "Immune cell enriched" "Detected in some" 7 "neutrophil: 8.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.7" "Cell line enriched" "Detected in some" 26 "RPMI-8226: 98.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041820, HPA046601, HPA077640" Enhanced "Intracellular and membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA041820: AB_2677691, HPA046601: AB_2679716, HPA077640: " "unprognostic (4.32e-2)" "prognostic favorable (3.66e-4)" "unprognostic (1.04e-2)" "unprognostic (2.04e-3)" "unprognostic (1.61e-1)" "unprognostic (3.89e-2)" "unprognostic (7.10e-2)" "unprognostic (2.94e-1)" "unprognostic (2.05e-1)" "unprognostic (1.45e-1)" "unprognostic (8.38e-2)" "unprognostic (1.90e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.16e-1)" "unprognostic (5.01e-2)" "unprognostic (1.24e-1)" 4.8 0.4 0.1 7.2 0.3 285.9 1.3 3.6 7.7 6.0 3.7 155.2 0.3 0.4 0.2 2.2 2.3 0.2 2.2 0.3 0.1 1.9 2.6 20.6 0.2 0.3 1.0 0.3 1.1 0.0 2.9 1.6 2.3 64.8 164.6 0.1 1.8 0.2 0.7 0.4 0.7 3.0 0.3 64.4 1.4 0.2 0.4 1.4 0.7 0.8 10.4 2.1 5.4 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.3 1.0 1.3 0.6 0.6 0.0 0.0 0.1 2.4 0.6 1.7 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.2 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.4 1.2 0.0 0.2 0.0 0.0 98.0 1.4 0.3 0.7 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.3 2.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 1.2 0.0 0.7 0.0 0.1 0.3 3.6 7.7 0.3 0.1 0.3 1.0 2.3 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.0 632.4 0.0 0.5 0.4 0.2 0.1 0.0 8.4 3.6 0.0 0.2 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 87.2 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 314.8 0.0 0.1 29.2 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 28.0 0.2 CD19 ENSG00000177455 "CD19 molecule" P15391 16 28931965-28939342 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 33.0;lymphoid tissue: 75.3" "Cell type enhanced" "Detected in some" "B-cells: 135.3;Early spermatids: 38.2;Plasma cells: 30.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 80 "memory B-cell: 138.2;naive B-cell: 172.1" "Lineage enriched" "Detected in many" 89 "B-cells: 172.1" "Cell line enhanced" "Detected in some" "Daudi: 143.3;REH: 77.1;U-698: 33.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB016110 Enhanced NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "CAB016110: AB_626952" "unprognostic (3.27e-3)" "unprognostic (1.19e-3)" "unprognostic (6.63e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-3)" "unprognostic (3.11e-5)" "unprognostic (2.61e-1)" "unprognostic (6.96e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (5.41e-6)" "unprognostic (2.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (2.07e-1)" 0.6 0.1 0.0 28.5 0.1 6.2 0.1 0.9 0.4 0.1 0.0 2.0 0.9 0.2 0.1 0.9 0.2 0.9 0.1 0.0 0.0 0.7 0.3 0.5 72.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 1.6 0.1 1.2 0.1 0.0 0.0 33.0 0.2 0.0 72.7 3.9 3.8 0.2 5.7 1.2 0.0 75.3 2.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 77.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 33.0 0.0 0.1 0.0 1.9 0.2 0.2 0.0 0.3 0.0 138.2 0.1 0.0 0.3 172.1 0.4 0.1 1.3 0.3 0.4 0.2 0.0 7.2 0.0 0.1 0.9 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.3 0.2 0.0 0.6 0.0 135.3 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.0 0.0 38.2 1.5 0.0 1.0 0.0 0.8 0.0 0.0 0.8 0.8 0.5 0.1 0.0 0.4 1.4 0.3 1.7 0.0 0.0 0.1 0.0 0.8 0.6 7.9 0.3 1.1 3.6 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.7 30.5 0.2 0.3 0.1 0.5 0.1 0.0 0.1 0.1 7.4 4.2 0.0 0.0 0.7 2.4 0.6 0.5 0.1 CD2 SRBC ENSG00000116824 "CD2 molecule" P06729 1 116754430-116769229 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 249.8" "Group enriched" "Detected in many" 6 "dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 6 "gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2" "Group enriched" "Detected in all" 10 "NK-cells: 1108.0;T-cells: 714.1" "Group enriched" "Detected in some" 25 "HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002430, HPA003883" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "CAB002430: AB_442057, HPA003883: AB_1846263" "prognostic favorable (4.36e-4)" "prognostic favorable (1.47e-4)" "unprognostic (3.34e-3)" "prognostic favorable (1.69e-5)" "unprognostic (1.52e-1)" "prognostic favorable (7.46e-5)" "unprognostic (9.32e-3)" "unprognostic (1.61e-2)" "prognostic favorable (3.97e-5)" "prognostic favorable (7.72e-4)" "unprognostic (4.18e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (4.82e-6)" "unprognostic (6.16e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-2)" "unprognostic (7.63e-3)" 4.6 4.6 0.6 51.3 0.7 11.4 7.6 0.6 1.0 5.8 0.8 13.9 17.2 3.7 2.8 8.4 4.2 16.8 2.6 0.5 0.8 2.5 7.8 21.0 119.6 1.7 0.7 2.8 2.9 0.9 0.7 1.0 1.1 5.2 16.0 0.0 8.6 2.3 1.4 3.5 28.4 4.4 1.0 44.1 24.1 1.8 1.0 249.8 3.8 1.7 79.1 20.8 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 224.1 0.0 0.4 0.0 0.0 0.0 0.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 145.8 0.1 0.5 0.0 0.0 166.9 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.8 0.4 0.0 11.3 5.2 1.6 421.8 3.7 403.1 3.8 610.2 714.1 95.4 2.5 316.3 486.2 14.1 1108.0 2.8 21.0 655.2 565.1 0.6 0.7 0.6 1.0 0.5 0.8 1.7 0.7 1.1 1.0 1.0 1.1 5.0 3.2 17.5 0.0 12.3 5.0 0.4 0.0 2.2 0.0 4.0 4.7 2.1 0.0 2.5 3.7 0.0 0.1 158.3 0.2 0.0 0.5 23.5 1.1 1.0 2.9 3.0 24.0 0.0 0.0 0.0 2.5 10.7 0.9 5.1 0.0 8.2 1.5 0.6 0.0 0.0 0.0 0.0 10.9 16.6 7.8 0.6 19.1 1.8 1.0 15.5 0.0 178.2 0.0 0.0 0.0 0.0 0.4 42.3 0.1 0.0 1.7 0.0 0.0 0.0 2.9 4.1 0.3 0.2 0.4 3.7 0.0 476.8 0.0 0.5 0.2 CD3D T3D ENSG00000167286 "CD3d molecule" P04234 11 118339075-118342705 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 30 "lymphoid tissue: 906.7" "Group enriched" "Detected in many" 14 "dendritic cells: 231.0;T-cells: 665.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 52 "gdT-cell: 1462.4;MAIT T-cell: 990.0;memory CD4 T-cell: 1206.1;memory CD8 T-cell: 1368.7;naive CD4 T-cell: 1091.4;naive CD8 T-cell: 1338.9;T-reg: 1660.4" "Lineage enriched" "Detected in all" 66 "T-cells: 1660.4" "Group enriched" "Detected in some" 4 "JURKAT: 621.5;MOLT-4: 1299.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB013055, HPA071778" Enhanced Uncertain "Endoplasmic reticulum" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Endoplasmic reticulum" "CAB013055: , HPA071778: " "prognostic favorable (3.00e-4)" "prognostic favorable (8.46e-5)" "unprognostic (1.05e-2)" "prognostic favorable (1.73e-7)" "unprognostic (6.00e-2)" "prognostic favorable (1.70e-4)" "unprognostic (3.82e-1)" "unprognostic (2.40e-2)" "unprognostic (2.24e-3)" "unprognostic (1.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (9.00e-2)" "unprognostic (2.02e-1)" "unprognostic (3.66e-2)" "prognostic favorable (6.16e-4)" 4.1 3.8 0.3 77.5 0.4 28.6 9.9 0.4 1.4 5.2 0.7 18.8 21.7 3.6 5.7 7.6 4.5 15.7 3.7 0.3 0.6 2.3 7.9 20.6 222.7 1.1 0.4 3.2 1.3 0.9 0.8 1.2 0.6 5.9 22.4 0.3 8.3 3.1 2.5 4.0 30.1 3.9 0.7 60.9 23.8 2.4 0.5 906.7 3.8 1.4 166.9 26.7 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 621.5 49.8 0.0 0.0 0.0 1299.8 237.2 1.2 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.2 0.8 0.0 0.5 0.0 1.5 1.1 0.0 0.9 1.1 0.4 0.0 0.1 0.0 10.1 5.3 4.6 1462.4 3.3 990.0 9.6 1206.1 1368.7 5.0 3.7 1091.4 1338.9 25.1 4.2 5.3 6.0 1660.4 1138.7 0.3 0.4 0.4 1.4 0.3 0.6 1.1 0.4 0.6 0.7 0.5 0.8 5.9 6.4 29.6 0.0 18.6 15.3 0.3 0.0 1.8 0.0 5.4 6.7 2.8 7.2 2.6 3.7 0.0 0.4 231.0 0.9 0.0 1.3 0.4 0.8 0.8 5.0 1.2 16.8 0.0 0.0 0.0 8.3 21.4 0.9 12.6 0.0 7.9 3.1 0.6 0.0 0.0 0.2 0.0 14.9 28.4 0.7 0.0 14.2 12.4 1.0 25.0 0.0 32.0 0.0 0.0 0.1 0.2 0.0 21.0 0.3 0.0 3.4 1.5 0.0 0.0 2.5 5.8 0.1 1.2 1.4 11.8 0.3 665.7 0.0 1.1 0.2 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304730-118316175 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 640.4" "Group enriched" "Detected in many" 7 "dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 26 "gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3" "Group enriched" "Detected in all" 21 "NK-cells: 202.2;T-cells: 501.3" "Group enriched" "Detected in some" 67 "JURKAT: 544.9;MOLT-4: 764.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced Supported "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "Endoplasmic reticulum, Plasma membrane" "Golgi apparatus" "CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favorable (1.72e-4)" "prognostic favorable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favorable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favorable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 6.4 5.6 0.9 85.8 1.1 36.7 6.7 0.9 1.2 7.1 1.3 15.3 22.0 5.8 4.6 9.5 5.4 20.1 3.8 0.7 1.0 3.5 9.7 23.0 209.6 1.8 0.9 3.8 2.2 0.7 1.0 1.6 1.4 6.6 19.3 0.0 11.6 3.0 1.9 5.4 36.4 5.1 1.2 78.9 24.4 1.7 1.3 640.4 5.3 1.6 147.0 24.8 4.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 544.9 0.9 2.0 0.0 0.0 764.9 0.6 0.3 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 1.6 8.0 9.8 0.0 0.6 0.0 16.4 1.8 2.4 490.6 1.3 420.8 1.6 414.4 463.5 1.5 2.1 491.7 501.3 12.2 202.2 2.0 8.6 426.3 333.0 0.9 1.1 0.9 1.2 0.7 1.0 1.8 0.9 1.4 1.2 1.3 1.6 4.9 0.0 8.6 0.0 12.9 5.2 0.3 0.0 0.0 0.0 3.8 4.8 0.3 0.0 0.6 1.8 0.0 0.2 213.6 0.4 0.0 0.2 7.0 0.5 0.9 2.5 0.0 6.9 0.1 0.0 0.0 5.3 24.5 0.9 7.6 0.0 8.9 2.4 0.3 0.0 0.1 0.0 0.0 7.6 8.3 0.2 0.0 12.6 12.4 1.0 8.4 0.0 154.5 0.0 0.1 0.0 1.1 0.0 41.4 0.1 0.2 2.1 0.0 0.0 0.0 1.3 2.7 0.0 0.0 1.6 5.4 0.3 601.4 0.0 0.6 0.3 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 94.7" "Group enriched" "Detected in many" 11 "dendritic cells: 139.6;T-cells: 294.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 21 "gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0" "Lineage enriched" "Detected in many" 26 "T-cells: 241.7" "Group enriched" "Detected in some" 52 "JURKAT: 70.9;MOLT-4: 193.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: AB_2676044" "prognostic favorable (6.33e-4)" "prognostic favorable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 0.7 0.8 0.6 10.5 0.8 1.3 1.0 1.1 0.8 0.7 1.1 2.3 3.3 0.5 0.6 1.4 0.9 2.5 0.5 0.5 0.4 0.6 1.6 2.8 27.9 0.9 0.6 0.4 0.5 0.2 0.0 0.3 0.8 0.9 2.7 0.4 1.6 0.3 10.5 0.9 4.6 0.6 0.3 11.5 4.1 0.4 0.8 94.7 0.6 0.3 20.4 3.0 0.4 1.9 0.2 0.2 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 70.9 2.5 0.3 0.0 0.6 193.8 1.3 0.2 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.5 0.2 0.0 1.1 0.1 0.0 0.6 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.7 0.3 0.2 0.2 0.1 9.2 1.2 1.2 229.0 0.6 135.6 0.8 187.3 197.3 0.6 0.9 192.6 241.7 6.4 1.4 1.2 1.5 200.0 90.4 0.6 0.8 1.1 0.8 0.5 0.4 0.9 0.6 0.8 0.3 0.8 1.9 3.2 3.2 6.9 0.0 7.8 2.3 0.1 0.0 1.8 0.2 2.0 2.9 0.8 1.5 1.9 0.0 0.0 0.1 139.6 0.4 0.0 0.3 1.0 0.4 0.4 1.4 0.0 3.4 0.1 0.0 0.0 2.3 13.7 0.4 6.3 0.0 4.2 1.7 0.1 0.0 0.1 0.2 0.0 3.8 5.8 1.4 0.0 7.7 5.4 1.0 8.1 0.0 14.4 0.0 0.3 0.0 0.1 0.0 18.5 0.0 0.0 0.6 0.7 0.8 0.0 1.3 1.6 0.2 0.4 0.6 2.4 0.3 294.0 0.1 0.3 0.0 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358981-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6" "Group enriched" "Detected in many" 9 "B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773" "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.6 1.5 0.6 16.2 1.1 53.9 5.2 0.8 1.3 3.5 0.4 14.8 13.7 2.3 2.5 27.2 1.7 1.2 0.9 0.7 1.1 2.3 1.7 2.5 32.6 1.3 1.1 0.7 0.6 0.2 0.3 9.7 1.1 0.8 16.0 0.2 4.4 0.7 0.3 11.3 12.2 7.3 0.8 11.7 7.0 49.1 1.7 52.6 1.7 0.2 50.8 3.3 7.0 1.3 311.9 148.2 202.8 133.4 6.9 17.6 193.5 140.3 125.0 400.0 211.4 234.5 250.9 178.3 80.1 130.1 140.6 212.8 225.3 267.9 331.5 140.8 165.6 261.4 143.6 147.3 2.1 184.3 91.4 6.0 12.4 278.2 249.6 35.1 172.2 167.5 120.2 119.3 184.0 120.4 179.2 113.5 257.2 147.0 196.9 255.8 277.9 112.9 98.5 81.3 119.2 58.9 248.1 165.8 76.6 154.9 116.3 231.7 90.2 118.9 276.2 133.7 445.0 90.6 86.7 185.7 85.2 227.6 181.6 0.0 0.1 0.0 0.3 0.0 0.0 4.2 3.2 3.5 0.9 0.9 0.1 0.3 0.7 9.5 0.0 0.2 11.6 2.8 0.6 1.1 0.8 1.3 0.7 1.1 1.3 1.1 1.1 0.8 1.7 1.3 2.1 0.0 1.1 0.0 12.2 10.5 3.8 17.6 6.2 0.5 6.4 9.7 0.7 1.5 4.8 0.0 0.0 65.0 2.8 16.9 0.0 2.2 135.0 14.6 2.4 4.5 0.0 96.0 0.2 0.4 146.2 9.3 11.7 4.6 0.0 46.5 7.9 1.3 37.4 0.0 0.0 18.5 24.4 6.2 7.5 18.5 2.8 9.3 0.0 0.0 1.8 0.3 0.0 0.0 1.6 0.7 0.5 1.9 34.4 2.7 3.2 3.1 8.3 2.9 0.0 1.0 25.4 126.5 39.8 47.3 8.4 10.7 5.1 1.6 37.5 7.4 CDC20B FLJ37927 ENSG00000164287 "Cell division cycle 20B" Q86Y33 5 55112971-55173177 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 2.1;kidney: 1.1;testis: 2.6" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 18.8;Ionocytes: 12.2;Respiratory ciliated cells: 24.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA053900 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 2: Karpas-707 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA053900: AB_2682299" "unprognostic (7.39e-3)" "unprognostic (1.02e-1)" "unprognostic (8.19e-2)" "unprognostic (1.78e-3)" "unprognostic (9.94e-2)" "unprognostic (1.59e-2)" "unprognostic (3.12e-1)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (7.84e-3)" "unprognostic (2.83e-2)" "unprognostic (3.06e-1)" "unprognostic (5.15e-4)" "unprognostic (1.99e-2)" "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.3 2.4 1.2 0.0 0.9 2.3 0.5 0.0 2.1 0.0 0.0 0.1 0.2 1.6 0.0 0.1 0.3 18.8 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.7 3.6 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.5 12.2 0.6 4.1 0.0 0.0 0.7 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 3.7 0.9 2.7 0.8 24.5 0.0 0.0 0.5 0.5 1.3 0.8 0.7 0.1 0.1 0.3 0.1 0.7 0.1 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188417 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005855, HPA008803" Approved "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 43: B-cells - Humoral immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Golgi apparatus" "HPA005855: AB_1846364, HPA008803: " "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.7 0.9 0.8 3.3 0.8 15.3 1.1 0.7 1.0 0.6 0.7 3.5 2.0 0.6 0.9 2.4 0.2 0.3 0.4 0.8 2.0 0.7 0.8 0.3 4.4 1.1 1.9 2.2 0.7 0.8 0.8 2.6 1.7 0.6 3.9 2.0 0.8 0.6 0.4 0.6 1.8 1.1 0.8 2.0 0.9 13.3 2.0 8.8 1.8 0.3 5.6 0.9 0.9 0.7 22.2 10.7 50.0 27.2 1.7 3.2 34.2 29.9 11.3 36.7 29.6 46.8 11.2 64.9 11.4 8.0 23.4 16.3 86.6 20.6 38.6 21.4 45.1 83.8 19.0 23.1 1.7 59.4 23.4 1.7 3.1 45.8 19.6 4.6 14.1 47.8 67.6 33.6 20.1 11.8 74.8 46.6 73.4 20.2 24.2 33.2 32.9 35.1 9.5 20.7 23.5 28.8 18.6 21.6 9.5 31.7 11.3 41.9 7.2 18.0 27.7 20.3 41.4 16.7 54.2 101.5 13.5 65.2 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.7 1.0 0.8 2.0 1.1 1.9 1.7 0.8 2.0 0.7 0.3 0.0 0.0 1.0 1.1 0.4 0.4 0.8 1.8 0.5 1.2 1.0 111.2 0.0 0.1 0.0 2.1 4.2 0.2 2.4 0.0 0.4 18.3 0.5 0.9 2.7 1.2 8.0 0.2 0.9 7.4 1.5 1.5 1.3 0.0 4.6 1.4 0.3 3.1 0.0 0.5 2.0 0.0 0.6 0.9 31.8 1.5 0.5 0.0 0.0 0.1 1.1 0.0 0.5 0.0 1.1 0.8 1.9 13.0 0.7 0.4 0.4 0.2 0.4 0.0 0.1 2.2 14.5 16.3 4.3 0.0 0.3 0.6 2.4 4.1 0.5 CDC25C "CDC25, PPP1R60" ENSG00000158402 "Cell division cycle 25C" P30307 5 138285269-138338355 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.8;lymphoid tissue: 8.9;testis: 18.1" "Cell type enhanced" "Detected in many" "Early spermatids: 41.4;Late spermatids: 42.1;Spermatocytes: 53.6;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB003800, HPA066991" Approved Enhanced "Nuclear speckles" No Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear speckles" "CAB003800: AB_562081, HPA066991: AB_2685760" "unprognostic (2.45e-3)" "unprognostic (5.89e-3)" "prognostic favorable (2.49e-4)" "unprognostic (9.72e-3)" "unprognostic (2.17e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.03e-6)" "prognostic unfavorable (4.38e-4)" "unprognostic (5.56e-2)" "unprognostic (2.08e-1)" "unprognostic (1.70e-3)" "unprognostic (1.00e-1)" "unprognostic (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.43e-1)" "unprognostic (2.59e-1)" "unprognostic (3.06e-1)" 0.2 0.2 0.2 2.1 0.2 5.8 0.7 0.3 0.3 0.3 0.2 3.4 3.0 0.4 0.2 1.4 0.2 0.2 0.1 0.2 0.2 0.1 0.5 0.3 3.2 0.2 0.3 0.0 0.4 0.1 0.1 1.2 0.2 0.2 4.1 0.1 0.3 0.1 0.0 1.4 3.0 0.8 0.1 0.9 1.1 18.1 0.2 8.9 0.1 0.0 4.6 0.5 0.5 0.2 27.9 11.0 38.4 28.9 0.9 3.6 9.9 16.4 17.5 36.2 50.3 27.3 52.8 13.3 13.8 10.1 40.5 14.9 31.7 25.9 34.9 11.1 21.5 9.6 15.0 21.2 0.3 6.3 10.0 0.8 0.9 22.0 18.0 3.8 24.6 28.9 14.8 24.2 22.9 15.5 19.3 16.7 9.7 22.3 12.2 11.9 34.2 15.0 6.4 8.4 19.2 11.9 36.8 11.0 16.9 32.6 18.7 13.9 7.2 19.9 16.8 13.9 26.5 15.0 13.4 13.0 8.3 14.3 15.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.1 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.1 0.0 0.0 1.3 0.9 0.6 0.3 1.1 1.8 0.0 0.9 0.8 0.3 0.0 0.2 0.0 0.0 5.0 0.5 1.8 0.0 0.1 41.4 0.4 0.9 0.6 0.0 9.5 1.3 0.0 6.9 1.1 3.6 1.2 0.0 5.5 1.4 0.4 2.7 0.0 1.0 3.9 2.0 0.6 0.5 42.1 1.8 1.2 0.0 1.0 0.6 0.0 0.0 1.0 0.3 0.0 1.4 0.4 4.5 0.3 0.9 0.1 0.1 0.0 0.0 0.2 0.9 53.6 13.0 4.3 0.4 1.4 0.6 0.2 4.9 0.6 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479457-19520612 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.4;lymphoid tissue: 20.4;testis: 23.4" "Cell type enhanced" "Detected in many" "Early spermatids: 120.5;Erythroid cells: 29.7;Spermatocytes: 72.3;Spermatogonia: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "K-562: 370.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavorable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.5 0.5 0.7 6.2 0.5 25.4 1.5 0.2 0.2 1.1 0.4 4.6 3.5 0.9 0.3 5.3 0.4 0.5 0.3 0.2 0.4 0.3 1.2 0.9 11.3 0.5 0.4 0.2 0.2 0.2 0.1 3.2 0.5 0.4 6.0 0.1 0.9 0.2 0.1 3.3 3.1 1.8 0.2 2.8 2.6 23.4 1.1 20.4 0.3 0.0 11.8 1.9 1.7 0.3 57.4 42.2 56.4 42.9 2.0 5.6 24.4 65.4 31.6 75.5 75.5 35.8 30.5 62.2 23.2 21.0 28.9 51.9 58.2 45.9 59.5 72.3 96.3 82.8 50.1 41.3 3.1 125.0 43.7 1.3 2.4 57.9 26.0 7.0 38.8 63.0 370.6 73.3 44.8 77.2 98.1 56.5 16.7 106.2 34.4 77.1 95.5 26.5 16.9 49.3 72.1 37.0 38.1 40.0 12.0 21.7 26.2 51.0 15.0 60.0 91.6 46.0 62.8 24.6 46.8 67.5 30.1 58.9 82.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.7 0.1 0.0 0.2 0.1 0.5 0.5 0.1 0.3 0.9 0.6 0.7 0.5 0.2 0.2 0.2 0.4 0.5 0.4 0.5 0.2 1.1 0.3 0.2 0.0 0.0 0.0 1.9 2.7 1.7 3.7 0.0 0.0 0.7 0.8 0.4 0.0 0.5 0.0 0.0 11.9 1.4 1.9 0.0 0.8 120.5 0.9 0.7 1.2 0.0 29.7 0.1 0.0 19.8 2.3 1.5 1.0 0.0 5.5 3.6 0.0 7.2 0.0 0.1 1.2 4.1 0.6 1.0 14.4 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.7 12.6 0.2 0.4 0.0 0.3 0.0 6.6 1.5 13.9 72.3 50.7 3.3 1.8 4.9 1.2 0.8 5.1 2.5 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287879-40304657 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.2;lymphoid tissue: 17.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 500.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA050114, HPA065070" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: AB_2681021, HPA065070: AB_2732729" "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 2.1 1.9 0.5 13.7 0.8 27.2 3.4 0.2 1.9 3.2 0.0 8.4 7.5 2.2 1.1 5.7 1.0 2.8 0.6 1.1 0.1 0.5 3.0 1.4 16.4 0.1 0.0 0.9 1.9 0.8 0.5 9.3 0.3 1.1 8.7 0.5 1.3 1.2 0.3 2.8 6.7 3.7 0.0 3.7 3.6 10.1 0.2 16.7 1.7 0.5 17.1 4.3 1.8 0.6 155.1 119.0 115.1 86.5 6.7 12.7 118.0 159.9 49.0 149.2 166.5 135.8 64.9 123.9 99.6 35.9 85.9 214.0 112.2 76.2 148.9 64.5 98.4 96.2 122.3 134.6 4.4 133.3 55.1 4.7 8.1 156.4 107.1 14.8 46.9 84.2 183.0 109.0 71.9 95.8 199.3 43.3 101.6 96.9 48.7 145.0 286.8 119.9 30.3 184.8 85.6 76.9 146.9 500.3 55.4 100.3 100.8 120.0 34.7 95.5 146.3 170.8 196.1 46.1 103.6 222.8 84.6 93.9 109.2 0.1 0.1 0.0 0.8 0.0 0.5 0.4 0.6 1.1 0.7 0.3 0.4 1.1 0.1 1.5 0.0 3.6 2.4 0.6 0.5 0.8 0.2 1.9 1.1 0.1 0.1 0.0 0.3 0.0 0.2 0.6 2.2 0.0 2.0 0.7 4.9 4.2 1.1 3.7 3.4 0.2 2.1 2.2 0.9 1.5 1.3 0.0 0.0 23.2 2.3 7.8 0.0 1.3 2.2 1.3 2.9 2.1 0.0 37.2 2.0 0.6 34.6 5.6 3.6 5.1 0.0 8.1 1.1 0.9 8.3 0.0 0.7 6.1 0.0 1.3 2.1 1.0 2.8 1.5 0.0 0.0 0.0 0.4 2.1 0.0 0.2 1.5 3.0 0.7 31.6 1.3 0.8 0.2 0.2 0.3 13.1 0.6 4.6 69.5 57.2 9.1 1.6 16.7 3.3 1.9 9.3 2.4 CDCA2 "PPP1R81, Repo-Man" ENSG00000184661 "Cell division cycle associated 2" Q69YH5 8 25459199-25507911 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 6.5;lymphoid tissue: 11.4;testis: 19.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA026293, HPA030049" Enhanced Supported Nucleoplasm Yes Yes "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA026293: AB_1846384, HPA030049: AB_10600862" "unprognostic (2.12e-1)" "unprognostic (4.75e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.92e-2)" "unprognostic (9.69e-2)" "unprognostic (3.56e-2)" "unprognostic (2.50e-5)" "unprognostic (1.47e-3)" "unprognostic (6.06e-2)" "unprognostic (2.91e-3)" "unprognostic (1.32e-3)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.30e-14)" "unprognostic (1.36e-2)" "unprognostic (4.02e-1)" "unprognostic (1.91e-1)" "unprognostic (5.30e-2)" 0.2 0.0 0.0 2.6 0.0 6.5 0.6 0.1 0.0 0.2 0.1 1.9 1.6 0.3 0.0 1.4 0.1 0.3 0.3 0.0 0.1 0.0 0.1 0.2 5.3 0.2 0.2 0.0 0.0 0.0 0.0 1.2 0.2 0.1 2.2 0.1 0.2 0.0 0.0 1.1 1.8 0.8 0.0 0.8 0.9 19.4 0.3 11.4 0.1 0.1 6.7 0.6 0.3 0.1 36.5 30.2 29.4 24.2 2.3 4.5 20.2 37.7 22.6 32.9 32.4 25.7 15.8 42.6 16.0 16.2 34.6 31.6 42.9 20.0 48.5 16.2 12.0 43.2 22.4 15.2 0.6 18.4 19.4 2.5 1.0 23.5 15.8 3.3 24.5 24.5 33.6 45.8 30.6 13.9 54.5 8.7 31.0 24.1 14.5 26.3 33.4 15.2 9.2 18.7 12.0 13.3 33.3 16.1 14.3 14.7 17.4 9.4 16.6 23.9 39.3 44.7 35.6 7.1 16.5 44.4 17.7 24.3 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.3 0.1 0.2 0.0 1.1 0.0 2.7 1.1 0.5 1.7 0.0 0.7 0.9 0.8 23.3 0.0 0.2 0.0 0.0 7.2 0.5 1.8 0.0 0.2 49.9 0.8 1.2 1.1 0.0 19.0 0.2 0.0 13.4 2.5 4.1 1.4 0.0 8.8 1.1 0.1 4.1 0.0 0.1 1.3 0.0 2.9 0.6 24.2 1.2 2.1 0.0 0.0 0.6 0.1 2.1 0.5 0.6 0.2 0.1 0.0 15.8 0.5 0.5 1.2 0.9 0.5 13.1 0.1 2.1 66.6 27.8 10.7 0.9 1.6 2.9 1.3 3.6 0.5 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8" "Cell type enhanced" "Detected in many" "Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NK-cell: 2.8;T-reg: 2.0" "Group enriched" "Detected in many" 5 "NK-cells: 2.8;T-cells: 2.0" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.4" "Low region specificity" "Detected in many" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.4 1.2 1.3 10.5 1.3 53.4 2.0 0.8 1.8 1.9 0.9 6.8 5.8 1.3 0.3 9.3 0.9 0.9 0.9 1.5 0.9 0.9 1.3 1.9 17.0 1.6 1.3 0.6 0.7 0.4 0.5 6.5 1.6 0.8 7.7 0.5 1.4 0.5 0.6 4.2 5.8 3.1 0.8 6.6 3.1 37.8 1.8 27.6 0.6 0.4 16.2 2.2 2.8 1.3 131.7 74.9 67.2 57.3 4.5 7.3 57.8 92.7 37.4 103.6 81.5 77.7 75.4 121.3 52.3 29.4 120.8 87.9 110.3 49.5 98.6 122.0 52.2 107.7 54.4 64.1 0.4 116.8 81.8 2.5 4.5 96.3 44.0 10.8 32.6 138.4 126.6 206.6 63.5 109.2 164.7 116.9 107.8 63.0 92.4 140.4 76.8 111.9 21.2 49.6 89.1 68.4 59.3 80.7 62.8 41.6 104.7 54.7 19.9 92.7 97.2 99.5 101.7 106.9 187.8 195.4 37.2 69.5 97.4 0.0 0.1 0.2 0.4 0.0 0.0 0.3 0.5 0.3 0.4 0.5 0.0 0.3 0.0 2.8 0.3 0.3 2.0 0.7 1.3 1.3 0.8 1.8 1.5 0.9 1.6 1.3 1.6 0.8 1.8 1.3 0.9 0.0 0.5 0.0 4.6 3.8 1.2 1.3 0.6 0.6 2.3 4.4 1.0 0.0 0.8 0.0 2.1 19.7 2.2 4.6 1.9 0.8 56.5 1.1 1.5 2.3 0.0 21.8 1.1 0.8 38.3 3.5 3.1 1.5 3.8 14.5 1.1 0.0 11.7 1.7 0.6 4.7 2.0 2.8 1.5 116.9 2.8 1.7 0.0 1.0 2.1 0.9 2.1 0.0 0.6 0.6 0.1 1.5 16.2 1.1 1.1 0.6 0.4 0.2 0.0 0.5 2.7 50.4 31.1 7.1 1.0 3.7 4.2 1.9 9.4 1.6 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692481-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.0 1.1 0.7 7.9 1.0 33.5 2.0 0.2 0.9 1.7 0.0 9.4 8.3 1.3 1.8 9.2 1.0 1.1 0.6 0.5 0.4 0.8 1.3 1.5 19.5 0.6 0.4 0.6 0.8 0.5 0.6 4.4 0.5 0.7 11.3 1.9 1.8 0.5 0.3 6.3 7.3 2.8 0.3 4.9 4.9 22.5 0.6 38.8 0.6 0.5 22.7 2.0 2.9 0.7 108.5 45.5 84.4 62.1 3.6 7.0 57.2 79.6 39.5 137.2 96.6 71.9 78.8 130.2 31.5 50.5 54.5 59.4 97.8 52.4 141.9 86.8 44.9 116.8 49.2 57.3 0.8 113.8 58.4 2.8 3.8 77.1 67.3 15.3 60.9 91.1 100.7 135.6 99.1 47.7 106.1 68.9 98.8 61.7 62.8 102.2 115.6 74.4 31.0 43.8 75.4 33.3 87.5 40.6 52.4 71.7 60.1 42.4 37.3 67.8 70.6 39.2 126.0 91.4 128.1 176.3 31.6 104.7 79.6 0.0 0.7 1.3 1.5 1.6 2.8 1.7 3.6 2.2 0.7 1.4 1.1 2.3 3.0 4.1 3.9 1.2 5.9 1.7 0.7 1.0 0.2 0.9 0.5 0.4 0.6 0.4 0.5 0.3 0.6 0.7 0.8 0.0 0.5 1.3 4.8 3.3 0.8 2.4 1.8 1.3 1.9 1.5 0.7 2.8 0.4 0.0 0.0 17.1 1.9 12.4 0.0 1.2 1.0 1.7 1.6 1.9 3.6 34.1 1.2 0.6 26.0 2.9 6.6 2.5 0.0 12.0 3.6 1.0 11.6 1.7 0.9 8.2 2.0 3.5 1.9 2.8 1.5 3.7 1.8 0.0 1.6 0.1 2.1 0.5 0.9 2.4 4.0 1.2 15.8 1.3 1.9 0.6 4.7 1.0 19.7 0.2 6.3 76.8 42.0 17.1 2.7 2.9 5.5 1.2 13.2 1.2 CDHR3 "CDH28, FLJ23834, FLJ44366" ENSG00000128536 "Cadherin related family member 3" Q6ZTQ4 7 105876796-106036432 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 46.4;fallopian tube: 108.8" "Cell type enhanced" "Detected in many" "Astrocytes: 170.7;Endometrial ciliated cells: 136.4;Excitatory neurons: 70.2;Inhibitory neurons: 63.8;Respiratory ciliated cells: 358.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.0;naive B-cell: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 5.7;Daudi: 6.5;WM-115: 4.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 11.8" HPA011218 Supported NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA011218: AB_1078886" "unprognostic (4.38e-4)" "unprognostic (9.18e-2)" "unprognostic (8.16e-3)" "unprognostic (8.08e-3)" "unprognostic (5.23e-2)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.18e-1)" "unprognostic (2.77e-2)" "unprognostic (3.70e-3)" "unprognostic (3.51e-3)" 1.2 0.9 4.6 0.9 3.9 0.9 4.1 4.2 5.0 4.6 46.4 7.5 1.9 1.7 3.2 0.5 108.8 0.2 1.7 5.7 2.3 2.0 2.1 14.2 0.7 9.8 20.4 2.4 1.0 0.0 1.6 0.1 7.8 0.9 1.6 6.7 0.4 0.6 0.8 0.7 4.7 3.2 7.0 0.2 9.3 0.5 5.6 0.1 2.6 0.4 0.9 0.7 0.8 5.6 0.1 0.3 5.7 0.7 1.5 2.1 0.1 0.3 0.3 0.3 0.1 0.0 0.1 6.5 0.0 0.3 0.6 0.0 1.4 0.0 0.2 0.4 0.8 0.0 0.2 0.7 0.0 0.1 0.2 0.6 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 1.1 2.2 0.4 0.0 0.0 0.2 0.1 0.1 0.4 2.1 0.0 0.4 0.3 0.8 0.0 0.0 0.2 1.0 0.2 1.3 0.0 0.0 0.0 2.1 0.1 0.1 4.9 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.9 0.1 0.0 0.9 0.3 0.1 0.1 0.3 0.1 4.6 3.9 4.2 5.0 5.7 2.3 9.8 20.4 7.8 7.0 5.6 5.6 2.5 3.2 10.4 170.7 1.7 2.7 1.6 9.5 2.8 6.4 1.8 3.4 1.4 5.7 37.6 0.0 0.0 0.6 2.8 2.0 5.9 0.7 8.5 136.4 1.4 1.8 29.9 0.0 70.2 0.6 0.3 2.8 15.3 2.9 3.8 3.8 0.0 2.9 0.1 0.0 63.8 4.9 8.2 0.0 2.7 3.8 2.8 0.7 8.8 16.9 0.0 10.2 6.2 4.0 4.3 0.2 3.3 1.5 1.4 0.7 5.0 6.2 358.4 1.3 6.6 2.2 8.8 1.2 3.2 0.6 2.0 0.3 2.4 1.4 3.0 0.7 CDHR4 "CDH29, VLLR9392" ENSG00000187492 "Cadherin related family member 4" A6H8M9 3 49790732-49799873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "fallopian tube: 59.4" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 74.2;Respiratory ciliated cells: 160.4" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 6.8" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;HeLa: 1.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.2" HPA076277 Enhanced "Intracellular and membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA076277: AB_2732306" "unprognostic (1.50e-4)" "unprognostic (4.87e-2)" "unprognostic (6.00e-2)" "unprognostic (2.00e-3)" "unprognostic (2.37e-2)" "unprognostic (2.45e-3)" "unprognostic (6.35e-7)" "unprognostic (1.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.12e-1)" "unprognostic (9.61e-2)" "unprognostic (2.35e-1)" "unprognostic (9.07e-11)" "unprognostic (2.65e-1)" "unprognostic (3.70e-2)" "unprognostic (1.13e-2)" "unprognostic (2.37e-1)" 0.5 0.1 0.6 0.1 0.6 0.2 0.2 0.4 0.3 5.5 1.0 0.5 0.1 1.7 0.4 0.1 59.4 0.1 0.2 0.6 0.7 0.2 0.1 7.4 0.0 2.7 6.1 0.2 0.0 0.0 0.1 0.1 3.4 0.3 0.1 0.0 0.2 0.2 0.2 1.3 0.1 0.2 1.2 0.0 0.1 7.5 0.8 0.0 0.2 0.0 0.0 0.2 0.3 1.0 0.1 0.5 0.1 0.0 0.1 1.3 0.1 0.1 0.0 0.2 0.3 0.0 0.8 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.2 1.5 0.3 0.0 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.7 0.0 0.6 0.4 0.0 1.9 2.0 0.2 0.1 0.7 0.1 0.2 0.1 0.1 0.7 0.4 0.1 0.1 1.0 0.5 0.1 0.2 0.1 3.9 0.6 0.6 0.4 0.3 0.6 0.7 2.7 6.1 3.4 1.2 0.8 1.0 0.2 0.0 3.4 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.1 0.1 0.4 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 74.2 0.9 0.5 0.0 0.0 0.1 0.2 0.1 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 20.3 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 160.4 0.0 0.0 0.2 1.7 4.8 0.8 0.0 0.0 0.0 0.2 0.1 0.2 0.1 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 53.2;lymphoid tissue: 74.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 3.2;T-reg: 3.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003387, CAB003799, CAB079974" Enhanced Supported Nucleoplasm,Cytosol NA Yes 51000 "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytosol" "CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favorable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (1.10e-6)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 3.8 1.8 0.9 17.0 1.0 53.2 7.4 0.9 1.5 5.2 0.9 17.6 16.3 7.1 12.2 17.5 3.7 4.3 1.4 0.9 1.0 3.1 3.2 4.7 40.6 1.2 1.2 2.3 0.8 2.5 4.1 19.4 1.1 1.7 20.8 1.3 3.2 5.2 1.4 13.2 14.5 8.0 0.9 9.0 10.1 25.1 1.4 74.0 3.6 2.2 47.5 7.1 6.9 1.0 249.9 93.5 241.1 96.0 15.4 23.6 99.0 183.8 132.7 218.8 209.0 218.9 213.7 226.2 69.6 50.6 79.6 149.9 166.2 106.8 225.8 162.3 121.1 119.4 84.4 128.1 2.8 184.5 117.6 4.7 10.4 142.1 137.0 49.6 133.3 146.2 185.1 270.3 246.9 66.3 234.0 131.1 106.6 149.3 193.1 199.7 224.5 111.3 84.3 81.4 112.7 98.7 123.5 184.9 96.3 130.0 199.9 111.5 55.4 92.8 197.9 99.1 255.8 104.9 180.8 205.6 79.9 203.5 117.6 0.0 0.0 0.0 0.3 0.1 0.2 0.5 0.7 1.3 0.3 0.4 0.2 0.7 0.0 3.2 0.1 0.9 3.4 0.9 0.9 1.0 0.9 1.5 0.9 1.0 1.2 1.2 1.1 0.9 1.4 1.0 7.7 0.0 3.2 0.3 7.1 39.8 5.4 29.9 2.8 1.1 5.3 6.1 0.8 0.0 10.2 18.4 0.0 80.9 3.6 8.9 3.9 0.8 18.7 10.8 6.2 10.5 3.0 209.6 0.4 0.0 144.6 13.3 13.3 9.4 0.0 51.5 7.5 1.3 57.2 0.0 0.2 14.6 30.5 20.5 18.1 10.4 2.1 16.5 1.8 1.9 1.0 1.0 3.1 0.0 0.1 0.4 0.7 0.7 32.1 4.3 2.2 3.0 17.6 0.7 0.0 0.5 24.6 110.0 39.6 33.8 18.6 22.0 10.3 2.1 26.6 10.4 CDKN3 "CDI1, KAP" ENSG00000100526 "Cyclin dependent kinase inhibitor 3" Q16667 14 54396849-54420218 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 207.0" "Cell type enhanced" "Detected in many" "Early spermatids: 2630.9;Late spermatids: 659.4;Spermatocytes: 606.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 18.8" "Group enriched" "Detected in all" 6 "NK-cells: 6.4;T-cells: 18.8" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005285, HPA039311, HPA058874" Enhanced Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842" "unprognostic (3.46e-2)" "unprognostic (9.95e-2)" "unprognostic (5.79e-2)" "unprognostic (6.78e-3)" "unprognostic (2.73e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-3)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.50e-3)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.46e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.71e-1)" "unprognostic (7.30e-2)" "unprognostic (7.92e-2)" "unprognostic (4.31e-2)" 3.4 1.6 2.8 12.2 2.7 43.4 3.4 5.0 4.2 2.2 3.4 13.9 12.4 2.8 0.4 10.2 1.3 2.9 5.3 2.9 3.1 2.0 2.4 2.1 28.4 2.5 2.7 1.3 1.1 0.5 1.6 6.7 3.3 1.6 16.9 2.6 3.3 0.7 3.0 5.9 12.6 7.4 2.1 4.9 5.0 207.0 3.5 30.9 1.7 4.1 30.0 5.8 4.1 2.6 276.7 102.5 74.0 78.2 12.5 15.3 46.5 63.1 97.0 135.8 146.9 81.8 136.5 139.9 44.4 96.7 135.9 195.9 114.6 78.3 245.6 169.5 59.3 65.8 69.0 126.8 10.1 86.2 47.6 5.4 4.9 84.3 138.3 44.4 88.4 129.8 36.1 162.2 159.8 186.9 118.1 67.9 27.9 254.7 216.4 72.7 66.6 29.7 70.5 56.9 30.6 42.0 118.7 67.4 52.5 54.6 142.9 69.4 33.0 59.2 195.8 91.7 155.0 38.6 47.4 91.4 98.6 120.4 110.9 0.0 1.3 1.3 1.6 1.7 0.7 2.1 5.5 4.8 1.8 0.9 2.9 2.3 1.0 6.4 1.2 1.5 18.8 3.1 2.8 2.7 5.0 4.2 2.9 3.1 2.5 2.7 3.3 2.1 3.5 2.6 1.4 0.0 0.0 0.7 10.5 9.3 4.3 9.7 4.6 3.2 6.4 11.6 9.7 0.0 2.4 1.8 2.1 42.6 2.7 7.3 0.0 3.5 2630.9 2.7 3.5 6.8 7.8 125.5 2.5 2.4 35.0 10.2 9.2 3.5 7.0 31.3 6.1 3.1 37.7 5.0 3.9 17.9 4.1 9.8 8.8 659.4 21.5 8.9 1.8 1.0 2.9 1.7 0.0 0.0 0.2 1.9 7.2 10.5 41.0 4.0 3.4 2.8 0.2 2.9 0.0 3.0 20.5 606.9 39.8 22.5 6.5 4.1 8.3 3.9 31.2 5.3 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803789-88809258 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 38.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 149.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.7 0.8 0.8 3.8 1.2 38.5 0.7 2.5 1.3 1.7 0.0 3.3 4.1 0.5 0.2 6.7 0.5 0.2 0.5 0.8 2.3 0.7 1.0 1.3 4.8 2.2 1.1 0.4 0.6 1.3 2.1 2.8 1.9 0.7 1.6 0.4 1.1 0.2 0.1 3.6 3.9 0.6 0.7 3.1 2.4 3.5 1.1 8.7 0.6 0.0 3.3 0.5 2.3 1.0 33.6 34.5 16.5 25.3 0.7 3.4 64.2 24.1 6.6 19.4 12.0 79.3 33.8 51.4 24.2 5.5 12.7 46.0 21.6 17.7 6.2 18.2 92.1 51.8 28.8 59.9 0.3 28.8 21.5 1.8 1.4 19.8 4.4 1.6 5.9 60.9 80.8 18.4 7.6 90.6 109.3 149.4 41.8 12.2 31.6 120.3 22.9 42.4 4.3 23.8 36.6 26.2 44.4 13.1 16.9 7.4 39.0 55.9 5.9 24.6 42.6 37.2 35.4 61.4 55.7 73.6 19.3 71.9 31.6 0.2 0.1 0.9 0.3 0.0 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.7 0.4 0.1 0.1 0.7 0.2 0.8 1.2 2.5 1.3 0.8 2.3 2.2 1.1 1.9 0.7 1.1 1.0 0.4 0.0 1.1 0.7 4.9 11.2 4.3 1.4 7.4 0.7 5.4 7.5 2.2 1.5 1.7 1.8 0.0 51.4 2.2 12.7 1.9 1.1 0.4 1.4 1.4 2.2 2.4 71.3 0.2 0.0 92.0 5.2 9.2 2.2 0.0 29.0 0.4 1.0 19.5 0.0 0.8 16.1 4.1 5.6 5.5 1.2 0.3 2.8 1.8 0.0 1.9 1.5 4.1 0.0 0.6 0.6 2.3 0.4 23.1 2.2 2.0 1.6 2.1 1.9 0.0 2.1 3.4 6.6 37.1 10.8 7.1 24.8 5.4 5.7 30.1 4.4 CEACAM8 "CD66b, CGM6" ENSG00000124469 "CEA cell adhesion molecule 8" P31997 19 42580243-42595055 "CD markers, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "bone marrow: 217.6" "Cell type enhanced" "Detected in single" "Paneth cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 1.6;non-classical monocyte: 1.2" "Group enriched" "Detected in many" 6 "granulocytes: 1.6;monocytes: 1.2" "Not detected" "Not detected" CAB033676 Approved "Intracellular and membrane" NA NA 9200000 "Cluster 51: Monocytes - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "CAB033676: AB_1125678" "unprognostic (2.01e-1)" "unprognostic (4.52e-2)" "unprognostic (3.31e-1)" "unprognostic (6.30e-2)" "unprognostic (2.68e-1)" "unprognostic (1.62e-1)" "unprognostic (1.71e-2)" "unprognostic (7.77e-2)" "unprognostic (9.62e-2)" 0.2 0.0 0.3 0.2 0.2 217.6 0.0 0.3 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.4 0.0 0.1 0.5 0.1 0.0 0.0 6.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 1.6 0.2 1.2 0.0 0.0 2.7 0.3 0.2 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 CENPA "CenH3, CENP-A" ENSG00000115163 "Centromere protein A" P49450 2 26764289-26801067 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.0;Extravillous trophoblasts: 33.2;Granulosa cells: 24.2;Plasma cells: 17.8;Spermatogonia: 28.6" "Cancer enhanced" "Detected in many" "testis cancer: 24.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB008371, HPA073086" Enhanced Supported Nucleoplasm NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB008371: AB_591074, HPA073086: AB_2686569" "unprognostic (3.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.13e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (2.88e-8)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.69e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.21e-3)" "unprognostic (0.00e+0)" "unprognostic (5.74e-2)" "unprognostic (1.33e-1)" "unprognostic (7.68e-2)" "unprognostic (2.07e-1)" 0.2 0.3 0.0 4.0 0.0 3.7 0.4 0.1 0.1 0.5 0.0 2.9 4.1 0.7 0.0 3.7 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.4 7.3 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.1 2.6 0.0 0.6 0.0 0.0 3.6 2.9 0.9 0.0 2.0 1.6 2.2 0.1 13.3 0.1 0.0 8.4 0.7 1.1 0.0 86.4 21.0 34.9 19.3 2.4 4.5 24.3 26.2 22.2 37.3 31.5 15.4 30.0 25.7 16.2 10.4 45.7 25.6 28.9 15.3 37.7 77.3 25.6 44.0 11.0 28.6 0.8 26.7 49.0 0.4 1.6 16.1 24.4 6.7 22.1 33.7 36.7 58.5 32.5 30.1 39.0 42.2 26.6 35.3 34.3 45.4 53.6 30.8 17.5 5.5 27.5 26.7 25.7 32.7 23.6 12.9 18.2 27.2 12.6 23.9 54.2 27.9 46.4 51.5 53.5 107.3 11.1 54.7 46.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 5.2 6.2 0.7 1.9 1.8 0.0 2.0 2.5 2.7 0.0 0.5 0.0 0.0 15.3 1.0 2.3 0.0 0.5 0.6 1.6 1.6 1.5 4.2 45.0 0.1 0.2 33.2 4.9 2.6 3.0 0.0 24.2 3.9 0.6 15.7 0.0 0.1 6.6 0.0 2.9 2.8 0.1 0.9 4.4 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.1 1.4 0.0 17.8 2.1 0.8 0.2 0.1 0.0 0.0 0.6 3.9 16.1 28.6 12.5 5.3 3.4 3.4 1.5 11.1 2.0 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105349-103198445 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 10.0;lymphoid tissue: 9.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011110, HPA042294" Enhanced Enhanced "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA011110: , HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 0.4 0.2 0.4 2.7 0.4 10.0 0.6 0.3 0.5 0.4 0.4 1.8 1.5 0.6 0.0 2.0 0.2 0.8 0.2 0.3 0.6 0.2 0.5 0.8 5.6 0.5 0.5 0.1 0.1 0.3 0.0 1.4 0.9 0.3 2.0 0.4 0.3 0.2 0.0 2.0 1.7 1.1 0.3 1.2 1.1 4.1 0.5 9.2 0.2 0.6 4.9 0.8 0.6 0.5 42.6 11.8 42.2 20.5 2.7 6.2 8.4 36.7 18.2 26.9 17.9 19.6 22.2 28.6 9.2 13.7 19.2 18.2 30.3 15.1 42.2 35.9 11.3 33.5 26.8 13.6 0.4 39.9 18.6 1.8 1.1 21.7 18.0 6.0 22.9 25.2 34.4 32.5 34.8 15.6 31.5 18.9 13.8 17.0 17.9 20.9 38.5 9.3 8.0 8.4 19.3 11.5 32.9 22.9 9.0 16.0 12.9 13.9 26.1 25.8 27.2 27.2 38.6 15.9 28.6 28.8 14.2 21.7 27.8 2.9 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.3 1.5 0.2 0.6 0.0 0.4 0.4 0.3 0.5 0.3 0.6 0.5 0.5 0.9 0.3 0.5 0.5 1.4 3.2 2.2 1.0 6.6 3.6 1.5 2.9 0.0 7.6 1.8 2.7 1.9 0.0 1.3 0.0 8.4 12.7 3.9 4.7 0.0 0.5 7.7 3.5 5.7 4.2 1.2 75.1 2.0 0.0 28.4 6.5 4.6 6.9 7.0 32.0 4.2 0.9 14.1 0.0 1.9 4.3 4.1 10.4 5.7 3.5 0.9 9.6 0.0 0.0 6.0 1.3 2.1 0.5 3.1 1.8 1.4 2.6 16.0 1.4 0.8 0.3 0.3 2.6 0.0 5.7 7.4 75.3 51.0 8.3 2.8 3.6 6.6 7.0 11.6 1.9 CENPF hcp-1 ENSG00000117724 "Centromere protein F" P49454 1 214603195-214664571 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis" "Developmental protein" "Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.8;lymphoid tissue: 33.0" "Cell type enhanced" "Detected in many" "Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA052382, HPA064308, CAB070134" Enhanced Supported Nucleoplasm Yes Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711" "unprognostic (2.80e-1)" "unprognostic (2.16e-1)" "unprognostic (2.65e-1)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" "unprognostic (2.58e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.58e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" "unprognostic (1.89e-2)" "unprognostic (4.12e-1)" 0.8 1.1 0.1 4.4 0.1 28.8 1.8 0.0 0.3 1.3 0.5 5.8 6.1 1.8 0.1 8.6 0.6 0.7 0.4 0.3 0.0 0.4 0.9 0.9 8.5 0.3 0.5 0.7 0.3 0.2 0.1 3.1 0.3 0.5 5.7 1.0 1.4 0.1 0.2 6.2 4.3 2.5 0.2 2.4 2.6 10.5 0.5 33.0 0.4 0.6 10.0 1.4 2.6 0.3 123.7 68.4 144.3 75.8 5.4 7.2 56.3 74.6 30.3 43.9 42.8 54.6 74.1 116.3 43.1 41.7 39.8 74.7 89.9 49.2 74.1 102.6 56.6 96.0 111.4 78.6 0.8 137.0 50.5 2.7 3.8 63.3 72.3 12.7 46.9 52.6 88.4 68.0 79.4 47.0 81.5 54.3 127.9 36.8 30.0 85.7 203.7 38.6 43.2 30.3 67.4 91.2 100.7 66.2 38.9 76.2 79.1 51.9 61.7 78.9 92.2 66.2 155.9 51.6 60.7 108.7 34.4 96.7 71.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.3 0.0 0.3 0.5 0.3 0.2 0.5 0.3 3.0 0.0 3.1 0.0 11.5 9.3 2.8 11.2 3.4 4.7 10.0 6.7 1.9 1.5 9.9 0.0 0.0 53.3 10.8 19.1 0.0 2.0 84.4 30.1 19.3 12.4 0.0 268.7 1.3 0.4 78.8 19.0 32.1 25.2 1.3 165.8 8.9 2.6 32.2 1.7 0.8 20.1 14.2 16.6 6.6 19.8 1.2 16.2 1.8 1.0 0.7 1.4 5.2 0.0 0.1 0.5 1.1 3.0 25.9 2.3 2.1 0.1 16.7 3.1 0.0 8.3 23.9 107.5 107.1 44.6 5.5 5.1 23.3 11.7 41.3 3.7 CENPI "CENP-I, FSHPRH1, LRPR1, Mis6" ENSG00000102384 "Centromere protein I" Q92674 X 101098218-101163681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 6.8;lymphoid tissue: 7.1" "Cell type enhanced" "Detected in some" "Erythroid cells: 4.8;Excitatory neurons: 2.9;Extravillous trophoblasts: 4.7;Granulosa cells: 3.2;Oligodendrocytes: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061297 Supported "Nuclear bodies,Cytosol" NA Yes "Cluster 33: Neutrophils - Chromatin organization" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies" Cytosol "HPA061297: AB_2684471" "unprognostic (3.10e-3)" "unprognostic (9.71e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (5.78e-6)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (3.62e-3)" "unprognostic (1.20e-3)" "unprognostic (4.51e-2)" "unprognostic (2.50e-13)" "unprognostic (1.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.42e-1)" 1.1 0.6 0.9 3.1 1.0 6.8 1.2 2.0 1.0 1.0 0.5 2.7 2.8 1.8 1.4 2.6 0.6 1.4 0.5 1.1 1.1 0.4 0.8 1.0 5.4 1.4 0.6 2.3 0.9 0.2 0.0 2.5 1.4 1.2 3.5 1.8 0.5 0.6 0.2 3.2 2.3 2.7 0.1 1.6 1.5 1.2 1.0 7.1 0.8 0.6 6.3 1.4 0.8 2.9 44.9 30.3 36.6 28.1 4.6 8.2 16.4 47.5 25.2 47.1 94.5 40.9 28.0 32.7 16.5 18.8 72.5 25.7 54.2 25.3 65.4 20.6 13.8 20.2 43.5 15.6 0.5 26.8 21.2 3.3 2.2 62.5 7.7 13.5 40.7 23.3 14.5 58.3 46.1 31.5 26.7 9.8 28.3 21.2 36.8 24.7 53.0 21.0 11.8 26.4 23.4 12.3 58.1 16.3 9.6 33.0 16.2 8.6 16.7 44.0 36.6 41.2 38.3 9.1 23.3 36.5 17.3 35.2 34.7 0.7 0.5 0.6 0.4 0.7 0.3 0.6 0.4 0.6 0.2 0.4 0.4 0.4 1.1 0.7 0.7 0.7 0.8 0.3 0.9 1.0 2.0 1.0 1.1 1.1 1.4 0.6 1.4 0.1 1.0 2.9 0.5 0.0 0.0 2.3 0.9 0.3 0.1 0.6 0.0 0.5 0.4 0.3 0.4 0.0 0.7 0.0 0.0 1.9 0.5 0.8 0.0 0.2 0.2 0.4 0.8 0.5 0.0 4.8 2.9 0.0 4.7 0.6 0.0 0.6 0.0 3.2 0.7 0.2 1.4 0.0 2.3 0.7 0.0 0.6 0.8 0.0 0.3 0.3 0.0 1.0 0.6 0.5 0.0 1.5 3.3 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.3 0.0 0.7 1.0 0.3 0.9 1.4 0.1 0.3 0.4 0.8 1.4 0.2 CENPK "CENP-K, FKSG14, SOLT" ENSG00000123219 "Centromere protein K" Q9BS16 5 65517766-65563168 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.6;lymphoid tissue: 22.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 50.9;Extravillous trophoblasts: 50.6;Spermatocytes: 101.3;Spermatogonia: 75.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA Yes "Cluster 20: T-cells - T-cell receptor" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "unprognostic (4.04e-2)" "unprognostic (1.77e-2)" "unprognostic (1.57e-2)" "unprognostic (5.04e-2)" "unprognostic (1.85e-1)" "unprognostic (3.04e-3)" "unprognostic (3.69e-4)" "unprognostic (3.22e-3)" "unprognostic (9.59e-3)" "unprognostic (3.32e-2)" "unprognostic (3.16e-3)" "unprognostic (1.98e-2)" "unprognostic (6.33e-15)" "unprognostic (2.22e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-2)" "unprognostic (3.11e-1)" 1.1 0.9 0.6 10.6 0.7 24.6 3.8 1.0 0.8 1.2 1.6 9.0 8.3 1.9 0.9 5.6 2.3 1.9 0.5 0.5 0.6 0.8 1.9 2.0 14.6 1.0 0.7 0.8 0.6 1.0 0.3 5.5 1.1 1.3 11.9 0.7 1.4 0.7 0.2 8.6 8.6 3.4 0.7 4.5 5.5 13.4 1.0 22.2 1.2 0.5 12.4 2.6 2.4 1.4 65.3 41.4 85.6 29.5 4.4 12.0 40.8 69.8 26.5 58.7 73.6 35.1 97.2 39.3 25.2 23.6 59.5 39.7 33.3 35.4 92.7 45.2 28.5 42.1 50.7 33.8 1.7 50.1 36.8 5.6 5.0 56.9 27.3 10.6 56.4 42.2 31.8 57.7 59.1 21.5 85.4 56.2 41.1 18.5 17.1 52.5 81.9 43.8 38.8 34.4 35.8 28.9 53.7 22.1 28.7 31.8 40.0 36.9 20.3 44.9 46.5 31.1 82.2 30.0 51.9 83.0 41.9 74.0 49.9 3.7 0.7 2.3 9.9 1.0 14.8 4.0 21.1 12.5 1.7 7.0 28.5 20.2 1.7 10.2 1.1 1.6 23.2 10.0 0.6 0.7 1.0 0.8 0.5 0.6 1.0 0.7 1.1 0.7 1.0 1.4 2.7 0.0 3.4 0.3 11.7 23.6 8.5 14.0 4.6 1.6 6.0 7.9 0.9 0.0 8.1 0.0 0.0 28.8 18.7 5.8 1.9 3.1 27.6 25.5 4.5 5.7 0.0 50.9 3.1 1.0 50.6 6.3 9.2 7.2 2.5 22.7 3.9 1.1 22.4 0.0 2.3 14.7 8.2 1.9 12.0 17.4 1.5 5.7 1.8 11.2 1.8 0.6 7.2 2.0 1.4 2.3 2.1 1.5 14.1 2.2 1.1 0.3 7.1 1.1 0.0 2.3 9.1 101.3 75.1 17.0 8.1 6.7 20.7 3.9 15.8 11.4 CENPU "CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1" ENSG00000151725 "Centromere protein U" Q71F23 4 184694085-184734130 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 62.6;testis: 29.5" "Cell type enhanced" "Detected in many" "Early spermatids: 489.7;Late spermatids: 900.3;Spermatocytes: 490.2;Spermatogonia: 215.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 20.7;eosinophil: 14.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 20.7" "Cell line enhanced" "Detected in many" "Karpas-707: 157.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022048 Supported "Nucleoplasm,Centriolar satellite" NA Yes "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Centriolar satellite" "HPA022048: AB_1853985" "unprognostic (1.47e-1)" "unprognostic (9.88e-2)" "unprognostic (5.02e-2)" "unprognostic (2.37e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (4.39e-3)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.67e-3)" "unprognostic (3.34e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.11e-9)" "unprognostic (2.19e-2)" "unprognostic (7.40e-3)" "unprognostic (4.46e-2)" "unprognostic (2.74e-1)" 1.5 1.1 0.1 5.4 0.3 62.6 5.7 0.6 0.3 2.4 0.1 7.8 5.1 1.5 0.7 10.5 0.9 1.1 1.5 0.2 0.2 0.7 3.7 1.7 16.2 0.2 0.2 0.6 1.0 1.4 0.2 4.8 0.6 1.3 8.0 1.5 2.7 0.4 0.9 15.3 5.4 2.7 0.2 2.3 3.7 29.5 0.4 12.8 1.3 0.1 13.6 2.1 3.9 0.5 57.8 17.1 67.9 35.8 4.3 6.4 37.6 40.8 19.4 32.2 21.2 24.8 32.1 45.9 3.8 18.7 20.2 23.0 52.4 33.2 30.6 23.4 23.0 50.4 17.5 12.6 0.7 71.1 29.3 2.7 2.1 33.3 8.4 9.4 32.1 53.9 44.1 157.3 51.1 38.2 111.4 53.0 33.8 12.7 21.5 74.5 24.3 15.6 17.1 26.7 52.0 49.0 31.4 39.4 23.9 25.0 44.1 50.2 20.9 23.8 31.3 23.5 39.7 26.5 29.5 37.6 37.2 55.4 94.5 20.7 0.7 14.2 0.5 2.0 0.4 0.9 0.7 0.8 0.4 0.9 0.6 0.8 0.1 3.5 2.8 1.9 2.5 0.6 0.1 0.3 0.6 0.3 0.2 0.2 0.2 0.2 0.6 0.2 0.4 0.5 1.4 9.6 3.2 0.3 6.5 13.9 6.0 11.5 3.4 0.9 11.5 7.9 2.3 4.3 8.7 1.8 0.0 31.5 5.4 8.9 3.9 4.8 489.7 9.5 4.0 3.8 0.0 115.7 0.4 2.5 48.4 7.3 9.2 6.6 8.9 27.1 1.1 0.9 21.6 0.0 0.4 10.0 10.2 5.1 7.3 900.3 9.0 15.3 0.0 1.0 5.3 0.2 4.1 0.5 1.9 3.0 1.0 6.8 28.3 2.6 0.9 0.7 5.6 1.4 19.7 2.0 7.2 490.2 215.1 29.1 21.5 7.5 6.3 4.4 18.1 11.6 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496612-93529092 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.4;testis: 21.7" "Cell type enhanced" "Detected in many" "Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "T-reg: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA023430 Approved Approved "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 1.3 0.6 0.0 7.6 0.0 5.0 1.4 0.0 0.2 1.7 0.0 7.0 6.7 1.4 0.1 7.3 0.4 1.4 0.3 0.0 0.1 0.3 0.6 1.3 14.7 0.1 0.3 0.2 0.2 0.2 0.3 3.5 0.2 0.3 8.8 0.0 1.2 0.3 0.1 4.5 6.3 5.2 0.0 2.4 4.6 21.7 0.4 27.4 0.5 0.2 15.5 3.1 2.3 0.1 208.5 81.5 53.0 67.7 5.8 12.0 29.6 112.4 78.2 103.5 106.4 87.2 108.6 55.4 48.2 72.8 69.6 115.4 64.8 54.8 123.4 167.2 33.7 21.0 49.2 29.9 0.6 36.3 46.3 2.8 3.8 110.6 133.5 30.7 97.1 89.9 19.3 101.8 118.5 48.3 96.3 54.8 20.9 64.2 58.8 41.3 86.9 30.3 47.1 25.5 21.7 30.7 86.3 26.3 64.9 40.1 68.9 36.4 61.4 65.3 90.6 90.5 186.7 45.1 66.1 66.8 51.0 134.8 59.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.4 0.1 0.2 0.0 1.3 0.0 2.7 3.6 0.9 1.9 0.0 0.0 1.8 2.0 0.4 2.8 0.2 0.0 0.0 7.7 0.9 3.3 0.0 0.6 29.4 1.7 2.0 1.5 0.0 2.5 0.5 0.2 17.1 2.3 8.2 3.6 0.0 19.8 2.2 0.3 12.9 0.0 0.3 4.5 4.1 7.0 5.1 8.2 0.3 5.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.4 14.8 1.1 0.4 0.0 0.2 0.0 0.0 0.5 4.5 77.3 17.3 16.1 1.3 1.5 4.3 1.6 7.9 1.7 CES4A "CES8, FLJ37464" ENSG00000172824 "Carboxylesterase 4A" Q5XG92 16 66988589-67009758 "Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 16.9;skin 1: 13.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 44.4;Excitatory neurons: 53.6;Oligodendrocytes: 37.6;Respiratory ciliated cells: 47.1" "Cancer enhanced" "Detected in many" "renal cancer: 5.3" "Region enhanced" "Detected in many" "white matter: 10.2" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 19.1;HMC-1: 5.2;PC-3: 4.5;SiHa: 7.8;SK-BR-3: 5.7;U-266/70: 5.9" "Not detected" "Not detected" HPA035701 Approved Approved Cytosol "Secreted - unknown location" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 31: Skin - Epidermis development" "Cluster 44: HDLM-2 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" Cytosol "HPA035701: AB_10696357" "unprognostic (6.34e-2)" "unprognostic (2.09e-1)" "unprognostic (3.18e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-1)" "unprognostic (6.20e-2)" "unprognostic (2.12e-2)" "unprognostic (2.04e-2)" "unprognostic (5.78e-3)" "unprognostic (3.93e-2)" "unprognostic (2.02e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.20e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-3)" 3.6 1.5 1.2 0.8 2.6 1.2 2.5 0.1 2.5 1.0 0.0 0.6 0.8 0.5 3.9 1.0 16.9 0.8 2.4 2.3 1.0 2.6 8.4 1.5 0.7 1.7 0.2 1.0 1.1 3.1 3.6 1.0 1.2 0.9 0.7 0.8 4.3 2.1 4.9 13.6 0.8 0.3 0.0 0.5 1.4 0.8 0.8 0.7 2.7 0.2 0.9 1.2 0.7 10.2 0.2 1.5 0.1 0.0 0.9 0.8 0.0 0.4 0.7 0.1 0.0 0.0 2.3 0.0 0.0 1.5 0.0 0.7 0.0 0.2 0.0 19.1 0.0 0.0 1.2 0.0 0.1 0.0 5.2 1.8 3.5 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 4.5 0.2 0.0 1.1 0.0 0.3 1.4 0.9 7.8 5.7 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 5.9 2.2 0.0 1.4 0.0 0.0 0.0 1.4 0.0 0.5 2.5 0.5 0.6 1.0 0.5 0.8 0.0 0.9 0.2 0.0 0.0 3.5 1.2 0.3 0.7 1.2 2.6 0.1 2.5 2.3 1.0 1.7 0.2 1.2 0.0 0.8 10.2 0.4 0.0 11.4 2.0 3.5 5.4 5.7 5.0 3.4 23.1 44.4 7.7 2.8 4.3 7.3 5.5 14.6 4.7 3.9 4.1 1.9 0.9 1.7 9.9 1.4 1.0 9.0 0.0 53.6 1.6 0.9 3.9 3.1 11.1 9.5 4.9 1.1 22.1 5.6 0.0 29.7 1.8 4.1 4.1 2.1 1.2 13.7 3.2 0.0 4.7 5.7 8.3 4.1 6.6 37.6 0.9 9.7 12.8 1.3 3.5 5.8 1.5 47.1 15.3 0.0 1.5 1.8 32.1 11.8 4.1 5.3 4.5 3.3 13.5 3.5 7.5 CETN2 "CALT, CEN2" ENSG00000147400 "Centrin 2" P41208 X 152826994-152830757 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 243.6" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 639.9;Proximal tubular cells: 345.8;Respiratory ciliated cells: 1116.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001470, HPA028956" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 18: U-2197 - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Centriolar satellite, Cytosol" "HPA001470: , HPA028956: AB_10601798" "unprognostic (3.32e-1)" "prognostic favorable (7.54e-6)" "unprognostic (7.73e-2)" "unprognostic (2.14e-2)" "unprognostic (2.14e-1)" "unprognostic (5.73e-3)" "unprognostic (9.58e-3)" "unprognostic (1.30e-1)" "unprognostic (1.28e-1)" "prognostic favorable (9.97e-4)" "unprognostic (5.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-3)" "unprognostic (5.90e-2)" "unprognostic (1.25e-2)" "unprognostic (1.34e-1)" "unprognostic (2.20e-1)" 30.2 41.0 61.8 19.8 62.3 26.2 40.3 58.3 80.4 64.6 90.5 54.6 15.2 57.6 116.2 37.2 243.6 31.7 34.6 60.6 65.8 74.7 31.5 39.8 16.0 68.0 75.8 57.2 24.0 55.7 73.9 21.4 70.4 50.3 25.8 40.1 24.4 77.7 19.6 23.8 21.6 54.8 67.4 16.8 29.3 23.3 64.8 21.0 67.2 20.2 21.9 37.3 36.1 67.1 145.2 65.0 78.8 59.6 102.5 110.5 31.4 61.6 73.8 79.9 60.9 29.5 75.8 51.6 157.8 83.1 128.8 55.3 55.3 76.7 94.1 23.2 40.0 11.5 32.1 86.6 38.5 48.7 12.5 67.0 99.2 74.1 39.1 95.4 64.0 40.3 31.0 20.9 78.3 67.9 36.4 53.0 27.5 119.9 82.6 31.9 57.2 53.2 146.9 35.4 38.5 50.0 41.2 42.2 38.2 70.8 45.4 37.2 59.8 56.0 44.9 111.9 69.9 20.9 29.7 81.0 118.3 28.9 28.0 19.9 11.4 35.9 11.7 13.6 14.2 11.9 11.5 13.1 13.5 9.7 12.2 12.5 10.9 12.3 13.7 20.0 10.5 11.8 61.8 62.3 58.3 80.4 60.6 65.8 68.0 75.8 70.4 67.4 64.8 67.1 21.6 51.3 35.7 3.9 19.2 22.6 52.4 201.6 21.6 13.6 46.1 47.6 37.1 64.3 155.8 169.2 6.2 66.6 16.2 13.8 238.7 100.3 60.1 639.9 65.4 29.6 37.1 33.2 4.2 41.1 69.8 42.9 12.2 68.7 24.6 41.0 44.3 96.5 50.0 13.5 3.5 31.7 150.5 23.7 21.3 72.5 67.7 27.3 37.4 1.9 27.8 104.4 20.6 0.5 2.5 39.6 16.0 111.7 16.6 29.3 15.4 345.8 1116.5 29.4 19.7 22.7 64.2 76.5 70.4 33.7 30.5 41.5 19.7 51.8 29.2 42.4 CFAP100 "CCDC37, FLJ40083, MIA1" ENSG00000163885 "Cilia and flagella associated protein 100" Q494V2 3 126394909-126436556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.3;choroid plexus: 30.6;fallopian tube: 27.1;testis: 32.4" "Group enriched" "Detected in some" 8 "Early spermatids: 316.1;Late spermatids: 703.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046354 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 31: Spermatids - Spermatogenesis" "HPA046354: AB_2679634" "unprognostic (1.79e-2)" "unprognostic (3.75e-3)" "unprognostic (7.17e-5)" "unprognostic (1.61e-3)" "unprognostic (6.75e-2)" "unprognostic (9.99e-3)" "unprognostic (1.47e-1)" "unprognostic (7.83e-2)" "unprognostic (1.61e-1)" "unprognostic (3.70e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.70e-5)" "unprognostic (3.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.96e-2)" "unprognostic (3.58e-4)" 0.0 0.0 5.2 0.0 4.9 0.0 0.0 2.1 2.0 3.1 30.6 0.0 0.0 1.0 0.0 0.0 27.1 0.0 0.0 5.2 4.5 0.1 0.0 6.2 0.1 16.6 23.3 0.1 0.0 0.0 0.3 0.0 9.8 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.0 32.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.9 2.1 2.0 5.2 4.5 16.6 23.3 9.8 11.8 5.3 6.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 316.1 60.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 703.3 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.8 48.1 0.0 6.6 0.0 0.0 5.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706988-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.6;choroid plexus: 35.9;fallopian tube: 59.5" "Group enriched" "Detected in some" 4 "Early spermatids: 56.8;Endometrial ciliated cells: 153.5;Late spermatids: 85.0;Respiratory ciliated cells: 189.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 7.3;HeLa: 6.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favorable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.2 0.3 2.4 0.1 1.4 0.1 0.2 0.8 0.4 9.1 35.9 0.1 0.0 1.1 1.8 0.8 59.5 0.6 0.3 3.2 3.3 0.5 0.1 11.2 0.4 12.6 18.6 0.4 1.1 0.2 4.7 0.2 7.2 0.3 0.0 0.1 0.5 0.2 0.3 0.6 0.1 0.1 7.5 0.3 0.2 10.1 2.6 0.1 0.4 0.0 0.0 0.4 0.1 1.9 1.4 7.3 0.9 1.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.8 0.8 1.4 1.0 0.0 1.6 3.6 0.0 0.0 0.0 2.8 1.2 0.8 6.2 1.7 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.5 0.0 2.1 2.9 0.4 0.0 5.0 1.1 0.4 0.7 1.5 3.6 2.0 1.1 1.2 0.0 0.3 5.1 1.0 1.7 2.9 0.4 0.1 2.4 0.4 1.5 1.6 1.4 4.1 0.8 0.7 2.3 0.9 0.7 0.9 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.4 0.8 0.4 3.2 3.3 12.6 18.6 7.2 7.5 2.6 1.9 0.2 9.6 10.5 0.0 0.0 0.0 0.3 0.0 0.0 0.7 1.3 0.6 0.0 0.0 27.9 0.0 0.0 0.1 0.1 0.2 1.9 0.3 56.8 153.5 1.9 0.8 0.0 0.0 0.0 0.0 0.1 1.0 0.0 4.8 2.5 0.1 0.4 0.2 0.2 0.0 0.0 0.6 0.0 0.6 0.0 85.0 0.3 0.5 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.1 0.7 0.1 0.4 0.5 0.4 189.5 0.4 0.0 0.4 0.3 14.3 0.9 0.0 0.0 0.0 0.3 1.4 0.3 0.2 CFAP161 "C15orf26, FLJ38615" ENSG00000156206 "Cilia and flagella associated protein 161" Q6P656 15 81007033-81149179 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 34.8;fallopian tube: 15.8" "Cell type enhanced" "Detected in some" "Early spermatids: 18.1;Endometrial ciliated cells: 26.5;Late spermatids: 5.4;Respiratory ciliated cells: 23.3;Spermatocytes: 15.6" "Cancer enriched" "Detected in some" 4 "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HEL: 84.4;K-562: 29.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076975 Supported NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "HPA076975: " "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.05e-4)" "unprognostic (1.57e-3)" "unprognostic (2.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (3.33e-2)" "unprognostic (3.13e-1)" "unprognostic (1.29e-3)" "unprognostic (8.93e-2)" "unprognostic (1.47e-1)" "unprognostic (9.24e-2)" "unprognostic (6.22e-2)" 0.4 0.1 0.8 0.1 1.2 0.6 0.2 4.3 1.1 0.6 34.8 0.1 0.0 0.6 0.6 0.1 15.8 0.2 0.6 1.2 0.6 0.3 0.2 2.7 0.1 2.5 3.5 0.1 0.2 0.3 1.7 1.3 2.0 0.1 0.0 1.3 0.2 0.2 0.2 0.5 0.1 0.2 3.0 0.5 0.2 6.4 1.2 0.0 0.6 0.8 0.2 0.2 0.1 1.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.3 0.0 84.4 0.2 0.2 0.0 0.0 11.0 0.0 0.0 0.3 1.0 0.0 1.7 0.0 29.2 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 1.2 0.2 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.4 0.1 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 3.4 0.8 1.2 4.3 1.1 1.2 0.6 2.5 3.5 2.0 3.0 1.2 1.0 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 26.5 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 2.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 23.3 0.6 0.0 0.0 0.0 15.6 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 CFAP206 "C6orf165, dJ382I10.1, FLJ25974" ENSG00000272514 "Cilia and flagella associated protein 206" Q8IYR0 6 87407972-87464465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 22.3;testis: 59.1" "Group enriched" "Detected in some" 4 "Early spermatids: 300.7;Spermatocytes: 128.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.3;RPTEC TERT1: 2.6;T-47d: 4.5" "HPA044891, HPA072261" Approved Approved "Nucleoplasm,Cell Junctions" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 6: T47d - Mammary gland" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Cell Junctions" "HPA044891: AB_10960832, HPA072261: AB_2686501" "unprognostic (4.31e-1)" "unprognostic (8.75e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-1)" "unprognostic (5.51e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-3)" "unprognostic (3.13e-2)" "unprognostic (3.99e-3)" "unprognostic (9.08e-3)" "unprognostic (4.22e-2)" "unprognostic (1.46e-1)" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" 0.1 0.4 1.0 0.0 0.9 0.0 0.3 0.5 0.9 0.7 4.3 0.0 0.0 0.5 0.6 0.0 22.3 0.1 0.2 0.8 1.4 0.9 0.1 1.5 0.0 2.3 2.6 0.1 0.1 0.7 1.2 0.1 1.6 0.5 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.1 1.5 0.0 0.0 59.1 1.7 0.0 1.4 0.1 0.0 0.2 0.0 0.9 0.0 0.5 0.2 1.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.6 0.5 0.3 0.2 0.2 0.1 0.0 4.5 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.5 0.9 0.8 1.4 2.3 2.6 1.6 1.5 1.7 0.9 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.9 0.3 300.7 15.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 32.5 2.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 1.4 43.7 0.4 0.0 0.0 0.1 128.8 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 CFAP20DC "C3orf67, FLJ42117, FLJ42930" ENSG00000163689 "CFAP20 domain containing" Q6ZVT6 3 58717365-59050084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "esophagus: 7.9;testis: 22.1" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 1.9;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069696 Approved "Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA069696: AB_2686174" "unprognostic (4.59e-1)" "unprognostic (4.63e-3)" "unprognostic (1.99e-1)" "unprognostic (4.49e-5)" "unprognostic (1.91e-1)" "unprognostic (9.33e-3)" "unprognostic (1.67e-3)" "unprognostic (3.72e-1)" "unprognostic (2.43e-1)" "unprognostic (6.68e-3)" "unprognostic (8.95e-2)" "unprognostic (6.19e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (3.06e-2)" "unprognostic (7.79e-2)" "unprognostic (2.81e-2)" 0.3 1.1 0.5 0.7 0.6 0.2 0.5 0.0 0.7 1.0 0.1 0.5 0.0 0.3 0.3 7.9 2.9 0.5 0.1 0.7 0.4 0.5 1.0 0.4 1.6 0.6 0.7 0.2 0.5 0.7 1.9 1.1 0.4 0.3 0.7 0.4 2.0 0.2 0.0 0.3 0.1 0.3 0.3 0.3 0.4 22.1 0.5 0.5 0.3 0.1 3.2 0.2 2.2 0.3 11.2 1.8 3.0 0.0 1.8 5.7 0.0 5.2 1.7 2.3 1.8 1.0 3.6 11.6 1.7 1.2 0.0 1.1 4.8 2.5 4.0 1.8 0.3 0.0 1.9 0.0 0.9 0.0 0.0 1.1 2.4 4.8 3.9 2.8 4.7 7.6 9.0 0.1 3.1 1.5 0.6 0.0 3.8 3.6 7.7 11.3 0.0 4.8 2.4 0.1 7.8 3.6 1.4 1.1 3.4 5.0 3.5 0.0 0.1 0.2 3.4 5.6 2.4 4.6 10.3 2.3 2.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.6 0.0 0.7 0.7 0.4 0.6 0.7 0.4 0.3 0.5 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 CFAP251 "CaM-IP4, MGC33630, WDR66" ENSG00000158023 "Cilia and flagella associated protein 251" Q8TBY9 12 121918592-122003927 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.3;testis: 19.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.7;Fibroblasts: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 31.8;hTCEpi: 30.8;hTERT-HME1: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039902, HPA040005" Supported Approved "Plasma membrane,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" "HPA039902: AB_10795236, HPA040005: AB_10795160" "unprognostic (4.92e-3)" "unprognostic (9.05e-2)" "unprognostic (7.99e-3)" "prognostic favorable (3.11e-4)" "unprognostic (5.58e-3)" "unprognostic (6.89e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (2.89e-1)" "unprognostic (2.34e-1)" "unprognostic (7.72e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "unprognostic (4.29e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" 1.1 0.8 1.6 0.3 2.4 0.1 1.3 1.3 1.7 3.5 13.2 0.2 0.1 1.9 4.7 0.3 22.3 1.2 1.3 2.4 3.9 2.7 1.4 3.0 0.6 5.5 6.6 2.2 1.7 2.9 6.5 0.9 3.6 0.7 0.1 4.6 1.1 1.6 0.3 1.5 0.2 0.6 2.7 1.7 0.4 19.9 4.1 0.5 4.7 0.4 0.9 0.3 1.3 1.6 4.7 0.4 0.4 0.2 0.5 0.5 0.5 0.3 2.5 1.2 3.0 0.3 1.4 0.2 3.7 0.2 0.7 0.9 0.3 31.8 4.4 0.2 0.5 0.2 0.6 0.3 3.7 0.1 8.6 1.8 30.8 2.4 19.9 0.7 1.3 0.5 7.5 0.1 1.9 0.9 0.3 0.6 0.4 0.4 0.2 0.4 0.8 0.0 5.4 0.5 2.5 0.1 0.2 0.1 0.2 0.8 0.9 0.1 1.0 2.5 3.9 0.5 0.5 0.5 0.2 3.8 2.9 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.0 1.6 2.4 1.3 1.7 2.4 3.9 5.5 6.6 3.6 2.7 4.1 1.6 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 CFAP299 C4orf22 ENSG00000197826 "Cilia and flagella associated protein 299" Q6V702 4 80335730-80963750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 19.8;testis: 27.4" "Cell type enriched" "Detected in some" 54 "Endometrial ciliated cells: 54.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;BJ: 1.6;hTERT-RPE1: 2.5;LHCN-M2: 1.0;SCLC-21H: 1.1;U-251 MG: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.0 0.9 0.0 1.0 0.0 0.1 1.4 0.5 0.7 2.6 0.1 0.1 0.2 0.0 0.0 19.8 0.1 0.0 1.0 1.0 0.3 0.0 1.4 0.1 5.3 3.7 0.1 0.0 0.0 0.1 0.0 2.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 27.4 1.2 0.1 0.6 0.0 0.0 0.0 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.7 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 1.0 1.4 0.5 1.0 1.0 5.3 3.7 2.3 3.5 1.2 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 54.5 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 CFAP300 "C11orf70, FBB5, MGC13040" ENSG00000137691 "Cilia and flagella associated protein 300" Q9BRQ4 11 102047437-102084554 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.2;testis: 30.2" "Cell type enriched" "Detected in some" 4 "Endometrial ciliated cells: 142.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038585 Enhanced Approved Centrosome NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" Centrosome "HPA038585: AB_10795357" "unprognostic (9.70e-2)" "unprognostic (3.18e-1)" "unprognostic (3.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.05e-1)" "unprognostic (2.04e-1)" "unprognostic (4.16e-2)" "unprognostic (2.62e-1)" "unprognostic (3.03e-2)" "unprognostic (5.00e-2)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-6)" "unprognostic (1.76e-2)" "unprognostic (8.68e-3)" "unprognostic (2.94e-2)" "unprognostic (6.73e-3)" 2.7 3.4 2.3 0.4 2.6 0.0 2.6 2.2 2.1 5.4 10.9 1.3 0.8 4.3 10.7 1.8 29.2 3.3 1.3 2.5 3.3 1.7 0.1 3.0 0.9 5.8 6.7 4.1 0.8 2.7 4.0 3.3 5.5 4.0 0.8 1.4 0.8 6.6 0.2 1.3 0.8 2.9 4.7 0.1 1.8 30.2 3.3 0.6 3.6 0.0 0.5 3.0 1.9 4.0 0.1 8.5 8.5 0.0 7.5 17.9 0.2 3.4 8.6 4.6 6.5 0.6 11.1 0.0 2.0 6.7 2.3 2.1 2.1 1.0 3.3 0.0 1.3 0.0 1.3 0.0 5.3 0.0 0.0 7.8 10.5 11.9 8.0 8.9 0.1 0.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.0 12.6 2.4 9.4 0.0 11.0 0.1 0.0 0.0 9.6 0.0 1.3 1.1 3.5 11.2 2.8 0.1 0.0 0.0 3.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 2.6 2.2 2.1 2.5 3.3 5.8 6.7 5.5 4.7 3.3 4.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.4 3.8 0.0 0.0 0.0 29.5 0.0 7.1 0.1 0.0 1.9 4.0 0.0 142.5 9.8 0.2 0.0 0.0 0.0 0.0 0.5 3.4 0.0 2.1 0.0 2.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.2 6.0 0.0 0.0 CFAP43 "bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96" ENSG00000197748 "Cilia and flagella associated protein 43" Q8NDM7 10 104129888-104232364 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 34.7;choroid plexus: 80.2;fallopian tube: 48.9;testis: 57.3" "Cell type enhanced" "Detected in many" "Early spermatids: 103.0;Endometrial ciliated cells: 161.0;Late spermatids: 58.4;Respiratory ciliated cells: 231.0;Spermatocytes: 53.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;U-266/70: 3.3;U-266/84: 2.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 5.9" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.20e-2)" "unprognostic (3.05e-2)" "unprognostic (3.61e-2)" "unprognostic (6.46e-3)" "unprognostic (2.03e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.78e-1)" "unprognostic (1.56e-1)" "unprognostic (2.80e-1)" "unprognostic (6.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.41e-1)" "unprognostic (3.35e-2)" "unprognostic (9.11e-4)" "unprognostic (6.67e-2)" 0.3 1.0 8.4 0.2 8.2 0.2 2.5 4.7 4.3 6.0 80.2 0.3 0.4 2.9 7.8 0.2 48.9 0.9 0.2 8.8 10.5 5.9 0.4 8.2 0.3 33.9 34.7 1.8 2.2 3.8 10.1 0.3 23.5 1.5 0.2 10.7 0.9 1.3 0.1 1.0 0.6 0.2 23.8 0.2 0.6 57.3 9.8 0.4 5.3 0.0 0.2 0.2 0.5 14.6 1.7 0.6 0.6 1.1 0.0 0.3 0.1 0.0 0.5 0.3 0.2 0.0 4.3 0.0 0.0 0.0 1.5 0.6 0.1 0.6 0.7 0.2 0.7 0.0 0.3 0.2 0.1 0.0 0.1 0.4 0.5 0.4 0.3 0.9 0.1 0.3 1.2 0.1 0.0 1.1 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.0 1.5 0.0 0.9 0.9 0.4 0.0 0.8 0.5 0.5 0.0 0.0 0.1 0.3 0.5 0.2 3.3 2.9 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.4 8.2 4.7 4.3 8.8 10.5 33.9 34.7 23.5 23.8 9.8 14.6 0.3 3.2 8.4 16.6 0.1 0.0 0.6 0.0 0.6 0.8 1.9 1.7 0.8 0.0 38.4 1.8 10.4 0.1 0.0 0.0 0.0 1.2 103.0 161.0 2.1 1.0 3.6 0.8 16.6 0.0 0.2 1.2 1.1 3.6 6.3 0.6 0.4 0.1 0.1 0.0 23.5 0.1 0.0 0.0 0.0 58.4 1.5 0.7 0.0 1.9 0.6 1.3 0.0 1.5 6.1 0.2 0.1 2.2 0.2 0.6 0.1 1.2 231.0 8.8 0.0 0.6 0.1 53.7 4.4 0.3 0.0 0.0 0.7 0.4 0.2 0.3 CFAP44 "FLJ11142, WDR52" ENSG00000206530 "Cilia and flagella associated protein 44" Q96MT7 3 113286930-113441610 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 57.4;Endometrial ciliated cells: 40.0;Late spermatids: 61.2;Respiratory ciliated cells: 104.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.7" HPA067258 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA067258: AB_2685814" "unprognostic (2.83e-1)" "unprognostic (7.07e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.35e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-4)" "unprognostic (6.73e-2)" "unprognostic (1.10e-1)" "unprognostic (2.89e-1)" "unprognostic (1.62e-2)" "unprognostic (2.18e-3)" "unprognostic (2.13e-6)" "unprognostic (8.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.77e-2)" "prognostic favorable (7.09e-6)" 1.6 1.2 1.1 0.9 1.2 0.8 2.5 1.2 1.0 3.7 11.9 2.7 0.7 2.7 2.6 1.6 6.8 1.0 1.7 1.3 1.4 1.9 2.1 2.5 1.3 5.5 4.8 3.3 3.7 1.9 6.3 0.7 2.6 4.2 2.3 8.7 4.9 1.1 1.3 2.3 2.9 0.7 4.4 2.0 3.0 6.1 1.4 1.4 3.2 0.4 1.0 2.4 2.6 2.0 1.1 0.7 1.6 1.4 0.9 1.5 1.5 0.5 0.3 0.3 0.7 0.1 0.6 1.4 0.1 0.2 0.3 1.5 0.9 0.5 0.6 0.3 1.0 0.8 3.4 0.3 0.0 1.5 0.9 0.4 1.4 0.3 0.3 2.0 0.2 1.3 0.2 0.7 0.3 0.7 0.8 1.3 0.5 1.9 1.8 0.8 0.2 0.0 0.8 1.8 1.5 1.4 0.7 0.1 0.8 0.8 1.0 1.1 1.1 0.5 0.8 0.4 0.5 0.9 0.6 0.1 0.7 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.2 1.0 1.3 1.4 5.5 4.8 2.6 4.4 1.4 2.0 3.8 9.6 13.7 27.4 2.9 0.0 2.1 0.0 5.7 7.5 6.7 5.2 5.1 2.8 18.6 3.7 20.9 0.9 1.1 3.2 0.0 2.6 57.4 40.0 6.3 4.2 0.0 1.3 34.8 3.0 1.0 5.2 12.2 9.5 11.4 4.3 1.8 3.7 0.5 8.4 14.0 4.7 0.0 0.6 0.0 61.2 6.2 1.8 0.0 20.6 0.9 4.0 3.1 21.1 21.9 2.1 1.9 6.8 2.5 2.2 2.2 1.1 104.9 19.0 0.0 9.7 2.5 23.6 4.9 1.8 0.0 0.8 2.9 6.2 2.7 2.2 CFAP45 "CCDC19, NESG1" ENSG00000213085 "Cilia and flagella associated protein 45" Q9UL16 1 159872364-159900165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 13.5;fallopian tube: 44.8;testis: 28.4" "Cell type enhanced" "Detected in many" "Early spermatids: 256.4;Endometrial ciliated cells: 98.2;Late spermatids: 57.4;Respiratory ciliated cells: 166.9;Spermatocytes: 43.7" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "eosinophil: 3.0;neutrophil: 2.4" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.0" "Cell line enhanced" "Detected in many" "BEWO: 9.0;HEL: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042204, HPA043618" Enhanced Enhanced Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA042204: AB_10966555, HPA043618: AB_10959305" "unprognostic (1.88e-1)" "unprognostic (4.15e-2)" "unprognostic (3.95e-1)" "unprognostic (5.18e-3)" "unprognostic (4.78e-3)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (2.57e-1)" "unprognostic (1.76e-1)" "unprognostic (5.21e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-12)" "unprognostic (2.95e-1)" "unprognostic (1.87e-1)" "unprognostic (3.83e-3)" "unprognostic (1.65e-1)" 0.6 0.1 1.8 0.4 1.3 0.8 0.6 1.0 0.9 2.7 13.5 0.3 0.2 1.4 0.0 0.4 44.8 0.2 0.8 1.7 1.8 0.7 0.1 5.0 0.2 7.9 7.0 0.3 0.2 0.1 0.4 0.4 4.7 0.4 0.1 0.0 0.3 0.4 0.2 0.5 0.3 0.4 5.9 0.7 0.6 28.4 2.3 0.3 0.7 0.1 0.2 0.5 0.3 4.1 2.1 0.4 0.0 0.0 0.1 0.2 9.0 1.1 1.3 1.9 0.8 1.5 2.7 0.8 0.4 0.3 1.0 1.3 0.2 0.3 1.1 0.3 0.2 12.2 0.5 0.0 0.4 1.1 0.4 0.8 0.6 2.1 0.7 2.8 1.4 0.2 1.3 0.4 0.3 3.0 0.2 0.9 0.5 1.7 1.0 0.0 0.9 0.4 0.1 0.5 0.8 0.1 1.0 3.2 0.3 2.6 3.1 0.2 1.8 0.8 2.4 1.6 2.0 0.8 0.0 0.2 4.3 0.3 0.7 0.0 0.1 3.0 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.0 0.2 2.4 0.0 0.0 0.1 0.0 0.1 1.8 1.3 1.0 0.9 1.7 1.8 7.9 7.0 4.7 5.9 2.3 4.1 2.0 0.0 4.8 0.0 0.4 0.0 0.9 0.0 0.6 0.1 1.4 0.9 5.5 0.0 29.7 5.5 0.0 1.6 0.6 0.0 0.0 1.9 256.4 98.2 1.3 3.2 0.0 0.0 0.1 2.2 7.4 1.2 0.0 3.2 3.8 0.1 1.4 0.0 0.4 0.0 0.1 0.1 0.0 0.6 0.0 57.4 2.1 4.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 1.6 0.0 1.5 3.2 1.3 0.1 0.4 166.9 0.0 0.0 0.7 0.9 43.7 3.1 1.2 0.0 0.8 1.2 0.6 0.1 1.1 CFAP46 "bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40" ENSG00000171811 "Cilia and flagella associated protein 46" Q8IYW2 10 132808392-132942823 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 22.5;skeletal muscle: 33.4;testis: 41.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 95.9;Endometrial ciliated cells: 70.8;Excitatory neurons: 42.8;Respiratory ciliated cells: 59.0;Rod photoreceptor cells: 74.4;Spermatocytes: 53.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037786, HPA038034, HPA038867, HPA038868" Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA037786: AB_10672392, HPA038034: AB_2675796, HPA038867: AB_2676246, HPA038868: AB_2676247" "unprognostic (2.83e-2)" "unprognostic (4.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.83e-1)" "unprognostic (4.11e-1)" "unprognostic (5.40e-2)" "unprognostic (6.41e-3)" "unprognostic (1.39e-1)" "unprognostic (1.64e-4)" "unprognostic (1.21e-2)" "unprognostic (8.08e-2)" "unprognostic (4.56e-3)" "unprognostic (2.08e-2)" 0.0 0.2 5.9 0.0 7.0 0.0 0.1 4.2 10.0 1.5 22.5 0.0 0.1 0.1 1.3 0.2 16.1 0.1 0.7 6.5 6.1 1.0 0.2 3.4 0.0 13.5 17.3 0.2 0.4 1.1 2.2 0.0 8.5 0.2 0.0 3.9 0.4 0.4 33.4 0.1 0.1 0.0 9.4 0.1 2.4 41.8 6.6 0.0 4.2 10.7 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 5.9 7.0 4.2 10.0 6.5 6.1 13.5 17.3 8.5 9.4 6.6 4.6 0.2 0.0 4.8 9.8 0.3 0.0 0.5 0.0 0.6 6.3 1.3 1.1 3.7 0.0 9.3 7.3 95.9 0.0 0.0 0.0 5.9 4.8 18.0 70.8 0.9 0.9 0.0 0.0 42.8 0.2 0.0 1.5 5.1 1.5 3.8 4.3 5.0 0.2 0.6 1.7 22.0 0.0 0.0 0.6 0.0 11.3 1.2 0.3 0.0 1.0 0.0 4.7 0.0 2.0 0.9 1.6 0.0 2.2 0.2 0.7 0.0 5.6 59.0 74.4 0.0 0.4 0.4 53.7 7.2 0.7 0.0 0.0 0.3 7.3 0.0 0.6 CFAP47 "CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1" ENSG00000165164 "Cilia and flagella associated protein 47" Q6ZTR5 X 35919734-36385317 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;choroid plexus: 7.1;fallopian tube: 4.7" "Cell type enhanced" "Detected in some" "Astrocytes: 45.4;Endometrial ciliated cells: 66.2;Respiratory ciliated cells: 20.4;Rod photoreceptor cells: 14.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Karpas-707: 1.6;U-266/70: 3.0" "HPA044633, HPA054859" Uncertain NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA044633: AB_10960684, HPA054859: AB_2682627" "unprognostic (1.88e-1)" "unprognostic (4.38e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (1.09e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (5.61e-2)" "unprognostic (1.50e-5)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "unprognostic (1.48e-2)" "unprognostic (5.19e-3)" 0.0 0.0 1.5 0.0 2.3 0.0 0.0 0.9 0.7 0.2 7.1 0.0 0.0 0.1 0.4 0.0 4.7 0.0 0.0 1.6 2.8 0.0 0.1 0.5 0.0 8.1 6.3 0.0 0.0 0.4 1.8 0.0 4.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.7 2.5 0.0 0.3 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.3 0.9 0.7 1.6 2.8 8.1 6.3 4.4 4.4 2.5 5.3 0.1 0.0 0.0 45.4 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.0 2.5 1.8 8.4 0.2 0.0 0.0 0.0 0.0 6.0 66.2 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 2.1 0.3 0.1 0.0 1.9 0.0 0.6 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 20.4 14.7 0.0 0.0 0.1 2.2 4.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 CFAP52 "FLJ37528, WDR16, WDRPUH" ENSG00000166596 "Cilia and flagella associated protein 52" Q8N1V2 17 9576627-9643447 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.7;choroid plexus: 18.2;fallopian tube: 57.8" "Group enriched" "Detected in some" 6 "Early spermatids: 32.4;Endometrial ciliated cells: 99.6;Respiratory ciliated cells: 81.6;Spermatocytes: 33.9" "Group enriched" "Detected in some" 4 "endometrial cancer: 1.5;glioma: 1.7;lung cancer: 0.6;ovarian cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;MCF7: 2.1;OE19: 2.7;REH: 1.4;T-47d: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023247, HPA030635" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria Nucleoplasm "HPA023247: AB_1858797, HPA030635: " "unprognostic (1.76e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (1.68e-2)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-2)" "unprognostic (2.11e-1)" "unprognostic (3.66e-1)" "unprognostic (2.22e-2)" "unprognostic (2.66e-1)" "unprognostic (7.85e-2)" "unprognostic (1.85e-1)" "unprognostic (9.23e-2)" "unprognostic (4.50e-2)" "unprognostic (7.09e-2)" 0.0 0.3 3.8 0.0 4.3 0.0 0.1 2.3 2.9 2.3 18.2 0.1 0.7 1.1 0.1 0.2 57.8 0.2 0.0 4.0 4.1 0.3 0.2 4.4 0.0 10.7 13.7 0.2 0.2 0.3 3.2 0.2 8.4 0.3 0.0 2.4 1.2 0.2 0.0 0.2 0.7 0.0 9.9 0.0 0.1 12.2 3.9 0.3 0.6 0.3 0.0 0.1 0.1 6.6 0.8 0.8 0.0 0.3 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.6 0.9 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.1 0.0 0.3 0.1 2.7 0.0 1.4 0.0 0.0 0.2 0.4 0.3 0.0 0.3 0.5 0.0 0.3 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 4.3 2.3 2.9 4.0 4.1 10.7 13.7 8.4 9.9 3.9 6.6 0.2 0.0 2.3 1.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.3 0.0 9.9 0.0 6.2 0.8 0.0 0.0 1.9 0.1 32.4 99.6 0.9 0.3 0.0 0.0 9.7 0.2 0.2 0.3 0.0 1.7 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 6.4 1.8 0.0 0.0 1.0 0.0 0.7 0.0 7.1 1.1 0.1 0.0 1.9 0.0 0.3 0.0 0.5 81.6 3.1 0.0 0.1 0.2 33.9 0.8 0.0 0.0 1.0 0.1 0.1 0.0 0.1 CFAP53 "CCDC11, FLJ32743" ENSG00000172361 "Cilia and flagella associated protein 53" Q96M91 18 50227193-50266495 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "fallopian tube: 28.5;testis: 79.6" "Group enriched" "Detected in many" 14 "Early spermatids: 809.6;Endometrial ciliated cells: 331.5;Late spermatids: 528.4;Respiratory ciliated cells: 216.5;Spermatocytes: 481.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 4.7" "HPA041069, HPA066142" Enhanced Approved Midbody Yes No "Cluster 26: Non-specific - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" Midbody "HPA041069: AB_10805835, HPA066142: AB_2732739" "unprognostic (1.73e-2)" "unprognostic (1.13e-2)" "unprognostic (5.83e-2)" "unprognostic (3.12e-3)" "unprognostic (3.31e-2)" "unprognostic (1.19e-1)" "unprognostic (3.64e-4)" "unprognostic (2.90e-2)" "unprognostic (3.68e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "prognostic favorable (5.85e-4)" "unprognostic (3.22e-1)" "unprognostic (1.17e-2)" "unprognostic (4.34e-3)" "unprognostic (4.61e-3)" 0.3 1.2 3.0 0.4 3.4 0.7 1.1 5.0 3.2 2.0 8.5 0.5 0.2 1.1 5.7 0.4 28.5 0.7 0.5 3.1 3.7 2.7 0.4 3.3 0.3 6.8 7.8 1.0 1.1 2.5 3.3 0.3 6.0 0.9 0.2 3.5 0.6 1.2 2.3 1.0 0.4 0.3 5.3 0.4 0.5 79.6 3.4 0.5 3.9 0.4 0.2 0.6 0.6 5.0 1.2 0.8 0.5 1.0 0.7 1.3 0.9 0.2 0.1 0.1 0.2 0.1 1.0 0.7 0.7 0.3 0.3 0.5 0.3 0.5 0.2 0.5 0.7 0.3 0.3 0.1 0.3 0.5 0.4 0.4 2.0 0.5 4.7 1.1 0.3 1.9 1.4 0.4 0.3 1.2 1.2 0.2 0.2 0.2 0.5 0.1 0.2 1.0 1.4 0.0 0.8 0.6 0.1 0.0 0.4 1.3 0.6 0.1 0.0 0.7 0.5 0.4 0.4 2.1 0.8 0.1 0.7 0.5 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.2 0.2 0.0 3.0 3.4 5.0 3.2 3.1 3.7 6.8 7.8 6.0 5.3 3.4 5.0 0.6 6.4 4.2 2.6 0.6 0.0 2.0 0.0 1.8 4.3 4.7 3.8 0.4 0.0 21.1 9.2 8.4 1.7 0.2 0.3 9.8 3.4 809.6 331.5 3.8 1.4 0.0 0.4 3.8 0.6 0.5 2.2 2.6 7.9 1.3 1.4 1.8 1.0 0.4 1.7 4.4 0.2 0.0 0.0 0.0 528.4 8.4 1.3 0.0 2.8 1.0 2.7 1.0 3.0 6.5 0.8 0.1 5.7 0.9 1.3 0.8 20.5 216.5 10.5 6.6 2.1 0.7 481.5 32.5 1.3 0.0 0.7 1.0 1.7 0.4 1.1 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7;choroid plexus: 30.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;Alveolar cells type 2: 80.1;Club cells: 42.7;Endometrial ciliated cells: 65.8;granulocytes: 37.8;Oligodendrocytes: 47.7;Respiratory ciliated cells: 106.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 7.7;TIME: 9.4" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 0.8 0.7 5.6 1.3 8.1 2.7 0.9 9.2 10.3 0.6 30.7 0.7 1.8 1.6 1.6 0.7 5.0 0.8 0.5 7.0 4.6 0.9 0.9 1.4 1.2 14.6 14.7 1.0 0.2 0.6 1.0 0.7 7.3 0.9 1.1 6.2 0.8 0.6 1.3 1.6 1.2 0.6 8.5 1.5 1.0 5.4 7.0 0.5 1.3 0.2 1.1 0.4 0.1 12.4 1.4 0.6 0.8 1.1 0.4 0.6 0.9 0.7 0.2 0.2 0.4 0.6 1.9 1.0 1.6 0.4 0.9 1.0 0.3 0.3 0.3 2.0 0.6 0.9 2.3 0.7 0.1 1.5 1.5 0.2 0.3 1.1 0.5 1.8 7.7 0.9 0.6 3.5 0.8 0.7 1.2 1.5 1.7 0.6 1.0 1.2 1.1 1.3 2.2 1.3 1.6 1.2 0.8 0.7 1.0 0.9 2.1 0.7 9.4 1.7 2.2 1.8 1.5 4.2 2.1 0.6 1.3 0.9 1.3 2.4 0.7 0.6 0.7 0.6 0.5 0.7 0.5 0.6 0.3 1.1 0.6 0.6 1.3 0.7 0.7 0.6 0.4 0.1 5.6 8.1 9.2 10.3 7.0 4.6 14.6 14.7 7.3 8.5 7.0 12.4 2.1 70.5 80.1 27.1 2.6 0.0 0.3 0.0 0.0 3.9 0.3 0.6 1.0 1.5 42.7 0.0 22.9 0.3 2.2 0.0 0.0 0.2 33.2 65.8 2.9 6.8 1.2 1.3 21.9 0.0 0.3 6.4 0.5 1.9 37.8 0.6 0.4 0.0 0.2 0.0 3.9 0.0 0.0 0.8 0.0 15.4 0.3 3.2 0.0 1.9 0.1 8.1 0.0 4.0 47.7 0.3 0.1 0.0 5.0 0.5 0.0 0.3 106.4 7.8 0.0 1.7 0.5 16.8 7.0 0.0 0.0 0.0 4.2 1.9 0.1 0.3 CFAP57 "FLJ32000, WDR65" ENSG00000243710 "Cilia and flagella associated protein 57" Q96MR6 1 43172330-43254358 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 10.7;fallopian tube: 23.4;testis: 15.8" "Group enriched" "Detected in some" 7 "Early spermatids: 38.6;Endometrial ciliated cells: 62.4;Late spermatids: 26.7;Respiratory ciliated cells: 85.2;Spermatocytes: 25.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 2.8;HDLM-2: 1.8;TIME: 1.5" "Low region specificity" "Detected in many" "HPA002736, HPA028623" Enhanced Approved Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA002736: AB_2272982, HPA028623: AB_10603234" "unprognostic (1.15e-2)" "unprognostic (2.29e-3)" "unprognostic (2.16e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.50e-2)" "unprognostic (3.71e-1)" "unprognostic (2.42e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (2.05e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-2)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-2)" "unprognostic (7.78e-2)" 0.4 0.1 0.8 0.0 1.2 0.0 0.3 0.3 0.5 1.0 10.7 0.0 0.0 0.6 2.8 0.1 23.4 0.2 0.2 1.2 1.6 1.0 2.7 2.5 0.0 3.6 4.9 0.2 0.6 0.1 2.0 0.2 2.5 0.4 0.1 1.5 0.1 0.2 0.0 0.6 0.0 0.1 2.7 0.0 0.1 15.8 1.7 0.2 1.0 0.0 0.1 0.2 0.1 1.2 0.9 0.3 0.2 0.1 0.0 0.0 0.2 0.3 0.7 0.5 0.5 0.3 0.3 0.0 0.3 1.0 0.3 2.8 0.2 0.3 1.1 1.8 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.5 0.5 0.1 0.7 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.2 0.2 0.3 0.1 0.3 0.0 0.3 0.3 0.6 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.8 1.2 0.3 0.5 1.2 1.6 3.6 4.9 2.5 2.7 1.7 1.2 0.2 6.4 0.5 1.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.3 0.5 0.0 5.6 0.0 6.2 0.9 0.0 0.2 0.0 0.2 38.6 62.4 0.6 0.3 0.0 0.0 3.5 0.2 0.1 0.6 0.0 1.2 0.0 0.1 1.1 0.5 0.1 1.7 1.2 0.0 0.0 0.0 0.0 26.7 0.9 0.2 0.0 0.0 2.1 0.6 0.0 0.0 1.1 0.3 0.0 0.7 0.0 0.1 0.7 1.9 85.2 1.2 0.0 0.0 0.1 25.4 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353833-104455102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.4;testis: 13.4" "Group enriched" "Detected in some" 4 "Early spermatids: 73.3;Endometrial ciliated cells: 25.1;Late spermatids: 58.9;Respiratory ciliated cells: 56.9;Spermatocytes: 34.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.1;U-2 OS: 6.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.9" "HPA036555, HPA071938" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 9: U-2 OS - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.4 0.6 1.0 0.5 1.3 0.4 0.4 0.4 0.7 2.2 2.4 0.5 0.1 1.8 0.2 0.2 8.4 0.2 2.5 0.8 1.2 0.7 0.1 1.3 0.3 2.9 3.7 0.5 0.3 0.7 1.5 0.4 2.2 0.5 0.0 0.6 0.2 0.4 1.3 0.3 0.2 0.6 2.0 0.3 0.3 13.4 1.0 0.1 0.8 0.8 0.4 0.3 0.6 1.1 0.1 0.0 0.7 0.1 0.1 0.3 0.1 1.0 3.1 0.6 1.6 0.0 0.0 2.4 0.2 0.4 1.7 0.2 0.0 0.2 1.8 0.3 0.1 0.5 0.9 0.0 0.3 0.3 0.4 0.3 1.3 0.5 1.6 1.3 1.0 0.1 0.7 0.7 0.8 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.2 0.0 0.1 0.5 0.7 0.1 0.4 2.0 0.6 6.5 0.3 1.8 0.2 0.0 0.1 0.7 0.8 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.4 0.7 0.8 1.2 2.9 3.7 2.2 2.0 1.0 1.1 0.4 0.0 0.5 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 10.0 0.0 9.3 0.0 0.0 0.1 0.1 0.0 0.0 0.6 73.3 25.1 0.3 0.4 0.0 0.0 4.0 0.2 0.4 0.7 0.0 0.4 0.0 0.3 1.8 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.0 58.9 0.6 0.2 0.0 1.9 0.1 0.7 1.0 1.0 0.0 0.3 0.0 1.2 0.0 0.2 0.0 0.0 56.9 0.3 0.0 0.8 1.0 34.4 4.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 CFAP61 "C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156" ENSG00000089101 "Cilia and flagella associated protein 61" Q8NHU2 20 20052514-20360703 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 16.1;skeletal muscle: 28.6;testis: 15.5" "Cell type enhanced" "Detected in some" "Early spermatids: 88.7;Excitatory neurons: 20.6;Late spermatids: 73.2;Spermatocytes: 17.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.7;HMC-1: 2.6;SCLC-21H: 5.1;SK-MEL-30: 2.2;U-87 MG: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009079 Approved NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA009079: AB_1078344" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (6.73e-2)" "unprognostic (1.38e-3)" "unprognostic (6.20e-3)" "unprognostic (3.67e-3)" "unprognostic (8.58e-4)" "unprognostic (8.24e-2)" "unprognostic (8.29e-2)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.56e-1)" "unprognostic (2.76e-4)" "unprognostic (2.77e-1)" "unprognostic (9.27e-2)" "unprognostic (3.10e-3)" "unprognostic (3.06e-1)" 0.1 0.7 1.4 0.0 2.2 0.0 0.2 0.9 1.2 0.6 16.1 0.1 0.0 0.7 0.9 0.1 12.2 0.1 12.4 2.2 3.2 0.7 0.0 1.3 0.1 5.3 7.3 0.3 0.3 0.5 3.6 0.0 3.9 0.3 0.0 1.8 0.2 0.2 28.6 0.5 0.0 0.1 4.3 0.0 0.1 15.5 3.7 0.1 0.7 10.2 0.1 0.0 0.1 2.6 0.2 0.5 0.1 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.4 4.7 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.5 0.7 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.8 0.4 0.0 5.1 0.0 0.1 0.3 2.2 0.0 0.4 0.0 0.4 0.0 0.2 0.3 0.2 0.7 0.3 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.4 2.2 0.9 1.2 2.2 3.2 5.3 7.3 3.9 4.3 3.7 2.6 0.0 0.0 0.5 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 12.7 0.0 2.5 1.8 4.2 0.0 1.4 0.0 0.0 0.0 88.7 12.1 0.3 0.1 0.0 0.0 20.6 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 12.6 0.0 0.0 0.0 0.0 73.2 0.6 0.2 0.0 1.0 0.0 0.0 0.0 3.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 8.7 0.5 0.0 0.6 0.1 17.3 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 CFAP65 "CCDC108, DKFZp434O0527, MGC35338" ENSG00000181378 "Cilia and flagella associated protein 65" Q6ZU64 2 219002846-219041527 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.1;choroid plexus: 13.5;fallopian tube: 25.7;testis: 9.4" "Group enriched" "Detected in many" 4 "Early spermatids: 204.5;Late spermatids: 164.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 10.8" "HPA055156, HPA063406" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Spermatids - Unknown function" "Plasma membrane, Cytosol" "HPA055156: AB_2682720, HPA063406: " "unprognostic (3.95e-2)" "unprognostic (1.80e-1)" "unprognostic (9.88e-3)" "prognostic favorable (6.08e-5)" "unprognostic (2.18e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-1)" "unprognostic (3.76e-3)" "unprognostic (3.71e-1)" "unprognostic (3.03e-1)" "unprognostic (5.58e-3)" "unprognostic (1.43e-1)" "unprognostic (6.62e-3)" "unprognostic (8.04e-2)" "unprognostic (2.81e-2)" "unprognostic (9.60e-2)" "unprognostic (6.60e-2)" 0.0 0.1 2.3 0.0 2.1 0.0 0.1 1.0 1.0 1.3 13.5 0.1 0.0 0.5 1.8 0.0 25.7 0.4 0.0 2.6 2.8 0.4 0.0 2.7 0.0 8.4 12.1 0.0 0.3 0.1 3.5 0.0 6.2 0.1 0.2 9.2 0.1 0.1 0.0 0.0 0.4 0.0 6.1 0.0 0.3 9.4 2.4 0.0 0.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.1 1.0 1.0 2.6 2.8 8.4 12.1 6.2 6.1 2.4 3.2 0.1 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.8 7.7 8.8 0.0 4.3 6.8 0.0 12.5 0.0 0.1 1.1 0.0 0.6 204.5 45.1 0.5 0.2 29.1 0.0 0.0 1.5 0.0 0.2 2.0 1.8 0.0 0.2 0.0 0.1 0.1 0.0 0.0 25.2 0.0 0.0 0.0 164.3 0.6 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 1.8 0.7 0.0 1.1 1.9 1.1 29.2 19.5 0.0 0.1 0.0 14.4 5.7 0.0 0.0 0.0 0.2 0.1 5.1 0.1 CFAP70 "FLJ25765, TTC18" ENSG00000156042 "Cilia and flagella associated protein 70" Q5T0N1 10 73253759-73358859 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 24.4;testis: 20.9" "Cell type enhanced" "Detected in many" "Astrocytes: 68.6;Early spermatids: 61.9;Endometrial ciliated cells: 153.6;Respiratory ciliated cells: 179.3;Spermatocytes: 60.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037582, HPA070304" Enhanced NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA037582: AB_2675560, HPA070304: AB_2732153" "unprognostic (2.29e-3)" "unprognostic (4.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.43e-2)" "unprognostic (2.41e-1)" "unprognostic (9.94e-2)" "unprognostic (2.81e-1)" "unprognostic (4.60e-2)" "unprognostic (2.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-3)" "unprognostic (5.95e-3)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" 1.3 4.5 4.3 0.5 4.4 0.3 3.1 3.9 4.9 2.8 24.4 0.7 1.2 1.6 11.3 0.6 14.7 1.4 1.3 4.9 5.5 7.8 2.3 3.1 0.7 10.0 12.5 3.2 2.9 4.7 13.5 0.5 8.4 4.3 0.6 10.5 2.3 1.9 0.9 2.9 0.7 0.5 8.4 1.4 1.3 20.9 5.0 0.6 6.3 0.6 0.8 0.9 1.1 6.2 1.1 1.3 1.4 1.2 2.4 2.1 0.4 0.5 0.1 0.3 0.4 1.0 4.6 0.5 0.7 0.2 0.9 0.7 0.8 1.0 0.5 1.0 2.3 1.0 1.0 1.1 0.2 0.5 0.6 1.3 2.3 0.7 0.6 1.7 0.0 3.1 0.4 2.9 0.4 1.8 1.3 1.0 0.5 1.1 5.4 0.8 1.2 2.4 2.3 0.3 1.9 0.2 0.4 0.9 0.9 0.8 1.8 0.8 0.8 0.3 1.2 0.5 1.3 3.0 1.8 1.5 1.7 1.0 0.4 0.0 0.0 0.4 0.3 0.1 0.7 0.5 0.6 0.5 0.2 0.8 1.3 1.1 0.1 0.5 0.1 0.4 0.6 0.2 4.3 4.4 3.9 4.9 4.9 5.5 10.0 12.5 8.4 8.4 5.0 6.2 2.0 9.6 8.4 68.6 2.2 0.0 3.6 0.0 2.8 15.3 6.7 3.9 2.1 1.5 36.5 5.5 29.2 1.4 0.3 0.3 3.9 1.9 61.9 153.6 3.3 1.8 4.9 0.4 29.5 0.6 0.2 3.2 3.1 7.4 2.5 3.2 4.6 2.6 0.5 6.7 37.6 0.5 0.0 0.3 0.0 39.0 4.7 1.1 0.0 5.6 0.1 16.0 0.0 12.1 22.4 0.2 0.1 3.0 1.3 5.5 0.5 2.8 179.3 28.0 6.6 5.3 1.1 60.4 14.8 2.0 0.0 0.3 1.3 8.1 0.8 2.5 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.6;choroid plexus: 28.1;fallopian tube: 42.2" "Cell type enriched" "Detected in some" 4 "Endometrial ciliated cells: 110.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.3;REH: 2.2;T-47d: 2.5;U-698: 9.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: AB_2680434" "unprognostic (2.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.4 3.2 0.4 2.8 2.1 0.3 1.1 1.0 3.8 28.1 0.3 0.3 0.5 0.3 0.5 42.2 0.2 0.2 5.5 5.8 1.7 0.5 7.1 0.7 17.9 21.6 0.4 0.4 0.1 1.2 0.0 11.3 0.6 0.0 0.2 2.3 0.7 0.3 4.7 0.5 0.0 15.0 0.6 4.0 0.5 4.6 0.0 0.8 0.0 1.2 0.2 0.2 3.4 0.2 0.0 0.2 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.3 2.0 4.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.2 1.7 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.7 0.2 0.7 0.3 0.8 0.1 2.2 0.0 0.3 0.5 0.5 0.4 0.1 0.0 0.6 0.0 0.2 2.5 0.0 0.1 0.1 0.7 0.2 0.1 0.4 0.1 9.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.8 1.1 1.0 5.5 5.8 17.9 21.6 11.3 15.0 4.6 3.4 0.0 0.0 1.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 6.2 3.7 0.0 0.1 0.1 0.2 0.0 0.0 0.4 110.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.6 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 23.3 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 CFAP74 "C1orf222, FLJ45476, KIAA1751" ENSG00000142609 "Cilia and flagella associated protein 74" Q9C0B2 1 1921951-2003837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.1;testis: 5.2" "Cell type enhanced" "Detected in many" "Early spermatids: 11.5;Endometrial ciliated cells: 36.0;Excitatory neurons: 11.6;Late spermatids: 20.3;Respiratory ciliated cells: 18.2;Spermatocytes: 16.4;Spermatogonia: 10.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028521, HPA029274, HPA030240" Enhanced NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" "HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_2732455" "unprognostic (5.41e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (9.12e-3)" "unprognostic (3.95e-2)" "unprognostic (2.21e-1)" "unprognostic (2.21e-2)" "unprognostic (1.81e-1)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.47e-1)" "unprognostic (1.26e-6)" "unprognostic (1.28e-1)" "unprognostic (2.11e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" 0.2 1.3 0.1 0.4 0.3 0.9 0.2 2.8 1.3 0.4 2.9 0.2 0.3 0.5 0.2 0.9 7.1 0.7 0.2 0.9 0.3 0.1 0.6 1.4 0.7 1.4 2.5 0.2 0.0 0.1 0.5 0.3 1.1 0.2 0.2 0.8 0.4 0.4 0.8 3.2 0.1 0.1 0.2 0.3 0.2 5.2 0.8 0.1 1.1 0.0 0.1 0.3 0.0 2.1 0.7 0.0 0.9 0.7 0.0 0.9 1.0 0.1 0.0 0.0 0.4 1.7 0.1 1.0 1.4 0.3 0.7 0.2 0.0 0.3 0.2 0.9 1.4 2.1 2.6 1.1 0.3 1.6 0.6 0.7 1.0 0.0 0.0 0.4 0.0 0.7 3.0 0.5 0.5 0.3 0.8 0.3 0.9 0.1 1.2 0.8 0.3 0.5 0.0 1.4 1.5 0.5 0.3 0.1 0.0 0.3 0.3 0.4 1.7 0.9 0.9 0.4 1.1 1.0 0.4 1.1 0.1 1.6 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.3 2.8 1.3 0.9 0.3 1.4 2.5 1.1 0.2 0.8 2.1 0.2 0.0 1.8 0.7 0.1 0.0 1.0 0.0 0.0 1.5 0.2 0.4 1.9 0.0 4.3 0.0 8.4 1.1 0.2 0.0 0.0 0.0 11.5 36.0 0.4 0.6 0.0 0.0 11.6 0.0 3.3 0.9 0.0 0.7 0.0 0.3 3.6 1.0 0.1 0.0 5.9 0.0 0.0 1.0 0.0 20.3 1.2 0.6 0.0 9.4 0.0 0.3 1.0 1.0 1.0 0.0 0.0 0.0 0.0 1.1 1.6 0.2 18.2 2.4 0.0 1.5 1.1 16.4 10.1 0.0 0.0 0.8 0.7 0.8 0.1 0.5 CFAP77 "C9orf171, FLJ46082" ENSG00000188523 "Cilia and flagella associated protein 77" Q6ZQR2 9 132410043-132573319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 11.5;fallopian tube: 29.7;testis: 19.3" "Cell type enhanced" "Detected in some" "Early spermatids: 127.1;Endometrial ciliated cells: 58.4;Late spermatids: 47.6;Respiratory ciliated cells: 36.5;Spermatocytes: 25.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021329, HPA024647, HPA061069" Enhanced Approved Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657" "unprognostic (7.28e-4)" "unprognostic (5.68e-2)" "unprognostic (5.25e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.70e-2)" "unprognostic (1.74e-1)" "unprognostic (3.01e-1)" "unprognostic (2.31e-2)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (1.77e-1)" "unprognostic (2.41e-3)" "unprognostic (2.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" 0.0 0.0 1.2 0.0 1.0 0.0 0.0 2.0 0.1 1.2 11.5 0.0 0.0 0.5 0.2 0.0 29.7 0.0 2.4 1.0 1.5 0.1 0.0 2.1 0.0 4.1 6.0 0.0 0.1 0.0 0.6 0.0 3.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 19.3 1.4 0.2 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 2.0 0.1 1.0 1.5 4.1 6.0 3.1 3.3 1.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 58.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.3 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 36.5 3.8 0.0 0.0 0.0 25.5 3.5 0.0 0.0 0.1 0.1 0.1 0.0 0.1 CFAP91 "AAT-1, AAT1, AAT1alpha, C3orf15, CaM-IP2, MAATS1, SPATA26" ENSG00000183833 "Cilia and flagella associated protein 91" Q7Z4T9 3 119703022-119767102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.1" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;hTERT-RPE1: 1.4;RPTEC TERT1: 2.4;SCLC-21H: 3.5;SH-SY5Y: 2.5;T-47d: 1.8;U-87 MG: 1.9" HPA074084 Supported NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" "HPA074084: " "unprognostic (6.70e-2)" "unprognostic (3.54e-2)" "unprognostic (3.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.40e-2)" "unprognostic (1.89e-2)" "unprognostic (1.36e-1)" "unprognostic (4.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (4.07e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (4.46e-2)" 0.6 2.1 0.8 0.0 1.0 0.0 1.8 0.5 1.0 3.4 5.7 1.4 0.0 4.0 5.0 0.3 14.1 1.2 0.4 1.0 1.7 2.5 0.4 2.1 0.1 2.4 2.1 3.4 4.9 4.0 7.2 0.2 1.8 2.3 0.5 4.1 1.5 4.5 0.1 0.3 0.6 0.8 1.6 2.4 1.7 8.7 1.4 0.4 4.6 0.0 0.3 1.1 1.1 1.0 0.1 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.2 1.2 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 2.4 0.0 3.5 2.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.5 1.0 1.0 1.7 2.4 2.1 1.8 1.6 1.4 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CFAP94 "CASC1, FLJ10921, LAS1, PPP1R54" ENSG00000118307 "Cilia and flagella associated protein 94" Q6TDU7 12 25108289-25195162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 12.4;fallopian tube: 14.0;testis: 22.9" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.9;Fibroblasts: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "T-47d: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039662, HPA040141" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 24: Non-specific - Transcription regulation" Cytosol Vesicles "HPA039662: AB_10795468, HPA040141: " "unprognostic (6.42e-3)" "unprognostic (1.26e-2)" "unprognostic (1.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.62e-1)" "unprognostic (1.85e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (2.22e-1)" "unprognostic (3.91e-2)" "unprognostic (6.21e-4)" "unprognostic (2.54e-2)" "prognostic favorable (3.13e-4)" "unprognostic (2.01e-1)" "unprognostic (8.74e-3)" "unprognostic (7.16e-2)" "unprognostic (1.19e-1)" 0.2 0.7 1.6 0.2 2.3 0.6 1.5 0.9 2.0 2.0 12.4 0.3 0.0 1.6 6.0 0.5 14.0 0.7 0.4 2.1 2.3 2.7 0.0 1.9 0.4 5.7 6.0 1.2 0.7 3.3 4.0 0.1 4.2 1.0 0.0 5.1 0.7 1.1 0.1 1.0 0.1 0.3 4.0 0.2 0.6 22.9 3.0 0.4 4.1 0.0 0.1 0.2 0.2 2.5 0.1 0.3 0.4 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.3 0.0 1.0 1.1 0.3 0.0 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.4 0.0 1.1 0.6 0.4 0.0 0.0 0.2 0.5 0.2 0.1 0.0 0.4 0.1 0.0 1.0 0.1 0.6 0.2 0.1 0.0 0.1 0.5 1.3 0.0 0.0 0.1 0.8 0.5 0.1 0.4 0.2 0.9 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.6 0.0 0.2 0.0 0.9 0.1 0.2 1.3 0.3 0.2 0.3 0.0 0.1 1.6 2.3 0.9 2.0 2.1 2.3 5.7 6.0 4.2 4.0 3.0 2.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CFAP97D2 ENSG00000283361 "CFAP97 domain containing 2" A0A1B0GU71 13 114154691-114223084 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.0;fallopian tube: 19.8;pancreas: 7.1" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 19.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "naive CD8 T-cell: 4.0" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" 0.0 0.0 2.1 0.0 2.3 0.9 0.0 1.8 1.4 0.4 4.1 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 2.0 2.0 0.0 0.0 0.6 0.3 5.0 3.9 0.0 7.1 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 0.0 2.0 1.9 0.4 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 2.3 1.8 1.4 2.0 2.0 5.0 3.9 3.5 4.5 1.9 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 17.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CFAP99 ENSG00000206113 "Cilia and flagella associated protein 99" 4 2418974-2462942 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.8;choroid plexus: 5.8;fallopian tube: 3.9;retina: 1.5;testis: 5.3" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Early spermatids: 11.6;Endometrial ciliated cells: 13.6;Late spermatids: 11.2;Rod photoreceptor cells: 5.5;Spermatocytes: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA071642 Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA071642: " "unprognostic (7.54e-3)" "unprognostic (6.46e-3)" "unprognostic (1.12e-1)" "unprognostic (2.31e-3)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.89e-1)" "unprognostic (8.14e-2)" "unprognostic (7.93e-5)" "unprognostic (1.15e-1)" "unprognostic (5.97e-3)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (6.94e-2)" "unprognostic (3.49e-1)" 0.0 0.8 0.5 0.0 0.5 0.0 0.0 0.8 0.3 0.2 5.8 0.0 0.0 0.2 0.1 0.0 3.9 0.0 0.0 0.9 0.8 0.2 0.1 0.6 0.0 3.2 4.8 0.0 0.3 0.0 0.8 0.0 1.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 5.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.8 0.3 0.9 0.8 3.2 4.8 1.8 2.0 1.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 0.0 1.8 3.7 4.2 0.0 0.0 0.0 0.0 0.2 11.6 13.6 0.2 0.1 0.0 0.0 1.2 0.6 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 11.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 1.5 2.9 5.5 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 CFP PFC ENSG00000126759 "Complement factor properdin" P27918 X 47623172-47630305 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 83.9;lymphoid tissue: 58.4" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 108.1;Kupffer cells: 356.7;Langerhans cells: 164.1;Macrophages: 177.3;monocytes: 473.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in all" 8 "classical monocyte: 1167.5;intermediate monocyte: 1273.6;myeloid DC: 994.5;neutrophil: 730.3;non-classical monocyte: 868.9" "Group enriched" "Detected in all" 46 "dendritic cells: 994.5;granulocytes: 730.3;monocytes: 1273.6" "Cell line enhanced" "Detected in some" "EFO-21: 20.7;HEL: 5.0;HMC-1: 5.5;NB-4: 10.7;U-937: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072644 Approved Vesicles "Secreted to blood" NA NA 6200000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 38: EFO-21 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "HPA072644: " "unprognostic (2.77e-3)" "unprognostic (2.21e-3)" "unprognostic (1.00e-1)" "unprognostic (2.15e-2)" "unprognostic (4.15e-2)" "unprognostic (9.66e-5)" "unprognostic (9.90e-3)" "unprognostic (1.30e-2)" "unprognostic (5.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (2.70e-1)" "unprognostic (1.97e-2)" "unprognostic (2.58e-1)" "unprognostic (1.32e-1)" "unprognostic (4.62e-2)" "unprognostic (2.17e-1)" 6.0 1.9 0.3 20.5 0.3 83.9 2.1 0.3 0.6 0.6 0.2 2.1 1.2 0.9 0.2 1.6 3.4 2.1 2.6 0.4 0.1 0.8 12.0 9.3 11.7 0.1 0.0 0.7 0.8 0.1 0.8 0.9 0.0 0.7 0.9 0.2 1.0 0.2 1.0 1.5 3.7 5.2 0.0 58.4 1.5 0.6 0.0 5.1 0.9 0.7 4.4 4.9 0.7 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 20.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 5.0 0.2 0.0 0.1 1.1 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.0 10.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.2 1.0 0.0 0.1 0.5 0.1 0.4 0.4 0.1 0.1 7.2 0.0 131.5 1167.5 39.9 3.0 1273.6 2.3 6.7 15.1 1.8 994.5 2.6 21.8 8.1 730.3 12.3 868.9 30.9 14.1 1071.9 0.3 0.3 0.3 0.6 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 9.1 1.0 5.8 4.0 0.1 0.3 1.2 3.4 0.7 0.4 0.9 1.5 2.8 0.0 0.0 0.3 1.7 0.3 0.0 0.2 0.2 0.4 0.4 7.4 0.0 2.5 1.4 0.7 0.5 2.0 1.1 0.6 1.3 4.0 108.1 2.0 17.3 1.7 1.1 0.0 0.0 356.7 164.1 0.3 0.9 177.3 5.4 0.0 473.7 0.3 4.1 2.0 0.3 0.3 0.1 1.2 1.2 0.3 0.1 0.5 7.5 1.9 0.0 1.5 1.2 0.0 0.2 0.5 3.0 0.4 4.8 3.1 0.6 0.0 CFTR "ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR" ENSG00000001626 "CF transmembrane conductance regulator" P13569 7 117287120-117715971 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Isomerase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 54.6;intestine: 42.7;pancreas: 210.7" "Group enriched" "Detected in many" 4 "Ductal cells: 485.4;Ionocytes: 252.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.9;pancreatic cancer: 28.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "CACO-2: 29.5;MOLT-4: 98.9;U-266/70: 49.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB001951, HPA021939, HPA079652" Enhanced NA NA "Cluster 25: Pancreas - Digestion" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" "CAB001951: , HPA021939: AB_1846578, HPA079652: " "unprognostic (6.38e-3)" "unprognostic (9.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.44e-2)" "unprognostic (8.74e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (3.20e-3)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (1.55e-2)" "unprognostic (2.14e-2)" "unprognostic (4.78e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (9.08e-2)" "unprognostic (6.64e-2)" 0.4 0.0 0.5 4.7 2.0 0.0 0.4 0.7 1.3 8.5 0.0 42.7 36.2 1.1 1.1 0.8 2.2 54.6 0.1 0.3 0.7 2.1 1.6 8.2 0.0 1.1 0.7 0.0 210.7 0.2 0.1 0.6 0.7 2.2 40.7 0.0 21.5 0.5 0.0 1.9 19.9 2.0 1.7 0.0 3.1 1.7 1.0 0.1 0.1 0.0 0.3 0.7 0.0 2.9 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 98.9 0.1 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 49.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.7 1.3 0.3 0.7 1.1 0.7 0.7 1.7 1.0 2.9 0.0 6.4 65.6 0.0 0.5 0.0 2.0 2.6 0.0 0.5 0.5 0.0 2.4 55.8 17.8 0.0 0.0 0.0 0.0 45.8 0.0 485.4 3.2 9.6 1.2 0.4 7.2 0.0 2.2 4.5 0.0 0.3 4.1 19.8 1.3 0.1 0.0 0.4 0.0 0.0 1.1 13.9 252.3 0.0 0.0 2.6 0.3 0.1 0.0 1.0 6.7 0.5 0.0 0.5 23.8 14.8 86.4 0.0 0.0 4.0 8.6 0.0 5.6 0.0 0.0 0.0 1.6 2.2 0.5 0.0 0.0 0.0 0.3 0.1 87.3 5.8 CGREF1 CGR11 ENSG00000138028 "Cell growth regulator with EF-hand domain 1" Q99674 2 27098889-27119128 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3;salivary gland: 25.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 12.6;Excitatory neurons: 16.6;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 12.5;Spermatogonia: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 40.1;SK-BR-3: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008241, HPA071103" Uncertain Approved "Golgi apparatus" "Secreted in brain" NA NA 700000 "Cluster 65: Brain - Ion transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA008241: AB_1846605, HPA071103: " "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (8.45e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" "unprognostic (1.92e-1)" "unprognostic (2.57e-1)" "unprognostic (2.27e-1)" "unprognostic (2.52e-3)" "unprognostic (1.05e-1)" "unprognostic (2.30e-2)" "unprognostic (7.24e-4)" "unprognostic (1.20e-2)" 4.2 2.3 20.4 1.0 21.7 1.9 6.3 17.1 28.3 3.5 2.1 2.6 3.9 11.6 1.4 3.5 12.4 3.9 4.9 27.0 18.1 3.8 14.9 1.1 0.5 12.8 12.1 13.9 2.1 0.2 3.3 0.3 12.8 4.2 3.8 3.7 25.3 0.9 6.5 2.3 5.6 5.4 10.2 0.6 11.4 3.8 17.2 0.2 1.8 6.9 0.4 3.7 1.5 16.4 7.6 6.3 0.3 8.1 18.3 6.8 0.7 9.1 0.0 0.8 0.4 1.7 6.2 0.1 2.4 18.2 2.2 0.4 1.4 2.1 0.5 0.7 3.7 0.1 10.4 16.4 16.9 5.3 0.6 4.7 18.1 2.6 2.1 11.6 0.7 1.3 0.2 0.4 1.2 24.0 4.0 6.8 2.1 40.1 16.8 0.3 0.0 0.6 0.1 0.3 17.8 26.6 17.7 78.7 9.4 0.2 25.3 13.3 0.0 0.0 6.9 0.0 0.7 2.3 0.8 0.7 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 21.7 17.1 28.3 27.0 18.1 12.8 12.1 12.8 10.2 17.2 16.4 0.1 0.0 0.0 2.6 0.4 0.6 0.2 0.0 1.8 9.2 9.2 12.6 1.4 0.0 0.0 0.0 4.2 0.0 0.1 0.2 0.0 0.1 1.1 0.3 3.0 0.4 0.0 5.5 16.6 1.5 0.2 3.8 4.6 0.1 0.0 0.4 3.6 5.0 0.4 0.0 15.9 6.8 0.0 0.6 0.7 3.1 4.4 0.2 0.0 1.9 0.0 0.5 0.0 12.5 0.8 2.1 0.0 8.6 1.1 1.8 3.4 4.4 0.0 2.2 0.0 1.7 0.7 3.2 16.2 2.2 0.4 0.1 0.1 3.2 0.9 0.1 CHRNA9 NACHRA9 ENSG00000174343 "Cholinergic receptor nicotinic alpha 9 subunit" Q9UGM1 4 40335333-40355217 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "breast cancer: 2.5;glioma: 3.5;lung cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "U-87 MG: 15.9" "Region enriched" "Detected in single" 6 "basal ganglia: 1.0" "Not detected" "Not detected" NA NA "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 33: Fibroblasts - ECM organization" "unprognostic (6.20e-3)" "unprognostic (9.18e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "unprognostic (3.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "unprognostic (7.30e-2)" "unprognostic (1.94e-1)" "unprognostic (8.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.76e-1)" "unprognostic (5.01e-2)" "unprognostic (9.18e-3)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.1 0.1 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST5 "FLJ22167, I-GLCNAC-6-ST" ENSG00000135702 "Carbohydrate sulfotransferase 5" Q9GZS9 16 75528535-75535247 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 85.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 5.2;Intestinal goblet cells: 3.7;Paneth cells: 8.1;Proximal enterocytes: 11.6;Undifferentiated cells: 2.6" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.4;stomach cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 1.5" "HPA043804, HPA068029" Enhanced "Intracellular and membrane" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 9: Intestine - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 45: Enterocytes - Digestion" "HPA043804: AB_10960563, HPA068029: " "unprognostic (6.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.99e-3)" "unprognostic (1.03e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-2)" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (2.09e-2)" "unprognostic (9.03e-3)" "unprognostic (4.27e-2)" "unprognostic (2.05e-3)" "unprognostic (3.56e-1)" "unprognostic (2.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.42e-2)" 0.1 0.2 2.2 1.3 2.0 0.6 0.4 1.9 2.2 0.4 2.2 46.1 85.0 0.4 0.3 0.2 1.1 0.2 0.3 2.2 1.0 0.4 0.1 0.3 0.3 1.9 1.5 0.5 0.1 0.4 0.7 0.2 0.7 0.3 55.3 1.5 0.1 0.3 7.7 0.2 75.6 1.0 1.2 0.4 4.7 0.7 1.8 0.3 0.3 0.8 0.1 0.2 0.1 1.6 0.1 0.3 0.4 0.5 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.2 0.6 0.4 0.2 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.5 0.0 0.2 0.6 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.4 0.0 0.9 0.2 1.3 0.3 0.0 1.5 0.2 0.1 0.9 0.5 0.1 0.7 1.2 0.6 0.4 0.0 0.0 0.3 0.1 0.0 0.5 0.3 0.9 0.1 0.2 0.7 0.0 0.3 0.1 0.3 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.4 0.1 0.2 0.2 0.1 0.0 2.2 2.0 1.9 2.2 2.2 1.0 1.9 1.5 0.7 1.2 1.8 1.6 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.3 0.0 0.0 2.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 2.0 0.6 0.0 8.1 0.0 0.0 0.0 11.6 0.0 1.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 CHST6 MCDC1 ENSG00000183196 "Carbohydrate sulfotransferase 6" Q9GZX3 16 75472052-75495445 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.5;cervix: 9.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 60.0;Oligodendrocytes: 17.0;Respiratory ciliated cells: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 9.3;CAPAN-2: 9.9;NTERA-2: 4.8;SK-MEL-30: 4.1;U-2 OS: 5.0;WM-115: 5.4" HPA068029 Approved "Intracellular and membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA068029: " "unprognostic (2.28e-2)" "unprognostic (2.25e-2)" "unprognostic (1.07e-1)" "unprognostic (3.93e-3)" "unprognostic (3.30e-2)" "unprognostic (4.02e-2)" "unprognostic (7.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (3.16e-2)" "unprognostic (1.07e-1)" "unprognostic (1.10e-7)" "unprognostic (1.23e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (2.80e-4)" 0.1 5.4 8.6 0.2 11.8 0.1 0.0 8.5 7.9 9.4 3.4 0.8 4.5 0.4 0.2 1.3 1.2 0.1 1.9 7.2 10.7 0.3 0.0 0.9 0.1 12.5 13.2 0.0 0.0 0.2 1.2 0.1 11.5 0.4 1.5 0.3 2.7 0.1 0.1 0.1 3.9 0.3 10.9 0.1 0.1 0.8 13.5 0.1 0.1 0.1 0.0 0.2 0.1 11.7 0.1 0.5 0.6 9.3 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.2 9.9 0.1 1.1 0.0 0.1 0.1 0.9 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 4.8 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 4.1 1.4 0.0 0.3 0.1 0.0 5.0 0.0 0.0 0.1 0.1 2.1 0.2 0.0 5.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 8.6 11.8 8.5 7.9 7.2 10.7 12.5 13.2 11.5 10.9 13.5 11.7 0.2 0.0 2.4 7.5 0.2 0.0 1.7 0.7 0.0 0.7 0.2 0.1 1.0 0.0 4.8 3.7 0.0 2.1 0.1 3.8 0.0 0.1 1.3 60.0 0.8 0.4 0.0 0.0 0.4 0.0 0.2 1.6 0.0 7.5 1.3 0.2 0.0 0.0 0.2 0.0 1.3 4.0 0.0 0.0 0.0 1.3 0.0 0.4 0.0 1.9 0.0 0.6 0.0 6.0 17.0 0.2 8.9 0.0 0.0 1.5 8.9 0.0 16.4 0.4 0.0 1.0 0.7 0.3 0.6 0.0 0.0 0.7 0.4 0.1 2.2 3.9 CHST9 "GALNAC-4-ST2, GALNAC4ST-2" ENSG00000154080 "Carbohydrate sulfotransferase 9" Q7L1S5 18 26906481-27185308 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 13.8" "Cell type enhanced" "Detected in many" "Club cells: 115.2;Muller glia cells: 69.2;Oligodendrocyte precursor cells: 167.4;Respiratory ciliated cells: 311.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;Hep G2: 13.8;RPTEC TERT1: 41.8;SCLC-21H: 9.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA011393 Uncertain "Intracellular and membrane" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA011393: AB_1846733" "unprognostic (9.24e-3)" "unprognostic (1.13e-2)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (4.53e-3)" "unprognostic (9.98e-3)" "unprognostic (9.21e-3)" "unprognostic (7.92e-2)" "unprognostic (1.61e-1)" "unprognostic (2.04e-2)" "unprognostic (3.54e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (3.93e-3)" 0.0 0.2 0.8 0.1 0.9 0.0 2.9 0.7 2.4 2.8 0.0 1.6 0.2 0.1 0.4 1.6 10.3 3.1 2.6 2.7 1.2 1.6 8.2 4.3 0.0 3.5 2.3 0.0 9.3 0.0 1.9 0.0 1.2 3.5 0.2 7.3 13.8 1.8 0.2 0.1 0.3 0.1 2.0 5.7 0.7 6.9 1.2 1.0 0.0 0.9 0.6 1.5 0.7 1.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 41.8 0.0 9.0 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.7 2.4 2.7 1.2 3.5 2.3 1.2 2.0 1.2 1.9 0.1 0.0 2.7 24.8 0.0 0.6 32.6 56.6 4.6 1.3 8.2 8.0 9.2 35.8 115.2 5.5 0.0 0.4 0.1 0.0 11.7 13.0 7.1 49.9 0.7 0.3 3.5 0.0 10.1 0.6 0.1 4.2 0.0 1.8 5.1 0.1 0.0 10.7 0.3 0.0 29.3 0.1 22.4 0.0 0.0 4.4 0.6 0.5 7.2 1.0 0.0 69.2 0.0 167.4 1.0 1.3 0.0 0.4 0.0 8.9 0.0 0.3 311.6 3.2 0.0 3.2 3.7 0.9 1.3 4.7 0.0 0.3 0.4 0.0 0.0 40.3 CIBAR2 "FAM92B, FLJ44299" ENSG00000153789 "CBY1 interacting BAR domain containing 2" Q6ZTR7 16 85098358-85112472 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "fallopian tube: 85.5" "Cell type enriched" "Detected in single" 8 "Plasma cells: 2.4" "Group enriched" "Detected in some" 5 "endometrial cancer: 5.4;lung cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA041022 Enhanced NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 24: Non-specific - Transcription regulation" "HPA041022: AB_10795500" "unprognostic (1.77e-4)" "unprognostic (7.44e-3)" "unprognostic (1.61e-1)" "unprognostic (2.11e-3)" "unprognostic (5.09e-3)" "unprognostic (1.14e-3)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (9.81e-2)" "unprognostic (3.70e-1)" "unprognostic (3.84e-2)" "unprognostic (2.05e-1)" "unprognostic (5.10e-13)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "unprognostic (2.47e-1)" "unprognostic (1.29e-1)" 0.1 1.3 2.0 1.3 1.8 0.4 0.3 1.0 0.8 3.5 11.2 0.7 1.3 1.3 0.2 0.1 85.5 0.1 0.0 1.9 4.9 0.2 0.0 10.2 0.6 8.2 11.2 0.1 0.1 0.0 16.2 0.0 5.5 0.1 0.4 0.3 0.5 0.1 0.0 0.4 0.7 0.0 5.3 2.6 0.4 0.4 4.7 0.2 0.0 0.0 1.9 1.1 0.0 2.5 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.0 1.8 1.0 0.8 1.9 4.9 8.2 11.2 5.5 5.3 4.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CILP HsT18872 ENSG00000138615 "Cartilage intermediate layer protein" O75339 15 65194760-65211473 "Disease related genes, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 42.9;Fibroblasts: 138.1;Leydig cells: 231.5;Peritubular cells: 57.6;Theca cells: 83.5" "Cancer enhanced" "Detected in many" "breast cancer: 30.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;ASC TERT1: 2.5;EFO-21: 1.1;HSkMC: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA003195 Uncertain "Secreted to extracellular matrix" NA NA 13000000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA003195: AB_1078524" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (4.22e-2)" "unprognostic (7.18e-2)" "unprognostic (2.94e-1)" "unprognostic (2.28e-1)" "unprognostic (2.60e-1)" "unprognostic (1.14e-1)" "unprognostic (1.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.84e-1)" "unprognostic (1.27e-1)" "unprognostic (2.31e-13)" "unprognostic (5.10e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (4.68e-3)" 49.8 0.8 0.2 9.5 0.2 0.1 21.9 0.3 0.3 44.9 0.1 20.3 2.3 13.8 3.6 11.0 15.8 36.8 27.4 0.2 0.2 1.0 1.6 2.9 1.6 0.2 0.2 7.5 3.0 0.3 0.7 2.5 0.2 3.1 6.9 0.5 9.4 4.8 15.5 14.0 22.6 51.0 0.2 0.6 8.3 12.1 0.2 1.8 2.4 32.9 0.8 26.9 28.1 0.2 0.0 0.0 0.0 0.0 4.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 8.1 0.0 0.0 0.0 0.0 5.2 0.1 0.2 0.0 0.9 0.4 0.5 2.1 0.0 0.4 1.8 0.0 0.0 0.2 0.1 0.0 0.1 1.7 1.2 42.9 1.5 0.0 0.0 0.3 0.0 0.0 138.1 4.1 1.7 0.0 0.1 2.2 0.1 0.1 0.0 0.6 0.1 2.0 0.0 11.9 7.1 231.5 1.7 1.8 1.9 0.0 0.2 0.0 1.0 0.3 0.0 0.0 57.6 0.3 0.1 0.0 0.0 0.0 0.1 0.0 14.7 6.6 0.6 0.3 0.1 6.1 0.0 1.6 83.5 0.2 0.0 CIP2A KIAA1524 ENSG00000163507 "Cellular inhibitor of PP2A" Q8TCG1 3 108549864-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.5;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Cytotrophoblasts: 8.0;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 12.9;Granulosa cells: 25.3;Hofbauer cells: 8.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavorable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 1.1 1.1 0.3 3.4 0.6 7.5 1.4 0.9 0.8 0.9 0.1 1.9 1.2 1.8 0.6 1.7 0.9 1.2 0.7 0.6 0.5 1.0 0.7 1.4 6.7 0.2 0.9 1.9 0.4 0.6 0.7 2.1 0.2 1.8 2.7 2.6 0.6 0.8 0.6 1.2 1.7 1.5 0.0 2.3 1.2 5.7 0.1 6.9 1.2 0.7 5.2 2.0 0.9 0.4 42.2 12.2 33.9 21.8 1.4 3.2 13.8 31.1 14.7 36.2 41.9 15.0 18.5 27.6 10.4 11.4 27.7 20.9 11.7 11.0 65.8 8.8 11.3 33.9 17.4 11.3 0.5 21.8 23.2 1.4 2.3 28.4 11.5 5.9 16.3 12.7 21.1 44.5 36.1 8.7 26.7 19.2 35.0 15.8 20.8 30.1 31.2 15.3 11.0 11.5 16.4 21.6 22.9 9.0 12.7 19.7 15.3 15.6 12.2 37.0 41.7 11.3 38.3 10.2 12.1 46.1 16.4 23.2 38.6 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.6 0.9 0.8 0.6 0.5 0.2 0.9 0.2 0.0 0.1 0.4 1.2 9.6 1.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 2.5 3.7 0.0 8.0 1.8 0.0 1.9 2.8 0.0 2.5 2.8 2.6 0.0 0.0 0.0 7.3 12.9 3.0 0.0 2.7 3.8 25.3 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.4 0.0 0.0 2.4 1.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.4 1.7 5.4 0.0 0.0 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736349-112764664 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Microtubules,Mitotic spindle,Cytosol" Yes Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Microtubules, Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 0.4 0.1 0.2 2.6 0.2 13.1 0.4 0.4 0.3 0.4 0.0 1.6 1.5 0.3 0.1 2.3 0.1 0.3 0.0 0.2 0.1 0.1 0.3 0.3 5.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 2.2 0.2 0.3 0.0 0.0 1.5 1.1 1.1 0.0 0.9 1.0 4.5 0.2 12.1 0.2 0.0 5.2 0.8 0.6 0.2 47.9 9.6 35.4 16.2 2.0 3.3 7.2 38.5 32.2 37.9 36.1 8.7 13.3 32.0 15.5 15.1 48.3 18.0 20.4 19.6 64.1 44.8 8.9 53.6 12.7 7.7 0.1 25.2 30.9 0.9 1.9 47.4 27.2 10.1 17.5 22.8 14.3 44.9 31.2 6.9 31.0 10.6 15.4 20.0 29.5 22.3 37.0 8.4 6.9 18.7 19.7 12.7 15.2 12.8 13.3 13.2 12.4 11.8 12.9 42.7 33.7 34.5 28.5 9.9 20.1 26.6 18.5 18.1 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.4 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 3.2 0.6 0.0 1.2 3.3 2.1 2.7 0.6 0.0 0.5 0.8 0.5 1.5 0.4 0.0 0.0 11.1 1.3 1.3 0.0 0.4 2.4 1.1 1.6 1.1 0.0 25.2 0.3 0.4 10.6 2.0 1.5 2.1 0.0 12.5 2.9 0.1 6.6 0.0 0.2 3.1 2.0 1.9 1.4 2.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 5.6 1.1 0.1 0.1 0.4 0.0 0.0 0.4 2.8 33.0 35.7 9.5 1.7 1.0 2.5 0.7 3.8 1.1 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Endometrial ciliated cells: 29.9;Respiratory ciliated cells: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: AB_2677822, HPA061117: AB_2684434" "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 3.6 7.8 5.7 1.3 6.0 1.6 5.8 3.7 6.4 8.0 11.1 5.6 1.7 7.6 11.5 7.8 14.9 3.4 3.0 6.2 7.5 15.9 6.9 5.8 1.5 5.5 6.5 7.1 14.4 9.3 21.7 1.8 4.4 9.6 2.6 3.1 8.1 6.1 1.8 7.6 3.1 3.3 5.0 3.2 5.9 23.9 7.0 1.3 18.2 1.2 1.2 6.0 5.4 4.2 5.1 8.9 2.7 8.3 2.6 3.8 4.1 4.0 3.7 4.7 2.1 0.8 8.7 0.5 8.3 4.0 2.5 10.9 1.0 6.0 3.0 4.2 3.2 0.3 8.9 0.4 9.2 2.3 2.2 2.3 13.6 5.1 10.1 8.0 2.7 4.2 3.1 1.4 2.8 17.5 0.9 6.6 3.4 5.0 8.5 3.2 1.5 2.9 10.4 2.9 17.1 8.9 5.7 2.5 5.0 1.7 18.0 3.1 3.0 5.9 2.7 12.0 3.1 1.6 1.1 0.5 7.6 0.7 4.2 0.4 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.1 0.1 5.7 6.0 3.7 6.4 6.2 7.5 5.5 6.5 4.4 5.0 7.0 4.2 1.0 16.0 3.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 7.4 7.4 0.0 0.0 2.5 16.5 0.0 1.8 0.4 0.0 3.9 7.9 0.0 29.9 8.1 0.9 0.0 0.0 0.0 1.3 0.8 1.3 0.0 8.8 2.5 3.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 6.5 19.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.4 6.5 0.0 0.0 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412138 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 63.6" "Cell type enriched" "Detected in some" 8 "Distal tubular cells: 187.9" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 153 "EFO-21: 691.6;RPTEC TERT1: 233.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA056020: AB_2683011" "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.1 0.7 0.3 0.2 0.4 0.0 0.2 0.0 0.5 0.1 1.5 0.0 0.0 0.3 0.6 0.5 2.9 0.7 0.0 0.2 0.2 63.6 2.2 0.4 1.5 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.4 0.9 0.0 3.2 0.0 0.4 0.1 0.1 0.1 0.1 0.3 0.3 9.7 0.0 1.0 0.3 0.2 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 691.6 0.0 0.3 0.7 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 233.2 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 2.2 0.0 0.3 1.4 1.2 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.5 0.2 0.2 0.2 0.1 0.2 0.1 0.3 0.6 0.1 0.0 0.0 0.3 0.0 7.0 5.8 2.6 0.6 0.3 0.8 0.3 0.4 4.3 1.6 9.2 0.0 0.4 0.0 0.0 187.9 3.4 2.0 3.0 0.1 0.2 0.0 0.0 5.0 0.4 0.2 0.9 0.0 0.5 1.3 0.3 0.0 1.6 0.1 3.3 3.6 0.0 0.0 0.3 1.2 0.2 0.0 0.4 5.4 2.8 0.0 0.2 0.0 4.0 0.1 0.5 0.0 0.4 0.0 6.7 0.0 0.9 22.1 0.2 0.0 0.8 0.6 0.3 0.3 0.9 12.6 6.2 0.2 0.2 0.0 3.1 CLDN18 SFTPJ ENSG00000066405 "Claudin 18" P56856 3 137998735-138033655 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 50 "lung: 252.2;stomach 1: 724.9" "Group enriched" "Detected in some" 53 "Alveolar cells type 1: 1602.5;Alveolar cells type 2: 431.2;Gastric mucus-secreting cells: 1153.4;Pancreatic endocrine cells: 442.5" "Group enriched" "Detected in some" 11 "pancreatic cancer: 113.6;stomach cancer: 186.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "OE19: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013010, CAB013243, HPA018446" Enhanced Approved "Cell Junctions" NA NA "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Cell Junctions" "CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (2.93e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (5.14e-4)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" "unprognostic (2.60e-1)" "unprognostic (9.54e-2)" "unprognostic (1.38e-2)" "unprognostic (4.42e-5)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (8.26e-2)" "unprognostic (2.95e-1)" 0.3 0.3 0.3 0.4 0.4 0.1 0.2 1.0 0.5 0.4 2.2 0.7 1.5 0.2 0.5 0.6 0.5 3.3 9.7 0.3 0.2 0.2 0.1 252.2 0.0 0.9 0.9 0.5 0.8 0.0 0.5 0.3 0.5 0.2 0.2 0.7 0.3 0.4 0.1 1.1 0.8 0.1 0.7 0.5 724.9 1.3 0.5 0.1 0.1 0.0 0.7 0.2 0.3 0.2 0.1 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.5 15.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.5 0.3 0.2 0.9 0.9 0.5 0.7 0.5 0.2 0.0 1602.5 431.2 1.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 17.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.3 0.2 0.6 0.0 0.0 0.5 11.4 0.0 1.4 1153.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.7 0.0 2.0 0.0 1.9 0.0 0.1 0.0 0.0 0.2 442.5 0.0 0.0 1.3 0.0 0.0 0.1 0.7 1.3 0.0 0.9 0.1 15.3 11.9 0.0 0.0 0.0 1.3 0.0 0.0 0.1 CLDN4 "CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8" ENSG00000189143 "Claudin 4" O14493 7 73799542-73832690 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 305.0;urinary bladder: 303.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB002610 Enhanced Supported "Plasma membrane" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane" "CAB002610: " "unprognostic (1.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-1)" "unprognostic (1.23e-2)" "unprognostic (1.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.16e-3)" "unprognostic (5.11e-1)" "prognostic favorable (3.46e-10)" "unprognostic (5.77e-2)" "unprognostic (1.37e-1)" "unprognostic (9.38e-2)" "unprognostic (4.63e-2)" 2.6 0.4 0.1 23.0 0.0 0.2 69.0 0.8 0.3 61.2 4.8 256.3 126.9 26.7 24.4 305.0 75.8 48.9 0.4 0.2 0.0 116.2 4.8 64.0 1.0 0.4 1.5 1.2 116.2 51.9 13.1 36.3 0.3 82.2 123.3 0.3 204.6 39.1 0.5 180.8 190.6 7.3 0.0 0.7 13.3 0.6 0.2 10.7 111.7 0.3 37.5 303.5 105.7 0.0 358.1 4.4 0.0 1.5 0.0 0.4 395.0 3.3 0.2 0.3 0.4 184.9 761.4 0.6 28.0 0.1 2.6 193.3 0.0 0.5 0.4 0.7 0.4 0.2 20.3 127.0 0.1 0.1 0.9 0.0 1.9 0.1 0.4 0.3 0.0 0.2 0.3 0.7 0.0 400.2 0.7 1.9 0.7 402.0 495.0 0.5 6.9 7.6 92.4 340.2 79.5 1.7 0.4 636.8 0.8 21.6 250.9 0.9 0.5 0.9 13.7 3.1 3.5 0.9 0.7 0.7 0.6 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.2 0.0 0.4 1.5 0.3 0.0 0.2 0.0 5.1 275.7 230.2 0.0 12.2 16.2 3149.1 641.6 31.3 0.4 1255.2 548.4 0.8 287.4 954.3 218.8 0.0 771.7 18.7 1985.0 13.7 1026.1 0.0 1201.7 231.0 41.3 675.5 0.0 0.2 447.1 739.7 27.0 94.8 2298.8 27.3 0.2 0.4 0.5 76.3 0.0 0.1 1266.9 905.3 0.6 8.6 0.0 2.5 29.3 14.2 0.0 15.6 0.8 0.0 0.0 0.0 950.2 2081.0 0.0 2.5 2184.8 1906.1 21.6 635.6 0.0 0.0 0.1 68.2 0.0 0.2 1068.1 54.0 956.1 40.7 0.1 965.1 8033.4 CLDN8 ENSG00000156284 "Claudin 8" P56748 21 30214006-30216097 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 68.9;intestine: 50.8;kidney: 69.3;salivary gland: 40.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 224.3;Distal enterocytes: 110.2" "Cancer enhanced" "Detected in many" "prostate cancer: 31.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "HaCaT: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA060605 Approved NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA060605: AB_2684331" "unprognostic (3.74e-2)" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (1.62e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.32e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 68.9 0.0 0.0 1.7 0.0 27.2 0.0 0.1 9.3 3.9 1.1 0.0 0.0 0.0 0.0 69.3 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.5 0.0 7.5 50.8 0.0 40.1 13.9 0.0 8.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 21.9 0.0 0.3 0.4 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 10.8 2.7 0.0 0.0 29.9 11.6 0.0 0.0 10.5 224.3 0.0 0.0 0.1 110.2 11.7 0.1 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.4 0.0 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 15.9 0.6 0.4 20.3 0.0 0.0 0.0 0.3 0.0 0.0 4.6 8.4 0.0 0.4 0.0 18.0 23.1 CLEC19A ENSG00000261210 "C-type lectin domain containing 19A" Q6UXS0 16 19285731-19322145 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.7" "Group enriched" "Detected in some" 4 "Microglial cells: 6.5;Respiratory ciliated cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.19e-1)" "unprognostic (3.72e-1)" "unprognostic (1.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" 0.0 0.0 2.5 0.0 1.8 0.0 0.0 1.2 2.7 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.8 1.2 2.7 2.2 0.2 0.0 0.7 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 CLEC4D "CD368, CLECSF8, Dectin-3, MCL, Mpcl" ENSG00000166527 "C-type lectin domain family 4 member D" Q8WXI8 12 8509475-8522366 "CD markers, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 64.7" "Group enriched" "Detected in some" 5 "Kupffer cells: 10.6;Macrophages: 11.9;monocytes: 15.1" "Cancer enriched" "Detected in single" 50 "testis cancer: 11.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "classical monocyte: 57.1;neutrophil: 98.7" "Group enriched" "Detected in many" 32 "granulocytes: 98.7;monocytes: 57.1" "Group enriched" "Detected in some" 5 "NB-4: 2.4;NTERA-2: 9.0;SuSa: 9.1;U-937: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004906 Approved NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 5: NTERA-2 - Transcription" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA004906: AB_1078535" "unprognostic (1.10e-1)" "unprognostic (4.94e-2)" "unprognostic (4.78e-2)" "unprognostic (1.27e-1)" "unprognostic (4.39e-1)" "unprognostic (3.84e-2)" "unprognostic (7.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-1)" "unprognostic (3.81e-1)" "unprognostic (7.91e-5)" "unprognostic (1.12e-2)" "unprognostic (8.57e-2)" "unprognostic (7.89e-2)" "unprognostic (2.18e-1)" 2.3 0.2 0.0 7.3 0.1 64.7 0.2 0.0 0.2 3.1 0.3 0.1 0.1 0.1 0.5 0.4 0.7 0.4 0.3 0.0 0.0 0.2 0.5 3.1 0.6 0.1 0.1 0.0 0.5 0.0 0.0 0.7 0.1 0.1 0.1 0.6 0.4 0.0 0.1 0.0 0.2 0.8 0.0 7.0 0.2 0.2 0.4 0.3 0.1 0.7 0.3 2.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 9.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.9 57.1 0.0 0.0 4.5 0.0 0.3 0.0 0.1 2.4 0.0 0.0 0.1 98.7 0.0 1.2 0.7 0.0 12.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.6 0.8 0.0 0.0 11.9 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 CLIC3 ENSG00000169583 "Chloride intracellular channel 3" O95833 9 136994608-136996568 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 317.0;skin 1: 122.0;thyroid gland: 109.6;vagina: 132.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 130.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 9 "plasmacytoid DC: 2635.7" "Lineage enriched" "Detected in all" 9 "dendritic cells: 2635.7" "Cell line enhanced" "Detected in many" "BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005963 Enhanced Supported "Nuclear bodies" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nuclear bodies" "HPA005963: AB_1078536" "unprognostic (4.30e-2)" "unprognostic (2.53e-1)" "unprognostic (3.54e-1)" "unprognostic (1.55e-2)" "unprognostic (5.42e-3)" "unprognostic (1.85e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-3)" "unprognostic (1.39e-1)" "unprognostic (3.26e-3)" "unprognostic (7.73e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.74e-4)" 8.6 0.6 0.9 1.3 1.0 4.0 2.6 1.3 1.6 75.0 1.4 1.3 0.3 1.8 4.6 317.0 1.7 0.8 8.6 0.7 1.0 1.0 1.0 38.6 4.1 1.3 0.9 0.6 0.6 0.2 2.4 41.6 1.0 3.0 0.2 0.0 37.7 1.1 1.0 122.0 1.7 0.3 0.8 6.9 7.5 0.7 1.0 7.6 109.6 1.2 20.5 2.1 132.2 1.2 28.8 0.0 0.0 0.0 0.5 1.4 350.3 2.7 1.5 1.0 0.4 3.7 14.0 0.1 22.5 24.3 0.1 12.5 0.0 1.2 0.0 0.0 0.2 0.0 20.7 4.5 3.9 0.0 0.0 1.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.1 0.1 0.2 0.1 58.4 5.8 0.0 0.5 0.0 0.0 0.0 0.8 0.0 45.9 65.0 0.0 0.0 147.2 0.0 118.4 0.0 4.1 2.5 0.1 0.0 0.0 0.1 0.5 0.0 0.0 2.9 0.8 2.6 232.3 2.1 99.3 2.6 32.0 143.8 9.4 5.5 6.9 120.4 10.3 283.2 2.3 2635.7 11.5 168.3 0.9 1.0 1.3 1.6 0.7 1.0 1.3 0.9 1.0 0.8 1.0 1.2 11.5 214.7 42.0 0.0 11.6 3.8 3.6 86.6 8.0 0.0 7.3 20.6 3.2 2.8 95.2 1.8 0.0 811.8 456.0 25.2 9.8 1.8 1.7 16.7 2.3 13.4 4.9 5.3 0.0 6.4 1219.2 27.0 22.4 14.4 1.3 1.8 3.6 1.1 91.6 0.0 0.0 5.6 4.1 2.2 5.9 7.8 125.6 8.5 10.6 1.9 4.9 0.0 541.7 0.0 0.0 84.6 10.4 41.8 23.7 4.5 0.7 0.4 12.0 0.0 0.0 0.2 4.4 0.0 1.0 70.2 19.5 2039.4 78.4 1.0 5.2 18.1 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 5.1" "Lineage enriched" "Detected in single" 17 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074371 Supported "Nuclear speckles,Plasma membrane" NA NA 400000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 18.9 1.5 3.2 4.3 4.4 0.2 6.5 1.5 2.9 19.0 0.5 28.6 20.9 2.1 0.9 2.9 4.5 3.0 102.7 2.1 5.0 54.7 0.3 70.8 1.7 2.1 3.8 0.5 1.1 1.7 3.0 16.5 2.2 2.6 25.8 16.9 2.7 1.4 289.7 1.2 36.6 2.3 1.8 44.5 1.6 1.4 5.5 1.0 7.3 98.3 1.9 2.0 2.6 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.5 0.0 9.2 0.0 0.0 0.3 0.0 0.1 0.0 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.4 1.6 0.0 11.9 0.3 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.1 0.1 2.0 1.3 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 1.0 0.5 3.2 4.4 1.5 2.9 2.1 5.0 2.1 3.8 2.2 1.8 5.5 1.9 59.6 509.6 30.0 4.6 1.4 0.1 0.1 0.0 1.2 0.3 0.5 0.4 285.7 5.7 26.9 14.7 0.0 0.2 0.7 164.2 0.0 1.7 52.9 4.6 0.5 29.8 13.1 0.4 8.6 0.2 0.1 7.9 0.5 5.7 1.3 0.0 0.7 0.0 0.0 0.0 5.4 23.5 0.0 0.0 0.0 93.8 0.9 0.7 0.0 34.7 0.6 53.8 0.0 0.5 2.9 2.9 51.1 0.7 3.4 3.2 126.0 2.9 11.4 1.8 0.0 6.1 4.3 1.0 0.1 0.1 0.1 2.2 5.8 0.1 13.5 4.3 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769978 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in some" 6 "basal ganglia: 7.8" "Low region specificity" "Detected in many" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 0.5 0.2 0.7 3.2 0.6 11.3 0.5 0.6 1.4 0.2 0.4 1.4 1.0 0.4 0.7 0.9 0.2 0.3 0.1 1.3 0.3 0.2 0.5 0.4 4.9 0.4 0.4 0.1 0.1 0.2 0.0 1.5 0.6 0.2 2.0 6.8 0.2 0.1 0.6 1.2 1.0 0.9 0.2 1.3 0.9 5.7 0.6 7.9 0.2 0.0 5.2 0.6 0.4 0.9 22.0 17.5 37.8 19.9 2.6 4.8 14.1 43.6 12.0 31.0 41.3 27.9 19.6 45.7 13.9 11.8 22.7 21.4 37.1 14.9 48.1 31.6 16.8 64.5 38.1 12.6 0.1 54.0 36.8 1.0 0.6 53.8 3.7 3.7 16.9 27.1 44.2 30.8 30.3 14.1 56.9 13.1 36.0 14.9 12.2 36.0 57.0 13.8 6.4 35.3 14.0 16.2 37.7 11.6 7.4 25.6 10.0 21.1 12.5 44.6 33.8 27.6 49.3 11.1 29.1 47.1 14.1 37.4 37.0 1.1 0.3 0.3 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.2 1.0 0.5 0.2 0.2 0.3 0.3 0.7 0.6 0.6 1.4 1.3 0.3 0.4 0.4 0.6 0.2 0.6 0.9 2.6 0.0 0.5 0.3 6.5 5.6 5.7 4.4 1.2 9.4 2.9 3.8 1.4 2.8 2.7 0.0 12.5 19.7 4.6 12.8 0.0 1.6 7.9 1.0 3.6 3.6 1.2 55.6 1.6 0.6 41.1 5.2 4.6 3.3 1.3 12.0 2.2 0.4 16.9 1.7 1.5 9.4 2.0 3.0 8.2 6.1 2.5 5.8 3.6 0.0 9.1 9.4 4.1 0.0 0.6 1.4 9.5 0.4 32.5 1.8 0.4 0.2 0.0 101.0 6.6 5.3 8.7 281.1 263.3 5.8 2.0 10.4 7.2 1.2 12.0 3.9 CNGA3 "ACHM2, CCNC1, CCNCa, CNCG3, CNG3" ENSG00000144191 "Cyclic nucleotide gated channel subunit alpha 3" Q16281 2 98346188-98398601 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.7;intestine: 4.2;pituitary gland: 10.1;retina: 5.9" "Cell type enriched" "Detected in some" 14 "Cone photoreceptor cells: 43.8" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "U-87 MG: 6.8" "Group enriched" "Detected in some" 6 "basal ganglia: 1.8;hypothalamus: 1.9" "Not detected" "Not detected" "HPA049378, CAB079025" Approved Approved NA NA "Cluster 77: Retina - Visual perception" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 9: Photoreceptor cells - Phototransduction" "CAB079025: , HPA049378: AB_2732551" "unprognostic (2.34e-2)" "unprognostic (1.83e-2)" "unprognostic (4.96e-2)" "unprognostic (4.81e-2)" "unprognostic (1.13e-1)" "unprognostic (2.18e-1)" "unprognostic (4.17e-4)" "unprognostic (4.65e-2)" "unprognostic (1.86e-3)" "unprognostic (2.88e-1)" "unprognostic (3.85e-3)" "unprognostic (8.98e-2)" "unprognostic (5.90e-2)" "unprognostic (3.71e-2)" 0.1 0.0 0.6 0.5 0.5 0.0 0.2 0.2 0.8 0.0 2.9 4.2 1.0 0.0 0.0 1.5 0.4 0.0 0.0 0.7 5.6 0.1 0.0 0.1 0.0 3.4 1.5 0.0 0.3 0.0 10.1 0.0 3.6 0.0 1.1 5.9 0.2 0.2 0.0 0.0 1.3 0.8 5.7 0.0 0.9 0.5 1.3 0.0 0.0 0.0 0.0 0.6 0.1 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.2 0.8 0.7 5.6 3.4 1.5 3.6 5.7 1.3 4.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.1 0.0 0.0 3.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CNGA4 "CNCA2, CNG5, CNGB2, OCNC2, OCNCb" ENSG00000132259 "Cyclic nucleotide gated channel subunit alpha 4" Q8IV77 11 6234765-6244479 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Ion channel, Ligand-gated ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 17.3;testis: 6.1" "Cell type enhanced" "Detected in some" "Astrocytes: 9.1;Early spermatids: 5.0;Endometrial ciliated cells: 2.7;Excitatory neurons: 3.0;Inhibitory neurons: 2.5;Late spermatids: 3.6;Oligodendrocytes: 3.1;Respiratory ciliated cells: 3.5" "Cancer enriched" "Detected in single" 6 "endometrial cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA074128 Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Plasma membrane" "HPA074128: " "unprognostic (1.11e-2)" "unprognostic (4.32e-2)" "unprognostic (2.69e-3)" "prognostic favorable (1.48e-4)" "unprognostic (4.96e-2)" "unprognostic (1.09e-1)" "unprognostic (2.01e-3)" "unprognostic (1.89e-1)" "unprognostic (8.51e-2)" "unprognostic (5.51e-2)" "unprognostic (1.83e-2)" "unprognostic (8.70e-2)" "unprognostic (1.03e-3)" "unprognostic (3.84e-2)" "unprognostic (3.47e-2)" "unprognostic (8.11e-2)" "unprognostic (3.55e-3)" 0.1 0.2 1.2 0.2 1.3 0.4 0.2 1.3 1.2 0.7 0.7 0.2 0.3 0.6 0.2 0.2 17.3 0.2 0.1 1.4 1.4 0.4 0.2 1.4 0.2 2.8 3.8 0.4 0.4 0.0 0.7 0.0 2.5 0.2 0.1 1.1 0.1 0.5 0.0 0.3 0.2 0.1 1.8 0.3 0.2 6.1 1.2 0.3 0.2 0.0 0.2 0.2 0.2 1.9 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 1.3 1.2 1.4 1.4 2.8 3.8 2.5 1.8 1.2 1.9 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 2.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CNIH2 "CNIH-2, Cnil, MGC50896" ENSG00000174871 "Cornichon family AMPA receptor auxiliary protein 2" Q6PI25 11 66278175-66285301 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 270.1" "Cell type enhanced" "Detected in some" "Early spermatids: 75.7;Enteroendocrine cells: 49.6;Excitatory neurons: 17.7;Horizontal cells: 16.8;Late spermatids: 28.1" "Cancer enriched" "Detected in many" 5 "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.8;AN3-CA: 13.9;MCF7: 13.9;NTERA-2: 15.1;SCLC-21H: 61.5;SH-SY5Y: 28.5;T-47d: 13.3" "Low region specificity" "Detected in all" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.84e-2)" "unprognostic (3.53e-3)" "unprognostic (3.40e-3)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (3.29e-1)" "unprognostic (3.25e-1)" "unprognostic (3.80e-2)" "unprognostic (7.66e-3)" "unprognostic (4.16e-2)" "unprognostic (6.95e-8)" "unprognostic (3.53e-1)" "unprognostic (3.19e-2)" "unprognostic (3.17e-2)" "unprognostic (3.55e-2)" 0.4 3.3 88.4 0.2 74.6 1.6 0.3 28.8 270.1 0.6 11.0 1.0 0.6 0.4 0.0 0.8 0.6 0.2 0.3 234.9 61.3 0.5 0.4 0.7 0.1 28.3 37.1 0.4 3.4 0.1 45.9 0.5 34.5 0.5 0.2 1.1 0.3 0.0 0.1 1.4 0.6 0.2 30.3 0.6 1.0 5.1 53.4 1.3 0.4 0.0 0.0 0.3 0.5 47.5 0.4 0.8 15.8 13.9 0.2 0.3 2.0 1.0 1.1 2.0 0.1 0.4 0.0 0.1 0.3 0.2 0.9 0.2 3.6 0.0 0.3 1.5 1.4 0.0 0.5 0.0 0.0 0.1 1.1 0.0 0.3 0.1 0.0 0.3 0.0 1.6 0.2 2.1 0.9 13.9 2.1 0.3 15.1 0.0 1.0 6.8 0.0 0.1 0.1 0.8 61.5 28.5 0.1 7.6 0.6 0.7 13.3 0.2 0.0 1.8 0.7 0.5 0.6 0.3 0.4 0.6 4.2 0.4 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.4 74.6 28.8 270.1 234.9 61.3 28.3 37.1 34.5 30.3 53.4 47.5 0.8 0.0 0.5 2.9 0.2 0.6 0.3 1.4 0.6 2.3 1.6 1.3 0.7 1.5 0.8 0.0 0.0 1.4 0.7 0.1 0.0 0.2 75.7 5.7 0.6 0.4 49.6 0.0 17.7 0.2 1.6 0.7 2.0 0.6 0.0 0.5 0.4 0.1 0.2 16.8 11.7 1.5 0.0 0.0 0.3 28.1 0.6 0.4 0.0 1.9 0.1 0.7 0.0 1.5 2.7 0.6 0.1 0.4 0.9 0.3 0.2 0.2 6.8 2.6 0.0 0.9 0.7 6.0 0.9 0.6 0.4 1.2 1.4 0.1 0.4 0.3 CNN1 "Sm-Calp, SMCC" ENSG00000130176 "Calponin 1" P51911 19 11538767-11550323 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 1872.4;intestine: 2657.3;smooth muscle: 2207.8" "Group enriched" "Detected in many" 5 "Breast myoepithelial cells: 191.0;Early spermatids: 335.0;Late spermatids: 554.6;Peritubular cells: 221.2;Smooth muscle cells: 180.9" "Cancer enhanced" "Detected in all" "prostate cancer: 142.1;stomach cancer: 103.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 91.5;BJ hTERT+: 34.9;BJ hTERT+ SV40 Large T+: 48.0;BJ hTERT+ SV40 Large T+ RasG12V: 64.6;HBF TERT88: 71.2;K-562: 35.8;SuSa: 72.5;U-2 OS: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000007, HPA014263" Enhanced Approved "Actin filaments" No No "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 34: Spermatids - Unknown function" "Actin filaments" "CAB000007: AB_2082148, HPA014263: AB_1847039" "unprognostic (4.98e-3)" "unprognostic (1.01e-1)" "unprognostic (3.04e-3)" "unprognostic (1.95e-1)" "unprognostic (2.47e-1)" "unprognostic (4.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.76e-1)" "unprognostic (1.35e-1)" "unprognostic (7.06e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (5.43e-6)" "unprognostic (1.70e-2)" "unprognostic (1.07e-1)" "unprognostic (2.78e-3)" "unprognostic (6.11e-3)" 115.6 58.4 6.4 160.6 8.3 0.0 89.7 5.7 14.2 366.9 7.5 2657.3 136.3 1872.4 177.0 677.5 655.6 234.3 274.1 6.8 8.5 42.9 10.6 98.7 7.3 6.1 6.8 114.1 24.2 3.0 9.0 28.4 6.3 676.0 326.4 0.7 61.6 1585.7 21.8 57.8 431.3 2207.8 6.1 22.1 673.7 91.4 7.5 2.6 38.5 11.7 0.9 1386.6 305.7 6.3 0.1 1.3 5.9 1.0 0.6 0.2 3.2 91.5 34.9 48.0 64.6 27.9 0.0 0.4 2.7 26.1 4.4 0.3 0.0 0.0 71.2 0.0 0.2 0.1 0.1 2.3 2.5 0.0 0.4 3.0 0.1 28.7 0.1 1.6 0.0 0.0 35.8 0.0 0.0 0.0 0.3 3.8 2.9 0.0 0.7 0.2 0.6 3.8 0.0 0.0 0.1 1.3 0.1 0.2 0.2 72.5 0.1 0.1 0.4 0.4 34.6 1.2 1.2 0.1 0.4 0.1 3.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.4 8.3 5.7 14.2 6.8 8.5 6.1 6.8 6.3 6.1 7.5 6.3 2.4 0.0 0.0 0.0 0.2 4.8 4.1 1.6 0.6 0.0 4.2 191.0 51.4 0.0 0.3 1.8 0.0 0.8 0.7 0.0 0.0 14.5 335.0 3.1 20.7 2.4 0.0 0.0 0.5 0.4 1.0 21.5 0.5 0.7 0.0 0.5 6.8 0.0 2.3 0.0 0.3 0.0 0.0 0.0 9.4 554.6 8.4 0.9 3.6 2.8 0.6 0.5 0.0 0.0 0.1 0.9 0.0 221.2 0.0 4.0 0.0 0.4 0.4 0.0 39.5 1.1 180.9 8.3 19.5 0.4 7.1 0.7 1.1 0.7 0.0 1.1 CNTN3 "BIG-1, PANG" ENSG00000113805 "Contactin 3" Q9P232 3 74262568-74521140 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.1" "Group enriched" "Detected in many" 7 "Excitatory neurons: 274.0;Inhibitory neurons: 195.1;Oligodendrocyte precursor cells: 228.7" "Cancer enhanced" "Detected in many" "prostate cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BJ: 7.1;fHDF/TERT166: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003341 Approved "Intracellular and membrane" NA NA 130000000 "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA003341: AB_1078556" "unprognostic (1.66e-2)" "unprognostic (1.86e-1)" "unprognostic (2.35e-3)" "unprognostic (9.86e-2)" "unprognostic (1.82e-2)" "unprognostic (1.94e-5)" "unprognostic (4.25e-2)" "unprognostic (2.13e-3)" "unprognostic (8.42e-2)" "unprognostic (3.85e-2)" "unprognostic (1.50e-1)" "unprognostic (7.25e-2)" "unprognostic (9.30e-7)" "unprognostic (4.23e-2)" "unprognostic (1.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" 2.7 3.0 5.0 0.4 6.4 0.0 1.4 0.0 10.1 2.4 0.7 3.2 0.4 0.9 1.7 0.4 7.6 2.0 2.1 6.2 0.7 3.7 3.1 0.8 0.1 1.3 3.0 1.3 2.0 0.2 4.0 0.1 1.9 5.8 2.8 1.3 0.8 4.2 0.2 0.8 0.5 0.4 0.0 1.8 1.4 0.7 1.3 0.9 1.6 0.2 0.5 4.3 0.5 1.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 7.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.4 0.0 1.4 0.0 0.1 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 6.4 0.0 10.1 6.2 0.7 1.3 3.0 1.9 0.0 1.3 1.0 0.2 3.2 1.7 21.9 0.0 0.6 0.8 0.3 0.0 6.2 2.2 1.3 3.5 10.0 4.2 9.2 0.0 0.0 0.0 3.3 1.9 1.9 2.9 32.7 1.8 0.7 1.2 0.0 274.0 0.5 0.0 4.5 0.0 10.8 0.0 0.4 5.7 6.6 0.1 21.9 195.1 6.4 0.0 0.0 2.1 1.8 0.0 0.1 0.0 3.7 0.0 0.2 0.0 228.7 9.8 0.9 3.9 0.0 0.0 4.0 0.6 7.4 4.8 0.9 0.0 2.3 0.9 0.1 1.1 0.0 0.3 0.0 0.5 0.1 7.1 1.9 CNTN5 "hNB-2, NB-2" ENSG00000149972 "Contactin 5" O94779 11 99020949-100358885 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.7;placenta: 2.6;salivary gland: 2.0;thyroid gland: 2.0" "Group enriched" "Detected in some" 14 "Excitatory neurons: 968.9;Inhibitory neurons: 2295.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039492, HPA041223" Approved "Intracellular and membrane" NA NA 480000 "Cluster 65: Brain - Ion transport" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA039492: AB_10795108, HPA041223: AB_10794549" "unprognostic (2.09e-2)" "unprognostic (3.40e-1)" "unprognostic (8.99e-3)" "unprognostic (4.20e-2)" "unprognostic (6.51e-5)" "unprognostic (3.85e-2)" "unprognostic (9.25e-2)" "unprognostic (6.13e-2)" "unprognostic (3.02e-2)" "unprognostic (8.72e-2)" "unprognostic (5.48e-3)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" 0.0 0.0 1.3 0.0 1.4 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 4.7 1.1 0.3 0.0 0.1 0.0 0.0 1.3 0.0 0.2 0.2 0.5 2.6 0.5 0.0 0.0 0.7 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.0 4.1 4.7 1.1 0.0 1.3 0.5 0.0 2.9 0.1 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.7 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.5 3.5 0.1 0.0 0.0 0.0 968.9 0.0 0.2 1.1 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 2295.2 0.0 2.0 0.0 0.0 0.4 0.9 0.0 0.0 42.2 0.0 0.1 0.0 112.1 23.2 0.1 0.0 1.9 0.0 0.0 0.0 0.2 12.5 0.7 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 CNTN6 NB-3 ENSG00000134115 "Contactin 6" Q9UQ52 3 1092658-1404217 "Predicted membrane proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;thyroid gland: 9.7" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 35.3;Excitatory neurons: 127.6;Inhibitory neurons: 75.9;Oligodendrocyte precursor cells: 52.8" "Group enriched" "Detected in some" 15 "renal cancer: 2.7;thyroid cancer: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;SH-SY5Y: 2.3;SuSa: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016645 Uncertain NA NA 4700000 "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA016645: AB_1847149" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-1)" "unprognostic (1.05e-4)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (3.80e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.26e-3)" "unprognostic (5.45e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.46e-2)" 0.0 3.2 1.3 0.0 2.4 0.0 0.1 11.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 1.4 0.1 0.0 3.2 0.0 2.2 2.2 0.0 0.0 0.0 0.3 2.0 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 3.7 0.0 9.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.4 11.0 2.3 1.1 1.4 2.2 2.2 2.7 1.9 3.7 1.3 0.0 35.3 3.6 15.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.5 0.0 3.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 127.6 0.0 0.2 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 75.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 52.8 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 1.1 0.0 0.0 COBL KIAA0633 ENSG00000106078 "Cordon-bleu WH2 repeat protein" O75128 7 51016212-51316818 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.2;skeletal muscle: 131.6;tongue: 107.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019033, HPA019167" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane, Cell Junctions" "HPA019033: AB_2083648, HPA019167: AB_1847070" "unprognostic (8.09e-2)" "unprognostic (1.08e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-3)" "unprognostic (3.13e-1)" "unprognostic (5.33e-3)" "unprognostic (2.90e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.21e-12)" "unprognostic (7.64e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (5.41e-3)" 3.0 1.0 83.8 1.4 96.7 0.0 14.8 62.0 91.1 4.8 41.6 13.3 18.9 2.2 2.1 13.6 19.1 5.8 54.8 81.8 67.9 12.9 19.6 13.8 0.2 76.6 88.3 2.8 18.4 31.5 12.8 4.7 69.2 14.4 10.9 23.3 47.3 4.2 131.6 27.5 21.5 2.7 66.6 0.3 17.6 3.0 89.8 1.3 8.3 107.9 1.0 1.8 5.8 118.2 12.4 8.8 0.2 0.3 0.0 0.0 33.7 0.0 0.0 0.0 0.0 24.1 18.2 0.0 0.9 0.0 1.4 21.1 12.0 0.0 0.0 0.0 9.6 0.0 57.0 4.7 0.0 0.0 0.1 1.5 2.3 0.0 0.0 0.0 0.0 1.6 6.5 0.2 0.2 7.9 0.1 0.1 9.0 53.4 8.0 0.1 0.5 45.5 17.4 0.0 11.0 0.2 3.2 26.2 3.9 32.6 16.6 0.1 0.0 0.0 9.8 0.3 0.9 0.0 34.1 0.1 0.1 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 83.8 96.7 62.0 91.1 81.8 67.9 76.6 88.3 69.2 66.6 89.8 118.2 1.4 38.5 19.6 48.0 1.0 17.8 3.4 1.2 4.0 2.3 38.0 34.7 76.2 28.6 13.2 9.2 58.4 23.3 4.6 59.4 0.0 21.5 3.8 65.9 3.3 2.2 18.6 0.0 198.7 9.7 9.2 7.7 35.7 74.6 10.1 4.6 0.4 29.7 2.2 0.0 96.6 35.2 4.1 0.8 1.7 3.1 0.6 0.9 16.0 10.3 1.1 94.4 0.0 353.9 548.8 23.2 35.0 0.4 0.2 25.3 76.8 18.6 31.4 73.6 0.0 10.5 1.5 0.7 8.8 6.8 35.7 40.2 1.7 11.2 14.4 7.3 COL28A1 ENSG00000215018 "Collagen type XXVIII alpha 1 chain" Q2UY09 7 7356203-7535873 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 18.2" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9" "Region enriched" "Detected in single" 8 "olfactory bulb: 3.6" "Region enriched" "Detected in some" 31 "spinal cord: 33.5" "HPA043844, HPA060468" Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 51: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "HPA043844: AB_2732508, HPA060468: AB_2684288" "unprognostic (6.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.28e-1)" "unprognostic (8.71e-3)" "unprognostic (1.89e-2)" "unprognostic (5.63e-3)" "unprognostic (2.61e-2)" "unprognostic (7.58e-2)" "unprognostic (2.72e-2)" "unprognostic (7.69e-2)" "unprognostic (3.90e-3)" "unprognostic (2.33e-2)" "unprognostic (3.45e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (2.48e-3)" "unprognostic (3.09e-2)" 1.0 3.2 0.8 1.6 1.0 0.3 2.8 1.9 2.7 3.3 1.4 11.7 1.2 2.2 14.1 2.1 4.9 1.5 3.7 1.1 0.9 6.3 0.7 1.2 0.2 0.9 3.6 1.2 5.8 0.2 11.2 0.5 1.4 3.9 4.1 6.7 18.2 5.1 5.9 2.1 3.4 1.7 0.2 0.4 6.5 3.7 1.1 0.2 1.2 3.2 0.1 2.9 4.5 1.5 1.5 0.0 0.0 0.0 0.1 0.7 0.2 0.1 0.4 0.0 0.0 1.1 0.4 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.2 1.4 0.1 0.2 0.0 0.7 0.9 0.3 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.1 0.5 0.7 0.1 0.5 1.3 0.0 9.8 2.8 0.0 0.2 0.6 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.8 1.0 1.9 2.7 1.1 0.9 0.9 3.6 1.4 0.2 1.1 1.5 0.4 0.0 4.1 39.5 0.0 0.3 0.1 0.2 0.0 5.3 1.6 1.5 0.9 0.0 3.3 3.7 18.8 0.3 0.1 0.8 0.0 0.1 2.0 21.1 0.5 0.1 0.0 0.0 23.4 0.2 0.0 3.1 0.0 3.9 1.3 0.5 1.8 0.0 0.1 5.0 22.6 0.5 0.0 0.3 0.3 1.1 0.9 0.1 0.0 7.5 0.0 2.2 0.0 12.5 9.1 0.4 5.4 0.7 0.0 0.1 0.2 0.5 16.3 5.4 0.0 1.8 0.2 0.9 1.0 0.1 0.1 0.3 0.1 0.2 0.3 0.1 CP ENSG00000047457 Ceruloplasmin P00450 3 149162410-149221829 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Copper transport, Ion transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 1871.4" "Cell type enhanced" "Detected in many" "Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4" "Cancer enhanced" "Detected in many" "liver cancer: 98.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "EFO-21: 318.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001834, CAB008591" Supported "Secreted to blood" NA NA 160000000000 440000000000 "Cluster 62: Liver - Hemostasis" "Cluster 38: EFO-21 - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "CAB008591: AB_1613734, HPA001834: AB_1078502" "unprognostic (3.58e-1)" "unprognostic (4.24e-1)" "unprognostic (9.61e-2)" "unprognostic (1.80e-2)" "unprognostic (4.14e-2)" "unprognostic (1.02e-2)" "unprognostic (1.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "unprognostic (6.03e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.68e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (2.70e-1)" 13.0 2.3 17.9 2.2 18.1 0.9 20.8 18.7 29.8 70.2 129.2 13.0 9.8 14.8 0.0 5.6 8.3 1.1 39.2 17.5 33.0 9.5 1871.4 13.4 18.9 28.1 20.3 0.8 6.5 3.9 28.6 3.4 24.9 7.9 16.4 246.5 39.9 0.9 2.6 13.0 20.8 2.4 19.2 23.1 3.0 1.5 20.1 0.5 16.1 8.3 20.0 23.9 2.3 29.0 0.2 18.8 15.6 0.0 3.3 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 318.8 0.0 29.4 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.4 32.7 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 2.5 5.4 0.0 0.0 0.0 0.4 6.7 16.2 0.0 0.2 0.3 1.0 0.1 0.4 0.0 0.4 0.0 0.2 1.7 0.2 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.9 18.1 18.7 29.8 17.5 33.0 28.1 20.3 24.9 19.2 20.1 29.0 2.3 19.2 76.6 3.3 10.6 3.3 8.3 28.6 0.6 6.9 14.0 0.6 0.6 65.8 558.1 9.2 6.2 0.1 0.3 0.1 0.0 83.4 0.9 190.5 51.0 12.6 0.0 34.7 1.5 21.4 0.2 16.3 0.0 406.0 2.5 0.1 34.6 1687.2 0.6 5.0 1.4 0.2 8.2 44.6 6.9 1.2 0.3 4.0 0.0 6.5 1.6 720.5 1.0 0.5 2.0 69.3 0.0 0.4 0.3 19.5 0.0 0.3 318.4 24.8 0.0 0.8 15.3 0.0 0.1 0.8 2.6 0.3 4.9 0.1 0.1 79.0 CPA3 ENSG00000163751 "Carboxypeptidase A3" P15088 3 148865296-148897203 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 112.0;lung: 86.3" "Cell type enriched" "Detected in some" 26 "granulocytes: 4422.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 1534 "basophil: 1115.4" "Lineage enriched" "Detected in single" 5518 "granulocytes: 1115.4" "Cell line enriched" "Detected in some" 45 "HEL: 303.3" "Not detected" "Not detected" "HPA006479, HPA008689, CAB020712" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" Nucleoplasm "CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-3)" "unprognostic (9.13e-3)" "unprognostic (3.50e-1)" "unprognostic (1.18e-3)" "unprognostic (2.47e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (1.89e-1)" "unprognostic (5.30e-3)" "unprognostic (3.50e-3)" "unprognostic (5.18e-3)" "unprognostic (3.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.69e-3)" 18.2 2.6 0.0 19.9 0.4 25.7 20.9 0.0 0.0 59.4 0.3 39.2 27.3 26.1 19.3 41.1 6.6 112.0 6.2 0.0 0.0 3.3 2.7 86.3 11.2 0.0 0.0 0.9 21.0 2.8 0.9 1.7 0.0 18.5 56.6 0.0 12.1 15.1 1.6 17.7 45.9 25.7 0.0 1.1 45.3 3.8 0.0 14.9 0.9 10.2 15.1 54.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 303.3 0.0 0.0 0.2 0.2 6.7 0.2 0.0 0.1 0.3 0.5 3.8 0.0 0.1 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1115.4 0.0 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 2.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 163.9 0.0 0.5 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 0.0 16.0 0.0 1.6 0.0 3.5 0.5 0.0 4422.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 6.7 0.3 0.0 0.0 8.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.3 0.0 41.7 0.0 0.0 0.3 CR1 "CD35, KN" ENSG00000203710 "Complement C3b/C4b receptor 1 (Knops blood group)" P17927 1 207496147-207641765 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 13.2;lymphoid tissue: 27.2" "Cell type enhanced" "Detected in some" "B-cells: 32.6;Erythroid cells: 20.4;Kupffer cells: 59.1;Macrophages: 24.9;monocytes: 13.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 53.7;eosinophil: 17.2;neutrophil: 15.6" "Lineage enriched" "Detected in many" 12 "granulocytes: 53.7" "Group enriched" "Detected in some" 9 "HL-60: 9.9;HMC-1: 21.8;NB-4: 9.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB002491, CAB016271, HPA042455, HPA043579, HPA049348" Enhanced NA NA 33000000 "Cluster 38: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723" "unprognostic (1.74e-1)" "unprognostic (3.16e-2)" "unprognostic (2.75e-2)" "unprognostic (6.12e-2)" "unprognostic (1.58e-2)" "unprognostic (7.14e-2)" "unprognostic (2.84e-1)" "unprognostic (3.86e-2)" "unprognostic (2.02e-1)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-3)" "unprognostic (4.38e-2)" "unprognostic (3.32e-2)" "unprognostic (6.45e-2)" "unprognostic (3.50e-3)" 13.2 0.8 0.1 27.2 0.5 10.5 0.6 0.1 2.9 1.2 1.3 1.5 1.3 0.5 0.2 0.9 1.4 2.1 0.6 0.2 0.2 2.5 2.6 3.2 20.1 0.7 0.5 0.2 0.3 0.1 0.2 9.1 1.6 0.2 1.5 0.0 0.4 0.4 0.2 0.1 4.4 6.3 0.1 24.4 1.7 0.6 2.1 1.6 0.3 1.0 17.9 6.7 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 9.9 21.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 53.7 4.2 17.2 0.0 2.4 0.7 4.5 0.9 0.4 0.3 2.2 0.2 0.1 15.6 0.0 2.3 0.0 0.0 1.3 0.1 0.5 0.1 2.9 0.2 0.2 0.7 0.5 1.6 0.1 2.1 1.8 0.3 0.0 4.2 0.3 32.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.2 0.2 0.0 20.4 0.3 0.0 0.1 0.6 0.0 0.2 1.3 0.3 0.0 0.4 9.7 0.0 0.4 0.0 0.0 59.1 1.4 0.0 0.0 24.9 0.0 1.9 13.3 0.0 0.0 1.5 4.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 1.3 0.5 0.0 0.0 CRISP2 "CRISP-2, CT36, GAPDL5, TPX1" ENSG00000124490 "Cysteine rich secretory protein 2" P16562 6 49692358-49713590 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "testis: 505.0" "Group enriched" "Detected in some" 33 "Early spermatids: 5765.5;Late spermatids: 21517.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031248 Enhanced "Secreted in male reproductive system" NA NA 820000 "Cluster 83: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "HPA031248: AB_10602211" "unprognostic (1.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (7.38e-2)" "unprognostic (2.35e-2)" "unprognostic (9.23e-3)" "unprognostic (4.05e-2)" 0.1 0.0 0.0 0.0 0.0 16.6 0.5 0.0 0.0 1.9 0.7 0.0 0.1 0.2 0.9 3.6 17.6 7.7 0.1 0.0 0.2 0.8 0.2 1.2 0.0 0.1 0.1 0.1 0.6 0.0 2.0 0.0 0.0 1.2 0.0 0.1 15.6 2.5 0.2 0.5 0.3 0.0 0.0 0.5 0.1 505.0 0.1 0.0 0.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.3 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5765.5 17.8 0.5 6.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 21517.6 133.9 6.1 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 83.8 0.0 2.8 0.2 0.1 24.1 0.0 65.7 0.0 0.0 409.8 65.1 0.0 0.0 0.0 0.0 0.0 0.3 2.3 CROCC2 ENSG00000226321 "Ciliary rootlet coiled-coil, rootletin family member 2" H7BZ55 2 240906330-240993311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.7;choroid plexus: 23.6;fallopian tube: 7.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 9.7;Endometrial ciliated cells: 43.6;Respiratory ciliated cells: 13.1" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 1.5" "Region enhanced" "Detected in many" "midbrain: 6.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.0;RPMI-8226: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA048678 Enhanced NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA048678: AB_2680491" "unprognostic (4.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.24e-2)" "unprognostic (1.68e-3)" "unprognostic (7.92e-2)" "unprognostic (1.75e-4)" "unprognostic (2.84e-3)" "unprognostic (3.10e-2)" "unprognostic (8.28e-2)" "unprognostic (3.45e-2)" "unprognostic (6.56e-3)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-2)" "unprognostic (9.90e-3)" "unprognostic (7.19e-2)" 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.2 0.1 1.2 23.6 0.0 0.2 0.1 0.0 0.0 7.0 0.0 0.0 1.9 0.8 0.1 0.2 1.5 0.6 3.0 6.7 0.1 0.0 0.0 0.4 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 2.3 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.4 0.2 0.1 1.9 0.8 3.0 6.7 2.5 1.6 1.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.1 1.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.2 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 CSF3R "CD114, GCSFR" ENSG00000119535 "Colony stimulating factor 3 receptor" Q99062 1 36466043-36483278 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "bone marrow: 379.7;lung: 136.7;lymphoid tissue: 375.6;placenta: 105.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 230.8;Cytotrophoblasts: 423.8;Kupffer cells: 177.7;monocytes: 197.6;Syncytiotrophoblasts: 1194.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 1962.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 1962.3" "Group enriched" "Detected in some" 18 "BEWO: 70.8;NB-4: 20.3;THP-1: 50.3;U-937: 47.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017116, HPA048086" Enhanced "Intracellular and membrane" NA NA 150000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "CAB017116: , HPA048086: AB_2680257" "unprognostic (5.57e-3)" "unprognostic (8.05e-2)" "unprognostic (7.23e-2)" "unprognostic (3.87e-2)" "unprognostic (2.88e-1)" "unprognostic (2.92e-2)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (5.65e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (6.33e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (2.03e-1)" "unprognostic (2.31e-2)" 36.2 7.1 5.8 148.2 5.6 379.7 13.0 6.7 19.0 5.2 6.3 6.4 2.6 3.1 0.4 5.6 31.5 15.8 14.6 5.5 7.3 9.7 22.9 136.7 7.3 10.3 7.8 3.2 4.9 1.6 5.5 105.1 11.4 7.5 1.8 0.1 7.4 1.8 3.6 1.6 9.8 12.2 9.6 375.6 9.9 1.2 10.7 5.7 5.8 21.7 2.7 22.2 6.2 11.9 0.0 0.0 0.0 0.0 0.0 0.0 70.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 1.6 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.5 0.0 50.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 47.8 0.0 1.1 280.8 8.7 0.2 56.8 0.6 0.1 0.4 0.2 97.2 0.4 0.1 0.3 1962.3 3.4 24.1 3.3 0.6 158.4 5.8 5.6 6.7 19.0 5.5 7.3 10.3 7.8 11.4 9.6 10.7 11.9 0.7 25.6 230.8 0.0 3.3 1.0 0.5 0.0 0.0 0.0 5.9 4.7 1.8 0.0 10.0 0.0 0.0 423.8 2.9 0.0 0.0 0.0 0.4 0.3 6.4 4.8 0.0 4.6 0.2 0.0 47.3 8.0 1.5 0.2 18.9 1.1 3.9 1.2 64.1 0.0 0.2 0.0 0.0 177.7 39.2 0.7 0.3 111.5 0.0 77.8 197.6 0.2 6.2 0.5 0.3 0.1 0.0 0.0 0.7 0.3 0.0 0.5 6.6 0.2 0.0 0.3 1.0 0.0 0.4 0.2 0.1 1194.8 4.0 0.0 0.0 3.0 CSMD1 "KIAA1890, PPP1R24" ENSG00000183117 "CUB and Sushi multiple domains 1" Q96PZ7 8 2935353-4994972 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 10.7" "Group enriched" "Detected in some" 20 "Excitatory neurons: 4868.4;Inhibitory neurons: 3913.1;Oligodendrocyte precursor cells: 4521.8" "Cancer enhanced" "Detected in some" "testis cancer: 0.9" "Region enhanced" "Detected in many" "cerebral cortex: 10.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 4.9;U-2 OS: 2.2;U-266/70: 2.2;U-266/84: 2.1;U-698: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074707 Approved Vesicles NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 1: K-562 - Erythropoiesis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "HPA074707: AB_2686707" "unprognostic (6.32e-2)" "unprognostic (4.23e-2)" "unprognostic (2.37e-1)" "unprognostic (1.67e-3)" "unprognostic (5.72e-2)" "unprognostic (4.26e-2)" "unprognostic (1.02e-2)" "unprognostic (4.66e-2)" "unprognostic (7.69e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-1)" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (2.74e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.11e-1)" 0.1 0.0 3.5 0.0 5.8 0.0 0.2 0.0 10.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 5.8 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.0 1.6 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.6 0.0 2.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.2 0.0 0.0 2.2 2.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 5.8 0.0 10.7 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.0 0.5 108.4 0.0 0.3 0.0 0.0 2.2 15.0 1.0 0.9 2.2 0.0 0.6 1.8 0.0 3.4 0.0 0.1 0.0 0.0 52.5 1.5 0.3 2.2 0.0 0.0 4868.4 0.0 1.3 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 3913.1 0.1 0.0 0.0 0.7 15.0 0.3 0.2 0.0 220.2 0.7 0.5 0.0 4521.8 135.2 0.0 0.1 0.4 0.0 0.0 0.0 1.2 9.7 0.6 0.0 0.2 0.5 10.2 5.3 1.0 0.1 3.6 0.1 2.8 0.0 0.1 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66012008-66013505 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "skin 1: 761.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0" "Group enriched" "Detected in many" 5 "thyroid cancer: 171.0;urothelial cancer: 43.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 130.2;CAPAN-2: 364.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 82000000 "Cluster 61: Skin - Cornification" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" Cytosol "CAB019316: , HPA044963: AB_2679158" "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 3.2 0.3 0.1 0.3 0.1 0.2 28.5 0.8 0.4 7.4 0.8 0.4 0.0 0.3 0.6 34.6 14.9 0.5 2.8 0.1 0.3 2.6 0.3 18.3 0.0 0.2 0.2 0.7 0.7 2.1 1.6 8.1 0.1 0.9 0.0 0.0 7.4 4.9 2.0 761.4 0.3 0.1 0.1 0.2 0.6 1.8 0.4 2.7 21.4 0.0 2.2 1.2 22.5 0.2 130.2 0.0 0.0 0.6 0.0 0.0 37.6 1.4 0.0 0.3 0.2 1.0 364.6 0.0 1.8 5.1 0.1 4.5 0.0 32.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.8 0.6 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.8 0.2 0.7 0.0 0.0 35.8 0.4 0.1 0.8 0.1 0.0 0.2 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.8 0.4 0.1 0.3 0.2 0.2 0.1 0.1 0.4 0.2 0.1 93.0 6.1 0.0 0.6 1.1 1.7 41.4 0.6 0.0 5.3 7.1 1.2 0.0 115.2 58.8 0.0 33.3 0.0 0.1 0.0 57.4 0.2 7.7 0.1 0.9 0.0 0.0 0.0 21.6 24.4 2.0 0.0 0.6 21.6 0.1 0.4 0.1 41.1 0.0 0.0 0.0 24.4 1.4 10.0 0.8 0.0 5.3 5.4 0.0 1.1 1.3 0.0 0.0 0.0 368.1 1.1 0.4 9.8 1.9 0.0 0.5 404.0 0.1 0.0 0.3 16.0 5.2 17.6 1.0 27.6 64.2 0.7 0.0 0.4 6.1 CTSG CG ENSG00000100448 "Cathepsin G" P08311 14 24573518-24576250 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 154 "bone marrow: 5352.9" "Cell type enriched" "Detected in some" 16 "granulocytes: 534.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "THP-1: 8681.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000110, HPA047737" Enhanced "Intracellular and membrane" NA NA 330000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "CAB000110: , HPA047737: AB_2680140" "unprognostic (1.67e-1)" "unprognostic (2.57e-2)" "unprognostic (6.92e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.57e-4)" "unprognostic (4.05e-2)" "unprognostic (4.13e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" "unprognostic (1.63e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.91e-4)" 23.4 0.1 0.0 13.5 0.0 5352.9 25.4 0.0 0.0 16.6 0.0 25.5 5.8 9.6 10.2 22.1 2.7 25.9 3.7 0.0 0.0 2.3 3.6 11.6 6.5 0.0 0.0 0.5 3.5 1.5 1.0 2.9 0.0 3.7 25.5 0.0 11.5 4.8 1.8 28.0 18.1 7.7 0.0 16.9 4.9 3.2 0.0 26.0 0.8 7.6 6.0 34.8 4.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 303.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.1 0.0 0.0 3.6 41.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.2 0.0 3.6 0.0 0.0 8681.4 0.0 0.0 0.3 0.0 5.3 0.0 0.8 2.8 0.0 1287.5 0.1 0.0 6.0 0.0 1.1 1.0 0.0 0.0 0.9 3.4 5.4 0.0 0.0 1.7 7.3 5.0 0.0 6.5 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.8 33.3 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.1 1.0 0.0 0.0 534.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 11.1 9.1 0.0 1.5 5.4 0.0 1.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.3 0.3 1.7 0.0 4.0 0.0 5.1 0.0 0.4 0.0 CTSK "CTSO, CTSO2, PKND, PYCD" ENSG00000143387 "Cathepsin K" P43235 1 150794880-150809577 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 420.6" "Cell type enhanced" "Detected in many" "Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebral cortex: 18.1" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.8" "Lineage enriched" "Detected in single" 4 "monocytes: 1.8" "Group enriched" "Detected in many" 9 "ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1" "Low region specificity" "Detected in all" HPA050346 Supported Vesicles "Intracellular and membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA050346: AB_2681101" "unprognostic (1.48e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (7.61e-3)" "unprognostic (5.08e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (6.60e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.54e-2)" "prognostic unfavorable (7.12e-5)" "unprognostic (6.07e-3)" "unprognostic (2.98e-2)" "unprognostic (5.93e-3)" "unprognostic (6.41e-2)" 224.1 12.5 2.7 33.1 2.8 3.1 227.7 2.9 18.1 420.6 16.4 68.6 13.8 334.0 44.9 46.0 74.0 299.2 35.8 2.7 2.6 12.7 9.0 36.4 42.1 2.7 2.7 78.4 10.6 6.1 14.6 18.9 2.6 34.1 61.8 6.9 53.3 38.0 15.7 219.8 63.8 141.6 2.8 20.2 41.7 15.1 2.7 12.3 34.7 46.3 48.7 210.5 176.2 2.9 0.7 0.3 1.4 0.8 2284.0 813.2 1.0 55.2 1949.1 3.3 8.3 0.3 0.3 0.4 0.6 129.8 0.0 0.6 0.3 0.4 1.2 0.4 0.4 1.4 0.5 0.0 11.0 0.2 1.3 156.5 1.7 50.5 0.7 137.6 4.2 0.6 0.4 1.4 1.5 1.4 0.0 3.0 10.2 1.0 0.0 0.2 0.1 0.1 3.2 0.1 0.6 2.9 0.4 0.0 29.3 3.9 1.0 1.5 1.0 0.7 0.5 0.6 0.6 2.3 1.7 3.6 184.1 0.0 9.9 0.0 1.8 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.4 0.6 2.7 2.8 2.9 18.1 2.7 2.6 2.7 2.7 2.6 2.8 2.7 2.9 17.9 3.2 4.6 2.6 1.1 68.8 0.5 1.6 2.2 12.1 3.7 9.5 2.0 1.5 3.9 3.7 4.2 1.3 2.8 1.5 0.0 1.0 0.9 2.5 59.0 10.2 1.2 0.8 5.0 0.2 2.5 372.4 11.2 3.8 0.0 77.5 14.6 0.5 21.4 3.3 7.7 1.6 8.2 4.6 123.6 4.4 119.0 8.7 97.8 7.5 4.9 2.7 3.1 7.1 2.5 1.4 1.4 149.7 0.8 1.0 1.4 0.1 2.2 7.7 13.1 4.5 33.9 1.4 1.0 2.6 59.1 1.0 5.4 80.9 1.0 0.7 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924491-7926135 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 275.1;endometrium 1: 85.7" "Cell type enriched" "Detected in many" 4 "Endometrial ciliated cells: 127.7" "Group enriched" "Detected in all" 4 "endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 6.5 12.5 176.3 0.9 275.1 0.1 3.2 0.0 173.0 36.9 0.0 61.3 0.9 85.7 2.9 2.6 43.0 0.2 1.0 199.1 58.0 11.7 0.4 7.0 0.0 0.0 21.3 6.2 2.2 1.1 57.0 0.3 1.0 16.3 0.4 0.2 6.4 12.4 0.5 4.1 4.7 4.9 0.0 1.4 8.8 27.8 85.5 0.3 2.8 0.1 0.0 21.2 13.2 40.7 33.5 8.1 20.5 96.4 0.0 0.3 4.8 8.5 2.3 4.1 2.4 2.4 5.0 0.2 16.2 2.0 2.2 35.9 4.7 0.9 0.2 3.0 67.5 0.7 5.3 1.5 0.9 1.8 1.9 0.0 2.7 1.4 0.9 9.8 5.4 9.1 21.3 0.3 0.5 40.5 18.5 13.6 72.4 2.4 34.1 57.3 0.0 6.4 15.0 1.4 56.2 94.5 5.2 2.8 9.9 1.7 21.2 0.6 8.3 2.1 33.1 3.9 4.8 0.7 1.0 4.8 8.0 3.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 176.3 275.1 0.0 173.0 199.1 58.0 0.0 21.3 1.0 0.0 85.5 40.7 0.6 0.0 0.0 3.3 0.7 1.1 4.1 1.5 2.2 0.3 15.3 6.7 0.4 1.5 1.0 9.2 4.2 0.2 0.2 0.5 3.9 7.8 9.5 127.7 22.4 1.6 9.1 0.0 20.6 0.4 0.4 3.0 0.0 7.9 0.0 13.3 0.7 0.1 0.3 0.0 3.5 0.5 2.0 0.3 0.5 27.1 1.2 0.5 1.8 4.7 0.0 0.6 0.0 1.5 2.9 1.7 1.2 1.9 0.0 19.9 0.0 11.9 21.0 0.4 0.0 0.2 17.7 6.0 16.0 0.3 2.0 0.3 0.6 3.2 0.2 6.4 CWH43 "CWH43-C, FLJ21511, PGAP2IP" ENSG00000109182 "Cell wall biogenesis 43 C-terminal homolog" Q9H720 4 48986275-49062081 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.0;prostate: 42.8;skin 1: 25.5" "Cell type enhanced" "Detected in some" "Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0" "Cancer enriched" "Detected in many" 4 "prostate cancer: 20.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA042814, HPA048140" Uncertain Uncertain "Golgi apparatus,Plasma membrane" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Plasma membrane" "HPA042814: AB_2678182, HPA048140: AB_2680280" "unprognostic (9.38e-3)" "unprognostic (6.23e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.32e-4)" "unprognostic (2.14e-1)" "unprognostic (5.00e-2)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-4)" "unprognostic (1.24e-1)" "prognostic favorable (2.29e-11)" "unprognostic (5.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.82e-2)" "unprognostic (2.51e-2)" 0.0 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.0 6.0 0.0 16.9 0.4 0.6 0.4 21.0 14.5 0.0 0.0 0.0 0.0 9.0 0.7 0.7 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 42.8 15.6 0.0 3.0 7.7 0.0 25.5 0.0 0.8 0.1 0.0 9.6 0.0 0.1 0.1 10.2 0.0 1.5 2.1 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 1.9 0.1 0.8 0.0 0.0 0.6 0.1 0.6 0.0 2.3 7.3 0.0 0.0 0.0 10.4 1.9 0.0 0.2 41.3 2.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 10.7 21.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 15.4 0.0 0.0 7.6 0.0 2.9 29.5 0.0 0.0 0.0 0.5 0.0 0.5 3.2 9.1 0.0 0.2 0.0 15.0 0.3 CXCR1 "CD181, CDw128a, CKR-1, CMKAR1, IL8RA" ENSG00000163464 "C-X-C motif chemokine receptor 1" P25024 2 218162841-218166962 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 5.1;dendritic cells: 5.2;granulocytes: 2.5;NK-cells: 11.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 14 "neutrophil: 1472.7" "Lineage enriched" "Detected in many" 62 "granulocytes: 1472.7" "Cell line enriched" "Detected in single" 26 "HMC-1: 5.8" "Not detected" "Not detected" HPA031991 Uncertain NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA031991: AB_2674103" "unprognostic (2.80e-1)" "unprognostic (2.91e-2)" "unprognostic (3.53e-2)" "unprognostic (5.74e-2)" "unprognostic (1.19e-1)" "unprognostic (1.68e-1)" "unprognostic (2.14e-2)" "unprognostic (3.36e-2)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (8.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-1)" "unprognostic (8.85e-2)" 13.2 0.5 0.3 25.1 0.5 9.5 0.4 0.3 1.7 0.7 0.5 0.4 0.2 0.2 0.0 1.6 2.9 4.1 1.8 0.3 0.3 0.5 2.0 9.7 0.3 0.4 0.4 0.1 1.5 0.3 0.2 2.6 1.2 0.3 0.2 0.0 0.5 0.1 0.4 0.3 0.6 1.8 0.3 40.5 0.9 0.2 0.5 1.8 0.4 12.0 0.6 5.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 2.3 2.9 23.7 0.8 0.3 0.2 2.1 6.1 0.7 0.1 0.4 8.7 1472.7 1.5 3.2 0.9 0.3 8.3 0.3 0.5 0.3 1.7 0.3 0.3 0.4 0.4 1.2 0.3 0.5 0.3 0.0 0.0 5.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.7 0.0 0.0 0.2 0.0 11.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137251 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.2;lymphoid tissue: 40.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 52 "neutrophil: 3273.9" "Lineage enriched" "Detected in many" 111 "granulocytes: 3273.9" "Group enriched" "Detected in some" 11 "BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1" "Low region specificity" "Detected in all" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" Yes NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 13.8 1.5 0.3 40.0 0.6 7.3 0.8 0.2 2.6 4.5 0.1 0.9 0.2 0.4 1.3 27.2 2.9 7.8 1.0 0.3 0.1 0.4 2.4 6.5 0.7 0.6 0.5 0.4 2.9 0.4 0.2 4.6 1.4 0.6 0.7 0.0 3.0 3.8 0.5 4.8 1.2 2.4 0.3 27.3 0.7 0.2 0.5 2.8 0.6 11.6 3.0 7.8 7.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 16.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 1.3 0.2 0.0 0.0 0.4 0.0 1.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 15.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 15.1 0.0 63.5 29.5 50.3 28.8 7.4 0.4 0.2 1.3 7.3 13.5 0.2 1.1 9.9 3273.9 6.8 3.6 25.0 0.5 17.4 0.3 0.6 0.2 2.6 0.3 0.1 0.6 0.5 1.4 0.3 0.5 0.4 0.0 0.0 10.5 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.2 0.0 1.9 0.0 0.0 0.7 12.9 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 6.3 3.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.2 1.6 0.0 0.0 2.8 0.0 1.0 3.7 0.0 40.2 0.0 0.1 0.0 2.2 0.0 1.4 0.1 0.0 0.1 0.3 0.0 0.0 0.4 0.4 0.0 0.0 11.6 0.1 0.3 4.1 0.1 0.1 1.9 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153446-54173986 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7" "Cancer enhanced" "Detected in many" "lung cancer: 18.3;urothelial cancer: 21.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "A549: 411.5;Hep G2: 122.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA022261, HPA063771" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 7: Kidney - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.0 0.0 0.2 0.4 0.4 0.0 3.7 0.0 0.3 1.7 0.0 0.0 0.1 14.9 0.2 3.8 0.2 0.0 0.0 0.1 1.8 35.3 0.4 0.7 0.2 0.4 2.0 0.0 0.0 0.0 0.2 10.0 0.3 2.9 0.0 0.0 0.3 2.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.2 1.3 0.0 10.5 28.7 1.3 0.2 0.5 411.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 12.6 0.0 3.2 0.0 0.9 15.8 0.0 0.1 0.1 0.0 0.0 0.0 6.5 122.6 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 7.0 1.3 0.0 2.6 0.6 0.0 0.1 0.1 0.0 0.0 0.0 16.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.1 1.8 0.4 2.0 0.3 0.1 0.6 0.2 0.0 0.0 0.0 0.0 1.3 22.8 48.3 142.7 74.0 0.0 11.0 8.6 0.4 0.0 47.0 0.0 0.0 0.1 0.1 0.1 5.9 0.1 0.0 0.7 0.5 0.3 0.0 0.0 0.2 0.0 0.1 2.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 9.8 0.0 61.3 13.1 0.0 0.0 0.0 0.6 0.0 0.0 3.3 19.6 0.1 0.1 0.0 0.2 36.7 CYP2A13 "CPAD, CYP2A" ENSG00000197838 "Cytochrome P450 family 2 subfamily A member 13" Q16696 19 41088451-41096195 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "liver: 2.0" "Group enriched" "Detected in some" 8 "Club cells: 2.0;Early spermatids: 4.2;Late spermatids: 3.7" "Cancer enriched" "Detected in single" 5 "liver cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "Cluster 62: Liver - Hemostasis" "Cluster 34: Spermatids - Unknown function" "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (9.79e-2)" "unprognostic (1.00e-1)" "unprognostic (4.51e-3)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CYP2A6 "CPA6, CYP2A, CYP2A3" ENSG00000255974 "Cytochrome P450 family 2 subfamily A member 6" P11509 19 40843541-40850447 "Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 171 "liver: 1612.0" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 322.3" "Cancer enriched" "Detected in some" 12 "liver cancer: 281.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.1" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 15: Hepatocytes - Hemostasis" "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (1.21e-1)" "unprognostic (4.10e-1)" "unprognostic (5.05e-2)" "unprognostic (2.64e-2)" "prognostic favorable (5.38e-5)" "unprognostic (4.98e-3)" "unprognostic (4.86e-2)" "unprognostic (6.23e-2)" "unprognostic (5.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.25e-2)" "unprognostic (8.83e-3)" "unprognostic (2.46e-1)" "unprognostic (3.07e-2)" "unprognostic (2.55e-1)" 0.6 0.2 0.0 0.0 0.1 0.0 9.4 0.0 0.2 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 1612.0 0.3 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.2 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.2 5.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 8.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 11.4 322.3 0.0 0.0 0.1 0.0 0.0 14.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 1.5 CYP2F1 CYP2F ENSG00000197446 "Cytochrome P450 family 2 subfamily F member 1" P24903 19 41114432-41128381 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 1.4;salivary gland: 1.0;testis: 2.1" "Cell type enriched" "Detected in some" 4 "Club cells: 67.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "HMC-1: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 71: Testis - DNA repair" "Cluster 3: HMC-1 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (2.04e-1)" "unprognostic (8.79e-2)" "unprognostic (4.63e-1)" "unprognostic (4.60e-2)" "unprognostic (2.54e-1)" "unprognostic (7.29e-3)" "unprognostic (6.23e-3)" "unprognostic (2.87e-2)" "unprognostic (3.91e-2)" "unprognostic (1.58e-6)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.5 0.0 67.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 16.5 0.0 0.0 0.0 1.6 8.0 5.3 1.5 0.0 0.0 0.6 0.0 0.0 0.1 CYP2W1 "FLJ20359, MGC34287" ENSG00000073067 "Cytochrome P450 family 2 subfamily W member 1" Q8TAV3 7 983181-989640 "Predicted intracellular proteins" "Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 19.1;intestine: 6.1;skin 1: 10.5" "Cell type enriched" "Detected in some" 7 "Enteroendocrine cells: 98.5" "Group enriched" "Detected in many" 5 "colorectal cancer: 25.3;stomach cancer: 15.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 13.5;Hep G2: 49.8" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 33: Fibroblasts - ECM organization" "unprognostic (7.09e-3)" "unprognostic (1.94e-2)" "unprognostic (2.75e-2)" "unprognostic (1.51e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (6.26e-2)" "unprognostic (2.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.34e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.85e-4)" 0.1 19.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.4 0.0 0.9 6.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.3 1.0 0.1 2.1 0.5 0.2 0.3 0.2 0.0 10.5 1.0 0.0 0.0 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 2.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 4.0 2.3 1.5 0.0 0.6 0.0 0.0 0.5 0.0 2.6 0.0 0.0 1.1 0.0 3.7 0.0 0.1 0.1 0.1 0.0 0.3 98.5 0.0 0.0 0.9 0.6 10.2 0.0 0.1 0.0 0.3 0.0 0.0 1.1 0.0 0.0 13.6 0.0 0.0 0.9 0.0 1.8 0.3 0.0 0.0 0.1 10.5 0.0 0.0 0.0 0.1 3.3 0.0 0.1 1.2 1.1 0.0 3.3 0.6 0.0 0.8 0.3 0.2 0.1 0.0 4.4 1.9 0.2 4.4 11.4 3.7 CYRIB "BM-009, CYRI, CYRI-B, FAM49B" ENSG00000153310 "CYFIP related Rac1 interactor B" Q9NUQ9 8 129839593-130017129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 198.6" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 117.7;dendritic cells: 66.2;Extravillous trophoblasts: 158.5;Hofbauer cells: 239.7;Syncytiotrophoblasts: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009076 Enhanced Approved Nucleoplasm,Cytosol NA NA 1100000 "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA009076: AB_1848402" "unprognostic (4.35e-2)" "unprognostic (5.22e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.80e-2)" "unprognostic (9.61e-3)" "prognostic unfavorable (3.02e-6)" "unprognostic (4.75e-2)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (3.25e-2)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.09e-10)" "unprognostic (3.85e-3)" "unprognostic (1.95e-1)" "unprognostic (2.67e-1)" "unprognostic (2.46e-1)" 41.3 26.3 24.8 97.4 37.9 198.6 25.9 29.9 46.1 13.5 23.1 31.1 30.3 15.9 21.1 29.4 15.3 30.7 18.4 28.3 32.2 22.9 26.5 39.0 119.7 35.9 33.1 11.4 15.9 17.8 17.6 42.0 34.9 14.8 35.8 28.5 18.2 13.1 25.8 19.0 42.3 28.8 35.7 83.6 28.6 29.9 33.6 79.2 28.5 24.3 105.1 50.6 14.1 49.9 167.5 87.7 93.6 52.9 8.2 12.1 124.2 49.4 47.8 67.2 71.4 50.9 111.8 165.5 105.9 32.6 53.3 81.2 78.2 130.6 100.3 349.1 54.5 166.4 44.6 57.7 31.9 109.2 137.1 19.3 60.1 45.3 93.9 54.9 60.2 132.0 121.2 186.3 74.5 74.5 372.0 80.3 79.8 130.4 119.7 160.1 63.3 278.3 138.4 67.4 62.1 81.2 99.2 61.9 152.5 84.1 72.4 139.0 37.5 24.7 158.5 52.8 106.8 61.5 195.7 275.1 38.8 233.5 65.3 350.7 212.5 404.4 161.6 256.2 124.7 122.7 91.2 134.0 280.9 98.7 80.1 132.3 553.9 189.6 232.8 179.8 136.7 306.0 24.8 37.9 29.9 46.1 28.3 32.2 35.9 33.1 34.9 35.7 33.6 49.9 8.4 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 117.7 66.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 158.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 239.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 60.5 8.4 0.0 0.0 0.0 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" A8MQ03 9 137224635-137226315 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "esophagus: 239.5" "Group enriched" "Detected in some" 10 "Pancreatic endocrine cells: 58.0;Squamous epithelial cells: 66.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 25.1;CAPAN-2: 28.9;HaCaT: 33.3;HeLa: 30.6;MCF7: 49.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.6 1.1 0.6 0.2 0.4 0.4 1.5 0.3 1.6 43.1 0.0 0.6 0.4 0.5 0.4 239.5 1.8 0.7 0.9 0.8 0.8 3.7 1.7 1.1 0.7 1.4 1.3 0.3 1.5 0.6 7.3 0.3 0.6 2.6 0.1 0.6 29.9 0.5 0.4 34.4 0.8 0.0 1.0 0.7 2.0 4.1 0.9 0.3 2.4 0.0 14.3 1.2 57.7 0.5 25.1 2.4 1.8 3.9 0.0 0.1 5.3 0.4 0.4 0.5 0.2 1.3 28.9 1.3 1.2 0.3 0.7 33.3 0.5 7.0 0.0 2.7 1.8 0.3 30.6 16.8 0.9 0.2 1.4 0.4 3.5 0.9 0.2 1.3 0.3 1.4 0.6 3.1 1.6 49.5 0.7 1.0 0.7 4.8 3.0 2.4 2.8 3.5 0.6 1.6 0.4 1.8 4.5 3.5 0.9 1.5 7.7 0.4 1.0 1.1 0.9 3.2 0.6 1.9 1.7 1.2 1.4 1.3 1.4 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.6 0.4 0.3 1.6 0.8 0.8 1.4 1.3 0.6 1.0 0.9 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.5 0.4 1.5 2.5 5.5 0.0 0.6 0.1 0.4 0.0 4.6 0.5 2.1 0.2 0.3 0.0 0.0 0.3 5.8 0.2 0.1 3.1 1.7 0.0 0.6 0.7 0.8 0.2 0.0 0.3 0.6 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 58.0 1.1 0.4 0.1 0.2 1.6 0.9 0.0 0.6 0.0 0.3 0.3 3.0 1.1 66.0 0.0 0.0 0.1 0.9 0.5 1.7 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 50.2;thyroid gland: 41.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9" "Lineage enriched" "Detected in many" 25 "granulocytes: 213.0" "Cell line enhanced" "Detected in many" "ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA071581: AB_2686421" "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 12.5 2.2 5.9 2.7 7.6 15.9 8.8 5.9 8.1 6.7 4.3 9.8 20.6 1.6 0.2 3.3 1.7 1.5 28.0 5.5 6.7 4.5 2.0 20.0 3.1 6.2 6.8 0.9 2.7 0.9 1.6 0.4 6.6 5.1 6.6 0.4 7.5 3.6 50.2 8.1 21.3 1.7 6.0 7.8 9.9 3.1 6.6 1.5 41.9 19.6 2.6 2.4 9.5 9.5 3.1 2.3 6.1 1.5 10.6 0.5 0.0 2.1 6.7 1.1 1.2 1.0 1.6 0.2 0.7 6.7 3.7 9.2 3.8 0.1 0.6 0.2 0.2 1.3 4.5 0.1 0.1 0.1 18.3 1.1 7.9 0.4 0.2 7.0 0.7 0.1 0.4 0.1 0.7 9.7 0.0 0.4 0.7 3.1 2.2 2.9 0.0 0.3 0.0 3.2 0.4 0.3 0.4 1.2 0.0 1.5 5.2 0.4 0.4 0.9 1.0 1.4 1.8 0.6 0.2 0.0 0.0 3.0 0.3 94.3 0.2 213.0 2.1 0.1 0.9 1.3 0.6 2.2 0.2 0.4 0.0 1.4 65.9 2.7 0.1 8.6 0.1 1.3 5.9 7.6 5.9 8.1 5.5 6.7 6.2 6.8 6.6 6.0 6.6 9.5 24.9 86.6 22.3 5.2 4.8 11.6 7.0 8.7 0.6 0.1 9.4 7.4 46.2 1.5 14.6 0.0 0.0 0.1 22.6 45.2 1.9 9.1 25.3 3.0 1.6 6.4 8.4 0.8 15.9 35.6 0.2 8.7 16.3 7.8 15.2 1.3 5.7 1.3 0.4 5.0 2.1 17.0 6.1 1.3 0.8 112.5 3.1 3.2 0.0 15.0 0.3 2.1 2.1 11.1 99.9 9.4 30.6 5.7 0.4 12.0 64.0 0.3 2.8 0.3 13.1 7.6 4.5 2.6 4.9 0.5 4.1 0.1 14.9 1.9 19.6 14.0 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "choroid plexus: 25.7;fallopian tube: 32.6;testis: 51.3" "Group enriched" "Detected in some" 13 "Early spermatids: 106.7;Late spermatids: 215.3;Respiratory ciliated cells: 113.9;Spermatocytes: 177.1" "Cancer enhanced" "Detected in some" "lung cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.8;HUVEC TERT2: 21.8;U-2197: 40.7" "Low region specificity" "Detected in many" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 18: U-2197 - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.6 0.0 4.3 0.1 5.3 0.3 0.4 2.9 4.7 0.7 25.7 0.2 0.0 0.1 0.3 0.5 32.6 0.3 0.5 4.5 4.5 0.2 0.4 3.0 0.2 7.3 8.8 0.1 0.0 0.2 0.2 0.8 5.5 0.0 0.0 0.7 0.1 0.0 3.6 0.2 0.0 0.1 6.8 0.2 0.1 51.3 5.4 0.4 0.1 0.0 0.2 0.1 0.0 5.4 0.8 0.0 0.1 0.0 0.3 1.2 0.6 0.8 0.4 0.9 0.6 5.4 0.5 0.2 0.0 0.2 8.8 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.1 1.7 0.0 1.0 0.7 5.8 21.8 0.0 0.0 0.3 0.4 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.1 0.3 0.1 0.2 0.4 0.1 0.8 0.0 0.0 0.2 0.0 0.5 2.2 0.2 2.0 40.7 0.0 0.0 0.1 0.3 3.9 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.3 2.9 4.7 4.5 4.5 7.3 8.8 5.5 6.8 5.4 5.4 0.0 0.0 1.1 0.3 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.7 0.0 11.5 0.0 4.2 0.2 0.0 0.0 0.0 0.2 106.7 11.2 0.0 0.2 0.0 0.0 6.2 0.0 2.8 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 8.2 0.0 0.0 215.3 3.4 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.1 3.0 0.2 2.6 0.0 0.1 0.0 0.1 113.9 0.3 0.0 0.7 2.1 177.1 4.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 DCDC1 "DCDC5, FLJ46154" ENSG00000170959 "Doublecortin domain containing 1" M0R2J8 11 30830369-31369810 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;choroid plexus: 10.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Early spermatids: 39.0;Endometrial ciliated cells: 47.7;Late spermatids: 18.0;Respiratory ciliated cells: 61.6;Rod photoreceptor cells: 19.0;Spermatocytes: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.5" "Low region specificity" "Detected in all" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.01e-2)" "unprognostic (1.57e-1)" "unprognostic (8.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (5.68e-2)" "unprognostic (4.73e-1)" "unprognostic (3.17e-1)" "unprognostic (4.47e-3)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-3)" "unprognostic (2.61e-1)" 0.0 0.1 0.9 0.0 1.0 0.0 0.3 0.3 0.4 0.4 10.6 0.0 0.0 0.2 1.7 0.0 4.1 1.8 0.0 2.4 1.3 0.9 2.7 0.4 0.0 4.5 4.5 0.2 1.0 1.1 1.8 0.0 2.7 0.0 0.0 3.6 0.1 0.1 0.0 0.2 0.0 0.0 3.4 0.0 0.0 2.4 1.7 0.0 0.7 0.1 0.0 0.0 0.0 1.3 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.3 0.4 2.4 1.3 4.5 4.5 2.7 3.4 1.7 1.3 0.2 0.0 1.5 3.3 0.1 0.3 0.3 0.9 0.0 6.0 0.8 0.9 1.0 2.8 4.8 0.0 20.9 0.0 0.0 0.0 0.0 0.9 39.0 47.7 0.8 0.2 0.0 0.0 5.3 0.0 0.0 0.7 0.0 1.7 0.0 0.3 0.0 3.4 0.1 0.0 1.9 0.0 2.0 0.6 0.3 18.0 1.5 0.1 0.0 1.0 0.0 4.6 0.0 1.5 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 61.6 19.0 0.0 0.1 0.7 15.4 4.4 0.0 0.0 0.0 0.1 0.4 0.0 0.1 DCDC2B ENSG00000222046 "Doublecortin domain containing 2B" A2VCK2 1 32209094-32216196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "fallopian tube: 27.6" "Group enriched" "Detected in some" 6 "Endometrial ciliated cells: 31.7;Respiratory ciliated cells: 112.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045832 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "HPA045832: AB_10962048" "unprognostic (6.45e-3)" "unprognostic (3.71e-2)" "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (2.18e-1)" "unprognostic (1.87e-3)" "unprognostic (7.66e-3)" "unprognostic (6.35e-2)" "unprognostic (4.84e-2)" "unprognostic (3.33e-1)" "unprognostic (2.71e-3)" "unprognostic (8.73e-2)" "unprognostic (6.18e-4)" "unprognostic (8.53e-2)" "unprognostic (2.00e-1)" "unprognostic (4.76e-2)" "unprognostic (4.39e-3)" 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.4 1.1 0.0 0.0 0.3 0.0 0.0 27.6 0.3 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.5 1.0 0.1 0.0 0.0 4.4 0.0 2.8 0.2 0.4 0.0 0.0 7.9 1.8 4.2 0.1 0.0 0.1 0.0 0.0 7.4 31.7 0.5 0.3 0.0 0.0 1.3 0.0 0.0 0.5 0.5 0.5 1.3 0.1 0.0 0.0 0.0 3.3 1.1 0.1 10.2 0.0 0.0 11.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 112.0 4.6 0.0 0.2 1.9 2.5 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131382 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.0" "Group enriched" "Detected in many" 6 "Excitatory neurons: 970.6;Inhibitory neurons: 664.8" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 29.0;ASC TERT1: 27.3;fHDF/TERT166: 23.5;GAMG: 34.8;HAP1: 17.9;HSkMC: 25.5;NTERA-2: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Cytosol "CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265" "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 15.5 2.5 22.0 4.0 27.5 0.0 14.2 10.2 45.3 11.8 0.0 4.2 1.1 6.0 4.1 5.4 4.6 7.2 5.5 37.1 37.8 2.8 0.1 2.4 4.2 17.9 13.2 6.1 1.2 1.1 13.7 0.1 53.0 4.1 3.8 17.3 3.4 4.0 2.1 8.4 4.1 19.1 15.7 4.5 3.6 1.3 17.5 1.6 2.8 4.6 2.2 4.3 5.9 18.7 0.0 0.4 6.8 0.0 29.0 27.3 0.0 0.2 0.4 0.2 0.2 0.0 0.1 0.0 0.0 23.5 34.8 0.0 17.9 0.3 0.0 0.0 1.0 0.0 0.8 0.0 1.1 0.0 0.0 25.5 13.0 0.6 0.4 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 37.1 0.0 0.4 0.0 2.0 0.0 1.0 0.0 7.3 4.4 0.0 0.0 2.2 10.4 0.0 0.0 0.0 0.1 6.1 7.6 1.3 0.1 0.0 0.0 2.4 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 27.5 10.2 45.3 37.1 37.8 17.9 13.2 53.0 15.7 17.5 18.7 8.0 9.6 0.6 132.2 0.1 15.2 1.3 1.8 0.0 9.4 7.8 7.0 5.8 0.0 7.9 3.7 4.2 0.0 0.0 0.0 0.0 0.1 1.5 0.7 1.7 3.8 0.0 0.0 970.6 0.0 0.0 82.6 0.5 0.3 0.0 75.5 0.4 0.0 0.1 10.1 664.8 0.0 4.1 0.3 14.7 1.6 20.8 0.7 14.2 44.0 0.0 73.8 0.0 31.2 19.1 0.2 0.0 4.1 0.3 0.6 0.0 0.6 3.1 4.2 6.6 10.8 22.0 1.3 1.4 1.0 9.7 0.0 0.8 30.1 0.0 1.7 DEFA1 "DEF1, DEFA2, HNP-1, MRS" ENSG00000206047 "Defensin alpha 1" P59665 8 6977649-6980080 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "bone marrow: 18020.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "NB-4: 2.1" "CAB032548, HPA052517" Enhanced "Secreted to blood" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "CAB032548: AB_2277258, HPA052517: AB_2681860" 31.6 4.3 0.7 0.6 0.8 18020.9 16.8 0.5 3.0 4.0 0.6 4.1 0.0 11.3 0.0 3.2 2.2 1.3 62.5 0.5 0.6 15.0 91.6 560.5 3.5 0.7 0.7 4.1 5.5 0.1 20.6 11.4 0.7 2.7 0.0 0.3 14.5 0.0 16.8 40.3 2.3 0.0 0.8 1803.8 6.4 3.1 0.8 37.0 15.8 0.0 0.8 3.4 5.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.5 3.0 0.5 0.6 0.7 0.7 0.7 0.8 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DEFA1B ENSG00000240247 "Defensin alpha 1B" P59665 8 6996766-6999195 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 872.0" "Cell type enriched" "Detected in single" 37 "T-cells: 3.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebral cortex: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052517 Supported "Secreted to blood" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 11: Alveolar cells - Smell perception" "HPA052517: AB_2681860" 2.3 0.3 0.1 0.8 0.1 872.0 1.1 0.1 2.0 0.0 0.1 0.2 0.0 0.9 0.0 0.1 0.1 0.0 3.8 0.2 0.1 0.9 9.1 52.1 0.0 0.2 0.1 0.3 0.1 0.0 1.4 7.2 0.4 0.1 0.0 0.1 9.4 0.0 0.8 0.2 0.2 0.0 0.1 150.4 0.6 0.1 0.4 27.8 1.2 5.8 1.4 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.0 0.2 0.1 0.2 0.1 0.4 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 DEFA3 "DEF3, HNP-3" ENSG00000239839 "Defensin alpha 3" P59666 8 7015869-7018297 "Cancer-related genes, Predicted secreted proteins" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 64 "bone marrow: 37615.2" "Cell type enhanced" "Detected in some" "B-cells: 17.9;Erythroid cells: 10.1;Hepatocytes: 17.0;Macrophages: 5.7;Plasma cells: 4.0;T-cells: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 19 "neutrophil: 854.3" "Lineage enriched" "Detected in many" 19 "granulocytes: 854.3" "Cell line enriched" "Detected in single" 8 "NB-4: 1.5" HPA052517 Supported "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "HPA052517: AB_2681860" "unprognostic (8.21e-2)" 8.8 1.2 0.5 1.0 0.3 37615.2 5.0 0.2 1.2 2.0 0.3 1.3 0.0 5.6 0.0 1.0 0.7 0.2 16.1 0.2 0.3 4.4 26.1 180.2 5.3 0.4 0.6 1.3 1.6 0.0 7.6 18.8 0.5 0.8 0.0 0.2 24.2 0.0 5.0 42.1 0.7 0.0 0.5 589.4 1.8 0.6 0.6 147.9 4.5 1.1 1.3 1.1 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 24.4 3.6 44.3 1.2 1.6 2.3 1.0 0.8 1.0 1.1 6.9 0.3 854.3 0.4 2.6 1.4 0.3 6033.6 0.5 0.3 0.2 1.2 0.2 0.3 0.4 0.6 0.5 0.5 0.6 0.2 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.8 17.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 DEFA4 "DEF4, HP-4" ENSG00000164821 "Defensin alpha 4" P12838 8 6935820-6938306 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "bone marrow: 2702.9" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.2;Hepatocytes: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 13 "neutrophil: 13.1" "Lineage enriched" "Detected in many" 13 "granulocytes: 13.1" "Cell line enriched" "Detected in single" 8 "THP-1: 6.8" HPA051266 Enhanced "Secreted to blood" NA NA 98000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "HPA051266: AB_2681414" 0.7 0.1 0.0 0.2 0.0 2702.9 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.3 2.7 14.2 0.6 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.4 2.0 0.1 0.0 0.0 46.4 0.1 0.1 0.0 8.9 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100159645 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.0;intestine: 34.8;skin 1: 54.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 82.8;Paneth cells: 77.0;Proximal enterocytes: 298.9;Respiratory ciliated cells: 144.8;Squamous epithelial cells: 86.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.5;eosinophil: 6.6;memory B-cell: 10.9;naive B-cell: 6.8" "Group enriched" "Detected in many" 5 "B-cells: 10.9;granulocytes: 6.6" "Group enriched" "Detected in some" 16 "OE19: 69.3;T-47d: 104.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046644 Approved Nucleoplasm,Nucleoli NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 31: Skin - Epidermis development" "Cluster 6: T47d - Mammary gland" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nucleoli" "HPA046644: AB_2797231" "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favorable (1.66e-4)" 0.4 0.1 6.4 1.0 7.2 0.2 6.1 18.3 7.1 4.8 3.6 8.9 24.7 3.3 0.5 37.0 2.0 6.5 0.2 5.1 4.5 10.8 0.9 1.6 0.6 5.9 5.3 1.0 6.9 0.4 3.3 0.4 6.0 2.3 4.5 0.2 8.6 2.1 0.3 54.2 34.8 0.5 4.8 0.8 20.1 1.1 5.3 0.1 2.4 0.0 1.8 6.5 10.1 4.9 0.0 0.3 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 2.4 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 1.1 1.6 0.0 0.0 4.2 0.4 0.3 0.1 69.3 0.0 0.4 0.0 3.6 0.0 1.6 5.2 0.1 0.0 3.1 0.0 0.1 104.4 1.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.5 0.4 6.6 1.6 0.0 0.0 10.9 0.1 0.7 0.7 6.8 0.0 1.0 0.2 0.2 0.0 0.1 0.0 0.7 6.4 7.2 18.3 7.1 5.1 4.5 5.9 5.3 6.0 4.8 5.3 4.9 0.7 3.2 5.0 5.2 3.7 1.8 3.3 22.9 1.2 4.6 24.2 15.2 0.6 37.1 34.8 82.8 0.0 7.7 3.3 24.2 1.9 19.0 1.2 15.3 4.3 3.8 55.3 1.3 0.5 1.5 4.9 1.3 54.6 28.9 9.5 0.9 0.4 0.3 1.6 0.0 0.4 53.5 34.6 0.9 0.6 1.6 0.3 1.5 0.0 3.7 0.5 1.2 12.3 0.0 1.5 2.4 77.0 0.0 3.7 1.7 298.9 0.4 144.8 22.0 0.0 1.1 3.1 3.2 4.0 86.9 15.3 37.4 2.5 0.2 69.6 21.0 DENND6B "AFI1B, FAM116B, MGC33692" ENSG00000205593 "DENN domain containing 6B" Q8NEG7 22 50309030-50327012 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 42.1;Late spermatids: 58.7;monocytes: 39.4;Respiratory ciliated cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 6.9;RPMI-8226: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018934, HPA021653, HPA029570" Uncertain Uncertain "Plasma membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131" "unprognostic (2.50e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.41e-4)" "prognostic favorable (5.93e-5)" "unprognostic (9.39e-2)" "unprognostic (3.17e-1)" "unprognostic (1.89e-3)" "unprognostic (1.16e-1)" "unprognostic (5.10e-2)" "unprognostic (4.50e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (8.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" 2.4 3.8 10.6 2.3 10.8 1.0 3.4 8.0 14.4 6.2 8.6 3.9 1.1 5.2 2.5 2.5 13.4 3.2 1.7 10.3 9.5 7.6 1.7 4.7 2.9 9.4 9.1 4.0 5.4 2.7 13.6 1.0 9.5 5.5 0.9 4.2 3.6 3.6 0.7 2.6 3.9 1.7 6.9 4.5 3.3 6.7 9.6 0.8 6.7 0.6 1.7 2.6 3.5 7.7 0.5 1.8 3.9 4.3 1.0 3.7 0.0 0.8 1.9 0.5 0.3 0.1 2.8 6.9 1.7 1.9 0.2 3.4 0.1 0.1 0.2 1.7 1.0 1.2 3.5 0.2 0.9 0.2 3.0 3.1 4.2 0.1 0.6 3.8 0.8 0.1 1.5 1.2 0.9 3.0 0.0 0.6 0.3 2.0 0.2 1.0 0.0 10.0 4.9 1.6 1.7 3.1 2.1 2.7 0.3 0.2 4.3 1.0 0.9 0.7 0.6 0.6 0.1 1.0 0.2 1.0 1.7 0.8 0.8 0.2 0.8 0.0 0.1 1.0 0.2 0.2 0.1 0.2 0.5 0.2 0.1 0.2 0.1 0.3 1.3 0.4 0.1 0.3 10.6 10.8 8.0 14.4 10.3 9.5 9.4 9.1 9.5 6.9 9.6 7.7 4.5 3.2 4.1 16.3 14.9 1.1 3.6 6.1 5.7 6.2 5.4 5.8 1.3 11.5 8.3 5.5 22.9 0.3 9.5 3.9 3.9 6.5 24.7 42.1 4.6 5.7 10.2 4.4 20.3 1.8 0.6 4.2 9.2 5.7 5.7 2.8 4.2 1.0 13.7 1.7 13.7 3.3 4.1 24.2 7.8 58.7 2.5 20.0 5.4 2.8 39.4 5.6 5.2 9.0 2.5 2.6 2.1 2.6 33.2 2.4 14.0 17.8 65.5 17.5 0.0 2.5 3.0 24.7 22.2 1.6 0.6 1.0 8.4 3.1 3.6 2.3 DEPDC1 "DEP.8, DEPDC1A, FLJ20354, SDP35" ENSG00000024526 "DEP domain containing 1" Q5TB30 1 68474152-68497221 "Predicted intracellular proteins" "Transcription, Transcription regulation" "GTPase activation, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.0;lymphoid tissue: 8.1;testis: 8.1" "Cell type enhanced" "Detected in many" "Early spermatids: 44.9;Erythroid cells: 31.8;Extravillous trophoblasts: 35.2;Late spermatids: 73.0;Spermatocytes: 86.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB017845 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli fibrillar center" "CAB017845: " "unprognostic (2.73e-1)" "unprognostic (7.40e-2)" "prognostic favorable (8.70e-5)" "unprognostic (1.23e-3)" "unprognostic (3.06e-1)" "unprognostic (7.73e-3)" "unprognostic (4.37e-6)" "unprognostic (3.39e-3)" "unprognostic (1.57e-3)" "unprognostic (8.59e-2)" "unprognostic (9.04e-6)" "unprognostic (2.18e-1)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.83e-2)" "unprognostic (1.11e-1)" 0.3 0.1 0.0 2.6 0.0 5.0 0.6 0.0 0.1 0.4 0.0 2.9 2.5 0.5 0.1 2.4 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.2 4.8 0.0 0.1 0.0 0.0 0.2 0.0 3.2 0.1 2.1 3.5 0.0 0.3 0.1 0.0 1.6 2.4 1.5 0.0 0.6 1.2 8.1 0.2 8.1 0.3 0.2 4.8 0.9 0.7 0.2 47.2 21.5 40.0 18.5 2.5 5.6 31.3 58.9 26.9 49.1 42.1 17.9 19.3 0.0 42.8 24.4 78.6 30.8 58.6 30.7 82.4 41.2 38.2 38.3 35.9 10.5 0.6 33.4 0.0 2.1 1.6 56.3 31.2 10.0 36.0 16.5 26.6 36.1 88.3 10.7 0.1 12.5 34.6 19.5 28.9 0.0 118.7 15.3 19.8 12.7 44.8 20.7 59.0 24.9 30.3 25.6 22.5 16.6 21.3 31.5 35.5 56.0 69.2 22.5 52.2 0.5 29.7 11.4 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.3 2.0 3.3 0.8 3.3 1.2 0.4 1.3 1.8 0.8 0.0 0.5 1.8 0.0 20.6 0.4 2.1 0.0 0.2 44.9 4.0 1.6 1.6 0.0 31.8 0.5 0.0 35.2 4.4 8.2 2.0 0.0 17.5 2.2 1.2 8.6 0.0 2.2 5.3 4.1 3.5 1.0 73.0 0.3 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 6.9 2.2 0.5 0.1 0.9 0.2 0.0 0.6 4.0 86.8 19.6 12.2 1.3 2.9 1.6 0.5 8.8 1.7 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.1;gallbladder: 21.0;lymphoid tissue: 20.7;testis: 12.6" "Cell type enhanced" "Detected in many" "Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.3 0.2 0.4 3.9 0.7 11.1 0.9 0.5 0.5 0.6 0.1 4.1 6.0 0.6 0.0 2.5 0.2 21.0 0.1 0.3 0.6 2.9 0.4 0.4 9.1 1.2 0.5 0.2 0.1 0.0 0.0 7.5 1.4 0.2 5.5 0.1 0.5 0.1 0.0 2.1 6.4 0.9 0.6 1.6 1.4 12.6 0.6 20.7 1.2 0.0 9.7 1.0 1.1 1.5 61.0 20.3 60.5 37.2 1.3 1.9 66.2 16.1 10.9 27.7 35.8 34.0 37.5 34.6 38.5 5.0 36.0 19.8 49.2 36.1 36.9 49.5 35.5 43.3 22.7 42.6 1.0 36.7 40.3 1.2 3.7 9.0 12.9 5.4 26.1 36.3 31.4 45.8 24.7 38.0 59.8 31.9 44.7 13.0 32.6 65.4 49.2 29.4 22.8 29.9 33.6 15.4 37.7 13.4 17.7 27.0 24.9 28.8 12.1 11.7 34.2 9.5 41.6 23.0 43.3 68.0 14.7 53.2 33.3 1.5 0.1 0.9 0.2 0.0 0.2 0.4 1.0 0.7 0.3 0.0 0.1 0.1 0.0 0.6 0.0 0.0 3.2 0.4 0.4 0.7 0.5 0.5 0.3 0.6 1.2 0.5 1.4 0.6 0.6 1.5 0.2 0.0 1.8 0.0 1.9 4.7 1.0 1.5 0.0 0.1 0.5 0.8 0.1 18.6 0.3 0.0 0.0 7.4 1.1 3.1 0.0 0.3 1.9 3.3 1.4 0.9 0.0 23.8 5.5 0.2 21.6 1.1 2.6 11.7 3.8 5.2 0.0 0.3 6.4 0.0 1.7 2.3 0.0 1.6 2.9 2.4 0.3 1.9 0.0 4.7 0.1 0.2 0.0 2.0 7.0 0.9 5.8 0.0 15.9 0.7 3.7 1.0 0.1 0.1 6.6 0.3 1.4 37.2 12.7 5.8 2.0 46.9 4.5 0.6 7.9 0.9 DERL3 "C22orf14, derlin-3, FLJ43842, IZP6, MGC71803" ENSG00000099958 "Derlin 3" Q96Q80 22 23834503-23839128 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 61.6;pancreas: 60.8;salivary gland: 51.1" "Cell type enriched" "Detected in many" 6 "Plasma cells: 1428.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "plasmacytoid DC: 187.4" "Lineage enriched" "Detected in many" 14 "dendritic cells: 187.4" "Cell line enhanced" "Detected in some" "Karpas-707: 26.9;RPMI-8226: 23.6;U-266/70: 48.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB037234, HPA049306" Approved Uncertain Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "CAB037234: AB_1840802, HPA049306: " "unprognostic (2.01e-3)" "prognostic favorable (8.70e-5)" "unprognostic (9.72e-3)" "unprognostic (7.47e-2)" "unprognostic (9.77e-3)" "prognostic favorable (8.01e-4)" "unprognostic (2.23e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (4.74e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.76e-13)" "unprognostic (1.53e-2)" "unprognostic (4.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.95e-1)" 2.6 3.2 1.4 4.3 1.4 1.8 5.4 1.3 2.2 6.1 1.9 30.6 10.0 3.7 0.2 4.3 7.1 2.3 7.7 1.3 1.6 5.7 9.1 9.2 9.2 1.8 2.2 2.0 60.8 0.8 8.1 0.8 1.7 3.3 10.9 0.2 51.1 3.8 2.7 0.8 33.7 0.7 1.7 61.6 29.4 24.8 1.7 1.6 14.6 0.2 17.6 3.6 2.3 1.5 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.5 4.8 0.9 0.0 1.4 0.0 1.1 1.3 0.0 0.5 4.8 0.4 4.6 0.0 0.7 3.2 0.6 0.0 0.2 0.5 0.0 0.1 0.1 0.5 0.8 26.9 0.0 0.0 1.3 2.2 1.0 2.3 0.3 4.2 0.0 23.6 0.9 0.3 0.6 0.1 0.1 0.0 0.2 0.7 0.0 1.5 0.0 0.0 0.0 0.4 0.1 48.5 6.3 8.3 0.8 6.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 13.8 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.0 0.0 187.4 0.0 1.3 1.4 1.4 1.3 2.2 1.3 1.6 1.8 2.2 1.7 1.7 1.7 1.5 0.5 0.0 1.1 0.3 183.8 1.8 1.5 3.7 0.6 1.1 19.3 1.8 3.5 1.5 4.1 0.0 2.1 0.8 141.7 2.7 0.0 0.5 113.2 33.8 0.9 1.1 1.8 8.2 0.3 5.8 6.2 2.2 7.7 1.7 2.5 15.7 4.6 7.8 3.4 0.0 1.7 7.9 4.1 2.2 2.1 158.2 2.5 5.4 224.1 1.9 0.5 0.8 0.0 1.0 0.5 1.1 0.5 4.1 1428.8 2.5 0.8 0.5 30.3 0.6 0.0 0.8 2.6 67.0 32.9 1.3 2.0 15.5 17.9 2.1 10.7 2.0 DES "CMD1I, CSM1, CSM2" ENSG00000175084 Desmin P17661 2 219418377-219426734 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 2531.9" "Cancer enhanced" "Detected in all" "prostate cancer: 562.1;stomach cancer: 400.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "midbrain: 29.5" "CAB000034, HPA018803" Enhanced Supported "Intermediate filaments" NA NA 1600000 "Cluster 7: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "CAB000034: , HPA018803: AB_1847616" "unprognostic (1.75e-1)" "unprognostic (1.95e-3)" "unprognostic (3.43e-2)" "unprognostic (8.76e-2)" "unprognostic (7.75e-3)" "unprognostic (6.61e-3)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (4.67e-1)" "unprognostic (3.84e-2)" "unprognostic (2.57e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (3.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (9.25e-3)" 235.3 57.1 2.1 436.2 4.9 1.1 51.2 2.1 9.6 504.3 5.0 8627.2 291.3 3015.2 86.0 1481.2 1085.0 452.1 13020.7 2.4 2.5 37.6 15.5 173.9 7.2 3.4 2.5 171.8 14.6 0.5 8.4 52.7 2.4 2218.8 245.6 0.0 255.3 2253.1 16532.0 152.4 1343.5 2557.5 2.1 25.2 1965.6 16.1 2.6 3.2 66.2 5753.8 1.2 4761.8 669.4 2.4 0.0 0.0 0.1 0.0 0.0 2.2 5.3 0.2 0.0 0.1 0.1 0.5 0.0 0.0 9.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 17.0 0.1 1.3 70.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 145.3 0.0 0.0 39.5 0.5 0.0 0.0 0.0 333.1 2.1 0.0 0.0 0.2 1.2 0.0 0.0 0.0 9.2 0.0 5.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.1 4.9 2.1 9.6 2.4 2.5 3.4 2.5 2.4 2.1 2.6 2.4 0.4 0.0 0.0 0.0 0.0 4.1 2.7 0.0 0.0 0.0 0.1 0.0 2531.9 1.5 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 90.6 0.5 6.7 22.7 0.0 0.0 0.1 0.0 5.2 104.6 0.0 0.1 0.0 0.0 1.8 0.0 5.6 0.0 0.0 0.9 0.0 0.0 10.7 71.6 28.9 2.8 12.4 0.0 0.6 0.0 0.0 0.5 0.0 0.5 0.0 50.4 0.0 8.7 0.0 0.1 0.0 0.0 46.0 497.8 210.5 5.0 5.1 0.1 9.8 8.5 2.4 0.0 0.2 2.9 DEUP1 "CCDC67, FLJ25393" ENSG00000165325 "Deuterosome assembly protein 1" Q05D60 11 93329971-93438487 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.8;testis: 16.4" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 16.8;Respiratory ciliated cells: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (4.68e-1)" "unprognostic (3.25e-1)" "unprognostic (3.93e-1)" "unprognostic (7.24e-3)" "unprognostic (2.09e-1)" "unprognostic (4.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.79e-2)" "unprognostic (1.16e-1)" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (1.41e-3)" "unprognostic (1.33e-1)" "unprognostic (6.03e-3)" "unprognostic (8.59e-2)" "unprognostic (2.25e-1)" 0.0 0.5 0.4 0.0 0.2 0.0 0.4 0.0 0.1 0.0 1.8 0.1 0.0 0.0 1.1 0.0 4.8 0.1 0.0 0.4 2.1 0.3 0.0 0.3 0.0 0.7 1.1 0.3 0.8 0.3 1.5 0.0 0.6 0.9 0.1 0.1 0.2 0.3 0.0 0.2 0.0 0.1 0.5 0.1 0.0 16.4 3.6 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.4 2.1 0.7 1.1 0.6 0.5 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 16.8 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 21.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DIO1 TXDI1 ENSG00000211452 "Iodothyronine deiodinase 1" P49895 1 53891239-53911086 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "kidney: 144.9;liver: 185.3;thyroid gland: 260.2" "Group enriched" "Detected in some" 5 "Hepatocytes: 61.5;Proximal tubular cells: 115.7" "Group enriched" "Detected in many" 8 "liver cancer: 44.7;thyroid cancer: 43.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "Hep G2: 33.9;SK-BR-3: 79.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 81: Kidney & Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (4.89e-2)" "unprognostic (4.86e-2)" "unprognostic (1.81e-2)" "unprognostic (1.21e-2)" "unprognostic (1.06e-1)" "unprognostic (2.68e-2)" "unprognostic (3.91e-3)" "unprognostic (6.96e-4)" "unprognostic (6.94e-2)" "unprognostic (4.83e-2)" "unprognostic (8.81e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-3)" "unprognostic (9.99e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (3.59e-2)" 0.1 0.2 0.2 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.2 4.6 1.0 0.6 0.1 0.1 144.9 185.3 0.4 0.8 0.3 0.2 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.7 0.3 0.0 260.2 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 1.0 0.3 0.0 33.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.0 0.3 0.1 0.1 0.2 0.3 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 79.0 0.0 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.9 0.1 15.2 11.5 0.4 0.0 0.0 0.5 0.1 0.0 11.7 0.0 3.6 0.3 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 61.5 0.5 0.0 0.5 0.0 0.0 2.2 0.0 5.3 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 115.7 10.2 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 2.3 0.3 0.1 0.0 0.0 DLEC1 "CFAP81, DLC1, FAP81" ENSG00000008226 "DLEC1 cilia and flagella associated protein" Q9Y238 3 38039205-38124025 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 14.7;fallopian tube: 27.9;testis: 13.2" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 45.0;Respiratory ciliated cells: 74.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019077 Enhanced Supported Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA019077: AB_1847724" "unprognostic (1.24e-4)" "unprognostic (3.60e-3)" "unprognostic (2.11e-1)" "unprognostic (1.09e-3)" "unprognostic (2.32e-1)" "unprognostic (1.76e-3)" "unprognostic (2.50e-3)" "unprognostic (8.54e-3)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (9.53e-2)" "unprognostic (7.62e-2)" "unprognostic (8.70e-4)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.94e-4)" 1.2 0.3 2.3 0.3 2.1 0.9 0.4 1.6 1.2 3.5 14.7 0.3 0.4 0.5 4.1 0.1 27.9 0.6 0.2 2.5 2.9 0.3 0.1 4.8 0.4 6.6 8.6 0.9 0.1 0.1 9.6 0.1 4.7 0.9 0.4 0.0 0.9 0.5 0.0 0.4 0.4 0.1 5.3 0.5 0.3 13.2 3.2 0.1 1.1 0.0 0.3 0.2 0.1 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 2.1 1.6 1.2 2.5 2.9 6.6 8.6 4.7 5.3 3.2 2.5 0.0 3.2 3.0 2.9 0.4 0.5 0.5 3.0 1.2 1.2 0.4 0.4 0.7 0.0 14.1 0.0 0.0 0.1 0.4 1.2 0.0 0.1 4.5 45.0 1.2 0.6 1.2 0.8 1.1 0.2 0.1 1.3 0.0 1.4 2.5 0.2 0.0 0.3 0.5 0.0 0.9 0.7 6.1 0.6 1.2 6.6 0.9 1.1 0.0 2.8 0.8 0.2 2.1 0.5 0.3 0.1 1.4 0.0 2.8 0.5 0.7 0.5 74.4 0.8 0.0 0.7 1.5 6.7 1.3 1.0 0.3 0.1 1.3 0.4 0.2 0.4 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191608 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "T-reg: 5.4" "Lineage enriched" "Detected in many" 5 "T-cells: 5.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.52e-6)" "prognostic unfavorable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 0.8 0.3 1.4 8.1 0.9 29.7 1.4 0.4 1.8 0.8 0.6 5.5 5.0 1.3 0.1 5.2 0.4 0.8 0.2 1.0 1.7 0.2 0.7 0.7 17.9 0.7 1.0 0.2 0.1 0.2 0.0 4.1 0.8 0.2 6.7 0.1 0.8 0.1 0.1 3.1 4.6 2.7 0.3 2.6 3.0 17.4 1.1 42.0 0.4 0.0 18.7 2.0 1.5 3.8 144.8 56.8 140.6 63.7 3.3 13.4 43.8 80.3 52.7 115.3 109.3 45.9 75.8 82.1 44.2 46.9 47.4 85.6 91.5 64.0 150.5 101.9 45.7 84.4 49.9 39.3 0.4 82.7 49.3 2.8 2.2 54.8 27.0 18.9 129.0 82.5 70.5 79.8 109.3 69.2 105.0 42.7 72.6 63.3 57.3 80.8 137.9 39.0 37.9 45.2 71.7 40.7 84.8 31.7 30.8 60.6 71.6 31.6 49.6 52.4 133.3 50.6 94.6 19.4 44.9 108.9 35.9 59.6 83.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 1.4 0.3 0.0 0.2 0.1 0.2 1.0 0.0 0.0 5.4 0.7 1.4 0.9 0.4 1.8 1.0 1.7 0.7 1.0 0.8 0.3 1.1 3.8 0.1 0.0 0.5 0.0 4.4 1.1 0.7 3.3 0.0 0.0 1.2 0.9 0.4 0.0 1.3 0.0 0.0 11.6 1.4 3.2 0.0 0.4 19.7 7.2 2.6 2.4 0.0 92.6 0.3 0.0 23.1 4.2 7.7 4.5 0.0 15.8 3.9 0.5 10.5 0.0 0.3 3.6 8.2 4.1 1.6 6.0 0.9 3.7 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.2 0.2 1.2 22.1 0.6 0.3 0.1 1.3 0.0 6.6 0.0 3.8 68.1 31.7 11.6 0.4 1.9 4.0 0.9 6.9 1.4 DNAAF1 "CILD13, DAU1, FLJ25330, LRRC50, ODA7, swt" ENSG00000154099 "Dynein axonemal assembly factor 1" Q8NEP3 16 84145287-84178767 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 22.7;testis: 45.3" "Cell type enhanced" "Detected in many" "Early spermatids: 116.2;Endometrial ciliated cells: 311.3;Plasma cells: 225.4;Respiratory ciliated cells: 494.5;Spermatocytes: 116.2" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 3.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.3" "Group enriched" "Detected in many" 4 "granulocytes: 2.3;T-cells: 1.0" "Cell line enhanced" "Detected in some" "Hep G2: 1.7;Karpas-707: 4.9;PC-3: 1.4;SK-BR-3: 1.4;U-266/70: 4.0;U-266/84: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041166, HPA074239" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "Nuclear speckles" "HPA041166: AB_10794190, HPA074239: AB_2732250" "unprognostic (5.25e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-2)" "prognostic favorable (2.14e-4)" "unprognostic (1.42e-1)" "unprognostic (9.99e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (7.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-5)" "unprognostic (2.70e-2)" "unprognostic (4.61e-3)" "unprognostic (1.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-4)" "unprognostic (7.51e-4)" 0.3 0.7 1.4 0.1 1.2 1.2 0.3 1.1 1.9 2.2 9.7 0.3 0.0 0.5 1.4 0.4 22.7 0.0 0.4 1.6 1.5 1.0 0.8 3.5 0.0 4.1 7.3 0.4 0.3 0.3 2.4 0.2 4.3 0.2 0.0 0.4 0.1 0.2 0.2 0.1 0.1 0.0 3.0 0.7 0.2 45.3 1.6 0.0 1.6 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 4.0 2.8 0.4 0.1 0.0 0.0 1.3 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.3 0.3 0.1 0.4 1.0 0.3 1.4 1.2 1.1 1.9 1.6 1.5 4.1 7.3 4.3 3.0 1.6 1.3 1.1 0.0 12.4 1.6 5.7 0.6 1.5 9.6 0.0 1.4 4.5 1.5 0.7 1.5 67.2 3.7 54.2 0.2 0.5 0.1 0.0 1.3 116.2 311.3 4.4 1.9 0.0 0.0 9.6 0.4 0.4 2.4 0.5 14.6 3.8 2.6 2.2 0.6 1.9 0.0 5.2 0.0 18.3 7.0 1.5 26.7 1.2 21.6 87.2 0.0 0.8 2.4 1.0 0.5 0.6 0.9 0.0 0.4 225.4 1.4 0.0 1.7 494.5 51.0 0.0 1.6 7.3 116.2 17.0 0.2 0.3 0.4 4.5 1.2 0.3 0.9 DNAAF3 "C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22" ENSG00000167646 "Dynein axonemal assembly factor 3" Q8N9W5 19 55158661-55166722 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "fallopian tube: 40.8;testis: 65.4" "Group enriched" "Detected in many" 5 "Early spermatids: 395.2;Late spermatids: 722.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 26.2;HEL: 31.6;K-562: 25.3;U-937: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056220 Approved "Nuclear bodies,Mitochondria" No No "Cluster 49: Ciliated cells - Cilium organization" "Cluster 36: HEL - Hemostasis" "Cluster 31: Spermatids - Spermatogenesis" Mitochondria "Nuclear bodies" "HPA056220: AB_2683071" "unprognostic (1.71e-2)" "unprognostic (2.67e-2)" "unprognostic (6.10e-2)" "unprognostic (9.93e-3)" "unprognostic (1.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.22e-2)" "unprognostic (1.82e-1)" "unprognostic (5.36e-2)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (1.83e-5)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (2.35e-2)" "unprognostic (8.03e-2)" 0.4 1.8 1.5 0.0 1.2 0.0 0.6 0.9 0.7 2.5 6.1 0.3 0.1 0.9 3.4 0.6 40.8 0.6 5.0 1.5 2.3 2.7 0.6 4.3 0.1 4.0 8.2 0.2 1.6 3.5 0.7 0.1 4.7 0.3 0.1 0.4 0.4 0.9 0.1 0.9 0.3 0.2 3.1 0.3 0.3 65.4 1.5 0.5 2.3 0.0 0.1 0.1 0.4 2.1 8.8 6.6 0.6 6.7 0.1 0.0 0.6 0.1 0.2 1.0 0.7 0.3 4.0 10.5 2.5 0.3 1.9 10.1 1.5 3.0 0.4 0.0 26.2 31.6 0.5 0.5 0.2 13.6 3.1 0.2 4.0 1.7 2.2 0.9 0.5 4.7 25.3 13.9 0.4 5.9 0.4 0.3 0.5 9.5 15.0 16.5 1.0 3.2 5.4 0.2 0.8 2.6 1.1 1.1 1.6 0.2 8.3 0.4 1.0 0.8 3.9 4.0 0.2 0.4 2.5 0.6 4.9 18.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 1.2 0.9 0.7 1.5 2.3 4.0 8.2 4.7 3.1 1.5 2.1 0.2 0.0 0.5 0.0 0.0 3.2 0.0 4.7 4.6 0.0 1.1 0.6 3.0 1.5 7.5 7.3 0.0 0.0 0.0 0.3 7.9 2.7 395.2 55.8 0.5 0.6 0.0 0.0 0.5 1.0 0.1 1.2 0.0 1.3 0.0 1.9 0.7 0.4 0.2 0.0 0.5 0.5 12.2 0.0 0.4 722.0 4.4 4.2 0.0 0.0 0.0 2.1 0.0 0.5 0.1 0.2 0.1 3.0 0.0 0.1 0.0 5.1 75.2 0.0 0.0 0.0 2.3 104.8 18.6 0.3 1.3 0.0 0.1 1.1 0.4 0.2 DNAAF6 "CXorf41, MGC35261, NYSAR97, PIH1D3, TWISTER" ENSG00000080572 "Dynein axonemal assembly factor 6" Q9NQM4 X 107206611-107244247 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 12.1;testis: 12.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "midbrain: 3.0" HPA072496 Enhanced NA NA "Cluster 11: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "HPA072496: AB_2732202" "unprognostic (8.66e-2)" "unprognostic (2.75e-3)" "unprognostic (7.73e-4)" "unprognostic (3.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.77e-2)" 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.3 0.2 0.3 1.0 0.0 0.0 0.1 0.6 0.0 12.1 0.0 0.0 0.3 0.4 0.1 0.0 1.5 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 12.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.2 0.3 0.4 1.6 1.2 0.9 0.7 0.3 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAH1 "DNAHC1, HDHC7, HL-11, HL11, XLHSRF-1" ENSG00000114841 "Dynein axonemal heavy chain 1" Q9P2D7 3 52316319-52400491 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 21.5;Respiratory ciliated cells: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "midbrain: 3.4" "HPA036805, HPA036806" Uncertain NA NA "Cluster 40: Neutrophils - Inflammatory response" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA036805: AB_10670924, HPA036806: AB_10670849" "unprognostic (8.34e-3)" "unprognostic (3.60e-2)" "unprognostic (9.60e-4)" "unprognostic (1.54e-2)" "unprognostic (2.99e-1)" "unprognostic (6.59e-4)" "unprognostic (1.62e-1)" "unprognostic (1.43e-2)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-2)" "unprognostic (4.98e-4)" "unprognostic (1.84e-3)" "unprognostic (8.66e-3)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (9.80e-5)" 2.1 1.4 0.2 2.1 0.7 6.2 1.7 0.0 1.1 1.4 2.1 1.4 1.3 1.5 1.3 1.3 4.0 1.6 1.0 0.3 0.5 1.5 2.4 2.4 3.1 1.3 1.7 1.9 1.5 1.4 1.8 1.0 0.8 1.6 1.3 2.5 1.5 0.7 1.1 1.7 2.9 1.7 0.3 2.9 1.6 4.1 0.6 1.9 1.5 0.5 2.4 1.1 1.1 1.8 0.1 0.7 1.0 1.0 1.2 4.6 0.5 0.6 1.0 0.2 0.2 0.0 0.6 0.3 0.6 0.8 0.1 0.1 0.0 0.2 0.4 0.8 1.4 2.0 0.1 0.2 0.6 1.5 1.3 2.0 0.3 0.8 1.0 2.1 0.8 0.8 0.2 1.7 0.8 0.2 0.4 1.4 0.5 0.1 0.9 0.7 0.0 0.6 0.3 0.8 0.1 0.5 1.0 0.1 0.7 0.3 0.2 2.4 1.0 0.3 0.2 0.9 0.2 1.8 1.8 0.5 0.3 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.1 0.3 0.5 1.3 1.7 0.8 0.3 0.6 1.8 2.2 6.4 3.7 9.1 3.2 0.5 0.4 2.0 0.6 1.8 1.7 1.8 4.4 0.0 2.7 0.0 4.2 0.6 3.1 2.3 0.0 0.3 9.7 6.9 1.6 2.1 5.4 2.7 13.8 0.6 0.2 1.2 8.2 3.8 3.8 3.2 2.2 3.9 1.2 5.0 10.0 2.6 8.2 3.5 1.6 21.5 1.2 3.2 1.8 3.7 3.4 0.9 4.1 2.5 10.7 0.3 2.1 0.4 2.4 0.9 4.8 0.9 35.5 5.2 0.0 1.4 1.9 6.9 1.5 1.1 0.3 0.8 3.3 1.7 2.2 0.6 DNAH10 FLJ43808 ENSG00000197653 "Dynein axonemal heavy chain 10" Q8IVF4 12 123762188-123935720 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;choroid plexus: 2.6;fallopian tube: 4.1;testis: 3.0" "Group enriched" "Detected in many" 5 "Early spermatids: 35.5;Endometrial ciliated cells: 88.5;Late spermatids: 68.9;Respiratory ciliated cells: 88.0" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039066 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA039066: AB_10673237" "unprognostic (1.37e-1)" "unprognostic (1.78e-1)" "unprognostic (6.08e-3)" "unprognostic (9.90e-3)" "unprognostic (2.16e-1)" "unprognostic (8.91e-2)" "unprognostic (3.39e-2)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" "unprognostic (1.08e-2)" "unprognostic (7.28e-3)" "unprognostic (5.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (7.23e-2)" "unprognostic (1.22e-2)" "unprognostic (9.11e-3)" 0.2 0.0 1.0 0.0 0.7 1.2 0.0 0.8 0.4 0.6 2.6 0.0 0.1 0.1 0.0 0.0 4.1 0.0 0.1 1.0 1.3 0.1 0.0 1.1 0.0 4.6 4.9 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 3.3 0.1 0.0 3.0 1.1 0.0 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.5 0.9 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.8 0.4 1.0 1.3 4.6 4.9 2.5 3.3 1.1 1.2 0.0 0.0 5.5 2.0 0.7 0.0 0.0 1.6 0.0 1.2 0.1 0.3 2.3 0.0 12.9 0.0 0.0 0.0 0.6 0.0 1.9 0.0 35.5 88.5 1.2 0.3 0.0 0.4 7.2 0.0 0.0 0.8 0.0 2.1 0.0 0.1 0.4 0.0 0.1 0.0 6.1 0.2 0.0 0.0 0.0 68.9 0.0 0.3 0.0 0.0 0.4 1.0 1.0 2.0 5.0 0.1 0.0 0.0 0.0 0.0 1.2 2.9 88.0 1.4 13.1 0.6 1.0 9.9 2.1 0.0 0.0 0.0 0.4 0.9 0.4 0.1 DNAH11 "CILD7, DNAHBL, Dnahc11, DNHBL, DPL11" ENSG00000105877 "Dynein axonemal heavy chain 11" Q96DT5 7 21543039-21901839 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "choroid plexus: 36.2;parathyroid gland: 71.3" "Group enriched" "Detected in many" 10 "Endometrial ciliated cells: 136.7;Oligodendrocyte precursor cells: 57.3;Respiratory ciliated cells: 128.8" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.9;U-2 OS: 1.0;U-2197: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 6.7" "HPA045880, HPA056474" Approved NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA045880: AB_10962003, HPA056474: AB_2683145" "unprognostic (2.24e-2)" "unprognostic (2.28e-1)" "unprognostic (1.01e-2)" "unprognostic (5.17e-3)" "unprognostic (4.15e-2)" "unprognostic (1.51e-1)" "unprognostic (9.01e-2)" "unprognostic (6.32e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "unprognostic (2.79e-2)" "unprognostic (3.10e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (3.86e-3)" "unprognostic (4.79e-3)" 0.1 1.8 1.5 0.0 1.5 0.0 0.0 0.7 0.3 0.4 36.2 0.1 0.0 0.3 0.3 0.6 5.2 0.1 0.4 2.0 1.8 0.2 0.3 1.1 0.0 8.9 5.6 0.3 0.1 71.3 0.1 0.3 4.1 0.4 0.0 0.0 0.1 0.1 0.3 0.7 0.3 0.0 6.4 0.0 0.1 0.5 1.8 0.3 1.0 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.3 0.5 0.0 0.7 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.3 1.0 1.3 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 0.7 0.3 2.0 1.8 8.9 5.6 4.1 6.4 1.8 3.2 0.2 6.4 3.9 4.6 0.4 2.4 4.2 6.4 1.2 0.2 0.7 0.3 3.6 5.7 10.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 3.8 136.7 1.0 0.8 0.0 0.4 3.0 0.0 2.1 0.7 0.0 3.9 0.0 0.1 0.0 0.3 0.1 6.7 3.5 0.0 4.1 0.3 1.1 2.3 0.3 0.6 1.8 3.7 0.6 0.0 1.0 57.3 7.3 0.1 0.0 0.4 0.0 8.3 0.0 0.1 128.8 0.1 0.0 3.8 1.9 0.7 1.9 0.3 0.3 1.6 0.3 0.1 0.1 1.5 DNAH12 "DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19" ENSG00000174844 "Dynein axonemal heavy chain 12" Q6ZR08 3 57293699-57544344 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 5.0;choroid plexus: 7.1;fallopian tube: 10.3;lung: 3.5;testis: 8.9" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 230.5;Respiratory ciliated cells: 318.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 9.6" "HPA037493, HPA058203, HPA061365" Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493" "unprognostic (4.85e-2)" "unprognostic (1.29e-2)" "unprognostic (2.23e-1)" "unprognostic (2.18e-3)" "unprognostic (2.96e-2)" "unprognostic (2.17e-1)" "unprognostic (2.80e-2)" "unprognostic (1.51e-3)" "unprognostic (3.06e-2)" "unprognostic (3.21e-1)" "unprognostic (4.40e-2)" "unprognostic (5.90e-2)" "unprognostic (3.43e-5)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (2.53e-2)" "unprognostic (5.47e-2)" 0.0 0.2 1.2 0.0 1.0 0.0 0.2 0.7 0.7 0.9 7.1 0.0 0.0 0.3 0.1 0.0 10.3 0.2 0.0 1.3 1.3 0.1 0.1 3.5 0.0 4.5 5.0 0.1 0.7 0.0 0.9 0.0 2.9 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 2.8 0.0 0.1 8.9 1.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 1.0 0.7 0.7 1.3 1.3 4.5 5.0 2.9 2.8 1.2 1.6 0.2 3.2 1.1 13.7 0.2 0.0 0.2 5.4 0.0 0.3 0.8 0.6 1.1 0.0 42.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 49.8 230.5 1.3 0.1 1.8 0.0 3.9 0.0 0.0 1.2 0.0 4.6 1.3 0.3 0.0 0.0 0.1 0.0 3.8 0.0 6.1 0.0 0.0 9.8 0.9 0.7 0.0 2.8 0.1 1.7 0.0 5.0 15.8 0.1 0.0 0.4 0.0 0.1 0.0 0.5 318.9 0.2 0.0 0.7 1.6 28.4 2.7 0.0 0.0 0.0 0.5 5.4 0.1 0.1 DNAH2 "DNHD3, FLJ46675, KIAA1503" ENSG00000183914 "Dynein axonemal heavy chain 2" Q9P225 17 7717354-7833744 "Predicted intracellular proteins, Predicted membrane proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 13.1;parathyroid gland: 10.5;retina: 21.1" "Group enriched" "Detected in many" 4 "Respiratory ciliated cells: 43.0;Rod photoreceptor cells: 123.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.6;CACO-2: 4.0;CAPAN-2: 2.4;OE19: 1.8;SCLC-21H: 2.3;SiHa: 2.3" "Low region specificity" "Detected in some" HPA067103 Enhanced Approved Microtubules NA NA "Cluster 77: Retina - Visual perception" "Cluster 39: CACO-2 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules "HPA067103: AB_2685778" "unprognostic (2.03e-2)" "unprognostic (1.79e-2)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-1)" "unprognostic (7.50e-3)" "unprognostic (1.29e-2)" "unprognostic (8.28e-2)" "unprognostic (2.51e-3)" "unprognostic (1.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (8.74e-3)" "unprognostic (4.60e-2)" 0.4 0.1 1.5 0.1 2.4 0.5 0.5 1.0 1.1 1.2 7.1 0.2 0.2 0.5 1.6 0.1 13.1 0.4 0.1 1.8 1.1 0.1 0.4 1.9 0.1 5.6 6.8 2.5 0.5 10.5 0.4 1.7 2.8 0.3 0.2 21.1 0.1 0.0 0.1 0.2 0.1 0.2 3.5 0.2 0.2 6.5 1.1 0.3 0.3 0.0 0.1 0.2 0.1 1.8 2.6 0.1 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 4.0 2.4 0.1 1.1 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.1 0.0 0.3 0.1 0.6 0.1 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.5 0.1 0.2 0.2 1.8 0.8 0.1 0.2 0.0 0.0 0.7 2.3 0.1 2.3 0.0 1.2 0.2 0.2 0.1 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.0 0.1 0.0 0.0 1.5 2.4 1.0 1.1 1.8 1.1 5.6 6.8 2.8 3.5 1.1 1.8 1.1 0.0 1.1 1.3 0.7 0.3 1.0 1.7 0.0 2.7 0.6 1.0 1.9 0.0 3.6 0.0 2.1 0.0 0.0 0.0 0.0 0.4 6.2 20.2 0.6 1.2 6.7 0.0 6.1 0.0 0.0 0.8 0.0 0.8 0.0 2.3 0.4 0.1 0.1 1.7 4.9 0.5 8.2 0.3 0.7 2.3 0.3 0.2 0.0 1.0 0.0 4.6 0.0 3.0 2.1 0.1 1.1 0.0 0.0 0.7 0.0 0.4 43.0 123.9 0.0 1.0 1.0 9.6 2.6 0.0 0.1 0.0 0.2 0.5 0.2 0.9 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;fallopian tube: 5.1;testis: 4.3" "Cell type enhanced" "Detected in some" "Early spermatids: 42.7;Endometrial ciliated cells: 31.0;Late spermatids: 17.1;Respiratory ciliated cells: 77.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062493 Approved "Nuclear membrane,Intermediate filaments" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.4 0.1 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.4 0.5 0.0 0.0 1.2 0.0 2.2 2.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 4.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.4 0.5 2.2 2.1 1.4 1.5 0.5 0.5 0.0 0.0 1.1 0.7 0.0 0.3 0.7 2.0 0.0 0.0 0.1 0.1 1.7 0.0 6.3 0.0 0.0 0.3 0.0 2.0 0.0 0.0 42.7 31.0 0.2 0.3 0.0 0.0 2.9 0.0 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 3.6 1.3 0.0 0.0 0.0 17.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 2.5 1.7 0.0 0.8 0.0 0.0 0.5 1.3 0.0 77.8 0.0 0.0 0.2 1.0 0.9 8.8 0.5 0.6 0.0 0.1 0.0 1.9 0.3 DNAH6 "Dnahc6, DNHL1, FLJ37357, HL-2" ENSG00000115423 "Dynein axonemal heavy chain 6" Q9C0G6 2 84516455-84819589 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6;choroid plexus: 12.1;fallopian tube: 5.4" "Cell type enhanced" "Detected in many" "Early spermatids: 77.5;Endometrial ciliated cells: 98.2;Excitatory neurons: 94.2;Respiratory ciliated cells: 143.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036391, HPA061401" Enhanced NA NA "Cluster 32: T-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA036391: AB_10672220, HPA061401: " "unprognostic (4.87e-2)" "unprognostic (4.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.72e-2)" "unprognostic (1.67e-1)" "unprognostic (6.43e-2)" "unprognostic (6.06e-2)" "unprognostic (3.46e-1)" "unprognostic (8.11e-8)" "unprognostic (2.04e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.80e-2)" "unprognostic (5.97e-2)" 0.3 0.2 1.4 0.1 2.4 0.0 0.4 0.0 1.7 0.2 12.1 0.1 0.0 0.5 1.2 0.0 5.4 0.1 0.0 1.5 1.1 0.4 1.1 0.8 0.1 4.4 4.6 0.3 0.2 1.6 0.4 0.0 2.4 0.1 0.2 0.8 0.0 0.2 0.0 0.0 0.1 0.1 2.7 0.0 0.5 2.7 1.6 0.5 1.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.4 2.4 0.0 1.7 1.5 1.1 4.4 4.6 2.4 2.7 1.6 1.6 0.6 6.4 4.1 18.6 0.6 0.1 2.2 5.4 0.0 0.8 1.4 1.8 1.2 1.5 13.7 0.0 2.1 0.9 0.3 0.3 0.0 0.3 77.5 98.2 1.5 0.9 0.0 0.4 94.2 0.9 0.2 2.7 4.1 3.0 0.0 1.6 0.0 6.9 0.1 0.0 28.2 1.0 10.2 0.3 0.2 25.0 0.6 0.3 1.8 9.4 0.0 2.0 0.0 5.5 13.7 0.3 0.3 0.7 0.1 1.0 0.2 1.0 143.6 4.8 0.0 2.1 1.7 23.3 5.1 0.0 0.0 0.3 1.3 0.3 1.1 0.3 DNAH7 KIAA0944 ENSG00000118997 "Dynein axonemal heavy chain 7" Q8WXX0 2 195737703-196068837 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9;choroid plexus: 29.8" "Cell type enhanced" "Detected in many" "Astrocytes: 197.2;Cone photoreceptor cells: 70.9;Early spermatids: 59.3;Endometrial ciliated cells: 103.5;Excitatory neurons: 93.0;Respiratory ciliated cells: 139.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 5.9;RPTEC TERT1: 2.8" "Region enhanced" "Detected in many" "midbrain: 4.4" "HPA034724, HPA044070" Enhanced Supported Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA034724: AB_10670977, HPA044070: AB_2678798" "unprognostic (1.71e-1)" "unprognostic (2.81e-2)" "unprognostic (2.65e-2)" "unprognostic (1.04e-2)" "unprognostic (3.56e-1)" "unprognostic (1.58e-2)" "unprognostic (6.74e-3)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.24e-1)" "unprognostic (7.76e-2)" "unprognostic (2.52e-3)" "unprognostic (3.98e-2)" 0.3 1.0 8.2 0.2 7.9 0.0 0.6 3.6 10.1 2.5 29.8 0.7 0.1 0.8 1.7 0.2 9.8 0.6 0.4 8.0 7.1 3.4 0.3 2.3 0.1 10.2 12.9 0.5 2.6 2.0 7.2 0.1 8.0 1.1 0.5 8.9 0.8 0.9 0.0 0.2 0.7 0.3 7.6 0.1 0.6 10.8 9.0 0.1 3.2 0.0 0.2 0.2 0.3 6.7 0.3 1.3 0.3 0.1 0.7 0.4 0.1 0.1 0.8 0.3 0.3 0.2 1.0 0.0 0.3 0.3 1.0 0.0 0.0 0.2 0.2 0.0 0.8 0.0 1.7 0.4 0.1 0.0 0.1 0.2 0.2 1.1 0.2 1.7 0.0 0.0 0.3 1.8 0.5 1.4 0.0 0.0 0.3 0.7 5.9 0.0 0.3 0.5 2.8 0.2 0.6 1.0 0.3 0.2 0.1 0.1 0.5 0.1 0.0 0.7 0.2 1.1 0.3 1.4 1.4 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 8.2 7.9 3.6 10.1 8.0 7.1 10.2 12.9 8.0 7.6 9.0 6.7 0.5 0.0 6.1 197.2 0.0 0.9 1.2 3.3 0.0 1.9 2.1 1.3 1.3 0.0 12.3 1.8 70.9 0.0 0.1 4.4 0.0 2.9 59.3 103.5 2.8 1.8 0.0 0.0 93.0 0.7 0.0 1.0 1.5 3.0 0.0 0.8 0.7 0.0 0.1 1.7 25.6 1.0 4.1 0.0 1.2 27.8 0.6 0.4 1.8 13.1 0.0 2.9 0.0 5.5 2.2 0.6 0.2 1.5 0.1 1.8 3.7 2.6 139.5 36.8 0.0 2.1 1.1 28.0 5.7 0.0 1.3 0.1 0.2 0.8 0.7 0.7 DNAH9 "DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357" ENSG00000007174 "Dynein axonemal heavy chain 9" Q9NYC9 17 11598470-11969748 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 28.2;choroid plexus: 27.6;fallopian tube: 35.4" "Cell type enhanced" "Detected in many" "Early spermatids: 48.7;Endometrial ciliated cells: 97.5;Excitatory neurons: 26.8;Late spermatids: 56.5;Respiratory ciliated cells: 110.5" "Group enriched" "Detected in some" 4 "endometrial cancer: 1.1;glioma: 1.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.1;WM-115: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052641 Enhanced NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA052641: AB_2681895" "unprognostic (4.16e-3)" "unprognostic (3.67e-2)" "unprognostic (9.31e-2)" "prognostic favorable (6.79e-5)" "unprognostic (8.37e-3)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (1.68e-1)" "unprognostic (1.26e-1)" "unprognostic (7.35e-2)" "unprognostic (1.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-3)" "unprognostic (5.31e-2)" 2.1 0.8 9.7 0.3 8.1 0.0 1.5 9.2 8.0 1.7 27.6 0.2 0.0 1.4 2.2 0.1 35.4 0.4 0.2 12.1 10.4 1.7 0.1 2.8 0.0 24.0 28.2 1.4 1.8 3.6 3.2 0.3 18.1 0.8 0.0 6.6 0.3 2.0 0.2 0.3 0.1 0.5 19.5 0.1 0.3 6.3 12.1 0.1 0.9 0.0 0.0 0.3 0.3 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 8.1 9.2 8.0 12.1 10.4 24.0 28.2 18.1 19.5 12.1 11.6 0.1 3.2 1.1 8.5 0.0 0.8 0.9 3.6 1.2 2.0 0.2 0.4 1.7 0.0 6.1 3.7 2.1 0.0 0.0 0.6 1.9 1.4 48.7 97.5 2.0 0.3 0.0 0.0 26.8 0.2 0.0 1.5 0.0 2.1 1.3 1.2 0.0 0.0 0.1 0.0 17.6 0.2 2.0 0.0 0.4 56.5 0.6 0.2 0.0 3.7 0.0 1.8 0.0 11.1 8.3 0.1 0.0 3.0 0.1 0.6 0.0 0.2 110.5 8.2 0.0 1.5 2.5 5.3 2.4 0.6 1.1 0.1 0.3 1.4 0.0 0.6 DNAI1 "CILD1, DIC1, PCD" ENSG00000122735 "Dynein axonemal intermediate chain 1" Q9UI46 9 34457414-34520988 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 9.9;choroid plexus: 28.3;fallopian tube: 33.9;pituitary gland: 9.5;testis: 33.5" "Cell type enhanced" "Detected in some" "Early spermatids: 29.6;Endometrial ciliated cells: 48.8;Late spermatids: 35.0;Respiratory ciliated cells: 132.2;Spermatocytes: 56.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;HDLM-2: 1.4;SK-BR-3: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021649, HPA021843" Enhanced NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 28: BEWO - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA021649: AB_1847913, HPA021843: AB_1847914" "unprognostic (9.61e-2)" "unprognostic (5.16e-2)" "unprognostic (4.59e-2)" "unprognostic (1.44e-3)" "unprognostic (3.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (6.39e-2)" "unprognostic (4.38e-1)" "unprognostic (1.51e-1)" "unprognostic (8.16e-3)" "unprognostic (8.14e-2)" "unprognostic (2.74e-2)" "unprognostic (3.77e-2)" "unprognostic (2.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" 0.0 0.0 2.7 0.0 3.2 0.0 0.5 2.3 2.5 2.2 28.3 0.0 0.0 0.9 0.2 0.0 33.9 0.1 0.1 2.8 3.1 1.3 0.1 4.5 0.0 7.3 9.9 0.1 0.9 1.2 9.5 0.0 4.8 0.2 0.0 2.7 0.0 0.1 0.1 0.0 0.0 0.0 5.5 0.0 0.2 33.5 3.2 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.6 0.2 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 1.0 0.2 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.2 2.3 2.5 2.8 3.1 7.3 9.9 4.8 5.5 3.2 2.4 0.0 0.0 0.5 3.9 0.1 0.0 0.0 5.0 0.0 0.0 0.5 0.3 0.4 0.0 11.0 0.0 4.2 0.2 0.0 0.0 1.9 0.0 29.6 48.8 0.5 0.2 0.0 0.0 9.4 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 16.2 0.0 2.0 0.0 0.0 35.0 0.3 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.1 0.0 0.4 132.2 1.3 0.0 0.0 1.4 56.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 DNAI2 "CILD9, DIC2" ENSG00000171595 "Dynein axonemal intermediate chain 2" Q9GZS0 17 74274234-74314884 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 30.4;testis: 19.3" "Cell type enhanced" "Detected in some" "Early spermatids: 21.7;Endometrial ciliated cells: 51.3;Late spermatids: 16.4;Respiratory ciliated cells: 68.1;Spermatocytes: 41.7" "Group enriched" "Detected in some" 4 "endometrial cancer: 2.2;lung cancer: 0.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 7 "NK-cell: 3.8" "Lineage enriched" "Detected in single" 7 "NK-cells: 3.8" "Cell line enriched" "Detected in single" 4 "HMC-1: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB006245, HPA050565" Enhanced NA NA "Cluster 15: NK-cells - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "CAB006245: AB_426059, HPA050565: AB_2681177" "unprognostic (6.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.36e-1)" "unprognostic (3.04e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (1.16e-3)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (3.14e-2)" "unprognostic (1.61e-3)" "unprognostic (1.44e-1)" "unprognostic (3.39e-3)" "unprognostic (2.89e-2)" "unprognostic (1.96e-1)" "unprognostic (1.46e-1)" "unprognostic (4.62e-3)" 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.2 0.1 1.8 6.5 0.0 0.0 0.3 0.0 0.0 30.4 0.0 0.0 0.9 0.9 0.0 0.0 3.0 0.0 3.0 4.3 0.0 0.0 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.9 0.0 19.3 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.6 0.4 0.2 0.1 0.9 0.9 3.0 4.3 2.1 2.3 0.8 0.7 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.7 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 21.7 51.3 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.3 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.0 0.0 4.4 16.4 0.6 0.3 0.0 1.0 0.6 0.0 1.0 1.0 0.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 68.1 0.0 0.0 0.0 0.9 41.7 0.5 0.0 0.0 0.0 0.4 0.6 0.2 0.0 DNAI3 "DIC3, FLJ30067, NYD-SP29, WDR63" ENSG00000162643 "Dynein axonemal intermediate chain 3" Q8IWG1 1 84999147-85133138 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 21.9;choroid plexus: 23.9;fallopian tube: 14.5;testis: 18.9" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.2" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.3;melanoma: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.4;HBEC3-KT: 4.4;HSkMC: 5.6;hTCEpi: 6.9;LHCN-M2: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038526 Enhanced NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "HPA038526: AB_2676063" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.61e-2)" "unprognostic (1.09e-4)" "unprognostic (1.10e-3)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.56e-1)" "unprognostic (2.53e-1)" "unprognostic (1.82e-3)" "unprognostic (2.31e-1)" "unprognostic (1.14e-5)" "unprognostic (8.57e-3)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" 0.2 21.9 1.8 0.4 1.8 0.0 0.2 1.6 0.9 0.9 23.9 0.7 0.2 0.6 4.1 0.3 14.5 0.4 0.8 2.4 2.6 0.7 0.1 1.8 0.4 7.7 10.0 0.1 0.5 5.7 3.0 0.5 5.7 0.3 0.5 0.7 0.8 0.2 0.1 2.1 0.1 0.4 6.6 0.2 0.1 18.9 2.5 0.8 1.1 2.2 0.2 0.5 0.1 4.0 0.1 0.4 0.1 0.3 3.0 8.4 1.6 1.7 3.4 0.5 0.9 0.0 0.5 0.4 0.0 0.3 2.0 0.0 0.3 4.4 0.7 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 5.6 6.9 2.9 0.2 0.3 0.1 0.5 0.0 0.0 6.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.2 0.1 0.0 0.0 0.2 1.1 1.6 0.0 2.9 0.0 0.5 0.2 0.0 0.4 0.0 0.0 0.3 3.3 0.1 1.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 1.8 1.8 1.6 0.9 2.4 2.6 7.7 10.0 5.7 6.6 2.5 4.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 DNAI4 "DIC4, FLJ23129, WDR78" ENSG00000152763 "Dynein axonemal intermediate chain 4" Q5VTH9 1 66812885-66924856 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 27.7;testis: 35.2" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 3.8" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 7.0;RPTEC TERT1: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (4.26e-2)" "unprognostic (4.04e-1)" "unprognostic (1.58e-3)" "unprognostic (2.19e-2)" "unprognostic (1.85e-1)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (8.19e-2)" "unprognostic (4.00e-1)" "unprognostic (1.68e-3)" "unprognostic (2.08e-2)" "prognostic favorable (9.60e-5)" "unprognostic (1.98e-1)" "unprognostic (5.79e-2)" "unprognostic (5.03e-2)" "unprognostic (1.69e-1)" 1.5 1.7 3.3 0.5 3.0 0.1 3.0 2.0 1.8 4.0 19.4 5.4 0.7 3.0 5.0 0.5 27.7 2.5 1.2 2.6 4.1 6.3 1.2 4.2 1.0 12.6 10.2 3.0 1.4 7.0 2.8 2.1 7.4 1.8 4.1 4.1 1.1 2.0 0.5 1.0 0.6 1.3 9.5 0.9 0.8 35.2 3.8 2.3 5.9 0.3 0.7 0.9 0.9 8.6 2.9 1.2 1.6 2.1 4.8 7.0 0.6 1.3 2.2 1.6 1.7 0.3 2.4 1.5 0.3 1.3 5.0 0.2 1.1 0.3 2.5 0.2 0.4 0.4 0.7 0.2 1.6 0.1 0.0 3.3 3.5 6.0 1.2 5.8 0.6 1.5 0.4 0.1 2.8 1.1 0.7 0.5 2.1 1.0 0.6 0.7 0.0 0.0 11.4 0.0 1.9 0.9 1.4 0.5 1.1 1.7 0.5 1.0 0.2 0.7 0.0 4.7 0.7 0.5 0.0 3.2 1.4 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.3 0.1 0.0 0.9 0.5 0.2 0.1 3.8 0.0 0.0 0.1 0.1 3.3 3.0 2.0 1.8 2.6 4.1 12.6 10.2 7.4 9.5 3.8 8.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 DNAJB13 "RSPH16A, TSARG6" ENSG00000187726 "DnaJ heat shock protein family (Hsp40) member B13" P59910 11 73951026-73970366 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Chaperone "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 53.2;testis: 18.9" "Group enriched" "Detected in some" 4 "Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA052465, HPA061330" Enhanced Approved "Plasma membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "HPA052465: AB_2681842, HPA061330: AB_2732659" "unprognostic (1.07e-1)" "unprognostic (3.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.56e-2)" "unprognostic (1.03e-1)" "unprognostic (1.20e-4)" "unprognostic (1.30e-2)" "unprognostic (1.72e-4)" "unprognostic (5.00e-2)" "unprognostic (4.73e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (3.32e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-2)" "unprognostic (2.40e-2)" 0.1 0.1 1.5 1.2 1.5 4.4 0.2 1.0 1.4 5.5 12.2 0.1 0.6 2.0 5.2 0.1 53.2 2.2 0.1 2.0 1.9 1.0 0.1 3.1 2.1 4.8 5.7 0.3 0.8 0.1 1.1 0.5 3.6 0.9 0.0 0.4 0.6 2.9 0.3 0.1 2.9 0.1 4.0 1.3 0.2 18.9 2.4 0.0 0.2 0.0 0.0 0.2 0.1 1.8 0.0 0.4 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.7 0.2 0.9 2.1 0.2 0.3 0.5 0.1 0.0 0.0 2.7 0.3 1.0 0.9 0.3 0.0 0.2 0.6 0.0 0.4 0.1 0.0 0.0 0.0 1.4 0.2 2.6 0.4 0.3 0.6 0.9 0.2 0.2 1.5 0.4 1.2 1.1 4.5 0.5 0.3 1.0 0.5 2.2 0.2 0.4 0.3 0.7 0.0 0.0 0.6 0.6 0.0 2.2 2.0 1.9 0.0 0.3 0.1 0.7 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.7 0.2 0.1 1.5 1.5 1.0 1.4 2.0 1.9 4.8 5.7 3.6 4.0 2.4 1.8 0.2 3.2 0.0 2.0 0.0 0.0 1.9 11.1 0.0 0.2 0.1 0.3 0.2 0.0 7.6 1.8 0.0 0.1 0.0 0.1 0.0 1.7 90.6 114.8 2.4 0.2 0.0 0.0 0.4 0.0 0.1 0.5 0.0 13.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 10.2 0.0 0.0 62.9 1.2 0.3 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 1.2 0.0 1.3 1.4 1.0 104.2 0.9 0.0 1.1 3.3 19.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 1.2 DNAL1 "1700010H15RiK, C14orf168, CILD16, MGC12435" ENSG00000119661 "Dynein axonemal light chain 1" Q4LDG9 14 73644875-73703732 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.2" "Cell type enhanced" "Detected in all" "Early spermatids: 335.4;Endometrial ciliated cells: 104.0;Respiratory ciliated cells: 141.4;Spermatocytes: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053129, HPA060974" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Centriolar satellite" "HPA053129: AB_2682051, HPA060974: " "unprognostic (1.11e-1)" "unprognostic (1.13e-2)" "unprognostic (2.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.66e-1)" "unprognostic (4.34e-1)" "unprognostic (4.25e-3)" "unprognostic (2.80e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-2)" "unprognostic (3.16e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.17e-8)" "unprognostic (9.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 7.5 6.2 8.3 6.2 11.0 6.1 5.1 12.2 10.0 5.9 18.5 4.7 2.7 7.9 12.2 4.6 23.7 9.3 9.2 13.0 9.6 11.2 3.7 7.7 5.2 8.8 11.0 7.5 6.1 14.7 8.4 4.7 8.9 5.7 5.5 18.1 4.4 7.0 5.2 3.0 3.0 9.5 7.6 4.7 5.6 55.2 11.2 6.1 16.4 5.9 4.5 6.1 3.3 8.8 15.4 11.2 13.5 12.3 9.3 11.8 10.7 15.2 11.6 19.3 20.0 11.7 23.9 6.1 11.1 16.2 18.4 9.2 12.8 11.7 28.0 9.0 5.3 5.1 16.7 4.3 9.7 5.9 5.8 9.0 9.0 21.3 15.2 14.8 12.7 9.7 5.8 13.7 23.8 25.2 15.4 7.0 6.3 12.7 10.9 10.7 20.2 2.6 16.1 16.1 20.7 9.8 25.0 4.8 12.2 10.3 26.7 3.9 12.0 24.1 43.8 18.2 14.3 7.8 18.2 13.4 19.9 3.1 17.2 4.3 2.3 2.5 2.7 2.5 3.8 2.7 2.6 2.7 2.1 4.1 2.3 2.6 2.1 2.1 2.1 5.9 2.6 1.3 8.3 11.0 12.2 10.0 13.0 9.6 8.8 11.0 8.9 7.6 11.2 8.8 10.8 19.2 14.9 11.4 6.3 3.2 7.4 19.8 2.2 16.0 9.4 5.7 14.4 15.7 23.1 18.4 60.5 5.4 5.4 5.7 9.8 15.5 335.4 104.0 20.4 11.2 10.2 4.8 21.7 14.0 9.3 12.9 7.7 16.4 10.1 11.8 11.0 5.3 8.4 15.2 15.5 6.1 18.3 6.7 7.9 57.8 17.4 6.9 12.4 6.5 6.5 19.9 12.3 10.1 5.8 12.3 4.1 16.6 5.8 5.9 1.7 24.9 141.4 40.2 13.1 21.6 12.4 187.7 24.7 2.1 2.0 2.5 6.2 11.9 5.6 5.0 DNALI1 "dJ423B22.5, hp28, P28" ENSG00000163879 "Dynein axonemal light intermediate chain 1" O14645 1 37556919-37566857 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 54.5" "Group enriched" "Detected in many" 4 "Early spermatids: 664.5;Endometrial ciliated cells: 302.8;Late spermatids: 1051.9;Respiratory ciliated cells: 484.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.3;ASC TERT1: 12.1;hTERT-RPE1: 18.8;RPTEC TERT1: 16.9;SH-SY5Y: 11.7;T-47d: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028305, HPA031633" Enhanced NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "HPA028305: AB_10601807, HPA031633: " "unprognostic (1.21e-2)" "unprognostic (9.04e-2)" "unprognostic (2.58e-2)" "unprognostic (6.09e-3)" "unprognostic (2.33e-1)" "unprognostic (3.14e-2)" "unprognostic (3.06e-2)" "prognostic favorable (6.02e-4)" "unprognostic (1.52e-1)" "unprognostic (5.50e-3)" "unprognostic (8.00e-3)" "unprognostic (3.52e-2)" "unprognostic (1.74e-2)" "unprognostic (1.19e-1)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" "unprognostic (5.52e-2)" 2.7 6.1 14.5 0.7 14.2 0.0 7.4 14.1 15.4 9.2 27.2 5.2 1.2 8.6 14.3 2.7 54.5 9.1 3.5 13.6 17.8 12.2 12.0 10.5 0.8 18.3 22.1 13.9 9.1 9.1 12.6 1.6 18.6 6.7 2.3 11.8 4.5 7.2 1.1 0.7 2.3 4.1 17.3 1.0 6.4 29.4 16.5 0.7 10.7 1.3 0.6 3.8 2.0 17.9 0.0 0.0 14.3 1.3 2.9 12.1 0.2 1.8 3.9 0.1 0.5 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.3 9.3 0.0 0.1 5.5 0.0 9.3 0.0 18.8 1.5 0.0 1.0 0.0 7.5 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.9 0.0 16.9 0.0 1.6 11.7 0.0 0.0 0.0 2.2 30.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 14.2 14.1 15.4 13.6 17.8 18.3 22.1 18.6 17.3 16.5 17.9 1.9 19.2 32.4 6.8 1.0 0.9 22.6 42.3 1.2 2.7 19.6 15.9 5.6 21.5 48.5 20.2 8.4 2.7 0.3 0.8 29.4 34.0 664.5 302.8 12.2 4.7 20.9 0.0 2.6 10.2 8.5 15.7 20.4 16.7 2.5 38.9 8.6 9.4 2.8 3.3 2.8 11.5 46.8 0.6 0.6 1051.9 13.7 2.0 0.0 0.0 0.0 18.7 0.0 3.0 1.7 12.5 1.0 12.0 0.0 21.0 1.0 43.3 484.1 19.6 6.6 17.5 18.5 140.0 18.5 0.3 0.6 3.4 1.1 21.0 4.9 9.3 DNER "bet, UNQ26" ENSG00000187957 "Delta/notch like EGF repeat containing" Q8NFT8 2 229357629-229714555 "Cancer-related genes, Predicted membrane proteins" "Notch signaling pathway" "Activator, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 73.0;brain: 147.5;choroid plexus: 143.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 123.3;Inhibitory neurons: 333.0;Oligodendrocyte precursor cells: 435.8;Oligodendrocytes: 247.7" "Cancer enriched" "Detected in many" 32 "glioma: 73.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "GAMG: 368.0;hTERT-HME1: 149.7;hTERT-RPE1: 409.5;U-138 MG: 252.2;U-87 MG: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017320 Enhanced NA NA 7900000 "Cluster 73: Brain - Neuropeptide signaling" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA017320: AB_1847808" "unprognostic (4.39e-2)" "unprognostic (1.83e-1)" "unprognostic (3.25e-1)" "unprognostic (1.00e-3)" "unprognostic (8.73e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.23e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.42e-4)" "unprognostic (2.59e-2)" "unprognostic (7.32e-2)" "unprognostic (5.63e-2)" "unprognostic (5.13e-3)" 2.0 73.0 88.3 1.3 121.0 0.0 2.3 139.7 82.9 2.0 143.8 5.2 0.4 2.8 5.7 0.3 4.1 0.2 11.8 72.3 130.9 11.2 0.1 1.0 0.3 121.3 121.0 0.6 0.9 8.9 30.3 0.4 117.8 1.9 1.1 60.5 43.4 0.4 0.8 10.3 1.6 1.2 124.7 0.1 10.7 1.0 147.5 0.5 0.1 0.5 1.2 0.8 1.1 137.2 0.4 1.9 3.9 0.3 0.6 0.5 0.0 0.2 1.4 8.6 2.6 0.0 1.1 0.0 0.4 0.1 368.0 0.1 0.3 1.2 4.3 0.0 0.1 0.0 12.4 0.0 1.4 0.0 0.1 2.6 9.3 6.5 149.7 409.5 0.0 0.0 0.0 0.3 2.3 0.1 0.0 0.0 2.5 0.2 14.0 0.1 1.6 0.0 14.6 0.0 30.3 2.5 0.8 0.1 0.8 0.4 0.1 0.0 0.0 252.2 0.0 8.5 39.7 0.0 0.0 0.0 149.6 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 88.3 121.0 139.7 82.9 72.3 130.9 121.3 121.0 117.8 124.7 147.5 137.2 0.1 0.0 0.0 68.9 0.0 0.4 5.9 1.9 1.8 123.3 1.6 0.6 12.2 0.0 1.4 3.7 14.6 0.0 0.0 0.0 1.9 0.2 7.3 4.1 1.5 0.6 28.7 0.0 24.1 1.3 0.2 4.3 0.0 6.7 0.0 1.6 0.0 0.0 0.1 11.8 333.0 0.0 6.1 0.0 0.8 1.9 5.9 0.9 19.6 8.4 0.1 52.0 0.0 435.8 247.7 0.3 0.0 6.0 0.0 4.5 0.0 1.2 34.1 55.0 0.0 0.1 0.8 1.2 1.1 0.5 0.0 0.1 0.2 0.6 0.1 0.5 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005514-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.2;choroid plexus: 26.5;testis: 37.8" "Group enriched" "Detected in many" 4 "Early spermatids: 284.7;Late spermatids: 200.4" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 13.1;MCF7: 10.8;REH: 11.0;SCLC-21H: 35.9;U-937: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 29: Early spermatids - Spermatogenesis" "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 2.7 4.5 47.5 0.2 57.6 1.0 1.9 34.7 72.2 2.8 26.5 6.8 0.7 1.4 0.3 1.8 8.7 0.7 1.4 60.3 28.3 5.3 0.9 5.6 0.3 34.0 38.5 15.4 1.6 0.8 9.4 0.1 35.4 8.2 1.3 1.1 1.4 0.5 0.2 0.6 2.6 0.7 27.5 6.0 0.8 37.8 38.2 0.1 1.0 0.0 0.1 1.1 2.2 42.5 0.9 1.8 1.2 0.7 0.4 0.0 13.1 0.4 0.9 0.5 0.4 5.6 3.3 0.0 1.1 0.1 1.6 0.3 7.1 2.7 0.3 0.0 0.7 1.1 0.3 0.2 0.5 1.0 3.5 1.6 0.8 0.2 0.8 6.5 0.0 3.9 0.3 0.0 0.0 10.8 2.2 4.0 1.7 4.0 5.1 11.0 0.0 0.5 0.4 0.8 35.9 2.3 0.3 3.0 0.3 2.6 3.4 2.0 0.0 0.0 1.5 0.1 0.2 0.2 0.0 0.0 0.2 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.5 57.6 34.7 72.2 60.3 28.3 34.0 38.5 35.4 27.5 38.2 42.5 1.5 0.0 4.6 8.8 0.4 0.6 3.5 2.5 6.8 3.7 4.0 3.4 0.7 1.5 7.8 1.8 22.9 0.3 0.2 3.0 1.9 0.1 284.7 12.2 0.2 1.7 1.2 0.0 28.2 0.0 1.0 2.1 1.5 0.3 0.0 3.5 2.5 0.0 0.5 0.0 10.7 3.6 10.2 1.9 1.0 200.4 0.6 2.2 1.8 4.7 0.1 2.3 0.0 3.5 2.6 0.0 1.0 1.9 0.1 2.3 0.3 0.3 57.5 2.0 0.0 0.5 0.9 3.2 6.1 0.6 0.9 0.1 0.3 2.5 4.3 1.1 DPCD "DKFZP566F084, RP11-529I10.4" ENSG00000166171 "Deleted in primary ciliary dyskinesia homolog (mouse)" Q9BVM2 10 101570560-101609662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 132.4" "Group enriched" "Detected in many" 4 "Early spermatids: 579.4;Late spermatids: 1068.7;Respiratory ciliated cells: 329.7;Spermatocytes: 313.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 20.2;intermediate monocyte: 22.2;myeloid DC: 29.6;non-classical monocyte: 9.5" "Group enriched" "Detected in all" 14 "dendritic cells: 29.6;monocytes: 22.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036603, HPA036604" Enhanced Approved "Nuclear speckles" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "HPA036603: AB_2675212, HPA036604: AB_10673503" "unprognostic (1.22e-2)" "unprognostic (1.73e-3)" "unprognostic (4.66e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.90e-1)" "unprognostic (9.13e-2)" "unprognostic (4.00e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (1.64e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (5.04e-2)" "unprognostic (3.83e-2)" "unprognostic (7.54e-2)" 10.5 18.7 35.1 8.7 37.2 11.8 19.4 31.5 42.0 21.8 55.1 17.3 6.8 16.7 41.3 20.4 73.3 15.5 29.6 37.4 39.1 30.9 10.4 14.0 6.2 36.2 37.1 23.5 14.7 49.3 49.5 10.6 36.5 16.1 13.5 55.8 21.2 15.7 19.2 13.2 7.1 18.0 33.3 4.5 14.4 132.4 39.7 6.6 33.0 18.3 8.2 14.4 14.9 33.4 97.1 53.4 37.9 77.2 35.2 61.7 15.6 44.5 53.6 59.4 55.1 38.8 51.4 9.0 74.6 42.7 25.2 54.0 55.4 65.3 61.2 23.0 57.5 11.3 49.8 56.7 20.3 58.8 8.1 42.3 54.8 72.0 56.1 153.7 50.8 14.0 32.4 12.6 45.1 122.9 0.0 48.1 28.7 26.9 41.6 0.0 51.8 20.5 92.6 25.3 37.1 63.3 36.5 23.4 31.3 34.1 71.2 23.9 35.5 27.3 24.9 55.7 62.3 37.9 45.9 16.9 94.7 13.7 11.7 0.0 20.2 1.0 1.8 22.2 1.7 1.3 1.4 1.4 29.6 0.7 1.5 1.8 0.9 1.6 9.5 4.1 0.6 8.1 35.1 37.2 31.5 42.0 37.4 39.1 36.2 37.1 36.5 33.3 39.7 33.4 6.9 35.3 12.4 4.9 2.1 9.7 29.5 89.2 9.6 16.4 25.4 29.5 33.7 30.0 56.6 49.7 18.8 24.6 0.9 10.5 95.9 63.3 579.4 136.5 23.5 11.1 23.9 14.1 7.7 27.5 16.7 21.2 10.2 20.2 1.3 19.2 11.4 10.9 24.0 11.8 6.2 12.5 52.9 4.4 14.6 1068.7 23.6 8.7 16.0 3.7 6.9 27.8 2.1 4.0 1.4 33.9 12.4 27.8 5.6 18.6 3.5 117.3 329.7 49.1 0.0 12.4 29.0 313.8 77.4 8.7 14.2 10.7 2.9 25.3 22.1 23.9 DRC1 "C2orf39, CCDC164, CILD21, FLJ32660, MGC16372" ENSG00000157856 "Dynein regulatory complex subunit 1" Q96MC2 2 26401920-26456711 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 10.3;fallopian tube: 39.3;testis: 20.8" "Group enriched" "Detected in some" 5 "Early spermatids: 142.0;Endometrial ciliated cells: 112.8;Late spermatids: 321.2;Respiratory ciliated cells: 260.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 89 "neutrophil: 8.9" "Lineage enriched" "Detected in single" 89 "granulocytes: 8.9" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 6.9" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (2.28e-3)" "unprognostic (2.68e-2)" "unprognostic (5.36e-2)" "unprognostic (5.27e-3)" "unprognostic (3.41e-3)" "unprognostic (8.56e-3)" "unprognostic (7.02e-4)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (7.26e-2)" "unprognostic (1.97e-3)" "unprognostic (2.99e-1)" "unprognostic (3.06e-3)" "unprognostic (8.19e-2)" "unprognostic (9.91e-3)" "unprognostic (2.16e-1)" "unprognostic (1.30e-2)" 0.0 0.0 2.3 0.0 2.5 0.7 0.0 1.4 1.4 1.5 10.3 0.1 0.0 0.9 0.1 0.0 39.3 0.0 0.0 2.1 2.8 0.2 0.0 3.1 0.0 5.7 7.3 0.0 0.0 0.0 3.2 0.0 4.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 20.8 2.9 0.3 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 2.3 2.5 1.4 1.4 2.1 2.8 5.7 7.3 4.5 5.0 2.9 4.9 0.2 0.0 1.1 1.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.3 0.5 0.0 17.9 1.8 0.0 0.0 0.0 0.1 0.0 0.0 142.0 112.8 1.2 0.3 0.0 0.0 4.3 0.7 0.0 0.5 0.0 1.5 1.3 0.0 0.0 0.0 0.1 0.0 4.8 0.1 10.2 0.0 0.0 321.2 2.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 1.2 0.4 0.0 0.2 1.3 0.1 260.8 0.0 0.0 0.0 2.4 39.5 1.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 DRC3 "CFAP134, DKFZP586M1120, LRRC48" ENSG00000171962 "Dynein regulatory complex subunit 3" Q9H069 17 17972813-18016889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 125.1;Early spermatids: 41.8;Endometrial ciliated cells: 121.8;Respiratory ciliated cells: 130.4;Rod photoreceptor cells: 88.7;Spermatocytes: 48.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036040, HPA036041" Approved NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA036040: AB_10602349, HPA036041: AB_2674915" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-3)" "unprognostic (9.48e-2)" "prognostic favorable (4.05e-5)" "unprognostic (1.06e-1)" "unprognostic (7.64e-5)" "unprognostic (6.11e-2)" "unprognostic (5.47e-3)" "unprognostic (8.59e-2)" "unprognostic (3.67e-1)" "unprognostic (1.33e-4)" "unprognostic (1.62e-1)" "unprognostic (1.15e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.56e-2)" 0.8 1.0 1.8 0.2 2.1 0.1 2.4 1.6 1.7 5.0 18.7 1.0 0.9 4.5 11.9 0.6 61.4 2.4 1.1 3.0 4.2 4.4 1.1 5.3 0.5 9.1 11.4 3.3 4.1 6.6 9.9 0.4 5.9 2.0 0.5 9.1 1.5 2.1 1.5 1.2 0.3 1.3 7.1 0.8 0.7 11.9 3.2 1.0 8.5 0.7 0.3 0.8 1.1 3.1 0.5 2.1 0.3 1.0 0.2 0.7 0.1 0.5 0.2 1.0 1.0 0.3 2.2 0.0 1.7 0.3 0.6 1.8 0.6 0.2 0.5 0.1 1.5 0.1 0.1 0.0 0.7 0.3 0.1 0.6 0.6 1.6 0.2 1.1 0.3 0.2 0.0 0.2 1.2 0.6 0.1 0.0 0.4 0.1 0.4 0.1 0.6 0.0 3.1 0.6 0.6 1.7 0.8 0.0 1.9 1.2 2.0 0.0 0.5 0.5 0.4 0.1 0.2 0.3 0.1 0.1 2.7 0.0 1.7 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.6 1.7 3.0 4.2 9.1 11.4 5.9 7.1 3.2 3.1 1.9 3.2 3.1 0.0 0.6 0.0 3.6 0.0 1.8 10.7 6.6 7.2 0.0 2.8 13.6 11.0 125.1 0.5 1.5 0.1 5.9 3.0 41.8 121.8 5.3 3.4 0.0 0.0 0.0 0.8 2.7 3.1 3.6 5.4 0.0 3.3 4.6 0.2 0.4 20.2 0.0 0.3 0.0 3.5 0.0 11.1 5.0 0.8 0.0 0.0 0.8 8.6 0.0 0.0 0.0 1.1 1.1 4.5 0.0 1.7 0.5 10.6 130.4 88.7 0.0 8.2 1.3 48.7 13.3 0.9 0.0 0.8 1.4 2.7 0.5 1.1 DRC7 "C16orf50, CCDC135, CFAP50, DKFZp434I099, FAP50" ENSG00000159625 "Dynein regulatory complex subunit 7" Q8IY82 16 57694793-57731805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 11.4;fallopian tube: 21.1;testis: 46.1" "Group enriched" "Detected in some" 4 "Early spermatids: 119.1;Late spermatids: 134.4;Spermatocytes: 48.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "basophil: 10.9" "Lineage enriched" "Detected in single" 43 "granulocytes: 10.9" "Cell line enhanced" "Detected in some" "Hep G2: 3.0;HMC-1: 1.6;JURKAT: 1.8;NB-4: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (4.04e-3)" "unprognostic (1.54e-1)" "unprognostic (4.11e-2)" "prognostic favorable (3.61e-4)" "unprognostic (9.96e-2)" "unprognostic (5.14e-2)" "unprognostic (1.80e-1)" "unprognostic (3.04e-1)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (1.04e-2)" "unprognostic (1.09e-1)" "unprognostic (5.34e-4)" "unprognostic (2.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.80e-2)" "unprognostic (5.53e-2)" 0.1 0.0 2.2 0.3 2.0 1.0 0.0 1.2 1.1 1.0 11.4 0.0 0.0 0.6 0.8 0.0 21.1 0.7 0.0 2.4 2.7 0.8 0.3 1.9 0.1 6.1 9.3 0.2 1.2 0.7 1.0 0.1 4.5 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.1 4.1 0.2 0.2 46.1 2.8 0.2 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.7 0.3 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 1.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.3 0.3 1.6 0.6 0.0 0.2 0.0 0.6 0.2 1.8 0.7 0.0 0.0 0.0 0.3 1.4 0.1 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 10.9 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.1 2.2 2.0 1.2 1.1 2.4 2.7 6.1 9.3 4.5 4.1 2.8 2.9 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.4 119.1 25.1 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 134.4 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.8 21.9 0.0 0.0 0.1 0.1 48.2 4.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 DTHD1 FLJ16686 ENSG00000197057 "Death domain containing 1" Q6ZMT9 4 36281616-36347511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 11.8;fallopian tube: 13.7;lung: 3.5;lymphoid tissue: 4.0" "Cell type enhanced" "Detected in some" "dendritic cells: 37.9;Early spermatids: 87.2;Endometrial ciliated cells: 109.2;NK-cells: 53.5;Respiratory ciliated cells: 199.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.4" "Lineage enriched" "Detected in single" 5 "T-cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (9.79e-6)" "unprognostic (4.04e-2)" "unprognostic (1.15e-2)" "unprognostic (5.54e-3)" "unprognostic (2.85e-1)" "unprognostic (5.45e-5)" "unprognostic (5.12e-3)" "unprognostic (9.11e-2)" "unprognostic (1.82e-2)" "unprognostic (7.59e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.05e-5)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.65e-2)" "unprognostic (7.12e-3)" 0.2 0.1 2.5 1.2 1.8 0.5 0.1 1.0 0.4 0.5 1.5 0.1 0.4 0.6 0.2 0.3 13.7 0.6 0.1 2.1 2.5 0.0 0.3 3.5 4.0 11.8 11.2 0.0 0.1 0.0 0.0 0.0 6.3 0.1 0.3 0.0 0.2 0.1 0.0 0.0 0.5 0.1 10.6 2.2 0.5 1.2 1.6 0.3 0.2 0.0 1.3 0.3 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.3 1.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.4 2.5 1.8 1.0 0.4 2.1 2.5 11.8 11.2 6.3 10.6 1.6 4.9 0.4 3.2 4.1 0.7 1.4 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.4 0.0 24.2 0.0 0.0 0.0 37.9 0.0 0.0 0.1 87.2 109.2 0.6 0.1 0.0 0.8 0.2 0.0 0.0 0.4 3.1 1.7 1.3 0.0 0.0 0.1 0.1 0.0 0.2 0.0 8.2 0.8 0.0 24.1 0.3 1.2 0.0 1.9 0.1 0.0 53.5 0.0 2.9 0.1 0.0 0.0 12.4 0.1 0.0 0.2 199.1 0.0 0.0 0.5 0.9 1.8 0.3 0.5 0.1 0.0 27.4 0.0 0.0 0.1 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 14.6;intestine: 4.7;lymphoid tissue: 14.2;placenta: 3.9;testis: 13.7" "Cell type enhanced" "Detected in many" "Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028016, HPA032023, HPA032031" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 0.6 0.2 0.0 4.1 0.0 14.6 1.9 0.0 0.1 0.6 0.0 3.3 2.3 1.1 0.1 1.9 0.4 0.4 0.1 0.0 0.0 0.1 1.2 1.4 5.6 0.0 0.1 0.1 0.1 0.5 0.2 3.9 0.0 0.4 4.7 0.0 0.4 0.1 0.1 2.1 3.0 1.9 0.0 2.5 1.3 13.7 0.1 14.2 0.5 0.0 6.4 1.2 0.7 0.0 34.1 28.1 48.0 23.6 2.9 5.8 23.3 41.3 25.5 38.1 56.1 17.6 29.0 25.2 15.4 16.1 25.0 25.8 62.5 34.9 54.7 31.4 30.9 40.7 33.6 21.5 0.1 54.1 25.3 2.5 1.2 62.2 32.4 6.8 17.7 44.7 49.1 51.1 44.4 13.5 75.3 24.3 56.6 25.2 32.9 57.2 84.0 49.2 11.6 22.9 29.6 46.0 39.2 37.5 17.6 47.7 32.0 24.1 9.7 38.2 28.6 40.5 47.8 18.4 30.5 57.7 19.1 35.5 37.8 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.3 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 2.3 2.3 0.4 1.7 0.0 0.0 1.3 1.3 7.0 1.5 0.9 0.0 0.0 12.8 1.4 1.5 0.0 0.4 25.3 0.4 1.3 5.2 0.0 36.2 0.2 0.0 16.2 2.4 3.1 1.0 0.0 11.4 0.7 0.4 4.7 0.0 0.3 3.3 0.0 0.3 0.8 12.4 1.2 2.2 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.4 0.0 12.8 0.2 0.6 0.0 0.1 0.0 0.0 0.2 2.7 53.2 20.8 5.6 1.7 1.5 2.6 1.6 5.2 0.7 DYDC1 "bA36D19.5, DPY30D1" ENSG00000170788 "DPY30 domain containing 1" Q8WWB3 10 80336105-80356755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 126.6" "Cell type enhanced" "Detected in some" "Early spermatids: 222.4;Late spermatids: 83.5;Spermatocytes: 349.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 2.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037790, HPA037791" Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA037790: AB_10805351, HPA037791: AB_10796215" "unprognostic (8.95e-2)" "unprognostic (8.28e-3)" "unprognostic (7.11e-2)" "unprognostic (3.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.90e-1)" "unprognostic (9.96e-2)" "unprognostic (7.95e-2)" 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.1 0.2 2.2 0.0 0.0 0.2 1.5 0.0 5.6 0.0 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 126.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.2 0.5 0.1 0.1 0.2 0.2 0.5 0.7 0.2 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.4 15.1 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 83.5 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.1 0.0 0.0 36.3 0.0 6.6 0.0 0.3 349.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYDC2 "bA36D19.6, MGC16186" ENSG00000133665 "DPY30 domain containing 2" Q96IM9 10 80344745-80368073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "fallopian tube: 97.4" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 182.5;Respiratory ciliated cells: 324.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.2;NTERA-2: 3.2;SCLC-21H: 2.9;SH-SY5Y: 1.9;U-2197: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038006, HPA038007" Enhanced NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "HPA038006: AB_10672734, HPA038007: AB_2675783" "unprognostic (1.60e-3)" "unprognostic (7.35e-2)" "unprognostic (1.89e-2)" "unprognostic (9.26e-3)" "unprognostic (8.85e-2)" "unprognostic (3.26e-1)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (2.34e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-4)" "unprognostic (9.86e-2)" "unprognostic (5.40e-2)" 0.1 0.1 1.6 0.1 2.6 0.8 0.3 1.7 2.1 2.2 5.3 0.3 0.1 1.8 4.5 0.5 97.4 0.3 0.0 2.1 2.4 0.3 0.6 4.6 0.0 5.5 5.7 0.1 0.8 0.3 0.8 0.3 3.7 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.1 5.9 0.0 0.3 10.8 3.7 0.2 0.2 0.0 0.1 0.0 0.1 3.6 0.1 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.4 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.8 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.4 0.0 3.2 0.0 0.0 0.9 0.2 0.8 0.0 0.0 2.9 1.9 0.0 0.0 0.3 0.8 0.0 1.4 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 2.6 1.7 2.1 2.1 2.4 5.5 5.7 3.7 5.9 3.7 3.6 0.0 0.0 3.1 0.3 0.0 0.0 0.1 20.6 0.0 0.0 0.3 0.1 0.2 0.0 29.6 0.0 0.0 0.0 0.1 0.1 1.9 0.5 61.4 182.5 1.6 0.1 0.0 0.0 0.8 0.5 0.0 0.9 0.0 2.4 0.0 1.3 0.0 0.6 0.1 0.0 0.3 0.0 14.2 0.0 0.3 30.4 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.3 0.0 0.1 324.1 0.0 0.0 0.2 4.3 8.5 3.1 0.1 0.0 0.0 0.4 0.2 0.0 0.1 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109410-103479863 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 173.7;Cone photoreceptor cells: 112.6;Endometrial ciliated cells: 124.0;Excitatory neurons: 164.7;Inhibitory neurons: 101.8;Respiratory ciliated cells: 171.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 4.2 3.0 5.0 1.2 5.2 0.3 3.5 5.6 10.2 5.1 14.6 3.2 1.6 4.6 3.7 1.6 6.5 3.2 2.0 4.1 6.1 3.7 0.8 2.8 0.9 8.3 8.9 5.6 2.9 6.7 6.8 1.4 6.3 2.6 0.7 10.5 2.6 2.5 0.8 2.8 2.1 2.3 5.5 1.9 2.2 7.9 6.7 1.8 4.6 1.5 0.7 3.3 3.0 5.9 1.3 2.7 7.0 3.3 9.5 21.2 0.4 4.0 6.4 6.5 7.0 1.6 1.5 0.0 5.5 8.0 3.1 5.5 5.5 7.7 5.3 0.0 4.6 1.2 4.8 0.2 9.3 2.2 1.3 13.6 2.8 14.9 16.9 10.3 2.7 1.4 0.2 0.0 8.6 5.4 0.7 0.7 1.9 0.0 7.7 0.0 5.9 0.1 7.5 0.9 4.6 3.6 6.5 1.7 3.1 1.7 6.8 1.5 6.4 7.9 3.3 7.7 3.0 0.0 0.0 0.1 2.3 6.7 2.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 5.0 5.2 5.6 10.2 4.1 6.1 8.3 8.9 6.3 5.5 6.7 5.9 12.7 0.0 13.1 173.7 2.3 6.6 13.4 17.3 9.6 25.9 8.2 9.7 10.1 4.3 18.0 27.6 112.6 0.3 2.1 0.2 1.9 7.0 26.1 124.0 43.7 11.1 17.3 1.3 164.7 3.4 0.5 32.0 5.6 7.5 3.8 15.4 9.3 0.8 2.5 32.0 101.8 1.0 4.1 0.8 5.8 11.1 20.8 3.1 8.8 45.0 0.9 16.5 1.0 86.0 72.6 10.5 2.9 18.4 3.3 4.9 0.9 16.9 171.0 85.1 19.7 40.8 18.5 90.6 11.6 5.0 5.5 0.5 5.0 23.5 1.7 5.9 DYNLRB2 "DNCL2B, DNLC2B, ROBLD2" ENSG00000168589 "Dynein light chain roadblock-type 2" Q8TF09 16 80540734-80550811 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 60.8;testis: 227.1" "Cell type enhanced" "Detected in many" "Early spermatids: 2380.9;Late spermatids: 965.0;Respiratory ciliated cells: 523.6;Spermatocytes: 706.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;MCF7: 5.6;RPTEC TERT1: 2.8;SCLC-21H: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.41e-2)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.91e-5)" "unprognostic (2.29e-2)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (1.17e-1)" "unprognostic (1.05e-3)" "unprognostic (1.41e-1)" "unprognostic (8.82e-3)" "unprognostic (1.73e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-4)" "unprognostic (1.55e-4)" 0.9 2.5 6.0 0.5 6.3 0.0 3.3 5.8 7.5 2.4 13.5 0.8 0.4 1.3 17.8 0.9 60.8 1.9 0.7 6.3 6.9 5.7 1.0 6.1 0.4 13.2 13.0 1.3 1.2 4.6 4.3 0.9 10.7 2.2 0.2 4.2 1.1 2.7 0.3 1.9 0.5 0.3 9.8 0.3 0.7 227.1 6.0 0.9 3.3 0.4 0.6 0.9 0.6 9.9 0.1 0.0 0.3 0.0 0.7 0.5 0.1 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.4 5.6 0.0 0.0 0.1 0.2 1.1 0.1 0.0 0.0 2.8 0.7 1.7 0.2 0.8 1.6 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.3 0.2 0.4 0.3 0.0 0.1 0.6 1.3 1.8 0.5 0.0 1.3 1.3 0.2 6.0 6.3 5.8 7.5 6.3 6.9 13.2 13.0 10.7 9.8 6.0 9.9 0.7 3.2 7.4 4.2 0.2 5.1 4.5 25.9 5.2 1.0 9.8 12.6 0.2 2.8 32.0 1.8 0.0 3.0 0.1 0.4 35.2 5.9 2380.9 274.1 2.8 2.0 3.0 0.0 2.5 1.5 0.7 2.7 0.0 5.1 7.6 1.1 1.1 0.8 0.6 0.0 2.3 1.3 30.5 0.8 0.3 965.0 19.6 2.3 0.0 1.0 3.1 23.9 1.0 0.5 1.5 1.2 0.1 15.4 0.5 2.7 0.3 44.7 523.6 2.6 13.1 0.5 7.8 706.2 22.1 0.8 2.8 3.4 0.9 2.9 0.2 3.0 DYNLT2B "MGC33212, TCTEX1D2" ENSG00000213123 "Dynein light chain Tctex-type 2B" Q8WW35 3 196291219-196318299 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Cardiomyocytes: 6.2;Cytotrophoblasts: 29.4;Extravillous trophoblasts: 9.9;Hofbauer cells: 16.8;Syncytiotrophoblasts: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 21.9;dendritic cells: 16.2;T-cells: 25.1" "Cell line enhanced" "Detected in many" "T-47d: 101.7" HPA049555 Approved Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA049555: AB_2680816" "unprognostic (1.16e-1)" "prognostic favorable (7.83e-4)" "unprognostic (5.34e-2)" "unprognostic (1.59e-2)" "unprognostic (1.47e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (4.61e-1)" "unprognostic (9.98e-3)" "unprognostic (3.99e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (6.23e-4)" "unprognostic (3.73e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" 5.0 7.9 15.2 4.5 15.7 5.1 6.5 14.6 18.6 8.7 15.0 9.1 3.4 7.1 7.9 13.0 36.2 5.1 6.3 15.2 16.0 16.9 2.3 7.0 8.8 15.2 16.8 7.3 5.1 7.9 13.8 3.1 17.0 7.0 4.2 15.0 5.2 3.9 3.0 8.4 4.0 3.7 15.7 4.3 5.0 30.9 16.6 14.7 10.1 1.5 6.0 6.7 9.4 15.0 33.1 23.9 45.3 28.0 11.1 22.3 5.4 13.8 9.3 16.8 18.8 7.9 45.0 21.0 23.0 12.1 7.0 33.7 17.8 14.5 16.3 18.4 13.3 8.6 22.3 3.4 12.7 6.4 0.9 12.1 38.2 14.7 17.1 30.5 10.2 44.0 13.3 10.8 32.6 79.0 28.9 29.4 29.6 36.6 41.5 37.3 7.7 8.7 38.9 13.4 50.9 39.7 29.2 17.2 28.0 18.7 101.7 18.3 19.2 15.0 5.8 6.1 18.0 16.9 38.0 48.8 45.0 11.4 25.8 0.0 3.1 1.4 11.7 1.2 7.1 21.9 13.9 9.0 8.8 13.7 9.1 9.4 1.8 4.6 0.8 16.2 25.1 6.3 15.2 15.7 14.6 18.6 15.2 16.0 15.2 16.8 17.0 15.7 16.6 15.0 5.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 29.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 9.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 6.2 0.5 0.0 0.0 0.0 DZANK1 "ANKRD64, bA189K21.8, C20orf12, C20orf84, dJ568F9.2, FLJ10600, FLJ30892" ENSG00000089091 "Double zinc ribbon and ankyrin repeat domains 1" Q9NVP4 20 18383367-18467281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 25.8;Endometrial ciliated cells: 35.5;Excitatory neurons: 32.2;Inhibitory neurons: 27.0;Respiratory ciliated cells: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "THP-1: 25.4;U-266/84: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059478, HPA064255" Uncertain Approved "Nucleoli fibrillar center" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center" "HPA059478: AB_2684033, HPA064255: AB_2685228" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (2.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (3.79e-2)" "unprognostic (2.78e-4)" "unprognostic (2.26e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (3.34e-2)" "unprognostic (2.29e-1)" "unprognostic (1.67e-2)" "unprognostic (5.68e-2)" "unprognostic (2.45e-1)" "unprognostic (6.05e-3)" "unprognostic (8.81e-3)" 1.2 1.3 3.2 0.8 3.1 2.8 2.7 3.2 4.2 2.2 3.3 1.0 0.4 1.0 0.9 1.0 3.5 0.4 0.7 3.0 3.1 3.3 1.0 1.8 1.0 2.9 3.6 2.1 1.7 1.0 5.7 0.5 3.0 1.7 0.6 3.4 1.2 0.4 0.7 1.7 1.2 0.3 2.3 1.8 1.1 4.9 3.0 0.4 3.8 0.2 0.8 1.2 1.1 3.3 0.3 1.7 1.7 1.5 1.6 1.0 0.3 0.9 0.4 2.4 1.5 6.4 0.8 3.3 0.4 0.8 1.0 0.6 5.5 0.6 1.8 0.4 1.1 1.6 0.9 0.8 1.2 2.6 1.1 0.6 1.0 4.4 0.8 0.6 0.8 1.1 0.1 1.1 0.6 2.7 0.2 1.2 3.6 1.0 0.2 0.8 0.7 0.2 3.4 1.5 1.6 2.2 2.6 1.3 3.1 1.3 1.0 25.4 0.1 2.1 0.4 1.8 1.2 3.6 27.9 3.8 0.7 3.1 0.8 2.6 0.3 0.5 0.1 0.9 0.1 1.1 0.1 0.4 0.3 0.3 0.2 0.2 1.0 0.5 0.7 0.4 0.4 0.2 3.2 3.1 3.2 4.2 3.0 3.1 2.9 3.6 3.0 2.3 3.0 3.3 1.7 0.0 3.6 12.1 6.1 1.5 1.1 1.6 1.8 4.3 7.7 9.7 1.6 1.5 8.8 3.7 16.7 0.5 2.3 1.5 1.9 2.1 25.8 35.5 5.1 1.5 0.0 0.4 32.2 1.1 0.8 2.3 1.5 5.1 3.8 3.8 1.4 0.3 2.3 6.7 27.0 1.2 8.2 3.8 1.8 19.3 0.3 2.5 5.4 5.6 1.1 4.0 1.0 9.0 16.7 2.5 0.3 1.9 4.0 0.7 0.6 4.1 41.9 18.0 0.0 2.6 2.6 11.6 12.4 0.8 1.4 0.3 2.6 3.2 1.9 0.6 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 4.9 1.4 1.7 2.2 2.2 8.8 4.7 5.9 2.1 8.6 15.3 5.0 2.2 8.1 1.9 2.5 12.8 5.7 3.3 2.2 2.3 5.6 1.0 5.7 0.9 5.7 7.4 7.0 6.3 2.7 2.1 2.0 4.2 4.1 1.5 4.6 2.1 3.3 1.0 7.8 2.1 4.6 4.3 2.6 7.2 4.1 2.6 0.4 3.6 0.9 0.7 6.1 5.3 2.2 5.4 3.1 6.1 5.1 3.8 5.1 1.4 8.6 5.1 5.0 6.3 2.0 0.4 0.0 4.3 8.0 7.0 1.7 4.5 2.0 2.4 1.2 4.4 2.4 7.5 0.3 3.1 1.8 4.0 5.4 2.0 5.5 2.6 5.1 2.8 1.4 1.8 0.0 6.9 0.3 0.0 0.8 7.4 0.0 1.1 0.0 7.1 0.0 2.3 8.5 2.1 4.8 8.9 0.0 4.3 3.4 2.3 3.7 2.2 12.3 5.6 6.0 4.5 0.0 0.0 0.1 4.9 2.6 4.8 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 2.2 5.9 2.1 2.2 2.3 5.7 7.4 4.2 4.3 2.6 2.2 1.4 3.2 2.0 4.2 0.0 3.6 0.6 1.9 7.4 8.6 0.2 2.5 2.9 7.2 7.7 1.8 8.4 0.1 0.0 0.0 5.9 3.8 17.4 58.8 8.5 2.6 0.0 1.3 4.0 1.2 0.1 6.5 7.1 1.1 0.0 7.4 0.0 0.0 1.4 3.3 2.9 0.0 2.0 3.2 2.6 1.8 6.2 3.5 0.0 3.7 0.6 2.7 0.0 2.5 0.2 5.9 0.0 4.1 0.0 0.4 0.0 0.8 74.0 19.4 0.0 7.2 9.8 0.6 2.3 1.7 4.3 0.0 0.5 1.7 0.0 0.1 DZIP3 "hRUL138, PPP1R66" ENSG00000198919 "DAZ interacting zinc finger protein 3" Q86Y13 3 108589705-108694840 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 327.4;Respiratory ciliated cells: 218.2;Spermatocytes: 351.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035066, HPA049232" Approved Approved Vesicles No No "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA035066: AB_10601549, HPA049232: AB_2680684" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (7.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (2.37e-2)" "unprognostic (3.33e-1)" "unprognostic (5.16e-2)" "unprognostic (2.74e-1)" "unprognostic (3.76e-2)" "unprognostic (2.59e-3)" "unprognostic (5.38e-2)" "prognostic favorable (3.65e-4)" "unprognostic (6.06e-2)" "unprognostic (2.78e-2)" "unprognostic (5.51e-3)" "unprognostic (3.81e-2)" 5.2 9.7 15.6 4.9 19.4 4.0 5.3 11.8 18.6 5.3 22.6 5.1 3.0 7.9 10.1 3.9 18.7 5.9 11.7 18.8 18.5 10.9 4.3 6.5 10.2 13.3 14.9 10.5 5.3 7.8 24.5 4.9 12.4 9.7 4.7 29.8 3.6 7.0 12.4 3.7 3.9 5.2 10.4 8.3 6.6 34.6 15.5 8.5 12.8 16.2 8.0 5.2 3.4 15.0 9.8 8.2 24.8 14.7 10.7 10.8 8.6 6.1 12.2 10.1 13.9 12.1 6.8 18.0 12.8 6.6 20.9 3.5 13.7 5.3 21.0 6.6 6.1 8.1 3.4 8.5 6.3 3.3 4.5 11.8 2.8 9.4 11.4 10.2 6.4 10.9 8.0 8.7 19.6 8.6 8.2 3.5 15.5 5.0 6.2 10.4 20.5 1.8 8.4 4.7 17.0 16.2 9.8 1.0 11.1 21.6 15.1 2.8 7.6 9.0 13.7 1.8 5.3 9.6 6.0 34.7 6.8 2.7 11.3 6.5 0.5 1.2 4.1 0.8 5.0 6.3 4.2 5.1 0.5 4.6 3.6 4.8 0.1 10.6 1.5 1.5 6.0 1.5 15.6 19.4 11.8 18.6 18.8 18.5 13.3 14.9 12.4 10.4 15.5 15.0 7.3 12.8 12.8 86.8 14.8 7.5 8.6 16.3 9.1 67.8 9.6 8.3 45.0 4.3 26.6 33.1 327.4 21.9 17.1 4.1 13.7 12.9 28.4 106.1 16.0 8.7 52.8 11.1 145.2 9.0 8.8 18.2 9.2 9.2 8.8 30.9 7.5 4.4 9.4 77.4 103.4 6.9 34.6 5.7 7.5 59.9 17.4 5.7 7.2 37.5 10.5 32.9 11.3 79.4 80.6 8.9 4.6 17.7 9.0 6.9 4.5 20.6 218.2 33.7 19.7 16.6 17.7 351.3 112.5 4.4 7.4 14.8 29.4 35.4 7.4 5.6 ECT2L "ARHGEF32, C6orf91, FBXO49, LFDH" ENSG00000203734 "Epithelial cell transforming 2 like" Q008S8 6 138795911-138904070 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "fallopian tube: 8.7" "Cell type enriched" "Detected in some" 6 "Respiratory ciliated cells: 91.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035488 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "HPA035488: AB_10672865" "unprognostic (2.88e-2)" "unprognostic (7.88e-2)" "unprognostic (2.52e-2)" "unprognostic (5.53e-3)" "unprognostic (3.48e-2)" "unprognostic (8.45e-3)" "unprognostic (9.42e-2)" "unprognostic (2.44e-2)" "unprognostic (1.18e-1)" "unprognostic (7.03e-2)" "unprognostic (5.90e-4)" "unprognostic (2.32e-1)" "unprognostic (5.21e-2)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (7.07e-3)" "unprognostic (2.65e-3)" 0.1 0.3 1.2 0.1 0.4 0.3 0.3 0.8 0.7 0.4 1.7 0.1 0.0 0.2 0.0 0.1 8.7 0.0 1.7 1.3 0.4 0.0 0.0 1.5 0.1 1.9 1.6 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.4 0.2 0.0 0.2 0.4 0.0 0.1 1.2 0.1 0.1 0.4 0.5 0.0 0.1 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.8 0.7 1.3 0.4 1.9 1.6 0.6 1.2 0.5 0.7 0.2 0.0 1.1 2.3 0.1 0.5 0.7 1.6 0.0 2.1 0.3 0.1 2.3 0.0 12.7 0.0 2.1 0.1 0.6 0.1 0.0 0.0 5.1 15.0 0.5 0.8 0.0 0.0 6.1 0.0 0.0 0.9 0.0 1.4 0.0 0.3 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.0 0.4 5.4 0.0 0.1 0.0 1.0 0.0 2.0 0.0 2.0 3.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 91.4 3.2 0.0 1.2 0.5 0.5 0.1 0.0 0.0 0.3 0.6 0.2 0.0 0.3 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 91.6;testis: 37.5" "Group enriched" "Detected in many" 19 "Early spermatids: 538.8;Endometrial ciliated cells: 159.1;Late spermatids: 552.0;Respiratory ciliated cells: 310.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 6.5;ASC diff: 2.6;ASC TERT1: 6.2;CAPAN-2: 3.1;hTEC/SVTERT24-B: 2.6;SCLC-21H: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: AB_2686220" "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.3 1.5 3.1 0.1 4.7 0.7 3.0 1.9 2.5 11.4 22.4 0.5 0.6 12.4 2.5 0.7 91.6 0.6 0.2 3.7 4.9 0.5 0.7 10.6 0.1 13.5 12.1 19.3 3.2 0.0 3.1 0.5 7.0 5.4 0.4 0.0 2.0 5.9 0.0 4.7 1.0 2.9 9.1 0.3 0.6 37.5 5.7 0.4 0.1 0.2 0.2 2.3 3.4 8.5 6.5 0.0 0.8 0.0 2.6 6.2 0.0 0.1 0.6 0.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 1.7 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.2 2.6 1.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.5 4.9 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.1 0.0 1.2 0.3 0.0 0.0 0.1 0.0 3.1 4.7 1.9 2.5 3.7 4.9 13.5 12.1 7.0 9.1 5.7 8.5 0.4 0.0 5.9 0.0 0.0 6.8 9.7 14.7 4.0 0.0 0.4 9.1 0.4 0.0 20.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 538.8 159.1 4.7 1.2 0.0 0.0 0.7 1.5 0.1 2.2 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 10.2 0.0 0.3 552.0 4.7 0.8 1.8 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 5.7 0.0 3.4 0.0 0.3 310.7 0.0 0.0 0.7 6.2 16.9 4.5 0.1 1.8 0.3 0.4 3.9 0.0 2.5 EFCAB10 ENSG00000185055 "EF-hand calcium binding domain 10" A6NFE3 7 105565120-105600875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.7;testis: 23.5" "Group enriched" "Detected in some" 11 "Early spermatids: 205.9;Endometrial ciliated cells: 138.5;Late spermatids: 78.7;Respiratory ciliated cells: 243.9;Spermatocytes: 96.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019751 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA019751: AB_1848011" "unprognostic (1.20e-1)" "unprognostic (2.24e-3)" "unprognostic (8.96e-2)" "unprognostic (4.76e-3)" "unprognostic (4.11e-2)" "unprognostic (3.58e-2)" "unprognostic (3.58e-2)" "unprognostic (6.07e-3)" "unprognostic (1.47e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-3)" "unprognostic (6.87e-2)" "unprognostic (3.07e-9)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" "unprognostic (5.67e-2)" 0.5 0.5 1.0 0.6 2.0 2.4 0.5 1.7 1.3 1.6 11.1 0.6 0.5 1.0 0.2 0.8 29.7 0.2 0.5 1.7 2.3 0.9 1.0 3.2 0.8 5.4 6.9 0.9 1.4 0.0 2.1 0.2 3.8 0.9 0.3 1.3 0.8 0.0 1.2 1.1 0.7 0.0 3.8 1.1 0.6 23.5 3.0 0.1 0.7 0.0 0.1 0.5 0.6 2.4 1.4 3.8 2.0 1.3 0.3 0.1 0.8 1.8 0.0 0.0 0.1 0.7 0.9 1.9 1.6 0.0 0.3 0.5 0.0 0.0 0.0 0.7 3.4 0.9 3.0 2.1 0.2 1.2 1.2 0.1 0.0 0.0 0.0 1.2 0.0 0.9 2.8 1.5 0.0 2.9 1.3 2.5 3.4 0.9 1.4 0.9 2.1 4.1 0.2 0.8 1.8 2.5 1.1 3.9 0.6 2.5 0.7 1.4 1.0 1.9 1.3 4.0 1.2 2.1 2.7 1.7 1.1 1.9 0.9 1.0 0.3 0.2 0.4 0.2 0.4 0.3 0.4 0.3 0.1 0.6 0.6 0.5 0.3 0.3 0.2 0.4 0.3 0.1 1.0 2.0 1.7 1.3 1.7 2.3 5.4 6.9 3.8 3.8 3.0 2.4 0.1 0.0 4.4 0.3 0.2 0.0 0.1 11.8 0.0 0.7 0.2 0.3 0.3 0.0 13.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 205.9 138.5 1.2 0.3 0.0 0.0 3.4 0.0 0.1 0.3 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.0 2.1 0.0 6.1 0.0 0.0 78.7 2.5 0.4 0.0 0.0 0.0 0.1 0.0 1.5 0.7 0.0 0.0 1.5 0.8 0.2 0.0 0.5 243.9 0.2 0.0 0.6 3.5 96.3 2.5 0.0 0.0 0.1 0.5 0.1 0.0 0.1 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 12.6;fallopian tube: 19.7" "Group enriched" "Detected in some" 4 "Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;RPTEC TERT1: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 8.9" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.3 0.4 0.8 0.1 1.0 0.8 0.3 1.7 1.1 1.1 12.6 0.1 0.0 0.3 0.8 0.0 19.7 0.2 0.3 1.4 1.5 0.8 1.2 1.7 0.1 4.9 7.0 1.0 0.6 1.7 3.6 0.1 3.2 3.0 0.0 1.6 0.2 0.2 0.0 0.1 0.3 0.0 3.6 0.4 0.7 6.9 2.4 0.2 1.2 0.0 0.2 0.0 0.1 1.0 0.1 0.7 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 1.5 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.4 0.3 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.7 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.7 1.1 1.4 1.5 4.9 7.0 3.2 3.6 2.4 1.0 0.2 3.2 1.7 0.3 0.5 0.5 0.1 0.8 0.0 0.4 0.7 0.4 1.3 1.5 1.8 0.0 2.1 0.0 0.3 0.1 0.0 0.2 29.6 31.9 0.7 0.5 0.0 0.0 2.7 0.2 0.1 0.5 3.1 1.9 0.0 0.1 0.0 1.1 0.1 5.0 0.8 0.3 2.0 0.0 0.0 20.1 0.3 0.3 0.0 0.0 0.1 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.9 46.0 5.6 0.0 0.5 0.6 6.8 2.7 0.7 0.3 0.0 0.3 0.3 0.0 0.2 EFCAB2 "CFAP200, DRC8, MGC12458" ENSG00000203666 "EF-hand calcium binding domain 2" Q5VUJ9 1 244969705-245127164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 112.3;Endometrial ciliated cells: 103.1;Late spermatids: 132.5;Respiratory ciliated cells: 177.2;Spermatocytes: 115.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 77.1;THP-1: 70.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031206, HPA031207" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA031206: AB_10599710, HPA031207: AB_10599946" "unprognostic (1.36e-2)" "unprognostic (9.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.21e-1)" "unprognostic (4.47e-2)" "unprognostic (9.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.02e-1)" "unprognostic (4.34e-3)" "unprognostic (8.41e-2)" "unprognostic (1.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (4.88e-2)" 13.0 10.6 11.5 6.7 13.8 14.4 16.0 14.4 21.9 8.7 26.7 6.8 3.3 21.2 17.5 10.5 36.1 14.7 15.0 11.4 14.4 11.1 5.6 12.6 9.6 18.1 16.9 11.3 9.0 15.4 8.5 16.8 13.9 8.9 12.4 17.7 8.8 13.1 19.7 6.9 7.4 11.4 14.9 7.5 12.4 28.0 12.9 7.4 26.8 7.5 10.7 8.2 4.9 16.3 7.3 9.1 20.3 5.2 7.2 16.7 24.7 9.2 9.7 11.5 10.6 23.5 19.5 25.3 19.2 11.6 12.2 5.7 8.2 5.3 7.1 2.7 5.0 12.4 41.3 10.7 15.2 12.8 77.1 14.6 11.0 15.5 14.4 13.7 18.0 0.7 48.0 20.1 10.0 7.6 2.6 34.6 26.0 10.4 6.9 48.4 3.1 6.8 29.0 12.3 15.9 21.4 16.0 6.1 13.6 22.7 5.9 70.5 2.8 14.1 5.3 7.9 33.7 6.9 12.4 17.2 11.2 35.9 11.7 0.9 1.3 2.3 0.4 1.4 0.5 3.1 0.5 0.3 4.3 3.3 0.4 0.4 3.8 2.3 1.1 8.7 0.6 1.0 11.5 13.8 14.4 21.9 11.4 14.4 18.1 16.9 13.9 14.9 12.9 16.3 13.3 3.2 14.5 76.0 11.5 5.1 11.8 17.2 10.2 12.6 11.6 11.0 58.6 8.6 23.0 23.9 14.6 16.3 9.3 5.4 50.9 8.2 112.3 103.1 18.5 11.7 18.8 17.2 54.6 10.8 46.3 15.5 11.2 11.1 0.0 13.6 12.5 7.3 11.2 5.0 90.3 6.5 22.4 21.3 6.5 132.5 9.0 13.2 7.2 42.2 6.6 19.2 1.0 74.9 75.9 5.6 6.6 6.4 12.0 7.1 2.7 35.6 177.2 19.1 6.6 15.5 15.8 115.9 30.6 5.4 3.0 34.2 7.5 8.3 6.9 10.6 EFCAB6 "dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672" ENSG00000186976 "EF-hand calcium binding domain 6" Q5THR3 22 43528744-43812337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Group enriched" "Detected in many" 8 "Early spermatids: 286.6;Late spermatids: 473.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.1;RPTEC TERT1: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA003098 Uncertain Nucleoplasm NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA003098: AB_1079087" "unprognostic (1.85e-1)" "unprognostic (8.85e-3)" "unprognostic (4.45e-2)" "unprognostic (1.04e-5)" "unprognostic (1.00e-1)" "unprognostic (4.25e-2)" "unprognostic (4.96e-2)" "unprognostic (8.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-3)" "unprognostic (3.66e-2)" "unprognostic (1.71e-3)" "unprognostic (4.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.65e-3)" "unprognostic (1.33e-2)" 0.4 0.8 0.9 0.1 0.9 0.0 1.1 0.0 0.7 1.1 6.8 0.5 0.3 1.2 2.1 0.4 7.7 0.5 0.4 0.9 1.4 1.4 0.4 1.2 0.2 2.2 3.2 1.4 1.2 2.4 2.0 0.2 1.5 0.9 0.2 3.1 0.8 1.1 0.2 0.4 0.2 0.5 1.4 0.1 0.9 24.3 1.4 0.2 3.1 0.2 0.1 0.4 0.4 0.4 0.1 0.3 0.4 0.7 0.6 2.1 0.0 0.5 0.4 0.1 0.2 0.0 0.1 0.0 0.3 0.2 0.8 0.6 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.8 0.5 0.1 0.5 0.1 0.2 0.0 0.0 0.3 1.4 0.0 0.1 0.6 0.4 0.2 0.0 0.0 0.0 1.5 0.3 0.9 0.3 1.4 0.0 0.7 0.3 0.2 0.0 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.7 0.9 1.4 2.2 3.2 1.5 1.4 1.4 0.4 0.2 3.2 1.8 18.9 0.5 0.3 0.9 1.0 2.2 3.0 1.2 1.0 1.7 0.0 2.3 0.0 6.2 0.0 0.0 0.4 0.0 0.9 286.6 21.8 1.5 0.4 0.0 0.0 46.0 0.7 0.1 1.3 1.1 1.9 1.3 1.5 0.4 0.4 0.3 6.7 36.8 0.4 2.0 0.3 0.3 473.7 3.1 0.3 0.0 15.9 0.6 1.7 0.0 15.1 10.2 1.0 0.1 1.5 0.2 0.5 0.1 1.1 20.4 12.5 6.6 1.3 0.8 24.1 4.7 0.8 0.1 0.1 0.1 1.4 0.4 0.3 EFHB "CFAP21, FLJ25200" ENSG00000163576 "EF-hand domain family member B" Q8N7U6 3 19879472-19947025 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.5;fallopian tube: 17.1;testis: 15.5" "Group enriched" "Detected in many" 4 "Early spermatids: 77.2;Endometrial ciliated cells: 49.9;Late spermatids: 25.7;Respiratory ciliated cells: 93.6;Spermatocytes: 32.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "RPTEC TERT1: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA034835 Approved Vesicles,Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol Vesicles "HPA034835: " "unprognostic (9.70e-2)" "unprognostic (2.71e-2)" "unprognostic (2.37e-1)" "unprognostic (2.33e-2)" "unprognostic (1.20e-2)" "unprognostic (9.56e-3)" "unprognostic (1.51e-5)" "unprognostic (4.43e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (4.92e-2)" "unprognostic (5.47e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (9.35e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" 0.5 0.7 1.6 0.1 1.5 0.2 0.9 1.0 1.4 0.9 2.6 0.2 0.0 1.1 0.6 0.4 17.1 0.6 0.2 1.4 1.6 1.0 0.2 2.0 0.2 6.5 5.0 1.5 0.2 0.4 0.4 0.4 3.4 0.4 0.3 0.8 0.2 0.5 0.2 0.4 0.2 0.5 3.7 0.5 0.2 15.5 1.6 0.3 0.5 0.2 0.3 0.3 0.2 2.2 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 19.5 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 1.5 1.0 1.4 1.4 1.6 6.5 5.0 3.4 3.7 1.6 2.2 1.0 0.0 1.1 5.5 0.3 0.1 0.5 1.9 0.6 0.8 1.8 1.4 0.3 5.7 12.4 3.7 2.1 0.9 1.6 0.5 5.9 0.3 77.2 49.9 1.8 0.7 1.2 3.6 1.7 0.2 0.5 1.3 0.0 1.8 3.8 1.8 1.8 0.6 0.5 1.7 2.2 0.2 4.1 1.3 0.3 25.7 2.5 1.0 0.0 1.9 0.2 5.3 0.0 3.0 1.7 0.6 0.1 2.2 0.0 0.3 1.2 8.3 93.6 0.8 0.0 3.6 1.7 32.7 4.3 0.1 0.1 0.8 0.3 1.0 0.4 0.3 EFHC1 "EJM, EJM1, FLJ10466, POC9, RIB72" ENSG00000096093 "EF-hand domain containing 1" Q5JVL4 6 52362123-52529886 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 34.6" "Cell type enhanced" "Detected in many" "Early spermatids: 242.0;Endometrial ciliated cells: 227.5;Respiratory ciliated cells: 529.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035307 Approved NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "HPA035307: AB_2674561" "unprognostic (2.11e-1)" "unprognostic (5.22e-2)" "unprognostic (3.31e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-1)" "unprognostic (4.03e-3)" "unprognostic (1.60e-4)" "unprognostic (2.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.33e-4)" "unprognostic (3.04e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (5.83e-2)" "unprognostic (3.14e-1)" "unprognostic (6.53e-2)" "unprognostic (3.27e-1)" 4.4 3.9 4.4 1.9 6.6 3.6 5.4 4.9 5.8 8.8 24.6 5.4 2.1 6.8 6.7 3.3 34.6 3.6 3.8 4.4 4.5 5.6 2.5 6.5 2.4 8.1 8.3 7.3 4.5 5.6 15.5 3.6 5.2 5.6 3.3 21.7 5.1 3.8 2.1 5.7 3.9 3.4 5.6 3.4 4.2 17.6 5.2 2.0 9.3 1.3 2.0 4.7 5.4 6.7 3.5 3.9 9.3 6.4 9.0 15.3 1.8 4.1 10.6 5.5 8.6 2.4 4.1 1.5 9.0 6.8 10.5 3.6 2.7 7.6 7.1 0.8 3.3 1.4 11.0 3.3 6.2 1.5 1.6 7.3 4.2 7.8 7.2 25.9 11.7 1.7 3.1 2.4 8.4 3.1 1.7 2.3 2.8 2.7 1.5 2.3 5.1 1.9 7.4 1.3 18.5 5.2 1.0 1.8 8.4 11.8 6.5 1.6 3.8 4.0 5.3 1.5 3.2 2.1 2.8 2.7 11.2 0.5 7.3 0.7 0.6 1.5 0.7 0.2 0.3 3.8 0.3 0.6 1.4 3.9 0.3 0.6 2.0 1.5 0.3 6.1 0.2 0.4 4.4 6.6 4.9 5.8 4.4 4.5 8.1 8.3 5.2 5.6 5.2 6.7 14.5 6.4 14.9 32.7 24.2 18.1 36.0 49.5 53.5 23.1 31.3 19.2 4.5 17.2 44.7 42.3 60.5 12.6 10.2 9.9 0.0 18.8 242.0 227.5 19.0 15.0 25.0 6.5 25.6 8.0 17.8 27.1 14.3 15.3 8.2 22.6 17.5 5.6 7.8 13.5 26.3 14.9 69.2 10.6 14.5 73.8 28.3 6.9 16.0 14.0 8.8 10.9 20.6 22.1 23.8 11.0 15.9 22.2 13.8 17.4 24.8 6.9 529.7 47.5 32.9 29.3 21.3 93.5 22.8 13.2 12.1 4.5 9.0 28.8 10.1 27.8 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147872-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 17.1;fallopian tube: 14.7" "Cell type enhanced" "Detected in many" "Astrocytes: 32.0;Early spermatids: 78.6;Endometrial ciliated cells: 55.3;Respiratory ciliated cells: 79.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 16.4;NK-cell: 5.8" "Group enriched" "Detected in many" 7 "granulocytes: 16.4;NK-cells: 5.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.7;HEL: 3.7;HMC-1: 12.0;NB-4: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034492 Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227" "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.4 0.3 1.5 0.3 1.9 1.4 0.7 1.0 1.4 2.7 17.1 1.1 0.3 3.7 3.4 1.8 14.7 1.4 3.7 1.5 2.1 1.8 0.0 2.0 0.2 5.2 3.9 1.7 0.1 0.2 3.1 0.8 2.8 1.9 0.3 2.0 8.2 3.6 0.0 3.5 0.5 1.6 2.7 0.3 0.9 6.7 2.5 0.5 2.3 0.1 0.4 0.5 0.9 2.6 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.7 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.1 0.0 0.1 3.7 0.0 0.0 0.0 0.0 12.0 0.2 0.2 0.1 0.0 0.1 0.0 0.6 1.1 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 1.5 0.0 0.6 0.1 0.6 0.1 0.3 0.1 0.5 0.7 1.5 5.8 0.0 0.0 0.0 0.9 1.5 1.9 1.0 1.4 1.5 2.1 5.2 3.9 2.8 2.7 2.5 2.6 0.1 0.0 3.9 32.0 0.0 3.1 6.0 9.6 1.2 0.2 0.4 0.5 10.8 4.3 5.1 0.0 2.1 0.0 1.6 1.2 1.9 0.9 78.6 55.3 6.0 0.3 0.0 1.7 7.2 5.9 0.1 0.8 0.0 17.1 16.4 3.8 0.4 0.0 0.3 0.0 1.7 1.5 4.1 0.0 0.4 19.0 6.8 4.9 0.0 0.0 0.4 5.3 3.1 1.5 0.2 1.0 0.0 7.2 0.2 1.0 3.8 0.7 79.6 0.1 6.6 0.1 3.7 11.3 10.5 7.3 2.8 0.3 1.6 0.4 5.2 6.0 EFNB3 "EPLG8, LERK-8" ENSG00000108947 "Ephrin B3" Q15768 17 7705202-7711372 "Cancer-related genes, Predicted membrane proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.2" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 11.6;Early spermatids: 9.2;Excitatory neurons: 9.1" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.9;AN3-CA: 32.3;hTERT-RPE1: 32.6;SH-SY5Y: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001623 Approved NA NA 11000 "Cluster 65: Brain - Ion transport" "Cluster 12: NES - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "HPA001623: AB_1848026" "unprognostic (5.17e-2)" "unprognostic (7.15e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (3.27e-1)" "unprognostic (1.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.64e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.21e-4)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.00e-1)" "unprognostic (8.56e-2)" "unprognostic (2.20e-2)" 3.5 2.0 23.1 0.7 25.8 0.0 3.5 0.1 25.3 7.4 5.6 0.7 0.3 10.3 0.5 2.0 5.5 1.2 1.1 23.0 37.3 1.2 1.7 1.0 0.3 9.2 10.7 4.7 1.2 12.0 5.7 1.2 8.7 2.1 0.6 3.6 1.4 0.5 0.3 5.9 0.9 3.7 5.8 0.1 0.8 3.6 38.2 0.4 0.7 0.1 0.9 1.0 2.4 10.7 0.0 1.0 53.9 32.3 1.0 0.7 0.4 0.6 7.2 4.8 3.1 2.0 3.4 0.0 1.1 2.1 0.3 0.4 13.9 6.9 2.8 0.0 6.8 0.2 0.0 0.1 1.5 0.0 0.0 3.1 1.4 1.5 1.1 32.6 0.3 0.5 0.0 0.0 0.9 5.4 0.0 0.0 4.8 0.0 1.0 0.2 0.1 0.0 7.4 0.7 3.4 28.1 0.0 0.0 1.1 9.4 2.9 0.0 0.1 3.2 10.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 25.8 0.1 25.3 23.0 37.3 9.2 10.7 8.7 5.8 38.2 10.7 2.1 0.0 0.0 1.0 0.2 4.1 3.8 4.6 6.8 2.2 5.9 11.6 1.7 1.5 0.9 0.0 0.0 0.3 0.0 0.1 0.0 1.1 9.2 2.5 5.9 1.3 6.7 2.7 9.1 0.2 1.0 4.6 0.0 0.7 1.3 3.3 2.2 0.0 0.4 5.0 6.8 0.3 4.1 0.0 0.4 5.6 4.7 0.2 0.0 1.0 0.0 1.4 0.0 0.5 1.3 0.2 0.0 3.4 0.0 1.6 0.0 0.0 6.0 0.7 0.0 0.0 2.2 0.7 0.7 1.8 2.8 0.3 0.1 1.2 0.0 1.6 EFR3B "FLJ37871, KIAA0953" ENSG00000084710 "EFR3 homolog B" Q9Y2G0 2 25042076-25159135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.1;skeletal muscle: 20.0" "Cell type enhanced" "Detected in many" "Astrocytes: 127.0;Excitatory neurons: 58.5;Inhibitory neurons: 110.7;Late spermatids: 46.0;Microglial cells: 54.4;Oligodendrocytes: 51.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 10.3;BEWO: 12.0;SH-SY5Y: 10.7;SK-BR-3: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038089, HPA071831" Uncertain Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 10: Brain - Neuronal signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Actin filaments, Cytosol" "HPA038089: AB_10672618, HPA071831: " "unprognostic (9.31e-2)" "unprognostic (3.92e-1)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.24e-3)" "unprognostic (3.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.32e-2)" "unprognostic (4.49e-6)" "unprognostic (4.83e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" 0.8 1.6 23.0 0.6 53.1 0.3 0.5 22.4 29.5 0.5 0.0 1.1 0.4 0.7 5.1 0.3 0.6 0.5 4.5 51.7 19.0 1.3 0.2 2.5 0.3 45.3 24.0 0.8 0.4 3.9 9.3 1.7 47.5 0.5 0.6 11.0 0.3 0.8 20.0 0.6 0.5 1.2 9.8 3.4 0.9 2.5 27.7 0.3 3.4 3.8 0.2 0.5 0.4 12.1 0.2 8.3 9.5 10.3 0.5 0.1 12.0 1.0 0.2 0.5 0.1 6.7 0.4 0.1 0.6 1.4 3.3 0.6 7.5 0.0 0.1 1.6 1.8 1.6 0.3 0.6 0.0 0.1 0.8 0.1 0.0 2.3 0.1 0.7 0.3 0.2 0.1 0.4 0.2 0.9 0.2 0.5 1.9 0.1 6.6 0.8 9.1 0.3 0.1 0.3 4.0 10.7 1.2 18.0 5.9 5.3 0.9 0.1 0.5 0.5 2.7 4.1 2.0 0.7 0.9 0.1 7.3 0.1 1.9 1.3 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 23.0 53.1 22.4 29.5 51.7 19.0 45.3 24.0 47.5 9.8 27.7 12.1 3.1 28.9 1.1 127.0 0.0 0.0 0.8 0.0 0.0 9.9 0.3 1.0 9.7 0.0 0.0 9.2 22.9 0.1 0.1 0.7 0.0 0.3 20.6 1.3 0.3 6.7 3.6 0.0 58.5 0.8 0.2 1.0 0.0 0.3 0.0 1.1 2.9 0.0 0.9 5.0 110.7 0.1 0.0 0.0 0.3 46.0 1.2 0.1 0.0 54.4 0.0 22.0 0.0 19.6 51.2 0.7 0.0 2.6 0.1 0.6 0.5 0.1 0.0 10.7 0.0 1.6 1.4 2.4 2.2 0.0 0.1 0.1 0.1 0.2 0.3 0.4 ELANE "ELA2, HLE, HNE, NE" ENSG00000197561 "Elastase, neutrophil expressed" P08246 19 851014-856247 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 91 "bone marrow: 3894.9" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 8.7;Fibroblasts: 16.2;Langerhans cells: 11.1;Leydig cells: 6.2;Melanocytes: 7.2;Suprabasal keratinocytes: 7.4" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "classical monocyte: 4.0;neutrophil: 12.1" "Group enriched" "Detected in many" 9 "granulocytes: 12.1;monocytes: 4.0" "Cell line enriched" "Detected in some" 91 "THP-1: 3105.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015409, HPA066836, HPA073774" Enhanced "Secreted to blood" NA NA 370000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" "CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: " "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-3)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.43e-2)" "unprognostic (3.92e-1)" "unprognostic (6.38e-3)" "unprognostic (5.80e-1)" "unprognostic (2.54e-2)" "unprognostic (4.06e-2)" "unprognostic (3.48e-2)" "unprognostic (1.19e-10)" "unprognostic (6.27e-3)" "unprognostic (4.00e-2)" "unprognostic (2.76e-2)" "unprognostic (4.75e-3)" 3.4 1.0 0.3 0.0 0.3 3894.9 3.4 0.1 0.7 0.5 0.2 2.0 0.4 1.0 0.0 1.1 1.4 0.1 4.0 0.3 0.2 0.7 3.3 19.4 0.6 0.1 0.2 0.5 0.5 0.0 1.2 0.8 0.1 2.9 0.0 0.0 2.4 0.1 1.5 5.4 1.8 0.1 0.1 42.6 1.4 0.4 0.2 6.3 3.1 0.0 0.0 2.1 1.0 0.2 2.0 0.1 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3105.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.8 0.0 34.0 0.0 0.0 4.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 27.2 0.3 0.3 0.1 0.7 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.9 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 0.0 4.2 0.1 0.0 1.3 16.2 0.0 0.1 0.0 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.0 3.4 11.1 0.0 6.2 1.1 7.2 0.0 0.9 0.0 1.0 0.0 0.1 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 0.0 0.0 7.4 0.0 0.7 0.2 0.0 0.0 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.4;epididymis: 6.3;testis: 5.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "basophil: 18.6" "Lineage enriched" "Detected in single" 33 "granulocytes: 18.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 0.5 0.3 0.2 1.7 0.3 4.4 0.6 0.1 0.4 0.5 0.0 0.9 0.8 0.4 6.3 1.1 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.4 2.3 0.3 0.2 0.5 0.2 0.1 0.1 1.4 0.3 0.2 1.3 0.4 0.5 0.1 0.2 1.1 0.7 0.6 0.1 0.9 0.5 5.7 0.3 3.3 0.2 0.0 2.6 0.4 0.5 0.4 13.9 20.0 26.2 13.7 1.2 2.6 18.8 14.2 5.4 19.3 17.7 31.7 11.0 11.0 18.3 5.7 12.0 10.7 24.5 11.3 27.3 21.7 19.3 26.3 23.3 14.8 0.1 10.9 8.4 0.5 0.8 22.3 9.2 2.6 4.5 31.2 16.3 25.6 11.6 15.2 25.0 13.9 15.1 14.2 13.6 25.5 50.7 15.4 4.3 5.6 10.1 20.2 8.7 4.8 8.1 20.9 16.8 12.3 3.1 24.8 14.9 16.6 19.7 16.0 17.4 10.5 7.8 12.2 15.6 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.3 0.1 0.4 0.1 0.1 0.3 0.2 0.3 0.1 0.3 0.4 0.1 0.0 1.1 0.3 0.8 0.1 0.3 0.5 0.6 1.5 0.5 0.3 0.4 0.0 0.7 0.0 0.0 4.6 0.5 0.6 0.0 0.3 0.5 0.8 0.7 0.4 0.0 3.8 0.1 0.0 4.8 0.8 2.0 0.5 0.0 4.5 0.0 0.3 2.2 0.0 0.1 0.9 0.0 0.0 1.4 0.6 0.6 0.8 0.0 0.0 1.0 0.5 1.0 0.0 0.3 0.1 0.0 0.0 2.5 0.1 0.1 0.0 0.9 0.3 0.0 0.6 1.0 13.2 9.1 1.5 0.1 1.1 0.5 0.6 1.3 0.2 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580632 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 230.6" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes "Cluster 42: Non-specific - Transcription" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 56.8 9.7 15.5 12.4 15.5 0.7 49.5 14.8 17.1 51.0 18.6 48.0 15.5 25.9 45.5 152.1 35.5 17.7 64.1 13.6 15.6 20.3 83.2 230.6 5.7 16.1 16.8 54.9 13.7 32.8 13.3 23.0 16.0 38.8 34.1 2.0 39.2 17.3 22.5 140.6 28.3 22.3 15.2 16.0 39.1 7.2 18.8 5.3 27.7 25.4 32.8 39.6 72.9 15.7 28.7 39.1 15.9 18.9 35.0 30.0 31.3 40.0 36.8 23.9 35.7 128.5 98.2 0.2 12.6 48.4 17.2 123.9 41.1 49.8 31.3 0.1 26.1 0.1 76.6 72.1 6.1 0.2 0.4 18.4 13.1 31.9 3.2 5.4 10.1 0.1 9.6 2.6 66.9 268.1 0.4 0.6 18.3 46.4 9.5 7.5 18.2 61.7 5.5 182.0 22.0 25.0 49.6 256.2 15.2 45.2 156.6 6.2 5.7 75.5 32.2 25.6 22.7 0.8 1.0 0.2 33.2 0.5 75.7 1.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 1.1 0.3 0.3 0.3 0.2 0.1 15.5 15.5 14.8 17.1 13.6 15.6 16.1 16.8 16.0 15.2 18.8 15.7 239.7 4163.5 368.4 13.1 3.1 356.9 137.9 172.2 111.0 2.3 105.0 94.0 53.1 100.1 255.8 42.3 0.0 74.2 3.1 119.5 0.0 3.8 8.0 78.8 30.9 183.9 104.9 0.0 0.7 67.0 17.8 152.7 46.4 51.9 36.7 68.7 161.0 235.1 10.1 0.0 0.6 207.8 81.4 19.6 136.5 9.3 190.7 17.0 87.2 41.2 33.6 5.7 0.0 22.6 0.6 32.9 158.4 276.1 1.6 86.0 21.0 0.2 142.8 2.2 52.6 256.3 129.3 5.7 12.9 319.5 1174.3 48.0 9.3 73.3 178.5 221.4 ENKUR "C10orf63, CFAP106, enkurin, MGC26778" ENSG00000151023 "Enkurin, TRPC channel interacting protein" Q8TC29 10 24981979-25062279 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.4;choroid plexus: 13.6;fallopian tube: 43.6" "Group enriched" "Detected in many" 4 "Early spermatids: 73.9;Endometrial ciliated cells: 143.5;Respiratory ciliated cells: 288.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.1;glioma: 4.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;CAPAN-2: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037593, HPA037594, HPA061503" Enhanced NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543" "unprognostic (2.33e-3)" "unprognostic (4.86e-2)" "unprognostic (1.13e-2)" "unprognostic (6.52e-3)" "unprognostic (3.31e-2)" "unprognostic (2.91e-2)" "unprognostic (1.38e-2)" "unprognostic (7.35e-2)" "unprognostic (1.18e-1)" "unprognostic (8.69e-2)" "unprognostic (6.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-6)" "unprognostic (3.94e-1)" "unprognostic (3.35e-2)" "unprognostic (3.45e-3)" "unprognostic (8.43e-3)" 0.1 0.4 8.7 0.5 8.3 0.4 0.1 9.8 9.1 1.4 13.6 0.3 1.3 1.6 0.2 0.0 43.6 0.3 0.1 9.1 12.6 0.4 0.7 4.4 0.0 14.2 14.4 0.2 0.0 0.0 5.5 0.6 13.8 0.1 0.1 1.9 0.1 0.0 0.2 0.1 1.5 0.2 12.0 0.3 0.3 6.9 9.7 0.1 0.5 0.1 0.1 0.0 0.0 12.4 0.1 0.4 0.4 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 2.7 0.2 0.3 0.0 0.4 0.2 0.0 0.3 0.0 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.8 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.1 0.3 0.0 6.2 8.7 8.3 9.8 9.1 9.1 12.6 14.2 14.4 13.8 12.0 9.7 12.4 0.2 0.0 1.1 19.2 0.6 0.0 0.7 10.7 0.0 0.3 0.1 0.4 0.3 0.0 27.3 1.8 0.0 0.4 0.2 4.0 0.0 2.5 73.9 143.5 2.3 1.0 2.4 0.0 8.1 5.1 1.8 1.4 3.6 1.8 1.3 0.3 0.0 0.2 0.0 0.0 3.3 0.6 8.2 0.0 0.0 12.6 1.2 25.0 0.0 2.8 2.0 18.7 4.1 2.0 3.1 11.2 0.1 0.7 0.0 0.7 2.0 0.9 288.8 1.6 0.0 0.7 2.9 35.8 4.9 0.0 0.1 0.3 0.3 0.7 0.5 0.2 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase 4" A6NNW6 10 116849499-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.5;choroid plexus: 4.7;fallopian tube: 5.0" "Cell type enhanced" "Detected in some" "Astrocytes: 16.3;Cone photoreceptor cells: 22.9;Early spermatids: 15.5;Endometrial ciliated cells: 15.8;Inhibitory neurons: 18.4;Late spermatids: 15.8;Oligodendrocytes: 62.4;Respiratory ciliated cells: 30.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: AB_2675746" "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.2 0.3 1.7 0.0 5.3 0.0 0.4 1.7 3.4 0.4 4.7 0.3 0.0 0.6 1.3 0.1 5.0 0.3 0.1 2.1 2.6 0.6 1.3 0.6 0.1 4.8 4.5 0.5 0.6 1.0 1.0 0.0 3.5 0.3 0.1 2.0 0.2 0.4 0.0 0.2 0.2 0.2 2.6 0.2 0.3 2.5 4.0 0.1 0.7 0.0 0.0 0.1 0.2 11.5 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 5.3 1.7 3.4 2.1 2.6 4.8 4.5 3.5 2.6 4.0 11.5 0.0 0.0 0.0 16.3 0.0 0.1 0.3 0.8 0.6 4.9 0.4 0.3 0.3 0.0 0.4 0.0 22.9 0.3 0.0 0.2 0.0 0.5 15.5 15.8 0.7 0.1 1.8 0.0 12.2 0.2 0.2 0.7 0.0 1.1 0.0 0.5 0.0 0.0 0.0 5.0 18.4 0.0 0.0 0.0 0.6 15.8 1.2 0.2 0.0 8.4 0.6 1.3 0.0 4.5 62.4 0.2 0.1 0.7 0.0 0.1 0.3 0.8 30.2 8.4 0.0 1.0 0.5 9.4 2.9 0.1 0.0 0.1 0.0 1.0 0.3 0.1 EPB41L5 "BE37, FLJ12957, KIAA1548, LULU, LULU1, YMO1, YRT" ENSG00000115109 "Erythrocyte membrane protein band 4.1 like 5" Q9HCM4 2 120013077-120179119 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 218.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 55.5;MCF7: 83.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037563, HPA037564" Uncertain Enhanced "Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane" "HPA037563: AB_2675546, HPA037564: AB_2675547" "unprognostic (1.27e-2)" "unprognostic (2.15e-1)" "unprognostic (2.56e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (5.93e-2)" "unprognostic (8.76e-2)" "unprognostic (2.20e-2)" "unprognostic (9.51e-2)" "prognostic favorable (2.28e-6)" "unprognostic (1.99e-1)" "unprognostic (3.88e-1)" "unprognostic (9.59e-2)" "unprognostic (2.61e-1)" 5.7 6.0 9.0 3.0 7.3 1.0 15.7 43.4 10.6 7.2 4.5 9.9 14.0 7.5 5.8 8.8 12.8 7.4 6.3 7.1 11.1 32.7 56.8 29.9 2.5 8.9 11.1 11.6 26.2 25.1 8.2 9.8 9.0 12.4 8.8 27.8 15.3 6.1 10.1 8.3 11.7 6.5 8.7 2.5 9.1 30.5 12.4 3.6 32.9 8.9 6.6 6.1 8.4 8.1 18.0 6.1 23.8 18.5 16.4 11.8 20.8 3.8 3.7 7.8 7.0 55.5 11.7 0.3 12.9 4.8 9.7 12.1 32.4 14.9 11.5 3.6 10.1 5.2 2.8 31.1 19.1 2.3 5.3 10.6 27.6 14.6 10.4 6.7 22.1 10.4 12.4 1.3 15.6 83.4 4.3 7.9 21.5 8.3 5.6 0.0 7.1 5.0 24.2 17.1 12.3 23.5 16.5 29.0 8.2 32.5 14.0 4.3 18.4 0.7 11.2 12.3 3.9 1.9 3.5 9.2 2.0 0.1 4.5 0.1 0.5 0.6 0.4 0.1 0.1 1.7 0.4 0.4 0.1 1.3 1.1 0.8 0.7 0.6 0.3 0.0 0.2 0.4 9.0 7.3 43.4 10.6 7.1 11.1 8.9 11.1 9.0 8.7 12.4 8.1 6.0 218.0 41.9 61.0 11.1 24.5 28.9 9.7 21.6 33.9 28.0 14.1 13.2 24.3 22.5 33.1 25.0 14.9 4.3 20.6 21.5 18.8 38.0 25.8 12.6 6.8 15.5 5.7 68.4 22.3 12.1 13.1 56.1 45.8 0.0 12.0 17.9 54.2 3.2 8.4 79.8 12.7 22.4 2.1 6.8 20.6 9.0 2.8 14.2 26.2 1.1 15.8 0.0 89.5 25.9 23.2 21.7 9.4 5.9 29.1 20.9 29.0 17.5 35.7 19.7 11.7 9.8 43.5 48.6 18.3 21.7 26.4 6.2 5.7 12.9 39.4 EPN3 "FLJ20778, MGC129899" ENSG00000049283 "Epsin 3" Q9H201 17 50532682-50543750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;stomach 1: 37.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 77.9;Distal enterocytes: 27.6;Gastric mucus-secreting cells: 44.9;Intestinal goblet cells: 24.9;Squamous epithelial cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 28.6;HBEC3-KT: 40.3;MCF7: 66.4;OE19: 62.8;RT4: 50.2;SK-BR-3: 25.8;T-47d: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055546, HPA063224" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 6: T47d - Mammary gland" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles Nucleoplasm "HPA055546: AB_2682844, HPA063224: AB_2684964" "unprognostic (1.91e-2)" "unprognostic (1.99e-2)" "unprognostic (2.41e-1)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (2.06e-1)" "unprognostic (5.70e-3)" "unprognostic (7.62e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.66e-3)" "unprognostic (1.00e-2)" "prognostic favorable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (1.16e-1)" "unprognostic (4.90e-1)" "unprognostic (3.52e-3)" 0.2 8.9 2.3 0.8 1.3 0.6 2.3 6.4 6.0 6.5 1.2 7.1 6.8 0.4 3.2 35.9 7.5 5.9 7.1 0.7 2.1 6.0 0.1 0.3 0.0 11.5 5.4 13.5 23.0 21.2 0.8 4.2 13.6 9.9 4.4 0.2 11.1 5.6 0.1 30.5 3.2 0.1 0.5 0.0 37.3 2.8 13.4 3.2 1.1 0.0 3.7 5.5 12.9 1.8 20.5 0.3 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 14.7 12.1 0.0 0.2 0.0 0.1 28.6 0.0 40.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 0.1 21.8 0.1 3.0 0.0 0.0 0.1 0.0 0.0 0.0 66.4 0.3 0.0 0.0 62.8 0.4 0.0 0.0 0.1 0.2 50.2 0.4 0.0 0.0 25.8 0.0 0.4 57.4 0.2 1.5 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.3 6.4 6.0 0.7 2.1 11.5 5.4 13.6 0.5 13.4 1.8 0.2 0.0 0.0 0.0 0.4 2.3 4.4 4.1 10.8 2.9 6.5 3.4 5.4 8.6 8.3 18.4 0.0 77.9 0.0 27.6 5.9 9.2 1.0 3.8 0.6 0.4 3.6 0.0 1.0 11.5 7.4 0.8 44.9 5.5 0.0 3.1 0.0 0.0 5.9 0.0 1.7 24.9 2.0 0.0 0.0 2.1 2.8 0.5 0.0 1.0 0.6 0.6 0.0 0.0 0.0 3.4 10.3 0.0 1.3 4.9 2.1 0.3 4.3 0.9 0.0 0.0 0.8 0.0 0.5 30.0 5.5 10.7 0.2 12.4 19.3 7.8 EPPIN "CT71, dJ461P17.2, EPPIN1, EPPIN2, EPPIN3, SPINLW1, WAP7, WFDC7" ENSG00000101448 "Epididymal peptidase inhibitor" O95925 20 45540626-45547752 "Predicted intracellular proteins, Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 83 "epididymis: 327.9;testis: 84.2" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 30.0;Granulosa cells: 13.6;Late spermatids: 29.2;Respiratory ciliated cells: 32.5;Sertoli cells: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.8;U-87 MG: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067335 Supported "Secreted in male reproductive system" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "HPA067335: " "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.08e-3)" "unprognostic (1.06e-2)" "unprognostic (3.75e-2)" "unprognostic (1.69e-1)" "unprognostic (2.94e-2)" "unprognostic (2.00e-2)" 0.3 0.3 0.7 0.3 1.1 2.4 0.2 1.9 2.4 0.5 0.1 0.4 0.7 0.7 327.9 0.3 1.3 0.2 0.1 0.9 0.0 0.2 2.3 0.4 0.5 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.6 0.2 0.4 1.2 0.3 0.8 0.2 0.8 0.7 0.1 0.0 0.4 0.2 84.2 0.4 0.0 0.7 0.0 0.2 0.1 0.0 2.0 0.8 0.1 0.3 0.3 0.0 0.1 0.5 0.8 0.0 0.0 0.0 0.5 0.3 0.6 0.3 0.0 0.6 0.3 0.1 0.0 0.0 0.5 0.1 0.3 0.5 0.4 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.6 1.8 0.0 0.4 0.2 0.7 0.8 0.1 0.2 0.7 0.2 0.5 0.1 0.2 0.3 0.5 0.3 0.1 0.3 0.3 0.4 0.4 0.7 0.7 0.6 0.9 0.5 0.6 0.8 0.3 2.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.7 1.1 1.9 2.4 0.9 0.0 0.1 0.0 0.6 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.1 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 30.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 29.2 4.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 32.5 0.0 13.1 0.0 0.4 5.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239027 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.2;lymphoid tissue: 3.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.7" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.7" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No Yes "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.1 0.1 0.1 1.3 0.2 3.2 0.4 0.8 0.2 0.4 0.1 0.9 0.7 0.2 0.2 1.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.1 2.3 0.1 0.0 0.3 0.1 0.0 0.1 0.5 0.1 0.1 1.1 0.5 0.3 0.0 0.1 0.6 0.6 0.3 0.0 0.5 0.7 0.8 0.2 3.6 0.1 0.0 2.7 0.2 0.4 0.6 19.0 16.3 14.6 9.3 1.0 1.7 8.0 19.8 9.1 17.0 17.7 13.3 11.6 30.5 7.3 7.2 23.0 15.2 27.8 14.8 30.1 17.5 20.2 10.5 5.5 7.9 0.0 20.7 14.2 0.2 0.9 23.7 4.4 2.8 9.6 15.1 14.1 7.3 17.6 14.8 19.8 12.1 26.6 18.3 24.8 16.4 26.2 5.4 4.4 11.5 12.0 8.6 14.7 9.8 3.6 11.8 7.5 4.6 6.0 11.4 18.3 21.8 13.1 5.7 9.4 25.9 8.1 14.1 11.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 1.7 0.1 0.1 0.4 0.1 0.1 0.2 0.8 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.9 0.3 0.2 0.5 0.0 0.0 0.3 0.6 0.5 1.5 0.2 0.0 0.0 1.1 0.9 0.6 0.0 0.0 0.3 0.9 0.8 0.3 0.0 3.4 0.9 0.0 1.7 0.5 0.0 0.5 0.0 2.5 0.0 0.0 1.0 0.0 0.7 0.4 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.4 2.1 2.4 2.4 0.1 0.4 0.3 0.2 0.9 0.1 ERICH3 "C1orf173, DKFZp547I048, RP11-653A5.1" ENSG00000178965 "Glutamate rich 3" Q5RHP9 1 74568117-74673792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 17.3;testis: 24.1" "Group enriched" "Detected in some" 4 "Early spermatids: 326.4;Endometrial ciliated cells: 139.8;Late spermatids: 326.9;Respiratory ciliated cells: 234.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028655, HPA072916" Approved NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA028655: AB_10961002, HPA072916: " "unprognostic (4.49e-4)" "unprognostic (1.02e-2)" "prognostic favorable (1.56e-5)" "unprognostic (1.71e-2)" "unprognostic (5.94e-2)" "unprognostic (6.83e-2)" "unprognostic (6.53e-2)" "unprognostic (4.76e-2)" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-4)" "unprognostic (9.21e-3)" "unprognostic (2.25e-1)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" 0.0 2.5 3.1 0.0 3.5 0.0 0.8 0.2 5.4 5.4 0.0 0.0 0.0 1.0 0.0 0.0 17.3 0.0 0.0 3.4 1.8 0.0 0.0 2.7 0.2 0.0 0.3 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.1 3.2 0.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.5 0.2 5.4 3.4 1.8 0.0 0.3 0.0 0.0 3.2 0.2 0.0 3.2 3.1 3.6 0.3 0.0 0.0 0.0 0.0 3.5 2.8 0.3 0.6 0.0 28.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 326.4 139.8 1.0 0.4 3.5 0.0 56.8 0.0 0.0 0.5 0.0 3.2 1.3 0.0 0.0 0.1 0.0 0.0 51.8 0.0 0.0 0.0 0.0 326.9 3.1 0.7 0.0 1.0 0.0 0.1 1.0 24.6 3.2 0.0 0.0 3.8 0.0 0.6 0.0 0.0 234.6 0.5 6.6 0.0 0.1 32.9 1.5 0.0 0.0 0.1 0.3 0.1 0.0 0.3 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064522-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 9 "myeloid DC: 2.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2" "Not detected" "Not detected" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.5 0.1 1.5 0.3 2.4 0.0 1.0 0.9 1.4 2.5 1.2 1.9 5.3 1.3 0.6 0.7 11.1 12.3 5.3 1.0 2.4 5.6 10.2 0.9 1.0 1.8 2.1 0.9 34.2 2.2 1.3 0.2 1.9 2.7 3.3 2.3 1.3 2.3 0.0 0.7 1.5 0.5 1.1 0.2 12.6 2.4 4.7 0.7 0.6 0.0 0.7 1.9 0.5 1.3 0.0 7.3 0.0 0.0 0.1 0.0 4.7 4.6 1.8 2.3 1.8 0.1 2.4 0.0 6.0 1.2 3.6 0.4 8.0 0.2 2.8 0.0 11.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.0 14.7 0.0 0.0 0.1 0.2 0.0 0.8 1.6 0.2 2.8 0.0 0.0 0.2 7.5 18.2 4.1 0.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 2.4 0.9 1.4 1.0 2.4 1.8 2.1 1.9 1.1 4.7 1.3 0.0 3.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 2.1 1.3 8.0 100.1 3.1 7.3 0.0 0.3 0.0 1.6 0.0 57.6 0.3 27.8 0.6 0.8 18.0 0.0 1.1 18.4 1.8 0.2 7.7 7.7 0.0 4.3 0.4 2.6 0.1 0.0 1.6 2.4 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.1 8.0 0.0 0.5 0.1 14.8 1.6 0.0 0.0 2.5 0.7 24.5 39.4 0.1 0.0 0.2 1.0 0.2 4.7 1.1 0.0 0.1 0.2 0.7 3.6 2.6 ERN2 IRE1b ENSG00000134398 "Endoplasmic reticulum to nucleus signaling 2" Q76MJ5 16 23690310-23713226 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix: 19.5;gallbladder: 17.0;intestine: 28.9;salivary gland: 22.9;stomach 1: 51.9" "Cell type enhanced" "Detected in some" "Club cells: 38.4;Distal enterocytes: 80.2;Gastric mucus-secreting cells: 193.7;Intestinal goblet cells: 143.9;Paneth cells: 37.2;Undifferentiated cells: 70.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 17.0;pancreatic cancer: 19.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 43.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA076875 Approved Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Endoplasmic reticulum, Cytosol" "HPA076875: " "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (3.45e-1)" "unprognostic (2.98e-2)" "unprognostic (3.83e-2)" "unprognostic (1.13e-2)" "unprognostic (7.67e-4)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (7.34e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-9)" "unprognostic (1.48e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-3)" 0.1 0.4 0.1 3.0 0.1 0.0 0.1 0.6 0.4 19.5 0.2 28.9 12.9 0.0 0.0 0.9 0.4 17.0 0.0 0.1 0.2 0.1 0.0 0.8 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 0.2 3.5 23.0 0.0 22.9 0.1 0.0 0.2 12.4 0.9 0.0 0.0 51.9 0.1 0.1 0.0 0.0 0.0 0.0 4.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.4 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.4 0.0 0.0 1.1 0.0 0.8 0.0 1.5 6.8 0.0 0.0 0.0 0.0 0.5 20.0 38.4 0.0 0.0 0.5 0.0 80.2 0.0 2.3 0.1 0.5 0.2 0.1 10.8 0.0 0.2 1.9 0.0 0.1 193.7 1.6 4.5 0.1 0.0 0.0 0.1 0.0 0.1 143.9 6.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 33.1 37.2 0.0 0.5 1.3 6.1 0.1 16.9 0.0 0.0 1.7 1.6 0.0 0.2 0.0 0.0 0.1 0.4 0.0 70.9 11.1 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7" "Group enriched" "Detected in many" 4 "Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 0.5 0.4 0.0 2.7 0.2 6.0 1.2 0.4 0.2 0.5 0.0 3.7 11.0 0.6 0.0 2.4 0.2 0.6 0.2 0.0 0.0 0.1 0.7 0.4 4.6 0.0 0.0 0.1 1.0 0.3 0.0 1.1 0.1 0.3 4.3 0.5 0.3 0.1 0.0 1.1 7.9 0.7 0.0 0.8 2.5 5.7 0.0 8.5 0.3 0.2 5.7 0.8 0.5 0.2 54.6 39.9 17.9 22.0 2.3 3.9 10.2 31.6 12.9 27.8 32.5 14.2 10.7 21.0 16.6 8.3 24.7 29.2 22.0 8.5 43.6 15.8 9.2 24.4 16.2 15.3 0.3 12.5 21.4 0.7 0.9 17.0 4.2 3.0 11.6 15.2 20.0 30.0 17.7 10.5 49.8 5.9 12.2 29.9 13.4 21.7 53.0 14.8 9.6 31.9 8.0 11.7 15.5 19.6 7.9 6.5 13.2 14.1 5.2 17.9 37.0 36.2 25.7 4.0 11.1 25.2 10.2 20.5 25.2 0.0 0.2 0.1 0.0 0.4 0.0 0.4 0.2 0.2 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.0 1.3 0.3 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 4.7 0.0 2.4 2.3 0.6 2.1 1.8 1.2 1.5 1.7 1.2 0.0 3.3 0.0 4.2 4.6 1.3 8.2 0.0 0.4 5.4 1.3 2.6 1.0 1.2 44.6 0.3 0.0 6.6 3.2 5.6 3.1 1.3 11.4 1.4 1.5 5.4 0.0 0.4 4.4 2.0 2.5 3.5 0.8 1.8 3.2 0.0 1.0 0.5 0.1 4.1 1.0 0.9 0.1 1.5 0.0 11.5 0.6 15.1 0.1 1.6 2.0 6.6 0.8 2.3 62.0 80.0 6.8 0.6 1.0 3.1 1.8 8.0 1.4 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293638 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7" "Cell type enhanced" "Detected in many" "Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.01e-5)" "prognostic unfavorable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favorable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.4 0.2 0.0 2.4 0.0 8.5 0.5 0.0 0.0 3.5 0.0 1.5 3.9 0.2 0.0 15.4 0.2 0.4 0.1 0.0 0.0 0.9 0.6 0.4 4.4 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.1 1.4 0.0 2.0 0.1 0.0 2.6 4.3 0.7 0.0 1.0 0.9 6.2 0.1 10.7 0.1 0.0 4.9 0.6 5.9 0.0 27.8 23.6 27.6 21.1 0.6 1.9 17.5 15.9 8.6 28.8 19.2 15.8 22.7 49.9 9.5 6.8 17.4 20.2 32.6 9.9 14.3 13.7 32.8 30.6 24.1 11.1 0.1 19.5 25.2 0.6 0.6 15.5 7.6 2.8 15.4 22.2 42.6 41.0 9.1 29.2 30.6 16.4 22.5 14.5 12.9 29.3 30.2 21.4 4.2 11.6 18.9 15.8 11.9 20.4 10.1 13.0 36.9 12.7 8.2 14.5 27.2 11.9 25.5 32.5 29.7 31.9 8.2 19.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.3 0.6 0.9 0.3 0.5 0.6 0.0 1.0 1.3 0.9 0.0 0.4 3.7 0.0 1.9 0.6 2.7 0.0 0.2 0.8 0.2 0.8 1.0 3.5 1.3 0.7 0.0 2.3 1.1 3.6 0.7 0.0 4.4 0.7 6.8 2.6 0.0 0.4 2.7 22.4 0.6 2.1 1.2 0.0 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.5 1.5 1.3 0.4 2.1 0.4 22.6 6.6 0.2 0.0 0.0 0.4 0.9 5.5 4.1 7.4 0.6 0.3 0.4 0.1 2.8 0.4 ESPN DFNB36 ENSG00000187017 Espin B1AK53 1 6424776-6461367 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing Actin-binding "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 129.1;retina: 117.8;testis: 145.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 13.4;thalamus: 6.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 2.6" "HPA028674, HPA060220" Enhanced Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" Vesicles "HPA028674: AB_10601316, HPA060220: AB_2684224" "unprognostic (5.06e-2)" "unprognostic (1.18e-2)" "unprognostic (2.69e-1)" "unprognostic (1.28e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.28e-1)" "unprognostic (1.16e-1)" "unprognostic (5.71e-2)" "unprognostic (7.48e-3)" "unprognostic (5.53e-2)" "unprognostic (6.26e-3)" "unprognostic (5.51e-2)" "unprognostic (1.16e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-2)" 0.6 5.7 0.4 2.6 1.0 28.0 9.2 13.4 1.0 30.3 0.2 28.2 90.4 2.4 39.9 34.3 18.6 0.3 0.9 0.4 1.7 63.4 129.1 3.2 0.3 0.6 1.3 0.4 0.9 26.8 42.1 0.9 1.1 10.0 6.8 117.8 9.4 6.2 0.8 91.7 89.5 0.8 0.3 0.9 2.7 145.3 6.1 1.6 0.4 0.0 1.7 1.3 22.3 0.5 14.1 0.7 0.6 0.1 0.0 0.0 48.9 0.0 0.0 0.2 0.0 29.9 1.5 0.5 6.5 0.0 0.1 32.6 2.3 0.1 0.0 2.0 0.7 0.4 0.7 81.5 0.0 0.6 2.7 0.1 0.6 0.0 0.0 0.0 0.0 1.0 17.6 0.0 0.0 28.2 0.2 1.0 0.6 3.8 12.2 0.0 0.4 10.9 0.2 0.1 21.0 0.7 3.7 160.1 5.0 0.3 53.6 7.4 15.6 0.1 0.8 0.6 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 13.4 1.0 0.4 1.7 0.6 1.3 1.1 0.3 6.1 0.5 0.2 0.0 0.6 0.0 0.8 7.8 2.4 4.5 12.5 5.6 10.7 3.9 1.4 11.5 3.8 9.2 68.8 3.0 0.2 175.5 13.7 0.2 137.5 19.1 0.9 0.8 6.0 8.2 0.2 3.1 0.5 0.3 5.6 12.4 0.0 0.0 3.9 109.4 0.2 0.0 0.2 36.3 8.2 3.2 0.9 461.6 3.7 1.5 0.0 0.0 0.0 272.5 0.0 0.0 0.1 0.1 186.3 2.2 0.0 1.6 512.1 102.2 9.0 72.5 0.0 0.0 0.2 12.3 3.9 17.6 22.7 6.6 1.5 0.0 35.3 2.9 ESRRG "ERR-gamma, ERRg, NR3B3" ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.6;parathyroid gland: 46.3;retina: 36.1;stomach 1: 35.1" "Group enriched" "Detected in many" 4 "Astrocytes: 330.7;Excitatory neurons: 415.2;Inhibitory neurons: 495.5;Oligodendrocyte precursor cells: 391.6;Oligodendrocytes: 218.7;Syncytiotrophoblasts: 214.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 23.0;SH-SY5Y: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm No NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favorable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.4 6.4 1.1 0.2 3.1 0.0 3.6 16.9 12.3 1.5 7.4 0.5 5.3 0.4 0.9 1.6 2.5 0.7 10.6 4.4 2.3 29.0 0.7 0.5 0.2 45.4 4.9 0.7 5.7 46.3 1.5 10.6 49.6 3.1 0.3 36.1 16.0 0.7 5.8 0.8 5.0 0.2 1.6 1.1 35.1 1.1 3.5 0.6 5.9 10.2 0.3 0.7 0.2 6.1 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.0 0.2 0.0 0.0 23.0 3.4 2.5 8.1 42.4 0.0 0.4 0.0 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 3.1 16.9 12.3 4.4 2.3 45.4 4.9 49.6 1.6 3.5 6.1 0.2 0.0 1.8 330.7 0.2 0.3 3.8 0.6 0.6 29.5 9.5 5.2 51.2 10.0 1.8 23.9 58.4 35.4 0.0 0.0 54.8 5.0 5.1 15.9 2.0 1.3 8.3 0.0 415.2 2.4 4.7 3.0 70.3 3.5 0.0 0.5 1.1 0.6 4.8 48.8 495.5 1.7 14.2 0.3 0.4 8.1 0.3 0.5 8.8 36.5 0.0 13.3 0.0 391.6 218.7 0.4 1.3 0.7 0.1 4.9 16.3 29.0 16.0 41.3 0.0 10.3 0.4 1.6 0.3 0.8 0.3 214.9 0.3 1.1 2.6 1.7 EXO1 "HEX1, hExoI" ENSG00000174371 "Exonuclease 1" Q9UQ84 1 241847967-241895148 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, Immunity, Meiosis" "DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.3;lymphoid tissue: 11.1" "Cell type enhanced" "Detected in some" "Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053079, HPA069738" Enhanced "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA053079: AB_2682037, HPA069738: AB_2732140" "unprognostic (6.33e-3)" "unprognostic (8.54e-3)" "unprognostic (9.47e-3)" "prognostic unfavorable (8.21e-4)" "unprognostic (2.43e-1)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.94e-7)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.40e-2)" "unprognostic (4.81e-3)" "unprognostic (9.40e-2)" "unprognostic (0.00e+0)" "unprognostic (6.72e-2)" "unprognostic (2.29e-1)" "unprognostic (1.75e-1)" "unprognostic (3.57e-1)" 0.5 0.3 0.2 3.3 0.2 17.3 1.2 0.1 0.7 0.5 0.1 3.2 2.9 0.8 0.0 2.5 0.3 0.4 0.2 0.3 0.1 0.3 0.5 0.6 5.8 0.1 0.2 0.2 0.3 0.7 0.1 3.3 0.2 0.2 3.7 0.0 0.5 0.2 0.1 1.8 2.5 1.2 0.2 1.5 1.6 5.7 0.3 11.1 0.4 0.0 6.4 1.2 0.8 0.4 41.3 26.8 43.4 28.6 2.7 6.7 36.5 53.4 17.7 46.7 50.5 33.9 22.5 44.3 25.3 12.6 25.1 40.0 55.5 22.5 54.8 69.5 48.4 41.5 28.8 17.3 1.0 59.8 29.4 1.7 1.1 46.8 12.5 5.7 14.7 43.4 84.6 57.0 37.8 19.0 65.9 33.6 60.4 49.7 26.0 46.2 40.5 47.5 9.6 25.6 48.1 60.9 34.8 27.9 19.5 20.2 25.8 36.6 5.5 44.9 39.5 42.7 72.9 41.5 59.0 71.3 15.6 48.1 54.9 0.8 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.3 0.2 0.2 0.1 0.7 0.3 0.1 0.1 0.2 0.2 0.2 0.3 0.4 0.2 0.0 0.0 0.3 0.7 0.8 0.1 0.7 0.0 0.0 0.3 0.5 2.3 0.0 0.1 0.0 0.0 5.3 0.2 1.2 0.0 0.1 9.3 0.3 0.4 0.7 0.0 7.4 1.0 0.0 16.7 0.9 1.1 0.5 0.0 4.6 0.4 0.0 3.3 0.0 2.9 0.5 0.0 0.3 0.8 2.1 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 11.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 9.3 9.8 2.7 0.1 4.0 0.8 0.8 1.9 0.3 EYA1 BOR ENSG00000104313 "EYA transcriptional coactivator and phosphatase 1" Q99502 8 71197433-71592025 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 18.7;parathyroid gland: 23.7" "Cell type enriched" "Detected in some" 11 "Astrocytes: 214.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 20.7" HPA028917 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nuclear bodies" "HPA028917: AB_2672826" "unprognostic (3.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.95e-2)" "unprognostic (9.17e-2)" "unprognostic (2.91e-4)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (1.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-12)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (3.81e-4)" "unprognostic (1.25e-2)" 0.6 0.6 2.8 0.1 7.8 0.0 0.2 0.5 2.1 5.1 18.7 0.1 0.1 0.1 0.1 0.4 2.0 0.3 4.5 1.3 2.5 0.1 0.0 0.4 0.0 2.1 4.9 0.2 0.0 23.7 10.8 0.0 2.3 12.0 0.2 0.4 0.8 4.0 2.8 0.0 0.2 0.2 0.0 0.1 0.8 0.8 4.6 11.7 0.6 2.5 0.1 2.6 4.3 0.6 0.2 0.0 6.4 27.6 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 1.6 0.0 0.0 4.7 0.0 2.2 0.0 0.0 0.5 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.0 2.0 0.0 1.5 0.0 21.3 9.5 0.0 0.0 2.2 51.4 0.0 0.0 1.6 5.9 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 6.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 7.8 0.5 2.1 1.3 2.5 2.1 4.9 2.3 0.0 4.6 0.6 0.2 0.0 0.0 214.5 0.0 0.1 0.0 6.4 0.6 0.1 0.0 0.1 8.8 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 3.1 0.1 0.2 0.0 0.0 1.3 0.0 0.5 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 13.5 0.0 2.0 0.0 0.0 6.4 0.3 0.0 0.0 11.2 0.0 0.1 0.0 18.6 0.6 0.0 0.0 0.4 0.0 0.1 0.0 0.3 10.5 0.2 0.0 0.2 0.5 0.8 1.0 1.1 0.1 0.5 0.0 1.4 0.0 0.1 F5 ENSG00000198734 "Coagulation factor V" P12259 1 169511951-169586588 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "choroid plexus: 142.8;liver: 176.2;placenta: 46.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5" "Cancer enriched" "Detected in many" 7 "liver cancer: 69.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2" "Group enriched" "Detected in many" 13 "granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2" "Group enriched" "Detected in some" 23 "Hep G2: 32.8;OE19: 125.5" "Group enriched" "Detected in many" 5 "basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4" "Group enriched" "Detected in all" 7 "amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6" HPA002036 Approved "Golgi apparatus" "Secreted to blood" NA NA 7670000000 13000000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA002036: AB_1078787" "unprognostic (3.67e-2)" "unprognostic (2.77e-4)" "unprognostic (5.42e-2)" "unprognostic (2.56e-4)" "unprognostic (2.03e-1)" "unprognostic (2.39e-4)" "unprognostic (3.46e-3)" "unprognostic (9.25e-3)" "unprognostic (2.02e-1)" "unprognostic (8.99e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.15e-2)" "unprognostic (3.41e-1)" "unprognostic (4.31e-1)" 1.1 0.0 0.3 3.2 1.4 3.7 0.6 4.4 1.3 0.1 142.8 0.3 0.9 0.1 0.2 0.2 3.5 17.6 2.7 4.4 1.6 1.5 176.2 0.9 2.2 1.9 2.2 0.0 0.8 0.0 1.6 46.9 2.4 1.3 0.6 1.0 6.2 0.0 0.2 1.3 0.3 1.1 0.8 1.8 4.9 0.5 2.2 0.5 0.4 0.2 2.3 3.8 0.1 4.2 0.0 0.6 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 32.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 125.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.1 8.1 0.0 0.2 0.0 0.0 1.4 0.2 0.4 0.0 0.3 0.0 7.0 0.0 0.0 0.0 6.2 1.1 0.3 1.4 4.4 1.3 4.4 1.6 1.9 2.2 2.4 0.8 2.2 4.2 0.0 3.2 0.6 1.6 0.7 0.1 6.1 0.0 0.0 0.3 0.7 0.3 9.4 74.4 1.9 0.0 2.1 82.7 0.1 0.3 0.0 2.4 2.4 0.9 0.0 2.4 25.2 0.0 5.4 0.2 2.3 5.3 4.1 0.2 0.0 2.8 3.6 253.4 5.3 0.0 2.6 0.1 0.0 12.3 0.4 0.3 0.0 7.1 3.6 0.0 18.2 1.0 2.1 0.5 1.0 1.9 0.0 0.0 0.1 1.8 0.0 0.2 3.1 0.1 0.0 2.4 0.2 0.5 0.5 0.0 0.0 59.5 2.5 0.0 0.0 11.8 FABP6 "I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP" ENSG00000170231 "Fatty acid binding protein 6" P51161 5 160187367-160238735 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 84 "intestine: 4531.3" "Cell type enriched" "Detected in some" 23 "Proximal enterocytes: 52213.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 31.6;EFO-21: 30.5;HDLM-2: 13.6;NB-4: 17.0;RPMI-8226: 17.2;RT4: 15.2;U-2197: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA012601, CAB024713" Enhanced "Intracellular and membrane" NA NA 890000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "CAB024713: , HPA012601: AB_1848435" "unprognostic (3.03e-2)" "unprognostic (7.55e-2)" "unprognostic (1.27e-1)" "unprognostic (5.00e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (5.35e-7)" "unprognostic (3.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.41e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.35e-9)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (2.48e-1)" "unprognostic (1.85e-3)" 0.0 14.4 7.9 2.5 8.1 0.1 0.2 8.3 11.7 3.1 8.7 3.3 4.9 1.9 0.0 1.2 53.9 0.2 2.2 7.4 11.2 0.2 0.1 5.3 4.2 8.9 8.5 0.1 0.1 0.0 0.7 0.1 10.4 0.2 0.0 0.9 0.2 0.2 0.0 0.4 4531.3 3.4 9.4 1.5 0.4 3.1 9.4 5.6 0.1 1.4 3.5 2.7 0.4 7.7 0.3 0.6 0.0 0.2 0.0 0.0 11.4 0.0 0.0 0.0 0.0 8.1 1.3 31.6 30.5 0.0 0.3 0.0 0.0 0.0 0.0 13.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 2.3 1.2 0.4 0.0 0.0 0.0 17.0 0.1 0.0 2.9 0.0 1.0 17.2 0.0 15.2 2.8 0.7 0.0 8.8 0.2 0.1 0.2 0.2 0.0 0.0 0.1 15.3 1.7 1.7 6.9 4.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 8.1 8.3 11.7 7.4 11.2 8.9 8.5 10.4 9.4 9.4 7.7 0.0 0.0 1.5 1.3 0.2 0.5 0.3 7.8 0.6 0.2 0.1 0.1 3.4 0.0 21.9 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.4 110.2 0.6 0.1 0.0 0.0 1.6 0.0 0.3 0.6 0.0 1.4 0.0 0.6 0.0 0.0 0.1 1.7 2.2 2244.4 2.0 0.0 4.2 0.2 0.3 0.4 0.0 0.0 0.6 0.2 0.0 0.0 0.9 0.3 2080.0 0.0 0.0 0.1 52213.9 0.1 134.9 0.7 0.0 0.0 1.2 0.1 2.1 2.0 0.1 0.0 0.1 1.7 1304.0 1.4 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127412 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.0" "Cell type enhanced" "Detected in many" "B-cells: 12.8;Erythroid cells: 9.1;Plasma cells: 8.8;Squamous epithelial cells: 7.1;Undifferentiated cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "memory B-cell: 3.3;naive B-cell: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol No Yes "Cluster 37: B-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 0.9 0.5 0.5 5.9 0.6 4.8 2.7 2.8 1.8 1.0 0.1 5.6 3.4 1.0 0.5 3.4 0.5 0.8 0.3 0.6 1.1 0.4 2.5 1.1 12.3 0.5 1.0 0.2 0.6 0.9 0.0 1.7 0.7 1.0 5.8 1.3 0.8 0.4 0.4 4.4 4.0 2.0 0.1 1.8 3.2 0.8 0.6 18.0 0.9 0.1 13.3 1.7 1.0 2.1 72.6 18.5 26.6 0.4 2.7 4.9 0.3 53.5 26.7 31.2 46.1 38.7 28.0 89.8 35.4 15.7 26.3 54.7 39.5 36.2 55.2 46.8 9.5 9.8 32.3 16.9 0.1 0.3 11.1 1.2 1.2 30.3 2.4 6.0 16.9 24.1 2.8 81.9 37.2 27.3 57.7 0.6 0.3 43.2 21.0 60.1 39.7 34.7 16.8 61.2 5.2 16.9 44.4 50.8 8.7 9.7 56.2 5.0 9.4 24.1 52.4 73.5 49.6 62.6 48.4 0.6 35.0 0.4 35.4 0.2 0.1 0.1 0.1 0.0 0.1 3.3 0.2 0.3 0.1 2.6 0.1 0.1 1.6 0.0 0.1 0.1 0.7 0.1 0.5 0.6 2.8 1.8 0.6 1.1 0.5 1.0 0.7 0.1 0.6 2.1 0.7 0.0 0.0 0.0 12.8 4.2 2.2 4.2 1.8 0.0 2.5 4.2 0.3 0.0 1.4 0.0 0.0 1.1 1.4 4.0 0.0 0.8 0.0 0.9 1.6 1.2 0.0 9.1 0.0 0.0 0.4 1.5 3.6 1.9 0.0 6.3 0.0 0.2 3.9 0.0 0.0 4.4 2.0 0.3 1.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 1.3 0.0 8.8 0.7 0.5 0.1 1.6 0.0 0.0 1.3 1.8 0.1 1.0 7.1 2.7 0.1 3.2 1.1 10.4 1.6 FAM160A1 FLJ43373 ENSG00000164142 "Family with sequence similarity 160 member A1" Q05DH4 4 151409176-151670503 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 32.3;skeletal muscle: 34.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 11.9;Excitatory neurons: 15.8;Oligodendrocyte precursor cells: 19.1;Suprabasal keratinocytes: 14.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 11 "cerebellum: 13.8" "Immune cell enriched" "Detected in single" 14 "plasmacytoid DC: 2.5" "Lineage enriched" "Detected in single" 14 "dendritic cells: 2.5" "Cell line enhanced" "Detected in many" "A-431: 8.6;HeLa: 10.0;hTERT-HME1: 9.2;SiHa: 8.9;SK-BR-3: 7.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA046348 Enhanced Approved Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA046348: AB_10966145" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.21e-3)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.33e-2)" "unprognostic (4.55e-2)" "unprognostic (1.52e-1)" "unprognostic (7.21e-3)" "unprognostic (1.30e-3)" "unprognostic (2.39e-1)" "unprognostic (1.51e-12)" "unprognostic (2.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (1.28e-1)" 0.6 1.3 0.8 0.3 0.7 1.8 4.4 13.8 1.2 3.2 32.3 3.3 1.9 1.6 4.0 7.8 2.7 0.9 3.4 1.2 0.0 3.4 0.7 1.9 0.2 0.6 0.6 2.4 10.2 8.3 1.3 0.5 0.8 2.2 3.4 6.7 4.7 1.5 34.5 13.4 2.0 1.1 0.3 0.5 2.5 3.4 0.4 1.5 6.8 16.5 2.3 2.2 3.4 0.2 8.6 0.7 0.0 0.2 0.0 0.1 2.9 0.3 1.4 0.8 0.2 3.6 3.0 0.0 0.8 0.3 2.6 7.4 2.1 6.1 0.9 0.0 3.3 0.0 10.0 0.9 0.0 0.0 0.2 0.2 7.0 0.0 9.2 2.4 0.2 0.7 0.0 0.0 0.5 1.2 0.0 0.0 2.8 2.8 0.8 0.0 2.0 0.2 5.1 5.5 1.2 0.4 8.9 7.8 0.2 2.2 3.3 0.0 0.0 0.4 3.7 0.2 1.4 0.0 0.0 0.0 1.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.8 0.7 13.8 1.2 1.2 0.0 0.6 0.6 0.8 0.3 0.4 0.2 0.1 3.2 2.0 1.3 0.0 11.9 6.6 2.9 10.8 0.1 2.7 1.9 1.8 0.0 5.2 0.0 0.0 0.3 0.5 5.9 0.0 1.6 3.3 5.9 0.6 0.4 0.0 0.0 15.8 1.8 0.6 0.6 6.1 10.8 1.3 0.3 0.0 0.5 0.3 8.4 2.4 2.3 0.0 0.0 2.1 1.5 0.0 0.6 0.0 1.0 0.0 2.5 0.0 19.1 1.3 1.9 0.3 0.0 1.4 7.9 2.2 0.7 1.3 4.7 0.0 1.0 0.4 6.1 5.8 11.6 14.5 1.6 0.2 0.3 1.8 8.6 FAM166B ENSG00000215187 "Family with sequence similarity 166 member B" A8MTA8 9 35561831-35563899 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "adrenal gland: 270.0;fallopian tube: 83.1;skeletal muscle: 185.9" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 108.0;Respiratory ciliated cells: 126.4" "Group enriched" "Detected in many" 5 "endometrial cancer: 11.7;ovarian cancer: 4.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045540 Enhanced NA NA "Cluster 39: Non-specific - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA045540: AB_10962627" "unprognostic (4.18e-5)" "unprognostic (7.56e-3)" "unprognostic (1.65e-1)" "prognostic favorable (2.61e-5)" "unprognostic (5.66e-3)" "unprognostic (3.48e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-2)" "unprognostic (2.21e-1)" "prognostic favorable (6.20e-6)" "unprognostic (3.69e-3)" "unprognostic (9.09e-2)" "unprognostic (4.37e-3)" "unprognostic (5.82e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (3.52e-5)" 5.2 270.0 1.9 0.0 1.5 0.0 2.5 1.2 1.2 3.6 8.8 0.3 0.0 1.3 9.0 0.6 83.1 0.1 0.5 1.7 2.3 0.7 0.6 4.2 0.1 4.7 7.0 0.3 0.2 0.1 0.4 0.0 4.5 0.3 0.2 0.1 0.7 0.6 185.9 0.6 0.6 0.1 5.5 0.2 0.4 0.2 2.2 0.0 0.3 18.3 0.3 0.2 0.2 2.7 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.5 1.2 1.2 1.7 2.3 4.7 7.0 4.5 5.5 2.2 2.7 0.3 0.0 0.5 0.0 0.0 4.7 1.2 9.2 2.2 0.0 0.3 2.4 0.3 0.0 10.1 0.0 2.1 0.2 0.3 0.0 0.0 0.2 0.3 108.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.2 0.0 0.1 0.4 0.5 0.1 0.0 0.1 0.0 24.4 0.0 0.7 0.3 0.3 0.3 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 3.3 126.4 0.2 0.0 3.1 3.3 0.2 0.2 2.0 2.0 0.0 0.3 2.1 0.2 0.5 FAM166C "C2orf70, LOC339778" ENSG00000173557 "Family with sequence similarity 166 member C" A6NJV1 2 26562585-26579532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.6;testis: 26.6" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062453 Enhanced Approved "Nuclear membrane,Vesicles" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 21: OE19 - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear membrane, Vesicles" "HPA062453: AB_2684769" "unprognostic (5.44e-2)" "unprognostic (9.30e-3)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (1.99e-2)" "unprognostic (9.40e-6)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (6.49e-4)" "unprognostic (4.58e-2)" "unprognostic (1.52e-1)" "unprognostic (2.98e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-3)" "unprognostic (7.08e-3)" 0.1 0.1 0.8 0.1 0.7 0.0 0.2 0.5 0.6 0.3 4.1 0.6 0.1 0.2 0.3 0.1 7.6 0.0 0.4 0.8 2.5 1.0 0.0 0.4 0.0 2.0 2.0 0.0 0.7 0.1 0.7 0.0 1.2 0.2 0.4 0.1 1.9 0.2 0.1 0.1 0.1 0.1 1.5 0.0 4.8 26.6 2.9 0.0 1.1 0.0 0.0 0.1 0.0 1.0 4.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 3.7 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 0.6 0.8 2.5 2.0 2.0 1.2 1.5 2.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM167A "C8orf13, DIORA-1" ENSG00000154319 "Family with sequence similarity 167 member A" Q96KS9 8 11421476-11475908 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.1;thyroid gland: 53.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Astrocytes: 28.4;Distal tubular cells: 13.7;Early spermatids: 24.8;Enteroendocrine cells: 19.1;Late spermatids: 41.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 57.6;RPMI-8226: 61.5;SH-SY5Y: 44.4;U-698: 44.8;U-87 MG: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023915, HPA030426" Approved Approved Mitochondria NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Mitochondria "HPA023915: AB_1845768, HPA030426: AB_10601318" "unprognostic (8.51e-3)" "unprognostic (2.43e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (5.96e-4)" "unprognostic (3.08e-2)" "unprognostic (4.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (4.06e-2)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (7.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.30e-2)" "unprognostic (2.21e-2)" 0.6 0.8 25.8 1.2 25.1 0.7 1.3 23.9 25.3 0.8 17.0 0.7 0.3 0.1 0.5 0.9 1.3 1.0 0.2 26.6 26.7 6.4 0.3 10.2 2.4 29.8 27.6 0.0 2.1 1.7 17.4 0.9 27.9 1.5 0.7 5.2 2.6 4.6 0.0 11.8 1.3 0.0 26.6 1.2 2.0 3.8 31.1 3.0 53.2 0.1 3.0 0.3 1.6 25.1 4.8 3.0 6.1 0.6 0.4 2.5 0.2 16.8 16.0 10.1 4.4 0.2 1.5 57.6 0.9 18.3 4.7 1.6 0.1 4.0 11.9 24.8 0.8 0.0 0.1 0.0 20.8 0.0 0.1 2.9 2.6 5.3 32.2 32.3 0.0 0.0 0.2 2.2 6.0 1.8 0.1 0.0 1.6 0.1 0.1 0.3 0.0 61.5 5.1 0.5 26.3 44.4 0.8 4.7 2.2 0.8 1.8 0.1 28.5 1.0 1.6 25.8 0.2 17.7 14.0 44.8 36.3 0.1 1.6 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 25.8 25.1 23.9 25.3 26.6 26.7 29.8 27.6 27.9 26.6 31.1 25.1 0.0 16.0 1.8 28.4 5.4 5.9 0.6 0.5 0.0 0.1 1.2 1.3 0.7 1.5 0.5 5.5 10.4 0.0 1.1 0.2 13.7 2.1 24.8 2.1 0.2 0.2 19.1 0.0 0.6 1.8 0.0 0.3 2.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.4 1.3 0.0 0.3 0.3 41.1 0.3 0.3 0.0 3.7 0.3 1.7 0.0 0.0 1.3 1.1 2.4 0.4 0.9 0.8 0.1 0.2 1.9 1.8 0.0 0.3 0.2 3.9 2.2 0.0 3.4 0.0 1.0 0.1 0.1 0.2 FAM183A "hCG23177, LOC440585" ENSG00000186973 "Family with sequence similarity 183 member A" A6NL82 1 43145153-43156396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "fallopian tube: 116.9" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 516.6;Late spermatids: 244.5;Respiratory ciliated cells: 1012.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 19.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.5;hTCEpi: 2.4;NTERA-2: 3.1;SCLC-21H: 2.7;SuSa: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043382, HPA049120" Approved NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 5: NTERA-2 - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "HPA043382: AB_2678456, HPA049120: AB_2680640" "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (9.56e-2)" "unprognostic (1.42e-3)" "unprognostic (6.79e-2)" "unprognostic (3.79e-2)" "unprognostic (1.44e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-2)" "unprognostic (1.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (4.30e-2)" "unprognostic (1.27e-2)" "unprognostic (7.88e-2)" "unprognostic (1.18e-3)" "unprognostic (1.73e-2)" 0.0 0.0 1.3 0.0 1.2 0.0 1.0 0.5 0.3 2.5 9.2 0.2 0.1 2.1 0.5 1.0 116.9 0.0 0.0 1.2 2.1 1.3 0.1 6.9 0.0 8.1 7.2 0.2 0.2 0.9 5.5 0.6 3.9 2.0 0.3 0.2 1.4 0.2 0.0 9.7 0.0 0.2 4.2 0.0 0.1 6.9 1.4 0.3 0.0 0.0 0.3 0.5 1.1 2.3 0.3 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.3 0.6 3.5 0.0 0.4 0.2 0.3 0.4 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 1.4 0.6 2.7 0.0 0.0 0.1 0.0 5.2 0.7 0.0 0.5 0.0 0.3 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.5 0.3 1.2 2.1 8.1 7.2 3.9 4.2 1.4 2.3 0.0 0.0 7.4 0.0 0.0 1.9 14.0 66.1 3.4 0.0 1.4 2.3 0.2 0.0 109.2 3.7 0.0 2.1 0.1 0.4 3.9 0.0 107.7 516.6 3.5 1.3 4.2 0.0 0.0 0.0 0.2 1.2 0.0 5.7 3.8 0.1 0.0 0.0 0.1 0.0 0.0 0.4 54.9 0.0 0.0 244.5 1.8 0.7 3.6 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.7 0.0 3.9 0.0 2.0 1012.8 0.1 0.0 0.0 13.3 7.6 3.5 2.3 2.6 2.1 0.6 0.2 0.5 9.7 FAM189A2 "C9orf61, X123" ENSG00000135063 "Family with sequence similarity 189 member A2" Q15884 9 69324567-69392558 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 48.3;thyroid gland: 58.2" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 157.0;Astrocytes: 256.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.2;NTERA-2: 5.1;RPTEC TERT1: 1.8;RT4: 2.3;SK-MEL-30: 5.0;SuSa: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029411, HPA057207" Approved NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA029411: AB_10602338, HPA057207: AB_2683369" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.16e-6)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.09e-1)" "unprognostic (2.71e-3)" "unprognostic (7.84e-2)" "unprognostic (1.07e-2)" "prognostic favorable (1.75e-5)" "unprognostic (3.42e-1)" "unprognostic (2.41e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-1)" 6.0 4.7 12.8 0.4 15.0 0.0 13.7 15.8 11.2 26.0 9.2 7.1 1.2 6.8 1.7 5.2 6.8 1.6 13.3 12.2 15.7 4.7 0.2 22.3 0.6 20.1 16.7 24.6 7.3 6.0 7.6 1.5 17.1 11.1 1.1 4.4 6.2 3.4 48.3 12.4 4.0 4.9 16.3 0.4 13.7 1.3 19.8 5.6 58.2 9.0 0.9 7.9 4.6 15.1 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.7 0.7 0.0 0.0 0.6 1.6 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 5.1 0.3 0.0 0.0 0.1 0.0 1.8 2.3 0.0 0.0 0.0 0.0 5.0 1.9 0.1 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 15.0 15.8 11.2 12.2 15.7 20.1 16.7 17.1 16.3 19.8 15.1 12.1 157.0 23.3 256.3 0.4 3.3 4.9 1.9 7.4 2.1 18.4 39.6 14.6 0.0 26.9 1.8 0.0 1.2 0.4 1.5 0.0 0.9 0.1 19.9 2.8 8.0 0.0 0.0 0.7 0.6 0.1 1.7 11.7 33.0 0.0 2.0 2.2 0.0 0.3 0.0 3.9 0.4 0.0 0.3 1.3 0.0 0.0 0.4 19.6 20.6 0.0 35.1 0.0 7.1 2.1 3.5 1.2 0.0 0.2 3.7 0.2 0.2 2.3 1.0 0.0 3.8 3.8 0.1 0.6 1.9 2.4 0.3 1.0 0.7 0.7 1.8 FAM216B "C13orf30, FLJ40919" ENSG00000179813 "Family with sequence similarity 216 member B" Q8N7L0 13 42781550-42791549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "fallopian tube: 77.6" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 162.2;Respiratory ciliated cells: 294.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-87 MG: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040118 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "HPA040118: AB_10674429" "unprognostic (1.03e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.35e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (2.54e-2)" "unprognostic (5.44e-3)" "unprognostic (1.32e-1)" "unprognostic (2.27e-1)" "unprognostic (8.14e-3)" "unprognostic (1.37e-1)" "unprognostic (1.30e-2)" 0.1 0.0 1.5 0.8 1.5 0.0 0.0 0.7 0.1 1.4 5.5 0.1 0.1 1.5 0.0 0.0 77.6 0.2 10.0 1.7 2.6 0.0 0.0 9.9 1.8 9.3 9.3 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.7 0.1 0.2 0.0 2.1 0.0 0.0 0.0 3.5 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 0.7 0.1 1.7 2.6 9.3 9.3 6.1 6.7 2.1 3.6 0.0 0.0 3.9 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 19.8 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 162.2 1.0 0.7 0.0 0.0 0.2 0.0 0.0 2.2 0.0 2.3 1.3 0.0 0.0 0.0 0.3 0.0 0.9 0.0 12.2 0.0 0.0 9.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 294.3 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 FAM227A ENSG00000184949 "Family with sequence similarity 227 member A" F5H4B4 22 38578120-38656629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 7.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6;Early spermatids: 87.3;Endometrial ciliated cells: 72.4;Late spermatids: 57.0;Respiratory ciliated cells: 115.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 10.4;Karpas-707: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003077 Uncertain Uncertain Nucleoplasm NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 2: Karpas-707 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA003077: AB_1079264" "unprognostic (7.52e-2)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "unprognostic (8.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.91e-3)" "unprognostic (4.79e-5)" "unprognostic (5.91e-2)" "unprognostic (3.04e-2)" "unprognostic (4.04e-2)" "unprognostic (1.85e-2)" "unprognostic (4.62e-2)" "unprognostic (6.46e-6)" "unprognostic (3.74e-1)" "unprognostic (3.47e-2)" "unprognostic (2.65e-3)" "unprognostic (1.35e-2)" 0.1 0.6 1.3 0.2 1.2 0.5 0.8 0.9 1.2 1.2 7.5 0.4 0.2 0.7 1.9 0.1 3.8 0.3 0.3 1.5 1.4 1.1 0.1 1.1 0.2 2.5 3.1 0.7 0.4 0.6 4.3 0.1 1.5 0.6 0.2 3.5 0.4 0.4 0.1 0.8 0.1 0.3 1.4 0.1 0.3 4.1 1.4 0.2 1.3 0.0 0.1 0.3 0.3 0.9 0.4 0.9 1.4 1.7 0.4 1.0 0.3 0.2 0.2 0.3 0.2 0.1 0.9 0.1 0.4 0.2 0.4 0.9 0.5 0.2 0.4 10.4 0.9 0.1 2.9 0.2 0.2 0.4 0.4 0.5 0.6 1.0 0.4 1.5 0.2 1.6 0.4 17.3 0.1 0.5 0.4 0.5 0.7 0.2 0.5 1.0 0.1 0.6 0.9 0.3 2.0 0.5 1.4 0.1 0.2 0.5 1.1 0.1 0.3 0.4 0.4 0.4 0.1 1.8 0.8 0.1 0.6 0.2 0.2 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 1.3 1.2 0.9 1.2 1.5 1.4 2.5 3.1 1.5 1.4 1.4 0.9 0.3 3.2 2.6 20.9 0.0 2.4 3.2 3.7 0.0 6.8 4.1 3.8 2.1 2.8 9.0 5.5 39.6 0.3 0.2 0.3 0.0 3.8 87.3 72.4 5.9 1.6 4.8 0.8 15.5 2.5 0.3 2.6 0.0 4.1 0.0 8.5 0.4 0.3 0.2 5.0 11.1 0.7 4.1 0.6 1.2 57.0 2.1 0.6 0.0 2.8 0.3 9.5 1.0 1.5 2.3 2.3 0.2 1.2 0.1 2.1 0.0 1.4 115.2 30.4 0.0 4.6 2.8 16.4 12.9 0.0 3.4 0.1 1.4 9.5 1.2 1.7 FAM47E "FLJ42946, LOC100129583" ENSG00000189157 "Family with sequence similarity 47 member E" Q6ZV65 4 76214040-76283783 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 47.3;Endometrial ciliated cells: 34.0;Respiratory ciliated cells: 91.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 5 "OE19: 28.0" HPA053331 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-4)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-8)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.04e-2)" "unprognostic (3.01e-2)" 6.2 4.9 7.6 0.4 8.3 1.0 6.8 7.5 8.8 2.9 7.9 2.6 3.2 1.7 11.0 1.3 19.6 4.0 1.9 8.0 8.4 7.3 9.1 4.0 0.5 8.1 8.5 0.8 9.1 7.6 8.5 1.5 7.8 4.2 2.9 8.8 4.4 2.7 6.4 1.3 3.5 1.1 7.8 1.2 5.1 8.0 9.5 0.7 9.7 3.2 0.4 1.9 0.7 9.1 0.6 2.1 2.1 0.6 1.6 0.2 0.5 0.2 2.0 0.4 0.4 2.6 2.2 0.1 0.6 0.7 4.5 0.6 0.9 0.5 0.7 2.1 0.1 0.1 1.3 3.6 0.9 0.5 0.3 1.0 0.5 0.6 0.5 0.9 0.2 0.3 0.2 1.5 0.6 3.1 0.2 0.2 0.4 28.0 1.0 0.3 0.5 0.3 3.4 1.8 3.7 2.9 1.0 1.6 0.3 0.5 1.7 0.2 0.5 0.4 0.5 1.2 0.5 5.5 1.2 0.1 1.6 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 7.6 8.3 7.5 8.8 8.0 8.4 8.1 8.5 7.8 7.8 9.5 9.1 1.6 9.6 2.6 4.2 0.4 0.6 2.5 5.1 0.0 12.9 7.7 9.1 7.9 8.6 8.4 0.0 12.5 3.3 0.1 6.2 9.8 7.5 47.3 34.0 0.6 1.8 7.7 0.8 1.0 7.8 1.6 1.5 3.1 2.0 0.0 1.5 1.8 3.6 0.8 1.7 1.1 5.7 14.2 1.0 0.0 6.2 0.6 0.7 1.8 1.0 0.0 4.7 0.0 0.0 2.9 5.8 3.0 0.4 0.4 2.8 13.0 10.3 91.4 7.4 0.0 2.0 2.2 8.8 4.3 0.3 0.3 3.4 0.2 0.8 3.1 1.9 FAM71E2 "C19orf16, DKFZp434G1729" ENSG00000180043 "Family with sequence similarity 71 member E2" Q8N5Q1 19 55354908-55363260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 152 "testis: 28.5" "Group enriched" "Detected in some" 18 "Early spermatids: 4.1;Late spermatids: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (5.97e-2)" "unprognostic (2.27e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523555 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0" "Group enriched" "Detected in many" 5 "Collecting duct cells: 31.3;Excitatory neurons: 83.0;Inhibitory neurons: 67.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 5.1;plasmacytoid DC: 11.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.7" "Cell line enriched" "Detected in many" 4 "Daudi: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA001847: AB_2666462, HPA065797: AB_2685560" "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 0.4 0.1 7.0 2.4 10.5 0.2 1.4 0.0 17.0 6.7 0.5 4.3 2.4 2.4 4.4 0.4 6.1 1.6 1.5 11.0 3.2 6.8 0.4 0.7 4.9 0.0 0.1 0.6 1.9 1.1 2.6 0.8 0.1 2.3 5.2 1.3 2.6 1.5 0.5 0.9 1.4 1.2 0.0 1.4 2.4 1.8 6.0 0.4 2.1 2.8 5.5 0.4 0.4 8.3 10.5 15.0 1.1 0.2 0.4 0.2 6.0 0.6 0.0 1.0 2.8 1.8 1.7 66.5 0.3 0.2 14.1 7.8 8.3 2.5 1.9 0.7 4.3 0.0 10.6 0.8 0.0 5.7 1.3 0.0 1.5 0.4 0.8 0.8 0.1 2.7 0.1 0.0 1.0 3.5 0.1 0.1 0.9 2.7 5.4 1.5 14.8 1.7 3.3 3.8 3.0 0.8 6.0 0.3 9.9 0.6 2.5 3.4 0.3 2.4 7.4 2.9 11.4 0.1 0.0 0.8 2.5 2.2 6.7 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.1 2.3 0.0 0.0 0.3 0.1 0.0 11.7 0.0 0.3 7.0 10.5 0.0 17.0 11.0 3.2 0.0 0.1 0.1 0.0 6.0 8.3 0.2 0.0 1.3 11.4 2.5 0.5 1.4 0.2 0.6 0.0 2.4 2.4 6.9 0.0 1.0 31.3 0.0 0.1 0.0 1.7 5.9 0.5 0.5 11.2 0.9 0.7 1.2 1.3 83.0 0.2 1.6 0.6 1.1 1.5 1.3 0.2 0.4 0.2 1.3 10.1 67.0 1.9 2.0 0.6 1.5 1.4 0.3 0.7 8.8 4.7 0.7 1.1 0.0 2.5 8.1 0.4 1.9 0.0 1.2 1.4 0.8 0.3 8.4 0.2 0.0 1.1 3.1 0.2 1.6 1.5 0.4 0.0 0.4 0.2 4.0 1.0 FAM81B FLJ25333 ENSG00000153347 "Family with sequence similarity 81 member B" Q96LP2 5 95391366-95450454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 48.3;testis: 83.5" "Group enriched" "Detected in some" 5 "Early spermatids: 854.5;Late spermatids: 1757.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 61 "basophil: 6.7" "Lineage enriched" "Detected in single" 61 "granulocytes: 6.7" "Cell line enriched" "Detected in single" 5 "CAPAN-2: 1.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA072554 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" "HPA072554: AB_2686533" "unprognostic (2.22e-3)" "unprognostic (8.86e-3)" "unprognostic (2.61e-3)" "unprognostic (1.37e-2)" "unprognostic (2.62e-1)" "unprognostic (2.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.83e-2)" "unprognostic (2.89e-2)" "unprognostic (5.70e-2)" "unprognostic (5.86e-2)" "unprognostic (4.24e-2)" "unprognostic (1.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.28e-2)" 0.0 0.1 0.7 0.0 1.1 0.6 0.3 2.0 1.2 2.0 16.4 0.0 0.0 0.9 3.7 0.0 48.3 0.2 7.5 1.1 1.5 1.7 0.0 4.4 0.0 4.2 5.3 0.1 0.4 2.5 3.7 0.0 3.7 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 3.5 0.0 0.2 83.5 1.6 0.1 1.6 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 1.1 2.0 1.2 1.1 1.5 4.2 5.3 3.7 3.5 1.6 4.6 0.0 9.6 1.8 0.0 0.0 0.4 0.0 9.5 0.0 0.0 1.0 0.6 6.1 0.0 23.9 5.5 0.0 0.1 0.1 0.0 0.0 0.5 854.5 158.5 0.8 0.5 1.8 0.0 0.9 0.7 0.1 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 12.2 0.0 0.0 1757.9 8.4 3.6 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.7 0.0 3.0 0.0 0.6 0.0 0.3 227.1 0.0 6.6 0.5 2.4 18.0 6.4 0.0 0.0 0.0 0.3 0.2 0.0 0.2 FAM83A "BJ-TSA-9, MGC14128" ENSG00000147689 "Family with sequence similarity 83 member A" Q86UY5 8 123178960-123210079 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 111.3;vagina: 55.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 71.2;Club cells: 58.2;Pancreatic endocrine cells: 28.7;Squamous epithelial cells: 19.3;Suprabasal keratinocytes: 15.2;Urothelial cells: 25.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 52.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 83.5;HBEC3-KT: 126.3;hTCEpi: 66.4;K-562: 206.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA052615 Approved Nucleoplasm,Cytosol NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Cytosol "HPA052615: AB_2797244" "unprognostic (4.48e-2)" "unprognostic (2.03e-3)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.98e-9)" "unprognostic (2.62e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (2.04e-1)" "unprognostic (2.22e-16)" "unprognostic (2.76e-1)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "unprognostic (6.07e-2)" 0.2 0.6 0.0 0.1 0.0 0.2 0.3 0.2 0.1 18.9 0.1 0.1 1.0 0.0 1.3 111.3 4.3 1.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.7 0.0 0.1 7.5 6.4 0.1 10.2 2.4 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.4 0.0 7.4 3.8 55.8 0.0 83.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.6 0.7 10.6 0.0 0.0 25.9 0.0 126.3 0.0 0.0 0.1 0.8 9.2 0.0 0.0 0.1 0.1 0.0 66.4 0.0 16.8 0.0 0.0 0.1 206.3 0.1 0.0 0.3 0.0 0.1 0.0 4.2 0.1 0.0 0.0 0.1 0.0 18.4 0.1 0.0 14.4 9.7 0.1 0.2 1.5 0.2 0.6 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.0 71.2 1.2 0.0 4.4 0.9 1.1 0.0 58.2 1.8 0.0 0.1 0.0 1.0 0.0 0.3 1.0 0.0 0.1 0.1 0.0 0.0 0.6 0.7 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 10.2 0.0 0.4 1.6 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 28.7 0.2 0.0 0.1 0.7 1.1 0.1 9.6 0.0 0.0 0.1 1.4 2.2 0.6 19.3 15.2 0.0 0.1 0.0 0.8 25.0 FAM83F ENSG00000133477 "Family with sequence similarity 83 member F" Q8NEG4 22 39994954-40043534 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 20.3;testis: 40.8" "Cell type enhanced" "Detected in many" "Late spermatids: 68.1;Proximal enterocytes: 39.9;Suprabasal keratinocytes: 34.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 12.1;HaCaT: 12.8;HBEC3-KT: 15.5;hTCEpi: 37.9;hTERT-HME1: 11.8;OE19: 17.6;RT4: 18.6;SCLC-21H: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051207, HPA064657" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 10: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria Nucleoplasm "HPA051207: AB_2681388, HPA064657: AB_2685313" "unprognostic (2.78e-2)" "unprognostic (3.91e-2)" "prognostic favorable (1.73e-4)" "unprognostic (5.36e-2)" "unprognostic (1.48e-5)" "unprognostic (1.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (4.79e-1)" "unprognostic (2.48e-1)" "prognostic favorable (9.40e-4)" "unprognostic (3.25e-1)" "unprognostic (1.10e-7)" "unprognostic (2.93e-1)" "unprognostic (2.37e-1)" "unprognostic (2.98e-2)" "unprognostic (8.32e-2)" 1.2 0.1 0.2 0.5 0.1 1.2 4.7 0.3 0.2 2.6 0.1 5.3 3.2 0.2 2.5 20.3 1.2 0.5 2.0 0.2 0.1 4.0 2.9 0.2 0.0 0.1 0.1 0.3 13.5 5.4 1.2 0.1 0.1 9.0 3.2 0.4 8.2 6.6 0.1 18.8 7.6 0.1 0.0 0.0 6.8 40.8 0.3 0.9 5.9 0.2 1.1 2.6 7.0 0.3 8.3 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 12.1 2.3 0.0 0.0 0.0 0.0 12.8 0.0 15.5 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 37.9 0.0 11.8 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.1 2.1 17.6 0.0 0.0 0.0 0.1 0.3 18.6 39.8 0.0 0.3 3.4 0.0 1.3 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.3 1.1 0.0 0.0 0.0 0.5 28.7 14.5 18.0 23.9 1.2 19.1 10.4 5.2 12.8 7.4 23.9 0.0 0.2 0.0 33.1 3.9 9.6 28.4 6.2 0.5 1.0 13.1 0.4 0.2 15.1 0.2 1.0 10.7 6.5 1.3 0.2 0.0 2.2 0.2 0.0 0.2 21.0 14.2 0.6 2.9 68.1 1.8 0.5 1.8 0.0 0.0 0.9 0.0 0.5 0.1 12.5 21.6 2.2 0.2 16.3 39.9 5.9 6.4 0.6 0.0 1.1 1.3 12.4 1.8 30.6 34.5 1.4 0.8 0.4 15.6 17.8 FANCI "FLJ10719, KIAA1794" ENSG00000140525 "FA complementation group I" Q9NVI1 15 89243945-89317261 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.4;lymphoid tissue: 44.2;testis: 32.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 48.6;Spermatocytes: 69.5;Spermatogonia: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 23.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039972, HPA040379" Approved Enhanced Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA039972: AB_10673265, HPA040379: AB_2676951" "unprognostic (6.88e-2)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.82e-3)" "unprognostic (1.15e-2)" "unprognostic (4.59e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.71e-13)" "unprognostic (2.40e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" 3.2 2.1 1.6 13.0 1.3 31.4 6.0 3.8 2.5 3.3 0.0 10.5 6.0 4.7 1.1 8.1 3.4 3.0 1.7 1.7 0.7 1.7 2.9 3.4 23.9 1.2 0.9 3.8 3.0 3.0 0.6 11.3 1.7 3.6 12.4 5.4 2.8 2.0 0.8 8.0 7.3 6.9 0.6 6.0 6.7 32.6 1.3 44.2 2.0 0.8 26.6 5.4 3.7 1.7 108.2 122.4 127.8 86.1 10.8 16.0 78.5 101.4 58.3 123.6 150.5 96.8 95.4 198.8 53.4 33.8 79.3 143.9 196.8 69.0 116.2 127.8 123.5 197.2 176.7 45.8 1.7 146.0 96.3 8.6 6.8 87.1 44.4 17.6 51.7 120.2 139.2 142.3 83.5 61.5 150.9 49.6 101.1 70.3 44.5 130.6 187.1 84.6 28.5 196.8 93.9 80.8 105.2 73.3 46.7 85.7 81.2 64.8 35.4 103.2 103.8 94.9 155.8 93.3 209.5 151.9 38.5 125.7 104.7 23.4 2.3 3.0 4.7 3.0 2.8 3.5 4.7 6.5 2.2 3.6 3.3 5.6 3.1 5.1 4.3 4.1 11.8 3.1 1.6 1.3 3.8 2.5 1.7 0.7 1.2 0.9 1.7 0.6 1.3 1.7 2.6 3.2 1.5 3.6 3.8 4.2 2.6 4.0 0.6 2.4 2.9 2.7 3.9 0.0 3.3 1.8 0.0 17.0 3.9 4.2 0.0 2.0 7.9 5.0 3.7 3.0 1.2 48.6 7.0 2.9 18.3 3.9 5.6 4.5 2.5 14.9 6.8 0.8 8.1 1.7 5.8 5.9 0.0 3.0 3.8 7.9 3.4 4.8 1.8 1.9 3.3 11.6 1.0 9.0 6.9 2.5 1.2 1.5 13.9 2.0 1.3 1.0 6.3 1.9 6.6 3.6 4.0 69.5 60.2 9.2 2.4 12.4 8.1 2.5 9.1 2.8 FANK1 ENSG00000203780 "Fibronectin type III and ankyrin repeat domains 1" Q8TC84 10 125896564-126009592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 34.2;fallopian tube: 35.1;testis: 56.5" "Cell type enhanced" "Detected in many" "Early spermatids: 603.8;Late spermatids: 603.0;Respiratory ciliated cells: 222.2;Spermatocytes: 126.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 16 "T-reg: 61.2" "Lineage enriched" "Detected in single" 612 "T-cells: 61.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.3;hTCEpi: 9.8;hTERT-RPE1: 13.0;RPTEC TERT1: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038413 Supported Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA038413: AB_10697249" "unprognostic (4.25e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.83e-4)" "unprognostic (1.17e-3)" "unprognostic (4.02e-2)" "unprognostic (6.29e-2)" "unprognostic (1.44e-1)" "unprognostic (3.12e-3)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (3.42e-2)" "unprognostic (9.53e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-2)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" 0.9 3.6 5.1 0.7 5.2 1.0 4.6 3.7 3.5 3.3 34.2 3.1 2.3 2.4 12.0 3.6 35.1 2.1 0.8 6.2 6.9 5.8 0.2 5.7 0.5 15.6 18.8 5.5 4.2 4.5 7.4 1.3 10.5 2.2 4.6 15.8 2.4 3.0 0.2 5.7 2.1 1.4 10.7 0.3 5.3 56.5 6.7 1.6 8.3 0.5 1.3 2.3 2.5 5.9 7.2 2.4 0.6 4.0 3.0 3.0 4.5 2.7 1.9 0.7 0.6 0.1 19.3 0.0 0.5 2.0 1.0 9.3 0.0 3.4 0.5 0.2 0.1 0.0 1.0 0.0 1.1 0.4 0.6 0.9 9.8 2.7 0.9 13.0 1.0 0.0 0.4 0.0 1.1 6.1 0.0 1.4 0.4 6.5 0.2 0.0 0.3 0.6 13.6 2.0 0.5 2.0 2.2 4.5 0.5 7.4 0.7 0.3 0.9 1.3 2.2 1.8 0.1 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.2 0.2 5.1 5.2 3.7 3.5 6.2 6.9 15.6 18.8 10.5 10.7 6.7 5.9 0.9 12.8 6.3 18.9 0.2 5.1 3.4 18.6 1.2 1.5 7.2 5.7 0.8 1.5 26.6 12.9 33.3 2.6 0.0 5.2 13.7 12.3 603.8 94.9 3.1 1.7 0.0 0.4 15.9 8.9 5.9 2.2 2.0 6.0 3.8 16.5 1.1 0.0 1.0 3.3 14.1 12.4 12.2 0.3 2.3 603.0 3.7 1.1 1.8 2.8 0.2 6.3 0.0 3.0 2.7 11.1 6.9 4.5 0.2 3.2 1.5 11.1 222.2 10.0 0.0 0.8 6.1 126.7 15.5 1.3 3.4 5.1 2.4 12.2 3.6 3.6 FBLN1 FBLN ENSG00000077942 "Fibulin 1" P23142 22 45502238-45601135 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9" "Cancer enhanced" "Detected in all" "endometrial cancer: 199.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001612, HPA001613, CAB004393, CAB068187" Enhanced Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 21000000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Endoplasmic reticulum" "CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824" "unprognostic (6.62e-2)" "unprognostic (2.47e-2)" "unprognostic (1.64e-1)" "prognostic favorable (9.28e-4)" "unprognostic (1.26e-3)" "unprognostic (4.82e-2)" "unprognostic (9.79e-3)" "unprognostic (2.49e-1)" "unprognostic (6.30e-2)" "unprognostic (3.86e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.02e-10)" "unprognostic (1.08e-3)" "unprognostic (1.46e-1)" "unprognostic (1.29e-2)" "unprognostic (3.64e-2)" 359.3 123.1 17.3 72.3 29.5 1.7 318.2 27.8 27.5 1131.0 802.4 200.7 75.5 410.6 126.0 305.8 497.6 676.1 773.7 47.0 11.9 61.3 15.7 414.9 16.1 21.8 24.5 214.1 106.3 216.9 90.3 505.7 23.1 466.8 83.6 3.1 121.2 158.5 36.0 296.3 174.5 180.3 15.9 24.9 269.1 21.9 24.7 20.5 195.3 47.5 13.0 704.6 940.5 14.6 17.7 41.6 122.9 258.0 1839.4 809.8 559.8 1029.3 1615.9 89.8 33.8 179.2 5.2 0.4 42.8 38.6 2.5 90.9 78.0 2.7 10.8 0.9 21.0 0.4 209.4 121.5 243.2 1.0 1.0 1345.8 15.8 89.6 32.7 1.8 0.2 1.4 0.9 2.1 63.3 2.4 0.8 3.2 173.8 3.7 15.4 1.4 0.9 2.1 41.1 1485.2 8.7 162.7 127.5 589.6 0.6 344.3 3.7 5.4 8.0 17.4 109.3 465.8 1.0 1.6 0.8 1.4 1.2 1.0 43.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.1 0.2 0.0 2.4 1.2 0.0 0.1 17.3 29.5 27.8 27.5 47.0 11.9 21.8 24.5 23.1 15.9 24.7 14.6 34.4 6.4 1.3 34.3 1.2 170.9 113.4 54.8 21.1 0.1 5.3 11.6 20.1 10.0 28.3 1.8 0.0 666.3 1.6 0.1 0.0 1.3 10.5 61.5 628.2 34.5 0.0 0.0 0.5 0.2 651.6 1506.5 38.7 256.5 1.3 29.0 22.1 0.6 82.4 0.0 0.8 0.3 6.1 0.0 222.9 25.4 92.2 11.4 170.7 41.2 0.0 0.1 0.0 0.0 0.4 1.0 0.1 30.5 4.5 47.4 0.0 0.3 10.2 0.6 118.3 37.1 81.5 42.2 68.7 23.8 130.3 1215.9 18.2 2.3 0.4 86.9 FBLN2 ENSG00000163520 "Fibulin 2" P98095 3 13549125-13638422 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 292.8" "Cell type enhanced" "Detected in many" "Adipocytes: 92.7;Endometrial stromal cells: 84.4;Fibroblasts: 458.4;Leydig cells: 170.9;Peritubular cells: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 6.7;naive CD8 T-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 384.0;fHDF/TERT166: 264.3;HMC-1: 311.6;HSkMC: 221.9;U-2197: 139.2" "Group enriched" "Detected in many" 4 "olfactory bulb: 12.4;white matter: 3.1" "Low region specificity" "Detected in all" "HPA001934, CAB018622" Enhanced Supported "Plasma membrane" "Secreted to extracellular matrix" NA NA 35000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "CAB018622: AB_2294196, HPA001934: AB_1078827" "unprognostic (1.19e-1)" "unprognostic (7.76e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (2.82e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.17e-4)" "unprognostic (8.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.89e-2)" "unprognostic (2.82e-2)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" 157.3 7.6 5.9 12.7 7.7 1.0 97.3 5.2 9.0 63.4 6.4 32.7 6.2 31.1 3.2 42.4 26.8 46.2 292.8 7.0 4.9 8.7 3.7 29.2 8.4 5.3 5.3 5.8 8.6 3.0 2.3 80.3 4.8 29.1 11.8 0.6 39.4 8.8 47.7 72.5 19.8 14.7 4.1 6.0 22.3 46.7 6.9 14.2 63.7 48.9 5.6 79.6 56.7 4.4 0.0 1.4 50.9 0.0 384.0 51.7 23.8 124.9 98.2 122.4 80.4 8.1 0.3 0.0 5.9 264.3 0.2 0.2 0.0 0.5 22.9 0.1 0.1 100.7 1.9 0.0 26.0 0.2 311.6 221.9 2.0 19.3 0.0 0.2 0.0 8.6 0.8 0.9 0.6 0.3 5.2 0.6 12.2 0.0 0.7 0.2 0.0 0.5 0.9 0.1 3.0 2.4 0.5 90.3 0.1 13.6 0.2 0.3 0.1 0.1 0.1 139.2 0.1 0.2 0.0 0.0 1.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.2 6.7 1.3 0.0 3.7 0.0 0.2 0.0 0.5 0.0 0.9 5.9 7.7 5.2 9.0 7.0 4.9 5.3 5.3 4.8 4.1 6.9 4.4 92.7 0.0 1.5 1.6 3.6 30.8 0.8 10.5 2.2 0.0 1.7 1.9 8.8 0.0 12.3 7.3 2.1 7.8 1.9 0.1 0.0 0.0 3.8 2.9 84.4 43.8 0.0 1.7 0.6 0.2 4.8 458.4 6.1 2.7 23.6 0.6 47.8 0.4 3.6 0.0 0.6 0.0 0.0 1.9 49.8 12.1 170.9 4.5 39.2 26.2 0.3 1.2 0.0 30.7 0.3 0.3 0.0 227.2 1.6 1.2 2.7 0.1 1.4 0.4 13.1 29.7 26.4 3.4 13.5 2.0 28.8 6.2 5.3 0.2 0.0 1.1 FBXO15 "FBX15, MGC39671" ENSG00000141665 "F-box protein 15" Q8NCQ5 18 74073353-74147843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.1;testis: 7.1" "Cell type enhanced" "Detected in many" "Early spermatids: 36.0;Endometrial ciliated cells: 41.1;Oligodendrocytes: 19.3;Respiratory ciliated cells: 59.2;Spermatocytes: 41.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "GAMG: 1.6;JURKAT: 2.6;SCLC-21H: 2.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "basal ganglia: 17.6" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.69e-2)" "unprognostic (1.97e-1)" "unprognostic (6.34e-6)" "unprognostic (1.65e-2)" "unprognostic (4.20e-1)" "unprognostic (6.77e-2)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (3.38e-2)" "unprognostic (1.00e-2)" "unprognostic (9.62e-2)" "unprognostic (4.46e-5)" "unprognostic (4.64e-2)" "unprognostic (3.35e-2)" "unprognostic (1.62e-4)" "unprognostic (2.87e-1)" 0.1 0.7 0.9 0.0 1.2 0.1 0.3 1.0 1.1 0.5 1.1 0.1 0.1 0.1 2.2 0.1 4.1 0.2 0.1 1.0 1.1 1.1 0.4 0.4 0.1 2.6 3.4 0.3 0.4 0.6 1.4 0.0 2.4 0.2 0.0 3.4 0.3 0.7 0.1 0.2 0.1 0.0 1.8 0.3 0.2 7.1 0.9 0.2 0.6 0.0 0.0 0.1 0.1 2.9 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.7 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 2.6 0.0 0.2 0.1 0.1 0.1 0.1 0.5 0.3 0.8 0.3 0.0 0.0 0.3 0.0 2.7 0.8 0.0 0.0 1.0 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 1.2 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.2 1.6 0.9 0.0 0.0 0.1 0.2 0.0 0.4 0.9 1.2 1.0 1.1 1.0 1.1 2.6 3.4 2.4 1.8 0.9 2.9 0.3 6.4 1.1 12.4 1.0 0.3 0.8 3.9 0.0 8.1 1.5 1.8 0.6 0.0 5.9 1.8 0.0 0.5 0.1 0.1 3.9 0.9 36.0 41.1 0.5 0.3 0.0 0.4 6.4 0.2 0.7 0.2 0.0 1.2 0.0 2.2 0.7 0.4 3.1 5.0 8.8 0.2 0.0 0.6 0.3 17.8 1.2 0.4 0.0 2.8 0.0 7.8 0.0 9.0 19.3 0.1 0.1 1.5 0.0 0.2 0.0 5.8 59.2 10.3 0.0 0.8 2.1 41.5 11.7 0.0 0.0 0.4 0.4 0.3 0.2 0.6 FBXO36 "Fbx36, FLJ37592" ENSG00000153832 "F-box protein 36" Q8NEA4 2 229922302-230013119 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5;Early spermatids: 61.7;Endometrial ciliated cells: 40.8;Respiratory ciliated cells: 53.0;Spermatocytes: 55.8" "Cancer enhanced" "Detected in all" "testis cancer: 9.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053865 Approved Nucleoplasm,Nucleoli NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli" "HPA053865: AB_2682282" "unprognostic (4.39e-3)" "unprognostic (6.51e-2)" "unprognostic (2.38e-2)" "prognostic favorable (2.28e-4)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.15e-2)" "unprognostic (2.38e-2)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.28e-2)" "unprognostic (8.04e-2)" "unprognostic (7.79e-3)" "unprognostic (3.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.68e-1)" 1.9 3.7 4.6 0.7 4.2 0.8 3.5 4.3 4.5 3.0 3.9 1.2 1.4 2.5 2.8 1.6 11.0 1.7 1.2 3.7 4.4 5.1 1.6 2.3 0.9 5.8 5.6 2.4 1.6 4.3 2.7 1.6 5.1 2.9 1.2 9.0 2.3 2.5 0.8 3.0 1.4 1.7 5.4 0.8 1.7 6.0 4.4 1.5 7.4 0.8 1.0 1.3 1.5 5.1 1.0 1.9 2.3 0.9 1.1 6.8 4.6 1.2 3.2 1.7 2.9 0.7 3.1 0.1 0.6 2.2 2.1 0.8 1.1 0.6 2.9 0.3 0.7 0.4 0.6 1.2 4.4 0.8 0.3 7.2 5.2 3.2 2.4 2.2 1.8 3.4 1.4 0.6 2.0 4.2 1.7 1.9 6.1 2.2 2.2 2.0 0.6 0.5 3.0 0.8 2.2 2.8 2.0 1.6 0.8 2.6 3.4 1.4 1.3 2.8 1.0 4.6 0.5 2.1 1.8 0.7 3.4 0.4 2.1 0.0 0.5 0.0 0.8 0.4 0.6 1.1 0.6 0.6 1.3 0.7 1.4 0.8 0.2 1.0 0.3 0.6 1.2 0.5 4.6 4.2 4.3 4.5 3.7 4.4 5.8 5.6 5.1 5.4 4.4 5.1 3.1 9.6 1.1 11.4 1.1 3.8 2.9 8.3 1.2 8.3 4.3 4.3 3.7 0.0 9.9 11.0 35.5 1.9 0.6 2.3 15.6 6.2 61.7 40.8 4.9 2.3 0.0 2.5 19.5 6.6 2.0 3.7 3.1 4.7 0.0 4.2 1.4 2.7 1.1 10.1 22.1 1.6 14.2 1.6 3.0 10.5 3.4 1.2 3.6 5.6 2.9 7.5 4.1 12.5 12.5 6.2 0.5 4.1 0.7 3.0 2.2 12.2 53.0 28.8 6.6 2.8 4.2 55.8 8.6 3.2 4.5 2.2 1.5 9.1 1.4 1.9 FBXO43 Fbx43 ENSG00000156509 "F-box protein 43" Q4G163 8 100133351-100145817 "Predicted intracellular proteins" "Meiosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 3.6" "Cell type enhanced" "Detected in some" "Early spermatids: 11.6;Erythroid cells: 9.9;Late spermatids: 6.9;Spermatocytes: 43.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.6" "Not detected" "Not detected" "HPA024292, HPA024295, HPA024824" Uncertain NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA024292: AB_1848462, HPA024295: AB_1848463, HPA024824: AB_1848464" "unprognostic (4.94e-2)" "unprognostic (4.35e-2)" "unprognostic (2.09e-2)" "unprognostic (4.34e-2)" "unprognostic (5.06e-2)" "unprognostic (3.51e-2)" "unprognostic (1.07e-5)" "unprognostic (4.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.84e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (7.97e-2)" "unprognostic (2.52e-2)" "unprognostic (5.91e-2)" "unprognostic (8.09e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.7 0.0 0.0 0.0 0.1 0.4 0.3 1.0 0.0 0.1 1.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.5 0.6 0.0 0.3 0.6 0.0 0.9 0.2 0.0 0.1 1.4 0.0 0.0 1.5 1.1 0.0 0.1 0.2 0.0 0.6 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 1.2 0.5 0.6 0.8 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 1.8 1.6 0.3 0.9 0.6 0.3 0.6 1.4 0.5 0.6 0.4 0.0 3.2 0.0 0.0 0.6 0.4 0.2 0.0 0.0 11.6 1.5 0.4 0.6 1.2 9.9 0.3 0.4 0.3 1.4 0.0 0.3 1.3 6.2 0.0 0.2 0.5 0.0 0.4 0.1 2.0 0.3 1.1 6.9 0.0 0.7 0.0 1.0 0.1 0.6 1.0 0.5 0.5 0.1 0.1 0.4 0.8 0.3 0.2 0.2 1.2 0.8 0.0 1.4 0.5 43.8 4.5 0.7 0.4 0.3 1.6 0.3 0.4 0.2 FBXW10 "C17orf1, C17orf1A, Fbw10, HREP, SM2SH2" ENSG00000171931 "F-box and WD repeat domain containing 10" Q5XX13 17 18744026-18779349 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 9.7" "Cell type enhanced" "Detected in some" "Early spermatids: 44.4;Late spermatids: 16.1;Respiratory ciliated cells: 5.3;Spermatocytes: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.0;CAPAN-2: 1.1;HaCaT: 1.5;HeLa: 1.4" "Low region specificity" "Detected in all" HPA047457 Approved Nucleoplasm NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA047457: " "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (9.59e-2)" "unprognostic (7.47e-2)" "unprognostic (4.54e-1)" "unprognostic (5.08e-2)" "unprognostic (6.67e-2)" "unprognostic (3.89e-1)" "unprognostic (2.30e-1)" "unprognostic (6.30e-2)" "unprognostic (5.65e-2)" "unprognostic (3.49e-2)" "unprognostic (2.20e-7)" "unprognostic (3.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (1.05e-1)" 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.3 0.1 0.1 0.2 0.0 0.6 0.2 0.5 0.2 0.0 0.1 0.1 0.3 0.9 0.3 0.0 0.2 0.4 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 9.7 0.1 0.0 0.8 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.2 0.0 0.6 1.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.4 0.2 0.1 0.4 0.0 0.0 1.2 0.0 0.0 0.1 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 16.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 0.4 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.2 0.1 9.8 0.7 0.4 0.1 0.0 0.0 2.9 0.0 0.1 FBXW9 "Fbw9, MEC-15, MGC10870" ENSG00000132004 "F-box and WD repeat domain containing 9" Q5XUX1 19 12688053-12696631 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 65.6;Respiratory ciliated cells: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042087 Approved Approved Cytosol NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA042087: AB_10794168" "unprognostic (4.46e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-2)" "unprognostic (1.65e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-3)" "unprognostic (4.69e-3)" "unprognostic (4.91e-2)" "unprognostic (2.97e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (2.71e-2)" "unprognostic (4.02e-2)" "unprognostic (6.08e-3)" "unprognostic (8.04e-2)" "unprognostic (2.61e-1)" "unprognostic (8.42e-3)" 4.2 7.9 4.4 2.1 4.4 4.2 5.6 2.9 5.8 5.2 9.0 5.2 4.4 4.9 2.0 10.3 13.1 2.9 2.9 4.7 4.3 8.6 5.1 4.5 3.0 4.1 6.3 4.0 7.3 4.3 7.4 2.6 4.2 7.2 1.7 2.0 7.6 3.5 2.7 9.4 4.0 1.7 4.0 3.9 5.6 14.9 4.4 2.9 7.5 0.8 1.9 4.6 5.8 3.2 16.6 11.1 7.2 10.6 3.1 5.2 8.7 5.3 5.4 11.1 9.1 6.2 10.0 4.1 13.5 4.8 2.7 14.7 6.9 10.0 1.9 2.9 18.5 4.9 13.2 10.4 7.0 12.3 2.9 7.0 15.8 7.7 3.8 6.6 8.8 9.4 11.9 2.7 2.5 34.5 13.4 16.1 12.2 8.8 10.4 7.0 5.0 23.2 10.0 4.9 16.5 19.6 7.9 16.5 7.6 2.3 16.5 9.3 4.3 6.5 6.0 8.1 8.5 16.4 7.3 4.5 8.1 4.5 4.3 0.0 7.4 0.0 2.7 7.1 4.6 2.8 2.9 2.1 11.1 2.5 2.8 2.0 0.3 4.7 4.9 3.1 5.7 5.0 4.4 4.4 2.9 5.8 4.7 4.3 4.1 6.3 4.2 4.0 4.4 3.2 4.8 3.2 5.4 1.3 1.3 6.0 5.2 18.6 8.0 2.0 12.1 13.0 0.7 8.6 14.3 1.8 6.2 14.4 1.5 5.7 5.9 18.1 6.4 65.6 6.9 4.2 4.8 11.8 3.7 16.0 8.4 4.4 5.6 6.8 0.0 10.7 4.6 3.6 7.0 0.0 3.1 9.2 22.4 4.5 3.7 8.5 2.5 5.9 3.6 0.0 4.2 4.9 1.0 1.0 1.2 11.6 5.6 4.5 1.7 4.2 5.5 17.4 80.3 7.1 6.6 4.4 6.5 30.8 17.3 9.2 8.2 6.4 2.4 20.3 12.5 4.9 FER1L5 DKFZp434I0121 ENSG00000249715 "Fer-1 like family member 5" A0AVI2 2 96642737-96704887 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 1.7;testis: 4.1" "Cell type enhanced" "Detected in some" "Astrocytes: 4.9;Early spermatids: 22.7;Excitatory neurons: 5.5;Late spermatids: 6.9;Spermatocytes: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-3)" "unprognostic (5.81e-3)" "unprognostic (2.06e-1)" "unprognostic (1.12e-4)" "unprognostic (4.49e-4)" "unprognostic (1.39e-2)" "unprognostic (6.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (2.95e-2)" "unprognostic (2.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.16e-3)" 0.0 0.0 0.3 0.0 0.9 0.0 0.3 0.4 0.3 0.0 1.7 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.2 0.7 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.4 0.3 0.4 0.3 0.2 0.7 0.2 0.0 0.2 0.1 0.1 3.2 1.1 4.9 0.5 0.0 1.1 0.0 0.0 0.3 0.7 0.3 1.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.9 0.5 22.7 0.1 0.5 0.2 0.0 0.0 5.5 0.6 0.0 0.3 0.0 0.1 1.3 0.1 1.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 6.9 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.5 0.3 0.1 0.0 0.4 0.1 0.6 0.0 0.1 1.5 0.1 0.0 0.4 0.2 4.3 1.4 0.0 0.0 0.3 0.2 1.3 0.0 0.4 FER1L6 C8ORFK23 ENSG00000214814 "Fer-1 like family member 6" Q2WGJ9 8 123851987-124120061 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 10.8;stomach 1: 43.1" "Group enriched" "Detected in some" 9 "Early spermatids: 15.8;Gastric mucus-secreting cells: 39.3;Intestinal goblet cells: 10.4;Late spermatids: 30.5;Pancreatic endocrine cells: 10.8" "Group enriched" "Detected in some" 6 "pancreatic cancer: 4.2;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;ASC TERT1: 1.8;BJ hTERT+: 1.2;PC-3: 1.7;U-87 MG: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054117 Enhanced NA NA "Cluster 4: Stomach - Digestion" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA054117: AB_2682387" "unprognostic (1.90e-1)" "unprognostic (3.08e-3)" "unprognostic (2.06e-3)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (9.49e-3)" "unprognostic (1.36e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (3.32e-2)" "unprognostic (3.23e-6)" "unprognostic (7.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.79e-3)" "unprognostic (6.39e-2)" 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.2 0.3 0.0 5.0 2.9 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 3.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.1 0.0 4.5 0.1 0.0 0.0 43.1 2.5 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.5 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.4 15.8 0.3 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.4 0.0 0.0 0.0 30.5 0.9 0.0 0.0 1.9 0.0 0.0 0.0 1.0 1.0 10.8 2.2 0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.8 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635185 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1" "Cell type enhanced" "Detected in many" "Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Daudi: 86.0;U-266/70: 153.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 25.0 6.8 12.8 62.2 11.9 207.8 16.0 11.9 19.1 7.6 11.5 6.0 3.9 8.1 1.7 5.2 15.6 12.7 8.7 11.4 12.3 7.5 10.8 86.5 27.5 13.6 12.7 2.9 5.8 1.6 2.7 7.9 14.5 7.2 4.0 0.7 6.6 2.4 3.2 4.5 10.1 16.3 12.5 141.1 5.9 2.5 17.2 8.4 7.4 6.5 20.0 17.8 7.3 12.6 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 1.7 29.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 3.8 5.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 153.1 2.1 6.5 0.0 19.5 0.0 30.8 381.4 229.4 189.5 469.1 11.3 54.0 15.8 89.1 196.1 84.0 8.0 78.4 272.9 264.5 405.2 9.0 1.2 494.1 12.8 11.9 11.9 19.1 11.4 12.3 13.6 12.7 14.5 12.5 17.2 12.6 8.6 6.4 20.0 0.0 24.9 2.8 0.6 0.2 0.0 0.0 0.4 0.6 1.6 1.5 5.7 1.8 0.0 0.5 55.2 0.0 0.0 0.0 0.3 0.1 0.2 14.9 0.0 7.4 0.2 0.2 0.7 2.7 1.5 0.1 13.3 0.1 6.8 1.9 56.8 0.0 0.1 0.0 0.0 182.2 63.8 0.7 0.3 155.9 1.8 6.5 159.7 0.1 259.5 1.0 0.4 0.0 1.2 0.0 4.2 0.4 0.0 0.7 1.5 0.0 0.0 0.7 0.6 0.2 0.5 0.5 1.1 1.0 28.0 0.0 0.0 2.5 FHAD1 KIAA1937 ENSG00000142621 "Forkhead associated phosphopeptide binding domain 1" B1AJZ9 1 15247272-15400283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 13.8;fallopian tube: 15.2;testis: 13.4" "Group enriched" "Detected in many" 7 "Early spermatids: 234.4;Endometrial ciliated cells: 179.0;Late spermatids: 244.9;Respiratory ciliated cells: 265.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 29.5;HMC-1: 80.4;K-562: 18.5;U-87 MG: 42.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054284 Enhanced NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA054284: AB_2682436" "unprognostic (3.18e-2)" "unprognostic (1.12e-3)" "unprognostic (2.36e-3)" "unprognostic (2.15e-2)" "unprognostic (5.55e-2)" "unprognostic (8.32e-2)" "unprognostic (2.46e-1)" "unprognostic (2.06e-2)" "unprognostic (1.04e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-1)" "unprognostic (1.40e-1)" "unprognostic (1.17e-3)" "unprognostic (2.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.83e-1)" "unprognostic (1.04e-3)" 0.4 0.2 1.0 0.7 1.1 0.0 1.0 0.2 0.9 2.1 13.8 0.3 0.9 0.5 1.8 0.1 15.2 0.5 0.1 1.9 2.0 0.6 0.3 3.5 0.2 3.8 8.1 0.3 0.7 0.9 0.6 0.4 3.4 0.3 0.3 0.1 0.5 0.5 0.0 0.2 1.0 0.3 2.2 0.1 2.2 13.4 1.5 0.1 1.2 0.0 0.2 0.8 0.2 1.5 2.1 0.5 1.7 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.2 1.1 5.6 0.8 0.3 0.2 0.5 0.2 0.0 0.3 29.5 0.2 0.1 0.0 0.0 0.5 2.5 80.4 0.8 0.0 0.3 0.0 0.1 0.0 0.0 18.5 0.0 0.0 0.3 0.3 0.3 0.1 0.3 0.9 0.0 0.5 0.0 0.1 0.1 0.7 0.6 0.0 0.1 0.5 0.1 0.1 0.5 0.0 7.1 0.2 8.3 0.1 0.0 10.0 0.0 42.9 0.1 0.3 0.0 0.4 0.0 0.9 0.2 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.1 1.0 1.1 0.2 0.9 1.9 2.0 3.8 8.1 3.4 2.2 1.5 1.5 0.4 0.0 2.2 2.6 0.1 0.1 0.8 4.4 0.0 0.4 0.3 0.6 1.9 4.3 29.0 0.0 0.0 0.0 0.3 0.4 0.0 2.0 234.4 179.0 2.1 1.5 1.8 0.0 4.7 1.4 0.0 2.4 7.7 13.5 0.0 0.5 0.0 0.0 2.6 3.3 2.4 1.2 6.1 1.3 1.7 244.9 2.1 2.6 0.0 1.9 0.1 0.2 0.0 1.0 1.3 0.8 1.1 0.0 0.0 0.4 0.7 0.6 265.6 0.0 13.1 0.2 2.6 14.9 9.5 0.0 0.0 0.1 0.3 0.3 0.6 1.7 FLACC1 ALS2CR12 ENSG00000155749 "Flagellum associated containing coiled-coil domains 1" Q96Q35 2 201288271-201357398 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.8;testis: 17.1" "Cell type enriched" "Detected in single" 8 "Cardiomyocytes: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.4;U-2197: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035793 Approved "Plasma membrane,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 18: U-2197 - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane, Cytosol" "HPA035793: AB_10602429" "unprognostic (1.45e-1)" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.40e-3)" "unprognostic (1.40e-5)" "unprognostic (1.37e-1)" "unprognostic (3.62e-2)" "unprognostic (1.14e-1)" "unprognostic (6.23e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-2)" "unprognostic (2.23e-1)" "unprognostic (8.25e-2)" 0.9 1.1 3.9 1.0 4.3 5.0 0.5 2.8 3.9 0.7 9.8 0.8 0.5 0.7 1.1 1.2 8.3 1.1 4.5 5.0 3.2 1.3 0.7 2.5 1.6 5.8 6.4 0.3 0.9 0.7 1.1 0.8 3.7 0.5 1.0 3.3 1.1 0.8 1.8 1.2 1.0 0.6 4.2 0.8 0.5 17.1 3.0 0.7 1.6 0.4 0.5 0.6 0.4 3.7 0.1 0.2 1.1 0.7 2.7 1.1 0.0 0.8 0.3 0.7 0.4 0.0 0.3 0.2 0.6 1.2 0.4 1.1 0.4 0.1 0.3 0.7 0.1 0.1 1.7 0.4 0.6 1.2 1.0 0.5 0.3 0.7 0.1 0.8 0.1 1.2 0.5 1.6 0.6 0.0 0.6 1.0 0.3 0.4 0.6 0.3 0.5 0.7 0.4 0.2 0.2 0.7 0.7 0.0 3.4 1.0 0.4 1.4 0.9 1.5 0.7 5.9 0.5 0.8 1.8 0.5 1.2 0.6 0.7 3.1 0.4 0.4 0.7 0.3 0.3 0.3 0.4 0.4 0.2 0.7 0.6 0.7 3.6 1.3 0.3 0.2 0.3 0.2 3.9 4.3 2.8 3.9 5.0 3.2 5.8 6.4 3.7 4.2 3.0 3.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLNA "ABP-280, FLN, FLN1, OPD1, OPD2" ENSG00000196924 "Filamin A" P21333 X 154348524-154374634 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation" Actin-binding "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 1203.7;intestine: 1462.2" "Cell type enhanced" "Detected in many" "Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000356, HPA000368, HPA001016, HPA001115, HPA002925" Enhanced Approved Enhanced "Plasma membrane,Actin filaments,Cytosol" NA NA 730000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane, Actin filaments, Cytosol" "CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869" "unprognostic (1.39e-1)" "unprognostic (9.40e-3)" "prognostic unfavorable (7.37e-4)" "unprognostic (3.68e-2)" "unprognostic (2.55e-1)" "unprognostic (6.05e-3)" "unprognostic (5.08e-2)" "unprognostic (1.08e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (3.23e-2)" "unprognostic (9.58e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (5.49e-3)" "unprognostic (1.78e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.88e-4)" 267.4 55.9 14.4 223.2 18.5 157.9 164.2 15.2 43.0 392.1 54.7 1462.2 89.9 1203.7 35.5 454.7 609.4 137.9 108.4 14.8 23.0 70.5 21.2 238.9 65.0 39.9 19.9 236.7 50.5 13.4 30.5 79.2 24.4 369.2 86.9 9.0 80.3 617.2 49.7 124.7 354.6 706.6 21.1 102.7 508.0 33.7 34.0 48.1 85.6 31.2 38.1 1053.9 286.4 21.5 947.2 719.2 246.7 316.1 209.8 278.4 400.9 614.0 680.1 552.5 489.8 469.2 169.4 80.5 1551.4 966.4 970.1 528.3 224.0 538.1 152.7 333.6 77.8 262.2 914.9 159.7 375.9 309.3 324.9 266.1 126.1 825.5 327.0 533.8 417.1 94.9 74.7 538.7 401.3 210.7 148.5 93.1 258.3 97.9 470.9 147.8 221.2 71.6 197.2 193.4 52.9 119.7 515.8 80.2 381.1 187.3 79.1 96.3 1016.6 625.2 586.8 640.0 1147.1 333.7 212.8 162.3 580.3 202.4 638.7 7.6 24.9 11.8 32.6 23.1 21.2 10.2 15.6 29.2 22.4 4.6 6.0 14.3 3.6 10.5 34.2 2.7 20.7 56.2 14.4 18.5 15.2 43.0 14.8 23.0 39.9 19.9 24.4 21.1 34.0 21.5 105.1 57.7 38.7 30.0 76.9 124.3 85.9 127.8 85.4 3.5 40.9 153.5 34.5 38.6 26.1 35.0 0.0 24.6 257.7 2.6 1.9 272.0 2.1 33.8 186.3 107.0 1.8 39.7 11.8 133.1 90.9 137.9 13.3 55.8 26.0 334.5 81.8 4.3 120.3 11.8 8.6 2.5 22.4 141.0 263.0 13.7 122.4 227.7 88.9 30.9 207.9 39.4 270.8 8.0 2.6 347.4 1.5 500.6 98.7 96.1 1.9 3.0 9.1 4.3 420.7 118.3 459.3 4.1 8.9 48.8 73.6 20.0 172.3 134.7 3.3 35.3 FMN2 ENSG00000155816 "Formin 2" Q9NZ56 1 240014348-240475187 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, Protein transport, Stress response, Transport" "Actin-binding, Developmental protein" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.0;parathyroid gland: 19.7;retina: 16.7" "Cell type enhanced" "Detected in many" "Astrocytes: 758.1;Excitatory neurons: 537.5;Horizontal cells: 124.5;Inhibitory neurons: 366.7;Oligodendrocyte precursor cells: 154.3" "Group enriched" "Detected in some" 8 "glioma: 5.9;testis cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 70.8;BJ hTERT+: 39.4;fHDF/TERT166: 73.8;LHCN-M2: 87.9;U-138 MG: 48.9;WM-115: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050649 Approved "Plasma membrane,Actin filaments" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Actin filaments" "HPA050649: AB_2681202" "unprognostic (1.55e-2)" "unprognostic (8.21e-2)" "unprognostic (4.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.97e-3)" "unprognostic (2.11e-2)" "unprognostic (2.93e-1)" "unprognostic (3.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.08e-1)" "unprognostic (1.11e-2)" "unprognostic (8.03e-3)" "unprognostic (9.78e-2)" "unprognostic (3.10e-2)" "unprognostic (1.40e-3)" 1.2 5.1 27.6 0.2 29.6 0.0 0.5 11.8 46.0 0.4 0.0 6.8 0.2 1.4 0.9 0.7 1.9 1.2 0.1 28.4 20.9 3.6 0.0 0.3 0.0 21.2 29.7 2.4 1.0 19.7 9.0 0.2 14.4 1.6 1.6 16.7 0.3 2.6 0.1 0.2 0.9 1.7 16.0 0.2 0.7 2.2 39.0 0.0 0.5 0.2 0.1 0.3 0.3 30.9 0.0 2.1 6.6 0.0 20.2 15.3 0.0 70.8 39.4 31.0 16.3 0.0 0.0 0.0 0.0 73.8 1.2 0.0 1.3 0.0 28.8 0.0 5.8 0.0 0.7 0.0 0.1 0.0 0.0 1.7 0.0 8.5 1.9 17.0 0.0 0.0 0.0 0.0 87.9 0.0 0.0 0.1 2.3 0.0 2.2 0.0 0.2 0.0 0.0 0.0 12.0 10.6 0.0 0.1 0.3 0.2 2.1 0.1 0.3 48.9 0.2 16.0 18.2 0.0 0.0 0.0 10.4 0.0 69.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 29.6 11.8 46.0 28.4 20.9 21.2 29.7 14.4 16.0 39.0 30.9 0.0 0.0 0.0 758.1 0.0 0.1 0.0 0.0 0.0 30.6 0.2 0.3 1.6 0.0 0.0 1.8 50.1 0.1 0.0 4.7 0.0 0.0 15.2 4.3 0.7 0.5 12.1 0.0 537.5 0.0 0.1 1.4 0.0 1.1 0.0 0.8 2.9 0.1 0.1 124.5 366.7 0.5 0.0 0.6 0.6 3.0 0.3 0.1 1.8 31.9 0.0 2.3 0.0 154.3 17.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.3 1.8 4.4 0.0 0.0 0.5 0.0 3.1 1.6 0.0 FMO1 ENSG00000010932 "Flavin containing dimethylaniline monoxygenase 1" Q01740 1 171248471-171285978 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "kidney: 199.0" "Group enriched" "Detected in many" 7 "Proximal enterocytes: 97.9;Proximal tubular cells: 196.9" "Cancer enriched" "Detected in many" 8 "renal cancer: 18.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HSkMC: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078132 Approved NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA078132: " "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (5.87e-2)" "unprognostic (1.34e-1)" "unprognostic (5.32e-3)" "unprognostic (1.89e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-1)" "unprognostic (9.16e-2)" "unprognostic (9.03e-2)" "unprognostic (1.36e-2)" "unprognostic (2.23e-1)" "prognostic favorable (2.81e-4)" "unprognostic (6.49e-4)" "unprognostic (1.40e-1)" "unprognostic (3.58e-1)" "unprognostic (1.37e-1)" 5.1 5.6 0.1 0.5 0.1 0.0 10.0 0.1 0.3 6.3 0.3 0.4 0.1 3.1 0.1 3.5 4.2 5.2 0.7 0.1 0.1 199.0 2.9 1.5 0.4 0.1 0.1 5.0 2.4 1.1 1.8 2.3 0.1 0.4 0.2 0.0 5.4 0.7 0.1 10.4 20.2 4.2 0.1 0.0 0.9 1.6 0.1 7.4 2.3 0.8 10.8 2.5 1.7 0.1 0.0 0.0 0.0 0.0 2.7 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.0 0.0 0.0 0.3 3.0 3.2 0.5 0.0 12.5 0.0 0.5 1.1 10.0 2.8 0.0 3.7 0.0 0.3 0.0 0.0 13.7 0.0 0.7 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.1 18.7 0.0 0.0 0.0 3.2 0.0 0.3 0.4 0.0 0.1 2.9 0.0 0.0 0.0 1.5 10.8 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 2.6 0.0 0.1 97.9 196.9 0.0 0.0 6.6 0.5 4.7 0.0 0.1 1.4 2.3 0.8 1.0 2.6 1.4 0.1 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "testis: 108.0" "Cell type enhanced" "Detected in some" "Club cells: 1.3;Collecting duct cells: 1.8;Endometrial ciliated cells: 5.1;Respiratory ciliated cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "memory B-cell: 1.5;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 7 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.2;EFO-21: 2.6;HaCaT: 1.5;OE19: 1.8;SH-SY5Y: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.4 0.1 0.2 0.3 0.1 0.5 0.6 0.1 0.3 0.8 0.3 0.3 0.1 0.4 2.3 0.2 1.2 0.3 0.2 0.1 1.1 1.2 0.1 0.9 0.6 0.5 0.5 0.4 0.1 0.0 0.9 0.1 0.3 0.6 0.0 0.0 0.4 0.1 0.1 0.4 0.6 0.0 0.4 1.0 0.4 108.0 0.5 0.3 0.5 0.0 0.4 0.7 0.6 0.2 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 5.2 0.3 2.6 0.0 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.6 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.1 1.8 0.4 0.0 0.0 0.0 0.9 0.0 0.2 3.3 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 1.5 0.1 0.2 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.1 0.3 0.1 1.1 0.5 0.5 0.3 0.4 0.5 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 6.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 FOXJ1 "FKHL13, HFH-4, HFH4" ENSG00000129654 "Forkhead box J1" Q92949 17 76136333-76141245 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 43.4;choroid plexus: 80.1;fallopian tube: 53.2" "Group enriched" "Detected in many" 8 "Endometrial ciliated cells: 234.7;Respiratory ciliated cells: 124.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 73.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 29.9;CAPAN-2: 25.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 43.1" HPA005714 Enhanced NA NA "Cluster 32: T-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA005714: AB_1078902" "prognostic favorable (9.39e-4)" "unprognostic (4.97e-3)" "unprognostic (1.22e-1)" "unprognostic (2.77e-3)" "unprognostic (1.19e-1)" "unprognostic (2.54e-3)" "unprognostic (1.71e-3)" "unprognostic (6.15e-2)" "unprognostic (1.00e-2)" "unprognostic (7.84e-3)" "unprognostic (1.43e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.49e-2)" "unprognostic (1.94e-1)" "unprognostic (2.27e-1)" "unprognostic (1.91e-1)" 0.0 0.0 12.2 0.1 12.7 0.3 0.0 13.0 10.8 6.6 80.1 0.6 0.3 2.2 0.5 0.3 53.2 0.0 0.0 14.6 18.3 3.4 0.0 10.4 0.0 36.7 43.4 0.2 0.9 0.0 2.2 0.0 25.2 0.5 0.2 0.4 0.1 2.5 0.4 0.8 0.2 0.0 23.3 0.0 0.5 16.7 22.6 0.2 3.0 0.0 0.0 0.9 0.1 14.9 0.0 0.5 1.7 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 3.1 25.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 12.2 12.7 13.0 10.8 14.6 18.3 36.7 43.4 25.2 23.3 22.6 14.9 2.2 9.6 3.1 1.0 2.3 0.8 1.0 4.4 0.0 0.4 5.6 4.2 0.9 1.5 12.0 9.2 4.2 0.2 4.8 1.0 0.0 0.6 21.4 234.7 4.5 0.7 1.8 3.0 0.0 0.0 0.6 1.6 4.1 10.7 1.3 0.1 0.4 0.0 0.1 0.0 0.1 3.2 4.1 0.6 0.0 19.1 0.3 1.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.8 0.4 1.3 0.5 0.2 3.5 124.0 8.7 0.0 1.8 3.5 20.7 2.0 0.8 0.9 0.3 3.5 1.1 2.3 0.7 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857680-2877174 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.0;lymphoid tissue: 32.2;testis: 21.4" "Cell type enhanced" "Detected in many" "Early spermatids: 22.4;Erythroid cells: 18.7;Extravillous trophoblasts: 18.2;Late spermatids: 25.5;Plasma cells: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.9 1.1 0.4 9.4 0.5 25.0 1.8 0.8 0.8 1.7 0.2 10.5 9.7 1.7 0.2 11.1 0.8 1.5 0.5 0.8 0.3 0.7 1.2 1.8 11.3 0.4 0.9 0.3 0.4 0.4 0.1 6.1 0.6 0.7 12.5 1.1 1.9 0.8 0.6 6.4 8.8 7.5 0.1 3.1 5.2 21.4 1.0 32.2 0.9 0.3 15.2 3.0 3.2 0.6 133.0 129.5 101.3 92.2 14.2 19.0 129.2 84.0 80.4 165.2 147.2 166.9 114.8 84.5 17.7 119.8 188.5 100.2 153.1 76.1 160.0 159.8 80.3 94.7 121.6 71.6 2.0 79.2 75.0 9.9 8.3 154.4 106.1 39.1 117.8 96.8 55.6 184.9 130.5 122.6 108.3 36.8 225.6 136.1 95.4 77.3 149.8 44.1 38.1 82.7 56.3 89.1 106.7 90.4 46.6 189.4 87.1 87.8 48.0 134.3 200.5 160.4 300.4 24.7 44.3 122.1 63.1 74.3 147.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.8 0.8 0.8 0.3 0.4 0.9 0.6 0.1 1.0 0.6 0.1 0.0 1.3 0.7 2.4 2.9 1.3 1.0 1.2 2.0 1.7 1.3 0.5 1.5 0.8 1.8 4.2 7.1 0.8 6.6 1.9 0.2 22.4 1.2 2.1 2.5 0.0 18.7 1.1 0.0 18.2 3.2 10.2 2.4 0.0 15.4 3.6 0.8 9.1 5.0 0.6 7.5 2.0 4.2 1.2 25.5 0.9 2.4 0.0 0.0 1.1 0.6 1.0 0.5 1.0 0.3 0.3 0.7 19.9 1.0 1.4 0.4 0.2 4.0 0.0 1.2 3.0 15.0 9.9 10.2 1.4 1.9 3.3 0.9 12.9 1.9 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277978-109309284 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 11.4" "Cell type enhanced" "Detected in some" "Early spermatids: 1.9;Endometrial ciliated cells: 2.6;Ionocytes: 2.0;Respiratory ciliated cells: 1.2;Spermatocytes: 2.8;Spermatogonia: 3.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;SCLC-21H: 3.5;SH-SY5Y: 3.6;U-266/70: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Mitochondria" Cytosol "HPA050018: AB_2680992" "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.2 1.8 0.5 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.8 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 11.4 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.6 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.1 2.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 195.3;lymphoid tissue: 166.0" "Group enriched" "Detected in many" 5 "Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 4199.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 4199.5" "Group enriched" "Detected in some" 5 "LHCN-M2: 17.2;U-87 MG: 67.1" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 69.6 10.0 3.8 166.0 4.4 195.3 5.3 4.1 8.7 8.2 5.7 4.6 3.1 3.7 0.5 8.9 15.4 28.6 7.5 3.6 8.1 4.5 21.4 50.8 12.7 15.2 8.2 2.4 11.2 5.1 3.5 45.1 11.9 3.1 3.3 2.6 4.1 2.3 1.8 1.3 5.2 42.9 8.6 129.2 5.4 2.2 9.9 8.4 3.1 22.8 10.3 66.9 2.7 18.2 0.5 0.8 0.3 0.4 1.0 2.1 0.5 0.2 0.0 0.5 2.0 0.3 0.7 1.2 0.6 0.0 3.9 0.4 0.0 0.0 0.1 0.1 0.0 0.7 0.9 1.0 6.0 0.3 0.5 4.8 0.2 1.8 1.8 9.2 0.0 0.3 0.1 0.6 17.2 0.9 0.1 0.3 0.4 0.3 0.7 0.3 0.7 0.0 1.5 0.5 0.2 0.3 0.6 0.1 0.5 0.2 1.0 1.1 1.0 2.0 0.4 0.1 3.5 0.2 0.0 0.5 67.1 1.7 0.1 317.1 759.9 204.9 1.6 319.7 1.5 0.7 1.0 0.7 174.1 1.0 1.0 1.2 4199.5 0.4 201.8 8.1 1.3 420.3 3.8 4.4 4.1 8.7 3.6 8.1 15.2 8.2 11.9 8.6 9.9 18.2 0.1 16.0 25.7 0.0 1.8 0.6 0.3 0.0 0.0 1.0 0.1 0.3 0.2 0.0 15.5 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.8 0.0 0.1 6.3 0.0 2.5 0.2 0.0 1.6 4.7 0.5 0.1 26.5 0.0 2.5 2.1 119.6 0.0 0.1 0.0 0.0 215.3 4.7 2.0 0.3 178.5 0.0 3.7 89.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.4 8.8 0.3 6.6 0.6 0.8 0.6 0.8 0.2 0.0 3.0 2.5 0.0 0.0 0.1 FRMPD2 "MGC35285, PDZD5C, PDZK5C" ENSG00000170324 "FERM and PDZ domain containing 2" Q68DX3 10 48153088-48274696 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.7;choroid plexus: 5.2;retina: 24.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 50.0;Cone photoreceptor cells: 287.7;Early spermatids: 97.7;Endometrial ciliated cells: 70.6;Late spermatids: 118.5;Respiratory ciliated cells: 62.9;Rod photoreceptor cells: 90.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HBEC3-KT: 1.0;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 77: Retina - Visual perception" "Cluster 28: BEWO - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (1.53e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-4)" "unprognostic (7.59e-2)" "unprognostic (2.37e-1)" "unprognostic (2.06e-1)" "unprognostic (6.54e-3)" "unprognostic (1.85e-1)" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (3.25e-12)" "unprognostic (3.48e-2)" "unprognostic (5.43e-2)" "unprognostic (1.54e-1)" "unprognostic (7.43e-5)" 0.0 0.0 2.4 0.0 2.0 0.0 0.4 2.7 1.3 0.2 5.2 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.9 2.1 2.7 0.1 0.0 0.2 0.0 4.7 6.7 0.0 0.0 0.0 0.1 0.0 4.1 0.3 0.1 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.0 2.7 1.3 2.1 2.7 4.7 6.7 4.1 4.0 3.5 3.4 0.0 0.0 0.5 36.6 0.0 0.1 0.4 1.6 0.0 50.0 1.1 0.4 5.0 0.0 4.6 3.7 287.7 0.2 0.0 0.1 0.0 0.1 97.7 70.6 0.5 0.3 3.0 0.0 2.0 0.0 0.3 0.8 0.0 1.6 0.0 0.0 0.0 0.2 0.1 3.3 0.9 0.6 6.1 0.0 0.0 118.5 0.3 0.2 0.0 0.0 0.0 5.2 0.0 0.5 0.3 0.2 0.1 0.4 0.0 0.4 4.2 0.5 62.9 90.8 0.0 0.2 0.6 2.1 1.0 0.0 0.3 0.0 0.1 0.1 0.7 0.4 FSIP1 FLJ35989 ENSG00000150667 "Fibrous sheath interacting protein 1" Q8NA03 15 39588357-39782841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 10.9;testis: 7.2" "Cell type enhanced" "Detected in many" "Early spermatids: 67.1;Excitatory neurons: 28.2;Inhibitory neurons: 21.5;Late spermatids: 48.3;Spermatocytes: 35.3" "Cancer enriched" "Detected in some" 8 "breast cancer: 6.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041002 Uncertain Uncertain Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "HPA041002: AB_10796565" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.43e-3)" "unprognostic (5.17e-3)" "unprognostic (5.37e-2)" "unprognostic (9.22e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.81e-1)" 0.2 0.2 1.6 0.2 1.8 0.6 0.9 0.0 1.6 0.2 1.7 7.3 0.1 0.3 0.3 0.1 1.2 0.2 0.2 1.2 1.8 0.8 0.1 0.2 0.1 1.1 1.3 0.1 0.1 0.8 1.4 0.3 0.9 0.2 10.9 0.9 0.1 0.2 0.2 0.9 0.1 0.3 0.3 0.2 0.5 7.2 2.0 1.4 0.4 0.1 0.1 0.3 0.1 0.4 0.4 1.3 3.4 0.5 0.6 1.1 0.0 4.1 0.8 0.6 1.2 1.0 0.3 0.2 0.3 1.2 1.7 0.8 0.5 0.7 1.0 1.4 0.3 2.5 0.9 0.0 0.3 0.5 2.7 0.7 2.8 1.5 0.6 0.8 0.7 1.4 0.1 0.3 1.0 0.1 0.3 0.2 0.4 0.2 0.6 0.3 0.7 0.1 1.3 1.5 0.8 2.5 0.8 0.1 0.1 0.3 1.1 0.3 0.6 1.6 0.9 0.9 0.4 0.7 1.6 0.2 3.3 0.9 0.8 0.4 0.3 0.4 0.7 0.2 0.5 0.1 0.3 0.4 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.4 1.6 1.8 0.0 1.6 1.2 1.8 1.1 1.3 0.9 0.3 2.0 0.4 0.7 0.0 0.5 8.1 1.1 0.6 0.6 3.4 0.0 1.1 14.5 7.9 0.8 2.8 2.9 1.8 12.5 0.9 1.4 17.5 1.9 1.0 67.1 10.0 2.1 1.0 0.0 0.0 28.2 0.4 0.1 1.5 0.5 0.6 15.8 0.4 0.4 0.0 0.1 0.0 21.5 3.5 0.0 0.0 0.3 48.3 1.2 0.6 0.0 7.5 0.1 1.0 3.1 3.0 3.2 0.1 6.6 0.7 0.4 0.7 0.0 3.2 12.6 6.1 0.0 1.2 1.5 35.3 8.3 0.2 0.0 5.6 3.3 0.7 2.9 0.3 FTL "MGC71996, NBIA3" ENSG00000087086 "Ferritin light chain" P02792 19 48965309-48966879 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Iron storage" "Cancer-related genes, Cataract, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 14422.9" "Cell type enhanced" "Detected in all" "Hofbauer cells: 74983.4;Kupffer cells: 70127.1;Macrophages: 34584.5;Proximal tubular cells: 58047.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 125209.0;monocytes: 102128.9" "Cell line enhanced" "Detected in all" "HHSteC: 24796.9;HSkMC: 20811.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020769, HPA041602" Enhanced Approved Cytosol NA NA 170000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" Cytosol "CAB020769: , HPA041602: AB_2677575" "unprognostic (2.95e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-1)" "unprognostic (1.56e-3)" "unprognostic (7.48e-2)" "unprognostic (5.28e-2)" "unprognostic (2.16e-3)" "unprognostic (6.17e-3)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" 6778.7 3262.2 6806.2 2353.2 7172.4 4213.8 4226.0 6782.1 10053.2 2094.3 6429.7 2451.1 2427.0 1523.4 1010.8 1306.2 2169.9 4298.0 2537.3 6497.7 6998.4 8845.6 14422.9 7261.1 3353.2 7250.8 6998.4 2455.3 2166.2 931.7 1730.4 3423.2 7218.5 1946.5 1800.0 684.9 1663.5 1390.4 1345.9 1449.7 2806.6 1842.3 7149.5 6751.4 3204.5 455.9 7581.8 1168.9 3000.4 1072.0 1334.6 4239.9 1804.7 7334.0 869.7 12906.5 949.6 1457.0 16013.9 16478.6 1693.1 2194.1 12820.0 3090.7 6903.8 2852.3 3413.2 656.4 4104.3 13203.9 6755.6 505.8 788.2 1301.8 2765.6 8895.0 507.6 1740.0 3222.8 18949.7 24796.9 4133.3 5591.2 20811.1 1735.9 5272.5 2301.6 4590.4 4549.8 774.6 3284.9 1328.2 6198.4 213.0 1152.1 2402.8 1729.8 15140.6 1306.9 947.6 643.0 6763.9 1989.7 545.0 1209.9 701.5 5761.7 313.4 1239.5 5104.1 183.2 8493.4 3438.3 3353.4 1740.1 4364.3 3083.1 5690.2 13742.1 625.1 3563.9 4334.7 6017.7 64938.4 71067.8 77353.0 6560.6 102128.9 7527.7 17097.3 7247.4 7054.3 25176.6 15607.2 8656.4 7466.9 125209.0 4978.3 91398.0 10579.6 9634.4 94147.5 6806.2 7172.4 6782.1 10053.2 6497.7 6998.4 7250.8 6998.4 7218.5 7149.5 7581.8 7334.0 2757.2 1125.0 3379.9 88.5 3311.5 2793.9 6799.5 2785.4 2159.8 474.7 2597.9 3977.3 777.8 4398.0 2550.4 2021.2 177.2 941.5 2199.4 2314.2 10704.0 4251.2 290.2 504.9 1413.1 4867.0 1613.4 4331.2 60.6 6134.8 1447.8 5703.3 1715.1 617.4 2365.7 942.2 4598.0 23702.0 74983.4 533.3 113.8 2368.8 3039.4 70127.1 16939.0 1601.8 4175.9 34584.5 5085.3 129.3 22965.8 3161.9 2020.6 55.8 309.7 6905.5 5604.7 2010.8 4884.7 9790.5 21474.5 58047.8 1908.0 682.6 1341.1 1643.8 3455.6 82.1 311.2 1985.5 2226.7 1502.7 2590.4 1492.0 2816.8 13083.6 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705951 "Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;salivary gland: 66.2;stomach 1: 28.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 56.4;Club cells: 69.4;Distal enterocytes: 110.0;Gastric mucus-secreting cells: 83.6;Ionocytes: 57.0;Paneth cells: 75.5;Proximal enterocytes: 182.4;Undifferentiated cells: 62.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "cerebellum: 5.5" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CAPAN-2: 63.6;OE19: 76.1" "Region enhanced" "Detected in some" "cerebellum: 2.3" "Low region specificity" "Detected in all" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favorable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.2 0.6 0.8 6.2 0.9 0.3 1.7 5.5 1.2 16.0 0.0 23.5 44.5 1.1 0.1 26.0 2.6 13.5 0.5 0.9 0.0 1.0 0.3 0.9 0.5 0.2 0.1 1.1 5.2 0.1 2.0 0.1 0.3 1.4 19.8 0.9 66.2 2.9 0.7 4.8 21.9 0.8 0.0 0.6 28.9 0.8 0.4 0.6 0.7 0.0 6.6 6.3 9.7 0.6 2.0 1.5 0.3 0.9 0.0 0.0 0.2 0.2 0.0 0.0 0.0 7.2 63.6 0.7 0.5 0.0 0.3 10.6 0.0 0.0 0.0 0.5 0.5 0.6 0.6 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 1.0 0.0 1.2 0.1 0.8 0.1 0.5 0.7 1.5 0.4 76.1 0.3 0.5 0.2 3.0 0.0 0.6 3.4 0.5 0.3 0.6 0.1 0.4 9.5 0.1 0.3 0.4 0.4 0.5 0.2 0.7 0.5 0.1 0.3 0.4 0.2 1.1 0.1 0.1 0.4 0.1 0.2 0.3 0.5 0.2 0.1 0.3 0.4 0.1 0.5 0.2 0.1 0.4 0.6 0.2 0.8 0.9 5.5 1.2 0.9 0.0 0.2 0.1 0.3 0.0 0.4 0.6 0.5 0.0 0.6 0.7 0.6 0.9 2.3 56.4 5.7 2.5 6.1 3.0 0.8 32.9 69.4 20.2 2.1 0.1 0.4 110.0 1.9 4.7 0.5 8.4 2.7 0.7 11.4 0.0 2.3 46.5 0.0 0.5 83.6 23.9 0.0 0.1 0.0 0.1 0.1 0.0 1.4 42.1 57.0 0.3 0.3 0.2 0.0 0.3 1.8 0.0 0.3 0.5 2.1 0.5 1.2 31.8 75.5 0.0 0.2 2.9 182.4 0.1 37.8 4.2 0.0 1.2 2.4 0.3 0.2 9.9 1.4 0.1 0.8 0.3 62.9 19.4 FUT7 ENSG00000180549 "Fucosyltransferase 7" Q11130 9 137030174-137032088 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 3.9;brain: 2.5;lymphoid tissue: 6.1" "Group enriched" "Detected in some" 8 "dendritic cells: 66.9;Langerhans cells: 38.7;monocytes: 20.7;NK-cells: 28.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 210.0" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "NB-4: 23.7;THP-1: 24.0;U-937: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA042780 Approved "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 2: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA042780: AB_2678162" "unprognostic (1.33e-2)" "unprognostic (4.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (5.42e-2)" "unprognostic (5.01e-6)" "unprognostic (2.50e-1)" "unprognostic (2.35e-2)" "unprognostic (6.75e-4)" "unprognostic (4.68e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (6.69e-6)" "unprognostic (3.99e-2)" "unprognostic (4.14e-2)" "unprognostic (1.03e-1)" "unprognostic (8.75e-2)" 0.3 0.1 0.6 1.7 1.7 3.9 0.1 1.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.7 1.2 0.1 0.1 0.9 4.6 1.9 1.2 0.0 0.0 0.0 0.2 0.1 1.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.1 0.7 6.1 0.3 0.2 1.2 1.0 0.2 0.4 3.2 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 23.7 0.0 0.2 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 2.0 7.5 1.5 10.4 1.6 52.5 20.1 52.1 28.9 21.7 5.5 0.9 4.3 91.6 127.1 0.2 210.0 90.2 15.4 0.6 1.7 1.0 1.3 0.7 1.2 1.9 1.2 1.1 0.7 1.2 2.5 0.1 0.0 0.0 0.0 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.2 0.0 3.7 38.7 0.0 0.0 2.7 0.0 0.0 20.7 0.0 28.8 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.7 0.0 FUZ "CPLANE3, FLJ22688, Fy" ENSG00000010361 "Fuzzy planar cell polarity protein" Q9BT04 19 49806866-49817376 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 78.7" "Group enriched" "Detected in many" 18 "Early spermatids: 1243.5;Late spermatids: 2329.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041779, HPA042196" Approved Approved Cytosol No NA "Cluster 5: Granulocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA041779: AB_10793974, HPA042196: AB_10797383" "unprognostic (2.40e-3)" "unprognostic (1.31e-1)" "unprognostic (7.73e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-2)" "unprognostic (4.36e-3)" "unprognostic (9.67e-2)" "unprognostic (1.47e-1)" "unprognostic (1.97e-2)" "unprognostic (1.06e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.50e-5)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.70e-1)" 9.3 17.6 17.3 2.8 21.0 6.2 9.3 18.8 20.8 11.2 19.7 12.1 4.2 11.1 7.3 6.8 19.5 5.2 13.6 16.4 16.8 16.8 7.1 7.7 4.6 19.9 19.1 15.4 12.3 7.1 12.5 4.0 18.2 11.2 1.9 4.9 7.5 7.3 20.4 6.6 6.9 4.1 19.5 8.8 10.2 78.7 18.7 6.0 11.5 12.4 2.2 9.0 8.2 20.4 0.1 10.6 9.5 12.2 8.9 9.5 2.7 5.2 5.4 7.9 11.0 0.9 17.2 3.1 10.6 4.9 2.5 4.3 2.7 9.2 3.5 11.7 20.5 13.0 7.6 0.0 10.1 7.6 7.0 10.1 6.3 16.1 4.0 6.2 7.5 18.6 3.0 8.7 4.1 0.5 14.1 15.4 15.7 8.4 6.3 24.4 7.7 7.4 9.7 2.7 26.5 31.0 1.0 10.8 17.9 3.7 6.2 4.7 3.7 6.6 5.9 1.9 1.9 24.9 26.5 8.4 7.6 0.2 8.4 7.0 4.6 17.7 4.9 2.2 4.1 5.3 3.1 4.2 3.8 6.0 3.8 4.3 10.6 3.8 1.6 15.0 3.8 2.6 17.3 21.0 18.8 20.8 16.4 16.8 19.9 19.1 18.2 19.5 18.7 20.4 9.2 0.0 2.8 6.2 8.4 3.8 19.3 10.1 8.6 7.2 14.5 14.6 3.9 17.2 7.3 7.3 4.2 17.5 12.2 1.9 66.5 15.3 1243.5 61.6 8.0 6.5 2.4 19.3 2.7 5.1 12.1 11.1 6.1 8.1 10.2 11.5 13.6 5.8 13.2 10.1 3.0 3.5 12.2 7.1 7.6 2329.6 27.7 6.7 0.0 2.8 7.9 26.1 5.2 2.0 9.9 4.5 6.1 17.7 10.9 8.0 7.3 86.1 35.4 11.3 0.0 17.1 9.9 95.3 13.5 5.0 4.1 12.0 6.4 13.7 5.5 14.1 GABRP ENSG00000094755 "Gamma-aminobutyric acid type A receptor subunit pi" O00591 5 170763350-170814047 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 152.3;esophagus: 171.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 169.0;Breast myoepithelial cells: 113.2;Club cells: 83.1;Endometrial ciliated cells: 146.0;Glandular and luminal cells: 464.0;Urothelial cells: 146.6" "Group enriched" "Detected in many" 4 "breast cancer: 35.4;cervical cancer: 49.3;endometrial cancer: 16.8;pancreatic cancer: 41.9;stomach cancer: 25.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 11.8" "Group enriched" "Detected in many" 8 "granulocytes: 11.8;monocytes: 5.7" "Cell line enhanced" "Detected in many" "A-431: 215.1;EFO-21: 236.8;HeLa: 166.8;PC-3: 331.3;SuSa: 418.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB014883 Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "CAB014883: " "unprognostic (3.98e-3)" "prognostic favorable (3.37e-4)" "unprognostic (8.34e-2)" "unprognostic (1.57e-1)" "unprognostic (8.90e-2)" "unprognostic (1.27e-1)" "unprognostic (7.89e-2)" "unprognostic (4.97e-3)" "unprognostic (3.72e-1)" "unprognostic (4.93e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (5.92e-3)" "unprognostic (6.52e-3)" 4.5 3.6 10.4 7.3 10.5 9.9 152.3 15.8 16.2 13.1 5.4 4.2 15.4 48.6 19.0 171.5 12.9 27.3 5.4 7.6 23.0 6.1 7.1 14.7 5.7 12.5 6.1 3.9 23.8 2.0 2.0 9.1 10.6 12.7 4.9 42.1 35.8 16.6 13.7 19.0 16.2 2.6 2.7 7.4 27.4 8.3 10.4 4.7 6.1 2.7 42.2 5.4 29.4 17.9 215.1 9.9 10.1 7.0 0.7 4.3 23.8 3.8 1.5 0.5 0.6 38.1 23.6 3.3 236.8 1.1 2.3 75.7 6.4 0.5 0.6 3.5 7.6 14.1 166.8 5.7 0.8 5.1 11.2 1.6 3.0 2.8 1.8 8.0 1.4 13.4 57.6 26.5 0.4 6.7 9.5 4.7 84.5 3.7 331.3 13.7 6.6 8.2 13.8 11.6 8.2 4.0 76.5 3.9 2.2 418.8 4.2 2.4 8.8 19.1 69.3 15.7 15.7 10.0 6.7 6.3 2.6 13.9 2.9 11.8 1.9 6.1 0.4 1.5 1.1 0.3 0.4 0.3 0.6 0.7 0.5 0.5 4.5 0.2 5.7 0.9 0.6 2.3 10.4 10.5 15.8 16.2 7.6 23.0 12.5 6.1 10.6 2.7 10.4 17.9 1.1 3.2 0.6 0.0 0.9 0.0 14.9 44.4 0.0 0.0 169.0 113.2 0.7 51.5 83.1 1.8 0.0 5.2 2.3 0.0 0.0 10.4 0.0 146.0 48.8 3.8 0.0 0.0 0.3 13.8 0.6 2.4 2.0 464.0 0.0 0.0 0.0 0.1 2.3 0.0 0.2 0.3 12.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 56.6 0.1 0.0 0.0 24.2 0.1 0.1 34.0 0.0 0.0 0.2 5.9 0.0 0.0 4.5 0.0 5.7 2.7 0.0 0.6 146.6 GALNT3 "GalNAc-T3, HFTC, HHS" ENSG00000115339 "Polypeptide N-acetylgalactosaminyltransferase 3" Q14435 2 165747588-165794659 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 77.3" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 152.8;Pancreatic endocrine cells: 188.1;Prostatic glandular cells: 155.7;Urothelial cells: 274.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 50.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.4;HaCaT: 108.3;HBEC3-KT: 69.2;hTCEpi: 88.2;OE19: 201.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA007613 Enhanced Supported "Golgi apparatus" NA NA 440000 "Cluster 46: Basophils - DNA binding" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA007613: AB_1078941" "unprognostic (1.95e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.16e-3)" "unprognostic (2.78e-1)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (4.13e-2)" "unprognostic (4.47e-2)" "unprognostic (2.74e-1)" "unprognostic (6.44e-2)" "unprognostic (3.62e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.57e-1)" 1.5 1.7 1.7 8.4 2.1 54.0 26.0 2.7 1.8 29.3 4.3 48.9 43.5 5.2 9.3 27.4 38.8 32.2 0.6 1.8 3.4 10.9 2.4 14.0 3.7 4.5 5.2 6.8 26.2 6.9 9.8 6.4 3.3 25.2 53.2 3.7 55.3 8.2 0.3 15.3 39.5 2.5 7.0 20.1 77.3 25.8 1.9 3.3 25.4 0.4 12.3 17.3 12.6 5.4 61.5 0.0 0.6 0.2 0.1 2.6 43.0 18.3 7.7 6.6 16.0 32.0 85.4 0.4 0.1 0.0 0.1 108.3 0.0 69.2 13.5 1.3 13.0 0.0 14.9 0.3 0.3 14.5 0.4 0.5 88.2 0.0 30.3 2.1 0.1 2.9 0.0 55.0 5.0 42.7 0.5 5.6 0.1 201.1 7.8 0.2 0.0 1.7 17.8 42.0 6.5 0.1 0.3 49.6 16.8 1.9 21.7 0.9 0.5 0.1 1.0 0.1 0.3 34.4 16.3 1.3 0.2 14.0 0.6 50.5 6.8 32.2 10.2 9.0 7.5 6.6 3.1 5.8 11.4 6.0 1.0 3.4 25.2 10.6 13.8 17.3 5.6 6.2 1.7 2.1 2.7 1.8 1.8 3.4 4.5 5.2 3.3 7.0 1.9 5.4 1.0 12.8 34.4 7.8 13.6 38.0 107.9 36.5 29.6 0.6 45.0 26.8 0.4 35.8 45.9 66.2 0.0 8.5 37.7 68.6 3.9 70.2 127.5 91.8 5.2 2.9 23.4 1.3 10.5 113.2 22.5 2.3 102.4 70.5 45.7 0.7 1.1 0.6 8.2 0.0 5.1 152.8 28.5 1.9 12.4 14.1 2.5 8.3 16.0 1.0 7.5 16.1 15.5 27.6 1.4 188.1 46.5 0.4 29.7 155.7 32.6 3.1 89.3 1.0 6.6 0.6 4.3 71.5 1.1 42.4 41.3 11.2 14.4 1.2 61.8 274.4 GAS2L2 GAR17 ENSG00000270765 "Growth arrest specific 2 like 2" Q8NHY3 17 35744511-35753239 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "choroid plexus: 6.5;fallopian tube: 16.4" "Group enriched" "Detected in some" 6 "Endometrial ciliated cells: 23.0;Respiratory ciliated cells: 32.8" "Cancer enriched" "Detected in some" 4 "endometrial cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HaCaT: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044370 Enhanced NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA044370: AB_2678915" "unprognostic (3.76e-2)" "unprognostic (1.43e-1)" "unprognostic (5.54e-3)" "prognostic favorable (7.00e-4)" "unprognostic (3.65e-2)" "unprognostic (1.07e-1)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (4.05e-2)" "unprognostic (4.09e-2)" "unprognostic (4.01e-4)" "unprognostic (3.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.16e-1)" "unprognostic (3.92e-2)" 0.6 0.0 1.1 0.0 1.2 0.0 0.5 0.6 1.0 0.9 6.5 0.1 0.0 0.2 1.9 0.0 16.4 0.0 0.1 1.0 1.1 0.1 0.0 2.0 0.0 1.9 2.6 0.0 0.1 0.1 0.0 0.0 1.7 0.1 0.0 0.2 0.1 1.2 2.8 0.3 0.1 0.0 2.2 0.0 0.1 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.6 1.0 1.0 1.1 1.9 2.6 1.7 2.2 1.0 1.2 0.1 0.0 1.1 1.0 0.1 0.6 0.0 1.3 0.0 0.1 0.6 0.3 0.5 0.0 4.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 23.0 0.2 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.8 0.0 0.0 0.0 0.5 0.2 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 GBP6 DKFZp686G0786 ENSG00000183347 "Guanylate binding protein family member 6" Q6ZN66 1 89364059-89388160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 327.3" "Cell type enriched" "Detected in some" 25 "Squamous epithelial cells: 325.0" "Group enriched" "Detected in many" 7 "cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "A-431: 5.4;HaCaT: 11.3" "Low region specificity" "Detected in all" HPA027744 Enhanced NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA027744: AB_10602809" "unprognostic (7.60e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-2)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (7.05e-3)" "unprognostic (5.85e-2)" "unprognostic (5.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "unprognostic (7.99e-4)" "unprognostic (1.63e-1)" "unprognostic (2.04e-6)" "unprognostic (1.43e-1)" "unprognostic (1.03e-1)" "unprognostic (3.41e-1)" "unprognostic (3.91e-3)" 0.0 0.0 0.3 0.2 0.3 0.2 0.2 0.3 0.4 25.9 0.1 0.0 0.0 0.1 0.1 327.3 0.3 0.2 0.1 0.3 0.2 0.0 0.1 0.3 0.1 0.5 0.2 0.4 0.1 0.0 0.8 0.0 0.5 0.1 0.0 0.1 62.8 0.1 0.2 0.9 0.0 0.0 0.3 0.2 0.3 0.0 0.3 1.1 0.2 0.2 55.0 0.1 32.0 0.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.3 0.3 0.7 0.2 0.1 0.1 0.6 0.1 0.3 0.3 0.3 0.4 0.3 0.2 0.5 0.2 0.5 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.2 12.5 0.1 0.0 0.0 0.2 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.5 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.4 0.0 0.0 12.8 0.0 0.0 0.0 1.2 0.0 0.1 325.0 0.0 0.0 0.2 1.2 0.0 1.2 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 325.7" "Cell type enhanced" "Detected in all" "Early spermatids: 185.0;Kupffer cells: 183.3;Macrophages: 153.5;monocytes: 228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 327.4;neutrophil: 864.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 864.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" NA NA 1300000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 30.5 13.5 16.4 62.6 23.0 325.7 17.6 20.2 28.8 12.2 11.4 18.0 19.3 9.8 24.6 10.9 16.2 23.0 9.7 15.9 17.7 18.3 15.0 26.5 33.0 25.5 20.7 8.5 16.6 10.4 8.2 25.2 23.6 12.2 19.6 10.6 12.3 9.7 2.7 7.0 18.7 18.8 21.6 70.1 25.1 24.1 19.5 18.4 17.0 14.9 25.4 26.1 5.7 37.3 2.6 4.2 10.7 0.0 2.5 2.2 0.4 4.0 11.1 6.2 11.1 8.7 30.6 3.7 27.0 0.3 14.2 1.6 4.1 12.7 7.7 17.1 16.8 33.5 2.9 17.7 3.0 41.6 9.1 2.8 4.3 5.7 1.2 15.8 0.9 25.9 0.6 12.1 0.5 33.0 0.9 24.2 6.5 22.5 16.4 14.2 2.7 18.5 32.7 18.6 6.9 12.0 5.1 23.3 19.7 12.5 15.8 17.7 0.8 1.6 11.2 17.8 6.2 11.5 23.2 0.6 9.2 15.8 7.7 38.8 132.4 327.4 2.7 78.4 3.5 21.6 4.8 4.8 63.2 21.1 8.1 5.0 864.2 2.5 63.3 17.2 10.2 71.4 16.4 23.0 20.2 28.8 15.9 17.7 25.5 20.7 23.6 21.6 19.5 37.3 28.8 16.0 36.5 10.1 54.5 15.4 28.2 19.6 12.5 10.2 32.6 16.4 4.1 50.1 21.2 33.1 2.1 55.5 17.3 14.4 76.3 49.5 185.0 21.1 9.1 26.4 39.4 36.1 25.9 60.5 20.8 14.4 43.8 24.9 44.9 13.6 48.9 15.0 107.9 11.8 15.4 29.9 32.6 183.3 60.5 32.8 10.8 153.5 16.0 17.8 228.5 21.1 10.3 1.0 98.0 36.5 25.7 6.4 23.4 24.3 18.4 69.7 24.7 4.4 6.6 12.2 18.3 52.6 13.5 15.1 18.2 46.9 16.3 16.7 28.9 21.0 GCSAML "C1orf150, FLJ44728" ENSG00000169224 "Germinal center associated signaling and motility like" Q5JQS6 1 247507058-247577690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.4;prostate: 5.5" "Cell type enriched" "Detected in some" 24 "granulocytes: 223.3" "Cancer enriched" "Detected in single" 13 "prostate cancer: 1.9" "Region enriched" "Detected in some" 5 "cerebellum: 6.4" "Immune cell enriched" "Detected in single" 661 "basophil: 227.7" "Lineage enriched" "Detected in single" 661 "granulocytes: 227.7" "Group enriched" "Detected in some" 71 "HEL: 151.8;HMC-1: 564.8" "Low region specificity" "Detected in all" "HPA027507, HPA027510" Uncertain Approved Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" Cytosol "HPA027507: AB_10600756, HPA027510: AB_2672309" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (4.07e-3)" "unprognostic (3.48e-2)" "unprognostic (1.72e-1)" "unprognostic (2.76e-4)" "unprognostic (3.21e-1)" "unprognostic (6.14e-2)" "unprognostic (5.42e-2)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.81e-1)" "unprognostic (9.51e-3)" "unprognostic (3.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" 0.5 0.2 0.4 0.8 0.4 1.8 1.0 6.4 0.7 0.7 0.4 1.2 1.5 0.8 0.5 1.1 0.3 1.4 0.2 0.3 0.4 0.1 0.2 2.1 0.3 0.4 0.3 0.1 0.4 0.1 0.0 0.3 1.2 5.5 1.5 1.2 0.3 0.4 0.2 0.7 1.4 0.6 0.1 0.4 0.9 3.4 0.4 0.7 0.3 0.7 0.2 0.7 0.3 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.8 0.2 0.1 0.0 0.1 151.8 0.2 0.0 0.0 0.3 564.8 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.0 0.1 0.3 0.3 5.0 0.2 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.4 0.0 0.0 0.3 0.2 0.0 2.3 0.1 0.4 227.7 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.4 0.4 6.4 0.7 0.3 0.4 0.4 0.3 1.2 0.1 0.4 1.2 0.0 0.0 4.4 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 1.9 0.0 9.1 0.0 0.1 0.6 0.0 5.0 0.4 0.0 0.0 0.3 0.0 0.0 223.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.7 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.3 1.7 0.0 0.6 0.0 1.4 0.1 0.0 0.2 GGTLC1 "dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4" ENSG00000149435 "Gamma-glutamyltransferase light chain 1" Q9BX51 20 23985050-23988779 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "lung: 32.3;testis: 18.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 137.8;Early spermatids: 45.2;Late spermatids: 130.2;Spermatocytes: 33.6" "Cancer enriched" "Detected in some" 8 "lung cancer: 7.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "HPA045635, HPA047534" Uncertain NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (1.94e-2)" "unprognostic (5.32e-1)" "unprognostic (4.19e-1)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 32.3 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.5 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 137.8 15.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 130.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 33.6 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 GINS1 "KIAA0186, PSF1" ENSG00000101003 "GINS complex subunit 1" Q14691 20 25407673-25452628 "Disease related genes, Predicted intracellular proteins" "DNA replication" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.3;testis: 9.0" "Cell type enhanced" "Detected in many" "Early spermatids: 60.2;Erythroid cells: 14.7;Extravillous trophoblasts: 17.9;Late spermatids: 21.9;Spermatocytes: 14.2;Spermatogonia: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051185 Uncertain Approved Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA051185: AB_2681378" "unprognostic (6.10e-3)" "unprognostic (2.58e-1)" "unprognostic (5.37e-3)" "unprognostic (1.74e-3)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (5.86e-3)" "unprognostic (1.42e-2)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.42e-11)" "unprognostic (5.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (2.55e-1)" 0.7 0.6 0.9 3.2 0.8 3.4 1.6 1.8 1.0 1.0 0.4 3.2 3.0 1.4 0.7 4.3 0.8 0.8 0.5 0.8 0.5 1.1 1.2 0.5 5.3 0.4 0.5 0.9 0.5 0.6 0.2 2.9 0.6 0.8 3.9 0.8 0.8 0.4 0.5 3.7 2.9 2.0 0.3 1.5 2.0 9.0 0.6 7.3 0.6 0.0 5.9 1.3 1.5 0.9 43.6 38.8 46.5 30.4 2.6 3.5 46.7 18.9 9.1 35.5 37.2 33.7 42.1 53.3 21.0 7.9 26.4 49.0 40.9 34.4 40.7 14.3 14.2 36.7 13.8 41.3 0.9 48.5 16.2 1.7 2.0 33.8 6.9 4.7 19.1 30.1 36.1 33.9 21.2 47.0 75.1 36.0 31.8 30.0 20.0 53.1 53.6 35.7 13.6 28.8 19.4 20.3 19.3 45.3 16.7 26.0 42.9 24.2 8.7 27.7 29.9 18.2 35.1 13.6 41.1 42.0 7.4 46.8 32.0 0.2 0.2 0.1 0.3 0.2 0.1 0.5 0.2 0.1 0.5 0.3 0.1 0.3 0.2 0.4 0.2 0.5 0.8 0.2 0.9 0.8 1.8 1.0 0.8 0.5 0.4 0.5 0.6 0.3 0.6 0.9 0.2 0.0 0.6 1.3 1.5 3.2 1.0 1.5 1.8 1.8 1.1 1.3 0.4 0.0 1.6 1.8 0.0 8.2 0.2 1.9 0.0 1.1 60.2 0.5 1.3 1.1 1.2 14.7 6.4 0.7 17.9 2.0 3.6 1.3 1.3 6.8 0.7 0.7 5.9 0.0 3.7 2.5 0.0 1.6 0.8 21.9 0.6 1.2 0.0 1.0 0.0 1.3 0.0 4.0 1.6 0.4 0.6 1.2 8.9 0.6 0.4 2.1 1.7 0.2 0.0 0.5 1.4 14.2 19.7 5.4 1.4 2.5 0.8 2.0 5.5 0.8 GINS2 "Pfs2, PSF2" ENSG00000131153 "GINS complex subunit 2" Q9Y248 16 85676198-85690073 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.7" "Cell type enhanced" "Detected in many" "Spermatocytes: 163.5;Spermatogonia: 148.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 8.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 271.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA057285 Uncertain Approved Nucleoplasm No Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA057285: AB_2683398" "unprognostic (3.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.04e-3)" "unprognostic (2.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.30e-1)" "unprognostic (2.45e-3)" "unprognostic (2.58e-2)" "unprognostic (1.67e-2)" "unprognostic (2.52e-3)" "unprognostic (2.19e-2)" "unprognostic (5.82e-3)" "unprognostic (5.70e-3)" "unprognostic (4.54e-2)" "unprognostic (6.30e-2)" "unprognostic (5.44e-3)" "unprognostic (1.60e-1)" 1.0 0.9 3.0 5.4 2.8 14.7 3.7 3.0 3.7 1.7 2.2 6.4 4.6 1.6 1.3 4.7 1.1 0.4 0.6 4.5 2.2 0.7 3.0 0.8 9.0 2.3 2.4 1.4 0.9 2.6 0.8 3.0 2.3 1.5 7.0 11.1 1.3 0.8 2.7 3.2 5.3 1.6 2.3 3.0 2.2 9.6 2.3 10.2 1.8 1.0 11.0 1.4 2.1 2.6 50.7 36.2 69.0 28.9 2.0 6.7 18.3 33.8 13.7 49.8 30.5 48.2 32.9 60.0 18.1 12.0 26.0 38.0 73.7 28.1 47.9 20.8 63.9 29.2 25.7 54.6 0.3 20.6 15.6 1.8 3.4 30.0 11.5 6.1 21.6 47.5 82.4 13.8 28.9 107.1 72.7 77.8 38.8 45.0 27.3 100.7 41.5 33.1 16.4 20.9 94.2 30.0 49.4 10.0 10.0 27.3 100.0 28.2 12.8 32.1 42.5 30.6 39.5 25.6 48.3 271.9 18.7 43.4 37.2 0.7 0.2 1.1 1.0 1.0 0.1 1.0 3.3 2.3 1.3 0.7 1.6 1.1 0.9 3.2 2.8 0.8 8.5 1.7 3.0 2.8 3.0 3.7 4.5 2.2 2.3 2.4 2.3 2.3 2.3 2.6 0.6 3.2 0.0 0.7 8.5 9.2 7.4 9.5 4.0 20.3 13.1 18.5 1.0 0.0 3.8 3.7 2.1 35.3 3.1 11.9 3.9 8.2 9.8 1.5 3.3 2.4 3.0 43.3 0.5 1.5 31.8 7.2 5.6 2.7 1.3 21.6 0.0 2.1 23.8 8.4 0.4 14.9 4.1 1.3 6.6 29.4 1.2 3.3 0.0 0.0 1.1 5.6 0.0 1.0 0.6 2.0 4.5 1.9 43.1 2.6 2.4 0.7 1.7 7.5 19.7 4.2 7.9 163.5 148.4 13.8 3.8 12.7 4.2 2.2 33.6 7.4 GINS4 "MGC14799, SLD5" ENSG00000147536 "GINS complex subunit 4" Q9BRT9 8 41529218-41545030 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 6.2" "Cell type enhanced" "Detected in many" "Granulosa cells: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024663, HPA026580" Uncertain Supported Nucleoplasm,Centrosome NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Centrosome "HPA024663: AB_1857224, HPA026580: AB_1857225" "unprognostic (7.74e-2)" "unprognostic (3.72e-2)" "unprognostic (2.25e-3)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.70e-1)" "unprognostic (4.01e-2)" "unprognostic (1.71e-3)" "unprognostic (8.01e-3)" "unprognostic (4.03e-3)" "unprognostic (1.50e-2)" "unprognostic (4.34e-4)" "unprognostic (1.79e-1)" "unprognostic (3.67e-5)" "unprognostic (2.40e-3)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (3.22e-1)" 0.8 0.8 0.9 4.0 1.2 5.9 1.8 1.5 1.1 0.9 0.9 2.1 1.6 1.4 0.7 1.7 0.8 1.5 0.7 0.9 0.9 0.6 1.4 0.7 5.1 1.4 1.0 1.1 0.9 0.6 0.2 2.6 1.2 0.7 3.0 0.8 0.8 0.5 0.5 2.1 1.7 1.5 0.5 1.7 1.3 2.9 1.0 6.2 1.3 0.1 6.0 1.2 0.8 2.3 20.3 28.3 39.4 17.9 2.4 3.1 16.4 28.1 16.9 28.8 33.6 26.4 17.3 28.1 11.2 14.3 21.6 15.0 32.1 23.4 41.9 10.4 17.8 40.8 20.6 17.9 0.6 8.9 20.2 1.7 1.1 47.2 10.4 6.6 14.4 33.0 20.3 9.0 20.4 13.8 37.6 10.1 22.0 21.5 15.4 34.4 36.8 11.8 10.3 19.1 12.2 9.5 20.3 8.8 8.1 19.9 22.8 9.9 10.0 19.3 28.9 36.1 28.8 10.6 16.4 33.0 13.8 20.9 48.3 1.5 0.7 0.3 1.5 0.7 0.9 1.2 2.5 1.0 0.3 2.8 1.5 1.0 1.9 1.4 0.3 2.9 3.7 1.0 0.9 1.2 1.5 1.1 0.9 0.9 1.4 1.0 1.2 0.5 1.0 2.3 1.3 0.0 1.1 0.7 6.4 2.8 2.8 2.3 1.2 4.0 2.1 4.3 0.8 0.0 1.3 9.2 2.1 9.1 5.6 3.7 0.0 1.8 0.9 2.0 2.3 1.9 3.5 9.9 0.2 1.8 12.4 3.5 4.1 3.7 1.3 17.5 1.1 0.5 4.8 0.0 0.7 4.0 4.1 1.8 9.4 0.6 1.2 5.7 0.0 0.0 9.6 1.7 3.1 0.0 2.5 2.1 0.3 2.2 9.2 1.2 0.5 0.9 0.3 2.5 0.0 3.6 5.9 9.6 11.8 2.5 1.1 5.9 6.9 9.0 6.0 1.6 GIPR ENSG00000010310 "Gastric inhibitory polypeptide receptor" P48546 19 45668221-45683722 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 22.7" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 29.9;Gastric mucus-secreting cells: 28.1;Respiratory ciliated cells: 44.5;Rod photoreceptor cells: 17.4" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 4.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 9.8;HMC-1: 20.6;SCLC-21H: 13.9;U-266/70: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB022710, HPA068054" Uncertain Uncertain Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "CAB022710: , HPA068054: " "unprognostic (2.40e-2)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-2)" "unprognostic (2.65e-1)" "unprognostic (3.70e-4)" "unprognostic (1.82e-2)" "unprognostic (2.94e-2)" "unprognostic (1.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.85e-3)" "unprognostic (2.78e-1)" "unprognostic (1.72e-2)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" "unprognostic (3.37e-2)" "unprognostic (2.59e-2)" 10.0 0.3 1.8 3.1 2.6 2.0 9.0 2.3 3.3 2.5 2.7 6.9 3.7 0.3 0.7 2.5 10.2 1.4 15.2 1.8 2.7 3.8 0.7 5.6 2.7 4.1 4.7 0.1 10.8 5.6 0.4 0.2 4.5 7.1 4.9 13.1 7.8 0.4 0.3 4.2 4.2 0.3 1.7 4.0 22.7 0.2 4.4 0.6 2.5 0.0 2.4 2.6 3.4 4.4 0.7 0.4 1.3 0.7 0.6 0.0 0.1 1.0 0.8 0.0 0.7 0.4 3.9 1.9 0.6 0.8 0.7 2.0 0.3 0.2 0.1 9.8 0.3 1.6 1.0 0.3 0.1 0.6 20.6 0.0 0.3 0.1 0.0 1.8 0.0 2.1 4.5 2.2 0.0 0.2 0.1 1.1 0.0 2.9 0.7 0.5 0.4 4.4 0.5 0.9 13.9 1.2 0.0 0.8 0.2 0.5 2.0 3.1 0.4 0.0 0.5 0.3 0.2 16.7 0.2 0.4 0.6 1.5 0.3 1.1 0.1 0.5 0.5 0.2 0.1 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.5 0.9 0.0 0.2 0.4 0.2 1.8 2.6 2.3 3.3 1.8 2.7 4.1 4.7 4.5 1.7 4.4 4.4 1.4 3.2 6.3 0.0 1.0 0.9 3.4 2.9 0.0 0.3 2.0 0.5 4.0 5.7 9.8 5.5 0.0 0.0 3.7 13.2 0.0 2.2 0.4 7.1 0.1 0.5 29.9 0.0 0.2 3.6 0.1 0.5 28.1 0.7 1.3 0.1 0.0 0.0 0.1 0.0 0.4 6.8 4.1 0.0 7.8 0.2 0.0 1.4 0.0 0.0 0.5 0.2 1.0 0.0 5.0 5.6 11.3 0.0 4.0 1.5 0.3 0.1 44.5 17.4 13.1 0.3 3.5 0.2 0.3 1.5 0.4 0.1 2.1 0.1 1.9 2.8 GJB5 CX31.1 ENSG00000189280 "Gap junction protein beta 5" O95377 1 34755047-34758512 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "esophagus: 101.0;skin 1: 95.1;vagina: 35.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 48.6;Basal prostatic cells: 38.0;Basal respiratory cells: 49.6;Squamous epithelial cells: 63.8;Suprabasal keratinocytes: 83.5;Urothelial cells: 66.2" "Cancer enhanced" "Detected in many" "cervical cancer: 36.7;head and neck cancer: 57.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 29.1;HaCaT: 90.8;HBEC3-KT: 40.7;hTCEpi: 147.4;RT4: 50.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA038146 Uncertain NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA038146: AB_10697242" "unprognostic (2.62e-1)" "unprognostic (1.63e-1)" "unprognostic (3.48e-1)" "unprognostic (5.71e-2)" "unprognostic (8.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.89e-2)" "unprognostic (2.76e-2)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.30e-2)" "unprognostic (1.09e-3)" "unprognostic (2.36e-1)" "unprognostic (2.41e-3)" "unprognostic (5.59e-2)" "unprognostic (5.67e-3)" 0.2 0.1 1.0 0.0 1.0 0.0 3.9 0.6 1.3 12.8 0.0 0.1 0.0 0.1 3.4 101.0 0.6 3.4 0.1 1.4 0.3 0.1 0.4 0.3 0.0 0.4 0.4 0.1 1.1 0.0 0.8 0.6 0.5 5.2 0.1 0.0 13.9 3.1 0.3 95.1 0.2 0.0 0.6 0.1 0.1 2.3 0.7 1.4 0.9 0.1 12.6 7.1 35.0 0.9 29.1 0.3 0.1 0.5 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 2.2 0.0 1.2 0.0 0.3 90.8 0.0 40.7 0.0 0.1 0.0 7.0 0.9 0.0 0.0 0.0 0.0 0.1 147.4 0.0 23.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 50.9 0.1 0.0 3.6 1.5 0.0 0.4 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.6 1.3 1.4 0.3 0.4 0.4 0.5 0.6 0.7 0.9 0.0 0.0 1.1 0.3 0.0 48.6 38.0 49.6 12.5 0.0 2.8 1.9 0.5 0.0 17.2 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 4.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 19.5 0.0 0.0 12.4 0.0 0.0 0.0 1.4 0.0 0.0 63.8 83.5 0.4 0.2 0.0 0.3 66.2 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282980-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "fallopian tube: 7.0;pituitary gland: 5.5;placenta: 2.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 10.4;Endometrial ciliated cells: 12.8;Ionocytes: 22.4;Respiratory ciliated cells: 18.4;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.5;HDLM-2: 7.6;MCF7: 4.1;OE19: 4.8;RT4: 3.6;SuSa: 2.4" "Not detected" "Not detected" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.2 0.0 0.1 0.3 0.0 1.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 7.0 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.1 5.5 2.6 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.2 1.5 0.0 0.1 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 4.1 0.0 0.1 1.2 4.8 0.0 0.1 0.0 0.0 0.0 3.6 0.1 0.0 0.8 0.0 0.0 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.6 0.1 0.1 0.4 0.1 0.5 0.0 0.1 0.2 0.2 0.0 0.0 0.7 0.1 0.0 0.0 1.3 0.0 2.5 0.6 0.3 0.2 0.0 0.5 0.0 0.0 10.4 0.5 0.1 0.0 0.2 1.1 12.8 0.8 0.3 0.0 0.0 0.7 0.2 4.4 0.6 0.0 3.0 0.0 0.1 0.4 0.0 0.5 0.0 1.1 0.0 22.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.0 0.0 0.0 0.0 18.4 0.6 0.0 1.7 0.3 0.3 0.3 0.0 0.0 7.3 0.5 0.2 0.3 0.2 GLT1D1 FLJ31978 ENSG00000151948 "Glycosyltransferase 1 domain containing 1" Q96MS3 12 128853427-128984968 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;liver: 27.6" "Cell type enhanced" "Detected in some" "Early spermatids: 14.6;Excitatory neurons: 37.6;Inhibitory neurons: 30.2;Late spermatids: 41.7;Oligodendrocyte precursor cells: 34.7" "Group enriched" "Detected in some" 6 "liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "neutrophil: 36.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 36.4" "Group enriched" "Detected in some" 7 "MOLT-4: 13.0;NTERA-2: 17.9;SCLC-21H: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039051, HPA039052" Enhanced Cytosol "Secreted to blood" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA039051: AB_10673299, HPA039052: AB_10672839" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (3.60e-2)" "unprognostic (3.47e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-1)" "unprognostic (4.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (2.20e-1)" "unprognostic (1.55e-3)" "unprognostic (2.41e-1)" 2.5 0.2 7.0 6.8 7.3 28.1 0.2 1.5 9.8 2.4 5.6 0.4 0.1 3.6 1.0 0.5 3.0 1.7 0.8 7.1 11.1 0.8 27.6 2.8 0.3 2.9 2.6 0.2 0.8 0.6 1.4 0.7 3.1 0.8 0.3 5.7 0.2 1.5 9.0 1.1 0.3 3.1 1.2 12.7 0.3 15.5 4.3 0.9 1.7 9.6 0.4 1.4 0.5 6.8 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.3 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.5 3.6 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 36.4 0.0 2.0 2.3 0.0 1.6 7.0 7.3 1.5 9.8 7.1 11.1 2.9 2.6 3.1 1.2 4.3 6.8 0.0 0.0 0.0 1.6 0.4 0.9 0.0 0.0 0.0 0.8 0.0 0.5 0.4 0.0 0.0 0.0 2.1 0.0 4.7 0.0 0.0 0.1 14.6 0.6 2.3 0.1 0.0 0.0 37.6 0.0 0.0 0.4 0.0 4.8 0.0 0.1 1.1 10.4 1.4 0.0 30.2 0.0 0.0 8.5 0.0 41.7 0.3 9.4 1.8 6.5 12.4 10.4 1.0 34.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.3 0.0 0.2 0.2 4.0 0.6 0.0 0.3 0.1 0.2 0.0 0.0 0.0 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4" "Cell line enhanced" "Detected in all" "BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 19000000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 17.4 20.5 29.3 30.0 39.7 20.6 28.0 38.9 31.1 30.8 17.9 19.7 15.8 15.1 30.8 56.2 15.4 23.4 26.2 27.1 34.3 11.4 24.8 39.0 61.4 42.6 37.9 21.3 14.9 28.3 6.6 57.9 44.3 21.1 26.3 11.7 17.0 17.9 7.2 81.8 16.3 20.0 39.0 36.0 15.8 11.6 36.2 72.3 13.0 10.5 77.9 40.3 49.5 46.7 22.3 14.8 15.1 71.7 98.0 48.2 207.1 35.0 75.1 19.0 25.6 30.3 26.1 71.9 35.1 26.9 51.1 60.0 16.7 291.8 27.2 41.4 10.5 11.7 16.8 37.9 23.7 19.1 117.1 65.4 287.0 24.4 16.4 26.0 27.6 85.1 11.4 30.7 30.1 9.6 38.4 18.0 10.2 11.4 32.3 17.7 7.1 46.3 18.4 43.3 3.9 13.4 29.1 133.0 58.3 52.0 30.7 22.5 24.6 46.0 17.6 38.3 10.6 75.2 96.8 187.0 53.1 30.1 19.4 7.6 40.4 2.4 3.7 13.6 2.7 30.9 4.3 3.9 39.6 29.8 6.1 4.8 8.7 4.4 3.4 28.0 5.4 18.6 29.3 39.7 38.9 31.1 27.1 34.3 42.6 37.9 44.3 39.0 36.2 46.7 5.8 16.0 23.0 5.5 25.0 14.9 18.5 63.2 26.7 5.8 5.4 15.5 30.9 0.0 29.7 18.4 2.1 53.6 8.3 4.4 1.9 7.2 0.5 5.7 6.8 7.3 3.6 5.0 2.2 8.1 224.7 10.2 10.7 7.7 69.6 16.3 8.6 24.2 100.8 6.7 2.7 5.4 10.2 55.7 32.5 1.6 8.1 67.8 8.8 2.8 52.5 8.0 7.2 3.5 9.5 6.0 4.7 13.9 28.8 6.7 6.2 5.4 19.9 3.7 0.0 7.9 6.9 1.8 4.2 45.6 23.9 52.5 5.6 6.4 6.7 36.5 GMNC GEMC1 ENSG00000205835 "Geminin coiled-coil domain containing" A6NCL1 3 190852737-190892429 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 2.8;fallopian tube: 8.1;liver: 4.1" "Cell type enhanced" "Detected in some" "Early spermatids: 14.6;Endometrial ciliated cells: 5.9;Hepatocytes: 6.1;Proximal tubular cells: 11.5;Respiratory ciliated cells: 4.4" "Cancer enriched" "Detected in some" 5 "ovarian cancer: 4.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 45 "SCLC-21H: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA043663 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA043663: AB_10959313" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (5.45e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (2.22e-3)" "unprognostic (2.73e-2)" "unprognostic (2.55e-3)" 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.2 0.1 0.2 2.8 0.0 0.0 0.8 0.0 0.0 8.1 0.0 0.1 0.3 1.7 1.9 4.1 0.0 0.0 0.6 0.7 0.1 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.1 0.3 1.7 0.6 0.7 0.5 0.7 0.7 2.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 14.6 5.9 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.5 4.4 0.2 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPC3 "DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1" ENSG00000147257 "Glypican 3" P51654 X 133535745-133985594 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 574.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 65.1;Extravillous trophoblasts: 61.0;Fibroblasts: 404.2;Muller glia cells: 88.9;Syncytiotrophoblasts: 148.6" "Cancer enriched" "Detected in all" 4 "liver cancer: 269.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.8" "Group enriched" "Detected in some" 5 "HAP1: 514.3;Hep G2: 1825.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006316 Supported "Plasma membrane" NA NA 27000 "Cluster 32: T-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 33: Fibroblasts - ECM organization" "Plasma membrane" "HPA006316: AB_1078994" "unprognostic (2.06e-1)" "unprognostic (2.36e-1)" "unprognostic (9.51e-2)" "unprognostic (4.17e-2)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (6.10e-2)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (3.92e-3)" "unprognostic (6.06e-2)" "unprognostic (1.71e-1)" "unprognostic (3.81e-3)" "prognostic unfavorable (4.83e-4)" "unprognostic (1.43e-1)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" 99.9 22.8 0.5 3.5 1.0 0.0 61.8 0.5 0.3 11.8 0.2 6.5 1.6 9.2 41.1 6.7 13.9 13.7 24.5 0.3 4.0 87.0 5.1 122.9 2.5 1.9 3.1 15.5 21.2 4.1 47.0 574.9 3.0 8.3 4.1 6.2 13.7 9.2 4.5 18.0 5.6 7.3 1.7 3.7 13.6 2.8 2.0 8.0 22.4 28.6 10.9 14.6 9.3 1.0 0.0 0.0 21.8 1.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 154.0 0.0 0.0 0.1 0.1 0.0 0.0 514.3 0.4 0.0 0.0 22.6 0.0 0.9 1825.2 0.3 0.0 0.5 12.9 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.5 0.1 132.1 0.1 0.0 0.0 0.0 0.1 122.4 6.1 15.3 40.3 0.0 0.0 0.4 233.8 0.5 23.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.8 1.2 0.0 0.7 0.0 0.0 0.0 0.1 0.5 1.0 0.5 0.3 0.3 4.0 1.9 3.1 3.0 1.7 2.0 1.0 28.5 0.0 1.7 0.3 1.0 10.5 4.8 17.0 0.0 0.4 5.0 10.4 0.5 1.5 20.0 5.5 0.0 65.1 0.8 0.5 19.6 0.3 0.9 0.2 0.4 1.8 1.8 0.0 2.5 1.6 61.0 404.2 0.5 1.5 0.0 1.0 2.2 0.0 26.7 0.0 2.5 3.1 2.0 0.0 6.1 2.4 10.5 1.0 3.6 23.4 0.0 88.9 0.0 3.5 1.4 1.7 2.6 3.0 0.4 2.7 1.2 40.7 24.3 3.1 0.0 21.7 21.3 6.9 7.1 0.2 4.0 148.6 1.1 7.6 4.1 0.6 GPM6A GPM6 ENSG00000150625 "Glycoprotein M6A" P51674 4 175632934-176002664 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "brain: 577.8;choroid plexus: 249.3;retina: 147.3" "Cell type enhanced" "Detected in many" "Astrocytes: 3712.4;Excitatory neurons: 833.0;Inhibitory neurons: 581.3;Muller glia cells: 459.6;Oligodendrocyte precursor cells: 1341.6" "Cancer enriched" "Detected in many" 107 "glioma: 110.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 34.8;naive B-cell: 16.6" "Lineage enriched" "Detected in many" 12 "B-cells: 34.8" "Group enriched" "Detected in some" 10 "AF22: 49.9;Daudi: 43.0;HAP1: 17.4;U-251 MG: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017338 Supported NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA017338: AB_1849933" "unprognostic (1.36e-4)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.34e-2)" "unprognostic (9.45e-2)" "unprognostic (1.34e-1)" "unprognostic (3.82e-5)" "unprognostic (2.24e-1)" "unprognostic (9.13e-3)" "unprognostic (1.06e-1)" "unprognostic (3.69e-2)" "unprognostic (7.73e-2)" "unprognostic (2.24e-2)" "unprognostic (3.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-3)" "unprognostic (2.60e-3)" 3.8 4.2 366.9 1.4 455.6 0.5 2.5 422.6 577.8 6.8 249.3 25.4 1.9 7.7 2.9 1.9 7.5 4.4 2.8 469.8 268.7 7.1 13.4 20.1 2.6 225.0 265.4 12.3 1.8 0.7 7.7 0.3 222.4 5.7 6.0 147.3 0.9 6.9 0.6 0.8 3.4 11.1 257.9 15.8 1.1 1.5 281.9 0.3 11.9 0.6 1.3 2.6 2.9 336.4 0.3 0.7 49.9 0.5 0.0 0.0 0.2 0.1 0.5 0.2 0.4 1.1 0.7 43.0 0.2 0.2 1.8 0.9 17.4 1.5 0.1 0.2 4.0 0.5 3.7 1.4 0.1 0.4 0.7 0.1 0.0 0.1 0.2 2.0 0.0 0.1 0.4 1.7 0.0 1.2 1.6 0.6 1.2 0.0 0.6 0.2 0.2 0.3 0.1 2.1 0.5 0.4 0.2 0.9 0.2 0.3 0.6 0.1 0.2 0.9 0.6 0.6 50.8 1.6 0.1 2.6 1.8 0.4 1.1 0.8 0.1 0.1 0.1 0.1 0.1 34.8 0.1 0.0 0.2 16.6 0.1 0.1 0.4 0.1 0.2 2.9 0.1 0.8 366.9 455.6 422.6 577.8 469.8 268.7 225.0 265.4 222.4 257.9 281.9 336.4 0.6 96.1 8.7 3712.4 9.6 1.8 5.3 0.0 0.0 220.3 0.2 0.1 0.7 1.5 0.6 0.0 14.6 0.0 0.0 0.1 1.9 0.0 11.7 0.4 0.1 29.0 0.0 5.3 833.0 0.2 0.2 2.4 0.0 0.2 0.0 0.2 116.0 2.1 0.3 124.5 581.3 0.0 0.0 4.4 0.4 3.6 3.4 1.6 0.0 208.0 0.0 459.6 0.0 1341.6 37.3 0.0 0.0 1.5 0.1 9.0 0.0 3.4 0.0 30.5 0.0 15.3 3.3 0.5 0.4 0.2 0.9 0.1 1.2 3.0 0.0 6.5 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316820 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;skin 1: 32.8;vagina: 23.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 139.2;Basal respiratory cells: 150.0;Suprabasal keratinocytes: 68.2;Syncytiotrophoblasts: 205.0;Urothelial cells: 211.4" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 110.8;CAPAN-2: 40.8;HaCaT: 90.6;HBEC3-KT: 116.7;hTCEpi: 152.8;hTERT-HME1: 62.2;RT4: 46.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.1 0.8 10.0 2.9 0.0 0.0 0.0 3.2 35.9 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 9.6 0.0 4.3 0.0 0.0 13.7 5.5 0.1 32.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 3.5 0.0 0.0 12.4 13.2 23.8 0.4 110.8 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.9 0.2 0.0 40.8 0.0 0.0 0.0 0.6 90.6 0.0 116.7 1.1 0.0 0.1 0.0 1.1 0.0 0.8 0.0 0.0 0.0 152.8 0.1 62.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.1 6.1 0.0 0.0 0.0 3.8 46.7 0.0 0.0 19.0 0.5 0.0 3.1 0.4 0.1 0.0 0.0 10.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.1 1.0 0.0 59.3 139.2 150.0 46.7 0.0 2.8 1.8 0.1 0.0 49.9 3.7 0.0 59.0 0.4 0.0 0.0 1.2 0.7 3.3 0.0 1.5 0.0 0.0 1.1 0.7 8.7 1.1 0.0 2.4 1.3 0.0 0.0 0.0 4.2 0.0 0.4 0.0 28.5 0.0 3.6 0.1 0.0 0.6 10.6 0.0 0.0 0.0 0.0 1.0 0.0 12.9 0.0 0.0 0.0 60.6 0.0 0.1 19.6 0.0 0.0 0.0 4.1 0.0 0.0 52.7 68.2 205.0 0.9 0.0 0.0 211.4 GPX2 GSHPX-GI ENSG00000176153 "Glutathione peroxidase 2" P18283 14 64939152-64942905 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 497.7;intestine: 453.8;liver: 634.0;stomach 1: 374.6;urinary bladder: 350.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 493.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 4748.8" "Region enhanced" "Detected in single" "pons and medulla: 1.2" "Low region specificity" "Detected in some" HPA003545 Enhanced Approved Nucleoplasm,Cytosol NA NA 82000 "Cluster 48: NK-cells - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "HPA003545: AB_10962695" "unprognostic (3.54e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-3)" "unprognostic (4.75e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.96e-2)" "unprognostic (2.93e-2)" "unprognostic (7.87e-2)" "unprognostic (1.54e-2)" "unprognostic (8.45e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (6.66e-4)" "unprognostic (1.73e-2)" 1.9 0.2 0.1 53.8 0.3 0.3 5.3 0.5 0.3 23.5 0.1 333.5 96.7 0.7 1.7 187.7 4.9 497.7 0.3 0.2 0.5 30.6 634.0 2.6 0.1 0.4 0.2 0.2 24.5 0.0 1.2 0.2 0.4 43.3 453.8 0.0 71.8 24.9 0.3 25.4 175.7 9.7 0.1 0.6 374.6 2.5 0.3 3.3 0.5 0.0 1.2 350.5 108.2 0.7 0.0 1152.6 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 36.9 9.6 0.0 6.0 0.0 1.9 303.7 0.6 4.8 0.0 0.2 0.1 0.1 1.1 1048.6 0.0 0.1 0.4 0.0 9.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 5.6 0.6 0.3 1.3 4748.8 0.2 0.5 0.2 0.2 0.1 727.5 324.2 0.2 0.1 13.4 0.0 0.6 0.5 0.0 0.0 0.0 0.8 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.3 0.2 0.5 0.4 0.2 0.4 0.1 0.3 0.7 0.1 0.0 0.0 0.3 6.9 9.9 169.4 104.5 42.1 0.2 0.6 4.1 0.4 386.1 17.1 23.9 0.0 0.1 0.0 436.6 11.7 272.8 13.8 3.8 0.5 3.5 115.2 50.8 0.2 260.6 0.1 2.1 912.3 2.8 13.4 0.1 17.5 753.4 0.0 0.0 0.2 438.6 36.7 26.1 0.8 66.6 0.9 3.5 0.0 1.9 3.2 0.0 0.0 0.0 0.4 163.7 463.0 0.0 2.4 100.7 68.1 31.4 9.0 0.7 0.0 0.0 3.6 0.4 0.0 315.5 9.7 0.0 5.9 0.1 776.8 1062.0 GREB1 KIAA0575 ENSG00000196208 "Growth regulating estrogen receptor binding 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "ovary: 278.3" "Cell type enriched" "Detected in many" 9 "Granulosa cells: 545.2" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.3;Hep G2: 39.6;MCF7: 61.8;SH-SY5Y: 40.5;SK-MEL-30: 30.4;T-47d: 138.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.8 3.4 8.5 0.7 9.6 0.4 13.7 2.1 9.9 60.2 0.8 1.0 0.7 61.3 7.0 0.6 53.4 2.8 4.6 7.8 20.4 1.8 3.1 1.4 0.6 8.7 8.5 278.3 7.6 0.7 8.9 3.0 4.4 63.4 0.2 1.5 1.1 3.8 4.0 2.7 0.9 12.8 3.2 0.2 3.0 14.9 10.7 0.3 0.6 4.8 0.3 1.7 21.5 6.5 0.1 1.0 40.3 0.5 0.2 0.2 1.8 0.0 0.1 0.1 0.3 0.3 0.2 2.5 0.3 0.0 6.9 0.2 3.1 0.2 0.1 5.1 3.6 0.4 0.3 39.6 0.5 0.3 2.1 0.5 2.2 0.6 0.4 0.4 0.0 3.9 0.5 1.0 0.3 61.8 1.2 2.0 13.0 0.1 0.1 29.1 0.0 1.9 0.1 0.0 11.8 40.5 0.9 1.1 30.4 5.2 138.0 0.7 0.0 4.1 2.0 0.4 0.1 6.0 4.4 24.7 6.8 11.9 1.2 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.1 0.1 0.0 8.5 9.6 2.1 9.9 7.8 20.4 8.7 8.5 4.4 3.2 10.7 6.5 0.4 0.0 0.5 20.2 0.7 0.8 1.9 0.0 0.6 4.8 24.7 13.7 8.3 5.7 0.6 0.0 2.1 0.2 0.1 0.1 0.0 0.3 0.8 35.7 36.0 1.3 0.0 0.0 15.0 0.2 3.6 16.9 0.0 23.4 3.8 545.2 0.7 8.9 3.2 3.3 46.9 0.0 0.0 0.0 1.2 2.5 20.2 1.4 5.4 1.0 0.0 0.2 0.0 11.6 20.9 0.4 0.0 55.3 5.0 14.3 0.0 2.5 2.9 0.5 0.0 7.2 14.8 1.1 2.9 0.3 0.3 0.3 1.1 33.1 0.0 2.5 GRIN3B GluN3B ENSG00000116032 "Glutamate ionotropic receptor NMDA type subunit 3B" O60391 19 1000419-1009732 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.9;fallopian tube: 4.1" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 15.1;Respiratory ciliated cells: 18.5;Spermatogonia: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 3.5" "Region enhanced" "Detected in single" "pons and medulla: 1.6" "Region enriched" "Detected in single" 9 "spinal cord: 4.8" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (7.86e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-2)" "unprognostic (3.43e-3)" "unprognostic (1.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (9.20e-2)" "unprognostic (1.49e-1)" "unprognostic (3.78e-3)" "unprognostic (9.35e-3)" "unprognostic (3.62e-2)" "unprognostic (3.34e-5)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" 0.1 0.1 0.3 0.1 0.4 0.1 0.1 0.6 0.5 0.8 0.2 0.1 0.2 0.1 0.0 0.1 4.1 0.0 0.1 0.2 0.5 0.7 0.1 1.4 0.3 2.0 1.9 0.2 0.2 0.0 0.5 0.1 2.9 0.2 0.0 0.3 0.2 0.0 0.1 0.4 0.1 0.0 0.5 0.9 0.1 0.5 0.2 0.0 0.4 0.0 0.0 0.1 0.2 0.8 0.1 0.4 0.3 0.1 0.1 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.1 0.2 0.3 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.3 0.1 0.1 0.1 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.1 0.2 0.3 0.0 3.5 0.9 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.5 0.2 0.5 2.0 1.9 2.9 0.5 0.2 0.8 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 15.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.2 1.7 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 0.0 0.1 1.5 10.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 GRM5 "GPRC1E, mGlu5, MGLUR5, PPP1R86" ENSG00000168959 "Glutamate metabotropic receptor 5" P41594 11 88504576-89065945 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 23.8" "Group enriched" "Detected in some" 26 "Excitatory neurons: 903.1;Inhibitory neurons: 968.3;Oligodendrocyte precursor cells: 1040.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 14.9;basal ganglia: 17.3;cerebral cortex: 23.8;hippocampal formation: 20.4;white matter: 6.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 10: Brain - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (9.57e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (2.62e-1)" "unprognostic (1.26e-1)" "unprognostic (7.16e-2)" "unprognostic (8.15e-4)" "unprognostic (3.43e-2)" 0.0 0.0 14.9 0.0 17.3 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 20.4 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.3 0.0 0.0 2.8 0.0 0.0 1.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 17.3 0.0 23.8 20.4 1.0 0.0 0.0 0.0 2.8 3.7 6.4 0.1 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 7.5 0.1 0.0 0.0 0.0 903.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.7 968.3 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 22.5 0.0 0.8 0.0 1040.5 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.8 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 GSTA1 ENSG00000243955 "Glutathione S-transferase alpha 1" P08263 6 52791371-52803860 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Oxidoreductase, Peroxidase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 916.5;kidney: 943.1;liver: 2610.5" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2" "Cancer enriched" "Detected in many" 4 "liver cancer: 555.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 263.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA 27800000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (4.84e-3)" "unprognostic (2.40e-2)" "unprognostic (3.40e-1)" "unprognostic (4.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-1)" "unprognostic (1.00e-2)" "prognostic favorable (8.66e-4)" "unprognostic (5.75e-2)" "unprognostic (6.90e-3)" "unprognostic (3.00e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.21e-1)" "unprognostic (4.26e-3)" "unprognostic (1.02e-1)" "unprognostic (2.16e-2)" 0.5 916.5 0.0 2.5 0.0 0.0 4.2 0.0 0.2 2.0 0.0 7.3 672.0 0.4 7.0 5.3 86.1 119.5 0.2 0.0 0.0 943.1 2610.5 12.2 0.5 0.0 0.0 78.9 148.6 0.0 0.2 0.5 0.0 18.7 8.1 0.0 21.5 0.6 0.1 1.2 674.6 0.3 0.0 0.2 135.5 336.8 0.3 0.1 0.1 0.0 11.5 2.2 5.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 19.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.5 0.1 263.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.4 2.1 0.0 0.2 1.5 2.1 0.3 0.0 0.0 1.1 0.0 0.2 0.5 0.5 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 6.4 7.7 0.0 13.5 0.0 5.0 35.7 0.0 0.0 7.0 1.5 0.0 453.2 159.9 73.5 0.0 0.1 0.1 5.8 536.1 71.3 11.8 0.4 0.1 3.1 3.0 45.5 0.0 1652.6 0.2 7.3 116.7 0.5 2.5 3177.1 26.4 1013.9 0.1 0.0 0.0 165.6 42.7 31.5 0.0 43.0 65.6 25.3 0.0 0.0 13.3 0.0 1.0 0.0 0.1 629.1 187.4 4.5 0.2 27.6 4294.8 3190.6 533.5 0.0 0.0 0.0 98.6 36.8 3.4 6.8 0.0 0.5 10.4 4578.2 295.3 58.7 GSTA2 GST2 ENSG00000244067 "Glutathione S-transferase alpha 2" P09210 6 52750087-52763475 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 696.0;liver: 2058.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 201.6;Distal tubular cells: 213.2;Exocrine glandular cells: 239.6;Pancreatic endocrine cells: 334.7;Proximal enterocytes: 367.0;Proximal tubular cells: 1186.6;Respiratory ciliated cells: 435.5" "Group enriched" "Detected in many" 16 "liver cancer: 124.6;renal cancer: 48.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 25.9;Hep G2: 20.0" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (6.43e-3)" "unprognostic (2.41e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (4.34e-2)" "unprognostic (1.91e-1)" "unprognostic (6.54e-2)" 0.4 4.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 149.5 0.0 0.7 0.1 2.5 109.4 0.0 0.0 0.0 696.0 2058.5 4.8 0.1 0.0 0.0 0.2 299.2 0.0 0.0 0.1 0.0 3.8 0.1 0.0 0.5 0.0 0.0 0.0 115.5 0.0 0.0 0.0 11.7 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 25.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.0 20.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.6 0.0 0.0 0.3 0.6 0.5 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 1.7 0.0 0.2 1.5 0.0 0.0 0.1 0.1 0.0 201.6 31.1 16.5 0.0 0.0 0.0 0.1 213.2 8.1 6.9 0.0 0.0 0.6 0.0 0.0 0.0 239.6 0.2 0.5 7.7 0.0 0.0 37.2 0.7 124.2 0.1 0.0 0.0 13.7 2.0 2.2 0.0 14.6 1.2 5.1 0.0 0.0 5.2 0.0 0.0 0.0 0.1 334.7 18.8 0.4 0.0 3.9 367.0 1186.6 435.5 0.0 0.0 0.0 1.5 1.9 0.7 0.0 0.0 0.0 2.6 10.4 30.1 1.3 GSTA3 ENSG00000174156 "Glutathione S-transferase alpha 3" Q16772 6 52896639-52909698 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 67.3;fallopian tube: 65.4;placenta: 22.7;skin 1: 26.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 194.9;Syncytiotrophoblasts: 515.3;Theca cells: 91.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.5;testis cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" "HPA004342, HPA048934, HPA053817" Approved Supported Cytosol NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (7.51e-2)" "unprognostic (7.06e-3)" "unprognostic (3.10e-1)" "unprognostic (5.53e-2)" "unprognostic (4.38e-3)" "unprognostic (2.86e-3)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (9.35e-2)" 0.0 67.3 0.0 0.1 0.1 0.0 1.8 0.0 0.0 1.1 0.5 0.0 0.3 0.8 0.8 0.0 65.4 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.5 0.9 0.1 2.9 0.0 22.7 0.0 0.1 0.0 0.0 0.3 0.2 0.0 26.0 0.4 0.1 0.0 0.0 2.4 11.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.3 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 6.2 0.0 0.0 194.9 0.0 0.0 0.0 0.0 1.3 47.0 0.5 0.5 0.0 0.0 0.0 0.0 7.5 1.1 0.0 0.7 1.3 7.4 0.0 0.4 15.7 0.0 0.0 0.0 2.0 0.0 0.4 2.1 1.5 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 24.8 0.0 0.0 0.0 0.8 0.5 0.5 0.0 9.8 515.3 0.1 91.3 0.0 0.0 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296870-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 11.2;lymphoid tissue: 19.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 52.2;Extravillous trophoblasts: 31.2;Granulosa cells: 27.1;Spermatocytes: 73.6;Spermatogonia: 27.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Yes Yes "Cluster 45: Eosinophils - Innate immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.90e-10)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 0.6 0.6 0.2 5.1 0.2 11.2 0.5 0.5 0.3 0.7 0.2 2.4 4.1 0.8 0.0 3.6 0.2 0.5 0.3 0.2 0.3 0.3 0.4 0.6 9.2 0.4 0.3 0.2 0.2 0.1 0.1 2.6 0.4 0.2 2.6 0.1 0.7 0.1 0.1 2.5 2.9 1.2 0.1 2.4 1.9 7.2 0.5 19.6 0.2 0.2 8.7 1.0 1.2 0.4 59.5 27.6 53.2 42.2 1.1 3.0 25.5 50.3 23.5 71.7 58.8 29.3 21.9 55.7 13.0 19.4 32.8 30.3 48.0 12.7 45.7 33.7 52.0 37.4 38.9 22.8 0.1 67.5 43.8 0.6 1.0 30.9 15.6 7.5 31.2 39.7 29.0 67.8 43.4 33.1 60.9 33.0 37.2 24.2 30.7 59.6 59.7 36.3 11.7 10.7 27.5 37.5 48.1 30.7 21.5 23.8 26.2 25.8 25.1 40.6 75.8 33.4 53.7 38.6 19.7 56.3 25.8 32.2 60.5 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.4 0.3 0.2 0.2 0.2 0.5 0.3 0.2 0.3 0.4 0.3 0.4 0.1 0.5 0.4 1.1 0.0 0.0 0.7 7.0 2.8 1.1 2.1 0.6 0.7 2.8 3.4 1.6 0.0 0.5 0.0 0.0 19.2 6.8 7.6 0.0 0.9 5.6 2.1 4.7 3.9 1.2 52.2 0.3 0.2 31.2 5.1 16.8 4.3 0.0 27.1 6.4 1.2 19.9 0.0 0.5 9.4 2.0 7.5 4.0 3.9 0.3 4.7 0.0 0.0 0.1 0.4 0.0 0.5 0.1 0.8 0.2 0.7 19.1 1.8 0.5 0.5 0.2 0.3 6.6 2.6 5.4 73.6 27.8 11.7 2.6 1.5 5.0 1.2 13.8 1.6 HAGHL MGC2605 ENSG00000103253 "Hydroxyacylglutathione hydrolase like" Q6PII5 16 726936-735525 "Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 43.8;Bipolar cells: 53.5;Endometrial ciliated cells: 40.5;Hofbauer cells: 41.0;Respiratory ciliated cells: 65.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 49.3;U-266/70: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074402 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA074402: AB_2732254" "unprognostic (6.74e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.49e-1)" "unprognostic (4.56e-2)" "unprognostic (5.62e-3)" "unprognostic (9.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.83e-2)" "unprognostic (6.37e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.92e-2)" "unprognostic (5.36e-1)" "unprognostic (3.41e-2)" "unprognostic (2.41e-1)" 3.3 2.7 7.6 2.1 12.8 1.4 3.0 13.3 11.5 6.6 20.1 5.2 0.8 4.7 0.0 2.6 17.9 0.7 13.0 5.9 9.5 10.2 1.9 7.6 3.1 12.4 10.7 4.0 2.1 1.7 21.9 0.4 10.6 5.7 0.0 0.5 3.7 0.9 0.5 3.4 13.6 0.1 12.2 15.2 3.5 8.5 10.5 2.0 3.5 0.1 1.1 4.1 3.8 12.5 4.4 4.4 0.8 4.9 0.9 2.0 3.9 4.1 1.7 0.7 0.6 2.0 5.3 9.6 5.5 0.3 1.2 5.9 0.9 1.3 0.1 26.3 3.7 3.1 11.4 3.6 4.6 12.1 8.5 3.4 1.2 0.0 1.2 1.4 0.5 7.8 5.5 7.5 1.0 26.5 0.3 16.5 5.6 4.3 8.8 6.3 2.7 49.3 1.5 1.2 19.5 11.6 1.9 15.1 17.8 0.1 9.0 19.5 4.3 4.2 6.5 1.5 2.2 60.3 8.6 14.2 6.0 11.4 8.1 0.0 0.7 1.0 3.6 0.3 4.1 8.8 2.9 4.2 0.9 2.1 0.8 2.7 0.0 4.3 0.1 3.5 3.4 2.2 7.6 12.8 13.3 11.5 5.9 9.5 12.4 10.7 10.6 12.2 10.5 12.5 1.1 3.2 0.6 43.8 19.7 1.1 2.0 16.2 0.6 53.5 6.3 10.9 10.6 0.0 7.1 3.7 0.0 0.5 10.4 1.6 35.2 2.4 6.6 40.5 7.9 1.4 3.6 10.9 24.6 0.0 1.4 2.8 3.6 1.9 8.2 0.6 1.1 0.5 41.0 11.8 15.4 2.6 4.1 6.9 3.2 18.4 6.8 10.4 19.6 6.5 5.9 10.6 13.4 6.6 30.9 3.2 1.2 6.0 5.7 10.0 0.0 9.0 65.8 9.9 0.0 0.5 3.3 8.5 6.8 0.8 0.3 0.4 12.8 0.9 1.7 0.9 HCAR1 "FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR" ENSG00000196917 "Hydroxycarboxylic acid receptor 1" Q9BXC0 12 122726076-122730844 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.5;parathyroid gland: 40.4" "Group enriched" "Detected in some" 4 "Breast glandular cells: 8.7;Breast myoepithelial cells: 5.2;Club cells: 3.2;Early spermatids: 9.6;Extravillous trophoblasts: 3.7;Late spermatids: 6.5" "Cancer enhanced" "Detected in many" "breast cancer: 7.9" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 2.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.1;MCF7: 8.1;RT4: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 15: RT4 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "prognostic unfavorable (3.61e-5)" "unprognostic (8.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-2)" "unprognostic (3.80e-4)" "unprognostic (5.43e-4)" "unprognostic (1.41e-1)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.85e-3)" "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (2.14e-2)" "unprognostic (2.51e-1)" "unprognostic (2.38e-1)" "unprognostic (1.87e-2)" 5.5 0.3 0.4 0.2 0.4 1.0 11.5 1.7 0.7 0.7 0.4 0.1 0.3 0.4 1.2 0.2 1.7 0.2 0.2 0.6 0.1 0.8 0.1 0.4 0.4 0.3 0.1 0.4 0.1 40.4 0.3 1.0 0.3 1.0 0.1 0.6 5.0 5.1 1.2 0.7 0.3 0.2 0.1 2.3 2.0 0.8 0.2 0.3 1.3 0.1 0.1 1.2 0.3 1.2 0.1 0.3 0.2 0.3 0.0 0.0 1.9 0.1 0.0 0.0 0.1 2.5 12.1 0.3 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.6 1.8 0.2 0.3 0.2 0.6 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.6 0.1 8.1 0.2 0.4 0.3 3.0 0.6 0.3 0.2 0.3 0.1 35.3 2.6 0.2 0.1 4.2 0.0 0.3 3.4 0.1 0.3 0.4 0.2 0.2 0.2 0.4 0.1 0.4 0.2 0.2 0.3 2.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 1.2 0.4 0.1 0.3 0.1 0.1 0.4 0.4 1.7 0.7 0.6 0.1 0.3 0.1 0.3 0.1 0.2 1.2 1.3 0.0 0.5 0.0 0.0 0.1 1.4 0.2 0.0 0.3 8.7 5.2 0.4 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 9.6 0.2 0.2 0.3 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 6.5 0.3 0.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 1.0 HCN4 ENSG00000138622 "Hyperpolarization activated cyclic nucleotide gated potassium channel 4" Q9Y3Q4 15 73319859-73368958 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Brugada syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 8.5;heart muscle: 8.4;testis: 7.2" "Group enriched" "Detected in some" 5 "Early spermatids: 29.4;Late spermatids: 49.5" "Cancer enriched" "Detected in some" 4 "testis cancer: 3.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 1.7;HDLM-2: 1.1;NTERA-2: 4.9;SuSa: 1.2;U-2 OS: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073174 Approved NA NA "Cluster 43: Testis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 31: Spermatids - Spermatogenesis" "HPA073174: " "unprognostic (2.21e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-2)" "unprognostic (3.14e-2)" "unprognostic (5.30e-3)" "unprognostic (1.92e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-2)" "unprognostic (2.37e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (6.05e-5)" "unprognostic (5.56e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-2)" "unprognostic (7.95e-2)" 0.0 0.4 3.6 0.0 0.7 0.0 0.0 2.2 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.4 1.0 2.8 0.0 0.0 0.0 0.0 5.0 4.2 0.0 0.1 0.0 0.5 0.0 4.6 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 2.5 0.0 0.1 7.2 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 2.2 1.8 1.0 2.8 5.0 4.2 4.6 2.5 8.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 29.4 0.6 0.0 0.2 1.8 0.0 1.5 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.3 1.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188534-93226469 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 96.2" "Group enriched" "Detected in some" 11 "Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1" "Group enriched" "Detected in many" 5 "colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SCLC-21H: 172.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 210000 "Cluster 9: Intestine - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 27: Mucus-secreting cells - Mucin production" "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.1 0.0 2.3 0.0 2.5 8.9 0.0 0.1 0.0 0.0 64.3 30.1 0.0 0.5 0.1 0.0 0.2 0.1 0.0 0.0 15.2 0.0 0.1 0.0 0.1 0.1 0.0 4.3 0.4 7.3 0.2 0.0 0.8 96.2 0.0 2.6 1.4 0.0 0.0 48.0 1.5 0.1 0.1 10.1 3.2 0.0 0.1 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 172.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.4 0.3 1.1 0.7 0.0 0.0 15.1 6.6 0.2 0.0 0.9 5.5 0.0 0.0 0.0 17.2 9.8 0.1 2.5 0.0 0.0 0.1 218.2 18.7 0.5 0.0 0.0 0.1 27.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.6 387.5 349.9 0.0 0.0 2.4 0.0 0.0 7.2 1.0 0.0 0.0 0.0 0.0 2.2 0.0 318.1 0.0 0.1 0.9 11.5 0.0 0.3 0.0 0.0 0.0 0.1 5.6 1.2 0.0 0.1 0.1 0.1 0.0 19.7 0.3 HHATL "C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3" ENSG00000010282 "Hedgehog acyltransferase like" Q9HCP6 3 42692663-42702824 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 241.1;heart muscle: 521.2;skeletal muscle: 282.3;tongue: 154.2" "Group enriched" "Detected in some" 8 "Astrocytes: 59.1;Bipolar cells: 119.6;Cardiomyocytes: 65.2;Muller glia cells: 49.9;Oligodendrocytes: 168.0" "Cancer enhanced" "Detected in many" "melanoma: 14.2;thyroid cancer: 25.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018174 Enhanced NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 56: Bipolar cells - Visual perception" "HPA018174: AB_2116671" "unprognostic (1.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.20e-2)" "unprognostic (9.71e-2)" "unprognostic (7.94e-3)" "unprognostic (3.79e-2)" "unprognostic (8.80e-2)" "unprognostic (2.47e-1)" "unprognostic (5.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (9.68e-2)" "unprognostic (1.01e-1)" "unprognostic (2.89e-1)" "unprognostic (3.14e-1)" 0.5 0.7 77.5 0.0 163.6 0.0 1.3 124.7 110.1 0.5 34.3 0.3 0.0 0.9 0.4 4.0 1.8 0.4 521.2 76.0 109.5 0.3 0.3 0.7 0.3 152.8 152.1 0.1 1.3 2.9 3.8 0.1 149.3 1.7 0.1 37.8 10.7 0.2 282.3 1.3 0.2 0.2 101.0 0.2 0.2 1.1 127.8 2.2 21.4 154.2 0.1 0.1 0.3 241.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.5 163.6 124.7 110.1 76.0 109.5 152.8 152.1 149.3 101.0 127.8 241.1 0.0 0.0 0.0 59.1 0.0 0.4 0.0 0.0 0.0 119.6 0.0 0.0 65.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.1 1.2 0.0 0.0 4.8 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 11.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 5.4 2.8 0.0 49.9 0.0 1.5 168.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.2 0.0 5.5 0.5 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HHLA2 "B7-H5, B7-H7, B7H7, B7y" ENSG00000114455 "HERV-H LTR-associating 2" Q9UM44 3 108296490-108378285 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 129.9" "Cell type enhanced" "Detected in some" "Distal enterocytes: 274.7;Paneth cells: 64.2;Proximal enterocytes: 186.8" "Group enriched" "Detected in many" 12 "colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HDLM-2: 4.0;Karpas-707: 2.8" "Low region specificity" "Detected in all" HPA055478 Enhanced NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA055478: AB_2682830" "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.11e-1)" "unprognostic (2.30e-1)" "unprognostic (1.59e-2)" "unprognostic (8.14e-5)" "unprognostic (1.76e-1)" "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-3)" "unprognostic (1.24e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-1)" "unprognostic (2.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.66e-2)" 0.4 0.2 0.5 5.6 0.4 1.1 0.2 0.7 1.3 0.0 0.0 87.9 86.8 0.3 0.8 0.5 3.7 29.2 0.2 0.6 0.7 7.6 0.1 5.7 0.6 0.7 0.3 0.1 2.9 0.1 0.2 0.1 0.6 0.2 83.0 1.2 0.2 0.3 0.5 0.3 129.9 2.0 0.2 0.3 9.4 3.3 0.6 0.4 0.2 0.0 0.3 0.0 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.7 0.2 0.1 0.1 0.0 0.1 0.2 0.6 0.0 0.0 4.0 0.1 0.1 1.4 0.2 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.8 0.0 0.2 0.4 1.5 0.5 0.2 0.3 0.3 0.1 0.8 0.0 0.1 0.7 0.7 0.7 0.0 0.1 0.5 0.1 0.2 0.1 0.1 0.7 0.2 0.2 1.3 0.7 0.3 0.0 0.4 0.1 0.5 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 1.8 0.1 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.5 0.4 0.7 1.3 0.6 0.7 0.7 0.3 0.6 0.2 0.6 0.8 0.0 0.0 2.0 0.7 0.4 0.0 0.1 0.7 0.0 0.0 0.7 0.3 0.2 27.1 1.6 0.0 0.0 0.0 0.0 274.7 0.0 8.5 3.3 3.2 0.0 0.3 1.8 0.0 1.3 37.6 0.1 0.3 2.6 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.5 12.5 2.0 0.0 0.7 4.2 0.3 0.3 0.0 0.0 1.1 0.0 0.0 0.5 0.9 35.7 64.2 0.0 0.0 0.1 186.8 20.4 19.4 0.0 0.0 0.1 0.1 0.7 0.3 0.0 0.0 0.1 0.5 0.0 17.7 0.1 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 47.4;lymphoid tissue: 30.4" "Cell type enhanced" "Detected in many" "Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 0.6 0.6 0.0 5.5 0.1 47.4 1.1 0.1 0.2 0.8 0.1 3.9 4.1 0.9 0.2 5.6 0.3 0.5 0.3 0.1 0.1 0.4 0.8 1.4 12.6 0.1 0.3 0.2 0.2 0.1 0.1 3.0 0.1 0.4 5.2 0.1 1.0 0.1 0.2 3.6 3.8 1.9 0.0 4.1 2.4 11.1 0.3 30.4 0.3 0.0 12.0 1.4 2.0 0.2 54.5 73.6 68.4 32.7 2.6 5.4 42.8 79.5 37.9 55.2 59.9 51.3 57.6 17.1 9.0 31.4 98.0 61.7 54.9 40.9 72.6 40.0 21.6 65.5 61.4 50.9 0.3 54.1 43.2 1.8 1.5 45.1 30.9 15.7 35.5 51.3 56.6 40.8 103.0 55.3 76.4 59.7 58.9 42.2 49.1 58.4 103.0 30.3 28.6 32.3 39.4 24.7 45.8 34.2 31.7 31.0 25.7 42.1 26.0 59.6 64.6 44.3 87.2 38.6 32.7 67.9 35.7 39.3 151.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.4 0.0 1.2 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.2 0.2 0.0 0.5 0.0 2.9 1.3 0.5 1.9 0.0 0.0 0.7 0.5 1.2 0.0 2.1 0.0 0.0 8.2 0.5 5.6 0.0 0.2 17.4 0.3 1.3 1.1 0.0 38.3 0.0 0.0 16.1 2.0 5.1 1.3 0.0 14.8 2.2 0.3 7.1 0.0 0.0 3.5 0.0 3.0 2.9 9.0 0.6 3.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 11.4 1.0 0.5 0.1 0.1 0.0 0.0 0.1 1.9 37.5 16.3 8.9 0.9 1.5 2.3 0.3 7.6 0.9 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491941 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.6;lymphoid tissue: 27.3;testis: 27.5" "Cell type enhanced" "Detected in many" "Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551" "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (5.52e-4)" "prognostic unfavorable (1.93e-7)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 0.8 0.7 0.2 10.1 0.3 20.6 2.1 0.3 0.4 1.1 0.1 6.6 7.4 0.8 0.2 4.0 0.5 0.9 0.8 0.2 0.2 0.7 1.7 0.9 18.1 0.5 0.3 0.2 0.3 0.9 0.2 6.2 0.4 0.5 8.8 0.8 0.8 0.2 1.2 4.2 6.5 2.9 0.3 2.9 3.6 27.5 0.7 27.3 0.7 0.4 17.7 2.2 1.4 0.5 77.0 47.2 94.5 50.8 5.0 9.0 70.3 71.4 34.9 88.0 78.9 96.8 145.1 127.5 66.0 22.2 118.5 86.3 112.4 69.0 148.6 116.1 34.4 76.7 32.3 48.4 1.4 68.7 67.3 2.4 4.1 82.8 64.0 14.7 50.6 85.7 73.2 101.0 93.2 28.5 72.3 38.8 81.9 51.2 51.6 78.0 126.3 63.9 34.8 20.4 78.8 43.8 106.3 32.8 38.6 45.1 97.3 54.5 32.9 63.2 52.4 50.6 97.2 53.7 96.3 102.4 41.4 104.2 61.1 0.2 0.2 0.0 0.1 0.1 0.3 0.3 0.3 0.1 0.2 0.2 0.1 0.2 0.1 0.5 0.0 0.6 1.5 0.2 0.2 0.3 0.3 0.4 0.2 0.2 0.5 0.3 0.4 0.3 0.7 0.5 0.4 0.0 1.1 1.3 6.0 2.5 1.8 4.5 2.8 0.6 3.2 3.7 2.5 4.3 3.2 0.0 0.0 37.3 2.3 5.3 0.0 0.8 86.2 3.8 3.1 3.1 1.2 133.3 0.6 0.2 55.1 4.6 11.7 5.7 0.0 21.6 5.3 3.8 22.2 0.0 0.4 7.8 6.1 8.8 2.7 60.9 2.1 7.6 0.0 0.0 2.3 0.1 1.0 0.5 1.2 0.2 0.3 0.7 22.9 1.5 1.3 2.6 2.8 1.0 6.6 0.6 3.8 100.9 23.3 14.1 1.4 4.5 5.2 1.6 15.6 3.0 HNF1A "HNF1, LFB1, MODY3, TCF1" ENSG00000135100 "HNF1 homeobox A" 12 120978543-121002512 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 15.4;kidney: 16.7;liver: 34.7;pancreas: 9.5" "Cell type enhanced" "Detected in some" "Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8" "Group enriched" "Detected in many" 4 "colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010430, HPA035231" Enhanced Supported Nucleoplasm NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "CAB010430: AB_2116746, HPA035231: AB_2674528" "unprognostic (5.92e-3)" "unprognostic (8.47e-2)" "unprognostic (4.12e-3)" "unprognostic (6.18e-3)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (9.18e-2)" "unprognostic (9.18e-2)" "unprognostic (2.99e-1)" "unprognostic (2.01e-1)" "unprognostic (9.77e-3)" "unprognostic (5.21e-2)" "unprognostic (6.25e-3)" "unprognostic (5.55e-2)" "unprognostic (2.48e-1)" "unprognostic (6.93e-3)" 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.2 0.0 5.5 15.4 0.2 0.0 0.1 1.1 0.8 0.0 0.1 0.1 16.7 34.7 0.0 0.0 0.1 0.1 0.0 9.5 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.2 14.3 0.1 0.0 0.0 4.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 29.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.6 0.2 0.0 1.2 4.3 0.0 1.8 0.0 0.1 0.4 14.5 0.0 2.6 0.0 1.3 0.2 0.3 4.8 0.0 0.2 5.3 0.1 0.2 4.6 0.5 0.0 0.1 0.4 15.8 0.1 0.0 0.2 9.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.7 0.5 0.0 0.5 0.0 3.9 14.8 0.0 0.1 0.5 33.4 16.0 0.0 0.3 0.0 0.8 0.3 0.1 0.3 0.0 0.3 0.0 0.5 0.0 10.8 0.4 HNF4A "HNF4, MODY, MODY1, NR2A1, TCF14" ENSG00000101076 "Hepatocyte nuclear factor 4 alpha" P41235 20 44355700-44434596 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 102.4;kidney: 43.3;liver: 117.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 48.2;liver cancer: 38.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004712, CAB019417" Enhanced Supported Nucleoplasm NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "CAB019417: AB_2295208, HPA004712: AB_1079075" "unprognostic (2.47e-1)" "unprognostic (3.08e-1)" "unprognostic (2.34e-1)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-2)" "unprognostic (4.79e-3)" "unprognostic (2.59e-2)" "unprognostic (3.77e-2)" "unprognostic (2.45e-2)" "unprognostic (1.05e-1)" "unprognostic (2.75e-2)" "unprognostic (8.40e-3)" "unprognostic (2.12e-1)" "unprognostic (2.70e-2)" 0.2 0.1 0.1 5.9 0.2 0.1 0.1 0.2 0.2 0.0 8.4 58.6 102.4 0.1 0.0 0.1 1.0 5.9 0.0 0.4 0.0 43.3 117.1 0.1 0.1 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 44.1 0.1 0.0 0.1 0.2 0.0 82.6 1.8 0.0 0.0 22.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 154.4 6.0 0.1 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 114.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 42.2 0.0 0.0 0.1 0.7 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 35.8 0.0 12.9 0.0 0.0 0.0 232.6 15.6 7.8 4.0 2.5 0.1 0.4 35.9 2.7 0.5 22.1 0.0 0.1 38.2 0.1 4.5 0.0 3.6 186.8 0.0 0.0 0.3 69.8 0.0 5.3 0.0 18.7 0.3 1.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 21.0 120.0 0.4 0.1 0.3 153.9 170.1 0.0 0.0 0.0 0.6 0.2 0.4 0.0 0.0 0.0 0.0 0.7 0.8 136.1 0.2 HNF4G NR2A2 ENSG00000164749 "Hepatocyte nuclear factor 4 gamma" Q14541 8 75407914-75566834 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 114.6" "Cell type enhanced" "Detected in many" "Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9" "Group enriched" "Detected in many" 5 "colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005438, HPA010610" Enhanced Enhanced "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA005438: AB_1850822, HPA010610: AB_2668318" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.77e-2)" "unprognostic (9.44e-2)" "unprognostic (5.60e-2)" "unprognostic (4.65e-2)" "unprognostic (5.26e-2)" "unprognostic (1.27e-2)" "unprognostic (3.92e-1)" "unprognostic (8.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.83e-2)" "unprognostic (6.93e-3)" "unprognostic (1.67e-2)" "unprognostic (2.11e-1)" "unprognostic (4.22e-2)" "unprognostic (2.47e-2)" 0.2 0.0 0.2 2.5 0.5 0.0 1.0 0.2 0.3 2.3 0.1 20.6 100.5 0.4 1.2 0.3 1.0 12.1 0.0 0.3 0.3 17.4 12.9 0.2 0.1 0.4 0.5 0.0 5.6 0.0 0.0 0.1 0.3 0.6 19.6 0.0 0.4 0.4 0.0 0.0 114.6 0.9 0.4 0.1 8.1 3.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.3 1.1 4.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 16.1 0.0 2.2 0.0 1.8 0.0 2.0 0.0 0.0 0.0 1.8 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.3 10.0 4.8 0.0 0.0 0.3 2.7 0.1 0.3 1.6 0.3 0.1 0.0 0.2 0.2 5.5 0.0 0.3 0.1 0.1 0.0 1.1 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.3 0.3 0.3 0.4 0.5 0.3 0.4 0.3 0.3 0.0 0.0 1.1 39.8 0.5 0.0 0.6 0.4 2.2 0.0 1.3 0.5 0.2 17.2 1.5 3.7 0.0 0.0 0.0 51.0 5.9 3.2 3.1 3.6 0.2 0.0 16.3 0.0 0.5 4.3 0.0 0.1 8.2 3.2 0.0 0.0 0.0 10.7 0.0 0.0 0.6 32.3 2.0 0.0 0.0 5.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 26.2 0.6 5.6 54.3 0.0 0.0 1.6 165.3 18.5 8.1 0.0 0.0 0.1 0.4 4.8 0.0 0.4 0.0 0.0 0.2 0.0 36.9 2.9 HOATZ "C11orf88, FLJ46266" ENSG00000183644 "HOATZ cilia and flagella associated protein" Q6PI97 11 111514785-111537031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "choroid plexus: 32.5;fallopian tube: 88.9;testis: 29.2" "Cell type enriched" "Detected in single" 28 "Cardiomyocytes: 5.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;Karpas-707: 1.7;SuSa: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 8.9" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 2: Karpas-707 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (2.25e-1)" "unprognostic (3.07e-5)" "unprognostic (3.85e-4)" "unprognostic (4.16e-2)" "unprognostic (4.44e-5)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "unprognostic (5.49e-3)" "unprognostic (2.86e-1)" "unprognostic (9.96e-3)" "unprognostic (2.70e-1)" "unprognostic (4.40e-2)" "unprognostic (6.80e-3)" "unprognostic (7.57e-2)" "unprognostic (6.22e-2)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" 0.0 0.0 2.1 0.1 2.2 0.1 0.0 1.0 0.5 6.9 32.5 0.0 0.2 3.1 0.4 0.0 88.9 0.2 0.0 2.2 2.7 0.0 0.0 11.6 0.1 9.7 12.4 0.1 0.0 0.0 0.4 0.3 7.6 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.0 6.7 0.2 0.1 29.2 2.1 0.1 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.2 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 2.1 2.2 1.0 0.5 2.2 2.7 9.7 12.4 7.6 6.7 2.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HOOK1 HK1 ENSG00000134709 "Hook microtubule tethering protein 1" Q9UJC3 1 59814786-59876322 "Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 52.8" "Group enriched" "Detected in many" 5 "Early spermatids: 611.0;Late spermatids: 942.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 6.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 35.4;OE19: 24.4;RPTEC TERT1: 32.9;SK-BR-3: 32.1" "Low region specificity" "Detected in all" "HPA018537, HPA018820" Enhanced NA NA "Cluster 32: T-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 25: RPMI-8226 - Immune response" "Cluster 34: Spermatids - Unknown function" "HPA018537: AB_1850907, HPA018820: AB_1850910" "unprognostic (9.82e-3)" "unprognostic (4.29e-1)" "prognostic favorable (4.53e-6)" "unprognostic (4.26e-2)" "unprognostic (3.42e-1)" "prognostic favorable (4.42e-4)" "unprognostic (1.79e-1)" "unprognostic (5.55e-2)" "unprognostic (3.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-1)" "unprognostic (3.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.49e-2)" "unprognostic (1.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.23e-1)" 0.9 5.4 3.6 3.3 4.3 3.6 11.3 6.8 5.2 4.7 6.1 15.4 12.0 2.0 5.7 13.4 6.9 3.8 2.2 4.3 2.0 16.0 30.9 3.7 2.8 0.6 1.3 0.5 18.4 28.0 8.6 2.3 0.7 6.2 13.5 52.8 17.8 4.9 0.2 11.0 15.9 0.5 0.3 1.4 10.5 16.5 2.7 2.3 13.7 0.0 4.7 3.3 5.5 2.7 17.0 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 14.4 0.1 35.4 0.0 0.1 9.5 3.6 7.3 0.0 0.5 16.0 0.3 4.8 17.7 0.0 0.1 3.7 0.0 15.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 7.1 0.0 0.0 13.6 24.4 6.5 0.0 0.0 18.5 32.9 17.3 13.6 5.6 0.2 32.1 0.4 13.8 19.1 0.3 0.0 0.0 0.1 0.0 0.0 21.9 17.4 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 1.7 1.1 1.8 0.4 0.0 2.2 6.6 2.0 0.0 1.8 0.0 0.0 0.3 0.7 3.6 4.3 6.8 5.2 4.3 2.0 0.6 1.3 0.7 0.3 2.7 2.7 0.2 16.0 29.9 3.9 10.4 39.6 18.1 17.0 51.8 134.4 30.9 16.8 19.0 32.9 51.3 20.2 79.2 21.9 4.6 42.5 31.3 28.2 611.0 46.9 6.7 1.7 36.5 5.9 51.5 34.4 3.0 5.4 25.5 93.6 0.0 10.0 1.1 56.1 1.6 79.1 46.2 36.0 22.4 0.6 1.8 942.1 5.0 1.9 16.0 4.7 0.7 154.4 1.0 2.0 2.6 18.7 41.0 3.4 14.0 24.7 52.7 59.9 50.4 100.3 0.0 2.5 2.2 33.2 9.3 45.4 49.7 35.8 6.8 0.0 51.0 19.7 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54033050-54035361 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.6;fallopian tube: 4.1" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.2;Fibroblasts: 2.6;Granulosa cells: 2.5;Leydig cells: 2.5;Peritubular cells: 2.6;Skeletal myocytes: 2.6;Smooth muscle cells: 2.5;Spermatocytes: 3.2;Squamous epithelial cells: 2.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Group enriched" "Detected in many" 15 "medulla oblongata: 3.4;pons: 3.6;spinal cord: 1.9;white matter: 1.2" "Immune cell enhanced" "Detected in single" "gdT-cell: 3.0" "Lineage enriched" "Detected in single" 31 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "AN3-CA: 7.1;ASC TERT1: 4.8;HSkMC: 4.5;SH-SY5Y: 7.6" "Region enriched" "Detected in single" 46 "pons and medulla: 4.6" "Group enriched" "Detected in some" 5 "medulla oblongata: 1.5;spinal cord: 2.1" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.0 0.9 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 2.7 0.9 4.1 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.2 3.4 0.1 2.6 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 0.0 0.2 1.2 1.1 0.7 1.5 1.9 0.0 2.1 1.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 1.2 0.8 1.9 0.0 7.1 4.0 4.8 0.0 0.4 0.3 0.8 0.6 3.0 0.4 0.0 0.5 2.1 0.0 1.1 0.1 0.0 0.3 2.4 2.4 0.0 1.0 0.1 0.1 0.0 0.1 4.5 0.4 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 7.6 0.5 0.2 3.9 0.9 1.4 0.0 0.0 1.2 0.7 2.6 0.2 0.0 0.0 0.0 0.1 0.1 2.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 3.6 1.9 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.2 0.0 0.3 0.9 0.1 0.0 0.0 1.8 0.0 0.1 0.8 0.0 1.9 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 2.6 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.6 2.5 3.2 1.0 2.2 0.9 0.3 0.1 1.0 0.1 0.0 HPCAL1 "BDR1, HLP2, VILIP-3" ENSG00000115756 "Hippocalcin like 1" P37235 2 10302889-10427617 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 182.4" "Cell type enhanced" "Detected in all" "Horizontal cells: 228.8;Intestinal goblet cells: 308.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 310.6;HDLM-2: 324.5;PC-3: 354.2;U-87 MG: 334.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043245 Supported NA NA 92000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA043245: AB_2678385" "unprognostic (3.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (4.11e-5)" "unprognostic (2.73e-1)" "unprognostic (6.76e-3)" "unprognostic (5.26e-2)" "unprognostic (7.36e-3)" "unprognostic (4.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (4.06e-1)" "unprognostic (3.64e-2)" "unprognostic (1.04e-1)" "unprognostic (2.55e-1)" 47.1 62.1 123.2 24.1 140.0 14.4 31.4 182.4 146.9 42.8 54.3 43.2 35.2 90.4 9.3 16.9 40.3 15.1 49.6 114.1 132.2 71.4 62.5 102.3 27.7 129.9 114.8 15.5 52.6 8.5 65.0 22.1 138.2 21.9 21.3 21.2 20.4 9.0 27.3 18.8 63.7 28.1 84.0 47.3 73.3 46.8 123.8 16.6 33.1 15.1 17.3 20.9 23.0 81.1 51.8 88.6 6.2 25.5 13.8 35.4 59.8 41.0 110.5 58.3 63.6 31.4 128.5 20.1 47.3 30.6 310.6 18.9 16.7 56.8 26.1 324.5 30.1 44.8 94.8 69.2 61.4 27.8 86.5 19.3 25.9 139.1 43.1 207.3 77.7 30.5 41.8 129.1 105.5 70.5 23.2 168.4 32.5 43.2 354.2 29.5 24.3 88.8 85.0 14.8 22.8 152.5 43.0 51.6 102.7 21.6 16.2 72.5 94.2 72.8 22.4 77.7 69.8 38.5 44.7 10.5 334.9 67.4 174.0 24.5 50.9 61.9 21.6 39.9 23.6 26.7 38.9 27.4 43.5 21.3 46.3 30.7 70.0 24.5 36.3 15.7 36.0 29.5 123.2 140.0 182.4 146.9 114.1 132.2 129.9 114.8 138.2 84.0 123.8 81.1 88.6 83.3 86.8 9.4 48.2 33.8 23.4 4.3 11.4 76.9 19.9 12.4 15.9 30.0 16.9 18.4 16.7 4.9 30.1 39.7 93.9 48.6 25.7 10.3 15.1 72.2 62.6 18.7 23.5 37.1 145.6 22.9 53.0 10.8 55.2 26.3 81.8 32.7 67.6 228.8 23.3 308.8 4.1 79.2 77.9 19.2 17.1 65.1 56.9 31.9 43.9 51.7 46.4 12.5 10.3 46.1 64.5 10.9 45.5 14.8 111.7 100.3 6.8 33.6 6.6 18.2 14.5 20.8 14.9 15.6 30.1 41.3 45.0 6.2 44.8 19.2 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 18.7" "Group enriched" "Detected in many" 18 "granulocytes: 1056.2;Hofbauer cells: 631.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 28 "basophil: 18.1" "Lineage enriched" "Detected in single" 28 "granulocytes: 18.1" "Group enriched" "Detected in some" 8 "HEL: 46.2;HMC-1: 13.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 250000 "Cluster 46: Basophils - DNA binding" "Cluster 19: Lung - Lung function" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 3.4 1.9 2.2 1.1 2.1 1.1 4.0 2.3 3.1 3.5 2.1 5.1 5.8 2.4 2.3 2.9 1.4 6.9 1.8 2.3 2.3 1.5 0.8 9.4 0.6 2.7 2.6 0.5 0.5 0.8 0.4 18.7 2.9 2.6 5.3 0.1 1.5 1.3 0.5 3.3 5.6 3.3 2.6 0.3 2.8 0.7 3.1 2.0 0.3 1.7 0.9 4.8 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 3.5 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.1 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.2 2.1 2.3 3.1 2.3 2.3 2.7 2.6 2.9 2.6 3.1 3.5 0.3 12.8 44.7 1.0 0.2 4.1 0.8 0.0 0.6 0.0 0.2 0.8 0.3 0.0 3.7 0.0 0.0 3.6 0.7 0.5 0.0 0.5 0.1 0.2 0.0 2.0 7.1 12.2 0.8 0.0 3.0 3.0 3.6 0.0 1056.2 0.0 0.0 0.0 631.9 0.0 0.6 0.0 0.0 11.4 13.1 0.0 0.3 16.3 3.6 32.8 0.1 0.0 0.0 0.0 0.5 0.1 1.2 0.4 2.1 3.9 0.0 0.0 1.5 0.1 0.0 0.6 0.4 0.0 0.1 0.0 5.4 5.5 20.5 0.3 0.9 0.2 HRH2 ENSG00000113749 "Histamine receptor H2" P25021 5 175658030-175710756 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.0;heart muscle: 26.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 26.2;Excitatory neurons: 62.2;Inhibitory neurons: 19.1;Kupffer cells: 29.4;Macrophages: 36.2;monocytes: 24.3;Smooth muscle cells: 33.6" "Group enriched" "Detected in many" 5 "melanoma: 2.9;renal cancer: 4.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 134.4;neutrophil: 161.7" "Group enriched" "Detected in many" 5 "granulocytes: 161.7;monocytes: 51.6" "Group enriched" "Detected in some" 4 "RPMI-8226: 65.6;SK-MEL-30: 19.2;THP-1: 18.0;U-937: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013770 Approved NA NA "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 25: RPMI-8226 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA013770: AB_1851086" "unprognostic (8.56e-3)" "unprognostic (1.62e-1)" "unprognostic (6.66e-2)" "unprognostic (5.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (9.93e-2)" "unprognostic (5.76e-2)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (3.71e-3)" "unprognostic (2.01e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-3)" "unprognostic (1.77e-2)" 7.6 1.5 4.5 12.0 14.4 37.0 3.0 1.1 9.6 5.1 0.5 1.4 6.2 2.2 0.9 1.4 2.9 2.5 26.3 5.3 1.4 2.3 1.0 7.2 3.8 1.2 1.6 1.1 1.5 1.3 0.8 10.2 1.1 4.7 1.1 0.3 1.4 4.6 0.8 2.2 6.4 3.6 1.7 18.0 19.5 0.5 3.9 8.5 1.5 1.5 3.1 4.1 2.0 5.1 0.0 1.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 5.0 2.9 0.0 0.0 7.1 0.0 65.6 0.0 0.3 0.5 0.0 0.0 0.0 19.2 1.7 0.1 18.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.6 4.3 134.4 45.8 52.8 0.2 44.9 0.3 0.0 3.8 1.0 23.5 0.1 7.9 4.8 161.7 2.1 51.6 18.3 3.3 15.3 4.5 14.4 1.1 9.6 5.3 1.4 1.2 1.6 1.1 1.7 3.9 5.1 1.1 0.0 2.5 1.0 1.0 0.8 0.1 0.0 0.6 9.3 3.7 0.9 26.2 0.0 2.5 0.0 0.0 0.1 8.4 0.0 0.0 0.0 0.6 0.1 0.8 1.9 0.0 3.0 62.2 2.4 0.2 3.3 7.1 0.1 2.5 3.0 0.0 0.2 11.8 1.7 19.1 0.6 0.0 29.4 8.5 1.0 0.0 36.2 0.0 10.3 24.3 0.1 0.0 1.5 1.7 0.3 0.0 0.4 0.3 0.2 0.6 0.3 0.7 0.2 0.0 0.1 33.6 0.2 0.9 0.1 0.3 0.0 4.7 0.1 0.5 0.0 HRK DP5 ENSG00000135116 "Harakiri, BCL2 interacting protein" O00198 12 116856144-116881441 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.4;choroid plexus: 4.5" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 14.6;Early spermatids: 11.3;Endometrial ciliated cells: 10.3;Enteroendocrine cells: 11.3;Excitatory neurons: 9.5;Paneth cells: 10.1" "Cancer enhanced" "Detected in many" "melanoma: 2.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 30 "eosinophil: 1.3;memory B-cell: 3.6;naive B-cell: 3.9" "Group enriched" "Detected in many" 27 "B-cells: 3.9;granulocytes: 1.3" "Cell line enhanced" "Detected in some" "Daudi: 11.1;SCLC-21H: 9.1;SH-SY5Y: 7.8;SK-MEL-30: 22.0;U-698: 37.0" "Low region specificity" "Detected in all" CAB025973 Uncertain NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 65: Brain - Ion transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "CAB025973: " "unprognostic (9.38e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-3)" "unprognostic (2.54e-1)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.67e-2)" "unprognostic (1.10e-1)" "unprognostic (8.44e-3)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (7.24e-3)" "unprognostic (5.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.66e-1)" "unprognostic (9.42e-2)" 0.2 0.7 4.5 0.4 6.1 0.7 0.1 0.6 7.4 0.0 4.5 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.1 14.4 3.4 0.1 0.0 0.1 0.8 1.5 2.1 0.0 0.0 0.0 2.8 0.0 1.1 0.0 0.1 0.3 0.2 0.0 0.5 0.2 0.1 0.0 1.3 0.2 0.0 0.5 3.9 3.5 3.8 0.0 0.7 0.0 0.0 2.8 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 11.1 0.4 0.0 0.2 4.5 2.4 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 0.0 2.1 0.1 0.0 0.0 0.1 0.5 0.0 1.0 0.0 0.1 1.0 0.0 1.5 0.1 0.0 9.1 7.8 0.5 0.0 22.0 0.4 0.6 0.2 0.0 0.0 1.8 0.2 0.0 1.0 0.5 37.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 6.1 0.6 7.4 14.4 3.4 1.5 2.1 1.1 1.3 3.9 2.8 1.1 0.0 0.0 0.0 7.0 0.1 0.1 0.1 0.0 4.5 3.2 3.0 2.4 0.0 0.8 0.0 14.6 0.1 0.1 2.2 0.0 0.1 11.3 10.3 0.1 1.4 11.3 0.0 9.5 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.4 4.5 0.0 0.2 3.6 5.6 0.6 0.2 0.0 6.6 0.3 0.0 10.1 0.0 1.1 0.3 0.0 0.2 6.6 0.6 0.0 0.1 0.7 0.4 3.0 0.7 0.0 0.1 0.3 0.0 1.0 0.1 HROB "C17orf53, MCM8IP, MGC3130" ENSG00000125319 "Homologous recombination factor with OB-fold" Q8N3J3 17 44141906-44162476 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA synthesis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.3;testis: 11.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.3;Cytotrophoblasts: 3.4;Extravillous trophoblasts: 8.6;Hofbauer cells: 2.9;Syncytiotrophoblasts: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023004, HPA023393, HPA024430" Uncertain Approved Nucleoplasm,Cytosol NA Yes "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoplasm, Cytosol" "HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879" "unprognostic (1.72e-1)" "unprognostic (5.95e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.59e-1)" "unprognostic (7.37e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (9.39e-4)" "unprognostic (1.90e-1)" "unprognostic (2.89e-1)" "unprognostic (3.66e-4)" "unprognostic (2.86e-1)" "unprognostic (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (5.88e-2)" "unprognostic (3.65e-2)" "unprognostic (8.40e-2)" 1.5 0.4 0.1 1.1 0.1 9.3 1.4 0.4 0.3 0.9 0.0 0.9 0.9 0.8 0.1 2.7 0.5 0.2 0.7 0.1 0.2 0.4 0.6 0.6 1.6 0.3 0.2 0.8 0.3 0.4 0.4 0.9 0.3 0.7 1.0 0.3 0.7 0.3 0.9 1.7 0.9 0.7 0.1 1.3 0.6 11.4 0.2 2.3 0.3 0.2 1.9 0.6 1.2 0.3 8.9 11.1 8.3 7.6 0.6 2.3 9.8 6.7 5.9 12.8 13.9 11.3 5.4 9.4 5.8 5.8 13.3 7.5 10.9 10.5 11.1 10.6 14.0 6.0 10.1 7.7 0.3 6.6 7.3 1.9 1.6 15.7 7.7 1.5 5.3 10.2 13.8 11.6 6.2 6.7 15.7 10.2 5.6 4.0 10.8 10.0 13.2 11.6 3.0 7.0 5.1 2.9 4.1 4.0 3.4 9.4 8.1 7.7 2.4 12.1 9.5 8.3 9.9 6.7 12.2 8.0 5.7 5.1 7.1 0.0 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.9 0.4 0.1 0.1 0.1 0.4 0.3 0.1 0.2 0.3 0.2 0.3 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 HS3ST6 HS3ST5 ENSG00000162040 "Heparan sulfate-glucosamine 3-sulfotransferase 6" Q96QI5 16 1911475-1918415 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 75.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 10.7;Horizontal cells: 21.9;Suprabasal keratinocytes: 9.1;Urothelial cells: 24.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (5.72e-2)" "prognostic favorable (3.73e-4)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-1)" "unprognostic (4.99e-3)" "unprognostic (2.10e-2)" "unprognostic (6.55e-3)" "unprognostic (2.42e-1)" "unprognostic (3.61e-1)" "unprognostic (2.26e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.5 0.0 0.0 0.0 14.4 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.0 1.4 0.0 0.0 1.9 0.0 0.3 75.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 4.1 10.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 3.4 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.7 1.8 0.0 0.2 0.0 6.3 0.0 0.0 4.5 10.7 0.5 0.1 0.0 0.0 0.1 0.0 0.4 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 21.9 0.1 0.9 4.1 0.0 1.5 1.4 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 0.0 2.7 0.2 0.2 5.0 0.2 0.0 0.0 0.3 0.0 0.0 4.5 9.1 0.1 0.1 0.0 1.7 24.9 HSPB7 cvHSP ENSG00000173641 "Heat shock protein family B (small) member 7" Q9UBY9 1 16014028-16019594 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 4135.3;skeletal muscle: 2417.8;tongue: 1229.5" "Cell type enriched" "Detected in some" 32 "Cardiomyocytes: 2389.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "fHDF/TERT166: 315.1" "Not detected" "Not detected" HPA027639 Approved Approved Nucleoplasm NA NA 130000 "Cluster 38: Heart - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA027639: AB_10601756" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.28e-3)" "unprognostic (7.44e-3)" "unprognostic (8.35e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (1.02e-1)" "unprognostic (5.32e-2)" "unprognostic (2.47e-3)" "unprognostic (3.19e-3)" "unprognostic (6.94e-2)" "unprognostic (1.55e-1)" "unprognostic (1.20e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (1.26e-4)" 306.8 123.4 3.9 32.1 4.4 0.2 119.7 8.8 5.1 49.6 8.6 138.3 5.1 179.5 7.5 44.2 64.8 18.7 4135.3 4.1 5.6 38.5 3.2 22.1 1.7 13.1 7.9 25.4 9.2 38.8 5.3 7.1 12.0 43.0 8.0 3.1 35.1 24.4 2417.8 19.3 34.0 189.2 5.3 4.5 71.4 20.2 4.7 0.6 14.1 1229.5 0.7 99.2 30.5 6.7 0.0 0.0 0.0 1.5 70.7 3.2 1.8 18.4 1.1 0.0 0.2 0.0 0.1 0.0 0.0 315.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 3.4 0.0 0.0 2.1 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 4.3 0.0 0.0 0.6 0.1 0.1 0.0 0.1 5.3 3.3 0.0 0.0 0.0 1.3 0.0 11.8 0.0 1.3 0.1 1.1 0.0 14.1 0.6 1.9 0.0 10.3 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 4.4 8.8 5.1 4.1 5.6 13.1 7.9 12.0 5.3 4.7 6.7 0.5 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.8 0.2 0.4 2389.7 0.0 0.0 3.7 0.0 2.8 0.0 0.0 13.7 1.4 55.5 0.1 0.7 26.6 0.0 0.0 0.0 0.2 1.4 46.3 0.0 0.1 0.0 0.4 0.0 0.0 1.6 1.7 0.1 0.0 0.0 0.0 4.6 74.2 14.3 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.5 0.0 0.2 0.0 0.6 0.0 20.2 42.6 1.9 0.9 0.1 2.6 3.3 0.5 3.0 0.0 0.1 HYDIN "CILD5, DKFZp434D0513, KIAA1864, PPP1R31" ENSG00000157423 "HYDIN axonemal central pair apparatus protein" Q4G0P3 16 70802084-71230722 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.9;choroid plexus: 23.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 150.6;Excitatory neurons: 49.2;Respiratory ciliated cells: 153.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.8;RPTEC TERT1: 2.8;SiHa: 5.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA067155, HPA074129" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA067155: AB_2685792, HPA074129: AB_2686665" "unprognostic (8.90e-2)" "unprognostic (1.04e-2)" "unprognostic (8.65e-2)" "unprognostic (4.88e-4)" "unprognostic (4.25e-3)" "unprognostic (1.81e-1)" "unprognostic (3.87e-2)" "unprognostic (2.45e-1)" "unprognostic (3.95e-1)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (2.52e-5)" "unprognostic (2.13e-3)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (3.97e-2)" 0.3 0.3 2.2 0.3 3.2 0.5 0.5 1.2 1.4 1.2 23.9 0.6 0.2 0.9 2.0 0.1 5.3 0.5 0.5 3.4 3.5 1.3 0.5 1.4 0.3 8.9 9.9 1.1 0.7 2.5 4.4 0.1 5.8 0.8 0.1 6.4 0.3 0.3 0.1 0.5 0.2 0.1 8.0 0.4 0.2 4.7 4.3 0.0 1.9 0.0 0.0 0.5 0.4 4.4 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.2 0.1 1.8 0.3 0.1 0.1 0.6 0.2 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.4 0.0 1.1 0.2 0.0 0.0 0.0 0.4 0.4 0.7 0.0 0.4 0.1 0.1 0.4 2.8 0.4 1.1 0.2 5.3 0.1 0.2 0.1 0.3 0.0 0.2 0.1 0.4 0.0 0.1 0.9 0.0 0.5 0.4 0.1 0.3 0.5 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.7 0.1 0.3 0.2 0.1 0.0 2.2 3.2 1.2 1.4 3.4 3.5 8.9 9.9 5.8 8.0 4.3 4.4 0.1 3.2 2.6 35.3 0.0 0.0 0.2 2.6 0.0 17.0 1.5 1.1 2.5 0.0 18.3 9.2 52.1 0.0 0.4 0.0 1.9 2.5 35.4 150.6 6.5 0.7 3.5 0.0 49.2 0.6 0.0 1.4 0.0 4.0 0.0 5.0 0.0 0.0 0.1 0.0 25.9 0.1 4.1 0.0 0.0 31.5 2.5 0.3 3.6 3.7 0.0 9.3 0.0 26.2 21.8 0.3 0.1 4.5 0.1 0.6 0.0 1.8 153.2 30.5 0.0 2.0 1.7 17.7 7.5 0.0 0.0 0.0 0.5 1.6 0.1 0.2 IFT172 "BBS20, NPHP17, osm-1, SLB, wim" ENSG00000138002 "Intraflagellar transport 172" Q9UG01 2 27444377-27489805 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 439.9;Late spermatids: 703.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044893 Uncertain NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 34: Spermatids - Unknown function" "HPA044893: AB_10795009" "unprognostic (1.05e-3)" "unprognostic (6.52e-2)" "unprognostic (7.04e-2)" "unprognostic (3.57e-3)" "unprognostic (1.95e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.05e-6)" "unprognostic (6.86e-3)" "unprognostic (1.45e-1)" "unprognostic (8.49e-2)" "unprognostic (1.08e-1)" "unprognostic (1.51e-2)" "unprognostic (4.32e-2)" "unprognostic (9.52e-2)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (5.47e-2)" 3.1 3.3 2.2 2.5 2.6 1.8 4.0 2.5 2.4 5.2 11.8 4.6 1.8 4.5 1.6 2.4 17.0 3.2 4.3 2.3 2.8 4.5 1.5 4.9 2.0 3.6 3.6 8.9 4.8 13.0 9.9 2.4 3.5 3.6 2.1 5.7 4.2 4.2 3.6 2.9 2.7 3.8 2.4 3.9 3.5 12.5 2.4 2.7 5.9 3.9 2.1 3.6 3.4 3.7 5.8 5.3 7.1 10.0 12.6 10.6 4.5 5.5 4.0 6.5 5.5 4.8 4.6 6.3 8.3 7.3 3.9 6.4 13.4 6.7 6.2 3.1 9.4 16.1 9.4 5.6 7.3 7.8 3.4 8.6 3.0 10.3 3.8 9.0 10.8 7.3 5.3 2.2 2.4 4.5 4.4 3.8 5.0 4.6 5.5 0.0 3.7 3.5 5.0 3.7 5.5 8.8 2.8 4.8 9.7 6.0 4.8 4.6 11.6 2.9 1.7 3.7 8.3 2.8 1.7 6.7 11.9 2.3 5.7 0.0 0.4 0.3 0.4 0.6 0.3 0.7 0.2 0.4 0.9 0.5 0.3 0.3 0.0 0.9 0.1 0.4 0.2 0.4 2.2 2.6 2.5 2.4 2.3 2.8 3.6 3.6 3.5 2.4 2.4 3.7 5.2 3.2 9.4 53.5 3.1 2.0 16.6 35.3 8.6 15.4 17.2 12.1 6.3 38.6 32.7 23.9 52.1 1.0 1.7 82.4 0.0 34.4 439.9 59.0 7.1 4.5 34.7 7.6 63.2 98.7 0.6 5.9 23.9 14.2 0.0 11.0 5.7 1.2 1.7 5.0 64.3 96.4 57.0 3.2 1.6 703.6 12.8 2.8 5.4 11.2 1.9 7.1 5.2 24.6 44.9 104.9 106.3 10.9 2.4 7.5 142.0 2.3 154.6 41.7 0.0 11.7 8.5 22.6 6.6 10.1 1.4 0.4 2.8 10.1 75.1 39.8 IFT22 "DKFZp761N0823, FAP9, FLJ13225, FLJ14117, RABL5" ENSG00000128581 "Intraflagellar transport 22" Q9H7X7 7 101310914-101321823 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 577.5;Late spermatids: 1478.7;Spermatocytes: 357.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 92.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042930 Approved Approved Microtubules,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "Microtubules, Cytosol" "HPA042930: AB_10794537" "unprognostic (1.55e-2)" "unprognostic (7.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (6.70e-3)" "unprognostic (1.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (9.99e-2)" "unprognostic (1.73e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-2)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" 12.4 22.1 20.2 3.7 21.4 2.8 14.3 19.1 25.7 18.6 27.2 22.1 2.8 21.1 22.9 8.5 27.8 12.1 24.0 21.4 21.7 35.5 7.8 13.1 4.0 20.0 21.1 19.5 18.4 29.9 31.1 2.8 20.2 18.0 3.4 41.4 14.7 6.4 26.3 10.1 7.5 5.8 20.7 4.7 14.9 76.4 21.2 10.1 24.4 19.6 3.6 17.2 11.5 19.9 26.1 38.6 20.7 47.9 17.1 14.5 4.6 8.6 4.8 10.6 7.9 15.4 19.3 3.1 22.1 17.8 41.1 16.6 12.2 12.7 8.2 6.2 16.4 0.6 16.4 15.8 12.6 8.7 4.9 14.9 10.9 25.2 5.9 36.5 10.4 18.2 11.2 3.4 12.6 92.5 15.6 16.3 21.6 19.5 17.4 14.4 13.1 5.3 20.1 15.8 22.3 37.0 25.3 21.0 13.7 33.5 16.3 6.6 10.6 33.1 24.6 64.0 18.0 3.1 10.3 7.5 21.7 2.5 17.3 1.4 0.8 0.9 4.0 1.7 3.8 7.5 4.8 3.6 1.6 5.9 4.3 4.4 1.1 5.8 3.3 4.7 2.0 2.3 20.2 21.4 19.1 25.7 21.4 21.7 20.0 21.1 20.2 20.7 21.2 19.9 12.0 25.6 14.3 6.5 11.9 0.0 25.1 0.0 22.2 26.6 35.5 54.4 42.9 55.8 19.2 49.7 54.2 19.7 2.3 4.0 138.9 73.9 577.5 176.0 32.1 17.0 18.5 17.4 7.2 36.9 17.3 28.3 12.8 28.0 9.5 37.9 21.8 10.7 17.7 32.0 5.3 13.1 0.0 2.7 0.0 1478.7 37.9 6.9 0.0 2.8 2.9 76.2 3.1 3.0 2.4 29.9 13.5 41.3 4.8 17.1 2.9 170.2 102.7 103.9 13.1 21.8 22.6 357.7 71.5 15.0 0.0 6.6 7.3 36.0 8.0 20.4 IFT27 "BBS19, FAP156, RABL4, RAYL" ENSG00000100360 "Intraflagellar transport 27" Q9BW83 22 36758202-36776256 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 257.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "U-138 MG: 159.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048791 Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 17: WM-115 - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "HPA048791: " "unprognostic (3.04e-2)" "unprognostic (7.25e-3)" "unprognostic (7.06e-2)" "prognostic favorable (1.91e-4)" "unprognostic (9.04e-2)" "unprognostic (6.05e-2)" "unprognostic (6.22e-2)" "unprognostic (1.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.75e-3)" "unprognostic (4.85e-3)" "unprognostic (2.10e-1)" "unprognostic (9.62e-3)" "unprognostic (8.08e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-1)" "prognostic favorable (5.55e-4)" 11.6 21.7 24.5 8.5 25.5 8.8 11.5 25.7 27.0 13.5 32.3 19.3 12.3 13.8 19.4 9.7 36.6 9.5 23.9 23.9 24.6 22.3 18.4 11.2 9.8 24.9 28.9 15.1 16.2 23.2 39.6 8.0 26.4 15.2 9.7 15.6 14.6 16.5 15.0 11.6 12.5 8.8 25.8 11.8 16.1 23.2 25.5 9.7 18.1 11.9 9.1 14.9 11.1 25.9 17.8 21.9 25.3 28.8 19.9 19.1 15.1 14.1 18.2 18.3 16.1 0.9 15.9 19.3 24.2 13.2 26.3 16.1 13.9 16.0 14.1 37.1 37.4 5.1 4.3 0.0 36.6 6.2 23.3 15.5 25.6 19.4 8.9 14.8 19.6 15.7 9.1 15.5 12.5 32.6 7.7 5.5 13.5 34.4 28.5 36.4 0.0 10.8 18.3 11.4 24.3 26.4 15.0 11.4 37.8 21.3 25.8 11.0 11.6 159.2 9.3 21.3 2.7 36.2 23.6 7.0 25.1 15.5 35.3 14.5 31.8 36.1 24.6 25.0 24.6 22.8 20.4 23.0 39.2 26.0 19.9 19.0 11.7 23.1 30.0 30.5 29.9 21.1 24.5 25.5 25.7 27.0 23.9 24.6 24.9 28.9 26.4 25.8 25.5 25.9 23.6 6.4 18.4 34.3 18.8 23.3 29.0 50.1 12.5 35.2 29.9 32.1 19.9 20.0 51.6 40.5 29.2 27.2 15.2 19.9 105.7 26.1 66.0 110.5 20.2 23.2 53.3 7.8 8.9 23.0 20.9 27.8 14.3 18.7 33.0 27.6 26.0 18.7 40.7 30.3 12.3 46.9 65.1 13.8 25.0 24.3 27.4 17.8 35.6 5.6 13.2 60.5 21.6 11.6 10.4 19.8 18.3 31.6 29.5 24.7 39.4 57.0 257.2 41.9 13.1 24.2 26.9 78.5 17.9 14.1 33.2 17.5 19.0 21.0 31.6 27.9 IFT46 "C11orf2, C11orf60, CFAP32, FLJ21827" ENSG00000118096 "Intraflagellar transport 46" Q9NQC8 11 118544528-118572970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 64.9;Respiratory ciliated cells: 84.3;Spermatocytes: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037909, HPA057550" Approved Approved "Actin filaments" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" "HPA037909: AB_10672731, HPA057550: AB_2683464" "unprognostic (8.77e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-3)" "unprognostic (6.76e-2)" "unprognostic (1.55e-2)" "unprognostic (1.07e-1)" "unprognostic (3.29e-2)" "unprognostic (3.75e-3)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (3.61e-1)" "unprognostic (9.02e-3)" "unprognostic (1.42e-1)" "unprognostic (2.48e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-1)" 14.7 19.4 29.0 8.8 29.7 5.6 26.8 33.9 35.8 23.1 37.3 18.6 7.7 19.4 24.8 13.7 66.8 16.4 21.3 28.5 32.5 26.9 17.0 15.1 11.0 32.1 37.2 27.2 16.7 18.4 28.9 8.7 31.8 20.9 11.1 35.7 15.9 20.2 17.9 13.5 10.3 20.7 31.5 11.8 15.0 28.1 31.4 16.0 27.5 17.6 12.8 16.0 16.7 32.1 15.6 18.4 26.1 16.9 42.8 35.7 3.2 31.9 46.2 29.3 27.6 22.5 28.8 23.8 46.1 38.6 7.2 22.1 26.7 31.8 34.4 9.1 21.8 49.2 9.0 8.6 32.0 11.8 13.8 32.4 37.0 49.0 46.2 26.6 28.9 32.1 27.4 16.0 37.3 71.7 31.3 15.6 7.7 27.3 38.0 25.6 20.0 19.0 23.5 21.4 16.7 18.3 23.2 29.9 20.1 15.0 46.2 16.7 24.6 31.6 20.2 18.4 12.0 9.9 14.3 26.7 16.0 21.2 23.2 2.8 5.2 5.9 8.6 4.3 9.9 11.1 7.6 7.9 6.9 8.3 9.2 5.5 1.6 11.0 4.2 7.0 9.9 4.8 29.0 29.7 33.9 35.8 28.5 32.5 32.1 37.2 31.8 31.5 31.4 32.1 5.5 9.6 10.3 10.4 4.9 4.0 8.3 14.4 8.0 12.5 11.6 8.4 14.5 10.0 15.4 11.0 18.8 5.3 3.8 1.6 5.9 17.1 20.5 64.9 11.7 9.3 4.2 6.6 8.7 11.6 7.1 9.5 4.1 9.6 12.0 10.2 8.6 5.9 8.8 1.7 8.9 4.3 14.2 2.4 3.5 15.7 10.2 3.1 1.8 5.6 5.5 14.8 2.1 4.0 6.4 10.2 4.2 18.4 6.1 6.1 3.4 14.3 84.3 16.5 0.0 11.3 11.5 44.9 38.4 6.5 7.0 1.9 4.2 9.8 5.3 3.9 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381484-65422947 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3;skeletal muscle: 10.6;tongue: 14.0" "Cell type enhanced" "Detected in many" "Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol NA NA 64000000 "Cluster 80: Striated muscle - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 0.9 2.5 5.6 2.4 6.9 0.0 0.5 5.8 2.5 3.4 0.0 0.8 0.5 1.4 4.2 1.6 1.7 4.2 0.9 2.9 7.2 0.1 0.0 0.2 0.6 11.2 9.4 8.5 0.1 0.3 0.9 5.6 6.8 0.4 0.6 0.8 0.5 0.4 10.6 0.8 0.8 1.0 6.9 0.2 1.1 0.6 11.3 0.7 1.9 14.0 0.6 2.1 2.0 4.5 0.0 4.4 9.4 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.3 0.5 8.1 0.0 4.5 0.3 0.0 0.0 2.3 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 5.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.8 7.2 0.0 0.0 0.0 2.3 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 0.0 3.7 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 6.9 5.8 2.5 2.9 7.2 11.2 9.4 6.8 6.9 11.3 4.5 0.2 0.0 0.0 18.6 0.0 2.3 0.0 0.0 0.0 7.7 0.2 0.5 2.2 0.0 0.0 3.7 31.3 0.4 0.1 0.0 0.0 0.4 0.4 0.0 2.1 0.3 0.0 0.0 0.9 0.0 0.6 14.7 1.1 0.0 0.0 8.8 0.0 0.0 0.7 0.0 6.3 0.0 0.0 0.0 2.5 1.4 34.8 0.3 5.4 14.0 0.0 1.0 1.0 17.6 1.0 0.3 0.0 4.1 0.1 0.1 0.0 0.7 0.0 12.2 6.6 29.8 1.0 0.8 2.6 0.1 1.1 0.8 0.3 7.0 0.0 0.0 IGF1 "IGF, IGF-I, IGF1A, IGFI" ENSG00000017427 "Insulin like growth factor 1" P05019 12 102395874-102481744 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 86.7;cervix: 89.0" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 1279.3;Leydig cells: 1103.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 24 "B-cells: 2.4" "Cell line enhanced" "Detected in some" "ASC diff: 37.9;HDLM-2: 49.6;K-562: 22.4;Karpas-707: 11.3;U-266/70: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048946 Approved "Secreted to blood" NA NA 103000000 330000000 "Cluster 24: B-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 36: Stromal cells - Cell proliferation" "HPA048946: AB_2680566" "unprognostic (1.25e-1)" "unprognostic (2.86e-3)" "unprognostic (1.46e-1)" "prognostic favorable (1.04e-4)" "unprognostic (1.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.59e-3)" "unprognostic (2.26e-1)" "unprognostic (9.98e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.04e-2)" "unprognostic (2.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.55e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-3)" 86.7 5.1 1.2 27.1 1.8 0.9 38.7 0.3 2.3 89.0 1.3 6.9 5.4 46.9 10.6 6.6 13.0 21.5 15.1 2.2 1.0 3.1 83.5 11.6 6.5 2.5 1.1 9.0 3.9 1.4 1.2 24.2 2.0 38.5 6.7 5.4 7.6 33.4 8.5 4.9 5.7 74.3 1.2 9.8 7.7 7.6 2.0 3.1 25.4 5.9 3.7 21.3 22.7 0.9 0.3 0.0 0.0 0.0 37.9 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 49.6 0.0 0.1 0.7 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 22.4 11.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.2 1.7 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.4 1.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.2 1.8 0.3 2.3 2.2 1.0 2.5 1.1 2.0 1.2 2.0 0.9 11.8 3.2 2.2 1.0 8.5 2.5 0.7 0.0 1.8 168.1 4.0 6.2 0.4 2.8 0.7 0.0 0.0 1.1 0.6 0.2 0.0 0.0 17.5 35.8 1279.3 38.9 0.0 5.3 1.2 0.6 1.5 259.7 2.6 34.5 0.0 0.3 6.4 243.0 122.0 0.0 123.9 0.0 16.2 25.8 12.5 58.0 1103.2 42.0 14.2 27.2 3.6 4.4 0.0 0.5 0.9 0.1 0.0 193.4 66.9 1.2 0.0 1.4 0.1 9.0 0.0 139.3 19.6 1.9 1.2 1.6 2.7 1.2 9.1 69.4 0.2 0.4 IGHA1 ENSG00000211895 "Immunoglobulin heavy constant alpha 1" P01876 14 105703995-105708665 "Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 7411.2;lymphoid tissue: 6397.6;salivary gland: 8904.9;stomach 1: 6664.9" "Group enriched" "Detected in many" 10 "B-cells: 17763.5;Plasma cells: 34095.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 203 "memory B-cell: 2571.8;naive B-cell: 1114.6" "Lineage enriched" "Detected in many" 284 "B-cells: 2571.8" "Cell line enhanced" "Detected in many" "HDLM-2: 17.4;RPMI-8226: 34.7;SH-SY5Y: 22.3;U-266/70: 78.2;U-266/84: 24.0" "HPA001217, HPA006013" Approved "Immunoglobulin genes" NA NA 130000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001217: AB_1079120, HPA006013: AB_1079119" "prognostic favorable (8.87e-5)" "unprognostic (5.36e-3)" "unprognostic (2.10e-2)" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "prognostic favorable (3.81e-5)" "unprognostic (1.17e-1)" "unprognostic (3.86e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.83e-7)" "unprognostic (8.10e-2)" "unprognostic (5.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" 200.6 41.7 1.4 1121.1 1.0 918.5 953.5 0.7 6.5 214.3 4.2 5973.6 7411.2 79.9 3.5 641.9 203.5 662.9 73.8 0.6 1.3 278.5 327.7 1305.3 1420.6 3.5 1.1 40.6 115.1 3.5 38.3 6.7 1.1 202.5 1338.5 0.0 8904.9 69.0 10.8 56.7 3788.8 69.5 1.4 6397.6 6664.9 23.2 1.0 131.0 447.3 0.4 1949.0 1616.2 302.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.8 0.0 0.0 3.6 0.0 0.0 0.0 17.4 0.0 3.7 0.0 0.0 0.0 5.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 4.1 14.4 5.5 0.0 0.0 3.8 4.3 34.7 0.0 0.0 9.7 22.3 2.6 0.0 0.0 0.0 0.0 1.6 5.1 0.0 3.9 4.2 3.2 78.2 24.0 2.2 0.0 2.4 0.0 3.8 3.0 0.6 1.3 0.3 1.0 2571.8 0.7 1.1 1.5 1114.6 0.4 1.0 9.0 0.9 0.9 1.7 1.0 508.3 1.4 1.0 0.7 6.5 0.6 1.3 3.5 1.1 1.1 1.4 1.0 1.9 11.8 131.4 783.5 0.0 17763.5 0.0 26.0 0.0 1.2 0.0 22.4 4.6 4.7 22.8 46.4 0.0 0.0 0.7 55.5 20.8 0.0 0.0 0.0 0.1 0.1 26.5 28.4 167.0 0.0 0.0 0.5 56.5 99.4 0.1 584.8 0.0 353.8 225.1 1.6 0.0 0.0 13.6 0.0 57.8 0.0 0.0 0.0 34.6 0.0 0.0 6.7 0.0 11.3 0.0 0.0 0.0 12.8 0.0 34095.8 33.2 0.0 1.4 16.0 0.0 0.0 2.0 13.6 0.0 0.0 0.8 0.0 6.0 2514.2 0.0 27.9 1.2 IGHA2 ENSG00000211890 "Immunoglobulin heavy constant alpha 2 (A2m marker)" P01877 14 105583731-105588395 "Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 5017.7;salivary gland: 3728.4" "Group enriched" "Detected in many" 22 "B-cells: 3713.4;Plasma cells: 10918.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 876 "memory B-cell: 279.6;naive B-cell: 123.8" "Lineage enriched" "Detected in single" 1214 "B-cells: 279.6" "Group enriched" "Detected in some" 42 "U-266/70: 181.9;U-266/84: 63.9" "Not detected" "Not detected" "HPA001217, HPA006013" Approved "Immunoglobulin genes" NA NA 67000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001217: AB_1079120, HPA006013: AB_1079119" "prognostic favorable (1.98e-9)" "unprognostic (3.20e-2)" "unprognostic (2.23e-2)" "unprognostic (1.53e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.40e-5)" "unprognostic (4.56e-2)" "unprognostic (2.59e-1)" "unprognostic (3.17e-1)" "unprognostic (3.69e-2)" "unprognostic (1.20e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.50e-6)" "unprognostic (2.12e-1)" "unprognostic (3.28e-2)" "unprognostic (9.70e-2)" "unprognostic (4.47e-1)" 24.3 3.7 0.0 14.2 0.0 12.4 329.7 0.0 0.0 47.6 0.0 5017.7 15.3 8.9 0.0 219.7 35.0 0.9 4.8 0.0 0.0 49.7 35.1 134.2 6.8 0.0 0.0 5.3 30.3 0.0 4.9 0.3 0.0 37.7 8.8 0.0 3728.4 0.1 2.1 17.8 2261.3 1.0 0.0 700.9 670.1 1.1 0.0 22.4 59.8 0.0 13.0 93.4 67.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.9 181.9 63.9 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 279.6 0.0 0.1 0.1 123.8 0.0 0.1 0.2 0.0 0.1 0.1 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.2 12.4 0.0 3713.4 0.0 2.4 0.0 2.8 0.0 1.4 0.3 1.2 5.7 0.6 0.0 0.0 0.1 3.2 3.7 0.0 0.0 0.0 0.0 0.0 15.6 8.5 56.2 0.0 0.0 0.0 8.0 10.7 0.0 15.2 0.0 78.9 6.0 0.3 0.0 0.0 2.9 0.0 10.8 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 10918.5 0.3 0.0 0.1 0.0 0.0 0.0 0.1 23.6 0.0 0.0 12.3 0.0 0.4 325.4 0.0 4.8 0.2 IGHD "FLJ00382, FLJ46727, MGC29633" ENSG00000211898 "Immunoglobulin heavy constant delta" P01880 14 105836765-105845678 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 330.9" "Group enriched" "Detected in some" 47 "B-cells: 261.8;Plasma cells: 588.1;T-cells: 474.2" "Cancer enhanced" "Detected in many" "lung cancer: 58.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 63 "memory B-cell: 279.1;naive B-cell: 815.9" "Lineage enriched" "Detected in many" 93 "B-cells: 815.9" "Group enriched" "Detected in some" 7 "Daudi: 82.3;U-698: 95.8" CAB012703 Approved "Immunoglobulin genes" NA NA 14000000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "CAB012703: AB_10554307" "prognostic favorable (1.49e-6)" "unprognostic (1.84e-2)" "unprognostic (3.99e-2)" "unprognostic (9.54e-2)" "unprognostic (3.06e-2)" "unprognostic (2.08e-3)" "unprognostic (4.63e-2)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" "unprognostic (6.16e-2)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-3)" "unprognostic (5.76e-2)" "unprognostic (2.64e-1)" "unprognostic (3.82e-3)" "unprognostic (4.30e-2)" 2.8 0.4 0.0 35.4 0.0 39.2 9.3 0.0 0.4 0.9 0.0 2.2 3.4 5.0 0.2 2.8 0.6 19.0 5.7 0.0 0.0 2.1 3.5 34.1 111.6 0.2 0.0 0.3 0.4 0.2 0.0 0.3 0.0 6.4 1.9 0.0 67.1 1.2 0.4 1.5 17.6 0.9 0.0 146.7 43.3 0.3 0.1 8.3 1.3 0.0 330.9 20.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 82.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 12.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 95.8 0.0 0.0 0.0 2.7 0.5 0.3 0.4 0.3 0.2 279.1 0.3 0.8 0.7 815.9 1.0 0.3 3.3 0.3 0.5 8.7 0.4 39.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 261.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.6 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.3 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 9.2 0.0 0.0 0.0 0.0 0.0 588.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 474.2 0.0 0.0 0.0 IGHD2-15 "D2, IGHD215" ENSG00000211918 "Immunoglobulin heavy diversity 2-15" 14 105897957-105897987 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 2.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "naive B-cell: 39.9" "Lineage enriched" "Detected in single" 400 "B-cells: 39.9" "Cell line enriched" "Detected in single" 28 "HEL: 2.7" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 36: HEL - Hemostasis" 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-10 "DXP'1, IGHD310" ENSG00000211923 "Immunoglobulin heavy diversity 3-10" 14 105904497-105904527 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "bone marrow: 1.3;intestine: 3.7;lymphoid tissue: 4.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "cervical cancer: 5.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 7 "naive B-cell: 5.4" "Lineage enriched" "Detected in single" 55 "B-cells: 5.4" "Cell line enriched" "Detected in single" 12 "NB-4: 1.1" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-22 IGHD322 ENSG00000211911 "Immunoglobulin heavy diversity 3-22" 14 105886031-105886061 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.6;lymphoid tissue: 2.7;stomach 1: 3.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 48.9" "Lineage enriched" "Detected in many" 7 "B-cells: 48.9" "Cell line enriched" "Detected in single" 13 "SH-SY5Y: 1.3" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "unprognostic (4.12e-1)" "unprognostic (1.53e-1)" 0.0 0.0 0.1 0.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.2 3.1 0.0 0.0 0.7 0.0 0.0 2.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 48.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-3 "DXP4, IGHD33" ENSG00000211930 "Immunoglobulin heavy diversity 3-3" 14 105914359-105914389 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;lymphoid tissue: 2.6;salivary gland: 3.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 62.6" "Lineage enriched" "Detected in single" 626 "B-cells: 62.6" "Group enriched" "Detected in some" 48 "NB-4: 6.9;SH-SY5Y: 2.6" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.13e-1)" "unprognostic (1.75e-1)" 0.0 0.0 0.0 0.9 0.1 4.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.0 0.0 0.0 1.9 1.6 0.1 0.0 0.1 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 62.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHG1 ENSG00000211896 "Immunoglobulin heavy constant gamma 1 (G1m marker)" P01857 14 105736343-105743071 "Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11451.9;urinary bladder: 3998.0" "Group enriched" "Detected in many" 16 "B-cells: 3900.5;Plasma cells: 9883.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 12.7" "Immune cell enriched" "Detected in some" 6 "memory B-cell: 766.8" "Lineage enriched" "Detected in many" 123 "B-cells: 766.8" "Group enriched" "Detected in many" 9 "Karpas-707: 157.8;U-698: 392.7" "HPA001245, CAB008642" Supported "Immunoglobulin genes" NA NA 230000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB008642: AB_1617595, HPA001245: AB_1079121" "unprognostic (6.47e-3)" "unprognostic (4.39e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-3)" "unprognostic (1.55e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.90e-2)" "unprognostic (3.25e-1)" "unprognostic (7.52e-2)" "unprognostic (5.36e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.49e-9)" "unprognostic (3.12e-1)" "unprognostic (3.52e-1)" "unprognostic (8.96e-2)" "unprognostic (7.61e-2)" 526.0 696.8 0.7 1661.1 0.6 681.1 203.2 0.5 4.5 518.2 2.8 302.1 103.7 210.6 18.4 334.4 661.5 312.9 143.2 0.4 2.2 491.7 356.1 962.4 3281.1 4.7 3.2 407.0 38.5 7.9 35.8 2.3 2.3 209.8 85.1 0.3 391.6 250.8 13.1 28.5 1008.8 27.6 12.7 11451.9 608.9 172.8 1.2 1773.7 1277.9 0.1 5826.8 3998.0 267.2 1.8 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.7 0.0 0.0 2.3 0.0 0.0 0.0 8.4 0.0 5.3 0.0 0.0 0.0 22.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 157.8 0.0 0.0 1.7 2.1 2.6 0.0 0.0 2.9 15.1 3.7 0.0 0.0 18.2 17.0 3.1 0.0 0.0 0.0 0.0 0.2 10.8 0.0 3.2 3.3 4.5 4.9 0.3 392.7 0.1 3.7 0.0 0.2 0.3 0.1 0.3 0.0 0.2 766.8 0.6 0.3 0.4 134.9 0.0 0.1 6.2 0.1 0.1 0.1 0.2 96.2 0.7 0.6 0.5 4.5 0.4 2.2 4.7 3.2 2.3 12.7 1.2 1.8 2.9 73.7 378.5 0.0 3900.5 0.0 8.1 0.0 0.0 0.0 0.5 0.0 2.8 22.8 9.3 0.0 0.0 0.0 0.4 7.0 0.0 0.0 0.5 0.0 0.1 8.5 13.9 83.4 0.0 0.0 0.0 13.6 8.2 0.0 209.4 0.0 46.1 52.9 0.1 0.0 0.0 5.0 0.0 62.8 0.0 0.9 0.0 9.7 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 5.4 0.0 9883.3 9.1 0.0 10.9 1.5 0.1 0.0 0.0 1.5 1.9 1.0 0.0 0.0 0.0 415.6 0.0 13.6 0.1 IGHG2 ENSG00000211893 "Immunoglobulin heavy constant gamma 2 (G2m marker)" P01859 14 105639559-105644790 "FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 4319.4" "Group enriched" "Detected in some" 8 "B-cells: 2050.1;Plasma cells: 2918.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 447 "memory B-cell: 339.0;naive B-cell: 119.3" "Lineage enriched" "Detected in single" 661 "B-cells: 339.0" "Group enriched" "Detected in some" 4 "RH-30: 9.6;RPMI-8226: 25.1" HPA001245 Approved "Immunoglobulin genes" NA NA 250000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001245: AB_1079121" "prognostic favorable (3.53e-4)" "unprognostic (6.88e-3)" "unprognostic (2.40e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "prognostic favorable (3.30e-6)" "unprognostic (1.06e-1)" "unprognostic (6.67e-2)" "unprognostic (1.74e-1)" "unprognostic (7.59e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (4.30e-8)" "unprognostic (4.72e-2)" "unprognostic (3.32e-2)" "unprognostic (1.05e-1)" "unprognostic (7.40e-2)" 109.5 11.0 1.3 170.0 1.4 34.8 56.0 0.2 4.1 59.9 0.8 202.8 7.5 55.8 0.8 90.2 51.5 20.7 15.2 0.2 1.1 157.5 98.2 171.0 65.4 0.9 0.2 16.3 8.0 0.1 8.2 0.0 0.5 64.2 9.4 0.0 201.2 1.2 3.5 13.3 330.7 1.0 1.5 4319.4 87.2 2.3 0.3 16.7 134.4 0.0 226.0 100.4 104.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 25.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 339.0 0.5 0.0 0.3 119.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 34.5 1.3 1.4 0.2 4.1 0.2 1.1 0.9 0.2 0.5 1.5 0.3 1.8 0.2 54.5 305.3 0.0 2050.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 2.8 13.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.2 4.1 0.0 32.5 0.0 0.0 0.0 3.1 0.0 0.0 126.1 0.0 8.2 5.1 0.1 0.0 0.0 0.9 0.0 12.4 0.0 0.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2918.6 0.7 0.0 3.5 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.1 305.5 0.0 0.7 0.0 IGHG3 ENSG00000211897 "Immunoglobulin heavy constant gamma 3 (G3m marker)" 14 105764503-105771405 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 1289.1" "Group enriched" "Detected in many" 7 "B-cells: 2548.4;Plasma cells: 4543.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 415 "memory B-cell: 211.0;naive B-cell: 64.4" "Lineage enriched" "Detected in single" 636 "B-cells: 211.0" "Group enriched" "Detected in some" 5 "HDLM-2: 23.8;Karpas-707: 18.7;U-698: 49.1" "Immunoglobulin genes" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (8.49e-3)" "unprognostic (3.93e-3)" "unprognostic (1.57e-1)" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.00e-5)" "unprognostic (1.92e-2)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "unprognostic (1.99e-2)" "unprognostic (8.36e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.46e-11)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (9.80e-2)" "unprognostic (6.79e-2)" 63.6 17.6 0.1 90.8 0.3 65.4 23.8 0.1 1.5 37.9 1.0 30.0 11.6 22.8 0.3 32.2 104.4 8.4 6.7 0.1 0.6 72.8 42.4 194.9 346.3 2.8 0.1 13.4 6.3 0.1 6.8 0.1 0.4 41.4 8.8 0.0 69.9 12.7 1.9 2.3 100.9 1.6 1.2 1289.1 65.4 31.7 0.1 27.1 87.6 0.0 929.0 87.3 29.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 6.0 3.9 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 49.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 211.0 0.0 0.0 0.0 64.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.7 0.1 0.3 0.1 1.5 0.1 0.6 2.8 0.1 0.4 1.2 0.1 1.0 1.9 57.7 363.7 0.0 2548.4 0.0 9.7 0.0 0.0 0.0 0.5 0.1 1.9 18.6 11.2 0.0 0.0 0.0 2.0 7.0 0.0 0.0 6.5 0.1 0.2 5.3 13.2 24.5 0.0 0.0 0.0 9.1 2.6 0.0 195.5 0.0 22.9 64.2 0.1 0.0 0.0 7.4 0.0 62.8 0.0 16.4 0.0 7.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 4543.8 13.3 0.0 0.5 2.2 0.0 0.0 0.0 0.7 4.7 0.7 0.0 0.0 0.0 467.3 0.0 13.5 0.1 IGHJ1 ENSG00000211905 "Immunoglobulin heavy joining 1" A0A0C4DH62 14 105865407-105865458 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "intestine: 354.8;lymphoid tissue: 414.0;salivary gland: 120.1;stomach 1: 305.5" "Cell type enriched" "Detected in single" 18 "Plasma cells: 1.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 1.9" "Group enriched" "Detected in some" 72 "memory B-cell: 276.3;naive B-cell: 180.8;plasmacytoid DC: 99.0" "Group enriched" "Detected in many" 73 "B-cells: 276.3;dendritic cells: 99.0" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.7;U-698: 1.8" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (5.28e-3)" "unprognostic (2.05e-2)" "unprognostic (6.81e-2)" "unprognostic (9.53e-2)" "prognostic favorable (3.55e-4)" "unprognostic (2.51e-1)" "unprognostic (2.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.90e-2)" 8.6 5.3 0.1 196.9 0.1 35.6 72.8 0.0 1.9 18.6 0.2 260.2 354.8 3.3 0.0 15.7 5.2 12.6 1.4 0.1 0.1 2.3 6.1 28.5 46.8 1.3 0.0 8.2 3.1 0.4 0.0 0.7 0.5 4.3 182.6 0.0 120.1 0.5 0.0 0.0 171.1 12.0 0.3 100.2 305.5 1.0 0.2 14.6 2.9 0.0 414.0 61.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.2 276.3 0.6 2.5 0.2 180.8 0.3 0.3 0.0 0.1 0.1 99.0 0.2 29.1 0.1 0.1 0.0 1.9 0.1 0.1 1.3 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ2 ENSG00000211904 "Immunoglobulin heavy joining 2" 14 105865199-105865250 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "cervix: 48.7;intestine: 127.5;lymphoid tissue: 174.5" "Cell type enriched" "Detected in single" 6 "Plasma cells: 3.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "medulla oblongata: 3.8" "Group enriched" "Detected in some" 18 "MAIT T-cell: 49.0;naive B-cell: 12.6" "Group enriched" "Detected in many" 45 "B-cells: 12.6;T-cells: 49.0" "Group enriched" "Detected in some" 25 "Daudi: 3.8;K-562: 1.1" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.03e-3)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (1.27e-2)" "prognostic favorable (1.05e-4)" "unprognostic (7.40e-2)" "unprognostic (6.38e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.33e-6)" "unprognostic (4.31e-2)" "unprognostic (1.68e-1)" "unprognostic (5.48e-2)" "unprognostic (4.60e-1)" 2.0 0.0 0.2 0.0 0.5 13.3 20.5 0.2 2.0 48.7 0.1 87.2 0.0 5.4 17.9 18.0 2.1 0.8 0.1 0.2 0.4 1.2 12.0 0.0 7.6 3.8 0.8 7.7 18.9 0.6 0.0 0.0 0.5 15.0 127.5 0.0 0.0 7.1 0.0 0.0 0.0 5.8 0.6 18.8 18.2 0.1 0.5 19.6 5.1 0.0 174.5 6.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 49.0 1.3 0.4 1.6 0.4 12.6 0.0 0.2 0.2 0.0 0.6 0.0 0.0 17.1 0.2 0.5 0.2 2.0 0.2 0.4 3.8 0.8 0.5 0.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ3 ENSG00000242887 "Immunoglobulin heavy joining 3" 14 105864587-105864635 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 36.4;intestine: 57.9;pancreas: 61.6" "Cell type enriched" "Detected in single" 48 "Plasma cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basophil: 9.0;naive B-cell: 29.1" "Group enriched" "Detected in many" 7 "B-cells: 29.1;granulocytes: 9.0" "Cell line enhanced" "Detected in some" "Daudi: 1.5;RPMI-8226: 6.1;TIME: 8.0;U-251 MG: 2.6" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (8.67e-4)" "unprognostic (8.67e-3)" "unprognostic (1.12e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.86e-5)" "unprognostic (3.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (4.22e-2)" "unprognostic (2.03e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (9.62e-2)" "unprognostic (1.30e-1)" 16.2 3.0 0.6 0.0 0.9 0.0 0.0 0.2 2.5 1.9 0.5 0.0 0.0 0.0 0.0 36.4 0.7 9.1 0.0 0.6 0.9 0.9 10.2 17.3 0.0 1.5 0.4 11.3 61.6 0.0 0.0 0.0 1.7 7.5 57.9 0.1 0.0 4.3 0.0 2.4 0.0 0.0 1.4 0.0 0.0 0.3 0.7 0.0 2.4 0.0 0.0 5.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.4 0.2 0.0 0.9 0.0 0.7 1.1 2.6 29.1 1.5 1.2 0.0 0.4 0.7 0.0 1.2 0.0 0.6 0.9 0.2 2.5 0.6 0.9 1.5 0.4 1.7 1.4 0.7 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGHJ4 ENSG00000240041 "Immunoglobulin heavy joining 4" 14 105864215-105864260 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 416.7;lymphoid tissue: 1568.0;urinary bladder: 551.2" "Cell type enriched" "Detected in single" 148 "Plasma cells: 103.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 187 "memory B-cell: 6029.7;naive B-cell: 2618.0" "Lineage enriched" "Detected in all" 261 "B-cells: 6029.7" "Cell line enriched" "Detected in some" 87 "U-698: 3990.3" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" 0.0 0.0 7.2 0.0 2.9 0.0 240.0 0.9 10.8 0.0 3.6 377.5 0.0 0.0 0.0 200.2 7.4 4.1 12.3 0.9 2.5 0.0 39.1 0.0 0.0 8.9 30.7 0.0 0.0 13.6 0.0 2.5 22.3 7.0 416.7 0.0 0.0 0.0 0.0 20.7 0.0 0.0 2.0 45.4 7.3 3.7 3.1 32.3 3.9 0.0 1568.0 551.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 14.0 17.5 0.0 0.0 0.0 0.0 6.8 3.6 0.0 0.0 0.0 0.0 0.0 8.9 0.0 45.8 0.0 0.0 6.2 0.0 3990.3 0.0 12.2 0.0 13.9 3.6 5.4 5.0 1.3 3.0 6029.7 13.2 4.0 23.1 2618.0 1.5 6.0 20.1 3.3 6.0 0.0 6.6 1048.2 7.2 2.9 0.9 10.8 0.9 2.5 8.9 30.7 22.3 2.0 3.1 1.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ5 ENSG00000242472 "Immunoglobulin heavy joining 5" 14 105863814-105863862 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 33.5;breast: 73.2;intestine: 72.3;prostate: 32.7" "Cell type enriched" "Detected in single" 397 "Plasma cells: 39.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 263 "memory B-cell: 1081.0" "Lineage enriched" "Detected in many" 263 "B-cells: 1081.0" "Group enriched" "Detected in some" 11 "HL-60: 10.5;REH: 14.0;RH-30: 18.0" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 85: Liver - Metabolism" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 55: Plasma cells - Humoral immune response" 33.5 0.0 0.7 0.0 3.7 0.0 73.2 0.7 2.0 0.0 2.0 72.3 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.9 4.2 4.5 29.4 17.1 0.0 3.1 1.0 0.0 4.7 0.0 0.0 0.0 1.9 32.7 0.2 0.2 0.0 0.0 0.0 7.9 0.0 0.0 1.6 0.0 0.0 0.4 1.3 0.0 4.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.6 2.1 1.2 0.7 1081.0 0.4 0.6 4.1 0.0 2.6 0.9 2.3 0.7 0.6 0.0 1.1 316.0 0.7 3.7 0.7 2.0 0.9 4.2 3.1 1.0 1.9 1.6 1.3 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ6 ENSG00000211900 "Immunoglobulin heavy joining 6" 14 105863198-105863258 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "cervix: 142.4;intestine: 38.6;lung: 47.0;testis: 151.4;urinary bladder: 113.5" "Cell type enriched" "Detected in single" 56 "Plasma cells: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory B-cell: 316.2;naive B-cell: 112.7" "Lineage enriched" "Detected in many" 21 "B-cells: 316.2" "Cell line enhanced" "Detected in some" "U-266/84: 1.3;U-937: 1.2" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 71: Testis - DNA repair" "Cluster 16: U-266 - Nucleosome" "Cluster 55: Plasma cells - Humoral immune response" 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.1 0.9 142.4 0.0 2.6 38.6 1.0 0.0 0.0 2.1 0.5 0.9 0.3 0.0 3.0 2.4 47.0 0.4 0.4 0.1 0.0 0.0 3.7 0.0 0.0 0.3 3.6 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.6 0.7 151.4 0.3 0.0 0.7 0.0 10.7 113.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.2 0.0 3.5 3.5 0.8 0.3 0.0 0.2 316.2 0.5 0.6 0.5 112.7 0.6 0.3 14.8 0.2 1.0 0.0 0.1 89.2 0.0 0.0 0.1 0.9 0.3 0.0 0.4 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHM ENSG00000211899 "Immunoglobulin heavy constant mu" P01871 14 105851705-105856218 "Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 1315.0;lymphoid tissue: 4112.3" "Group enriched" "Detected in many" 14 "B-cells: 3757.1;Plasma cells: 9906.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 16 "memory B-cell: 4278.4;naive B-cell: 6731.2" "Lineage enriched" "Detected in all" 19 "B-cells: 6731.2" "Group enriched" "Detected in many" 9 "Daudi: 4983.6;U-698: 4905.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" CAB008643 Uncertain "Immunoglobulin genes" NA NA 110000000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB008643: AB_1617732" "unprognostic (2.91e-3)" "prognostic favorable (6.49e-4)" "unprognostic (9.30e-3)" "unprognostic (9.90e-3)" "unprognostic (2.05e-1)" "prognostic favorable (3.70e-6)" "unprognostic (9.61e-3)" "unprognostic (1.01e-1)" "unprognostic (1.52e-2)" "unprognostic (3.23e-3)" "unprognostic (2.46e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (3.01e-1)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (6.28e-3)" 52.0 9.0 0.4 373.7 0.4 395.3 56.6 0.2 1.7 67.9 1.8 446.8 1204.9 11.1 10.2 66.8 38.5 141.7 50.5 0.2 0.4 48.4 84.7 180.6 3192.1 1.9 0.3 9.7 44.5 0.6 8.7 3.6 0.7 15.1 201.4 0.0 325.1 6.1 2.7 1.7 1315.0 7.9 1.0 4112.3 528.9 70.9 0.7 117.3 37.0 0.7 497.1 128.0 10.5 0.5 4.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 4983.6 2.9 0.0 0.0 0.8 0.0 0.0 0.0 21.6 0.0 3.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 1.7 28.7 1.2 0.0 0.0 580.2 2.2 6.9 0.0 0.0 4.0 5.8 3.0 0.5 1.2 0.0 0.2 3.8 6.5 0.0 13.8 1.2 2.5 1.5 1.5 4905.9 0.0 2.4 0.0 10.8 5.4 5.6 3.1 1.2 2.3 4278.4 5.5 6.8 5.4 6731.2 4.5 3.8 25.4 11.4 4.5 346.1 11.4 815.2 0.4 0.4 0.2 1.7 0.2 0.4 1.9 0.3 0.7 1.0 0.7 0.5 1.0 38.5 254.5 0.0 3757.1 0.0 0.2 0.0 1.2 0.0 2.2 0.8 0.3 31.5 14.2 0.0 0.0 0.0 63.8 1.8 0.0 0.0 0.0 0.0 0.1 4.2 6.7 474.1 0.0 0.0 0.0 10.8 27.5 0.0 152.6 0.0 56.7 147.9 0.1 0.0 0.0 2.2 0.0 158.1 0.0 0.0 0.0 12.4 0.0 0.0 5.2 0.0 11.3 0.0 0.0 0.0 1.2 0.0 9906.5 0.3 0.0 2.2 1.5 0.0 0.0 0.4 16.8 0.0 0.0 0.2 0.0 0.0 415.0 0.3 4.1 0.1 IGHV1-18 ENSG00000211945 "Immunoglobulin heavy variable 1-18" A0A0C4DH31 14 106184901-106185394 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 223.2;lymphoid tissue: 486.7;salivary gland: 234.3" "Cell type enriched" "Detected in some" 259 "Plasma cells: 13773.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 21 "memory B-cell: 73.2" "Lineage enriched" "Detected in many" 21 "B-cells: 73.2" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HL-60: 3.0;RPMI-8226: 2.9;TIME: 1.6" "Immunoglobulin genes" NA NA 4700000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (3.47e-4)" "unprognostic (2.53e-2)" "unprognostic (8.73e-3)" "unprognostic (2.56e-2)" "unprognostic (9.67e-3)" "prognostic favorable (8.27e-4)" "unprognostic (5.47e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-1)" "unprognostic (3.50e-2)" "unprognostic (3.60e-1)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.84e-7)" "unprognostic (3.22e-1)" "unprognostic (2.62e-1)" "unprognostic (2.87e-1)" "unprognostic (2.44e-2)" 22.0 3.5 0.0 0.0 0.3 0.0 22.9 0.0 0.6 54.6 0.0 223.2 0.0 8.9 4.5 162.5 24.3 7.7 2.3 0.0 0.0 16.2 14.3 58.3 0.0 0.6 0.1 8.5 3.2 1.9 1.3 0.2 0.4 10.8 0.0 0.0 234.3 0.0 0.4 1.3 103.2 2.6 0.0 486.7 84.0 0.5 0.1 0.0 33.9 0.2 0.0 156.1 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.6 0.5 0.8 0.0 0.0 1.1 1.2 2.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.4 1.0 0.5 0.0 0.3 0.0 1.4 0.0 3.4 0.0 0.1 0.0 0.0 0.1 73.2 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 53.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13773.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 3.2 0.0 0.1 0.0 IGHV1-2 V35 ENSG00000211934 "Immunoglobulin heavy variable 1-2" P23083 14 105986582-105987083 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 462.7;lymphoid tissue: 1157.3" "Cell type enriched" "Detected in some" 38 "Plasma cells: 609.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 52 "memory B-cell: 285.2;naive B-cell: 347.4" "Lineage enriched" "Detected in many" 57 "B-cells: 347.4" "Cell line enriched" "Detected in some" 8 "U-266/70: 14302.7" "Immunoglobulin genes" NA NA 4000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.63e-3)" "unprognostic (1.09e-3)" "unprognostic (1.88e-1)" "unprognostic (9.46e-2)" "unprognostic (5.78e-2)" "prognostic favorable (1.67e-5)" "unprognostic (9.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (2.37e-1)" "unprognostic (1.99e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (2.17e-2)" "unprognostic (8.59e-2)" "unprognostic (3.19e-1)" "unprognostic (1.17e-2)" 16.7 43.1 0.3 364.1 0.2 76.0 84.1 0.0 1.2 41.5 0.5 462.7 223.7 13.1 1.3 34.5 58.5 54.4 26.2 0.0 0.1 13.7 18.9 60.7 404.9 0.4 0.0 36.5 3.0 0.6 1.3 0.6 0.2 23.2 283.8 0.0 222.4 52.5 0.4 4.5 121.9 7.5 0.2 393.2 216.1 35.0 0.1 72.1 33.7 0.0 1157.3 255.5 8.9 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 2.6 0.0 0.0 2.3 0.4 2.8 0.0 0.0 3.1 0.6 0.5 0.0 0.0 1.3 1.8 0.1 0.0 0.6 0.0 0.0 0.2 0.3 0.0 1.5 0.0 1.3 14302.7 1755.5 0.5 0.0 0.4 0.0 0.3 0.6 0.1 0.3 0.0 0.2 285.2 1.6 0.7 0.2 347.4 1.5 0.6 6.1 0.2 0.3 0.5 1.1 34.0 0.3 0.2 0.0 1.2 0.0 0.1 0.4 0.0 0.2 0.2 0.1 0.6 0.0 0.0 1.3 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 609.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 IGHV1-24 ENSG00000211950 "Immunoglobulin heavy variable 1-24" A0A0C4DH33 14 106276548-106277043 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 186.8;salivary gland: 76.3" "Cell type enriched" "Detected in some" 4 "Plasma cells: 231.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "medulla oblongata: 1.2" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.8" "Lineage enriched" "Detected in single" 9 "B-cells: 2.8" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HL-60: 1.8;JURKAT: 1.3;RH-30: 1.4" "Immunoglobulin genes" NA NA 3100000000 "Cluster 24: B-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (9.01e-4)" "unprognostic (2.67e-2)" "unprognostic (1.66e-2)" "unprognostic (1.93e-3)" "prognostic favorable (3.61e-4)" "unprognostic (1.28e-1)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.59e-1)" "unprognostic (4.10e-1)" "prognostic unfavorable (2.07e-7)" "unprognostic (5.43e-2)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "unprognostic (4.78e-2)" 6.8 1.4 0.1 33.7 0.0 0.0 8.5 0.0 0.3 56.3 0.1 30.5 0.0 5.7 0.0 46.2 6.5 4.6 1.8 0.0 0.1 7.0 6.4 17.7 0.0 1.2 0.1 19.6 1.4 0.1 0.4 0.3 0.0 3.1 14.0 0.0 76.3 0.0 0.1 0.8 24.0 2.1 0.0 186.8 37.0 14.2 0.0 0.4 14.5 0.0 18.4 63.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.8 0.1 0.0 0.0 2.8 0.1 0.2 0.0 0.0 0.0 0.0 0.1 3.6 0.1 0.0 0.0 0.3 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 231.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 5.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 IGHV1-3 VI-3B ENSG00000211935 "Immunoglobulin heavy variable 1-3" A0A0C4DH29 14 106005095-106005574 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 223.2;lymphoid tissue: 629.4" "Cell type enriched" "Detected in some" 335 "Plasma cells: 13473.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "memory B-cell: 52.8;naive B-cell: 27.8" "Lineage enriched" "Detected in many" 9 "B-cells: 52.8" "Cell line enriched" "Detected in some" 11 "Karpas-707: 148.5" "Immunoglobulin genes" NA NA 2600000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.39e-2)" "unprognostic (3.81e-3)" "unprognostic (2.96e-2)" "unprognostic (4.93e-2)" "unprognostic (7.41e-3)" "unprognostic (2.42e-1)" "unprognostic (7.85e-2)" "unprognostic (5.60e-2)" "unprognostic (3.07e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (5.67e-7)" "unprognostic (7.02e-2)" "unprognostic (4.31e-1)" "unprognostic (1.75e-1)" "unprognostic (3.26e-1)" 10.6 59.3 0.0 207.8 0.0 36.4 46.7 0.0 0.5 41.6 0.3 193.3 218.5 4.8 15.3 45.5 6.5 85.4 3.2 0.0 0.1 8.2 8.9 40.9 171.8 0.2 0.0 8.4 7.0 0.3 0.6 0.1 0.1 6.0 223.2 0.0 120.6 23.5 0.6 0.9 140.9 11.2 0.0 246.6 189.1 0.4 0.1 57.8 24.2 0.0 629.4 92.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 14.1 1.0 148.5 0.0 0.0 0.8 1.1 0.1 0.0 0.0 0.0 0.7 0.7 0.0 0.0 10.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 2.8 1.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 52.8 0.6 0.2 0.0 27.8 1.6 0.5 0.0 0.0 0.0 5.8 1.7 6.1 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13473.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 IGHV1-45 ENSG00000211961 "Immunoglobulin heavy variable 1-45" A0A0A0MS14 14 106506996-106507491 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 18.9;lymphoid tissue: 30.3;stomach 1: 17.5" "Cell type enriched" "Detected in single" 20 "Plasma cells: 2.0" "Cancer enriched" "Detected in many" 7 "lung cancer: 15.4" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.2;U-266/84: 1.3" "Immunoglobulin genes" NA NA 380000000 "Cluster 32: T-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.57e-4)" "unprognostic (5.07e-3)" "unprognostic (2.12e-3)" "unprognostic (1.46e-1)" "unprognostic (7.64e-3)" "unprognostic (2.90e-1)" "unprognostic (3.50e-2)" "unprognostic (3.16e-1)" "unprognostic (1.48e-1)" "unprognostic (1.05e-1)" "unprognostic (4.05e-1)" "unprognostic (1.28e-3)" "unprognostic (2.94e-2)" "unprognostic (2.87e-1)" "unprognostic (2.32e-1)" "unprognostic (3.16e-1)" 0.2 0.1 0.0 3.7 0.0 1.8 18.9 0.0 0.0 0.3 0.0 4.5 1.1 0.5 0.0 6.4 0.2 0.6 0.1 0.0 0.0 0.2 0.2 3.5 7.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 6.1 0.0 11.5 0.0 0.0 0.1 2.3 0.7 0.0 6.9 17.5 0.1 0.0 2.9 0.3 0.0 30.3 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.1 0.6 0.3 0.0 1.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-46 ENSG00000211962 "Immunoglobulin heavy variable 1-46" P01743 14 106511117-106511856 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.9;lymphoid tissue: 125.7;salivary gland: 67.4" "Cell type enriched" "Detected in some" 201 "Plasma cells: 8432.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;RPMI-8226: 1.2;SH-SY5Y: 1.2;TIME: 2.3;U-266/70: 1.1;U-266/84: 1.2" "Immunoglobulin genes" NA NA 2900000000 "Cluster 24: B-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.28e-4)" "unprognostic (2.49e-2)" "prognostic favorable (7.34e-4)" "unprognostic (1.10e-2)" "unprognostic (3.53e-2)" "unprognostic (1.80e-3)" "unprognostic (1.87e-1)" "unprognostic (6.76e-2)" "unprognostic (8.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-1)" "prognostic unfavorable (1.56e-6)" "unprognostic (6.19e-2)" "unprognostic (2.52e-1)" "unprognostic (2.27e-1)" "unprognostic (5.13e-1)" 5.1 1.3 0.0 0.0 0.0 0.0 7.2 0.0 0.1 6.2 0.0 67.9 0.0 2.5 1.0 4.9 3.5 0.7 5.0 0.0 0.0 3.2 4.2 15.3 0.0 0.1 0.0 3.0 5.3 0.1 0.3 0.3 0.1 1.9 45.1 0.0 67.4 0.0 0.1 0.7 34.2 0.0 0.0 125.7 25.1 0.2 0.0 0.0 10.5 0.2 0.0 5.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.0 0.5 1.2 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.1 1.1 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 1.9 41.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8432.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 IGHV1-58 ENSG00000211968 "Immunoglobulin heavy variable 1-58" A0A0C4DH39 14 106622357-106622855 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "urinary bladder: 204.7" "Group enriched" "Detected in some" 17 "B-cells: 2.4;Plasma cells: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 49 "memory B-cell: 8.7;naive B-cell: 12.7" "Lineage enriched" "Detected in single" 58 "B-cells: 12.7" "Cell line enhanced" "Detected in single" "MOLT-4: 1.5" "Immunoglobulin genes" NA NA 120000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (9.63e-3)" "unprognostic (6.78e-2)" "unprognostic (5.64e-2)" "unprognostic (4.04e-2)" "prognostic favorable (7.25e-4)" "unprognostic (4.56e-2)" "unprognostic (1.21e-1)" "unprognostic (4.62e-1)" "unprognostic (1.46e-2)" "unprognostic (4.89e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (3.24e-2)" "unprognostic (5.28e-2)" "unprognostic (6.79e-2)" "unprognostic (1.36e-1)" 8.1 3.4 0.0 13.8 0.0 5.9 3.8 0.0 0.0 0.8 0.0 19.5 15.7 0.4 0.0 8.3 1.1 4.7 1.0 0.0 0.0 1.5 1.4 5.4 41.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 27.8 0.0 23.5 1.9 0.0 0.2 9.8 0.1 0.0 26.2 13.1 0.5 0.0 10.3 1.1 0.0 51.1 204.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-69 IGHV1-E ENSG00000211973 "Immunoglobulin heavy variable 1-69" P01742 14 106714684-106715181 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 139.1;lymphoid tissue: 170.2;urinary bladder: 162.6" "Cell type enriched" "Detected in some" 85 "Plasma cells: 231.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 22 "medulla oblongata: 2.5;pons: 3.0" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.5;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.4;HMC-1: 1.0;MOLT-4: 6.2;SCLC-21H: 1.1;U-698: 1.9" "Immunoglobulin genes" NA NA 2700000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (3.51e-3)" "unprognostic (7.03e-2)" "prognostic favorable (9.56e-5)" "prognostic favorable (8.32e-4)" "unprognostic (1.06e-2)" "unprognostic (1.69e-1)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (1.64e-2)" "unprognostic (1.70e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (2.77e-7)" "unprognostic (1.28e-1)" "unprognostic (2.95e-1)" "unprognostic (8.20e-2)" "unprognostic (6.82e-2)" 7.7 1.4 0.0 0.0 0.1 0.1 6.5 0.0 0.0 21.4 0.1 56.9 0.0 6.9 0.0 7.0 5.7 77.4 0.7 0.0 0.1 7.0 4.8 18.0 0.0 2.5 0.0 2.0 0.8 1.8 0.5 0.0 3.0 4.6 139.1 0.0 55.9 13.0 0.1 0.5 31.7 6.8 0.0 170.2 31.0 0.1 0.0 0.0 25.2 0.0 0.0 162.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.0 0.0 1.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 231.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 IGHV1-69-2 IGHV1-F ENSG00000281990 "Immunoglobulin heavy variable 1-69-2" A0A0G2JMI3 14 106737110-106737547 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.1;lymphoid tissue: 47.1" "Cell type enriched" "Detected in some" 226 "Plasma cells: 10423.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.7;naive B-cell: 5.5" "Lineage enriched" "Detected in many" 6 "B-cells: 6.7" "Cell line enriched" "Detected in some" 6 "MOLT-4: 11.2" "Immunoglobulin genes" NA NA 1100000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" 6.3 0.3 0.0 5.8 0.0 2.5 3.6 0.0 0.0 1.5 0.0 12.0 22.1 1.1 0.2 2.1 1.2 14.5 1.6 0.0 0.0 2.7 0.9 4.5 13.5 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.5 14.4 0.0 16.4 0.9 0.0 0.0 18.0 0.2 0.0 47.1 9.9 0.2 0.0 3.7 1.1 0.0 36.5 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 6.7 0.5 0.9 0.0 5.5 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 1.4 23.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10423.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 IGHV1-69D ENSG00000280411 "Immunoglobulin heavy variable 1-69D" A0A0B4J2H0 14 106762092-106762588 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 2878.6;stomach 1: 989.1" "Group enriched" "Detected in some" 6 "Plasma cells: 5.8;T-cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 225 "memory B-cell: 184.5;naive B-cell: 433.4" "Lineage enriched" "Detected in many" 316 "B-cells: 433.4" "Cell line enhanced" "Detected in some" "Daudi: 2.8;HL-60: 2.3;MOLT-4: 4.2;RPMI-8226: 2.5;U-266/70: 3.3;U-698: 7.9" "Immunoglobulin genes" NA NA 1200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (3.32e-3)" "unprognostic (1.75e-2)" "unprognostic (3.87e-2)" "unprognostic (3.77e-2)" "unprognostic (2.49e-4)" "prognostic favorable (2.88e-4)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.72e-8)" "unprognostic (5.14e-2)" "unprognostic (9.96e-2)" "unprognostic (2.84e-2)" "unprognostic (2.08e-2)" 26.1 95.3 0.1 462.7 0.1 113.1 146.7 0.0 0.7 37.5 1.0 628.2 491.2 15.0 16.8 98.6 16.0 78.0 20.2 0.0 0.1 17.5 46.6 149.6 2878.6 1.1 0.0 35.9 3.3 0.6 1.1 0.4 0.1 16.5 406.2 0.0 385.0 100.0 0.5 5.2 121.3 43.8 0.2 452.7 989.1 6.8 0.0 135.7 38.3 0.0 2219.2 295.4 11.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.2 0.3 1.3 0.0 0.0 0.9 0.8 2.5 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.6 0.4 3.3 0.1 7.9 0.0 0.7 0.0 0.8 0.3 0.1 0.0 0.0 0.2 184.5 0.3 0.0 0.2 433.4 0.4 0.1 0.4 0.2 0.4 1.3 0.2 33.5 0.1 0.1 0.0 0.7 0.0 0.1 1.1 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 IGHV1OR15-1 IGHV1/OR15-1 ENSG00000270505 "Immunoglobulin heavy variable 1/OR15-1 (non-functional)" 15 22160431-22160868 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 78.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.0;B-cells: 1.1;granulocytes: 1.3;T-cells: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 94.3;naive B-cell: 111.6" "Group enriched" "Detected in many" 18 "B-cells: 111.6;T-cells: 60.9" "Group enriched" "Detected in some" 4 "JURKAT: 10.3;Karpas-707: 6.9;MOLT-4: 2.5" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (2.14e-1)" "unprognostic (1.13e-1)" 0.6 0.4 0.0 18.2 0.1 7.0 5.8 0.1 0.1 0.8 0.0 15.6 13.8 0.8 0.0 4.0 0.6 14.4 0.6 0.0 0.1 0.4 0.7 2.8 52.0 0.2 0.1 1.0 0.4 0.1 0.1 0.1 0.1 2.3 10.2 0.0 4.8 0.4 0.0 0.1 13.7 0.4 0.2 18.1 11.1 0.1 0.1 58.7 1.1 0.0 78.8 9.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.2 0.0 3.3 94.3 54.9 18.1 0.1 111.6 60.9 14.5 0.5 4.8 0.1 3.3 35.9 20.5 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.0 3.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.2 0.0 IGHV1OR15-9 "IGHV1/OR15-9, IGHV1OR159, VSIG7" ENSG00000188403 "Immunoglobulin heavy variable 1/OR15-9 (non-functional)" 15 19964666-19965101 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "breast: 4.1;intestine: 8.6;lymphoid tissue: 8.6;stomach 1: 8.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "lung cancer: 5.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 14: B-cells - Humoral immune response" "prognostic favorable (1.79e-4)" "unprognostic (8.93e-2)" "unprognostic (2.97e-3)" "unprognostic (9.34e-2)" "prognostic favorable (6.84e-4)" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (3.79e-1)" "unprognostic (1.07e-4)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (2.66e-1)" "unprognostic (2.11e-1)" 0.0 0.0 0.0 8.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 8.6 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 8.3 0.0 0.0 1.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV2-26 ENSG00000211951 "Immunoglobulin heavy variable 2-26" A0A0B4J1V2 14 106301396-106301862 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 128.8;lymphoid tissue: 98.5;urinary bladder: 227.1" "Group enriched" "Detected in some" 39 "B-cells: 8.3;Plasma cells: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 14 "memory B-cell: 13.9" "Lineage enriched" "Detected in single" 140 "B-cells: 13.9" "Cell line enhanced" "Detected in some" "HL-60: 1.3;RH-30: 1.4" "Immunoglobulin genes" NA NA 190000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 57: B-cells - Immune response" "unprognostic (9.39e-3)" "unprognostic (4.50e-2)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" "prognostic favorable (6.05e-4)" "unprognostic (4.59e-2)" "unprognostic (1.18e-1)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-2)" "unprognostic (4.99e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (6.68e-2)" "unprognostic (2.61e-1)" "unprognostic (2.24e-1)" "unprognostic (8.09e-2)" 6.2 7.7 0.0 59.0 0.0 21.6 14.0 0.0 0.3 15.5 0.2 35.0 61.5 4.2 0.0 31.5 3.8 128.8 5.6 0.0 0.4 2.3 6.0 20.7 3.5 0.2 0.6 0.5 1.6 0.0 0.3 0.0 0.1 6.3 86.5 0.0 44.2 0.9 0.1 0.5 55.1 4.4 0.2 98.5 65.1 0.0 1.1 0.0 6.8 0.0 21.8 227.1 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.4 0.2 0.6 0.1 0.2 1.1 0.2 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGHV2-5 ENSG00000211937 "Immunoglobulin heavy variable 2-5" P01817 14 106037902-106038365 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 465.8;lymphoid tissue: 1426.6;stomach 1: 707.9" "Cell type enriched" "Detected in some" 333 "Plasma cells: 9414.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "memory B-cell: 66.7;naive B-cell: 67.3" "Lineage enriched" "Detected in many" 22 "B-cells: 67.3" "Cell line enriched" "Detected in some" 5 "Karpas-707: 8.8" "Immunoglobulin genes" NA NA 700000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.38e-2)" "unprognostic (4.10e-3)" "unprognostic (2.51e-2)" "unprognostic (6.62e-3)" "prognostic favorable (1.41e-4)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "unprognostic (3.63e-1)" "unprognostic (1.47e-1)" "unprognostic (8.45e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.74e-2)" "unprognostic (1.69e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" 16.9 5.0 0.0 183.0 0.2 112.8 106.0 0.0 0.5 45.0 0.2 465.8 266.6 7.5 2.5 27.9 10.7 65.0 5.8 0.0 0.1 20.9 16.4 83.9 188.0 0.5 0.2 13.8 9.3 1.0 1.1 0.3 0.7 9.4 296.3 0.0 201.4 8.8 0.4 2.9 177.0 17.4 0.3 351.0 707.9 2.3 0.0 121.5 27.6 0.0 1426.6 249.3 12.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.6 0.4 0.0 0.1 1.2 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.4 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 66.7 0.0 0.0 0.1 67.3 0.1 0.1 3.0 0.0 0.0 0.0 0.0 10.5 0.0 0.2 0.0 0.5 0.0 0.1 0.5 0.2 0.7 0.3 0.0 0.4 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 27.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9414.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 IGHV2-70 ENSG00000274576 "Immunoglobulin heavy variable 2-70" P01814 14 106770577-106771020 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "lymphoid tissue: 727.6;stomach 1: 502.1" "Cell type enriched" "Detected in single" 5 "Plasma cells: 2.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 5.2" "Group enriched" "Detected in some" 241 "memory B-cell: 24.6;naive B-cell: 23.5" "Lineage enriched" "Detected in single" 247 "B-cells: 24.6" "Cell line enriched" "Detected in some" 8 "U-698: 12.4" "Immunoglobulin genes" NA NA 170000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (8.01e-3)" "unprognostic (2.93e-2)" "unprognostic (3.56e-3)" "unprognostic (2.38e-2)" "unprognostic (1.12e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-1)" "unprognostic (3.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (9.10e-2)" "unprognostic (2.50e-1)" "unprognostic (8.93e-2)" "unprognostic (2.91e-1)" 7.3 25.7 0.0 96.2 0.0 69.2 86.1 0.0 5.2 62.3 0.0 86.7 53.2 4.1 0.0 44.3 8.1 37.5 2.5 0.0 1.4 4.8 13.2 69.9 82.7 0.1 1.1 5.0 1.0 0.9 0.3 0.2 0.1 6.8 82.8 0.0 94.5 14.1 0.1 0.9 42.1 2.5 2.2 156.4 502.1 1.2 0.0 59.5 8.5 0.0 727.6 50.4 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.4 0.8 0.0 0.0 0.8 0.6 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.7 0.0 0.1 0.0 12.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 5.2 0.0 1.4 0.1 1.1 0.1 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV2-70D ENSG00000211974 "Immunoglobulin heavy variable 2-70D" A0A0C4DH43 14 106723574-106724093 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.8;lymphoid tissue: 90.8;stomach 1: 47.0" "Cell type enriched" "Detected in single" 10 "B-cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 68 "memory B-cell: 9.7;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 97 "B-cells: 9.7" "Cell line enriched" "Detected in single" 7 "MOLT-4: 1.7" "Immunoglobulin genes" NA NA 110000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (5.57e-2)" "unprognostic (9.48e-3)" "prognostic favorable (3.34e-4)" "unprognostic (4.34e-2)" "unprognostic (8.37e-3)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.13e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (6.70e-2)" "unprognostic (3.83e-1)" "unprognostic (3.66e-2)" "unprognostic (8.11e-2)" 1.7 0.7 0.0 16.6 0.0 4.1 7.1 0.0 0.0 5.6 0.1 36.8 14.2 1.9 0.0 5.2 4.5 20.9 1.7 0.0 0.0 2.5 2.3 6.2 4.6 0.0 0.0 0.8 0.3 0.1 0.1 0.0 0.0 0.7 33.1 0.0 30.3 0.1 0.0 0.1 21.7 0.6 0.0 41.4 47.0 0.0 0.0 4.5 2.5 0.0 90.8 3.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-11 ENSG00000211941 "Immunoglobulin heavy variable 3-11" P01762 14 106116635-106117204 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 220.1;lymphoid tissue: 613.1;stomach 1: 206.7" "Cell type enriched" "Detected in some" 142 "Plasma cells: 1655.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 445 "memory B-cell: 43.1;naive B-cell: 45.7" "Lineage enriched" "Detected in single" 458 "B-cells: 45.7" "Cell line enhanced" "Detected in some" "Daudi: 1.1;SH-SY5Y: 1.2" "Immunoglobulin genes" NA NA 18000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.07e-3)" "unprognostic (4.84e-2)" "unprognostic (5.81e-3)" "unprognostic (1.07e-2)" "unprognostic (1.04e-2)" "prognostic favorable (3.42e-5)" "unprognostic (4.12e-1)" "unprognostic (6.50e-2)" "unprognostic (2.37e-1)" "unprognostic (3.44e-2)" "unprognostic (3.51e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.86e-1)" "unprognostic (1.30e-1)" 9.3 25.9 0.0 175.0 0.0 38.0 66.0 0.0 0.5 34.7 0.2 220.1 193.4 6.8 12.3 38.6 6.6 43.7 8.6 0.0 0.0 6.8 10.5 29.1 123.7 0.8 0.0 7.8 2.0 0.2 0.8 0.0 0.1 4.0 167.9 0.0 119.7 3.7 0.3 0.7 116.8 11.2 0.1 219.2 206.7 1.3 0.4 44.9 17.0 0.0 613.1 109.4 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1655.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGHV3-13 ENSG00000211942 "Immunoglobulin heavy variable 3-13" P01766 14 106129540-106130072 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.5;lymphoid tissue: 137.3;urinary bladder: 90.5" "Group enriched" "Detected in some" 6 "B-cells: 6.7;Plasma cells: 13.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 193 "memory B-cell: 18.8;naive B-cell: 19.6" "Lineage enriched" "Detected in single" 197 "B-cells: 19.6" "Cell line enhanced" "Detected in some" "MOLT-4: 1.8;U-266/70: 1.0" "Immunoglobulin genes" NA NA 33000000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "prognostic favorable (3.24e-4)" "unprognostic (7.42e-2)" "unprognostic (1.96e-2)" "unprognostic (5.03e-2)" "prognostic favorable (6.67e-6)" "unprognostic (5.44e-2)" "unprognostic (1.23e-2)" "unprognostic (1.53e-1)" "unprognostic (5.31e-2)" "unprognostic (8.27e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (7.21e-5)" "unprognostic (6.79e-2)" "unprognostic (3.21e-1)" "unprognostic (4.45e-1)" "unprognostic (7.87e-2)" 1.3 36.6 0.0 24.1 0.0 6.9 17.2 0.0 0.1 1.9 0.0 67.5 49.5 1.5 0.0 15.4 4.3 9.7 1.8 0.0 0.0 1.1 1.5 7.2 39.5 0.0 0.1 1.5 0.7 0.0 0.1 0.0 0.0 1.1 36.1 0.0 30.9 1.4 0.0 0.1 22.8 5.6 0.1 56.5 42.9 0.9 0.0 9.3 2.8 0.0 137.3 90.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGHV3-15 ENSG00000211943 "Immunoglobulin heavy variable 3-15" A0A0B4J1V0 14 106153624-106154163 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 183.3;lymphoid tissue: 380.2;salivary gland: 177.7;stomach 1: 112.8;urinary bladder: 172.6" "Cell type enriched" "Detected in some" 112 "Plasma cells: 6281.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "MAIT T-cell: 21.6;memory B-cell: 24.4" "Group enriched" "Detected in many" 9 "B-cells: 24.4;T-cells: 21.6" "Cell line enhanced" "Detected in some" "BEWO: 2.2;Daudi: 1.9;HL-60: 2.1;K-562: 2.0;NB-4: 2.4;RH-30: 1.9;RPMI-8226: 4.1;SH-SY5Y: 3.7" "Immunoglobulin genes" NA NA 20000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (8.85e-5)" "unprognostic (2.07e-1)" "unprognostic (1.94e-2)" "unprognostic (1.41e-2)" "unprognostic (1.62e-2)" "prognostic favorable (3.34e-5)" "unprognostic (5.20e-2)" "unprognostic (2.44e-1)" "unprognostic (9.67e-2)" "unprognostic (3.24e-2)" "unprognostic (2.53e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (6.85e-2)" "unprognostic (6.92e-2)" "unprognostic (7.12e-2)" "unprognostic (3.63e-1)" 12.2 36.8 0.0 24.7 0.5 1.8 23.2 0.0 1.2 13.0 0.1 183.3 4.5 5.0 0.9 11.7 16.3 29.6 1.4 0.0 0.2 9.1 10.6 40.0 0.0 1.0 0.0 5.8 19.1 0.4 1.3 0.4 0.3 9.5 14.6 0.0 177.7 23.0 0.8 4.2 107.2 0.3 0.0 380.2 112.8 0.5 0.0 0.0 14.9 0.0 10.4 172.6 9.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.8 2.4 0.7 0.0 0.0 0.0 1.9 4.1 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.1 0.4 1.6 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.1 0.1 0.0 21.6 24.4 0.1 0.2 0.2 0.0 0.2 0.1 2.5 0.0 0.0 0.2 0.1 1.8 0.0 0.5 0.0 1.2 0.0 0.2 1.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 1.1 8.2 0.0 0.0 0.1 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6281.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 IGHV3-16 ENSG00000211944 "Immunoglobulin heavy variable 3-16 (non-functional)" A0A0C4DH30 14 106165205-106165730 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 3200000000 "Cluster 43: B-cells - Humoral immune response" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-20 ENSG00000211946 "Immunoglobulin heavy variable 3-20" A0A0C4DH32 14 106210936-106211453 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 99.2;lymphoid tissue: 216.6;stomach 1: 122.5;urinary bladder: 81.9" "Cell type enriched" "Detected in some" 24 "Plasma cells: 142.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 242 "memory B-cell: 28.5;naive B-cell: 19.8" "Lineage enriched" "Detected in single" 286 "B-cells: 28.5" "Cell line enhanced" "Detected in single" "Daudi: 1.2" "Immunoglobulin genes" NA NA 2200000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.56e-5)" "unprognostic (2.30e-1)" "unprognostic (9.51e-2)" "unprognostic (1.45e-2)" "prognostic favorable (2.93e-4)" "unprognostic (1.35e-2)" "unprognostic (2.37e-1)" "unprognostic (2.45e-1)" "unprognostic (2.62e-1)" "unprognostic (2.42e-1)" "unprognostic (2.93e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (2.09e-1)" "unprognostic (1.87e-1)" "unprognostic (1.19e-1)" "unprognostic (1.76e-1)" 2.8 2.1 0.0 36.3 0.2 22.6 23.7 0.0 0.1 17.4 0.2 64.8 99.2 1.8 0.0 10.1 2.2 20.7 3.1 0.0 0.0 1.5 4.7 10.5 58.0 0.1 0.0 2.7 0.4 0.1 0.2 0.0 0.0 1.2 62.5 0.0 43.1 1.4 0.0 0.3 37.7 2.0 0.0 59.6 122.5 1.1 0.0 16.6 2.8 0.0 216.6 81.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 IGHV3-21 ENSG00000211947 "Immunoglobulin heavy variable 3-21" A0A0B4J1V1 14 106235064-106235594 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 209.7;lymphoid tissue: 398.1;salivary gland: 213.2" "Cell type enriched" "Detected in some" 86 "Plasma cells: 3885.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.1;NB-4: 2.1;NTERA-2: 1.2;RH-30: 2.3;TIME: 1.9" "Immunoglobulin genes" NA NA 37000000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.30e-4)" "unprognostic (1.21e-2)" "unprognostic (7.19e-3)" "unprognostic (1.51e-2)" "unprognostic (9.16e-3)" "prognostic favorable (9.34e-4)" "unprognostic (3.15e-2)" "unprognostic (1.76e-1)" "unprognostic (4.42e-2)" "unprognostic (3.03e-2)" "unprognostic (2.48e-1)" "unprognostic (4.05e-1)" "prognostic unfavorable (9.31e-8)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (1.35e-1)" "unprognostic (1.77e-1)" 18.1 2.7 0.3 0.0 0.3 0.0 24.8 0.2 1.1 16.8 0.3 209.7 0.0 7.1 0.9 17.4 30.9 0.0 2.0 0.2 0.3 15.4 10.7 55.3 0.0 0.4 0.3 2.9 16.2 2.3 1.3 0.6 0.4 7.2 0.0 0.0 213.2 0.3 0.4 4.3 111.3 0.8 0.4 398.1 83.0 0.4 0.3 0.0 25.6 0.0 0.0 27.7 10.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.3 0.2 1.1 0.2 0.3 0.4 0.3 0.4 0.4 0.3 1.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.0 21.4 0.0 0.0 0.1 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3885.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 IGHV3-23 ENSG00000211949 "Immunoglobulin heavy variable 3-23" P01764 14 106268606-106269140 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1683.1;lymphoid tissue: 2989.8" "Cell type enriched" "Detected in some" 139 "Plasma cells: 15979.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 406 "memory B-cell: 548.5;naive B-cell: 336.7" "Lineage enriched" "Detected in many" 503 "B-cells: 548.5" "Cell line enhanced" "Detected in some" "BEWO: 4.4;HL-60: 3.3;NB-4: 4.1;RH-30: 3.0;RPMI-8226: 9.0;SH-SY5Y: 5.8" "Immunoglobulin genes" NA NA 42000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.17e-3)" "unprognostic (5.43e-2)" "unprognostic (9.68e-3)" "unprognostic (3.31e-3)" "unprognostic (1.34e-2)" "prognostic favorable (3.85e-4)" "unprognostic (3.26e-1)" "unprognostic (4.79e-1)" "unprognostic (7.26e-2)" "unprognostic (6.52e-3)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.79e-7)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.36e-1)" "unprognostic (6.42e-2)" 66.5 189.3 0.4 912.2 0.4 185.5 343.1 0.1 2.1 80.1 1.5 1683.1 1640.8 37.0 9.8 342.6 30.1 231.2 46.4 0.1 0.3 27.3 56.4 248.7 859.5 0.8 0.1 42.6 31.0 1.5 2.7 0.9 0.4 35.3 1087.1 0.1 697.8 53.4 0.9 15.0 886.8 40.0 0.8 802.7 1058.8 35.0 0.2 197.5 52.3 0.1 2989.8 993.6 27.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 4.1 0.7 0.0 0.0 0.6 3.0 9.0 0.0 0.0 2.7 5.8 0.8 0.1 0.0 0.0 0.0 0.0 1.8 0.0 1.3 1.3 1.1 1.5 0.0 0.3 0.0 0.9 0.0 0.4 0.4 0.1 0.2 0.0 0.1 548.5 0.2 0.3 0.3 336.7 0.1 0.2 1.0 0.2 0.2 0.2 0.8 62.4 0.4 0.4 0.1 2.1 0.1 0.3 0.8 0.1 0.4 0.8 0.2 1.4 0.1 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 12.0 0.0 0.0 0.0 1.6 19.4 0.0 1.3 0.0 1.8 2.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15979.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.1 0.0 IGHV3-30 ENSG00000270550 "Immunoglobulin heavy variable 3-30" "P01768, P0DP03" 14 106335082-106335613 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 534.0;lymphoid tissue: 1294.8;salivary gland: 459.9;stomach 1: 572.6;urinary bladder: 378.9" "Cell type enriched" "Detected in some" 184 "Plasma cells: 14426.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 409 "memory B-cell: 164.0;naive B-cell: 136.6" "Lineage enriched" "Detected in single" 446 "B-cells: 164.0" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Daudi: 1.7;NB-4: 2.3;RPMI-8226: 1.7;SCLC-21H: 1.7;SH-SY5Y: 3.0;U-266/70: 1.3" "Immunoglobulin genes" NA NA 8500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.12e-3)" "unprognostic (5.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "unprognostic (1.72e-2)" "prognostic favorable (3.23e-5)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.94e-2)" "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.32e-1)" "unprognostic (2.16e-1)" "unprognostic (2.01e-1)" "unprognostic (6.96e-2)" 25.3 38.5 0.1 320.5 0.2 119.7 143.9 0.0 0.4 49.3 0.5 534.0 265.5 13.3 0.0 134.6 44.8 146.5 30.3 0.4 0.2 29.2 25.1 128.2 374.9 0.6 0.2 23.0 12.3 0.7 3.3 0.7 0.2 18.6 254.9 0.0 459.9 20.4 0.9 3.5 296.1 23.6 0.1 797.4 572.6 5.9 0.1 158.2 76.6 0.1 1294.8 378.9 34.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 164.0 0.2 0.0 0.1 136.6 0.3 0.1 0.3 0.0 0.0 0.2 0.0 24.4 0.1 0.2 0.0 0.4 0.4 0.2 0.6 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 78.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 5.4 16.3 0.0 1.3 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14426.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.0 IGHV3-33 ENSG00000211955 "Immunoglobulin heavy variable 3-33" P01772 14 106359793-106360324 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1066.7;lymphoid tissue: 2371.2;stomach 1: 1778.8" "Cell type enriched" "Detected in some" 26 "Plasma cells: 556.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 4.0" "Group enriched" "Detected in many" 101 "memory B-cell: 378.9;naive B-cell: 364.1" "Lineage enriched" "Detected in many" 103 "B-cells: 378.9" "Cell line enhanced" "Detected in some" "HDLM-2: 5.4;HL-60: 5.3;RPMI-8226: 7.7;SH-SY5Y: 3.8;U-266/70: 8.1" "Immunoglobulin genes" NA NA 7500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.04e-3)" "unprognostic (2.38e-2)" "unprognostic (8.95e-3)" "prognostic favorable (6.36e-4)" "unprognostic (6.84e-2)" "prognostic favorable (7.19e-5)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (7.31e-2)" "unprognostic (3.82e-2)" "unprognostic (1.70e-1)" "unprognostic (5.18e-1)" "prognostic unfavorable (4.10e-6)" "unprognostic (6.23e-2)" "unprognostic (1.69e-1)" "unprognostic (3.26e-1)" "unprognostic (5.92e-2)" 27.9 67.4 1.0 513.8 0.8 117.8 289.5 0.2 4.0 53.6 2.4 1066.7 882.1 16.2 14.5 127.5 18.9 141.9 32.9 0.2 0.4 15.7 41.8 210.1 795.2 1.4 0.2 110.0 29.4 1.9 1.7 0.8 0.4 23.2 775.6 0.0 619.6 39.5 0.5 3.6 343.9 37.3 0.5 476.1 1778.8 29.4 0.7 296.8 42.2 0.1 2371.2 379.8 18.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.5 0.0 0.0 0.0 5.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.1 0.8 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.8 2.9 7.7 0.0 0.0 1.4 3.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.7 8.1 0.0 0.2 0.0 0.8 0.0 0.2 0.6 0.1 1.1 0.0 1.9 378.9 3.6 0.9 0.3 364.1 1.4 0.6 1.0 0.2 0.1 0.2 0.5 44.6 1.0 0.8 0.2 4.0 0.2 0.4 1.4 0.2 0.4 0.5 0.7 0.7 0.0 0.0 0.6 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.0 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 556.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 IGHV3-35 ENSG00000211957 "Immunoglobulin heavy variable 3-35 (non-functional)" A0A0C4DH35 14 106389392-106389858 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 14.1;lymphoid tissue: 12.8;salivary gland: 7.6;stomach 1: 16.7;urinary bladder: 20.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "memory B-cell: 3.7" "Lineage enriched" "Detected in single" 35 "B-cells: 3.7" "Cell line enriched" "Detected in single" 6 "MOLT-4: 1.3" "Immunoglobulin genes" NA NA 19000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.39e-3)" "unprognostic (9.98e-2)" "unprognostic (1.16e-2)" "unprognostic (1.60e-2)" "prognostic favorable (2.53e-4)" "unprognostic (1.06e-1)" "unprognostic (4.74e-1)" "unprognostic (3.44e-1)" "unprognostic (2.37e-1)" "unprognostic (3.21e-1)" "unprognostic (4.29e-6)" "unprognostic (4.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" 0.1 0.1 0.0 12.8 0.0 3.3 1.1 0.0 0.0 2.8 0.0 10.3 14.1 0.4 0.0 0.5 1.1 1.1 0.5 0.0 0.0 0.1 0.7 2.4 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 11.1 0.0 7.6 0.5 0.0 0.2 6.0 0.6 0.0 5.3 16.7 0.0 0.0 0.0 0.0 0.0 2.2 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-38 ENSG00000211958 "Immunoglobulin heavy variable 3-38 (non-functional)" A0A0C4DH36 14 106410493-106411021 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.9;lymphoid tissue: 10.4;stomach 1: 5.9;urinary bladder: 7.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory B-cell: 3.4;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 34 "B-cells: 3.4" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2900000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "unprognostic (1.03e-5)" "unprognostic (5.11e-2)" "unprognostic (3.29e-3)" "unprognostic (1.02e-1)" "unprognostic (1.31e-3)" "unprognostic (8.40e-2)" "unprognostic (3.54e-2)" "unprognostic (2.05e-1)" "unprognostic (1.98e-1)" "unprognostic (1.75e-8)" "unprognostic (6.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.99e-1)" "unprognostic (2.52e-1)" 0.3 0.1 0.0 5.9 0.0 1.6 3.3 0.0 0.0 1.4 0.0 7.7 9.9 0.1 0.0 0.9 0.1 0.9 0.2 0.0 0.0 0.1 0.4 1.8 2.2 0.0 0.0 0.6 0.4 0.0 0.0 0.2 0.0 0.2 7.0 0.0 4.1 0.0 0.0 0.2 5.8 0.0 0.0 4.4 5.9 0.7 0.0 0.0 0.0 0.0 10.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-43 ENSG00000232216 "Immunoglobulin heavy variable 3-43" A0A0B4J1X8 14 106470264-106470800 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 211.9;stomach 1: 312.2;urinary bladder: 153.0" "Cell type enriched" "Detected in some" 28 "Plasma cells: 557.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 321 "memory B-cell: 29.4;naive B-cell: 39.0" "Lineage enriched" "Detected in single" 366 "B-cells: 39.0" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SH-SY5Y: 2.3" "Immunoglobulin genes" NA NA 4000000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.31e-4)" "unprognostic (2.22e-2)" "prognostic favorable (1.46e-4)" "unprognostic (4.87e-3)" "prognostic favorable (8.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.34e-1)" "unprognostic (4.63e-1)" "unprognostic (7.27e-3)" "unprognostic (4.50e-2)" "unprognostic (8.73e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (1.75e-2)" 9.3 2.3 0.0 23.7 0.3 11.5 43.7 0.0 0.3 46.0 0.0 101.8 102.5 2.0 0.0 10.2 3.5 10.7 0.4 0.0 0.0 2.7 9.8 10.8 4.3 0.7 0.0 4.2 2.2 1.0 0.3 0.1 0.2 2.7 66.1 0.0 58.1 5.4 0.1 1.0 48.3 4.4 0.0 83.7 312.2 0.2 0.1 0.0 3.8 0.0 211.9 153.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 557.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 IGHV3-48 ENSG00000211964 "Immunoglobulin heavy variable 3-48" P01763 14 106537810-106538344 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 516.4;lymphoid tissue: 858.8;stomach 1: 404.9" "Cell type enriched" "Detected in some" 100 "Plasma cells: 5878.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Group enriched" "Detected in some" 527 "memory B-cell: 187.1;naive B-cell: 97.5" "Lineage enriched" "Detected in single" 693 "B-cells: 187.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.6" "Immunoglobulin genes" NA NA 49000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (9.19e-3)" "unprognostic (1.87e-2)" "unprognostic (5.12e-2)" "unprognostic (9.07e-3)" "unprognostic (1.77e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.23e-1)" "unprognostic (9.59e-2)" "unprognostic (2.65e-1)" "unprognostic (4.02e-2)" "unprognostic (2.64e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (4.88e-8)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" 8.7 22.9 0.0 232.6 0.0 81.2 56.4 0.0 1.3 25.9 0.2 434.1 516.4 8.1 0.1 33.4 12.1 38.6 6.9 0.0 0.0 10.8 18.6 32.3 125.3 0.3 0.0 12.2 8.8 0.9 0.9 0.1 0.7 6.8 253.2 0.0 164.6 16.0 0.6 1.6 134.4 17.7 0.1 271.1 404.9 27.9 0.0 36.3 16.0 0.0 858.8 248.6 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.9 0.4 0.0 0.0 0.0 0.8 0.9 0.0 0.0 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 187.1 0.0 0.0 0.1 97.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 22.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.7 17.9 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5878.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 IGHV3-49 ENSG00000211965 "Immunoglobulin heavy variable 3-49" A0A0A0MS15 14 106556936-106557477 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 210.7;lymphoid tissue: 373.5;stomach 1: 182.3" "Cell type enriched" "Detected in some" 46 "Plasma cells: 717.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 187 "memory B-cell: 59.4;naive B-cell: 42.2" "Lineage enriched" "Detected in single" 219 "B-cells: 59.4" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Immunoglobulin genes" NA NA 1600000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (7.16e-4)" "unprognostic (7.91e-3)" "unprognostic (2.50e-2)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.34e-6)" "unprognostic (4.47e-2)" "unprognostic (4.30e-2)" "unprognostic (7.00e-3)" "unprognostic (9.17e-2)" "unprognostic (2.18e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.43e-6)" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (8.96e-2)" "unprognostic (3.00e-1)" 20.8 7.1 0.0 112.3 0.0 45.7 42.5 0.0 0.5 11.5 0.3 210.7 184.4 4.6 3.9 20.0 5.1 10.9 9.4 0.0 0.2 5.0 12.8 43.2 108.6 0.7 0.0 26.5 1.7 0.2 0.4 0.0 0.3 3.0 139.3 0.0 88.5 12.1 0.2 0.4 88.2 11.5 0.1 183.1 182.3 1.8 0.1 21.4 9.7 0.0 373.5 100.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 0.0 0.0 0.0 42.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 717.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 IGHV3-53 ENSG00000211967 "Immunoglobulin heavy variable 3-53" P01767 14 106592676-106593347 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 81.5;lymphoid tissue: 129.5;stomach 1: 43.3" "Cell type enriched" "Detected in some" 22 "Plasma cells: 176.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 99 "memory B-cell: 54.7;naive B-cell: 52.7" "Lineage enriched" "Detected in single" 101 "B-cells: 54.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 4300000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.41e-3)" "unprognostic (1.12e-1)" "unprognostic (2.46e-3)" "prognostic favorable (5.66e-4)" "prognostic favorable (3.95e-4)" "unprognostic (3.91e-2)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (6.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (2.04e-5)" "unprognostic (1.79e-1)" "unprognostic (8.26e-2)" "unprognostic (2.64e-1)" "unprognostic (3.72e-1)" 2.9 0.8 0.0 37.1 0.0 7.9 15.5 0.0 0.1 4.7 0.0 66.5 81.5 1.0 0.3 4.1 1.9 6.7 1.4 0.0 0.0 1.8 2.8 7.7 38.5 0.1 0.0 3.2 1.3 0.1 0.1 0.0 0.0 1.1 74.0 0.0 32.2 1.9 0.0 0.3 33.9 2.3 0.0 66.9 43.3 1.6 0.0 8.2 4.6 0.0 129.5 10.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 54.7 0.0 0.0 0.0 52.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 176.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGHV3-64 ENSG00000223648 "Immunoglobulin heavy variable 3-64" A0A075B6Q5 14 106657725-106658258 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.9;lymphoid tissue: 32.1;salivary gland: 21.0" "Cell type enriched" "Detected in some" 38 "Plasma cells: 88.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 19 "memory B-cell: 11.1" "Lineage enriched" "Detected in single" 111 "B-cells: 11.1" "Cell line enhanced" "Detected in single" "HL-60: 1.1" "Immunoglobulin genes" NA NA 4300000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.09e-6)" "unprognostic (6.52e-2)" "unprognostic (2.11e-3)" "unprognostic (3.10e-2)" "unprognostic (1.39e-3)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (8.01e-2)" "unprognostic (2.13e-2)" "unprognostic (2.33e-1)" "unprognostic (2.52e-1)" "prognostic unfavorable (3.93e-5)" "unprognostic (1.58e-1)" "unprognostic (1.85e-1)" "unprognostic (3.86e-2)" "unprognostic (1.07e-2)" 1.7 0.1 0.0 2.0 0.0 8.6 7.2 0.0 0.4 0.7 0.0 17.9 6.9 0.9 0.0 1.2 1.9 4.1 1.2 0.0 0.0 0.8 2.2 4.3 0.0 0.1 0.0 3.3 3.6 0.0 0.1 0.0 0.0 0.5 1.2 0.0 21.0 0.4 0.0 0.1 11.3 1.3 0.0 32.1 6.0 0.0 0.0 0.0 1.5 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 IGHV3-64D ENSG00000282639 "Immunoglobulin heavy variable 3-64D" A0A0J9YX35 14 106088122-106088573 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 145.2;lymphoid tissue: 272.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 301 "memory B-cell: 43.3;naive B-cell: 18.7" "Lineage enriched" "Detected in single" 420 "B-cells: 43.3" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 7: Non-specific - Mitochondria" 8.3 0.5 0.2 140.3 0.1 10.9 84.2 0.0 0.8 12.9 0.3 130.9 20.4 3.3 1.4 35.4 7.8 46.3 4.8 0.5 0.0 1.5 4.2 36.7 48.8 0.1 0.0 5.1 8.1 0.1 0.1 0.1 0.0 4.1 145.2 0.0 28.9 11.5 0.0 3.8 68.8 3.6 0.1 67.4 74.8 0.5 0.0 16.5 2.9 0.0 272.7 40.5 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.2 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-66 ENSG00000211972 "Immunoglobulin heavy variable 3-66" A0A0C4DH42 14 106675017-106675544 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 47.3;intestine: 59.5;urinary bladder: 103.9" "Cell type enriched" "Detected in some" 107 "Plasma cells: 958.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 137 "memory B-cell: 39.7" "Lineage enriched" "Detected in single" 137 "B-cells: 39.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.7;U-2 OS: 2.3" "Immunoglobulin genes" NA NA 7200000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.43e-6)" "unprognostic (2.48e-2)" "unprognostic (5.05e-3)" "unprognostic (1.31e-3)" "unprognostic (2.20e-3)" "unprognostic (8.65e-2)" "unprognostic (1.59e-1)" "unprognostic (4.83e-2)" "unprognostic (1.87e-2)" "unprognostic (6.95e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.89e-6)" "unprognostic (3.87e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" "unprognostic (1.19e-1)" 3.8 0.9 0.0 0.0 0.1 11.1 3.9 0.0 0.4 15.3 0.3 59.5 0.0 1.4 1.2 27.0 3.2 47.3 0.3 0.0 0.0 1.3 3.5 13.1 41.1 0.2 0.0 5.6 0.4 0.0 0.1 0.0 0.0 3.9 32.3 0.0 16.1 5.7 0.0 1.5 10.1 1.3 0.0 31.8 6.3 0.6 0.0 0.0 2.5 0.0 39.7 103.9 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 39.7 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 958.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGHV3-7 ENSG00000211938 "Immunoglobulin heavy variable 3-7" P01780 14 106062151-106062683 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 461.3;lymphoid tissue: 971.3" "Cell type enriched" "Detected in some" 255 "Plasma cells: 20463.1" "Cancer enhanced" "Detected in many" "stomach cancer: 18.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 147 "memory B-cell: 134.0;naive B-cell: 107.0" "Lineage enriched" "Detected in single" 163 "B-cells: 134.0" "Cell line enhanced" "Detected in some" "Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9" "Immunoglobulin genes" NA NA 39000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.29e-2)" "unprognostic (5.57e-3)" "unprognostic (1.37e-2)" "prognostic favorable (1.47e-6)" "unprognostic (1.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (5.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.35e-5)" "unprognostic (5.18e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (7.70e-2)" 47.8 10.1 0.7 50.1 1.0 71.1 202.7 0.3 0.8 87.4 0.6 461.3 154.1 37.7 8.2 17.8 13.4 37.0 2.2 0.2 0.4 17.6 20.3 56.4 102.5 1.6 2.8 24.7 4.8 2.9 1.8 0.3 2.3 9.2 303.5 0.0 265.5 22.9 1.3 9.6 206.0 3.6 3.9 610.4 230.4 13.2 0.4 0.0 21.1 0.1 971.3 42.9 14.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.4 2.6 5.8 0.0 0.0 2.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.7 0.0 1.2 1.6 0.0 0.1 0.0 0.6 0.0 0.4 0.8 0.2 0.1 0.0 0.2 134.0 0.2 0.2 0.3 107.0 0.1 0.1 0.1 0.1 0.2 0.6 0.2 12.6 0.7 1.0 0.3 0.8 0.2 0.4 1.6 2.8 2.3 3.9 0.4 1.3 0.0 0.0 0.0 0.0 80.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.5 0.0 5.3 0.0 0.0 0.0 4.4 31.1 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20463.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 7.4 0.0 0.5 0.0 IGHV3-72 ENSG00000225698 "Immunoglobulin heavy variable 3-72" A0A0B4J1Y9 14 106790691-106791233 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.7;lymphoid tissue: 121.6;urinary bladder: 101.3" "Cell type enriched" "Detected in some" 271 "Plasma cells: 3507.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "memory B-cell: 52.4" "Lineage enriched" "Detected in many" 50 "B-cells: 52.4" "Cell line enhanced" "Detected in some" "NB-4: 1.3;RH-30: 1.3;RPMI-8226: 1.2;TIME: 2.2;U-698: 5.8" "Immunoglobulin genes" NA NA 9600000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (9.10e-6)" "unprognostic (2.18e-2)" "unprognostic (1.32e-2)" "unprognostic (2.93e-2)" "prognostic favorable (8.57e-5)" "unprognostic (9.14e-3)" "unprognostic (3.98e-2)" "unprognostic (1.86e-1)" "unprognostic (9.20e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "prognostic unfavorable (4.40e-4)" "unprognostic (9.29e-2)" "unprognostic (1.29e-1)" "unprognostic (8.81e-2)" "unprognostic (1.32e-1)" 4.8 2.6 0.1 18.4 0.1 15.5 7.0 0.0 0.6 5.2 0.1 75.7 28.4 3.0 2.9 17.4 3.4 0.3 0.3 0.0 0.0 1.9 5.3 8.6 2.7 0.5 0.0 2.3 3.4 0.1 0.2 0.1 0.1 1.9 47.6 0.0 46.6 0.9 0.1 0.3 58.2 5.4 0.1 121.6 29.4 0.0 0.0 2.6 2.2 0.5 12.1 101.3 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 1.3 0.2 0.0 0.0 0.1 1.3 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.0 0.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 52.4 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.1 0.0 0.6 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3507.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 IGHV3-73 ENSG00000211976 "Immunoglobulin heavy variable 3-73" A0A0B4J1V6 14 106802694-106803233 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 141.8;lymphoid tissue: 83.0;urinary bladder: 81.7" "Cell type enhanced" "Detected in some" "B-cells: 6.1;Cholangiocytes: 1.5;Erythroid cells: 5.3;Plasma cells: 3.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 86 "memory B-cell: 69.9;naive B-cell: 42.9" "Lineage enriched" "Detected in single" 107 "B-cells: 69.9" "Cell line enhanced" "Detected in some" "Daudi: 1.4;HEL: 1.1;HL-60: 1.1;K-562: 1.7" "Immunoglobulin genes" NA NA 3200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 57: B-cells - Immune response" "prognostic favorable (7.89e-4)" "unprognostic (3.61e-2)" "unprognostic (1.55e-2)" "unprognostic (8.79e-2)" "prognostic favorable (7.25e-7)" "unprognostic (4.23e-2)" "unprognostic (4.32e-2)" "unprognostic (5.40e-1)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.37e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (4.45e-1)" "unprognostic (2.52e-1)" "unprognostic (5.25e-2)" "unprognostic (4.37e-2)" 4.4 13.3 0.0 9.4 0.0 15.8 10.5 0.0 0.5 4.7 0.3 76.9 141.8 5.1 0.0 4.0 3.9 19.1 10.4 0.0 0.0 3.0 9.8 12.3 0.0 0.1 0.0 1.5 5.9 0.0 0.5 0.1 0.2 4.3 58.0 0.0 30.6 3.9 0.4 0.2 23.6 0.4 0.1 83.0 47.5 0.4 0.0 0.0 4.1 0.0 0.2 81.7 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 69.9 0.1 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 IGHV3-74 ENSG00000224650 "Immunoglobulin heavy variable 3-74" A0A0B4J1X5 14 106810442-106811131 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 103.9;lymphoid tissue: 327.0;salivary gland: 102.6" "Cell type enriched" "Detected in some" 454 "Plasma cells: 19404.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 861 "Daudi: 2948.0" "Immunoglobulin genes" NA NA 27000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.47e-4)" "unprognostic (9.70e-2)" "prognostic favorable (8.33e-4)" "unprognostic (6.96e-3)" "unprognostic (1.42e-1)" "prognostic favorable (7.79e-4)" "unprognostic (1.06e-1)" "unprognostic (7.06e-2)" "unprognostic (3.94e-1)" "unprognostic (3.07e-2)" "unprognostic (2.42e-1)" "unprognostic (9.85e-2)" "prognostic unfavorable (4.70e-6)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-1)" 11.3 1.2 0.1 0.0 0.2 0.0 12.6 0.0 1.5 9.3 0.0 103.9 0.0 2.1 1.9 87.3 2.6 1.3 0.7 0.0 0.3 4.7 6.6 22.2 0.0 0.6 0.0 2.5 1.9 0.6 0.8 0.1 0.2 6.5 0.0 0.0 102.6 0.0 0.5 3.2 74.1 0.0 0.3 327.0 27.5 0.2 0.1 0.0 7.7 0.0 0.0 46.4 5.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 2948.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 1.1 0.2 0.0 0.0 0.1 1.2 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.7 0.3 0.4 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.3 0.6 0.0 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.0 42.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.4 27.5 0.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 19404.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.1 0.3 IGHV3OR16-10 IGHV3/OR16-10 ENSG00000233732 "Immunoglobulin heavy variable 3/OR16-10 (non-functional)" 16 32995048-32995505 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 4.8;intestine: 6.3;lymphoid tissue: 8.3;salivary gland: 7.0;stomach 1: 5.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.1" "Not detected" "Not detected" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.40e-3)" "unprognostic (4.22e-2)" "unprognostic (3.45e-2)" "unprognostic (3.41e-4)" "unprognostic (2.20e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (2.30e-1)" 0.0 0.2 0.0 1.0 0.0 1.1 0.7 0.2 0.3 0.0 0.0 4.1 6.2 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.3 0.0 7.0 0.0 0.0 0.0 2.1 1.1 0.1 1.4 5.6 3.5 0.1 0.9 0.2 0.0 8.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.4 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-12 IGHV3/OR16-12 ENSG00000270467 "Immunoglobulin heavy variable 3/OR16-12 (non-functional)" 16 33802764-33803217 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "intestine: 13.7;lymphoid tissue: 20.3;stomach 1: 9.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "memory B-cell: 4.5" "Lineage enriched" "Detected in single" 46 "B-cells: 4.5" "Not detected" "Not detected" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "unprognostic (1.38e-2)" "unprognostic (2.04e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-3)" "unprognostic (1.07e-1)" "unprognostic (7.10e-2)" "unprognostic (5.02e-1)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 7.7 0.0 1.0 3.3 0.0 0.0 1.2 0.0 8.3 13.7 0.0 0.0 1.1 0.1 1.6 0.0 0.0 0.0 0.1 0.3 1.3 1.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 4.1 0.0 2.5 0.0 0.0 0.0 3.6 0.0 0.0 2.1 9.8 0.2 0.0 1.0 0.0 0.0 20.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-13 IGHV3/OR16-13 ENSG00000271178 "Immunoglobulin heavy variable 3/OR16-13 (non-functional)" 16 33827214-33827661 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 32.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "stomach cancer: 4.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 28 "memory B-cell: 18.1" "Lineage enriched" "Detected in single" 181 "B-cells: 18.1" "Cell line enriched" "Detected in some" 818 "Daudi: 1604.0" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (7.59e-4)" "unprognostic (4.14e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.23e-5)" "unprognostic (1.34e-1)" "unprognostic (2.50e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "unprognostic (3.26e-5)" "unprognostic (6.83e-2)" "unprognostic (1.71e-1)" "unprognostic (3.09e-1)" "unprognostic (3.04e-1)" 0.2 0.0 0.1 5.3 0.0 0.6 0.4 0.0 0.1 1.3 0.0 6.7 6.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.2 0.3 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.9 0.0 7.0 0.0 0.0 0.0 4.0 0.1 0.0 32.2 4.2 0.0 0.0 1.0 0.3 0.0 10.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1604.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-17 IGHV3/OR16-17 ENSG00000259680 "Immunoglobulin heavy variable 3/OR16-17 (non-functional)" 16 33844784-33845229 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 11.5;lymphoid tissue: 24.4;stomach 1: 11.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "memory B-cell: 1.5;naive B-cell: 2.5" "Lineage enriched" "Detected in single" 26 "B-cells: 2.5" "Not detected" "Not detected" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "unprognostic (1.57e-3)" "unprognostic (1.35e-2)" "unprognostic (5.32e-2)" "prognostic favorable (6.96e-5)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-3)" "unprognostic (7.52e-2)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.58e-1)" 0.2 0.1 0.0 9.3 0.0 4.3 3.3 0.0 0.0 4.0 0.0 11.5 9.6 0.1 0.0 4.0 0.1 0.5 1.0 0.0 0.0 0.0 0.4 1.0 1.3 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 6.4 0.0 4.3 0.0 0.0 0.0 5.6 0.4 0.0 4.1 11.8 0.0 0.0 0.5 0.0 0.0 24.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-8 IGHV3/OR16-8 ENSG00000271130 "Immunoglobulin heavy variable 3/OR16-8 (non-functional)" 16 33009175-33009620 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 32.0;lymphoid tissue: 49.4;stomach 1: 32.9;urinary bladder: 40.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 13 "memory B-cell: 7.3" "Lineage enriched" "Detected in single" 74 "B-cells: 7.3" "Not detected" "Not detected" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "unprognostic (2.58e-4)" "unprognostic (3.25e-2)" "unprognostic (9.53e-3)" "unprognostic (1.56e-1)" "unprognostic (2.43e-4)" "unprognostic (1.31e-1)" "unprognostic (4.47e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (2.60e-7)" "unprognostic (2.24e-2)" "unprognostic (4.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.16e-2)" 2.3 0.8 0.0 13.8 0.0 5.9 4.5 0.0 0.0 2.7 0.0 30.1 32.0 0.2 0.0 1.9 0.7 5.3 0.0 0.0 0.0 0.1 0.9 3.2 3.6 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 14.8 0.0 10.0 0.0 0.0 0.0 9.0 1.8 0.0 5.8 32.9 0.1 0.0 3.0 0.7 0.0 49.4 40.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-9 IGHV3/OR16-9 ENSG00000270472 "Immunoglobulin heavy variable 3/OR16-9 (non-functional)" 16 32066065-32066358 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 73.2;lymphoid tissue: 88.5;stomach 1: 79.0;urinary bladder: 54.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 136 "memory B-cell: 20.0;naive B-cell: 7.1" "Lineage enriched" "Detected in single" 200 "B-cells: 20.0" "Not detected" "Not detected" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "unprognostic (1.32e-3)" "unprognostic (8.31e-2)" "unprognostic (2.49e-3)" "prognostic favorable (1.29e-4)" "unprognostic (2.29e-1)" "unprognostic (5.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.31e-1)" "unprognostic (1.01e-5)" "unprognostic (1.57e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "unprognostic (1.55e-1)" 11.1 9.8 0.1 32.9 0.0 13.7 17.1 0.3 0.6 8.3 0.0 73.2 45.8 0.9 0.0 26.5 1.5 8.3 2.9 0.0 0.1 0.8 3.7 9.1 13.0 0.6 0.0 6.2 1.3 0.1 0.0 0.0 0.4 1.1 37.7 0.0 49.3 0.0 0.0 0.0 38.6 0.3 0.4 27.0 79.0 0.3 0.1 8.6 0.1 0.0 88.5 54.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.3 0.6 0.0 0.1 0.6 0.0 0.4 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV4-28 ENSG00000211952 "Immunoglobulin heavy variable 4-28" A0A0C4DH34 14 106324254-106324760 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 44.8;lymphoid tissue: 87.4;salivary gland: 39.9;stomach 1: 30.7;urinary bladder: 122.6" "Cell type enriched" "Detected in some" 230 "Plasma cells: 346.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "spinal cord: 1.3" "Group enriched" "Detected in some" 206 "memory B-cell: 28.7;naive B-cell: 12.5" "Lineage enriched" "Detected in single" 288 "B-cells: 28.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (3.14e-3)" "unprognostic (1.32e-2)" "unprognostic (8.05e-2)" "unprognostic (6.64e-3)" "prognostic favorable (2.63e-4)" "unprognostic (1.58e-2)" "unprognostic (7.52e-2)" "unprognostic (1.03e-1)" "unprognostic (5.74e-2)" "unprognostic (4.76e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.45e-1)" "unprognostic (1.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-1)" 1.8 11.3 0.0 40.9 0.0 6.0 12.9 0.0 0.2 3.3 0.1 44.8 44.8 1.0 0.0 12.5 1.9 7.7 1.2 0.0 0.0 1.8 2.4 8.9 10.0 0.0 0.0 3.5 0.4 0.0 0.2 0.0 0.0 0.8 44.1 0.0 39.9 1.7 0.0 0.5 30.2 2.0 1.3 42.3 30.7 0.5 0.0 5.8 4.3 0.0 87.4 122.6 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGHV4-31 ENSG00000231475 "Immunoglobulin heavy variable 4-31" A0A087WSY4 14 106349283-106349792 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 467.7;urinary bladder: 190.8" "Cell type enriched" "Detected in some" 183 "Plasma cells: 1651.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "spinal cord: 1.6" "Group enriched" "Detected in some" 48 "memory B-cell: 43.6;naive B-cell: 19.4" "Lineage enriched" "Detected in single" 66 "B-cells: 43.6" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.4;SH-SY5Y: 1.0" "Immunoglobulin genes" NA NA 710000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.53e-3)" "unprognostic (9.05e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.74e-4)" "prognostic favorable (4.64e-5)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (1.04e-1)" "unprognostic (5.05e-2)" "unprognostic (1.72e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (6.38e-6)" "unprognostic (2.00e-1)" "unprognostic (1.48e-1)" "unprognostic (3.63e-1)" "unprognostic (1.09e-1)" 4.3 1.7 0.0 48.0 0.0 5.4 37.6 0.0 0.3 15.4 0.0 103.8 72.1 6.5 1.5 32.2 5.3 105.2 11.7 0.0 0.7 3.9 6.3 19.1 104.0 0.2 0.2 58.0 4.7 0.2 0.5 0.0 0.1 11.4 24.9 0.0 53.2 8.4 0.1 1.3 90.4 3.1 1.6 138.6 87.8 1.3 0.2 76.0 15.7 0.0 467.7 190.8 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.1 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.2 0.1 1.6 0.2 0.1 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1651.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGHV4-34 ENSG00000211956 "Immunoglobulin heavy variable 4-34" P06331 14 106373663-106374145 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 283.3;urinary bladder: 278.5" "Cell type enriched" "Detected in some" 197 "Plasma cells: 15696.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 602 "U-698: 5353.4" "Immunoglobulin genes" NA NA 4300000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (5.34e-3)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (5.34e-3)" "unprognostic (6.12e-2)" "prognostic favorable (2.77e-4)" "unprognostic (8.06e-2)" "unprognostic (3.89e-1)" "unprognostic (1.23e-1)" "unprognostic (4.27e-2)" "unprognostic (2.68e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.55e-6)" "unprognostic (2.61e-1)" "unprognostic (1.01e-1)" "unprognostic (1.75e-1)" "unprognostic (7.51e-2)" 7.9 3.0 0.0 0.0 0.3 0.0 9.8 0.1 1.5 12.0 0.1 83.5 0.0 5.5 0.9 7.3 22.5 0.0 2.3 0.0 0.2 7.2 7.0 33.4 0.0 0.6 0.2 22.0 1.3 0.4 0.9 0.3 0.3 3.8 2.2 0.0 82.1 0.0 0.3 2.8 54.2 0.3 0.1 283.3 48.0 0.3 0.1 0.0 19.3 0.0 0.0 278.5 4.0 1.4 3.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 2.6 3.2 0.0 0.0 1.4 0.0 4.1 0.0 0.3 0.0 0.6 3.7 0.0 0.1 8.8 0.4 1.8 0.0 0.8 5353.4 0.0 3.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.1 0.5 0.0 0.8 0.0 0.3 0.1 1.5 0.0 0.2 0.6 0.2 0.3 0.1 0.1 1.4 0.0 0.0 0.0 0.0 79.4 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15696.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.6 0.0 0.0 0.0 IGHV4-39 ENSG00000211959 "Immunoglobulin heavy variable 4-39" P01824 14 106421711-106422218 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 251.6;lymphoid tissue: 474.9;salivary gland: 247.1;urinary bladder: 541.3" "Cell type enriched" "Detected in some" 432 "Plasma cells: 48104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.6;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.3;Daudi: 1.8;HL-60: 2.4;NB-4: 2.2;RH-30: 2.1;RPMI-8226: 1.4;U-266/70: 2.1;U-698: 2.0" "Immunoglobulin genes" NA NA 5000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.95e-3)" "unprognostic (1.46e-2)" "unprognostic (5.65e-2)" "unprognostic (2.38e-3)" "unprognostic (4.48e-2)" "unprognostic (2.63e-1)" "unprognostic (1.77e-1)" "unprognostic (2.23e-2)" "unprognostic (2.35e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (2.04e-2)" "unprognostic (2.77e-1)" "unprognostic (7.68e-2)" "unprognostic (8.33e-2)" 17.8 6.5 0.5 378.0 0.5 14.5 33.2 0.1 0.8 24.0 1.5 251.6 4.4 12.5 2.5 19.1 17.7 0.0 11.4 0.1 0.2 13.8 13.8 54.9 0.0 0.8 1.2 17.6 3.7 1.2 1.4 0.0 0.6 7.1 5.0 0.0 247.1 9.5 0.5 12.1 143.6 2.0 0.1 474.9 108.1 1.3 0.4 2.8 37.2 0.0 5.3 541.3 13.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 1.1 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.2 0.2 0.0 2.1 0.0 2.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.2 1.6 0.1 0.1 0.1 1.7 0.5 0.1 1.1 0.1 0.1 0.2 0.1 0.0 0.5 0.5 0.1 0.8 0.1 0.2 0.8 1.2 0.6 0.1 0.4 0.3 0.0 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 111.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48104.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.3 0.0 IGHV4-4 ENSG00000276775 "Immunoglobulin heavy variable 4-4" A0A075B6R2 14 106011922-106012420 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 567.7;urinary bladder: 768.4" "Cell type enriched" "Detected in some" 285 "Plasma cells: 2624.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "midbrain: 4.8" "Group enriched" "Detected in some" 23 "memory B-cell: 56.6;naive B-cell: 31.2" "Lineage enriched" "Detected in many" 30 "B-cells: 56.6" "Cell line enriched" "Detected in some" 18 "Karpas-707: 34.5" "Immunoglobulin genes" NA NA 3800000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.03e-3)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.60e-6)" "unprognostic (2.24e-1)" "unprognostic (6.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.10e-1)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.69e-5)" "unprognostic (3.16e-1)" "unprognostic (2.59e-1)" "unprognostic (1.55e-1)" "unprognostic (2.05e-1)" 9.4 2.5 0.0 131.4 0.0 17.8 63.6 0.0 0.2 37.5 0.1 205.2 159.9 3.8 0.8 59.8 53.4 104.9 0.9 0.0 0.1 5.5 6.6 36.9 173.2 0.3 4.8 10.0 6.0 0.4 0.4 0.0 0.1 4.0 140.2 0.0 78.2 15.0 0.3 3.8 78.6 13.4 0.4 186.4 175.0 1.6 0.1 31.8 16.7 0.0 567.7 768.4 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 34.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 56.6 0.2 0.2 0.0 31.2 0.6 0.0 0.0 0.0 0.0 1.9 0.6 4.1 0.0 0.0 0.0 0.2 0.0 0.1 0.3 4.8 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2624.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 IGHV4-59 ENSG00000224373 "Immunoglobulin heavy variable 4-59" P01825 14 106627249-106627825 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 525.9;lymphoid tissue: 911.2;urinary bladder: 702.5" "Cell type enriched" "Detected in some" 301 "Plasma cells: 12374.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "spinal cord: 2.0" "Group enriched" "Detected in some" 37 "memory B-cell: 169.0;naive B-cell: 77.2" "Lineage enriched" "Detected in many" 51 "B-cells: 169.0" "Cell line enhanced" "Detected in some" "MOLT-4: 8.1;SCLC-21H: 2.0;SH-SY5Y: 4.2" "Immunoglobulin genes" NA NA 5500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.62e-5)" "unprognostic (3.95e-2)" "unprognostic (7.25e-3)" "unprognostic (9.13e-2)" "unprognostic (1.13e-2)" "prognostic favorable (9.18e-5)" "unprognostic (2.88e-2)" "unprognostic (3.55e-1)" "unprognostic (2.16e-1)" "unprognostic (3.22e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (6.04e-2)" "unprognostic (2.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.76e-1)" 23.9 3.2 0.0 260.5 0.3 95.5 89.3 0.0 1.1 40.4 0.8 525.9 301.0 12.1 2.7 89.6 17.9 168.0 27.9 0.0 0.6 13.8 20.6 89.9 148.0 0.3 0.1 23.5 10.3 1.7 1.5 0.3 0.2 12.6 456.0 0.0 225.7 8.8 0.5 3.6 222.6 19.5 2.0 465.3 260.5 15.0 0.2 86.4 44.1 0.0 911.2 702.5 10.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 8.1 1.0 0.3 0.3 0.0 0.8 1.0 0.7 0.0 0.0 2.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.4 0.4 0.1 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 169.0 0.0 0.2 1.4 77.2 0.1 0.0 0.0 0.0 0.1 3.3 0.1 11.9 0.0 0.3 0.0 1.1 0.0 0.6 0.3 0.1 0.2 2.0 0.2 0.3 0.0 0.0 0.6 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.2 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12374.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.6 0.0 0.5 0.0 IGHV4-61 ENSG00000211970 "Immunoglobulin heavy variable 4-61" A0A0C4DH41 14 106639119-106639657 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 206.7;lymphoid tissue: 385.2;stomach 1: 143.1" "Cell type enriched" "Detected in some" 98 "Plasma cells: 2432.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 43 "memory B-cell: 39.0;naive B-cell: 25.5" "Lineage enriched" "Detected in single" 52 "B-cells: 39.0" "Cell line enriched" "Detected in single" 11 "MOLT-4: 8.7" "Immunoglobulin genes" NA NA 4400000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.11e-3)" "unprognostic (6.59e-2)" "unprognostic (4.92e-2)" "unprognostic (1.12e-2)" "prognostic favorable (3.71e-6)" "unprognostic (6.96e-2)" "unprognostic (5.98e-2)" "unprognostic (1.26e-1)" "unprognostic (1.72e-2)" "unprognostic (9.95e-2)" "unprognostic (9.02e-2)" "prognostic unfavorable (4.13e-6)" "unprognostic (3.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.24e-1)" "unprognostic (2.32e-2)" 6.4 44.4 0.0 97.5 0.1 30.8 56.0 0.0 0.2 10.1 0.1 206.7 185.7 5.8 0.0 15.5 5.0 22.4 3.1 0.0 0.1 5.5 10.5 28.2 54.4 0.3 0.1 10.4 1.3 0.2 0.7 0.0 0.3 4.1 121.8 0.0 104.3 7.0 0.2 0.7 86.5 8.0 0.3 181.3 143.1 0.9 0.0 30.1 23.0 0.0 385.2 43.9 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 8.7 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 39.0 0.0 0.1 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.6 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2432.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 IGHV5-51 ENSG00000211966 "Immunoglobulin heavy variable 5-51" A0A0C4DH38 14 106578744-106579236 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 245.7;lymphoid tissue: 547.1;salivary gland: 224.5;urinary bladder: 353.3" "Cell type enriched" "Detected in some" 87 "Plasma cells: 5993.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.7;K-562: 2.4;NB-4: 1.7;TIME: 3.3" HPA006014 Approved "Immunoglobulin genes" NA NA 2700000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA006014: " "unprognostic (2.03e-3)" "unprognostic (1.00e-1)" "unprognostic (3.21e-2)" "unprognostic (7.65e-3)" "unprognostic (1.80e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.40e-2)" "unprognostic (1.15e-1)" "unprognostic (3.92e-2)" "unprognostic (6.47e-2)" "unprognostic (2.49e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.31e-7)" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.70e-1)" "unprognostic (1.17e-1)" 20.0 4.8 0.3 0.0 0.0 0.0 25.9 0.1 1.7 17.8 0.7 245.7 0.0 8.6 6.3 19.1 15.2 27.1 2.1 0.1 0.7 15.4 15.0 56.2 0.0 0.9 0.0 8.8 17.1 1.0 2.2 0.6 0.2 11.2 0.0 0.0 224.5 0.0 0.7 3.2 144.8 1.7 0.6 547.1 99.9 4.8 0.1 0.0 25.6 0.0 0.0 353.3 14.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 1.3 1.2 0.8 0.0 0.1 0.0 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 1.7 0.1 0.7 0.9 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.0 0.0 68.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.8 44.9 0.0 0.0 0.0 0.7 1.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5993.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 IGHV6-1 ENSG00000211933 "Immunoglobulin heavy variable 6-1" A0A0B4J1U7 14 105939756-105940253 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 441.3;lymphoid tissue: 159.0" "Cell type enriched" "Detected in some" 175 "Plasma cells: 2295.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "naive B-cell: 19.7" "Lineage enriched" "Detected in single" 53 "B-cells: 19.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 930000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.35e-4)" "unprognostic (9.66e-2)" "unprognostic (4.55e-3)" "unprognostic (1.26e-1)" "prognostic favorable (1.85e-5)" "unprognostic (1.84e-1)" "unprognostic (2.13e-2)" "unprognostic (1.89e-3)" "unprognostic (1.41e-1)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.48e-6)" "unprognostic (3.69e-2)" "unprognostic (6.93e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" 13.0 2.1 0.3 0.0 0.1 0.0 7.5 0.0 0.4 4.2 0.2 441.3 0.0 1.2 0.0 17.9 4.3 1.5 2.7 0.0 0.1 3.2 6.2 13.6 0.0 0.3 0.1 0.9 11.5 0.0 0.3 0.0 0.1 1.6 0.0 0.0 56.7 8.6 0.1 2.0 40.9 11.2 0.3 159.0 19.5 0.3 0.2 0.0 6.8 0.0 0.0 3.7 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.1 19.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.1 0.3 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2295.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 IGHV7-81 ENSG00000211979 "Immunoglobulin heavy variable 7-81 (non-functional)" A0A0B4J1V7 14 106874583-106875071 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 12.7;lymphoid tissue: 18.3;stomach 1: 12.3" "Group enriched" "Detected in some" 12 "B-cells: 1.5;Plasma cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory B-cell: 5.5;naive B-cell: 3.9" "Lineage enriched" "Detected in single" 14 "B-cells: 5.5" "Cell line enhanced" "Detected in some" "A549: 1.1;Daudi: 6.1;OE19: 1.2;U-698: 2.0" "Immunoglobulin genes" NA NA 270000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (5.71e-4)" "unprognostic (3.87e-1)" "unprognostic (1.06e-1)" "unprognostic (6.85e-2)" "unprognostic (2.67e-3)" "unprognostic (2.24e-1)" "unprognostic (2.07e-1)" "unprognostic (1.14e-2)" "unprognostic (6.16e-5)" "unprognostic (1.69e-3)" "unprognostic (1.78e-2)" "unprognostic (1.08e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-1)" "unprognostic (3.63e-2)" 0.1 0.1 0.0 8.4 0.0 4.6 3.6 0.0 0.0 0.3 0.0 7.6 6.4 0.4 0.0 0.6 0.3 7.9 0.2 0.0 0.0 0.3 0.2 1.8 4.2 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 2.3 12.7 0.0 5.0 0.1 0.0 0.2 6.2 0.4 0.0 2.3 12.3 0.1 0.0 1.4 0.0 0.0 18.3 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.3 0.1 0.0 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV8-51-1 "IGHV(III)-51-1, IGHVIII-51-1" ENSG00000254167 "Immunoglobulin heavy variable IGHV8-51-1 (non-functional)" 14 106583501-106583807 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "lymphoid tissue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "MOLT-4: 10.8" "Immunoglobulin genes" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKC HCAK1 ENSG00000211592 "Immunoglobulin kappa constant" 2 88857161-88857683 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "intestine: 35196.7;lymphoid tissue: 63075.6" "Group enriched" "Detected in many" 12 "B-cells: 72318.1;Plasma cells: 96515.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 21 "memory B-cell: 39143.0;naive B-cell: 35081.5" "Lineage enriched" "Detected in all" 23 "B-cells: 39143.0" "Group enriched" "Detected in many" 6 "Daudi: 9909.1;U-266/70: 10337.6;U-266/84: 3927.9;U-698: 12154.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB015377 Uncertain "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB015377: AB_2251264" "prognostic favorable (6.59e-4)" "unprognostic (1.04e-2)" "unprognostic (3.54e-2)" "unprognostic (1.06e-2)" "unprognostic (8.82e-3)" "prognostic favorable (1.18e-4)" "unprognostic (1.24e-1)" "unprognostic (1.79e-1)" "unprognostic (3.19e-2)" "unprognostic (2.81e-3)" "unprognostic (2.82e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (2.17e-9)" "unprognostic (1.85e-1)" "unprognostic (2.47e-1)" "unprognostic (9.26e-2)" "unprognostic (1.59e-1)" 1025.4 2379.8 13.1 20500.0 13.3 6315.2 11287.7 11.3 33.6 3649.2 26.7 35196.7 24515.5 877.3 474.1 5708.4 1137.6 5995.3 810.4 11.4 16.7 1176.6 1580.5 5824.2 21356.1 25.1 18.2 2214.9 462.9 72.6 101.8 22.2 15.3 843.6 30618.3 4.0 19606.1 2123.2 32.9 250.8 17061.1 1259.7 43.5 26904.1 22740.5 1083.9 13.4 8576.0 2151.1 8.1 63075.6 24817.5 705.0 20.2 17.1 0.0 0.0 0.0 0.0 0.0 103.7 0.0 0.0 0.1 0.0 0.0 0.0 9909.1 15.3 0.0 1.0 22.2 0.0 0.0 0.0 510.2 0.0 30.9 0.0 0.0 0.0 67.8 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.8 0.4 0.0 0.0 18.3 83.2 28.8 0.0 0.0 16.7 56.4 1509.5 0.6 0.0 79.6 146.1 19.6 1.5 6.0 0.5 0.5 17.2 66.7 0.0 56.9 24.3 44.0 10337.6 3927.9 12154.4 0.0 28.9 0.0 47.5 55.6 31.6 24.6 11.2 21.7 39143.0 28.3 18.3 46.6 35081.5 15.2 16.8 65.2 24.1 29.1 1735.4 23.7 8567.0 13.1 13.3 11.3 33.6 11.4 16.7 25.1 18.2 15.3 43.5 13.4 20.2 58.6 336.5 1863.8 0.0 72318.1 0.0 189.2 0.0 2.2 0.0 8.8 7.0 5.7 163.0 88.5 0.0 0.0 48.0 452.1 39.8 3.9 0.0 2.8 0.7 0.3 72.8 77.8 1658.9 0.0 0.2 37.3 186.5 64.7 0.4 849.0 15.5 340.2 334.8 8.9 0.0 0.0 35.1 0.0 496.3 0.0 11.0 0.0 64.4 0.0 0.0 26.4 0.0 59.8 0.0 0.0 0.0 25.9 0.4 96515.7 193.2 0.3 45.2 12.4 0.0 0.0 3.7 38.4 0.3 0.2 5.9 0.0 49.4 6505.3 0.1 50.2 1.9 IGKJ1 J1 ENSG00000211597 "Immunoglobulin kappa joining 1" A0A0A0MT89 2 88861886-88861923 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 3082.3;lymphoid tissue: 3301.5;salivary gland: 1202.6;stomach 1: 2816.8;urinary bladder: 1106.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 418 "memory B-cell: 38345.4;naive B-cell: 32121.1;plasmacytoid DC: 14778.6" "Group enriched" "Detected in all" 390 "B-cells: 38345.4;dendritic cells: 14778.6" "Cell line enriched" "Detected in many" 4 "U-266/70: 21925.7" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" 70.6 227.2 1.9 3301.5 1.5 424.8 363.1 1.3 9.2 71.7 5.0 1960.8 3082.3 41.6 0.0 278.0 18.1 157.4 31.0 3.2 2.2 31.7 92.0 382.5 839.3 3.4 2.4 127.7 50.3 2.0 0.0 6.3 2.9 50.4 1743.7 0.2 1202.6 16.4 6.9 8.8 2231.5 61.2 3.4 1516.0 2816.8 31.2 2.1 115.3 6.2 0.0 2770.1 1106.5 0.0 2.9 22.9 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 7.4 0.0 9.9 2.5 0.0 0.0 14.6 0.0 0.0 0.0 851.1 0.0 10.1 0.0 0.0 0.0 34.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 10.3 12.1 11.8 0.0 0.0 23.1 0.0 4365.8 0.0 0.0 10.3 18.7 0.0 0.0 4.9 0.0 0.0 31.0 0.0 0.0 9.7 2.4 34.6 21925.7 5461.9 93.7 0.0 6.3 0.0 48.3 44.8 22.7 19.1 17.9 25.4 38345.4 27.2 13.8 57.2 32121.1 20.1 20.9 68.0 38.9 26.9 14778.6 29.9 3897.0 1.9 1.5 1.3 9.2 3.2 2.2 3.4 2.4 2.9 3.4 2.1 2.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKJ2 J2 ENSG00000211596 "Immunoglobulin kappa joining 2" 2 88861525-88861563 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 2670.6;lymphoid tissue: 2226.1;salivary gland: 1187.7;stomach 1: 1719.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 50 "memory B-cell: 22200.6;naive B-cell: 20663.6" "Lineage enriched" "Detected in all" 52 "B-cells: 22200.6" "Group enriched" "Detected in many" 7 "HDLM-2: 213.9;RPMI-8226: 179.1" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" 67.9 154.0 0.6 1862.6 0.9 296.5 312.9 0.1 4.0 158.7 0.7 1762.7 2670.6 37.5 0.0 308.3 14.3 114.1 19.6 0.6 0.6 27.0 61.7 236.7 693.3 4.3 1.4 71.6 72.5 1.9 0.0 1.1 1.2 46.0 1364.3 0.0 1187.7 20.2 2.9 5.2 1974.3 28.2 1.5 1097.1 1719.7 44.8 0.9 73.5 5.1 0.0 2226.1 494.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.1 0.0 0.0 3.5 0.0 0.0 0.0 213.9 0.0 9.7 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 8.0 3.6 0.0 0.0 7.4 2.5 179.1 0.0 0.0 3.2 17.5 4.8 0.0 0.0 0.0 0.0 29.6 10.7 0.0 3.4 3.7 7.6 5.3 0.0 29.0 0.0 1.8 0.0 19.7 33.6 12.8 10.3 7.7 12.8 22200.6 15.0 8.1 23.3 20663.6 9.5 9.6 42.6 10.8 18.6 430.3 17.4 2451.2 0.6 0.9 0.1 4.0 0.6 0.6 4.3 1.4 1.2 1.5 0.9 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGKJ3 ENSG00000211595 "Immunoglobulin kappa joining 3" 2 88861221-88861258 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 1010.8;lymphoid tissue: 997.2;stomach 1: 710.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 12 "spinal cord: 18.3" "Group enriched" "Detected in all" 26 "memory B-cell: 8663.4;naive B-cell: 7153.9" "Lineage enriched" "Detected in all" 28 "B-cells: 8663.4" "Group enriched" "Detected in some" 6 "HDLM-2: 105.2;RPMI-8226: 89.2;U-698: 41.2" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 44: HDLM-2 - Immune response" 15.1 19.6 0.8 886.7 0.7 115.0 111.2 0.3 1.3 19.2 0.5 587.3 1010.8 7.6 0.0 68.8 7.9 44.8 9.3 0.9 0.6 14.3 41.1 101.9 490.2 1.2 0.5 31.1 0.0 0.0 0.0 1.9 1.5 18.2 546.6 0.6 362.3 12.6 8.7 2.5 726.3 19.9 18.3 548.6 710.1 9.7 0.9 53.9 5.1 3.9 997.2 236.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 105.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 89.2 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.9 0.0 0.0 41.2 0.0 0.0 0.0 17.0 8.6 57.9 1.9 1.1 9.2 8663.4 3.0 3.3 5.9 7153.9 5.7 5.1 61.8 7.1 15.2 309.9 7.8 660.0 0.8 0.7 0.3 1.3 0.9 0.6 1.2 0.5 1.5 18.3 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKJ4 ENSG00000211594 "Immunoglobulin kappa joining 4" 2 88860886-88860922 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 3282.9;lymphoid tissue: 2905.5;stomach 1: 2295.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 42 "memory B-cell: 36413.7;naive B-cell: 27723.7" "Lineage enriched" "Detected in all" 48 "B-cells: 36413.7" "Cell line enhanced" "Detected in some" "BEWO: 16.9;Daudi: 23.5;HDLM-2: 58.4;RPMI-8226: 43.3;SH-SY5Y: 27.6;U-698: 25.7" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 44: HDLM-2 - Immune response" 80.0 268.7 0.6 2905.5 0.7 407.6 414.6 0.3 4.1 110.0 0.5 1844.1 3282.9 29.5 62.5 433.0 33.3 138.1 34.8 0.6 1.1 48.2 104.6 481.3 932.6 2.9 0.7 117.5 29.3 1.7 0.0 1.3 1.3 56.4 1849.6 0.3 1142.3 54.8 3.9 17.3 2184.0 78.1 2.6 1246.0 2295.9 39.7 1.8 113.5 11.4 0.0 2661.5 645.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.0 9.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 2.0 10.4 0.0 0.0 0.0 0.0 9.1 43.3 0.0 0.0 6.7 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.3 8.5 3.3 0.0 25.7 0.0 0.0 0.0 114.4 64.9 20.3 24.9 9.5 16.8 36413.7 15.8 15.2 32.5 27723.7 22.7 16.1 60.0 21.5 25.4 759.9 22.8 3519.3 0.6 0.7 0.3 4.1 0.6 1.1 2.9 0.7 1.3 2.6 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKJ5 ENSG00000211593 "Immunoglobulin kappa joining 5" 2 88860568-88860605 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "intestine: 1221.3;lymphoid tissue: 1365.8;salivary gland: 643.7;stomach 1: 1066.6;urinary bladder: 436.6" "Cell type enriched" "Detected in single" 13 "B-cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 24 "memory B-cell: 9254.1;naive B-cell: 8737.5" "Lineage enriched" "Detected in all" 25 "B-cells: 9254.1" "Cell line enriched" "Detected in some" 24 "U-698: 3392.4" NA NA "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (4.92e-2)" "unprognostic (2.57e-2)" "unprognostic (3.68e-2)" "unprognostic (9.30e-3)" "prognostic favorable (1.83e-4)" "unprognostic (1.12e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (5.49e-6)" "unprognostic (2.00e-2)" "unprognostic (4.25e-1)" "unprognostic (2.02e-1)" 25.2 42.2 0.5 1365.8 0.7 164.5 236.5 0.6 4.5 73.7 0.3 1194.4 1221.3 13.4 5.8 130.7 8.8 78.5 26.1 0.9 0.7 18.0 30.8 157.6 529.7 1.6 0.6 63.3 29.2 6.6 0.0 4.1 1.2 22.8 1171.9 0.0 643.7 17.1 0.0 5.8 1078.7 40.6 4.9 672.7 1066.6 12.4 0.7 61.5 4.3 0.0 1213.5 436.6 0.0 0.9 17.7 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 142.3 0.0 0.0 0.0 0.0 0.0 7.2 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 58.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.3 3.5 11.4 3.2 1.9 3392.4 0.0 8.1 0.0 3.3 10.1 10.2 3.8 1.3 2.2 9254.1 18.4 3.5 7.4 8737.5 9.5 3.4 9.4 7.6 3.4 373.6 8.8 1167.3 0.5 0.7 0.6 4.5 0.9 0.7 1.6 0.6 1.2 4.9 0.7 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1-12 "IGKV112, L19" ENSG00000243290 "Immunoglobulin kappa variable 1-12" A0A0C4DH73 2 89040224-89040745 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 395.8;lymphoid tissue: 788.8" "Cell type enriched" "Detected in some" 92 "Plasma cells: 12442.9" "Cancer enhanced" "Detected in many" "stomach cancer: 17.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 820 "memory B-cell: 259.8;naive B-cell: 164.2" "Lineage enriched" "Detected in single" 1005 "B-cells: 259.8" "Cell line enhanced" "Detected in some" "BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9" HPA048721 Approved "Immunoglobulin genes" NA NA 13000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (6.09e-4)" "prognostic favorable (1.59e-4)" "unprognostic (7.33e-2)" "unprognostic (3.74e-2)" "prognostic favorable (3.85e-5)" "unprognostic (5.89e-2)" "unprognostic (5.74e-1)" "unprognostic (7.13e-2)" "unprognostic (6.15e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (6.59e-8)" "unprognostic (1.18e-1)" "unprognostic (1.84e-1)" "unprognostic (2.68e-1)" "unprognostic (1.71e-1)" 13.6 144.8 0.0 201.7 0.2 73.1 116.8 0.0 0.4 50.8 0.2 395.8 240.6 7.3 0.0 57.1 16.2 69.6 9.9 0.1 0.1 13.7 17.8 65.3 238.6 0.6 0.0 18.1 7.2 0.2 1.4 0.0 1.1 7.2 278.6 0.0 219.0 5.4 0.4 2.8 231.2 11.2 1.2 360.5 254.9 6.7 0.0 69.5 32.7 0.0 788.8 243.3 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 259.8 0.0 0.1 0.1 164.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 24.3 0.0 0.2 0.0 0.4 0.1 0.1 0.6 0.0 1.1 1.2 0.0 0.3 0.0 0.0 0.0 0.0 134.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 20.4 0.0 0.0 0.0 1.8 1.6 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12442.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.3 5.0 0.0 0.0 0.0 IGKV1-16 "IGKV116, L1" ENSG00000240864 "Immunoglobulin kappa variable 1-16" P04430 2 89099859-89100361 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 279.7;lymphoid tissue: 597.8;urinary bladder: 260.3" "Cell type enriched" "Detected in some" 559 "Plasma cells: 18463.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 523 "memory B-cell: 164.7;naive B-cell: 112.8" "Lineage enriched" "Detected in single" 621 "B-cells: 164.7" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" HPA048721 Approved "Immunoglobulin genes" NA NA 10000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (2.63e-4)" "unprognostic (7.81e-2)" "unprognostic (1.43e-3)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.69e-2)" "unprognostic (1.87e-1)" "unprognostic (8.35e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (2.84e-1)" "unprognostic (1.17e-1)" "unprognostic (3.84e-2)" "unprognostic (5.82e-2)" 11.8 4.7 0.1 159.1 0.1 40.0 75.9 0.0 0.8 76.0 0.6 279.7 199.4 6.3 0.5 34.3 6.6 99.0 11.4 0.0 0.1 9.2 14.9 40.5 155.0 0.2 0.0 17.7 2.0 0.1 3.6 0.1 0.1 5.6 235.6 0.0 126.9 30.9 0.8 0.7 143.6 11.8 0.1 315.4 158.9 2.0 0.1 45.7 18.4 0.0 597.8 260.3 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 164.7 0.0 0.0 0.1 112.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 16.9 0.1 0.1 0.0 0.8 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.6 21.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18463.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 IGKV1-17 "A30, IGKV117" ENSG00000240382 "Immunoglobulin kappa variable 1-17" P01599 2 89117342-89117844 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 375.0;lymphoid tissue: 454.4" "Cell type enriched" "Detected in some" 113 "Plasma cells: 4510.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 425 "memory B-cell: 105.7;naive B-cell: 82.2" "Lineage enriched" "Detected in single" 478 "B-cells: 105.7" "Cell line enhanced" "Detected in some" "Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4" HPA048721 Approved "Immunoglobulin genes" NA NA 8400000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (7.72e-3)" "unprognostic (1.60e-1)" "unprognostic (7.37e-3)" "unprognostic (1.78e-2)" "unprognostic (5.08e-3)" "prognostic favorable (4.11e-4)" "unprognostic (8.04e-2)" "unprognostic (1.00e-1)" "unprognostic (9.59e-2)" "unprognostic (1.76e-2)" "unprognostic (5.06e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (3.44e-7)" "unprognostic (3.12e-3)" "unprognostic (8.83e-2)" "unprognostic (3.80e-1)" "unprognostic (7.28e-2)" 12.8 26.5 0.1 183.7 0.2 27.7 87.1 0.0 0.7 11.9 0.4 358.5 294.8 6.6 4.1 54.7 12.4 55.7 10.9 0.0 0.1 10.3 14.2 36.5 95.7 0.6 0.0 12.4 3.3 1.1 1.0 0.1 0.2 5.5 375.0 0.0 134.3 31.0 1.3 1.2 152.7 4.7 0.1 306.1 159.7 2.4 0.3 45.6 25.8 0.0 454.4 182.6 6.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.8 2.0 0.0 0.0 0.5 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 105.7 0.0 0.0 0.1 82.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 12.6 0.1 0.2 0.0 0.7 0.0 0.1 0.6 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4510.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 IGKV1-27 "A20, IGKV127" ENSG00000244575 "Immunoglobulin kappa variable 1-27" A0A075B6S5 2 89213423-89213928 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 268.0;lymphoid tissue: 347.1;salivary gland: 177.6" "Cell type enriched" "Detected in some" 126 "Plasma cells: 4951.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 683 "memory B-cell: 152.7;naive B-cell: 185.3" "Lineage enriched" "Detected in single" 748 "B-cells: 185.3" "Cell line enhanced" "Detected in single" "BEWO: 1.8" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 8300000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (2.56e-5)" "unprognostic (6.50e-3)" "unprognostic (2.65e-2)" "unprognostic (1.68e-3)" "unprognostic (1.72e-2)" "prognostic favorable (8.14e-4)" "unprognostic (9.60e-2)" "unprognostic (1.31e-1)" "unprognostic (2.41e-1)" "unprognostic (6.99e-3)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (8.84e-5)" "unprognostic (3.23e-2)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.67e-2)" 17.2 9.2 0.0 133.5 0.0 28.5 70.0 0.0 0.4 16.8 0.1 268.0 183.3 6.2 7.7 30.4 6.9 37.5 10.7 0.1 0.1 11.8 9.7 55.2 124.7 0.7 0.3 8.8 4.9 0.2 1.0 0.0 0.1 6.4 212.3 0.0 177.6 8.8 0.6 0.9 200.2 5.1 0.2 276.9 91.9 1.0 0.0 46.9 19.4 0.0 347.1 87.7 6.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 152.7 0.1 0.1 0.1 185.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 15.8 0.0 0.0 0.0 0.4 0.1 0.1 0.7 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 12.2 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4951.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 IGKV1-33 "IGKV133, O18" ENSG00000242076 "Immunoglobulin kappa variable 1-33" P01594 2 89266494-89268506 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Bence-Jones protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1727.5;stomach 1: 627.3;urinary bladder: 623.3" "Cell type enriched" "Detected in some" 131 "Plasma cells: 2044.1" "Cancer enhanced" "Detected in many" "stomach cancer: 5.5" "Region enriched" "Detected in many" 7 "spinal cord: 12.0" "Group enriched" "Detected in some" 378 "memory B-cell: 369.6;naive B-cell: 441.5" "Lineage enriched" "Detected in many" 411 "B-cells: 441.5" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5" HPA048721 Approved "Immunoglobulin genes" NA NA "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (1.76e-2)" "unprognostic (6.79e-2)" "unprognostic (1.52e-2)" "prognostic favorable (4.58e-5)" "unprognostic (5.06e-2)" "unprognostic (8.55e-3)" "unprognostic (2.31e-1)" "unprognostic (1.63e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-1)" 50.5 21.9 0.1 266.2 0.5 139.5 320.5 0.6 1.0 129.8 0.4 471.5 296.2 20.7 2.8 106.2 33.4 187.2 23.2 0.2 1.6 36.7 37.9 130.4 529.5 0.4 1.0 37.0 8.3 1.9 2.7 0.4 0.7 18.7 511.9 0.2 476.4 127.7 0.7 2.5 175.9 14.5 12.0 820.8 627.3 13.5 0.2 381.9 53.9 0.2 1727.5 623.3 26.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.1 1.9 2.7 0.0 0.0 9.1 8.8 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.4 3.5 0.7 0.0 0.2 0.0 0.6 0.0 0.4 0.3 0.4 0.1 0.0 0.1 369.6 0.2 0.1 0.3 441.5 0.2 0.1 1.0 0.2 0.3 0.3 0.2 39.5 0.1 0.5 0.6 1.0 0.2 1.6 0.4 1.0 0.7 12.0 0.2 1.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2044.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 IGKV1-37 "IGKV137, O14" ENSG00000239862 "Immunoglobulin kappa variable 1-37 (non-functional)" A0A075B6S9 2 89297264-89297785 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.2;lymphoid tissue: 17.2;urinary bladder: 5.6" "Cell type enriched" "Detected in some" 24 "Plasma cells: 73.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 247 "memory B-cell: 21.2;naive B-cell: 28.2" "Lineage enriched" "Detected in single" 283 "B-cells: 28.2" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (3.47e-1)" "unprognostic (1.17e-1)" 0.1 0.2 0.0 2.9 0.0 0.8 2.4 0.0 0.0 0.5 0.0 4.5 3.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.4 1.2 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 2.6 0.6 0.0 0.0 2.0 0.2 0.0 3.7 1.5 0.0 0.0 0.9 0.1 0.0 17.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1-39 ENSG00000242371 "Immunoglobulin kappa variable 1-39" P01597 2 89319625-89320146 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 108.5;lymphoid tissue: 254.9;salivary gland: 151.2;stomach 1: 83.2" "Cell type enriched" "Detected in some" 151 "Plasma cells: 16225.1" "Cancer enhanced" "Detected in many" "stomach cancer: 13.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 388 "memory B-cell: 1069.8;naive B-cell: 935.1" "Lineage enriched" "Detected in many" 415 "B-cells: 1069.8" "Cell line enriched" "Detected in some" 21 "Daudi: 194.2" HPA048721 Approved "Immunoglobulin genes" NA NA 8000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (1.76e-4)" "unprognostic (5.10e-3)" "unprognostic (4.71e-2)" "prognostic favorable (1.70e-5)" "unprognostic (2.38e-1)" "unprognostic (7.33e-2)" "unprognostic (1.78e-1)" "unprognostic (6.62e-6)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (4.27e-1)" "unprognostic (2.25e-1)" 10.9 9.1 0.0 54.7 0.1 14.2 17.7 0.0 0.1 21.8 0.0 108.5 70.5 5.7 0.0 11.6 12.5 14.3 1.5 0.2 0.0 10.9 6.8 27.2 36.5 0.0 0.0 1.8 3.2 0.0 0.5 0.0 0.2 4.2 13.3 0.0 151.2 0.9 0.2 1.3 74.4 1.2 0.0 254.9 83.2 0.3 0.0 5.9 31.0 0.0 42.5 17.5 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 1.8 0.0 9.0 0.0 0.0 0.0 0.9 1.0 0.7 0.3 0.3 0.3 1069.8 0.5 0.4 1.1 935.1 0.3 0.6 2.5 0.4 0.6 1.3 0.8 136.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 10.7 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16225.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 4.9 0.0 0.3 0.0 IGKV1-5 ENSG00000243466 "Immunoglobulin kappa variable 1-5" P01602 2 88947301-88947957 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 777.1;lymphoid tissue: 1459.2;urinary bladder: 945.2" "Cell type enriched" "Detected in some" 240 "Plasma cells: 39194.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 364 "memory B-cell: 859.0;naive B-cell: 860.5" "Lineage enriched" "Detected in many" 364 "B-cells: 860.5" "Cell line enhanced" "Detected in some" "Daudi: 4.0;HL-60: 2.4;RPMI-8226: 5.0;SCLC-21H: 2.9;SH-SY5Y: 4.5" HPA048721 Approved "Immunoglobulin genes" NA NA 8400000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (1.19e-4)" "unprognostic (1.26e-2)" "unprognostic (3.12e-3)" "unprognostic (5.00e-3)" "unprognostic (1.59e-2)" "prognostic favorable (3.47e-4)" "unprognostic (7.60e-2)" "unprognostic (2.84e-1)" "unprognostic (1.68e-1)" "unprognostic (3.32e-2)" "unprognostic (2.28e-1)" "unprognostic (3.58e-1)" "prognostic unfavorable (4.36e-8)" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.27e-2)" "unprognostic (3.17e-2)" 35.8 82.0 0.2 639.7 0.2 115.4 233.9 0.1 1.6 115.8 0.6 777.1 528.7 17.1 2.0 146.2 86.9 124.8 18.7 0.1 0.5 36.2 32.0 125.3 387.2 1.0 0.2 60.8 10.8 0.5 3.0 0.4 0.3 16.7 745.0 0.0 392.2 34.8 0.9 3.2 429.7 24.4 1.3 915.4 456.3 11.5 0.2 155.3 58.4 0.0 1459.2 945.2 28.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 1.6 0.5 0.0 0.0 0.3 1.0 5.0 0.0 0.0 2.9 4.5 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.4 0.7 0.4 0.6 0.1 0.4 0.0 0.6 0.0 0.7 1.2 1.3 0.5 0.2 0.4 859.0 2.3 0.3 1.0 860.5 0.2 0.3 1.4 0.4 0.6 0.7 0.6 113.5 0.2 0.2 0.1 1.6 0.1 0.5 1.0 0.2 0.3 1.3 0.2 0.5 0.0 0.0 0.6 0.0 163.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 7.0 89.7 0.0 0.0 0.0 0.7 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39194.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 11.8 0.0 0.2 0.0 IGKV1-6 ENSG00000239855 "Immunoglobulin kappa variable 1-6" A0A0C4DH72 2 88966262-88966767 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 155.5;lymphoid tissue: 606.3" "Cell type enriched" "Detected in some" 33 "Plasma cells: 877.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 801 "memory B-cell: 123.6;naive B-cell: 85.7" "Lineage enriched" "Detected in single" 946 "B-cells: 123.6" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 12000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (3.44e-5)" "unprognostic (5.25e-3)" "unprognostic (3.78e-2)" "unprognostic (8.68e-3)" "unprognostic (3.23e-2)" "prognostic favorable (1.81e-4)" "unprognostic (3.86e-3)" "unprognostic (3.86e-2)" "unprognostic (3.00e-2)" "unprognostic (5.80e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (4.37e-6)" "unprognostic (5.23e-3)" "unprognostic (3.02e-1)" "unprognostic (2.54e-1)" "unprognostic (2.54e-1)" 8.2 1.7 0.1 84.1 0.1 37.0 50.3 0.0 0.4 16.5 0.1 155.5 110.5 4.0 4.1 23.5 5.0 18.1 5.3 0.0 0.0 7.7 6.3 20.0 82.3 0.1 0.1 4.0 1.8 0.0 1.1 0.0 0.0 4.3 145.9 0.0 95.0 2.2 0.2 0.6 59.1 5.1 0.2 209.5 130.3 0.7 0.0 22.7 16.4 0.0 606.3 144.8 8.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 123.6 0.0 0.0 0.1 85.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.1 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 877.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 IGKV1-8 "IGKV18, L9" ENSG00000240671 "Immunoglobulin kappa variable 1-8" A0A0C4DH67 2 88992409-88992931 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 29.7;lymphoid tissue: 55.0;salivary gland: 21.2;stomach 1: 18.6;urinary bladder: 41.7" "Cell type enriched" "Detected in some" 40 "Plasma cells: 622.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 311 "memory B-cell: 131.0;naive B-cell: 136.4" "Lineage enriched" "Detected in single" 317 "B-cells: 136.4" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 6100000000 "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (1.64e-4)" "unprognostic (1.56e-2)" "unprognostic (8.07e-2)" "unprognostic (6.41e-3)" "prognostic favorable (5.13e-4)" "unprognostic (6.87e-2)" "unprognostic (2.91e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-2)" "unprognostic (1.75e-1)" "unprognostic (7.79e-2)" "prognostic unfavorable (4.14e-7)" "unprognostic (6.94e-2)" "unprognostic (1.34e-1)" "unprognostic (4.22e-2)" "unprognostic (2.98e-1)" 2.1 2.5 0.0 13.5 0.0 7.1 6.7 0.0 0.1 2.0 0.0 29.7 12.0 1.3 0.0 2.9 1.4 5.4 1.5 0.0 0.0 3.3 2.1 4.8 13.7 0.0 0.0 0.5 0.9 0.0 0.1 0.0 0.0 1.4 19.3 0.0 21.2 0.7 0.0 0.1 13.9 0.6 0.0 51.3 18.6 0.3 0.0 7.0 3.3 0.0 55.0 41.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 131.0 0.0 0.4 0.1 136.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 12.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 622.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 IGKV1-9 "IGKV19, L8" ENSG00000241755 "Immunoglobulin kappa variable 1-9" A0A0C4DH69 2 89009982-89010515 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 428.1;lymphoid tissue: 671.3;stomach 1: 283.7" "Cell type enriched" "Detected in some" 116 "Plasma cells: 7178.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Group enriched" "Detected in some" 705 "memory B-cell: 300.5;naive B-cell: 296.8" "Lineage enriched" "Detected in single" 709 "B-cells: 300.5" "Cell line enhanced" "Detected in some" "HL-60: 1.2;NB-4: 1.0;RPMI-8226: 2.9;TIME: 1.2" HPA048721 Approved "Immunoglobulin genes" NA NA 4500000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (2.10e-7)" "unprognostic (1.30e-2)" "unprognostic (1.95e-2)" "unprognostic (2.55e-3)" "unprognostic (4.70e-2)" "prognostic favorable (4.91e-4)" "unprognostic (3.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.09e-2)" "unprognostic (6.80e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.04e-8)" "unprognostic (4.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (3.40e-1)" 12.6 12.6 0.2 184.3 0.4 53.6 202.8 0.0 1.3 15.8 0.4 428.1 267.0 8.3 0.8 52.9 78.3 30.0 13.9 0.1 0.1 15.4 17.9 40.1 201.8 0.3 0.1 20.7 2.5 0.5 1.3 0.1 0.2 12.8 348.6 0.0 221.3 13.3 0.5 1.6 182.8 13.3 0.4 313.1 283.7 35.1 0.1 85.1 34.2 0.0 671.3 187.5 8.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 1.0 0.3 0.0 0.0 0.0 0.9 2.9 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.2 0.4 0.1 0.2 0.0 0.1 300.5 0.1 0.0 0.3 296.8 0.0 0.1 0.3 0.2 0.2 0.1 0.3 34.5 0.2 0.4 0.0 1.3 0.1 0.1 0.3 0.1 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.0 61.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.7 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7178.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 IGKV1D-12 ENSG00000278857 "Immunoglobulin kappa variable 1D-12" P01611 2 90159840-90160335 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.6;lymphoid tissue: 47.5;salivary gland: 34.6" "Cell type enriched" "Detected in some" 178 "Plasma cells: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 34 "memory B-cell: 13.0;naive B-cell: 12.2" "Lineage enriched" "Detected in single" 35 "B-cells: 13.0" "Cell line enhanced" "Detected in single" "RH-30: 2.2" HPA048721 Approved "Immunoglobulin genes" NA NA 12000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (1.94e-4)" "unprognostic (9.04e-4)" "unprognostic (3.42e-2)" "prognostic favorable (3.23e-4)" "unprognostic (3.09e-2)" "unprognostic (4.66e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (1.61e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 1.7 0.3 0.0 9.6 0.0 0.9 7.6 0.0 0.2 3.0 0.0 26.6 1.6 1.3 0.0 2.2 1.8 0.0 0.3 0.0 0.0 1.7 1.0 11.6 12.5 0.1 0.0 0.2 0.4 0.0 0.2 0.1 0.1 1.1 9.1 0.0 34.6 0.3 0.1 0.2 22.7 5.5 0.0 47.5 9.5 0.2 0.0 1.3 4.0 0.0 9.4 2.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.1 12.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1D-16 ENSG00000241244 "Immunoglobulin kappa variable 1D-16" P01601 2 90100236-90100738 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 79.1;intestine: 92.0;lymphoid tissue: 165.5" "Cell type enriched" "Detected in some" 249 "Plasma cells: 1994.1" "Cancer enhanced" "Detected in many" "lung cancer: 17.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 327 "memory B-cell: 57.6;naive B-cell: 120.1" "Lineage enriched" "Detected in single" 442 "B-cells: 120.1" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 9000000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (2.41e-4)" "unprognostic (4.41e-3)" "unprognostic (3.96e-3)" "unprognostic (5.39e-2)" "unprognostic (1.35e-3)" "unprognostic (8.61e-2)" "unprognostic (2.92e-1)" "unprognostic (1.27e-1)" "unprognostic (1.54e-2)" "unprognostic (6.61e-3)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (4.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.66e-2)" "unprognostic (2.84e-1)" 2.4 0.4 0.0 30.2 0.0 15.0 18.9 0.0 0.4 11.0 0.1 92.0 39.0 1.6 0.0 13.8 2.5 79.1 1.3 0.0 0.0 1.7 3.9 10.0 27.5 0.0 0.0 2.5 0.9 0.6 0.1 0.0 0.1 3.6 50.3 0.0 30.3 0.9 0.0 0.2 34.4 1.0 0.3 56.6 26.7 0.4 0.0 9.9 2.7 0.0 165.5 23.5 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 57.6 0.0 0.0 0.1 120.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1994.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 IGKV1D-33 ENSG00000239975 "Immunoglobulin kappa variable 1D-33" P01593 2 89913982-89916052 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.7;lymphoid tissue: 63.0;salivary gland: 73.3" "Cell type enriched" "Detected in some" 410 "Plasma cells: 5131.4" "Cancer enhanced" "Detected in many" "stomach cancer: 5.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 116 "memory B-cell: 6.3;naive B-cell: 16.8" "Lineage enriched" "Detected in single" 169 "B-cells: 16.8" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 4900000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (5.10e-3)" "unprognostic (2.03e-1)" "unprognostic (2.11e-2)" "unprognostic (2.03e-4)" "unprognostic (7.90e-2)" "unprognostic (6.50e-2)" "unprognostic (6.82e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-2)" 2.8 0.5 0.0 3.8 0.1 2.3 8.3 0.0 0.1 3.6 0.1 32.7 1.3 1.4 0.0 4.6 2.7 2.6 0.2 0.2 0.2 4.0 2.2 17.9 6.8 0.0 0.2 0.4 0.5 0.0 0.1 0.0 0.0 1.6 2.0 0.0 73.3 8.6 0.0 0.5 19.1 0.0 0.5 63.0 21.2 0.1 0.0 4.7 3.3 0.2 9.1 16.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5131.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 IGKV1D-37 "IGKV1D37, O4" ENSG00000250036 "Immunoglobulin kappa variable 1D-37 (non-functional)" P0DSN7 2 89884740-89885216 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 12.7;stomach 1: 15.0;urinary bladder: 20.1" "Cell type enriched" "Detected in single" 11 "Plasma cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 209 "memory B-cell: 13.6;naive B-cell: 29.1" "Lineage enriched" "Detected in single" 284 "B-cells: 29.1" "Cell line enriched" "Detected in single" 5 "HDLM-2: 2.5" HPA048721 Approved "Immunoglobulin genes" NA NA 6700000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (2.68e-1)" 0.1 0.0 0.0 4.2 0.0 3.3 2.4 0.0 0.0 0.8 0.0 8.6 12.7 0.1 0.4 2.1 0.2 0.5 0.2 0.4 0.0 0.1 0.4 0.8 4.1 0.0 0.1 0.4 1.2 0.0 0.0 0.1 0.0 0.7 1.0 0.0 7.1 0.0 0.2 0.0 6.0 0.2 0.0 6.5 15.0 0.2 0.0 1.1 0.1 0.0 2.5 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1D-39 ENSG00000251546 "Immunoglobulin kappa variable 1D-39" P04432 2 89862482-89862981 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 2922.1;lymphoid tissue: 6491.8;stomach 1: 2259.8" "Cell type enriched" "Detected in some" 298 "Plasma cells: 7890.2" "Cancer enhanced" "Detected in many" "stomach cancer: 12.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 226 "memory B-cell: 470.5;naive B-cell: 733.0" "Lineage enriched" "Detected in many" 275 "B-cells: 733.0" "Group enriched" "Detected in some" 36 "Daudi: 731.4;U-698: 516.7" HPA048721 Approved "Immunoglobulin genes" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (1.88e-4)" "unprognostic (4.70e-2)" "unprognostic (2.14e-3)" "prognostic favorable (5.99e-5)" "unprognostic (3.84e-1)" "unprognostic (4.34e-2)" "unprognostic (1.28e-1)" "unprognostic (9.06e-2)" "unprognostic (2.96e-2)" "unprognostic (3.92e-1)" "unprognostic (1.84e-1)" 147.3 181.1 0.6 1609.8 0.8 466.1 990.4 0.5 4.2 369.0 2.1 2922.1 2055.2 80.0 52.5 611.3 132.1 629.8 87.5 0.4 2.0 82.3 171.8 685.1 1968.9 2.6 0.8 214.9 26.5 3.5 5.5 1.3 3.6 80.9 2261.1 0.4 1229.7 148.4 2.3 33.2 1255.9 88.7 4.2 1712.0 2259.8 27.6 1.3 770.5 209.3 0.0 6491.8 1816.1 46.9 2.5 0.3 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 731.4 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 3.2 0.0 0.0 0.0 5.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 2.3 6.6 2.4 0.0 0.0 1.0 2.9 10.3 0.0 0.0 11.1 17.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.8 2.5 0.0 0.1 516.7 0.0 1.6 0.0 0.5 0.4 0.8 0.6 0.2 0.4 470.5 0.3 0.3 0.4 733.0 0.5 0.2 2.6 0.8 0.4 0.4 0.3 47.6 0.6 0.8 0.5 4.2 0.4 2.0 2.6 0.8 3.6 4.2 1.3 2.5 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7890.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 14.0 0.0 0.0 0.0 IGKV1D-42 ENSG00000211633 "Immunoglobulin kappa variable 1D-42 (non-functional)" A0A075B6H8 2 90190193-90190681 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.7;lymphoid tissue: 25.3" "Cell type enriched" "Detected in single" 93 "Plasma cells: 9.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "memory B-cell: 5.6;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 57 "B-cells: 5.6" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 2.6" HPA048721 Approved "Immunoglobulin genes" NA NA 41000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 37: Intestine - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (8.08e-6)" "unprognostic (4.83e-2)" "unprognostic (2.22e-2)" "unprognostic (2.51e-3)" "unprognostic (1.84e-1)" "unprognostic (2.10e-2)" "unprognostic (1.66e-5)" "unprognostic (1.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (1.39e-1)" 0.1 0.0 0.0 7.6 0.0 6.6 10.8 0.0 0.0 0.8 0.0 18.8 7.5 0.2 0.3 1.4 0.2 1.7 0.1 0.0 0.0 0.0 0.3 2.8 2.6 0.1 0.0 4.1 1.1 0.0 0.0 0.0 0.0 0.1 47.7 0.0 8.5 0.0 0.0 0.1 7.9 0.0 0.0 4.2 13.9 0.0 0.0 0.6 0.3 0.0 25.3 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1D-43 ENSG00000242580 "Immunoglobulin kappa variable 1D-43" A0A0B4J1Z2 2 90209873-90210529 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.9;lymphoid tissue: 4.8;stomach 1: 3.6" "Cell type enriched" "Detected in some" 86 "Plasma cells: 695.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 152 "memory B-cell: 13.3;naive B-cell: 17.0" "Lineage enriched" "Detected in single" 171 "B-cells: 17.0" "Cell line enriched" "Detected in single" 310 "RPMI-8226: 79.1" HPA048721 Approved "Immunoglobulin genes" NA NA 380000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (3.32e-5)" "unprognostic (6.71e-2)" "unprognostic (4.01e-2)" "unprognostic (1.27e-2)" "unprognostic (4.57e-3)" "unprognostic (1.37e-3)" "unprognostic (3.15e-1)" "unprognostic (2.67e-2)" "unprognostic (3.82e-5)" "unprognostic (3.96e-2)" "unprognostic (2.20e-1)" "unprognostic (6.26e-2)" "unprognostic (1.06e-1)" 0.2 0.0 0.0 2.8 0.0 1.3 1.4 0.0 0.0 0.0 0.0 2.7 1.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 2.0 0.2 0.0 0.0 2.9 0.0 0.0 1.8 3.6 0.0 0.0 0.5 0.1 0.0 4.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 79.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 695.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGKV1D-8 ENSG00000239819 "Immunoglobulin kappa variable 1D-8" A0A087WSZ0 2 90220727-90221384 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 4.2;lymphoid tissue: 14.2;salivary gland: 5.6" "Cell type enriched" "Detected in some" 29 "Plasma cells: 338.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 323 "memory B-cell: 32.7;naive B-cell: 31.8" "Lineage enriched" "Detected in single" 328 "B-cells: 32.7" "Cell line enriched" "Detected in some" 26 "RPMI-8226: 38.3" HPA048721 Approved "Immunoglobulin genes" NA NA 1900000000 "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (2.93e-4)" "unprognostic (1.03e-3)" "unprognostic (2.23e-2)" "unprognostic (2.76e-3)" "prognostic favorable (8.80e-5)" "unprognostic (6.07e-2)" "unprognostic (9.76e-3)" "unprognostic (2.67e-1)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (1.35e-1)" "unprognostic (9.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.32e-1)" 0.5 0.0 0.0 5.3 0.0 0.7 1.2 0.0 0.0 0.6 0.0 4.2 1.6 0.1 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.3 0.3 1.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 2.6 0.0 5.6 0.0 0.0 0.0 2.8 0.0 0.0 8.3 1.9 0.0 0.0 1.2 0.6 0.0 14.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 338.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGKV1OR2-108 "IGKV1/OR2-108, IGKV1OR2108, IGO1" ENSG00000231292 "Immunoglobulin kappa variable 1/OR2-108 (non-functional)" 2 113406396-113406872 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.2;lymphoid tissue: 56.7" "Cell type enriched" "Detected in single" 652 "Plasma cells: 65.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 55 "memory B-cell: 13.5;naive B-cell: 12.2" "Lineage enriched" "Detected in single" 58 "B-cells: 13.5" "Cell line enhanced" "Detected in some" "Daudi: 6.6;HBEC3-KT: 7.2;hTEC/SVTERT24-B: 4.1;REH: 4.1" "Not detected" "Not detected" HPA048721 Approved NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (1.53e-6)" "unprognostic (2.73e-2)" "unprognostic (1.55e-2)" "unprognostic (3.37e-1)" "unprognostic (3.64e-3)" "unprognostic (3.57e-2)" "unprognostic (3.20e-1)" "unprognostic (5.21e-2)" "unprognostic (1.17e-1)" "unprognostic (4.63e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (9.96e-6)" "unprognostic (6.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.95e-1)" 0.5 1.4 0.1 23.3 0.4 11.2 16.7 0.0 0.3 4.8 5.6 38.2 21.8 0.3 0.0 6.8 0.4 5.5 0.2 0.8 0.0 0.1 1.4 6.9 14.0 0.1 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.9 22.1 0.1 15.2 0.5 0.1 4.8 13.9 0.8 0.0 12.7 16.9 0.0 0.1 3.8 1.3 0.0 56.7 21.7 0.1 0.0 2.1 0.7 0.3 0.0 0.0 0.0 0.4 0.0 2.2 0.3 1.5 3.0 1.2 6.6 0.0 0.9 1.1 0.3 0.0 7.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.1 2.4 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.6 0.4 0.0 1.6 4.1 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.6 0.0 1.3 0.2 0.2 0.1 1.2 0.1 0.4 0.4 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.5 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.1 0.4 0.0 0.3 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV2-24 ENSG00000241294 "Immunoglobulin kappa variable 2-24" A0A0C4DH68 2 89176328-89177160 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 272.7;lymphoid tissue: 474.9;urinary bladder: 935.2" "Cell type enriched" "Detected in some" 252 "Plasma cells: 5620.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 4 "memory B-cell: 48.1" "Lineage enriched" "Detected in single" 482 "B-cells: 48.1" "Cell line enhanced" "Detected in single" "NB-4: 1.3" "Immunoglobulin genes" NA NA 840000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.74e-6)" "unprognostic (4.92e-3)" "unprognostic (1.04e-2)" "unprognostic (2.38e-2)" "unprognostic (3.79e-3)" "prognostic favorable (1.59e-4)" "unprognostic (5.02e-2)" "unprognostic (1.65e-1)" "unprognostic (2.71e-2)" "unprognostic (1.31e-1)" "unprognostic (4.10e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.82e-5)" "unprognostic (1.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" 13.7 14.6 0.1 65.8 0.1 27.4 91.8 0.0 0.6 11.5 0.4 272.7 250.8 3.2 1.1 82.0 6.6 24.1 14.7 0.2 1.0 7.8 8.6 30.0 131.7 0.6 0.1 6.3 5.6 0.2 0.9 0.2 0.9 5.4 180.6 0.0 219.3 3.3 0.3 3.3 98.5 7.9 1.1 474.9 106.8 1.2 0.2 23.7 11.1 0.0 235.6 935.2 14.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.0 0.6 0.2 1.0 0.6 0.1 0.9 1.1 0.2 0.3 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5620.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 IGKV2-28 ENSG00000244116 "Immunoglobulin kappa variable 2-28" A0A075B6P5 2 89221698-89222461 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1044.6;lymphoid tissue: 1735.3" "Cell type enriched" "Detected in some" 92 "Plasma cells: 1868.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 13 "naive B-cell: 11.1" "Lineage enriched" "Detected in single" 13 "B-cells: 11.1" "Cell line enhanced" "Detected in some" "BEWO: 2.4;Daudi: 2.8;HL-60: 3.6;K-562: 2.0;NB-4: 2.7;RPMI-8226: 4.5;SCLC-21H: 2.1;SH-SY5Y: 1.7" "Immunoglobulin genes" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.03e-2)" "unprognostic (1.73e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.32e-4)" "unprognostic (2.12e-2)" "unprognostic (6.32e-3)" "unprognostic (3.14e-1)" "unprognostic (3.71e-2)" "unprognostic (5.21e-2)" "unprognostic (2.64e-2)" 36.2 40.2 0.2 402.4 0.2 180.2 425.2 0.1 1.1 56.6 0.9 1044.6 756.7 38.2 4.9 662.7 29.0 130.8 22.3 0.1 0.3 46.2 40.2 157.6 584.6 0.6 0.9 87.9 19.5 3.8 3.3 0.5 0.3 21.1 709.6 0.1 732.4 95.0 1.8 7.1 425.6 23.9 0.8 1207.7 530.0 161.9 0.2 167.6 84.8 0.0 1735.3 494.1 30.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 1.1 4.5 0.0 0.4 2.1 1.7 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 11.1 0.2 0.1 0.8 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.1 1.1 0.1 0.3 0.6 0.9 0.3 0.8 0.2 0.9 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1868.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 IGKV2-30 ENSG00000243238 "Immunoglobulin kappa variable 2-30" P06310 2 89244781-89245596 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 631.0;lymphoid tissue: 670.2;stomach 1: 323.1" "Cell type enriched" "Detected in some" 365 "Plasma cells: 25365.6" "Cancer enhanced" "Detected in many" "stomach cancer: 26.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 316 "memory B-cell: 561.0;naive B-cell: 325.4" "Lineage enriched" "Detected in many" 400 "B-cells: 561.0" "Cell line enriched" "Detected in some" 388 "U-698: 8426.0" "Immunoglobulin genes" NA NA 6800000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.84e-5)" "unprognostic (1.26e-2)" "unprognostic (2.88e-2)" "unprognostic (1.41e-1)" "prognostic favorable (6.78e-5)" "unprognostic (6.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.45e-2)" "unprognostic (9.82e-3)" "unprognostic (1.84e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (4.53e-6)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.53e-1)" "unprognostic (3.50e-1)" 15.0 9.4 0.1 160.7 0.2 75.9 237.0 0.1 1.3 19.6 0.7 631.0 394.3 5.6 0.8 37.8 11.5 35.0 17.9 0.1 0.1 15.1 29.6 67.3 176.7 1.4 0.1 15.8 7.8 0.1 2.3 0.2 0.2 7.8 324.5 0.0 220.5 23.3 0.6 2.0 260.2 19.1 0.6 670.2 323.1 21.2 0.1 40.9 18.8 0.0 600.3 207.5 21.5 1.1 5.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 13.1 4.6 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.3 0.0 0.0 0.1 2.7 1.9 0.0 0.4 0.0 0.9 3.8 0.0 2.6 0.0 0.0 5.6 0.0 0.0 21.7 0.1 2.6 0.3 1.7 8426.0 0.0 2.7 0.0 0.5 0.4 0.2 0.2 0.0 0.2 561.0 0.1 0.2 0.4 325.4 0.0 0.2 1.4 0.2 0.3 0.7 0.3 53.3 0.1 0.2 0.1 1.3 0.1 0.1 1.4 0.1 0.2 0.6 0.1 1.1 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.3 30.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25365.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.3 0.0 IGKV2-40 ENSG00000273962 "Immunoglobulin kappa variable 2-40" A0A087WW87 2 89330110-89330429 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 42.8;urinary bladder: 34.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 48 "memory B-cell: 15.4;naive B-cell: 7.1" "Lineage enriched" "Detected in single" 66 "B-cells: 15.4" "Cell line enhanced" "Detected in single" "Daudi: 1.7" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "unprognostic (3.31e-1)" "unprognostic (1.94e-2)" 0.4 0.1 0.0 9.3 0.0 1.1 6.7 0.0 0.1 10.2 0.0 9.7 42.8 0.9 0.0 10.5 15.5 0.1 0.1 0.0 0.0 0.3 1.4 10.9 0.9 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 1.1 7.1 0.0 5.9 2.0 0.0 0.1 6.2 0.0 0.0 17.8 19.6 0.2 0.0 1.9 1.2 0.1 6.2 34.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV2D-24 ENSG00000241566 "Immunoglobulin kappa variable 2D-24 (non-functional)" A0A075B6R9 2 90004797-90005629 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.7;lymphoid tissue: 25.5;urinary bladder: 15.3" "Cell type enriched" "Detected in single" 207 "Plasma cells: 165.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "hippocampal formation: 1.8" "Group enriched" "Detected in some" 48 "memory B-cell: 6.7;naive B-cell: 2.7" "Lineage enriched" "Detected in single" 68 "B-cells: 6.7" "Cell line enriched" "Detected in single" 8 "U-937: 1.0" "Immunoglobulin genes" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.21e-4)" "unprognostic (1.78e-1)" "prognostic favorable (8.07e-4)" "unprognostic (2.09e-2)" "prognostic favorable (2.11e-4)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (4.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.74e-5)" "unprognostic (7.60e-2)" "unprognostic (1.57e-2)" "unprognostic (3.85e-1)" "unprognostic (3.47e-1)" 0.6 0.8 0.0 4.3 0.0 2.7 6.1 0.0 0.7 0.5 0.0 16.8 19.7 0.1 0.0 1.5 0.4 3.5 0.1 1.8 0.0 0.6 0.5 1.8 6.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 7.2 0.0 9.6 0.5 0.0 0.3 7.0 0.1 0.1 25.0 5.2 0.1 0.1 1.7 0.4 0.0 25.5 15.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV2D-28 ENSG00000242534 "Immunoglobulin kappa variable 2D-28" P01615 2 89959979-89960754 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 221.6;lymphoid tissue: 462.7;salivary gland: 259.7" "Cell type enriched" "Detected in some" 98 "Plasma cells: 4332.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 224 "memory B-cell: 3054.0;naive B-cell: 2203.9" "Lineage enriched" "Detected in all" 260 "B-cells: 3054.0" "Cell line enhanced" "Detected in some" "HDLM-2: 5.0;RPMI-8226: 2.0;SCLC-21H: 1.9;SH-SY5Y: 4.3;U-698: 4.4" "Immunoglobulin genes" NA NA 3500000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (3.88e-3)" "unprognostic (2.68e-2)" "unprognostic (2.51e-3)" "unprognostic (1.22e-1)" "unprognostic (1.13e-1)" "unprognostic (4.17e-1)" "unprognostic (1.13e-1)" "unprognostic (2.66e-1)" 9.9 4.8 0.1 162.1 0.2 23.3 35.2 0.0 1.5 7.6 0.3 203.7 221.6 8.3 1.2 113.5 14.0 26.1 4.8 0.3 0.4 11.5 13.3 40.6 166.6 0.7 0.2 2.8 1.9 0.1 0.9 0.4 0.4 11.1 65.9 0.0 259.7 19.2 0.3 1.4 143.3 8.7 0.2 462.7 186.4 5.7 0.2 40.9 37.8 0.3 192.0 157.9 8.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 1.1 0.0 0.0 0.0 5.0 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.1 0.0 0.0 0.7 0.0 2.0 0.0 0.0 1.9 4.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.6 1.3 0.0 4.4 0.0 1.1 0.0 11.7 7.8 1.2 1.2 0.5 1.3 3054.0 1.3 0.9 2.0 2203.9 0.2 0.9 2.2 1.0 1.5 1.4 1.3 248.7 0.1 0.2 0.0 1.5 0.3 0.4 0.7 0.2 0.4 0.2 0.2 0.3 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4332.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 31.5 0.0 0.1 0.0 IGKV2D-29 ENSG00000243264 "Immunoglobulin kappa variable 2D-29" A0A075B6S2 2 89947512-89948279 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 252.2;lymphoid tissue: 464.7" "Cell type enriched" "Detected in some" 8 "Plasma cells: 184.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Group enriched" "Detected in some" 253 "memory B-cell: 360.5;naive B-cell: 489.4" "Lineage enriched" "Detected in many" 292 "B-cells: 489.4" "Cell line enhanced" "Detected in some" "Daudi: 8.5;HDLM-2: 1.2;TIME: 2.1;U-698: 2.2" "Immunoglobulin genes" NA NA 1500000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (3.31e-4)" "unprognostic (2.43e-2)" "unprognostic (1.34e-3)" "unprognostic (1.76e-2)" "prognostic favorable (8.34e-4)" "unprognostic (4.43e-3)" "unprognostic (1.54e-1)" "unprognostic (2.34e-1)" "unprognostic (2.47e-2)" "unprognostic (5.09e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (9.46e-2)" "unprognostic (2.20e-1)" "unprognostic (2.61e-1)" "unprognostic (7.80e-2)" 11.3 1.0 0.0 73.7 0.1 29.4 49.4 0.1 1.3 12.6 0.8 252.2 97.0 3.9 0.0 9.5 6.5 14.2 3.8 0.1 0.2 3.6 8.4 41.4 139.4 0.3 0.0 9.8 2.8 0.2 0.3 0.0 0.2 3.6 110.9 0.0 106.8 10.3 0.4 3.0 67.9 2.9 0.4 170.2 126.0 1.0 0.1 38.0 7.8 0.0 464.7 35.1 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.1 0.2 0.1 0.0 2.2 0.0 0.1 0.0 0.3 0.4 0.2 0.1 0.0 0.2 360.5 0.2 0.1 0.6 489.4 0.0 0.1 1.6 0.2 0.4 0.2 0.2 42.2 0.0 0.1 0.1 1.3 0.1 0.2 0.3 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 184.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 IGKV2D-30 ENSG00000239571 "Immunoglobulin kappa variable 2D-30" A0A075B6S6 2 89936859-89937679 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.3;lymphoid tissue: 33.5;stomach 1: 22.2" "Cell type enriched" "Detected in some" 222 "Plasma cells: 1314.8" "Cancer enhanced" "Detected in some" "stomach cancer: 2.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 379 "memory B-cell: 124.9;naive B-cell: 164.0" "Lineage enriched" "Detected in single" 430 "B-cells: 164.0" "Cell line enriched" "Detected in some" 6 "U-698: 51.7" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.17e-3)" "unprognostic (6.82e-2)" "unprognostic (1.58e-1)" "unprognostic (2.98e-4)" "unprognostic (5.74e-3)" "unprognostic (3.19e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.55e-1)" 0.4 0.4 0.0 6.4 0.0 4.3 5.9 0.0 0.1 0.8 0.0 15.3 11.8 0.4 0.0 1.0 0.4 0.8 0.8 0.1 0.1 1.4 0.7 2.8 6.7 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.5 11.2 0.0 13.0 4.6 0.0 1.2 8.5 2.0 0.0 29.3 22.2 0.1 0.0 1.6 0.8 0.0 33.5 5.6 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 51.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 124.9 0.0 0.1 0.1 164.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 19.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1314.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 IGKV2D-40 ENSG00000251039 "Immunoglobulin kappa variable 2D-40" P01614 2 89851791-89852497 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 123.3" "Cell type enriched" "Detected in some" 489 "Plasma cells: 1517.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 30.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 494 "memory B-cell: 134.9;naive B-cell: 96.8" "Lineage enriched" "Detected in single" 575 "B-cells: 134.9" "Cell line enhanced" "Detected in single" "Daudi: 3.7" "Immunoglobulin genes" NA NA 1900000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.01e-4)" "unprognostic (1.16e-2)" "unprognostic (8.37e-2)" "unprognostic (6.04e-2)" "prognostic favorable (9.78e-7)" "unprognostic (1.87e-1)" "unprognostic (2.29e-1)" "unprognostic (2.32e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (3.59e-2)" "unprognostic (3.02e-1)" "unprognostic (2.91e-1)" "unprognostic (1.25e-1)" 1.7 1.4 0.0 21.0 0.0 14.8 13.5 0.0 0.1 10.0 0.0 16.6 6.9 3.0 0.0 35.6 14.4 7.7 2.0 0.0 0.0 1.0 2.9 19.5 65.7 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.6 21.8 0.0 32.3 21.7 0.0 0.0 31.2 1.6 0.0 44.8 38.6 0.4 0.0 26.3 5.7 0.0 123.3 34.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 134.9 0.0 0.0 0.0 96.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1517.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGKV3-11 ENSG00000241351 "Immunoglobulin kappa variable 3-11" P04433 2 89027171-89027731 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1373.3;lymphoid tissue: 2812.9;urinary bladder: 1822.6" "Cell type enriched" "Detected in some" 129 "Plasma cells: 27475.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "spinal cord: 19.8" "Group enriched" "Detected in many" 292 "memory B-cell: 1729.8;naive B-cell: 1401.2" "Lineage enriched" "Detected in many" 323 "B-cells: 1729.8" "Cell line enhanced" "Detected in some" "BEWO: 3.0;Daudi: 2.0;SCLC-21H: 3.7;SH-SY5Y: 4.6" HPA047702 Approved "Immunoglobulin genes" NA NA 18000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "unprognostic (3.97e-3)" "unprognostic (1.17e-2)" "unprognostic (3.51e-2)" "unprognostic (1.91e-2)" "unprognostic (2.70e-2)" "prognostic favorable (1.36e-5)" "unprognostic (2.02e-1)" "unprognostic (3.20e-1)" "unprognostic (5.73e-2)" "unprognostic (2.86e-2)" "unprognostic (1.70e-1)" "unprognostic (2.34e-1)" "prognostic unfavorable (2.26e-8)" "unprognostic (5.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" 45.8 60.5 0.4 733.2 0.3 189.1 385.3 0.2 2.1 136.2 0.6 1373.3 701.6 32.1 11.5 143.5 34.0 253.5 18.9 0.2 0.6 44.4 55.2 227.4 575.7 0.6 0.7 120.8 13.7 1.9 3.2 0.9 0.9 30.1 1090.9 0.1 496.0 60.9 1.2 14.2 536.0 59.5 19.8 1100.0 788.6 22.2 0.3 261.9 88.8 0.9 2812.9 1822.6 33.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.4 1.8 1.5 0.0 0.0 3.7 4.6 0.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.7 0.7 0.6 1.8 0.3 0.1 0.0 1.4 0.0 1.9 1.3 1.2 2.0 0.2 0.7 1729.8 0.8 0.6 1.6 1401.2 0.8 0.8 5.3 0.9 1.1 1.2 1.3 186.7 0.4 0.3 0.2 2.1 0.2 0.6 0.6 0.7 0.9 19.8 0.3 1.0 0.0 0.0 0.5 0.0 211.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 82.6 0.0 0.0 0.0 2.5 1.9 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.7 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27475.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 62.0 0.0 0.3 0.0 IGKV3-15 ENSG00000244437 "Immunoglobulin kappa variable 3-15" P01624 2 89085177-89085787 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 785.8;lymphoid tissue: 1996.3;urinary bladder: 784.8" "Cell type enriched" "Detected in some" 85 "Plasma cells: 22923.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 561 "memory B-cell: 2243.8;naive B-cell: 1651.4" "Lineage enriched" "Detected in all" 646 "B-cells: 2243.8" "Cell line enhanced" "Detected in some" "Daudi: 1.7;K-562: 1.3;NB-4: 1.9;RH-30: 1.2;RPMI-8226: 2.2;SCLC-21H: 1.4;SH-SY5Y: 2.5" HPA047702 Approved "Immunoglobulin genes" NA NA 7200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (1.57e-4)" "unprognostic (1.29e-2)" "unprognostic (7.02e-3)" "unprognostic (3.89e-3)" "unprognostic (9.06e-3)" "unprognostic (2.06e-3)" "unprognostic (5.36e-2)" "unprognostic (3.55e-1)" "unprognostic (1.45e-1)" "unprognostic (5.82e-3)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.15e-7)" "unprognostic (2.00e-1)" "unprognostic (2.54e-1)" "unprognostic (2.07e-1)" "unprognostic (1.17e-1)" 47.9 114.5 0.0 603.8 0.1 131.0 174.3 0.0 1.5 141.8 0.3 785.8 431.4 19.4 34.7 120.0 30.0 144.4 14.8 0.1 0.3 35.2 36.7 184.8 500.9 0.7 0.3 55.4 9.3 2.5 3.0 0.5 0.3 18.3 649.4 0.0 399.3 114.2 1.0 2.7 335.8 29.5 1.5 1020.7 629.8 64.8 0.2 250.2 77.7 0.0 1996.3 784.8 28.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 1.9 0.6 0.0 0.0 0.0 1.2 2.2 0.0 0.0 1.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.4 0.7 0.5 0.0 0.0 0.0 1.0 0.0 1.8 3.4 0.8 1.0 0.4 0.8 2243.8 1.0 1.1 1.8 1651.4 1.0 1.1 1.9 1.0 1.3 1.7 1.5 193.1 0.0 0.1 0.0 1.5 0.1 0.3 0.7 0.3 0.3 1.5 0.2 1.0 0.0 0.0 0.0 0.0 269.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.6 73.4 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22923.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.5 0.0 0.0 0.2 0.0 0.0 28.2 0.0 0.0 0.0 IGKV3-20 ENSG00000239951 "Immunoglobulin kappa variable 3-20" P01619 2 89142574-89143160 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 3080.6;lymphoid tissue: 5246.5" "Cell type enriched" "Detected in some" 138 "Plasma cells: 52154.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 329 "memory B-cell: 1602.7;naive B-cell: 1222.4" "Lineage enriched" "Detected in many" 373 "B-cells: 1602.7" "Group enriched" "Detected in many" 215 "U-266/70: 3769.9;U-266/84: 1732.3" HPA047702 Approved "Immunoglobulin genes" NA NA 20000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (1.86e-4)" "unprognostic (4.16e-2)" "unprognostic (1.64e-2)" "unprognostic (1.97e-2)" "unprognostic (1.13e-1)" "prognostic favorable (9.01e-4)" "unprognostic (1.43e-1)" "unprognostic (3.43e-1)" "unprognostic (1.37e-1)" "unprognostic (3.93e-3)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (7.35e-2)" "unprognostic (5.08e-1)" "unprognostic (6.64e-2)" "unprognostic (2.70e-2)" 104.8 56.4 0.9 1791.2 0.9 380.3 736.4 0.5 4.2 326.9 2.6 3080.6 1714.2 59.0 7.8 302.1 105.2 637.2 55.7 0.5 1.6 106.2 113.5 454.0 2815.6 2.1 8.4 153.5 32.8 5.8 9.6 1.8 1.4 56.1 2731.8 0.2 1270.5 224.5 3.3 13.4 1355.8 82.8 10.4 2699.1 1412.9 24.7 1.2 671.5 224.3 1.8 5246.5 1644.0 70.0 1.5 2.5 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.5 0.0 2.1 0.0 0.0 0.0 6.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 2.0 5.9 2.8 0.0 0.0 3.0 6.0 10.4 0.0 0.0 7.7 12.8 1.4 0.0 0.1 0.0 0.0 0.8 4.4 0.0 2.0 1.5 4.3 3769.9 1732.3 1.8 0.0 2.3 0.0 4.0 1.2 0.7 0.7 0.4 0.8 1602.7 0.8 0.6 3.5 1222.4 0.4 0.7 4.2 0.8 1.0 0.9 0.8 196.9 0.9 0.9 0.5 4.2 0.5 1.6 2.1 8.4 1.4 10.4 1.2 1.5 0.1 3.2 1.3 0.0 376.9 0.0 0.0 0.0 5.2 0.0 0.1 0.1 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 9.4 0.0 0.0 0.0 55.3 124.4 0.0 1.3 0.0 3.6 5.0 0.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 52154.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 0.0 0.0 26.7 0.0 0.2 0.0 IGKV3-7 ENSG00000243063 "Immunoglobulin kappa variable 3-7 (non-functional)" A0A075B6H7 2 88978468-88979081 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.6;lymphoid tissue: 22.2;salivary gland: 15.9;stomach 1: 10.2" "Group enriched" "Detected in some" 37 "B-cells: 1.5;Plasma cells: 5.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 61 "memory B-cell: 27.8;naive B-cell: 24.3" "Lineage enriched" "Detected in single" 65 "B-cells: 27.8" "Not detected" "Not detected" HPA047702 Approved "Immunoglobulin genes" NA NA 850000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (1.17e-4)" "unprognostic (3.07e-3)" "unprognostic (3.96e-2)" "unprognostic (1.28e-2)" "unprognostic (1.20e-3)" "unprognostic (1.19e-1)" "unprognostic (5.91e-2)" "unprognostic (2.73e-1)" "unprognostic (4.24e-2)" "unprognostic (2.15e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (1.27e-5)" "unprognostic (1.16e-1)" "unprognostic (1.40e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" 0.3 0.4 0.0 15.0 0.0 4.2 3.9 0.0 0.0 2.1 0.0 18.6 15.1 0.3 0.1 1.5 0.1 1.3 0.0 0.0 0.0 0.2 0.5 1.8 2.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 13.6 0.0 15.9 0.1 0.0 0.0 11.2 0.7 0.0 4.9 10.2 0.0 0.0 1.4 0.1 0.0 22.2 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 24.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV3D-11 ENSG00000211632 "Immunoglobulin kappa variable 3D-11" A0A0A0MRZ8 2 90172802-90173414 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.6;lymphoid tissue: 58.5;stomach 1: 27.7" "Cell type enriched" "Detected in some" 34 "Plasma cells: 196.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 468 "memory B-cell: 152.5;naive B-cell: 146.1" "Lineage enriched" "Detected in single" 478 "B-cells: 152.5" "Cell line enhanced" "Detected in single" "U-266/70: 2.1" HPA047702 Approved "Immunoglobulin genes" NA NA 6700000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (6.40e-5)" "unprognostic (7.90e-3)" "unprognostic (1.91e-2)" "unprognostic (2.24e-3)" "prognostic favorable (5.58e-5)" "unprognostic (2.65e-2)" "unprognostic (2.13e-1)" "unprognostic (2.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.49e-1)" "unprognostic (3.61e-1)" "prognostic unfavorable (2.20e-6)" "unprognostic (1.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "unprognostic (1.24e-2)" 1.3 0.7 0.3 35.9 0.2 8.9 6.4 0.0 0.1 1.7 0.0 38.6 32.2 0.8 0.0 2.4 2.1 2.7 0.5 0.0 0.1 2.1 1.3 12.4 13.0 0.1 0.3 1.5 0.5 0.0 0.1 0.0 0.1 0.7 26.6 0.0 18.8 0.3 0.0 0.1 23.6 0.7 0.2 29.9 27.7 0.2 0.0 4.2 2.3 0.0 58.5 17.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 152.5 0.0 0.0 0.1 146.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 30.2 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 196.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 IGKV3D-15 ENSG00000224041 "Immunoglobulin kappa variable 3D-15" A0A087WSY6 2 90114838-90115402 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 126.7;lymphoid tissue: 203.0;salivary gland: 54.1;stomach 1: 87.4;urinary bladder: 58.0" "Cell type enriched" "Detected in some" 622 "Plasma cells: 3673.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 191 "memory B-cell: 181.1;naive B-cell: 155.6" "Lineage enriched" "Detected in single" 206 "B-cells: 181.1" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;HL-60: 2.6;SiHa: 1.7" HPA047702 Approved "Immunoglobulin genes" NA NA 4800000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (6.11e-4)" "prognostic favorable (7.46e-4)" "unprognostic (9.16e-3)" "unprognostic (1.74e-1)" "unprognostic (1.90e-3)" "unprognostic (7.20e-2)" "unprognostic (9.19e-2)" "unprognostic (4.93e-1)" "unprognostic (3.42e-2)" "unprognostic (1.41e-1)" "unprognostic (2.97e-1)" "prognostic unfavorable (1.82e-6)" "unprognostic (8.99e-2)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.04e-1)" 3.1 4.4 0.1 93.5 0.4 11.1 17.1 0.1 0.5 5.9 0.3 111.6 63.0 1.0 0.0 16.4 5.2 10.1 2.3 0.1 0.2 3.6 2.0 18.0 43.6 0.4 0.2 17.9 4.0 0.3 0.1 0.0 0.2 1.7 126.7 0.0 54.1 1.1 0.1 0.6 46.7 4.3 0.3 56.3 87.4 0.2 0.1 13.0 4.5 0.0 203.0 58.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.6 0.0 0.1 0.8 0.0 0.0 0.0 0.0 181.1 0.0 0.0 0.1 155.6 0.0 0.0 0.0 0.1 0.1 0.0 0.1 27.5 0.1 0.4 0.1 0.5 0.1 0.2 0.4 0.2 0.2 0.3 0.1 0.3 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3673.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGKV3D-20 ENSG00000211625 "Immunoglobulin kappa variable 3D-20" A0A0C4DH25 2 90038848-90039479 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 131.8;lymphoid tissue: 275.4" "Cell type enriched" "Detected in some" 38 "Plasma cells: 289.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 1042 "memory B-cell: 197.3;naive B-cell: 99.0" "Lineage enriched" "Detected in single" 1388 "B-cells: 197.3" "Cell line enriched" "Detected in some" 4 "U-266/70: 19.5" HPA047702 Approved "Immunoglobulin genes" NA NA 11000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (6.82e-4)" "unprognostic (4.70e-3)" "unprognostic (3.16e-2)" "unprognostic (8.10e-3)" "unprognostic (2.05e-1)" "unprognostic (2.60e-3)" "unprognostic (3.37e-1)" "unprognostic (1.68e-1)" "unprognostic (5.15e-2)" "unprognostic (2.53e-2)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.56e-6)" "unprognostic (7.10e-2)" "unprognostic (2.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" 4.0 6.3 0.0 81.2 0.0 16.0 32.4 0.0 0.6 12.2 0.1 131.8 55.9 2.7 0.0 15.3 4.2 16.2 6.4 0.0 0.1 3.0 6.4 20.6 73.5 0.2 0.1 7.1 3.3 0.0 0.3 0.1 0.1 3.7 88.1 0.0 64.0 3.3 0.1 2.6 77.7 6.0 0.3 88.4 82.5 1.2 0.0 16.2 5.2 0.0 275.4 38.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.5 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 197.3 0.0 0.1 0.1 99.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34.1 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 289.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 IGKV3D-7 ENSG00000228325 "Immunoglobulin kappa variable 3D-7" A0A0C4DH55 2 90234812-90235370 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.6;lymphoid tissue: 5.5;stomach 1: 4.4;urinary bladder: 5.5" "Cell type enriched" "Detected in single" 415 "Plasma cells: 207.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "memory B-cell: 2.8;naive B-cell: 4.3" "Lineage enriched" "Detected in single" 44 "B-cells: 4.3" "Cell line enriched" "Detected in some" 12 "RPMI-8226: 48.7" HPA047702 Approved "Immunoglobulin genes" NA NA 3700000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "unprognostic (2.74e-1)" "unprognostic (8.62e-3)" "unprognostic (6.59e-2)" "unprognostic (2.14e-1)" "unprognostic (3.05e-1)" "unprognostic (4.02e-1)" 0.1 0.0 0.0 5.5 0.2 1.3 0.1 0.0 0.1 0.2 0.0 4.0 4.6 0.0 0.0 1.9 0.1 1.5 0.0 0.1 0.1 0.0 0.2 0.5 1.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.1 0.1 0.0 0.0 4.4 0.0 0.0 3.8 4.4 0.0 0.1 0.2 0.6 0.0 4.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 207.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV3OR2-268 "IGKV268, IGKV3/OR2-268, IGKV3/OR2-268A, IGKV3OR2-268A" ENSG00000233999 "Immunoglobulin kappa variable 3/OR2-268 (non-functional)" 2 87338511-87339035 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 100.4;lymphoid tissue: 85.7" "Cell type enriched" "Detected in some" 302 "Plasma cells: 2604.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 220.0;naive B-cell: 78.9" "Lineage enriched" "Detected in many" 7 "B-cells: 220.0" "Group enriched" "Detected in some" 71 "U-266/70: 183.9;U-266/84: 593.2" HPA047702 Approved NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (8.06e-4)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.26e-1)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (8.68e-2)" "unprognostic (2.61e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.12e-6)" "unprognostic (2.80e-2)" "unprognostic (3.83e-1)" "unprognostic (1.58e-1)" "unprognostic (4.41e-1)" 0.4 1.3 0.3 45.8 0.4 11.8 28.5 0.1 0.6 3.4 0.2 100.4 33.9 0.9 0.0 1.3 0.7 24.7 1.3 0.3 0.4 0.6 2.6 7.5 23.8 0.3 0.2 3.3 1.2 0.0 0.0 0.1 0.2 1.6 59.5 0.0 29.4 1.6 0.0 0.6 27.7 4.1 0.1 19.3 34.0 0.4 0.2 10.3 1.2 0.0 85.7 24.4 0.8 0.5 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.4 3.8 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.5 0.2 183.9 593.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 220.0 2.8 0.1 0.1 78.9 0.0 0.1 0.1 0.1 0.0 0.2 30.0 32.7 0.3 0.4 0.1 0.6 0.3 0.4 0.3 0.2 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2604.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 IGKV4-1 "B3, IGKV41" ENSG00000211598 "Immunoglobulin kappa variable 4-1" P06312 2 88885397-88886153 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1805.7;lymphoid tissue: 3169.0" "Cell type enriched" "Detected in some" 219 "Plasma cells: 46306.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 588 "memory B-cell: 3036.3;naive B-cell: 3070.9" "Lineage enriched" "Detected in all" 591 "B-cells: 3070.9" "Cell line enhanced" "Detected in some" "Daudi: 14.9;RPMI-8226: 10.4;SH-SY5Y: 6.9;U-266/70: 7.5" "Immunoglobulin genes" NA NA 8500000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.41e-5)" "unprognostic (9.19e-2)" "unprognostic (4.29e-3)" "unprognostic (5.42e-3)" "unprognostic (2.08e-2)" "prognostic favorable (8.25e-4)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (3.32e-1)" "unprognostic (3.71e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-1)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" "unprognostic (1.19e-1)" 55.9 296.3 0.4 1054.1 0.9 342.1 665.2 0.4 3.4 145.2 2.4 1805.7 1769.7 46.8 19.4 195.7 41.3 188.2 51.9 0.4 1.2 35.0 76.1 302.3 816.8 1.9 0.8 86.5 28.3 2.5 2.8 1.0 3.5 43.9 1318.2 0.1 701.8 89.6 1.0 8.6 1023.0 66.4 3.6 972.3 1125.7 125.7 0.7 405.1 51.0 0.1 3169.0 758.2 19.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.6 3.6 0.3 0.0 0.0 1.4 2.2 10.4 0.0 0.0 4.0 6.9 2.3 0.0 0.0 0.0 0.0 0.7 2.6 0.0 0.8 1.1 1.0 7.5 0.2 0.8 0.0 1.2 0.0 3.9 3.2 5.1 1.6 0.9 1.7 3036.3 1.9 1.1 2.8 3070.9 2.1 1.3 2.4 1.6 2.4 2.3 1.7 344.9 0.4 0.9 0.4 3.4 0.4 1.2 1.9 0.8 3.5 3.6 0.7 1.5 0.0 0.0 0.0 0.0 210.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.0 0.0 0.0 0.0 17.0 40.2 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46306.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 15.7 0.0 0.1 0.0 IGKV5-2 "B2, IGKV52" ENSG00000211599 "Immunoglobulin kappa variable 5-2" P06315 2 88897232-88897784 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.9;lymphoid tissue: 83.1" "Cell type enriched" "Detected in some" 193 "Plasma cells: 1664.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "memory B-cell: 21.4;naive B-cell: 17.2" "Lineage enriched" "Detected in many" 21 "B-cells: 21.4" "Group enriched" "Detected in some" 19 "Daudi: 4.2;HDLM-2: 1.8;RPMI-8226: 2.3" "Low region specificity" "Detected in all" "Immunoglobulin genes" NA NA 4700000 "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.77e-3)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (2.49e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.37e-1)" "unprognostic (2.26e-1)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (8.62e-6)" "unprognostic (2.60e-1)" "unprognostic (2.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.85e-2)" 0.9 0.0 0.0 10.3 0.0 6.4 19.6 0.0 0.0 5.3 0.0 23.3 35.9 0.8 0.0 4.0 0.9 0.9 0.1 0.0 0.0 0.9 1.0 6.3 17.3 0.0 0.0 0.4 0.4 0.5 0.0 0.0 0.0 0.6 11.1 0.0 14.9 1.9 0.0 0.5 14.3 0.2 0.0 23.5 15.3 0.0 0.0 3.0 1.0 0.0 83.1 4.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1664.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGKV6-21 "A26, IGKV621" ENSG00000211611 "Immunoglobulin kappa variable 6-21 (non-functional)" A0A0C4DH24 2 89159751-89160366 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 97.3;lymphoid tissue: 141.0" "Cell type enriched" "Detected in some" 142 "Plasma cells: 1715.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 194 "memory B-cell: 28.8;naive B-cell: 9.8" "Lineage enriched" "Detected in single" 289 "B-cells: 28.8" "Cell line enriched" "Detected in some" 6 "U-266/70: 10.5" "Immunoglobulin genes" NA NA 250000000 "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.82e-4)" "unprognostic (1.80e-2)" "unprognostic (4.99e-3)" "unprognostic (2.32e-2)" "unprognostic (1.51e-3)" "unprognostic (1.93e-1)" "unprognostic (6.32e-2)" "unprognostic (4.74e-2)" "unprognostic (8.91e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" 2.2 0.4 0.0 41.6 0.0 12.0 37.4 0.0 0.1 3.3 0.0 97.3 38.8 1.8 0.6 8.4 1.9 5.9 0.5 0.0 0.0 2.7 2.6 11.9 64.4 0.2 0.0 2.1 0.8 0.0 0.1 0.0 0.0 1.5 79.3 0.0 43.5 9.0 0.0 0.5 38.5 5.0 0.1 63.8 36.3 0.9 0.0 10.2 3.5 0.0 141.0 37.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1715.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGKV6D-21 "A10, IGKV6D21" ENSG00000225523 "Immunoglobulin kappa variable 6D-21 (non-functional)" A0A0A0MT36 2 90021567-90022185 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "intestine: 67.0;lymphoid tissue: 152.7;urinary bladder: 227.3" "Cell type enriched" "Detected in some" 7 "Plasma cells: 234.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 154 "memory B-cell: 14.2;naive B-cell: 16.5" "Lineage enriched" "Detected in single" 166 "B-cells: 16.5" "Not detected" "Not detected" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.95e-4)" "unprognostic (5.47e-3)" "unprognostic (2.85e-3)" "prognostic favorable (5.25e-5)" "unprognostic (1.51e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (3.45e-7)" "unprognostic (7.23e-2)" "unprognostic (2.00e-1)" "unprognostic (1.24e-1)" "unprognostic (2.07e-1)" 1.1 0.4 0.0 17.2 0.0 17.2 11.8 0.0 0.1 5.4 0.0 67.0 38.8 1.6 0.0 22.1 0.8 2.7 2.1 0.2 0.0 1.6 2.4 6.3 19.8 0.6 0.0 1.1 1.1 0.0 0.0 0.0 0.1 0.8 31.8 0.0 21.1 17.3 0.0 1.2 37.8 1.0 0.0 45.3 13.4 3.4 0.0 9.1 1.4 0.0 152.7 227.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 234.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGLC1 IGLC ENSG00000211675 "Immunoglobulin lambda constant 1" 22 22895375-22895834 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 3264.2;lymphoid tissue: 5586.9;stomach 1: 2335.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 37.3;granulocytes: 15.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 743 "memory B-cell: 5729.2;naive B-cell: 5821.4" "Lineage enriched" "Detected in all" 749 "B-cells: 5821.4" "Cell line enriched" "Detected in many" 5 "U-266/70: 600.3" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" 132.3 163.1 2.2 1208.8 1.9 641.9 903.4 1.7 7.0 190.8 4.4 3038.0 3264.2 63.1 2.1 535.0 113.2 640.0 104.5 1.7 2.2 148.2 114.7 470.6 2372.4 3.9 1.7 135.6 69.8 8.0 13.2 1.9 2.2 71.5 2133.6 0.7 2047.0 124.0 4.9 28.8 1389.9 78.0 2.6 3332.0 2335.3 23.7 2.3 873.2 224.5 0.0 5586.9 1948.8 79.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.0 0.0 1.0 0.0 1.9 0.2 0.0 0.0 6.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 9.1 0.0 0.0 1.1 10.2 2.0 0.0 0.0 2.3 8.9 33.4 0.0 0.0 6.3 11.1 1.4 0.0 0.0 0.0 0.0 0.3 2.5 0.0 1.3 4.3 2.6 600.3 119.9 36.5 0.0 3.5 0.0 4.2 7.7 2.0 3.7 1.7 2.9 5729.2 3.8 2.5 6.0 5821.4 0.9 2.2 7.6 2.8 4.8 5.2 3.4 897.2 2.2 1.9 1.7 7.0 1.7 2.2 3.9 1.7 2.2 2.6 2.3 3.4 0.0 6.4 37.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 IGLC2 IGLC ENSG00000211677 "Immunoglobulin lambda constant 2" P0DOY2 22 22900976-22901437 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Bence-Jones protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 9734.6;lymphoid tissue: 19988.7;stomach 1: 10849.9" "Group enriched" "Detected in many" 40 "B-cells: 24632.2;Plasma cells: 18795.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 36 "memory B-cell: 11361.1;naive B-cell: 10650.3" "Lineage enriched" "Detected in all" 37 "B-cells: 11361.1" "Group enriched" "Detected in many" 190 "RPMI-8226: 62032.1;U-266/70: 102644.1;U-266/84: 83511.6" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.76e-5)" "unprognostic (2.29e-2)" "unprognostic (4.54e-3)" "unprognostic (1.46e-2)" "unprognostic (4.02e-2)" "prognostic favorable (1.14e-4)" "unprognostic (1.96e-2)" "unprognostic (7.52e-2)" "unprognostic (7.15e-2)" "unprognostic (7.69e-3)" "unprognostic (2.83e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (4.47e-9)" "unprognostic (2.00e-1)" "unprognostic (3.43e-1)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" 386.6 782.7 7.7 3871.2 6.2 2741.4 2183.6 4.6 14.9 815.5 11.4 8217.0 9734.6 194.3 207.0 1690.0 231.5 2091.8 318.3 4.6 5.7 301.6 382.3 1442.8 5543.4 11.1 5.0 540.2 112.7 16.8 31.0 7.5 6.6 264.0 5055.4 0.7 5934.2 384.9 8.6 74.2 5290.6 306.2 6.6 7090.0 10849.9 256.0 5.4 2071.4 491.7 0.6 19988.7 6482.1 176.7 10.7 120.6 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 221.4 12.0 0.0 0.0 61.9 0.0 0.0 0.0 30.5 0.0 7.7 0.0 0.0 0.0 19.2 343.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 64.7 0.0 0.0 70.1 27.7 52.3 0.0 0.0 45.3 436.2 62032.1 0.0 0.0 46.7 45.7 5.6 43.0 17.3 0.0 17.7 57.2 11.7 0.0 38.9 23.4 78.2 102644.1 83511.6 298.8 0.7 21.9 0.7 9.9 18.6 5.6 5.8 3.0 5.7 11361.1 5.8 4.5 10.9 10650.3 3.5 4.7 118.0 5.8 8.7 303.3 6.5 2385.6 7.7 6.2 4.6 14.9 4.6 5.7 11.1 5.0 6.6 6.6 5.4 10.7 4.1 32.1 121.0 0.0 24632.2 0.0 0.3 0.0 1.2 0.0 16.1 3.0 3.9 44.3 8.1 0.0 0.0 0.3 8.0 28.0 0.0 0.0 0.0 0.0 0.1 86.3 62.5 222.4 0.0 0.0 0.3 42.5 14.8 0.0 65.6 0.0 222.8 539.9 2.1 0.0 0.0 21.5 0.0 134.5 0.0 0.0 0.0 8.5 0.0 0.0 11.4 0.0 15.5 0.0 0.0 0.0 20.6 0.0 18795.5 0.0 0.0 1.4 1.5 0.0 0.0 0.2 10.2 0.0 0.0 2.8 0.0 0.1 538.6 0.0 23.7 0.0 IGLC3 IGLC ENSG00000211679 "Immunoglobulin lambda constant 3 (Kern-Oz+ marker)" P0DOY3 22 22906342-22906803 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Bence-Jones protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 4115.7;lymphoid tissue: 8175.8;stomach 1: 4130.0;urinary bladder: 3726.3" "Group enriched" "Detected in many" 35 "B-cells: 12202.8;Plasma cells: 5357.3;T-cells: 3582.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 34 "memory B-cell: 7254.6;naive B-cell: 6119.2" "Lineage enriched" "Detected in all" 37 "B-cells: 7254.6" "Cell line enriched" "Detected in many" 15 "RPMI-8226: 10741.3" "CAB000050, CAB016533" Supported "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB000050: , CAB016533: AB_629719" "prognostic favorable (2.32e-4)" "unprognostic (1.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.54e-2)" "unprognostic (8.41e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.45e-2)" "unprognostic (4.59e-2)" "unprognostic (8.77e-2)" "prognostic favorable (4.58e-4)" "unprognostic (9.71e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.04e-9)" "unprognostic (1.21e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (5.97e-2)" 156.2 550.9 2.6 2377.2 2.7 840.6 1388.6 1.4 9.1 220.4 7.1 4115.7 4046.3 115.2 33.2 508.5 88.0 707.7 63.7 1.3 2.8 178.6 171.7 1081.6 2745.8 7.2 1.4 247.8 47.6 7.0 19.0 3.2 2.0 134.0 2268.4 0.3 2264.0 177.1 5.8 20.7 2373.2 113.9 3.4 4261.5 4130.0 55.4 2.1 426.9 232.0 0.9 8175.8 3726.3 111.5 6.4 0.6 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 60.1 0.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 18.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 338.0 0.0 0.0 10.8 15.0 2.8 0.0 0.0 700.2 9.3 10741.3 0.0 0.0 16.6 25.1 4.4 20.8 0.0 0.0 4.9 0.8 11.1 0.0 6.3 7.2 5.0 88.0 103.4 36.1 1.2 5.3 0.5 6.4 9.1 3.9 6.0 2.0 27.3 7254.6 5.1 3.6 6.9 6119.2 2.6 3.3 60.7 4.3 4.6 195.3 4.7 1415.5 2.6 2.7 1.4 9.1 1.3 2.8 7.2 1.4 2.0 3.4 2.1 6.4 2.0 22.4 97.3 0.0 12202.8 0.0 0.7 0.0 0.0 0.0 5.4 0.5 15.3 8.6 3.7 0.0 0.0 0.2 8.8 5.0 0.0 0.0 0.0 0.0 0.1 7.4 12.2 54.8 0.0 0.0 0.0 22.1 5.6 0.1 47.9 0.0 195.9 127.7 0.2 0.0 0.0 3.5 0.0 23.1 0.0 0.0 0.0 5.6 0.0 0.0 2.0 0.0 2.1 0.0 0.0 0.0 3.1 0.0 5357.3 0.2 0.0 1.1 2.2 0.0 0.0 0.0 4.2 0.0 0.0 0.8 0.0 0.1 3582.0 0.0 6.3 0.9 IGLC7 ENSG00000211685 "Immunoglobulin lambda constant 7" 22 22922594-22923034 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 88.1;lymphoid tissue: 107.7;salivary gland: 70.1;stomach 1: 113.1" "Cell type enriched" "Detected in some" 10 "B-cells: 109.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 341 "memory B-cell: 128.8;naive B-cell: 133.0" "Lineage enriched" "Detected in single" 346 "B-cells: 133.0" "Cell line enriched" "Detected in some" 913 "Karpas-707: 122629.0" "Immunoglobulin genes" NA NA "Cluster 37: B-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.20e-3)" "unprognostic (5.94e-2)" "unprognostic (3.91e-1)" "unprognostic (2.16e-2)" "prognostic favorable (2.03e-4)" "unprognostic (2.11e-1)" "unprognostic (9.60e-3)" "unprognostic (2.47e-2)" "unprognostic (1.88e-1)" "unprognostic (2.74e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (1.61e-6)" "unprognostic (2.86e-1)" "unprognostic (2.14e-1)" "unprognostic (1.30e-1)" "unprognostic (9.62e-2)" 5.6 4.7 0.0 27.9 0.0 19.9 15.6 0.0 0.4 5.1 0.0 54.1 88.1 4.4 0.5 8.4 4.3 10.7 1.4 0.0 0.5 2.3 3.5 8.3 40.8 0.3 0.0 2.5 1.7 0.1 0.2 0.0 0.2 4.4 23.1 0.0 70.1 0.6 0.1 0.2 23.1 0.9 0.0 107.7 113.1 0.8 0.1 20.0 5.7 0.0 104.2 19.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122629.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 134.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.7 3.0 0.6 111.2 0.0 47.3 0.3 0.1 0.0 0.0 0.1 0.0 128.8 0.0 0.0 0.1 133.0 0.0 0.2 0.1 0.0 0.1 0.3 0.1 25.5 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.4 3.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 IGLJ1 ENSG00000211674 "Immunoglobulin lambda joining 1" A0A0A0MT76 22 22893692-22893818 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "intestine: 95.1;lymphoid tissue: 50.0;salivary gland: 32.5;stomach 1: 40.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory B-cell: 19.6;naive B-cell: 11.0" "Lineage enriched" "Detected in single" 31 "B-cells: 19.6" "Group enriched" "Detected in some" 6 "Daudi: 274.6;U-266/70: 310.0;U-698: 88.7" "Immunoglobulin genes" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "unprognostic (4.18e-4)" "unprognostic (4.80e-3)" "unprognostic (6.97e-2)" "unprognostic (4.68e-1)" 2.3 0.6 0.1 43.3 0.1 9.8 1.8 0.2 0.6 0.0 0.4 17.1 95.1 0.8 0.0 2.0 0.4 5.1 0.2 0.0 0.1 0.2 0.1 2.7 50.0 0.5 0.1 0.5 0.0 0.0 0.0 0.2 0.3 0.6 13.5 0.0 32.5 0.0 0.0 0.0 43.4 2.6 0.2 31.5 40.8 1.3 0.2 5.2 0.0 0.0 34.5 4.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 274.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 3.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 310.0 37.0 88.7 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 19.6 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.1 0.1 0.2 0.6 0.0 0.1 0.5 0.1 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLJ2 ENSG00000211676 "Immunoglobulin lambda joining 2" 22 22899481-22899655 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 260.8;lymphoid tissue: 189.8;stomach 1: 212.7" "Cell type enriched" "Detected in single" 5 "Plasma cells: 1.7" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.9;endometrial cancer: 21.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 12 "memory B-cell: 876.1;naive B-cell: 864.5" "Lineage enriched" "Detected in many" 12 "B-cells: 876.1" "Cell line enhanced" "Detected in some" "Daudi: 10.8;HMC-1: 34.1;RH-30: 89.7;U-698: 19.8" NA NA "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (6.99e-3)" "unprognostic (5.36e-2)" "unprognostic (5.54e-2)" "unprognostic (1.13e-2)" "unprognostic (5.94e-7)" "unprognostic (1.51e-2)" "unprognostic (3.63e-2)" "unprognostic (3.66e-2)" "unprognostic (5.17e-2)" "unprognostic (2.92e-1)" 8.4 54.9 0.2 173.0 0.0 25.4 11.2 0.1 0.8 6.1 0.1 134.5 260.8 2.9 4.2 13.5 1.0 12.5 2.9 0.1 0.2 2.1 6.9 21.5 94.5 0.3 0.0 4.7 5.9 0.1 0.0 0.0 0.9 4.0 31.1 0.0 75.6 4.2 0.0 0.2 206.0 1.9 0.1 128.3 212.7 2.3 0.0 15.5 0.3 0.0 189.8 60.8 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.7 89.7 1.3 0.0 0.0 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.0 0.0 0.6 19.8 0.0 0.5 0.0 1.4 1.9 0.6 0.4 0.2 0.7 876.1 0.3 0.3 0.9 864.5 0.2 0.4 9.3 0.7 0.8 71.8 0.5 136.5 0.2 0.0 0.1 0.8 0.1 0.2 0.3 0.0 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLJ3 ENSG00000211678 "Immunoglobulin lambda joining 3" 22 22904850-22905025 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "intestine: 552.2;lymphoid tissue: 227.6;salivary gland: 149.1;stomach 1: 462.5;urinary bladder: 147.8" "Group enriched" "Detected in some" 44 "B-cells: 4.5;Plasma cells: 4.3" "Group enriched" "Detected in some" 13 "colorectal cancer: 5.1;endometrial cancer: 10.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Group enriched" "Detected in many" 24 "memory B-cell: 1223.9;naive B-cell: 1139.6" "Lineage enriched" "Detected in many" 25 "B-cells: 1223.9" "Group enriched" "Detected in some" 7 "Daudi: 53.6;REH: 69.6;U-266/70: 42.8;U-266/84: 22.5" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (1.19e-1)" "unprognostic (2.06e-3)" "unprognostic (2.05e-1)" "unprognostic (1.37e-1)" "unprognostic (5.00e-1)" 5.7 29.4 0.4 212.4 0.3 37.4 32.5 0.1 1.5 9.7 0.4 130.1 552.2 3.2 0.0 40.0 4.0 32.7 3.1 0.1 0.1 2.9 9.9 41.7 132.1 0.4 0.2 31.1 1.9 0.0 0.0 0.1 0.1 9.6 71.4 0.0 149.1 1.6 0.0 1.5 205.9 6.1 0.0 207.6 462.5 6.1 0.1 23.2 0.8 0.0 227.6 147.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 69.6 2.5 6.7 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.0 42.8 22.5 4.3 0.0 0.0 0.0 0.8 1.6 0.7 0.9 0.3 4.3 1223.9 0.8 0.5 1.3 1139.6 0.4 0.5 8.5 0.6 1.2 49.2 0.8 193.9 0.4 0.3 0.1 1.5 0.1 0.1 0.4 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLJ6 ENSG00000211682 "Immunoglobulin lambda joining 6" 22 22918132-22918201 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "intestine: 6.6;lymphoid tissue: 7.9;urinary bladder: 5.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "colorectal cancer: 1.2;endometrial cancer: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 48 "memory B-cell: 31.6;naive B-cell: 38.3" "Lineage enriched" "Detected in single" 52 "B-cells: 38.3" "Group enriched" "Detected in some" 8 "Daudi: 14.5;U-698: 4.3" NA NA "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 0.0 0.0 0.2 7.2 0.2 0.0 0.4 0.0 0.3 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 1.0 0.0 7.9 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 5.3 1.0 0.0 0.4 0.0 0.0 0.0 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.2 0.2 0.0 0.3 0.1 0.8 0.3 0.4 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV1-36 ENSG00000211655 "Immunoglobulin lambda variable 1-36" A0A0B4J1U3 22 22431958-22432465 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 268.7;stomach 1: 122.4;urinary bladder: 86.4" "Cell type enriched" "Detected in some" 13 "Plasma cells: 59.2" "Cancer enhanced" "Detected in many" "lung cancer: 33.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 625 "memory B-cell: 60.9;naive B-cell: 85.8" "Lineage enriched" "Detected in single" 731 "B-cells: 85.8" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 980000000 "Cluster 37: B-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.55e-4)" "unprognostic (5.15e-2)" "unprognostic (2.04e-2)" "prognostic favorable (2.60e-4)" "unprognostic (1.11e-3)" "unprognostic (1.15e-2)" "unprognostic (1.50e-1)" "unprognostic (6.51e-2)" "unprognostic (2.12e-1)" "unprognostic (4.53e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.64e-5)" "unprognostic (2.99e-2)" "unprognostic (5.76e-2)" "unprognostic (1.54e-1)" "unprognostic (1.07e-1)" 1.8 0.3 0.0 19.6 0.0 14.4 23.7 0.0 0.1 6.0 0.0 28.2 21.6 0.7 0.6 10.5 9.1 7.3 6.0 0.0 0.0 3.3 3.3 8.7 16.6 0.0 0.0 1.7 1.1 0.0 0.1 0.0 0.0 1.6 44.7 0.0 37.3 3.0 0.0 0.6 12.3 0.8 0.0 108.1 122.4 0.3 0.0 30.5 2.8 0.0 268.7 86.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 60.9 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGLV1-40 ENSG00000211653 "Immunoglobulin lambda variable 1-40" P01703 22 22409766-22410282 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1291.5;stomach 1: 1287.4" "Cell type enriched" "Detected in some" 358 "Plasma cells: 43406.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 3.0" "Group enriched" "Detected in some" 496 "memory B-cell: 666.4;naive B-cell: 576.7" "Lineage enriched" "Detected in many" 532 "B-cells: 666.4" "Cell line enhanced" "Detected in some" "Daudi: 3.5;RPMI-8226: 2.2;SH-SY5Y: 3.4;TIME: 2.3" "Immunoglobulin genes" NA NA 2300000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.64e-3)" "unprognostic (4.68e-3)" "unprognostic (3.88e-2)" "unprognostic (3.37e-3)" "unprognostic (9.60e-3)" "prognostic favorable (5.74e-6)" "unprognostic (2.39e-2)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (5.51e-2)" "unprognostic (1.06e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.44e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (4.57e-2)" 43.4 13.0 0.8 203.5 0.5 114.3 138.5 0.1 3.0 68.1 1.1 553.8 551.6 14.8 0.6 125.4 21.5 236.0 15.2 0.2 0.2 28.8 28.3 115.4 282.5 0.3 0.2 56.6 10.0 1.1 3.4 0.6 0.6 46.1 336.7 4.2 413.8 19.7 1.2 3.1 287.2 14.3 0.2 1029.8 1287.4 7.2 0.3 179.2 61.2 0.0 1291.5 464.8 19.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 1.0 1.1 0.0 0.0 0.2 0.8 2.2 0.0 0.0 1.3 3.4 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.4 0.7 0.7 1.1 1.1 0.8 0.0 0.3 0.0 0.4 0.7 0.2 0.3 0.1 0.6 666.4 0.3 0.3 0.6 576.7 0.1 0.2 1.2 0.3 0.3 0.6 0.4 53.7 0.8 0.5 0.1 3.0 0.2 0.2 0.3 0.2 0.6 0.2 0.3 1.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.2 8.0 0.0 0.0 0.0 28.6 64.2 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 43406.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 7.4 0.0 0.1 0.0 IGLV1-44 ENSG00000211651 "Immunoglobulin lambda variable 1-44" P01699 22 22380766-22381347 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 589.7;lymphoid tissue: 1918.7;stomach 1: 534.3" "Cell type enriched" "Detected in some" 108 "Plasma cells: 12023.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 840 "memory B-cell: 968.8;naive B-cell: 850.4" "Lineage enriched" "Detected in many" 894 "B-cells: 968.8" "Cell line enhanced" "Detected in some" "Daudi: 21.3;RPMI-8226: 5.5;SCLC-21H: 4.1;U-698: 15.2" "Immunoglobulin genes" NA NA 4000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.88e-3)" "unprognostic (1.51e-2)" "unprognostic (2.40e-2)" "unprognostic (7.23e-3)" "unprognostic (4.81e-3)" "prognostic favorable (4.71e-5)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-1)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.55e-8)" "unprognostic (1.85e-1)" "unprognostic (1.98e-1)" "unprognostic (6.48e-2)" "unprognostic (5.49e-2)" 33.9 2.0 0.1 297.2 0.0 133.4 110.2 0.0 0.8 14.3 0.0 378.7 589.7 11.8 0.0 80.1 19.5 78.7 17.5 0.0 0.0 18.7 17.1 122.2 519.5 1.3 0.2 15.3 3.6 0.0 2.6 0.0 0.4 13.8 263.1 0.0 273.0 9.4 0.7 2.4 236.5 21.4 0.0 608.7 534.3 11.6 0.1 117.8 35.1 0.0 1918.7 240.5 16.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.5 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 968.8 0.0 0.0 0.7 850.4 0.0 0.0 0.0 0.0 0.1 1.0 0.1 100.0 0.1 0.0 0.0 0.8 0.0 0.0 1.3 0.2 0.4 0.0 0.1 0.8 0.0 0.0 0.6 0.0 111.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.0 3.5 48.4 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12023.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.3 0.0 IGLV1-47 ENSG00000211648 "Immunoglobulin lambda variable 1-47" P01700 22 22357739-22358260 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 706.6;lymphoid tissue: 1804.0;stomach 1: 625.5" "Cell type enriched" "Detected in some" 114 "Plasma cells: 10777.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 638 "memory B-cell: 1518.1;naive B-cell: 819.6" "Lineage enriched" "Detected in many" 828 "B-cells: 1518.1" "Cell line enhanced" "Detected in some" "HL-60: 2.1;RH-30: 2.1;RPMI-8226: 4.2;SCLC-21H: 2.7;SH-SY5Y: 2.4;U-698: 7.1" "Immunoglobulin genes" NA NA 3000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (5.19e-3)" "unprognostic (2.69e-2)" "unprognostic (1.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.66e-4)" "unprognostic (4.44e-2)" "unprognostic (1.09e-1)" "unprognostic (5.69e-2)" "unprognostic (3.14e-2)" "unprognostic (2.28e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (5.12e-8)" "unprognostic (5.00e-3)" "unprognostic (1.62e-1)" "unprognostic (7.08e-2)" "unprognostic (1.15e-2)" 36.0 216.0 0.6 323.0 0.4 162.3 200.5 0.4 2.3 82.1 0.7 706.6 704.7 23.8 3.0 163.7 21.3 112.7 27.2 0.2 0.5 23.2 31.8 126.7 689.2 2.6 0.4 43.5 8.9 4.9 2.1 0.5 1.2 22.5 531.5 0.2 526.6 70.2 0.7 4.7 332.8 34.7 0.5 813.7 625.5 9.8 0.4 260.1 34.1 0.0 1804.0 367.0 10.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.7 2.1 4.2 0.0 0.0 2.7 2.4 0.5 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.0 0.1 0.6 0.0 7.1 0.0 0.9 0.0 0.7 1.2 0.5 0.7 0.1 0.5 1518.1 0.7 0.6 1.0 819.6 0.3 0.6 0.6 0.5 0.5 1.8 0.6 159.6 0.6 0.4 0.4 2.3 0.2 0.5 2.6 0.4 1.2 0.5 0.4 2.4 0.0 0.0 0.0 0.0 94.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 1.7 29.0 0.0 0.0 0.0 0.7 1.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10777.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 IGLV1-50 ENSG00000211645 "Immunoglobulin lambda variable 1-50 (non-functional)" A0A075B6I6 22 22327300-22327814 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.4;lymphoid tissue: 14.7;stomach 1: 20.4" "Cell type enriched" "Detected in single" 2575 "Plasma cells: 1545.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 21 "memory B-cell: 11.0;naive B-cell: 2.9" "Lineage enriched" "Detected in single" 33 "B-cells: 11.0" "Cell line enhanced" "Detected in single" "HEK 293: 1.1" "Immunoglobulin genes" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.75e-4)" "unprognostic (8.01e-2)" "unprognostic (1.28e-3)" "unprognostic (6.91e-2)" "unprognostic (2.10e-1)" "prognostic favorable (7.08e-4)" "unprognostic (2.81e-1)" "unprognostic (2.41e-1)" "unprognostic (2.02e-1)" "unprognostic (3.62e-2)" "unprognostic (1.83e-1)" "unprognostic (7.38e-2)" "unprognostic (1.58e-4)" "unprognostic (4.89e-3)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" 0.5 0.5 0.1 6.1 0.1 3.3 6.7 1.7 1.9 0.5 0.0 5.4 16.4 0.6 1.2 2.4 0.5 0.8 0.0 0.6 0.0 0.2 0.2 4.4 1.9 0.6 0.0 0.9 0.1 0.1 0.1 0.0 0.6 0.3 4.5 0.7 4.6 0.3 0.4 0.0 9.4 0.2 0.0 3.9 20.4 0.4 0.0 0.6 0.2 0.0 14.7 9.3 0.1 1.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.3 0.5 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.0 0.3 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 1.7 1.9 0.6 0.0 0.6 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1545.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV1-51 ENSG00000211644 "Immunoglobulin lambda variable 1-51" P01701 22 22322472-22322969 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 1318.8;lymphoid tissue: 3027.3;urinary bladder: 1584.8" "Cell type enriched" "Detected in some" 312 "Plasma cells: 34336.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 275.9;naive B-cell: 178.3" "Lineage enriched" "Detected in many" 10 "B-cells: 275.9" "Cell line enhanced" "Detected in many" "HEK 293: 17.9" "Immunoglobulin genes" NA NA 1700000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.85e-4)" "unprognostic (1.71e-2)" "unprognostic (3.12e-3)" "unprognostic (1.76e-3)" "unprognostic (1.61e-1)" "prognostic favorable (1.95e-5)" "unprognostic (3.55e-3)" "unprognostic (3.78e-2)" "unprognostic (1.84e-1)" "unprognostic (1.61e-2)" "unprognostic (1.41e-1)" "unprognostic (4.86e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (1.21e-1)" "unprognostic (5.70e-2)" "unprognostic (1.89e-1)" "unprognostic (1.07e-1)" 43.5 318.8 1.1 484.8 1.9 274.1 627.0 4.6 7.1 73.2 2.0 1318.8 1139.1 38.0 16.9 287.4 52.8 238.0 70.2 1.4 1.6 32.7 53.3 179.1 343.1 4.0 1.4 185.0 39.0 5.8 4.1 1.5 4.2 34.4 930.0 3.1 695.2 49.5 1.9 13.1 702.1 49.8 1.9 934.5 956.7 11.7 1.5 274.0 63.0 1.7 3027.3 1584.8 17.7 2.7 1.3 0.6 1.6 3.8 3.5 1.7 5.9 1.4 3.2 3.1 2.0 2.3 1.0 8.8 1.6 0.8 1.1 3.1 1.9 3.8 2.2 1.4 17.9 3.9 4.5 2.4 0.7 3.4 1.7 5.2 1.0 2.7 0.3 0.4 3.1 0.9 3.9 0.9 3.0 1.6 2.6 3.8 3.0 2.8 4.1 2.3 2.7 8.8 3.6 1.4 8.3 4.9 2.0 1.4 1.8 0.9 2.7 0.3 4.3 4.4 9.2 1.0 1.2 2.0 2.0 2.0 0.4 2.8 0.8 0.1 0.5 0.0 0.2 0.2 26.3 275.9 0.2 0.3 0.1 178.3 0.7 0.5 0.4 0.1 0.3 0.2 0.2 26.4 1.1 1.9 4.6 7.1 1.4 1.6 4.0 1.4 4.2 1.9 1.5 2.7 0.0 0.0 0.5 0.0 109.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 4.8 35.7 0.1 0.0 0.0 0.7 1.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34336.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 19.3 0.0 0.0 9.4 0.0 0.0 0.0 IGLV10-54 ENSG00000211642 "Immunoglobulin lambda variable 10-54" A0A075B6I4 22 22038643-22215270 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 7 "breast: 121.9;intestine: 324.6;lymphoid tissue: 329.7;salivary gland: 253.6;stomach 1: 194.5" "Cell type enriched" "Detected in some" 17 "Plasma cells: 358.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 2.2" "Group enriched" "Detected in some" 32 "memory B-cell: 60.0;naive B-cell: 35.2" "Lineage enriched" "Detected in many" 41 "B-cells: 60.0" "Cell line enhanced" "Detected in single" "TIME: 2.3" "Immunoglobulin genes" NA NA 54000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (9.35e-5)" "unprognostic (2.65e-2)" "unprognostic (9.06e-2)" "unprognostic (8.71e-3)" "unprognostic (1.29e-1)" "prognostic favorable (8.30e-5)" "unprognostic (1.40e-1)" "unprognostic (1.83e-1)" "unprognostic (5.62e-1)" "unprognostic (1.18e-1)" "unprognostic (3.22e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (3.33e-1)" "unprognostic (5.57e-2)" "unprognostic (5.17e-2)" "unprognostic (3.86e-1)" 3.6 1.9 0.1 96.4 0.3 33.8 121.9 0.1 2.2 2.0 0.8 324.6 294.8 1.5 0.0 22.5 24.3 21.9 12.0 0.1 0.3 2.5 7.0 22.3 64.7 1.4 0.1 2.6 11.6 0.0 0.4 0.4 0.2 6.4 155.1 0.0 253.6 2.3 0.1 1.0 138.9 12.7 0.2 155.3 194.5 0.4 0.1 22.9 2.5 0.0 329.7 21.8 4.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 60.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.1 0.3 0.1 2.2 0.1 0.3 1.4 0.1 0.2 0.2 0.1 0.7 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGLV11-55 ENSG00000211641 "Immunoglobulin lambda variable 11-55 (non-functional)" A0A075B6I3 22 22201663-22202161 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.1" "Cell type enhanced" "Detected in some" "Late spermatids: 3.5;Plasma cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Daudi: 8.6;U-698: 2.7" "Immunoglobulin genes" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.22e-1)" "unprognostic (6.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV2-11 ENSG00000211668 "Immunoglobulin lambda variable 2-11" P01706 22 22792491-22793007 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1542.6;lymphoid tissue: 2926.9" "Cell type enriched" "Detected in some" 85 "Plasma cells: 7693.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 37 "memory B-cell: 1402.5;naive B-cell: 850.1" "Lineage enriched" "Detected in many" 46 "B-cells: 1402.5" "Cell line enhanced" "Detected in some" "Karpas-707: 75.0;U-266/70: 20.9;U-266/84: 15.3" "Immunoglobulin genes" NA NA 980000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (9.76e-3)" "unprognostic (6.86e-2)" "unprognostic (3.46e-3)" "unprognostic (7.67e-3)" "unprognostic (2.82e-3)" "prognostic favorable (4.74e-5)" "unprognostic (1.18e-2)" "unprognostic (1.12e-1)" "unprognostic (9.19e-2)" "unprognostic (1.77e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.38e-7)" "unprognostic (3.93e-2)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (2.27e-1)" 33.6 7.3 0.6 344.7 0.3 157.3 447.8 0.1 2.7 27.7 0.8 1455.8 1542.6 18.4 0.5 212.0 30.0 191.3 44.6 0.2 0.7 22.4 41.1 179.8 680.1 1.5 0.2 30.5 22.4 0.6 2.1 0.5 1.1 17.0 868.3 0.0 425.0 36.0 1.7 2.9 713.8 21.3 0.6 637.7 876.1 75.4 0.5 286.4 62.2 0.0 2926.9 661.1 14.8 2.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 75.0 0.0 0.0 0.9 4.6 1.1 0.0 0.0 0.8 2.8 8.3 0.0 0.0 2.9 4.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 1.1 0.3 1.6 20.9 15.3 0.0 0.3 1.1 0.0 1.2 1.0 0.7 11.5 0.2 1.4 1402.5 1.5 5.9 0.9 850.1 1.0 4.6 30.2 11.1 0.8 0.9 0.8 149.8 0.6 0.3 0.1 2.7 0.2 0.7 1.5 0.2 1.1 0.6 0.5 2.2 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 15.8 0.0 0.0 0.0 1.4 11.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7693.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 IGLV2-14 ENSG00000211666 "Immunoglobulin lambda variable 2-14" P01704 22 22758700-22759218 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 2622.2;lymphoid tissue: 5374.9;stomach 1: 2530.1" "Cell type enriched" "Detected in some" 179 "Plasma cells: 58316.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 50 "memory B-cell: 3655.3;naive B-cell: 2657.4" "Lineage enriched" "Detected in all" 58 "B-cells: 3655.3" "Cell line enriched" "Detected in many" 5 "RPMI-8226: 22672.4" "Immunoglobulin genes" NA NA 2200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (3.23e-4)" "unprognostic (9.05e-3)" "unprognostic (1.18e-2)" "unprognostic (7.20e-3)" "unprognostic (2.00e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.69e-1)" "unprognostic (1.97e-1)" "unprognostic (7.99e-2)" "unprognostic (1.83e-2)" "unprognostic (9.11e-2)" "unprognostic (4.97e-1)" "prognostic unfavorable (5.74e-7)" "unprognostic (1.15e-1)" "unprognostic (1.33e-1)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" 83.9 192.1 0.8 754.9 1.7 357.8 749.8 0.5 6.4 119.7 3.8 2622.2 2470.7 47.8 20.7 245.2 49.0 442.1 45.2 0.6 1.0 54.3 102.1 399.3 3320.0 1.6 0.6 75.3 52.1 4.5 5.6 1.2 1.0 71.0 1074.1 0.1 797.3 119.4 2.7 21.3 1262.7 62.0 1.4 1580.6 2530.1 13.9 1.3 586.1 116.5 0.5 5374.9 1165.2 35.1 2.1 0.2 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4453.2 0.0 0.0 8.7 8.0 1.7 0.0 0.0 4.9 3.7 22672.4 0.0 0.0 11.8 11.1 0.4 17.3 0.0 0.0 7.1 0.0 5.1 0.0 4.1 5.7 1.1 20.4 37.7 1.4 12.1 1.7 5.0 3.9 5.3 1.7 47.1 1.0 28.8 3655.3 9.6 53.9 3.3 2657.4 1.4 12.7 11.6 62.5 2.4 2.2 2.1 451.3 0.8 1.7 0.5 6.4 0.6 1.0 1.6 0.6 1.0 1.4 1.3 2.1 0.0 0.0 0.0 0.0 324.1 0.0 0.0 0.0 1.2 0.0 0.3 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 14.7 0.0 0.0 0.0 9.9 121.8 0.0 0.0 0.0 1.4 1.7 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 58316.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 36.6 0.0 0.8 0.0 IGLV2-18 ENSG00000211664 "Immunoglobulin lambda variable 2-18" A0A075B6J9 22 22734607-22735089 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 271.5;lymphoid tissue: 224.4" "Cell type enriched" "Detected in some" 210 "Plasma cells: 2488.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 44 "memory B-cell: 321.2;naive B-cell: 126.9" "Lineage enriched" "Detected in many" 64 "B-cells: 321.2" "Group enriched" "Detected in some" 7 "RPMI-8226: 13.4;U-266/70: 22.3;U-266/84: 7.2" "Immunoglobulin genes" NA NA 570000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.06e-5)" "unprognostic (2.81e-2)" "unprognostic (7.47e-3)" "unprognostic (1.13e-2)" "prognostic favorable (7.75e-4)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (7.58e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (1.95e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-2)" 3.4 0.3 0.0 73.0 0.0 23.7 67.1 0.0 0.3 6.7 0.1 271.5 262.0 4.2 0.0 39.6 10.8 36.3 12.5 0.0 0.0 2.0 2.8 12.6 37.6 0.1 0.0 4.1 1.1 2.1 0.2 0.1 0.4 1.7 138.6 0.0 64.3 4.9 0.1 0.3 150.2 6.5 0.0 95.8 72.5 0.5 0.0 22.1 2.8 0.0 224.4 18.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 13.4 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 22.3 7.2 0.1 0.1 0.1 0.0 0.2 1.8 0.0 1.6 0.0 0.8 321.2 0.3 1.3 0.1 126.9 0.7 0.6 0.5 5.0 0.1 0.2 0.1 69.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2488.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGLV2-23 ENSG00000211660 "Immunoglobulin lambda variable 2-23" P01705 22 22697789-22698407 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 691.1;lymphoid tissue: 1598.0;stomach 1: 672.8" "Cell type enriched" "Detected in some" 132 "Plasma cells: 12487.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 369 "memory B-cell: 2072.7;naive B-cell: 2596.0" "Lineage enriched" "Detected in all" 410 "B-cells: 2596.0" "Cell line enriched" "Detected in some" 10 "Karpas-707: 85411.7" "Immunoglobulin genes" NA NA 540000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (3.43e-5)" "unprognostic (7.99e-2)" "unprognostic (3.89e-2)" "unprognostic (2.35e-3)" "unprognostic (2.73e-2)" "unprognostic (1.30e-2)" "unprognostic (9.33e-2)" "unprognostic (2.13e-1)" "unprognostic (1.19e-1)" "unprognostic (5.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.50e-7)" "unprognostic (8.20e-2)" "unprognostic (7.79e-2)" "unprognostic (1.20e-1)" "unprognostic (7.42e-2)" 16.0 38.9 0.7 306.7 0.3 103.6 184.7 0.1 1.5 45.2 0.6 634.1 691.1 16.2 1.3 78.7 25.5 66.8 19.9 0.2 0.1 18.6 26.2 160.8 623.2 1.0 0.1 16.3 8.2 0.6 1.7 0.6 0.4 10.8 457.1 0.0 356.7 38.1 0.5 2.1 517.3 16.1 0.3 530.5 672.8 5.9 0.2 277.6 39.1 0.4 1598.0 274.5 11.9 0.3 0.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 65.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.3 82.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 85411.7 0.0 0.0 2.2 4.2 0.5 0.0 0.0 0.7 1.9 8843.9 0.0 0.0 2.1 4.5 0.0 4.7 0.0 0.0 1.9 0.0 1.0 0.0 1.1 3.4 0.7 213.9 81.1 0.5 92.6 0.2 35.5 1.8 3.1 1.0 1.6 0.9 1.3 2072.7 1.6 0.8 2.6 2596.0 0.6 0.9 6.3 1.6 1.7 0.9 1.3 231.7 0.7 0.3 0.1 1.5 0.2 0.1 1.0 0.1 0.4 0.3 0.2 0.3 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 13.7 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12487.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.5 0.0 0.2 0.0 IGLV2-33 ENSG00000211656 "Immunoglobulin lambda variable 2-33 (non-functional)" A0A075B6J2 22 22588155-22588688 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.3;lymphoid tissue: 2.7;salivary gland: 2.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 1.9" "Lineage enriched" "Detected in single" 30 "B-cells: 2.9" "Group enriched" "Detected in some" 9 "RPMI-8226: 1.5;U-266/70: 5.1;U-266/84: 3.4" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "unprognostic (1.29e-2)" "unprognostic (1.79e-3)" "unprognostic (2.13e-1)" "unprognostic (4.30e-1)" "unprognostic (2.64e-3)" "unprognostic (2.47e-2)" "unprognostic (2.06e-1)" "unprognostic (6.68e-2)" 0.0 0.1 0.0 1.5 0.0 1.3 0.4 0.0 0.0 0.0 0.0 2.2 4.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 2.6 0.0 0.0 0.0 2.3 0.2 0.0 1.5 1.5 0.0 0.0 0.1 0.0 0.0 2.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV2-8 ENSG00000278196 "Immunoglobulin lambda variable 2-8" P01709 22 22822658-22823289 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1141.8;lymphoid tissue: 1012.4" "Cell type enriched" "Detected in some" 80 "Plasma cells: 5288.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 125 "memory B-cell: 1439.0;naive B-cell: 2097.3" "Lineage enriched" "Detected in all" 149 "B-cells: 2097.3" "Group enriched" "Detected in many" 617 "U-266/70: 64161.5;U-266/84: 56786.5" "Immunoglobulin genes" NA NA 1500000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.92e-4)" "unprognostic (1.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.05e-2)" "unprognostic (1.65e-1)" "prognostic favorable (5.07e-5)" "unprognostic (2.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" "unprognostic (5.05e-2)" "unprognostic (1.61e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.04e-2)" "unprognostic (2.67e-1)" "unprognostic (9.90e-2)" "unprognostic (1.62e-1)" 18.7 7.0 1.1 325.0 0.6 96.0 155.2 0.3 2.4 26.0 1.7 1141.8 977.0 9.4 3.5 91.4 7.9 132.4 30.5 0.3 0.3 15.4 24.3 59.2 228.2 0.8 0.3 57.2 30.3 1.4 1.4 0.2 0.7 9.0 250.6 0.0 255.5 60.3 0.6 1.9 451.5 20.1 0.8 437.7 433.9 3.4 0.3 90.6 23.7 0.0 1012.4 259.0 10.3 1.0 62.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.6 0.0 0.0 23.1 0.0 0.0 0.0 22.3 0.0 0.5 0.0 0.0 0.0 0.7 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 0.0 0.0 11.3 1.9 14.8 0.0 0.0 97.9 0.9 10.1 0.0 0.0 1.4 2.8 0.2 0.0 9.3 0.0 0.0 29.5 0.9 0.0 9.8 0.6 38.9 64161.5 56786.5 20.4 0.0 10.1 0.0 1.2 2.4 0.6 2.1 0.7 0.9 1439.0 1.3 1.5 1.9 2097.3 0.4 1.0 14.1 1.3 1.4 0.6 0.7 174.0 1.1 0.6 0.3 2.4 0.3 0.3 0.8 0.3 0.7 0.8 0.3 1.0 0.0 3.2 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.5 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5288.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 IGLV3-1 ENSG00000211673 "Immunoglobulin lambda variable 3-1" P01715 22 22880706-22881396 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1234.9;lymphoid tissue: 3325.7;stomach 1: 1460.4" "Cell type enriched" "Detected in some" 321 "Plasma cells: 56277.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 725 "memory B-cell: 779.5;naive B-cell: 1038.5" "Lineage enriched" "Detected in many" 828 "B-cells: 1038.5" "Cell line enhanced" "Detected in some" "Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9" HPA003285 Approved "Immunoglobulin genes" NA NA 4300000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003285: AB_1079122" "prognostic favorable (9.70e-5)" "unprognostic (9.06e-2)" "unprognostic (5.39e-3)" "unprognostic (2.37e-2)" "unprognostic (8.13e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (1.92e-2)" "unprognostic (1.63e-2)" "unprognostic (2.86e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (9.06e-9)" "unprognostic (2.70e-2)" "unprognostic (4.35e-1)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" 44.5 70.9 0.3 485.2 0.2 332.4 317.1 0.2 2.0 192.0 0.9 1234.9 643.4 39.2 0.0 217.7 19.2 310.4 28.1 0.1 0.4 26.3 70.1 176.2 1117.0 1.0 0.3 34.1 7.6 2.7 2.0 0.7 1.5 21.9 684.4 0.2 627.3 19.6 1.2 4.1 481.7 37.2 0.4 654.2 1460.4 56.0 0.3 335.5 35.9 0.0 3325.7 679.7 30.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.0 0.0 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.2 2.4 0.8 0.0 0.0 0.5 3.0 4.5 0.0 0.0 9.1 9.9 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.6 1.7 1.8 1.2 2.8 0.0 0.3 0.0 0.7 1.1 0.5 0.3 0.4 0.4 779.5 0.6 0.2 1.2 1038.5 0.2 0.3 0.6 0.4 0.8 0.5 0.5 52.3 0.3 0.2 0.2 2.0 0.1 0.4 1.0 0.3 1.5 0.4 0.3 0.9 0.0 3.2 0.0 0.0 111.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122.5 0.0 0.0 0.0 0.0 0.0 10.7 174.8 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56277.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 11.7 0.0 0.2 0.0 IGLV3-10 ENSG00000211669 "Immunoglobulin lambda variable 3-10" A0A075B6K4 22 22811747-22812281 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 317.0;lymphoid tissue: 707.7;stomach 1: 288.7" "Cell type enriched" "Detected in some" 52 "Plasma cells: 1090.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.3;medulla oblongata: 1.8" "Group enriched" "Detected in some" 786 "memory B-cell: 548.7;naive B-cell: 315.0" "Lineage enriched" "Detected in single" 998 "B-cells: 548.7" "Cell line enhanced" "Detected in some" "Daudi: 4.9;HL-60: 1.0;RH-30: 1.6" HPA003285 Approved "Immunoglobulin genes" NA NA 2000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003285: AB_1079122" "unprognostic (6.00e-2)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.73e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.27e-4)" "unprognostic (7.40e-3)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (9.55e-2)" "unprognostic (2.79e-1)" "unprognostic (3.55e-1)" "prognostic unfavorable (6.95e-8)" "unprognostic (9.23e-2)" "unprognostic (1.48e-1)" "unprognostic (1.77e-1)" "unprognostic (6.04e-2)" 33.3 112.9 0.5 144.0 0.4 65.5 111.1 0.1 3.3 41.3 0.6 308.0 176.3 7.6 4.5 56.3 7.9 43.5 20.5 0.1 0.2 12.2 20.8 48.0 230.5 1.8 0.2 14.6 10.8 0.9 0.8 0.4 0.6 11.0 317.0 0.0 139.7 10.8 0.2 8.1 94.9 5.8 0.1 217.1 288.7 97.4 0.2 25.9 8.6 0.0 707.7 140.2 7.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.2 0.0 0.2 548.7 0.1 0.2 0.2 315.0 0.0 0.2 0.3 0.1 0.1 0.3 0.1 43.2 0.5 0.4 0.1 3.3 0.1 0.2 1.8 0.2 0.6 0.1 0.2 0.2 0.0 0.0 0.6 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 7.1 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1090.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.2 0.0 IGLV3-12 ENSG00000211667 "Immunoglobulin lambda variable 3-12" A0A075B6K2 22 22771824-22772582 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 4.2;memory B-cell: 9.2;memory CD8 T-cell: 4.0;naive B-cell: 6.7;NK-cell: 5.6" "Group enriched" "Detected in many" 64 "B-cells: 9.2;NK-cells: 5.6;T-cells: 4.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 850000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 57: B-cells - Immune response" "unprognostic (1.92e-3)" "unprognostic (4.30e-2)" "unprognostic (1.68e-3)" "unprognostic (2.03e-2)" "prognostic favorable (8.39e-6)" "unprognostic (8.44e-2)" "unprognostic (4.62e-2)" "unprognostic (5.01e-2)" "unprognostic (2.88e-2)" "unprognostic (3.15e-4)" "unprognostic (3.62e-2)" "unprognostic (4.71e-1)" "unprognostic (3.14e-1)" "unprognostic (1.52e-1)" 0.8 1.2 0.0 3.9 0.0 2.7 1.9 0.0 0.3 0.3 0.1 7.3 5.5 0.5 0.0 1.0 0.6 3.3 0.0 0.0 0.0 0.1 0.5 2.7 15.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.5 3.8 0.0 5.1 1.7 0.0 0.2 2.7 0.1 0.0 4.6 8.2 0.9 0.0 3.9 0.2 0.0 30.1 1.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 1.1 9.2 1.0 4.0 0.0 6.7 0.0 0.2 0.0 5.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV3-16 ENSG00000211665 "Immunoglobulin lambda variable 3-16" A0A075B6K0 22 22747383-22747921 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 80.3;urinary bladder: 42.9" "Group enriched" "Detected in some" 49 "B-cells: 6.2;Plasma cells: 3.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 393 "memory B-cell: 107.2;naive B-cell: 121.2" "Lineage enriched" "Detected in single" 417 "B-cells: 121.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 350000000 "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 57: B-cells - Immune response" "prognostic favorable (5.01e-5)" "unprognostic (2.40e-3)" "unprognostic (4.30e-3)" "unprognostic (4.05e-1)" "prognostic favorable (2.99e-5)" "unprognostic (3.88e-1)" "unprognostic (1.12e-1)" "unprognostic (9.83e-2)" "unprognostic (9.82e-2)" "prognostic unfavorable (9.08e-7)" "unprognostic (4.31e-2)" "unprognostic (3.41e-1)" "unprognostic (7.02e-2)" "unprognostic (1.60e-1)" 1.5 0.0 0.0 6.9 0.0 6.3 4.9 0.0 0.0 0.7 0.0 10.7 9.9 0.2 0.0 2.5 1.9 1.2 0.6 0.0 0.0 0.7 1.3 4.7 13.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.6 10.8 0.0 10.8 0.0 0.0 0.1 5.2 0.6 0.0 12.8 13.0 0.3 0.0 3.5 0.2 0.0 80.3 42.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 107.2 0.0 0.1 0.1 121.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV3-19 ENSG00000211663 "Immunoglobulin lambda variable 3-19" P01714 22 22720623-22721145 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1026.7;lymphoid tissue: 1979.7;stomach 1: 1240.2" "Cell type enriched" "Detected in some" 61 "Plasma cells: 3121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 355 "memory B-cell: 618.3;naive B-cell: 503.7" "Lineage enriched" "Detected in many" 391 "B-cells: 618.3" "Cell line enhanced" "Detected in some" "RPMI-8226: 6.2;SCLC-21H: 9.4;SH-SY5Y: 10.7;U-251 MG: 4.2" "Immunoglobulin genes" NA NA 1200000000 "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.92e-5)" "unprognostic (1.52e-2)" "unprognostic (1.60e-3)" "prognostic favorable (6.11e-5)" "unprognostic (1.14e-1)" "unprognostic (1.24e-3)" "unprognostic (9.58e-3)" "unprognostic (3.57e-1)" "unprognostic (1.55e-1)" "unprognostic (1.00e-1)" "unprognostic (3.13e-1)" "unprognostic (3.03e-1)" "prognostic unfavorable (9.37e-10)" "unprognostic (2.10e-1)" "unprognostic (2.31e-1)" "unprognostic (2.44e-1)" "unprognostic (8.52e-2)" 49.1 20.1 0.1 402.2 0.3 185.1 313.5 0.1 2.4 69.2 0.3 1026.7 713.6 19.0 263.4 154.0 65.8 182.4 36.9 0.1 0.3 26.0 57.5 192.2 464.9 1.5 0.4 44.9 11.5 1.3 2.7 0.4 0.4 17.2 912.2 0.0 304.9 62.4 0.9 4.8 385.2 34.9 0.6 714.2 1240.2 6.0 0.4 435.0 55.4 0.0 1979.7 642.5 13.6 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 2.7 0.3 0.0 0.0 0.1 0.9 6.2 0.0 0.0 9.4 10.7 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 4.2 0.8 0.5 0.7 0.0 0.5 0.0 0.4 0.4 1.0 0.5 0.3 0.7 618.3 0.2 0.3 0.5 503.7 0.4 0.3 1.5 0.3 0.4 0.6 0.4 36.2 0.1 0.3 0.1 2.4 0.1 0.3 1.5 0.4 0.4 0.6 0.4 1.1 0.0 0.0 0.0 0.0 51.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.4 15.8 0.0 1.3 0.0 2.2 1.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3121.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 IGLV3-21 ENSG00000211662 "Immunoglobulin lambda variable 3-21" P80748 22 22711689-22713203 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1812.1;urinary bladder: 773.9" "Cell type enriched" "Detected in some" 59 "Plasma cells: 5013.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 339 "memory B-cell: 432.0;naive B-cell: 224.7" "Lineage enriched" "Detected in single" 445 "B-cells: 432.0" "Cell line enriched" "Detected in some" 103 "REH: 282.7" "Immunoglobulin genes" NA NA 4700000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 14: REH - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.75e-3)" "unprognostic (6.04e-3)" "unprognostic (4.21e-2)" "unprognostic (2.59e-3)" "unprognostic (4.06e-3)" "prognostic favorable (3.26e-7)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (1.53e-1)" "unprognostic (5.30e-2)" "unprognostic (3.86e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (9.54e-8)" "unprognostic (7.83e-2)" "unprognostic (1.88e-1)" "unprognostic (2.67e-1)" "unprognostic (7.52e-2)" 17.6 63.4 0.3 321.9 0.2 248.2 120.7 0.1 1.6 110.0 1.6 357.4 350.4 12.9 0.5 63.1 10.2 120.4 10.8 0.1 0.2 21.5 36.4 108.6 272.7 1.0 0.1 35.6 5.7 0.7 1.4 0.4 0.4 16.8 230.8 0.0 260.8 20.2 0.5 2.3 150.7 9.0 0.3 421.0 504.5 14.4 0.3 171.6 19.9 0.0 1812.1 773.9 17.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.0 282.7 1.8 2.0 0.0 0.0 1.6 1.8 0.1 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 0.5 0.5 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.1 432.0 0.1 0.1 0.3 224.7 0.1 0.1 0.9 0.1 0.1 0.2 0.1 36.6 0.3 0.2 0.1 1.6 0.1 0.2 1.0 0.1 0.4 0.3 0.3 1.3 0.0 0.0 0.0 0.0 84.4 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 20.4 0.0 0.0 0.0 3.3 2.5 0.1 0.0 0.0 0.0 0.0 1.3 0.0 4.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5013.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.0 1.8 0.0 0.2 0.0 IGLV3-25 ENSG00000211659 "Immunoglobulin lambda variable 3-25" P01717 22 22686726-22687271 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 2440.7;stomach 1: 1015.7" "Cell type enriched" "Detected in some" 41 "Plasma cells: 17441.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 45 "memory B-cell: 545.0;naive B-cell: 794.2" "Lineage enriched" "Detected in many" 53 "B-cells: 794.2" "Cell line enhanced" "Detected in some" "HL-60: 2.6;RPMI-8226: 2.7;SCLC-21H: 4.6;SH-SY5Y: 5.1" HPA003285 Approved "Immunoglobulin genes" NA NA 3200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003285: AB_1079122" "prognostic favorable (5.55e-4)" "unprognostic (8.28e-2)" "unprognostic (4.28e-3)" "unprognostic (2.89e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.43e-4)" "unprognostic (1.92e-2)" "unprognostic (1.05e-1)" "unprognostic (1.87e-1)" "unprognostic (1.98e-2)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.78e-7)" "unprognostic (1.25e-1)" "unprognostic (4.78e-1)" "unprognostic (2.16e-1)" "unprognostic (1.72e-1)" 56.8 163.2 0.2 293.2 0.2 243.2 430.9 0.1 1.7 151.9 1.3 847.4 338.9 20.8 2.1 161.5 49.8 177.1 29.8 0.2 0.3 17.1 45.7 870.5 1024.7 1.8 0.2 21.8 14.5 1.7 1.7 0.5 0.6 18.9 467.5 0.0 532.3 116.5 0.7 2.4 228.9 34.1 0.4 543.5 1015.7 59.8 0.5 155.9 23.1 0.0 2440.7 779.6 20.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 1.7 0.4 1.7 0.0 0.0 1.6 1.5 2.7 0.0 0.0 4.6 5.1 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 0.1 0.8 1.8 0.2 0.7 0.0 1.3 0.0 0.8 0.4 0.3 0.7 0.1 0.2 545.0 0.4 0.1 0.5 794.2 0.2 0.1 14.9 0.3 0.6 0.3 0.3 76.5 0.2 0.2 0.1 1.7 0.2 0.3 1.8 0.2 0.6 0.4 0.5 0.6 0.0 0.0 0.0 0.0 84.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 1.9 40.8 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17441.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 417.4 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 IGLV3-27 ENSG00000211658 "Immunoglobulin lambda variable 3-27" P01718 22 22668288-22668806 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 401.6" "Cell type enriched" "Detected in some" 135 "Plasma cells: 1406.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 719 "memory B-cell: 194.0;naive B-cell: 367.8" "Lineage enriched" "Detected in single" 941 "B-cells: 367.8" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 720000000 "Cluster 24: B-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (3.45e-2)" "unprognostic (1.87e-3)" "unprognostic (5.44e-2)" "unprognostic (4.30e-3)" "prognostic favorable (3.60e-7)" "unprognostic (8.55e-2)" "unprognostic (2.16e-1)" "unprognostic (5.91e-2)" "unprognostic (9.56e-2)" "unprognostic (4.55e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (4.95e-9)" "unprognostic (1.82e-2)" "unprognostic (2.09e-1)" "unprognostic (1.90e-1)" "unprognostic (2.07e-1)" 8.8 1.8 0.1 16.4 0.0 29.4 29.7 0.0 0.5 23.7 0.1 56.7 19.3 2.2 0.0 10.3 5.1 10.5 3.1 0.0 0.0 3.7 3.7 29.3 64.3 0.4 0.0 2.9 0.3 0.2 0.4 0.0 0.1 2.4 26.9 0.0 40.6 0.8 0.0 0.5 24.4 0.6 0.0 103.9 59.8 24.2 0.0 47.6 2.8 0.0 401.6 27.4 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1 194.0 0.2 0.0 0.3 367.8 0.0 0.0 0.2 0.0 0.1 0.1 0.1 11.8 0.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1406.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGLV3-9 ENSG00000211670 "Immunoglobulin lambda variable 3-9" A0A075B6K5 22 22819010-22819756 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 313.9;stomach 1: 117.3" "Cell type enriched" "Detected in some" 9 "Plasma cells: 13.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 51 "memory B-cell: 64.7;naive B-cell: 168.7" "Lineage enriched" "Detected in many" 74 "B-cells: 168.7" "Cell line enriched" "Detected in some" 5 "U-266/70: 41.3" HPA003285 Approved "Immunoglobulin genes" NA NA 1500000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003285: AB_1079122" "prognostic favorable (2.59e-4)" "unprognostic (6.52e-3)" "unprognostic (1.95e-1)" "unprognostic (5.40e-2)" "prognostic favorable (9.80e-5)" "unprognostic (1.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.68e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (6.00e-7)" "unprognostic (3.47e-2)" "unprognostic (4.58e-2)" "unprognostic (4.55e-2)" "unprognostic (3.22e-1)" 1.8 23.5 0.1 84.6 0.0 27.8 14.9 0.0 0.1 7.3 0.1 87.1 58.7 2.0 0.0 20.8 1.8 18.6 7.6 0.0 0.0 3.2 6.2 17.1 139.8 0.7 0.0 3.9 2.4 0.2 0.1 0.0 0.1 1.4 64.0 0.0 46.2 3.1 0.1 1.5 60.3 5.2 0.0 64.6 117.3 1.6 0.1 35.0 3.8 0.0 313.9 72.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.3 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.9 0.3 0.0 41.3 5.8 0.7 0.0 3.9 0.0 0.0 0.1 0.0 1.2 0.0 2.2 64.7 1.3 1.4 0.0 168.7 0.4 1.8 0.1 0.5 0.1 0.0 0.1 6.5 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 IGLV4-3 ENSG00000211672 "Immunoglobulin lambda variable 4-3" A0A075B6K6 22 22871507-22872035 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lymphoid tissue: 15.7;stomach 1: 28.9" "Cell type enriched" "Detected in some" 23 "Plasma cells: 50.3" "Cancer enhanced" "Detected in many" "lung cancer: 4.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 98 "memory B-cell: 11.7;naive B-cell: 7.8" "Lineage enriched" "Detected in single" 118 "B-cells: 11.7" "Cell line enriched" "Detected in single" 5 "Daudi: 1.3" "Immunoglobulin genes" NA NA 1600000 "Cluster 37: B-cells - Transcription" "Cluster 4: Stomach - Digestion" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (7.22e-2)" "unprognostic (5.51e-3)" "unprognostic (2.71e-1)" "unprognostic (4.37e-4)" "unprognostic (1.87e-1)" "unprognostic (2.74e-1)" "unprognostic (1.49e-1)" "unprognostic (1.36e-1)" 0.2 0.0 0.0 2.1 0.0 1.4 1.6 0.0 0.0 0.3 0.0 5.1 4.5 0.3 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.1 0.1 1.0 10.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 3.3 0.0 2.8 0.0 0.0 0.0 3.0 0.0 0.0 5.3 28.9 0.2 0.0 1.4 0.4 0.0 15.7 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV4-69 ENSG00000211637 "Immunoglobulin lambda variable 4-69" A0A075B6H9 22 22030934-22031472 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 430.3;lymphoid tissue: 461.2;salivary gland: 116.6;stomach 1: 285.6;urinary bladder: 204.0" "Cell type enriched" "Detected in some" 140 "Plasma cells: 4593.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 4 "medulla oblongata: 1.1" "Group enriched" "Detected in some" 302 "memory B-cell: 331.7;naive B-cell: 224.0" "Lineage enriched" "Detected in single" 361 "B-cells: 331.7" "Cell line enhanced" "Detected in some" "Daudi: 1.0;NB-4: 1.0;REH: 1.3;RPMI-8226: 5.4;SH-SY5Y: 1.3" "Immunoglobulin genes" NA NA 320000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.02e-4)" "unprognostic (1.32e-2)" "unprognostic (2.19e-3)" "unprognostic (1.34e-3)" "unprognostic (2.67e-2)" "prognostic favorable (4.04e-5)" "unprognostic (2.59e-3)" "unprognostic (2.50e-1)" "unprognostic (1.67e-1)" "unprognostic (5.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.89e-5)" "unprognostic (9.74e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-1)" "unprognostic (6.08e-2)" 15.6 9.7 0.0 172.4 0.1 43.2 64.1 0.1 0.2 27.9 0.1 325.8 430.3 5.7 0.2 52.2 5.5 44.1 15.1 0.0 0.0 6.2 14.5 72.1 450.4 1.1 0.0 10.6 8.5 0.3 1.1 0.1 0.2 6.3 209.5 0.0 116.6 6.3 0.2 0.7 219.6 3.4 0.0 305.9 285.6 1.4 0.2 82.1 9.8 0.1 461.2 204.0 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.3 0.0 5.4 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.6 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.1 331.7 0.2 0.1 0.2 224.0 0.0 0.1 0.9 0.1 0.1 0.1 0.2 32.3 0.0 0.1 0.1 0.2 0.0 0.0 1.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 11.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4593.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 IGLV5-45 ENSG00000211650 "Immunoglobulin lambda variable 5-45" A0A087WSX0 22 22375986-22376505 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 40.5;intestine: 43.5;lymphoid tissue: 97.5;salivary gland: 49.0" "Cell type enriched" "Detected in some" 116 "Plasma cells: 6697.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "memory B-cell: 1.2;naive B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 160000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (4.62e-4)" "unprognostic (6.18e-2)" "unprognostic (2.26e-2)" "unprognostic (1.48e-2)" "unprognostic (2.29e-1)" "prognostic favorable (2.70e-5)" "unprognostic (1.58e-3)" "unprognostic (2.77e-1)" "unprognostic (8.89e-2)" "unprognostic (1.06e-1)" "unprognostic (5.16e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (5.95e-6)" "unprognostic (6.14e-2)" "unprognostic (2.28e-1)" "unprognostic (1.20e-1)" "unprognostic (8.36e-2)" 2.2 0.3 0.0 0.0 0.0 0.4 5.5 0.0 0.4 3.3 0.0 43.5 0.0 0.7 0.0 40.5 2.0 0.0 0.2 0.0 0.0 2.5 3.1 9.6 0.0 0.1 0.0 0.6 0.6 0.0 0.2 0.0 0.1 1.1 0.2 0.0 49.0 0.0 0.1 0.7 42.1 0.0 0.0 97.5 14.1 0.4 0.0 0.0 4.0 0.0 1.4 14.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.8 57.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6697.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 IGLV6-57 ENSG00000211640 "Immunoglobulin lambda variable 6-57" P01721 22 22195799-22196276 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1814.6;urinary bladder: 675.2" "Cell type enriched" "Detected in some" 72 "Plasma cells: 10791.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory B-cell: 353.9;naive B-cell: 292.4" "Lineage enriched" "Detected in many" 13 "B-cells: 353.9" "Cell line enhanced" "Detected in some" "Daudi: 148.0;RPMI-8226: 40.6;U-266/70: 21.6;U-698: 47.3" "Immunoglobulin genes" NA NA 1900000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.92e-6)" "unprognostic (5.73e-2)" "unprognostic (2.59e-2)" "unprognostic (2.11e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.36e-5)" "unprognostic (1.87e-2)" "unprognostic (2.56e-1)" "unprognostic (6.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.30e-6)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (1.11e-1)" 15.6 9.1 0.0 220.8 0.1 191.7 215.5 0.0 0.6 82.3 0.4 485.0 351.3 19.1 4.4 171.4 38.2 75.8 39.2 0.1 0.0 10.7 26.8 97.0 237.6 0.6 0.1 20.3 7.7 17.8 1.1 0.4 0.5 17.2 318.8 0.0 249.6 12.7 0.3 3.2 174.3 11.5 0.1 276.6 437.6 15.9 0.1 139.7 15.3 0.0 1814.6 675.2 8.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 148.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.2 1.0 40.6 0.0 0.0 2.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.2 0.4 21.6 15.2 47.3 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.0 2.3 353.9 0.1 0.1 0.2 292.4 0.1 0.1 27.9 0.1 0.1 1.2 0.2 27.6 0.0 0.1 0.0 0.6 0.1 0.0 0.6 0.1 0.5 0.1 0.1 0.3 0.0 0.0 0.6 0.0 148.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 1.8 26.7 0.0 0.0 0.0 4.4 67.8 0.0 0.0 0.0 3.6 2.8 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10791.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 6.2 0.0 0.5 0.0 IGLV7-43 ENSG00000211652 "Immunoglobulin lambda variable 7-43" P04211 22 22395018-22395489 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 161.9;lymphoid tissue: 238.7;stomach 1: 115.9" "Cell type enriched" "Detected in some" 57 "Plasma cells: 1304.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 325 "memory B-cell: 132.0;naive B-cell: 54.2" "Lineage enriched" "Detected in single" 461 "B-cells: 132.0" "Cell line enhanced" "Detected in some" "Daudi: 1.9;RPMI-8226: 1.4;U-698: 1.5" HPA003182 Approved "Immunoglobulin genes" NA NA 130000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003182: " "prognostic favorable (6.49e-6)" "unprognostic (7.85e-3)" "prognostic favorable (7.00e-4)" "unprognostic (5.57e-2)" "unprognostic (3.62e-2)" "prognostic favorable (3.08e-5)" "unprognostic (7.63e-3)" "unprognostic (8.20e-2)" "unprognostic (2.42e-1)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (6.29e-2)" "unprognostic (8.34e-2)" "unprognostic (1.68e-1)" "unprognostic (2.29e-1)" 8.0 0.8 0.0 31.2 0.1 15.8 45.7 0.0 0.5 4.9 0.0 161.9 132.8 3.6 0.5 7.9 3.3 22.1 3.5 0.0 0.1 3.1 4.2 13.0 59.0 0.0 0.0 4.1 2.2 0.0 1.0 0.2 0.1 2.3 129.3 0.0 72.5 4.7 0.1 0.5 57.1 17.7 0.0 168.6 115.9 0.5 0.0 31.3 6.4 0.7 238.7 31.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 132.0 0.0 0.0 0.0 54.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.2 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1304.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.2 0.0 IGLV7-46 ENSG00000211649 "Immunoglobulin lambda variable 7-46" A0A075B6I9 22 22369614-22370087 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 400.6;lymphoid tissue: 459.1;stomach 1: 250.7;urinary bladder: 444.0" "Cell type enriched" "Detected in some" 180 "Plasma cells: 6758.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "hypothalamus: 1.6" "Group enriched" "Detected in some" 377 "memory B-cell: 183.6;naive B-cell: 82.3" "Lineage enriched" "Detected in single" 521 "B-cells: 183.6" "Cell line enhanced" "Detected in some" "Daudi: 8.0;RPMI-8226: 2.8;U-698: 6.6" HPA003182 Approved "Immunoglobulin genes" NA NA 270000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003182: " "prognostic favorable (3.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (3.94e-3)" "unprognostic (4.25e-3)" "unprognostic (4.68e-3)" "unprognostic (1.74e-1)" "unprognostic (2.77e-2)" "unprognostic (7.47e-3)" "unprognostic (2.17e-1)" "unprognostic (4.02e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.78e-1)" "unprognostic (1.87e-1)" "unprognostic (2.99e-1)" "unprognostic (2.02e-1)" 15.1 3.8 0.0 59.8 0.3 44.2 171.7 0.1 0.9 4.1 0.1 400.6 162.4 4.4 0.0 43.7 3.0 56.0 5.2 0.0 1.6 5.7 7.7 44.9 82.2 0.4 0.0 9.0 6.2 0.1 0.8 0.1 0.2 2.5 298.6 0.0 107.2 5.2 0.5 0.8 133.1 12.1 0.1 248.1 250.7 0.7 0.2 57.3 8.7 0.0 459.1 444.0 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.3 0.0 6.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 183.6 0.1 0.0 0.1 82.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 15.2 0.0 0.3 0.1 0.9 0.0 1.6 0.4 0.0 0.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 12.8 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6758.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 IGLV8-61 ENSG00000211638 "Immunoglobulin lambda variable 8-61" A0A075B6I0 22 22098700-22099212 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 805.8;lymphoid tissue: 984.2" "Cell type enriched" "Detected in some" 4 "B-cells: 25.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 3.5" "Group enriched" "Detected in some" 630 "memory B-cell: 257.8;naive B-cell: 529.3" "Lineage enriched" "Detected in single" 848 "B-cells: 529.3" "Cell line enhanced" "Detected in some" "Daudi: 2.2;RPMI-8226: 3.6;SH-SY5Y: 1.8;U-266/70: 6.6" "Low region specificity" "Detected in all" "Immunoglobulin genes" NA NA 620000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.07e-3)" "unprognostic (2.73e-2)" "prognostic favorable (3.84e-4)" "unprognostic (1.07e-2)" "unprognostic (5.24e-2)" "unprognostic (1.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.75e-3)" "unprognostic (2.05e-1)" "unprognostic (2.11e-1)" "unprognostic (3.32e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (8.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-1)" 9.4 4.9 0.1 125.5 0.2 63.9 78.3 0.1 3.5 43.5 1.0 201.1 805.8 22.7 0.8 10.6 5.6 46.4 11.7 0.1 0.2 5.3 13.7 82.2 257.2 0.2 0.1 9.2 13.4 1.3 0.8 0.0 0.7 10.5 191.0 0.0 108.6 1.0 0.2 4.0 161.6 13.0 0.8 275.7 179.2 3.3 0.1 16.5 11.5 0.0 984.2 247.8 3.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 0.0 0.2 3.6 0.0 0.0 1.0 1.8 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.3 6.6 1.0 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.2 0.1 257.8 0.3 0.0 0.4 529.3 0.0 0.0 0.2 0.1 0.4 0.1 0.2 32.7 0.1 0.2 0.1 3.5 0.1 0.2 0.2 0.1 0.7 0.8 0.1 1.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGLV9-49 ENSG00000223350 "Immunoglobulin lambda variable 9-49" A0A0B4J1Y8 22 22343187-22343732 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 125.5;lymphoid tissue: 118.0" "Cell type enriched" "Detected in some" 20 "Plasma cells: 46.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 672 "memory B-cell: 70.3;naive B-cell: 88.1" "Lineage enriched" "Detected in single" 747 "B-cells: 88.1" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 43000000 "Cluster 37: B-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (3.04e-5)" "unprognostic (4.30e-3)" "unprognostic (1.83e-2)" "unprognostic (5.61e-2)" "prognostic favorable (2.00e-5)" "unprognostic (6.29e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.27e-2)" "unprognostic (2.81e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (1.12e-8)" "unprognostic (1.66e-1)" "unprognostic (3.07e-1)" "unprognostic (3.90e-2)" "unprognostic (7.16e-2)" 2.4 125.5 0.0 14.7 0.0 9.8 6.1 0.1 0.5 3.3 0.0 33.6 36.5 2.2 0.0 6.0 3.2 1.1 1.2 0.2 0.0 1.2 4.4 43.8 118.0 0.2 0.0 3.3 1.4 0.0 0.1 0.1 0.2 0.9 15.1 0.0 29.7 1.0 0.1 0.1 28.2 0.4 0.0 65.9 46.3 2.0 0.0 14.0 3.4 0.1 97.9 39.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.1 88.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.1 0.5 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 58.9;Kupffer cells: 81.4;Macrophages: 61.4;monocytes: 114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 59.9;NB-4: 52.5;THP-1: 74.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 62000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favorable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 9.1 5.6 5.5 9.6 11.3 31.8 6.9 5.7 7.5 5.4 6.8 4.7 3.8 5.4 5.0 5.2 6.0 3.6 4.6 6.3 5.5 3.7 5.7 10.0 6.9 9.8 7.3 4.5 5.2 3.9 3.8 3.5 8.9 5.0 3.4 1.5 5.2 2.8 1.8 6.9 6.2 5.3 7.7 16.6 5.6 2.0 7.7 15.4 4.2 2.6 5.6 4.6 4.7 9.6 7.9 4.5 4.1 5.1 8.0 4.6 5.1 11.5 7.4 5.3 6.8 4.4 5.1 7.1 4.6 11.6 6.9 12.4 5.6 5.4 3.7 11.6 6.6 0.0 2.6 2.8 9.2 59.9 17.8 6.8 7.9 4.7 3.7 5.2 5.7 5.6 3.0 7.3 5.5 6.7 7.2 52.5 2.2 10.1 4.3 1.6 0.8 1.3 5.1 5.8 2.8 0.1 8.0 6.7 5.7 4.6 5.3 74.7 15.9 4.1 5.8 6.1 4.3 5.8 3.4 3.3 6.0 28.3 4.5 8.5 7.4 7.2 1.1 3.4 0.9 0.5 1.5 1.2 3.9 0.4 2.4 1.8 16.5 1.5 3.5 1.8 1.0 2.6 5.5 11.3 5.7 7.5 6.3 5.5 9.8 7.3 8.9 7.7 7.7 9.6 14.0 12.8 14.1 2.9 13.8 8.8 6.6 10.2 10.8 3.9 7.2 5.8 6.1 10.0 8.6 5.5 8.4 6.1 18.7 23.6 0.0 8.7 4.0 7.2 8.1 13.7 13.2 9.2 8.3 12.6 11.9 13.6 29.0 9.7 7.6 58.9 17.5 11.1 34.0 3.3 6.4 13.9 6.1 81.4 16.2 2.1 9.0 61.4 8.8 41.2 114.2 4.3 28.8 12.5 11.4 12.2 12.4 4.5 10.3 9.1 14.7 3.4 8.0 2.9 13.1 10.4 10.0 3.0 13.4 9.0 6.8 6.4 25.4 8.1 12.4 9.6 IL1R2 "CD121b, IL1RB" ENSG00000115590 "Interleukin 1 receptor type 2" P27930 2 101991960-102028544 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 90.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 495.7;Kupffer cells: 207.9;Langerhans cells: 1083.3;Macrophages: 210.8;Pancreatic endocrine cells: 211.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Group enriched" "Detected in some" 6 "cerebral cortex: 6.4;pons: 1.9" "Immune cell enriched" "Detected in some" 26 "neutrophil: 377.5" "Lineage enriched" "Detected in many" 26 "granulocytes: 377.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 469.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA027597, HPA027598" Uncertain "Secreted to blood" NA NA 7130000 27000000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 64: Macrophages - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" "HPA027597: AB_10600768, HPA027598: AB_10601229" "unprognostic (3.54e-2)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (3.83e-2)" "unprognostic (6.59e-2)" "unprognostic (1.42e-1)" "unprognostic (6.36e-2)" "unprognostic (4.82e-3)" "unprognostic (1.62e-2)" "unprognostic (7.15e-2)" "unprognostic (8.20e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.58e-12)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "unprognostic (1.77e-1)" "unprognostic (6.62e-2)" 19.7 5.9 0.2 35.5 0.7 52.8 3.7 0.3 6.4 10.3 1.9 29.7 0.8 2.5 3.5 41.2 17.7 5.3 4.0 0.2 0.5 16.0 11.6 30.8 3.3 0.5 0.4 1.2 3.7 0.3 0.8 20.1 1.9 2.3 43.7 0.1 7.9 2.2 1.2 30.7 4.6 3.4 0.3 90.1 33.0 0.5 0.7 7.4 1.9 2.9 38.5 6.2 20.5 0.3 7.3 0.9 0.0 0.0 0.9 1.2 0.8 0.0 0.2 0.0 0.1 7.7 0.2 0.1 14.7 0.0 0.3 2.9 0.0 0.5 0.0 469.8 0.4 0.1 0.1 4.0 2.5 0.0 0.0 9.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 60.4 0.0 0.0 0.0 0.0 24.0 1.7 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.0 1.1 0.4 7.2 0.2 0.0 0.3 0.0 0.5 0.2 0.0 0.1 4.3 0.0 0.0 2.3 0.0 0.0 0.9 0.0 14.5 0.0 0.0 0.0 377.5 0.2 0.1 0.2 5.9 1.5 0.2 0.7 0.3 6.4 0.2 0.5 0.5 0.4 1.9 0.3 0.7 0.3 1.2 6.4 1.1 0.0 1.7 147.9 13.5 2.0 495.7 0.0 0.5 0.4 0.6 10.0 0.3 1.8 0.0 1.2 1.2 23.8 5.9 15.0 2.8 14.5 1.5 4.4 6.7 2.7 0.0 8.3 36.3 6.1 18.3 8.0 2.5 0.0 3.6 16.2 5.8 0.0 0.0 117.4 0.0 207.9 1083.3 4.0 0.3 210.8 32.0 0.0 3.5 0.0 0.0 0.0 0.0 211.0 26.8 0.0 1.6 20.4 0.0 0.7 2.2 0.0 6.6 0.7 3.8 0.7 2.2 38.1 84.0 27.8 2.7 0.4 26.8 14.4 IL5RA "CD125, CDw125, IL5R" ENSG00000091181 "Interleukin 5 receptor subunit alpha" Q01344 3 3066324-3126613 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.0;fallopian tube: 10.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 28.0;granulocytes: 19.0;Plasma cells: 9.9;Respiratory ciliated cells: 13.9" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 192 "basophil: 178.4;eosinophil: 355.1" "Lineage enriched" "Detected in many" 255 "granulocytes: 355.1" "Cell line enriched" "Detected in some" 28 "HMC-1: 71.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 910000 "Cluster 2: Granulocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.38e-3)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (6.13e-3)" "unprognostic (2.66e-1)" "unprognostic (1.54e-3)" "unprognostic (7.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.83e-1)" "unprognostic (1.67e-1)" "unprognostic (9.84e-4)" "unprognostic (4.32e-3)" "unprognostic (3.08e-2)" "unprognostic (6.95e-2)" "unprognostic (2.20e-1)" "unprognostic (7.49e-2)" "unprognostic (4.93e-2)" 0.2 0.2 0.8 0.6 0.7 0.6 1.0 0.6 0.3 1.0 9.0 0.7 1.7 0.4 0.2 0.5 10.7 0.7 1.0 0.8 1.2 0.4 0.1 2.7 0.4 5.0 4.6 0.1 0.4 0.0 1.5 0.1 3.2 1.8 1.1 0.0 0.7 0.1 0.4 0.1 1.6 0.3 4.5 1.8 1.1 1.1 1.2 0.5 0.2 0.0 1.5 1.7 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 2.5 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 178.4 0.1 355.1 0.9 0.1 0.1 0.4 1.0 0.7 0.1 1.3 0.3 0.7 1.0 0.0 0.1 0.1 0.1 0.7 0.8 0.7 0.6 0.3 0.8 1.2 5.0 4.6 3.2 4.5 1.2 0.9 0.2 0.0 2.5 0.0 4.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 2.3 1.5 1.4 0.0 0.0 0.1 2.8 0.0 0.0 0.0 2.4 28.0 0.3 0.1 0.0 0.8 0.7 0.0 0.0 0.2 0.0 0.5 19.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.3 5.7 0.0 0.1 5.4 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 9.9 0.8 0.0 0.1 13.9 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.1 IQCC FLJ10547 ENSG00000160051 "IQ motif containing C" Q4KMZ1 1 32205671-32208682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 22.2;Spermatogonia: 11.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028602, HPA028686" Approved Approved Vesicles NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 14: REH - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Vesicles "HPA028602: AB_10600298, HPA028686: AB_10601985" "unprognostic (1.45e-3)" "unprognostic (4.25e-3)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (2.56e-1)" "unprognostic (4.00e-3)" "unprognostic (7.81e-6)" "prognostic favorable (5.65e-4)" "unprognostic (4.97e-2)" "unprognostic (2.97e-2)" "prognostic favorable (8.23e-5)" "unprognostic (2.00e-1)" "unprognostic (3.28e-1)" "unprognostic (3.12e-3)" "prognostic favorable (3.79e-4)" "unprognostic (4.22e-2)" "unprognostic (1.66e-1)" 1.0 1.8 2.3 1.0 2.7 2.1 2.1 3.6 3.1 1.5 5.3 1.5 0.9 1.5 4.4 1.2 3.5 1.4 1.2 2.6 2.2 1.7 0.8 1.1 1.6 2.1 2.2 2.1 2.4 2.9 3.6 1.1 1.9 1.6 1.5 2.8 1.8 1.7 1.6 2.3 1.2 1.2 2.0 1.3 1.9 8.8 2.4 2.1 3.4 1.3 1.7 1.2 1.3 2.4 6.6 2.3 5.1 4.8 0.9 1.9 3.3 3.7 4.2 7.8 7.2 5.3 5.7 2.3 3.9 1.1 1.3 5.5 5.4 3.3 6.5 3.2 5.6 4.2 5.2 2.3 1.2 4.5 2.7 1.3 3.5 6.9 3.1 2.9 1.6 8.9 7.6 0.5 3.5 4.6 7.7 4.7 3.3 3.6 4.9 10.4 3.1 5.5 2.9 2.3 7.3 2.9 7.4 4.2 4.1 4.7 5.1 4.5 2.2 2.8 5.1 4.1 6.2 2.9 2.1 2.1 3.9 4.2 5.9 0.8 0.3 0.1 1.1 0.4 1.0 2.3 1.2 0.9 0.7 0.8 1.3 0.7 1.1 1.6 0.4 1.0 1.6 0.5 2.3 2.7 3.6 3.1 2.6 2.2 2.1 2.2 1.9 2.0 2.4 2.4 1.7 0.0 2.3 2.0 0.7 0.3 1.0 0.9 1.2 5.4 2.9 1.9 1.6 7.2 0.4 3.7 6.2 1.9 2.1 2.3 3.9 1.8 1.7 8.5 2.0 1.6 3.0 7.0 2.0 1.4 1.6 2.0 1.5 2.1 1.3 2.1 0.0 0.4 0.9 6.7 1.9 4.8 0.0 0.0 1.1 1.8 1.2 0.7 0.0 0.0 1.2 2.6 1.0 0.5 1.3 1.1 1.8 2.6 0.6 0.6 0.9 0.6 3.6 8.6 0.0 2.4 1.7 22.2 11.6 1.1 0.9 1.0 1.3 1.8 2.0 0.3 IQCD "CFAP84, DRC10" ENSG00000166578 "IQ motif containing D" Q96DY2 12 113195441-113221094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.0;testis: 44.3" "Group enriched" "Detected in many" 6 "Early spermatids: 155.2;Endometrial ciliated cells: 76.6;Late spermatids: 104.6;Respiratory ciliated cells: 125.8;Spermatocytes: 92.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.9;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.4;granulocytes: 1.9;monocytes: 1.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 28.2;RPTEC TERT1: 13.8;U-698: 15.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046810, HPA048782" Supported Approved Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA046810: AB_2679818, HPA048782: AB_2680519" "unprognostic (3.90e-2)" "unprognostic (4.61e-2)" "unprognostic (4.97e-2)" "unprognostic (4.28e-3)" "unprognostic (1.81e-1)" "unprognostic (7.11e-2)" "unprognostic (2.26e-5)" "unprognostic (2.23e-1)" "unprognostic (3.38e-2)" "unprognostic (3.04e-1)" "prognostic favorable (3.90e-4)" "unprognostic (1.54e-1)" "unprognostic (3.48e-3)" "unprognostic (4.09e-2)" "unprognostic (3.22e-2)" "unprognostic (1.79e-1)" "unprognostic (5.20e-2)" 0.8 0.9 2.5 1.0 2.6 0.3 1.3 2.7 2.5 2.2 8.4 0.7 0.2 1.9 2.0 1.8 22.0 1.0 1.4 2.4 2.8 2.9 0.2 2.6 1.0 4.4 5.7 1.5 1.0 5.1 3.9 0.6 3.6 0.7 0.8 3.7 1.1 1.2 0.4 0.7 0.4 1.0 3.8 0.2 0.5 44.3 2.7 0.7 1.8 0.1 2.6 1.9 0.8 4.1 3.6 4.1 1.3 1.1 1.5 1.6 0.9 0.5 28.2 1.4 1.9 0.7 10.9 3.9 3.0 0.8 11.0 0.7 0.6 1.2 2.3 0.3 1.2 1.3 1.5 0.7 0.8 0.4 0.9 0.6 0.8 4.3 1.4 7.6 0.9 1.5 0.2 0.3 0.3 4.1 0.2 7.6 0.3 1.9 1.0 0.2 0.6 1.0 13.8 4.3 3.1 1.3 1.0 1.4 4.5 1.0 5.0 2.2 0.3 0.6 2.0 1.3 0.8 1.1 0.9 15.6 2.0 0.2 2.4 1.9 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 2.5 2.6 2.7 2.5 2.4 2.8 4.4 5.7 3.6 3.8 2.7 4.1 0.7 3.2 1.7 4.2 0.6 2.4 3.2 10.1 1.2 0.5 2.4 2.8 4.3 4.3 16.2 5.5 14.6 1.4 0.3 3.7 13.7 3.7 155.2 76.6 3.4 0.5 6.6 0.0 1.2 0.8 0.3 2.7 1.1 11.6 0.0 1.0 1.1 0.4 2.1 0.0 1.0 0.7 6.1 0.3 0.6 104.6 2.1 2.3 3.6 1.9 2.5 7.2 1.0 0.0 2.9 0.7 3.4 5.3 0.3 1.8 0.2 16.6 125.8 5.2 0.0 1.2 4.1 92.9 4.8 0.7 1.7 1.9 0.9 1.5 0.3 4.8 IQCG "CFAP122, DKFZp434B227, DRC9" ENSG00000114473 "IQ motif containing G" Q9H095 3 197889077-197960142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 52.8;testis: 43.9" "Cell type enhanced" "Detected in all" "Early spermatids: 255.0;Endometrial ciliated cells: 176.3;Late spermatids: 489.4;Respiratory ciliated cells: 322.2;Spermatocytes: 122.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042787, HPA051981" Enhanced Approved "Actin filaments,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" Cytosol "HPA042787: AB_10797021, HPA051981: AB_2732572" "unprognostic (1.50e-2)" "unprognostic (6.20e-3)" "unprognostic (6.20e-2)" "unprognostic (1.10e-2)" "unprognostic (2.51e-2)" "unprognostic (9.20e-2)" "unprognostic (1.05e-1)" "unprognostic (4.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (7.54e-2)" "unprognostic (1.79e-1)" "unprognostic (2.94e-2)" "unprognostic (9.15e-2)" "unprognostic (1.73e-1)" "unprognostic (2.72e-3)" "unprognostic (7.75e-2)" 6.0 5.2 8.9 3.3 9.7 3.2 5.8 8.4 9.5 5.9 25.2 3.2 2.6 4.6 10.0 4.0 52.8 4.6 4.4 8.7 10.6 6.4 3.7 9.1 3.8 15.0 19.8 3.6 2.0 4.4 6.1 3.5 14.1 3.9 3.7 18.1 2.5 4.5 2.0 2.7 2.7 4.3 14.3 3.4 3.7 43.9 10.9 2.9 8.1 2.1 4.2 3.6 2.2 14.6 5.3 5.8 7.3 7.1 15.6 15.7 2.9 6.4 7.1 7.5 7.6 1.2 5.0 1.9 7.0 5.2 9.6 4.9 5.4 5.0 12.0 4.4 3.8 3.2 3.3 2.9 3.6 4.4 5.0 8.1 6.1 8.1 2.6 6.1 3.6 8.8 3.5 7.2 5.8 12.2 2.4 2.1 4.6 7.8 7.6 6.8 4.8 2.6 7.2 2.2 6.4 7.7 10.6 4.3 4.4 6.4 32.2 3.0 3.7 4.8 3.3 14.5 6.7 6.2 18.4 3.1 18.1 6.1 7.8 2.0 3.8 4.3 3.4 2.7 2.2 4.3 2.9 2.3 3.3 1.6 2.7 3.7 2.3 3.3 2.6 2.9 3.1 2.3 8.9 9.7 8.4 9.5 8.7 10.6 15.0 19.8 14.1 14.3 10.9 14.6 7.4 6.4 7.7 16.6 8.5 9.3 3.3 14.8 2.2 13.1 27.9 15.2 11.0 5.7 31.8 5.5 75.0 6.4 10.1 3.1 15.6 7.1 255.0 176.3 15.0 8.2 4.2 4.8 10.1 4.2 5.8 13.1 5.6 16.3 8.8 30.9 5.3 4.2 6.6 10.1 8.8 2.9 26.4 6.0 24.9 489.4 22.7 10.3 14.2 14.0 2.9 13.5 11.3 10.6 13.2 11.9 1.9 23.7 5.7 2.2 1.4 10.4 322.2 43.8 6.6 6.8 18.7 122.7 31.6 5.9 8.9 5.2 10.8 46.5 2.9 2.5 IQCH FLJ12476 ENSG00000103599 "IQ motif containing H" Q86VS3 15 67254786-67502260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.5" "Cell type enhanced" "Detected in many" "Astrocytes: 27.4;Early spermatids: 59.4;Excitatory neurons: 26.5;Late spermatids: 37.3;Respiratory ciliated cells: 30.3;Spermatocytes: 48.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040845 Uncertain Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA040845: AB_10672898" "unprognostic (2.69e-1)" "unprognostic (2.94e-3)" "unprognostic (3.11e-2)" "unprognostic (5.89e-5)" "unprognostic (2.48e-1)" "unprognostic (9.83e-2)" "unprognostic (2.57e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (3.25e-1)" "unprognostic (5.37e-2)" "unprognostic (1.70e-1)" "unprognostic (1.51e-3)" "unprognostic (2.81e-1)" "unprognostic (3.81e-2)" "unprognostic (6.16e-3)" "unprognostic (6.42e-2)" 0.3 1.1 0.7 0.3 0.8 0.1 1.6 0.7 1.4 0.9 4.2 0.5 0.2 0.8 2.6 0.5 6.8 0.6 0.9 0.7 1.8 2.2 1.0 0.9 0.4 2.5 2.2 0.3 0.7 3.7 2.0 0.4 1.6 0.6 0.7 5.0 0.6 0.8 0.5 0.6 0.1 0.3 2.0 0.4 1.1 11.5 1.9 1.0 4.1 0.0 0.2 0.7 0.3 1.4 1.7 1.6 0.8 1.3 1.1 2.6 0.6 0.9 0.7 1.3 0.9 0.1 1.9 1.2 0.8 1.5 1.5 2.8 2.6 1.0 2.3 0.2 1.2 0.3 1.6 0.2 1.7 0.5 0.3 1.7 1.1 2.9 2.8 1.3 0.5 3.1 2.6 1.1 1.0 1.8 0.4 0.4 0.9 1.0 1.1 0.3 1.2 1.3 1.6 0.7 2.6 0.7 1.2 1.6 4.8 1.6 4.3 0.3 1.2 1.5 0.7 2.4 1.0 2.5 3.2 0.3 3.1 1.3 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.8 0.7 1.4 0.7 1.8 2.5 2.2 1.6 2.0 1.9 1.4 0.7 3.2 1.1 27.4 0.3 1.3 1.0 1.6 1.8 1.5 2.7 2.2 1.1 0.0 2.8 1.8 8.4 0.2 0.3 0.4 0.0 1.0 59.4 15.9 1.1 0.9 0.0 0.4 26.5 0.8 0.5 0.7 8.2 2.0 0.0 0.7 0.0 0.0 0.3 1.7 18.2 0.5 4.1 0.0 0.7 37.3 0.9 0.3 0.0 8.4 1.0 1.1 0.0 9.0 9.5 0.7 0.0 0.7 0.5 0.3 0.2 2.2 30.3 5.4 0.0 1.5 0.6 48.8 18.2 1.2 0.4 0.3 0.4 4.2 0.4 1.0 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 128.3;Cone photoreceptor cells: 114.7;Respiratory ciliated cells: 98.7;Rod photoreceptor cells: 107.4;Spermatocytes: 101.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: AB_2680520" "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 3.8 2.7 5.3 1.3 5.7 0.5 5.9 5.2 6.8 7.5 8.7 2.6 3.8 4.6 15.4 1.6 20.2 5.7 3.5 5.1 8.7 8.7 2.1 4.0 1.5 6.2 7.2 6.5 3.6 19.4 6.3 3.2 5.7 3.4 2.9 11.0 6.4 7.6 3.0 2.1 1.6 3.8 6.8 1.8 3.9 18.2 5.6 1.6 16.8 2.9 1.1 4.1 2.0 8.0 2.6 6.8 8.7 5.7 2.6 8.1 0.5 0.0 4.4 4.0 3.1 0.4 4.8 0.3 4.7 2.4 2.5 3.0 1.9 3.3 2.8 1.1 1.8 0.1 1.9 3.4 8.2 1.6 0.0 4.7 2.7 5.4 1.2 4.5 4.4 4.2 2.8 0.8 2.5 8.5 1.6 0.9 2.6 2.8 6.4 5.3 0.8 0.4 10.0 1.8 8.1 3.4 3.9 1.2 5.3 1.6 3.6 0.9 3.1 1.1 0.9 4.6 0.9 0.1 0.6 0.0 5.4 0.2 1.9 0.0 0.3 0.0 0.5 1.3 0.9 0.5 0.5 0.8 0.1 0.2 1.0 0.5 0.0 0.0 1.3 0.3 0.5 0.3 5.3 5.7 5.2 6.8 5.1 8.7 6.2 7.2 5.7 6.8 5.6 8.0 42.4 16.0 5.1 128.3 1.7 6.1 9.7 16.4 9.6 54.1 18.3 16.5 0.7 24.3 17.8 46.0 114.7 4.9 1.3 8.6 46.9 47.2 57.2 76.9 19.0 22.1 5.4 0.8 31.9 29.6 2.8 11.8 12.8 14.9 0.0 6.2 11.7 2.1 6.0 3.3 45.9 4.3 32.6 2.4 3.9 34.8 18.0 3.7 17.8 15.0 1.5 26.3 0.0 37.2 53.4 29.8 2.2 18.0 2.3 7.3 2.0 32.5 98.7 107.4 6.6 7.5 15.6 101.7 35.8 3.9 5.1 4.1 3.0 18.1 6.7 5.1 IQGAP3 ENSG00000183856 "IQ motif containing GTPase activating protein 3" Q86VI3 1 156525405-156572604 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.5" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA030142, HPA030143" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA030142: AB_10600108, HPA030143: AB_10601104" "unprognostic (9.99e-3)" "unprognostic (5.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.55e-3)" "unprognostic (1.52e-1)" "unprognostic (4.69e-3)" "prognostic unfavorable (8.94e-6)" "unprognostic (1.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.98e-1)" "unprognostic (6.35e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.46e-2)" "unprognostic (1.53e-1)" "unprognostic (6.30e-2)" "unprognostic (6.81e-2)" 0.7 0.7 0.2 2.2 0.4 15.5 0.6 0.0 0.6 1.1 0.2 4.1 6.6 0.5 1.1 5.2 0.2 0.7 0.4 0.5 0.1 0.6 0.6 1.6 1.6 0.9 0.4 0.1 0.2 0.1 0.1 2.8 0.9 0.4 5.0 0.0 1.0 0.1 0.3 3.7 5.7 2.9 0.0 0.8 4.6 3.8 0.6 3.4 0.2 0.0 2.2 0.9 2.1 0.4 59.2 28.4 25.6 18.1 1.6 4.0 12.4 43.1 28.3 41.0 36.6 32.4 52.5 5.2 15.6 25.2 21.6 54.6 17.5 22.1 36.3 0.1 15.7 7.8 62.6 16.1 0.2 9.7 0.1 1.2 2.5 34.3 50.0 10.0 24.1 12.5 16.1 8.1 30.2 31.2 5.7 13.7 18.6 57.7 28.0 18.9 28.8 6.1 10.4 20.3 16.3 25.2 38.7 44.9 14.9 29.8 35.8 25.6 16.8 36.8 43.7 30.4 51.4 4.0 2.1 2.4 12.4 15.1 42.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.4 0.0 0.6 0.5 0.1 0.9 0.4 0.9 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.4 0.6 0.0 1.4 1.3 1.0 2.8 0.1 0.0 0.0 2.2 0.1 3.9 0.0 0.3 6.5 0.5 0.7 0.6 1.2 6.5 0.7 0.0 3.6 0.9 11.2 1.4 0.0 4.4 2.5 0.4 3.9 0.0 0.2 3.7 0.0 1.3 6.1 26.6 0.3 1.9 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.5 0.4 0.8 0.4 0.0 0.0 0.0 0.0 1.4 6.4 2.6 3.6 1.0 0.8 0.2 0.3 7.4 0.4 IQUB FLJ35834 ENSG00000164675 "IQ motif and ubiquitin domain containing" Q8NA54 7 123452193-123535077 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 33.4" "Group enriched" "Detected in many" 7 "Early spermatids: 283.9;Endometrial ciliated cells: 82.6;Late spermatids: 157.5;Respiratory ciliated cells: 88.2;Spermatocytes: 116.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049626 Approved "Nucleoplasm,Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "Nucleoplasm, Intermediate filaments, Cytosol" "HPA049626: AB_2732554" "unprognostic (8.71e-2)" "unprognostic (1.25e-2)" "unprognostic (1.98e-1)" "unprognostic (6.42e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (6.23e-2)" "unprognostic (7.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "unprognostic (3.76e-1)" "unprognostic (5.44e-6)" "unprognostic (2.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.14e-1)" "unprognostic (7.30e-2)" 0.1 0.6 0.2 0.0 0.4 0.0 0.5 1.7 0.9 0.8 3.9 0.1 0.0 0.7 1.1 0.0 5.0 0.8 0.1 0.2 0.5 3.0 0.0 0.8 0.0 1.8 2.0 0.2 0.3 1.7 1.0 0.1 1.3 0.5 0.0 1.1 0.2 0.6 0.1 0.1 0.0 0.2 1.0 0.0 0.1 33.4 0.6 0.0 3.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.4 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.3 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.7 0.9 0.2 0.5 1.8 2.0 1.3 1.0 0.6 0.4 1.1 6.4 0.5 19.6 0.0 0.5 0.7 3.8 0.0 2.5 1.9 1.8 1.8 0.0 11.4 18.4 4.2 0.4 0.1 0.1 1.9 1.1 283.9 82.6 3.2 0.9 1.8 0.0 12.0 0.4 0.3 1.1 0.0 1.7 1.3 0.3 0.7 0.0 0.1 3.3 8.6 0.2 8.2 0.0 0.3 157.5 2.5 0.4 0.0 4.7 0.3 1.8 0.0 5.0 2.6 0.2 0.0 3.0 0.0 0.5 0.0 5.7 88.2 9.0 6.6 0.7 2.7 116.2 6.0 0.2 0.1 0.7 0.3 2.9 0.0 0.3 IRAK3 IRAK-M ENSG00000090376 "Interleukin 1 receptor associated kinase 3" Q9Y616 12 66189195-66254622 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 78.1" "Cell type enhanced" "Detected in many" "Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0" "Group enriched" "Detected in many" 12 "dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043097 Approved Approved Vesicles "Intracellular and membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" Vesicles "HPA043097: AB_10795612" "unprognostic (7.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-1)" "unprognostic (7.56e-3)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (8.52e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (5.58e-2)" "unprognostic (4.64e-2)" "unprognostic (3.41e-2)" "unprognostic (3.23e-2)" 18.7 3.8 3.7 12.4 4.1 78.1 11.6 4.1 7.5 9.3 5.4 4.6 1.3 4.0 3.0 3.8 8.0 6.9 7.9 3.2 4.7 3.5 2.8 19.0 4.1 5.6 5.7 3.2 2.5 0.9 8.9 6.8 6.5 5.3 2.8 0.4 6.2 5.6 2.6 3.4 5.6 5.4 5.0 27.5 6.9 1.8 5.6 2.7 5.0 4.6 3.9 8.4 6.6 5.1 0.0 0.0 0.4 0.0 25.9 21.1 0.0 2.9 0.0 1.5 2.3 0.0 2.2 0.0 1.4 5.3 0.0 0.0 3.2 0.0 1.3 0.0 0.0 22.9 1.4 0.0 13.4 30.8 4.0 13.5 0.1 1.2 0.0 0.0 7.6 0.0 0.0 0.0 1.0 0.0 0.0 25.1 1.3 0.0 0.0 0.0 6.4 0.0 0.1 3.3 0.1 0.0 11.6 0.0 1.2 0.1 0.1 37.3 8.2 0.0 0.0 0.0 0.0 0.9 0.2 2.2 0.0 26.8 0.0 12.7 23.4 4.3 0.0 24.2 0.0 0.1 0.0 0.0 11.5 0.7 0.0 0.0 12.9 1.8 42.0 0.1 0.6 7.3 3.7 4.1 4.1 7.5 3.2 4.7 5.6 5.7 6.5 5.0 5.6 5.1 83.3 9.6 19.4 1.3 2.3 1.5 4.8 27.5 6.2 0.3 2.5 1.8 2.8 0.0 46.9 3.7 0.0 0.2 14.8 0.5 0.0 0.6 6.4 0.5 7.5 38.5 0.0 9.7 0.4 1.2 0.4 22.3 18.3 0.5 27.3 0.5 36.4 1.2 9.4 0.0 5.6 1.1 36.7 123.0 12.1 5.3 7.2 126.3 5.4 114.3 96.9 0.2 3.1 2.0 0.6 4.9 0.1 11.3 9.1 1.6 0.0 0.2 35.1 0.1 0.0 18.1 10.2 0.8 1.8 1.2 1.3 0.3 3.5 12.5 0.7 2.5 IRS4 "IRS-4, PY160" ENSG00000133124 "Insulin receptor substrate 4" O14654 X 108719946-108736563 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.7;choroid plexus: 8.0;pituitary gland: 5.3" "Cell type enhanced" "Detected in some" "Inhibitory neurons: 2.9;Oligodendrocytes: 1.1" "Cancer enhanced" "Detected in some" "breast cancer: 0.8" "Region enhanced" "Detected in many" "hypothalamus: 14.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 9.4;NTERA-2: 1.3;RT4: 3.1;WM-115: 2.2" "Group enriched" "Detected in many" 5 "basal ganglia: 11.7;hypothalamus: 45.0" "Group enriched" "Detected in many" 5 "basal ganglia: 14.5;hypothalamus: 36.7" HPA017372 Uncertain NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA017372: AB_2669600" "unprognostic (3.74e-3)" "unprognostic (3.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-1)" "unprognostic (1.65e-1)" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (9.28e-4)" "unprognostic (8.71e-2)" 0.0 0.0 4.1 0.0 1.3 0.0 0.0 0.0 0.5 1.0 8.0 0.0 0.0 1.4 0.5 0.0 0.2 0.0 0.0 1.3 14.7 0.0 0.0 0.0 0.0 2.0 2.6 4.6 0.0 0.0 5.3 0.0 3.3 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.9 0.0 0.2 0.0 10.6 3.8 1.8 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.3 0.0 0.5 1.3 14.7 2.0 2.6 3.3 0.9 10.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITLN2 HL-2 ENSG00000158764 "Intelectin 2" Q8WWU7 1 160945025-160954809 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "intestine: 408.3" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 76.9" "Group enriched" "Detected in many" 4 "colorectal cancer: 2.8;testis cancer: 4.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 11.9;HHSteC: 1.9;HMC-1: 3.4;SK-MEL-30: 4.0;SuSa: 3.8" "Low region specificity" "Detected in all" "HPA006683, HPA067326" Enhanced "Secreted to digestive system" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 36: HEL - Hemostasis" "Cluster 11: Alveolar cells - Smell perception" "HPA006683: AB_2129681, HPA067326: AB_2732764" "unprognostic (1.42e-1)" "unprognostic (9.62e-3)" "unprognostic (4.61e-2)" "unprognostic (7.45e-2)" "unprognostic (2.25e-1)" "unprognostic (6.84e-4)" "unprognostic (2.47e-2)" "unprognostic (5.74e-2)" "unprognostic (1.31e-2)" "unprognostic (1.36e-1)" "unprognostic (5.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.49e-1)" "unprognostic (2.31e-1)" "unprognostic (4.91e-2)" 6.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 238.7 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.4 11.7 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.2 408.3 0.0 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 1.9 0.0 3.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.0 4.0 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.9 5.3 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.3 1.4 0.0 0.2 0.0 0.4 11.0 0.3 0.1 0.0 0.0 5.0 0.0 0.3 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 5.3 0.0 0.6 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 6.3 17.5 0.4 JCHAIN "IGCJ, IGJ, JCH" ENSG00000132465 "Joining chain of multimeric IgA and IgM" P01591 4 70655541-70681817 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 3028.0;intestine: 7979.6;stomach 1: 5916.2" "Cell type enriched" "Detected in many" 16 "Plasma cells: 101294.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 121 "memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1" "Group enriched" "Detected in all" 137 "B-cells: 4173.0;dendritic cells: 3578.1" "Cell line enhanced" "Detected in many" "Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034436, HPA044132" Enhanced "Secreted to blood" NA NA 2200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 9: Intestine - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB034436: AB_2233368, HPA044132: AB_2678826" "prognostic favorable (1.81e-6)" "unprognostic (1.45e-3)" "unprognostic (7.44e-3)" "unprognostic (1.82e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.56e-7)" "unprognostic (2.37e-2)" "unprognostic (2.70e-2)" "unprognostic (6.30e-2)" "unprognostic (2.64e-3)" "unprognostic (3.36e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (3.43e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-1)" "unprognostic (1.96e-1)" 130.2 76.6 0.7 1089.0 0.8 76.3 3028.0 0.4 3.0 205.2 3.1 7979.6 6145.8 94.2 25.0 654.4 115.0 492.4 45.6 0.4 1.4 43.3 116.8 620.2 1033.5 1.9 1.0 183.5 78.3 2.1 2.0 2.4 0.8 90.2 6426.5 0.3 2420.5 258.4 4.2 13.2 4277.1 200.3 7.0 819.4 5916.2 40.0 0.8 155.3 19.4 0.8 1746.7 1059.4 11.6 2.8 8.9 0.0 0.0 0.0 0.0 0.0 15.5 8.2 1.5 0.1 0.1 0.0 0.0 3953.8 3.3 12.7 0.1 6.6 0.0 0.0 0.6 2.1 0.0 3.3 0.0 0.0 0.0 3.3 9.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.4 2117.6 0.1 0.0 6.1 14.9 4.9 0.0 0.0 4.8 2.6 4469.2 0.0 0.0 3.3 15.7 3.7 2.6 2.7 0.0 0.8 6.8 3.9 9.9 11.8 4.9 6.3 8794.0 3519.2 4949.0 2.1 5.2 1.2 25.1 7.5 2.6 4.0 1.5 19.1 4173.0 2.5 3.8 6.6 2555.1 2.1 2.1 28.3 4.5 2.5 3578.1 2.6 1310.4 0.7 0.8 0.4 3.0 0.4 1.4 1.9 1.0 0.8 7.0 0.8 2.8 3.0 22.4 101.3 0.0 6154.9 0.0 28.2 0.0 8.6 0.0 11.7 1.9 2.2 15.7 8.1 0.0 0.0 0.1 700.0 5.1 0.0 0.0 0.5 0.0 0.1 38.1 7.3 139.0 0.0 0.0 0.1 48.8 228.8 0.0 79.5 0.1 66.4 24.6 0.3 0.0 0.0 5.3 0.0 35.8 0.0 0.3 0.0 42.0 0.0 0.0 3.9 0.0 6.2 0.0 0.0 0.0 5.1 0.0 101294.9 32.7 0.0 5.4 3.6 0.0 0.0 0.6 88.4 1.4 0.3 24.3 0.0 0.3 1487.8 0.0 3.5 0.6 JPH2 JP-2 ENSG00000149596 "Junctophilin 2" Q9BR39 20 44106590-44187188 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 85.2;skeletal muscle: 120.4" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 64.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9" "Low region specificity" "Detected in some" HPA052646 Approved NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA052646: AB_2681899" "unprognostic (1.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.61e-4)" "unprognostic (4.71e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (1.06e-2)" "unprognostic (2.45e-3)" "unprognostic (6.87e-2)" "unprognostic (9.16e-2)" "unprognostic (2.57e-2)" "unprognostic (9.73e-2)" "unprognostic (4.76e-2)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "unprognostic (1.10e-2)" 6.0 1.9 0.5 4.5 0.6 0.1 5.7 0.4 0.7 15.1 0.7 63.3 2.1 51.6 2.9 11.9 30.0 3.5 85.2 0.4 0.5 1.4 0.3 5.2 0.2 1.1 1.1 3.9 0.3 0.1 1.2 3.8 0.8 23.8 4.5 0.2 5.8 22.1 120.4 3.8 11.8 27.5 0.9 1.3 16.0 0.8 0.6 0.1 1.5 48.3 0.1 40.5 10.6 0.7 7.5 0.8 0.4 0.0 0.3 0.4 1.5 2.2 4.1 5.4 2.3 15.3 5.9 0.0 15.0 19.1 6.1 10.5 0.0 0.5 2.1 0.0 0.0 0.0 12.6 0.1 0.1 0.3 0.0 0.7 1.1 2.7 3.7 3.3 0.0 0.0 0.0 0.0 7.3 4.3 0.0 0.2 0.3 0.0 0.9 1.7 3.4 0.0 0.4 0.1 0.0 0.1 12.9 3.1 0.1 8.6 10.8 0.1 0.3 2.4 2.7 0.5 4.7 0.1 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.4 0.7 0.4 0.5 1.1 1.1 0.8 0.9 0.6 0.7 0.2 0.0 0.0 0.3 0.0 6.6 0.5 0.9 0.0 0.0 0.4 5.1 64.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.8 0.0 0.5 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.2 0.0 6.6 15.9 12.8 0.0 1.5 0.0 2.0 0.5 0.1 0.0 0.2 0.1 JSRP1 "FLJ32416, JP-45" ENSG00000167476 "Junctional sarcoplasmic reticulum protein 1" Q96MG2 19 2252252-2269759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "skeletal muscle: 335.4" "Cell type enhanced" "Detected in many" "B-cells: 31.7;Melanocytes: 46.2;Plasma cells: 139.4;Skeletal myocytes: 132.6" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 11.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 10 "B-cells: 2.6" "Cell line enhanced" "Detected in some" "Karpas-707: 164.1;RPMI-8226: 109.8;U-266/70: 444.1;U-266/84: 57.8" "Group enriched" "Detected in many" 6 "amygdala: 8.4;basal ganglia: 11.6;cerebral cortex: 9.9;hippocampal formation: 4.4;white matter: 5.1" "Not detected" "Not detected" HPA044741 Enhanced Approved "Endoplasmic reticulum" NA NA 13000 "Cluster 24: B-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA044741: AB_10794295" "unprognostic (9.41e-3)" "unprognostic (1.52e-2)" "unprognostic (1.39e-1)" "unprognostic (5.85e-2)" "unprognostic (2.15e-1)" "unprognostic (9.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.80e-2)" "unprognostic (2.44e-2)" "unprognostic (1.87e-2)" "unprognostic (8.64e-5)" "unprognostic (3.63e-1)" "unprognostic (4.43e-1)" "unprognostic (2.07e-1)" "unprognostic (2.71e-1)" 0.2 0.1 0.4 0.9 0.4 0.4 0.4 0.4 0.4 0.3 0.2 1.5 2.9 0.1 0.0 0.3 0.3 0.1 0.0 0.3 0.4 0.6 0.3 0.7 0.5 0.3 0.3 0.1 0.5 0.0 0.3 0.0 0.3 1.9 0.1 0.0 8.9 0.0 335.4 0.3 1.4 0.0 0.3 5.4 1.7 1.9 0.5 0.1 0.6 18.6 0.6 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 26.8 0.0 0.0 0.2 0.0 0.0 0.0 46.6 0.1 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.1 7.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 26.7 109.8 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 444.1 57.8 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.5 0.3 0.1 0.0 5.3 0.0 31.7 0.5 0.3 0.2 0.6 0.8 0.6 0.4 0.6 1.5 0.1 0.0 2.1 0.2 0.7 1.7 0.0 1.8 19.0 0.7 0.3 0.3 5.4 1.3 0.2 1.0 0.6 1.1 1.5 1.1 6.3 2.9 0.7 0.6 0.5 0.0 0.1 2.3 2.0 1.3 2.2 18.2 0.6 1.1 46.2 0.0 0.0 0.5 1.0 0.0 0.1 1.0 0.3 0.0 139.4 0.3 0.6 0.4 1.7 0.5 0.0 132.6 0.6 7.6 1.9 0.2 1.0 0.3 5.0 0.5 0.7 0.2 KATNAL2 "DKFZP667C165, MGC33211" ENSG00000167216 "Katanin catalytic subunit A1 like 2" Q8IYT4 18 46917492-47102243 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 84.2;Early spermatids: 91.8;Inhibitory neurons: 41.8;Late spermatids: 71.4;Oligodendrocytes: 38.7;Spermatocytes: 58.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.5;Daudi: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040712, HPA042029" Approved Approved "Nucleoplasm,Intermediate filaments" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Intermediate filaments" "HPA040712: AB_2677092, HPA042029: AB_2677807" "unprognostic (3.40e-1)" "unprognostic (7.75e-2)" "unprognostic (9.00e-3)" "unprognostic (9.28e-2)" "unprognostic (1.74e-2)" "unprognostic (6.55e-3)" "unprognostic (6.97e-2)" "unprognostic (1.28e-2)" "unprognostic (3.90e-2)" "unprognostic (5.36e-2)" "unprognostic (9.52e-6)" "unprognostic (1.28e-1)" "prognostic favorable (1.24e-7)" "unprognostic (1.64e-1)" "unprognostic (7.14e-4)" "unprognostic (1.06e-3)" "unprognostic (1.61e-1)" 5.3 3.4 9.6 1.8 11.1 2.7 4.0 14.4 14.7 3.4 23.1 2.6 1.4 2.3 5.5 2.6 7.1 4.4 4.4 9.1 9.2 10.4 6.9 3.3 3.2 10.6 11.5 3.3 2.9 18.0 8.0 1.7 11.2 4.3 2.5 10.8 4.4 2.7 6.1 7.4 2.2 1.8 8.6 3.7 2.2 15.5 10.3 1.9 17.5 2.9 2.1 2.3 3.1 12.9 2.7 5.7 3.5 21.5 7.1 7.9 1.6 2.4 2.1 1.9 2.5 0.2 7.5 28.2 2.2 4.2 2.6 0.9 6.9 0.7 1.6 2.6 3.7 1.3 2.0 0.4 2.8 1.7 2.4 16.5 2.6 3.5 0.9 4.9 0.7 12.8 1.0 2.3 11.5 2.7 1.9 3.7 7.6 4.0 3.9 7.8 1.5 0.1 6.4 0.4 7.6 8.8 2.7 0.5 1.0 11.9 15.5 16.7 1.5 7.1 0.7 2.7 1.7 1.8 1.5 19.7 3.7 18.0 13.4 0.1 0.1 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.0 0.6 0.3 0.3 0.2 0.1 0.2 0.1 0.0 0.0 9.6 11.1 14.4 14.7 9.1 9.2 10.6 11.5 11.2 8.6 10.3 12.9 3.7 0.0 1.1 84.2 1.0 1.5 3.0 2.9 8.0 9.9 1.6 1.3 2.9 1.5 5.2 3.7 6.2 0.0 0.2 2.5 13.7 0.9 91.8 22.6 6.2 2.5 0.0 1.7 28.2 0.2 0.0 3.1 3.6 1.6 0.0 3.9 2.2 4.2 3.6 11.8 41.8 0.7 2.0 1.9 0.9 71.4 1.5 1.5 3.6 18.7 0.9 2.6 0.0 26.7 38.7 0.2 0.3 2.2 0.4 1.0 0.2 12.1 35.2 2.3 0.0 7.5 1.9 58.7 4.6 2.8 1.1 0.1 0.6 2.6 2.3 1.9 KATNIP "JBTS26, KIAA0556" ENSG00000047578 "Katanin interacting protein" O60303 16 27550133-27780369 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 2.7;Cardiomyocytes: 4.5;Cytotrophoblasts: 3.0;dendritic cells: 1.4;Extravillous trophoblasts: 2.6;Hofbauer cells: 2.6;Syncytiotrophoblasts: 2.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 14.3;eosinophil: 3.6;neutrophil: 9.9;NK-cell: 5.0" "Group enriched" "Detected in all" 5 "granulocytes: 14.3;NK-cells: 5.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035089, HPA035090" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" "Plasma membrane" "HPA035089: AB_10671509, HPA035090: AB_10601129" "unprognostic (1.81e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" "unprognostic (3.65e-3)" "unprognostic (7.76e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.72e-2)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.12e-1)" "unprognostic (1.47e-3)" "unprognostic (2.98e-1)" "unprognostic (2.11e-1)" "unprognostic (1.50e-3)" "unprognostic (1.45e-1)" 4.4 4.8 5.2 4.7 5.9 6.7 5.4 3.9 6.9 6.3 22.7 6.5 4.8 6.3 6.2 9.7 29.7 5.1 5.4 5.4 4.1 7.8 4.0 6.3 4.4 6.7 7.8 5.1 9.0 7.7 11.5 4.4 4.9 8.8 7.2 31.3 7.9 5.7 3.3 8.9 6.0 5.5 4.9 6.2 9.3 9.9 6.3 5.6 15.9 1.7 4.0 5.3 5.8 6.6 6.7 13.5 7.5 7.0 11.1 10.1 12.4 8.9 9.6 7.7 10.4 12.0 10.9 5.7 12.4 12.8 15.0 11.0 9.7 11.5 15.4 26.5 6.7 4.5 14.9 7.0 6.6 6.1 11.0 10.8 9.9 17.1 18.2 10.0 15.5 6.3 7.3 4.7 11.1 15.3 6.7 7.5 4.6 8.6 5.5 9.6 9.1 6.2 14.5 9.2 9.5 6.1 8.9 7.9 5.0 10.3 17.8 5.3 13.5 9.8 6.2 7.7 7.9 6.3 5.7 6.4 11.3 5.9 8.9 14.3 1.8 3.6 0.7 1.2 0.7 0.8 0.4 1.2 1.2 1.1 1.6 0.3 9.9 5.0 0.4 1.4 1.6 0.3 5.2 5.9 3.9 6.9 5.4 4.1 6.7 7.8 4.9 4.9 6.3 6.6 2.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 3.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539030-49558337 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 39.4;pituitary gland: 25.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 11.4;Excitatory neurons: 58.2;Inhibitory neurons: 19.2;Late spermatids: 10.6;Respiratory ciliated cells: 10.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Group enriched" "Detected in many" 21 "amygdala: 29.6;basal ganglia: 25.6;cerebral cortex: 39.4;hippocampal formation: 30.6;white matter: 24.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.8;AN3-CA: 3.5;HMC-1: 3.4;RPTEC TERT1: 9.1;U-2 OS: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Mitochondria" "HPA051088: AB_2681340" "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.3 2.9 29.6 0.0 25.6 0.2 0.6 0.0 39.4 0.8 0.0 0.2 0.1 0.6 0.1 0.1 5.8 0.3 0.8 30.6 1.3 3.4 0.3 1.0 0.5 0.0 0.2 0.3 1.3 2.6 25.7 0.0 0.6 0.7 0.0 0.0 0.3 0.3 0.1 0.3 0.3 0.0 0.0 1.4 0.3 2.8 1.4 0.2 1.3 0.0 0.2 0.1 0.3 24.8 0.4 5.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.2 1.7 0.6 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 9.1 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 29.6 25.6 0.0 39.4 30.6 1.3 0.0 0.2 0.6 0.0 1.4 24.8 0.1 0.0 0.5 4.9 0.0 0.1 0.2 0.5 0.0 0.1 0.1 2.0 1.0 5.7 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.2 6.0 11.4 0.4 0.1 2.4 0.0 58.2 0.0 0.1 0.6 0.0 0.5 0.0 2.4 0.7 0.0 0.0 1.7 19.2 0.0 0.0 0.6 0.5 10.6 0.3 0.6 0.0 1.0 0.7 0.4 2.1 6.0 2.6 0.1 0.1 1.2 0.1 0.0 0.0 0.2 10.9 0.3 0.0 0.4 0.3 1.1 3.4 0.0 0.3 0.0 0.7 0.0 0.2 0.0 KCNH7 "erg3, HERG3, Kv11.3" ENSG00000184611 "Potassium voltage-gated channel subfamily H member 7" Q9NS40 2 162371407-162838767 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.9;retina: 1.6" "Group enriched" "Detected in some" 7 "Excitatory neurons: 685.6;Inhibitory neurons: 352.4" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebral cortex: 5.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "SCLC-21H: 6.0;SK-BR-3: 5.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebral cortex: 53.0" HPA018039 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA018039: AB_1852125" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.66e-1)" "unprognostic (5.55e-2)" "unprognostic (3.05e-2)" "unprognostic (5.51e-2)" "unprognostic (8.12e-3)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (3.52e-2)" "unprognostic (7.55e-3)" "unprognostic (2.76e-3)" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.68e-2)" 0.0 0.1 0.7 0.1 0.8 0.1 0.0 1.2 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.8 1.2 5.9 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.1 0.0 0.0 685.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.1 21.9 352.4 0.0 0.0 0.6 0.0 68.3 0.0 0.1 0.0 4.7 0.0 0.2 0.0 20.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 KCNMB1 hslo-beta ENSG00000145936 "Potassium calcium-activated channel subfamily M regulatory beta subunit 1" Q16558 5 170374671-170389634 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 59.2;intestine: 75.1;smooth muscle: 53.1" "Cell type enriched" "Detected in many" 6 "Peritubular cells: 354.3" "Cancer enhanced" "Detected in many" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 5.9" "Cell line enhanced" "Detected in some" "REH: 8.8;SK-BR-3: 2.1;U-937: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 14: REH - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (2.06e-2)" "unprognostic (2.70e-4)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (8.88e-2)" "unprognostic (1.61e-2)" "unprognostic (3.46e-1)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (5.37e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.08e-1)" "unprognostic (2.49e-1)" "unprognostic (4.31e-2)" "unprognostic (1.04e-2)" 5.7 1.8 2.7 10.5 2.3 1.7 6.9 2.5 2.7 16.8 1.4 75.1 4.3 59.2 6.2 16.6 20.6 7.3 4.2 2.1 2.4 1.4 0.7 4.0 1.7 5.9 4.0 4.0 0.7 0.3 0.5 1.1 6.2 24.5 8.9 1.1 6.8 50.6 1.0 2.9 14.3 53.1 3.4 2.3 21.5 2.7 4.2 1.0 1.4 1.1 1.3 32.6 11.2 3.9 0.1 0.1 1.5 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.1 1.0 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.1 1.2 0.6 0.2 0.0 0.4 0.2 0.2 0.0 0.1 0.2 0.1 0.1 0.4 0.3 0.7 0.1 0.7 0.0 0.8 0.3 0.0 0.1 8.8 0.0 0.2 0.0 0.2 0.4 0.2 0.1 2.1 0.0 0.7 0.1 1.0 0.5 0.2 0.3 0.3 0.0 0.4 0.2 0.1 0.1 3.8 0.1 1.3 3.3 0.3 0.1 5.9 0.1 0.2 0.2 0.1 5.7 0.3 0.1 0.1 0.9 0.4 5.1 2.0 0.2 1.0 2.7 2.3 2.5 2.7 2.1 2.4 5.9 4.0 6.2 3.4 4.2 3.9 1.3 0.0 6.3 0.3 1.2 2.0 1.2 0.4 0.0 1.6 2.5 55.1 3.7 4.3 4.5 1.8 6.2 0.5 1.7 0.1 0.0 0.1 0.6 0.6 14.4 3.6 0.0 1.3 0.1 0.4 0.6 9.8 0.0 0.6 19.7 0.4 1.8 0.4 7.4 1.7 0.3 0.2 0.0 18.9 10.9 4.5 38.5 15.6 3.6 4.7 27.8 0.6 2.1 0.0 0.1 0.0 0.0 354.3 0.3 1.3 0.0 0.1 4.5 2.3 46.0 2.2 43.6 0.7 1.2 0.1 1.7 0.5 1.7 1.4 0.0 0.7 KCNRG ENSG00000198553 "Potassium channel regulator" Q8N5I3 13 50015254-50020922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "fallopian tube: 35.7" "Cell type enhanced" "Detected in some" "Early spermatids: 19.4;Endometrial ciliated cells: 46.0;Late spermatids: 12.6;Respiratory ciliated cells: 88.6" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001027 Uncertain Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA001027: " "unprognostic (1.85e-3)" "unprognostic (1.66e-2)" "unprognostic (1.08e-2)" "prognostic favorable (2.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.39e-3)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (1.71e-1)" "unprognostic (5.91e-1)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (4.69e-2)" "unprognostic (1.52e-1)" "unprognostic (9.16e-2)" 0.6 0.3 0.5 0.6 2.3 1.9 0.8 3.2 1.6 1.4 0.1 0.6 0.5 1.3 0.5 0.8 35.7 0.4 0.6 0.5 1.2 0.8 0.4 3.1 0.6 2.1 0.9 0.5 0.4 1.1 0.5 0.2 1.3 0.6 0.8 0.8 0.5 0.4 0.6 0.9 0.6 0.5 0.6 0.6 0.5 2.0 1.5 0.6 0.5 0.5 0.6 0.7 0.5 3.5 0.4 0.3 1.1 0.4 0.4 0.5 0.2 0.0 0.9 0.8 0.0 1.3 0.4 0.8 0.2 1.1 0.5 0.5 0.8 0.3 0.6 0.6 0.5 1.7 0.5 0.7 1.0 1.5 0.4 0.6 0.8 0.5 1.4 0.7 1.6 3.1 0.7 0.1 1.0 0.5 1.6 1.5 0.9 1.0 0.6 1.0 0.0 0.0 0.7 1.0 1.0 2.2 0.3 0.7 0.8 0.6 0.6 0.4 0.5 0.7 0.3 0.4 0.3 0.1 0.2 0.9 0.2 0.5 0.2 1.0 0.3 0.2 0.1 0.3 0.2 0.4 0.1 0.3 0.3 0.6 0.2 0.2 1.2 0.4 0.2 0.3 0.4 0.1 0.5 2.3 3.2 1.6 0.5 1.2 2.1 0.9 1.3 0.6 1.5 3.5 1.1 0.0 2.7 0.7 0.9 0.1 0.9 3.8 0.0 1.0 0.6 0.9 0.5 0.0 6.2 0.0 2.1 0.8 0.5 0.8 0.0 0.5 19.4 46.0 1.0 0.8 4.2 0.0 0.7 1.4 0.5 0.8 0.0 1.0 0.0 0.5 0.0 0.3 0.5 3.3 0.7 0.9 0.0 0.0 0.3 12.6 0.6 1.3 0.0 0.0 1.3 0.7 0.0 1.0 0.5 0.6 0.3 0.7 0.0 0.9 0.8 2.1 88.6 1.2 0.0 1.4 1.5 11.4 1.5 0.0 0.1 0.7 0.5 0.5 0.7 1.3 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646191 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 12.3;pituitary gland: 4.1" "Group enriched" "Detected in some" 8 "Astrocytes: 119.5;Early spermatids: 65.6;Excitatory neurons: 129.2;Inhibitory neurons: 72.7;Late spermatids: 96.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enhanced" "Detected in single" "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "A-431: 2.0;A549: 2.0;GAMG: 2.1;HDLM-2: 2.4;HeLa: 1.9;SCLC-21H: 3.8;U-266/84: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "HPA015607: AB_1852299, HPA076313: AB_2732308" "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.0 0.4 10.0 0.2 10.3 0.0 0.1 4.3 10.4 0.1 0.6 0.4 0.0 0.0 0.0 0.0 1.6 0.2 0.0 9.2 5.8 0.0 0.0 0.6 0.0 7.2 7.4 0.0 1.4 0.1 4.1 0.0 7.6 0.4 0.4 1.2 0.2 0.0 0.0 0.7 0.2 0.1 2.7 0.2 0.8 1.1 12.3 0.0 0.0 0.0 0.1 0.0 0.0 4.8 2.0 2.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.6 0.9 0.0 2.1 0.8 0.3 0.0 0.0 2.4 1.0 0.0 1.9 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.1 3.8 0.2 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.4 0.3 3.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 10.0 10.3 4.3 10.4 9.2 5.8 7.2 7.4 7.6 2.7 12.3 4.8 0.1 3.2 0.5 119.5 0.6 0.0 0.0 0.5 0.0 3.6 0.1 0.1 1.4 0.0 1.5 0.0 0.0 0.0 0.0 1.4 0.0 0.4 65.6 2.6 0.1 0.0 10.2 0.0 129.2 0.0 0.0 0.3 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 72.7 0.8 0.0 0.0 0.0 96.8 0.6 0.2 0.0 5.6 0.6 0.3 0.0 5.0 3.1 0.3 0.1 0.7 0.0 0.2 0.0 0.1 10.9 0.9 0.0 0.1 0.0 1.2 1.5 0.0 0.0 0.7 0.1 0.1 0.3 0.3 KIAA2012 ENSG00000182329 KIAA2012 2 202073255-202205188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 6.9;choroid plexus: 3.1;fallopian tube: 9.2" "Group enriched" "Detected in some" 6 "Early spermatids: 38.9;Endometrial ciliated cells: 12.3;Excitatory neurons: 24.8;Late spermatids: 28.6;Respiratory ciliated cells: 43.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077834 Enhanced NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 49: Ciliated cells - Cilium organization" "HPA077834: " "unprognostic (1.91e-2)" "unprognostic (3.17e-1)" "unprognostic (2.56e-1)" "unprognostic (5.35e-2)" "unprognostic (2.85e-2)" "unprognostic (3.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "unprognostic (7.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.81e-2)" "unprognostic (6.94e-5)" "unprognostic (1.60e-1)" "unprognostic (9.44e-2)" "unprognostic (3.37e-1)" "unprognostic (9.95e-3)" 0.0 0.0 1.0 0.0 2.0 0.0 0.0 0.1 1.3 0.3 3.1 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 1.9 1.1 0.0 0.9 0.8 0.0 5.6 6.9 0.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.0 0.1 1.3 1.9 1.1 5.6 6.9 3.1 4.9 1.9 0.9 0.2 3.2 0.0 1.0 0.1 0.0 0.3 0.0 0.0 2.9 0.4 0.1 1.0 0.0 1.8 0.0 2.1 0.1 0.2 0.0 0.0 0.0 38.9 12.3 0.6 0.4 0.0 0.0 24.8 0.2 0.1 0.6 0.0 0.6 0.0 0.2 1.1 4.8 0.1 3.3 2.8 0.0 0.0 0.0 0.0 28.6 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.5 0.9 0.0 0.0 0.0 0.0 0.3 0.2 0.0 43.0 2.4 0.0 0.8 0.2 1.5 3.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92574105-92655395 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.4;lymphoid tissue: 37.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (8.19e-7)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 1.1 0.7 0.5 8.5 0.7 19.4 2.5 0.4 0.6 1.4 0.5 6.3 5.5 1.8 1.0 6.7 1.0 1.2 0.6 0.5 0.5 1.0 1.1 1.3 17.5 0.6 0.6 0.6 0.5 0.7 0.3 3.9 0.6 1.0 7.4 0.8 1.3 0.7 0.2 6.0 5.3 2.5 0.5 2.9 3.9 11.6 0.4 37.9 1.6 0.3 18.5 2.3 2.3 0.6 103.1 45.2 100.6 94.5 7.3 10.5 24.2 72.6 62.8 78.8 78.1 39.6 67.2 111.1 36.5 34.4 32.9 72.0 72.1 36.5 92.4 68.3 41.3 70.5 41.4 42.4 1.4 116.0 63.0 3.6 3.3 61.4 55.9 18.3 50.0 46.1 51.2 126.4 61.1 41.4 99.3 65.8 40.3 42.5 30.7 106.6 98.8 40.2 21.0 30.1 30.0 42.9 56.4 25.9 29.2 34.1 67.9 37.6 28.6 35.7 51.3 37.1 96.9 35.4 58.3 113.4 29.5 82.3 50.3 0.8 0.0 0.1 0.0 0.3 0.3 0.6 0.4 0.4 0.2 0.1 0.1 0.2 0.2 1.0 0.1 0.1 1.1 0.2 0.5 0.7 0.4 0.6 0.5 0.5 0.6 0.6 0.6 0.5 0.4 0.6 0.4 0.0 2.0 1.3 3.5 2.9 1.1 1.6 3.4 1.0 1.8 1.8 1.7 1.5 2.5 1.8 0.0 6.7 2.3 2.9 1.9 0.5 16.3 3.4 4.3 2.0 0.0 39.1 2.1 0.6 11.4 4.7 9.2 4.9 0.0 20.7 2.2 0.4 8.2 0.0 1.8 4.3 4.1 4.6 3.4 4.4 0.9 4.0 0.0 0.0 1.0 0.7 2.1 2.5 1.1 0.2 0.4 0.7 15.2 0.8 0.5 0.6 3.7 0.4 0.0 1.7 3.7 38.0 23.4 12.6 3.3 1.5 4.5 2.5 8.0 1.7 KIF14 KIAA0042 ENSG00000118193 "Kinesin family member 14" Q15058 1 200551497-200620751 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.5;lymphoid tissue: 10.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038061, HPA058220" Uncertain Supported "Midbody ring,Cytosol" Yes Yes "Cluster 18: Basophils - Vesicular transport" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Midbody ring" "HPA038061: AB_10669515, HPA058220: AB_2683642" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.00e-2)" "unprognostic (1.87e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (8.64e-4)" "unprognostic (8.47e-3)" "unprognostic (1.02e-1)" "unprognostic (2.54e-5)" "unprognostic (2.31e-2)" "unprognostic (0.00e+0)" "unprognostic (6.28e-3)" "unprognostic (3.31e-1)" "unprognostic (8.14e-2)" "unprognostic (7.44e-2)" 0.2 0.2 0.1 2.0 0.0 6.5 0.3 0.2 0.3 0.2 0.1 0.9 1.2 0.3 0.0 1.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.2 3.2 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.2 0.1 0.1 0.0 0.0 1.0 1.1 0.6 0.0 0.6 0.6 2.5 0.1 10.9 0.1 0.0 3.2 0.4 0.3 0.1 29.7 17.3 26.8 15.0 0.8 3.0 14.8 20.0 11.7 18.7 16.8 10.5 15.1 18.0 7.0 9.6 11.6 23.0 21.6 13.3 26.7 22.1 11.3 28.8 24.8 10.3 0.1 45.5 15.7 0.6 0.6 20.9 17.8 4.0 13.5 26.3 44.0 22.6 23.5 12.1 26.9 14.2 22.6 8.7 15.0 24.3 35.4 22.8 6.3 8.3 12.7 14.0 28.3 9.5 11.0 19.8 12.9 11.6 11.1 14.7 17.3 16.2 35.3 8.2 8.9 25.8 8.6 24.0 30.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.0 1.9 2.4 1.0 1.1 0.6 2.3 1.5 1.9 0.8 0.0 0.9 0.0 2.1 4.2 0.6 2.5 0.0 0.2 4.1 3.7 2.2 1.6 0.0 27.1 1.1 0.0 7.7 3.3 10.2 5.0 2.5 13.2 2.5 0.9 5.4 0.0 0.9 5.2 0.0 2.9 1.9 2.5 0.6 2.3 0.0 0.0 0.4 0.5 0.0 0.5 0.8 0.3 0.0 0.7 11.3 1.2 0.2 0.1 1.4 0.8 6.6 1.4 2.1 22.8 16.3 8.3 0.9 1.4 2.3 0.7 4.3 1.9 KIF15 "HKLP2, KNSL7, NY-BR-62" ENSG00000163808 "Kinesin family member 15" Q9NS87 3 44761721-44873376 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 5.0;lymphoid tissue: 9.2;testis: 7.3" "Group enriched" "Detected in many" 4 "Early spermatids: 177.5;Late spermatids: 78.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035516, HPA035517, HPA061469" Approved NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: " "unprognostic (2.26e-1)" "unprognostic (1.85e-1)" "prognostic favorable (3.12e-4)" "unprognostic (3.49e-2)" "unprognostic (2.69e-1)" "unprognostic (5.17e-3)" "unprognostic (6.68e-7)" "unprognostic (1.35e-2)" "unprognostic (1.51e-2)" "unprognostic (6.94e-2)" "unprognostic (3.14e-4)" "unprognostic (2.72e-2)" "unprognostic (0.00e+0)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.58e-1)" 0.2 0.1 0.1 1.2 0.1 5.0 0.4 0.2 0.2 0.3 0.0 1.4 1.4 0.3 0.0 1.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 2.2 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 1.6 0.1 0.2 0.1 0.0 0.8 1.4 0.4 0.1 0.4 0.8 7.3 0.1 9.2 0.0 0.0 2.2 0.3 0.4 0.1 7.5 3.9 17.6 12.8 1.2 1.4 3.9 8.6 5.3 10.8 9.0 6.6 7.2 13.8 2.8 3.1 4.0 6.3 10.1 4.7 13.1 11.6 2.3 14.9 7.7 8.4 0.1 15.6 6.6 0.3 0.2 7.3 7.1 1.6 8.6 18.4 9.3 17.2 8.2 3.9 30.0 5.7 18.2 9.7 7.0 11.9 19.0 7.9 2.4 4.9 8.2 7.8 14.2 4.6 2.9 4.6 7.7 11.7 4.8 10.4 8.5 8.8 11.5 7.2 12.7 17.3 5.5 16.3 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.6 1.6 1.9 0.4 0.9 0.0 0.1 0.5 0.8 1.8 0.0 0.7 0.0 2.1 3.3 0.8 2.5 0.0 0.8 177.5 1.3 1.7 1.2 0.0 28.0 3.2 0.0 5.9 1.9 5.1 1.4 0.0 12.3 0.0 0.2 3.5 0.0 3.8 2.6 0.0 1.6 1.4 78.0 0.0 1.8 0.0 0.0 0.3 0.7 1.0 3.0 4.7 0.5 0.1 0.4 9.7 0.5 0.5 0.1 0.2 0.0 0.0 0.4 1.9 20.2 14.7 6.0 1.0 0.7 3.1 1.1 5.3 0.5 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947773 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.7;lymphoid tissue: 14.4" "Cell type enhanced" "Detected in some" "Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.4" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" Yes Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavorable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.4 0.4 0.3 3.8 0.4 12.7 0.2 0.7 0.3 0.9 0.3 2.0 2.7 0.4 0.0 5.1 0.2 0.4 0.3 0.3 0.4 0.2 0.4 0.8 5.7 0.5 1.1 0.1 0.1 0.0 0.1 1.9 0.6 0.2 1.7 0.1 0.7 0.0 0.4 3.0 2.5 1.1 0.3 2.9 1.5 2.9 0.6 14.4 0.2 0.0 4.7 0.6 1.6 0.5 31.5 41.7 35.3 32.8 0.8 3.0 28.1 25.8 10.3 34.6 26.9 34.0 27.4 28.3 10.9 10.8 21.5 34.0 25.1 11.3 17.9 56.6 36.4 35.4 51.7 22.1 0.0 30.0 30.2 0.7 0.6 29.7 12.2 4.7 17.9 29.2 28.1 48.0 18.2 25.9 60.0 31.1 25.4 30.4 28.9 43.5 51.8 19.2 5.8 16.7 26.2 24.7 18.0 16.1 9.8 17.0 30.2 21.6 11.2 49.9 48.0 28.8 56.8 15.1 15.7 34.4 16.3 22.9 33.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.7 0.3 0.3 0.4 0.5 1.1 0.6 0.3 0.6 0.5 0.1 0.0 0.0 0.0 0.9 0.4 0.1 0.2 0.0 0.5 0.5 0.4 2.6 0.0 0.0 0.0 0.0 2.4 0.4 1.9 0.0 0.0 0.0 0.3 0.8 0.6 0.0 9.0 0.3 0.0 3.8 1.4 1.5 0.5 0.0 5.9 0.4 0.3 2.3 0.0 0.3 1.6 0.0 2.2 1.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 7.1 0.1 0.1 0.0 0.0 2.1 0.2 0.3 0.0 0.0 0.3 0.0 0.2 0.8 1.1 2.9 2.5 0.4 0.8 1.3 0.3 3.2 0.3 KIF19 "FLJ37300, KIF19A" ENSG00000196169 "Kinesin family member 19" Q2TAC6 17 74326210-74355820 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 16.7;fallopian tube: 12.0;lymphoid tissue: 13.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 44.4;Enteroendocrine cells: 23.8;Hepatic stellate cells: 15.4;Intestinal goblet cells: 14.1;Plasma cells: 15.6;Respiratory ciliated cells: 57.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043638, HPA073303" Enhanced Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "Actin filaments, Centrosome" "HPA043638: AB_10962579, HPA073303: AB_2686593" "unprognostic (1.59e-3)" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (5.37e-3)" "unprognostic (9.64e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (1.05e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-9)" "unprognostic (5.16e-5)" "unprognostic (2.72e-1)" "unprognostic (1.67e-2)" "unprognostic (1.53e-1)" 1.4 0.1 7.5 0.4 10.3 0.2 1.2 4.0 11.4 2.2 3.5 1.7 3.0 0.3 0.0 0.5 12.0 0.4 0.3 7.2 7.4 0.2 0.9 1.9 0.1 7.5 8.0 0.2 1.1 0.0 0.3 0.0 5.9 0.9 0.6 0.1 1.0 0.2 0.4 0.6 2.3 0.4 6.2 13.5 0.7 0.6 7.7 1.0 1.9 0.6 0.1 1.6 1.5 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.4 7.5 10.3 4.0 11.4 7.2 7.4 7.5 8.0 5.9 6.2 7.7 16.7 1.3 0.0 0.0 2.0 1.3 0.0 0.4 2.5 0.0 1.1 0.1 0.0 1.6 0.0 6.3 0.0 0.0 0.0 3.5 0.8 0.0 0.0 0.5 44.4 0.2 4.2 23.8 0.4 0.0 0.0 3.1 1.0 1.1 0.7 0.0 0.0 15.4 0.1 0.1 0.0 0.1 14.1 4.1 0.6 1.6 0.3 0.0 0.3 3.6 0.0 0.1 5.7 3.1 4.0 3.7 0.0 0.1 0.0 15.6 0.3 0.2 0.0 57.6 0.3 0.0 1.8 1.3 0.2 1.6 0.0 0.1 0.0 2.5 0.2 1.9 0.2 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187723 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1;lymphoid tissue: 24.6;testis: 11.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.0;Erythroid cells: 24.6;Extravillous trophoblasts: 13.1;Granulosa cells: 11.1;Spermatocytes: 21.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 6.6;T-reg: 2.5" "Group enriched" "Detected in many" 46 "NK-cells: 6.6;T-cells: 2.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036909, HPA036910" Approved Uncertain "Nucleoplasm,Cytokinetic bridge" Yes Yes "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (2.14e-12)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 0.7 0.8 0.0 4.5 0.1 14.1 1.3 0.1 0.1 1.0 0.1 3.3 3.5 1.4 0.0 6.6 0.4 0.8 0.5 0.0 0.1 0.4 0.9 0.9 8.6 0.1 0.2 0.2 0.2 0.1 0.0 5.4 0.1 0.2 5.1 0.0 1.0 0.1 0.1 4.4 2.8 5.8 0.0 1.9 2.1 11.7 0.5 24.6 0.5 0.1 13.1 1.6 2.0 0.1 87.8 59.5 127.8 84.4 6.7 12.3 53.9 75.0 68.9 162.3 121.4 111.9 80.5 38.8 39.2 96.5 60.6 85.9 121.7 142.5 160.9 56.4 57.4 57.2 101.1 70.7 0.3 28.2 25.1 4.8 2.3 86.2 49.5 27.1 106.7 53.9 24.4 70.4 113.9 81.5 47.6 26.7 80.6 51.8 63.7 51.2 128.5 39.5 43.9 42.3 37.8 37.5 144.1 47.9 30.9 161.6 60.8 28.5 51.1 41.6 60.5 38.0 126.4 36.0 37.5 42.0 26.7 81.1 82.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 2.5 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.3 0.0 1.7 0.0 0.8 0.4 0.4 2.9 0.0 0.0 1.1 1.3 0.3 0.0 0.7 0.0 0.0 11.0 0.1 2.8 0.0 0.1 1.0 1.0 1.9 1.7 0.0 24.6 0.0 0.0 13.1 3.1 2.6 1.3 4.5 11.1 3.3 0.4 6.1 0.0 0.0 1.6 6.1 2.2 0.4 2.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.4 3.0 0.3 1.2 0.0 0.9 0.0 0.0 0.5 4.4 21.7 7.5 5.3 0.4 1.0 0.7 0.8 3.4 0.6 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.6;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 4.6" "Group enriched" "Detected in many" 13 "granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes "Cluster 49: Eosinophils - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.0 1.5 0.3 5.7 0.2 21.6 1.4 0.2 0.3 1.5 1.4 4.1 3.9 2.0 0.1 5.3 0.9 1.3 0.6 0.3 0.2 4.6 0.5 1.5 7.9 0.2 0.3 0.7 0.5 0.4 0.1 6.4 0.3 0.9 5.0 0.2 1.1 1.2 0.1 3.7 3.8 4.2 0.2 2.2 2.0 10.6 0.3 15.9 0.3 0.2 9.8 1.8 2.1 0.2 100.7 81.5 64.2 59.0 3.7 7.3 36.3 105.3 57.0 154.8 120.6 50.2 72.4 56.8 31.4 53.1 78.6 110.5 121.6 39.5 158.7 52.9 60.2 55.3 78.8 30.7 2.1 55.6 48.3 3.3 4.2 71.8 60.5 19.4 52.0 46.9 36.0 70.2 95.4 44.1 31.2 28.2 71.6 35.5 33.2 37.0 133.8 31.2 39.3 49.7 32.5 25.3 120.4 51.9 44.9 74.5 50.6 25.3 34.5 90.0 120.8 62.0 157.6 26.3 74.3 48.4 31.5 72.2 78.0 0.0 1.2 4.6 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.2 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.4 0.0 0.5 0.0 2.3 1.9 3.7 4.2 0.0 0.2 1.8 2.8 0.8 5.7 4.7 7.3 2.1 24.2 1.4 3.3 3.9 1.8 13.3 13.1 3.6 2.2 1.8 42.3 1.8 0.0 32.4 5.8 3.6 8.7 2.5 22.4 3.9 0.3 8.1 0.0 1.0 3.1 0.0 2.8 3.4 4.8 0.9 3.2 0.0 1.0 8.1 0.2 0.0 0.0 0.2 0.4 0.4 1.9 6.8 1.6 0.8 0.9 3.6 0.1 6.6 0.4 8.2 70.8 20.9 11.3 1.0 2.5 4.2 3.6 8.6 3.3 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1860.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "T-reg: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in some" "white matter: 2.1" "Not detected" "Not detected" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 0.7 0.8 0.7 7.0 0.7 33.0 1.6 2.3 0.7 1.8 1.1 6.2 5.5 1.8 0.7 7.3 0.9 1.3 1.3 0.6 1.1 0.8 0.7 1.3 16.4 1.1 0.9 0.6 0.5 1.3 0.4 5.4 1.4 0.8 7.6 0.8 1.3 0.7 0.9 6.0 5.1 3.2 0.9 3.7 3.5 76.5 0.8 37.4 1.1 0.7 19.2 2.1 2.7 0.8 119.7 45.8 99.6 79.8 5.3 11.6 66.6 86.9 62.1 175.0 151.3 77.6 84.2 136.2 41.3 43.2 121.7 55.2 102.8 59.6 158.2 89.1 44.4 162.1 83.3 65.5 0.6 121.5 71.8 2.7 5.8 125.0 60.3 16.5 57.6 95.4 130.4 113.1 112.4 46.5 127.5 72.9 97.1 58.4 56.5 101.1 149.3 86.4 29.6 42.8 68.3 48.5 116.1 81.6 71.5 71.9 47.2 90.7 34.7 62.9 124.2 69.0 155.6 59.4 65.0 195.3 40.3 115.4 123.9 0.0 0.0 0.0 0.9 0.0 0.0 0.6 1.7 1.2 0.1 0.1 0.3 0.2 0.0 2.0 0.1 0.8 2.9 0.5 0.7 0.7 2.3 0.7 0.6 1.1 1.1 0.9 1.4 0.9 0.8 0.8 0.1 0.0 0.5 1.6 1.3 1.8 0.5 2.4 0.0 1.0 0.9 0.9 1.6 0.0 1.7 1.8 2.1 12.2 1.9 2.9 1.9 0.3 461.1 1.2 1.4 1.6 0.0 34.5 0.8 0.4 23.4 3.2 3.1 2.1 0.0 13.0 2.9 0.2 9.2 0.0 1.0 3.5 0.0 1.9 1.5 1860.6 9.3 3.4 0.0 1.0 4.3 0.4 0.0 0.5 0.2 0.1 0.2 6.8 7.8 0.8 0.3 0.2 0.3 0.2 6.6 0.8 3.4 60.6 36.8 4.6 0.4 3.7 2.7 0.8 7.4 0.7 KIF4A "FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100" ENSG00000090889 "Kinesin family member 4A" O95239 X 70290104-70420886 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA-binding, Motor protein" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 11.2;lymphoid tissue: 12.6" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 18.6;Erythroid cells: 29.5;Extravillous trophoblasts: 11.5;Granulosa cells: 12.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA034745, HPA034746, HPA061583" Approved Supported Nucleoplasm,Midbody Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (8.17e-3)" "unprognostic (2.78e-2)" "unprognostic (1.02e-2)" "unprognostic (3.46e-3)" "unprognostic (3.20e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.37e-6)" "unprognostic (2.18e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (3.79e-2)" "unprognostic (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" 0.3 0.3 0.3 3.2 0.2 11.2 0.7 0.1 0.3 0.6 0.3 3.7 3.1 0.8 0.0 3.6 1.5 0.5 0.2 0.2 0.5 0.2 0.5 0.5 5.5 0.9 0.7 0.1 0.1 0.1 0.5 2.3 0.6 0.1 4.5 0.6 0.5 0.1 0.1 2.2 3.3 1.3 0.7 2.4 1.7 1.5 0.6 12.6 0.2 0.0 6.6 0.9 1.1 0.2 60.2 41.1 61.0 30.1 2.9 5.1 24.0 44.7 23.8 59.7 51.6 46.7 34.3 36.7 27.4 22.1 46.2 35.1 66.6 24.2 66.8 42.5 33.4 41.7 50.1 33.4 0.7 46.7 27.8 1.7 1.5 49.6 28.2 7.3 37.0 27.7 53.8 79.1 57.0 38.7 43.0 23.1 61.7 63.8 43.2 47.1 82.2 34.6 14.5 23.4 40.1 33.5 72.9 30.5 18.6 30.6 24.5 18.1 26.0 39.3 50.6 42.6 54.1 22.6 41.7 52.0 20.8 50.4 60.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.2 0.1 0.3 0.2 0.5 0.9 0.7 0.6 0.7 0.6 0.2 0.1 0.0 0.5 1.3 1.3 1.8 0.3 1.4 0.6 0.2 1.1 0.8 0.4 1.5 0.2 0.0 0.0 7.0 0.9 2.2 0.0 0.0 0.4 18.6 1.5 1.3 1.2 29.5 1.9 0.0 11.5 2.1 3.1 1.6 0.0 12.2 1.1 0.1 5.3 0.0 1.9 4.6 2.0 1.3 0.7 0.8 0.0 1.4 0.0 0.0 0.2 3.1 0.0 2.0 0.7 0.1 0.1 0.0 8.2 0.4 0.3 0.1 0.4 0.0 0.0 0.2 2.9 8.7 5.4 7.2 0.3 1.8 1.8 1.3 6.6 0.5 KIF6 "C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317" ENSG00000164627 "Kinesin family member 6" Q6ZMV9 6 39329990-39725408 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.3;testis: 5.3" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 220.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 22.1;RPMI-8226: 9.2;SCLC-21H: 12.2;SK-MEL-30: 5.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.7" "HPA038811, HPA058624" Enhanced Approved Centrosome NA NA "Cluster 11: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Centrosome "HPA038811: AB_10795140, HPA058624: AB_2683781" "unprognostic (4.94e-2)" "unprognostic (3.38e-2)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (1.55e-1)" "unprognostic (8.25e-4)" "unprognostic (3.12e-3)" "unprognostic (1.00e-1)" "unprognostic (3.06e-1)" "unprognostic (3.48e-2)" "unprognostic (9.12e-4)" "unprognostic (1.08e-1)" "unprognostic (3.07e-2)" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" 0.3 0.3 8.0 0.1 15.5 0.1 0.5 10.5 9.3 0.3 1.5 0.2 0.5 0.2 0.5 0.3 3.8 0.4 0.3 7.2 8.6 0.3 0.3 0.8 0.3 12.3 9.8 0.2 0.4 0.3 1.2 0.3 11.1 0.2 0.1 3.0 0.1 0.1 0.4 0.2 0.2 0.1 8.0 0.2 0.2 5.3 10.0 0.1 0.6 0.2 0.1 0.0 0.0 18.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 1.0 0.3 0.5 0.1 0.0 0.0 0.1 1.0 22.1 0.2 0.1 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.5 9.2 0.2 0.0 12.2 0.1 0.0 0.1 5.0 0.3 0.1 0.1 0.1 0.0 0.1 2.9 0.7 0.2 0.0 0.0 0.7 0.0 1.5 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.1 0.6 0.0 0.0 8.0 15.5 10.5 9.3 7.2 8.6 12.3 9.8 11.1 8.0 10.0 18.3 0.2 0.0 0.6 31.3 0.1 0.1 0.7 1.0 0.0 3.9 0.5 0.5 1.3 0.0 2.2 0.0 10.4 0.3 0.0 0.0 1.9 1.5 9.1 23.9 1.0 0.8 2.4 0.0 8.6 0.9 0.5 2.7 0.0 1.0 0.0 0.4 0.0 0.0 0.3 3.3 15.6 0.0 0.0 0.0 1.5 10.3 0.3 0.3 0.0 1.9 0.1 12.9 0.0 5.0 220.3 0.1 0.1 0.0 0.1 0.3 0.0 3.5 40.0 16.3 0.0 3.1 0.8 17.0 3.1 0.1 0.4 0.3 0.2 2.2 0.0 0.4 KIF9 MGC104186 ENSG00000088727 "Kinesin family member 9" Q9HAQ2 3 47228395-47283451 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.4" "Cell type enhanced" "Detected in all" "Early spermatids: 690.3;Endometrial ciliated cells: 398.0;Respiratory ciliated cells: 359.0;Spermatocytes: 328.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022031, HPA022033, HPA030429" Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA022031: AB_1852502, HPA022033: AB_1852504, HPA030429: AB_10601921" "unprognostic (1.93e-2)" "unprognostic (6.37e-2)" "prognostic favorable (2.26e-4)" "unprognostic (1.17e-3)" "unprognostic (8.86e-2)" "unprognostic (1.13e-1)" "unprognostic (2.80e-3)" "unprognostic (1.70e-1)" "unprognostic (2.94e-2)" "unprognostic (4.59e-2)" "unprognostic (7.47e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.95e-6)" "unprognostic (4.21e-2)" "unprognostic (2.03e-1)" "unprognostic (9.17e-2)" "unprognostic (1.23e-1)" 6.5 7.4 9.3 3.1 10.1 11.8 10.6 8.8 14.4 7.6 23.1 9.1 6.1 7.9 20.5 5.8 26.3 6.4 14.1 10.1 9.8 26.8 6.0 8.6 2.6 12.0 12.9 5.0 12.7 10.1 16.4 3.7 11.4 7.7 8.1 18.7 8.9 4.8 9.4 8.4 5.6 4.5 11.0 5.7 9.3 64.4 10.0 2.3 21.0 5.7 3.1 6.8 5.4 9.5 19.4 21.7 7.6 19.1 3.6 8.7 6.2 5.9 6.1 8.8 7.8 8.4 23.0 12.8 7.3 7.6 11.8 12.0 22.6 15.3 8.7 6.6 14.6 11.9 16.5 26.9 3.4 25.3 3.8 4.5 15.3 12.8 9.6 7.4 19.0 13.5 26.5 5.1 6.6 15.5 13.7 37.6 21.7 44.4 30.5 8.6 5.3 18.3 36.7 10.9 10.8 19.9 6.8 13.0 21.8 3.9 8.4 17.6 9.0 5.1 11.0 8.3 13.6 4.4 19.7 16.1 18.9 25.1 11.3 2.5 3.6 2.1 1.5 2.6 3.0 3.5 1.4 2.3 5.7 0.6 1.7 1.9 6.3 3.5 2.3 3.3 1.0 1.3 9.3 10.1 8.8 14.4 10.1 9.8 12.0 12.9 11.4 11.0 10.0 9.5 34.5 19.2 18.4 4.2 6.7 20.1 53.7 44.3 20.5 7.2 61.4 74.5 28.2 38.6 51.9 64.4 35.5 10.7 7.5 23.8 109.5 45.5 690.3 398.0 17.8 29.3 58.9 20.0 16.6 32.7 11.1 12.1 34.1 38.5 29.1 11.3 17.9 20.7 9.2 5.0 10.3 40.1 52.9 7.2 7.1 160.6 14.0 8.0 16.0 2.8 3.8 17.2 3.1 2.5 3.2 26.0 15.7 13.2 5.7 37.6 15.1 198.1 359.0 44.0 13.1 42.2 16.7 328.8 37.3 17.2 20.2 8.2 7.8 21.8 37.8 37.4 KIFC1 "HSET, KNSL2" ENSG00000237649 "Kinesin family member C1" Q9BW19 6 33391823-33409896 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.7;lymphoid tissue: 47.5" "Cell type enhanced" "Detected in many" "Early spermatids: 32.0;Erythroid cells: 62.3;Extravillous trophoblasts: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055997, HPA062674" Enhanced Approved Centrosome NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Centrosome "HPA055997: AB_2683001, HPA062674: AB_2684829" "unprognostic (7.33e-2)" "unprognostic (1.28e-2)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (7.07e-8)" "unprognostic (6.34e-3)" "unprognostic (9.36e-3)" "unprognostic (8.58e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (1.83e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.17e-2)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (4.52e-1)" 1.1 1.1 0.2 10.6 0.3 39.7 2.2 0.3 1.2 2.5 0.4 8.0 8.8 1.8 0.2 11.7 0.8 1.5 0.6 0.7 0.3 0.8 1.0 2.3 24.6 0.4 0.7 2.0 0.7 0.3 0.6 5.5 0.5 0.9 8.2 0.4 2.1 0.2 0.2 9.8 8.1 4.1 0.2 5.3 4.7 12.3 0.6 47.5 0.7 0.4 24.9 2.7 3.9 0.5 133.5 47.9 120.6 124.2 5.2 8.1 64.0 82.5 48.4 122.6 104.6 80.6 53.3 120.2 38.3 41.5 102.0 88.1 87.1 60.7 79.7 114.3 60.3 93.9 71.6 73.5 0.5 96.0 75.7 2.5 4.7 73.2 38.8 13.8 64.2 87.5 76.0 112.3 81.0 86.2 125.7 103.2 47.5 67.6 48.4 129.7 110.7 61.4 38.4 42.8 100.1 57.2 54.3 91.9 44.1 51.3 78.7 105.4 32.2 74.6 104.6 56.2 128.9 58.2 132.4 126.1 18.8 94.8 101.0 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.2 0.2 0.0 0.0 0.0 1.0 0.3 0.0 1.6 0.5 0.2 0.3 0.3 1.2 0.7 0.3 0.4 0.7 0.5 0.2 0.6 0.5 0.4 0.0 2.5 1.0 4.1 5.6 1.5 4.6 2.2 0.4 2.8 2.2 0.5 0.0 1.9 0.0 0.0 18.7 3.7 8.8 0.0 0.7 32.0 2.7 1.9 2.4 0.0 62.3 0.3 0.0 39.6 4.2 4.1 6.1 1.3 15.0 1.8 0.3 14.3 0.0 0.3 8.0 2.0 2.4 9.8 12.0 0.3 4.7 3.6 1.0 3.1 0.3 0.0 1.0 0.6 0.3 2.1 0.7 12.0 0.9 2.1 0.7 0.8 0.5 0.0 2.5 7.5 13.9 9.6 14.4 3.7 6.7 5.7 0.6 12.1 3.1 KIT "C-Kit, CD117, PBT, SCFR" ENSG00000157404 "KIT proto-oncogene, receptor tyrosine kinase" P10721 4 54657918-54740715 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 114.9" "Cell type enhanced" "Detected in many" "Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7" "Cancer enhanced" "Detected in many" "testis cancer: 28.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1" "Group enriched" "Detected in many" 7 "granulocytes: 20.3;NK-cells: 13.1" "Group enriched" "Detected in many" 13 "HEL: 247.2;HMC-1: 496.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003288, HPA004471, CAB068253, CAB072867, HPA073252" Enhanced Supported Supported "Plasma membrane" NA NA 49000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 5: Breast - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Plasma membrane" "CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589" "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (4.04e-2)" "unprognostic (8.19e-2)" "unprognostic (3.96e-2)" "unprognostic (2.18e-2)" "unprognostic (2.33e-2)" "unprognostic (1.97e-2)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.20e-1)" "unprognostic (1.92e-2)" "prognostic favorable (5.63e-4)" "unprognostic (1.34e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.30e-1)" 6.6 1.8 8.2 5.3 6.3 6.4 114.9 21.4 6.5 17.6 5.1 13.5 9.2 9.6 5.9 13.0 2.9 20.3 3.4 23.9 5.1 12.4 0.8 21.8 3.4 6.8 12.3 45.0 2.6 1.7 1.9 10.0 8.8 5.6 16.0 3.2 21.4 8.7 1.1 24.5 13.4 10.1 5.9 5.0 17.4 6.2 16.7 3.1 47.1 6.9 6.2 14.5 4.9 5.1 0.0 0.0 3.9 0.0 0.7 0.3 0.0 3.3 4.6 12.6 15.8 0.0 0.0 0.0 0.0 7.3 0.6 0.3 2.6 0.0 10.8 0.0 5.9 247.2 0.0 0.0 0.0 0.0 496.2 0.0 0.0 0.0 0.0 0.0 28.4 4.3 3.5 0.5 0.0 0.0 1.4 2.5 6.9 0.0 0.0 0.8 0.0 0.0 0.0 24.2 6.0 2.1 0.0 0.0 0.0 14.1 0.0 2.6 0.3 0.5 0.0 4.9 0.1 0.4 0.0 0.0 0.5 0.9 0.6 20.3 0.0 12.8 0.1 0.0 2.3 0.0 0.4 0.9 2.3 0.0 0.0 0.0 1.0 13.1 1.4 0.1 0.0 0.2 8.2 6.3 21.4 6.5 23.9 5.1 6.8 12.3 8.8 5.9 16.7 5.1 7.3 6.4 21.9 9.8 1.0 14.3 0.9 0.4 2.2 4.5 83.1 59.2 0.7 4.3 3.6 3.7 0.0 0.1 5.2 0.4 3.9 1.0 0.0 0.2 0.7 9.2 5.4 15.5 0.9 0.0 0.1 2.8 8.6 0.7 529.3 0.5 1.8 0.0 0.3 0.0 111.2 0.5 101.7 0.3 4.2 0.4 1.2 1.6 211.7 14.0 0.2 2.4 0.0 16.1 3.7 0.0 0.1 0.0 3.2 0.5 0.0 0.8 0.1 0.2 0.0 0.7 0.8 0.1 12.3 2.2 3.8 0.3 8.8 63.7 0.6 0.3 KLHDC9 KARCA1 ENSG00000162755 "Kelch domain containing 9" Q8NEP7 1 161098361-161100346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 29.0" "Group enriched" "Detected in many" 4 "Early spermatids: 424.7;Late spermatids: 448.2;Spermatocytes: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;HDLM-2: 1.5;HEK 293: 1.8;MCF7: 1.4;T-47d: 1.4;U-266/70: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043197 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes NA "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA043197: AB_2678359" "unprognostic (1.79e-1)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "unprognostic (1.04e-3)" "unprognostic (2.53e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-1)" "unprognostic (4.87e-3)" "unprognostic (6.31e-2)" "prognostic favorable (4.20e-6)" "unprognostic (1.81e-3)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.53e-1)" "unprognostic (5.51e-2)" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" 0.4 3.0 1.3 0.1 1.8 0.0 0.7 1.0 2.9 1.1 2.1 1.4 0.2 1.4 0.5 0.5 2.2 0.0 0.9 1.7 2.2 4.7 1.9 0.8 0.0 1.7 1.8 1.0 2.4 1.1 4.6 0.0 1.6 1.7 0.2 0.4 1.0 0.4 0.7 0.3 0.8 0.0 1.2 0.3 1.3 29.0 2.4 0.0 2.4 0.1 0.1 1.0 0.5 0.9 0.1 1.1 0.4 1.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 1.5 1.8 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.2 0.9 1.0 0.0 0.7 0.2 0.0 1.0 0.4 0.0 0.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 1.0 2.9 1.7 2.2 1.7 1.8 1.6 1.2 2.4 0.9 2.4 0.0 6.7 8.8 1.5 0.9 11.7 11.5 0.6 13.7 15.3 16.3 9.3 14.3 11.7 29.5 2.1 2.3 0.4 7.6 56.7 10.2 424.7 57.5 2.8 3.4 5.4 0.0 8.9 5.5 3.6 3.2 3.1 10.3 1.3 1.6 3.9 9.5 0.6 3.3 6.8 10.6 16.2 0.6 0.7 448.2 8.1 0.9 7.2 2.8 0.6 35.1 1.0 6.0 1.7 3.9 8.2 8.2 2.1 6.4 2.5 47.8 77.8 20.0 13.1 2.8 4.4 198.1 15.6 2.6 0.9 0.8 1.2 1.7 8.7 8.2 KLHL32 "BKLHD5, KIAA1900" ENSG00000186231 "Kelch like family member 32" Q96NJ5 6 96924620-97140754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 65.2" "Cell type enhanced" "Detected in many" "Astrocytes: 143.7;Excitatory neurons: 168.8;Inhibitory neurons: 143.9;Oligodendrocyte precursor cells: 197.5;Oligodendrocytes: 724.3" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.0;T-cells: 2.6" "Cell line enhanced" "Detected in some" "Daudi: 3.3;HDLM-2: 4.5;RPMI-8226: 2.1;SCLC-21H: 1.8;U-266/70: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039150 Enhanced NA NA "Cluster 32: T-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA039150: AB_2676367" "unprognostic (1.75e-1)" "unprognostic (7.99e-2)" "unprognostic (6.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (5.22e-2)" "unprognostic (5.00e-1)" "unprognostic (3.12e-3)" "unprognostic (5.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.51e-5)" "unprognostic (5.82e-2)" "unprognostic (6.04e-2)" "unprognostic (7.01e-2)" "unprognostic (1.86e-2)" "unprognostic (7.48e-2)" "unprognostic (4.49e-4)" 0.2 0.9 19.6 0.4 40.7 0.1 0.3 24.7 33.3 0.3 1.7 0.6 0.8 0.2 0.4 0.0 6.4 0.3 0.7 21.6 25.9 1.9 0.6 0.7 0.4 31.2 28.2 0.9 1.3 0.7 1.2 0.0 29.9 0.2 0.9 2.5 0.5 0.2 1.2 0.1 1.1 0.1 25.3 0.3 0.5 1.6 29.1 0.7 0.7 0.3 0.4 0.1 0.1 65.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 3.3 0.1 0.0 0.0 0.1 0.3 0.1 0.0 4.5 0.7 0.2 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 1.6 0.0 0.0 0.8 0.2 0.2 0.1 0.1 0.1 0.0 2.1 0.0 0.0 1.8 0.6 0.0 0.0 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.3 0.4 1.3 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.9 1.0 1.7 0.6 0.0 0.7 1.9 2.6 0.0 0.4 0.0 0.0 1.2 0.8 19.6 40.7 24.7 33.3 21.6 25.9 31.2 28.2 29.9 25.3 29.1 65.2 0.2 3.2 0.0 143.7 1.1 0.0 0.3 0.1 0.0 2.5 0.4 0.5 2.6 0.0 0.1 5.5 0.0 0.1 0.2 0.3 3.9 0.2 6.9 7.5 0.1 0.0 11.3 0.0 168.8 0.2 0.0 0.3 1.5 0.2 0.0 3.2 0.4 1.3 0.1 18.5 143.9 4.1 0.0 0.0 0.0 3.3 0.0 0.1 0.0 13.1 0.0 1.1 0.0 197.5 724.3 0.0 0.1 0.0 0.5 0.2 0.5 2.4 15.3 1.1 0.0 0.2 0.1 0.8 1.8 0.0 0.0 0.0 0.7 1.1 0.5 0.0 KLK12 KLK-L5 ENSG00000186474 "Kallikrein related peptidase 12" Q9UKR0 19 51029092-51035230 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "cervix: 108.5;esophagus: 208.6;salivary gland: 64.7;vagina: 99.4" "Cell type enhanced" "Detected in some" "Early spermatids: 30.7;Enteroendocrine cells: 40.3;Intestinal goblet cells: 24.9;Ionocytes: 14.2;Late spermatids: 34.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB025473 Uncertain "Secreted in other tissues" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "CAB025473: " "unprognostic (2.84e-1)" "unprognostic (1.41e-1)" "unprognostic (1.08e-3)" "unprognostic (1.15e-1)" "unprognostic (5.80e-3)" "unprognostic (4.99e-3)" "unprognostic (3.18e-1)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.51e-1)" "unprognostic (1.56e-1)" "prognostic favorable (8.01e-4)" "unprognostic (8.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 108.5 2.2 2.1 4.0 0.0 0.0 208.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.1 0.5 0.8 0.0 64.7 0.0 0.0 0.6 5.8 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.1 0.0 8.9 0.0 99.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.5 0.2 0.0 2.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 30.7 0.0 0.0 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 14.2 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.2 8.4 0.0 0.0 0.0 0.0 1.3 1.7 KLK13 KLK-L4 ENSG00000167759 "Kallikrein related peptidase 13" Q9UKR3 19 51055626-51065114 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "esophagus: 519.9" "Group enriched" "Detected in some" 4 "Late spermatids: 246.9;Squamous epithelial cells: 68.3" "Group enriched" "Detected in many" 4 "cervical cancer: 20.6;head and neck cancer: 42.3;melanoma: 10.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HaCaT: 27.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA062136 Enhanced "Secreted in other tissues" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "HPA062136: AB_2684694" "unprognostic (1.99e-3)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (3.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.69e-1)" "unprognostic (6.76e-2)" "unprognostic (2.18e-2)" "unprognostic (8.30e-2)" "unprognostic (7.07e-6)" "unprognostic (7.33e-2)" "unprognostic (2.53e-1)" "unprognostic (6.38e-2)" "unprognostic (7.06e-2)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.2 96.3 0.9 0.6 1.6 0.5 0.4 519.9 0.5 1.1 0.2 0.1 0.1 0.1 0.2 0.7 0.0 0.2 0.5 0.2 4.4 0.4 0.3 0.0 0.1 0.6 0.1 0.0 74.9 0.0 0.1 10.8 0.8 0.3 0.1 0.1 1.4 4.3 0.1 0.2 0.3 0.0 63.5 0.2 122.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 27.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.5 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.6 1.1 4.0 0.0 0.9 1.9 0.4 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.1 0.1 0.3 1.8 0.0 0.0 1.3 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 246.9 0.3 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.0 0.7 68.3 1.3 0.0 0.4 0.4 0.0 2.1 KLRF1 "CLEC5C, NKp80" ENSG00000150045 "Killer cell lectin like receptor F1" Q9NZS2 12 9827481-9845007 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.8;lymphoid tissue: 18.0" "Group enriched" "Detected in many" 7 "dendritic cells: 302.0;NK-cells: 963.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 7 "NK-cell: 664.4" "Lineage enriched" "Detected in all" 7 "NK-cells: 664.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.5;HAP1: 1.5;U-937: 4.4" HPA054038 Approved "Plasma membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "HPA054038: " "unprognostic (2.96e-1)" "unprognostic (8.59e-2)" "unprognostic (3.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-4)" "unprognostic (6.06e-2)" "unprognostic (3.68e-2)" "unprognostic (9.95e-3)" "unprognostic (3.00e-1)" "unprognostic (2.90e-1)" "unprognostic (4.43e-2)" "unprognostic (6.53e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.89e-3)" 1.5 0.1 0.6 1.4 0.6 12.8 0.8 0.6 1.4 0.7 0.6 0.7 0.3 0.9 3.8 0.6 1.5 1.4 0.6 0.6 0.6 1.2 4.5 4.4 3.4 0.8 0.6 0.1 1.3 0.3 0.5 1.0 0.6 0.5 1.0 0.1 1.4 1.1 1.2 0.5 0.8 0.8 0.6 18.0 1.2 0.6 0.6 0.4 0.8 0.4 3.5 0.9 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.4 0.6 0.4 0.8 0.9 71.5 1.5 94.4 3.4 3.6 35.2 1.5 1.5 1.4 35.4 5.8 664.4 1.1 2.3 1.2 83.0 0.6 0.6 0.6 1.4 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.6 3.2 0.0 2.2 0.0 2.3 1.5 1.1 0.2 0.6 0.0 1.3 0.1 0.3 5.7 1.3 0.0 0.0 0.9 302.0 0.1 9.8 0.5 0.5 0.5 0.5 2.2 0.0 24.0 0.1 0.2 0.7 1.2 0.0 1.0 1.3 0.1 8.9 1.8 1.4 0.0 0.2 0.1 0.0 9.1 6.6 1.1 0.0 2.1 12.4 2.8 3.9 0.4 963.0 0.0 0.3 0.4 0.0 0.0 12.7 0.9 0.0 0.8 0.2 0.0 0.0 0.1 0.2 0.2 2.0 0.2 1.1 0.5 80.6 0.0 0.3 3.1 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes "Cluster 21: B-cells - Adaptive immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.2 0.1 0.1 1.9 0.0 5.3 0.3 0.2 0.2 0.2 0.2 1.3 1.6 0.3 0.2 1.0 0.1 0.3 0.1 0.1 0.1 0.5 0.7 0.4 3.6 0.1 0.3 0.0 0.0 0.3 0.0 1.3 0.1 0.1 1.4 0.2 0.2 0.0 0.0 0.8 1.7 0.7 0.0 0.6 0.9 16.9 0.3 7.4 0.3 0.1 3.4 0.5 0.2 0.1 19.1 9.3 18.0 13.8 0.5 2.6 8.6 20.5 8.1 16.0 13.1 11.6 7.2 11.9 6.1 9.3 12.0 21.9 17.6 9.7 16.3 21.4 5.0 35.5 15.5 3.9 0.0 26.2 17.8 0.5 0.4 10.8 6.4 2.1 13.8 20.9 22.9 19.2 18.3 6.1 23.5 6.1 9.4 11.3 9.5 21.2 25.8 5.9 2.6 15.6 15.9 7.7 17.7 10.6 2.1 5.9 11.1 9.0 13.1 18.7 16.3 21.9 11.7 7.5 27.9 22.3 7.6 18.5 18.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.1 0.3 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 1.8 1.8 0.0 8.5 2.6 0.0 1.9 0.2 0.0 3.5 3.5 1.9 0.0 0.0 0.0 0.6 11.3 4.2 0.0 2.9 0.0 22.8 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 11.5 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.7 1.9 1.7 0.0 0.0 KRT40 "FLJ36600, KA36" ENSG00000204889 "Keratin 40" Q6A162 17 40977716-40987135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "pituitary gland: 2.5;retina: 1.8;skin 1: 2.3" "Group enriched" "Detected in some" 61 "Enteroendocrine cells: 22.1;Muller glia cells: 27.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075961 Supported NA NA "Cluster 77: Retina - Visual perception" "Cluster 5: Muller glia cells - Visual perception" "HPA075961: " "unprognostic (2.33e-2)" "unprognostic (9.35e-4)" "unprognostic (8.90e-2)" "unprognostic (1.73e-2)" "unprognostic (1.87e-1)" "unprognostic (1.92e-1)" "unprognostic (9.09e-3)" "unprognostic (2.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.08e-1)" "unprognostic (2.01e-4)" "unprognostic (1.47e-2)" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 22.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LAMA3 "BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa" ENSG00000053747 "Laminin subunit alpha 3" Q16787 18 23689453-23956222 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 171.0;Gastric mucus-secreting cells: 138.1;Pancreatic endocrine cells: 585.5;Paneth cells: 170.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 40.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "HBEC3-KT: 1237.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA009309, CAB010757" Uncertain Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 1800000 "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Endoplasmic reticulum" "CAB010757: AB_477162, HPA009309: AB_1079224" "unprognostic (1.49e-2)" "unprognostic (2.14e-2)" "unprognostic (6.36e-2)" "unprognostic (3.82e-3)" "unprognostic (2.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-3)" "unprognostic (1.59e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (3.58e-6)" "unprognostic (1.98e-1)" "unprognostic (2.36e-1)" "unprognostic (3.15e-1)" "unprognostic (9.91e-3)" "unprognostic (3.98e-2)" "unprognostic (1.13e-1)" 10.0 1.2 8.3 8.5 3.6 0.1 20.3 2.8 5.9 15.4 5.4 13.6 17.8 15.6 4.7 14.5 12.0 7.4 4.2 4.1 3.5 3.2 1.7 20.9 4.1 3.8 5.9 5.7 4.7 10.9 3.0 24.8 3.6 12.2 8.4 3.7 21.3 13.5 2.0 32.1 19.7 6.9 3.5 0.8 31.8 3.3 4.3 9.5 2.3 1.7 4.1 12.2 23.1 2.9 140.5 15.7 0.1 0.1 6.9 1.3 0.3 2.6 1.8 1.3 1.7 5.4 159.5 0.1 17.3 1.8 0.4 248.5 0.2 1237.9 0.9 0.2 8.8 0.0 5.6 2.8 1.2 0.0 0.6 1.6 139.1 0.8 140.0 0.9 5.2 0.2 0.0 0.2 1.6 0.4 0.1 0.1 1.4 42.6 14.4 2.6 0.1 0.2 51.8 15.4 0.6 2.5 4.9 2.0 0.4 0.3 4.5 1.8 12.3 0.9 1.0 6.7 0.6 0.2 0.1 0.6 2.9 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 3.6 2.8 5.9 4.1 3.5 3.8 5.9 3.6 3.5 4.3 2.9 28.8 115.4 26.4 13.1 0.7 31.4 104.2 117.1 100.7 6.0 21.8 41.8 2.3 4.3 20.4 1.8 0.0 0.6 0.5 171.0 0.0 30.2 3.9 21.5 4.3 7.5 8.3 0.0 8.3 34.4 0.4 3.6 138.1 24.0 5.7 9.5 2.5 0.9 0.2 0.0 18.5 23.7 4.1 0.0 1.5 4.5 5.9 2.0 1.8 68.4 0.6 0.2 0.0 1.0 2.0 585.5 170.1 3.4 0.2 45.6 39.5 0.0 15.6 2.2 6.6 1.5 22.1 4.5 4.0 28.2 9.9 0.1 1.5 5.9 28.4 18.2 LCA5L "C21orf13, MGC33295" ENSG00000157578 "Lebercilin LCA5 like" O95447 21 39405728-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 110.5" "Group enriched" "Detected in many" 11 "Early spermatids: 1312.6;Late spermatids: 472.4;Spermatocytes: 465.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 3.7;T-47d: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: AB_2674110" "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.7 0.6 0.4 0.7 0.3 1.7 1.4 1.1 1.8 3.4 0.6 0.4 1.2 7.6 0.4 7.2 0.8 0.5 0.6 0.8 2.4 0.7 1.5 0.3 2.0 2.5 0.9 1.3 2.2 2.0 0.3 1.6 0.8 0.5 10.8 0.9 0.9 2.1 0.9 0.4 0.6 2.0 0.4 0.8 110.5 0.9 0.3 4.3 1.5 0.2 0.5 0.5 1.1 0.9 1.0 0.6 1.7 0.8 0.7 0.1 0.2 0.4 0.5 0.0 0.5 1.0 0.7 0.7 0.9 0.2 0.2 0.1 0.5 0.3 0.3 0.8 0.4 0.8 0.1 0.7 1.1 0.0 0.6 2.3 1.6 1.7 1.1 0.3 1.0 1.7 0.6 0.6 3.7 0.3 0.4 3.2 0.6 1.0 0.2 0.2 0.7 1.7 0.3 1.1 0.5 2.0 0.8 1.4 0.3 3.9 0.1 0.1 0.3 0.2 0.9 0.2 1.8 1.1 0.1 1.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.4 1.1 0.6 0.8 2.0 2.5 1.6 2.0 0.9 1.1 1.1 3.2 0.5 5.5 0.3 0.5 0.9 2.7 1.2 2.0 4.5 5.0 2.6 1.5 16.8 7.3 6.2 1.1 0.1 0.4 19.6 3.5 1312.6 34.9 2.4 1.6 4.2 0.0 3.8 2.2 0.2 2.2 0.5 2.8 0.0 1.8 1.4 1.6 0.5 1.7 2.6 1.4 0.0 0.6 0.7 472.4 6.5 1.3 1.8 1.0 0.6 3.2 0.0 0.5 2.1 1.6 0.5 7.9 0.0 0.6 0.2 12.0 68.0 17.4 19.7 3.6 1.7 465.8 26.7 0.3 0.6 0.3 0.3 3.2 0.9 0.7 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007298-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "fallopian tube: 116.2" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 98.1;Respiratory ciliated cells: 329.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 2.2;Hep G2: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA052489: AB_2681850" "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.5 0.2 0.1 0.1 0.1 0.6 0.6 0.2 4.4 0.2 0.1 0.0 0.7 0.1 0.6 116.2 0.8 0.0 0.1 0.1 0.1 0.1 6.9 0.1 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.2 1.1 0.2 0.1 3.4 0.1 0.2 0.3 0.1 0.0 0.0 0.2 1.4 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 2.2 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.6 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.2 0.1 0.1 0.3 0.1 0.2 0.0 0.2 0.5 0.0 6.4 7.2 0.0 0.0 0.0 0.2 5.0 0.0 0.0 0.5 0.1 0.1 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 98.1 0.8 0.7 20.9 0.0 0.1 0.2 0.0 1.1 0.0 2.1 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 12.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.0 0.0 329.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.3;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 0.9 1.0 0.7 0.3 1.0 0.2 1.6 0.9 0.7 0.5 1.9 0.6 1.0 0.7 3.4 0.3 3.8 0.4 0.9 0.9 1.1 1.4 0.7 0.6 1.0 1.9 1.7 0.9 1.0 1.5 1.5 0.2 1.5 0.9 0.6 1.8 0.6 0.6 0.2 0.4 0.6 0.4 1.6 0.5 0.9 12.8 1.1 0.7 2.3 0.2 0.4 0.5 0.2 1.0 3.3 1.2 0.0 0.7 0.4 0.2 0.1 0.1 0.5 0.6 0.5 0.1 1.7 0.0 0.9 0.4 1.2 1.2 0.0 0.3 1.3 0.5 0.3 1.0 0.1 0.0 0.0 1.0 0.2 1.5 0.8 0.1 0.9 0.3 0.3 0.0 0.7 0.6 1.2 1.2 0.0 0.7 1.0 0.9 0.7 0.0 0.8 0.8 1.0 0.2 1.9 0.7 1.0 0.7 0.0 0.2 2.2 1.8 0.0 0.1 0.3 0.2 0.5 2.9 0.5 0.0 0.5 0.7 1.0 0.6 0.0 0.0 0.2 0.0 0.4 0.8 0.4 0.0 0.3 0.9 0.4 0.2 0.0 0.7 0.0 0.5 0.6 0.1 0.7 1.0 0.9 0.7 0.9 1.1 1.9 1.7 1.5 1.6 1.1 1.0 0.5 0.0 1.1 19.9 6.3 1.3 1.1 1.4 2.8 1.2 2.7 3.9 1.5 1.5 2.8 3.7 2.1 0.3 0.7 1.5 3.9 0.7 96.8 20.7 1.4 0.6 0.0 2.1 6.5 1.6 0.1 1.1 9.7 2.8 1.3 1.4 0.0 1.8 0.2 3.3 11.8 0.9 0.0 1.6 1.3 47.7 1.5 1.8 1.8 3.7 1.1 1.7 0.0 8.0 8.0 1.0 0.6 1.9 2.5 0.7 1.2 5.4 28.0 4.8 0.0 0.6 1.4 65.2 4.3 2.2 0.9 0.1 2.3 1.1 0.9 0.8 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319983 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 2.0;liver: 3.8;placenta: 1.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.5;Inhibitory neurons: 3.7;Late spermatids: 4.4;Oligodendrocytes: 5.9;Proximal tubular cells: 5.6;Respiratory ciliated cells: 3.0" "Cancer enriched" "Detected in some" 4 "lung cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.2;BEWO: 3.3;CACO-2: 1.6;HeLa: 1.8;Karpas-707: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 2.0 3.8 0.2 0.0 0.3 0.1 0.0 0.3 0.0 0.0 1.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 0.0 2.2 0.0 1.1 1.9 0.1 1.2 2.0 0.0 0.1 0.0 0.0 3.5 0.2 0.5 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.3 0.0 3.7 0.7 0.0 0.3 0.0 4.4 0.3 0.1 0.0 1.9 0.0 0.0 0.0 1.5 5.9 0.0 0.3 0.0 0.1 0.2 0.1 5.6 3.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.4 0.1 0.1 0.8 0.2 LILRA5 "CD85, CD85f, ILT11, LILRB7, LIR9" ENSG00000187116 "Leukocyte immunoglobulin like receptor A5" A6NI73 19 54307070-54313166 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.5;lymphoid tissue: 76.3" "Group enriched" "Detected in some" 5 "Kupffer cells: 64.1;Macrophages: 136.1;monocytes: 53.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 128.6;intermediate monocyte: 252.7;neutrophil: 137.2;non-classical monocyte: 311.7" "Group enriched" "Detected in many" 6 "granulocytes: 137.2;monocytes: 311.7" "Cell line enriched" "Detected in single" 31 "RPMI-8226: 4.1" "Secreted to blood" NA NA 670000 "Cluster 51: Monocytes - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "unprognostic (8.52e-2)" "unprognostic (3.61e-1)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "unprognostic (1.57e-2)" "unprognostic (6.56e-2)" "unprognostic (2.90e-1)" "unprognostic (1.86e-1)" "unprognostic (3.11e-1)" "unprognostic (6.61e-3)" "unprognostic (2.01e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (3.61e-2)" "unprognostic (6.51e-3)" "unprognostic (4.68e-2)" "unprognostic (6.21e-2)" 7.9 1.3 0.2 36.9 0.2 43.5 1.9 0.2 0.9 0.7 0.6 1.8 0.0 1.0 0.0 0.9 4.1 1.7 2.5 0.3 0.2 1.8 3.8 22.2 0.5 0.6 0.3 0.6 0.9 0.0 0.9 1.6 0.5 1.4 1.2 0.0 1.2 0.0 0.7 0.3 2.8 6.9 0.3 76.3 2.1 0.3 0.4 0.4 1.0 0.0 0.4 15.7 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 128.6 0.5 0.0 252.7 0.3 0.0 0.0 0.0 39.2 0.1 0.0 0.0 137.2 0.3 311.7 20.3 0.1 65.0 0.2 0.2 0.2 0.9 0.3 0.2 0.6 0.3 0.5 0.3 0.4 0.4 0.1 0.0 8.5 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 3.1 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.1 1.0 0.0 0.0 11.4 0.0 0.4 0.7 6.5 0.0 0.1 0.0 0.0 64.1 14.3 0.0 0.0 136.1 0.0 0.0 53.4 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.4 2.2 0.0 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.1 LILRA6 "CD85b, ILT8, LILRB6" ENSG00000244482 "Leukocyte immunoglobulin like receptor A6" Q6PI73 19 54236592-54242791 "Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 9.0;lymphoid tissue: 16.9" "Group enriched" "Detected in some" 4 "Hofbauer cells: 13.8;Kupffer cells: 31.7;Macrophages: 30.6;monocytes: 19.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 3.4;intermediate monocyte: 3.9;neutrophil: 8.2" "Group enriched" "Detected in many" 26 "granulocytes: 8.2;monocytes: 3.9" "Not detected" "Not detected" HPA026985 Approved "Plasma membrane,Cytosol" NA NA 21000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" Cytosol "HPA026985: " "unprognostic (1.00e-1)" "unprognostic (8.38e-2)" "unprognostic (5.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.95e-2)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (2.51e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-1)" "unprognostic (9.11e-2)" "unprognostic (1.51e-1)" "unprognostic (7.47e-5)" "unprognostic (7.76e-2)" "unprognostic (4.01e-3)" "unprognostic (1.90e-1)" "unprognostic (4.33e-2)" 3.3 1.1 0.0 1.3 0.0 1.6 1.1 0.0 0.1 0.4 0.0 1.0 0.1 0.5 0.0 0.3 2.2 0.2 1.1 0.0 0.0 0.7 1.3 9.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.9 0.0 0.4 0.3 0.8 1.4 0.0 16.9 0.8 0.2 0.1 0.0 0.5 0.0 0.0 1.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.8 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 5.3 0.0 0.0 0.2 0.4 0.0 0.1 3.8 0.0 0.7 0.9 13.8 0.0 0.0 0.0 0.0 31.7 5.2 0.0 0.0 30.6 0.0 1.0 19.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 LILRB3 "CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB" ENSG00000204577 "Leukocyte immunoglobulin like receptor B3" O75022 19 54216278-54223506 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 27.0;lymphoid tissue: 49.9" "Group enriched" "Detected in many" 5 "Hofbauer cells: 63.4;Kupffer cells: 88.6;Macrophages: 88.8;monocytes: 71.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 44.8" "Group enriched" "Detected in many" 4 "granulocytes: 44.8;monocytes: 15.4" "Not detected" "Not detected" HPA026985 Approved "Plasma membrane,Cytosol" NA NA 16000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" Cytosol "HPA026985: " "unprognostic (7.51e-2)" "unprognostic (3.52e-2)" "unprognostic (9.59e-2)" "unprognostic (4.53e-1)" "unprognostic (1.83e-3)" "unprognostic (5.28e-3)" "unprognostic (2.91e-2)" "unprognostic (2.55e-1)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.92e-8)" "unprognostic (2.18e-1)" "unprognostic (2.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.75e-1)" 9.9 3.4 0.4 8.3 0.4 14.6 2.9 0.4 2.1 1.2 0.9 2.7 0.3 1.2 0.3 1.3 5.4 0.1 3.4 0.4 0.4 2.3 4.1 27.0 0.3 1.2 0.8 1.0 1.9 0.0 1.3 1.2 1.3 1.7 0.0 0.2 2.4 0.0 1.1 0.8 2.6 0.1 0.6 49.9 2.3 0.5 1.8 0.6 1.6 0.0 0.2 3.2 1.6 1.4 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 15.4 0.6 0.1 14.3 0.2 0.1 0.3 0.0 7.2 0.1 0.0 0.1 44.8 0.0 5.6 0.5 0.0 11.6 0.4 0.4 0.4 2.1 0.4 0.4 1.2 0.8 1.3 0.6 1.8 1.4 1.5 9.6 13.0 0.3 2.2 2.4 1.2 6.5 0.0 0.7 1.6 2.2 0.4 4.3 8.3 1.8 0.0 1.5 2.1 0.6 0.0 0.3 1.3 0.8 1.9 3.0 0.0 0.8 0.2 0.6 6.7 2.9 0.0 2.2 7.6 0.5 1.8 3.2 63.4 0.0 0.1 1.9 0.0 88.6 8.4 4.1 0.3 88.8 1.8 1.9 71.2 0.9 3.1 0.0 0.1 0.2 1.3 0.7 2.1 1.6 0.4 0.4 5.2 2.9 6.6 4.3 1.3 0.8 1.5 0.1 3.0 1.2 3.8 2.6 2.0 0.4 LKAAEAR1 C20orf201 ENSG00000171695 "LKAAEAR motif containing 1" Q8TD35 20 64083380-64084359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 32.3" "Group enriched" "Detected in some" 14 "Early spermatids: 496.7;Late spermatids: 694.8" "Group enriched" "Detected in some" 4 "endometrial cancer: 0.8;glioma: 1.2;ovarian cancer: 1.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "intermediate monocyte: 8.6;non-classical monocyte: 13.5" "Lineage enriched" "Detected in many" 13 "monocytes: 13.5" "Group enriched" "Detected in some" 4 "REH: 5.6;SCLC-21H: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA056463 Approved Nucleoplasm NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA056463: AB_2683139" "unprognostic (5.47e-3)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-1)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.19e-1)" "unprognostic (2.58e-1)" "unprognostic (7.93e-2)" "unprognostic (3.78e-3)" "unprognostic (6.74e-2)" "unprognostic (3.16e-4)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (3.12e-1)" "unprognostic (2.30e-2)" 0.1 0.1 1.6 0.0 0.9 0.1 0.1 0.3 1.9 0.2 0.0 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.2 1.1 1.6 0.0 0.0 0.6 0.0 1.1 1.6 0.0 0.2 0.0 0.7 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.2 0.0 32.3 1.7 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 1.1 0.4 0.2 0.0 0.9 5.6 0.0 0.1 0.0 0.0 5.5 1.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.1 8.6 0.6 0.1 0.6 0.1 1.0 0.0 0.7 0.2 0.0 0.0 13.5 0.2 0.0 0.9 1.6 0.9 0.3 1.9 1.1 1.6 1.1 1.6 1.0 0.6 1.7 0.5 0.5 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 1.1 0.6 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 496.7 40.3 1.3 0.5 0.0 0.8 1.1 0.0 0.0 0.6 0.0 0.5 0.0 0.1 1.4 0.1 1.6 0.0 0.9 0.0 0.0 1.8 0.0 694.8 3.7 2.2 0.0 0.0 1.4 0.7 0.0 1.0 0.5 0.1 0.0 3.0 0.4 0.2 0.0 0.2 0.0 1.0 13.1 0.3 0.4 24.0 6.6 0.1 0.0 0.1 0.8 0.1 0.0 0.2 LMLN "Gp63, LMNL1, Msp" ENSG00000185621 "Leishmanolysin like peptidase" Q96KR4 3 197960200-198043720 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 39.7;Endometrial ciliated cells: 35.2;Respiratory ciliated cells: 37.5;Spermatocytes: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016481, HPA028844" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 16: U-266 - Nucleosome" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Focal adhesion sites" "HPA016481: AB_1852955, HPA028844: AB_10602347" "unprognostic (2.54e-1)" "unprognostic (3.15e-1)" "unprognostic (7.63e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-1)" "unprognostic (6.36e-2)" "unprognostic (2.98e-1)" "unprognostic (4.82e-3)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" 2.1 2.6 2.7 1.2 3.4 1.2 2.2 3.6 4.7 3.1 4.7 2.1 1.0 2.2 10.7 2.2 4.9 2.6 3.3 2.7 3.7 3.4 2.2 2.5 1.3 4.2 3.3 3.3 3.8 3.8 6.5 2.0 4.5 2.3 2.0 9.7 2.4 3.4 2.4 3.4 1.4 2.0 3.0 1.5 2.0 10.1 4.0 1.1 4.1 2.0 1.2 1.9 2.3 3.2 7.7 2.8 3.3 4.0 6.4 9.0 2.9 3.9 3.6 6.9 5.6 2.8 2.7 2.4 17.7 2.8 14.9 2.8 3.1 3.1 10.0 0.3 2.3 1.4 2.3 2.1 4.0 4.4 2.0 4.3 6.8 8.6 5.5 4.0 3.0 6.0 7.5 4.5 6.7 5.7 2.6 3.8 3.8 5.5 6.7 3.0 0.8 2.6 7.1 2.0 5.4 1.5 5.4 4.8 3.9 3.7 12.5 3.2 6.6 8.4 1.3 10.3 6.7 8.0 16.7 0.7 12.0 7.4 7.8 0.0 0.1 0.1 0.2 0.4 0.3 0.4 0.1 0.3 0.4 0.2 0.4 0.5 0.1 0.3 0.2 0.1 0.0 0.2 2.7 3.4 3.6 4.7 2.7 3.7 4.2 3.3 4.5 3.0 4.0 3.2 4.4 16.0 14.8 24.5 1.7 2.0 1.5 2.6 4.0 8.1 6.4 4.8 11.6 2.8 9.2 9.2 16.7 3.6 1.2 2.2 0.0 3.5 39.7 35.2 11.5 3.2 4.8 0.8 25.3 2.7 2.2 5.5 1.5 11.5 2.5 6.3 4.2 3.1 5.0 8.4 23.1 3.6 0.0 1.9 2.3 21.9 4.7 2.3 3.6 9.4 1.1 5.9 1.0 6.6 13.7 2.1 1.0 5.7 2.1 1.8 0.7 3.5 37.5 17.7 0.0 6.6 3.8 33.2 23.6 3.7 1.7 2.9 2.1 10.6 2.8 1.1 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.7;fallopian tube: 17.0;testis: 14.8" "Group enriched" "Detected in some" 4 "Astrocytes: 15.0;Early spermatids: 49.0;Endometrial ciliated cells: 17.6;Late spermatids: 40.6;Respiratory ciliated cells: 14.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.2;RT4: 7.7;SH-SY5Y: 7.6;U-2197: 26.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome NA NA "Cluster 6: Non-specific - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 18: U-2197 - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Centrosome" "HPA038640: AB_2676127" "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.1 4.0 0.7 5.8 0.3 0.9 6.1 3.9 0.5 3.7 3.6 1.4 0.7 0.6 0.3 17.0 0.8 0.2 5.2 6.0 0.7 0.2 1.3 0.3 12.5 14.7 0.2 0.5 0.0 0.7 0.2 8.3 0.2 3.4 1.2 0.0 0.2 0.2 0.4 0.6 1.1 8.8 0.6 0.6 14.8 5.8 0.2 0.9 0.0 0.2 0.3 0.0 9.8 0.4 0.3 0.0 0.2 0.2 1.6 2.7 3.3 6.2 1.4 0.2 0.0 0.4 0.2 0.1 0.0 3.9 0.1 0.3 0.1 0.3 1.1 0.1 1.1 0.9 2.3 0.3 0.1 0.1 0.5 0.2 1.8 0.5 0.1 0.1 0.0 2.3 0.4 0.0 0.5 0.0 0.4 1.8 0.1 0.6 0.5 0.2 0.2 0.2 7.7 0.2 7.6 0.1 0.4 4.3 0.9 0.3 1.8 0.3 0.2 1.0 26.8 0.3 0.8 1.6 1.8 0.3 1.8 2.9 0.5 0.1 0.1 0.2 0.0 0.1 0.4 0.2 0.2 0.1 0.5 0.2 0.3 0.5 0.1 0.0 0.5 0.1 0.1 4.0 5.8 6.1 3.9 5.2 6.0 12.5 14.7 8.3 8.8 5.8 9.8 0.1 0.0 0.0 15.0 0.1 0.0 2.4 0.0 0.0 0.0 0.2 0.3 0.6 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.9 0.0 49.0 17.6 0.1 0.1 0.0 0.0 1.5 0.0 0.3 0.3 0.0 0.2 0.0 0.7 0.0 0.4 0.1 0.0 1.0 0.0 0.0 0.3 0.0 40.6 0.0 0.3 0.0 5.6 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.1 14.6 0.0 0.0 0.7 0.1 1.1 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.9 LRGUK "CFAP246, FLJ32786" ENSG00000155530 "Leucine rich repeats and guanylate kinase domain containing" Q96M69 7 134127299-134264591 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.2;fallopian tube: 3.7;testis: 4.8" "Cell type enhanced" "Detected in some" "Early spermatids: 27.6;Endometrial ciliated cells: 13.8;Excitatory neurons: 21.8;Inhibitory neurons: 13.9;Ionocytes: 12.2;Respiratory ciliated cells: 21.5;Spermatocytes: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SH-SY5Y: 1.8;SK-MEL-30: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029505, HPA029506" Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 5: NTERA-2 - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "HPA029505: AB_10599606, HPA029506: AB_10601752" "unprognostic (4.08e-3)" "unprognostic (1.87e-1)" "unprognostic (6.94e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-2)" "unprognostic (2.64e-2)" "unprognostic (7.85e-4)" "unprognostic (6.92e-2)" "unprognostic (2.43e-1)" "unprognostic (4.28e-2)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (1.27e-3)" "unprognostic (2.22e-3)" "unprognostic (3.83e-2)" "unprognostic (3.01e-3)" "unprognostic (2.10e-2)" 0.2 0.2 0.8 0.2 0.9 0.5 0.4 0.0 0.6 0.4 5.2 0.2 0.1 0.3 1.5 0.1 3.7 0.2 0.1 1.3 1.0 0.5 0.4 0.5 0.1 3.0 3.0 0.1 0.8 0.1 0.7 0.0 1.7 0.6 0.2 2.1 0.5 0.1 0.0 0.4 0.2 0.1 1.6 0.5 0.2 4.8 1.4 0.2 0.5 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.0 0.1 0.2 1.9 0.0 0.4 0.2 0.0 0.0 0.3 0.1 0.6 1.8 0.5 0.0 1.9 0.2 0.1 0.4 0.0 0.1 0.2 0.1 0.2 0.4 0.6 0.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.6 1.3 1.0 3.0 3.0 1.7 1.6 1.4 0.6 0.2 0.0 0.0 5.5 0.1 0.0 0.1 0.4 0.6 0.0 0.8 0.5 0.4 1.5 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 27.6 13.8 0.5 0.3 0.0 0.0 21.8 0.4 0.0 0.4 0.0 1.2 0.0 0.8 0.0 0.4 0.2 0.0 13.9 0.0 12.2 0.0 0.3 2.1 0.3 0.2 1.8 5.6 0.0 0.9 0.0 5.0 2.5 0.0 0.0 0.4 0.1 0.1 0.0 0.2 21.5 2.1 0.0 0.3 0.6 8.6 0.9 0.3 0.4 0.3 0.1 0.5 0.0 0.2 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508749-61511018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 42.4;fallopian tube: 28.7;pituitary gland: 33.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.8" "Region enhanced" "Detected in many" "basal ganglia: 42.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4" "Region enriched" "Detected in many" 7 "basal ganglia: 222.5" "Group enriched" "Detected in many" 5 "basal ganglia: 30.9;hippocampal formation: 24.2" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli No NA "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Nucleoli "HPA047619: AB_2680106" "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 3.7 0.9 11.1 0.4 42.4 0.0 2.9 0.5 11.2 5.9 3.6 2.2 0.3 4.9 1.9 0.5 28.7 0.3 1.7 13.5 5.2 2.2 0.1 4.9 0.0 4.0 4.0 2.3 1.3 2.2 33.7 0.5 2.1 1.6 0.3 0.1 1.3 0.5 0.7 0.9 1.4 1.6 3.1 0.4 2.9 5.9 7.9 2.7 1.6 0.9 0.0 1.1 2.5 3.4 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 5.4 0.5 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 42.4 0.5 11.2 13.5 5.2 4.0 4.0 2.1 3.1 7.9 3.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.6 0.4 1.1 0.0 3.5 1.8 0.0 0.0 0.0 0.1 0.0 0.0 3.2 49.3 0.5 0.4 4.2 0.0 1.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 6.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 37.2 0.2 19.7 0.7 20.6 0.8 1.1 0.0 0.3 0.1 0.1 0.2 0.1 0.1 LRRC18 "MGC34773, UNQ933, UNQ9338, VKGE9338" ENSG00000165383 "Leucine rich repeat containing 18" Q8N456 10 48909483-48914232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "choroid plexus: 12.1;fallopian tube: 7.6;testis: 14.0" "Group enriched" "Detected in some" 8 "Early spermatids: 222.0;Late spermatids: 64.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039256, HPA076699" Enhanced Approved Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "HPA039256: AB_10671873, HPA076699: " "unprognostic (1.31e-2)" "unprognostic (3.66e-2)" "unprognostic (9.83e-4)" "unprognostic (3.10e-1)" "unprognostic (4.82e-2)" "unprognostic (1.98e-1)" "unprognostic (2.00e-1)" "unprognostic (8.11e-2)" "unprognostic (1.11e-1)" "unprognostic (3.16e-2)" "unprognostic (8.57e-3)" "unprognostic (4.08e-1)" "unprognostic (1.13e-1)" 0.0 0.0 0.3 0.4 0.2 0.4 0.3 0.5 0.3 0.6 12.1 0.4 0.2 0.2 0.0 0.1 7.6 0.3 0.3 0.8 0.3 0.0 0.0 1.5 0.2 1.0 0.9 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.7 0.0 0.1 0.0 0.0 0.8 0.4 0.2 0.6 0.1 0.2 14.0 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.3 0.8 0.3 1.0 0.9 0.8 0.6 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.0 6.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 64.1 1.8 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.2 2.8 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 101.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 204.6;Respiratory ciliated cells: 244.2;Rod photoreceptor cells: 138.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli, Nucleoli rim" "HPA037766: AB_10672609, HPA057533: AB_2683459" "prognostic favorable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 2.5 3.2 11.3 1.1 11.4 2.5 3.6 11.1 11.2 5.2 20.5 3.4 0.9 5.0 12.5 1.8 101.8 3.0 4.7 11.3 12.4 6.2 2.5 8.9 1.8 18.6 22.4 4.8 2.1 6.7 7.4 2.2 16.9 3.6 2.1 25.1 2.8 3.7 6.3 2.4 2.0 3.6 16.6 2.4 3.4 26.3 12.6 3.1 6.2 5.8 2.7 2.9 2.6 13.2 5.2 9.9 1.6 3.6 7.2 5.4 5.8 2.0 7.0 3.3 6.3 2.1 10.4 4.5 2.2 5.4 9.6 1.3 2.9 4.3 7.1 3.6 1.5 3.2 3.7 4.1 5.8 1.8 3.0 3.8 7.8 6.4 5.7 8.6 4.6 11.0 1.9 2.5 3.9 5.9 4.0 1.2 1.0 7.7 2.8 3.7 8.1 5.3 6.6 1.5 2.6 6.3 3.2 4.3 6.6 10.2 2.2 4.1 2.0 3.3 8.6 3.8 2.3 2.3 1.6 3.8 8.1 2.3 4.8 0.6 2.7 6.4 2.2 2.6 3.0 5.7 2.2 1.9 2.6 2.8 2.4 2.4 0.5 4.0 2.6 3.9 0.1 1.3 11.3 11.4 11.1 11.2 11.3 12.4 18.6 22.4 16.9 16.6 12.6 13.2 12.6 0.0 22.4 11.4 12.6 6.5 10.0 15.1 11.4 17.8 15.3 19.3 8.2 20.0 34.4 12.9 50.1 8.2 9.4 5.2 37.2 13.6 43.4 204.6 13.1 9.7 18.0 7.4 5.8 17.3 12.5 12.6 10.7 12.9 5.7 12.1 14.6 7.5 13.5 13.5 4.4 8.6 16.2 11.9 8.9 47.0 8.4 13.7 8.8 6.5 11.0 38.6 11.3 1.5 6.4 15.3 4.7 12.4 10.5 6.4 4.5 46.5 244.2 138.1 13.1 21.1 13.5 63.6 13.1 8.4 5.8 4.5 11.8 7.1 5.6 7.3 LRRC26 bA350O14.10 ENSG00000184709 "Leucine rich repeat containing 26" Q2I0M4 9 137168758-137170051 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "salivary gland: 290.0" "Cell type enriched" "Detected in many" 5 "Intestinal goblet cells: 598.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 47.6" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Immune cell enriched" "Detected in single" 1177 "plasmacytoid DC: 117.6" "Lineage enriched" "Detected in single" 1177 "dendritic cells: 117.6" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 130.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA056312 Approved Supported "Nucleoli fibrillar center,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 25: RPMI-8226 - Immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane" "Nucleoli fibrillar center" "HPA056312: AB_2683098" "unprognostic (1.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.04e-2)" "prognostic favorable (4.82e-6)" "unprognostic (3.39e-1)" "unprognostic (1.67e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "prognostic favorable (3.48e-4)" "unprognostic (3.27e-1)" "unprognostic (2.29e-1)" 0.1 0.0 0.2 0.3 0.4 0.0 7.3 2.6 0.5 0.4 0.0 11.2 1.7 1.1 0.0 2.8 1.1 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.1 53.1 0.5 0.0 290.0 0.5 0.0 5.1 7.2 0.0 0.2 0.1 5.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 5.4 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.9 0.1 0.3 0.7 20.8 0.1 130.9 0.0 0.0 1.0 0.2 0.5 6.0 0.0 0.0 2.7 0.5 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.6 0.0 0.5 0.2 0.4 2.6 0.5 0.1 0.5 0.0 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.3 1.2 1.0 1.7 0.5 0.0 0.0 101.2 64.4 0.4 4.3 1.0 0.0 0.0 0.1 81.8 15.2 1.9 0.1 0.5 13.0 1.6 1.0 9.0 0.0 0.1 0.4 0.0 0.4 9.2 21.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 598.0 4.1 0.0 0.9 1.1 0.0 1.4 56.9 0.0 0.6 0.0 0.0 0.0 0.1 0.2 11.8 0.0 0.6 28.4 28.8 0.1 0.4 0.0 0.0 0.0 0.4 0.2 2.8 3.5 0.3 0.0 0.6 0.0 24.3 3.7 LRRC34 MGC27085 ENSG00000171757 "Leucine rich repeat containing 34" Q8IZ02 3 169793003-169812986 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 137.9;Respiratory ciliated cells: 129.6;Spermatocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 8.1;HL-60: 8.9;JURKAT: 7.1;NTERA-2: 7.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035747 Approved Approved "Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "Cell Junctions, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA035747: AB_10670120" "unprognostic (1.04e-2)" "unprognostic (5.71e-2)" "unprognostic (5.67e-2)" "unprognostic (5.64e-2)" "unprognostic (9.74e-3)" "unprognostic (5.46e-2)" "unprognostic (9.74e-2)" "unprognostic (8.24e-2)" "unprognostic (6.39e-3)" "unprognostic (2.57e-1)" "unprognostic (6.05e-2)" "unprognostic (1.23e-1)" "unprognostic (8.39e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (3.37e-1)" "unprognostic (2.79e-1)" 1.5 0.4 1.6 0.6 2.1 1.4 1.1 1.6 2.7 0.9 2.8 0.5 0.2 0.7 0.3 0.2 5.5 0.3 1.1 1.2 2.1 0.7 0.2 1.0 0.8 2.1 2.5 0.8 0.2 0.3 2.8 0.2 2.2 0.6 0.1 5.6 0.3 0.7 0.4 0.5 0.4 0.2 2.1 0.7 0.4 12.8 1.9 0.6 0.9 0.4 0.3 0.4 0.4 1.8 2.3 0.4 0.5 0.0 0.9 3.0 0.0 0.9 1.9 2.4 2.1 0.1 0.0 1.5 0.1 0.6 3.1 0.0 1.8 0.0 0.8 0.4 5.6 8.1 0.2 0.0 0.6 8.9 1.8 0.9 0.4 0.8 0.0 0.1 1.6 7.1 0.2 0.0 0.9 0.0 0.8 1.1 7.7 0.0 2.6 4.0 0.0 0.4 2.1 0.2 4.0 3.1 0.5 0.3 0.0 0.2 0.0 4.2 0.5 0.4 0.0 0.3 0.1 0.1 0.1 1.9 3.5 0.1 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 1.6 2.1 1.6 2.7 1.2 2.1 2.1 2.5 2.2 2.1 1.9 1.8 3.9 3.2 2.6 8.5 1.5 0.4 0.9 5.3 0.0 6.9 0.4 0.9 3.2 0.0 12.9 5.5 37.5 0.2 1.6 0.1 1.9 0.5 137.9 33.8 5.8 3.0 4.2 4.2 15.1 0.2 0.3 5.0 0.5 1.0 1.3 1.0 10.4 0.3 2.4 11.8 12.5 0.4 6.1 0.8 1.2 36.3 10.5 1.2 0.0 3.7 3.8 7.4 0.0 9.5 3.6 0.3 0.0 10.5 0.7 0.4 0.0 3.6 129.6 18.8 0.0 3.6 3.7 104.4 9.2 0.1 0.3 0.5 0.9 1.9 0.2 0.4 LRRC43 MGC35140 ENSG00000158113 "Leucine rich repeat containing 43" Q8N309 12 122167738-122203471 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 4.9;choroid plexus: 16.1;fallopian tube: 19.0;testis: 6.4" "Cell type enhanced" "Detected in some" "Early spermatids: 23.2;Endometrial ciliated cells: 21.8;Late spermatids: 43.5;Proximal tubular cells: 15.9;Respiratory ciliated cells: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.1;HSkMC: 1.3;HUVEC TERT2: 2.7;SCLC-21H: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA039425 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" Vesicles "HPA039425: AB_2676501" "unprognostic (6.42e-3)" "unprognostic (1.33e-1)" "unprognostic (2.71e-1)" "unprognostic (2.83e-3)" "unprognostic (2.48e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.56e-2)" "unprognostic (6.03e-5)" "unprognostic (1.19e-1)" "unprognostic (4.52e-3)" "unprognostic (2.61e-1)" "unprognostic (6.21e-4)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.39e-1)" "unprognostic (2.49e-1)" 0.5 0.3 2.1 0.0 2.7 0.5 0.3 1.5 2.2 1.1 16.1 0.3 0.5 0.7 1.8 0.1 19.0 0.9 0.7 2.3 2.7 2.1 0.1 1.6 0.0 3.5 4.9 0.3 0.6 1.9 2.2 0.1 2.8 0.7 0.1 0.6 1.1 1.2 0.1 0.3 0.1 0.2 3.7 0.3 0.2 6.4 2.9 0.0 1.6 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.7 0.2 0.2 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.1 0.0 0.2 1.3 0.0 0.4 0.0 0.0 2.7 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.1 0.0 0.3 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.9 0.2 0.2 0.0 0.2 2.1 2.7 1.5 2.2 2.3 2.7 3.5 4.9 2.8 3.7 2.9 1.4 0.0 6.4 0.0 4.6 0.1 0.0 0.1 1.0 0.0 0.4 0.3 0.3 0.5 0.0 2.7 1.8 4.2 0.1 1.7 0.2 1.9 0.1 23.2 21.8 0.4 0.1 0.0 0.8 3.5 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 2.8 0.0 2.0 0.0 0.3 43.5 0.6 0.3 0.0 1.0 0.0 0.9 2.1 2.0 0.7 0.0 0.0 0.4 0.1 0.1 0.0 15.9 35.2 0.1 0.0 0.1 0.5 8.2 1.2 0.0 0.0 0.1 0.5 0.0 0.1 0.1 LRRC46 MGC16309 ENSG00000141294 "Leucine rich repeat containing 46" Q96FV0 17 47831634-47837719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "fallopian tube: 78.4;testis: 54.3" "Group enriched" "Detected in some" 6 "Early spermatids: 143.1;Endometrial ciliated cells: 166.7;Late spermatids: 61.5;Respiratory ciliated cells: 225.8;Spermatocytes: 125.7" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 11.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "T-47d: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021882, HPA074893" Enhanced Approved Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA021882: AB_1853320, HPA074893: AB_2732271" "unprognostic (1.06e-1)" "unprognostic (6.01e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.40e-1)" "unprognostic (2.81e-2)" "unprognostic (4.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.21e-3)" "unprognostic (3.63e-2)" "unprognostic (2.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-1)" 0.2 0.3 1.4 0.1 1.0 0.5 0.3 1.3 0.8 2.6 4.2 0.1 0.1 1.1 0.9 0.2 78.4 0.2 0.3 1.0 1.8 0.7 0.5 4.8 0.3 2.4 6.7 0.3 0.5 0.2 1.7 0.1 3.2 0.5 0.0 2.3 0.3 0.3 0.1 0.1 0.2 0.0 3.1 0.5 0.2 54.3 1.3 0.4 0.9 0.0 0.1 0.2 0.2 2.1 0.7 2.8 0.3 1.4 0.2 0.4 0.8 0.1 0.8 0.7 1.3 1.1 0.7 0.2 1.7 0.3 0.8 0.7 0.3 0.6 1.1 1.1 1.2 0.6 0.9 0.5 0.1 0.0 0.7 0.0 0.5 1.7 0.5 0.2 0.1 0.4 0.6 0.4 1.1 1.2 1.1 0.0 0.1 0.2 0.4 0.9 0.0 0.6 1.4 0.5 1.2 0.9 0.3 0.0 0.5 0.1 3.6 0.1 0.2 1.6 0.5 0.2 0.2 0.6 0.5 0.5 1.1 0.2 0.1 1.3 0.4 0.5 0.0 0.5 0.0 0.1 0.0 0.3 0.7 0.1 0.2 0.0 0.5 0.8 0.4 0.3 0.0 0.1 1.4 1.0 1.3 0.8 1.0 1.8 2.4 6.7 3.2 3.1 1.3 2.1 0.3 0.0 2.3 0.0 0.5 0.0 0.3 9.7 0.0 0.6 0.7 0.9 0.5 1.5 21.9 5.5 2.1 0.1 0.4 0.2 0.0 0.9 143.1 166.7 1.9 0.4 0.0 0.4 0.2 0.0 0.5 1.2 0.0 3.3 0.0 0.3 0.0 0.1 0.5 0.0 0.3 0.6 12.2 0.0 0.3 61.5 2.8 1.0 0.0 1.0 0.8 1.0 0.0 0.0 0.4 0.6 1.1 1.9 0.2 0.3 0.1 1.4 225.8 7.0 0.0 0.4 3.7 125.7 4.2 0.0 0.0 0.1 0.7 0.3 0.0 0.2 LRRC56 "DKFZp761L1518, FLJ00101" ENSG00000161328 "Leucine rich repeat containing 56" Q8IYG6 11 537527-554912 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.3;testis: 22.3" "Group enriched" "Detected in many" 6 "Early spermatids: 68.0;Late spermatids: 141.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.8;Daudi: 1.3;Karpas-707: 2.4;SK-BR-3: 1.6;T-47d: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038728 Approved NA NA "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "HPA038728: AB_10671864" "unprognostic (2.77e-2)" "unprognostic (9.54e-3)" "unprognostic (1.28e-2)" "prognostic favorable (7.39e-4)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (2.29e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.32e-4)" "unprognostic (1.17e-1)" "unprognostic (7.89e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-3)" 0.8 0.8 0.5 0.1 1.9 0.2 1.6 0.3 0.5 2.4 0.6 1.7 0.1 0.9 1.3 2.7 6.4 0.0 0.5 0.8 0.3 3.2 1.6 2.9 0.0 0.5 0.3 1.8 2.4 0.0 12.3 0.0 0.1 3.7 0.0 0.1 2.0 0.3 1.2 2.5 2.2 0.0 0.4 2.2 2.1 22.3 0.6 0.1 2.7 0.0 0.2 1.2 2.0 0.3 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.4 1.1 0.4 0.8 0.0 0.2 0.0 0.0 0.5 0.0 2.4 0.0 0.0 0.1 0.7 0.0 0.7 0.7 0.0 0.0 0.5 0.2 0.0 0.3 0.2 0.0 1.6 0.0 0.0 2.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 1.9 0.3 0.5 0.8 0.3 0.5 0.3 0.1 0.4 0.6 0.3 0.5 0.0 3.4 3.3 3.0 1.7 1.5 1.5 0.0 1.1 2.1 0.9 0.6 1.5 2.4 3.7 16.7 0.3 0.6 4.9 0.0 1.1 68.0 11.6 0.6 0.5 12.5 0.4 5.2 0.4 0.2 1.1 1.5 1.3 0.0 0.5 1.1 0.3 0.3 6.7 3.8 2.1 6.1 0.6 0.3 141.2 1.2 0.3 1.8 1.0 0.0 2.7 1.0 1.5 2.8 0.5 1.4 1.2 0.1 1.2 0.2 0.8 14.4 7.0 0.0 0.2 0.6 6.6 2.2 0.6 0.9 0.5 1.4 0.7 0.6 0.8 LRRC6 "CILD19, LRTP, tilB, TSLRP" ENSG00000129295 "Leucine rich repeat containing 6" Q86X45 8 132570416-132675592 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 23.2;testis: 26.2" "Cell type enhanced" "Detected in many" "Early spermatids: 228.5;Endometrial ciliated cells: 101.5;Excitatory neurons: 85.8;Inhibitory neurons: 67.1;Late spermatids: 62.1;Respiratory ciliated cells: 152.7;Spermatocytes: 102.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.5;RPTEC TERT1: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028058 Approved NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA028058: AB_1853337" "unprognostic (1.53e-1)" "unprognostic (2.77e-1)" "unprognostic (6.91e-3)" "unprognostic (3.56e-2)" "unprognostic (2.50e-2)" "unprognostic (8.04e-3)" "unprognostic (4.06e-2)" "unprognostic (1.20e-1)" "unprognostic (7.39e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-1)" "unprognostic (9.51e-2)" "unprognostic (3.38e-2)" "unprognostic (8.42e-3)" "unprognostic (3.95e-2)" "prognostic unfavorable (5.98e-4)" "unprognostic (4.17e-2)" 3.1 4.3 9.4 1.9 12.2 3.5 2.7 5.6 14.1 4.9 23.2 2.4 0.9 3.1 5.6 1.2 19.5 3.6 2.3 9.7 8.3 11.5 1.5 4.1 0.9 12.8 12.8 3.5 2.8 5.6 8.3 1.7 9.1 2.3 1.5 13.8 2.0 2.2 0.4 1.3 2.6 1.8 10.6 4.0 1.3 26.2 9.1 0.8 7.7 0.6 0.7 2.1 2.2 10.4 0.4 2.2 3.5 0.0 2.9 4.8 7.5 0.3 0.5 1.7 1.5 0.4 8.5 0.0 2.5 3.1 2.4 0.0 0.6 1.1 1.7 0.3 0.0 0.0 0.6 0.1 1.2 0.0 3.8 4.2 2.1 3.9 0.1 4.0 0.8 3.6 0.3 0.0 2.2 2.8 0.0 0.1 5.6 2.6 2.1 0.0 0.1 1.2 15.7 0.0 1.8 2.6 0.3 0.0 0.4 5.4 0.9 0.5 0.0 2.0 7.2 6.3 0.7 0.0 1.0 0.2 5.3 0.4 0.2 0.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.3 0.0 0.3 9.4 12.2 5.6 14.1 9.7 8.3 12.8 12.8 9.1 10.6 9.1 10.4 2.2 6.4 0.5 24.5 0.5 1.3 3.7 7.7 1.8 2.5 3.3 3.7 2.8 1.5 18.0 9.2 8.4 0.0 0.2 1.7 21.5 6.4 228.5 101.5 7.3 3.1 1.2 0.8 85.8 1.8 0.2 4.4 0.0 7.3 0.0 2.9 4.2 0.5 2.1 1.7 67.1 0.7 8.2 0.8 1.4 62.1 3.7 2.8 0.0 11.2 0.6 7.2 1.0 6.6 5.3 0.7 1.4 4.5 0.0 1.2 2.6 34.7 152.7 13.7 0.0 1.3 4.5 102.6 10.5 1.2 1.1 0.0 0.5 6.0 1.7 1.9 LRRC63 RP11-139H14.4 ENSG00000173988 "Leucine rich repeat containing 63" 13 46211940-46277366 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;testis: 3.4" "Cell type enriched" "Detected in some" 7 "Oligodendrocytes: 255.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 1.7;JURKAT: 3.0;Karpas-707: 1.6;U-87 MG: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039318, HPA039763" Uncertain Approved "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA039318: AB_10796224, HPA039763: AB_10795408" "unprognostic (3.40e-2)" "unprognostic (2.81e-1)" "unprognostic (5.33e-1)" "unprognostic (2.12e-3)" "unprognostic (1.96e-1)" "unprognostic (3.99e-1)" "unprognostic (1.06e-2)" "unprognostic (7.28e-2)" "unprognostic (3.05e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-2)" "unprognostic (7.61e-2)" "unprognostic (1.18e-6)" "unprognostic (1.27e-1)" "unprognostic (2.98e-1)" "unprognostic (4.57e-2)" "unprognostic (7.31e-2)" 0.1 0.3 1.8 0.1 5.0 0.3 0.1 4.9 2.9 0.2 0.7 0.1 0.0 0.0 2.4 0.0 1.1 0.1 0.1 1.7 2.9 0.1 0.1 0.4 0.2 6.6 4.0 0.0 0.0 0.1 0.0 0.1 6.2 0.5 0.0 2.4 0.3 0.1 0.0 0.0 0.0 0.1 4.8 0.1 0.1 3.4 4.1 1.3 0.0 0.1 0.1 0.0 0.0 10.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.4 0.7 0.6 0.0 2.1 0.0 0.2 0.0 0.1 1.7 0.5 0.7 0.0 0.0 0.1 0.4 1.1 0.4 0.0 0.2 0.0 0.0 0.0 3.0 0.0 1.6 0.0 0.0 1.0 0.3 0.1 0.0 0.2 0.2 0.0 0.2 0.3 0.0 0.5 0.6 0.0 0.0 0.7 0.8 0.0 0.5 0.3 0.2 0.1 0.0 0.3 0.6 1.3 0.1 2.0 1.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 0.1 0.1 1.8 5.0 4.9 2.9 1.7 2.9 6.6 4.0 6.2 4.8 4.1 10.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 34.1 3.1 0.1 0.1 0.0 1.3 0.9 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.0 0.0 0.5 0.0 5.2 0.0 0.0 0.8 0.3 8.4 0.0 0.2 0.0 1.9 0.0 0.1 0.0 4.0 255.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 2.8 0.0 0.0 0.2 3.8 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 LRRC71 "C1orf92, FLJ32884" ENSG00000160838 "Leucine rich repeat containing 71" Q8N4P6 1 156920632-156933094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.8;fallopian tube: 12.4;testis: 25.4" "Group enriched" "Detected in some" 4 "Early spermatids: 236.9;Late spermatids: 605.3" "Cancer enriched" "Detected in single" 7 "endometrial cancer: 3.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.5;PC-3: 1.6;TIME: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (8.91e-2)" "unprognostic (4.21e-2)" "unprognostic (6.13e-2)" "unprognostic (1.95e-3)" "unprognostic (5.43e-2)" "unprognostic (3.98e-2)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (8.02e-2)" "unprognostic (5.07e-3)" "unprognostic (5.18e-1)" "unprognostic (1.68e-7)" "unprognostic (2.29e-1)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" 0.2 0.5 0.9 0.0 0.5 0.0 0.1 0.3 0.1 1.0 8.8 0.0 0.0 0.2 0.0 0.0 12.4 0.0 0.1 1.1 1.3 0.1 0.0 2.3 0.0 3.9 4.8 0.1 0.0 0.0 0.1 0.1 2.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 25.4 1.1 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.3 0.1 1.1 1.3 3.9 4.8 2.4 3.9 1.1 1.0 0.2 0.0 1.8 0.7 0.0 0.0 0.0 3.1 0.0 0.5 0.0 0.0 0.7 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 236.9 37.8 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.0 605.3 4.4 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 3.4 0.0 0.1 0.0 0.0 89.6 0.6 0.0 0.0 1.1 54.2 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 LRRC73 "C6orf154, dJ337H4.2" ENSG00000204052 "Leucine rich repeat containing 73" Q5JTD7 6 43506969-43510686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 44.2" "Group enriched" "Detected in many" 4 "Early spermatids: 411.0;Spermatocytes: 121.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.1;MCF7: 3.2;OE19: 4.5;T-47d: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046698 Enhanced Approved Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 21: OE19 - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol "HPA046698: AB_10959526" "unprognostic (3.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (4.42e-3)" "unprognostic (1.04e-2)" "unprognostic (3.52e-1)" "unprognostic (6.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.25e-1)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-1)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-3)" "unprognostic (1.89e-2)" 0.2 6.4 4.6 0.0 4.8 0.0 0.3 0.0 8.9 0.9 0.6 0.4 0.6 0.6 0.3 0.2 5.1 0.5 1.5 5.6 2.4 2.6 0.5 0.9 0.0 1.3 1.4 0.9 1.2 2.9 4.7 0.2 1.5 1.0 0.1 1.3 0.6 0.6 0.0 0.3 0.2 0.3 0.2 0.5 1.0 44.2 3.5 0.0 1.1 0.0 0.0 0.4 0.3 3.7 0.3 0.7 0.4 3.1 0.5 1.5 0.1 0.1 0.9 0.2 0.1 0.0 0.1 0.1 0.0 0.5 0.4 1.2 0.3 0.4 0.0 0.0 0.5 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.6 1.0 0.1 1.5 0.1 0.1 0.2 0.3 0.6 3.2 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.8 0.0 1.1 1.3 0.3 0.2 0.1 0.0 3.2 0.0 0.1 0.2 0.3 1.1 0.1 0.3 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.8 0.0 8.9 5.6 2.4 1.3 1.4 1.5 0.2 3.5 3.7 0.3 0.0 0.0 1.0 0.0 0.4 3.1 0.7 0.0 5.6 0.8 1.3 1.0 1.5 1.6 3.7 0.0 0.1 0.0 1.0 7.9 0.6 411.0 27.1 4.0 0.6 5.4 0.0 3.3 0.9 0.1 0.8 1.5 1.3 0.0 0.6 0.0 0.8 0.1 28.6 3.3 2.2 0.0 0.0 0.0 58.3 4.4 0.4 1.8 0.0 0.0 8.7 0.0 0.0 0.3 0.2 0.1 4.1 0.0 2.8 2.2 9.4 12.6 8.4 6.6 0.3 0.9 121.6 12.4 0.0 0.0 0.3 0.1 7.1 0.8 0.6 LRRC74B ENSG00000187905 "Leucine rich repeat containing 74B" Q6ZQY2 22 21045960-21064168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.7;choroid plexus: 4.0;fallopian tube: 3.8" "Cell type enhanced" "Detected in some" "Club cells: 12.4;Endometrial ciliated cells: 25.8;Respiratory ciliated cells: 72.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049947 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "HPA049947: AB_2680966" "unprognostic (3.43e-2)" "unprognostic (1.76e-1)" "unprognostic (3.28e-4)" "unprognostic (1.06e-1)" "unprognostic (6.44e-3)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-2)" "unprognostic (1.18e-1)" "unprognostic (7.57e-9)" "unprognostic (4.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-2)" "unprognostic (4.92e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.6 4.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.9 0.0 0.0 1.0 0.0 1.2 1.7 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.9 1.2 1.7 0.5 1.4 0.1 0.3 0.1 0.0 1.8 2.9 0.1 0.0 0.7 0.0 0.0 1.1 0.3 0.5 0.6 0.0 12.4 0.0 4.2 0.2 0.5 0.0 0.0 0.0 3.7 25.8 0.5 0.5 0.0 0.0 2.0 0.0 0.1 0.7 0.0 0.9 0.0 0.1 0.4 0.4 0.1 1.7 0.6 0.0 0.0 0.0 0.0 1.0 0.3 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 72.1 1.5 0.0 2.5 0.4 4.6 3.1 0.0 0.0 0.3 0.4 0.5 0.1 0.1 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;choroid plexus: 12.4;testis: 8.1" "Cell type enhanced" "Detected in some" "Early spermatids: 112.6;Excitatory neurons: 28.0;Inhibitory neurons: 18.0;Late spermatids: 75.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.3 0.1 0.9 0.0 1.6 0.1 0.0 1.0 0.6 0.0 12.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 5.2 5.4 0.0 0.0 0.7 0.5 0.0 3.7 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 4.3 0.0 0.0 8.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 1.0 0.6 1.0 1.7 5.2 5.4 3.7 4.3 1.9 5.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.6 1.5 0.1 0.1 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 18.0 0.0 0.0 0.0 0.0 75.8 0.9 0.1 0.0 1.9 0.0 0.8 0.0 5.5 2.0 0.0 0.0 0.7 0.0 0.7 0.4 0.0 2.9 0.2 0.0 0.0 0.0 10.3 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 LRRIQ1 "FLJ12303, KIAA1801" ENSG00000133640 "Leucine rich repeats and IQ motif containing 1" Q96JM4 12 85036314-85264457 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.1;choroid plexus: 18.1;fallopian tube: 13.7;retina: 8.8;testis: 15.5" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 185.6;Early spermatids: 423.8;Endometrial ciliated cells: 287.5;Late spermatids: 248.1;Respiratory ciliated cells: 381.5;Rod photoreceptor cells: 257.6;Spermatocytes: 190.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.1;SH-SY5Y: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046162 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA046162: AB_10963055" "unprognostic (3.55e-2)" "unprognostic (7.81e-2)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (1.01e-2)" "unprognostic (9.69e-2)" "unprognostic (4.81e-2)" "unprognostic (4.05e-3)" "unprognostic (1.52e-1)" "unprognostic (1.22e-1)" "unprognostic (1.97e-2)" "unprognostic (6.98e-2)" "unprognostic (1.25e-3)" "unprognostic (3.35e-2)" "unprognostic (6.10e-3)" "unprognostic (1.64e-1)" 0.1 0.7 2.8 0.1 3.2 0.0 1.0 1.9 2.5 1.6 18.1 0.1 0.0 1.4 2.4 0.0 13.7 0.4 0.2 2.9 3.8 2.0 0.0 2.6 0.0 11.1 8.5 0.4 0.3 3.0 1.4 0.0 6.5 1.4 0.0 8.8 0.4 0.7 0.0 0.0 0.0 0.6 6.7 0.1 0.2 15.5 3.7 0.1 2.4 0.0 0.0 0.1 0.1 4.3 0.0 0.3 2.0 0.0 0.5 1.3 0.2 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.6 0.8 0.2 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.0 0.5 1.8 0.8 0.9 1.5 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.4 0.0 3.1 0.0 1.6 2.5 0.1 0.0 0.2 0.4 0.9 0.1 0.1 1.8 0.5 0.7 0.1 0.0 0.5 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.2 1.9 2.5 2.9 3.8 11.1 8.5 6.5 6.7 3.7 4.3 0.2 3.2 4.8 22.2 0.0 0.4 1.6 12.0 0.0 11.1 2.9 3.2 1.3 4.3 49.2 16.5 185.6 0.1 0.0 0.2 9.8 11.3 423.8 287.5 2.1 1.6 11.5 0.0 24.5 1.3 0.0 1.3 0.0 7.1 1.3 3.9 0.0 0.0 0.1 0.0 4.8 0.3 14.2 0.0 0.3 248.1 4.4 1.2 3.6 2.8 0.0 16.7 0.0 1.5 1.8 1.6 0.1 4.1 0.1 3.1 0.0 6.1 381.5 257.6 13.1 2.4 3.3 190.8 46.3 0.0 0.0 0.1 0.3 0.7 0.2 0.3 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 20.4" "Group enriched" "Detected in many" 5 "Early spermatids: 258.5;Late spermatids: 103.6;Spermatocytes: 204.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 7.9;JURKAT: 4.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 43: Testis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.6 0.7 0.5 0.7 0.5 0.1 0.7 0.6 0.7 0.2 1.2 0.3 0.2 0.2 0.3 0.1 2.1 0.4 0.3 0.4 0.6 2.0 0.9 0.3 0.7 0.7 0.8 0.3 0.2 1.2 0.5 0.2 0.7 0.4 0.2 0.5 0.7 0.4 0.1 0.1 0.2 0.0 0.6 0.4 0.3 20.4 0.7 1.0 1.5 0.5 0.6 0.2 0.1 0.7 0.2 1.0 0.1 0.4 1.0 0.4 0.6 0.6 0.4 0.8 0.9 0.1 1.4 1.4 1.2 0.1 7.9 0.1 2.1 2.0 1.0 3.5 0.0 1.3 0.3 0.7 0.1 2.3 0.7 0.7 1.0 1.4 0.5 0.3 0.4 4.8 1.1 1.9 1.4 0.0 0.9 0.3 1.1 2.5 0.6 1.1 0.8 1.4 1.2 0.1 1.0 0.7 0.1 0.1 3.1 0.2 0.9 1.3 0.1 0.1 0.7 0.5 1.2 2.0 0.7 1.1 1.5 0.2 1.1 0.0 0.0 0.8 0.9 0.5 1.1 1.6 1.0 1.1 0.1 0.7 0.9 1.3 0.0 0.4 0.1 0.4 1.6 0.3 0.5 0.5 0.6 0.7 0.4 0.6 0.7 0.8 0.7 0.6 0.7 0.7 1.0 0.0 1.5 2.0 2.8 1.1 1.2 4.0 0.0 1.0 2.0 2.8 1.2 2.8 2.6 0.0 4.2 1.7 0.5 0.3 13.7 1.5 258.5 21.6 0.8 0.8 3.0 0.4 4.1 1.7 1.5 0.3 0.0 1.5 0.0 3.2 0.7 1.8 1.3 0.0 3.9 0.6 0.0 0.6 0.2 103.6 1.8 0.5 0.0 1.9 0.8 1.2 2.1 2.0 4.0 0.9 0.1 1.5 0.6 0.9 0.1 6.3 36.0 0.7 0.0 0.2 1.5 204.8 31.3 0.0 0.1 0.3 1.5 3.6 0.7 1.2 LRTOMT "CFAP111, COMT2, DFNB63, LRRC51, LRTOMT1, LRTOMT2" ENSG00000184154 "Leucine rich transmembrane and O-methyltransferase domain containing" Q96E66 11 72080337-72096895 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 67.1;testis: 49.3" "Group enriched" "Detected in many" 12 "Early spermatids: 574.9;Late spermatids: 2222.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039949 Approved Uncertain Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Microtubules "HPA039949: AB_10960708" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (1.85e-2)" "prognostic favorable (7.70e-4)" "unprognostic (8.09e-2)" "unprognostic (9.07e-2)" "unprognostic (1.42e-1)" "unprognostic (1.90e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.36e-4)" "unprognostic (6.12e-2)" "unprognostic (8.43e-2)" "unprognostic (2.64e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" 5.0 4.5 21.1 2.5 21.8 2.1 8.7 19.5 24.2 8.7 25.1 5.4 3.7 7.2 17.1 3.8 67.1 3.4 3.7 19.1 19.2 11.7 7.9 7.7 3.2 23.0 25.7 8.1 8.9 10.3 8.9 5.4 21.4 9.3 7.7 19.7 4.4 5.4 7.5 5.8 3.4 5.7 23.4 4.0 5.5 49.3 21.0 4.5 11.0 4.6 3.6 4.1 3.8 22.0 3.9 13.7 8.9 6.9 7.3 6.7 2.1 4.4 3.6 4.0 3.5 6.6 20.4 5.1 6.6 7.8 9.6 7.3 6.3 10.8 4.5 9.4 6.2 3.5 6.3 4.8 1.3 3.0 3.9 2.9 5.4 6.0 4.6 6.4 1.5 10.2 4.0 7.8 6.0 13.6 9.0 6.0 4.4 22.8 3.6 10.8 8.6 7.7 15.9 4.7 8.2 6.2 8.7 19.4 10.4 6.1 39.6 3.3 6.5 4.0 5.7 11.3 3.1 8.0 9.4 5.8 4.0 2.5 4.5 1.8 1.7 3.5 2.0 1.9 1.9 3.2 2.1 1.6 1.0 3.5 1.8 1.8 6.1 6.6 1.3 2.8 4.6 1.4 21.1 21.8 19.5 24.2 19.1 19.2 23.0 25.7 21.4 23.4 21.0 22.0 4.6 0.0 1.5 3.3 2.5 2.3 7.5 10.0 1.8 3.5 8.4 7.5 2.2 5.7 10.7 3.7 12.5 12.7 1.4 4.4 11.7 7.5 574.9 84.3 3.0 6.5 1.2 3.6 2.0 2.5 7.7 5.3 4.1 7.2 0.0 2.2 3.6 6.0 3.1 6.7 1.9 10.8 10.2 1.6 2.8 2222.2 14.9 3.3 1.8 1.9 1.4 21.3 4.1 2.0 3.6 2.0 2.5 10.1 5.1 6.8 4.0 19.9 113.1 16.6 6.6 6.1 7.9 90.3 28.1 2.2 2.4 13.1 1.7 2.9 3.4 6.5 MAD2L1 "HSMAD2, MAD2" ENSG00000164109 "Mitotic arrest deficient 2 like 1" Q13257 4 120055623-120066858 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.9;lymphoid tissue: 5.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 81.8;Extravillous trophoblasts: 119.2;Spermatocytes: 127.8;Spermatogonia: 76.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003348 Uncertain Approved Nucleoplasm NA Yes "Cluster 20: T-cells - T-cell receptor" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA003348: AB_10603014" "unprognostic (4.08e-3)" "unprognostic (7.31e-2)" "unprognostic (5.17e-3)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (5.15e-5)" "prognostic unfavorable (2.17e-4)" "unprognostic (6.74e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "unprognostic (3.87e-3)" "prognostic unfavorable (3.07e-11)" "unprognostic (3.06e-2)" "unprognostic (4.05e-1)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" 0.3 0.4 0.5 2.1 0.6 5.9 1.2 0.8 0.7 0.5 0.2 2.2 1.8 0.7 0.3 1.6 1.4 0.4 0.5 0.5 0.5 0.4 0.5 0.4 4.0 0.4 0.4 0.5 0.2 0.4 0.1 1.4 0.5 0.6 2.6 1.0 0.3 0.5 0.2 1.0 1.9 0.8 0.4 0.8 0.9 2.3 0.4 5.7 0.4 0.2 3.6 0.7 0.5 0.6 27.2 11.6 26.9 17.5 2.8 3.4 11.5 21.0 11.8 21.5 16.5 15.7 16.3 39.6 6.8 7.6 9.5 7.1 27.1 16.1 30.0 18.8 18.8 22.0 10.5 14.9 0.8 36.3 12.0 1.9 2.3 14.6 9.1 5.4 12.6 16.4 26.7 22.0 11.4 12.0 35.0 15.6 18.3 14.1 13.0 17.8 35.9 16.2 8.7 10.3 28.4 20.1 10.5 12.8 6.5 12.9 8.4 13.0 7.8 14.2 16.1 14.6 27.0 20.1 23.2 25.7 13.3 18.4 19.1 0.9 0.1 0.1 0.4 0.1 0.6 0.5 1.2 1.0 0.1 0.4 1.1 1.1 0.3 0.9 0.2 0.7 1.3 0.5 0.5 0.6 0.8 0.7 0.5 0.5 0.4 0.4 0.5 0.4 0.4 0.6 2.4 0.0 1.3 1.0 11.5 17.3 7.3 23.5 4.0 9.7 7.2 8.3 3.4 1.5 6.0 7.3 2.1 52.0 7.6 7.5 0.0 3.4 2.4 31.3 6.0 5.4 1.8 81.8 1.3 1.5 119.2 13.7 8.6 7.8 15.2 34.6 3.9 2.9 27.9 20.2 1.2 13.7 36.7 7.3 13.4 4.8 4.7 6.1 8.8 0.0 3.1 12.3 5.2 0.5 1.0 1.6 3.7 1.5 33.1 5.0 3.7 7.2 12.9 3.8 13.1 7.3 14.9 127.8 76.2 26.0 8.9 10.8 20.1 11.9 29.2 8.7 MAK "dJ417M14.2, RP62" ENSG00000111837 "Male germ cell associated kinase" P20794 6 10762723-10838553 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "retina: 118.9" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 369.1;Early spermatids: 119.7;Rod photoreceptor cells: 330.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 9 "neutrophil: 6.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.3" "Cell line enhanced" "Detected in single" "HDLM-2: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 79: Retina - Phototransduction" "Cluster 44: HDLM-2 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (1.23e-3)" "unprognostic (8.77e-3)" "unprognostic (2.44e-1)" "unprognostic (3.81e-2)" "unprognostic (6.62e-2)" "unprognostic (1.35e-3)" "unprognostic (1.97e-2)" "unprognostic (2.53e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (6.73e-2)" "unprognostic (6.59e-5)" "unprognostic (1.55e-1)" "unprognostic (8.40e-2)" "unprognostic (7.71e-3)" "unprognostic (4.59e-2)" 0.3 0.1 0.2 0.6 0.0 0.6 0.4 1.5 0.4 0.3 5.4 0.0 0.1 0.4 0.0 0.2 5.4 0.4 0.1 0.1 0.0 0.2 0.0 0.7 0.1 0.7 0.9 0.1 0.2 4.6 0.8 0.1 0.1 0.2 0.0 118.9 0.2 0.0 0.1 0.3 0.1 0.0 0.2 0.7 0.3 4.7 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.4 0.7 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.4 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.1 1.3 0.4 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.4 0.6 0.3 0.3 0.3 0.3 0.1 0.3 0.2 0.3 0.4 0.3 0.5 6.3 0.2 0.6 0.3 0.1 0.1 0.2 0.0 1.5 0.4 0.1 0.0 0.7 0.9 0.1 0.2 0.2 0.4 2.1 0.0 6.4 16.3 1.5 0.4 2.3 0.8 2.8 14.6 4.0 3.9 0.9 0.0 5.3 3.7 369.1 0.5 0.5 0.1 0.0 0.4 119.7 43.3 1.7 1.8 0.0 1.3 45.6 0.2 1.0 2.2 1.1 3.8 2.5 0.3 1.1 0.1 0.2 5.0 39.4 0.0 2.0 0.6 0.7 47.1 0.6 1.3 1.8 12.2 1.3 23.6 0.0 30.7 21.5 0.1 0.0 0.4 1.0 1.1 0.0 0.1 48.9 330.1 0.0 5.4 1.5 15.2 5.5 0.7 0.4 0.8 0.8 0.3 0.0 0.8 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964485-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 5.0;choroid plexus: 9.3;fallopian tube: 18.3;testis: 5.4" "Group enriched" "Detected in some" 8 "Early spermatids: 59.7;Endometrial ciliated cells: 73.7;Late spermatids: 148.4;Respiratory ciliated cells: 121.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011388 Uncertain Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.0 0.1 1.1 0.0 1.2 0.0 0.0 0.8 0.8 0.5 9.3 0.0 0.0 0.6 0.0 0.0 18.3 0.0 0.1 1.1 1.9 0.0 0.0 1.5 0.1 5.0 3.6 0.0 0.0 0.0 0.3 0.0 3.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.0 3.8 0.0 0.0 5.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.8 0.8 1.1 1.9 5.0 3.6 3.0 3.8 1.9 3.1 0.1 0.0 1.1 2.3 0.1 0.0 0.1 2.6 0.0 0.3 0.0 0.0 0.4 0.0 11.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 59.7 73.7 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 2.0 0.0 0.0 148.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 121.0 0.2 0.0 0.0 0.8 7.5 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669038 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 76.8;retina: 96.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 81.2;Cone photoreceptor cells: 158.4;Excitatory neurons: 75.8;Horizontal cells: 50.5;Inhibitory neurons: 43.3;Late spermatids: 41.9" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 37.8;CACO-2: 38.1;HDLM-2: 21.5;SCLC-21H: 62.4;SH-SY5Y: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326" "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favorable (3.41e-4)" "prognostic favorable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 4.8 19.0 68.3 2.0 68.0 0.0 3.5 50.7 70.6 10.6 64.4 23.0 1.7 18.1 21.0 4.2 40.7 6.4 8.6 67.7 71.5 17.0 1.2 7.8 0.7 70.2 64.6 8.0 3.6 22.0 76.8 1.5 70.8 17.8 3.5 96.1 3.6 21.1 1.0 8.1 4.8 13.1 52.9 2.4 10.7 18.6 68.5 0.8 7.9 1.3 0.5 7.1 8.4 59.7 0.2 0.7 37.8 0.1 0.1 0.0 0.0 3.8 0.2 0.3 0.0 38.1 0.1 0.6 1.4 6.3 1.3 0.0 3.4 0.5 0.0 21.5 0.5 0.0 0.0 0.0 1.0 0.0 0.0 2.1 0.5 0.1 0.2 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.9 0.0 2.9 0.0 0.0 0.1 0.1 0.5 62.4 31.7 4.6 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.3 68.0 50.7 70.6 67.7 71.5 70.2 64.6 70.8 52.9 68.5 59.7 1.2 3.2 3.7 25.8 0.1 0.8 1.7 0.7 0.0 81.2 0.8 1.8 8.4 1.5 3.1 11.0 158.4 0.2 0.2 0.0 1.9 0.1 27.7 28.2 4.6 1.6 13.1 0.0 75.8 0.2 0.0 2.9 0.0 0.8 0.0 0.8 2.2 0.3 0.1 50.5 43.3 0.0 6.1 0.0 1.1 41.9 7.5 0.3 5.4 1.9 0.0 18.7 0.0 13.0 13.3 0.2 0.0 18.4 0.1 1.4 0.0 1.2 25.4 10.2 0.0 1.9 5.7 23.5 4.3 0.1 0.4 0.0 0.3 0.1 0.0 0.4 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.6;epididymis: 36.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "basophil: 3.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "HPA051508: AB_2681513, HPA059537: AB_2684054" "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.2 2.8 11.6 0.3 15.3 0.7 0.4 12.5 66.6 0.3 0.0 0.7 0.7 0.6 36.4 0.2 2.3 0.5 0.4 13.9 16.3 3.5 0.1 0.2 0.2 35.8 7.0 0.3 1.1 0.0 3.9 7.6 28.9 0.8 0.8 14.6 0.2 2.0 0.5 0.9 1.2 0.4 3.0 0.1 8.7 9.6 17.1 2.3 0.1 0.1 0.3 0.1 0.3 20.0 0.0 13.3 1.1 0.1 0.1 0.3 0.0 1.4 0.0 0.2 0.1 19.3 0.5 2.3 2.0 0.0 0.2 0.0 0.0 0.0 0.1 1.0 25.0 0.0 21.4 11.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.2 5.0 1.0 0.0 0.3 0.0 0.0 1.5 0.0 29.1 5.0 12.8 4.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.5 1.4 0.1 1.4 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 11.6 15.3 12.5 66.6 13.9 16.3 35.8 7.0 28.9 3.0 17.1 20.0 0.2 3.2 0.0 4.6 0.6 1.8 0.3 7.2 0.6 29.1 0.9 1.1 1.2 0.0 2.5 0.0 2.1 93.0 0.8 2.2 3.9 1.3 16.4 0.6 0.2 0.7 9.6 0.0 45.5 0.9 9.2 1.1 28.1 0.7 0.0 12.3 0.0 0.2 6.1 18.5 55.2 0.6 2.0 0.0 0.7 17.8 0.6 0.7 0.0 6.5 0.0 2.8 0.0 11.1 3.6 0.8 4.8 1.9 0.9 1.0 3.5 18.8 6.9 8.1 0.0 0.6 0.8 57.8 134.9 0.9 1.6 30.6 0.4 0.9 1.3 0.5 MAPK10 "JNK3, p493F12, p54bSAPK, PRKM10" ENSG00000109339 "Mitogen-activated protein kinase 10" P53779 4 85990007-86594625 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.3" "Cell type enhanced" "Detected in many" "Astrocytes: 902.0;Excitatory neurons: 1018.9;Inhibitory neurons: 727.8;Late spermatids: 400.5;Oligodendrocyte precursor cells: 596.6;Oligodendrocytes: 302.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "AF22: 155.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022625 Approved NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB022625: " "unprognostic (2.46e-2)" "unprognostic (4.36e-2)" "unprognostic (1.13e-1)" "unprognostic (4.05e-2)" "unprognostic (5.17e-2)" "unprognostic (2.03e-1)" "unprognostic (4.59e-2)" "unprognostic (4.82e-2)" "unprognostic (3.81e-2)" "unprognostic (4.45e-2)" "unprognostic (1.18e-3)" "unprognostic (3.02e-2)" "prognostic favorable (3.11e-4)" "unprognostic (1.92e-2)" "unprognostic (1.44e-1)" "unprognostic (6.22e-3)" "prognostic favorable (5.57e-4)" 26.1 15.6 45.2 5.1 61.6 14.5 7.4 25.4 91.3 17.5 23.5 5.7 3.6 14.5 18.8 9.8 15.8 13.8 6.9 60.4 24.9 20.4 3.2 8.6 5.2 29.0 36.2 14.7 7.4 10.3 25.5 4.3 31.4 22.4 5.4 18.3 4.7 24.2 2.6 4.6 5.1 15.5 24.9 7.4 6.6 26.4 39.2 3.4 20.5 4.2 4.6 14.0 18.4 55.6 2.9 4.9 155.0 4.8 4.1 3.6 5.6 3.2 2.9 2.7 1.2 3.3 4.4 7.1 5.1 1.9 3.8 9.4 1.8 4.2 4.3 4.9 4.0 5.7 7.3 4.6 3.6 2.7 3.1 4.1 1.9 3.7 5.0 5.5 3.5 4.8 5.2 27.9 1.7 3.5 4.4 3.1 8.8 0.7 3.2 4.9 4.0 2.5 10.7 16.9 9.2 8.4 3.3 5.9 2.2 5.0 8.8 3.3 7.5 6.3 6.4 3.0 2.7 8.2 5.1 4.4 9.9 3.5 3.8 3.3 0.7 1.2 0.8 0.7 1.0 1.3 0.7 1.0 0.6 1.1 1.0 1.4 4.4 1.2 0.7 1.2 1.2 0.9 45.2 61.6 25.4 91.3 60.4 24.9 29.0 36.2 31.4 24.9 39.2 55.6 4.3 22.4 33.8 902.0 1.6 0.8 15.7 5.5 4.0 26.1 3.2 3.7 1.6 8.6 12.8 22.0 6.2 0.3 0.1 0.0 11.7 2.4 219.5 61.1 25.1 1.3 2.4 0.0 1018.9 0.0 0.5 16.9 2.0 7.1 2.5 6.2 1.1 0.0 0.3 38.7 727.8 0.0 4.1 0.3 0.0 400.5 26.4 1.5 1.8 185.5 0.0 15.7 0.0 596.6 302.8 2.0 0.0 54.9 0.1 7.6 0.0 22.6 68.9 10.8 6.6 7.2 18.5 10.5 5.5 1.3 1.0 0.1 0.9 28.5 0.0 22.6 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716340-143722458 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 54.9;fallopian tube: 46.7" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 62.5;Respiratory ciliated cells: 107.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 18.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.6;HeLa: 20.7;MCF7: 14.3;T-47d: 14.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 1.6 0.1 3.3 0.2 4.0 0.0 1.9 1.7 8.1 6.9 54.9 1.0 0.3 2.5 2.4 1.1 46.7 0.2 0.6 5.0 3.6 10.5 0.3 12.1 0.4 10.2 14.5 0.9 4.4 9.4 6.9 0.3 7.0 2.2 0.2 0.0 2.2 1.7 0.1 4.0 0.8 0.4 6.6 0.7 0.8 11.4 6.4 1.1 16.1 0.0 0.2 0.5 2.1 3.0 0.4 0.6 1.9 0.0 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.5 9.6 0.0 1.6 0.0 0.0 5.5 0.1 0.2 0.0 1.0 2.0 0.0 20.7 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.2 3.4 0.0 0.0 14.3 0.0 0.0 2.5 1.2 1.2 0.0 3.7 0.5 1.0 1.6 3.6 5.1 0.0 3.3 0.0 0.2 14.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.0 1.7 8.1 5.0 3.6 10.2 14.5 7.0 6.6 6.4 3.0 0.1 0.0 6.4 0.0 0.1 0.4 0.3 5.7 0.0 0.0 1.0 1.3 0.7 0.0 11.8 0.0 0.0 0.0 0.0 0.1 0.0 1.1 13.8 62.5 0.5 0.3 0.0 0.0 0.2 0.0 0.7 0.8 0.0 1.7 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.6 16.2 0.0 0.0 11.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 1.4 107.9 0.0 0.0 0.4 2.2 2.3 0.9 0.0 0.3 0.1 0.2 0.1 0.3 0.1 MAPRE3 "EB3, RP3" ENSG00000084764 "Microtubule associated protein RP/EB family member 3" Q9UPY8 2 26970637-27027219 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 146.6" "Group enriched" "Detected in many" 5 "Early spermatids: 428.2;Late spermatids: 311.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009263 Uncertain NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" "HPA009263: AB_1078716" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (8.31e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-2)" "unprognostic (3.40e-2)" "unprognostic (2.22e-2)" "unprognostic (1.35e-3)" "unprognostic (1.75e-2)" "unprognostic (3.49e-1)" "unprognostic (4.77e-3)" "unprognostic (2.37e-1)" "unprognostic (1.22e-2)" "unprognostic (3.84e-2)" "unprognostic (3.43e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" 24.0 23.1 100.7 7.3 102.4 1.3 23.6 73.5 133.2 26.6 50.8 25.4 7.2 24.8 10.4 12.2 42.2 12.6 45.2 108.8 105.2 30.4 37.6 17.8 5.9 94.4 82.9 46.1 14.7 36.8 101.7 10.8 98.1 26.1 9.8 70.5 18.3 15.0 146.6 43.3 10.5 12.9 66.5 15.8 23.2 56.4 107.0 7.6 24.4 56.8 6.5 22.0 19.0 95.8 19.8 15.2 13.6 24.0 24.4 13.5 3.9 15.3 12.2 12.7 12.9 5.7 25.8 0.0 14.4 19.1 33.5 10.1 7.6 16.3 7.5 16.5 18.7 2.9 8.1 1.3 22.4 2.3 36.5 11.1 28.5 6.4 11.9 34.6 3.1 1.7 19.4 15.1 7.7 9.0 0.1 1.0 6.0 69.2 23.9 0.1 0.3 2.0 8.8 13.0 34.4 17.0 10.6 7.5 11.0 8.9 8.0 1.4 3.3 11.1 11.4 16.0 13.7 11.5 4.4 0.1 39.9 1.5 22.6 0.2 1.3 0.3 0.7 1.4 0.4 0.6 0.3 0.2 0.8 0.3 0.5 0.1 3.5 0.5 1.7 0.0 0.1 0.7 100.7 102.4 73.5 133.2 108.8 105.2 94.4 82.9 98.1 66.5 107.0 95.8 13.7 3.2 2.8 25.8 2.6 8.8 21.8 15.2 11.4 44.0 6.4 8.8 8.3 5.7 6.6 3.7 25.0 1.4 1.6 32.3 17.6 11.5 428.2 64.7 11.2 5.5 25.1 2.5 43.7 4.6 4.6 11.2 11.2 4.1 38.1 13.8 14.3 8.6 2.1 58.9 45.0 1.9 18.3 2.8 4.5 311.4 12.8 4.6 7.2 5.6 0.8 69.3 4.1 26.2 27.4 12.0 8.4 11.7 2.7 9.6 0.2 6.8 48.8 44.6 32.9 10.2 14.0 21.0 14.4 6.5 13.8 18.9 3.4 38.6 3.0 15.0 MARCHF10 "FLJ35757, MARCH-X, MARCH10, RNF190" ENSG00000173838 "Membrane associated ring-CH-type finger 10" Q8NA82 17 62701314-62808344 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 137.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;EFO-21: 4.7;HSkMC: 2.1;SCLC-21H: 8.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA023322 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Cytosol" "HPA023322: AB_1856351" "unprognostic (2.79e-2)" "unprognostic (2.32e-1)" "unprognostic (9.60e-3)" "unprognostic (6.95e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-2)" "unprognostic (1.67e-1)" "unprognostic (1.39e-1)" "unprognostic (7.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (9.37e-3)" "unprognostic (2.66e-1)" 0.1 0.2 1.3 0.2 1.6 0.0 0.1 1.2 0.9 1.4 10.5 1.1 0.0 0.4 7.5 0.1 12.8 0.1 0.1 1.1 1.3 1.5 0.0 2.7 0.0 3.6 5.0 0.1 0.2 0.3 12.7 0.0 2.6 0.6 0.0 0.1 0.3 0.1 0.0 0.2 0.4 0.0 3.6 0.1 0.4 137.6 1.3 0.2 0.1 0.0 0.0 0.1 0.2 2.0 0.1 0.0 0.1 0.0 0.0 0.1 2.5 1.1 0.1 0.8 0.2 0.0 0.0 0.0 4.7 0.3 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.8 0.6 0.0 1.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.7 0.0 8.3 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.2 0.1 1.3 1.6 1.2 0.9 1.1 1.3 3.6 5.0 2.6 3.6 1.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MAT1A "MAT, MATA1, SAMS, SAMS1" ENSG00000151224 "Methionine adenosyltransferase 1A" Q00266 10 80271820-80289658 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "liver: 1346.5" "Cell type enriched" "Detected in some" 55 "Hepatocytes: 5534.4" "Cancer enriched" "Detected in many" 54 "liver cancer: 209.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 94.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048627 Supported NA NA 1900000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "HPA048627: AB_2680465" "unprognostic (6.92e-2)" "unprognostic (2.63e-1)" "unprognostic (2.88e-2)" "unprognostic (9.43e-2)" "unprognostic (3.79e-2)" "unprognostic (2.49e-2)" "unprognostic (2.03e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-16)" "unprognostic (8.59e-3)" "unprognostic (9.90e-2)" "unprognostic (3.58e-1)" "unprognostic (5.98e-2)" 0.5 0.5 0.4 0.1 0.8 0.0 0.4 0.1 0.5 0.2 0.9 0.2 0.2 0.1 57.5 0.1 1.2 0.0 0.2 0.2 0.2 0.9 1346.5 0.4 0.1 0.6 0.8 6.3 43.8 0.1 0.8 0.1 0.4 0.0 0.0 0.0 0.3 1.9 0.0 4.2 0.0 0.2 0.8 0.5 0.2 3.7 0.2 0.4 0.4 0.0 0.0 0.5 0.1 0.2 6.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.0 3.2 0.1 0.0 0.0 0.0 0.3 0.5 1.6 0.0 94.9 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 1.0 0.2 0.0 0.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.1 0.5 0.2 0.2 0.6 0.8 0.4 0.8 0.2 0.2 0.0 0.0 0.5 0.0 8.8 2.0 0.1 0.4 0.0 0.0 0.2 0.6 0.7 67.2 0.9 1.8 0.0 0.0 0.0 0.0 1.9 0.1 23.9 3.0 0.0 5.3 0.0 69.5 0.1 4.6 0.0 0.0 0.0 0.2 0.0 7.6 76.8 5534.4 0.1 0.0 0.0 0.0 0.0 100.4 0.6 5.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 0.0 0.1 0.0 0.6 10.2 0.0 0.0 0.0 0.2 2.7 0.3 0.0 2.7 0.0 6.0 1.0 0.0 0.0 MCIDAS "IDAS, MCI, MCIN" ENSG00000234602 "Multiciliate differentiation and DNA synthesis associated cell cycle protein" D6RGH6 5 55219564-55227315 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation" Activator "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "parathyroid gland: 2.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Collecting duct cells: 1.8;Endometrial ciliated cells: 1.2;Respiratory ciliated cells: 3.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 4.9;HeLa: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049981, HPA058073" Uncertain Supported "Nuclear bodies" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear bodies" "HPA049981: , HPA058073: AB_2683596" "unprognostic (3.11e-2)" "unprognostic (7.50e-4)" "unprognostic (2.48e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (2.41e-3)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" "unprognostic (3.63e-2)" "unprognostic (3.17e-2)" "unprognostic (4.67e-1)" "unprognostic (2.90e-3)" "unprognostic (4.17e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "unprognostic (2.70e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 2.9 0.4 0.0 0.6 0.0 0.0 4.9 0.0 0.0 0.4 0.7 4.0 4.4 0.0 0.4 0.0 1.2 0.7 2.9 0.2 0.0 0.2 4.0 0.0 6.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 1.9 1.4 0.0 0.0 1.6 0.0 0.1 0.2 0.7 2.2 0.8 1.5 0.0 1.7 2.6 1.3 0.0 2.1 0.5 2.2 0.0 4.0 0.4 0.0 0.0 3.4 0.2 0.1 3.3 4.2 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.7 0.0 0.9 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161558-13211110 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.2;lymphoid tissue: 8.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 1.2 0.1 0.0 3.3 0.1 9.2 0.8 0.1 0.2 0.4 0.1 1.7 1.5 0.4 0.1 1.9 0.2 0.2 0.1 0.0 0.0 0.1 0.7 0.3 4.8 0.0 0.1 0.2 0.1 0.2 0.1 2.1 0.1 0.1 2.2 0.1 0.3 0.0 0.5 1.1 1.2 0.8 0.0 1.0 0.8 1.5 0.2 8.1 0.3 0.1 4.5 0.6 0.6 0.1 38.0 42.0 48.6 36.9 1.6 2.9 21.2 38.7 5.9 42.7 44.0 41.3 26.4 56.7 17.1 9.9 15.7 43.3 69.0 22.8 39.2 29.7 32.9 70.9 17.6 27.7 0.0 36.6 30.8 0.6 0.8 43.3 4.0 3.5 14.0 45.0 85.2 37.6 23.4 34.0 87.7 15.7 28.9 36.3 10.3 68.3 43.0 34.6 9.8 13.7 9.7 36.6 31.3 22.0 5.9 25.2 27.7 24.9 8.6 27.0 50.3 41.0 42.4 11.7 49.0 74.3 17.2 39.6 21.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.9 0.3 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 1.7 0.0 0.0 0.0 1.8 1.7 0.4 0.8 0.0 0.0 0.8 0.5 2.4 0.0 0.8 0.0 0.0 11.8 0.8 2.4 0.0 0.4 1.0 0.3 1.2 1.4 0.0 23.5 0.4 0.2 20.9 1.8 1.1 1.0 0.0 7.2 0.0 0.2 5.3 0.0 0.4 1.2 2.0 0.6 0.4 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.4 15.3 0.2 0.2 0.0 0.0 0.0 0.0 0.4 6.4 15.8 12.9 3.6 0.4 3.4 1.2 0.8 3.1 0.4 MDH1B "FLJ25341, RP11-95H11" ENSG00000138400 "Malate dehydrogenase 1B" Q5I0G3 2 206737763-206765328 "Metabolic proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 15.7;fallopian tube: 22.5;testis: 24.5" "Cell type enhanced" "Detected in many" "Early spermatids: 186.0;Endometrial ciliated cells: 50.1;Late spermatids: 33.7;Respiratory ciliated cells: 100.5;Spermatocytes: 114.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.6;SCLC-21H: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073761 Approved NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA073761: AB_2732241" "unprognostic (1.03e-2)" "unprognostic (9.44e-2)" "unprognostic (1.58e-1)" "unprognostic (9.84e-2)" "unprognostic (1.54e-1)" "unprognostic (6.31e-2)" "unprognostic (2.55e-2)" "unprognostic (8.21e-2)" "unprognostic (2.01e-1)" "unprognostic (3.66e-2)" "unprognostic (3.23e-3)" "unprognostic (3.08e-1)" "unprognostic (6.10e-3)" "unprognostic (1.15e-1)" "unprognostic (3.09e-2)" "unprognostic (7.84e-3)" "unprognostic (3.01e-1)" 0.4 1.5 2.2 0.2 2.5 0.1 1.2 1.9 2.4 1.7 15.7 1.2 0.0 1.7 1.7 0.5 22.5 0.8 1.3 2.4 2.8 3.1 0.3 2.0 0.3 4.2 5.3 1.0 0.9 4.2 9.3 0.0 3.9 0.9 0.5 8.5 1.0 1.3 0.4 0.4 0.3 0.8 3.5 0.2 0.7 24.5 2.8 0.5 4.8 0.5 0.2 0.5 0.4 3.0 0.3 1.2 0.9 2.5 0.1 1.1 0.3 0.0 0.4 0.5 0.3 0.1 0.8 0.5 0.5 0.1 1.1 0.6 0.0 0.7 0.5 0.0 0.0 0.2 0.2 0.8 0.5 0.4 1.2 0.7 0.2 0.0 0.1 0.5 0.7 1.1 0.0 0.7 0.3 1.5 0.8 0.3 1.6 0.1 1.4 1.6 0.9 0.0 3.6 0.2 3.5 0.7 1.1 0.5 0.3 0.5 1.1 0.0 0.0 0.6 0.6 0.1 0.3 0.3 1.6 0.2 1.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.5 1.9 2.4 2.4 2.8 4.2 5.3 3.9 3.5 2.8 3.0 0.2 6.4 1.5 6.8 0.0 0.8 1.4 3.9 1.8 3.0 2.1 2.4 1.3 2.8 6.4 0.0 0.0 0.1 0.0 0.0 13.7 1.3 186.0 50.1 1.2 0.6 1.2 0.0 8.9 0.0 0.1 1.3 1.5 1.6 0.0 1.1 0.0 0.0 0.1 3.3 6.3 0.0 10.2 0.0 0.2 33.7 1.8 0.5 1.8 1.9 0.0 9.6 0.0 1.0 1.3 0.1 0.0 3.0 0.0 0.4 0.0 6.0 100.5 10.2 0.0 0.5 1.7 114.9 5.1 0.5 0.3 0.0 0.2 1.6 0.1 0.9 MEIG1 "bA2K17.3, SPATA39" ENSG00000197889 "Meiosis/spermiogenesis associated 1" Q5JSS6 10 14959388-14988050 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.7;testis: 10.2" "Cell type enhanced" "Detected in some" "Early spermatids: 128.5;Endometrial ciliated cells: 28.9;Late spermatids: 21.4;Respiratory ciliated cells: 31.7;Spermatocytes: 52.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 6.1;SK-MEL-30: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 37: B-cells - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (5.51e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (3.75e-6)" "unprognostic (6.89e-2)" "unprognostic (1.36e-5)" "unprognostic (2.97e-1)" "unprognostic (3.74e-3)" "unprognostic (8.40e-3)" "unprognostic (3.15e-1)" 0.2 0.3 1.3 0.0 1.4 0.0 0.0 1.4 1.9 0.2 1.6 0.1 0.0 0.1 0.0 0.1 3.7 0.0 0.1 1.4 1.4 0.3 0.2 0.4 0.2 1.6 1.7 0.0 0.2 0.2 0.8 0.1 1.4 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 1.5 0.2 0.1 10.2 1.4 0.3 0.1 0.0 0.1 0.1 0.0 1.6 0.8 0.7 1.2 0.6 0.3 0.2 0.0 0.2 0.3 0.4 0.4 0.0 1.1 0.2 0.0 0.2 0.6 0.1 0.8 0.1 0.1 6.1 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.4 0.1 0.3 0.6 0.6 1.2 0.2 0.0 0.6 0.6 0.9 1.2 0.2 0.4 0.6 0.0 0.9 1.6 0.3 0.3 3.3 0.2 0.6 0.1 0.0 0.0 0.0 0.3 0.0 1.9 1.7 1.7 0.7 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.2 1.4 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.3 0.2 0.7 0.0 1.3 1.4 1.4 1.9 1.4 1.4 1.6 1.7 1.4 1.5 1.4 1.6 0.2 0.0 0.5 1.3 0.2 0.0 0.5 2.8 0.0 0.2 0.8 1.0 0.8 0.0 3.2 1.8 0.0 0.8 0.1 0.1 1.9 0.4 128.5 28.9 0.3 0.1 0.0 0.0 1.3 0.9 0.4 0.2 0.0 0.8 0.0 0.3 0.0 1.4 0.6 0.0 1.4 0.5 4.1 0.3 0.3 21.4 2.1 0.5 0.0 0.0 0.3 2.6 1.0 0.5 1.4 0.2 0.0 0.0 0.1 0.5 0.0 0.7 31.7 0.3 0.0 0.2 0.7 52.2 3.7 0.0 0.4 0.3 0.5 0.1 0.3 0.4 MELK KIAA0175 ENSG00000165304 "Maternal embryonic leucine zipper kinase" Q14680 9 36572862-36677683 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.0;lymphoid tissue: 21.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 16.1;Erythroid cells: 15.2;Extravillous trophoblasts: 44.1;Spermatocytes: 23.2;Spermatogonia: 21.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "T-reg: 1.7" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA017214 Uncertain NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 12: Non-specific - Cell cycle regulation" "HPA017214: AB_1853798" "unprognostic (5.03e-2)" "unprognostic (9.57e-2)" "unprognostic (2.27e-2)" "unprognostic (3.42e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.91e-7)" "prognostic unfavorable (3.99e-4)" "unprognostic (1.26e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (4.69e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (8.86e-3)" "unprognostic (1.37e-1)" "unprognostic (2.40e-1)" "unprognostic (1.35e-1)" 0.9 0.5 0.0 5.7 0.0 10.0 1.4 0.0 0.1 1.3 0.0 6.8 5.2 1.0 0.0 7.9 0.3 0.6 0.2 0.0 0.0 0.3 0.7 0.9 10.0 0.0 0.1 0.2 0.3 0.1 0.0 5.3 0.1 0.3 8.5 0.0 1.2 0.1 0.0 3.4 4.4 2.4 0.0 2.0 3.2 9.2 0.3 21.0 0.3 0.1 11.7 1.7 2.3 0.0 123.4 62.1 81.6 48.5 11.1 18.8 47.1 88.8 62.2 121.5 148.2 47.8 47.3 40.9 27.8 43.8 106.5 41.0 71.7 55.5 133.1 112.3 28.6 32.0 69.1 48.1 4.3 50.2 39.0 6.9 9.8 93.9 53.0 15.6 62.2 61.9 41.7 63.2 100.9 40.9 63.1 23.4 65.1 55.1 47.9 57.4 54.9 25.8 37.7 40.7 55.1 40.8 47.4 45.3 28.6 45.2 38.0 23.7 30.8 65.4 81.8 56.1 82.3 12.3 47.9 60.7 41.2 36.8 91.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 1.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.7 1.9 4.6 0.9 3.5 0.0 0.0 0.9 0.8 0.4 0.0 2.0 0.0 0.0 16.1 0.7 4.5 0.0 1.1 2.8 2.9 1.4 1.3 0.0 15.2 0.8 1.1 44.1 3.3 4.6 2.1 0.0 7.8 1.4 0.7 10.1 0.0 0.7 4.7 4.1 1.6 3.0 2.7 1.2 1.9 0.0 0.0 3.1 0.0 2.1 1.0 0.4 1.7 2.7 0.0 10.2 0.5 0.6 0.1 2.0 0.0 0.0 0.0 3.7 23.2 21.3 9.3 1.7 8.9 2.7 0.7 8.9 2.3 MEPE ENSG00000152595 "Matrix extracellular phosphoglycoprotein" Q9NQ76 4 87821411-87846817 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 107 "brain: 10.6" "Cell type enriched" "Detected in single" 18 "Inhibitory neurons: 12.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 10.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038003, HPA038004" Uncertain "Secreted to extracellular matrix" NA NA 810000 "Cluster 10: Brain - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA038003: AB_2675780, HPA038004: AB_10670537" "unprognostic (2.88e-1)" "unprognostic (8.15e-2)" "unprognostic (3.62e-1)" "unprognostic (1.91e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.41e-1)" "unprognostic (5.64e-4)" 0.0 0.0 4.6 0.0 1.1 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.1 0.0 10.6 0.9 4.0 0.3 0.0 0.9 0.2 0.1 2.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MGAM MGA ENSG00000257335 Maltase-glucoamylase O43451 7 141907813-142106747 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 25.5;intestine: 87.6" "Group enriched" "Detected in some" 5 "Late spermatids: 156.4;Proximal enterocytes: 521.4" "Cancer enriched" "Detected in some" 7 "renal cancer: 4.9" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" "Immune cell enriched" "Detected in some" 7 "neutrophil: 13.5" "Lineage enriched" "Detected in single" 102 "granulocytes: 13.5" "Cell line enhanced" "Detected in some" "A549: 1.8;BJ hTERT+: 1.6;HL-60: 2.8;U-937: 4.3;WM-115: 1.0" "Region enriched" "Detected in single" 12 "olfactory bulb: 2.0" "Low region specificity" "Detected in many" HPA002270 Enhanced NA NA 310000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 32: U-937 - Innate immune response" "Cluster 45: Enterocytes - Digestion" "HPA002270: AB_1079366" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (6.95e-3)" "unprognostic (2.80e-1)" "unprognostic (7.81e-2)" "unprognostic (7.32e-3)" "unprognostic (3.83e-2)" "unprognostic (4.97e-1)" "unprognostic (2.17e-2)" "unprognostic (6.86e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.16e-5)" "unprognostic (1.82e-1)" "unprognostic (2.82e-1)" "unprognostic (1.34e-3)" "unprognostic (3.03e-1)" 2.6 0.1 0.2 2.5 0.4 18.1 0.2 0.2 2.3 0.4 0.3 0.5 58.9 0.1 25.5 0.3 1.2 0.4 0.3 0.1 0.3 18.7 0.5 3.2 0.1 0.5 0.4 0.1 0.2 0.0 0.1 0.3 0.6 0.1 0.2 0.0 0.1 7.1 0.1 0.1 87.6 0.4 0.2 12.6 1.8 1.3 0.6 0.4 0.1 1.0 0.0 0.5 0.1 0.4 0.0 1.8 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.0 4.3 1.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 2.3 0.1 0.3 0.5 0.4 0.6 0.2 0.6 0.4 0.0 0.0 2.5 3.3 0.1 0.0 0.0 0.6 0.0 0.2 0.5 0.1 1.4 0.0 3.2 12.9 0.0 0.0 2.8 1.8 1.9 0.1 59.7 0.1 0.2 0.3 1.2 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.7 17.8 0.0 0.0 2.5 156.4 0.6 1.1 0.0 0.0 0.7 0.6 5.2 1.5 0.6 0.2 16.3 0.4 0.0 0.1 521.4 24.4 6.7 0.0 0.0 0.5 0.1 1.8 1.2 0.0 0.0 0.0 0.4 0.0 7.3 0.3 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 11.8;pancreas: 4.0;salivary gland: 5.9" "Group enriched" "Detected in some" 4 "Early spermatids: 27.4;Late spermatids: 18.2" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 1.6;RH-30: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA055697 Enhanced Approved Vesicles,Cytosol NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" Vesicles Cytosol "HPA055697: AB_2682890" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.1 0.0 0.0 0.4 0.0 0.2 1.1 0.0 0.4 0.0 0.2 1.5 11.8 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.9 0.0 0.0 0.0 9.6 0.0 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 27.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 MGAT3 GNT-III ENSG00000128268 "Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase" Q09327 22 39457012-39492194 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.0;intestine: 28.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Bipolar cells: 30.7;Excitatory neurons: 25.1;Inhibitory neurons: 27.4;Oligodendrocytes: 45.7;Proximal enterocytes: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.4;eosinophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 65.1;HMC-1: 56.0;OE19: 58.8;U-266/70: 73.6;U-266/84: 32.6;U-698: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017598 Approved "Intracellular and membrane" NA NA 170000 "Cluster 52: Eosinophils - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "HPA017598: AB_1853853" "unprognostic (1.41e-3)" "unprognostic (5.98e-3)" "unprognostic (4.79e-2)" "unprognostic (2.96e-1)" "unprognostic (2.76e-1)" "unprognostic (5.71e-3)" "unprognostic (8.92e-2)" "unprognostic (2.17e-1)" "unprognostic (4.35e-3)" "unprognostic (6.77e-2)" "unprognostic (8.12e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (5.04e-8)" "unprognostic (6.73e-2)" "unprognostic (1.46e-1)" "unprognostic (5.89e-2)" "unprognostic (4.92e-2)" 7.8 1.1 26.8 4.0 20.9 10.8 6.4 7.6 47.0 6.2 0.0 5.2 21.5 3.8 0.8 1.1 3.4 3.8 4.8 30.3 10.0 3.0 0.2 14.9 7.6 28.1 15.6 1.2 3.1 0.4 1.8 10.5 21.8 1.2 4.6 6.7 1.8 1.0 1.5 2.3 28.4 2.8 4.8 4.8 7.4 5.4 23.9 1.8 1.5 1.8 9.0 1.6 1.5 27.3 0.3 0.4 10.4 1.0 0.0 0.0 65.1 0.5 0.7 0.5 0.0 14.9 3.7 23.4 8.1 0.0 0.2 1.3 5.4 0.0 0.1 0.0 0.5 18.9 0.0 0.2 0.2 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 15.8 2.9 0.0 0.2 0.6 1.4 3.1 58.8 0.0 1.2 0.0 3.9 0.4 0.6 6.0 4.4 0.0 0.0 0.0 18.5 0.8 1.0 0.0 0.1 8.1 0.1 0.1 73.6 32.6 32.6 0.2 0.1 1.7 1.4 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.8 20.9 7.6 47.0 30.3 10.0 28.1 15.6 21.8 4.8 23.9 27.3 2.0 44.8 3.0 6.5 2.2 0.4 0.1 1.8 0.0 30.7 0.6 1.1 1.9 1.5 3.7 0.0 6.2 5.5 0.0 4.1 0.0 0.0 19.1 0.9 11.0 2.5 7.8 13.7 25.1 0.2 12.0 2.3 10.2 2.0 2.5 0.0 0.0 0.0 1.5 13.5 27.4 3.8 2.0 0.0 2.3 16.6 4.4 0.9 0.0 0.0 0.1 1.5 0.0 21.6 45.7 1.8 6.1 3.8 1.7 0.3 37.4 1.8 5.2 2.3 6.6 0.3 4.3 0.7 1.2 0.2 0.6 3.7 0.5 0.6 4.5 1.5 MGAT4D GnT1IP ENSG00000205301 "MGAT4 family member D" A6NG13 4 140442262-140498377 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 37 "testis: 22.7" "Group enriched" "Detected in some" 19 "Early spermatids: 19.5;Late spermatids: 26.7;Spermatocytes: 64.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036523 Enhanced NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA036523: AB_10670110" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 26.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MKI67 "MIB-1, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126423 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 46.3;lymphoid tissue: 52.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 0.9 0.7 0.0 8.5 0.1 46.3 1.7 0.0 0.1 1.2 0.2 8.1 6.2 1.0 0.0 10.0 0.3 0.9 0.3 0.1 0.1 0.4 0.8 1.4 14.9 0.1 1.0 0.2 0.2 0.1 0.1 4.1 0.6 0.4 9.2 0.0 1.4 0.1 0.0 6.6 5.8 2.6 0.0 4.8 4.2 2.3 0.9 52.7 0.4 0.1 16.4 1.8 2.8 0.3 204.6 101.5 103.2 73.6 4.3 8.7 32.1 75.7 55.3 70.3 62.3 83.9 82.3 152.6 21.3 51.9 46.4 120.7 109.3 56.8 104.7 161.8 53.1 131.0 79.4 52.7 0.1 186.0 68.0 2.0 2.5 72.2 73.2 17.2 69.8 69.5 61.2 142.1 70.5 80.9 111.7 56.6 41.3 52.7 45.7 82.2 135.1 20.3 25.6 56.2 35.9 38.9 107.1 38.0 17.3 33.9 31.4 39.3 65.0 37.0 73.6 53.0 206.8 64.2 54.9 177.2 30.7 83.3 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.6 0.0 0.9 0.3 0.6 0.0 5.4 0.0 16.0 6.4 1.6 5.3 0.6 0.0 3.9 3.2 1.6 1.5 5.3 0.0 0.0 30.6 7.4 25.0 0.0 0.8 4.2 2.3 10.2 6.7 6.7 232.9 0.0 0.0 86.1 13.5 34.7 13.2 1.3 87.0 5.7 1.7 42.1 0.0 0.0 22.4 2.0 12.9 13.7 0.9 0.3 16.6 3.6 0.0 0.2 0.0 8.2 0.0 0.0 0.1 3.0 0.4 107.4 4.6 2.6 0.1 1.6 0.0 0.0 0.5 13.6 8.1 24.1 50.4 3.0 7.8 23.0 2.7 47.1 4.8 MLF1 ENSG00000178053 "Myeloid leukemia factor 1" P58340 3 158571163-158607252 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Differentiation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 182.3;testis: 393.7" "Group enriched" "Detected in many" 10 "Early spermatids: 4964.0;Late spermatids: 12837.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 8.7" "Lineage enriched" "Detected in single" 9 "T-cells: 8.7" "Cell line enhanced" "Detected in many" "A-431: 84.0" "Low region specificity" "Detected in all" "HPA069479, HPA079339" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 43: Testis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA069479: AB_2686140, HPA079339: " "unprognostic (6.49e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.72e-2)" "unprognostic (2.65e-2)" "unprognostic (8.55e-2)" "unprognostic (4.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.21e-2)" "unprognostic (1.07e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.54e-4)" "unprognostic (9.34e-3)" "unprognostic (2.47e-3)" "unprognostic (3.36e-2)" 10.9 6.8 16.8 3.0 19.8 3.2 17.4 17.3 22.0 9.8 34.5 10.0 1.8 15.9 14.8 10.2 67.9 15.1 138.9 19.1 19.3 21.2 3.6 17.9 2.9 25.1 25.2 12.8 9.6 20.2 18.1 2.7 24.0 6.2 4.7 46.9 5.1 4.6 182.3 6.2 4.0 14.2 22.0 3.5 6.2 393.7 19.4 2.3 16.5 107.2 4.8 14.1 4.2 24.2 84.0 7.7 28.4 0.1 13.8 18.1 7.8 6.8 8.4 31.9 30.5 0.0 44.8 0.0 29.3 13.1 42.8 16.3 0.3 14.2 44.5 0.0 15.3 3.9 6.3 0.9 10.2 0.0 6.4 10.5 22.3 13.8 8.8 28.2 7.3 0.0 6.3 0.1 22.2 12.5 0.0 0.2 7.6 46.4 21.3 0.0 15.4 0.7 25.0 6.4 34.8 21.7 38.1 13.7 43.9 27.7 41.1 8.9 3.8 27.2 27.2 35.4 31.0 15.6 8.2 0.1 20.0 0.1 20.6 0.0 0.0 0.0 2.8 0.0 1.4 0.5 6.9 6.9 0.2 0.3 1.5 3.2 0.3 0.9 0.3 0.1 8.7 2.0 16.8 19.8 17.3 22.0 19.1 19.3 25.1 25.2 24.0 22.0 19.4 24.2 42.0 25.6 28.2 11.8 6.0 44.7 143.4 35.3 27.3 14.9 52.8 68.7 231.2 17.2 55.2 20.2 33.3 0.7 12.0 12.8 72.4 26.9 4964.0 203.9 29.3 28.4 33.9 3.6 20.2 7.6 5.0 56.3 18.8 24.0 43.8 10.0 18.5 0.2 8.0 10.1 14.1 29.3 28.5 4.1 19.7 12837.2 69.9 11.5 23.2 3.7 1.0 28.5 3.1 9.0 12.7 10.2 14.3 50.4 3.4 37.4 1.3 36.6 329.7 71.1 19.7 131.0 40.5 854.2 192.2 10.4 34.2 1.6 25.3 55.9 14.7 83.1 MMP25 "MMP20, MMPL1, MT6-MMP" ENSG00000008516 "Matrix metallopeptidase 25" Q9NPA2 16 3046062-3060726 "Enzymes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.1;lymphoid tissue: 81.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 6.7;Langerhans cells: 5.8;monocytes: 15.0" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "basophil: 18.3;neutrophil: 20.3" "Lineage enriched" "Detected in single" 39 "granulocytes: 20.3" "Cell line enriched" "Detected in some" 15 "HMC-1: 102.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB025177, HPA055640" Uncertain Supported "Plasma membrane" "Secreted to blood" NA NA 120000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 3: Monocytes - Immune response regulation" "Plasma membrane" "CAB025177: , HPA055640: " "unprognostic (4.51e-3)" "unprognostic (9.28e-3)" "unprognostic (7.57e-2)" "unprognostic (2.95e-3)" "unprognostic (2.26e-1)" "prognostic favorable (1.09e-5)" "unprognostic (1.36e-1)" "unprognostic (7.39e-3)" "unprognostic (7.63e-3)" "unprognostic (2.29e-2)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (2.37e-3)" "unprognostic (1.17e-2)" "unprognostic (8.30e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" 5.8 0.4 0.5 15.1 0.4 33.1 1.4 0.3 1.6 0.7 0.6 1.7 1.1 0.5 0.1 1.3 6.2 1.1 2.4 0.3 0.3 1.4 2.9 14.4 2.6 0.6 0.5 0.4 1.2 0.2 0.8 1.0 0.6 1.0 1.4 0.0 1.2 0.1 0.5 0.7 3.5 0.9 0.3 81.8 1.9 0.4 0.7 1.4 1.2 3.5 1.9 2.2 0.9 0.3 0.0 0.0 1.2 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.7 0.1 0.0 6.7 0.5 0.0 0.0 0.0 0.0 0.2 102.2 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.7 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.3 7.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 1.1 0.1 18.3 0.2 4.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 20.3 0.5 0.0 0.4 0.2 0.0 0.5 0.4 0.3 1.6 0.3 0.3 0.6 0.5 0.6 0.3 0.7 0.3 1.0 3.2 6.7 0.0 0.7 0.4 0.4 0.2 0.0 0.8 2.0 1.3 1.0 0.0 0.8 1.8 0.0 0.0 1.8 0.2 0.0 0.4 0.0 1.2 1.2 1.0 0.0 2.7 1.6 0.6 0.2 0.6 1.1 3.8 1.3 0.2 0.0 0.3 0.1 0.0 1.9 0.2 0.0 3.5 5.8 0.0 0.0 3.3 0.0 1.0 15.0 0.3 3.1 1.5 0.5 1.3 0.0 0.7 0.8 0.4 1.2 0.2 0.1 0.0 0.0 0.7 0.9 0.1 0.2 0.6 0.3 0.0 4.0 0.1 0.3 0.3 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831351-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 292.9;lymphoid tissue: 107.8" "Cell type enhanced" "Detected in many" "Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 6012.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 6012.8" "Group enriched" "Detected in some" 14 "NB-4: 151.8;THP-1: 282.7;U-937: 185.5" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol" NA NA 400000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Nucleoli, Nucleoli rim, Vesicles, Cytosol" "HPA034532: AB_10669677, HPA073215: AB_2686582" "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 24.2 14.9 2.7 82.4 2.8 292.9 6.0 2.9 4.4 6.3 3.2 6.7 3.7 4.0 1.4 7.4 5.7 26.6 4.3 2.6 3.1 3.6 11.5 47.3 15.6 5.2 4.3 2.2 4.8 3.7 1.6 20.4 4.3 3.8 7.7 12.1 5.7 3.5 3.8 5.1 7.7 20.7 5.1 107.8 4.5 5.1 4.2 14.4 3.8 19.0 14.5 23.4 1.8 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 282.7 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 185.5 0.0 155.4 1354.4 243.8 2.6 534.3 3.7 33.5 1.6 1.9 616.5 15.3 1.6 1.4 6012.8 2.8 270.6 9.6 1.5 1099.5 2.7 2.8 2.9 4.4 2.6 3.1 5.2 4.3 4.3 5.1 4.2 5.4 2.6 35.3 56.0 0.0 34.7 2.4 0.0 0.0 0.0 1.2 1.1 3.4 0.9 5.7 9.3 0.0 0.0 0.9 5.9 0.0 0.0 0.0 0.4 0.1 0.1 5.0 0.0 22.3 0.0 0.4 1.3 6.5 0.5 0.1 44.1 0.0 3.9 2.2 219.1 0.0 0.1 0.0 0.0 408.5 241.7 3.3 1.2 412.0 1.8 33.7 1118.9 136.1 26.8 0.5 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.7 8.0 4.8 13.1 1.5 8.2 0.9 0.3 0.4 2.3 1.0 11.7 0.0 0.0 0.1 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Human disease related genes, Predicted intracellular proteins" Meiosis "Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.2;testis: 48.2" "Group enriched" "Detected in many" 5 "Early spermatids: 504.6;Endometrial ciliated cells: 256.5;Respiratory ciliated cells: 232.5;Spermatocytes: 249.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.9 1.4 2.6 1.6 2.4 4.6 3.1 10.1 2.9 3.5 12.3 1.9 2.3 3.6 1.3 2.7 21.2 3.3 2.5 2.2 2.4 10.5 1.9 3.4 1.3 7.2 6.8 4.0 2.4 0.6 3.5 1.6 5.1 2.3 2.0 4.7 2.0 1.7 1.0 1.4 2.1 1.3 6.1 1.4 2.2 48.2 2.7 5.6 2.9 1.1 1.2 1.3 2.5 3.9 32.1 7.4 3.8 11.3 3.1 6.7 0.7 7.6 4.4 8.8 18.6 10.5 15.0 17.8 9.4 3.2 12.8 12.3 4.7 4.4 17.9 0.0 1.9 22.9 8.8 1.8 1.1 7.9 2.4 2.7 0.2 17.9 2.6 3.7 1.6 6.8 5.2 0.0 7.6 4.2 0.3 9.8 1.2 16.4 4.3 15.0 22.6 0.2 8.7 6.1 29.5 8.9 12.7 3.8 13.6 0.9 9.1 12.1 0.7 12.0 13.6 11.6 18.8 3.6 11.9 0.3 13.4 18.3 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 10.1 2.9 2.2 2.4 7.2 6.8 5.1 6.1 2.7 3.9 0.7 0.0 4.7 1.0 0.8 3.3 8.8 9.3 1.8 10.5 4.7 8.3 6.0 4.3 28.3 35.0 25.0 1.8 0.2 3.7 11.7 10.9 504.6 256.5 7.8 2.0 1.2 3.0 4.9 1.9 3.9 14.0 5.1 7.2 0.0 11.0 6.8 0.4 7.0 15.2 3.7 4.5 10.2 1.0 5.5 60.8 12.8 2.0 0.0 0.0 0.8 12.4 0.0 1.5 2.8 1.2 0.1 8.6 0.5 3.0 0.3 12.3 232.5 32.6 0.0 21.6 6.5 249.6 25.0 7.1 1.4 0.5 1.0 6.4 6.0 3.5 MOK "RAGE, RAGE1, STK30" ENSG00000080823 "MOK protein kinase" Q9UQ07 14 102224500-102305190 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 125.8;testis: 54.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 185.6;Early spermatids: 212.8;Late spermatids: 185.8;Respiratory ciliated cells: 156.9;Rod photoreceptor cells: 465.7" "Cancer enriched" "Detected in many" 4 "melanoma: 7.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 149.0;hTEC/SVTERT24-B: 383.5;NB-4: 499.1;U-138 MG: 200.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027292 Supported "Endoplasmic reticulum" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum" "HPA027292: AB_10600989" "unprognostic (8.16e-2)" "unprognostic (1.82e-1)" "unprognostic (6.68e-2)" "unprognostic (6.05e-3)" "unprognostic (1.34e-2)" "unprognostic (1.81e-2)" "unprognostic (4.43e-2)" "unprognostic (3.49e-4)" "unprognostic (2.19e-1)" "unprognostic (2.03e-2)" "unprognostic (2.93e-1)" "unprognostic (3.01e-3)" "unprognostic (5.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.48e-1)" 9.2 11.2 15.7 1.8 16.0 3.0 6.8 14.8 18.6 8.9 26.9 5.3 3.4 7.8 7.3 4.3 21.2 4.6 13.0 17.2 16.9 12.6 5.8 5.3 1.7 16.2 17.2 12.9 9.7 7.1 18.6 2.4 15.9 7.6 1.8 125.8 6.3 3.5 2.2 6.8 3.0 3.9 15.0 4.7 9.3 54.0 17.1 1.7 14.8 0.7 1.3 8.4 5.5 15.6 18.9 16.5 2.2 9.5 3.8 13.1 4.2 37.7 11.0 53.4 63.7 1.5 45.4 14.5 3.1 7.2 11.5 4.1 3.3 19.4 149.0 16.2 14.1 3.4 2.3 12.7 15.9 1.6 17.9 11.1 4.9 383.5 35.3 41.3 2.0 2.9 3.4 1.0 35.3 12.5 1.2 499.1 0.7 8.3 39.4 2.2 1.0 0.3 21.9 0.8 6.0 3.9 6.8 2.6 109.4 0.8 11.2 1.5 1.4 200.4 10.4 7.7 12.1 1.3 2.4 1.2 40.2 1.2 93.1 0.0 0.7 0.0 0.5 0.6 0.8 0.0 0.4 1.4 3.0 0.5 0.7 1.7 0.5 8.0 0.1 0.0 0.0 0.9 15.7 16.0 14.8 18.6 17.2 16.9 16.2 17.2 15.9 15.0 17.1 15.6 5.8 19.2 17.5 68.6 1.0 10.7 6.3 12.0 7.4 40.9 19.1 17.3 12.3 10.0 27.5 12.9 185.6 1.4 2.4 6.1 5.9 8.3 212.8 122.1 16.9 7.2 4.8 3.6 54.7 16.0 2.6 17.6 12.2 10.7 3.8 12.2 8.6 2.0 2.1 16.8 37.5 2.4 6.1 1.3 5.3 185.8 30.4 2.5 80.0 7.5 0.5 59.5 1.0 16.1 6.8 6.5 1.2 16.1 1.1 2.7 3.5 11.1 156.9 465.7 26.3 22.4 13.4 121.4 32.0 5.4 5.8 1.2 4.2 13.4 4.2 3.8 MORN1 FLJ13941 ENSG00000116151 "MORN repeat containing 1" Q5T089 1 2321253-2391707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 25.4;Endometrial ciliated cells: 38.1;Late spermatids: 25.1;Respiratory ciliated cells: 36.7;Spermatocytes: 25.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005858, HPA070703" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Mitochondria" "HPA005858: AB_1848709, HPA070703: AB_2686299" "unprognostic (1.39e-3)" "unprognostic (6.49e-2)" "unprognostic (1.58e-1)" "unprognostic (8.21e-3)" "unprognostic (9.12e-2)" "unprognostic (5.87e-3)" "unprognostic (1.87e-1)" "unprognostic (2.65e-1)" "unprognostic (3.61e-2)" "unprognostic (5.97e-2)" "unprognostic (1.11e-2)" "unprognostic (2.60e-1)" "unprognostic (8.88e-3)" "unprognostic (2.53e-1)" "unprognostic (6.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" 2.5 2.7 2.5 1.5 3.2 1.0 4.2 14.3 4.7 7.1 8.2 3.7 1.9 5.3 4.4 3.1 15.7 2.3 1.9 2.6 2.4 6.4 3.2 3.8 1.5 4.6 5.7 9.8 4.0 2.7 10.0 0.9 2.5 6.0 1.1 3.9 4.4 3.2 2.3 2.9 2.6 1.1 3.2 2.2 2.8 14.8 3.1 2.0 13.5 1.0 1.4 3.0 4.0 2.1 6.4 7.6 5.2 4.8 1.7 0.8 5.4 1.9 1.3 3.0 2.5 3.6 7.0 1.7 4.0 1.2 2.2 7.7 1.1 3.0 2.9 3.9 8.0 1.6 16.4 4.0 1.5 2.1 0.9 1.0 0.6 2.8 2.5 2.3 2.1 3.2 2.7 1.9 1.1 8.9 2.1 0.7 3.1 3.3 6.5 2.2 4.7 2.7 2.3 2.8 8.6 4.2 5.0 8.9 4.1 2.3 4.8 0.6 0.7 3.4 5.0 2.5 2.2 4.5 1.8 1.1 6.9 1.2 2.4 0.0 0.3 0.1 0.5 0.1 0.3 0.4 0.6 0.4 0.4 0.8 0.9 0.4 1.7 0.3 2.0 1.5 0.0 0.4 2.5 3.2 14.3 4.7 2.6 2.4 4.6 5.7 2.5 3.2 3.1 2.1 1.7 3.2 3.2 9.8 3.7 1.7 4.1 4.6 1.8 8.9 5.3 5.2 3.3 4.3 3.9 14.7 20.9 3.6 1.0 2.1 3.9 2.2 25.4 38.1 4.4 1.4 5.4 4.8 17.7 1.4 1.8 2.5 5.6 4.3 5.7 3.4 1.1 1.8 2.9 10.1 10.7 0.9 6.1 0.6 0.7 25.1 2.5 1.0 1.8 4.7 1.2 7.1 4.1 3.5 2.9 1.3 0.6 3.0 2.1 2.0 2.3 9.7 36.7 21.5 0.0 5.7 3.6 25.3 6.4 2.5 2.3 1.9 2.0 2.8 2.2 3.2 MORN2 MOPT ENSG00000188010 "MORN repeat containing 2" Q502X0 2 38875962-38929072 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 174.2" "Cell type enhanced" "Detected in many" "Early spermatids: 1976.5;Endometrial ciliated cells: 783.4;Late spermatids: 3753.7;Respiratory ciliated cells: 848.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057815 Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA057815: AB_2683537" "unprognostic (7.28e-3)" "unprognostic (3.84e-2)" "unprognostic (8.65e-2)" "unprognostic (1.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (6.01e-2)" "unprognostic (2.60e-2)" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-2)" "unprognostic (3.55e-1)" "unprognostic (8.80e-2)" 13.5 30.5 41.9 6.2 44.6 9.7 20.6 42.8 55.9 30.5 62.8 14.5 6.6 16.6 73.3 13.7 96.3 16.0 26.2 42.4 44.9 69.3 17.6 18.0 5.5 45.0 46.4 19.4 20.2 79.5 56.8 8.0 45.7 18.0 13.5 37.6 21.3 18.8 20.0 10.2 8.1 11.3 43.7 6.6 15.2 174.2 43.6 8.2 46.0 17.3 5.7 14.5 13.2 44.3 60.9 30.5 37.2 46.0 40.4 60.5 21.0 27.7 42.9 42.5 40.2 18.3 33.5 3.8 21.8 40.9 42.4 15.9 16.5 34.9 63.4 25.3 32.8 12.9 32.6 46.1 34.8 21.2 9.2 35.6 42.8 51.5 18.9 54.0 39.9 11.7 22.7 8.9 35.8 58.6 9.3 40.5 27.6 40.0 31.7 5.2 38.8 13.3 83.0 33.4 37.1 49.4 41.3 27.0 59.6 21.7 36.5 28.5 26.5 30.2 29.8 48.0 44.1 16.6 26.4 2.3 68.8 6.0 54.4 1.5 8.3 1.2 1.6 6.7 3.1 2.5 1.9 2.4 5.9 2.7 3.2 3.3 0.7 2.7 5.5 3.0 4.0 3.8 41.9 44.6 42.8 55.9 42.4 44.9 45.0 46.4 45.7 43.7 43.6 44.3 14.1 16.0 25.3 2.6 7.9 9.7 25.5 103.9 10.2 16.7 29.5 45.7 40.5 35.8 90.9 60.7 10.4 15.9 4.2 19.5 270.1 61.4 1976.5 783.4 34.1 16.0 22.9 7.4 2.5 44.4 22.9 28.8 18.8 43.6 9.5 35.2 12.8 24.5 23.6 16.8 2.3 18.1 73.2 9.0 6.7 3753.7 53.4 15.1 23.2 0.0 10.2 106.7 3.1 1.5 1.8 41.0 34.3 51.6 5.5 22.4 7.4 396.6 848.6 35.1 26.3 21.3 40.5 530.7 92.0 15.7 10.5 7.7 6.1 51.8 22.0 30.0 MORN3 ENSG00000139714 "MORN repeat containing 3" Q6PF18 12 121648742-121672631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 4.1;fallopian tube: 3.9;testis: 4.5" "Cell type enriched" "Detected in many" 6 "Late spermatids: 2271.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "BEWO: 13.6;CACO-2: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038709, HPA038710" Uncertain Approved Nucleoplasm NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA038709: AB_2676164, HPA038710: AB_2676165" "prognostic favorable (1.16e-4)" "unprognostic (2.70e-3)" "unprognostic (5.56e-2)" "unprognostic (5.13e-2)" "unprognostic (7.38e-3)" "unprognostic (3.46e-3)" "unprognostic (7.44e-2)" "unprognostic (3.70e-2)" "unprognostic (4.31e-2)" "unprognostic (3.09e-2)" "unprognostic (3.65e-3)" "unprognostic (3.11e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-1)" "unprognostic (2.21e-1)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" 0.2 0.3 1.4 0.5 1.6 0.9 0.4 1.3 1.6 0.4 4.1 0.2 0.2 0.3 0.5 0.1 3.9 0.4 0.2 1.5 1.5 0.7 0.1 1.0 1.2 1.7 2.2 0.3 0.3 2.3 1.3 0.8 1.1 0.2 0.2 0.6 0.4 0.3 0.2 2.0 0.4 0.2 1.3 0.7 0.6 4.5 1.6 0.9 0.6 0.0 0.6 0.2 0.2 1.4 0.2 0.1 0.4 0.2 0.0 0.3 13.6 0.2 0.1 0.0 0.1 8.3 0.4 0.2 0.2 0.1 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.6 0.5 0.5 0.2 0.5 0.9 0.1 0.3 0.4 0.0 0.1 0.3 1.0 0.2 0.3 0.1 0.3 0.9 0.7 0.3 0.0 0.1 0.4 0.0 0.1 0.5 0.2 1.2 1.1 0.1 0.2 0.0 0.6 1.1 0.1 0.2 0.2 0.2 0.4 0.2 0.2 0.1 0.4 1.0 0.4 0.2 1.3 0.3 0.1 0.7 0.1 0.8 0.3 0.8 0.4 0.1 0.5 0.7 0.5 1.2 0.9 0.3 0.5 0.8 0.2 1.4 1.6 1.3 1.6 1.5 1.5 1.7 2.2 1.1 1.3 1.6 1.4 1.1 3.2 1.3 0.0 1.6 3.2 1.2 3.3 0.0 1.3 2.5 1.8 1.4 4.3 8.2 1.8 0.0 0.5 6.6 0.0 7.9 4.4 352.0 34.1 1.2 2.1 0.0 0.0 2.7 1.4 0.7 1.4 0.0 3.0 2.5 2.5 0.7 0.0 0.9 0.0 2.3 0.0 4.1 0.0 0.3 2271.5 9.3 1.7 0.0 0.0 1.8 5.4 5.2 0.0 0.1 2.2 0.0 9.4 3.5 0.7 0.1 1.1 51.7 2.2 0.0 1.5 1.4 8.7 6.7 0.0 4.0 7.3 6.7 3.4 0.2 1.1 MORN5 "C9orf113, C9orf18, FLJ46909" ENSG00000185681 "MORN repeat containing 5" Q5VZ52 9 122159908-122200088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 111.0;testis: 81.7" "Cell type enhanced" "Detected in many" "Early spermatids: 490.3;Endometrial ciliated cells: 240.0;Late spermatids: 692.9;Respiratory ciliated cells: 454.7;Spermatocytes: 142.1" "Group enriched" "Detected in many" 4 "endometrial cancer: 9.2;glioma: 4.0;ovarian cancer: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.6;U-87 MG: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (5.24e-3)" "unprognostic (7.30e-3)" "unprognostic (1.12e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (7.80e-3)" "unprognostic (1.91e-3)" "unprognostic (3.25e-3)" "unprognostic (2.64e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.95e-1)" 0.0 0.1 8.1 0.6 8.4 0.0 0.2 7.3 8.7 3.5 16.2 24.8 0.9 6.2 2.2 2.2 111.0 0.6 0.0 8.3 9.2 1.3 0.0 5.8 0.0 13.0 14.8 0.5 0.3 2.8 3.9 0.0 11.8 0.8 5.4 10.0 0.9 3.7 0.0 0.0 2.3 17.1 10.3 0.0 3.8 81.7 8.7 0.1 0.0 0.0 0.0 2.2 0.5 9.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 8.4 7.3 8.7 8.3 9.2 13.0 14.8 11.8 10.3 8.7 9.6 0.1 0.0 3.6 0.3 0.0 0.0 0.2 30.3 0.0 1.1 0.1 0.5 0.1 0.0 36.9 3.7 2.1 0.0 0.0 0.0 0.0 0.1 490.3 240.0 1.6 0.7 0.0 0.0 1.8 0.0 0.0 0.7 0.0 3.0 0.0 0.2 0.0 0.0 0.1 1.7 1.5 0.0 63.1 0.0 0.0 692.9 6.5 0.7 0.0 0.0 0.0 5.6 0.0 1.0 0.3 0.0 0.0 4.1 0.0 1.2 0.0 4.9 454.7 8.1 0.0 0.0 8.4 142.1 6.4 0.0 0.0 0.0 0.3 0.1 0.0 0.1 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269855-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "bone marrow: 4023.1" "Cell type enriched" "Detected in some" 30 "Erythroid cells: 87.4" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 94 "HL-60: 3517.4;NB-4: 4589.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" No NA 576000000 24000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.5 0.4 0.8 0.6 0.6 4023.1 0.3 0.6 1.1 0.0 0.3 0.2 0.0 0.2 1.1 0.1 0.1 0.3 1.1 0.8 0.7 0.2 1.8 8.4 1.7 0.9 1.0 0.1 0.1 0.0 1.5 1.4 0.9 0.2 0.2 0.4 66.3 0.1 1.1 4.3 0.2 0.3 0.8 21.7 0.1 0.4 0.8 10.9 0.3 0.3 0.2 0.5 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3517.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4589.9 0.0 0.0 0.0 5.3 3.2 0.6 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 4.0 0.0 0.0 6.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.1 7.5 0.8 0.6 0.6 1.1 0.8 0.7 0.9 1.0 0.9 0.8 0.8 0.7 0.0 0.0 0.5 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.9 0.0 0.5 0.1 0.0 0.1 0.0 87.4 0.3 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.7 0.3 0.9 0.0 0.2 0.0 0.0 1.2 0.0 1.3 0.0 2.9 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.3 0.1 0.0 0.1 0.6 0.0 0.0 0.0 MRLN "Linc-RAM, LINC00948, M1, MLN, MUSER1" ENSG00000227877 Myoregulin P0DMT0 10 59736692-59756041 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "skeletal muscle: 269.3;tongue: 147.3" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 118.8;Proximal tubular cells: 25.8;Respiratory ciliated cells: 35.7;Rod photoreceptor cells: 37.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Region enriched" "Detected in some" 4 "cerebellum: 4.5" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "RH-30: 13.3" "Region enriched" "Detected in many" 11 "cerebellum: 21.6" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (4.54e-1)" "unprognostic (3.17e-3)" "unprognostic (9.77e-2)" "unprognostic (1.09e-2)" "unprognostic (8.49e-2)" "unprognostic (1.23e-1)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (6.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" 0.1 0.2 0.4 0.1 0.4 0.3 0.2 4.5 0.7 0.5 0.4 0.2 1.0 0.5 0.8 1.2 5.1 0.7 0.1 0.4 0.2 8.1 0.2 0.7 0.1 0.5 0.3 0.3 2.8 0.0 12.0 0.1 1.0 1.3 0.1 30.6 7.0 0.1 269.3 0.6 1.1 0.1 0.1 0.5 1.0 0.8 0.3 0.3 0.3 147.3 0.1 0.0 0.1 0.6 0.0 0.8 0.4 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.6 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.7 0.2 1.8 1.1 0.1 0.0 0.6 1.0 0.0 0.6 0.0 0.1 0.0 0.1 0.1 1.0 0.0 1.1 0.0 1.0 0.2 0.2 0.8 0.5 13.3 0.0 0.0 0.2 0.6 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.3 0.3 0.6 0.2 0.5 0.1 0.1 0.4 0.3 0.0 1.7 0.3 0.4 0.6 0.1 0.4 0.5 0.3 0.3 0.2 0.6 0.2 0.5 1.2 0.3 0.3 0.4 0.3 0.0 0.4 0.4 4.5 0.7 0.4 0.2 0.5 0.3 1.0 0.1 0.3 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.1 1.0 0.0 1.8 0.0 2.1 0.0 0.1 1.5 0.0 0.2 5.6 118.8 0.8 0.7 0.0 0.0 1.3 0.2 6.4 0.4 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.5 0.6 0.3 0.0 0.4 0.0 0.1 0.0 25.8 35.7 37.8 0.0 10.1 0.2 2.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 MROH9 "ARMC11, C1orf129, FLJ23550" ENSG00000117501 "Maestro heat like repeat family member 9" Q5TGP6 1 170935471-171064765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.5;fallopian tube: 2.5;testis: 1.5" "Cell type enhanced" "Detected in some" "Early spermatids: 11.0;Endometrial ciliated cells: 20.7;Oligodendrocyte precursor cells: 56.8;Respiratory ciliated cells: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 68: Oligodendrocytes - Mixed function" "unprognostic (1.16e-1)" "unprognostic (1.04e-1)" "unprognostic (7.94e-3)" "unprognostic (3.67e-2)" "unprognostic (9.73e-2)" "unprognostic (7.62e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (8.07e-5)" "unprognostic (3.66e-8)" "unprognostic (5.96e-2)" 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.8 0.4 0.3 0.4 1.5 1.3 0.7 1.0 0.8 1.1 0.9 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 20.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 3.8 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.3 3.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MS4A1 "B1, Bp35, CD20, MS4A2" ENSG00000156738 "Membrane spanning 4-domains A1" P11836 11 60455846-60470752 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "B-cell activation" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 673.3" "Cell type enriched" "Detected in some" 35 "B-cells: 970.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 96 "memory B-cell: 625.4;naive B-cell: 627.0" "Lineage enriched" "Detected in many" 96 "B-cells: 627.0" "Group enriched" "Detected in some" 26 "Daudi: 731.3;U-698: 364.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000015, HPA014341, HPA014391" Enhanced Supported "Plasma membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" "CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264" "prognostic favorable (4.34e-5)" "unprognostic (4.45e-4)" "unprognostic (1.19e-4)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (5.53e-7)" "unprognostic (2.46e-3)" "unprognostic (1.85e-3)" "unprognostic (3.06e-2)" "unprognostic (2.89e-4)" "unprognostic (6.96e-2)" "unprognostic (2.84e-2)" "unprognostic (3.96e-5)" "unprognostic (2.23e-1)" "unprognostic (8.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-1)" 3.6 0.4 0.0 149.7 0.0 19.1 0.8 0.0 0.1 0.5 0.1 9.0 3.0 2.2 1.0 4.2 0.5 8.4 1.8 0.0 0.1 3.4 2.1 4.0 500.4 0.2 0.0 0.3 0.2 7.3 0.3 0.9 0.1 5.1 10.6 0.0 8.9 0.3 0.8 0.1 123.5 1.2 0.1 253.8 18.4 1.2 0.1 50.6 6.7 0.1 673.3 16.3 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 731.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.5 0.2 0.0 0.1 0.0 364.1 0.0 0.2 0.0 0.8 0.5 0.3 2.4 0.1 3.7 625.4 2.8 5.5 0.5 627.0 0.5 2.1 2.0 6.5 0.6 0.5 0.8 32.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.3 0.0 3.8 0.0 970.5 0.1 0.1 0.0 0.0 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.0 14.5 0.3 0.0 0.0 4.5 0.7 0.1 0.3 0.0 7.0 0.0 0.0 0.1 1.8 2.0 0.1 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.2 0.0 0.6 0.3 2.0 0.0 4.6 7.2 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.5 0.2 0.1 0.8 0.1 0.0 27.3 0.7 0.2 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756867-60776733 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lung: 43.9" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 1: 96.1" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 3.2" "Lineage enriched" "Detected in single" 12 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1" "Region enriched" "Detected in some" 28 "olfactory bulb: 166.8" "Region enriched" "Detected in single" 26 "olfactory bulb: 20.2" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 19: Lung - Lung function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.2 0.4 0.2 0.1 2.2 0.3 0.4 0.3 0.2 0.3 1.0 1.2 0.3 0.4 1.0 0.2 0.3 0.7 0.2 0.1 0.0 43.9 0.5 0.4 0.2 1.8 0.1 0.0 0.0 0.7 0.4 0.3 0.6 0.4 0.1 1.2 0.0 0.0 2.2 1.6 0.1 0.3 0.4 0.6 0.2 3.8 0.3 0.0 1.8 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.5 1.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 4.0 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 3.2 0.2 0.2 0.2 0.3 0.4 0.7 0.2 0.4 0.2 0.4 0.1 0.2 0.3 0.2 96.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 2.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.1 0.2 0.1 0.0 0.0 MS4A2 "APY, FCER1B, IGER, MS4A1" ENSG00000149534 "Membrane spanning 4-domains A2" Q01362 11 60088261-60098467 "FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 12.6" "Cell type enriched" "Detected in some" 20 "granulocytes: 967.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 908 "basophil: 275.5" "Lineage enriched" "Detected in single" 1467 "granulocytes: 275.5" "Cell line enhanced" "Detected in some" "HEL: 2.7;THP-1: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 15.3" HPA059967 Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" "HPA059967: AB_2684183" "unprognostic (7.28e-2)" "unprognostic (9.21e-2)" "unprognostic (2.50e-4)" "unprognostic (4.97e-2)" "unprognostic (4.47e-1)" "unprognostic (2.40e-6)" "unprognostic (1.88e-2)" "unprognostic (6.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.63e-3)" "unprognostic (6.49e-3)" "unprognostic (9.95e-2)" "unprognostic (4.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.74e-1)" 2.6 0.2 0.3 2.4 0.3 0.9 2.7 0.5 0.5 6.3 0.6 4.9 5.5 4.2 3.7 4.8 0.9 8.2 0.6 0.3 0.3 0.5 0.4 12.6 1.1 0.4 0.3 0.1 0.5 0.3 0.1 0.3 0.4 3.0 5.4 0.0 1.8 2.4 2.9 2.5 6.7 4.1 0.3 0.2 5.3 1.0 0.3 1.2 0.1 1.2 1.8 3.8 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 275.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.4 0.3 0.3 0.5 0.5 0.3 0.3 0.4 0.3 0.4 0.3 0.3 0.5 0.1 0.0 30.9 0.0 0.3 0.0 0.9 0.0 0.0 0.3 0.1 0.1 0.5 0.0 6.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.3 0.0 46.7 0.1 0.0 0.1 1.1 0.0 0.1 967.4 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.7 0.4 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.0 12.2 0.0 0.0 0.2 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071115 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 93 "bone marrow: 420.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 1478 "basophil: 2686.3" "Lineage enriched" "Detected in single" 4507 "granulocytes: 2686.3" "Cell line enhanced" "Detected in some" "HEL: 48.9;K-562: 94.2;NB-4: 109.8;THP-1: 319.0;U-937: 126.2" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.1 0.0 0.0 0.3 0.0 420.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.9 0.0 0.0 0.0 17.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.2 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 319.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 126.2 0.0 2686.3 0.1 1.8 0.1 0.1 0.3 0.2 0.4 0.0 0.3 0.2 0.2 0.4 0.9 0.1 0.5 0.2 0.1 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 19.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.8 0.0 3.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 MS4A4A "CD20L1, MS4A4, MS4A7" ENSG00000110079 "Membrane spanning 4-domains A4A" Q96JQ5 11 60185657-60318080 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 63.1" "Group enriched" "Detected in many" 7 "Hofbauer cells: 376.8;Kupffer cells: 445.0;Macrophages: 264.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 61.2;myeloid DC: 27.6;non-classical monocyte: 82.9;plasmacytoid DC: 27.7" "Group enriched" "Detected in many" 30 "dendritic cells: 27.7;monocytes: 82.9" "Cell line enhanced" "Detected in some" "HEL: 35.6;HMC-1: 45.8;K-562: 154.9" HPA029323 Approved NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 1: K-562 - Erythropoiesis" "Cluster 4: Macrophages - Innate immune response" "HPA029323: AB_10601866" "unprognostic (7.93e-2)" "unprognostic (2.05e-2)" "unprognostic (1.37e-3)" "unprognostic (1.98e-1)" "unprognostic (4.46e-2)" "unprognostic (2.31e-1)" "unprognostic (9.66e-2)" "unprognostic (1.59e-1)" "unprognostic (4.56e-1)" "unprognostic (6.65e-2)" "unprognostic (8.10e-2)" "unprognostic (2.11e-1)" "unprognostic (5.02e-3)" "unprognostic (3.32e-2)" "unprognostic (4.66e-2)" "unprognostic (4.89e-2)" "unprognostic (4.21e-2)" 42.8 24.7 3.5 16.5 3.6 6.1 12.3 3.7 8.6 14.1 4.4 14.0 5.2 4.9 3.4 8.9 11.6 25.8 8.4 3.5 3.9 4.8 15.4 28.0 31.3 4.2 3.4 4.1 4.0 3.3 3.3 63.1 3.6 3.4 16.1 2.0 7.6 4.9 2.3 2.9 13.5 20.0 2.5 33.3 6.6 3.0 5.5 11.5 3.7 10.4 7.5 28.0 3.3 4.3 0.3 0.1 0.1 0.6 0.0 0.2 0.7 0.6 0.0 0.2 0.4 0.3 0.9 0.8 0.4 0.0 0.4 0.3 0.5 0.1 0.6 1.6 0.0 35.6 0.7 0.6 0.1 1.2 45.8 0.4 0.3 0.2 0.8 0.2 0.0 0.4 154.9 4.2 0.6 0.7 0.6 0.9 0.7 0.3 0.1 0.7 0.0 2.5 0.1 1.5 0.5 0.5 0.3 0.3 0.1 0.7 0.7 8.9 0.8 1.5 0.6 0.4 0.2 6.0 0.7 0.5 0.2 0.8 0.2 0.1 9.9 0.0 0.1 61.2 0.2 1.0 0.1 0.1 27.6 0.3 0.2 0.1 0.9 1.8 82.9 27.7 0.1 6.0 3.5 3.6 3.7 8.6 3.5 3.9 4.2 3.4 3.6 2.5 5.5 4.3 2.3 0.0 7.9 0.0 3.0 1.8 0.1 0.0 0.6 0.0 0.3 2.2 3.4 2.8 2.5 0.0 0.0 1.8 7.5 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.0 13.0 0.1 0.0 2.0 1.6 0.0 0.0 7.6 0.0 47.5 4.6 376.8 0.0 0.1 0.0 0.0 445.0 24.9 1.0 0.9 264.6 3.6 10.3 8.3 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 13.1 1.2 1.1 0.1 0.2 0.7 1.8 3.6 1.5 0.1 0.0 0.1 MS4A8 "CD20L5, MS4A4, MS4A8B" ENSG00000166959 "Membrane spanning 4-domains A8" Q9BY19 11 60699585-60715807 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 129.7;intestine: 197.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 376.4;Enteroendocrine cells: 473.4;Ionocytes: 140.4;Proximal enterocytes: 694.6;Respiratory ciliated cells: 502.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.9;RPMI-8226: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA007319 Enhanced NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "HPA007319: AB_1854138" "unprognostic (7.28e-3)" "unprognostic (2.11e-1)" "unprognostic (9.03e-2)" "unprognostic (1.91e-2)" "unprognostic (2.52e-2)" "unprognostic (9.41e-2)" "unprognostic (4.89e-3)" "unprognostic (9.33e-2)" "unprognostic (7.97e-3)" "unprognostic (2.40e-1)" "unprognostic (2.40e-9)" "unprognostic (2.46e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-3)" 0.0 0.8 1.6 3.5 1.3 0.0 0.0 0.0 1.1 25.6 5.4 18.2 189.8 8.2 0.0 0.3 129.7 10.8 0.0 0.6 0.4 0.1 0.0 16.6 0.2 0.0 0.2 0.3 2.2 0.7 7.5 0.1 0.0 1.7 16.9 0.0 0.6 7.1 4.6 0.0 197.7 1.0 0.0 0.0 45.7 0.5 0.9 0.1 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.3 0.0 1.1 0.6 0.4 0.0 0.2 0.0 0.0 0.9 0.0 0.0 6.4 6.4 0.0 0.2 0.0 0.2 11.9 0.0 0.0 0.0 0.0 0.3 18.6 58.8 1.8 0.0 0.0 0.0 15.0 0.0 0.3 1.3 376.4 3.2 0.3 473.4 0.0 0.4 2.5 0.0 2.0 14.3 11.6 1.3 0.0 0.0 0.0 0.0 0.0 0.1 42.5 140.4 0.0 0.0 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 46.1 0.0 0.0 1.7 694.6 0.2 502.8 0.0 0.0 0.0 3.5 0.3 0.7 0.0 0.0 0.0 0.5 0.2 24.7 0.4 MSMB "IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94" ENSG00000263639 "Microseminoprotein beta" P08118 10 46033307-46048180 "Cancer-related genes, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "prostate: 9384.0" "Cell type enriched" "Detected in many" 4 "Prostatic glandular cells: 10715.4" "Cancer enriched" "Detected in many" 42 "prostate cancer: 3435.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 25.6;NB-4: 21.6;RPMI-8226: 11.3;SH-SY5Y: 6.1;SK-BR-3: 5.9;U-2197: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB026357, HPA051257" Enhanced "Secreted in male reproductive system" NA NA 6000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "CAB026357: , HPA051257: AB_2681410" "unprognostic (6.47e-2)" "unprognostic (7.21e-3)" "unprognostic (1.37e-2)" "unprognostic (8.18e-3)" "unprognostic (4.28e-3)" "unprognostic (9.24e-3)" "unprognostic (1.66e-1)" "unprognostic (8.66e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (2.01e-1)" "unprognostic (7.04e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.19e-4)" 5.1 4.5 0.0 3.0 0.0 0.1 20.5 0.0 0.0 3.2 0.0 2.8 10.3 0.3 45.1 12.3 4.6 3.0 0.5 0.0 0.0 1.8 1.8 29.9 0.2 0.0 0.0 0.3 2.3 0.2 0.5 0.6 0.0 9384.0 0.1 0.0 31.9 0.6 0.4 39.7 2.3 0.0 0.0 0.7 552.3 10.1 0.0 1.0 0.7 0.0 10.0 7.2 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 21.6 0.2 0.0 0.0 0.0 0.0 11.3 0.0 1.6 1.0 6.1 0.0 5.9 0.0 0.2 0.4 0.0 0.0 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.3 0.0 195.9 586.4 0.0 0.0 6.4 1.3 0.0 4.3 2203.2 0.0 0.0 2.1 0.1 0.3 0.0 0.1 48.9 0.6 0.0 10.7 0.0 0.0 0.1 0.2 0.4 9.5 404.2 0.2 1.3 0.0 0.0 1.2 0.2 0.0 0.0 0.8 419.1 0.0 0.0 78.8 0.3 30.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 29.6 0.0 0.8 10715.4 0.3 0.0 570.6 0.0 0.0 0.0 271.0 0.5 1.4 0.0 0.4 1.5 14.3 0.0 0.1 192.4 MSRB1 "SelR, SelX, SepR, SEPX1" ENSG00000198736 "Methionine sulfoxide reductase B1" Q9NZV6 16 1938229-1943293 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 234.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 1414.9;neutrophil: 3051.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 3051.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008650, HPA043463, HPA069557" Enhanced Enhanced Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153" "unprognostic (3.93e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.88e-2)" "unprognostic (4.90e-2)" "unprognostic (5.29e-2)" "unprognostic (3.60e-1)" "unprognostic (4.27e-2)" "unprognostic (8.46e-2)" "unprognostic (4.92e-2)" "unprognostic (7.31e-2)" "unprognostic (4.59e-3)" 28.1 15.1 26.2 31.8 27.3 96.3 21.3 27.8 28.4 17.5 25.8 36.7 29.4 29.5 11.2 45.3 33.5 23.2 47.3 25.6 26.8 80.3 234.2 30.4 17.7 29.3 28.0 16.4 149.6 14.8 14.5 13.2 27.1 32.0 17.4 2.7 16.5 29.2 76.0 31.1 27.5 36.8 27.5 67.0 33.3 17.7 28.5 13.7 12.5 93.6 12.2 40.8 20.1 27.1 23.6 59.1 21.3 50.4 39.9 17.0 36.4 27.8 36.0 41.2 35.6 96.2 25.5 22.7 90.6 33.5 36.0 37.9 36.3 25.2 12.8 127.7 41.1 17.5 20.5 154.9 36.1 49.3 40.3 32.0 21.9 29.6 6.0 12.9 41.9 28.8 28.2 12.3 22.3 131.2 28.2 82.7 29.2 42.7 33.5 40.3 29.3 106.0 66.0 37.2 20.5 26.9 32.3 35.6 17.3 13.9 38.7 87.9 24.8 12.3 33.7 24.3 16.7 32.0 53.4 42.4 12.5 47.4 22.0 493.5 412.0 1414.9 31.9 194.8 32.2 28.0 26.5 26.7 171.2 28.3 20.5 22.7 3051.8 42.2 182.9 73.2 45.9 226.7 26.2 27.3 27.8 28.4 25.6 26.8 29.3 28.0 27.1 27.5 28.5 27.1 24.9 9.6 13.4 3.9 10.0 6.5 9.1 21.5 8.0 6.5 27.9 21.3 36.1 32.9 14.9 33.1 4.2 33.3 12.3 69.1 93.9 65.9 5.9 23.9 13.4 15.4 60.3 21.5 0.8 111.2 121.4 13.7 11.7 17.0 4.5 12.2 20.7 275.6 63.5 8.4 1.2 38.6 34.6 59.2 21.2 13.9 9.3 37.9 16.0 2.8 178.7 22.5 25.7 1.5 2.9 66.0 62.8 23.0 13.0 16.3 97.3 496.8 37.9 4.2 0.0 8.1 22.8 28.9 8.7 11.1 9.5 38.6 10.6 14.8 33.5 21.9 MUC16 "CA125, FLJ14303" ENSG00000181143 "Mucin 16, cell surface associated" Q8WXI7 19 8848844-8981342 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 7.2;cervix: 15.9;fallopian tube: 5.9;salivary gland: 6.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 40.3;Club cells: 81.8;Endometrial ciliated cells: 74.3;Glandular and luminal cells: 157.8;Ionocytes: 99.7;Respiratory ciliated cells: 197.4" "Cancer enriched" "Detected in many" 4 "ovarian cancer: 21.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 23.3;HeLa: 45.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB055172, HPA065600" Enhanced "Secreted in other tissues" NA NA 25000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB055172: AB_2148831, HPA065600: AB_2732736" "unprognostic (8.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.37e-2)" "unprognostic (3.07e-1)" "unprognostic (1.76e-2)" "unprognostic (3.01e-3)" "unprognostic (3.83e-3)" "unprognostic (1.31e-2)" "unprognostic (1.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (2.60e-8)" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (1.43e-1)" "unprognostic (3.68e-3)" 7.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.9 0.0 0.0 0.0 2.1 0.0 0.3 5.9 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 6.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.2 0.0 0.1 0.0 0.1 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.6 2.8 0.0 0.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.3 0.1 40.3 0.0 0.0 4.1 0.9 3.4 1.5 81.8 0.0 0.0 2.1 0.2 0.0 0.0 0.2 14.3 74.3 14.8 1.2 0.0 0.0 0.4 0.0 0.4 1.0 0.0 157.8 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 99.7 0.3 0.0 16.4 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.1 197.4 0.0 0.0 0.0 8.6 0.3 0.2 0.0 0.3 3.3 0.6 0.0 0.0 0.7 MUC4 ENSG00000145113 "Mucin 4, cell surface associated" Q99102 3 195746765-195811973 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 19.2;intestine: 31.1;prostate: 14.8;vagina: 15.0" "Cell type enhanced" "Detected in many" "Club cells: 193.7;Distal enterocytes: 185.1;Gastric mucus-secreting cells: 163.1;Intestinal goblet cells: 193.3;Respiratory ciliated cells: 336.1;Undifferentiated cells: 174.5;Urothelial cells: 319.4" "Cancer enhanced" "Detected in many" "cervical cancer: 16.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "basal ganglia: 3.4" "HPA005895, CAB013536" Approved "Secreted in other tissues" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB013536: , HPA005895: AB_1079427" "unprognostic (4.16e-3)" "unprognostic (1.00e-2)" "unprognostic (6.79e-2)" "unprognostic (1.11e-2)" "unprognostic (3.03e-2)" "unprognostic (5.16e-2)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (3.19e-1)" "unprognostic (4.22e-3)" "unprognostic (6.68e-3)" "unprognostic (5.30e-2)" "unprognostic (2.43e-3)" "unprognostic (3.19e-1)" "unprognostic (6.78e-2)" "unprognostic (3.46e-3)" "unprognostic (9.97e-3)" 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.1 5.4 0.0 31.1 0.0 0.0 0.0 19.2 2.1 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.8 0.0 7.8 0.0 0.0 0.0 3.4 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.2 1.2 15.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 6.4 15.6 0.3 2.1 0.0 18.5 82.1 0.6 0.0 25.7 2.9 2.5 0.0 193.7 0.0 0.0 0.1 0.3 185.1 0.0 1.6 3.5 6.2 0.2 0.7 16.4 0.0 0.9 5.2 4.3 0.6 163.1 5.1 2.5 0.1 0.0 0.0 0.1 0.0 1.0 193.3 40.7 0.0 0.0 0.7 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.2 37.5 64.3 0.4 0.8 12.4 1.1 0.2 336.1 0.0 0.0 0.5 11.1 2.1 1.9 0.4 0.0 0.1 1.2 2.3 174.5 319.4 MUC5AC MUC5 ENSG00000215182 "Mucin 5AC, oligomeric mucus/gel-forming" P98088 11 1157953-1201138 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 101 "stomach 1: 185.1" "Cell type enriched" "Detected in some" 248 "Gastric mucus-secreting cells: 10434.9" "Group enriched" "Detected in many" 4 "pancreatic cancer: 25.3;stomach cancer: 61.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "A549: 19.9;OE19: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002774, CAB009395, HPA040615" Enhanced "Secreted to digestive system" NA NA "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042" "unprognostic (2.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.51e-2)" "unprognostic (4.56e-2)" "unprognostic (6.49e-2)" "unprognostic (2.44e-2)" "unprognostic (1.30e-3)" "unprognostic (8.46e-2)" "unprognostic (5.83e-4)" "unprognostic (1.84e-1)" "unprognostic (9.21e-3)" "unprognostic (4.07e-1)" "unprognostic (1.37e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 13.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 17.4 0.0 0.1 5.4 0.0 0.0 0.1 0.0 2.7 0.0 42.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 2.8 10434.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 4.1 0.0 0.0 0.2 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.1 0.0 30.0 8.9 0.0 0.0 10.0 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.1 7.9 0.0 0.0 28.1 MUC5B "MG1, MUC5" ENSG00000117983 "Mucin 5B, oligomeric mucus/gel-forming" Q9HC84 11 1223066-1262172 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "salivary gland: 2621.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "OE19: 113.9;PC-3: 120.0" "Not detected" "Not detected" "HPA008246, CAB009396" Enhanced Supported Vesicles "Secreted in other tissues" NA NA 1300000 "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "CAB009396: AB_2282256, HPA008246: AB_1854203" "unprognostic (2.01e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (2.76e-3)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (4.89e-2)" "unprognostic (7.80e-3)" "unprognostic (3.75e-1)" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (8.95e-2)" "unprognostic (2.57e-7)" "unprognostic (2.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (8.13e-2)" 0.1 0.7 0.2 2.0 0.1 0.0 1.3 0.0 0.4 229.4 0.0 58.0 0.1 0.3 0.0 101.0 1.1 221.3 0.1 0.0 0.0 0.1 2.4 7.5 0.0 0.1 0.0 0.1 9.8 0.0 0.4 0.0 0.0 0.6 17.1 0.0 2621.9 0.0 0.3 0.4 2.6 0.6 0.0 0.0 6.9 0.3 0.0 0.0 0.2 0.0 0.4 0.2 0.1 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.1 0.2 0.0 113.9 120.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 2.3 0.0 0.0 6.7 0.6 0.0 6.4 4.3 12.4 443.2 64.0 0.0 0.0 0.1 0.0 158.4 0.0 0.9 0.0 1.4 0.8 0.9 24.5 0.0 0.1 0.0 0.1 1.1 12.8 7.2 4.5 0.0 0.0 1.2 0.2 0.0 0.0 210.1 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 53.4 0.0 1.4 1.3 0.1 0.2 24.5 0.0 0.0 0.0 3.0 0.0 0.5 1.6 0.0 0.1 0.7 0.1 183.1 1.1 MYB c-myb ENSG00000118513 "MYB proto-oncogene, transcription factor" P10242 6 135181308-135219173 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0" "Group enriched" "Detected in many" 5 "breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 5.4" "Cell line enhanced" "Detected in many" "HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB017704, HPA071605" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "CAB017704: , HPA071605: " "unprognostic (1.69e-1)" "unprognostic (5.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.37e-2)" "unprognostic (4.06e-1)" "unprognostic (8.35e-3)" "unprognostic (1.13e-3)" "unprognostic (2.48e-2)" "unprognostic (6.44e-2)" "unprognostic (1.00e-1)" "unprognostic (3.71e-2)" "prognostic favorable (9.65e-4)" "unprognostic (2.41e-11)" "prognostic favorable (9.87e-4)" "unprognostic (8.35e-2)" "unprognostic (3.04e-2)" "unprognostic (9.40e-2)" 0.3 0.5 1.6 5.3 1.7 35.2 20.1 0.0 0.7 1.6 0.4 25.3 10.9 1.0 0.1 3.0 8.4 0.9 0.1 0.3 0.2 0.1 0.4 2.0 6.3 0.9 1.0 0.0 0.3 3.6 0.0 0.4 0.6 1.4 26.5 0.3 0.6 0.9 0.1 3.0 9.4 1.4 0.2 1.2 2.0 0.7 0.3 66.1 0.1 0.0 7.0 1.1 1.3 0.1 1.8 0.3 1.9 3.0 0.0 0.1 0.3 1.0 0.6 1.1 1.1 0.3 1.4 10.9 0.4 0.3 0.4 0.9 5.6 0.0 0.7 18.0 2.5 138.8 1.0 0.5 0.1 219.8 105.1 0.0 0.1 0.6 0.0 0.5 0.3 133.4 114.6 20.1 1.1 11.6 403.1 208.5 1.5 19.2 1.7 244.9 5.9 33.2 0.3 1.5 10.5 6.9 0.5 10.4 0.6 0.5 7.9 343.8 0.4 0.3 1.6 7.9 2.4 27.7 7.7 66.0 0.1 186.1 2.3 4.6 0.7 5.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.5 0.4 0.2 1.6 1.7 0.0 0.7 0.3 0.2 0.9 1.0 0.6 0.2 0.3 0.1 0.2 0.0 1.3 0.0 2.3 2.7 1.3 1.3 0.6 0.9 47.8 12.6 0.4 2.8 7.1 0.0 0.0 1.4 9.1 18.1 0.0 0.0 0.1 24.3 0.3 0.3 17.6 83.2 0.6 0.8 0.4 0.5 4.6 2.2 26.0 0.4 0.0 0.0 1.1 0.0 2.7 32.7 26.4 1.2 1.7 0.2 0.0 2.1 8.8 0.0 2.8 0.9 0.0 0.0 0.2 0.1 10.2 0.0 4.6 2.1 2.3 0.0 37.2 0.0 0.0 0.6 0.9 0.0 1.8 10.2 7.0 0.3 3.6 0.1 52.0 2.2 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716495 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 91.8;lymphoid tissue: 55.5" "Cell type enhanced" "Detected in many" "B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 34 "plasmacytoid DC: 91.5" "Lineage enriched" "Detected in many" 34 "dendritic cells: 91.5" "Cell line enhanced" "Detected in many" "MCF7: 763.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.6 0.6 0.1 24.2 0.1 91.8 1.6 0.1 0.2 1.1 0.2 8.6 7.0 1.4 0.1 10.1 0.4 1.0 0.4 0.1 0.1 0.6 1.1 1.8 55.5 0.1 0.1 0.3 11.2 0.1 0.2 5.7 0.1 0.5 6.9 0.0 1.6 0.2 0.1 4.2 7.8 2.1 0.1 27.8 6.1 15.6 0.4 33.3 0.5 0.0 53.5 3.5 2.5 0.1 195.8 121.8 105.4 109.6 1.0 3.5 136.2 87.0 29.0 265.6 194.6 600.2 118.8 393.6 49.2 37.8 55.8 116.1 192.1 59.6 98.8 74.2 124.1 183.2 118.7 164.2 0.2 168.6 121.7 2.4 5.1 101.6 22.9 5.9 72.2 189.6 188.1 470.3 23.8 763.7 346.0 236.3 121.8 155.4 105.4 237.3 216.3 222.1 49.6 39.7 96.7 140.6 255.6 253.3 26.1 110.4 167.2 183.1 34.0 16.3 264.3 118.3 151.5 162.1 363.8 606.5 34.2 142.3 103.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.2 0.0 91.5 1.3 0.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.2 0.0 0.0 0.0 33.0 4.2 0.8 0.8 0.0 0.0 2.5 3.4 2.0 1.5 0.1 0.0 0.0 14.4 32.6 3.4 0.0 0.4 5.9 0.9 1.3 1.8 0.0 82.3 0.4 0.9 32.3 4.8 10.2 2.9 0.0 18.9 0.7 1.4 13.5 0.0 0.3 5.1 0.0 2.4 2.6 14.1 0.0 3.2 1.8 0.0 0.0 0.0 1.0 0.0 0.5 0.7 1.1 0.0 139.6 0.3 0.5 0.0 0.0 0.0 0.0 0.1 3.9 7.0 33.6 8.2 2.4 3.7 3.0 1.2 8.6 2.4 MYCBPAP "AMAP-1, DKFZp434N1415" ENSG00000136449 "MYCBP associated protein" Q8TBZ2 17 50508384-50531501 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 65.1" "Cell type enhanced" "Detected in many" "Early spermatids: 224.2;Late spermatids: 145.2;Respiratory ciliated cells: 40.4;Spermatocytes: 69.9;Theca cells: 54.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.4;JURKAT: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA023257, HPA024405" Enhanced Approved Vesicles NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 34: Spermatids - Unknown function" Vesicles "HPA023257: AB_2671126, HPA024405: " "unprognostic (2.05e-2)" "unprognostic (1.79e-2)" "unprognostic (9.13e-3)" "unprognostic (3.98e-5)" "unprognostic (8.62e-4)" "unprognostic (3.65e-2)" "unprognostic (1.52e-3)" "unprognostic (1.61e-1)" "unprognostic (2.38e-3)" "unprognostic (1.11e-1)" "unprognostic (7.32e-4)" "unprognostic (2.52e-1)" "unprognostic (1.39e-4)" "unprognostic (7.15e-2)" "unprognostic (1.97e-1)" "unprognostic (7.37e-2)" "unprognostic (2.02e-2)" 0.7 0.8 1.7 0.6 1.8 1.3 0.4 2.4 3.4 1.2 3.4 0.4 0.2 0.9 1.1 0.8 5.3 1.0 0.6 1.3 1.0 0.8 0.2 1.5 1.0 2.9 2.4 2.5 0.2 0.4 0.9 0.3 1.4 1.0 0.4 1.1 0.8 1.3 1.1 1.0 0.3 0.9 1.5 0.6 0.4 65.1 1.6 0.9 0.8 0.3 0.6 0.3 0.5 1.1 0.1 0.8 0.3 0.3 0.8 0.4 0.8 0.7 0.3 0.2 0.2 0.4 2.0 0.2 0.1 0.2 0.8 0.3 0.1 0.9 0.2 4.4 0.2 1.3 1.3 0.4 0.7 0.1 0.2 1.2 0.2 0.4 1.8 0.8 0.6 3.8 0.2 0.4 0.6 0.1 0.2 0.3 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.2 0.6 1.6 0.3 0.2 0.1 0.5 0.3 0.8 2.0 0.3 0.4 0.1 0.1 2.3 0.8 0.1 0.5 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.7 1.8 2.4 3.4 1.3 1.0 2.9 2.4 1.4 1.5 1.6 1.1 0.3 0.0 1.7 7.2 0.7 0.1 1.4 0.7 0.0 3.6 0.4 0.3 0.9 0.0 6.5 1.8 0.0 2.4 1.7 0.4 0.0 0.1 224.2 18.6 1.2 1.1 0.0 3.6 2.5 0.4 0.3 2.0 0.0 0.6 0.0 5.6 0.0 0.0 0.4 0.0 2.2 1.8 0.0 0.6 0.5 145.2 6.8 0.6 0.0 2.8 0.0 4.3 3.1 0.5 1.0 0.1 0.1 3.8 0.6 1.1 1.4 0.2 40.4 0.5 0.0 2.7 1.4 69.9 7.6 0.1 0.4 0.1 1.4 54.9 0.4 0.8 MYH11 "SMHC, SMMHC" ENSG00000133392 "Myosin heavy chain 11" P35749 16 15703135-15857028 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 3322.6;seminal vesicle: 1665.5;urinary bladder: 2048.3" "Group enriched" "Detected in many" 8 "Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6" "Group enriched" "Detected in many" 5 "prostate cancer: 173.2;stomach cancer: 125.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "midbrain: 39.8" "CAB002302, HPA014539, HPA015310" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 23000000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane, Cytosol" "CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (4.18e-2)" "unprognostic (9.21e-3)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "prognostic favorable (1.10e-5)" "unprognostic (1.41e-2)" "unprognostic (1.87e-1)" "unprognostic (3.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-3)" "unprognostic (4.06e-2)" "unprognostic (9.53e-2)" "unprognostic (5.00e-2)" "unprognostic (5.45e-3)" 172.9 38.6 5.0 109.1 17.2 0.2 78.4 5.5 14.5 372.3 11.1 3322.6 95.4 1074.6 219.7 759.7 606.1 250.6 74.8 5.3 5.2 27.9 9.2 108.9 9.5 9.0 7.0 144.0 10.7 2.8 11.6 68.2 7.1 762.7 293.2 0.4 83.3 1665.5 41.2 68.5 487.4 1053.2 5.8 46.0 832.5 60.9 7.2 2.9 46.0 34.6 5.3 2048.3 314.2 6.3 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.6 0.2 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.9 0.0 0.2 0.2 7.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 5.0 17.2 5.5 14.5 5.3 5.2 9.0 7.0 7.1 5.8 7.2 6.3 7.6 0.0 1.8 0.0 4.4 13.3 2.1 1.7 5.7 2.7 5.3 122.3 40.5 0.0 1.9 0.0 8.4 0.3 3.4 0.4 0.0 0.2 50.2 4.7 19.5 12.8 1.2 0.8 0.8 0.4 0.3 22.2 0.0 3.4 0.0 27.3 6.4 0.1 1.1 0.0 5.2 0.5 0.0 2.2 17.3 46.2 42.9 2.8 12.4 15.9 3.7 0.3 3.1 1.5 10.7 0.4 0.2 1669.7 2.4 5.6 0.1 0.2 2.5 1.9 624.5 4.3 964.6 3.1 8.8 3.5 18.6 0.0 5.7 34.7 0.4 2.6 MYL9 "LC20, MLC2, MRLC1, MYRL2" ENSG00000101335 "Myosin light chain 9" P24844 20 36541497-36551447 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 8015.9" "Group enriched" "Detected in many" 4 "Breast myoepithelial cells: 860.2;Cardiomyocytes: 1856.1;Peritubular cells: 1891.9;Sertoli cells: 2143.1;Smooth muscle cells: 2525.7;Theca cells: 881.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.2;neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 783.3;BJ: 1047.3;fHDF/TERT166: 844.3;hTERT-RPE1: 645.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 76.1" "HPA039262, HPA045244, HPA059197" Supported NA NA 34000000 "Cluster 52: Eosinophils - Transcription" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" "unprognostic (2.67e-3)" "unprognostic (5.38e-2)" "unprognostic (7.17e-2)" "unprognostic (5.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (9.06e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (7.92e-7)" "unprognostic (1.90e-2)" "unprognostic (8.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.92e-2)" 944.6 948.6 61.6 347.0 76.7 5.2 649.5 63.3 132.2 1083.0 104.6 8015.9 270.5 2897.3 238.2 999.8 1643.3 364.3 2294.5 61.4 63.1 352.2 116.6 617.9 56.4 66.3 66.3 717.2 82.0 45.4 91.2 160.3 66.1 2347.4 345.8 22.8 200.7 2248.7 164.3 289.2 1287.7 2107.8 62.0 274.3 1946.4 260.7 66.5 27.4 431.7 111.4 23.2 4176.1 943.6 63.3 79.4 1.3 60.3 1.2 783.3 298.6 264.5 1047.3 450.9 541.3 349.9 612.3 9.1 0.2 535.6 844.3 120.6 29.4 0.2 2.4 125.7 0.9 0.2 16.7 114.4 57.3 500.4 0.4 17.7 420.8 54.4 359.9 1.6 645.9 19.2 0.0 2.4 28.0 461.7 0.2 0.3 7.8 24.0 16.1 5.6 0.4 0.0 5.8 4.6 5.8 0.6 4.1 11.1 26.6 0.6 257.5 232.9 15.6 137.0 510.9 220.1 75.5 1.0 0.8 4.0 2.3 194.3 0.8 0.6 0.0 0.1 2.2 0.0 0.0 0.0 0.9 0.0 0.1 0.3 0.2 0.0 0.0 1.9 0.2 0.0 0.4 0.0 7.2 61.6 76.7 63.3 132.2 61.4 63.1 66.3 66.3 66.1 62.0 66.5 63.3 325.3 394.2 52.3 0.0 6.6 60.7 320.2 167.1 21.6 1.4 36.8 860.2 1856.1 24.3 50.8 90.1 0.0 37.0 6.3 0.1 27.4 310.3 9.3 13.1 419.9 179.7 0.0 5.7 0.2 116.0 78.3 410.4 10.2 9.3 15.2 234.3 169.9 2.7 32.0 1.7 0.1 1.2 14.2 5.0 76.6 55.4 331.8 111.7 72.9 30.9 19.4 230.4 6.2 0.0 0.5 47.9 2.5 1891.9 6.4 156.9 105.5 42.1 31.8 6.1 2143.1 65.9 2525.7 16.3 9.5 6.5 53.4 26.8 14.7 881.1 2.0 61.9 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46702282-46790407 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 103.4;skeletal muscle: 46.5;tongue: 72.6" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 169.0;Endometrial ciliated cells: 44.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.9;HEL: 40.2;K-562: 6.5;SK-BR-3: 7.9" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.6;hippocampal formation: 5.1" "Region enriched" "Detected in single" 5 "hippocampal formation: 3.5" HPA073447 Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Vesicles "HPA073447: AB_2732225" "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 1.9 0.1 1.7 0.3 0.1 1.1 2.3 0.4 1.7 0.0 0.1 0.3 0.8 4.3 1.7 0.2 103.4 2.5 2.8 1.1 0.1 0.4 0.2 9.8 12.2 0.3 0.1 0.0 0.4 0.5 8.2 2.2 0.1 0.2 2.1 0.1 46.5 0.1 0.1 0.2 5.9 0.1 0.1 6.0 1.9 0.1 0.1 72.6 0.1 0.0 0.0 3.0 0.0 0.1 0.1 0.1 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 2.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 6.5 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.4 0.0 7.9 0.2 3.5 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 1.9 1.7 1.1 2.3 2.5 2.8 9.8 12.2 8.2 5.9 1.9 3.0 0.2 0.0 3.3 0.7 0.5 0.0 0.7 0.0 0.0 0.9 1.3 0.0 169.0 0.0 3.7 0.0 2.1 2.0 0.2 0.0 0.0 0.0 8.1 44.8 7.1 1.7 0.0 0.0 0.9 0.2 0.5 6.7 0.0 2.2 1.3 1.6 0.7 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 7.2 0.6 0.8 0.0 0.0 0.2 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.8 0.0 0.2 8.7 1.3 0.0 4.9 2.7 1.0 0.7 0.0 0.0 0.3 0.8 0.7 0.0 0.8 MZB1 "HSPC190, MEDA-7, MGC29506, PACAP, pERp1" ENSG00000170476 "Marginal zone B and B1 cell specific protein" Q8WU39 5 139387467-139390081 "Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 89.8;lymphoid tissue: 272.2" "Cell type enriched" "Detected in many" 6 "Plasma cells: 4000.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 160.4;plasmacytoid DC: 569.3" "Group enriched" "Detected in many" 116 "B-cells: 160.4;dendritic cells: 569.3" "Group enriched" "Detected in some" 5 "Karpas-707: 581.5;RPMI-8226: 2193.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043745, HPA052694" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 350000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA043745: AB_10960359, HPA052694: AB_2681919" "unprognostic (4.97e-3)" "unprognostic (1.75e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.27e-4)" "unprognostic (2.21e-2)" "prognostic favorable (4.60e-5)" "unprognostic (6.57e-2)" "unprognostic (1.35e-1)" "unprognostic (6.45e-3)" "unprognostic (7.10e-3)" "unprognostic (2.57e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.15e-8)" "unprognostic (7.22e-2)" "unprognostic (3.14e-1)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" 4.4 9.1 0.0 87.4 0.1 33.0 21.0 0.0 0.7 18.3 0.2 70.1 89.8 1.8 0.4 10.1 5.7 14.3 2.3 0.0 0.0 5.9 5.8 15.9 123.2 0.1 0.0 4.9 1.3 0.0 0.7 0.0 0.1 5.1 39.9 0.0 56.7 4.9 0.1 0.4 47.8 2.1 0.4 272.2 66.6 2.4 0.1 147.3 9.1 0.0 117.8 58.7 3.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 256.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 144.6 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 128.5 0.5 581.5 0.0 0.0 227.8 2.2 0.0 0.0 0.0 90.1 0.3 2193.9 0.0 0.0 0.3 0.8 0.0 11.4 0.0 0.0 3.1 0.1 0.6 0.0 1.8 0.1 0.0 262.0 16.7 223.0 0.1 0.4 0.0 0.0 0.1 0.1 1.5 0.1 3.0 160.4 0.6 1.1 0.5 75.6 0.1 0.2 3.1 2.7 0.0 569.3 0.2 26.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.3 0.4 6.4 10.1 0.0 665.7 2.5 1.3 0.1 0.0 0.0 3.7 3.2 1.1 4.3 2.0 0.0 0.0 0.1 235.0 0.9 0.0 0.1 0.1 1.8 0.4 2.0 1.2 49.3 0.0 0.0 0.1 2.0 6.1 0.4 2.5 0.1 11.4 14.0 0.1 0.0 0.0 1.1 0.0 7.1 3.4 1.1 0.0 4.7 540.7 0.0 1.0 0.0 4.1 0.0 0.0 0.1 0.4 0.0 4000.1 3.0 1.2 1.9 1.2 0.0 0.0 1.7 2.1 0.1 0.1 0.4 2.4 2.2 100.7 0.5 9.7 0.4 NAIP "BIRC1, NLRB1" ENSG00000249437 "NLR family apoptosis inhibitory protein" Q13075 5 70968166-71025339 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 31.6" "Cell type enhanced" "Detected in many" "Kupffer cells: 138.4;Macrophages: 97.4;Microglial cells: 113.4;Oligodendrocytes: 177.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 8.4;myeloid DC: 5.3" "Group enriched" "Detected in many" 16 "dendritic cells: 5.3;granulocytes: 4.4;monocytes: 8.4" "Cell line enhanced" "Detected in some" "MOLT-4: 3.9;SiHa: 2.1;T-47d: 2.3" HPA042438 Approved NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA042438: AB_10796578" "unprognostic (9.03e-2)" "unprognostic (6.03e-2)" "unprognostic (1.31e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "unprognostic (1.12e-3)" "unprognostic (1.12e-1)" "unprognostic (2.23e-2)" "unprognostic (4.36e-2)" "unprognostic (1.86e-1)" "unprognostic (2.54e-2)" "unprognostic (5.13e-1)" "unprognostic (1.69e-3)" "unprognostic (1.17e-1)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (9.96e-2)" 5.5 2.7 1.1 2.7 0.8 1.6 3.4 1.8 1.7 3.0 1.0 3.2 0.3 2.1 0.8 1.4 4.5 1.1 2.9 1.0 0.8 2.7 3.4 6.8 2.4 0.8 0.5 2.9 3.3 0.2 1.4 0.6 1.0 2.2 0.5 2.1 1.8 0.5 1.0 2.2 4.6 0.8 0.5 31.6 2.8 4.1 1.2 0.4 3.6 0.0 0.2 3.0 2.7 1.0 0.0 0.0 0.6 0.3 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.4 0.5 0.7 0.1 0.8 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.4 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.2 0.1 0.4 0.0 2.1 0.0 0.1 0.4 2.3 0.0 0.0 0.6 0.2 0.1 0.0 0.5 0.0 0.3 0.1 0.1 0.4 0.2 8.4 0.0 0.2 2.0 0.1 0.0 0.0 0.1 5.3 0.2 0.2 0.1 4.4 0.3 0.4 0.3 0.1 2.5 1.1 0.8 1.8 1.7 1.0 0.8 0.8 0.5 1.0 0.5 1.2 1.0 8.5 19.2 9.7 60.7 9.4 3.6 2.4 2.2 2.8 16.2 10.2 4.6 3.2 11.5 8.2 5.5 22.9 3.7 7.3 4.1 0.0 1.9 44.0 10.0 15.1 11.1 10.7 18.3 50.2 2.3 2.4 8.2 14.3 10.9 5.1 15.8 9.3 7.3 69.3 16.8 46.4 5.6 2.0 138.4 16.4 11.6 10.8 97.4 1.8 113.4 44.2 6.7 4.1 67.8 177.5 1.6 2.5 7.2 9.8 2.3 1.6 1.3 6.9 38.4 6.6 12.8 5.5 13.7 4.4 3.6 3.8 2.9 8.5 6.0 4.0 1.5 NCAPG "CAP-G, FLJ12450, hCAP-G, YCG1" ENSG00000109805 "Non-SMC condensin I complex subunit G" Q9BPX3 4 17810979-17844865 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.9;lymphoid tissue: 15.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 59.3;Extravillous trophoblasts: 26.6;Plasma cells: 20.4;Spermatocytes: 63.7;Spermatogonia: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.6" "Low region specificity" "Detected in all" HPA039613 Uncertain NA Yes 9500 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "HPA039613: AB_10805481" "unprognostic (5.23e-2)" "unprognostic (3.37e-1)" "unprognostic (1.59e-3)" "prognostic unfavorable (8.28e-4)" "unprognostic (4.22e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (1.18e-3)" "unprognostic (1.63e-2)" "unprognostic (6.70e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.44e-2)" "unprognostic (0.00e+0)" "unprognostic (1.94e-2)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" 0.7 0.5 0.1 4.1 0.1 13.9 0.9 0.5 0.1 0.7 0.2 3.0 3.8 0.6 0.0 3.5 0.2 0.9 0.3 0.0 0.2 0.2 0.7 0.6 8.7 0.6 1.2 0.2 0.2 0.1 0.1 3.0 0.7 0.3 2.4 0.3 0.7 0.0 0.2 3.5 3.2 1.0 1.2 2.1 1.9 5.6 0.3 15.8 0.3 0.1 8.7 1.2 1.0 0.2 45.1 28.3 63.8 42.2 4.0 7.8 23.1 56.8 22.2 55.0 55.8 36.3 26.8 66.8 11.3 16.0 47.6 19.9 54.5 22.1 74.8 30.5 27.0 53.6 37.3 29.8 0.2 38.4 20.3 1.5 1.5 40.7 18.6 8.8 27.9 28.9 53.1 74.1 55.0 13.4 44.1 36.9 32.8 26.1 27.9 42.8 57.4 28.0 16.6 13.9 50.0 29.7 51.2 10.9 15.7 27.2 25.6 21.3 23.2 52.5 23.6 30.0 78.9 23.2 23.3 56.1 21.7 39.1 35.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.4 0.1 0.1 0.5 0.1 0.0 0.2 0.6 1.2 0.7 1.2 0.3 0.2 0.3 0.0 1.1 0.0 3.3 2.4 0.6 1.9 1.2 0.2 0.6 0.6 0.2 0.0 0.8 0.0 0.0 11.7 1.6 2.9 0.0 0.1 15.8 0.9 1.9 1.7 1.8 59.3 0.2 0.0 26.6 3.8 7.1 2.3 1.3 14.2 2.2 0.5 9.5 0.0 0.4 3.1 2.0 2.6 2.9 9.5 0.6 3.7 1.8 1.0 0.7 0.3 3.1 0.5 0.5 0.2 0.1 0.0 20.4 0.4 0.2 0.0 0.0 0.2 0.0 0.2 4.3 63.7 24.3 11.0 1.1 2.2 3.7 0.7 5.6 1.3 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335766-96377091 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.2;lymphoid tissue: 37.4;testis: 35.4" "Cell type enhanced" "Detected in many" "Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "T-reg: 6.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.8;T-cells: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavorable (9.53e-6)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.2 0.7 0.3 9.9 0.4 35.2 1.8 0.9 0.9 1.3 0.1 7.7 5.6 0.9 0.2 6.3 0.5 1.6 0.4 0.3 0.2 0.4 1.0 1.1 20.3 0.1 0.0 0.3 0.3 0.5 0.2 5.2 0.3 0.4 9.3 1.8 1.5 0.2 0.3 4.7 6.2 2.8 0.0 3.7 3.6 35.4 0.1 37.4 0.4 0.1 22.0 2.6 2.0 0.3 134.1 52.0 115.1 60.6 3.9 6.1 80.8 58.7 40.3 115.1 118.4 93.5 71.5 121.0 41.8 26.6 106.2 57.2 100.2 39.6 117.2 110.0 63.4 123.7 49.3 74.5 0.7 112.2 101.3 1.8 4.2 89.1 35.9 10.2 46.6 89.7 89.5 88.8 53.0 59.5 183.8 104.2 85.9 57.6 56.6 133.4 106.7 95.5 23.6 49.6 71.2 52.3 34.8 46.5 19.9 42.4 36.6 80.0 24.1 83.5 126.3 76.9 101.9 44.4 70.1 134.0 33.7 111.5 95.3 3.8 0.0 0.2 0.8 0.9 0.1 0.9 1.2 1.0 0.4 0.9 0.0 0.4 0.3 0.1 0.0 0.0 6.2 0.5 0.3 0.4 0.9 0.9 0.3 0.2 0.1 0.0 0.3 0.0 0.1 0.3 4.9 0.0 0.0 0.0 3.5 0.6 0.7 1.9 1.2 0.4 1.0 0.8 0.5 0.0 1.6 0.0 8.4 9.4 2.0 2.1 0.0 0.5 5.9 1.7 0.9 1.8 0.0 16.4 0.4 0.0 16.3 1.8 4.1 1.2 1.3 5.5 1.4 0.4 8.5 0.0 0.3 2.8 0.0 3.8 3.7 4.9 0.9 2.2 1.8 0.0 0.2 8.5 0.0 0.5 1.0 0.2 0.1 0.4 26.3 0.7 0.4 0.0 1.6 2.3 0.0 0.2 3.5 89.3 29.4 8.8 0.9 1.9 5.1 0.6 5.7 1.1 NCR1 "CD335, LY94, NK-p46, NKP46" ENSG00000189430 "Natural cytotoxicity triggering receptor 1" O76036 19 54906148-54916140 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.5" "Group enriched" "Detected in some" 7 "dendritic cells: 30.2;NK-cells: 110.2" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Region enriched" "Detected in single" 7 "cerebral cortex: 1.0" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049311 Approved "Endoplasmic reticulum" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Endoplasmic reticulum" "HPA049311: AB_2680707" "unprognostic (3.92e-2)" "unprognostic (2.21e-3)" "unprognostic (1.67e-1)" "unprognostic (2.87e-4)" "unprognostic (2.89e-1)" "unprognostic (6.32e-4)" "unprognostic (2.22e-2)" "unprognostic (3.29e-1)" "unprognostic (1.07e-1)" "unprognostic (1.89e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-5)" "unprognostic (1.82e-2)" "unprognostic (5.92e-2)" "unprognostic (3.81e-3)" "unprognostic (6.05e-3)" 0.2 0.0 0.1 0.2 0.0 0.7 0.1 0.1 1.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 6.6 0.4 0.0 0.0 0.1 1.1 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.0 1.8 0.0 1.9 0.1 0.0 110.2 0.5 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 NDC80 "HEC, HEC1, hsNDC80, KNTC2, TID3" ENSG00000080986 "NDC80 kinetochore complex component" O14777 18 2571557-2616635 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.2;lymphoid tissue: 29.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 63.4;Spermatocytes: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 7.2;granulocytes: 8.3;T-cells: 11.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA066330 Supported Nucleoplasm,Centrosome NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Centrosome "HPA066330: AB_2685661" "unprognostic (1.96e-1)" "unprognostic (5.38e-2)" "unprognostic (2.96e-1)" "unprognostic (2.21e-3)" "unprognostic (1.87e-1)" "unprognostic (3.63e-2)" "prognostic unfavorable (2.53e-8)" "unprognostic (1.16e-2)" "unprognostic (2.58e-3)" "unprognostic (2.86e-2)" "unprognostic (3.19e-3)" "unprognostic (7.74e-2)" "unprognostic (0.00e+0)" "unprognostic (9.69e-3)" "unprognostic (1.69e-1)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" 1.8 0.9 1.4 9.6 1.3 31.2 2.5 2.2 1.7 2.7 0.1 7.0 5.9 4.3 2.1 5.6 1.2 2.5 1.2 1.0 0.6 1.2 1.6 1.5 20.5 1.9 0.6 0.8 0.9 0.5 0.1 10.4 2.9 5.3 9.8 0.7 1.1 14.0 0.9 7.9 6.2 5.0 0.4 5.5 3.8 15.1 1.2 29.2 1.6 0.6 19.3 3.2 4.6 2.5 80.3 17.7 86.5 38.6 4.5 9.8 44.5 91.7 49.1 117.7 99.7 49.2 44.0 86.6 40.4 35.9 49.7 47.9 98.2 39.9 123.6 32.2 24.6 68.8 49.5 38.1 1.5 133.2 55.1 5.1 3.7 67.8 47.8 12.0 54.3 52.8 56.8 107.1 104.0 36.2 65.1 57.2 44.9 51.6 25.3 71.0 88.6 69.7 31.0 38.0 69.3 31.4 84.4 21.7 32.7 34.0 36.7 52.4 33.2 75.7 168.1 60.7 123.2 46.5 78.6 116.0 33.5 60.8 65.8 3.5 0.6 2.5 1.8 0.4 1.7 7.2 3.2 3.8 0.2 5.3 2.0 2.0 8.3 1.7 0.5 1.3 11.3 1.3 1.4 1.3 2.2 1.7 1.0 0.6 1.9 0.6 2.9 0.4 1.2 2.5 2.8 0.0 0.6 0.3 5.8 2.3 0.7 3.8 0.6 0.0 0.6 0.9 15.8 0.0 2.4 0.0 0.0 15.5 4.8 2.1 0.0 0.9 22.0 1.3 3.7 1.9 0.0 63.4 0.6 0.4 21.7 6.8 2.6 2.1 0.0 20.8 5.7 0.5 11.5 0.0 0.5 2.8 8.2 3.2 2.4 7.6 7.5 1.7 0.0 1.0 0.4 0.0 7.2 0.5 0.5 0.3 0.1 23.3 14.1 0.4 0.4 0.2 1.4 0.0 19.7 0.6 6.8 82.8 21.1 4.2 0.6 2.1 8.7 9.8 6.2 1.5 NEIL3 "FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3" ENSG00000109674 "Nei like DNA glycosylase 3" Q8TAT5 4 177309874-177362936 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 6.6;lymphoid tissue: 23.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 14.7;Granulosa cells: 4.8;Plasma cells: 6.1;Squamous epithelial cells: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 72.1;HL-60: 79.1;Karpas-707: 99.1;MOLT-4: 80.7" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.3" HPA065761 Enhanced Nucleoplasm NA Yes "Cluster 48: NK-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA065761: AB_2685555" "unprognostic (6.03e-2)" "unprognostic (5.79e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.45e-4)" "unprognostic (4.91e-2)" "unprognostic (2.05e-1)" "unprognostic (3.64e-7)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (6.51e-4)" "unprognostic (2.82e-3)" "unprognostic (0.00e+0)" "unprognostic (3.25e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-2)" 0.1 0.0 0.0 1.7 0.0 6.6 0.3 0.0 0.1 0.2 0.0 1.1 1.1 0.1 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 3.6 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 2.3 1.3 0.5 0.0 0.4 0.6 1.5 0.1 23.6 0.0 0.0 3.5 0.4 0.4 0.0 19.3 15.8 16.4 8.2 1.8 3.3 8.0 23.4 8.6 25.3 14.9 5.8 16.5 21.2 3.4 6.2 25.1 8.8 17.4 9.3 36.6 72.1 11.4 14.7 11.9 15.2 0.5 79.1 9.7 0.3 0.5 26.2 5.6 5.2 9.9 53.9 15.3 99.1 16.7 8.4 80.7 30.2 7.5 5.7 11.5 16.2 11.2 6.8 6.8 2.6 12.8 8.9 11.7 13.4 6.3 7.2 10.9 20.4 4.7 15.2 11.8 7.8 24.0 6.8 4.8 33.5 10.1 27.8 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.1 0.4 1.2 0.0 0.2 0.1 0.4 0.0 1.3 0.0 0.0 2.6 1.6 0.5 0.0 0.0 0.1 0.1 0.6 0.3 0.0 14.7 0.1 0.2 3.3 0.9 0.0 0.5 0.0 4.8 0.4 0.0 1.5 0.0 0.1 1.0 0.0 1.3 0.4 0.2 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 6.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.5 2.7 2.4 4.5 1.3 0.3 1.0 0.5 1.2 0.2 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 36.6;tongue: 20.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 87.6;Early spermatids: 123.5;Endometrial ciliated cells: 59.3;Excitatory neurons: 131.4;Inhibitory neurons: 130.2;Late spermatids: 61.7;Respiratory ciliated cells: 104.2" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 6.0;LHCN-M2: 8.2;U-2 OS: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favorable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.2 0.3 3.0 0.3 5.3 0.3 14.0 0.0 9.4 1.4 3.3 2.0 2.5 0.8 8.3 1.8 11.0 1.4 3.3 9.6 5.0 1.7 2.5 2.4 0.5 3.3 5.7 0.7 0.7 0.4 3.4 0.1 2.7 1.7 0.5 6.2 0.3 1.2 12.4 0.3 0.8 0.3 2.3 0.4 1.0 36.6 6.1 0.5 0.7 20.0 0.6 1.2 0.2 0.9 0.8 1.6 0.8 0.9 0.6 1.5 0.3 6.0 0.9 1.6 1.4 0.0 0.4 0.5 1.4 2.5 1.1 0.1 0.4 0.4 1.7 1.1 0.6 0.1 3.4 2.9 0.1 0.3 0.8 1.8 0.4 2.5 0.1 2.0 1.1 3.4 0.1 0.6 8.2 0.1 0.6 0.4 0.5 0.2 0.2 0.8 0.3 0.2 3.0 0.5 0.1 0.2 0.9 0.3 0.4 0.5 4.8 0.3 0.7 4.3 6.8 0.2 0.6 0.2 0.2 0.4 3.6 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 5.3 0.0 9.4 9.6 5.0 3.3 5.7 2.7 2.3 6.1 0.9 1.5 6.4 0.0 11.4 0.3 0.3 0.3 3.2 0.0 14.5 25.8 7.4 12.9 4.3 9.3 1.8 87.6 0.0 0.8 0.2 0.0 0.4 123.5 59.3 1.3 2.4 0.0 0.0 131.4 0.0 0.3 3.1 0.0 7.7 0.0 1.1 0.7 1.3 0.2 0.0 130.2 0.4 12.2 1.0 0.8 61.7 1.8 1.1 0.0 32.8 0.1 1.0 1.0 20.6 12.9 0.2 2.7 1.2 0.1 1.9 2.1 0.3 104.2 19.1 0.0 14.9 2.4 32.2 2.2 0.1 0.4 0.0 1.1 3.7 0.6 0.4 NEK11 FLJ23495 ENSG00000114670 "NIMA related kinase 11" Q8NG66 3 131026850-131350465 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 26.2" "Cell type enhanced" "Detected in many" "Astrocytes: 60.7;Early spermatids: 156.4;Endometrial ciliated cells: 69.2;Excitatory neurons: 91.0;Late spermatids: 109.2;Respiratory ciliated cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016908 Approved Supported Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA016908: AB_1854364" "unprognostic (9.15e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (4.85e-3)" "unprognostic (2.48e-5)" "unprognostic (5.38e-2)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "prognostic favorable (5.92e-6)" "unprognostic (2.46e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" 3.1 4.3 8.3 0.5 8.3 0.1 6.6 6.9 7.7 5.4 26.2 2.1 1.3 4.9 7.1 2.3 21.4 4.6 2.1 7.3 9.0 6.3 0.6 4.3 1.0 14.2 15.5 6.4 2.2 4.8 5.6 2.2 12.4 2.9 2.4 5.6 2.9 3.7 1.1 2.2 1.8 2.7 12.8 1.2 1.6 15.5 9.3 0.9 9.6 0.8 1.2 2.8 2.5 12.8 5.7 2.2 1.6 4.8 6.2 9.3 0.9 2.7 5.0 4.1 3.1 2.1 7.7 0.2 1.9 4.8 3.9 3.0 0.4 4.6 5.6 0.5 0.6 0.8 0.3 1.0 2.1 0.6 1.3 3.9 7.7 4.2 1.9 4.3 0.8 2.4 0.2 0.8 6.9 3.9 0.1 0.4 0.5 0.9 2.1 0.0 0.1 0.1 9.3 2.2 2.0 2.2 1.3 0.1 1.9 0.7 4.4 0.1 0.9 4.1 2.0 3.3 1.3 1.2 2.2 0.1 2.9 0.2 0.7 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.3 0.0 8.3 8.3 6.9 7.7 7.3 9.0 14.2 15.5 12.4 12.8 9.3 12.8 2.5 16.0 3.2 60.7 1.5 4.2 3.4 4.5 4.6 2.6 7.3 7.5 1.6 4.3 18.8 1.8 6.2 1.0 1.4 3.3 5.9 6.4 156.4 69.2 6.1 3.5 2.4 0.4 91.0 2.5 1.1 7.7 2.6 6.6 0.0 8.1 5.7 0.6 2.0 0.0 42.0 3.5 6.1 0.3 1.7 109.2 6.8 2.0 0.0 21.5 0.8 6.4 1.0 38.7 38.9 3.7 3.9 6.0 0.8 1.6 1.7 10.6 102.7 7.3 6.6 7.2 3.7 33.4 5.2 2.6 2.0 1.6 1.4 11.5 2.4 2.7 NEK2 "NEK2A, NLK1, PPP1R111, RP67" ENSG00000117650 "NIMA related kinase 2" P51955 1 211658657-211675630 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 17.9;lymphoid tissue: 19.2;testis: 67.1" "Group enriched" "Detected in many" 4 "Early spermatids: 76.1;Spermatocytes: 244.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 5.7" "Low region specificity" "Detected in all" "CAB017530, HPA064967" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Centrosome" "CAB017530: AB_1126558, HPA064967: AB_2685393" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (9.47e-6)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.95e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-3)" "unprognostic (8.49e-2)" "unprognostic (0.00e+0)" "unprognostic (8.21e-2)" "unprognostic (4.11e-2)" "unprognostic (1.25e-2)" "unprognostic (2.71e-1)" 0.7 0.4 0.5 5.3 0.4 17.9 1.5 0.9 0.6 1.1 0.6 5.9 7.4 1.3 0.5 4.4 2.2 0.8 0.4 0.5 0.3 0.3 0.7 0.7 9.0 0.4 0.2 0.4 0.1 0.1 0.0 3.2 0.3 2.5 7.6 1.5 0.8 0.2 0.4 4.3 6.9 2.0 0.2 1.7 2.7 67.1 0.6 19.2 0.4 0.2 10.6 1.3 1.6 0.9 86.0 60.5 45.3 32.6 2.6 4.5 49.7 32.4 30.1 55.4 47.5 32.3 81.7 45.1 15.2 25.2 35.1 44.5 39.9 24.2 69.6 69.5 33.2 21.6 51.4 44.2 0.4 43.2 28.3 1.4 2.9 42.9 45.9 13.4 36.3 45.2 59.9 76.9 56.0 23.6 47.3 28.8 43.0 55.0 30.5 46.2 69.2 68.7 19.7 24.2 41.0 45.0 46.6 51.5 39.3 38.4 79.4 25.1 19.0 27.6 54.1 54.8 88.3 31.6 62.6 59.6 24.1 32.6 46.8 1.2 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 0.4 0.3 0.2 0.7 1.5 0.1 0.2 1.6 0.3 0.5 0.4 0.9 0.6 0.5 0.3 0.4 0.2 0.3 0.2 0.6 0.9 0.1 0.0 0.5 0.3 1.7 2.9 0.7 3.8 0.6 11.3 1.9 2.2 0.5 0.0 2.9 0.0 0.0 9.4 0.8 1.9 0.0 0.2 76.1 15.2 0.7 0.8 0.0 39.6 0.8 0.2 14.1 1.4 5.6 1.5 0.0 3.6 3.6 0.7 5.8 3.3 0.0 3.2 10.2 2.5 1.1 39.0 2.5 2.1 0.0 0.0 0.0 1.6 2.1 0.0 0.1 0.0 2.5 0.7 5.4 0.7 2.1 0.1 5.2 1.8 6.6 0.0 1.5 244.2 26.1 8.6 1.7 1.4 2.0 0.9 9.5 1.4 NEK5 ENSG00000197168 "NIMA related kinase 5" Q6P3R8 13 52033611-52129092 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.1;choroid plexus: 7.4;fallopian tube: 8.8;testis: 10.8" "Group enriched" "Detected in many" 4 "Early spermatids: 57.9;Endometrial ciliated cells: 75.8;Late spermatids: 32.0;Respiratory ciliated cells: 98.6;Spermatocytes: 32.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;OE19: 2.4;T-47d: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035565, HPA041399" Enhanced NA NA "Cluster 11: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA035565: AB_10672095, HPA041399: AB_2677453" "unprognostic (4.14e-2)" "unprognostic (1.49e-1)" "unprognostic (1.89e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-2)" "unprognostic (2.47e-1)" "unprognostic (3.57e-2)" "unprognostic (6.50e-2)" "unprognostic (8.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.94e-1)" "unprognostic (2.06e-3)" "unprognostic (1.83e-3)" "unprognostic (1.10e-1)" "unprognostic (1.19e-3)" "unprognostic (9.44e-3)" 0.1 0.1 1.1 0.2 1.5 0.3 0.4 0.7 0.7 0.3 7.4 0.1 0.1 0.5 0.3 0.0 8.8 0.1 0.4 1.5 1.7 0.4 0.0 1.3 0.1 5.1 5.1 0.1 0.1 0.7 0.1 0.4 2.5 0.5 0.2 1.6 0.1 0.1 0.3 0.2 0.1 0.2 3.6 0.2 0.1 10.8 2.6 0.3 0.3 0.1 0.1 0.1 0.0 2.7 0.1 0.1 0.1 0.6 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.4 0.6 0.1 0.2 0.0 0.1 0.1 0.0 1.2 0.4 0.2 0.0 0.5 0.1 0.3 0.2 2.4 0.2 0.0 0.0 0.0 0.6 0.1 0.1 0.3 0.2 0.0 0.2 0.3 1.1 0.4 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.1 1.5 0.7 0.7 1.5 1.7 5.1 5.1 2.5 3.6 2.6 2.7 1.4 0.0 2.0 2.6 1.5 0.0 1.9 0.3 0.0 9.2 3.0 1.8 2.0 2.8 12.1 7.3 14.6 2.6 2.5 0.5 1.9 1.3 57.9 75.8 1.9 3.0 1.8 0.8 3.8 2.9 2.4 1.6 0.0 2.8 2.5 1.2 0.4 1.2 1.2 13.5 3.1 0.4 2.0 0.3 0.4 32.0 2.1 0.6 0.0 4.7 1.4 2.1 3.1 1.0 6.6 0.8 0.7 2.2 0.5 3.7 1.3 1.5 98.6 13.2 6.6 4.6 1.3 32.2 12.9 0.3 0.1 1.9 1.0 1.2 1.1 1.3 NGEF ARHGEF27 ENSG00000066248 "Neuronal guanine nucleotide exchange factor" Q8N5V2 2 232878701-233013256 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 56.2;brain: 129.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.0;Excitatory neurons: 105.9;Proximal enterocytes: 66.7" "Cancer enhanced" "Detected in many" "testis cancer: 22.5" "Region enhanced" "Detected in many" "basal ganglia: 129.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 53.9;HDLM-2: 45.3;HeLa: 21.6;PC-3: 57.0;T-47d: 32.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 167.6;cerebral cortex: 133.8;hippocampal formation: 73.0" HPA008160 Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" "HPA008160: AB_1854450" "unprognostic (3.92e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-3)" "unprognostic (1.66e-1)" "unprognostic (5.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.15e-1)" "unprognostic (2.39e-3)" "unprognostic (5.41e-3)" "unprognostic (2.58e-1)" "unprognostic (6.94e-3)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.80e-2)" "unprognostic (2.74e-1)" 1.1 56.2 16.3 2.2 129.6 0.1 1.9 0.0 59.4 4.1 0.0 14.2 42.7 5.0 4.1 10.3 4.8 3.1 2.2 19.8 0.0 7.0 35.5 0.7 0.2 0.0 0.0 2.0 6.0 11.9 2.7 0.3 0.0 1.8 10.5 1.4 2.0 0.7 0.9 30.3 31.3 6.7 0.0 0.4 10.7 3.7 0.2 0.0 0.9 0.7 0.3 1.8 5.2 29.4 53.9 15.4 0.6 0.2 0.2 8.2 0.9 0.9 0.1 0.4 0.0 0.7 5.2 0.0 15.2 10.9 5.5 6.9 11.6 3.0 0.4 45.3 3.8 0.1 21.6 16.7 0.2 0.0 0.3 0.0 0.2 3.5 0.6 0.2 1.9 0.2 0.2 0.2 0.5 4.0 0.0 0.1 1.3 0.2 57.0 0.0 0.0 0.1 1.0 1.4 1.9 0.4 6.6 3.3 0.1 2.0 32.2 0.4 0.0 0.5 4.5 0.3 1.0 0.5 0.2 0.0 3.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 129.6 0.0 59.4 19.8 0.0 0.0 0.0 0.0 0.0 0.2 29.4 0.0 0.0 0.0 10.4 0.0 9.9 1.2 1.2 2.8 0.3 2.1 1.4 2.4 4.3 0.5 0.0 0.0 0.1 0.0 38.0 0.0 3.9 0.7 9.1 0.9 0.4 4.9 0.0 105.9 10.5 0.3 0.7 17.3 2.0 0.0 0.3 0.4 20.4 0.1 1.7 12.8 14.6 0.0 0.3 0.6 2.0 0.0 0.3 1.8 6.5 0.0 5.5 0.0 4.5 6.0 12.1 23.5 1.2 0.1 0.5 66.7 9.8 2.5 0.2 0.0 0.2 0.3 1.1 0.8 3.8 7.5 0.0 0.2 0.5 20.2 1.1 NHLRC4 ENSG00000257108 "NHL repeat containing 4" P0CG21 16 567005-569495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.7;kidney: 10.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 23.9;Endometrial ciliated cells: 23.3;Erythroid cells: 11.8;Leydig cells: 8.1;Respiratory ciliated cells: 18.1;Theca cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 3.3;HMC-1: 9.6;REH: 2.6;RPMI-8226: 4.3" "Low region specificity" "Detected in single" HPA077301 Approved Mitochondria NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "HPA077301: " "unprognostic (7.95e-2)" "unprognostic (5.87e-2)" "unprognostic (4.28e-3)" "unprognostic (2.53e-2)" "unprognostic (1.08e-1)" "unprognostic (5.95e-3)" "unprognostic (2.21e-1)" "unprognostic (2.48e-1)" "unprognostic (2.28e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-3)" "unprognostic (1.19e-2)" "unprognostic (1.16e-2)" "unprognostic (5.16e-3)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.60e-1)" 0.8 5.4 0.6 0.7 0.5 2.9 1.2 0.8 0.5 1.8 2.1 0.9 1.0 1.1 2.1 0.3 11.7 0.9 0.9 0.7 1.0 10.5 0.2 2.0 1.9 2.8 3.3 3.0 0.2 3.2 1.1 0.6 1.7 1.4 0.2 0.0 2.2 2.4 0.5 0.3 1.5 0.3 2.3 3.8 0.6 2.7 0.8 2.4 0.4 0.2 0.6 0.7 0.6 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.1 3.3 0.0 0.8 0.7 0.2 9.6 1.9 0.0 0.1 0.2 0.0 0.2 0.6 1.0 1.1 0.0 0.0 0.3 2.5 0.2 0.0 0.0 2.6 0.0 4.3 0.2 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.4 0.5 0.5 0.0 0.0 0.0 0.0 1.5 1.4 0.7 0.0 0.1 0.2 0.0 0.2 2.3 0.1 0.0 0.2 0.4 0.5 0.2 0.2 0.2 0.5 0.3 0.0 0.3 0.1 1.7 0.5 0.3 0.6 0.5 0.8 0.5 0.7 1.0 2.8 3.3 1.7 2.3 0.8 0.6 1.6 0.0 0.0 0.3 1.2 0.0 0.5 0.8 0.6 0.1 1.9 1.4 0.2 0.0 2.2 23.9 0.0 0.2 1.8 0.1 0.0 0.0 0.0 23.3 1.1 1.0 0.0 11.8 0.1 0.2 0.0 2.3 0.0 1.0 0.0 0.4 1.1 0.0 1.7 0.0 0.5 0.2 2.0 0.6 0.9 0.4 8.1 0.5 0.0 1.0 0.2 1.5 1.0 0.0 0.0 0.0 0.0 4.5 0.9 0.3 0.3 0.1 18.1 0.1 6.6 0.1 2.0 0.1 0.1 0.0 0.1 0.0 0.7 12.7 0.2 0.3 NME5 "nm23-H5, RSPH23" ENSG00000112981 "NME/NM23 family member 5" P56597 5 138115175-138139443 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 37.2;testis: 53.3" "Group enriched" "Detected in many" 4 "Early spermatids: 704.9;Endometrial ciliated cells: 205.8;Late spermatids: 256.5;Respiratory ciliated cells: 431.9;Spermatocytes: 326.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035648, HPA044555, HPA058103" Enhanced Approved "Nucleoplasm,Nuclear bodies" Yes NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear bodies" "HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: " "unprognostic (2.49e-2)" "unprognostic (7.63e-4)" "unprognostic (9.97e-2)" "prognostic favorable (7.24e-5)" "unprognostic (3.27e-2)" "unprognostic (2.27e-1)" "unprognostic (3.04e-3)" "unprognostic (3.06e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (1.83e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.76e-4)" "unprognostic (9.14e-4)" "unprognostic (1.11e-3)" "unprognostic (3.45e-1)" "unprognostic (3.16e-2)" 1.4 6.5 9.7 0.5 10.5 0.0 4.5 9.2 11.7 8.6 18.6 2.1 0.2 4.9 23.1 1.0 37.2 8.7 3.6 10.5 9.2 20.5 0.5 4.5 0.4 10.5 12.3 5.3 4.4 24.3 8.9 0.1 12.1 5.0 1.1 12.9 3.7 4.5 0.4 0.3 0.6 3.1 9.6 0.2 2.8 53.3 11.0 0.7 12.4 0.6 0.2 2.1 0.6 8.9 0.0 0.0 3.9 4.3 0.0 0.0 0.0 0.7 0.4 0.7 0.3 0.1 1.8 0.0 1.1 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 1.7 0.0 0.0 2.1 0.0 0.9 0.0 3.8 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 29.9 0.0 6.7 2.5 0.0 0.8 4.9 1.7 0.5 1.6 0.0 0.7 0.0 0.0 0.9 0.4 0.8 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 10.5 9.2 11.7 10.5 9.2 10.5 12.3 12.1 9.6 11.0 8.9 1.0 6.4 7.5 26.8 0.3 0.6 8.5 41.1 0.0 11.7 9.0 7.9 4.3 8.6 38.1 33.1 14.6 0.5 0.1 0.3 86.1 23.8 704.9 205.8 9.2 3.5 5.4 0.0 57.9 4.0 0.0 4.2 2.6 12.7 0.0 7.7 3.6 0.6 0.1 6.7 42.2 3.3 44.7 0.0 0.3 256.5 9.0 1.4 10.6 3.7 0.6 19.1 0.0 11.1 8.1 4.2 0.3 13.9 0.0 4.8 0.2 92.3 431.9 25.8 0.0 0.5 12.6 326.8 24.7 0.0 0.3 0.0 0.8 10.9 1.7 5.9 NME9 "NM23-H9, TXL-2, TXNDC6" ENSG00000181322 "NME/NM23 family member 9" Q86XW9 3 138261437-138329886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 14.6;fallopian tube: 17.6" "Group enriched" "Detected in some" 6 "Astrocytes: 27.4;Endometrial ciliated cells: 20.0;Excitatory neurons: 26.6;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 36.6;Respiratory ciliated cells: 48.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020943, HPA040000, HPA043881" Enhanced Approved "Centriolar satellite,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Centriolar satellite" "CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712" "unprognostic (2.71e-5)" "unprognostic (1.68e-1)" "unprognostic (5.09e-2)" "unprognostic (3.01e-3)" "unprognostic (3.67e-1)" "unprognostic (1.69e-3)" "unprognostic (4.58e-2)" "unprognostic (5.19e-2)" "unprognostic (1.66e-1)" "unprognostic (1.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.72e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (9.14e-2)" "unprognostic (4.89e-2)" "unprognostic (7.17e-3)" 0.7 0.7 4.1 0.4 4.0 2.9 0.7 8.8 5.5 1.1 14.6 0.6 0.2 0.6 0.7 0.4 17.6 0.4 0.5 3.4 4.1 1.0 0.4 2.2 0.3 6.9 7.0 0.7 1.3 0.9 3.7 0.2 4.2 0.8 0.0 7.4 1.6 0.7 2.7 0.8 0.8 0.2 5.2 0.5 0.6 4.3 5.0 0.5 1.1 0.0 0.2 0.5 0.5 4.4 0.3 0.2 0.4 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.3 0.6 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.7 0.8 0.1 0.0 1.0 1.7 0.3 0.0 0.0 0.0 0.7 0.0 0.7 0.2 0.4 0.0 0.1 0.1 1.0 0.2 0.1 0.3 0.3 0.0 0.3 0.5 0.9 0.9 0.2 0.6 0.1 0.1 0.3 0.3 0.0 1.1 0.3 0.2 0.3 0.1 0.3 0.4 0.4 0.2 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.1 0.2 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.0 4.1 4.0 8.8 5.5 3.4 4.1 6.9 7.0 4.2 5.2 5.0 4.4 0.2 0.0 0.5 27.4 0.0 0.0 0.2 1.1 0.0 1.5 0.1 0.0 1.5 2.8 2.3 1.8 0.0 0.1 0.0 0.0 0.0 0.2 3.1 20.0 0.2 0.3 0.0 0.0 26.6 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.4 0.0 0.0 3.3 17.9 0.0 0.0 0.3 0.0 1.4 0.3 0.0 0.0 1.0 0.0 2.7 0.0 67.8 36.6 0.0 0.0 0.0 0.3 0.2 0.0 0.5 48.4 2.3 0.0 0.5 0.7 5.0 0.7 0.0 0.0 0.3 0.2 0.4 0.0 0.1 NOXRED1 "C14orf148, FLJ32809" ENSG00000165555 "NADP dependent oxidoreductase domain containing 1" Q6NXP6 14 77394021-77423517 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 5.9;testis: 6.9" "Group enriched" "Detected in some" 25 "Early spermatids: 137.8;Late spermatids: 125.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA055658, HPA060408" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 34: Spermatids - Unknown function" Vesicles "Plasma membrane" "HPA055658: AB_2682878, HPA060408: " "unprognostic (1.92e-2)" "unprognostic (4.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (2.49e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (2.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.24e-2)" "unprognostic (1.29e-2)" "unprognostic (2.60e-1)" "unprognostic (5.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.07e-3)" 0.2 0.6 0.5 0.1 0.6 0.2 0.5 0.2 0.5 0.2 1.7 0.5 0.5 0.5 0.5 0.3 0.5 0.6 0.1 0.5 0.6 0.5 0.3 0.3 0.6 0.8 1.0 0.3 0.4 0.2 0.7 0.3 0.7 0.3 0.5 5.9 0.2 0.4 0.1 1.1 0.3 0.4 0.9 0.5 0.2 6.9 0.5 0.5 0.9 0.0 0.4 0.2 0.2 0.7 0.3 0.7 0.3 0.4 0.1 0.7 0.5 0.3 0.5 0.3 0.2 0.4 0.3 0.7 0.1 0.6 0.1 0.2 0.1 0.1 0.4 0.3 0.2 0.4 0.0 0.7 0.2 0.1 0.6 0.4 0.9 0.3 0.5 0.4 0.2 0.8 0.1 0.5 0.1 0.8 0.2 0.2 0.0 0.2 0.6 0.2 0.1 0.0 0.3 0.1 0.7 0.5 0.4 0.1 0.1 0.7 0.7 0.4 0.9 0.2 0.2 0.4 0.1 0.7 0.7 0.4 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.2 0.5 0.5 0.6 0.8 1.0 0.7 0.9 0.5 0.7 0.2 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 4.2 0.0 0.0 0.3 0.0 0.0 137.8 0.6 0.1 0.2 1.8 0.0 4.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 3.0 0.0 0.0 0.3 0.2 125.8 0.9 0.3 0.0 0.0 0.0 0.4 0.0 3.0 4.4 0.1 0.0 1.2 0.1 0.1 0.3 0.1 0.2 1.5 0.0 0.0 0.1 4.1 2.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 NPHP1 "JBTS4, NPH1, SLSN1" ENSG00000144061 "Nephrocystin 1" O15259 2 110122311-110205066 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Ciliopathy, Disease variant, Joubert syndrome, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.2" "Cell type enhanced" "Detected in many" "Early spermatids: 148.5;Endometrial ciliated cells: 136.3;Respiratory ciliated cells: 167.4;Spermatocytes: 146.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046093, HPA074071" Approved NA NA "Cluster 24: B-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "HPA046093: AB_2679535, HPA074071: " "unprognostic (2.10e-2)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (5.58e-2)" "unprognostic (4.63e-2)" "unprognostic (1.56e-3)" "unprognostic (4.66e-2)" "unprognostic (1.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.66e-2)" "unprognostic (1.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-3)" "unprognostic (3.35e-2)" "unprognostic (1.82e-1)" "unprognostic (8.64e-2)" 3.1 3.7 4.5 1.0 4.7 0.1 4.0 4.0 8.6 4.7 11.1 5.3 1.0 5.4 9.0 1.3 17.1 3.3 4.8 4.6 5.2 8.0 0.8 4.3 0.9 5.4 5.8 4.5 3.2 17.0 11.7 1.3 5.0 4.4 1.7 10.8 2.5 4.7 36.2 1.7 1.9 4.6 4.6 1.9 3.6 24.9 5.5 1.1 7.4 10.8 0.6 4.1 2.7 4.6 9.8 3.1 5.9 4.3 3.3 7.9 1.3 2.4 7.9 8.5 8.4 3.1 7.1 0.5 6.0 5.8 7.8 4.7 2.8 7.5 10.0 1.7 3.9 0.2 1.9 2.1 4.5 1.4 0.0 5.2 4.4 12.7 3.6 12.0 4.7 1.9 0.1 0.8 4.9 2.0 1.0 2.1 2.8 0.2 4.9 0.2 6.5 0.3 14.5 0.8 3.0 3.1 3.2 4.2 9.2 2.8 5.1 1.0 3.2 4.9 4.2 5.0 7.7 2.4 2.9 0.7 13.9 0.2 3.3 0.3 0.0 0.0 0.3 0.1 0.5 0.8 0.2 0.1 0.3 1.5 0.5 0.3 0.2 1.1 0.0 0.0 0.0 0.1 4.5 4.7 4.0 8.6 4.6 5.2 5.4 5.8 5.0 4.6 5.5 4.6 8.3 6.4 8.9 31.6 1.6 5.2 8.7 18.1 2.8 11.8 5.3 6.6 14.3 8.6 23.3 9.2 47.9 1.9 0.3 0.8 19.6 15.6 148.5 136.3 15.8 7.0 0.0 0.0 29.1 4.9 0.5 8.1 0.0 17.0 0.0 13.4 9.3 2.7 1.4 21.9 15.0 0.9 18.3 0.8 3.1 65.2 7.5 1.4 7.2 4.7 0.0 12.3 0.0 12.1 11.5 6.4 1.3 9.8 0.1 3.1 0.2 35.9 167.4 69.1 13.1 14.3 10.3 146.3 24.9 1.0 4.0 0.3 1.3 9.6 1.7 5.8 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.0;parathyroid gland: 39.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Nucleoli" "HPA041070: AB_2677285" "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favorable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favorable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.6 18.4 11.0 0.1 16.9 1.2 2.1 7.4 40.0 4.9 2.2 1.1 2.2 5.0 0.9 1.0 3.2 1.9 2.3 12.4 9.2 6.6 1.6 1.8 0.6 7.5 7.6 1.5 11.0 39.2 18.5 0.5 10.0 6.6 1.0 5.7 2.7 1.4 0.3 2.2 1.2 3.6 2.3 12.5 1.9 5.1 7.1 2.9 25.3 0.3 0.4 2.0 2.3 13.5 3.9 0.5 0.2 0.2 0.9 0.0 1.5 0.5 0.5 2.4 4.9 1.6 3.6 0.0 1.1 0.0 0.2 17.7 0.5 0.0 1.4 0.1 0.5 14.5 1.0 32.4 3.1 1.9 1.3 0.5 2.3 0.0 0.3 3.7 0.0 9.5 0.5 0.0 0.1 0.0 0.2 3.9 0.7 6.4 0.4 0.3 1.4 0.8 5.6 0.1 3.8 0.2 0.0 0.1 4.6 0.0 0.7 11.2 0.0 0.0 0.3 0.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 0.0 0.2 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 11.0 16.9 7.4 40.0 12.4 9.2 7.5 7.6 10.0 2.3 7.1 13.5 0.1 0.0 1.1 1.0 0.7 0.1 9.7 3.7 0.6 29.4 3.1 5.2 2.1 5.7 8.8 0.0 20.9 0.1 0.5 0.6 3.9 9.4 15.1 1.1 0.3 0.6 11.4 0.4 21.3 8.0 0.2 1.7 1.5 1.1 0.0 1.4 2.5 0.5 4.6 6.7 21.9 2.1 2.0 0.0 0.3 14.4 0.6 0.9 10.6 1.9 1.0 0.9 0.0 2.5 1.6 4.3 0.8 0.4 0.6 3.4 0.5 14.6 7.7 4.2 0.0 0.4 1.6 0.5 0.9 1.1 1.1 0.3 2.7 7.6 1.2 5.8 NRG4 HRG4 ENSG00000169752 "Neuregulin 4" Q8WWG1 15 75935969-76059795 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;retina: 4.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Early spermatids: 16.1;Exocrine glandular cells: 23.3;Gastric mucus-secreting cells: 31.1;Rod photoreceptor cells: 22.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 6.8;HL-60: 2.1;U-937: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA010957 Uncertain "Secreted to digestive system" NA NA "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA010957: AB_1079504" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (3.94e-2)" "unprognostic (1.67e-2)" "unprognostic (5.66e-2)" "unprognostic (4.10e-2)" "unprognostic (1.12e-2)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (2.82e-5)" "unprognostic (1.91e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-5)" "unprognostic (8.28e-2)" "unprognostic (7.45e-2)" "unprognostic (1.08e-2)" "unprognostic (2.06e-1)" 0.0 0.1 0.3 0.1 0.2 1.0 0.2 3.8 0.7 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.4 0.1 0.4 0.2 0.2 0.5 0.5 0.1 0.9 0.0 0.0 0.4 0.4 0.2 0.1 4.3 0.5 0.1 0.8 0.7 0.1 0.0 0.5 0.1 0.9 0.7 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.4 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.6 0.3 0.0 0.0 0.9 0.6 0.1 0.0 0.1 0.4 0.1 6.8 0.0 0.0 2.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.2 0.2 0.0 0.0 0.1 0.4 1.6 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 3.8 0.7 0.4 0.4 0.5 0.5 0.4 0.5 0.6 0.3 0.7 0.0 0.0 3.9 0.9 7.5 1.2 3.9 0.6 3.7 0.5 0.0 0.2 0.0 3.9 1.8 14.6 2.2 0.5 1.1 1.9 0.3 16.1 6.1 1.2 0.7 1.2 0.0 13.3 23.3 2.5 2.6 31.1 1.4 2.5 0.9 0.7 3.4 0.3 6.7 9.7 0.1 2.0 0.0 0.8 8.9 0.6 0.3 1.8 0.0 0.2 1.9 1.0 3.5 0.8 9.6 3.2 0.0 0.3 2.3 0.1 0.1 10.7 22.9 0.0 0.5 1.1 7.6 1.3 3.4 1.3 0.8 0.4 0.6 0.5 4.5 NSUN7 FLJ14001 ENSG00000179299 "NOP2/Sun RNA methyltransferase family member 7" Q8NE18 4 40749925-40811184 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.5" "Cell type enhanced" "Detected in many" "Early spermatids: 47.5;Late spermatids: 75.6;Respiratory ciliated cells: 36.4;Spermatocytes: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "A-431: 2.6;CAPAN-2: 5.5;Karpas-707: 4.0;MCF7: 2.6;SuSa: 3.0;T-47d: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020653 Uncertain Approved Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 25: Spermatids - Spermatogenesis" Vesicles "HPA020653: AB_1848710" "unprognostic (2.32e-1)" "unprognostic (4.22e-1)" "unprognostic (4.77e-2)" "unprognostic (1.50e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (4.01e-3)" "unprognostic (4.37e-2)" "unprognostic (3.06e-1)" "unprognostic (2.24e-1)" "unprognostic (8.42e-2)" "prognostic favorable (2.76e-8)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-2)" 0.6 0.9 0.6 1.0 0.6 0.6 3.8 0.4 0.4 2.5 7.2 2.8 1.7 2.2 2.7 1.8 6.8 1.2 2.1 0.5 1.5 4.7 0.4 3.3 0.3 1.8 2.4 2.3 7.2 3.3 3.6 1.3 1.5 4.5 2.4 0.7 4.8 1.5 0.0 1.5 2.1 1.2 1.2 2.7 3.2 16.5 2.0 0.3 4.7 0.2 0.3 1.3 1.2 0.8 2.6 0.1 1.2 0.0 0.0 0.0 1.7 0.0 0.2 0.1 0.1 1.0 5.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 2.6 0.1 0.0 1.4 0.0 0.3 0.1 0.0 0.0 2.4 0.7 0.6 1.5 0.3 1.7 0.0 3.0 3.9 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.4 0.4 0.5 1.5 1.8 2.4 1.5 1.2 2.0 0.8 0.1 9.6 7.8 3.6 4.3 1.1 3.1 1.5 2.2 0.1 8.6 7.1 3.5 0.0 10.5 9.2 0.0 9.2 0.1 2.7 9.8 5.8 47.5 20.7 0.9 0.6 8.3 0.4 0.7 5.4 3.6 1.2 4.6 5.4 0.0 8.5 0.7 0.2 3.8 0.0 0.9 7.1 4.1 0.8 0.4 75.6 1.5 2.2 0.0 8.4 1.0 2.1 0.0 18.1 1.3 4.7 2.7 0.0 0.3 4.5 2.2 5.5 36.4 0.1 0.0 0.4 0.8 38.9 11.4 8.2 1.0 4.5 0.7 3.4 7.7 5.7 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2 component of NDC80 kinetochore complex" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "T-reg: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 0.8 0.6 0.5 6.9 0.8 28.4 1.2 0.5 0.8 1.0 0.4 4.2 4.3 1.1 0.3 5.8 0.4 1.0 0.3 0.6 0.6 0.3 0.7 0.9 18.2 0.9 0.8 0.4 0.2 0.6 0.2 4.7 0.9 0.4 5.3 1.5 0.9 0.3 0.1 4.1 4.3 2.3 0.7 3.6 2.6 53.5 0.8 26.0 0.5 0.2 16.7 1.8 1.8 1.0 90.8 30.8 80.5 33.9 2.5 8.1 43.6 55.9 39.3 88.9 77.3 23.7 77.7 77.4 45.5 22.6 37.0 51.6 49.6 21.0 111.5 81.4 35.6 30.3 34.8 34.4 0.3 53.0 60.2 1.0 2.0 45.0 31.6 16.8 41.1 74.5 58.1 103.9 85.0 17.6 97.3 70.6 43.9 66.1 47.0 65.0 70.3 68.4 25.3 12.4 59.9 68.9 29.9 32.2 30.6 49.7 49.3 109.5 29.4 65.9 73.8 50.1 115.1 73.9 111.5 148.9 22.0 42.9 74.7 1.4 0.1 1.3 1.2 0.0 0.5 0.6 1.8 1.2 0.2 0.7 1.2 1.0 0.4 1.8 0.1 0.3 4.3 0.4 0.5 0.8 0.5 0.8 0.6 0.6 0.9 0.8 0.9 0.7 0.8 1.0 0.5 0.0 0.5 1.3 5.3 5.9 1.9 4.2 1.2 1.2 1.3 2.7 0.9 0.0 3.3 0.0 0.0 21.7 3.6 2.6 0.0 0.8 17.7 2.5 2.5 1.8 0.0 60.8 1.1 0.2 29.7 3.4 5.6 3.0 4.5 18.3 3.3 0.4 14.0 0.0 1.4 3.3 0.0 5.2 3.6 21.4 2.5 3.1 0.0 1.0 0.9 2.0 6.2 0.5 3.6 0.2 0.1 2.2 17.8 0.8 0.9 0.2 0.7 2.3 6.6 0.9 4.2 208.2 40.3 10.6 2.4 4.0 5.0 1.7 9.0 3.8 NUP62CL FLJ20130 ENSG00000198088 "Nucleoporin 62 C-terminal like" Q9H1M0 X 107123427-107206433 "Metabolic proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 17.3;fallopian tube: 17.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 21.5;Endometrial ciliated cells: 26.6;Respiratory ciliated cells: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 21.9;CAPAN-2: 23.5;HeLa: 30.7;K-562: 23.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001884 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA001884: AB_1079512" "unprognostic (1.62e-2)" "prognostic favorable (5.66e-5)" "unprognostic (8.80e-2)" "unprognostic (4.23e-2)" "unprognostic (1.44e-1)" "unprognostic (8.19e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.56e-1)" "unprognostic (5.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-2)" "unprognostic (6.47e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-1)" "unprognostic (2.82e-3)" "unprognostic (4.52e-3)" 0.2 13.9 0.9 1.6 1.0 2.2 3.1 0.7 0.6 1.3 7.6 2.7 3.0 1.8 17.3 1.3 17.2 1.5 1.8 0.8 1.2 6.0 1.9 1.6 1.3 3.6 3.8 1.4 4.3 4.2 2.5 0.4 2.1 0.9 3.3 1.0 2.1 2.9 0.1 1.5 3.0 0.3 2.5 0.2 1.7 12.0 1.2 2.0 10.0 0.5 2.3 0.9 0.9 1.3 13.5 21.9 1.9 0.0 0.0 0.1 9.4 0.0 0.8 0.5 0.5 2.1 23.5 7.7 2.5 0.0 11.9 11.9 13.9 4.8 0.1 0.0 17.8 0.8 30.7 3.9 0.0 0.0 0.0 0.2 6.3 0.1 3.3 0.0 0.0 11.8 23.0 1.9 0.0 6.6 3.0 0.0 2.8 19.1 7.9 0.0 0.0 0.7 7.1 3.6 5.5 6.4 7.8 2.4 0.0 7.8 0.0 0.4 0.0 0.0 7.0 0.1 0.0 2.5 9.4 4.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.2 2.0 0.9 0.0 0.0 1.0 0.4 0.5 0.0 0.7 0.2 0.0 0.4 0.2 0.9 1.0 0.7 0.6 0.8 1.2 3.6 3.8 2.1 2.5 1.2 1.3 0.3 3.2 0.0 0.3 1.7 1.9 3.9 6.3 1.8 0.5 2.8 1.7 1.0 2.8 3.5 9.2 0.0 2.0 0.8 1.7 21.5 2.1 8.8 26.6 0.3 0.4 0.0 3.8 0.4 3.4 1.0 0.2 1.5 4.2 0.0 1.7 0.0 2.2 0.9 1.7 0.5 3.5 6.1 0.0 1.1 3.3 0.3 0.3 5.4 2.8 0.2 1.2 0.0 0.0 0.3 1.4 0.7 0.7 2.4 1.1 1.1 5.7 21.6 0.2 6.6 0.4 0.9 9.6 9.7 1.6 2.8 1.0 1.1 0.0 2.4 2.6 NUSAP1 "ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41320794-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 88.6;lymphoid tissue: 101.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "basophil: 10.7;T-reg: 7.7" "Group enriched" "Detected in many" 15 "granulocytes: 10.7;T-cells: 7.7" "Low cell line specificity" "Detected in many" "HPA042904, HPA074847" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" Yes Yes "Cluster 34: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavorable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavorable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 1.8 14.1 0.2 7.8 0.2 88.6 1.5 0.3 0.4 3.6 0.3 6.1 7.0 1.1 0.1 17.7 1.1 1.0 1.1 0.2 0.2 2.6 5.0 3.8 28.7 0.3 0.4 4.4 1.3 0.0 0.6 6.5 0.3 1.1 8.0 0.1 3.6 0.6 5.4 9.4 7.4 2.7 0.2 7.8 4.5 10.9 0.3 101.5 0.9 0.1 31.5 1.9 6.4 0.3 146.0 38.3 165.1 64.6 3.5 5.9 37.0 107.4 74.6 138.9 130.6 58.4 67.0 63.5 42.5 44.4 99.1 107.6 104.2 46.2 132.4 98.5 62.3 149.6 102.0 50.7 0.2 67.3 57.2 0.9 1.3 69.1 37.3 21.7 72.0 104.2 70.1 237.5 105.7 30.7 147.5 82.2 59.8 139.8 55.0 136.5 156.5 67.5 42.4 29.3 85.7 55.2 129.8 88.5 25.7 46.0 106.2 76.1 33.7 89.9 104.8 101.5 206.2 81.3 145.8 200.5 42.1 163.6 171.2 10.7 0.1 0.5 0.1 0.0 0.0 0.3 0.5 0.5 0.3 0.6 0.0 0.3 0.2 0.4 0.0 0.3 7.7 0.5 0.2 0.2 0.3 0.4 0.2 0.2 0.3 0.4 0.3 0.2 0.3 0.3 1.9 0.0 1.5 1.3 14.2 38.5 10.3 21.2 31.9 0.9 9.9 13.7 1.1 17.2 5.0 0.0 0.0 72.2 13.4 14.4 3.9 2.3 33.2 10.7 11.6 7.3 3.0 266.7 1.4 0.5 121.2 14.6 25.5 21.8 7.0 93.3 10.8 3.9 36.7 0.0 1.5 15.5 24.4 13.8 22.7 14.6 0.3 17.5 3.6 1.9 6.1 1.9 4.1 1.0 1.3 1.5 0.4 1.9 57.2 5.3 2.6 5.4 1.1 1.0 0.0 2.8 12.1 99.6 59.9 69.5 24.9 19.3 22.9 38.8 30.0 10.3 NWD1 ENSG00000188039 "NACHT and WD repeat domain containing 1" Q149M9 19 16719847-16817963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "choroid plexus: 192.4" "Group enriched" "Detected in some" 4 "Astrocytes: 41.4;Endometrial ciliated cells: 83.9;Respiratory ciliated cells: 92.0" "Cancer enriched" "Detected in many" 6 "prostate cancer: 9.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-937: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075476 Approved Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 32: U-937 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli, Cytosol" "HPA075476: " "unprognostic (5.29e-3)" "unprognostic (3.08e-2)" "unprognostic (3.05e-2)" "prognostic favorable (2.55e-4)" "unprognostic (2.49e-1)" "unprognostic (4.20e-4)" "unprognostic (6.54e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.94e-2)" "unprognostic (1.76e-1)" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (5.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.25e-1)" 0.0 0.0 5.4 0.0 6.2 0.1 0.2 7.6 4.9 1.3 192.4 0.5 0.0 0.2 0.4 0.2 12.6 0.2 0.0 12.2 5.2 0.2 0.0 1.3 0.0 6.2 8.8 0.0 1.5 0.0 0.7 0.0 6.1 6.8 0.1 1.1 1.3 1.8 0.0 0.2 0.0 0.0 3.2 0.0 0.8 0.2 10.1 0.2 0.7 0.0 0.0 0.1 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 6.2 7.6 4.9 12.2 5.2 6.2 8.8 6.1 3.2 10.1 3.7 0.0 0.0 1.5 41.4 0.3 0.3 1.7 3.5 0.0 0.2 0.5 0.3 0.9 0.0 4.5 0.0 0.0 0.1 0.0 0.4 0.0 0.1 17.9 83.9 0.8 0.3 1.2 0.0 2.4 0.0 0.2 0.3 0.0 3.7 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.6 2.0 0.0 0.4 3.3 0.6 0.3 0.0 0.0 0.0 8.9 0.0 1.5 1.2 0.2 0.4 0.0 0.0 4.0 0.0 0.1 92.0 0.6 0.0 1.1 1.4 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.4 1.4 NXF2B bA353J17.1 ENSG00000269437 "Nuclear RNA export factor 2B" Q9GZY0 X 102360396-102439932 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 15.3;testis: 7.1" "Cell type enhanced" "Detected in some" "Late spermatids: 1.8;Respiratory ciliated cells: 1.2;Spermatocytes: 2.1;Spermatogonia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "U-266/84: 35.6" HPA002079 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA002079: AB_1079515" 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 15.3 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.0 2.4 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 0.2 0.3 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OAF MGC52117 ENSG00000184232 "Out at first homolog" Q86UD1 11 120211032-120230334 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 396.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4" "Group enriched" "Detected in many" 14 "dendritic cells: 2.4;monocytes: 3.3" "Cell line enhanced" "Detected in many" "EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047412 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 69000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA047412: AB_10960631" "unprognostic (1.59e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" "unprognostic (2.80e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.11e-1)" "unprognostic (3.98e-3)" "unprognostic (5.09e-2)" "unprognostic (3.90e-2)" "unprognostic (3.28e-2)" "unprognostic (1.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.12e-2)" "unprognostic (7.15e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-1)" 66.0 91.5 47.7 18.0 56.8 10.8 42.6 35.8 57.1 66.7 40.5 61.9 47.7 54.2 16.0 22.8 54.6 34.5 55.1 48.1 36.5 51.4 396.6 19.2 5.8 39.0 37.8 61.0 74.1 6.7 27.4 8.1 37.1 33.5 36.5 30.7 53.9 13.7 13.2 12.0 57.3 29.1 35.9 54.4 33.5 3.7 45.0 4.6 25.9 12.2 3.7 42.6 40.4 44.6 24.9 7.5 30.9 14.4 47.8 53.4 1.7 47.7 53.8 20.5 30.0 7.5 37.3 0.0 115.5 35.6 33.7 25.7 8.9 13.2 8.2 18.7 21.1 21.1 4.7 190.1 42.4 46.7 7.9 66.8 7.9 19.8 54.8 39.9 59.7 12.7 14.0 22.7 5.0 9.4 0.3 139.9 11.6 7.3 40.8 11.8 0.9 23.7 31.8 13.4 1.5 10.0 14.0 15.2 40.2 8.6 4.8 74.7 32.7 39.3 14.7 40.8 4.6 0.8 0.7 0.4 30.3 76.2 14.1 0.0 3.3 0.0 0.1 1.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.1 0.0 0.3 0.5 0.1 0.8 47.7 56.8 35.8 57.1 48.1 36.5 39.0 37.8 37.1 35.9 45.0 44.6 19.4 0.0 0.6 102.2 3.7 9.4 33.6 7.3 12.5 3.2 6.0 7.0 5.5 34.3 3.5 71.7 2.1 2.1 1.1 135.9 27.4 14.8 0.2 4.7 70.9 40.0 22.8 12.8 0.6 28.7 5.5 135.9 11.7 12.2 1.3 2.6 12.5 218.8 6.0 0.0 2.3 56.5 4.1 11.5 20.9 1.1 16.8 11.0 16.0 23.4 10.2 279.4 0.0 5.5 11.0 28.2 56.5 4.5 14.5 31.3 111.1 79.3 0.4 10.6 52.6 8.6 40.8 0.7 6.9 11.3 10.2 6.2 3.1 149.0 45.8 192.5 ODF3B FAP123 ENSG00000177989 "Outer dense fiber of sperm tails 3B" A8MYP8 22 50529710-50532580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 88.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 455.4;Late spermatids: 807.7;Respiratory ciliated cells: 417.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 92.0;intermediate monocyte: 75.6;myeloid DC: 55.5;neutrophil: 56.2;non-classical monocyte: 53.6" "Group enriched" "Detected in many" 16 "dendritic cells: 55.5;granulocytes: 56.2;monocytes: 92.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.5;Karpas-707: 40.8;U-266/70: 57.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062837 Enhanced NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA062837: AB_2684877" "unprognostic (4.30e-3)" "unprognostic (1.45e-2)" "unprognostic (5.98e-2)" "prognostic favorable (2.84e-4)" "unprognostic (2.60e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (5.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.65e-5)" "unprognostic (2.72e-1)" "unprognostic (1.51e-2)" "unprognostic (6.10e-2)" "unprognostic (3.61e-2)" 21.9 6.0 6.3 26.8 4.0 13.3 24.3 6.6 4.4 13.8 22.3 8.4 6.9 6.1 0.9 14.4 88.8 9.8 18.6 8.4 11.8 16.4 32.4 36.4 14.0 32.7 35.3 2.1 9.0 3.9 7.9 6.8 16.0 19.9 1.6 0.0 46.5 5.5 5.4 13.5 12.3 2.1 17.0 24.1 12.2 16.3 11.9 5.9 21.9 1.7 4.2 6.8 11.3 6.4 2.9 1.8 0.3 0.7 0.0 3.6 1.7 0.1 0.6 0.1 1.8 3.2 13.5 1.0 3.4 0.1 0.5 8.1 0.0 0.0 0.0 1.4 0.9 0.6 2.5 2.4 10.0 0.0 6.5 2.1 1.7 0.0 0.0 1.0 0.2 1.0 0.8 40.8 0.0 0.0 0.0 1.5 0.2 0.8 1.9 1.5 0.2 7.2 0.0 0.0 0.2 11.6 1.3 1.6 0.2 0.2 1.2 2.0 1.0 0.3 1.1 0.8 0.2 57.9 5.9 0.9 1.3 0.2 1.0 10.1 92.0 11.3 0.6 75.6 0.9 4.2 1.6 1.1 55.5 2.2 1.0 0.6 56.2 0.1 53.6 5.3 2.3 28.6 6.3 4.0 6.6 4.4 8.4 11.8 32.7 35.3 16.0 17.0 11.9 6.4 73.3 19.2 52.9 0.0 32.3 24.1 21.9 70.0 61.5 0.2 63.8 61.8 5.3 24.3 66.5 3.7 0.0 3.4 8.9 8.6 0.0 76.7 144.5 455.4 8.9 33.0 20.4 0.4 0.0 74.8 39.6 29.1 27.5 22.0 6.3 0.0 21.0 30.2 36.2 0.0 0.1 23.6 46.8 66.0 33.2 807.7 5.3 82.5 17.8 1.0 113.8 0.0 7.2 0.0 0.0 35.0 29.4 3.4 73.3 30.4 53.0 16.9 417.1 0.1 0.0 36.0 27.6 10.0 3.7 46.4 36.1 5.5 11.4 0.0 9.2 33.7 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121180 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 555.7;choroid plexus: 246.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 193.1;Hepatic stellate cells: 78.1;Inhibitory neurons: 70.0" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.8;intermediate monocyte: 2.8;myeloid DC: 2.6" "Group enriched" "Detected in many" 27 "dendritic cells: 2.6;monocytes: 2.8" "Cell line enhanced" "Detected in many" "HeLa: 96.0;MCF7: 84.1;NTERA-2: 104.9;OE19: 78.9;SCLC-21H: 155.6;SiHa: 131.8;T-47d: 200.2;U-2197: 87.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" NA NA 200000000 "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 6: T47d - Mammary gland" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "Nucleoplasm, Cytosol" "HPA057444: AB_2683443" "unprognostic (6.77e-2)" "prognostic favorable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 36.7 25.4 410.4 13.0 427.0 0.2 36.8 309.6 555.7 29.9 246.9 24.0 5.0 29.0 70.4 12.1 30.3 8.6 20.7 474.7 309.0 20.3 4.8 15.0 14.5 296.6 301.7 19.4 12.3 4.9 82.8 1.0 293.9 19.3 13.8 47.3 14.0 18.1 17.5 15.3 16.5 17.9 279.9 35.1 15.4 6.8 317.0 11.5 17.5 23.0 19.1 25.0 26.7 372.3 0.0 6.1 12.1 0.2 1.7 1.4 0.5 3.6 0.0 0.0 0.0 0.1 2.7 0.1 0.8 5.2 49.2 2.3 2.6 0.0 0.0 14.4 0.9 0.2 96.0 0.0 0.5 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.3 84.1 0.5 0.3 104.9 78.9 0.0 0.1 0.3 48.3 0.0 0.1 155.6 20.5 131.8 0.4 8.6 7.9 200.2 0.0 0.1 7.7 16.6 87.1 0.2 0.2 0.1 0.3 0.7 0.1 4.3 0.0 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 410.4 427.0 309.6 555.7 474.7 309.0 296.6 301.7 293.9 279.9 317.0 372.3 44.2 0.0 7.9 43.8 0.1 9.7 3.3 0.0 3.4 21.6 3.1 3.0 5.9 11.5 1.8 0.0 43.8 0.0 0.1 2.4 0.0 9.7 5.8 0.5 20.4 50.0 2.4 0.0 193.1 2.7 0.0 17.3 0.0 0.7 2.5 14.4 78.1 1.1 0.4 38.7 70.0 2.5 0.0 3.2 7.3 11.9 44.4 2.8 21.4 32.8 2.7 38.6 0.0 48.7 17.3 2.5 2.5 29.3 0.4 5.1 0.0 0.1 0.0 15.7 0.0 13.3 8.8 0.6 3.7 1.3 6.3 0.0 0.7 12.9 4.2 1.4 OMG OMGP ENSG00000126861 "Oligodendrocyte myelin glycoprotein" P23515 17 31272013-31297539 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 116.5;choroid plexus: 44.1" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 458.9;Respiratory ciliated cells: 708.8" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.5;glioma: 9.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008206, HPA012693" Enhanced "Intracellular and membrane" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 49: Ciliated cells - Cilium organization" "HPA008206: AB_1854240, HPA012693: AB_1854239" "unprognostic (8.05e-4)" "unprognostic (2.11e-2)" "unprognostic (1.27e-1)" "unprognostic (3.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.16e-2)" "unprognostic (1.63e-1)" "unprognostic (3.81e-2)" "unprognostic (9.54e-2)" "unprognostic (8.60e-2)" "unprognostic (7.03e-2)" "unprognostic (1.52e-1)" "unprognostic (3.96e-13)" "unprognostic (7.80e-3)" "unprognostic (6.00e-2)" "unprognostic (3.24e-1)" "unprognostic (2.42e-2)" 0.0 0.1 69.7 0.0 78.1 0.7 0.0 70.7 116.5 0.0 44.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 71.9 71.6 0.0 0.0 0.1 0.0 68.6 66.5 0.0 0.0 0.0 0.3 0.0 71.5 0.0 0.1 19.5 0.0 0.0 0.0 0.0 0.1 0.0 69.6 0.3 0.1 0.0 70.5 0.0 0.0 0.0 0.0 0.0 0.0 88.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.7 78.1 70.7 116.5 71.9 71.6 68.6 66.5 71.5 69.6 70.5 88.4 0.5 0.0 3.7 18.3 0.3 0.4 0.0 72.8 0.0 4.2 0.1 0.1 0.7 0.0 44.2 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 458.9 3.8 1.6 0.0 0.0 28.0 0.0 0.6 1.5 0.0 7.0 0.0 0.0 0.7 0.1 0.5 0.0 18.7 0.0 61.1 20.1 0.7 0.0 0.0 1.1 0.0 3.7 0.2 78.2 1.0 78.4 101.8 0.0 0.0 0.0 0.9 0.0 0.0 0.1 708.8 2.4 0.0 0.7 19.1 0.0 0.0 0.2 0.1 11.8 1.4 0.0 0.0 0.0 ORC1 "HSORC1, ORC1L, PARC1" ENSG00000085840 "Origin recognition complex subunit 1" Q13415 1 52372829-52404423 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 29.0;lymphoid tissue: 11.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 5.5;Early spermatids: 5.6;Erythroid cells: 14.1;Extravillous trophoblasts: 9.9;Plasma cells: 6.3;Spermatogonia: 6.5" "Cancer enhanced" "Detected in many" "testis cancer: 15.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "NK-cell: 3.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027439, HPA027450" Approved Supported Nucleoplasm NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA027439: , HPA027450: AB_10602041" "unprognostic (3.28e-1)" "unprognostic (4.42e-3)" "prognostic favorable (1.74e-5)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (3.77e-3)" "prognostic unfavorable (3.69e-4)" "unprognostic (3.86e-2)" "unprognostic (2.70e-3)" "unprognostic (8.39e-2)" "unprognostic (1.25e-10)" "unprognostic (4.56e-3)" "unprognostic (1.05e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" 0.4 0.6 0.2 3.5 0.1 29.0 1.1 0.6 0.2 0.6 0.0 3.4 1.7 0.6 0.1 2.7 0.3 0.4 0.2 0.1 0.2 0.5 0.6 0.6 6.7 0.3 0.0 0.5 0.3 0.3 0.3 1.9 0.2 0.4 4.0 1.0 0.6 0.1 0.5 2.0 2.3 0.9 0.0 2.0 1.0 5.2 0.2 11.6 0.3 0.1 7.7 0.9 1.0 0.3 19.3 20.8 33.0 21.7 0.8 2.7 31.8 13.5 12.2 38.9 40.0 25.8 10.7 44.2 11.6 8.5 17.8 25.9 48.9 16.9 33.8 19.0 28.1 53.2 30.2 25.8 0.2 71.9 29.2 1.4 0.8 38.1 4.3 2.7 11.7 27.6 63.0 20.9 12.8 14.4 56.9 34.0 73.1 11.7 29.5 60.2 51.3 43.1 6.8 25.0 18.5 15.6 31.0 18.8 10.3 30.5 10.2 28.7 5.4 15.8 22.5 24.9 34.0 10.9 31.1 54.4 15.6 52.6 19.5 0.0 0.1 0.0 0.2 0.1 0.2 0.2 0.4 0.4 0.6 0.8 0.1 0.3 0.4 3.4 0.2 0.0 1.2 0.3 0.2 0.1 0.6 0.2 0.1 0.2 0.3 0.0 0.2 0.0 0.2 0.3 0.6 0.0 0.0 0.3 1.7 0.9 0.3 0.4 1.2 0.7 0.7 1.1 0.5 0.0 0.1 0.0 0.0 5.5 0.7 1.2 0.0 0.3 5.6 0.5 0.6 0.5 0.0 14.1 0.7 0.2 9.9 0.7 0.5 0.6 0.0 2.8 0.0 0.2 2.9 0.0 0.7 1.3 0.0 0.3 0.4 3.8 0.6 0.6 0.0 1.0 0.3 0.2 0.0 0.5 0.5 0.2 0.8 0.4 6.3 0.2 0.2 3.9 0.1 0.9 0.0 0.6 0.7 4.1 6.5 2.5 1.1 1.8 1.1 0.9 3.7 0.4 ORC6 ORC6L ENSG00000091651 "Origin recognition complex subunit 6" Q9Y5N6 16 46689643-46698394 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.3;lymphoid tissue: 7.4;testis: 9.6" "Cell type enhanced" "Detected in many" "Granulosa cells: 56.7;Spermatocytes: 102.6;Spermatogonia: 108.9;Theca cells: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016330, HPA072587" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Cluster 24: B-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli fibrillar center" "CAB016330: AB_670295, HPA072587: AB_2686537" "unprognostic (3.47e-2)" "unprognostic (8.99e-3)" "unprognostic (2.92e-1)" "unprognostic (4.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-2)" "unprognostic (3.15e-6)" "unprognostic (1.36e-2)" "prognostic unfavorable (3.53e-4)" "prognostic favorable (1.48e-4)" "unprognostic (1.50e-4)" "unprognostic (3.97e-2)" "unprognostic (3.90e-14)" "unprognostic (2.08e-1)" "unprognostic (4.24e-1)" "unprognostic (2.79e-1)" "unprognostic (5.98e-2)" 0.3 0.7 2.0 2.2 1.6 10.3 0.6 1.5 1.9 0.7 1.0 1.7 1.5 0.8 1.1 4.1 0.4 0.6 1.5 1.9 1.8 0.4 0.9 0.6 7.4 1.5 1.9 0.4 0.3 0.7 0.6 3.3 1.7 0.3 1.9 0.3 0.7 0.2 0.1 1.1 1.5 1.0 1.6 2.4 0.8 9.6 1.8 6.2 0.5 0.3 7.3 1.2 1.3 1.8 28.6 27.4 43.7 33.9 5.4 6.8 31.6 54.2 20.2 59.3 30.9 39.3 18.0 35.6 27.1 10.5 29.1 29.9 57.9 15.1 50.4 17.2 46.4 27.9 13.2 40.1 6.6 46.5 23.7 1.8 2.6 32.4 17.1 9.3 20.0 30.1 36.0 17.4 35.9 26.9 65.6 60.7 48.1 20.7 76.0 78.6 80.6 35.8 14.9 9.8 52.2 30.4 24.5 29.8 18.1 34.9 15.6 37.9 11.6 53.7 34.6 33.6 51.8 12.5 18.9 123.2 22.2 29.5 40.1 0.0 0.3 0.3 0.9 0.7 0.4 0.7 0.5 0.5 0.6 1.4 0.8 0.3 0.0 0.8 0.8 1.0 1.2 0.7 2.0 1.6 1.5 1.9 1.9 1.8 1.5 1.9 1.7 1.6 1.8 1.8 1.6 3.2 14.5 1.0 8.8 6.6 2.2 3.6 8.6 6.6 4.1 5.8 3.7 1.5 6.3 5.5 4.2 39.3 6.0 9.5 1.9 2.5 13.2 6.5 7.5 4.3 1.8 45.4 6.3 0.7 40.9 8.0 7.1 9.4 1.3 56.7 0.7 9.9 15.7 11.8 2.7 12.4 6.1 3.8 11.9 8.9 2.8 7.7 33.8 2.8 1.2 2.5 2.1 0.0 2.0 2.1 1.4 3.4 18.5 2.6 2.3 1.0 10.7 10.2 0.0 5.1 7.3 102.6 108.9 16.9 6.0 10.9 7.5 47.5 14.4 2.7 OSBPL6 ORP6 ENSG00000079156 "Oxysterol binding protein like 6" Q9BZF3 2 178194481-178402893 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 33.8;tongue: 20.3" "Cell type enhanced" "Detected in many" "Astrocytes: 281.4;Excitatory neurons: 314.2;Inhibitory neurons: 404.2;Oligodendrocyte precursor cells: 134.2" "Cancer enhanced" "Detected in many" "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 48.8;hTERT-HME1: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032131 Enhanced Approved "Plasma membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "HPA032131: AB_10670963" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "unprognostic (2.47e-1)" "unprognostic (5.95e-3)" "unprognostic (5.26e-2)" "unprognostic (1.40e-2)" "unprognostic (7.55e-2)" "unprognostic (4.81e-2)" "unprognostic (3.32e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.49e-2)" "unprognostic (1.15e-5)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (3.73e-4)" "unprognostic (4.44e-6)" 1.3 1.5 4.1 1.0 6.1 0.2 1.7 3.7 16.3 1.1 0.0 1.0 0.7 0.8 0.7 2.4 1.0 1.1 3.8 6.1 8.0 2.7 5.6 4.0 1.1 5.7 6.9 1.4 1.2 0.8 6.7 0.6 5.3 3.1 1.0 8.4 2.2 1.5 33.8 8.7 3.5 1.4 1.7 1.0 0.8 1.3 7.5 1.6 2.3 20.3 0.8 1.0 1.5 8.3 0.0 1.1 8.3 16.9 6.8 7.5 6.3 13.9 7.2 12.0 14.6 1.4 0.2 0.0 0.5 12.9 6.6 0.3 19.6 11.4 20.2 0.2 10.2 48.8 2.9 0.0 4.4 8.0 0.3 5.0 17.6 26.4 50.8 4.3 5.8 6.2 0.9 5.8 15.9 7.0 0.1 0.0 10.0 0.0 10.2 0.0 16.9 3.2 0.9 0.0 6.3 3.8 6.2 1.8 13.7 9.2 2.4 0.1 11.4 13.7 8.5 9.3 16.3 31.8 13.4 0.0 16.3 0.0 6.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 4.1 6.1 3.7 16.3 6.1 8.0 5.7 6.9 5.3 1.7 7.5 8.3 0.7 0.0 7.2 281.4 0.0 13.3 2.1 1.3 7.4 59.4 2.1 1.7 15.2 4.3 6.5 0.0 25.0 0.2 0.0 0.1 1.9 0.6 1.0 4.4 1.0 1.7 1.8 0.0 314.2 0.8 4.9 4.3 0.0 0.4 7.0 2.0 0.0 6.2 3.9 1.7 404.2 6.0 4.1 3.5 1.0 1.1 0.0 0.7 5.4 62.8 0.0 10.6 0.0 134.2 10.3 0.2 0.0 1.5 1.5 2.2 9.5 6.2 78.2 6.9 0.0 25.4 5.8 0.1 2.1 6.4 20.9 0.1 0.9 14.5 1.4 0.5 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 58.0;testis: 76.1" "Cell type enhanced" "Detected in many" "Early spermatids: 453.5;Endometrial ciliated cells: 88.6;Respiratory ciliated cells: 199.1;Spermatocytes: 163.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 6.8 8.2 9.7 2.4 10.4 2.0 9.4 7.4 10.5 9.5 31.3 7.3 2.9 10.0 22.0 5.0 58.0 8.8 7.9 11.1 13.0 19.1 2.8 11.0 1.9 11.3 14.7 9.1 8.2 30.2 23.1 5.6 10.9 9.9 3.9 23.1 8.7 8.9 4.9 6.8 2.7 7.9 9.9 1.4 6.3 76.1 13.5 3.6 17.9 5.2 1.5 5.9 4.8 8.3 6.7 6.3 7.6 8.9 8.9 8.6 1.4 4.0 9.7 9.7 6.6 0.1 5.8 1.5 7.3 7.3 7.1 5.1 0.2 7.5 6.2 1.1 5.9 0.1 3.9 0.7 10.9 0.8 1.2 9.8 12.0 13.7 5.9 14.1 6.7 6.3 0.1 1.7 7.7 4.8 3.6 2.5 7.8 2.6 2.6 3.8 3.1 1.2 16.0 2.3 20.4 9.0 7.5 3.5 5.4 7.2 7.6 1.1 5.8 7.0 2.6 12.7 6.9 2.8 3.1 0.8 13.4 0.2 4.7 0.0 0.2 0.0 0.2 0.6 0.0 0.1 0.3 0.2 0.6 0.2 0.6 1.0 0.1 0.1 0.0 1.2 0.7 0.2 9.7 10.4 7.4 10.5 11.1 13.0 11.3 14.7 10.9 9.9 13.5 8.3 3.0 9.6 10.9 4.6 0.4 1.5 5.5 21.3 3.4 5.4 7.9 7.5 5.5 5.7 21.3 12.9 16.7 12.2 0.0 2.0 23.5 15.1 453.5 88.6 5.8 3.3 4.9 1.7 8.1 9.3 3.4 6.4 6.1 7.7 0.0 4.8 2.2 2.3 4.2 5.0 6.9 2.3 32.6 0.8 1.2 66.8 12.5 1.4 3.6 1.0 0.1 12.9 0.0 5.0 2.6 7.2 4.0 9.1 0.4 3.5 0.5 26.1 199.1 21.3 0.0 4.7 7.7 163.7 20.6 3.6 3.1 20.1 0.7 13.9 2.3 5.2 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 166.1;endometrium 1: 155.1;fallopian tube: 155.3" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 243.1;Leydig cells: 784.1;Peritubular cells: 758.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 16 "ASC diff: 542.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Plasma membrane" Nucleoplasm "HPA052425: AB_2681826, HPA063486: AB_2685022" "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favorable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 45.0 9.9 0.0 2.4 0.0 0.6 26.0 0.2 0.2 166.1 0.0 9.2 0.6 155.1 53.7 15.1 155.3 12.9 4.2 0.0 0.0 1.3 0.3 3.6 2.4 0.0 0.0 93.2 4.2 3.0 2.7 8.2 0.0 40.2 3.8 0.0 6.8 72.2 5.6 27.9 24.9 47.1 0.0 0.2 5.1 35.6 0.0 0.8 5.6 5.1 1.1 27.2 83.8 0.0 32.3 4.5 0.0 4.4 542.4 17.2 4.3 17.6 33.1 13.7 13.6 3.4 3.9 0.0 2.9 26.7 0.8 12.4 2.7 4.7 6.7 1.5 13.0 0.6 3.3 1.6 8.9 0.9 0.6 17.0 9.8 2.3 1.6 0.8 0.0 4.8 4.0 0.4 0.6 14.6 2.9 5.7 0.0 2.6 2.8 13.8 1.6 1.1 1.1 2.7 1.4 0.1 1.9 7.5 0.4 0.3 4.3 7.5 0.2 2.1 0.1 13.9 1.0 0.7 0.5 0.3 0.9 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.9 14.1 6.6 3.4 1.2 0.0 7.9 5.3 0.7 0.0 3.3 0.0 0.0 17.2 0.9 0.7 0.0 0.0 5.8 7.8 243.1 3.7 0.0 0.0 0.0 0.0 138.4 71.7 0.5 5.9 0.0 0.2 0.0 0.0 9.3 0.0 0.0 18.4 10.2 1.9 21.9 24.1 784.1 2.7 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 758.3 4.6 3.6 103.9 0.1 1.7 0.0 32.9 8.8 21.3 5.1 4.5 0.3 9.1 24.2 2.3 95.6 22.3 2.2 OTX1 ENSG00000115507 "Orthodenticle homeobox 1" P32242 2 63050057-63057836 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "salivary gland: 18.0;skin 1: 8.4" "Cell type enhanced" "Detected in some" "Astrocytes: 9.8;Basal respiratory cells: 6.3;Club cells: 4.1;Ionocytes: 6.1;Respiratory ciliated cells: 6.8;Suprabasal keratinocytes: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 95 "neutrophil: 9.4" "Lineage enriched" "Detected in single" 95 "granulocytes: 9.4" "Cell line enriched" "Detected in many" 9 "THP-1: 54.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052122 Uncertain Approved Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA052122: AB_2681736" "unprognostic (2.25e-2)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-3)" "unprognostic (2.32e-1)" "unprognostic (1.67e-2)" "unprognostic (6.92e-3)" "unprognostic (3.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (2.26e-3)" "unprognostic (1.71e-1)" "unprognostic (0.00e+0)" "unprognostic (4.64e-2)" "unprognostic (2.31e-1)" "unprognostic (3.80e-4)" "unprognostic (3.67e-3)" 0.1 0.0 2.1 0.0 1.7 0.0 0.2 0.1 2.5 0.0 3.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.9 1.4 0.0 0.0 0.1 0.0 0.2 2.5 0.0 0.2 0.0 0.0 0.0 0.7 0.7 0.0 0.0 18.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.2 0.3 2.8 0.0 0.0 0.0 0.5 0.0 0.1 1.8 2.3 1.3 4.2 2.5 0.0 0.1 5.9 0.0 0.3 0.3 0.4 4.4 2.2 0.1 0.8 0.0 1.1 3.0 2.7 1.9 0.5 1.1 2.5 2.7 2.2 5.0 0.0 1.9 2.0 0.0 0.7 0.0 0.7 0.8 0.0 2.6 2.4 0.0 0.2 2.1 2.6 4.6 0.0 2.2 1.6 2.3 3.6 0.7 1.2 0.8 0.4 0.5 1.8 0.2 1.5 0.0 1.0 54.1 0.1 0.9 1.7 0.0 0.9 1.5 1.1 4.0 0.3 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 2.1 1.7 0.1 2.5 1.9 1.4 0.2 2.5 0.7 0.0 2.8 1.8 0.2 0.0 0.0 9.8 0.1 1.7 0.0 6.3 0.6 0.0 0.8 1.0 0.8 0.0 4.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.2 0.6 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.7 0.3 0.3 0.5 1.1 2.6 0.1 0.0 0.1 0.2 0.1 PACRG "FLJ32724, Glup, HAK005771, PARK2CRG" ENSG00000112530 "Parkin coregulated" Q96M98 6 162727132-163315492 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 35.7;testis: 29.5" "Cell type enhanced" "Detected in many" "Early spermatids: 310.9;Excitatory neurons: 124.3;Inhibitory neurons: 174.9;Late spermatids: 369.8;Respiratory ciliated cells: 118.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066293 Enhanced NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA066293: AB_2685652" "unprognostic (3.06e-2)" "unprognostic (1.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (3.34e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" "prognostic favorable (2.55e-6)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (8.35e-2)" "unprognostic (2.93e-3)" 0.8 2.5 13.6 1.1 15.2 5.7 2.0 5.9 14.2 2.3 13.2 1.2 1.4 5.3 9.7 3.0 35.7 5.1 13.0 11.9 12.5 10.2 4.8 3.8 1.4 15.1 15.7 4.2 4.3 2.0 23.7 0.4 10.9 3.4 2.4 7.5 2.2 3.6 2.1 4.6 0.8 2.1 9.4 1.8 2.3 29.5 13.5 0.7 4.0 1.3 1.0 4.4 0.9 24.2 0.5 1.7 0.7 1.0 0.0 0.6 1.2 0.4 1.6 0.0 0.3 3.5 0.4 3.2 0.4 0.0 0.3 1.4 0.8 0.0 1.7 0.0 1.1 0.0 1.9 0.0 0.0 0.4 0.5 1.0 0.0 0.5 0.0 0.6 0.0 1.1 0.5 0.7 0.3 0.1 0.2 1.2 0.0 2.8 2.9 0.6 0.0 0.0 3.6 3.6 6.9 3.1 0.0 0.0 0.0 0.2 0.0 1.1 1.2 0.7 0.3 0.0 0.2 1.3 0.5 1.2 0.3 0.8 1.3 2.3 0.7 0.7 0.7 0.2 0.5 0.3 1.1 0.4 0.1 0.6 1.4 0.6 2.5 0.0 0.1 0.5 0.5 0.2 13.6 15.2 5.9 14.2 11.9 12.5 15.1 15.7 10.9 9.4 13.5 24.2 0.3 0.0 1.7 61.0 0.1 0.3 4.2 8.7 2.8 1.3 1.3 3.0 41.0 0.0 8.9 5.5 8.4 0.1 0.0 0.1 54.8 3.4 310.9 67.0 3.1 1.2 6.6 0.0 124.3 7.1 0.1 1.2 0.0 1.9 0.0 0.7 0.7 3.9 0.1 0.0 174.9 0.3 10.2 0.6 0.3 369.8 3.7 0.4 0.0 11.2 0.0 6.0 0.0 59.3 20.0 1.6 1.2 2.6 0.1 3.2 0.0 6.3 118.4 8.1 0.0 1.1 2.2 53.4 6.1 1.1 0.3 0.3 0.3 2.9 0.4 2.7 PARPBP "C12orf48, FLJ20641, PARI" ENSG00000185480 "PARP1 binding protein" Q9NWS1 12 102120183-102197520 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.3;lymphoid tissue: 7.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 20.0;Spermatogonia: 17.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039677 Approved Supported Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA039677: AB_10673426" "unprognostic (7.84e-3)" "unprognostic (1.34e-2)" "unprognostic (4.54e-3)" "unprognostic (3.03e-2)" "unprognostic (1.84e-1)" "unprognostic (3.03e-1)" "unprognostic (1.30e-5)" "unprognostic (2.52e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.38e-1)" "unprognostic (3.95e-3)" "unprognostic (2.83e-1)" "unprognostic (5.61e-8)" "unprognostic (3.50e-3)" "unprognostic (2.34e-1)" "unprognostic (9.16e-3)" "unprognostic (6.14e-2)" 0.8 0.6 0.2 3.1 0.2 9.3 1.8 0.3 0.4 1.2 0.1 3.0 2.3 1.2 0.5 3.6 0.6 1.1 0.4 0.3 0.4 0.8 0.6 0.6 4.2 0.3 0.4 0.7 0.2 0.3 0.2 2.3 0.3 1.0 3.8 0.2 0.9 0.9 0.4 1.9 2.7 1.7 0.3 1.2 1.8 3.9 0.3 7.5 0.5 0.3 5.1 1.9 1.1 0.3 13.5 27.2 23.6 13.7 3.8 3.4 16.7 19.9 11.0 32.0 27.9 14.8 10.4 25.4 11.4 7.8 16.2 14.5 38.5 11.7 34.2 25.7 22.6 31.9 15.7 13.9 1.1 33.5 9.1 3.3 2.8 22.3 14.4 8.3 21.6 18.9 31.0 15.3 21.1 10.7 30.5 31.1 31.7 17.8 26.6 20.4 38.9 16.7 10.3 21.1 15.9 14.7 13.8 16.6 11.8 24.0 27.1 12.1 8.5 16.5 15.7 20.2 25.3 11.3 24.8 22.8 11.4 33.7 22.4 2.6 0.4 1.0 0.5 0.6 0.1 1.1 0.9 0.8 0.7 0.7 0.5 0.6 0.0 0.5 0.4 0.7 1.8 0.7 0.2 0.2 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.3 1.1 0.0 0.0 2.9 4.3 3.7 1.5 3.6 0.6 1.9 2.4 2.4 0.7 1.5 2.5 1.8 0.0 11.3 2.3 1.5 5.9 1.6 2.5 3.0 11.6 2.5 1.8 20.0 4.1 1.3 13.9 4.8 6.1 3.0 5.7 15.0 2.2 0.1 6.5 3.3 5.3 3.1 10.2 5.7 4.3 2.6 1.2 3.1 0.0 3.7 1.7 0.2 2.1 3.5 4.1 1.2 0.8 0.4 14.2 0.7 1.3 1.8 1.4 0.9 0.0 1.1 2.8 16.0 17.7 9.8 1.6 3.6 4.1 9.3 7.8 1.6 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679362 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "esophagus: 81.0;lymphoid tissue: 20.5;parathyroid gland: 43.0;salivary gland: 51.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 45.3;Basal squamous epithelial cells: 174.8;Ionocytes: 40.7;Squamous epithelial cells: 172.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.3;HDLM-2: 58.3;PC-3: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001572, CAB016239" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoli Nucleoplasm "CAB016239: AB_2159984, HPA001572: " "unprognostic (3.09e-1)" "prognostic favorable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.0 7.3 0.1 0.7 0.0 0.2 0.3 81.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.1 43.0 2.2 0.0 0.0 3.7 0.1 0.0 51.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 20.5 0.7 0.0 8.5 0.7 7.1 0.0 5.3 2.3 0.0 2.5 2.1 3.8 2.0 0.0 0.3 0.0 0.0 1.6 1.8 1.6 0.8 0.0 0.5 11.4 2.1 12.3 0.0 58.3 7.3 0.9 1.2 0.0 0.0 0.0 4.2 0.7 6.0 0.0 1.9 0.0 0.0 5.3 2.3 0.3 0.2 7.3 0.9 0.0 0.1 1.9 18.9 0.0 0.0 0.0 0.0 6.9 3.4 0.0 1.3 7.0 1.4 0.9 5.1 0.0 0.0 0.0 0.6 2.2 1.0 0.0 0.1 4.4 0.7 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.4 45.3 174.8 0.0 1.6 1.3 0.4 0.0 25.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.6 0.0 0.4 0.0 0.2 0.2 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 40.7 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 20.9 0.0 0.0 26.8 0.0 0.0 0.1 2.0 2.4 0.9 172.0 0.3 0.1 0.1 0.0 0.6 12.1 PBK "CT84, FLJ14385, Nori-3, SPK, TOPK" ENSG00000168078 "PDZ binding kinase" Q96KB5 8 27809624-27838082 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 22.8;testis: 70.3" "Group enriched" "Detected in many" 5 "Early spermatids: 364.9;Spermatocytes: 436.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 282.8" "Group enriched" "Detected in many" 4 "basal ganglia: 4.7;white matter: 13.9" "Not detected" "Not detected" "HPA005753, HPA050656" Enhanced Supported Approved Cytosol NA Yes "Cluster 48: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA005753: AB_1855018, HPA050656: AB_2681205" "unprognostic (7.17e-2)" "unprognostic (7.21e-3)" "unprognostic (1.04e-3)" "unprognostic (2.77e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.29e-5)" "unprognostic (3.65e-3)" "unprognostic (7.38e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.18e-12)" "unprognostic (9.61e-2)" "unprognostic (1.86e-1)" "unprognostic (8.30e-2)" "unprognostic (8.68e-2)" 1.1 0.6 0.1 6.6 0.1 9.1 2.3 0.0 0.1 1.1 0.0 8.9 8.4 1.2 0.0 6.6 0.6 0.7 0.2 0.1 0.1 0.4 1.1 0.7 12.8 0.1 0.3 0.2 0.4 0.2 0.0 5.1 0.2 0.4 10.1 0.0 0.9 0.0 0.2 4.8 8.1 2.7 0.1 1.5 3.6 70.3 0.3 22.8 0.5 0.1 12.4 1.6 2.1 0.1 282.8 94.2 94.4 57.9 8.3 15.7 36.9 129.5 63.0 133.2 112.3 33.7 51.2 156.4 43.3 51.7 150.2 76.4 87.6 44.7 145.7 35.8 48.0 35.0 64.6 49.2 0.6 25.7 54.1 4.4 36.0 62.6 32.8 24.3 68.5 75.9 54.3 100.6 160.4 34.5 87.7 29.1 15.6 80.1 80.0 54.4 126.9 41.2 51.2 44.9 36.1 53.2 48.2 56.0 75.0 26.2 58.0 37.3 40.6 85.6 207.3 111.5 141.5 15.4 39.4 70.1 54.0 43.4 188.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.3 0.1 0.2 0.0 0.0 0.0 4.2 8.9 2.8 10.8 0.0 0.0 2.9 2.4 0.5 2.8 2.6 0.0 0.0 29.8 1.3 5.5 0.0 0.6 364.9 2.5 2.2 2.4 0.0 61.7 0.1 0.0 49.3 6.7 6.6 3.5 0.0 13.5 5.7 1.7 5.0 0.0 0.1 9.4 6.1 1.9 1.6 76.8 8.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 3.0 14.0 2.0 1.5 0.3 0.1 0.0 6.6 0.1 5.8 436.4 38.1 9.4 2.4 6.7 1.9 2.4 18.7 3.8 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051374-141059346 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Cardiomyocytes: 2.7;Respiratory ciliated cells: 2.2;Skeletal myocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.2 0.4 0.1 0.4 0.4 0.0 0.9 0.5 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.4 0.1 0.1 0.4 0.2 0.3 0.1 0.1 0.2 0.4 0.3 0.1 0.4 0.3 0.5 0.1 0.4 0.1 0.0 0.5 0.2 0.0 1.4 0.3 0.2 0.0 0.1 0.2 0.3 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.2 0.2 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.5 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.2 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.4 0.4 0.9 0.5 0.4 0.2 0.4 0.3 0.4 0.1 0.3 0.4 0.0 0.0 1.1 0.0 0.4 0.0 0.9 0.0 0.0 0.3 0.1 0.0 2.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.2 0.4 0.0 1.2 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 PCLAF "KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15" ENSG00000166803 "PCNA clamp associated factor" Q15004 15 64364304-64387687 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 128.6;lymphoid tissue: 73.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 82.2;Extravillous trophoblasts: 160.2;Granulosa cells: 48.8;Hofbauer cells: 110.2;Syncytiotrophoblasts: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 4 "T-reg: 23.6" "Lineage enriched" "Detected in many" 4 "T-cells: 23.6" "Low cell line specificity" "Detected in all" HPA047929 Supported Centrosome NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Centrosome "HPA047929: AB_2680215" "unprognostic (5.34e-2)" "unprognostic (1.36e-3)" "unprognostic (9.39e-2)" "unprognostic (1.28e-1)" "unprognostic (4.16e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (4.38e-3)" "unprognostic (1.91e-3)" "unprognostic (7.26e-2)" "unprognostic (2.56e-3)" "unprognostic (9.65e-2)" "prognostic unfavorable (9.77e-15)" "unprognostic (5.59e-2)" "unprognostic (2.05e-1)" "unprognostic (8.65e-2)" "unprognostic (3.22e-1)" 2.1 1.4 0.9 22.9 1.0 128.6 3.9 1.4 1.1 1.7 0.8 19.0 14.7 4.5 1.2 15.2 1.3 2.5 0.4 0.9 0.6 1.2 3.6 2.5 49.5 1.0 0.8 0.4 1.9 0.8 0.5 8.7 0.9 2.0 22.6 0.3 2.3 0.3 0.4 6.7 15.8 5.0 0.5 7.4 8.1 1.1 1.0 73.8 2.2 0.1 47.1 7.9 4.9 1.9 212.6 165.8 154.4 140.8 15.9 60.9 134.4 146.2 84.8 185.4 276.4 198.4 202.1 343.7 46.4 57.4 64.8 153.6 340.7 83.1 235.3 192.5 124.8 352.5 202.5 209.8 1.5 285.3 153.8 20.0 7.9 156.4 31.9 52.3 168.9 175.9 201.3 104.4 248.1 187.8 268.0 605.5 73.9 179.9 73.4 416.6 353.8 247.1 115.9 200.2 19.1 86.7 112.8 105.2 69.3 78.9 153.8 365.3 36.3 158.4 308.6 177.8 386.7 65.5 223.4 229.0 67.7 512.9 108.5 2.4 0.3 0.9 1.4 0.2 0.2 2.0 4.4 4.2 2.8 0.6 0.5 1.0 2.7 5.7 0.4 0.3 23.6 2.3 0.9 1.0 1.4 1.1 0.9 0.6 1.0 0.8 0.9 0.5 1.0 1.9 0.5 9.6 11.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 27.5 25.5 0.0 0.0 5.0 1.8 0.0 82.2 8.3 0.0 1.9 6.5 0.0 18.6 10.4 8.5 0.0 0.0 0.0 3.0 160.2 25.4 0.0 13.8 3.8 48.8 0.0 0.0 110.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.3 0.0 0.0 3.0 3.6 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 42.1 5.8 7.6 0.0 0.0 PCSK4 "DKFZp434B217, MGC34749, PC4, SPC5" ENSG00000115257 "Proprotein convertase subtilisin/kexin type 4" Q6UW60 19 1481428-1490752 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 66.0" "Group enriched" "Detected in many" 4 "Early spermatids: 277.1;Late spermatids: 679.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.7;HMC-1: 3.7;JURKAT: 5.3;U-266/70: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA005572 Uncertain NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA005572: AB_1855087" "unprognostic (1.00e-2)" "unprognostic (9.12e-2)" "unprognostic (2.36e-3)" "prognostic favorable (9.45e-5)" "unprognostic (5.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.78e-1)" "unprognostic (6.34e-3)" "unprognostic (2.94e-1)" "unprognostic (8.29e-3)" "unprognostic (1.93e-2)" "unprognostic (7.44e-2)" "unprognostic (6.56e-2)" "unprognostic (3.82e-2)" "unprognostic (1.71e-2)" "unprognostic (3.57e-2)" "unprognostic (7.03e-2)" 0.8 1.4 1.1 0.3 1.1 0.6 1.2 0.9 2.5 1.7 1.3 1.3 1.7 1.1 0.1 1.1 3.2 0.6 0.5 1.4 1.6 3.7 4.0 1.1 0.3 1.9 2.8 1.1 2.8 0.9 7.1 0.2 1.5 1.8 0.1 0.6 1.1 1.2 0.3 0.6 1.1 0.1 1.8 0.7 1.4 66.0 1.6 0.4 3.4 0.0 0.1 1.0 1.2 0.9 0.6 0.3 1.2 6.7 0.1 0.2 1.8 0.5 0.1 0.0 0.2 0.6 1.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.1 0.3 1.1 1.0 0.4 0.0 3.7 0.6 0.0 0.0 0.1 0.3 0.2 5.3 1.2 1.8 0.0 0.0 0.1 0.3 0.1 0.3 0.4 1.2 0.1 0.1 0.4 0.0 0.0 1.4 0.1 0.3 0.1 0.4 2.5 0.4 0.0 0.5 0.0 0.1 0.0 7.7 1.5 0.3 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 1.1 0.9 2.5 1.4 1.6 1.9 2.8 1.5 1.8 1.6 0.9 0.2 0.0 1.1 12.1 0.1 0.6 0.9 1.8 0.6 1.5 3.1 2.2 2.3 1.5 3.6 0.0 8.4 0.5 1.7 1.6 5.9 1.8 277.1 5.2 1.0 0.5 0.0 1.7 3.2 1.0 0.5 0.8 3.1 1.1 0.0 3.3 0.0 3.2 0.8 3.3 3.7 1.4 0.0 0.3 0.0 679.2 6.2 1.1 3.6 3.7 0.0 2.4 0.0 1.0 1.6 0.9 1.1 5.3 1.4 0.5 2.8 1.9 8.3 9.1 0.0 0.2 0.5 98.0 9.6 1.2 0.0 0.3 0.7 2.4 2.1 0.7 PCYOX1 "KIAA0908, PCL1" ENSG00000116005 "Prenylcysteine oxidase 1" Q9UHG3 2 70257386-70281185 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 599.4;Hepatocytes: 187.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 313.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035193 Approved "Intracellular and membrane" NA NA 510000000 "Cluster 44: Non-specific - Transcription" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 11: Alveolar cells - Smell perception" "HPA035193: AB_10602017" "unprognostic (1.09e-1)" "unprognostic (1.72e-2)" "unprognostic (7.91e-2)" "unprognostic (1.15e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" "unprognostic (6.87e-2)" "unprognostic (6.28e-2)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (1.61e-1)" "unprognostic (4.38e-2)" "prognostic favorable (1.89e-4)" "unprognostic (3.26e-2)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" 78.5 33.5 15.4 12.7 15.7 3.7 34.4 12.1 18.4 56.5 29.3 26.9 24.9 39.9 33.6 38.8 35.6 31.7 37.7 14.7 27.8 92.6 103.5 56.2 14.6 16.5 22.0 39.6 20.6 66.0 17.9 29.0 24.9 44.3 23.6 30.7 70.1 46.6 92.1 33.0 24.5 40.8 14.6 15.6 22.1 14.2 28.4 11.1 60.0 50.4 14.2 25.7 25.2 13.2 38.8 54.9 43.2 48.6 313.2 160.0 37.9 64.8 59.4 35.4 26.5 86.5 33.6 4.0 27.3 89.2 58.2 62.2 31.7 50.2 40.5 22.1 26.9 14.9 41.0 75.7 31.4 14.1 12.7 154.9 54.1 47.4 13.3 93.9 42.6 14.2 27.0 27.8 50.7 23.6 10.7 22.8 26.1 55.9 23.1 19.6 90.2 34.5 50.1 42.8 11.3 24.1 97.8 47.7 45.5 61.0 39.1 18.2 53.4 59.2 32.7 52.9 34.2 22.9 55.1 5.1 71.3 19.3 22.1 16.3 6.5 6.8 8.3 5.4 10.4 3.7 8.0 6.7 5.9 2.8 10.8 9.2 4.1 6.1 6.0 7.4 7.8 6.5 15.4 15.7 12.1 18.4 14.7 27.8 16.5 22.0 24.9 14.6 28.4 13.2 37.3 599.4 77.5 16.0 12.2 21.3 23.1 43.9 29.6 48.7 46.0 31.8 81.1 40.0 49.9 53.3 43.8 43.4 12.1 30.7 7.9 26.7 1.7 18.4 65.9 33.4 8.5 12.0 24.7 10.2 36.0 81.9 22.4 36.2 10.1 20.9 39.7 187.8 22.1 57.2 36.8 21.0 36.7 17.4 9.2 3.9 89.2 14.3 24.9 23.4 8.6 90.3 11.3 21.6 18.0 13.9 21.0 120.7 26.2 27.0 47.7 69.0 25.0 36.9 72.3 65.5 63.7 14.7 32.2 40.8 28.3 22.0 14.5 56.2 26.5 18.4 PCYT1B "CCT-beta, CTB" ENSG00000102230 "Phosphate cytidylyltransferase 1, choline, beta" Q9Y5K3 X 24558087-24672677 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.2;retina: 12.1;testis: 13.4" "Cell type enhanced" "Detected in some" "Astrocytes: 23.5;Early spermatids: 29.1;Late spermatids: 90.1;Muller glia cells: 30.1;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 41.9" "Cancer enhanced" "Detected in some" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.3;CACO-2: 22.2;HEL: 25.7;Hep G2: 10.2;NTERA-2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006367 Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 36: HEL - Hemostasis" "Cluster 31: Spermatids - Spermatogenesis" "HPA006367: AB_1079585" "unprognostic (4.49e-1)" "unprognostic (2.20e-1)" "unprognostic (1.16e-1)" "unprognostic (7.39e-2)" "unprognostic (9.88e-2)" "unprognostic (6.83e-2)" "unprognostic (5.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-1)" "unprognostic (1.65e-2)" "unprognostic (5.64e-2)" "unprognostic (2.63e-6)" "unprognostic (2.62e-4)" "unprognostic (4.56e-2)" "unprognostic (1.75e-2)" "unprognostic (1.96e-4)" 0.1 0.8 12.1 0.2 12.2 0.8 0.1 10.6 12.8 0.7 7.5 1.2 0.3 1.6 0.6 0.8 2.2 0.4 2.9 13.2 9.8 0.2 0.0 0.7 0.0 9.5 10.2 1.4 1.5 0.0 1.3 1.3 9.8 0.8 0.2 12.1 0.1 2.4 0.0 0.1 0.6 2.5 8.6 0.2 0.2 13.4 11.4 0.5 0.0 0.0 0.0 0.3 0.3 12.9 0.0 0.0 10.3 0.1 0.0 0.0 0.1 0.0 0.9 0.3 0.1 22.2 0.0 0.0 5.2 0.0 0.0 1.0 4.2 0.0 0.0 0.0 0.1 25.7 0.0 10.2 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 3.9 0.5 11.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 7.2 5.8 0.0 0.0 0.5 7.1 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 4.4 0.7 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 12.1 12.2 10.6 12.8 13.2 9.8 9.5 10.2 9.8 8.6 11.4 12.9 0.0 0.0 0.0 23.5 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.5 1.6 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 29.1 10.7 0.2 0.1 1.8 1.3 5.6 0.0 0.0 0.4 0.0 0.2 4.5 5.8 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 90.1 0.3 0.9 0.0 3.7 0.3 30.1 0.0 23.6 41.9 0.2 0.0 2.6 0.1 0.1 0.0 0.5 6.4 1.6 0.0 0.0 1.0 1.8 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 22.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA052801: AB_2681956" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 34.1 4.2 2.5 3.9 3.5 0.2 51.9 2.8 3.0 27.8 1.9 9.0 0.9 15.8 10.3 3.0 23.3 13.4 11.1 2.3 2.3 1.3 0.7 4.7 1.2 2.7 2.6 42.9 6.9 9.0 7.4 9.0 2.5 5.4 3.1 0.6 13.1 6.7 18.4 11.0 2.6 26.0 2.4 0.8 6.2 6.5 2.9 3.8 33.0 38.0 2.0 6.5 12.0 3.3 0.0 17.7 1.0 189.4 5.6 2.5 13.8 4.6 159.1 7.5 31.3 1.0 0.2 0.0 0.9 2.5 24.7 0.0 11.6 0.9 3.7 0.2 14.5 0.0 5.3 4.1 14.6 0.0 0.0 86.9 0.1 9.2 0.1 0.0 13.0 1.6 0.0 2.4 1.1 12.5 0.2 0.4 9.9 0.7 3.6 0.0 0.2 0.4 1.0 11.4 0.6 1.2 1.4 1.7 3.3 11.4 0.6 0.0 2.6 0.2 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 3.5 2.8 3.0 2.3 2.3 2.7 2.6 2.5 2.4 2.9 3.3 15.5 0.0 3.6 2.3 0.3 13.3 0.5 4.3 0.6 0.6 2.9 3.3 4.5 1.5 2.8 0.0 0.0 14.9 0.7 0.4 0.0 4.1 36.0 2.4 5.4 4.1 1.2 0.0 1.1 7.1 19.9 186.2 0.5 4.7 0.0 0.3 1.4 0.2 3.5 0.0 3.5 1.3 2.0 0.0 14.6 6.7 74.6 1.6 10.6 1.9 1.6 1.4 0.0 3.0 1.3 3.1 0.1 70.7 0.2 1.9 0.4 0.1 0.2 0.4 0.0 8.0 10.7 0.8 1.9 0.6 9.9 9.7 1.7 1.5 0.4 0.5 PDLIM7 ENIGMA ENSG00000196923 "PDZ and LIM domain 7" Q9NR12 5 177483394-177497606 "Predicted intracellular proteins" "Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 570.3;skeletal muscle: 661.5" "Cell type enhanced" "Detected in many" "Ductal cells: 164.8;Exocrine glandular cells: 242.1;Pancreatic endocrine cells: 320.1;Peritubular cells: 223.0;Sertoli cells: 164.3;Smooth muscle cells: 157.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 177.1;eosinophil: 121.2;neutrophil: 438.7" "Lineage enriched" "Detected in all" 9 "granulocytes: 438.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018794, HPA048815" Approved Enhanced "Actin filaments,Focal adhesion sites" NA NA 1700000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Actin filaments, Focal adhesion sites" "HPA018794: AB_1855155, HPA048815: AB_2680530" "unprognostic (7.70e-3)" "unprognostic (3.75e-2)" "unprognostic (9.27e-3)" "prognostic unfavorable (5.45e-4)" "unprognostic (1.40e-1)" "unprognostic (3.48e-2)" "unprognostic (9.18e-3)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.01e-2)" "unprognostic (3.10e-1)" "unprognostic (7.24e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (6.19e-10)" "unprognostic (6.72e-3)" "unprognostic (3.02e-1)" "unprognostic (1.93e-1)" "unprognostic (3.68e-2)" 74.3 26.7 23.0 74.5 27.2 50.3 58.2 18.8 39.8 183.7 30.2 570.3 31.5 489.5 28.8 64.5 236.0 45.0 79.9 22.3 27.6 52.8 16.0 84.7 15.1 23.9 23.4 94.2 15.1 9.6 66.3 33.2 24.9 245.3 24.9 5.7 42.3 200.7 661.5 38.0 111.7 177.6 20.8 84.5 156.1 37.6 28.5 11.5 37.1 70.5 7.6 315.4 125.0 20.5 115.8 25.8 120.7 89.4 32.5 59.9 118.9 232.4 132.8 128.9 89.0 50.9 109.6 20.4 220.4 156.4 69.5 59.5 19.7 160.6 30.3 27.5 27.6 73.6 92.2 52.6 83.6 38.8 237.3 132.0 29.1 115.6 51.5 191.9 85.4 18.3 52.4 15.3 102.5 103.9 7.0 88.6 75.7 23.2 108.8 144.4 101.3 14.0 89.1 29.6 17.5 35.8 91.5 16.9 44.6 39.9 24.3 31.3 292.9 153.8 168.1 60.5 211.7 4.0 4.7 24.1 73.3 44.2 35.7 177.1 46.7 121.2 5.3 22.9 6.3 9.6 3.1 7.2 26.7 5.3 3.0 4.0 438.7 2.3 29.3 1.9 7.0 23.9 23.0 27.2 18.8 39.8 22.3 27.6 23.9 23.4 24.9 20.8 28.5 20.5 36.6 0.0 0.6 11.1 7.5 14.5 47.1 106.8 6.2 6.3 7.6 65.3 21.0 4.3 20.9 25.8 14.6 12.5 4.4 5.5 25.4 164.8 27.0 7.5 44.8 51.0 3.5 9.4 13.9 242.1 53.3 65.0 9.7 7.3 17.2 18.6 51.0 1.6 64.0 8.4 7.4 2.1 36.7 16.6 18.3 49.3 44.7 44.9 10.6 5.6 31.0 16.2 1.0 2.0 1.7 320.1 33.6 223.0 3.2 30.4 1.0 15.7 13.2 22.6 164.3 24.6 157.7 11.6 38.7 12.2 15.8 14.1 10.8 18.2 3.1 25.3 PFKFB4 ENSG00000114268 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4" Q16877 3 48517684-48562015 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 40.3;Proximal enterocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.5;eosinophil: 21.9;intermediate monocyte: 13.8;neutrophil: 40.4;non-classical monocyte: 25.1" "Group enriched" "Detected in many" 6 "granulocytes: 40.4;monocytes: 25.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 52.5;U-87 MG: 83.9;WM-115: 74.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047719, HPA066058" Uncertain Approved Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 58: Brain - Synaptic function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli "HPA047719: AB_2680129, HPA066058: AB_2685606" "unprognostic (7.60e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.90e-3)" "unprognostic (7.96e-2)" "unprognostic (1.72e-6)" "unprognostic (1.65e-1)" "unprognostic (3.75e-2)" "unprognostic (6.78e-2)" "unprognostic (3.78e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.91e-8)" "unprognostic (2.04e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-3)" "unprognostic (3.35e-2)" 1.8 2.5 5.1 4.0 5.5 14.8 1.9 6.1 6.3 3.3 3.4 3.3 18.4 2.0 18.0 7.3 1.6 1.6 1.5 5.1 6.5 3.5 1.7 4.2 1.5 6.8 6.4 3.3 11.2 3.2 5.2 10.2 6.9 3.6 3.4 16.1 2.7 1.3 5.4 3.8 20.8 2.4 5.9 10.3 1.3 24.0 7.7 1.3 1.6 3.4 1.1 2.0 5.8 6.7 12.0 3.9 8.3 8.1 2.8 4.0 16.6 6.1 10.4 11.9 29.3 6.0 4.2 5.5 5.8 4.6 28.4 3.5 3.6 10.6 10.6 3.5 2.9 12.3 9.3 6.7 2.5 2.3 5.1 4.2 15.6 19.4 1.9 52.5 2.9 6.7 4.4 4.5 9.7 2.8 0.8 17.3 5.0 2.3 8.0 0.9 4.1 5.9 4.5 11.4 2.5 5.4 6.6 3.0 23.6 8.2 6.3 5.3 0.9 12.0 4.7 1.6 36.7 21.6 4.4 3.2 83.9 4.3 74.8 0.0 12.5 21.9 0.4 13.8 0.1 0.3 0.6 0.1 5.1 0.2 1.0 0.3 40.4 0.5 25.1 0.6 0.0 4.9 5.1 5.5 6.1 6.3 5.1 6.5 6.8 6.4 6.9 5.9 7.7 6.7 0.1 0.0 1.3 13.1 0.3 3.2 0.3 7.0 1.8 6.3 1.6 1.3 1.0 2.8 2.1 0.0 2.1 13.8 0.2 1.3 0.0 2.9 2.8 1.9 2.4 0.8 4.2 0.4 4.5 1.5 40.3 1.2 0.5 3.3 1.3 2.0 1.1 1.0 6.0 6.7 7.3 13.0 2.0 7.8 0.5 2.6 0.9 7.3 1.8 3.7 3.5 3.3 1.0 6.0 13.9 2.9 1.4 0.7 1.8 0.4 43.6 0.2 2.7 4.4 0.0 0.1 1.5 0.5 0.8 2.5 1.7 5.5 0.9 1.3 3.7 0.1 PIFO "C1orf88, FLJ23853, pitchfork" ENSG00000173947 "Primary cilia formation" Q8TCI5 1 111346600-111353013 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 174.2" "Group enriched" "Detected in many" 4 "Early spermatids: 430.6;Endometrial ciliated cells: 495.3;Late spermatids: 458.1;Respiratory ciliated cells: 990.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.4;RPTEC TERT1: 4.7;RT4: 5.9;SuSa: 7.9;T-47d: 3.8;U-87 MG: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.18e-3)" "unprognostic (3.23e-2)" "unprognostic (7.33e-2)" "unprognostic (3.03e-3)" "unprognostic (6.00e-2)" "unprognostic (7.43e-4)" "unprognostic (8.78e-7)" "unprognostic (6.43e-3)" "unprognostic (7.28e-2)" "unprognostic (9.07e-3)" "prognostic favorable (2.48e-4)" "unprognostic (3.32e-2)" "prognostic favorable (1.44e-4)" "unprognostic (6.03e-3)" "unprognostic (4.73e-2)" "unprognostic (6.37e-2)" "unprognostic (6.83e-2)" 1.0 2.8 8.6 0.7 9.1 0.1 5.7 8.2 9.2 4.3 36.5 5.1 0.6 7.4 12.5 3.5 174.2 3.5 9.3 8.5 10.8 8.3 0.0 12.9 0.3 14.3 15.0 3.3 6.4 15.1 9.8 2.9 13.7 12.2 1.1 5.1 3.1 6.0 0.1 1.4 1.1 4.7 12.2 0.4 4.4 24.8 10.8 1.7 15.0 0.9 0.6 5.4 0.8 14.0 0.0 0.0 0.5 0.6 0.6 0.7 1.0 0.0 1.2 0.2 0.0 0.8 1.1 0.0 0.2 0.0 1.1 0.0 0.8 0.2 0.0 1.4 0.2 0.0 0.1 0.9 0.4 0.0 0.0 0.4 3.2 0.0 0.0 3.4 0.0 0.2 0.2 0.1 2.0 0.3 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 4.7 5.9 2.2 0.2 0.0 0.1 0.1 7.9 3.8 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.4 3.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 9.1 8.2 9.2 8.5 10.8 14.3 15.0 13.7 12.2 10.8 14.0 0.3 3.2 18.5 3.3 0.5 4.2 9.1 71.5 1.8 0.7 6.0 12.6 17.3 0.0 83.2 5.5 4.2 11.6 0.1 0.0 21.5 13.0 430.6 495.3 5.8 1.6 3.0 0.0 0.5 2.0 4.4 3.7 1.5 9.0 0.0 3.8 0.7 0.1 1.2 0.0 1.4 0.0 77.3 0.0 0.7 458.1 5.9 1.5 8.8 0.0 0.0 11.8 0.0 0.5 0.6 1.2 0.0 3.4 0.4 6.2 0.0 36.3 990.5 5.4 6.6 4.6 22.8 127.1 10.5 0.5 2.8 7.0 1.0 8.4 0.1 4.3 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112063218-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 66.5" "Cell type enhanced" "Detected in many" "Early spermatids: 425.9;Endometrial ciliated cells: 68.8;Late spermatids: 157.5;Respiratory ciliated cells: 115.3;Spermatocytes: 215.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.8 1.0 1.8 0.5 1.8 0.4 1.9 1.6 1.8 1.8 9.6 0.9 0.5 1.7 4.8 1.2 14.8 1.6 1.3 1.9 2.0 3.9 0.7 2.9 0.4 4.0 4.6 1.2 1.1 4.1 3.3 0.7 3.4 0.9 0.8 12.4 1.3 1.4 1.0 1.2 0.4 0.6 3.5 0.3 1.0 66.5 2.1 0.6 5.3 0.4 0.4 0.8 0.8 2.5 1.9 1.1 3.1 1.6 0.7 0.8 2.3 0.7 2.2 1.8 2.3 3.0 6.4 0.9 2.4 1.8 2.5 2.6 0.6 1.8 1.9 0.9 2.1 1.3 1.4 1.6 1.3 1.8 0.3 1.2 2.3 4.7 2.6 1.6 0.9 1.3 2.0 0.6 1.3 0.7 0.7 2.5 1.0 1.0 1.6 1.1 2.0 2.6 5.6 0.9 3.6 1.0 2.9 0.5 1.0 0.7 8.0 0.5 0.1 1.6 1.4 0.8 0.6 0.4 0.3 1.3 1.9 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 1.8 1.6 1.8 1.9 2.0 4.0 4.6 3.4 3.5 2.1 2.5 1.4 6.4 0.5 10.1 0.0 0.6 1.6 7.8 1.8 2.6 1.9 2.2 3.1 5.7 9.9 3.7 2.1 0.9 0.0 0.5 15.6 3.8 425.9 68.8 2.8 1.3 3.0 0.0 5.1 2.3 0.7 1.5 0.0 2.6 1.3 1.5 1.1 0.2 0.7 1.7 5.8 0.5 10.2 0.3 0.4 157.5 2.8 0.8 3.6 1.9 0.6 5.6 0.0 4.0 3.9 1.6 0.4 1.5 0.0 0.6 0.2 10.4 115.3 16.9 0.0 0.7 3.3 215.5 8.4 0.4 1.0 0.3 0.6 1.6 0.4 0.9 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444441-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.9" "Group enriched" "Detected in some" 6 "Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Immune cell enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 161.8" "Region enhanced" "Detected in many" "white matter: 5.7" "Low region specificity" "Detected in single" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes "Cluster 22: NK-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 0.5 2.5 0.3 1.3 0.0 2.5 0.8 1.1 0.4 0.9 0.0 3.3 3.0 0.8 0.0 3.3 0.3 0.7 0.3 0.1 0.1 0.3 0.3 0.7 1.5 0.2 0.0 0.8 0.2 0.1 0.1 0.6 0.0 0.3 4.1 0.4 0.7 0.1 0.0 2.7 3.1 2.0 0.0 6.0 1.2 0.3 0.1 13.9 0.4 0.0 2.1 1.3 1.3 0.2 42.1 54.1 161.8 73.1 1.5 4.5 12.6 47.9 29.8 78.6 52.5 32.8 17.9 0.0 18.8 39.8 39.9 29.9 82.6 21.6 41.9 64.6 33.9 0.1 33.8 41.2 0.2 1.7 48.9 2.4 1.5 32.2 12.4 8.0 24.8 36.8 10.1 23.0 49.9 30.5 9.2 0.5 70.9 34.0 37.8 74.9 64.8 29.6 12.9 6.4 36.5 51.3 41.7 42.5 39.1 20.4 19.9 4.0 11.9 59.9 48.4 36.0 80.7 8.2 31.5 0.2 23.6 20.4 94.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.2 1.0 0.1 0.0 0.3 0.3 0.3 0.0 1.1 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.2 0.0 0.4 1.2 0.6 0.0 0.0 0.0 0.0 0.6 5.5 0.0 0.7 1.3 21.5 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.0 0.0 PIP "GCDFP-15, GCDFP15, GPIP4" ENSG00000159763 "Prolactin induced protein" P12273 7 143132077-143139739 "Plasma proteins, Predicted secreted proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "salivary gland: 16791.8" "Group enriched" "Detected in many" 4 "Breast glandular cells: 1117.6;Breast myoepithelial cells: 324.2;Melanocytes: 403.8" "Cancer enriched" "Detected in many" 70 "breast cancer: 672.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 333 "T-47d: 703.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB002661, HPA009177" Enhanced "Secreted in other tissues" NA NA 66000000 "Cluster 37: B-cells - Transcription" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" "CAB002661: , HPA009177: AB_1845459" "unprognostic (2.80e-1)" "unprognostic (2.15e-1)" "unprognostic (1.08e-3)" "unprognostic (3.01e-2)" "unprognostic (5.93e-2)" "unprognostic (2.25e-2)" "unprognostic (1.54e-1)" "unprognostic (1.05e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.14e-1)" "unprognostic (3.49e-2)" "unprognostic (5.55e-1)" 9.1 3.6 0.7 0.2 4.8 0.1 3458.7 2.7 2.7 5.6 0.0 0.5 0.0 0.1 2.7 1.3 4.2 0.1 4.8 0.9 4.6 0.5 2.0 6.4 0.8 8.5 4.4 3.8 21.1 0.4 1.9 2.3 6.8 33.3 0.0 0.0 16791.8 3140.5 1.7 189.7 0.6 0.0 3.5 0.6 0.6 0.7 4.6 0.3 0.7 0.0 1.8 0.6 1.5 11.5 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 703.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.8 2.7 2.7 0.9 4.6 8.5 4.4 6.8 3.5 4.6 11.5 6.9 0.0 2.0 0.0 3.6 10.8 6.6 18.8 0.0 0.0 1117.6 324.2 0.1 0.0 48.2 1.8 0.0 0.0 7.0 0.0 0.0 9.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.5 0.0 3.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.4 0.0 1.6 0.0 0.0 1.5 403.8 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 0.0 13.1 0.0 0.1 147.1 0.0 0.0 0.0 9.2 0.0 0.0 0.0 1.7 0.0 2.5 0.0 0.0 13.7 PKIB PRKACN2 ENSG00000135549 "CAMP-dependent protein kinase inhibitor beta" Q9C010 6 122471917-122726373 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.4;intestine: 90.8;parathyroid gland: 63.7;placenta: 60.4" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 542.7;Distal enterocytes: 750.2;Extravillous trophoblasts: 420.5;Langerhans cells: 251.9;Late spermatids: 251.1;Paneth cells: 355.4;Proximal enterocytes: 255.0;Syncytiotrophoblasts: 959.8" "Cancer enhanced" "Detected in all" "breast cancer: 16.3" "Region enriched" "Detected in all" 5 "cerebellum: 70.4" "Immune cell enriched" "Detected in some" 11 "myeloid DC: 34.8" "Lineage enriched" "Detected in many" 11 "dendritic cells: 34.8" "Cell line enhanced" "Detected in many" "AF22: 71.8;MCF7: 84.9;OE19: 91.2;PC-3: 112.5;RPTEC TERT1: 187.1;SCLC-21H: 157.7" "Region enhanced" "Detected in all" "cerebellum: 63.0" "Region enhanced" "Detected in all" "cerebellum: 45.0" HPA030156 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA030156: AB_10602816" "unprognostic (1.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (9.45e-2)" "prognostic unfavorable (4.72e-7)" "unprognostic (1.94e-2)" "unprognostic (5.88e-2)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (2.47e-7)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" 2.2 5.8 4.4 9.0 3.9 0.2 23.3 70.4 5.2 4.9 3.4 90.8 15.5 3.4 3.4 5.2 5.5 5.7 0.5 5.9 6.9 2.8 8.2 4.1 2.2 13.9 7.4 0.8 6.3 63.7 22.1 60.4 14.6 6.2 62.4 56.1 8.5 2.4 0.7 9.1 28.3 3.9 3.9 3.2 34.4 4.2 6.8 3.7 1.1 0.6 4.1 5.4 1.2 5.0 0.1 2.8 71.8 0.3 0.6 0.3 62.4 0.0 0.8 0.3 1.2 0.4 3.0 0.0 0.4 0.0 3.8 0.3 0.0 1.5 0.8 0.4 3.7 1.2 3.9 1.7 0.2 0.0 12.3 0.3 1.2 1.2 15.3 34.0 0.3 0.5 22.3 0.4 0.2 84.9 0.3 0.4 29.6 91.2 112.5 0.6 10.8 0.4 187.1 10.6 157.7 0.2 0.0 17.1 2.0 39.4 12.0 1.8 5.7 0.2 47.3 0.2 6.2 0.2 0.3 0.2 46.7 1.5 0.4 0.0 0.6 0.0 0.0 3.2 0.7 0.0 0.0 0.0 34.8 0.1 0.4 0.1 0.1 1.9 0.3 0.5 0.4 0.7 4.4 3.9 70.4 5.2 5.9 6.9 13.9 7.4 14.6 3.9 6.8 5.0 3.0 3.2 3.9 17.0 4.6 19.8 2.3 2.5 2.8 23.6 94.8 53.3 0.3 2.8 10.2 1.8 4.2 542.7 0.9 750.2 19.6 22.6 106.0 5.3 1.6 3.9 98.0 4.0 5.5 35.8 420.5 6.9 52.0 5.5 38.7 0.3 1.1 3.8 53.1 6.7 15.5 94.9 14.2 75.5 251.9 251.1 1.2 51.2 44.4 9.4 25.5 15.2 0.0 6.0 8.5 50.4 355.4 0.4 1.2 13.8 255.0 26.9 58.3 54.8 6.6 0.3 2.7 3.3 5.8 12.4 17.0 959.8 3.5 0.2 92.9 8.3 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980479 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;testis: 56.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 29.0;Extravillous trophoblasts: 52.0;Plasma cells: 22.9;Spermatocytes: 114.7;Spermatogonia: 46.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "T-reg: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 1.1 1.0 0.4 6.8 0.5 27.6 0.6 1.6 1.4 2.2 0.2 3.9 2.8 0.6 0.3 11.5 0.4 0.6 0.9 0.5 0.2 0.9 1.6 2.0 8.0 0.7 0.6 0.3 1.8 0.1 1.0 3.1 0.8 1.0 1.3 17.4 1.9 0.1 2.4 4.4 4.0 1.0 0.5 5.6 3.3 56.9 0.7 9.6 0.5 0.0 4.5 0.7 3.3 0.8 84.2 57.0 22.0 31.2 0.3 0.9 64.0 65.5 15.1 40.0 38.4 45.0 49.3 54.2 29.2 7.9 24.2 106.7 15.7 20.7 7.2 71.7 56.7 27.9 52.7 40.0 0.0 31.2 73.6 0.7 1.8 24.0 6.5 5.0 8.4 57.6 80.6 87.0 13.5 127.5 83.6 88.0 37.9 39.3 34.4 93.7 51.2 100.7 7.8 17.7 42.6 46.7 31.9 77.7 23.9 12.1 44.7 56.9 7.7 53.2 69.7 77.3 68.0 67.6 54.2 94.0 19.4 40.0 61.2 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.3 0.4 0.5 1.6 1.4 0.5 0.2 0.7 0.6 0.8 0.5 0.7 0.8 0.0 0.0 1.1 0.0 1.9 2.5 1.3 2.1 0.6 0.4 1.5 1.3 0.6 1.5 1.6 1.8 6.2 16.0 1.3 5.0 0.0 0.8 20.0 0.6 0.8 0.8 1.8 29.0 0.4 0.6 52.0 2.5 3.1 1.9 0.0 4.5 0.0 0.4 11.8 0.0 0.2 3.6 6.1 2.1 1.8 8.6 0.3 1.9 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.6 0.3 0.4 22.9 0.7 0.3 0.1 0.2 7.1 0.0 0.1 2.6 114.7 46.1 11.2 0.6 7.4 4.2 0.5 8.6 2.0 PLA2G2A "PLA2B, PLA2L" ENSG00000188257 "Phospholipase A2 group IIA" P14555 1 19975431-19980416 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Inflammatory response, Lipid metabolism, Phospholipid metabolism" "Antimicrobial, Bacteriolytic enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 1302.4;intestine: 1973.9;placenta: 756.7;urinary bladder: 813.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 536.5;Exocrine glandular cells: 1031.5;Fibroblasts: 656.0;Intestinal goblet cells: 393.6;Paneth cells: 574.1;Prostatic glandular cells: 921.1;Undifferentiated cells: 861.9" "Cancer enhanced" "Detected in all" "prostate cancer: 875.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 645.0;OE19: 2384.4" "Not detected" "Not detected" HPA015236 Enhanced "Secreted to blood" NA NA 1000000 680000 "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 21: OE19 - Mitochondria" "Cluster 50: Fibroblasts - ECM organization" "HPA015236: AB_10601047" "unprognostic (2.33e-2)" "unprognostic (1.28e-1)" "unprognostic (2.79e-2)" "unprognostic (7.85e-3)" "unprognostic (8.71e-2)" "unprognostic (9.27e-2)" "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "prognostic favorable (1.49e-4)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.77e-15)" "unprognostic (2.72e-2)" "unprognostic (9.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.51e-1)" 1302.4 7.0 0.1 280.2 0.1 0.0 27.4 0.1 0.7 5.4 2.9 1474.0 786.8 4.3 3.3 29.3 14.8 57.7 137.4 0.0 0.2 6.6 238.6 16.8 5.4 0.6 0.7 44.1 7.8 0.9 2.5 756.7 0.2 203.9 1668.0 0.1 24.6 6.1 6.0 18.1 1973.9 164.4 0.1 0.4 11.6 36.8 1.3 1.7 11.1 114.2 15.0 813.6 12.1 0.1 0.0 0.0 1.6 0.0 248.3 0.0 8.5 0.0 0.1 0.1 0.0 11.2 0.0 0.0 1.1 0.0 0.8 18.7 0.0 0.0 0.0 0.1 0.3 0.0 0.3 645.0 0.0 0.1 1.1 2.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.4 2384.4 0.0 0.0 0.0 7.6 0.0 198.2 1.0 4.7 0.0 20.1 0.0 31.1 0.1 0.0 0.0 0.0 0.0 44.7 0.2 0.4 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.7 0.0 0.2 0.6 0.7 0.2 0.1 1.3 0.1 20.6 6.4 6.7 0.0 9.1 13.9 10.8 0.2 0.6 0.9 1.0 0.8 14.9 12.8 9.3 0.0 0.0 3.6 0.4 536.5 1.9 0.7 4.0 0.7 43.1 6.9 62.3 13.5 0.0 1031.5 4.6 656.0 6.1 0.6 4.5 0.0 30.0 310.9 9.5 0.0 0.0 393.6 2.0 18.8 31.1 11.6 171.2 3.5 14.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 574.1 1.2 2.6 921.1 328.2 0.2 1.9 0.0 0.0 2.4 37.8 0.9 1.5 4.9 16.8 6.8 6.2 0.1 861.9 32.2 PLB1 "FLJ30866, PLB" ENSG00000163803 "Phospholipase B1" Q6P1J6 2 28457145-28644142 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 39.0" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 112.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "classical monocyte: 3.0;eosinophil: 3.0;intermediate monocyte: 4.4;myeloid DC: 5.7;neutrophil: 8.8;non-classical monocyte: 5.0" "Group enriched" "Detected in many" 40 "dendritic cells: 5.7;granulocytes: 8.8;monocytes: 5.0" "Cell line enhanced" "Detected in some" "BEWO: 3.6;OE19: 7.8;RT4: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "unprognostic (2.18e-2)" "unprognostic (2.49e-1)" "unprognostic (6.58e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (4.91e-3)" "unprognostic (4.74e-2)" "unprognostic (4.48e-2)" "unprognostic (2.03e-2)" "unprognostic (1.53e-1)" "unprognostic (2.17e-1)" "unprognostic (2.61e-9)" "unprognostic (2.48e-2)" "unprognostic (2.19e-2)" "unprognostic (4.99e-2)" "unprognostic (8.03e-2)" 1.8 5.7 3.4 1.8 3.3 5.0 1.8 1.0 3.0 1.9 2.2 1.5 0.7 1.6 1.7 1.0 1.3 1.5 1.2 2.7 2.6 0.7 0.5 1.6 0.4 2.4 2.3 0.9 0.6 0.3 1.6 2.1 2.0 2.1 1.8 0.1 1.4 1.5 2.0 7.9 39.0 2.7 2.5 4.1 0.9 2.6 2.9 0.6 2.0 0.6 0.3 1.7 1.3 1.6 0.4 0.0 2.4 0.0 0.5 0.3 3.6 0.1 1.0 0.2 0.2 2.5 0.2 0.2 0.2 0.4 1.0 0.5 0.0 1.9 0.2 0.1 0.0 0.2 0.4 0.4 0.8 0.4 0.1 0.4 1.1 0.4 0.5 0.4 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 7.8 0.5 0.0 0.4 0.0 1.1 2.7 1.0 0.2 0.1 0.1 0.2 0.2 0.0 1.3 0.2 0.2 0.7 0.1 0.1 0.5 0.1 0.0 0.8 1.8 0.0 0.0 3.0 3.0 0.0 4.4 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 8.8 0.0 5.0 0.3 0.1 1.1 3.4 3.3 1.0 3.0 2.7 2.6 2.4 2.3 2.0 2.5 2.9 1.6 0.6 0.0 0.6 0.7 0.3 0.4 1.0 0.6 0.6 0.1 1.6 1.5 1.6 0.0 1.5 0.0 0.0 0.5 2.1 6.5 1.9 1.6 27.0 2.4 1.0 1.5 1.2 0.0 3.2 0.9 23.2 0.6 0.0 1.1 5.7 0.1 1.1 0.0 12.5 0.0 3.4 5.4 0.0 17.4 10.1 18.3 1.2 12.5 0.0 15.0 4.8 0.3 0.0 1.5 0.4 1.0 2.6 0.7 0.5 0.4 112.6 0.0 1.5 0.0 0.0 1.1 0.3 1.0 0.9 0.3 0.4 8.2 1.5 0.6 2.5 1.6 PLEKHG7 "C12orf74, FLJ46688" ENSG00000187510 "Pleckstrin homology and RhoGEF domain containing G7" Q32Q52 12 92702843-92772455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 1.8;epididymis: 1.9;fallopian tube: 2.8" "Cell type enriched" "Detected in some" 4 "Respiratory ciliated cells: 72.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "memory B-cell: 1.9;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SK-BR-3: 1.5" HPA060632 Uncertain NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA060632: AB_2684333" "unprognostic (4.47e-3)" "unprognostic (3.95e-2)" "unprognostic (1.16e-1)" "unprognostic (1.05e-3)" "unprognostic (1.80e-2)" "unprognostic (9.91e-5)" "unprognostic (1.38e-1)" "unprognostic (9.44e-2)" "unprognostic (1.61e-1)" "unprognostic (6.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (2.56e-1)" "unprognostic (2.13e-1)" "unprognostic (2.75e-1)" "unprognostic (3.27e-5)" 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.5 0.3 0.3 1.9 0.0 2.8 0.4 0.0 0.0 0.0 0.3 0.2 0.8 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.4 1.7 0.0 0.0 0.2 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.8 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.9 0.1 0.3 6.1 0.0 0.4 0.0 0.0 0.7 0.0 16.3 1.8 0.0 0.0 0.0 0.2 0.0 0.6 1.0 13.7 0.3 0.1 1.2 0.0 0.1 0.2 0.0 0.0 1.1 1.6 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 4.1 0.0 0.0 0.9 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.3 0.2 0.1 72.0 0.6 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 1.3 PLEKHS1 "bA211N11.2, C10orf81, FLJ23537" ENSG00000148735 "Pleckstrin homology domain containing S1" Q5SXH7 10 113751262-113783429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 30.5;cervix: 63.6;intestine: 43.9;pancreas: 36.9;salivary gland: 57.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 35.1;Club cells: 70.7;Endometrial ciliated cells: 33.8;Exocrine glandular cells: 31.1;Ionocytes: 38.7;Proximal enterocytes: 42.1;Respiratory ciliated cells: 157.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.1;OE19: 53.5;RT4: 22.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA037583 Approved Vesicles,Centrosome NA NA "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Centrosome Vesicles "HPA037583: AB_10671762" "unprognostic (2.64e-1)" "unprognostic (1.64e-2)" "unprognostic (2.74e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (2.63e-2)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (8.43e-2)" "unprognostic (6.82e-2)" "unprognostic (2.57e-1)" "unprognostic (1.21e-2)" "unprognostic (0.00e+0)" "unprognostic (4.00e-3)" "unprognostic (2.19e-1)" "unprognostic (2.27e-1)" "prognostic favorable (1.03e-4)" 0.3 0.1 0.0 7.3 0.0 0.3 30.5 0.0 0.3 63.6 0.0 3.6 43.9 1.8 3.9 1.0 9.4 2.7 0.4 0.0 0.0 0.9 0.1 6.7 0.2 0.2 0.0 0.1 36.9 0.1 0.2 0.1 0.0 6.0 4.7 0.4 57.0 3.3 0.0 0.8 38.7 0.5 0.0 0.2 8.8 0.9 0.0 0.1 0.1 0.0 2.8 1.5 0.0 0.1 0.2 1.4 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.7 0.2 10.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 53.5 0.0 0.2 6.4 0.3 1.7 22.3 0.1 0.2 0.1 1.4 0.0 0.0 6.3 0.0 0.0 0.2 0.2 0.2 0.5 4.7 0.2 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 3.2 3.2 0.3 0.0 0.1 0.3 35.1 0.0 0.0 16.6 8.3 0.4 0.0 70.7 0.0 0.0 0.0 0.1 6.7 0.0 4.9 13.2 33.8 0.3 0.5 0.0 0.0 0.2 31.1 0.0 0.6 3.1 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 5.6 38.7 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.2 2.8 0.4 0.0 1.4 42.1 0.3 157.3 0.0 0.0 0.3 3.7 0.2 0.1 0.6 0.0 0.0 0.3 0.0 12.1 0.5 PLG ENSG00000122194 Plasminogen P00747 6 160702238-160754097 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 2666.4" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 1772.7" "Cancer enriched" "Detected in some" 84 "liver cancer: 180.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000668, CAB016678, HPA021602, HPA048823" Supported "Secreted to blood" NA NA 140000000000 45000000000 "Cluster 85: Liver - Metabolism" "Cluster 15: Hepatocytes - Hemostasis" "CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.44e-1)" "unprognostic (8.54e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (6.28e-2)" "unprognostic (7.25e-2)" "prognostic favorable (4.22e-4)" "unprognostic (3.97e-3)" "unprognostic (5.21e-2)" "unprognostic (2.33e-2)" 0.4 0.4 0.3 0.2 0.4 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.3 0.2 0.0 0.1 2.4 0.5 0.1 0.2 0.3 240.9 2666.4 0.4 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.9 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.6 30.0 0.0 1.8 0.0 0.0 0.3 0.0 19.6 0.0 0.2 3.0 0.1 1.2 0.0 24.0 0.6 0.0 0.0 0.0 0.0 0.1 1.3 0.0 28.5 1772.7 0.1 0.0 0.5 0.0 0.0 35.4 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 235.7 1.5 0.1 0.0 0.4 0.2 0.4 0.4 0.0 0.0 0.0 2.3 0.1 0.0 0.0 PLK1 PLK ENSG00000166851 "Polo like kinase 1" P53350 16 23677656-23690367 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.0;lymphoid tissue: 43.9;testis: 33.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 32.3;Early spermatids: 123.7;Erythroid cells: 38.3;Extravillous trophoblasts: 55.9;Spermatocytes: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "T-reg: 5.6" "Lineage enriched" "Detected in many" 5 "T-cells: 5.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051638, HPA053229" Approved NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "HPA051638: AB_2681561, HPA053229: AB_2682084" "unprognostic (7.21e-3)" "unprognostic (1.77e-1)" "unprognostic (1.98e-3)" "unprognostic (4.97e-3)" "unprognostic (9.56e-2)" "unprognostic (5.12e-2)" "prognostic unfavorable (2.70e-7)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.55e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.33e-1)" "unprognostic (8.10e-2)" "unprognostic (1.19e-1)" "unprognostic (1.26e-2)" 1.4 1.5 2.3 13.4 2.3 32.0 1.5 2.5 3.2 2.3 2.0 9.6 10.4 1.2 0.4 13.9 1.0 1.4 1.0 2.3 2.1 1.4 1.9 1.9 27.8 2.3 2.3 1.3 1.1 0.2 1.2 6.4 2.2 1.2 10.1 1.2 2.4 0.3 1.0 5.7 9.2 4.0 2.0 9.1 6.2 33.1 2.5 43.9 0.9 0.4 30.0 2.8 4.0 2.8 199.9 207.5 166.2 90.9 5.2 11.7 92.8 111.0 74.5 172.5 127.0 184.3 131.0 99.1 56.3 76.5 90.1 112.8 229.5 93.5 206.1 139.5 128.0 125.2 163.4 257.1 1.7 147.5 133.7 4.8 5.2 124.7 125.2 21.6 127.9 127.5 200.7 133.9 134.8 187.8 139.8 151.4 189.5 82.1 103.5 217.2 111.7 160.0 49.3 43.9 94.3 65.3 126.8 88.9 55.8 94.4 114.4 92.1 65.1 82.7 102.7 79.9 194.1 93.2 156.8 173.6 69.3 127.7 137.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.3 0.3 0.0 0.0 0.0 0.4 0.9 0.0 0.0 5.6 1.4 2.3 2.3 2.5 3.2 2.3 2.1 2.3 2.3 2.2 2.0 2.5 2.8 0.6 3.2 0.0 3.3 7.6 1.3 1.2 6.5 0.0 1.4 1.7 2.3 0.6 0.0 1.4 0.0 4.2 32.3 0.4 5.5 0.0 0.8 123.7 3.4 1.3 2.5 0.0 38.3 3.1 0.8 55.9 4.7 10.2 1.8 1.3 19.9 3.3 1.1 20.8 0.0 2.3 7.3 4.1 6.9 3.2 13.9 1.2 7.2 0.0 2.8 0.4 1.1 0.0 1.5 2.3 1.2 0.3 0.7 23.0 2.0 1.5 0.1 1.3 1.3 0.0 2.3 6.1 79.5 13.5 12.2 1.8 3.8 2.5 1.2 17.9 2.0 PLK4 "Sak, STK18" ENSG00000142731 "Polo like kinase 4" O00444 4 127880893-127899224 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6" "Cell type enhanced" "Detected in many" "Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017327, HPA035026, HPA043198" Approved Supported Centrosome,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Centrosome, Cytosol" "HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504" "unprognostic (2.44e-1)" "unprognostic (4.24e-2)" "prognostic favorable (7.46e-5)" "unprognostic (2.18e-1)" "unprognostic (3.79e-1)" "unprognostic (9.20e-2)" "unprognostic (1.06e-5)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.44e-3)" "unprognostic (5.66e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.27e-1)" "unprognostic (2.22e-11)" "unprognostic (2.29e-2)" "unprognostic (3.58e-1)" "unprognostic (4.75e-2)" "unprognostic (7.93e-2)" 1.0 1.1 0.4 4.9 0.5 22.6 2.0 0.2 0.7 0.9 0.1 3.5 2.8 1.5 0.6 3.2 1.3 1.1 0.5 0.5 0.6 0.6 0.8 0.9 7.4 0.5 0.5 1.0 0.4 0.6 0.2 3.6 0.4 0.9 4.3 2.1 0.9 0.9 0.1 2.3 2.9 1.8 0.4 1.6 2.0 22.6 0.6 14.4 0.9 0.7 7.3 1.3 1.4 0.4 26.1 12.1 44.3 22.9 1.5 4.2 20.1 24.9 17.6 32.4 33.3 17.0 26.1 34.9 9.0 13.9 26.3 16.7 31.6 19.9 49.6 27.4 13.1 31.6 20.0 16.0 0.5 45.2 35.9 1.4 2.0 29.7 13.6 5.9 25.3 26.3 37.5 45.2 27.6 18.2 69.9 20.1 20.7 26.3 13.6 36.0 30.9 12.1 10.8 16.4 24.4 20.0 15.8 14.2 7.6 18.7 11.5 19.3 11.0 25.3 24.4 17.4 31.4 23.1 27.4 49.0 13.0 33.7 28.7 0.0 0.1 0.4 0.4 0.2 0.3 0.1 0.5 0.5 0.2 0.2 0.1 0.6 0.0 0.4 0.1 0.1 1.2 0.2 0.4 0.5 0.2 0.7 0.5 0.6 0.5 0.5 0.4 0.4 0.6 0.4 1.6 0.0 0.6 0.0 1.6 1.7 0.9 1.7 1.2 1.8 1.0 0.9 0.9 0.0 0.6 1.8 0.0 6.0 1.9 2.0 0.0 0.6 65.9 4.7 1.0 1.0 2.4 19.6 0.8 0.4 12.9 1.6 4.1 2.0 1.3 7.5 0.4 0.5 3.7 0.0 0.8 3.3 6.1 1.3 0.6 87.5 2.8 1.5 0.0 1.0 1.2 1.1 1.0 1.0 1.2 0.1 0.5 0.4 8.7 0.7 0.5 0.6 3.7 0.8 0.0 0.4 3.6 53.5 13.4 6.8 0.9 3.8 2.1 0.8 4.5 1.7 PLN "CMD1P, PLB" ENSG00000198523 Phospholamban P26678 6 118548296-118561716 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 1563.4;skeletal muscle: 507.3" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 2452.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB005597, HPA026900" Enhanced NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "CAB005597: AB_2252716, HPA026900: AB_1855314" "unprognostic (2.49e-1)" "unprognostic (5.67e-2)" "unprognostic (1.96e-3)" "unprognostic (4.81e-2)" "unprognostic (1.20e-1)" "unprognostic (5.54e-2)" "unprognostic (2.35e-3)" "unprognostic (4.66e-2)" "unprognostic (3.97e-1)" "unprognostic (8.98e-2)" "unprognostic (8.98e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.11e-4)" "unprognostic (2.98e-3)" "unprognostic (1.80e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (5.59e-4)" 40.1 12.3 1.5 12.3 3.0 0.6 15.9 2.9 4.0 31.7 2.0 148.7 13.6 121.7 21.8 43.9 81.9 92.2 1563.4 1.6 1.6 15.0 1.2 15.4 2.7 1.8 2.0 20.4 3.2 1.3 1.5 0.3 1.8 35.1 24.4 0.2 5.3 37.0 507.3 8.3 41.6 128.4 1.5 3.0 34.1 4.3 2.2 1.0 12.7 230.2 0.9 44.1 22.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.0 2.9 4.0 1.6 1.6 1.8 2.0 1.8 1.5 2.2 2.0 4.5 0.0 0.0 0.3 0.2 4.2 0.2 0.0 1.2 1.8 0.4 0.6 2452.8 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 108.2 0.2 0.7 21.4 0.0 0.0 1.0 0.0 0.0 49.1 0.5 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.9 0.0 0.0 0.0 4.7 25.0 0.9 0.4 3.6 1.0 0.0 0.0 0.0 2.0 1.1 0.1 0.0 11.7 0.0 0.7 0.0 0.0 0.0 0.3 276.1 16.7 248.0 9.2 0.8 0.3 1.6 0.0 0.8 0.0 0.0 0.4 PLPP2 "LPP2, PAP-2c, PPAP2C" ENSG00000141934 "Phospholipid phosphatase 2" O43688 19 281040-291403 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.2;MAIT T-cell: 6.6" "Lineage enriched" "Detected in single" 41 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "A549: 144.1;CAPAN-2: 154.6;OE19: 255.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055540, HPA058428" Uncertain Supported "Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane" "HPA055540: AB_2682839, HPA058428: " "prognostic unfavorable (4.55e-4)" "unprognostic (8.91e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.21e-8)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.83e-3)" "unprognostic (5.48e-2)" "unprognostic (1.59e-1)" "unprognostic (5.67e-2)" "unprognostic (1.18e-3)" "unprognostic (3.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-3)" 4.8 13.2 37.7 8.5 61.6 0.0 36.9 57.1 50.0 63.4 26.2 40.5 62.7 16.8 8.4 27.2 81.8 52.4 1.7 38.8 43.5 11.5 3.7 8.3 1.4 57.3 53.6 2.7 37.3 19.5 11.8 3.6 56.2 31.7 32.1 29.6 105.7 32.9 0.6 53.2 51.0 6.4 44.8 4.7 50.3 7.6 49.2 5.2 5.7 0.5 6.0 36.5 14.2 83.9 85.5 144.1 2.1 0.1 0.0 0.3 0.2 8.2 0.0 25.3 18.9 41.7 154.6 0.0 88.3 11.9 0.1 45.3 0.0 17.6 11.1 0.8 2.6 0.0 55.9 0.0 28.6 0.0 5.5 5.2 7.6 12.7 16.7 53.4 4.2 0.0 0.7 0.1 0.0 98.5 0.4 0.1 61.5 255.8 0.0 0.0 0.0 2.4 62.1 13.7 17.4 40.9 23.3 38.3 60.3 5.8 50.0 2.5 4.5 55.7 36.5 0.5 61.9 0.8 101.7 70.4 15.5 0.0 46.9 0.0 0.0 0.0 3.2 0.0 6.6 0.0 1.3 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 37.7 61.6 57.1 50.0 38.8 43.5 57.3 53.6 56.2 44.8 49.2 83.9 17.0 6.4 7.5 0.0 1.5 0.0 134.2 0.0 8.0 19.7 137.1 149.9 0.0 204.5 35.3 22.0 10.4 0.5 2.7 77.0 3.9 352.1 0.3 115.2 9.2 15.2 8.5 0.0 0.0 139.5 15.1 3.0 91.3 90.1 1.3 0.0 0.0 0.5 0.9 16.8 0.0 38.8 0.0 1.0 0.0 1.6 0.0 1.9 0.0 0.0 2.6 21.7 0.0 0.0 0.0 128.8 85.2 0.0 1.6 97.4 209.8 1.4 91.1 234.9 0.0 0.8 2.7 0.6 35.1 20.3 0.0 0.8 3.5 0.1 87.2 205.8 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821955 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 9.8;brain: 21.1;fallopian tube: 11.1" "Cell type enriched" "Detected in some" 7 "Endometrial ciliated cells: 37.2" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 61.8;THP-1: 128.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 65: Brain - Ion transport" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.0 0.0 16.8 0.2 14.1 9.8 2.2 0.0 21.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 11.1 0.1 0.1 14.2 11.5 0.0 0.0 2.3 0.1 4.1 8.2 0.3 0.0 0.2 0.4 0.0 1.5 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 2.3 0.2 0.1 3.2 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.5 12.2 0.0 0.0 0.0 6.9 0.2 0.1 0.0 0.0 0.7 0.1 0.1 8.4 0.1 0.1 0.3 2.3 0.0 0.0 0.0 5.2 0.0 1.6 0.0 0.5 4.4 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 12.0 0.3 0.0 1.1 0.0 61.8 9.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 15.5 0.3 0.0 0.0 6.3 5.4 128.9 0.1 0.2 0.2 0.3 0.1 0.2 0.5 0.2 0.0 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 14.1 0.0 21.1 14.2 11.5 4.1 8.2 1.5 2.3 13.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 3.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 37.2 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.1 5.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 PNMA8C ENSG00000277531 "PNMA family member 8C" A0A1B0GUJ8 19 46424697-46428951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 15.9;pituitary gland: 8.6" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.3;Endometrial ciliated cells: 1.3" "Cancer enriched" "Detected in some" 11 "glioma: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 1.1;HMC-1: 2.4;SH-SY5Y: 3.7" "Low region specificity" "Detected in all" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (3.25e-2)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (4.91e-3)" "unprognostic (2.58e-1)" "unprognostic (4.61e-3)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-2)" "unprognostic (2.92e-2)" 0.0 1.1 12.3 0.1 13.0 0.1 0.2 1.6 11.4 0.0 1.5 0.2 0.0 0.1 2.0 0.0 1.2 0.2 0.1 11.0 15.1 0.0 0.0 0.1 0.0 5.9 10.2 0.1 0.0 0.1 8.6 0.0 7.1 0.3 0.0 2.0 0.0 0.4 0.7 0.1 0.1 0.1 5.9 0.0 0.0 0.6 15.9 0.0 0.0 0.0 0.0 0.1 0.0 8.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 12.3 13.0 1.6 11.4 11.0 15.1 5.9 10.2 7.1 5.9 15.9 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 PNOC "N/OFQ, NOP, PPNOC" ENSG00000168081 Prepronociceptin Q13519 8 28316986-28343355 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Neuropeptide, Neurotransmitter, Opioid peptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.3;fallopian tube: 18.2;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in some" "B-cells: 61.5;dendritic cells: 12.6;Inhibitory neurons: 23.3;Melanocytes: 14.2;Plasma cells: 80.4" "Cancer enriched" "Detected in many" 8 "ovarian cancer: 32.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 20 "memory B-cell: 231.2;naive B-cell: 260.3;plasmacytoid DC: 194.0" "Group enriched" "Detected in many" 20 "B-cells: 260.3;dendritic cells: 194.0" "Group enriched" "Detected in some" 6 "Daudi: 38.3;Karpas-707: 29.2;RPMI-8226: 11.2;U-698: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA044507, HPA056724" Enhanced "Secreted to blood" NA NA 12300 "Cluster 19: B-cells - Humoral immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "HPA044507: AB_10795043, HPA056724: AB_2683216" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (3.53e-2)" "prognostic unfavorable (2.94e-6)" "unprognostic (3.71e-2)" "unprognostic (5.16e-5)" "unprognostic (1.03e-1)" "unprognostic (1.50e-1)" "unprognostic (7.81e-4)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" "unprognostic (7.57e-9)" "unprognostic (2.19e-2)" "unprognostic (5.45e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-1)" 0.2 0.8 5.4 9.9 5.1 2.7 0.6 1.3 10.8 0.2 1.3 2.9 4.3 0.1 0.0 0.6 18.2 1.1 0.1 2.9 9.9 0.7 0.2 1.0 25.1 10.4 6.3 0.4 0.0 0.0 0.0 0.0 9.9 0.2 1.5 0.0 1.6 0.1 0.0 0.1 5.8 0.5 14.3 14.4 3.2 0.6 4.3 2.7 0.4 0.0 23.6 3.7 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.0 4.4 23.0 0.1 0.1 0.0 0.2 11.5 2.3 0.2 7.7 0.1 231.2 0.2 0.1 1.1 260.3 0.1 0.1 1.3 1.2 3.2 194.0 0.5 11.1 5.4 5.1 1.3 10.8 2.9 9.9 10.4 6.3 9.9 14.3 4.3 3.0 0.1 0.0 1.9 1.3 61.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.4 0.4 0.2 0.0 23.3 0.1 0.0 0.0 0.3 2.8 0.3 1.7 14.2 1.0 3.0 0.0 1.0 0.0 0.9 0.1 0.0 0.0 80.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 1.1 0.0 0.3 0.5 PODN "MGC24995, PCAN, PODOCAN, SLRR5A" ENSG00000174348 Podocan Q7Z5L7 1 53062052-53085501 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Fibroblasts: 123.5;Leydig cells: 268.7;Peritubular cells: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "gdT-cell: 5.1;memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 52 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "ASC diff: 23.0;BJ: 39.2;fHDF/TERT166: 23.9;HHSteC: 94.1;U-2197: 46.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 910000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (8.69e-2)" "unprognostic (4.73e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.31e-1)" "unprognostic (1.88e-1)" "unprognostic (3.65e-1)" "unprognostic (1.90e-3)" "unprognostic (1.71e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (2.02e-5)" "unprognostic (5.91e-3)" "unprognostic (1.62e-1)" "unprognostic (6.11e-2)" "unprognostic (5.02e-2)" 191.0 14.3 9.1 13.3 8.2 0.2 116.3 6.4 8.7 106.1 7.1 76.1 11.6 105.1 19.7 36.1 127.5 103.8 87.1 6.8 8.1 5.2 12.5 66.3 3.8 7.3 10.3 178.0 20.8 2.9 19.5 18.1 8.2 69.8 8.2 0.6 48.8 34.4 20.2 45.4 26.1 44.7 6.7 3.3 75.5 26.9 10.3 10.8 71.5 30.5 2.7 101.3 87.9 6.7 0.0 0.0 0.0 0.0 23.0 3.1 0.1 39.2 5.3 0.4 0.3 0.0 0.0 0.0 0.6 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.1 0.0 0.0 14.9 0.0 0.9 0.0 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.8 9.1 8.2 6.4 8.7 6.8 8.1 7.3 10.3 8.2 6.7 10.3 6.7 8.5 0.0 3.3 0.0 0.0 6.4 0.4 0.0 0.6 0.5 0.8 0.9 1.7 1.5 0.6 0.0 0.0 0.4 1.3 0.0 0.0 0.0 1.6 0.3 11.2 3.8 0.0 0.0 0.0 0.0 0.4 123.5 2.6 0.3 0.0 0.7 4.2 0.1 0.6 0.0 1.9 0.0 0.0 0.3 8.8 9.2 268.7 1.3 5.4 6.5 0.0 0.3 3.1 5.5 0.2 0.0 0.0 261.1 1.6 0.5 0.1 0.0 0.0 0.5 0.0 4.4 16.0 0.7 0.6 0.7 6.0 0.5 1.6 0.0 0.0 0.2 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;lymphoid tissue: 4.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.5" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.1 0.2 0.0 1.6 0.1 6.0 0.4 1.0 0.2 0.2 0.0 1.2 1.2 0.2 0.0 2.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 2.0 0.0 0.3 0.0 0.0 1.4 0.9 0.4 0.0 0.8 0.5 2.2 0.0 4.5 0.0 0.0 2.3 0.3 0.5 0.0 18.2 12.1 10.2 7.2 0.9 1.2 9.2 8.5 3.2 9.7 12.9 9.8 6.6 21.5 3.7 4.6 11.7 14.0 12.2 5.4 16.4 6.3 6.7 13.8 8.0 6.1 0.1 15.1 12.1 0.2 0.4 8.9 5.4 1.7 4.9 7.9 9.3 15.9 10.3 7.1 13.7 8.8 9.7 5.5 5.9 11.4 12.2 7.6 3.1 10.3 5.5 5.0 9.8 5.2 3.4 8.8 4.8 14.8 3.8 8.6 11.2 3.4 11.1 8.0 6.9 21.8 4.1 11.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.6 0.7 0.9 0.5 0.6 0.0 0.9 0.6 0.6 1.6 0.0 2.0 0.0 0.0 3.1 0.6 1.6 0.0 0.1 0.4 0.9 1.0 0.5 0.0 16.4 9.5 0.0 3.3 1.2 4.6 1.0 0.0 12.6 0.0 0.2 2.3 0.0 7.8 1.6 2.0 1.3 1.2 0.7 0.3 1.7 0.0 1.0 0.6 0.4 0.0 1.5 1.3 0.2 1.2 0.0 12.2 0.5 0.2 0.1 2.4 0.2 0.0 0.1 1.0 6.8 3.4 4.9 0.1 0.3 1.8 0.9 3.2 0.8 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 35.6;testis: 18.9" "Cell type enhanced" "Detected in many" "Early spermatids: 374.4;Endometrial ciliated cells: 226.5;Late spermatids: 75.1;Respiratory ciliated cells: 228.6;Spermatocytes: 101.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;ASC diff: 9.2;ASC TERT1: 11.5;hTERT-RPE1: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.1 0.9 4.7 0.6 5.2 0.2 3.0 5.7 5.3 3.8 12.2 1.3 1.4 3.0 9.0 1.4 35.6 1.1 2.1 4.8 5.2 4.3 0.6 4.7 0.6 7.5 8.2 5.3 2.3 5.2 2.7 1.1 5.5 1.2 1.0 7.4 2.3 2.7 4.3 1.3 0.7 2.0 7.2 0.8 1.7 18.9 5.1 0.8 11.1 1.7 0.6 1.5 1.2 7.6 1.4 1.2 1.1 6.0 9.2 11.5 0.6 0.0 2.2 0.5 0.1 0.1 1.6 0.0 0.4 0.6 0.8 0.9 1.0 0.0 0.3 0.4 0.4 0.5 0.1 0.0 4.6 0.5 0.2 2.4 5.6 0.2 3.5 8.6 0.7 1.3 0.6 0.4 0.4 0.6 0.1 0.7 0.2 4.0 0.8 0.6 0.0 0.5 4.7 0.1 1.3 2.1 0.1 0.3 3.9 0.3 0.4 0.9 0.3 0.1 0.2 1.0 0.2 0.2 0.1 0.1 1.9 0.1 0.4 0.8 0.1 0.2 0.1 0.1 0.1 1.5 0.2 0.1 0.3 0.5 0.1 0.1 0.4 0.4 0.1 0.4 0.1 0.2 4.7 5.2 5.7 5.3 4.8 5.2 7.5 8.2 5.5 7.2 5.1 7.6 2.6 6.4 6.9 11.8 1.8 2.2 3.7 18.2 2.8 2.4 5.7 7.0 3.7 2.8 22.1 3.7 2.1 0.8 0.4 0.9 25.4 1.9 374.4 226.5 7.3 1.8 3.0 0.4 15.0 1.2 0.8 3.9 2.6 5.8 0.0 4.1 1.1 0.2 0.4 1.7 6.1 2.0 22.4 0.0 0.3 75.1 5.3 1.1 3.6 3.7 0.6 7.8 0.0 8.5 6.2 0.7 0.8 5.3 0.8 3.8 1.5 13.0 228.6 13.4 0.0 5.2 5.6 101.4 21.5 1.9 3.0 0.7 1.2 3.0 2.0 1.5 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755854-58985179 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 39.2;retina: 22.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1" "Cancer enhanced" "Detected in some" "glioma: 2.7;prostate cancer: 3.0" "Group enriched" "Detected in many" 4 "cerebral cortex: 31.6;hippocampal formation: 39.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Yes No "Cluster 46: Basophils - DNA binding" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.1 5.5 5.3 0.1 4.8 0.0 0.1 1.0 31.6 0.2 0.0 0.1 0.1 0.3 0.9 0.0 1.5 0.1 1.0 39.2 7.3 0.7 1.0 0.2 0.2 1.9 4.2 0.2 0.6 0.3 1.3 0.0 3.2 1.4 0.0 22.3 0.2 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.5 6.7 8.0 0.2 0.1 0.1 0.2 0.1 0.1 2.3 0.0 0.1 12.2 0.6 0.0 0.0 0.9 0.0 0.0 0.9 1.4 0.0 0.0 8.0 0.1 0.1 2.7 0.0 19.9 0.0 0.5 0.2 5.9 0.0 0.2 0.0 1.3 0.6 2.6 0.3 1.6 0.1 0.0 0.6 0.0 4.9 2.1 0.0 0.0 3.6 9.9 0.0 3.5 0.0 1.0 0.0 1.5 0.0 0.0 0.0 9.1 18.7 0.3 0.0 1.3 0.1 0.0 8.7 0.0 0.0 2.2 0.0 2.9 0.1 0.1 5.4 0.3 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.8 1.0 31.6 39.2 7.3 1.9 4.2 3.2 0.3 8.0 2.3 0.1 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 22.0 0.1 0.4 3.3 0.0 1.8 0.0 31.3 0.0 0.0 0.1 0.0 0.0 30.8 3.9 0.1 0.3 3.0 0.0 220.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 1.4 0.1 77.4 288.4 0.0 0.0 0.3 0.0 17.6 0.0 0.1 0.0 5.6 0.0 4.2 0.0 109.1 38.4 0.0 0.2 0.4 0.0 1.3 0.0 0.1 0.0 13.8 0.0 0.0 0.5 12.1 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 PPOX "PPO, VP" ENSG00000143224 "Protoporphyrinogen oxidase" P50336 1 161166056-161178013 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 65.9;Respiratory ciliated cells: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030123 Uncertain Approved Vesicles,Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "Vesicles, Cytosol" "HPA030123: AB_10603987" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (9.88e-2)" "unprognostic (2.13e-2)" "unprognostic (3.24e-1)" "unprognostic (1.64e-2)" "unprognostic (9.58e-3)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.18e-3)" "unprognostic (7.12e-3)" "prognostic unfavorable (9.89e-4)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "unprognostic (1.80e-2)" 9.3 17.1 24.2 3.5 24.5 25.2 10.3 25.2 38.2 14.5 24.7 12.7 3.9 10.9 8.3 8.9 22.0 4.7 13.1 24.4 24.7 15.5 11.5 8.6 5.7 25.0 25.0 13.8 10.8 7.2 13.7 6.5 24.6 13.4 3.9 12.6 8.7 7.7 7.6 11.2 8.5 6.6 25.0 13.6 10.9 6.9 24.0 5.0 11.9 5.6 5.2 11.6 9.6 25.4 10.0 8.0 12.7 8.5 10.4 9.3 3.5 5.9 5.7 7.5 10.3 10.4 9.3 7.4 14.3 5.3 4.1 6.3 9.8 8.8 7.1 4.6 20.3 9.0 18.9 23.9 8.6 3.0 4.6 7.6 11.0 6.3 9.4 9.4 14.7 7.0 22.8 11.2 5.6 9.2 12.0 8.6 8.2 11.2 18.8 13.6 8.2 16.7 15.1 4.2 9.8 14.7 6.6 10.3 12.0 14.6 19.9 9.5 5.7 6.5 7.1 6.5 7.5 19.4 15.3 10.5 6.8 6.0 4.9 6.3 7.2 5.3 10.4 7.6 7.2 9.0 7.8 7.6 10.4 8.2 6.8 6.9 2.9 12.0 5.2 6.6 16.1 7.8 24.2 24.5 25.2 38.2 24.4 24.7 25.0 25.0 24.6 25.0 24.0 25.4 10.9 3.2 13.7 10.4 9.8 12.0 8.3 16.6 9.1 18.0 12.1 14.1 10.1 4.3 15.6 7.3 22.9 21.4 10.6 3.6 21.5 9.5 9.8 39.1 5.9 8.3 6.0 65.9 5.9 5.6 9.4 9.1 5.1 4.6 6.3 12.3 8.9 6.1 9.3 15.2 7.5 7.3 26.4 4.7 8.4 12.1 10.2 8.0 1.8 5.6 8.1 10.4 8.2 9.0 8.9 6.3 3.8 6.8 16.9 3.2 6.6 17.2 84.4 20.9 6.6 9.6 15.6 12.8 9.3 7.2 14.9 10.4 10.6 11.1 7.5 6.2 PPP1R16A "MGC14333, MYPT3" ENSG00000160972 "Protein phosphatase 1 regulatory subunit 16A" Q96I34 8 144477969-144502121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 208.9;Proximal enterocytes: 440.8;Proximal tubular cells: 404.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MCF7: 49.9" "Low region specificity" "Detected in all" HPA023755 Uncertain Approved "Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane" "HPA023755: AB_1854268" "unprognostic (9.63e-2)" "unprognostic (4.51e-2)" "unprognostic (5.45e-3)" "unprognostic (3.11e-1)" "unprognostic (5.60e-2)" "unprognostic (3.75e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-1)" "unprognostic (3.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" "unprognostic (1.03e-1)" "unprognostic (9.45e-2)" "unprognostic (2.79e-2)" 6.1 15.0 10.2 4.7 8.6 3.8 8.2 4.3 15.0 10.5 16.7 25.1 27.1 10.5 1.6 9.8 18.9 3.1 9.6 12.9 8.9 26.7 23.5 10.8 2.9 10.2 10.4 7.9 17.7 7.4 36.9 1.7 7.1 15.5 2.4 2.9 11.6 5.6 6.3 9.0 24.6 1.6 8.1 8.0 14.1 33.3 10.3 2.4 27.0 1.0 1.0 9.1 6.7 5.1 30.4 24.3 3.9 15.1 1.6 2.7 19.3 8.2 5.1 6.3 5.1 6.4 21.2 5.0 21.1 3.0 5.6 19.8 2.0 6.7 1.0 10.3 11.9 6.0 26.4 6.8 4.7 4.3 7.9 2.7 8.9 7.3 2.1 4.1 4.5 8.2 24.0 6.1 2.3 49.9 15.3 19.9 7.4 15.6 30.3 15.9 1.9 10.1 5.7 10.0 12.5 23.9 14.9 13.7 13.0 1.0 32.3 9.1 7.7 7.1 33.2 19.8 15.8 4.0 4.3 1.8 22.8 8.3 6.5 0.0 0.8 0.0 1.0 1.2 0.9 0.8 0.8 1.0 1.2 0.1 0.5 1.1 0.2 0.2 1.7 0.7 0.6 0.8 10.2 8.6 4.3 15.0 12.9 8.9 10.2 10.4 7.1 8.1 10.3 5.1 7.9 3.2 15.4 28.1 6.2 43.2 36.2 47.6 54.1 25.0 78.3 82.0 85.8 157.3 24.6 40.5 14.6 7.2 6.0 135.9 121.3 33.7 12.6 43.8 15.6 13.3 51.6 6.1 7.8 41.6 24.3 13.3 70.3 24.2 3.8 16.4 12.8 208.9 6.1 30.3 7.6 98.1 26.4 7.0 27.1 14.4 22.7 9.8 8.8 5.6 3.8 102.8 5.2 6.6 2.8 29.3 109.8 15.4 5.9 40.0 440.8 404.2 59.8 50.9 6.6 17.2 17.3 52.9 28.7 77.8 61.8 6.7 7.1 69.2 116.0 28.3 PPP1R32 "C11orf66, FLJ32771, IIIG9" ENSG00000162148 "Protein phosphatase 1 regulatory subunit 32" Q7Z5V6 11 61481120-61490931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.8" "Group enriched" "Detected in many" 4 "Early spermatids: 253.2;Late spermatids: 363.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039068 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 25: Spermatids - Spermatogenesis" "HPA039068: AB_10672840" "unprognostic (1.70e-1)" "unprognostic (3.18e-3)" "unprognostic (4.48e-4)" "prognostic favorable (4.13e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (1.50e-3)" "unprognostic (4.52e-2)" "unprognostic (2.81e-1)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (3.03e-2)" "unprognostic (9.44e-9)" "unprognostic (2.64e-1)" "unprognostic (2.71e-1)" "unprognostic (2.32e-1)" "unprognostic (1.75e-2)" 5.3 3.4 18.1 3.8 18.3 5.5 5.7 14.9 20.5 8.8 32.7 6.4 3.6 6.2 12.7 2.9 40.6 3.7 4.4 18.6 20.9 6.5 7.7 10.9 7.3 28.0 36.7 6.6 3.6 1.9 14.0 4.2 25.7 6.0 2.7 2.6 4.1 4.5 4.6 11.5 5.0 4.8 24.6 7.4 4.2 93.8 19.4 6.4 4.4 2.0 4.3 4.4 5.6 21.8 0.7 1.4 8.4 3.5 3.7 5.5 1.1 1.7 1.3 1.1 0.9 0.4 7.4 1.6 2.3 0.8 0.4 0.9 1.2 0.6 2.1 2.7 1.7 2.1 0.4 0.2 3.6 1.4 1.6 5.8 2.1 0.4 6.2 6.7 0.8 6.0 0.8 5.0 0.5 1.9 2.1 3.0 0.6 1.4 0.8 4.1 0.2 0.5 1.1 0.3 0.9 2.0 0.3 3.7 0.6 0.7 4.3 4.6 3.1 0.4 1.7 1.3 0.3 8.0 2.3 1.0 0.9 6.0 0.7 1.5 1.1 0.7 1.0 1.3 1.0 0.4 0.6 0.2 0.5 0.4 0.4 1.3 2.0 0.8 0.4 0.4 0.8 0.9 18.1 18.3 14.9 20.5 18.6 20.9 28.0 36.7 25.7 24.6 19.4 21.8 1.5 3.2 1.1 6.8 0.5 0.1 0.8 2.5 0.0 0.5 4.2 4.1 1.3 0.0 6.1 5.5 0.0 1.0 2.2 0.7 31.3 0.5 253.2 27.9 0.9 1.5 3.5 0.0 2.2 1.6 0.3 1.1 0.0 0.8 0.0 1.7 0.4 10.8 0.8 0.0 1.1 1.0 4.1 1.8 1.2 363.8 3.7 0.8 0.0 1.9 1.3 3.0 2.1 1.5 2.7 0.6 1.1 4.1 0.9 1.8 2.1 20.3 72.1 0.2 0.0 0.7 2.6 8.1 1.9 0.1 0.3 0.4 0.7 0.6 0.9 0.8 PPP1R36 C14orf50 ENSG00000165807 "Protein phosphatase 1 regulatory subunit 36" Q96LQ0 14 64549920-64589381 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.5;testis: 37.1" "Group enriched" "Detected in many" 4 "Early spermatids: 350.6;Late spermatids: 791.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077492 Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 22: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 25: Spermatids - Spermatogenesis" "HPA077492: AB_2732348" "unprognostic (3.43e-4)" "unprognostic (5.75e-2)" "unprognostic (4.48e-2)" "unprognostic (6.04e-4)" "unprognostic (1.12e-2)" "unprognostic (9.37e-2)" "unprognostic (1.52e-3)" "unprognostic (9.21e-2)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" "unprognostic (2.42e-1)" "unprognostic (1.17e-1)" "unprognostic (4.80e-3)" "unprognostic (9.77e-3)" "unprognostic (3.53e-1)" "unprognostic (7.12e-2)" "unprognostic (5.46e-2)" 1.9 0.5 1.2 0.4 1.6 0.0 1.4 1.2 2.0 1.0 1.6 6.5 6.6 0.9 3.0 0.6 12.5 2.0 0.5 1.2 1.4 2.4 0.1 1.2 0.2 1.8 1.6 0.1 10.8 0.4 1.9 0.9 2.1 0.2 5.6 0.1 3.8 0.3 0.2 1.0 4.7 0.5 1.8 0.1 7.2 37.1 1.5 0.2 0.2 0.6 0.3 0.9 0.3 2.2 0.2 0.1 0.3 0.1 1.4 0.7 1.0 0.8 0.4 0.5 1.2 0.2 13.9 0.0 0.1 0.7 0.5 0.4 0.0 0.0 0.6 0.1 0.1 0.4 0.8 0.1 0.8 0.0 0.1 0.9 0.7 0.2 0.5 0.9 0.3 0.1 0.0 0.0 0.7 0.8 0.1 0.4 0.0 0.4 0.0 0.1 0.1 0.1 0.5 0.6 3.0 0.1 1.4 0.1 0.0 0.2 0.1 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.2 0.0 1.2 1.6 1.2 2.0 1.2 1.4 1.8 1.6 2.1 1.8 1.5 2.2 1.5 0.0 0.6 2.3 0.5 0.5 0.5 1.6 1.8 0.0 2.7 4.6 0.7 4.3 6.3 3.7 0.0 0.4 1.5 5.0 1.9 0.9 350.6 44.3 1.6 3.2 4.2 0.0 1.7 8.2 2.5 0.8 6.6 6.4 0.0 0.1 2.9 0.0 0.4 0.0 1.4 7.3 0.0 0.6 0.7 791.2 3.4 1.4 0.0 3.7 0.1 0.8 2.1 0.0 5.8 6.8 3.4 3.8 0.3 0.2 8.1 0.1 36.2 0.2 0.0 3.2 1.4 124.8 8.0 1.8 0.4 0.5 0.5 0.2 6.6 0.9 PPP1R42 "dtr, LRRC67, TLLR" ENSG00000178125 "Protein phosphatase 1 regulatory subunit 42" Q7Z4L9 8 66964099-67056604 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "fallopian tube: 4.9;testis: 8.7" "Group enriched" "Detected in many" 5 "Early spermatids: 68.1;Endometrial ciliated cells: 79.3;Respiratory ciliated cells: 127.2;Spermatocytes: 111.8" "Cancer enhanced" "Detected in some" "glioma: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA024313, HPA027983, HPA028628" Uncertain NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA024313: AB_1853053, HPA027983: AB_10599300, HPA028628: AB_2250064" "unprognostic (8.03e-3)" "unprognostic (5.45e-2)" "unprognostic (4.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (5.42e-2)" "unprognostic (1.99e-2)" "unprognostic (1.03e-1)" "unprognostic (3.61e-3)" "unprognostic (6.86e-2)" "unprognostic (8.58e-3)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-1)" 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.2 0.4 0.1 1.4 0.0 0.0 0.1 0.3 0.0 4.9 0.0 0.0 0.4 0.4 0.2 0.0 0.3 0.0 1.4 1.2 0.0 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.7 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.4 0.4 0.4 1.4 1.2 0.9 0.9 0.5 0.6 0.0 0.0 1.1 11.8 0.0 0.0 0.0 6.0 0.0 0.1 0.7 1.0 0.9 0.0 10.8 5.5 0.0 0.0 0.0 0.0 3.9 0.5 68.1 79.3 0.7 0.2 0.0 0.0 3.2 0.0 0.0 0.6 0.0 1.0 0.0 0.3 0.0 0.0 0.0 1.7 2.8 0.0 6.1 0.0 0.0 16.5 0.6 0.3 0.0 1.0 0.0 3.6 0.0 3.5 2.9 0.1 0.0 1.9 0.0 0.0 0.0 1.9 127.2 3.5 6.6 0.0 1.4 111.8 3.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966040-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 89.9;testis: 55.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 34.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 34.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 7.4 6.2 6.4 10.0 6.1 89.9 6.4 10.3 8.4 8.1 5.0 16.3 10.6 5.7 2.3 37.6 6.0 3.0 6.9 5.6 4.9 5.6 4.8 9.0 16.9 4.8 5.2 8.1 8.9 2.6 3.6 15.3 5.2 4.9 16.5 4.9 9.5 1.5 4.1 20.1 13.0 9.4 4.9 12.5 11.7 55.0 4.2 43.0 4.3 2.3 24.9 4.8 13.7 5.6 167.9 199.9 164.8 113.6 16.8 28.7 87.5 237.8 139.3 257.2 195.3 134.6 158.5 65.5 91.4 151.9 156.9 220.9 188.8 101.2 240.6 118.7 206.4 135.6 263.5 123.5 4.1 71.4 109.0 7.7 12.8 145.8 146.9 56.6 146.4 100.5 114.0 132.4 241.1 144.4 66.9 98.5 66.6 216.4 84.9 69.7 205.1 86.3 115.3 123.6 151.2 118.9 225.4 121.9 82.7 112.3 149.1 127.1 91.2 168.2 146.0 140.5 345.1 43.5 127.7 80.0 74.5 162.0 265.3 34.4 0.6 2.9 0.6 0.1 0.4 1.1 1.3 1.3 2.4 0.5 1.2 0.4 0.4 3.0 0.3 2.6 8.0 1.0 6.4 6.1 10.3 8.4 5.6 4.9 4.8 5.2 5.2 4.9 4.2 5.6 2.5 0.0 3.1 1.3 6.8 16.6 6.6 8.0 2.2 6.4 3.4 4.3 3.2 0.0 7.6 3.7 0.0 45.5 2.8 16.5 0.0 3.2 41.5 4.5 4.0 4.7 5.4 142.9 5.0 2.9 68.3 7.2 16.3 6.8 8.9 13.2 9.3 2.1 21.5 3.3 5.2 17.0 10.2 8.7 15.0 15.4 3.7 5.2 3.6 1.9 5.5 3.8 4.1 2.0 1.7 2.3 3.2 1.9 17.5 5.9 2.0 0.1 3.2 4.6 6.6 7.4 10.9 136.4 74.2 38.0 14.2 14.6 6.8 0.4 24.1 6.7 PRMT8 "HRMT1L3, HRMT1L4" ENSG00000111218 "Protein arginine methyltransferase 8" Q9NR22 12 3381349-3593973 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.8;retina: 3.9;testis: 2.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 21.7;Cone photoreceptor cells: 16.7;Early spermatids: 22.8;Excitatory neurons: 60.5;Inhibitory neurons: 63.8;Late spermatids: 15.4" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "hTERT-HME1: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039747, HPA069769" Enhanced NA NA "Cluster 58: Brain - Synaptic function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA039747: AB_2732482, HPA069769: AB_2686193" "unprognostic (3.09e-1)" "unprognostic (9.47e-2)" "unprognostic (5.59e-1)" "unprognostic (3.34e-3)" "unprognostic (4.80e-3)" "unprognostic (9.41e-2)" "unprognostic (3.41e-5)" "unprognostic (5.99e-1)" "unprognostic (1.93e-1)" "unprognostic (1.50e-2)" "unprognostic (7.06e-2)" "unprognostic (2.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.64e-1)" "unprognostic (6.02e-2)" "unprognostic (5.49e-2)" 0.0 0.0 3.2 0.0 7.8 0.0 0.0 3.8 7.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 5.4 1.5 0.6 0.0 0.8 0.0 2.1 3.0 0.0 0.6 0.0 0.1 0.0 0.7 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 4.0 1.1 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 48.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 7.8 3.8 7.2 5.4 1.5 2.1 3.0 0.7 0.3 4.0 3.6 0.0 6.4 1.7 1.6 0.1 0.0 0.0 0.0 0.0 21.7 0.1 0.0 1.3 0.0 5.0 0.0 16.7 0.0 0.0 0.1 0.0 0.0 22.8 2.2 0.1 0.3 0.0 0.0 60.5 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 5.0 63.8 0.0 4.1 0.0 4.2 15.4 0.6 0.4 0.0 1.0 0.0 0.7 0.0 3.0 1.0 0.0 0.0 0.4 0.0 0.1 0.0 0.8 7.5 1.6 0.0 0.0 0.2 3.5 1.5 0.0 0.0 0.0 0.2 0.0 0.1 0.2 PROM1 "AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4" ENSG00000007062 "Prominin 1" O43490 4 15963076-16084378 "CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 272.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 581.7;Respiratory ciliated cells: 144.8;Rod photoreceptor cells: 311.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 37.2;CACO-2: 70.6;CAPAN-2: 28.9;EFO-21: 62.2;NTERA-2: 97.4;RPTEC TERT1: 91.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004922, CAB011525, HPA031053" Enhanced NA NA "Cluster 79: Retina - Phototransduction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 9: Photoreceptor cells - Phototransduction" "CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713" "unprognostic (6.33e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-1)" "unprognostic (3.39e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-1)" "unprognostic (2.39e-1)" "unprognostic (6.64e-2)" "unprognostic (2.18e-2)" "unprognostic (2.17e-1)" "unprognostic (1.21e-2)" "unprognostic (9.06e-2)" "prognostic favorable (2.56e-5)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (9.38e-2)" "unprognostic (1.17e-1)" 0.3 0.3 4.1 6.2 3.0 4.0 27.7 2.7 3.5 44.9 2.0 30.7 12.4 6.0 4.3 5.1 5.4 30.9 6.7 3.3 2.8 20.9 1.8 3.1 0.0 3.8 4.3 0.1 14.4 0.0 0.1 30.1 3.6 2.8 16.7 272.9 57.9 7.1 1.0 0.9 22.9 3.5 2.8 0.2 24.8 8.0 5.0 0.1 4.8 0.0 0.1 4.2 0.2 3.1 0.0 0.0 37.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 70.6 28.9 0.6 62.2 0.0 0.0 0.1 7.3 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 97.4 0.0 0.0 1.4 0.1 0.0 91.1 0.1 12.0 3.6 0.0 2.4 1.9 3.5 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 3.0 2.7 3.5 3.3 2.8 3.8 4.3 3.6 2.8 5.0 3.1 0.2 3.2 4.8 1.3 0.3 0.0 0.1 7.2 0.0 14.8 38.2 30.0 8.6 31.5 29.9 82.8 581.7 0.6 1.0 39.3 0.0 64.1 31.4 71.1 1.7 5.1 44.4 2.1 0.9 15.5 0.1 4.4 31.6 14.8 0.0 3.8 0.7 0.1 0.1 10.1 5.4 15.0 34.6 0.0 0.0 44.3 3.1 0.7 0.0 27.2 0.6 47.5 0.0 45.8 1.2 38.2 28.3 6.4 0.4 1.5 18.8 3.6 144.8 311.3 0.0 0.8 3.1 2.1 1.0 0.7 0.0 0.1 0.7 0.3 26.0 4.1 PRR15 ENSG00000176532 "Proline rich 15" Q8IV56 7 29563835-29567293 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 62.6;intestine: 81.4;stomach 1: 49.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 263.0;Granulosa cells: 194.2;Proximal enterocytes: 122.4;Respiratory ciliated cells: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.7;HaCaT: 45.1;OE19: 97.7;RT4: 34.5;SK-BR-3: 74.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA040996, HPA048121" Enhanced Uncertain "Vesicles,Cell Junctions" NA NA "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "Cell Junctions" "HPA040996: AB_2677241, HPA048121: AB_2680271" "unprognostic (5.46e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "prognostic favorable (6.37e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (3.69e-3)" "unprognostic (1.25e-1)" "prognostic favorable (1.83e-6)" "unprognostic (1.30e-2)" "unprognostic (5.71e-2)" "unprognostic (2.33e-3)" "unprognostic (1.58e-2)" 6.5 0.7 0.6 4.8 0.4 1.1 9.2 0.1 0.7 62.6 0.0 81.4 72.3 18.1 21.6 1.0 9.0 7.8 1.3 0.4 1.0 16.9 0.3 2.3 0.4 0.6 0.4 5.9 3.0 1.4 3.0 4.8 0.5 2.5 52.6 0.0 7.5 3.1 0.2 0.3 72.4 2.3 0.6 0.2 49.3 0.9 1.3 0.1 1.1 0.0 0.7 16.6 0.5 0.6 16.8 23.3 0.0 0.0 8.7 10.7 29.3 0.7 1.1 0.4 0.2 20.5 38.7 0.0 4.1 5.5 0.6 45.1 4.9 0.0 0.0 0.0 3.3 1.3 4.5 22.7 2.8 0.0 0.1 0.1 7.3 0.0 1.7 0.0 0.1 1.5 0.0 0.0 0.0 3.9 0.6 3.2 3.5 97.7 18.5 0.1 0.0 21.4 26.5 34.5 0.5 0.3 2.3 74.9 0.0 12.8 5.4 0.0 19.9 0.5 0.0 0.1 0.9 1.8 3.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.1 0.7 0.4 1.0 0.6 0.4 0.5 0.6 1.3 0.6 1.8 0.0 0.5 0.0 0.4 0.1 1.2 11.0 0.0 0.0 10.0 7.1 0.5 12.8 16.4 38.6 0.0 14.2 0.2 263.0 29.4 6.9 0.8 31.3 2.3 1.2 8.4 0.0 0.1 21.8 9.9 1.3 16.8 34.7 0.0 194.2 0.4 0.2 2.7 0.0 0.0 45.3 26.4 0.0 0.3 0.1 1.5 2.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 14.4 58.5 2.2 0.1 3.0 122.4 14.4 63.1 0.0 0.0 0.0 7.8 0.0 0.4 1.2 0.0 6.3 0.6 0.4 56.9 23.3 PRR18 MGC35308 ENSG00000176381 "Proline rich 18" Q8N4B5 6 166305300-166308448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 127.0" "Cell type enriched" "Detected in some" 5 "Oligodendrocytes: 27.3" "Group enriched" "Detected in some" 5 "glioma: 3.1;liver cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 4.3;SH-SY5Y: 2.5" "Low region specificity" "Detected in all" HPA077250 Enhanced NA NA "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA077250: AB_2732336" "unprognostic (2.91e-1)" "unprognostic (7.18e-2)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (9.65e-2)" "unprognostic (5.60e-3)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.44e-3)" "unprognostic (4.79e-3)" "unprognostic (2.43e-1)" "unprognostic (3.35e-3)" "unprognostic (9.49e-2)" "unprognostic (9.58e-2)" "unprognostic (1.07e-1)" 0.3 0.0 36.1 0.0 90.6 0.0 0.1 38.8 63.8 0.1 10.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 34.3 37.2 0.2 3.3 0.2 0.0 54.5 61.1 0.0 0.2 1.2 0.9 0.0 42.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 32.8 0.0 0.1 0.0 60.2 0.0 0.1 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.5 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 90.6 38.8 63.8 34.3 37.2 54.5 61.1 42.6 32.8 60.2 127.0 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.6 2.8 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 27.3 0.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR29 "C17orf72, DKFZp761M2312, FLJ11724" ENSG00000224383 "Proline rich 29" P0C7W0 17 63998351-64004305 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 58.2" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 57.4;Respiratory ciliated cells: 89.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.5;REH: 3.7;TIME: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051264 Uncertain Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoli "HPA051264: " "unprognostic (2.05e-2)" "unprognostic (6.46e-2)" "unprognostic (2.87e-2)" "unprognostic (2.92e-3)" "unprognostic (4.71e-3)" "unprognostic (3.22e-2)" "unprognostic (3.84e-1)" "unprognostic (3.95e-2)" "unprognostic (1.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.30e-3)" "unprognostic (6.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.98e-3)" 2.0 0.3 3.2 0.5 2.5 0.3 2.2 1.8 1.2 6.1 12.7 0.4 0.2 0.6 0.3 0.2 58.2 0.7 1.5 4.1 4.2 1.9 0.2 10.4 0.4 12.7 16.0 0.6 0.3 0.9 10.7 0.3 7.3 0.7 0.0 0.0 0.5 0.6 0.6 0.4 0.7 0.2 9.0 5.7 0.3 13.9 4.0 0.2 4.7 0.0 0.3 0.8 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 0.0 3.5 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 1.0 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.7 0.1 3.7 0.0 1.5 0.3 0.0 0.2 1.0 0.0 0.1 0.2 0.5 0.5 0.0 2.8 0.1 1.1 0.4 0.1 0.4 0.1 0.2 0.4 0.1 0.0 0.9 0.2 0.0 0.4 0.5 0.1 0.1 0.4 0.2 0.1 0.2 0.7 0.4 0.2 0.2 0.4 0.0 0.2 0.3 3.2 2.5 1.8 1.2 4.1 4.2 12.7 16.0 7.3 9.0 4.0 3.9 3.3 0.0 2.8 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.2 1.5 9.9 3.7 0.0 0.0 0.7 0.0 0.0 0.1 12.4 57.4 0.5 2.1 0.0 0.0 0.5 0.0 0.1 0.6 0.0 1.1 0.0 1.6 1.8 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.0 10.5 0.0 0.9 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.1 89.6 0.0 0.0 0.3 0.3 18.1 1.4 0.0 0.0 0.3 0.7 3.5 0.0 0.1 PRTN3 "ACPA, AGP7, C-ANCA, MBT, P29, PR-3" ENSG00000196415 "Proteinase 3" P24158 19 840999-848175 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "bone marrow: 2098.1" "Cell type enriched" "Detected in some" 17 "Erythroid cells: 26.5" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 8 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.0" "Cell line enriched" "Detected in some" 6 "THP-1: 2054.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005938, CAB017558" Enhanced Approved Vesicles,Cytosol "Secreted to blood" NA NA 390000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Vesicles "CAB017558: AB_2172317, HPA005938: AB_1855764" "unprognostic (2.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.83e-3)" "unprognostic (4.20e-1)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.98e-3)" "unprognostic (3.67e-2)" "unprognostic (8.62e-6)" "unprognostic (5.31e-2)" "unprognostic (2.00e-1)" "unprognostic (5.14e-2)" 0.8 0.2 0.6 0.0 0.7 2098.1 0.4 0.2 1.3 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.6 0.6 0.4 0.3 2.8 11.7 0.4 0.3 0.4 0.1 0.1 0.2 1.3 0.6 0.4 0.3 0.0 0.0 1.6 0.0 0.3 1.3 0.0 0.0 0.2 38.2 0.1 0.2 0.6 7.1 0.4 0.0 0.0 0.0 0.1 0.4 1.2 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 343.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2054.4 0.0 0.0 0.0 0.2 0.9 0.0 0.2 0.3 0.0 14.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 9.9 0.6 0.7 0.2 1.3 0.6 0.4 0.3 0.4 0.4 0.2 0.6 0.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.8 1.3 0.4 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 26.5 0.4 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.5 0.0 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 PSCA ENSG00000167653 "Prostate stem cell antigen" O43653 8 142670308-142682725 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "stomach 1: 3019.3" "Cell type enriched" "Detected in many" 4 "Gastric mucus-secreting cells: 5332.3" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 785.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 22.4;HeLa: 45.7;OE19: 17.6;RT4: 61.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "spinal cord: 38.2" "HPA030783, HPA056418" Approved Supported "Plasma membrane" NA NA 18000 "Cluster 4: Stomach - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" "HPA030783: AB_2673611, HPA056418: AB_2683123" "unprognostic (1.21e-3)" "unprognostic (1.76e-3)" "unprognostic (3.20e-1)" "unprognostic (2.24e-1)" "unprognostic (1.77e-2)" "unprognostic (7.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.81e-3)" "unprognostic (8.25e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (6.82e-2)" "unprognostic (2.38e-3)" "unprognostic (4.93e-2)" "unprognostic (2.68e-1)" "unprognostic (3.07e-1)" "unprognostic (1.06e-3)" 4.8 0.4 0.5 0.5 0.6 0.2 1.9 0.3 0.9 67.8 0.2 7.8 4.0 0.4 0.6 334.0 7.9 10.0 0.4 0.6 0.2 5.8 0.7 6.3 0.1 0.5 0.3 0.6 3.2 0.0 0.6 2.4 0.4 230.6 4.8 0.0 23.5 1.9 0.3 11.1 2.5 0.1 0.2 0.4 3019.3 1.4 0.5 0.4 0.4 0.0 15.0 629.0 167.7 0.5 10.7 0.7 0.0 0.0 2.1 6.8 10.6 4.9 1.1 2.1 1.8 0.1 22.4 0.0 0.4 0.4 8.1 2.1 0.0 0.4 1.3 0.6 0.0 0.0 45.7 0.0 0.1 0.0 1.5 6.0 7.8 4.6 0.0 0.6 0.0 0.0 0.0 0.0 1.7 5.8 1.7 0.6 1.2 17.6 1.2 0.7 0.0 0.9 1.0 61.7 0.2 0.5 5.1 15.6 3.5 0.3 0.2 0.2 1.0 1.5 1.7 2.7 0.0 1.9 0.1 0.0 2.9 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.3 0.9 0.6 0.2 0.5 0.3 0.4 0.2 0.5 0.5 0.2 3.2 1.5 1.6 7.7 0.9 26.0 120.0 0.0 0.0 3.9 2.7 1.2 71.4 894.2 1.8 0.0 2.3 0.0 1.9 7.9 3.2 0.3 1.3 0.1 1.1 275.1 0.0 0.3 1.2 5.0 3.3 5332.3 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.2 12.9 179.0 0.6 1.0 0.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 57.1 0.2 0.0 13.4 238.7 0.3 0.4 994.9 0.0 0.0 0.0 48.9 0.0 0.5 13.1 1.3 28.5 4.6 0.0 0.9 1241.5 PSENEN PEN2 ENSG00000205155 "Presenilin enhancer, gamma-secretase subunit" Q9NZ42 19 35745600-35747519 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 573.3;Respiratory ciliated cells: 954.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047435 Enhanced NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA047435: AB_2680047" "unprognostic (1.96e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.64e-1)" "unprognostic (2.01e-1)" "unprognostic (2.79e-1)" "unprognostic (1.03e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (3.51e-3)" "unprognostic (2.30e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.70e-4)" "unprognostic (6.85e-2)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (5.41e-3)" 50.4 65.7 87.8 39.0 86.9 35.6 54.2 91.0 89.6 59.4 127.3 57.3 42.0 46.5 134.6 69.5 228.0 37.8 55.2 88.5 96.1 76.5 78.4 54.9 41.2 95.5 103.8 37.5 63.0 75.1 60.0 36.4 100.2 46.7 63.4 38.5 55.6 53.3 51.9 45.4 43.1 47.7 96.0 57.6 52.2 148.9 89.3 54.0 58.4 46.7 61.7 59.3 44.6 97.5 94.2 187.8 75.1 87.2 136.5 85.3 43.2 49.8 108.9 111.0 117.7 52.3 173.7 48.9 116.0 99.4 76.2 54.6 65.3 86.1 105.0 81.8 55.1 34.5 44.1 50.6 118.9 53.7 60.5 88.8 153.4 129.7 106.2 95.8 112.2 94.1 53.7 116.5 127.8 108.5 62.8 63.7 55.9 214.9 49.7 58.8 30.2 89.9 226.4 46.7 62.1 94.5 65.6 144.3 45.6 98.8 92.0 119.7 46.4 88.4 52.9 60.3 81.1 88.0 107.6 62.1 152.0 50.3 72.1 140.8 208.3 202.0 131.3 232.9 123.9 109.3 95.8 114.0 154.8 100.4 73.1 92.9 539.2 91.4 191.1 337.1 107.4 245.3 87.8 86.9 91.0 89.6 88.5 96.1 95.5 103.8 100.2 96.0 89.3 97.5 58.4 38.5 38.2 4.2 53.5 38.7 59.3 192.5 39.3 13.2 55.6 36.7 29.7 51.5 137.6 128.8 14.6 92.5 73.2 132.8 60.7 146.8 199.1 573.3 42.7 52.4 70.2 36.6 1.9 151.0 135.9 50.5 34.1 75.6 57.7 22.5 42.1 49.7 164.4 6.7 2.1 66.1 185.1 51.2 90.9 126.5 54.7 69.8 71.2 1.9 85.9 58.6 86.5 2.0 6.3 171.4 152.5 40.6 83.1 44.2 122.4 194.4 954.0 19.7 52.6 33.9 147.7 344.8 35.8 48.4 48.4 104.1 53.3 56.3 67.3 74.0 PTGFRN "CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6" ENSG00000134247 "Prostaglandin F2 receptor inhibitor" Q9P2B2 1 116909916-116990353 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 66.2;Cardiomyocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-87 MG: 146.8;WM-115: 111.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017074 Approved NA NA 340000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA017074: AB_1855888" "unprognostic (1.18e-1)" "unprognostic (2.11e-3)" "unprognostic (3.03e-1)" "unprognostic (8.58e-2)" "unprognostic (3.20e-1)" "unprognostic (2.91e-2)" "unprognostic (1.48e-3)" "unprognostic (3.39e-2)" "unprognostic (1.76e-2)" "unprognostic (7.28e-2)" "unprognostic (2.77e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "unprognostic (4.15e-2)" 11.6 21.1 3.2 10.1 3.5 0.0 10.6 3.3 4.8 14.9 8.3 40.6 11.3 31.2 10.6 21.2 23.9 17.2 48.8 3.3 2.6 4.0 6.6 6.6 2.5 2.8 4.5 15.9 13.3 6.3 2.9 5.0 2.2 18.0 21.7 1.4 18.5 23.6 2.9 17.8 14.0 46.6 4.6 3.1 10.5 5.3 4.1 5.3 6.9 3.9 6.2 20.1 15.1 3.2 40.0 10.3 18.4 42.8 3.2 8.3 2.6 2.8 4.4 15.4 5.8 7.2 8.7 0.0 35.7 10.6 12.7 69.7 41.4 74.4 9.7 0.4 25.1 2.9 24.0 11.1 1.1 0.1 3.9 37.3 66.0 2.0 36.4 21.9 30.0 4.2 16.5 0.2 23.5 50.9 0.0 5.5 21.5 3.3 0.1 0.0 100.6 0.2 51.3 32.4 9.0 20.8 80.0 55.9 22.9 32.1 48.8 12.3 77.6 22.4 33.2 37.2 25.1 0.0 0.1 0.1 146.8 0.0 111.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 3.5 3.3 4.8 3.3 2.6 2.8 4.5 2.2 4.6 4.1 3.2 2.3 3.2 5.9 15.0 0.5 66.2 13.4 25.6 22.2 6.5 10.9 11.9 79.4 10.0 12.2 3.7 0.0 0.8 0.3 20.6 1.9 31.2 4.8 10.2 19.3 12.1 13.9 0.0 13.6 31.8 5.5 32.0 10.7 16.9 0.0 22.1 3.9 11.1 4.4 0.0 7.4 18.2 14.2 8.8 9.7 6.3 19.3 4.7 8.8 3.7 3.1 1.2 0.0 31.2 0.9 27.9 11.1 30.1 0.0 15.1 15.8 1.2 13.6 0.2 19.7 48.5 12.5 0.8 5.2 20.3 45.3 0.8 1.4 28.3 26.3 17.4 PTPN3 PTPH1 ENSG00000070159 "Protein tyrosine phosphatase non-receptor type 3" P26045 9 109375466-109498313 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 63.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 48.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "thalamus: 26.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 29.4;RPTEC TERT1: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038343, HPA046728" Approved NA NA "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" "HPA038343: AB_10671741, HPA046728: AB_2679776" "prognostic unfavorable (6.71e-4)" "unprognostic (3.48e-1)" "unprognostic (3.64e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (3.71e-2)" "unprognostic (5.38e-2)" "unprognostic (6.37e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.22e-15)" "unprognostic (1.64e-2)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (8.21e-2)" 4.0 2.2 7.1 1.7 1.0 0.1 7.5 0.0 2.6 6.6 8.5 9.5 12.4 2.2 17.7 13.2 10.1 2.7 21.1 3.2 5.2 23.0 29.5 5.7 1.1 0.3 14.7 0.6 14.8 10.7 2.9 7.3 1.6 5.9 10.1 2.5 8.5 5.1 63.5 30.1 12.9 1.4 0.4 0.3 9.7 3.2 26.7 3.6 10.1 46.9 4.4 4.2 7.2 0.4 11.1 13.5 0.5 3.5 0.0 0.0 21.1 2.3 0.0 2.9 3.2 7.2 17.7 0.0 2.4 0.1 7.3 25.8 3.7 15.2 2.9 6.2 8.2 0.0 6.2 7.5 0.1 0.0 0.1 0.2 16.0 3.6 7.7 1.2 0.0 4.5 0.0 0.1 0.2 14.0 19.3 3.3 1.6 29.4 10.0 0.1 4.4 0.3 34.0 21.1 8.6 1.8 5.9 21.8 0.0 7.1 12.5 1.8 0.1 1.0 8.2 1.4 0.0 10.4 18.2 0.0 11.2 0.0 7.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 7.1 1.0 0.0 2.6 3.2 5.2 0.3 14.7 1.6 0.4 26.7 0.4 0.4 16.0 28.4 0.7 0.5 11.9 25.9 19.3 4.0 13.4 7.8 8.6 48.6 24.3 24.7 31.3 0.0 23.6 0.1 30.0 17.6 14.5 21.5 27.6 3.1 3.3 13.1 0.0 16.1 19.2 23.7 1.8 15.8 38.4 1.3 0.9 4.6 36.3 2.6 0.0 5.2 18.7 8.2 0.0 1.8 18.5 1.2 0.8 3.6 1.0 0.7 0.3 1.0 0.5 0.6 29.1 24.0 1.9 0.2 26.1 27.9 19.2 28.4 2.2 6.6 3.2 6.0 1.6 10.4 7.0 20.6 10.8 0.8 0.4 18.4 29.0 PTPRT "KIAA0283, RPTPrho" ENSG00000196090 "Protein tyrosine phosphatase receptor type T" O14522 20 42072752-43189970 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.9;fallopian tube: 10.8" "Group enriched" "Detected in some" 14 "Excitatory neurons: 500.7;Inhibitory neurons: 700.2;Oligodendrocyte precursor cells: 418.7" "Group enriched" "Detected in many" 5 "breast cancer: 5.1;prostate cancer: 1.9" "Region enhanced" "Detected in many" "cerebral cortex: 23.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017336, CAB069423" Approved NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB069423: AB_1622602, HPA017336: AB_1855943" "unprognostic (7.17e-3)" "unprognostic (1.02e-1)" "unprognostic (5.61e-3)" "unprognostic (1.08e-2)" "unprognostic (5.95e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (6.93e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-6)" "unprognostic (3.16e-1)" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" 0.1 0.2 10.1 0.1 10.7 0.0 2.7 0.0 23.9 0.6 0.0 0.1 0.5 0.0 0.2 0.0 10.8 0.1 0.2 7.4 0.0 0.1 0.2 1.0 0.4 0.1 0.0 0.0 0.4 0.0 3.0 2.8 0.0 0.2 0.0 3.6 1.0 2.6 0.0 0.4 0.3 0.0 0.0 0.1 0.8 1.6 0.0 6.3 0.0 0.1 0.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 10.7 0.0 23.9 7.4 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.4 0.0 1.1 13.1 0.0 0.9 0.0 0.0 0.0 36.2 2.6 6.9 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 3.2 0.1 0.2 0.0 0.0 500.7 0.0 0.0 1.2 0.0 0.2 0.0 3.3 6.4 0.2 0.2 5.0 700.2 0.0 0.0 0.3 0.3 12.6 0.0 0.1 0.0 8.4 0.0 10.3 0.0 418.7 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 18.5 2.1 0.0 0.5 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 PTRH1 "C9orf115, PTH1" ENSG00000187024 "Peptidyl-tRNA hydrolase 1 homolog" Q86Y79 9 127690348-127724873 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 125.4;Theca cells: 460.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021223 Uncertain NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA021223: AB_1845798" "unprognostic (6.58e-2)" "unprognostic (7.01e-3)" "unprognostic (3.46e-3)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (3.90e-2)" "unprognostic (1.74e-1)" "unprognostic (6.58e-3)" "unprognostic (8.67e-2)" "unprognostic (4.08e-2)" "unprognostic (5.98e-3)" "unprognostic (5.74e-4)" "unprognostic (1.38e-2)" "unprognostic (1.91e-1)" "unprognostic (1.72e-2)" 16.6 25.5 9.0 5.0 9.1 4.3 15.7 8.0 13.7 11.9 6.8 12.1 4.3 12.7 9.5 10.4 15.1 3.8 18.3 9.1 7.8 26.7 18.1 12.7 3.3 6.7 6.9 8.3 20.9 7.7 17.7 2.7 6.8 13.6 2.3 2.8 11.5 5.3 19.9 24.8 7.6 3.5 6.0 12.6 14.5 17.4 8.2 4.1 20.1 3.3 2.5 12.9 9.6 8.3 28.4 11.7 2.2 7.5 3.9 5.1 20.3 18.6 5.0 7.0 3.9 5.2 10.1 9.4 24.3 8.0 9.2 31.0 2.4 13.3 2.5 15.4 3.5 4.0 15.4 11.8 11.2 6.3 12.0 4.2 13.1 8.6 8.9 3.5 13.4 14.2 11.8 8.2 7.8 24.4 12.7 7.9 3.5 23.5 52.9 10.0 5.5 22.9 13.2 5.6 11.9 10.7 18.7 23.0 14.4 2.0 20.3 3.0 15.8 9.2 13.9 36.0 11.1 23.5 14.1 7.1 13.2 4.2 11.8 8.5 31.1 14.0 67.5 37.2 69.3 21.7 34.3 68.5 28.0 17.1 24.8 57.0 4.0 28.1 20.1 25.3 37.2 31.6 9.0 9.1 8.0 13.7 9.1 7.8 6.7 6.9 6.8 6.0 8.2 8.3 17.4 3.2 9.1 2.0 8.6 17.0 41.2 27.4 9.1 28.3 26.5 23.1 0.3 21.5 13.8 47.8 45.9 13.1 13.4 11.2 66.5 60.5 86.6 54.9 25.2 19.7 30.1 10.8 1.3 33.6 23.7 20.1 10.7 25.5 17.2 15.8 18.5 28.1 46.6 16.8 1.0 25.8 32.6 11.3 13.9 18.7 22.1 11.6 16.0 1.0 15.4 22.2 22.6 2.0 1.0 48.1 13.4 94.0 8.8 85.3 14.6 125.4 43.8 59.0 0.0 15.2 17.0 24.6 9.2 14.4 21.2 18.7 16.0 460.9 17.5 34.8 PTTG1 "EAP1, HPTTG, PTTG, securin, TUTR1" ENSG00000164611 "PTTG1 regulator of sister chromatid separation, securin" O95997 5 160421855-160428739 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 160.1;lymphoid tissue: 144.9;testis: 175.6" "Cell type enhanced" "Detected in many" "Early spermatids: 770.5;Erythroid cells: 415.9;Langerhans cells: 412.3;Spermatocytes: 708.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 218.0" "Lineage enriched" "Detected in all" 7 "T-cells: 218.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008373, HPA008890, HPA045034" Enhanced Supported Nucleoli,Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Nucleoli "CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (6.48e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.46e-3)" "unprognostic (5.81e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (7.50e-3)" "unprognostic (5.24e-2)" "unprognostic (3.47e-2)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.23e-2)" "unprognostic (3.35e-2)" 3.7 3.5 4.2 25.2 5.3 160.1 10.9 4.1 11.5 9.6 4.0 33.9 24.6 4.8 9.6 59.7 5.0 6.1 3.5 8.1 6.6 3.0 5.3 8.7 81.5 3.9 4.8 1.8 1.5 2.3 4.3 21.2 4.2 3.1 44.1 2.4 10.3 2.7 2.5 36.0 24.1 19.2 4.0 18.6 11.8 175.6 5.3 127.0 79.3 1.3 144.9 12.5 19.9 4.7 345.4 178.2 385.8 279.5 64.4 63.3 120.8 177.5 406.1 463.4 503.5 341.1 294.9 373.3 154.7 204.2 527.5 176.1 243.5 496.1 661.2 428.3 220.3 196.7 241.8 208.6 13.0 181.5 165.6 29.6 81.5 315.4 189.5 139.9 333.4 243.3 160.7 282.3 485.4 162.3 220.7 446.1 197.5 279.3 251.4 199.4 452.4 320.7 239.6 82.6 241.0 151.3 258.6 156.3 535.6 309.3 319.9 195.7 144.8 208.3 275.9 164.9 531.3 239.2 235.6 432.3 225.9 310.4 379.6 9.7 3.2 10.3 25.5 8.7 9.6 30.9 52.3 60.6 23.9 23.5 12.7 31.4 3.0 14.6 5.8 22.6 218.0 19.8 4.2 5.3 4.1 11.5 8.1 6.6 3.9 4.8 4.2 4.0 5.3 4.7 11.8 6.4 21.5 0.0 40.0 247.9 64.5 163.6 142.3 3.4 15.8 40.5 4.0 4.3 31.1 5.5 0.0 125.4 38.3 17.7 3.9 5.8 770.5 22.7 9.3 20.6 6.0 415.9 1.3 5.3 196.2 35.6 28.1 16.7 37.5 66.2 18.5 7.1 87.5 0.0 1.6 39.2 126.1 36.3 412.3 105.1 11.1 39.1 87.2 0.0 24.7 3.5 6.2 0.0 0.6 3.0 10.7 7.9 91.4 54.1 9.0 2.0 17.1 1.0 6.6 18.6 43.2 708.0 57.3 232.0 156.1 31.9 73.7 16.8 70.3 50.3 PYGL GSD6 ENSG00000100504 "Glycogen phosphorylase L" P06737 14 50857891-50944483 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 145.6" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 151.2;Hofbauer cells: 177.6;Muller glia cells: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 141.1;neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 279.1;HMC-1: 304.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000962, HPA004119" Enhanced Supported "Plasma membrane,Cytosol" NA NA 16000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 5: Muller glia cells - Visual perception" "Plasma membrane, Cytosol" "HPA000962: AB_1079722, HPA004119: AB_1079723" "unprognostic (2.70e-2)" "unprognostic (8.64e-3)" "unprognostic (1.46e-2)" "unprognostic (8.55e-2)" "unprognostic (9.41e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.66e-1)" "unprognostic (1.34e-2)" "unprognostic (3.34e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (2.63e-4)" "unprognostic (4.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.95e-2)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.12e-3)" 110.1 21.0 5.9 24.1 6.6 108.9 36.4 5.0 8.4 33.6 10.4 19.0 3.7 20.7 6.4 55.8 19.1 13.0 14.9 5.2 6.2 10.2 145.6 26.1 6.3 10.7 17.6 18.2 5.7 21.1 7.5 49.3 8.7 13.0 24.0 78.2 26.8 29.7 5.1 37.0 8.4 26.7 8.6 49.4 9.6 5.2 9.0 4.8 10.2 5.8 6.8 41.7 38.1 10.3 145.7 40.8 10.1 64.3 47.0 56.2 114.5 28.6 24.1 77.4 117.3 107.4 18.3 0.1 54.4 171.7 91.2 279.1 107.0 144.8 132.0 0.5 46.8 28.0 60.5 82.4 83.8 106.9 304.4 119.4 56.8 104.1 43.6 75.4 69.3 0.8 11.6 0.5 55.4 144.7 0.4 141.7 39.3 12.8 152.0 2.7 36.2 6.1 104.7 95.1 4.5 4.4 131.0 43.3 1.7 38.6 20.6 200.4 3.2 29.7 49.6 56.0 92.9 1.2 0.3 0.5 27.3 107.7 15.9 50.2 55.9 141.1 0.0 24.2 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 153.7 0.6 15.7 1.2 0.2 24.8 5.9 6.6 5.0 8.4 5.2 6.2 10.7 17.6 8.7 8.6 9.0 10.3 6.7 22.4 6.3 1.3 1.8 30.7 10.5 40.5 6.8 4.6 7.0 3.8 3.4 5.7 35.4 7.3 0.0 28.9 0.2 11.2 3.9 10.9 1.0 35.4 18.9 7.8 1.2 9.0 1.8 2.1 151.2 18.8 6.6 62.6 6.3 9.3 8.2 65.4 177.6 1.7 2.2 7.1 14.2 56.7 7.9 1.5 14.3 54.6 19.6 15.9 52.4 265.1 2.1 14.1 0.6 7.4 5.2 21.8 1.8 9.7 0.0 6.4 24.5 11.9 6.6 15.4 8.8 0.7 1.4 22.4 22.3 21.1 2.3 4.0 14.0 9.2 PZP CPAMD6 ENSG00000126838 "PZP alpha-2-macroglobulin like" P20742 12 9148840-9208395 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "liver: 81.6" "Group enriched" "Detected in some" 4 "Early spermatids: 26.2;Hepatocytes: 26.4;Late spermatids: 11.0;Oligodendrocyte precursor cells: 8.5;Respiratory ciliated cells: 24.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.0;liver cancer: 0.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.1;MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Group enriched" "Detected in some" 9 "HeLa: 5.7;SiHa: 2.5" "HPA041403, HPA041471" Supported "Secreted to blood" NA NA 15000000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA041403: AB_10804003, HPA041471: AB_10795636" "unprognostic (8.48e-3)" "unprognostic (1.12e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-4)" "unprognostic (4.79e-1)" "unprognostic (3.50e-2)" "unprognostic (2.04e-4)" "unprognostic (4.57e-2)" "unprognostic (2.18e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-5)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (9.81e-3)" 0.2 0.0 0.4 0.0 1.3 0.1 0.2 0.9 0.6 0.2 0.6 0.0 0.0 1.3 0.1 0.0 1.2 0.0 0.7 0.9 0.6 0.2 81.6 0.8 0.0 2.3 6.7 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.6 0.0 2.3 1.0 0.0 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.9 0.6 0.9 0.6 2.3 6.7 3.9 0.9 1.0 1.3 1.9 3.2 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.8 0.0 0.0 1.6 0.0 2.7 0.0 2.1 0.0 1.4 0.0 0.0 0.0 26.2 4.7 0.2 2.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 1.7 0.0 0.0 1.8 26.4 0.0 0.0 2.9 0.0 0.0 0.3 0.0 11.0 0.0 0.2 0.0 2.8 0.0 0.0 2.1 8.5 4.6 0.0 0.0 0.4 0.7 0.0 0.0 0.0 24.7 0.6 0.0 0.3 0.4 0.5 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 QPCT "GCT, QC" ENSG00000115828 "Glutaminyl-peptide cyclotransferase" Q16769 2 37342827-37373322 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 170.3;epididymis: 104.0" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 217.0;Ionocytes: 138.4;Langerhans cells: 163.4;Melanocytes: 528.3" "Cancer enhanced" "Detected in all" "melanoma: 97.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 1527.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 1527.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 117.1;SK-MEL-30: 426.8;U-266/84: 341.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008406 Enhanced Approved Cytosol "Secreted to blood" NA NA 390000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "HPA008406: AB_1855981" "unprognostic (6.25e-3)" "unprognostic (6.69e-2)" "unprognostic (4.95e-2)" "unprognostic (1.44e-1)" "unprognostic (1.44e-2)" "unprognostic (9.32e-2)" "unprognostic (1.13e-3)" "unprognostic (9.73e-2)" "unprognostic (2.71e-3)" "unprognostic (7.86e-2)" "unprognostic (3.67e-2)" "unprognostic (1.17e-1)" "unprognostic (6.78e-2)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (9.48e-3)" "unprognostic (3.62e-3)" 5.6 170.3 8.4 14.2 7.5 47.3 15.8 5.1 11.5 21.2 4.2 25.3 5.6 9.8 104.0 3.4 2.2 10.8 5.1 8.9 27.4 6.1 2.6 5.6 8.1 9.7 11.6 1.0 13.7 14.8 27.0 9.2 14.7 7.2 10.2 11.9 25.5 6.7 4.1 36.3 4.5 8.3 7.8 13.9 7.6 2.0 20.3 5.1 3.8 2.8 12.5 15.2 4.6 6.7 1.0 40.7 0.1 0.0 6.0 13.3 0.1 6.6 86.5 6.4 10.1 2.9 7.1 0.2 3.0 32.6 72.9 0.1 2.7 0.6 10.3 0.6 76.0 18.7 0.3 7.7 0.6 3.0 0.1 8.5 0.0 47.3 0.2 0.4 26.2 0.0 0.0 0.0 0.2 4.5 0.0 1.7 0.6 0.3 0.0 0.0 0.0 0.8 42.6 10.9 117.1 0.2 6.4 1.4 426.8 8.0 0.7 2.9 19.4 0.0 0.2 0.1 0.6 15.3 341.7 0.3 25.8 0.3 0.0 9.8 344.8 3.2 0.4 38.7 1.0 2.6 0.6 0.5 124.7 1.2 0.5 0.3 1527.7 0.2 3.3 2.4 0.1 169.8 8.4 7.5 5.1 11.5 8.9 27.4 9.7 11.6 14.7 7.8 20.3 6.7 1.8 3.2 2.3 0.3 12.5 39.0 13.6 40.0 2.2 21.8 7.9 8.5 1.1 1.5 17.7 22.0 2.1 0.7 0.8 6.1 1.9 45.4 0.6 2.6 24.7 17.5 217.0 1.7 8.5 2.4 6.1 26.7 3.1 4.0 55.3 1.6 22.5 0.3 20.5 43.7 7.3 6.6 138.4 21.2 163.4 2.9 3.1 26.8 528.3 6.5 64.3 0.8 3.1 3.0 1.3 31.8 1.8 23.7 26.0 9.1 0.2 11.7 4.3 3.2 13.1 0.6 6.6 1.7 0.7 0.6 14.5 4.7 5.6 5.0 7.3 5.8 RAB36 ENSG00000100228 "RAB36, member RAS oncogene family" O95755 22 23145326-23164350 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 32.8" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 41.2;Late spermatids: 24.5;Respiratory ciliated cells: 69.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "neutrophil: 11.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 11.0" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.5;U-266/84: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059631 Approved Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA059631: " "unprognostic (2.74e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-2)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (6.60e-2)" "unprognostic (1.22e-1)" "unprognostic (3.46e-1)" "unprognostic (2.49e-2)" "unprognostic (7.94e-2)" "unprognostic (2.02e-3)" "unprognostic (5.56e-3)" "prognostic favorable (4.55e-4)" "unprognostic (7.08e-2)" "unprognostic (7.18e-2)" "unprognostic (1.64e-1)" "unprognostic (3.08e-1)" 2.0 5.1 8.8 1.3 8.7 0.7 2.6 3.8 8.4 5.1 21.7 3.2 0.7 4.8 4.4 2.1 32.8 5.3 1.4 9.9 9.1 9.1 0.4 4.8 1.1 9.4 11.2 6.2 3.4 5.6 17.1 2.9 6.9 3.9 1.1 2.0 3.3 6.6 0.6 1.8 1.2 3.8 7.9 1.6 2.1 6.7 10.4 0.3 17.6 0.4 1.3 2.5 2.1 5.1 8.1 9.4 7.1 10.7 1.6 3.4 2.8 4.5 9.1 9.8 3.7 0.6 0.0 0.0 4.8 6.0 5.4 10.0 0.3 5.2 3.1 0.0 4.3 0.1 0.4 0.9 4.1 0.0 1.2 4.3 1.9 9.1 1.8 6.4 1.4 0.0 0.4 8.1 0.4 6.4 0.1 0.1 0.9 5.3 2.5 0.0 0.0 25.5 12.7 1.5 17.3 7.5 0.4 3.9 2.2 0.5 0.0 0.9 0.8 1.3 2.9 3.4 6.5 17.3 26.2 0.1 8.8 0.0 5.8 0.3 0.6 0.0 0.5 0.2 0.3 0.8 0.1 0.2 0.2 0.2 0.3 0.3 11.0 1.6 0.3 0.0 0.0 0.3 8.8 8.7 3.8 8.4 9.9 9.1 9.4 11.2 6.9 7.9 10.4 5.1 0.6 0.0 3.2 3.6 1.4 0.5 0.8 4.2 0.0 0.7 1.8 2.8 0.8 4.3 7.0 1.8 6.2 6.0 0.3 0.0 5.9 3.5 10.6 41.2 2.9 0.7 6.7 0.0 2.9 0.2 0.4 2.0 1.5 2.6 1.3 2.4 1.1 0.1 0.4 1.7 1.7 0.7 6.1 0.8 0.3 24.5 3.4 0.3 1.8 1.0 0.5 3.6 1.0 1.5 1.0 0.2 0.2 3.0 0.3 0.4 0.0 9.6 69.6 0.7 0.0 1.0 2.0 3.6 1.6 0.5 0.1 2.9 0.4 4.5 0.3 0.4 RABL2A ENSG00000144134 "RAB, member of RAS oncogene family like 2A" Q9UBK7 2 113627229-113643396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.8" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.6" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (7.76e-3)" "unprognostic (7.79e-3)" "unprognostic (7.00e-2)" "unprognostic (2.94e-2)" "unprognostic (1.99e-1)" "unprognostic (4.23e-2)" "unprognostic (4.89e-2)" "unprognostic (6.77e-3)" "unprognostic (6.61e-2)" "unprognostic (7.36e-2)" "unprognostic (5.78e-3)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.89e-2)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (3.19e-5)" 2.5 1.2 2.7 1.3 2.9 0.9 2.8 2.3 3.4 3.8 4.6 3.3 1.3 4.4 3.6 1.5 19.8 1.6 2.4 3.0 2.5 2.0 1.9 2.7 1.0 2.6 4.8 5.0 1.5 1.3 2.9 0.8 3.2 2.7 1.0 6.6 2.1 2.0 1.3 2.5 1.8 2.1 3.3 1.7 1.9 5.3 2.9 3.0 3.5 1.4 1.9 2.6 2.8 2.7 2.1 3.7 5.0 4.0 4.1 5.8 3.7 2.0 1.6 2.9 2.0 3.3 1.4 3.1 8.5 0.7 2.0 2.3 2.5 0.3 1.9 4.1 4.7 1.6 0.1 0.4 3.3 0.6 1.1 2.1 4.3 0.5 1.2 4.2 2.1 4.6 1.5 0.8 1.7 1.8 10.6 0.7 2.8 1.9 1.3 2.0 1.9 1.3 2.1 0.5 2.0 7.0 1.9 2.2 1.9 1.5 0.4 3.0 0.5 0.4 0.6 0.7 1.4 2.9 3.4 0.8 5.8 2.3 1.0 0.0 4.3 2.4 6.2 7.1 6.9 8.9 9.0 6.5 7.1 8.2 7.5 5.7 0.5 12.8 7.1 9.1 4.9 5.4 2.7 2.9 2.3 3.4 3.0 2.5 2.6 4.8 3.2 3.3 2.9 2.7 4.2 9.6 8.1 13.4 6.4 4.5 5.6 8.1 5.2 7.6 6.4 8.0 9.5 2.8 12.1 7.3 10.4 3.4 6.3 4.9 13.7 7.6 16.3 36.9 5.6 3.4 7.2 3.0 30.2 3.1 2.9 6.8 5.6 2.8 11.4 9.9 5.3 4.4 3.6 16.8 20.5 4.3 4.1 3.2 3.5 14.5 8.1 3.1 7.2 3.7 5.7 7.3 9.2 7.1 19.4 3.6 3.2 7.2 0.8 2.9 7.2 6.8 123.2 16.8 0.0 5.9 8.1 22.3 9.6 3.6 4.8 2.5 6.0 4.4 4.1 3.6 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783662 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 99.4;Respiratory ciliated cells: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favorable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 13.2 12.9 18.1 18.6 18.8 14.4 15.8 18.1 22.4 23.9 73.6 16.5 12.5 21.7 90.3 13.3 66.6 14.5 10.2 23.3 17.0 17.7 12.2 21.8 23.1 23.3 33.2 22.5 16.3 14.6 26.7 11.6 17.9 16.2 16.7 30.2 16.8 16.9 8.8 22.2 15.6 15.6 21.9 19.3 14.5 23.1 20.1 21.6 28.2 4.6 20.3 17.0 15.7 18.5 23.0 20.4 34.1 26.7 37.3 29.6 25.0 16.7 18.5 13.2 18.1 5.8 19.7 14.7 14.7 24.1 21.6 29.5 15.8 19.6 14.2 13.3 23.2 12.8 40.2 15.1 15.4 36.1 13.0 25.3 26.2 17.5 21.9 39.2 15.0 26.0 9.9 17.9 26.7 28.8 18.2 15.9 13.2 14.0 15.0 30.1 19.8 16.1 25.9 22.4 14.6 26.5 20.5 17.8 13.4 23.4 17.7 11.2 23.2 12.6 25.1 10.9 11.4 15.2 7.4 7.2 23.8 8.8 18.1 1.8 14.4 13.1 21.4 23.5 15.5 15.2 16.4 17.3 15.7 19.2 18.7 18.3 5.4 15.9 28.4 18.0 18.6 14.7 18.1 18.8 18.1 22.4 23.3 17.0 23.3 33.2 17.9 21.9 20.1 18.5 6.2 12.8 13.4 14.4 16.8 5.4 13.4 13.3 15.9 15.2 13.3 11.8 5.1 12.8 24.1 22.0 31.3 12.1 16.2 10.6 13.7 21.3 25.7 99.4 11.2 7.2 5.4 9.9 25.7 10.8 11.1 11.4 9.7 8.6 3.8 22.1 5.3 8.9 12.0 16.8 18.9 8.0 22.4 10.1 6.9 24.2 14.0 8.4 17.8 4.7 14.4 13.9 36.0 7.1 15.1 10.4 4.9 10.9 8.0 7.3 8.6 16.3 188.6 40.0 6.6 15.0 14.8 38.8 27.0 8.8 5.7 6.7 16.0 11.9 10.7 6.5 RAD51 "BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA" ENSG00000051180 "RAD51 recombinase" Q06609 15 40694774-40732340 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.7;testis: 24.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3" "Cancer enhanced" "Detected in all" "testis cancer: 19.9" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010381, HPA039310" Enhanced Supported "Nucleoli rim,Cytosol" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoli rim" Cytosol "CAB010381: AB_2253533, HPA039310: AB_2676434" "prognostic unfavorable (7.94e-4)" "unprognostic (7.20e-3)" "unprognostic (1.22e-1)" "unprognostic (2.72e-2)" "unprognostic (8.23e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-3)" "unprognostic (2.53e-3)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (2.34e-1)" "unprognostic (9.59e-2)" "unprognostic (1.94e-2)" 0.9 0.6 0.4 5.5 0.5 10.5 1.9 1.7 0.7 1.0 0.6 8.3 3.2 1.2 0.4 4.2 0.7 1.3 0.6 0.4 0.5 0.5 1.3 1.1 11.0 0.4 0.3 0.6 1.4 0.5 0.2 6.8 0.5 0.8 9.1 0.3 1.0 0.3 1.0 3.1 4.1 2.4 0.1 2.4 1.8 24.3 0.3 15.7 0.6 0.5 13.3 1.7 1.5 0.5 33.8 16.1 33.4 16.3 4.4 7.8 31.1 54.9 16.5 43.3 43.8 35.4 22.1 20.4 26.8 20.9 18.9 67.7 56.6 22.1 42.3 39.0 22.2 47.7 28.2 30.4 0.4 37.9 28.5 1.7 2.9 30.0 13.5 6.4 22.5 48.5 59.6 55.8 36.6 28.5 54.4 43.6 35.2 69.2 19.0 61.0 49.0 30.7 15.4 45.3 15.4 27.0 23.6 41.4 8.5 39.2 27.0 39.4 9.9 32.8 22.2 48.7 27.2 12.0 65.1 59.8 16.3 78.0 33.5 1.3 0.6 1.7 2.4 1.3 0.6 1.7 2.5 3.2 1.0 1.1 0.6 1.2 1.2 1.8 1.4 0.9 5.9 1.2 0.4 0.5 1.7 0.7 0.4 0.5 0.4 0.3 0.5 0.1 0.3 0.5 0.0 0.0 0.0 0.3 1.9 3.6 1.5 2.0 0.0 0.8 0.1 0.0 0.9 0.0 1.0 0.0 0.0 35.3 1.4 3.0 0.0 0.0 5.7 0.2 0.2 1.0 0.0 16.0 1.6 0.0 67.2 1.3 2.0 0.2 0.0 0.6 2.2 0.2 12.7 0.0 1.2 5.3 2.0 1.6 1.7 5.3 0.6 0.5 0.0 1.0 0.3 0.3 2.1 0.5 0.6 0.1 5.0 0.7 8.2 0.9 1.0 0.0 0.1 0.0 0.0 0.5 0.9 53.6 24.8 3.9 1.6 25.3 1.2 0.1 8.0 2.1 RAD51AP1 PIR51 ENSG00000111247 "RAD51 associated protein 1" Q96B01 12 4538798-4560047 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Meiosis" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.9;lymphoid tissue: 14.4" "Cell type enhanced" "Detected in many" "Early spermatids: 33.4;Erythroid cells: 47.8;Extravillous trophoblasts: 34.1;Hofbauer cells: 40.8;Late spermatids: 68.1;Spermatocytes: 35.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051499 Approved Nucleoplasm Yes Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA051499: AB_2681508" "unprognostic (1.03e-1)" "unprognostic (5.44e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (6.30e-2)" "unprognostic (5.25e-3)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.15e-2)" "unprognostic (2.26e-2)" "unprognostic (6.29e-3)" "prognostic unfavorable (1.22e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.44e-15)" "unprognostic (2.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.88e-2)" "unprognostic (3.75e-2)" 0.9 0.8 0.3 4.8 0.4 16.9 2.7 0.4 0.7 0.9 0.3 5.2 5.2 1.2 0.6 3.2 1.0 1.1 0.5 0.3 0.3 0.8 1.8 1.4 8.9 0.4 0.4 0.5 0.4 0.6 0.3 3.8 0.4 1.3 6.5 1.5 1.0 1.0 0.5 3.2 4.8 1.9 0.4 3.4 2.7 6.3 0.4 14.4 1.0 0.6 7.9 1.7 1.3 0.5 37.5 13.0 45.3 22.7 2.7 5.7 53.0 48.2 21.2 52.6 68.9 35.4 35.4 48.6 7.0 10.4 24.7 23.1 31.8 14.5 80.0 38.7 27.0 61.4 21.6 24.8 0.6 56.6 29.9 1.2 1.5 31.6 30.4 7.5 21.4 33.0 39.2 54.4 33.7 13.6 46.5 20.5 110.4 36.3 14.4 46.0 54.3 19.2 16.1 18.3 15.1 16.6 35.9 27.7 11.6 45.5 11.3 32.6 9.5 35.5 36.5 38.8 52.4 7.8 10.0 93.3 13.3 40.0 29.4 0.0 0.5 0.7 0.1 2.3 0.5 3.1 0.4 1.0 0.4 3.4 0.1 0.2 0.0 1.4 2.0 6.9 1.0 0.6 0.3 0.4 0.4 0.7 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 1.4 0.0 0.5 0.7 6.1 5.2 2.3 6.6 1.2 3.1 3.4 5.7 1.4 2.8 4.5 0.0 4.2 20.3 11.3 5.7 0.0 3.0 33.4 3.3 2.9 2.9 2.4 47.8 2.7 2.7 34.1 5.2 6.1 3.6 1.3 22.6 2.5 1.2 40.8 0.0 1.1 6.4 16.2 6.2 5.6 68.1 1.2 10.1 0.0 3.7 6.8 2.7 3.1 0.5 2.4 1.5 0.8 1.5 15.5 1.0 1.2 1.5 0.9 4.8 0.0 2.4 4.2 35.9 25.0 10.0 2.6 4.7 4.6 2.0 14.6 2.7 RAD54L "hHR54, hRAD54, RAD54A" ENSG00000085999 "RAD54 like" Q92698 1 46246461-46278480 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.4;testis: 15.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 7.2;Extravillous trophoblasts: 9.4;Glandular and luminal cells: 8.0;Spermatocytes: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028954, HPA051537" Approved Enhanced Nucleoplasm NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA028954: AB_2672840, HPA051537: AB_2681525" "unprognostic (2.12e-2)" "prognostic favorable (6.67e-4)" "unprognostic (5.12e-2)" "unprognostic (5.36e-3)" "unprognostic (3.24e-1)" "unprognostic (1.08e-2)" "unprognostic (9.75e-6)" "unprognostic (3.91e-2)" "unprognostic (2.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.77e-4)" "unprognostic (5.58e-2)" "unprognostic (1.11e-16)" "unprognostic (6.76e-3)" "unprognostic (1.66e-1)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" 0.5 0.7 3.0 4.1 3.8 8.7 1.0 4.3 3.9 1.3 2.1 3.2 2.0 0.7 0.1 5.4 0.4 0.5 0.7 2.9 2.5 1.4 0.5 1.2 5.5 3.2 3.0 0.5 0.5 0.3 0.4 3.4 3.8 1.0 4.6 0.4 0.9 0.4 1.2 2.3 2.8 1.7 2.8 2.8 1.5 15.6 3.1 15.4 1.8 0.0 8.3 0.8 1.8 3.7 22.2 16.1 46.8 29.1 3.3 2.4 43.9 25.8 11.3 42.8 43.3 33.3 14.2 42.5 19.1 11.0 38.5 22.2 44.6 14.5 36.8 23.7 43.0 53.0 49.7 32.1 0.1 54.0 29.3 1.6 1.2 42.1 12.5 6.9 13.5 49.7 38.2 41.7 23.1 20.4 68.9 60.0 42.5 19.4 25.2 52.8 26.8 19.0 9.4 17.5 22.4 16.3 18.4 25.2 5.7 38.0 9.1 37.7 5.7 43.9 26.1 23.6 43.7 17.6 10.6 46.9 11.5 35.1 18.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.2 3.0 3.8 4.3 3.9 2.9 2.5 3.2 3.0 3.8 2.8 3.1 3.7 0.0 0.0 0.0 1.0 0.7 0.3 0.7 0.5 1.8 0.0 0.5 0.5 0.8 0.0 0.1 0.0 0.0 4.3 0.4 1.8 0.0 0.3 2.7 2.3 0.8 0.5 0.0 7.2 2.8 0.0 9.4 1.1 0.5 8.0 4.5 5.6 0.4 0.0 2.6 0.0 1.1 1.3 0.0 0.3 0.3 0.7 0.0 0.4 0.0 0.0 0.0 0.0 1.0 1.0 2.9 0.3 0.1 0.0 4.7 0.4 0.4 0.0 0.1 0.0 0.0 0.4 4.0 12.4 5.6 3.1 0.3 1.6 1.1 0.2 2.9 1.0 RASGRP4 ENSG00000171777 "RAS guanyl releasing protein 4" Q8TDF6 19 38409051-38426305 "Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 20.8;lymphoid tissue: 8.9" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 39.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 25.7;HMC-1: 24.0;U-937: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041929 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041929: AB_10961405" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (1.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.00e-1)" "unprognostic (5.23e-4)" "unprognostic (6.54e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (2.19e-2)" "unprognostic (1.05e-1)" "unprognostic (4.56e-1)" "unprognostic (2.66e-2)" 3.2 0.8 0.3 6.7 0.3 20.8 0.7 0.3 0.9 1.1 0.4 1.2 1.2 0.5 0.1 1.0 1.0 1.9 0.6 0.2 0.3 0.3 0.7 3.3 1.1 0.9 0.4 0.4 1.1 0.3 0.2 2.3 0.6 0.5 0.8 0.0 0.4 0.5 0.8 0.5 1.8 2.0 0.7 8.9 0.9 0.2 1.1 1.1 0.2 1.4 0.7 2.5 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 25.7 0.0 0.0 0.0 0.1 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 12.5 13.5 20.1 0.0 15.4 0.0 0.1 0.3 0.0 9.4 0.1 0.0 0.0 39.4 0.0 17.9 0.7 1.4 4.4 0.3 0.3 0.3 0.9 0.2 0.3 0.9 0.4 0.6 0.7 1.1 1.0 0.2 0.0 0.6 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.3 18.1 0.0 1.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.7 0.0 0.2 0.4 0.0 0.0 26.6 0.0 1.4 0.0 15.1 0.0 0.4 0.0 0.0 32.9 11.6 0.0 0.0 19.1 1.8 0.0 25.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.7 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.3 1.5 0.0 0.0 0.1 RGMA RGM ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 126.3;skeletal muscle: 199.1" "Cell type enhanced" "Detected in many" "Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 2000000 "Cluster 80: Striated muscle - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 30.2 3.2 62.1 22.5 73.8 0.4 30.3 72.5 59.1 55.9 7.7 79.4 9.9 50.9 2.9 57.4 39.9 7.7 29.4 60.4 68.0 3.6 0.6 4.6 2.4 126.3 113.9 38.5 11.4 0.8 6.9 1.3 70.4 12.8 6.2 1.0 24.2 6.4 199.1 17.1 42.9 60.6 91.5 1.3 73.6 33.5 120.6 2.6 10.0 45.0 3.4 10.0 29.2 62.8 2.1 0.3 50.0 0.8 10.3 5.7 14.6 0.3 0.0 0.0 0.0 0.6 0.6 0.1 0.2 0.4 0.0 3.4 8.4 0.2 0.0 0.0 9.2 0.1 0.3 0.0 0.0 0.1 0.2 6.1 0.2 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.0 1.0 15.5 0.2 22.2 0.1 0.0 13.1 11.4 0.1 0.0 0.5 5.1 3.0 0.5 0.2 0.0 2.6 4.0 2.7 0.0 0.1 10.4 0.3 0.1 0.1 0.0 0.2 0.2 0.2 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 62.1 73.8 72.5 59.1 60.4 68.0 126.3 113.9 70.4 91.5 120.6 62.8 4.2 0.0 1.5 143.3 0.5 5.5 20.4 10.2 40.5 1.9 7.5 4.4 4.4 0.0 3.9 0.0 2.1 4.4 0.5 0.3 0.0 6.5 1.2 0.6 10.9 2.7 0.0 0.4 16.8 0.7 1.2 40.5 1.5 2.3 0.0 0.6 1.8 0.3 2.1 0.0 2.8 0.0 12.2 2.5 2.3 6.4 119.0 1.6 3.6 9.4 0.6 4.5 0.0 11.1 1.6 0.4 0.0 116.9 0.1 61.3 0.0 0.1 1.3 1.2 13.1 69.3 20.3 0.9 43.8 58.3 2.8 2.5 1.4 0.1 0.1 29.2 RGS13 ENSG00000127074 "Regulator of G protein signaling 13" O14921 1 192636138-192660311 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 48.0" "Cell type enriched" "Detected in some" 16 "granulocytes: 520.0" "Cancer enhanced" "Detected in single" "stomach cancer: 0.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 39 "basophil: 6.8" "Lineage enriched" "Detected in single" 39 "granulocytes: 6.8" "Cell line enriched" "Detected in some" 20 "Daudi: 47.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076656 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 60: Granulocytes - Receptor signaling" "HPA076656: " "unprognostic (1.99e-2)" "unprognostic (6.08e-3)" "unprognostic (3.25e-4)" "unprognostic (1.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.37e-5)" "unprognostic (1.93e-1)" "unprognostic (2.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (7.39e-2)" "unprognostic (1.28e-1)" "unprognostic (8.65e-2)" "unprognostic (3.42e-1)" "unprognostic (2.35e-1)" "unprognostic (6.86e-2)" "unprognostic (1.96e-1)" 0.5 0.0 0.0 9.5 0.0 0.7 2.3 0.0 0.0 1.6 0.0 2.3 3.1 1.0 0.7 1.7 0.3 3.7 0.1 0.0 0.0 0.0 0.0 3.9 48.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 1.6 0.0 0.3 0.6 0.0 0.3 5.7 1.2 0.0 0.3 2.0 0.1 0.1 1.3 0.0 0.2 35.1 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 30.8 0.0 4.8 1.9 2.1 0.0 0.0 0.0 0.1 0.3 0.3 0.0 1.3 0.0 0.0 0.0 2.9 0.1 0.0 0.1 0.0 0.0 0.0 0.3 7.1 0.0 0.2 0.0 0.0 0.9 12.2 0.0 520.0 0.0 0.0 0.0 0.3 0.0 0.6 0.6 0.0 0.6 7.1 0.0 0.0 3.8 7.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 3.9 1.7 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.3 0.0 7.9 0.5 1.6 0.1 RGS22 "CT145, DKFZP434I092, PRTD-NY2" ENSG00000132554 "Regulator of G protein signaling 22" Q8NE09 8 99960936-100131268 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 61.3" "Group enriched" "Detected in many" 8 "Early spermatids: 619.6;Late spermatids: 1623.3" "Cancer enhanced" "Detected in some" "breast cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053026 Supported "Nucleoli fibrillar center,Actin filaments,Cytosol" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli fibrillar center" "Actin filaments, Cytosol" "HPA053026: " "unprognostic (3.04e-2)" "unprognostic (2.62e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-1)" "unprognostic (3.47e-5)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (3.19e-2)" "unprognostic (1.47e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-2)" "unprognostic (7.96e-3)" "unprognostic (1.98e-5)" "unprognostic (3.71e-2)" "unprognostic (1.31e-2)" "unprognostic (3.25e-3)" "unprognostic (8.36e-4)" 2.7 0.9 1.7 0.0 2.4 0.0 0.6 1.0 1.5 1.4 10.4 0.3 0.0 2.9 1.1 0.3 10.6 1.2 0.3 1.1 3.9 0.2 0.1 1.7 0.3 5.9 7.4 7.3 0.5 0.0 1.1 0.5 3.7 1.3 0.1 1.0 0.1 2.3 0.1 0.6 0.1 1.5 3.7 0.0 0.1 61.3 5.3 0.1 0.3 0.1 0.3 0.4 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.1 0.0 0.3 1.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.4 1.0 1.5 1.1 3.9 5.9 7.4 3.7 3.7 5.3 2.9 0.1 0.0 0.0 14.4 0.0 2.2 0.0 1.6 0.6 1.2 1.2 0.8 0.8 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 619.6 58.1 14.2 0.7 0.0 0.0 2.3 0.0 0.2 8.6 0.5 0.8 0.0 1.3 0.0 0.0 0.2 0.0 1.6 0.0 4.1 0.0 2.9 1623.3 131.4 0.4 0.0 6.5 0.0 10.9 0.0 20.1 2.5 0.0 0.0 62.8 0.0 0.0 0.0 0.0 77.2 0.2 0.0 0.4 1.6 70.9 11.1 0.1 2.0 0.8 0.4 8.3 0.0 0.1 RHOV "ARHV, Chp, WRCH2" ENSG00000104140 "Ras homolog family member V" Q96L33 15 40872214-40874234 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 211.8;skin 1: 129.8;vagina: 92.2" "Cell type enhanced" "Detected in many" "Paneth cells: 142.3;Squamous epithelial cells: 375.0;Suprabasal keratinocytes: 283.0;Urothelial cells: 275.1" "Cancer enhanced" "Detected in many" "cervical cancer: 91.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 328.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053343 Enhanced NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA053343: AB_2682122" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (8.29e-3)" "unprognostic (4.34e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (3.29e-3)" "unprognostic (1.05e-1)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (8.43e-3)" "unprognostic (5.63e-3)" 0.5 0.1 0.9 0.2 0.9 0.2 16.0 1.1 1.8 26.3 0.5 2.8 0.6 0.7 9.5 211.8 2.7 0.5 0.1 1.0 1.1 5.5 0.2 2.3 0.2 2.1 0.8 0.3 16.3 2.2 3.0 3.2 2.4 16.6 2.6 0.0 44.3 2.4 0.2 129.8 0.6 0.1 0.8 0.1 1.2 0.3 1.9 2.6 0.5 0.0 23.3 20.7 92.2 0.9 1.6 9.7 0.1 2.7 0.2 0.0 5.2 0.1 0.8 0.4 0.2 4.0 4.4 0.0 2.4 0.0 0.3 77.9 4.5 0.6 0.2 10.5 12.5 0.5 11.3 0.6 0.0 0.5 0.0 0.3 6.0 0.3 0.1 0.4 0.1 2.3 2.1 0.5 0.0 27.2 0.6 2.3 1.7 19.3 3.7 4.0 0.4 1.8 5.1 34.3 4.0 0.8 8.0 328.9 0.2 0.5 40.9 0.3 0.1 0.0 1.1 0.2 0.3 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 1.1 1.8 1.0 1.1 2.1 0.8 2.4 0.8 1.9 0.9 0.6 0.0 3.2 0.3 0.5 84.1 42.5 80.9 19.9 0.0 75.2 48.5 0.9 2.8 103.0 29.5 0.0 60.7 1.9 43.1 13.7 107.5 0.0 18.5 1.9 2.5 22.7 0.0 1.5 56.2 6.0 2.0 7.1 25.5 1.3 0.4 0.0 0.0 4.6 0.0 0.5 54.7 67.1 0.0 13.3 0.0 0.0 0.8 32.0 0.0 3.6 0.0 0.0 0.0 0.3 13.8 142.3 0.7 0.1 89.8 1.0 0.9 26.2 0.0 0.0 0.2 7.3 0.0 0.9 375.0 283.0 42.4 1.9 0.0 66.3 275.1 RHPN1 "KIAA1929, ODF5, RHPN" ENSG00000158106 "Rhophilin Rho GTPase binding protein 1" Q8TCX5 8 143368876-143384221 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.1;thyroid gland: 20.4" "Cell type enhanced" "Detected in many" "Astrocytes: 47.0;Collecting duct cells: 38.6;Cone photoreceptor cells: 31.3;Respiratory ciliated cells: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 28.3;MOLT-4: 25.8;RPMI-8226: 19.0;T-47d: 44.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024288, HPA024671" Approved Approved Nucleoplasm NA NA "Cluster 43: Testis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA024288: AB_1856274, HPA024671: AB_1856275" "unprognostic (2.04e-1)" "unprognostic (3.71e-1)" "unprognostic (1.54e-2)" "unprognostic (2.20e-1)" "unprognostic (5.82e-2)" "unprognostic (6.38e-2)" "unprognostic (2.07e-3)" "unprognostic (3.12e-1)" "unprognostic (3.57e-1)" "unprognostic (1.02e-1)" "unprognostic (8.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-3)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-2)" 2.6 1.6 11.8 0.9 9.1 2.1 4.7 6.7 12.9 3.3 8.5 2.0 0.1 1.3 1.3 2.4 5.0 0.7 1.1 13.5 8.2 13.6 1.3 3.5 1.1 7.5 9.3 0.7 4.2 2.9 20.1 0.1 7.2 4.0 0.1 0.6 3.6 1.9 0.3 2.7 3.0 0.3 5.9 5.3 3.0 4.0 9.9 8.8 20.4 0.0 0.5 2.6 1.9 7.1 2.9 4.9 1.2 3.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.7 1.9 0.2 9.8 0.0 0.2 1.3 0.0 0.0 0.0 0.6 4.4 0.0 3.5 0.3 0.4 0.3 3.1 0.0 0.8 0.0 0.0 0.9 1.0 11.5 1.1 5.8 0.0 28.3 25.8 2.6 1.7 5.9 13.4 7.0 0.0 19.0 3.9 4.6 7.2 2.7 1.5 8.1 1.8 0.0 44.2 0.0 0.0 0.0 5.1 0.1 0.2 1.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 9.1 6.7 12.9 13.5 8.2 7.5 9.3 7.2 5.9 9.9 7.1 6.7 6.4 7.5 47.0 2.0 2.5 2.7 3.9 3.4 3.4 13.4 8.9 1.0 2.8 5.9 38.6 31.3 1.6 3.3 2.4 11.7 8.7 5.1 21.9 1.2 5.7 22.7 1.7 20.2 2.8 0.2 1.1 11.7 4.1 0.0 6.6 5.3 1.4 3.2 6.7 10.2 3.1 6.1 1.3 6.0 11.2 0.3 1.6 7.2 3.7 1.4 11.5 0.0 15.1 3.6 3.3 1.2 1.5 1.4 3.2 0.0 15.8 38.6 25.2 0.0 0.7 1.5 7.6 7.2 2.5 1.4 1.9 5.5 1.1 4.3 3.7 RIBC1 FLJ32783 ENSG00000158423 "RIB43A domain with coiled-coils 1" Q8N443 X 53422690-53431120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 27.5;testis: 39.3" "Group enriched" "Detected in many" 5 "Early spermatids: 249.1;Late spermatids: 609.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 6.1;T-47d: 7.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001150 Approved "Nuclear bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" "HPA001150: AB_2666211" "unprognostic (1.08e-2)" "prognostic favorable (1.90e-5)" "unprognostic (1.25e-1)" "prognostic favorable (9.66e-4)" "unprognostic (1.11e-1)" "unprognostic (2.39e-3)" "unprognostic (9.88e-2)" "unprognostic (3.97e-4)" "unprognostic (2.25e-2)" "unprognostic (7.89e-3)" "unprognostic (3.79e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" 0.7 3.9 3.2 0.7 3.1 0.6 1.5 2.9 3.4 2.7 10.2 1.1 0.9 2.4 2.9 0.7 27.5 1.4 1.1 3.1 3.9 3.2 0.7 3.3 0.8 7.5 6.5 2.6 1.9 2.6 6.6 0.3 4.7 1.8 0.5 11.4 2.0 1.6 0.7 1.2 0.8 0.6 5.4 0.9 0.9 39.3 3.4 1.7 3.5 0.5 0.6 0.8 0.9 4.8 1.3 3.5 1.3 0.9 0.4 0.9 0.8 0.4 0.2 0.7 0.7 1.3 2.1 1.3 2.3 0.1 2.3 2.4 0.3 0.7 0.9 0.8 2.3 0.8 6.1 0.6 0.2 0.8 1.3 0.3 0.3 2.0 0.5 1.7 0.6 1.0 0.6 1.5 0.5 0.9 1.5 0.7 1.7 0.6 0.9 1.1 0.9 1.0 2.0 0.7 2.9 0.5 3.4 1.2 0.8 4.1 7.8 0.3 0.2 0.3 1.7 1.0 0.5 1.4 1.1 0.7 1.3 0.3 0.6 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.2 0.5 0.3 0.3 0.1 0.1 0.8 1.2 0.4 0.2 0.5 0.2 3.2 3.1 2.9 3.4 3.1 3.9 7.5 6.5 4.7 5.4 3.4 4.8 0.3 0.0 0.5 1.0 0.2 1.3 2.1 3.7 1.8 2.2 1.7 2.2 1.2 2.8 6.5 0.0 4.2 0.5 0.2 0.3 1.9 1.4 249.1 73.2 1.0 0.8 1.2 0.0 0.2 0.2 0.5 0.9 0.0 1.6 2.5 0.5 0.0 0.7 0.1 1.7 0.3 0.1 10.2 0.6 0.3 609.6 2.5 0.5 1.8 0.0 0.0 5.5 0.0 0.0 0.5 0.5 0.1 1.9 0.0 0.8 0.7 7.2 71.4 11.3 0.0 1.6 1.0 14.2 6.4 0.4 0.9 0.4 0.6 2.1 0.3 0.7 RIBC2 "C22orf11, DKFZp566F0546, FLJ25720" ENSG00000128408 "RIB43A domain with coiled-coils 2" Q9H4K1 22 45413693-45432509 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "choroid plexus: 14.4;fallopian tube: 9.8;testis: 30.7" "Cell type enhanced" "Detected in some" "Early spermatids: 218.6;Endometrial ciliated cells: 77.5;Late spermatids: 40.4;Respiratory ciliated cells: 101.4;Spermatocytes: 159.4" "Cancer enhanced" "Detected in many" "cervical cancer: 8.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 7.6;CAPAN-2: 7.7;MCF7: 9.2;SiHa: 13.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 14.9" HPA003210 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA003210: AB_1078347" "unprognostic (2.55e-1)" "prognostic favorable (7.08e-8)" "unprognostic (3.58e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (1.71e-2)" "unprognostic (1.30e-3)" "unprognostic (9.51e-3)" "unprognostic (7.21e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (9.95e-5)" "unprognostic (1.41e-1)" "unprognostic (5.32e-2)" "unprognostic (7.91e-2)" "unprognostic (1.13e-1)" 0.0 0.1 0.9 0.6 0.9 1.9 0.2 0.3 0.3 0.9 14.4 0.5 0.3 0.6 0.4 0.7 9.8 0.4 0.0 0.6 0.5 0.1 0.0 0.8 0.4 2.5 2.6 0.2 0.2 1.2 1.4 0.3 1.7 0.6 0.3 0.2 0.2 0.1 0.0 0.9 0.5 0.2 1.6 0.1 0.5 30.7 0.8 0.5 0.5 0.0 0.4 0.1 0.5 2.2 5.9 4.0 0.6 0.0 0.0 0.0 0.5 7.6 0.6 1.5 2.1 4.2 7.7 0.0 1.8 0.7 0.0 6.8 0.0 0.0 1.1 0.0 0.2 0.0 5.7 0.2 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.8 0.9 0.0 0.0 0.5 9.2 4.0 2.0 0.9 0.1 2.2 4.5 0.0 0.0 2.1 0.8 3.9 0.0 13.0 2.6 0.0 0.4 4.8 2.8 0.4 0.0 0.0 4.6 0.0 2.2 2.3 0.0 0.0 1.2 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.9 0.3 0.3 0.6 0.5 2.5 2.6 1.7 1.6 0.8 2.2 0.2 0.0 0.0 0.0 0.1 0.3 0.8 3.6 0.0 0.0 0.6 0.8 0.2 1.5 7.7 0.0 0.0 1.5 0.4 0.8 1.9 0.1 218.6 77.5 1.8 0.3 0.0 4.0 0.9 0.0 0.6 0.9 0.5 2.5 0.0 0.6 0.0 0.0 1.1 0.0 0.3 1.8 12.2 0.0 0.4 40.4 1.2 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.4 0.1 0.0 101.4 3.6 0.0 0.0 1.9 159.4 22.2 1.2 0.1 0.3 0.4 0.1 1.1 0.3 RIIAD1 "C1orf230, FLJ36032, NCRNA00166" ENSG00000178796 "Regulatory subunit of type II PKA R-subunit domain containing 1" A6NNX1 1 151710433-151729805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 24.9;pituitary gland: 34.7;testis: 16.9" "Cell type enhanced" "Detected in many" "Early spermatids: 88.9;Endometrial ciliated cells: 133.2;Enteroendocrine cells: 46.2;Late spermatids: 57.1;Respiratory ciliated cells: 73.9;Spermatocytes: 30.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;SCLC-21H: 1.6;SH-SY5Y: 2.7" "Low region specificity" "Detected in all" HPA045703 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Cytosol Nucleoplasm "HPA045703: AB_10965795" "unprognostic (8.28e-3)" "unprognostic (3.42e-1)" "unprognostic (8.21e-2)" "prognostic favorable (5.46e-4)" "unprognostic (1.06e-2)" "unprognostic (3.09e-1)" "unprognostic (8.99e-2)" "unprognostic (3.20e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-3)" "unprognostic (8.50e-2)" "unprognostic (1.57e-3)" "unprognostic (2.79e-2)" "unprognostic (3.06e-2)" "unprognostic (2.48e-4)" 0.0 1.6 1.9 0.0 2.5 0.0 0.0 3.5 2.5 1.4 0.4 1.0 0.0 0.8 0.1 0.1 24.9 0.0 0.4 2.2 2.5 0.8 0.0 2.4 0.0 1.2 0.9 0.1 0.8 0.1 34.7 0.0 0.5 0.4 0.3 4.8 0.0 0.4 0.1 0.0 0.3 0.3 0.3 0.0 0.9 16.9 2.3 0.0 0.0 0.0 0.0 0.3 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 2.7 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 3.5 2.5 2.2 2.5 1.2 0.9 0.5 0.3 2.3 1.1 0.0 19.2 1.5 0.0 0.0 0.0 0.0 1.0 0.0 8.5 1.1 0.4 15.7 0.0 9.3 5.5 16.7 0.0 0.0 0.1 3.9 3.8 88.9 133.2 0.8 0.4 46.2 0.0 1.8 0.9 0.0 1.2 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 1.1 3.2 0.0 0.0 0.0 57.1 0.6 0.2 3.6 0.0 0.0 0.8 0.0 1.0 0.2 0.4 0.1 1.5 0.0 0.1 0.1 3.0 73.9 3.0 0.0 0.5 1.8 30.1 8.9 0.0 0.0 0.0 0.2 0.1 0.8 0.0 RNASE3 "ECP, RAF1, RNS3" ENSG00000169397 "Ribonuclease A family member 3" P12724 14 20891399-20892348 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "bone marrow: 934.3" "Cell type enhanced" "Detected in some" "Early spermatids: 22.9;Erythroid cells: 5.9;Kupffer cells: 4.5;Late spermatids: 10.9;Macrophages: 3.0;Rod photoreceptor cells: 3.5" "Cancer enriched" "Detected in single" 8 "glioma: 2.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 22 "eosinophil: 304.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 304.6" "Cell line enhanced" "Detected in some" "HL-60: 150.4;NB-4: 51.1;THP-1: 63.6;U-937: 301.8" HPA056183 Enhanced "Secreted to blood" NA NA 4200000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA056183: AB_2683059" "unprognostic (2.54e-2)" "unprognostic (6.61e-2)" "unprognostic (1.84e-1)" "unprognostic (2.50e-1)" "unprognostic (1.37e-2)" "unprognostic (8.21e-2)" "unprognostic (6.45e-2)" "unprognostic (9.20e-3)" "unprognostic (1.20e-1)" "unprognostic (9.21e-2)" "unprognostic (8.62e-7)" "unprognostic (6.29e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (2.37e-1)" 0.4 0.4 0.5 0.5 0.5 934.3 0.1 0.5 1.2 0.1 0.3 0.2 0.0 0.1 0.3 0.1 0.3 0.3 0.2 0.5 1.0 0.2 2.0 2.7 0.7 1.1 0.7 0.2 0.1 0.0 0.3 0.6 0.9 0.2 0.1 3.8 1.2 0.1 0.1 1.7 0.1 1.0 1.0 9.8 0.1 1.8 0.5 9.4 0.1 0.0 0.0 0.3 0.1 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 150.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 301.8 0.0 11.3 8.8 304.6 0.0 1.2 0.1 0.0 0.0 0.0 14.1 0.0 0.0 0.0 4.3 0.0 0.5 1.6 0.0 4.4 0.5 0.5 0.5 1.2 0.5 1.0 1.1 0.7 0.9 1.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 10.9 0.3 3.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 11.4;granulocytes: 16.0;T-cells: 6.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 28: Placenta - Pregnancy" "Cluster 12: NES - Nervous system development" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 27.4 39.3 13.7 39.4 15.9 20.4 28.2 16.2 16.1 24.7 18.6 26.4 12.2 21.0 30.9 53.1 16.9 48.3 18.8 15.6 19.8 19.5 15.3 73.6 38.7 11.1 13.1 29.0 12.3 47.7 19.4 52.4 11.6 25.9 29.3 33.8 25.6 32.7 9.0 22.3 16.6 27.4 14.3 29.2 26.7 12.1 20.3 26.5 33.8 13.7 48.4 68.1 24.4 14.7 65.5 63.5 95.2 115.1 98.5 43.6 18.6 51.3 88.9 46.3 74.6 22.2 52.9 22.4 89.7 45.3 87.9 83.1 75.9 67.3 80.9 92.7 27.2 47.2 68.5 18.4 42.1 31.4 43.2 27.0 118.8 43.2 63.0 64.7 46.2 53.6 47.7 83.6 44.1 1.9 36.1 9.8 41.3 20.5 32.0 47.3 41.6 44.8 61.4 22.3 34.5 63.9 51.8 54.7 86.5 64.7 38.5 28.4 49.7 51.6 47.0 41.9 92.1 18.4 27.6 20.6 60.3 38.4 113.1 3.5 2.5 16.0 3.0 2.6 3.5 11.4 4.4 3.6 1.9 5.1 5.8 4.0 9.5 2.3 2.3 2.7 6.3 1.3 13.7 15.9 16.2 16.1 15.6 19.8 11.1 13.1 11.6 14.3 20.3 14.7 34.1 112.2 244.1 25.1 62.9 122.7 102.0 90.0 73.4 106.7 97.2 77.3 12.7 65.8 114.0 36.8 58.4 2.8 55.1 98.4 19.6 75.0 28.9 27.5 37.1 75.7 54.1 67.5 89.2 114.4 24.3 45.7 52.0 36.7 69.1 30.2 127.8 19.5 45.5 114.4 74.2 41.8 32.6 115.0 240.8 39.5 46.3 69.4 65.8 52.5 153.9 56.1 47.4 40.2 38.9 108.6 53.7 51.9 38.1 123.8 16.9 10.6 65.6 53.4 46.0 25.4 46.5 19.2 34.8 81.9 99.4 10.9 69.3 19.0 72.0 163.1 RNF183 MGC4734 ENSG00000165188 "Ring finger protein 183" Q96D59 9 113297093-113303376 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.4;kidney: 11.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 15.9;Club cells: 9.8;Endometrial ciliated cells: 13.4;Glandular and luminal cells: 20.5;Ionocytes: 22.4;Proximal tubular cells: 26.4;Respiratory ciliated cells: 13.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057675 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 44: Endometrium - Transcription" "HPA057675: AB_2683499" "unprognostic (1.23e-2)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.95e-6)" "unprognostic (2.56e-1)" "unprognostic (1.75e-2)" "unprognostic (1.54e-3)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.51e-4)" "unprognostic (5.50e-2)" "unprognostic (8.84e-2)" "unprognostic (9.61e-2)" "unprognostic (2.53e-3)" 0.1 0.1 0.3 0.4 0.2 0.0 1.0 0.2 0.4 1.5 0.2 0.5 0.4 1.2 16.4 4.9 1.3 5.7 0.1 0.2 0.1 11.5 0.2 0.3 0.0 0.2 0.2 0.3 0.3 0.1 2.0 0.0 0.2 1.0 0.4 1.2 6.8 0.3 0.0 0.4 0.3 0.0 0.3 0.1 3.4 5.0 0.4 0.0 0.4 0.0 0.1 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.3 0.4 0.3 0.3 0.0 0.0 0.3 0.5 0.0 0.4 15.9 0.0 0.6 3.8 2.9 0.4 5.7 9.8 5.5 0.0 0.0 0.2 0.9 1.9 0.2 0.2 13.4 1.1 0.5 8.4 0.0 0.0 0.9 0.1 0.2 4.6 20.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 22.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 2.2 0.7 0.4 0.0 0.5 0.2 26.4 13.0 3.3 0.0 0.4 0.6 3.3 0.7 1.4 0.0 0.0 0.3 0.1 1.5 1.0 RNF224 ENSG00000233198 "Ring finger protein 224" P0DH78 9 137227502-137229640 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 3.4;pituitary gland: 5.8" "Cell type enhanced" "Detected in single" "Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.5;HeLa: 4.3;MCF7: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA079078 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Golgi apparatus" "HPA079078: " "unprognostic (2.45e-1)" "unprognostic (2.34e-3)" "unprognostic (7.01e-4)" "unprognostic (6.04e-2)" "unprognostic (5.26e-2)" "unprognostic (1.70e-3)" "unprognostic (3.87e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-3)" "unprognostic (4.57e-2)" "unprognostic (5.24e-2)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "unprognostic (4.95e-2)" "unprognostic (1.27e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 0.2 0.2 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.5 0.0 0.3 0.3 0.2 0.0 3.4 1.4 0.3 0.5 0.1 0.1 2.1 0.0 0.8 0.1 0.8 1.2 0.1 0.8 0.0 5.8 0.0 0.3 1.0 0.0 0.2 1.4 0.0 0.1 0.6 0.5 0.0 0.5 0.2 0.6 1.2 0.5 0.0 0.9 0.0 0.1 0.4 0.9 0.2 0.6 1.0 0.4 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 5.5 0.1 0.2 0.0 0.3 2.7 0.0 0.1 0.0 1.8 0.2 0.0 4.3 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.2 0.4 0.0 9.8 0.1 0.0 0.4 0.7 1.3 0.6 0.2 0.1 0.1 0.6 0.0 1.1 0.5 2.0 0.0 0.7 1.9 0.2 0.2 0.2 0.1 1.1 0.0 0.6 0.2 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.8 1.2 0.3 0.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.9 2.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ROPN1B ENSG00000114547 "Rhophilin associated tail protein 1B" Q9BZX4 3 125969160-125983454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 214.2" "Group enriched" "Detected in many" 4 "Early spermatids: 2012.7;Late spermatids: 1967.9" "Group enriched" "Detected in some" 5 "breast cancer: 1.3;melanoma: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SK-MEL-30: 54.6;WM-115: 18.5" HPA052530 Supported NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 34: Spermatids - Unknown function" "HPA052530: AB_2681861" "unprognostic (7.73e-3)" "unprognostic (1.35e-2)" "unprognostic (2.22e-3)" "unprognostic (2.76e-2)" "unprognostic (7.19e-2)" "unprognostic (3.39e-2)" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (8.15e-2)" "unprognostic (1.96e-2)" "unprognostic (1.09e-2)" "unprognostic (8.18e-2)" "unprognostic (5.91e-2)" "unprognostic (5.01e-2)" "unprognostic (1.74e-2)" "unprognostic (6.89e-3)" "unprognostic (3.78e-2)" 0.3 0.5 1.3 0.2 1.6 0.1 38.2 2.0 1.8 0.2 0.0 0.1 0.1 0.3 22.1 0.1 0.5 0.0 3.0 1.3 1.2 0.3 1.2 0.3 0.6 0.8 1.3 0.3 0.3 0.0 3.0 0.2 0.9 0.7 0.0 1.8 14.6 0.2 0.4 7.0 0.1 0.0 0.5 0.1 0.1 214.2 0.9 0.0 0.7 0.8 0.3 0.4 0.1 2.0 0.0 0.0 0.3 0.2 0.0 0.0 2.9 0.0 0.3 0.2 0.2 0.2 2.4 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.1 1.1 0.2 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.3 0.9 0.3 0.1 0.0 54.6 0.1 0.7 0.7 0.0 0.0 0.5 0.2 0.2 5.4 1.1 0.3 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.6 2.0 1.8 1.3 1.2 0.8 1.3 0.9 0.5 0.9 2.0 0.6 0.0 0.0 1.3 0.3 3.7 0.1 1.4 0.0 0.2 60.1 86.2 18.8 0.0 3.9 0.0 0.0 0.3 2.0 0.0 0.0 0.2 2012.7 3.1 0.1 1.6 0.0 0.0 0.5 0.2 2.5 1.3 0.0 0.1 0.0 0.2 0.0 0.5 0.1 3.3 0.4 0.0 2.0 0.0 2.0 1967.9 19.0 1.5 149.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 9.8 0.0 0.6 0.0 0.1 17.8 0.2 19.7 0.0 1.0 493.4 11.8 0.0 0.6 0.1 0.5 0.0 0.0 1.2 ROPN1L "ASP, FLJ25776, RSPH11" ENSG00000145491 "Rhophilin associated tail protein 1 like" Q96C74 5 10441524-10472029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 323.0" "Group enriched" "Detected in many" 5 "Early spermatids: 3125.2;Late spermatids: 3173.9;Spermatocytes: 987.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 9.6;ovarian cancer: 3.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "basophil: 45.1;eosinophil: 55.0;neutrophil: 105.3" "Lineage enriched" "Detected in many" 18 "granulocytes: 105.3" "Cell line enriched" "Detected in some" 5 "NB-4: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039193, HPA041830" Enhanced NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" "HPA039193: AB_10673415, HPA041830: AB_2677695" "unprognostic (2.39e-4)" "unprognostic (1.21e-1)" "unprognostic (3.78e-3)" "unprognostic (6.84e-3)" "unprognostic (3.59e-2)" "unprognostic (2.82e-1)" "unprognostic (5.88e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (3.13e-1)" "unprognostic (1.32e-3)" "unprognostic (7.54e-3)" "unprognostic (1.58e-2)" "unprognostic (1.73e-2)" "unprognostic (3.22e-2)" 0.7 0.2 1.3 0.3 1.3 4.3 0.8 0.7 0.8 2.0 6.5 0.2 0.0 0.8 0.0 0.1 27.4 0.3 0.6 1.8 1.5 0.8 0.3 5.3 0.4 5.0 8.4 0.2 1.1 0.0 1.2 0.2 4.9 0.6 0.0 1.0 0.1 0.1 0.2 0.3 0.3 0.0 4.2 4.5 0.3 323.0 1.3 0.2 0.8 0.3 0.0 0.2 0.1 2.1 0.1 0.4 0.0 0.0 0.4 0.0 0.5 0.0 0.6 0.5 0.5 0.1 0.1 0.0 1.5 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 2.7 0.0 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.1 0.0 0.1 0.0 13.4 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.2 0.4 0.0 0.0 0.9 1.5 0.1 0.1 0.4 0.0 1.5 1.6 0.3 45.1 0.8 55.0 4.0 0.3 2.7 0.0 3.5 4.7 0.1 0.0 2.3 2.7 105.3 0.4 1.4 0.0 5.8 2.1 1.3 1.3 0.7 0.8 1.8 1.5 5.0 8.4 4.9 4.2 1.3 2.1 2.0 3.2 2.0 1.6 0.1 0.3 0.0 38.0 0.0 0.2 0.4 0.4 0.4 0.0 45.3 0.0 0.0 0.0 2.2 0.0 0.0 1.0 3125.2 311.3 2.0 4.0 0.0 0.0 5.4 0.0 0.1 0.9 0.0 3.4 1.3 0.0 7.5 0.2 0.1 3.3 4.0 0.0 38.7 0.6 0.3 3173.9 36.1 2.2 0.0 0.0 0.2 0.2 0.0 1.0 0.3 0.1 0.0 18.4 0.1 0.3 0.0 1.3 482.3 3.3 13.1 0.4 14.1 987.8 35.8 0.0 0.1 0.1 0.8 2.9 0.0 0.1 RP1 "DCDC4A, ORP1" ENSG00000104237 "RP1 axonemal microtubule associated" P56715 8 54509422-54871720 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "retina: 236.4" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 333.6;Rod photoreceptor cells: 1115.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;HDLM-2: 5.2;hTERT-RPE1: 2.0;RPTEC TERT1: 10.2;U-2197: 2.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.3" HPA042257 Enhanced NA NA "Cluster 79: Retina - Phototransduction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA042257: AB_10797385" "unprognostic (3.19e-3)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.70e-1)" "unprognostic (9.16e-3)" "unprognostic (6.24e-2)" "unprognostic (4.56e-2)" "unprognostic (4.13e-5)" "unprognostic (2.48e-1)" "unprognostic (2.16e-5)" "unprognostic (8.92e-2)" "unprognostic (6.18e-2)" "unprognostic (1.89e-2)" "unprognostic (8.96e-2)" 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 0.1 0.0 0.7 0.1 3.5 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 236.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.5 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.6 0.0 0.1 0.0 0.7 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.0 0.1 0.1 0.5 16.0 4.8 0.0 0.0 0.0 0.0 1.2 0.0 72.5 3.0 1.4 0.4 0.0 31.1 5.5 333.6 0.0 0.0 0.0 3.9 0.0 0.3 81.9 0.4 10.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 32.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 130.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 149.0 1115.8 0.0 0.0 0.4 3.2 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 RPGRIP1L "CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134" ENSG00000103494 "RPGRIP1 like" Q68CZ1 16 53598153-53703938 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 40.5;Excitatory neurons: 59.8;Respiratory ciliated cells: 85.9;Spermatocytes: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039405, HPA040530" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA039405: AB_10794636, HPA040530: AB_2677023" "prognostic unfavorable (6.93e-4)" "unprognostic (1.52e-1)" "unprognostic (2.19e-3)" "unprognostic (2.26e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-4)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (5.22e-3)" "unprognostic (1.52e-1)" "unprognostic (4.92e-4)" "unprognostic (5.95e-2)" 1.6 3.5 2.3 2.1 2.2 1.5 3.2 1.0 5.2 3.1 9.5 1.7 1.3 3.8 3.7 2.2 6.8 2.7 1.9 2.7 3.0 3.0 1.1 1.9 1.8 2.4 3.2 3.5 2.0 7.6 6.0 2.1 1.9 2.9 1.7 2.9 1.7 2.8 1.0 1.9 0.9 3.5 1.0 0.9 1.9 13.5 3.5 2.6 4.6 1.4 1.8 2.2 1.8 3.2 11.8 13.7 11.6 10.7 13.9 13.3 5.6 12.7 7.9 9.8 2.7 7.1 9.5 7.5 8.5 11.1 7.8 12.5 9.4 11.6 19.1 4.6 7.2 2.8 12.1 7.5 6.0 6.7 5.0 8.1 6.9 11.4 6.9 11.4 8.9 10.0 7.2 4.3 14.8 4.5 11.2 4.7 7.4 3.7 6.3 19.3 15.9 9.4 14.0 3.1 19.9 7.5 14.3 6.4 5.3 6.7 10.0 5.7 7.8 12.2 8.6 9.7 11.0 5.4 6.9 13.1 18.9 3.9 7.3 0.7 0.2 0.3 1.2 0.3 1.2 1.1 0.8 1.0 0.2 1.5 0.8 1.8 0.6 0.8 0.3 0.7 0.7 0.4 2.3 2.2 1.0 5.2 2.7 3.0 2.4 3.2 1.9 1.0 3.5 3.2 3.1 6.4 4.8 15.7 2.9 4.6 2.8 11.1 4.6 5.5 6.9 8.0 9.8 1.5 15.1 11.0 8.4 5.5 1.5 1.3 17.6 7.4 21.5 40.5 20.7 3.9 0.0 3.0 59.8 3.3 7.4 12.9 5.1 8.6 7.0 12.9 2.5 3.8 2.9 3.3 36.6 5.6 4.1 1.2 3.1 12.0 4.7 1.9 1.8 9.4 1.8 6.3 2.1 14.1 8.6 3.3 0.5 6.4 2.1 1.7 0.2 19.8 85.9 8.7 6.6 7.8 9.7 43.2 11.2 4.7 5.4 1.6 2.7 11.5 4.4 2.4 RRM2 "C2orf48, FLJ25102" ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10211725 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 44.2;esophagus: 18.4;intestine: 19.7;lymphoid tissue: 58.1" "Group enriched" "Detected in many" 4 "Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056994 Enhanced Supported Cytosol Yes Yes 13000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "HPA056994: AB_2683304" "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 1.5 1.3 0.3 12.4 0.3 44.2 2.9 0.5 0.4 3.0 1.9 14.2 9.4 2.2 0.7 18.4 0.8 1.1 0.5 0.3 0.3 0.9 3.2 2.4 35.5 0.4 0.4 0.3 1.1 0.3 0.2 4.6 0.4 0.9 19.7 0.2 2.1 0.5 0.1 3.7 7.5 6.1 0.3 11.1 6.0 2.9 0.8 58.1 0.9 0.1 37.6 6.0 4.6 0.5 110.2 25.0 127.1 49.9 7.4 22.5 116.8 209.2 128.6 170.2 187.9 70.8 59.1 114.4 9.5 88.6 151.1 55.0 188.0 136.6 198.0 210.7 41.8 146.3 52.1 105.1 0.8 146.7 87.4 8.1 3.4 234.6 16.2 27.7 103.3 110.4 63.4 328.6 214.3 57.1 167.3 90.9 83.0 133.3 103.6 87.6 187.0 67.8 87.1 62.7 67.7 56.2 198.0 116.6 17.3 51.8 69.2 31.4 57.6 93.1 125.1 66.9 289.6 212.1 184.9 195.9 51.0 134.4 107.7 0.3 0.1 0.1 1.2 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.1 0.4 0.4 0.8 0.0 0.1 0.2 0.2 0.3 0.3 0.5 0.4 0.3 0.3 0.4 0.4 0.4 0.3 0.8 0.5 0.2 3.2 1.5 0.0 25.0 10.5 3.0 9.2 1.2 0.0 3.9 4.4 1.4 1.5 2.3 0.0 0.0 42.3 5.6 12.9 1.9 1.2 3.9 2.2 3.5 4.2 0.0 214.0 0.1 0.0 254.1 11.2 11.7 3.6 5.7 12.2 3.9 3.7 47.9 0.0 0.0 26.9 2.0 7.2 8.8 6.8 0.3 5.0 0.0 1.0 0.0 0.0 7.2 0.0 0.0 0.5 0.3 0.4 248.0 1.5 2.4 2.1 4.6 0.0 0.0 0.2 14.6 22.9 34.0 51.5 1.6 48.7 11.9 1.2 36.7 5.6 RSPH1 "CILD24, FLJ32753, RSP44, RSPH10A, TSGA2" ENSG00000160188 "Radial spoke head component 1" Q8WYR4 21 42472486-42496246 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 161.5" "Group enriched" "Detected in many" 8 "Endometrial ciliated cells: 857.0;Respiratory ciliated cells: 1058.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 3.0" "Group enriched" "Detected in some" 4 "MCF7: 11.0;OE19: 39.0;RPTEC TERT1: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016816, HPA017382" Enhanced Supported Centrosome NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" Centrosome "HPA016816: AB_1858393, HPA017382: AB_1858392" "unprognostic (1.76e-3)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.12e-3)" "unprognostic (5.48e-2)" "unprognostic (2.43e-1)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" "unprognostic (2.53e-1)" "unprognostic (1.46e-1)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (1.10e-2)" "unprognostic (8.41e-2)" "unprognostic (2.58e-2)" "unprognostic (5.22e-3)" "unprognostic (1.99e-1)" 0.4 3.5 12.7 0.8 13.3 0.3 2.1 10.7 11.8 6.7 30.2 4.0 7.5 5.4 17.0 0.9 161.5 3.0 0.2 11.9 13.1 7.7 0.6 14.2 0.3 20.1 25.0 1.2 3.2 5.1 25.9 0.1 20.4 3.2 3.6 12.4 1.4 3.3 0.7 3.6 5.6 1.0 17.0 0.2 5.2 30.9 14.1 1.5 8.0 0.1 0.3 1.5 0.8 15.5 1.6 1.2 0.1 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 3.4 0.1 0.5 0.0 0.4 1.9 0.0 0.5 0.0 0.2 0.1 5.4 0.5 0.0 0.0 0.1 0.2 0.3 0.8 0.0 0.1 0.0 0.0 0.9 0.0 0.2 0.0 11.0 0.1 0.2 0.3 39.0 0.5 0.0 0.4 0.0 15.4 1.3 2.5 0.9 2.4 3.7 0.3 0.0 4.2 0.4 0.2 0.0 0.1 0.1 0.0 0.4 2.5 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.0 0.1 0.1 12.7 13.3 10.7 11.8 11.9 13.1 20.1 25.0 20.4 17.0 14.1 15.5 0.4 0.0 6.2 6.5 0.9 5.1 4.5 64.6 2.8 13.3 7.2 5.8 0.6 24.3 107.1 18.4 37.5 0.1 2.9 10.5 39.2 12.6 73.9 857.0 6.2 1.3 9.0 0.0 11.5 3.8 0.0 2.7 4.6 13.9 0.0 0.4 0.0 0.2 0.1 3.3 5.9 13.5 61.1 0.0 0.0 113.4 1.8 0.9 0.0 0.0 1.0 19.9 0.0 0.5 0.3 1.9 11.2 2.6 0.8 9.5 21.4 15.7 1058.1 28.1 0.0 0.9 23.9 79.3 16.8 0.7 4.5 0.8 1.3 2.1 10.6 6.4 RSPH10B ENSG00000155026 "Radial spoke head 10 homolog B" P0C881 7 5925550-5970683 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.4;testis: 19.7" "Group enriched" "Detected in some" 8 "Early spermatids: 59.2;Late spermatids: 143.2;Respiratory ciliated cells: 41.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049182 Supported NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 31: Spermatids - Spermatogenesis" "HPA049182: AB_2680666" "unprognostic (4.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.47e-1)" "unprognostic (5.31e-2)" "unprognostic (9.41e-3)" "unprognostic (2.80e-1)" "unprognostic (2.88e-3)" "unprognostic (1.11e-3)" "unprognostic (2.93e-3)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (2.47e-2)" "unprognostic (1.76e-3)" "unprognostic (1.75e-2)" "unprognostic (4.06e-2)" "unprognostic (5.80e-2)" "unprognostic (1.31e-3)" 0.1 0.3 0.8 0.0 0.8 0.0 0.1 0.7 0.8 0.8 3.9 0.1 0.0 0.3 0.2 0.1 8.4 0.0 0.1 1.2 1.2 0.2 0.4 1.4 0.0 2.4 3.4 0.2 0.1 0.9 1.1 0.0 1.5 0.2 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 2.2 1.0 0.1 19.7 1.7 0.0 0.2 0.1 0.0 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.7 0.8 1.2 1.2 2.4 3.4 1.5 2.2 1.7 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 59.2 10.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 143.2 0.3 0.1 1.8 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.1 4.9 1.1 0.0 0.3 0.0 0.1 0.9 0.0 0.0 RSPH10B2 ENSG00000169402 "Radial spoke head 10 homolog B2" B2RC85 7 6754109-6799365 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 10.1;testis: 19.5" "Group enriched" "Detected in some" 8 "Early spermatids: 32.1;Late spermatids: 64.3;Respiratory ciliated cells: 47.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049182 Supported NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA049182: AB_2680666" "unprognostic (7.74e-2)" "unprognostic (1.60e-1)" "unprognostic (2.28e-2)" "unprognostic (5.35e-3)" "unprognostic (3.41e-1)" "unprognostic (3.05e-3)" "unprognostic (2.58e-2)" "unprognostic (4.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-5)" "unprognostic (1.66e-1)" "unprognostic (4.38e-2)" "unprognostic (8.27e-3)" "unprognostic (7.02e-2)" 0.0 0.1 0.6 0.0 0.6 0.3 0.0 0.7 0.5 0.4 4.8 0.0 0.0 0.2 0.4 0.0 10.1 0.0 0.0 0.8 1.0 0.1 0.1 1.4 0.1 2.6 4.1 0.1 0.0 1.2 0.6 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.6 0.3 0.1 19.5 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.7 0.5 0.8 1.0 2.6 4.1 1.8 1.6 0.8 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 5.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 64.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 RSPH14 RTDR1 ENSG00000100218 "Radial spoke head 14 homolog" Q9UHP6 22 23059415-23145021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.0" "Group enriched" "Detected in many" 6 "Early spermatids: 139.7;Late spermatids: 252.0" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 7.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 7.7" "Cell line enhanced" "Detected in some" "GAMG: 3.2;RPTEC TERT1: 4.2;U-266/70: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA018420, HPA050425" Approved Uncertain Nucleoli NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Nucleoli "HPA018420: AB_1856496, HPA050425: " "unprognostic (8.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.80e-3)" "unprognostic (1.97e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (1.22e-2)" "unprognostic (8.31e-2)" "unprognostic (7.28e-2)" "prognostic favorable (4.04e-4)" "unprognostic (5.18e-2)" "unprognostic (4.40e-2)" "unprognostic (3.16e-1)" "unprognostic (7.73e-2)" 0.3 2.0 7.7 0.2 9.4 0.2 0.4 5.9 11.8 1.0 9.4 0.6 0.2 0.8 3.5 0.4 12.4 1.3 0.4 8.3 9.9 7.3 0.4 1.5 0.2 8.6 10.9 3.9 0.9 2.4 3.7 0.1 7.7 0.8 0.2 11.4 0.6 1.7 0.7 1.1 0.3 0.3 7.6 0.5 0.7 25.0 7.2 0.1 1.9 0.1 0.2 0.2 0.4 9.5 0.2 2.5 1.9 2.0 0.0 0.9 0.1 0.0 0.5 0.4 0.4 0.4 0.7 0.5 0.7 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.1 0.1 1.0 0.0 0.2 0.4 0.0 1.2 0.0 0.8 0.0 1.0 0.0 0.3 0.3 0.4 0.0 0.6 0.0 0.1 0.0 2.0 4.2 0.0 2.7 0.9 0.0 0.0 0.1 0.1 0.3 0.5 0.0 1.5 0.5 0.1 0.0 4.9 1.9 1.6 1.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 7.7 0.1 1.8 0.0 0.0 0.6 7.7 9.4 5.9 11.8 8.3 9.9 8.6 10.9 7.7 7.6 7.2 9.5 1.9 0.0 0.0 2.0 0.0 0.0 0.9 0.0 0.0 1.1 0.2 0.5 0.1 1.5 3.7 0.0 4.2 0.0 0.2 0.0 7.9 1.0 139.7 17.8 0.5 0.4 0.0 0.0 3.5 0.2 0.0 0.5 0.0 0.5 0.0 1.2 0.7 0.0 0.1 11.8 2.8 0.1 0.0 0.0 0.0 252.0 2.1 0.3 0.0 0.0 0.0 4.6 0.0 1.0 1.1 0.4 0.0 1.9 0.1 0.2 0.0 17.7 29.2 5.1 0.0 0.8 0.9 29.4 8.3 0.0 0.0 0.0 0.4 2.8 0.1 0.3 RSPH4A "CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B" ENSG00000111834 "Radial spoke head component 4A" Q5TD94 6 116616479-116632985 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 21.0;fallopian tube: 37.2" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 92.4;Respiratory ciliated cells: 260.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 3.3;U-266/84: 2.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 14.5" "HPA031196, HPA031197, HPA031198" Enhanced Approved Nucleoplasm No NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025" "unprognostic (9.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (9.69e-3)" "unprognostic (9.37e-2)" "unprognostic (1.13e-3)" "unprognostic (4.52e-1)" "unprognostic (1.07e-1)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (9.56e-5)" "unprognostic (2.87e-1)" "unprognostic (2.69e-4)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (5.21e-2)" 0.6 0.5 1.5 0.3 1.6 0.9 0.6 1.3 0.6 1.7 21.0 0.3 0.3 1.6 0.5 0.2 37.2 0.5 0.4 1.5 2.0 0.7 0.5 4.6 0.3 6.1 6.2 0.8 0.8 2.0 4.3 0.1 3.8 0.5 0.2 6.0 0.4 0.2 0.9 0.5 0.5 0.4 4.5 0.9 0.5 2.8 2.4 0.5 0.8 0.2 0.3 0.3 0.3 2.8 0.0 0.1 0.6 1.4 0.0 0.0 0.1 0.1 0.3 0.2 0.3 0.3 0.5 0.4 0.1 0.0 0.5 0.1 0.1 0.2 0.2 0.3 0.5 0.2 0.2 0.5 0.0 0.3 0.4 0.1 0.1 0.4 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.3 0.7 3.3 1.3 0.2 1.2 0.5 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 2.4 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.6 1.3 0.6 1.5 2.0 6.1 6.2 3.8 4.5 2.4 2.8 0.8 3.2 3.4 7.2 0.3 0.0 0.1 4.9 0.0 3.3 0.4 0.8 0.6 0.0 22.9 0.0 2.1 0.0 0.1 0.1 1.9 0.4 33.1 92.4 1.6 2.2 0.0 0.0 10.6 0.4 0.1 1.1 0.5 1.4 2.5 0.7 1.8 0.0 0.1 1.7 12.9 0.0 10.2 0.0 0.0 9.3 0.3 0.4 1.8 0.0 0.0 2.0 0.0 3.5 5.0 0.2 0.0 0.0 0.2 0.3 0.0 0.1 260.6 3.7 0.0 2.0 2.4 9.3 1.6 0.0 0.1 0.3 0.5 5.7 0.0 0.1 RSPH9 "C6orf206, CILD12, FLJ30845, MRPS18AL1" ENSG00000172426 "Radial spoke head component 9" Q9H1X1 6 43645036-43672600 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.3;testis: 15.2" "Group enriched" "Detected in many" 4 "Early spermatids: 195.6;Endometrial ciliated cells: 96.3;Respiratory ciliated cells: 327.5;Spermatocytes: 89.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-87 MG: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031703 Enhanced NA NA "Cluster 24: B-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "HPA031703: AB_10602126" "unprognostic (2.54e-2)" "unprognostic (1.85e-3)" "unprognostic (3.57e-3)" "unprognostic (4.06e-2)" "unprognostic (7.28e-2)" "unprognostic (6.62e-2)" "unprognostic (1.81e-3)" "unprognostic (2.78e-3)" "unprognostic (6.42e-2)" "unprognostic (7.27e-2)" "unprognostic (6.89e-3)" "unprognostic (1.33e-1)" "unprognostic (2.62e-4)" "unprognostic (1.48e-1)" "unprognostic (2.42e-2)" "unprognostic (1.16e-2)" "unprognostic (3.73e-2)" 0.6 0.7 1.0 0.3 0.9 0.6 0.6 1.9 1.0 1.5 3.8 0.7 0.2 1.3 0.2 0.6 8.3 0.3 0.7 0.8 1.6 0.8 0.5 2.1 0.2 1.7 2.1 0.7 0.4 0.2 3.3 0.4 0.9 1.1 0.1 1.0 0.5 0.3 0.6 0.5 0.5 0.4 0.8 0.7 0.8 15.2 1.9 0.1 0.5 0.1 0.1 0.7 0.8 0.5 0.3 0.1 0.5 0.5 0.1 1.6 0.5 0.7 0.2 0.0 0.0 0.8 0.1 0.1 0.2 0.3 0.3 0.3 0.1 0.0 0.0 0.2 0.4 0.4 0.2 0.2 1.3 0.5 0.2 0.5 0.0 0.5 0.0 0.2 0.1 0.3 0.5 0.5 0.0 0.4 0.3 0.6 0.2 1.7 0.4 0.2 0.4 0.4 0.0 0.5 0.6 0.8 0.0 0.4 0.5 0.6 0.2 0.5 0.2 0.3 0.3 0.3 0.2 0.6 1.0 0.5 2.0 0.4 0.6 0.1 0.6 0.3 0.6 0.2 0.5 0.7 0.4 0.3 0.5 1.5 0.5 0.4 1.0 0.6 0.1 0.3 0.5 0.8 1.0 0.9 1.9 1.0 0.8 1.6 1.7 2.1 0.9 0.8 1.9 0.5 0.4 0.0 4.8 0.3 0.4 0.5 0.6 24.0 0.0 0.4 0.3 2.7 1.0 2.8 28.9 0.0 2.1 0.5 0.0 0.3 0.0 0.6 195.6 96.3 2.3 1.9 1.2 0.0 1.4 0.0 3.0 3.4 0.0 1.5 3.8 0.6 0.4 0.2 0.6 1.7 1.5 0.2 38.7 0.3 0.3 26.4 2.8 4.2 7.2 1.0 1.2 6.4 0.0 0.5 0.5 0.4 0.1 1.5 0.0 0.4 0.4 0.3 327.5 1.7 0.0 1.8 8.4 89.9 2.3 0.0 0.3 0.5 0.4 1.1 0.3 0.1 S100A12 "CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6" ENSG00000163221 "S100 calcium binding protein A12" P80511 1 153373711-153375621 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 3489.7" "Group enriched" "Detected in many" 20 "Kupffer cells: 711.7;Macrophages: 475.0;monocytes: 998.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 51.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "classical monocyte: 1321.1;neutrophil: 1781.4" "Group enriched" "Detected in many" 13 "granulocytes: 1781.4;monocytes: 1321.1" "Cell line enhanced" "Detected in some" "hTCEpi: 2.6;THP-1: 1.6" "Region enhanced" "Detected in some" "cerebral cortex: 4.0" "HPA002881, CAB025872" Enhanced "Secreted to blood" NA NA 28500000 8300000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "CAB025872: , HPA002881: AB_1848175" "unprognostic (1.33e-1)" "unprognostic (4.51e-2)" "unprognostic (7.49e-2)" "unprognostic (1.36e-1)" "unprognostic (7.30e-2)" "unprognostic (4.36e-2)" "unprognostic (3.79e-2)" "unprognostic (8.79e-3)" "unprognostic (9.04e-2)" "unprognostic (3.14e-2)" "unprognostic (1.58e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (5.03e-4)" "unprognostic (3.68e-3)" "unprognostic (1.05e-1)" "unprognostic (1.31e-2)" "unprognostic (7.70e-2)" 54.9 3.2 2.6 82.0 3.1 3489.7 7.0 2.9 7.7 21.9 3.2 5.5 1.7 2.1 0.0 52.4 19.3 6.7 16.6 2.7 2.6 15.2 25.6 148.4 1.9 3.2 2.9 2.1 3.6 1.3 4.3 19.8 3.9 3.5 0.4 0.3 11.4 0.2 4.0 3.7 4.4 40.4 3.0 523.2 8.9 0.9 2.9 30.2 6.0 14.8 46.5 41.9 33.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 1321.1 5.2 1.9 44.9 1.0 3.2 0.8 1.5 122.7 1.0 1.1 0.5 1781.4 0.4 9.6 8.3 2.0 1031.8 2.6 3.1 2.9 7.7 2.7 2.6 3.2 2.9 3.9 3.0 2.9 2.9 0.0 19.2 24.4 0.0 6.1 0.1 0.3 9.8 0.0 0.0 0.1 0.0 1.1 8.6 9.2 1.8 0.0 0.5 2.9 0.0 0.0 0.1 1.4 0.0 0.0 2.1 0.0 14.1 0.1 0.2 0.9 4.1 1.1 0.0 13.9 0.0 6.8 3.8 8.6 0.0 0.1 0.0 0.0 711.7 0.8 1.8 0.0 475.0 0.0 1.0 998.3 0.0 36.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 7.8 0.0 0.0 0.8 0.4 0.0 0.2 5.7 0.0 0.5 6.9 0.0 0.1 0.2 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361023 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 24579.6;neutrophil: 33654.0" "Group enriched" "Detected in all" 6 "granulocytes: 33654.0;monocytes: 24579.6" "Cell line enriched" "Detected in many" 6 "SK-BR-3: 2398.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1200000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 706.4 126.1 19.7 1505.7 24.3 32194.3 189.8 21.4 67.8 7849.1 28.5 123.9 24.1 50.0 2.0 30581.7 486.1 147.4 208.5 19.4 21.9 171.7 284.0 1629.4 69.3 28.7 24.2 51.5 73.9 11.5 65.4 370.1 30.0 91.3 20.2 3.6 5790.0 9.6 92.2 416.7 120.6 480.7 22.0 5381.4 187.6 16.7 26.5 197.7 90.4 150.4 4378.8 955.1 14027.7 25.4 24.6 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.5 0.0 9.2 372.2 0.0 0.4 23.0 0.0 157.3 0.0 0.4 0.0 6.2 0.0 0.1 0.0 7.8 0.0 0.0 130.2 0.0 8.4 0.0 0.0 0.1 7.6 3.5 0.0 31.4 0.8 3.3 0.1 3.1 0.2 0.8 5.1 82.2 0.3 100.4 1.3 0.6 4.0 2398.2 1.7 1.2 38.1 312.3 6.8 0.0 3.3 0.4 0.4 0.7 1.6 3.3 0.5 71.7 0.0 373.8 24579.6 2626.3 30.5 1754.8 52.6 29.7 25.3 17.2 4664.8 24.8 17.7 15.4 33654.0 18.8 860.2 153.3 29.2 24461.7 19.7 24.3 21.4 67.8 19.4 21.9 28.7 24.2 30.0 22.0 26.5 25.4 1.8 230.8 392.4 0.0 92.1 20.0 123.1 5771.3 28.5 0.0 55.6 6.7 8.0 57.2 1685.0 36.8 0.0 126.1 115.1 7.7 5.9 102.6 1.7 1.2 1.9 26.9 0.0 92.8 0.0 39.4 52.9 50.9 3.6 9.4 164.0 0.2 70.6 54.5 1926.0 0.0 0.0 3.7 309.3 7537.0 13.4 4.0 5.9 3678.1 0.0 0.0 11103.1 0.0 483.0 0.0 0.0 15.3 1.4 0.0 13.1 55.6 0.8 25.2 262.8 0.3 0.0 13.3 60.4 0.3 1.2 3263.1 33.2 1236.0 79.9 0.0 12.5 551.3 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 15.3;testis: 17.7" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 62.6;Early spermatids: 81.8;Endometrial ciliated cells: 38.8;Late spermatids: 111.7;Respiratory ciliated cells: 41.5;Rod photoreceptor cells: 75.7;Spermatocytes: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.5 0.8 1.7 0.3 2.8 0.6 1.0 0.7 1.5 0.7 7.7 0.2 0.3 1.0 5.3 0.2 4.5 1.1 0.1 1.7 3.4 1.9 0.1 0.8 1.4 2.8 3.5 0.7 2.0 2.4 2.4 0.3 2.0 0.7 0.3 15.3 0.3 0.7 0.2 0.5 0.2 0.3 1.4 0.2 0.4 17.7 2.7 0.4 3.9 0.0 1.4 0.8 0.2 0.8 2.5 3.4 1.3 2.7 0.3 1.4 1.2 1.0 0.9 2.6 2.3 2.5 2.2 2.8 1.1 1.0 2.3 2.4 0.9 1.4 3.7 0.2 0.5 0.4 1.0 0.6 0.1 0.5 2.9 1.3 0.9 2.3 0.2 1.1 1.8 1.4 0.3 0.7 1.1 7.6 0.6 0.2 0.5 0.6 1.0 1.2 1.2 0.1 4.6 1.4 2.8 1.8 3.5 0.5 0.5 0.5 4.3 0.8 0.7 2.5 1.4 2.6 1.3 0.4 2.4 1.8 3.1 0.1 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 2.8 0.7 1.5 1.7 3.4 2.8 3.5 2.0 1.4 2.7 0.8 0.7 0.0 0.0 1.0 0.3 0.3 0.5 0.6 0.0 11.2 0.9 0.9 1.9 2.8 1.8 0.0 62.6 0.3 0.8 0.7 1.9 2.8 81.8 38.8 4.6 0.5 3.6 0.0 1.3 0.6 0.2 1.0 0.0 1.4 0.0 1.3 0.4 0.0 0.1 3.3 0.6 0.5 0.0 0.0 0.0 111.7 1.5 0.3 0.0 0.0 0.1 5.5 0.0 0.5 0.4 0.9 0.1 0.0 0.0 0.2 0.0 3.5 41.5 75.7 0.0 1.0 1.0 59.3 7.3 0.0 0.0 0.3 0.3 6.0 0.1 0.3 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 59.9;testis: 21.6" "Group enriched" "Detected in many" 4 "Early spermatids: 90.9;Endometrial ciliated cells: 71.5;Late spermatids: 175.4;Respiratory ciliated cells: 201.9;Spermatocytes: 57.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 10.5;K-562: 10.0;SCLC-21H: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.1 2.1 0.3 2.2 0.6 3.2 2.3 2.7 2.3 8.3 1.3 0.7 2.2 17.9 0.6 59.9 1.0 1.3 2.5 2.3 2.7 0.9 8.0 1.2 3.2 5.0 1.7 1.6 4.7 4.9 0.4 2.4 2.6 2.0 6.9 2.8 1.2 1.3 2.1 1.6 0.6 3.1 1.2 2.5 21.6 2.5 2.6 3.5 0.8 1.6 1.3 1.0 3.7 1.4 1.9 1.1 4.1 0.9 1.8 0.5 0.5 0.3 0.8 1.5 0.2 2.3 1.4 1.0 0.0 2.2 10.5 1.8 1.6 1.8 1.0 6.8 0.5 3.4 0.0 0.1 0.3 0.4 1.2 2.2 1.4 1.2 2.3 1.7 2.9 10.0 0.7 1.0 1.0 0.5 0.0 2.7 0.5 0.8 1.4 0.5 0.9 0.8 0.9 7.8 1.2 1.1 0.0 1.5 0.6 4.0 0.4 0.2 2.0 1.1 4.2 0.8 2.1 2.6 0.9 1.9 0.5 1.3 0.0 0.0 3.0 0.5 0.0 0.8 1.3 0.2 1.5 0.1 3.3 0.9 0.4 0.0 2.0 0.1 0.8 0.0 0.3 2.1 2.2 2.3 2.7 2.5 2.3 3.2 5.0 2.4 3.1 2.5 3.7 1.8 0.0 2.7 9.1 1.5 0.0 2.0 0.0 2.8 2.7 4.5 4.1 2.7 1.5 24.1 3.7 4.2 0.5 0.9 0.1 1.9 0.7 90.9 71.5 1.5 0.9 2.4 0.8 21.1 0.5 0.4 1.5 10.2 2.0 1.3 3.7 0.4 0.3 0.1 0.0 16.4 1.9 0.0 0.6 0.0 175.4 2.5 0.5 0.0 3.7 0.0 3.7 0.0 9.0 8.0 0.3 0.1 2.2 1.9 1.5 0.3 4.6 201.9 5.0 6.6 1.0 1.0 57.7 12.7 0.9 0.0 0.3 0.7 3.0 0.5 1.6 SCARA5 "FLJ23907, MGC45780, NET33" ENSG00000168079 "Scavenger receptor class A member 5" Q6ZMJ2 8 27869883-27992673 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 90.0" "Group enriched" "Detected in some" 4 "Fibroblasts: 174.0;Leydig cells: 135.8;Theca cells: 44.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 121 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 211 "dendritic cells: 21.1" "Cell line enriched" "Detected in some" 20 "ASC diff: 229.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 5 "spinal cord: 19.5" HPA024661 Approved NA NA 1400000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA024661: AB_1853902" "unprognostic (2.76e-2)" "unprognostic (7.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.53e-2)" "unprognostic (2.34e-2)" "unprognostic (4.62e-2)" "unprognostic (2.01e-1)" "unprognostic (2.15e-1)" "unprognostic (9.13e-2)" "unprognostic (2.40e-1)" "unprognostic (4.21e-2)" "unprognostic (1.10e-1)" "unprognostic (7.09e-6)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" 60.5 4.0 0.4 7.2 0.8 0.0 34.6 0.8 1.8 16.6 4.9 38.5 8.7 2.9 8.2 21.1 23.7 22.5 90.0 0.6 0.4 1.0 4.1 20.2 2.4 0.3 0.2 11.2 2.4 0.2 5.4 12.5 0.2 8.4 33.7 0.3 29.0 3.3 15.1 31.1 26.3 6.5 0.5 3.3 27.3 11.6 0.2 3.2 21.1 34.5 2.1 77.1 36.8 0.3 0.0 7.9 0.0 0.0 229.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 11.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.1 0.4 0.8 0.8 1.8 0.6 0.4 0.3 0.2 0.2 0.5 0.2 0.3 7.1 0.0 0.0 0.0 0.1 6.5 0.1 0.0 0.6 0.0 0.5 0.6 4.6 0.0 0.0 0.0 0.0 0.1 6.7 0.2 0.0 0.0 1.5 0.7 27.9 2.4 0.0 0.0 0.3 0.0 0.4 174.0 4.1 0.8 0.0 0.0 0.0 0.0 0.4 0.0 2.9 0.0 0.0 0.0 17.0 4.6 135.8 1.3 7.2 5.6 0.0 1.9 0.0 0.0 0.2 0.0 0.0 11.3 0.8 0.1 0.0 0.0 0.0 0.1 0.0 7.4 3.6 0.7 1.1 0.9 6.0 0.1 1.1 44.5 0.3 0.1 SCD5 "ACOD4, FADS4, FLJ21032, HSCD5, SCD4" ENSG00000145284 "Stearoyl-CoA desaturase 5" Q86SK9 4 82629539-82798796 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 156.7;brain: 353.6" "Cell type enhanced" "Detected in many" "Astrocytes: 248.4;Oligodendrocyte precursor cells: 892.7;Oligodendrocytes: 513.6" "Group enriched" "Detected in all" 6 "glioma: 152.4;thyroid cancer: 38.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 69.2;RPTEC TERT1: 90.1" "Low region specificity" "Detected in all" HPA042380 Uncertain NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 68: Oligodendrocytes - Mixed function" "HPA042380: AB_10794797" "unprognostic (3.23e-2)" "unprognostic (3.84e-2)" "unprognostic (2.86e-1)" "unprognostic (6.98e-2)" "unprognostic (1.58e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (3.82e-2)" "unprognostic (6.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "prognostic favorable (2.32e-5)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.88e-3)" "unprognostic (2.92e-2)" 6.8 156.7 226.1 3.7 283.7 2.9 5.7 302.5 260.4 10.6 85.2 12.9 4.5 12.5 97.6 5.8 18.7 9.3 8.1 212.6 277.4 33.1 2.5 15.0 3.0 353.6 272.7 93.7 40.9 18.7 31.4 7.5 291.0 12.7 4.0 70.2 18.0 24.3 1.3 8.2 6.0 12.0 314.1 4.5 10.6 33.3 255.6 10.6 35.5 4.2 4.4 7.7 8.7 316.2 11.2 7.1 36.0 18.6 19.7 12.5 0.6 69.2 33.9 29.7 22.8 0.5 1.7 22.5 23.5 14.5 8.0 19.9 10.6 7.6 37.0 4.4 4.7 1.0 8.1 0.7 2.9 10.0 6.9 10.0 30.6 5.9 5.2 30.5 48.4 25.8 1.3 2.2 15.6 4.4 42.6 2.1 2.6 0.2 5.0 35.6 21.5 17.9 90.1 11.2 20.1 11.5 11.4 0.5 6.8 3.5 1.3 5.0 59.5 31.5 18.1 11.9 18.9 6.0 2.5 2.2 15.3 10.5 9.0 1.9 0.6 0.1 3.9 0.2 2.5 0.2 0.8 2.3 0.3 0.4 0.7 2.6 0.7 1.1 0.4 0.7 0.2 1.2 226.1 283.7 302.5 260.4 212.6 277.4 353.6 272.7 291.0 314.1 255.6 316.2 1.4 44.8 3.9 248.4 0.8 10.7 16.5 16.3 5.7 101.4 6.8 4.8 2.9 27.1 25.7 27.6 25.0 1.9 3.9 0.4 13.7 79.7 115.0 13.5 9.3 7.7 7.7 0.0 84.3 46.9 0.2 16.8 2.6 14.8 0.0 10.5 10.4 0.2 1.1 101.0 107.0 0.3 10.2 1.3 3.3 100.3 55.0 1.8 3.6 23.4 1.9 145.3 4.1 892.7 513.6 8.9 0.0 58.3 0.7 11.3 0.2 20.4 13.0 14.6 6.6 3.6 11.5 2.9 3.7 2.7 7.2 0.1 3.2 137.4 2.0 9.3 SCEL "FLJ21667, MGC22531" ENSG00000136155 Sciellin O95171 13 77535674-77645263 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 385.5;skin 1: 302.7" "Cell type enriched" "Detected in many" 12 "Alveolar cells type 1: 679.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 17.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039737, HPA040154" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA039737: AB_10805485, HPA040154: AB_10795359" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.91e-2)" "unprognostic (4.54e-2)" "unprognostic (6.62e-2)" "unprognostic (3.51e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (1.24e-4)" "unprognostic (4.57e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.81e-1)" "unprognostic (2.82e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (1.73e-5)" 3.1 0.1 0.0 0.1 0.1 0.1 19.5 0.1 0.1 69.9 0.0 1.1 0.0 0.1 0.1 385.5 0.3 0.1 0.1 0.0 0.0 0.4 0.1 59.8 0.0 0.1 0.2 0.2 0.2 0.3 0.5 0.8 0.2 0.1 2.0 0.1 57.8 0.0 1.5 302.7 0.1 0.0 0.1 0.0 0.6 2.3 0.1 0.5 2.2 0.0 76.8 0.1 121.6 0.2 16.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 1.8 0.0 0.0 54.6 0.0 25.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 74.2 14.9 0.0 0.0 0.0 107.2 0.0 2.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.1 679.5 31.6 0.0 0.0 10.7 0.1 12.9 0.0 0.0 0.0 0.0 0.2 0.0 49.7 0.0 0.0 0.3 0.0 0.7 0.0 3.2 6.6 0.7 0.1 0.2 0.0 0.0 0.2 0.2 0.0 2.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 7.8 8.2 0.0 1.1 20.9 0.0 0.3 1.8 0.0 0.0 1.6 0.0 1.0 1.7 45.5 0.2 0.0 0.0 0.1 0.0 0.1 7.1 0.0 0.0 0.0 1.2 7.9 5.0 48.8 55.8 0.1 0.3 0.8 0.1 2.7 SCGB1A1 "CC10, CC16, CCSP, UGB" ENSG00000149021 "Secretoglobin family 1A member 1" P11684 11 62405103-62423195 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Phospholipase A2 inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lung: 3079.0" "Cell type enriched" "Detected in some" 4 "Club cells: 43564.7" "Cancer enriched" "Detected in many" 8 "lung cancer: 215.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 71 "HaCaT: 1977.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025686, HPA031828" Enhanced "Secreted in other tissues" NA NA 13000000 "Cluster 19: Lung - Lung function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB025686: , HPA031828: AB_2674061" "unprognostic (2.40e-3)" "unprognostic (1.55e-2)" "unprognostic (5.46e-2)" "unprognostic (2.70e-2)" "unprognostic (4.69e-3)" "unprognostic (2.12e-2)" "unprognostic (1.23e-2)" "unprognostic (2.31e-2)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" 1.1 2.0 0.6 0.9 0.7 0.1 0.3 1.3 1.1 0.6 0.3 0.2 0.4 0.2 0.7 11.0 334.2 0.2 0.6 0.5 0.6 0.2 0.4 3079.0 0.2 0.6 0.9 2.0 1.9 0.0 2.4 1.7 0.5 85.1 0.0 0.2 0.5 0.9 0.3 0.3 1.6 0.0 0.5 7.2 4.3 0.2 1.0 2.8 0.4 0.0 5.9 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 1977.1 0.0 0.3 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 27.9 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.1 0.0 0.0 0.6 1.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.0 0.0 1.0 2.0 0.0 1.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.3 1.1 0.5 0.6 0.6 0.9 0.5 0.5 1.0 0.5 0.0 1125.0 2573.3 0.0 0.0 0.0 71.4 3938.5 0.0 0.0 0.0 0.0 0.0 0.0 43564.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 113.5 0.0 0.0 0.1 0.0 0.0 304.5 0.0 0.5 691.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4534.8 0.0 0.0 0.7 0.0 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 134.7 0.0 0.0 9997.0 0.0 0.0 0.0 850.3 0.0 0.0 3.9 0.0 0.0 83.7 0.0 0.0 800.2 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208673-62213943 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 2021.0;epididymis: 1372.0" "Group enriched" "Detected in many" 6 "Endometrial ciliated cells: 2506.4;Glandular and luminal cells: 2597.0" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 971.9" "Region enhanced" "Detected in some" "medulla oblongata: 3.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 8.6" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favorable (1.22e-4)" "prognostic favorable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favorable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.2 0.0 0.0 0.2 0.0 0.0 57.8 0.0 0.0 2021.0 0.1 12.7 1.3 118.8 1372.0 4.2 238.4 13.4 0.2 0.1 0.4 1.9 0.1 2.4 0.0 3.5 1.4 0.7 17.2 1.1 5.1 0.1 0.8 6.8 16.3 0.0 29.6 15.6 0.0 8.6 1.0 2.2 0.5 0.0 45.9 0.0 1.1 2.7 5.8 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.1 0.0 0.7 0.1 0.0 1.6 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 3.5 1.4 0.8 0.5 1.1 0.2 0.6 0.0 4.8 0.0 0.4 0.1 3.8 4.8 0.0 0.0 123.6 71.0 0.0 48.6 10.1 16.5 0.0 0.2 1.6 9.7 3.9 6.6 0.0 2506.4 397.7 7.6 37.1 0.0 0.0 5.3 0.0 3.8 26.5 2597.0 0.0 0.3 0.0 0.1 4.9 0.0 0.0 59.9 10.2 0.3 0.0 0.0 0.0 14.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 10.8 0.0 0.0 27.0 0.7 0.1 109.3 0.0 0.0 0.0 8.5 0.0 0.0 1.7 0.4 0.0 13.7 0.1 7.0 16.6 SCGB3A1 "HIN-1, HIN1, LU105, PnSP-2, UGRP2" ENSG00000161055 "Secretoglobin family 3A member 1" Q96QR1 5 180590105-180591499 "Plasma proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 270.0;lung: 508.1;salivary gland: 746.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 2883.9;Breast myoepithelial cells: 4199.8;Club cells: 13674.8;Respiratory ciliated cells: 3325.6;Urothelial cells: 3139.7" "Group enriched" "Detected in many" 7 "endometrial cancer: 114.2;lung cancer: 288.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 51.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 2.3;T-47d: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 10000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (7.70e-3)" "unprognostic (4.90e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-2)" "unprognostic (3.03e-1)" "unprognostic (1.36e-2)" "unprognostic (7.87e-3)" "unprognostic (2.00e-2)" "unprognostic (3.20e-1)" "unprognostic (4.88e-2)" "unprognostic (3.55e-2)" "unprognostic (7.19e-2)" "unprognostic (8.74e-3)" "unprognostic (5.43e-2)" "unprognostic (4.62e-1)" "unprognostic (4.50e-1)" "unprognostic (1.50e-2)" 1.8 1.5 1.1 0.2 1.2 0.5 122.4 0.7 1.2 270.0 11.7 0.5 0.6 1.5 1.2 74.8 29.9 2.9 0.7 1.1 5.9 1.5 7.0 508.1 0.4 1.4 1.6 2.0 18.2 0.0 12.6 0.1 1.0 37.9 0.0 0.0 746.5 2.4 0.3 4.9 1.0 0.0 1.2 9.4 50.7 3.0 3.0 0.8 3.1 0.0 0.8 14.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 20.3 2.4 17.2 13.3 1.8 3.3 4.5 10.1 0.0 5.9 5.0 0.0 0.0 51.8 0.2 4.3 2.6 1.1 1.2 0.7 1.2 1.1 5.9 1.4 1.6 1.0 1.2 3.0 1.5 36.4 173.1 1441.5 0.0 5.9 0.5 51.2 2883.9 0.6 0.0 1831.7 4199.8 0.4 1554.2 13674.8 0.0 0.0 0.0 30.4 0.1 0.0 20.5 0.1 1.6 0.1 40.5 0.0 10.7 0.2 1.6 0.3 15.2 3.6 1.7 35.3 1.0 68.9 1.1 0.4 0.0 0.0 0.1 1566.5 1.2 0.6 0.2 0.6 14.8 5.4 0.0 0.6 0.0 0.0 0.0 0.1 146.1 0.5 0.0 0.0 214.9 0.0 0.0 3325.6 0.0 0.0 1.6 305.2 0.3 4.4 140.8 0.4 0.0 20.2 0.1 0.2 3139.7 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 410.9" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 515.9;Pancreatic endocrine cells: 476.4;Suprabasal keratinocytes: 472.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 512.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 320000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 15: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 68.0 73.1 90.3 26.3 116.8 10.1 113.1 90.2 120.7 53.0 68.5 102.6 37.8 53.0 11.8 124.3 76.6 72.2 65.9 66.4 90.2 166.9 410.9 168.3 9.8 120.5 127.8 26.3 90.3 34.7 43.2 27.3 95.4 53.0 62.6 35.1 103.7 45.9 101.5 190.4 42.4 53.8 89.9 32.3 140.1 47.1 151.9 8.2 51.1 35.4 35.2 124.7 68.7 71.4 162.1 20.7 11.1 0.8 269.2 164.3 474.4 201.5 273.0 222.9 158.6 242.7 400.0 0.2 88.1 255.4 224.5 203.1 8.2 512.2 269.0 46.7 7.4 4.9 15.8 95.8 292.4 1.0 8.2 223.1 336.5 92.4 223.2 123.3 29.9 3.7 8.2 0.5 130.5 159.9 0.2 14.2 20.4 139.9 63.1 0.3 99.7 0.6 367.7 211.7 4.3 15.6 277.2 169.4 51.4 125.2 123.1 9.7 56.4 169.4 141.4 17.3 131.8 8.5 6.7 0.7 266.2 16.4 103.2 1.5 1.6 0.4 0.7 0.6 2.1 0.3 2.0 0.8 1.5 0.3 0.4 0.5 0.8 0.7 0.6 1.4 4.4 0.7 90.3 116.8 90.2 120.7 66.4 90.2 120.5 127.8 95.4 89.9 151.9 71.4 21.9 291.7 391.2 106.7 3.8 373.7 322.2 352.8 75.1 14.5 208.8 90.6 59.3 245.9 218.4 189.4 12.5 38.9 7.8 174.3 64.6 296.0 1.2 116.6 20.8 16.0 55.1 7.4 0.2 515.9 230.0 43.0 170.7 179.0 13.9 10.8 11.4 260.6 18.8 0.0 0.3 131.9 160.7 19.3 106.0 3.8 4.1 39.5 76.5 5.6 33.0 10.0 0.0 3.5 1.8 476.4 121.7 5.3 2.1 284.2 59.0 153.8 178.6 23.6 0.0 34.9 33.5 1.8 2.5 170.9 472.8 67.5 16.8 3.2 90.7 423.9 SDR42E2 ENSG00000183921 "Short chain dehydrogenase/reductase family 42E, member 2" A6NKP2 16 22165583-22191754 "Metabolic proteins, Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.2;choroid plexus: 1.8;fallopian tube: 2.1;pituitary gland: 1.2;testis: 2.1" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 38.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 4.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.9" "Cell line enriched" "Detected in single" 6 "RPMI-8226: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 45: Enterocytes - Digestion" "unprognostic (8.03e-3)" "unprognostic (2.80e-1)" "unprognostic (2.06e-1)" "unprognostic (1.72e-4)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (8.77e-2)" "unprognostic (3.72e-1)" "unprognostic (4.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.32e-3)" "unprognostic (2.01e-1)" "unprognostic (7.09e-2)" "unprognostic (4.76e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (6.61e-2)" 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.4 1.2 0.4 1.8 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.6 0.2 0.0 0.0 0.4 0.0 1.5 3.2 0.1 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.2 0.2 0.3 0.5 0.3 0.3 0.1 0.8 0.5 0.3 4.9 0.4 0.1 0.3 0.3 0.2 0.6 0.7 0.4 1.2 0.6 0.2 1.5 3.2 1.0 1.2 0.4 0.8 8.9 0.0 2.4 2.6 8.7 0.8 0.7 0.9 0.6 7.7 5.2 11.6 1.9 10.0 0.4 0.0 0.0 0.9 7.4 15.6 0.0 0.9 1.8 3.9 8.4 2.6 2.4 5.7 2.0 0.5 0.3 2.6 12.8 3.2 2.5 1.7 5.0 3.4 2.3 5.0 0.7 15.1 4.1 13.1 3.8 1.4 5.9 5.1 1.8 0.0 6.4 14.7 10.3 0.5 0.4 0.3 3.2 1.5 5.9 1.1 38.2 0.6 3.5 3.7 0.0 0.9 3.0 0.6 0.6 1.4 1.7 1.4 11.1 2.6 8.8 0.3 SEC14L3 TAP2 ENSG00000100012 "SEC14 like lipid binding 3" Q9UDX4 22 30447959-30472017 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.8;liver: 2.9;retina: 9.0" "Group enriched" "Detected in some" 8 "Muller glia cells: 27.6;Respiratory ciliated cells: 22.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059450 Uncertain NA NA "Cluster 77: Retina - Visual perception" "Cluster 5: Muller glia cells - Visual perception" "HPA059450: AB_2684024" "unprognostic (2.42e-1)" "unprognostic (2.56e-1)" "unprognostic (1.42e-1)" "unprognostic (5.35e-2)" "unprognostic (2.00e-4)" "unprognostic (3.62e-3)" "unprognostic (6.68e-2)" "unprognostic (3.19e-1)" "unprognostic (2.41e-10)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (4.10e-1)" 0.0 0.1 0.2 0.1 0.1 3.8 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 2.9 1.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.4 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690665-169711702 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 150.4;lymphoid tissue: 231.4" "Group enriched" "Detected in many" 5 "B-cells: 221.4;dendritic cells: 206.0;Kupffer cells: 68.9;Macrophages: 86.3;monocytes: 208.7;NK-cells: 110.2;T-cells: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 11.2;JURKAT: 29.4;MOLT-4: 21.2;U-266/70: 38.8;U-698: 19.4;U-937: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 4700000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 29.3 2.3 2.8 118.8 4.5 150.4 2.6 8.4 6.2 3.7 2.7 6.8 3.2 2.6 1.7 5.5 4.7 24.1 3.1 3.2 4.0 3.0 12.1 19.4 231.4 7.4 4.5 1.0 3.7 28.0 13.9 11.2 6.1 3.7 7.1 1.0 3.8 1.9 3.4 0.6 17.0 14.5 6.4 166.8 5.6 1.1 3.9 132.2 2.8 13.6 202.0 37.9 1.4 8.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.2 0.7 0.0 0.3 11.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 7.7 1.3 0.5 0.0 0.0 0.0 0.0 1.8 29.4 0.1 1.4 0.0 1.8 21.2 0.3 0.1 0.4 0.3 7.8 0.2 0.7 6.1 0.3 0.0 0.0 0.0 1.4 0.0 0.8 0.0 0.0 0.0 0.6 0.2 0.0 0.0 38.8 0.0 19.4 2.0 11.1 0.3 3688.4 992.6 1696.7 284.3 211.6 78.1 613.0 528.9 294.2 756.3 734.4 1169.2 683.6 4201.4 2551.1 93.1 622.9 1011.2 2052.5 2.8 4.5 8.4 6.2 3.2 4.0 7.4 4.5 6.1 6.4 3.9 8.0 1.8 9.6 13.7 0.7 221.4 0.4 0.3 0.0 0.6 0.1 0.5 0.3 0.6 2.8 1.8 11.0 0.0 13.9 206.0 0.1 0.0 0.2 0.0 0.1 0.0 3.4 0.0 25.2 0.2 0.0 0.6 3.3 2.6 0.1 10.1 0.5 3.9 1.1 5.6 0.0 0.1 0.1 0.0 68.9 2.7 0.2 0.6 86.3 1.8 1.0 208.7 2.5 110.2 0.0 0.8 0.1 0.0 0.0 25.8 0.0 0.0 0.9 1.5 0.0 0.0 0.2 0.6 0.0 0.1 0.3 0.1 28.5 104.9 0.5 0.0 0.6 SEMA3E "coll-5, KIAA0331, M-SemaK, SEMAH" ENSG00000170381 "Semaphorin 3E" O15041 7 83363238-83649139 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 176.3;Alveolar cells type 2: 110.2;Bipolar cells: 75.7;Excitatory neurons: 84.9;Oligodendrocyte precursor cells: 250.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.9;SK-BR-3: 19.9;U-2 OS: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029419, HPA063804" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA029419: AB_10602090, HPA063804: AB_2685127" "unprognostic (4.42e-2)" "unprognostic (1.48e-2)" "unprognostic (7.82e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (4.27e-2)" "unprognostic (9.36e-2)" "unprognostic (4.09e-2)" "unprognostic (3.25e-1)" "unprognostic (1.42e-1)" "unprognostic (9.09e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-6)" "unprognostic (1.32e-2)" "unprognostic (1.14e-1)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" 1.2 0.1 3.1 0.2 2.8 0.0 2.8 0.6 2.3 1.8 0.1 2.1 0.6 1.9 0.3 1.2 0.6 2.3 0.1 5.0 5.3 0.1 0.1 2.2 0.0 1.6 4.3 0.1 0.4 0.0 0.2 0.2 1.3 4.3 1.7 3.9 2.2 3.3 0.2 0.5 1.2 1.1 3.2 0.0 1.3 0.0 4.3 1.7 0.6 1.0 0.1 3.2 0.7 3.7 0.2 1.1 0.2 0.0 0.5 3.1 0.0 0.0 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.5 0.0 3.4 0.0 1.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 0.0 0.0 0.5 0.4 1.1 0.0 2.0 0.0 0.0 0.8 0.1 0.0 0.0 19.9 0.0 3.2 1.6 0.0 0.0 0.7 6.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.8 0.6 2.3 5.0 5.3 1.6 4.3 1.3 3.2 4.3 3.7 10.5 176.3 110.2 2.9 0.2 1.1 1.3 1.6 0.0 75.7 19.0 7.5 1.7 18.6 43.2 1.8 0.0 0.8 0.2 0.1 0.0 3.9 1.1 3.8 1.2 10.7 0.0 0.0 84.9 1.1 0.4 21.3 3.1 9.3 24.0 0.2 0.0 0.3 0.1 0.0 12.3 0.0 4.1 1.0 2.1 0.0 0.9 3.6 1.8 1.0 1.0 29.6 0.0 250.3 6.0 6.2 0.0 0.0 0.3 2.6 0.1 0.5 35.7 3.6 0.0 0.8 1.0 0.3 0.6 0.3 0.4 0.3 2.8 0.0 0.0 2.5 SERPINA6 CBG ENSG00000170099 "Serpin family A member 6" P08185 14 94304248-94323389 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 776.6" "Group enriched" "Detected in some" 4 "Cholangiocytes: 204.5;Hepatocytes: 390.8" "Cancer enriched" "Detected in many" 9 "liver cancer: 244.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "T-47d: 961.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA017864 Approved "Secreted to blood" NA NA 60800000000 37000000000 "Cluster 62: Liver - Hemostasis" "Cluster 6: T47d - Mammary gland" "Cluster 15: Hepatocytes - Hemostasis" "HPA017864: AB_1856721" "unprognostic (2.82e-2)" "unprognostic (1.67e-1)" "unprognostic (1.02e-3)" "prognostic favorable (6.96e-5)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (4.43e-2)" "unprognostic (3.11e-1)" "unprognostic (4.80e-3)" "unprognostic (2.94e-1)" "unprognostic (2.47e-2)" "unprognostic (4.54e-2)" "unprognostic (1.43e-1)" "unprognostic (2.14e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 1.9 0.0 3.5 0.1 0.5 0.0 0.0 12.6 35.1 0.0 0.0 0.0 43.5 776.6 0.1 0.0 0.0 0.0 0.3 17.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 114.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.4 0.4 4.5 0.1 0.4 0.0 0.1 0.7 0.0 0.0 961.9 0.0 0.0 0.5 0.0 0.6 0.0 0.3 0.0 0.5 1.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.1 0.1 0.7 0.0 0.0 4.4 0.0 0.4 204.5 0.3 0.0 0.0 0.3 0.0 0.4 1.9 33.1 0.0 62.6 0.3 0.4 9.0 16.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.2 9.7 390.8 0.0 0.0 0.0 0.8 2.0 8.7 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.0 1.2 0.0 0.0 0.0 0.1 43.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.8 0.1 SERPINB10 "bomapin, PI10" ENSG00000242550 "Serpin family B member 10" P48595 18 63897174-63936111 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "bone marrow: 74.7" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.3;eosinophil: 1.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "U-937: 104.1" "Not detected" "Not detected" "HPA015480, HPA059582" Uncertain Supported Nucleoplasm,Cytosol NA NA 59000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Cytosol "HPA015480: AB_1855456, HPA059582: AB_2684072" "unprognostic (4.66e-1)" "unprognostic (5.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (9.56e-2)" "unprognostic (2.56e-1)" "unprognostic (4.59e-1)" "unprognostic (1.10e-1)" "unprognostic (3.64e-1)" "unprognostic (1.25e-4)" 0.3 0.1 0.1 0.1 0.2 74.7 0.0 0.5 0.4 0.3 0.1 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.1 1.2 0.1 0.1 0.1 0.7 0.1 0.0 0.3 0.9 0.0 0.0 0.6 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 14.5 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.7 0.1 1.5 0.1 0.0 0.0 0.1 0.1 104.1 0.1 0.1 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.5 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.0 4.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.2 SERPINB11 EPIPIN ENSG00000206072 "Serpin family B member 11" Q96P15 18 63647579-63726432 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 27.4;prostate: 32.5" "Cell type enhanced" "Detected in some" "Club cells: 6.8;Prostatic glandular cells: 3.3;Respiratory ciliated cells: 4.4;Squamous epithelial cells: 13.7;Urothelial cells: 21.9" "Cancer enriched" "Detected in some" 5 "prostate cancer: 6.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "unprognostic (5.04e-3)" "unprognostic (4.76e-2)" "unprognostic (4.05e-2)" "unprognostic (3.44e-1)" "unprognostic (2.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 32.5 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 9.0 2.9 6.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.2 0.0 0.0 21.9 SERPINB3 "HsT1196, SCC, SCCA1, T4-A" ENSG00000057149 "Serpin family B member 3" P29508 18 63655197-63661893 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "cervix: 418.5;esophagus: 809.7;vagina: 669.6" "Group enriched" "Detected in some" 6 "Basal respiratory cells: 6903.4;Club cells: 6726.1" "Group enriched" "Detected in many" 4 "cervical cancer: 186.5;head and neck cancer: 69.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.9;HaCaT: 6.5;HBEC3-KT: 1.6;SiHa: 4.1;U-2197: 8.2" "CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992" Enhanced Approved "Plasma membrane,Cytosol" NA NA 9100000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 18: U-2197 - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "Plasma membrane" "CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998" "unprognostic (2.95e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (2.91e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (4.19e-3)" 0.1 0.1 0.0 0.3 0.0 0.0 1.1 0.0 0.0 418.5 0.0 0.1 0.0 3.2 0.0 809.7 0.2 0.2 0.4 0.0 0.0 0.1 0.2 3.1 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 7.6 0.0 0.0 100.0 0.0 0.1 42.9 0.1 0.0 0.0 0.1 0.5 1.9 0.0 4.8 0.1 0.0 19.6 73.8 669.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.1 6.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 35.2 6903.4 2.2 0.0 0.0 0.0 0.0 0.0 6726.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 31.4 0.1 0.2 0.5 0.0 0.0 0.0 8.9 0.0 3.0 0.0 0.9 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 986.7 0.0 0.0 55.4 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.4 0.0 60.2 0.0 0.2 447.6 0.0 0.0 0.0 178.1 1.0 0.3 413.5 0.0 0.3 0.8 0.0 0.0 265.9 SERPINF1 "EPC-1, PEDF, PIG35" ENSG00000132386 "Serpin family F member 1" P36955 17 1762029-1777565 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 1875.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 697.8;Cytotrophoblasts: 795.6;Fibroblasts: 951.9;Hepatocytes: 765.0;Leydig cells: 1818.0;Peritubular cells: 1045.7" "Cancer enhanced" "Detected in all" "liver cancer: 245.2" "Region enhanced" "Detected in many" "hippocampal formation: 85.4" "Immune cell enriched" "Detected in many" 18 "plasmacytoid DC: 1454.4" "Lineage enriched" "Detected in all" 121 "dendritic cells: 1454.4" "Group enriched" "Detected in many" 4 "ASC diff: 1232.0;ASC TERT1: 956.3;Hep G2: 606.0;HHSteC: 410.6;HSkMC: 1313.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005825 Uncertain "Secreted to blood" NA NA 9290000000 44000000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA005825: AB_1079921" "unprognostic (3.85e-1)" "prognostic favorable (5.49e-4)" "unprognostic (9.44e-2)" "unprognostic (2.32e-2)" "unprognostic (2.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.32e-3)" "unprognostic (2.33e-1)" "unprognostic (7.88e-2)" "unprognostic (5.92e-2)" "unprognostic (1.69e-1)" "unprognostic (4.18e-2)" "prognostic unfavorable (1.40e-8)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (4.53e-3)" "unprognostic (1.25e-3)" 535.5 57.5 5.7 124.2 9.6 11.9 490.2 17.9 28.0 558.7 1875.2 131.3 41.9 358.2 90.2 109.3 557.4 559.7 376.5 85.4 1.1 35.1 974.8 158.9 133.5 0.1 5.1 408.3 207.6 11.2 62.4 311.6 1.3 202.8 52.0 61.4 124.6 105.8 434.8 162.9 131.7 221.7 2.8 133.2 124.7 277.7 25.4 106.2 193.1 465.5 117.7 323.4 273.5 7.0 0.5 3.7 2.8 2.0 1232.0 956.3 20.4 56.8 49.8 0.6 0.0 9.7 0.5 2.3 1.9 71.8 0.3 3.2 86.0 4.4 0.0 0.6 46.0 1.0 1.2 606.0 410.6 1.1 1.1 1313.4 6.9 0.9 1.1 11.4 0.6 4.2 117.5 0.4 63.2 0.2 7.0 7.2 30.7 0.3 1.0 2.9 219.9 1.6 0.1 6.0 1.9 42.2 0.7 0.7 57.0 3.4 6.7 184.2 2.0 0.5 17.6 14.1 1.2 0.7 2.4 28.1 1.7 0.6 0.8 0.1 12.0 1.1 0.6 4.4 0.4 9.0 0.7 0.9 79.8 5.2 2.0 5.5 1.7 1.3 0.2 1454.4 0.8 14.2 5.7 9.6 17.9 28.0 85.4 1.1 0.1 5.1 1.3 2.8 25.4 7.0 59.0 3.2 10.4 0.3 10.8 95.0 238.0 697.8 27.9 59.3 6.7 71.2 12.1 11.5 167.7 1.8 223.1 795.6 226.1 0.0 0.0 0.3 11.2 12.5 372.4 26.2 0.0 19.2 5.3 24.5 98.7 951.9 11.2 6.7 22.9 1.7 28.2 765.0 151.6 3.3 2.6 0.0 366.2 60.4 262.6 53.0 1818.0 79.0 108.5 9.4 79.0 11.6 1.0 0.5 2.0 6.8 0.1 1045.7 7.0 155.5 0.2 27.3 105.5 39.1 19.7 193.3 202.8 12.7 8.7 4.5 78.6 534.8 14.3 10.2 0.3 47.7 SERPINI2 "MEPI, PANCPIN, PI14, TSA2004" ENSG00000114204 "Serpin family I member 2" O75830 3 167441789-167479004 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "pancreas: 1370.0" "Cell type enhanced" "Detected in some" "Astrocytes: 37.5;Exocrine glandular cells: 93.4;Respiratory ciliated cells: 22.9" "Cancer enriched" "Detected in some" 6 "pancreatic cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "THP-1: 9.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 8.7" "Secreted to digestive system" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 25: Pancreas - Digestion" "Cluster 43: THP-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.88e-2)" "unprognostic (2.23e-3)" "unprognostic (1.14e-1)" "unprognostic (5.27e-2)" "unprognostic (1.17e-2)" "unprognostic (1.29e-2)" "unprognostic (1.11e-2)" "unprognostic (2.04e-1)" "unprognostic (3.13e-1)" "unprognostic (1.76e-5)" "unprognostic (5.35e-2)" "unprognostic (4.16e-2)" 0.1 0.1 3.7 0.0 2.9 0.4 0.1 4.4 1.5 0.2 10.2 0.1 1.0 0.2 0.2 0.2 3.9 0.0 0.5 2.5 3.7 0.2 0.0 1.0 0.1 9.6 7.7 0.5 1370.0 0.0 0.4 0.0 7.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 1.9 0.1 9.4 0.2 0.3 0.1 4.3 0.0 0.0 0.2 0.1 0.1 0.1 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.7 2.9 4.4 1.5 2.5 3.7 9.6 7.7 7.1 9.4 4.3 5.8 0.0 0.0 1.1 37.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 5.9 0.1 0.1 0.0 0.0 3.6 93.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 1.2 0.0 0.0 2.0 0.9 4.8 0.0 0.0 0.0 0.0 0.7 0.0 22.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 SERTM1 C13orf36 ENSG00000180440 "Serine rich and transmembrane domain containing 1" A2A2V5 13 36674020-36697839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;endometrium 1: 23.9;fallopian tube: 35.3" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 9.6;Bipolar cells: 17.9;Endometrial ciliated cells: 5.7;Excitatory neurons: 10.8;Granulosa cells: 14.2;Inhibitory neurons: 17.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.7" "Region enhanced" "Detected in many" "hippocampal formation: 18.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 1.2;HEK 293: 1.4;NTERA-2: 3.6;SH-SY5Y: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054814, HPA070485" Enhanced Vesicles NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA054814: AB_2682611, HPA070485: AB_2686272" "unprognostic (8.71e-2)" "unprognostic (2.11e-1)" "unprognostic (5.58e-3)" "unprognostic (4.66e-3)" "unprognostic (4.05e-3)" "unprognostic (5.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.63e-2)" "unprognostic (1.00e-8)" "unprognostic (2.51e-2)" "unprognostic (5.60e-2)" "unprognostic (4.44e-2)" 6.2 1.3 7.3 0.0 6.0 0.0 0.6 0.1 8.1 12.3 0.0 0.2 0.1 23.9 0.7 0.0 35.3 0.0 0.4 18.9 0.0 0.1 0.0 5.4 0.0 0.0 1.7 6.4 0.3 1.3 11.5 0.0 3.6 0.9 0.0 3.3 0.0 0.6 0.0 0.2 0.0 17.1 0.3 0.0 0.4 0.3 0.4 0.0 9.2 0.0 0.0 0.3 6.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 6.0 0.1 8.1 18.9 0.0 0.0 1.7 3.6 0.3 0.4 1.2 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.1 0.0 0.0 0.0 10.8 0.0 0.0 1.3 0.0 0.6 0.0 14.2 0.0 0.0 0.0 1.7 17.9 0.0 0.0 0.0 0.4 0.0 0.3 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186206 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes "Cluster 37: B-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.3 0.1 0.3 3.3 0.7 8.7 0.5 0.9 0.5 0.4 0.0 2.1 2.3 0.4 0.0 1.9 0.1 0.4 0.1 0.3 0.4 0.3 0.6 0.3 6.2 0.8 0.6 0.2 0.1 0.2 0.0 1.7 0.6 0.2 2.8 0.1 0.4 0.1 0.1 1.1 2.5 1.0 0.3 1.4 1.5 6.7 0.6 13.0 0.2 0.0 6.6 0.9 0.7 1.2 20.3 23.9 29.9 18.5 1.4 2.6 20.2 21.3 10.1 31.2 33.6 16.5 24.0 30.7 10.6 8.6 21.2 11.4 28.7 11.3 37.6 40.9 19.6 34.6 15.6 12.8 0.2 32.0 28.8 0.3 0.9 33.3 13.1 4.0 18.5 34.9 31.3 52.2 24.6 19.4 52.4 15.4 30.0 20.3 17.0 31.8 38.4 17.7 7.5 14.9 14.2 15.4 23.6 27.2 13.1 22.7 18.2 21.3 4.7 22.5 27.3 20.5 43.3 22.8 57.4 35.2 12.5 31.1 35.0 10.0 0.1 1.4 0.2 0.2 0.1 8.8 0.6 0.7 0.3 8.9 0.2 0.3 1.4 0.3 0.2 4.1 2.6 0.6 0.3 0.7 0.9 0.5 0.3 0.4 0.8 0.6 0.6 0.3 0.6 1.2 0.1 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.4 0.0 0.0 0.0 1.8 0.0 16.5 1.5 0.0 0.0 1.1 0.0 2.3 1.6 1.2 0.0 0.0 0.0 1.8 42.6 3.3 0.0 2.9 1.3 20.3 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.9 1.0 4.3 0.0 0.0 SH2D1B EAT2 ENSG00000198574 "SH2 domain containing 1B" O14796 1 162395268-162412138 "Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.5;skeletal muscle: 12.1;tongue: 6.6" "Group enriched" "Detected in some" 7 "dendritic cells: 47.3;NK-cells: 154.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 8 "NK-cell: 376.5;non-classical monocyte: 149.2" "Group enriched" "Detected in many" 38 "monocytes: 149.2;NK-cells: 376.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.4;EFO-21: 2.7;Karpas-707: 4.4;TIME: 1.3" "Not detected" "Not detected" HPA054791 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA054791: AB_2682600" "unprognostic (7.82e-3)" "unprognostic (6.06e-3)" "unprognostic (1.41e-1)" "unprognostic (2.52e-2)" "unprognostic (1.43e-3)" "unprognostic (2.55e-3)" "unprognostic (1.89e-2)" "unprognostic (6.54e-2)" "unprognostic (5.96e-2)" "unprognostic (4.35e-1)" "unprognostic (1.12e-1)" "unprognostic (4.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.72e-1)" "unprognostic (3.80e-1)" "unprognostic (8.45e-2)" "unprognostic (1.15e-3)" 0.5 0.0 0.7 0.7 1.1 4.5 0.2 0.0 1.0 0.1 0.1 0.5 0.8 0.7 0.1 1.4 0.2 0.5 0.1 0.7 0.1 0.4 1.0 2.2 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.5 0.0 0.3 0.6 12.1 0.0 1.1 0.1 0.1 7.5 0.1 0.3 0.2 0.2 0.1 6.6 1.0 0.2 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 1.1 6.7 31.0 0.4 0.3 0.1 1.8 6.8 0.1 0.4 1.3 3.0 376.5 149.2 0.5 0.4 67.3 0.7 1.1 0.0 1.0 0.7 0.1 0.1 0.2 0.2 0.1 0.2 1.2 0.1 3.2 0.6 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 1.3 0.0 0.0 0.0 47.3 0.2 0.0 0.0 0.1 1.4 0.3 0.2 0.0 5.3 4.3 0.0 0.0 0.2 0.0 2.1 0.0 0.0 1.8 0.6 0.1 0.0 0.5 0.0 0.0 1.6 0.3 0.5 0.0 2.0 0.0 1.0 1.6 0.0 154.5 0.0 0.7 0.5 0.0 0.0 3.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 13.9 0.0 0.1 0.0 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579066-17797124 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 123.8;retina: 75.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No "Cluster 6: Brain - Smell perception" "Cluster 15: RT4 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045" "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 0.3 0.2 63.0 0.1 69.0 0.0 0.1 92.3 123.8 2.3 1.9 0.5 0.2 2.2 1.2 0.5 2.0 0.0 4.3 77.7 26.6 16.8 0.2 1.1 0.0 27.9 28.5 1.8 3.0 0.3 26.2 0.0 25.9 1.8 0.6 75.0 0.1 0.1 0.1 0.1 0.5 1.7 29.3 0.1 8.7 6.5 41.1 0.7 1.5 0.0 0.0 4.3 0.4 55.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 7.5 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 9.3 0.0 21.1 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 18.7 0.0 0.1 0.0 0.0 0.1 0.2 2.5 0.0 2.4 0.0 0.0 0.0 0.0 41.8 26.5 0.0 0.3 0.0 0.8 0.8 0.0 0.0 0.0 0.0 2.2 0.0 1.5 0.0 0.4 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.0 69.0 92.3 123.8 77.7 26.6 27.9 28.5 25.9 29.3 41.1 55.5 0.0 0.0 0.0 16.3 0.0 0.1 0.4 0.0 0.0 89.4 0.1 0.0 1.8 0.0 0.0 7.3 22.9 0.0 0.0 0.1 11.7 0.0 16.7 0.2 0.1 0.3 5.3 0.0 390.8 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 13.5 140.9 0.7 0.0 0.0 0.3 47.4 1.2 0.1 0.0 13.1 0.1 9.0 0.0 41.7 10.2 0.2 0.1 0.4 0.0 2.2 0.0 22.2 0.0 28.0 0.0 0.0 0.1 2.4 6.1 0.0 0.0 0.1 0.0 1.2 0.7 0.4 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46578591-46621379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.4;lymphoid tissue: 10.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Approved "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" Yes Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: AB_2680542" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 0.7 0.5 0.5 5.1 0.5 17.4 0.9 1.2 0.6 0.6 0.4 1.9 1.2 0.6 0.6 3.5 0.2 0.6 1.0 0.4 0.2 5.4 0.2 1.0 9.8 0.4 0.3 0.3 0.2 0.2 0.2 2.4 0.4 0.3 2.2 0.2 0.8 0.2 1.5 3.3 1.5 1.7 0.1 4.4 0.9 5.2 0.5 8.8 0.3 0.2 10.6 1.2 1.2 0.7 33.8 30.8 11.9 15.3 3.1 6.2 16.2 60.7 24.6 59.2 26.8 14.6 20.8 28.0 30.2 28.8 26.8 21.0 29.3 21.7 73.8 17.7 17.2 28.2 25.8 30.3 0.1 28.5 35.4 1.2 1.6 45.9 18.1 5.9 33.0 14.9 12.7 28.3 69.7 21.5 24.0 23.7 10.0 17.2 31.6 45.4 89.9 44.8 13.7 9.4 5.0 7.2 46.0 23.7 11.1 11.4 13.0 23.4 16.1 43.9 28.7 43.5 54.0 24.9 36.7 46.7 21.4 31.3 45.8 0.2 0.3 0.6 0.2 0.5 0.0 1.7 0.3 0.1 0.3 1.2 0.0 0.1 0.4 0.1 2.4 0.7 1.2 1.1 0.5 0.5 1.2 0.6 0.4 0.2 0.4 0.3 0.4 0.1 0.5 0.7 0.2 0.0 1.1 1.3 7.1 1.7 0.7 1.2 0.0 0.3 0.6 1.1 1.9 1.5 1.4 0.0 0.0 11.3 0.8 1.9 0.0 0.2 8.4 0.7 1.7 1.7 0.0 36.2 2.1 0.0 28.7 3.7 4.1 1.5 0.0 7.6 1.8 0.3 12.6 0.0 0.7 2.2 2.0 4.5 3.3 2.3 0.6 4.0 1.8 2.8 2.8 0.8 0.0 1.0 0.5 0.1 0.1 0.4 38.3 0.5 0.4 0.1 0.1 0.3 0.0 0.5 6.3 33.7 23.7 3.6 0.6 3.7 2.2 0.8 3.4 1.1 SHKBP1 "PP203, Sb1" ENSG00000160410 "SH3KBP1 binding protein 1" Q8TBC3 19 40576853-40591399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 127.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041887 Uncertain Approved "Cell Junctions" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Cell Junctions" "HPA041887: AB_10794639" "unprognostic (1.26e-1)" "unprognostic (7.55e-2)" "unprognostic (1.38e-1)" "unprognostic (4.52e-2)" "unprognostic (8.24e-2)" "unprognostic (9.14e-2)" "unprognostic (1.66e-3)" "unprognostic (3.53e-2)" "unprognostic (6.98e-2)" "unprognostic (6.69e-3)" "unprognostic (1.42e-1)" "unprognostic (6.87e-2)" "unprognostic (5.29e-2)" "unprognostic (6.15e-2)" "unprognostic (2.67e-1)" "unprognostic (1.65e-1)" "unprognostic (8.64e-2)" 33.7 32.1 14.6 39.4 16.5 66.8 29.1 15.3 19.4 35.3 15.4 34.9 18.4 34.4 7.7 47.0 33.3 14.4 29.6 14.8 16.1 42.3 30.0 52.3 40.9 19.7 16.6 25.2 37.6 15.8 21.8 14.3 17.2 35.1 10.4 1.3 31.7 13.5 15.8 32.6 45.5 15.8 15.6 127.1 41.2 17.2 19.4 29.5 35.0 6.8 25.0 36.5 35.6 20.0 70.9 107.1 21.1 30.2 18.0 20.0 39.7 26.8 39.9 41.1 56.2 46.9 47.5 73.9 52.1 42.3 35.0 30.2 27.3 50.8 19.4 114.6 65.1 53.9 29.4 32.1 38.8 50.6 147.9 32.4 36.2 37.4 23.3 30.0 60.8 81.7 30.7 60.2 32.0 61.6 52.1 70.5 15.3 63.5 39.2 92.9 27.4 55.7 34.0 57.0 17.4 40.2 41.4 22.3 25.1 20.2 35.5 82.7 46.4 41.2 54.0 65.1 54.1 56.4 28.4 50.6 66.2 59.5 37.4 223.9 217.9 216.7 74.2 202.2 60.1 77.5 71.4 76.5 157.3 69.0 41.1 48.2 453.9 72.3 246.4 46.4 109.8 213.1 14.6 16.5 15.3 19.4 14.8 16.1 19.7 16.6 17.2 15.6 19.4 20.0 28.8 12.8 19.9 1.3 53.1 8.5 20.5 41.7 10.2 2.1 9.5 7.2 4.3 17.2 30.8 29.5 6.2 24.5 40.8 35.2 29.4 42.5 8.6 5.4 9.3 25.0 22.8 25.0 2.1 38.6 53.1 13.5 37.2 13.3 51.5 18.2 26.7 13.2 76.5 3.3 1.8 17.9 48.8 82.0 36.3 18.4 14.6 66.8 23.2 3.7 93.3 6.3 56.7 1.5 6.4 39.0 35.9 12.4 33.9 11.5 28.1 31.7 14.2 1.8 0.0 7.0 15.2 3.5 26.8 19.3 9.8 29.6 45.0 14.4 22.0 20.7 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777242-45851753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;fallopian tube: 3.1" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.5;ovarian cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "EFO-21: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA "Cluster 21: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.0 0.2 0.7 0.1 0.9 0.1 0.0 2.3 0.8 0.9 0.0 0.0 0.0 0.3 0.3 0.0 3.1 0.0 0.0 0.6 0.7 0.6 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.3 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 2.3 0.8 0.6 0.7 0.8 3.0 0.8 0.6 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.5 0.0 0.0 1.8 2.1 0.0 0.0 0.0 1.9 0.0 0.0 28.6 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.6 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 SIGLEC5 "CD170, CD33L2, OB-BP2, SIGLEC-5" ENSG00000105501 "Sialic acid binding Ig like lectin 5" O15389 19 51611927-51645545 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 14.7;lymphoid tissue: 12.4" "Cell type enhanced" "Detected in some" "granulocytes: 8.2;Hofbauer cells: 5.6;Kupffer cells: 10.4;Macrophages: 4.4;monocytes: 3.0" "Cancer enriched" "Detected in single" 5 "urothelial cancer: 1.7" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "neutrophil: 152.5;non-classical monocyte: 49.3" "Group enriched" "Detected in many" 6 "granulocytes: 152.5;monocytes: 49.3" "Group enriched" "Detected in some" 5 "HMC-1: 59.2;U-937: 25.6" "HPA009085, CAB024900" Supported NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "CAB024900: , HPA009085: AB_1079965" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (2.02e-2)" "unprognostic (1.03e-2)" "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (3.28e-1)" "unprognostic (7.44e-2)" "unprognostic (1.01e-1)" "unprognostic (4.05e-1)" "unprognostic (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (3.55e-3)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" 1.4 0.4 0.3 6.6 0.6 14.7 0.2 0.3 1.2 0.2 0.0 0.7 0.1 0.3 0.0 0.3 0.7 0.7 0.4 0.3 0.3 0.3 1.5 3.4 3.1 0.4 0.3 0.1 0.2 0.3 0.1 0.8 0.5 0.3 0.7 0.2 0.3 0.1 0.0 0.0 2.0 0.9 0.4 12.4 0.6 0.8 0.4 0.7 0.2 0.4 2.2 1.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 15.5 22.2 0.5 0.0 24.2 0.0 2.5 0.0 0.0 15.6 2.0 0.0 0.0 152.5 0.7 49.3 5.0 0.0 8.4 0.3 0.6 0.3 1.2 0.3 0.3 0.4 0.3 0.5 0.4 0.4 0.6 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 8.2 0.0 0.0 0.0 5.6 0.0 0.2 0.0 0.0 10.4 1.2 0.5 0.3 4.4 0.0 1.0 3.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51517819-51531856 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "placenta: 106.7" "Group enriched" "Detected in some" 13 "Cytotrophoblasts: 76.0;granulocytes: 55.0;Syncytiotrophoblasts: 188.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 4.9;memory B-cell: 7.2;naive B-cell: 4.5;plasmacytoid DC: 11.0" "Group enriched" "Detected in many" 13 "B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9" "Cell line enriched" "Detected in some" 7 "HMC-1: 500.7" "HPA008945, HPA009084, HPA018198" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 3: HMC-1 - Innate immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane, Cytosol" "HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 0.6 0.1 0.2 3.0 0.3 0.5 0.7 0.4 0.3 1.6 0.1 2.2 2.2 1.5 1.0 2.5 0.3 2.5 0.4 0.2 0.0 0.1 0.1 4.3 3.8 0.1 0.1 0.1 0.3 0.1 0.0 106.7 0.2 1.0 3.1 0.4 0.5 0.7 0.5 0.5 3.3 1.3 0.0 1.7 2.6 0.3 0.2 0.7 0.0 0.6 4.2 1.8 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 15.8 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 73.1 0.0 0.0 0.0 1.2 500.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.3 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 19.1 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.2 4.9 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 1.6 4.5 0.0 0.0 0.2 0.6 0.0 11.0 0.0 0.4 0.2 0.3 0.4 0.3 0.2 0.0 0.1 0.1 0.2 0.0 0.2 0.5 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 76.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 5.2 0.7 0.0 0.0 55.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.7 0.5 0.0 0.0 0.0 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643421-60658259 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli No No "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Nucleoli "CAB058690: AB_2665581, HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavorable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favorable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 5.5 0.4 0.3 0.0 0.5 0.0 1.9 0.5 1.2 15.2 1.0 0.0 0.0 0.0 0.4 1.1 0.8 0.5 0.0 0.3 0.3 0.0 0.0 1.5 0.5 0.3 0.4 0.2 0.3 47.8 19.8 0.0 0.4 13.2 0.0 0.0 51.1 0.2 119.4 0.3 0.0 0.0 0.3 0.0 0.4 1.7 0.5 9.7 1.9 46.3 0.2 1.6 0.8 0.4 15.2 3.5 0.6 28.1 17.0 20.6 0.4 4.1 10.6 4.9 4.0 0.0 8.2 0.0 2.2 0.6 2.1 4.4 10.3 6.4 2.1 0.0 17.1 2.0 1.9 6.8 0.0 0.0 0.2 15.6 4.9 2.3 0.7 36.3 0.3 1.6 5.8 0.0 142.2 2.8 0.0 0.5 0.0 0.0 8.9 0.0 71.9 0.0 5.9 16.3 2.5 0.3 5.0 0.3 6.1 0.5 3.3 0.4 13.9 6.7 5.4 7.9 6.5 0.5 0.1 0.0 1.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 1.2 0.3 0.3 0.3 0.4 0.4 0.3 0.5 0.4 0.8 3.2 1.5 0.0 0.0 0.1 30.7 30.8 0.6 0.0 1.0 0.8 0.9 0.0 33.9 1.8 0.0 0.2 0.0 0.1 1.9 0.0 0.2 1.1 0.1 1.6 0.0 0.0 0.0 0.8 0.4 5.7 0.5 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.5 0.0 0.0 0.6 0.0 0.3 0.0 1.9 0.0 0.8 0.0 1.0 0.1 0.2 0.0 1.2 0.0 27.4 0.0 0.1 67.1 0.2 0.0 77.3 5.1 0.0 25.0 0.1 0.1 0.3 0.1 0.1 0.0 18.3 SIX3 HPE2 ENSG00000138083 "SIX homeobox 3" O95343 2 44941702-44946071 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 22.7;choroid plexus: 12.2;parathyroid gland: 9.1;pituitary gland: 27.8;retina: 25.3" "Group enriched" "Detected in some" 14 "Bipolar cells: 203.9;Horizontal cells: 185.1;Muller glia cells: 392.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 68.7;SCLC-21H: 63.1;SH-SY5Y: 25.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 38.7;hypothalamus: 19.5" HPA067988 Approved Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA067988: AB_2685939" "unprognostic (1.19e-3)" "unprognostic (1.05e-2)" "unprognostic (4.76e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-2)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (6.82e-2)" "unprognostic (1.22e-1)" "unprognostic (2.49e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-2)" 0.0 0.0 8.3 0.0 22.7 0.0 0.1 0.8 16.4 0.7 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 18.2 0.1 0.0 0.0 0.1 0.5 4.5 0.0 0.6 9.1 27.8 0.0 0.5 0.0 0.0 25.3 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 1.8 10.9 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.6 0.0 11.7 0.0 0.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 68.7 0.0 1.4 0.0 0.0 0.0 0.0 0.4 2.7 0.4 0.0 0.3 0.0 0.4 0.0 0.0 0.0 63.1 25.2 0.1 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.4 0.4 0.5 0.2 0.3 0.1 8.3 22.7 0.8 16.4 1.8 18.2 0.5 4.5 0.5 0.2 10.9 1.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 203.9 1.1 1.3 0.7 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 11.2 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.1 0.1 0.2 0.0 0.0 0.3 2.7 0.0 0.1 0.0 0.0 0.0 392.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.2 18.3 0.0 0.5 0.4 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SIX4 AREC3 ENSG00000100625 "SIX homeobox 4" Q9UIU6 14 60709539-60724351 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "choroid plexus: 6.0;parathyroid gland: 15.1;salivary gland: 6.9;skeletal muscle: 14.4;tongue: 15.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9;Endometrial ciliated cells: 36.1;Glandular and luminal cells: 37.8;Prostatic glandular cells: 23.8;Respiratory ciliated cells: 30.3;Urothelial cells: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 32.1;hTERT-RPE1: 23.3;RH-30: 30.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA031794 Uncertain Approved Nucleoplasm NA NA "Cluster 8: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA031794: AB_10602928" "unprognostic (2.23e-1)" "unprognostic (9.50e-2)" "unprognostic (2.63e-4)" "unprognostic (9.74e-2)" "unprognostic (2.69e-2)" "unprognostic (1.03e-1)" "unprognostic (5.39e-2)" "unprognostic (1.28e-2)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (4.39e-2)" "unprognostic (5.38e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.08e-1)" 0.7 0.7 1.0 0.2 0.8 0.1 1.6 2.0 2.6 2.2 6.0 0.3 0.1 0.9 0.7 0.2 2.4 0.6 0.5 1.0 1.6 0.8 0.1 0.7 0.0 2.4 1.6 1.4 1.5 15.1 2.7 0.9 2.3 2.6 0.0 0.3 6.9 0.6 14.4 0.1 0.1 0.4 1.2 0.0 1.5 0.3 1.4 1.3 1.0 15.7 0.1 1.1 0.4 1.5 32.1 2.1 1.9 7.9 7.2 8.7 14.5 7.1 10.5 2.0 3.0 1.5 10.2 0.0 4.6 3.5 2.0 11.8 8.4 5.8 4.7 2.6 6.4 0.9 3.2 2.1 2.3 3.4 0.3 4.2 2.7 1.7 9.5 23.3 1.8 0.6 6.6 0.0 10.6 7.6 0.0 0.3 5.3 0.2 13.2 2.1 30.2 0.0 3.8 17.3 5.0 0.5 4.3 6.7 1.9 2.8 9.7 0.2 6.4 6.3 14.0 4.2 6.3 2.2 0.1 0.0 2.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 2.0 2.6 1.0 1.6 2.4 1.6 2.3 1.2 1.4 1.5 0.1 3.2 0.5 0.0 0.1 0.4 13.9 6.9 6.8 0.5 11.9 9.7 3.3 0.0 8.3 1.8 20.9 5.0 0.3 0.1 0.0 0.2 0.1 36.1 2.9 0.9 1.8 0.0 2.6 1.1 4.1 3.2 0.0 37.8 1.3 0.1 0.4 0.3 0.3 0.0 3.2 0.0 2.0 0.0 0.3 0.0 0.3 0.7 1.8 0.0 0.0 1.6 0.0 4.0 0.1 2.9 0.0 1.5 1.3 23.8 0.0 0.3 30.3 0.4 0.0 9.7 2.5 0.4 1.3 2.2 0.6 3.1 0.9 0.1 0.0 17.2 SKA1 "C18orf24, MGC10200" ENSG00000154839 "Spindle and kinetochore associated complex subunit 1" Q96BD8 18 50375040-50394168 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.0;lymphoid tissue: 4.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 22.3;Extravillous trophoblasts: 9.2;Plasma cells: 10.0;Spermatocytes: 16.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "Karpas-707: 82.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045495 Approved Approved Microtubules NA Yes "Cluster 17: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Microtubules "HPA045495: AB_10960405" "unprognostic (2.18e-2)" "unprognostic (7.85e-3)" "unprognostic (7.66e-3)" "unprognostic (5.93e-3)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (9.60e-8)" "unprognostic (1.03e-3)" "unprognostic (1.16e-2)" "unprognostic (1.20e-2)" "unprognostic (1.18e-4)" "unprognostic (3.91e-3)" "unprognostic (0.00e+0)" "unprognostic (4.50e-3)" "unprognostic (4.66e-2)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" 0.4 0.5 0.9 2.2 0.8 12.0 0.3 2.5 1.1 0.4 0.8 1.6 1.7 0.6 0.2 2.5 0.2 0.3 0.2 1.0 0.5 0.1 0.3 0.4 4.9 1.0 0.9 0.2 0.4 0.1 0.0 1.6 1.2 0.3 2.1 0.4 0.3 0.1 0.6 1.5 1.4 1.1 0.3 1.3 0.8 4.3 1.3 3.6 0.3 0.2 4.8 0.5 0.7 2.4 27.1 10.8 18.6 19.0 1.2 2.1 9.9 30.7 10.6 29.9 28.5 4.7 10.6 21.1 7.6 11.0 25.8 23.6 25.6 13.0 31.4 34.6 2.6 27.0 5.5 18.3 2.3 42.2 26.8 1.5 1.3 20.7 8.2 3.2 20.0 20.0 30.8 82.6 26.4 5.7 34.6 12.1 14.2 6.5 6.4 17.3 18.3 23.5 8.5 1.6 13.7 10.9 17.2 9.9 13.6 15.3 11.4 20.2 10.1 32.8 19.0 12.8 31.8 27.5 41.6 32.4 18.2 34.9 33.3 0.9 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.2 0.3 0.2 0.1 0.6 0.6 0.2 0.2 0.4 0.2 0.9 0.8 2.5 1.1 1.0 0.5 1.0 0.9 1.2 0.3 1.3 2.4 0.2 0.0 2.2 0.0 2.8 1.0 0.2 0.4 0.0 0.4 0.7 0.6 0.4 0.0 0.8 0.0 2.1 4.4 0.7 1.6 0.0 0.1 4.5 0.5 0.7 0.4 1.2 22.3 0.2 0.0 9.2 1.4 0.5 1.1 0.0 4.9 2.2 0.1 5.3 0.0 0.1 2.7 0.0 0.8 0.9 2.2 0.3 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 1.1 0.0 10.0 0.4 0.1 0.1 0.2 0.8 0.0 0.2 1.4 16.7 13.5 3.7 0.3 1.5 1.4 0.5 3.4 1.0 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176552 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.7;lymphoid tissue: 12.1;testis: 6.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Mitotic spindle" "Centrosome, Cytosol" "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.2 0.1 0.2 2.5 0.2 4.7 0.8 0.1 0.3 0.2 0.0 1.7 1.0 0.5 0.0 1.9 0.2 0.4 0.0 0.5 0.2 0.1 0.2 0.2 4.3 0.2 0.2 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.0 0.0 0.2 0.0 0.0 1.8 2.1 1.1 0.2 0.7 1.0 6.3 0.3 12.1 0.1 0.1 3.7 0.4 0.5 0.2 26.1 13.0 25.8 20.5 0.9 5.1 19.1 35.0 14.8 42.1 28.7 23.4 27.8 35.6 10.0 19.3 18.5 24.4 34.4 15.2 54.7 30.3 15.9 47.3 7.7 12.7 0.0 39.5 17.7 1.5 1.0 34.9 15.4 4.2 20.7 30.6 26.3 14.2 33.9 21.0 60.7 37.8 27.9 42.8 23.8 36.5 50.3 15.8 12.2 9.9 30.1 11.1 11.8 17.1 8.1 17.9 15.3 33.5 8.7 16.0 23.8 17.0 43.9 9.0 19.7 34.5 4.4 31.1 51.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.2 0.2 0.1 0.3 0.5 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.4 0.0 0.0 0.0 2.6 2.0 0.7 2.4 0.0 0.1 0.9 0.8 0.8 0.0 1.8 0.0 0.0 8.7 1.0 2.1 0.0 1.2 6.3 2.8 0.9 1.4 0.0 12.8 0.8 1.3 21.0 2.1 1.5 1.6 0.0 5.8 1.8 0.4 5.5 0.0 0.6 1.8 2.0 1.9 2.9 7.7 1.5 1.6 0.0 1.9 0.8 0.3 3.1 0.0 0.2 1.0 1.6 1.2 8.5 0.3 0.4 0.6 2.0 0.4 0.0 0.3 2.3 21.7 18.2 5.8 2.8 2.2 1.2 0.5 5.0 0.7 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241093-117279430 "Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease variant, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.1;cervix: 30.0" "Cell type enriched" "Detected in many" 5 "granulocytes: 636.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 11 "hypothalamus: 20.8;midbrain: 81.1;pons: 70.5" "Immune cell enriched" "Detected in some" 15 "basophil: 59.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 59.5" "Cell line enriched" "Detected in some" 19 "HMC-1: 351.0" "Region enhanced" "Detected in many" "midbrain: 62.7" "Region enriched" "Detected in all" 4 "midbrain: 111.6" HPA073224 Enhanced Approved Vesicles,Centrosome NA NA "Cluster 38: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Vesicles, Centrosome" "HPA073224: AB_2732222" "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.1 14.6 0.1 0.9 1.1 2.4 1.8 0.1 0.3 30.0 0.2 2.3 1.5 2.6 1.6 2.5 0.5 3.6 0.7 0.2 20.8 0.9 2.8 7.4 0.6 3.8 81.1 10.4 3.4 0.2 0.2 0.1 70.5 9.2 3.5 0.4 0.8 1.3 0.8 6.3 2.1 2.3 0.0 0.3 4.4 0.9 5.0 6.1 0.0 0.5 0.9 2.9 7.9 0.2 0.2 1.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.3 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.7 18.6 0.1 0.2 0.0 1.0 351.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 0.7 0.0 0.1 1.0 0.3 0.2 0.3 0.6 0.2 0.4 0.2 0.0 0.2 3.4 0.7 0.3 0.1 0.0 0.2 0.0 0.1 0.3 0.1 2.5 0.3 0.8 0.5 0.4 0.2 0.4 1.9 0.3 59.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 3.8 0.0 2.0 0.1 1.1 0.1 0.3 0.2 20.8 3.8 81.1 70.5 0.0 5.0 0.2 0.0 9.6 16.2 1.0 0.2 1.9 0.0 0.0 0.0 2.1 0.2 0.0 0.3 0.0 2.5 0.0 4.2 0.0 5.7 0.4 0.0 0.0 0.0 13.1 16.1 0.7 8.9 4.2 1.1 0.0 0.0 3.4 4.1 112.4 636.0 2.4 9.7 0.3 0.8 0.0 1.7 0.0 0.0 1.0 3.6 0.2 0.6 3.5 1.8 0.0 0.1 0.4 0.0 0.5 0.6 0.1 0.1 4.9 1.9 3.8 0.0 0.1 0.7 0.8 0.0 0.4 1.3 0.2 2.1 0.0 2.7 0.0 5.6 9.8 0.1 0.1 SLC22A4 "DFNB60, MGC34546, OCTN1" ENSG00000197208 "Solute carrier family 22 member 4" Q9H015 5 132294394-132344190 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.7" "Group enriched" "Detected in many" 5 "Erythroid cells: 57.0;Proximal enterocytes: 25.6;Respiratory ciliated cells: 78.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "neutrophil: 36.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 36.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 59.1;U-138 MG: 24.4" "Region enhanced" "Detected in all" "cerebellum: 64.5" "Low region specificity" "Detected in all" "CAB015468, HPA036974" Approved Approved Mitochondria NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "CAB015468: , HPA036974: AB_2732474" "unprognostic (1.33e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (8.42e-3)" "unprognostic (6.17e-2)" "unprognostic (6.22e-3)" "unprognostic (4.17e-3)" "unprognostic (3.33e-1)" "unprognostic (1.30e-1)" "unprognostic (9.79e-2)" "unprognostic (1.95e-3)" "unprognostic (7.82e-2)" "unprognostic (1.74e-2)" "unprognostic (2.31e-3)" "unprognostic (1.20e-1)" "unprognostic (1.95e-2)" "unprognostic (4.06e-2)" 1.9 3.0 2.1 2.9 1.9 20.7 2.2 3.7 1.8 1.5 1.1 2.0 3.5 1.4 1.4 0.4 11.3 1.9 1.9 1.9 3.6 7.1 0.8 2.9 0.3 4.0 3.7 2.1 0.6 2.6 2.6 1.0 3.4 4.0 2.2 2.2 1.7 1.4 7.2 1.3 9.1 1.0 3.6 5.1 1.4 0.6 3.4 0.4 0.7 2.7 0.2 1.4 0.9 2.9 1.9 3.0 0.2 0.7 1.3 1.0 0.9 12.9 59.1 9.7 10.1 1.1 3.3 0.6 3.6 7.6 7.2 3.2 0.0 2.1 6.8 2.6 0.3 0.1 5.6 0.2 1.0 4.1 0.0 2.3 0.4 5.3 4.9 3.5 4.3 0.3 5.3 6.7 7.6 1.1 0.0 9.5 0.3 0.3 3.2 0.0 0.8 0.4 1.5 0.2 0.8 0.4 14.0 0.9 0.4 0.4 0.6 2.4 5.2 24.4 2.4 9.7 3.3 0.0 2.7 0.0 7.2 4.7 2.9 0.0 5.6 5.8 0.0 1.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 36.2 0.0 0.4 0.3 0.0 1.2 2.1 1.9 3.7 1.8 1.9 3.6 4.0 3.7 3.4 3.6 3.4 2.9 1.1 3.2 0.0 5.5 0.1 0.8 1.0 3.8 1.8 2.0 1.9 1.3 0.8 1.5 10.0 0.0 0.0 1.0 0.1 8.8 0.0 3.2 0.0 4.7 1.8 3.8 1.2 57.0 7.2 0.4 2.3 3.1 0.5 2.2 0.0 0.6 1.4 0.0 4.0 3.3 8.0 0.8 4.1 0.8 0.8 0.3 0.6 3.7 0.0 1.9 2.2 1.6 0.0 4.5 2.3 1.9 1.7 0.0 0.1 1.7 25.6 8.6 78.5 0.4 0.0 9.3 1.8 0.3 0.4 0.2 0.4 2.5 0.2 0.1 1.0 0.9 SLC23A1 "SLC23A2, SVCT1, YSPL3" ENSG00000170482 "Solute carrier family 23 member 1" Q9UHI7 5 139367196-139384553 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "fallopian tube: 54.2;intestine: 65.3;kidney: 40.2;liver: 22.5" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0" "Group enriched" "Detected in many" 5 "endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9" "Region enhanced" "Detected in some" "midbrain: 3.2" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047612 Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 45: Enterocytes - Digestion" "HPA047612: AB_2680102" "unprognostic (4.00e-3)" "unprognostic (2.66e-3)" "unprognostic (2.63e-2)" "unprognostic (1.75e-3)" "unprognostic (1.93e-1)" "unprognostic (6.36e-6)" "unprognostic (7.41e-2)" "unprognostic (6.55e-2)" "unprognostic (5.88e-2)" "unprognostic (3.90e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (4.16e-2)" "unprognostic (1.55e-2)" "unprognostic (3.65e-3)" 0.2 0.1 0.1 1.2 0.2 2.8 0.2 1.1 0.2 2.3 0.1 3.3 26.3 0.7 0.0 0.3 54.2 2.4 0.1 0.2 0.4 40.2 22.5 0.9 1.7 1.1 3.2 0.3 1.2 0.3 0.2 0.1 0.8 6.3 1.5 0.6 3.2 0.6 0.4 1.9 65.3 0.2 0.1 1.3 1.5 0.2 0.2 5.5 0.2 0.0 1.2 0.4 0.3 0.6 0.3 2.1 0.4 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.4 1.3 5.8 3.0 0.0 0.1 0.3 0.0 0.0 0.1 8.3 0.1 0.2 0.8 13.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 15.5 0.1 10.9 0.0 0.2 5.7 1.0 0.1 0.8 0.1 6.8 0.3 10.9 0.5 0.4 0.3 0.3 0.3 1.9 0.0 0.7 5.0 0.1 0.3 0.3 0.3 0.1 0.0 16.6 2.2 7.6 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.1 0.0 0.1 0.2 1.1 0.2 0.2 0.4 1.1 3.2 0.8 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.3 1.5 2.0 0.0 4.2 0.4 0.4 1.9 5.9 0.2 0.0 65.2 0.7 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 1.5 0.0 0.1 0.4 19.3 0.1 0.0 1.2 3.6 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.1 3.1 0.0 0.4 0.9 131.7 27.0 13.4 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.0 4.2 0.2 SLC26A9 ENSG00000174502 "Solute carrier family 26 member 9" Q7LBE3 1 205913048-205943460 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "salivary gland: 72.4;stomach 1: 33.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 50.1;Cardiomyocytes: 26.2;Gastric mucus-secreting cells: 29.0;Proximal tubular cells: 25.4" "Cancer enhanced" "Detected in many" "pancreatic cancer: 9.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.5;Hep G2: 5.1;OE19: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051485 Enhanced Approved "Cell Junctions" NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 11: Alveolar cells - Smell perception" "Cell Junctions" "HPA051485: AB_2681503" "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-1)" "unprognostic (1.83e-2)" "prognostic favorable (8.55e-5)" "unprognostic (1.26e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (8.85e-2)" "unprognostic (3.41e-1)" "unprognostic (2.43e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (7.45e-3)" "unprognostic (2.01e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 1.3 0.2 0.0 0.0 0.1 0.0 7.7 0.0 0.3 0.3 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 72.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 33.9 0.0 0.1 0.0 0.4 0.3 5.3 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.1 0.1 0.0 3.2 50.1 1.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 26.2 0.0 2.7 1.8 0.0 0.0 0.0 0.0 1.9 4.3 0.5 0.2 0.0 0.3 0.0 0.0 0.1 2.2 0.0 1.7 29.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.0 0.4 0.0 25.4 2.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 1.5 0.0 0.4 SLC27A2 "ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS" ENSG00000140284 "Solute carrier family 27 member 2" O14975 15 50182196-50236385 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 157.7;liver: 288.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2" "Cancer enhanced" "Detected in many" "liver cancer: 49.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 30 "basophil: 63.5" "Lineage enriched" "Detected in many" 30 "granulocytes: 63.5" "Cell line enhanced" "Detected in many" "A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA026089 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA026089: AB_1857060" "unprognostic (3.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (2.10e-2)" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-3)" "unprognostic (3.33e-1)" "unprognostic (1.89e-1)" "unprognostic (6.38e-3)" "unprognostic (4.83e-2)" "unprognostic (1.82e-1)" "prognostic favorable (7.48e-6)" "unprognostic (5.01e-3)" "unprognostic (4.08e-1)" "unprognostic (1.22e-2)" "prognostic favorable (6.40e-4)" 4.8 16.0 1.7 2.9 2.0 6.5 13.3 1.7 3.2 1.6 9.2 18.2 11.1 0.3 65.9 2.6 10.9 2.3 0.0 2.7 2.4 157.7 288.0 1.7 1.5 0.8 1.1 0.1 7.2 4.1 12.4 17.3 0.8 5.4 16.2 3.4 0.9 1.0 0.0 1.2 21.3 0.8 0.8 0.4 1.8 0.9 2.5 0.5 4.6 0.0 1.7 3.6 1.2 0.7 0.0 50.0 0.0 0.0 0.0 0.0 0.1 0.9 0.4 0.9 1.3 26.2 6.9 0.0 0.6 1.2 0.6 89.3 22.8 0.7 2.3 36.0 27.9 37.5 43.0 23.6 0.5 66.3 25.8 0.0 2.1 0.2 0.1 0.0 0.0 16.9 11.6 0.0 0.0 8.3 1.8 44.5 1.7 101.8 1.8 0.0 0.0 1.8 4.7 45.7 40.4 2.6 8.7 1.1 0.0 1.1 4.7 22.8 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 21.2 0.0 63.5 0.0 0.9 0.8 0.0 0.7 0.3 0.7 0.8 0.0 0.2 0.1 0.2 0.3 2.0 0.0 0.0 0.9 0.5 1.7 2.0 1.7 3.2 2.7 2.4 0.8 1.1 0.8 0.8 2.5 0.7 0.3 0.0 1.1 0.7 2.2 1.0 1.3 8.7 1.2 1.1 1.1 0.3 0.3 0.0 13.6 9.2 0.0 265.5 1.6 17.2 11.7 0.6 0.7 9.8 0.1 0.8 4.2 8.0 4.9 2.0 7.6 0.9 1.5 0.7 6.3 0.1 3.9 205.7 16.4 1.7 6.6 18.9 10.2 3.2 0.3 0.9 0.3 1.2 0.0 1.0 0.0 0.6 1.0 0.0 0.4 1.4 26.6 0.0 0.8 3.3 81.0 198.9 70.2 1.9 0.0 0.0 1.0 4.4 4.2 5.1 0.3 54.9 4.6 0.2 25.9 4.9 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9" "Cell type enhanced" "Detected in many" "Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favorable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favorable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 2.4 6.9 4.5 0.7 3.5 0.4 3.4 2.3 3.1 10.9 5.6 0.4 0.1 0.5 2.6 16.5 1.7 1.1 0.8 2.9 1.4 51.3 0.2 2.0 1.4 2.0 2.3 0.2 0.5 0.6 4.3 0.2 2.6 5.4 0.3 0.4 54.0 7.0 5.2 12.8 0.6 0.3 0.8 0.7 2.5 5.9 4.3 1.0 60.9 0.1 1.8 3.4 5.8 1.9 11.0 15.5 1.8 7.9 5.1 1.3 21.1 5.4 3.4 2.8 1.6 1.1 14.1 0.0 6.1 1.9 6.6 70.6 8.3 16.8 0.5 0.1 3.2 0.7 7.5 43.0 3.2 4.0 13.6 0.7 6.8 3.4 3.2 2.3 7.0 9.8 1.6 9.7 2.9 7.2 0.5 0.4 12.1 13.6 20.7 2.6 10.3 3.5 16.9 30.7 0.9 4.9 2.7 17.5 0.3 5.4 6.7 7.0 12.1 2.1 7.0 0.5 2.7 0.4 0.6 0.1 0.1 2.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 4.5 3.5 2.3 3.1 2.9 1.4 2.0 2.3 2.6 0.8 4.3 1.9 0.8 0.0 0.0 1.6 0.0 0.8 2.2 16.3 8.0 0.2 4.9 4.4 1.1 0.0 25.5 112.2 0.0 0.1 0.6 0.8 0.0 0.7 5.8 2.3 0.6 0.7 0.0 0.0 0.3 0.5 0.1 0.3 5.1 4.2 0.0 0.2 1.1 0.0 0.4 0.0 0.1 0.2 79.3 0.3 0.0 2.2 0.0 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.3 3.0 1.3 0.4 0.0 3.7 0.0 0.5 48.1 0.2 26.3 0.6 5.8 3.0 4.7 3.3 0.4 0.0 0.2 0.1 0.2 5.7 SLC52A1 "FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1" ENSG00000132517 "Solute carrier family 52 member 1" Q9NWF4 17 5032600-5052009 "Disease related genes, Metabolic proteins, Predicted membrane proteins" Transport "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "intestine: 35.8;placenta: 18.4;skin 1: 11.1" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 820.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.4;BEWO: 1.9;EFO-21: 1.8;HMC-1: 4.6;SK-BR-3: 2.6;T-47d: 1.6" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "unprognostic (8.81e-3)" "prognostic favorable (9.54e-4)" "unprognostic (9.34e-2)" "unprognostic (7.30e-4)" "unprognostic (6.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.82e-3)" "unprognostic (1.72e-1)" "unprognostic (2.36e-1)" "unprognostic (1.15e-1)" "unprognostic (7.19e-2)" "unprognostic (5.17e-5)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (4.07e-2)" "unprognostic (6.60e-2)" 0.1 0.1 0.1 0.1 0.1 0.5 0.5 0.5 0.3 0.6 0.0 1.0 35.8 0.2 0.3 1.0 0.9 0.3 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.1 0.0 0.1 0.3 0.6 0.1 18.4 0.1 1.0 0.4 0.2 0.4 0.6 0.3 11.1 23.5 0.1 0.0 0.3 0.3 0.5 0.0 0.6 0.3 0.0 0.2 1.1 0.7 0.4 0.1 2.4 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.3 0.3 0.0 0.1 0.1 1.8 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 4.6 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.5 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.4 2.6 0.0 0.0 1.6 0.7 0.3 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.7 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.7 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 1.1 1.6 2.0 0.6 0.0 0.2 0.5 0.7 0.0 0.9 0.0 0.0 185.7 0.1 4.1 0.0 0.0 0.2 1.7 0.1 0.6 1.2 0.0 0.0 0.0 15.3 1.2 0.0 0.5 0.0 0.3 2.2 0.0 15.7 0.0 0.1 6.6 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 76.4 0.1 7.7 0.0 0.0 0.2 0.1 2.0 2.1 2.3 1.7 820.1 0.3 0.1 2.6 1.5 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500460-173603072 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;choroid plexus: 1.9;testis: 6.0" "Cell type enriched" "Detected in some" 4 "Astrocytes: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.3 1.2 0.2 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 6.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.2 0.2 0.5 0.3 1.3 1.2 0.8 0.8 0.4 0.6 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.0 1.3 0.0 6.2 0.1 1.3 0.1 0.0 0.1 6.2 1.7 0.1 0.4 0.0 0.0 5.0 0.0 0.5 0.3 0.0 0.1 0.0 0.5 0.4 1.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 4.7 0.0 0.7 0.0 1.5 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.1 0.1 5.4 0.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 82.0;choroid plexus: 28.6" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 487.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 5: NTERA-2 - Transcription" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "HPA071152: AB_2686350" "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.0 0.1 48.9 0.1 65.9 0.1 4.0 43.5 80.2 0.0 28.6 0.1 0.0 0.1 0.2 0.1 0.3 0.2 0.9 41.3 46.4 1.2 11.5 2.8 0.7 54.0 51.9 0.2 2.4 0.2 0.4 1.2 52.6 0.7 0.0 0.6 15.8 0.0 0.4 0.5 0.1 0.0 45.2 0.5 0.3 1.9 48.3 0.6 0.2 0.0 0.4 0.2 0.0 82.0 2.1 0.6 0.8 0.1 0.0 0.0 3.4 0.0 0.0 0.1 0.0 3.8 1.4 0.1 2.1 0.2 0.0 0.3 0.3 0.2 0.5 0.7 0.9 0.0 0.5 1.5 0.0 0.4 0.3 0.0 1.7 0.2 0.2 1.5 0.1 0.4 4.0 1.2 0.0 2.6 0.4 0.1 16.7 2.0 0.2 0.2 0.2 12.0 0.0 2.2 1.9 2.9 0.0 0.2 0.2 16.1 3.2 0.9 0.0 0.1 1.7 0.8 0.4 23.1 9.8 0.2 0.1 0.3 0.0 0.2 0.1 0.1 0.4 0.1 0.6 0.4 0.6 0.4 0.0 0.2 0.6 0.4 1.3 0.3 0.0 0.2 0.5 0.1 48.9 65.9 43.5 80.2 41.3 46.4 54.0 51.9 52.6 45.2 48.3 82.0 0.0 35.3 3.1 5.9 0.0 0.0 0.0 0.0 0.0 0.2 3.5 2.8 0.5 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.8 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 102.1 0.0 0.1 0.0 2.5 487.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.4 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 SLITRK6 FLJ22774 ENSG00000184564 "SLIT and NTRK like family member 6" Q9H5Y7 13 85792790-85806683 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 27.7;urinary bladder: 14.7" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 22.8;Bipolar cells: 41.7;Club cells: 27.4;Ionocytes: 16.2;Respiratory ciliated cells: 41.6" "Cancer enhanced" "Detected in many" "breast cancer: 21.1;urothelial cancer: 18.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 28.8;OE19: 24.2;RT4: 101.4;WM-115: 23.7" "Region enhanced" "Detected in many" "thalamus: 22.6" "Low region specificity" "Detected in many" "HPA014491, HPA014513" Uncertain Supported "Plasma membrane" NA NA 28000 "Cluster 24: Salivary gland - Salivary secretion" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" "HPA014491: AB_10601603, HPA014513: AB_2669026" "unprognostic (6.14e-2)" "unprognostic (5.21e-3)" "unprognostic (1.40e-1)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.69e-1)" "unprognostic (4.82e-2)" "unprognostic (7.60e-2)" "unprognostic (7.92e-2)" "unprognostic (3.31e-5)" "unprognostic (5.60e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (2.51e-2)" 0.1 0.2 1.0 0.9 4.4 0.0 3.2 2.2 1.9 1.2 0.1 5.5 3.5 1.0 2.5 1.9 0.5 1.4 1.5 0.2 2.0 0.1 0.9 3.3 0.0 0.6 2.3 0.0 0.2 0.0 0.1 0.9 0.9 7.6 6.8 4.8 27.7 2.2 0.0 5.6 5.7 0.4 0.3 0.1 1.5 0.3 5.7 0.2 0.3 0.1 0.1 14.7 1.4 0.4 0.0 2.9 0.1 0.5 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.9 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 28.8 0.0 3.3 2.7 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 24.2 1.9 0.2 0.0 0.0 0.0 101.4 1.0 1.2 0.5 0.1 0.1 1.7 0.5 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.4 2.2 1.9 0.2 2.0 0.6 2.3 0.9 0.3 5.7 0.4 0.1 0.0 1.8 0.0 0.0 3.8 5.0 22.8 0.0 41.7 5.3 1.5 0.4 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.2 4.3 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.0 2.7 0.0 2.2 2.2 0.0 0.2 0.0 0.4 1.7 16.2 0.0 0.6 0.0 9.6 0.1 0.0 1.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.4 0.0 1.5 0.0 0.1 41.6 2.0 0.0 0.0 0.8 0.0 0.1 3.8 2.4 0.0 0.2 0.1 0.5 4.5 SMIM31 LINC01207 ENSG00000248771 "Small integral membrane protein 31" A0A1B0GVY4 4 164754064-164803795 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 7.8;intestine: 24.6;prostate: 11.0" "Group enriched" "Detected in some" 5 "Exocrine glandular cells: 93.3;Pancreatic endocrine cells: 139.7" "Cancer enhanced" "Detected in many" "prostate cancer: 8.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted - unknown location" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 9: Intestine - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (2.47e-2)" "unprognostic (1.87e-4)" "unprognostic (2.95e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-2)" "unprognostic (4.82e-1)" "unprognostic (9.47e-2)" "unprognostic (5.63e-3)" 0.1 0.1 0.3 1.4 0.3 1.0 1.0 0.6 0.5 5.0 0.3 15.4 22.0 0.3 0.9 0.1 0.1 7.8 0.1 0.3 0.1 0.1 0.1 0.4 0.3 0.4 0.2 0.1 0.4 0.1 0.0 0.1 0.4 11.0 15.5 0.2 1.2 0.1 0.2 0.2 24.6 0.7 0.1 0.1 0.6 0.1 0.4 0.0 0.1 0.0 0.1 1.7 0.0 0.9 0.1 0.8 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.3 0.1 0.4 0.0 0.1 0.0 0.3 1.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.3 1.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.6 0.3 0.1 0.3 0.0 0.0 0.3 0.3 0.6 0.5 0.3 0.1 0.4 0.2 0.4 0.1 0.4 0.9 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 0.0 0.0 9.3 3.7 0.0 0.1 0.0 0.0 0.0 3.8 0.0 2.5 2.2 0.3 0.0 0.0 0.0 93.3 0.0 0.2 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.8 10.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 125.0;Distal tubular cells: 92.0;Endometrial ciliated cells: 69.4;Erythroid cells: 142.5;Glandular and luminal cells: 67.6;Urothelial cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 56 "plasmacytoid DC: 207.6" "Lineage enriched" "Detected in many" 56 "dendritic cells: 207.6" "Cell line enhanced" "Detected in some" "HEL: 2.3;MCF7: 10.5;OE19: 2.8;SK-BR-3: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles "Golgi apparatus" "HPA065332: AB_2685471, HPA071268: AB_2686377" "unprognostic (6.97e-2)" "prognostic favorable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favorable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 1.3 0.6 4.5 1.9 8.5 11.4 1.5 8.5 6.4 8.4 10.7 10.5 9.6 1.2 0.8 27.4 7.4 4.4 12.2 5.0 5.6 28.4 1.4 3.1 1.1 11.2 8.8 2.7 2.5 3.4 2.4 1.9 9.6 4.2 2.6 0.7 7.8 1.9 0.5 14.3 15.2 0.5 7.2 4.8 10.1 2.2 7.8 0.6 15.9 0.3 3.6 6.1 14.6 16.4 1.8 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.4 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 10.5 0.1 0.0 0.0 2.8 0.1 0.3 0.3 0.0 0.0 2.0 0.8 0.0 0.0 4.5 0.0 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.5 0.5 1.1 0.3 0.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.1 0.0 207.6 0.0 13.7 4.5 8.5 8.5 6.4 5.0 5.6 11.2 8.8 9.6 7.2 7.8 16.4 0.7 9.6 7.0 0.7 1.6 1.1 7.3 4.8 0.6 1.5 1.2 0.9 25.1 10.0 13.9 125.0 2.1 3.1 51.9 48.4 92.0 2.9 0.1 69.4 10.1 1.8 14.4 142.5 0.0 0.5 5.8 2.3 26.0 67.6 0.0 0.3 1.8 0.2 0.7 0.0 0.0 16.1 44.7 0.6 0.9 0.3 0.6 17.0 7.2 0.0 1.2 3.3 1.0 0.0 17.9 10.7 54.2 1.5 0.9 7.4 15.5 0.9 48.0 2.1 0.0 1.4 3.1 0.4 0.5 10.0 8.4 32.8 0.8 0.3 2.3 90.6 SMKR1 ENSG00000240204 "Small lysine rich protein 1" H3BMG3 7 129502531-129512918 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "testis: 123.6" "Group enriched" "Detected in many" 50 "Early spermatids: 1894.5;Late spermatids: 6100.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 19.7;SCLC-21H: 32.8" "Low region specificity" "Detected in all" HPA078358 Approved Nucleoli NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" Nucleoli "HPA078358: AB_2686883" "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (9.24e-2)" "unprognostic (4.05e-2)" "unprognostic (2.00e-1)" "unprognostic (6.30e-2)" "unprognostic (1.72e-6)" "unprognostic (1.67e-2)" "unprognostic (1.11e-2)" "unprognostic (6.40e-2)" "unprognostic (3.67e-2)" 0.3 1.1 5.2 0.4 5.9 0.1 1.9 4.2 5.8 0.5 4.1 0.1 0.4 0.3 1.4 0.4 6.6 0.2 0.1 5.4 5.5 0.8 0.1 0.3 0.9 4.5 5.0 0.2 2.3 6.4 6.1 0.2 4.7 0.4 0.2 0.7 0.2 0.3 0.1 0.4 0.4 0.1 4.5 0.5 0.4 123.6 6.4 0.3 0.7 0.1 0.8 0.1 0.2 5.2 13.4 13.0 0.4 11.1 0.0 0.0 0.1 0.0 0.4 1.1 1.1 0.1 3.4 0.0 1.1 0.7 7.2 1.6 2.3 0.1 1.6 12.6 1.3 0.0 2.5 0.0 2.3 0.2 8.2 0.1 5.5 3.3 2.3 1.4 0.4 7.9 0.7 0.3 0.6 19.7 2.5 1.2 1.5 3.4 11.2 1.3 0.0 2.9 4.7 0.0 32.8 9.0 9.6 1.1 0.8 2.1 3.0 1.7 0.1 0.0 0.3 7.3 2.8 3.2 4.5 0.2 4.5 0.5 0.9 0.0 0.0 0.0 1.3 0.0 0.6 1.0 0.2 0.7 0.0 0.8 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.1 5.2 5.9 4.2 5.8 5.4 5.5 4.5 5.0 4.7 4.5 6.4 5.2 0.1 3.2 0.0 1.0 6.4 0.1 2.2 1.1 2.2 1.4 8.9 10.9 0.3 0.0 1.4 5.5 0.0 0.0 7.7 0.1 9.8 2.3 1894.5 21.1 0.3 1.9 9.0 0.4 2.9 6.2 0.3 1.0 1.5 0.9 0.0 2.1 0.7 0.0 0.1 0.0 2.3 0.0 4.1 0.3 0.4 6100.1 37.6 2.3 1.8 0.0 0.8 1.1 40.2 0.5 0.3 3.0 0.0 27.4 2.4 5.3 0.0 1.9 12.6 0.6 0.0 1.1 0.7 78.8 29.7 1.4 0.3 0.1 5.3 0.1 0.2 1.2 SNTN "FLJ44379, S100AL" ENSG00000188817 "Sentan, cilia apical structure protein" A6NMZ2 3 63652675-63679020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "fallopian tube: 173.4" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 410.9;Respiratory ciliated cells: 726.5" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "MOLT-4: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA043322, HPA058399" Enhanced NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA043322: AB_10793945, HPA058399: AB_2683705" "unprognostic (9.70e-3)" "unprognostic (3.67e-1)" "unprognostic (4.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.34e-3)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (8.43e-3)" 0.1 0.2 0.6 0.6 0.5 0.8 0.2 3.9 1.9 3.6 0.0 0.3 0.4 2.9 0.4 0.2 173.4 0.5 0.0 0.7 0.2 0.1 0.1 13.4 0.8 1.0 1.1 0.3 0.9 0.1 0.0 0.2 1.2 0.4 0.5 1.0 0.3 0.2 0.3 1.1 0.5 0.3 0.0 0.3 0.8 0.3 0.8 0.1 17.8 0.1 0.2 0.1 0.0 1.4 0.2 0.1 0.2 0.4 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.2 1.0 0.2 0.1 0.7 0.1 0.2 0.6 0.1 0.0 0.2 0.5 0.9 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.4 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.3 1.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.0 0.6 0.5 3.9 1.9 0.7 0.2 1.0 1.1 1.2 0.0 0.8 1.4 0.0 3.2 4.2 0.3 0.0 0.0 0.1 34.0 0.0 0.0 0.3 0.1 0.3 0.0 60.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 3.6 410.9 2.3 0.3 0.0 0.0 0.1 0.4 0.0 1.4 0.0 4.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 38.7 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 726.5 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.5 0.2 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.6" "Group enriched" "Detected in some" 9 "Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "HPA035388: AB_2674601, HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.3 0.9 2.3 0.6 2.5 0.0 0.1 2.4 6.6 0.4 0.0 0.3 0.1 0.7 0.0 0.8 0.3 0.7 0.2 2.6 1.7 0.2 0.1 1.0 0.2 3.8 1.2 1.2 0.6 0.0 2.0 0.4 1.9 0.4 0.2 1.2 0.4 0.1 0.1 0.3 0.6 0.1 0.7 0.4 1.3 0.7 3.8 0.0 0.6 0.1 0.0 0.4 0.3 4.4 0.3 4.2 9.3 1.5 0.0 0.8 0.4 0.9 1.1 1.2 2.9 0.3 0.4 0.6 0.3 0.2 7.3 0.0 1.0 0.0 0.7 1.1 0.1 0.8 0.0 0.1 0.0 0.4 0.2 1.5 0.0 4.4 0.0 1.0 0.0 1.5 0.4 0.2 0.7 0.7 6.5 0.0 4.3 0.0 1.0 0.6 2.2 0.0 0.2 0.0 28.9 16.9 0.0 0.0 0.2 1.1 0.0 0.4 0.2 6.8 1.5 0.5 2.2 0.3 0.1 0.1 5.4 1.5 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 2.5 2.4 6.6 2.6 1.7 3.8 1.2 1.9 0.7 3.8 4.4 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 57.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 44.2 32.9 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 SOWAHA ANKRD43 ENSG00000198944 "Sosondowah ankyrin repeat domain family member A" Q2M3V2 5 132813302-132816786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 100.9;intestine: 39.3" "Cell type enhanced" "Detected in some" "Distal enterocytes: 39.5;Horizontal cells: 132.9;Muller glia cells: 26.8;Proximal enterocytes: 108.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 13.4;T-47d: 32.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 61.0" HPA064621 Approved NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 6: T47d - Mammary gland" "Cluster 45: Enterocytes - Digestion" "HPA064621: AB_2685302" "unprognostic (1.59e-1)" "unprognostic (5.58e-2)" "unprognostic (3.75e-3)" "unprognostic (5.34e-3)" "unprognostic (8.28e-2)" "unprognostic (3.05e-3)" "unprognostic (1.18e-1)" "unprognostic (5.99e-2)" "unprognostic (1.27e-1)" "unprognostic (2.65e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.92e-2)" "prognostic favorable (9.38e-5)" "unprognostic (4.36e-1)" "unprognostic (3.00e-1)" "unprognostic (2.53e-3)" "unprognostic (1.42e-1)" 0.4 0.8 62.6 0.6 100.9 0.0 0.5 13.2 59.2 0.3 5.3 8.3 36.4 0.0 6.1 0.1 1.4 1.6 0.1 49.7 13.3 4.8 1.8 0.1 0.0 12.9 13.0 0.2 2.4 1.2 2.6 0.1 15.3 2.6 6.7 4.3 3.2 2.8 0.0 0.2 39.3 0.0 15.0 0.0 5.6 0.5 24.3 2.0 1.1 0.0 0.1 1.1 0.1 23.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.9 1.5 0.0 0.7 0.0 0.1 0.0 2.6 0.4 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 1.0 1.7 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.7 13.4 0.5 0.1 0.0 0.0 1.6 32.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.6 100.9 13.2 59.2 49.7 13.3 12.9 13.0 15.3 15.0 24.3 23.5 0.0 0.0 0.0 1.6 0.2 0.0 0.4 0.1 0.0 0.7 1.0 0.1 0.3 14.3 0.2 5.5 0.0 0.4 0.0 39.5 0.0 0.3 0.0 0.5 0.1 0.1 11.5 0.0 4.8 1.1 0.0 0.1 2.6 0.5 0.0 0.0 0.0 2.1 0.1 132.9 0.6 19.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 26.8 0.0 5.5 15.2 0.4 21.0 0.4 0.0 2.2 108.7 5.5 0.8 3.1 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.1 0.2 0.0 19.1 0.6 SOX2 ENSG00000181449 "SRY-box transcription factor 2" P48431 3 181711925-181714436 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;esophagus: 24.5" "Group enriched" "Detected in some" 6 "Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 0.3 0.9 58.0 0.5 58.5 0.0 0.2 47.1 56.6 2.1 8.6 5.5 0.4 0.1 0.2 24.5 3.1 0.2 0.5 46.5 59.0 0.0 0.1 1.8 0.0 50.5 58.9 0.3 0.1 0.0 13.6 0.0 45.2 2.5 0.4 15.0 18.4 0.3 0.1 0.6 1.4 0.2 59.8 0.0 7.9 1.9 59.2 0.4 0.1 0.1 5.3 1.3 4.8 62.2 0.1 9.0 277.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.3 0.0 0.1 0.0 0.2 0.7 118.6 3.2 0.0 0.1 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 226.2 12.4 0.5 0.0 0.6 0.0 31.0 0.4 0.5 1.2 0.0 0.0 0.1 45.7 1.7 0.1 0.0 0.0 4.2 0.0 54.0 0.0 0.0 0.0 0.2 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 58.5 47.1 56.6 46.5 59.0 50.5 58.9 45.2 59.8 59.2 62.2 0.2 0.0 6.0 0.0 0.0 0.3 35.5 28.5 362.0 4.9 0.2 0.4 0.5 0.0 48.4 3.7 0.0 0.2 0.0 1.1 0.0 0.0 0.9 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.1 1.6 19.4 0.0 1.3 0.2 0.7 0.1 0.1 0.0 0.0 0.5 38.7 0.0 0.4 0.4 0.6 0.8 3.6 0.0 0.0 383.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 5.8 0.0 0.1 52.8 13.1 0.0 0.2 1.6 3.9 0.4 229.1 0.4 0.3 0.6 0.2 0.0 7.5 SPA17 "CT22, SP17" ENSG00000064199 "Sperm autoantigenic protein 17" Q15506 11 124673844-124697518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 231.3" "Cell type enhanced" "Detected in many" "Early spermatids: 1583.7;Endometrial ciliated cells: 371.2;Late spermatids: 2667.9;Respiratory ciliated cells: 368.6;Spermatocytes: 580.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037568 Enhanced Approved Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 6: T47d - Mammary gland" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "HPA037568: AB_10672905" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (2.39e-3)" "prognostic favorable (1.03e-4)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-4)" "unprognostic (2.64e-1)" "unprognostic (3.80e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.71e-3)" "unprognostic (6.78e-2)" "unprognostic (9.78e-3)" "unprognostic (8.52e-2)" "unprognostic (2.71e-1)" 3.2 4.2 2.6 1.1 2.8 1.6 3.8 2.4 2.6 4.4 9.0 5.4 1.4 4.4 10.5 5.0 24.5 2.3 4.5 2.8 3.1 11.6 2.1 7.7 1.0 4.6 4.9 1.6 4.3 4.7 13.5 0.9 4.1 4.3 3.2 1.0 3.5 2.1 1.2 2.6 3.0 1.6 3.8 1.8 4.0 231.3 3.3 2.6 8.9 0.2 1.4 3.2 3.0 3.3 4.1 5.4 12.6 4.3 4.2 6.4 4.7 3.8 8.4 5.4 4.4 1.4 11.5 2.8 2.2 6.7 4.3 3.4 4.9 8.0 7.3 2.6 3.6 3.6 0.8 2.4 2.3 1.0 1.6 2.6 4.8 7.9 4.1 4.2 4.5 5.7 5.5 2.2 12.4 5.5 0.5 0.2 4.7 8.3 4.3 3.8 1.5 0.1 12.8 3.1 6.6 5.8 9.1 2.7 1.8 4.6 17.1 3.1 3.2 4.8 3.8 2.8 4.5 1.4 0.9 1.1 5.0 0.9 5.1 0.5 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.6 0.1 0.0 0.2 2.6 2.8 2.4 2.6 2.8 3.1 4.6 4.9 4.1 3.8 3.3 3.3 5.9 3.2 12.6 3.6 0.9 2.7 4.7 26.9 1.8 2.6 6.2 6.5 2.1 17.2 54.2 20.2 4.2 6.7 2.3 13.0 19.6 29.2 1583.7 371.2 13.8 7.2 7.2 3.2 5.8 15.5 10.8 5.8 8.2 19.4 0.0 7.1 1.8 1.5 11.9 0.0 2.8 9.2 32.6 3.1 1.0 2667.9 28.0 6.6 1.8 1.9 2.6 8.1 0.0 1.0 0.7 12.7 10.0 18.0 1.4 2.9 6.3 47.0 368.6 1.2 13.1 6.2 10.5 580.0 63.6 4.9 2.3 2.7 2.6 8.4 10.4 5.6 SPACA9 "C9orf9, Mast" ENSG00000165698 "Sperm acrosome associated 9" Q96E40 9 132878027-132890201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 74.0;testis: 131.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Distal tubular cells: 33.2;Endometrial ciliated cells: 99.8;Proximal tubular cells: 23.9;Respiratory ciliated cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "JURKAT: 48.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022243, HPA051600" Enhanced Approved Mitochondria No No "Cluster 19: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "HPA022243: AB_1845844, HPA051600: AB_2681546" "unprognostic (2.69e-1)" "unprognostic (2.14e-3)" "unprognostic (8.00e-3)" "prognostic favorable (8.61e-4)" "unprognostic (1.59e-1)" "unprognostic (5.73e-2)" "unprognostic (3.76e-3)" "unprognostic (2.60e-1)" "unprognostic (6.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.15e-2)" "unprognostic (9.51e-2)" "prognostic favorable (8.31e-4)" "unprognostic (5.11e-2)" "unprognostic (1.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" 5.0 7.6 17.4 1.3 17.7 1.5 5.2 17.4 19.5 9.7 18.2 11.5 1.3 8.3 74.0 9.5 39.2 5.4 10.4 16.8 19.0 12.2 2.3 7.4 2.2 20.3 22.2 11.3 5.2 3.8 11.5 3.2 19.1 7.0 1.9 8.2 9.8 7.1 1.7 11.9 3.7 4.9 21.3 3.6 6.5 131.2 18.5 7.9 15.6 1.8 3.2 6.1 8.1 19.0 3.0 3.2 4.8 3.9 6.6 8.4 5.7 1.9 3.5 2.6 2.8 0.8 9.1 0.7 4.3 8.7 5.4 4.2 2.0 5.4 2.3 3.5 3.9 0.8 2.3 1.0 9.6 2.2 0.3 9.6 11.4 6.4 6.9 10.6 3.0 48.5 0.8 2.4 7.1 6.4 7.6 8.6 1.0 5.6 3.0 3.6 1.0 2.1 10.5 1.1 1.2 4.7 8.0 1.3 6.3 3.6 10.3 0.7 2.9 5.5 3.7 5.3 0.8 1.0 1.7 2.6 10.2 0.8 2.7 4.0 1.1 1.9 1.1 1.1 1.3 3.0 1.2 0.6 1.6 2.6 1.3 1.3 1.5 4.4 1.9 0.5 2.0 0.9 17.4 17.7 17.4 19.5 16.8 19.0 20.3 22.2 19.1 21.3 18.5 19.0 3.6 3.2 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.3 17.9 0.0 0.0 5.0 23.9 0.0 18.2 0.8 0.0 33.2 8.6 0.0 99.8 7.1 1.9 0.0 0.0 0.0 7.1 12.4 3.9 0.0 8.1 0.0 6.7 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 23.9 63.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 7.3 0.8 7.7 0.0 0.0 SPAG16 "DKFZp666P1710, FLJ22724, PF20, WDR29" ENSG00000144451 "Sperm associated antigen 16" Q8N0X2 2 213284379-214410501 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 243.1;Inhibitory neurons: 273.7;Respiratory ciliated cells: 330.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 70.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037542 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA037542: AB_10672353" "unprognostic (4.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.67e-1)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.90e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-1)" "unprognostic (1.17e-1)" 16.3 16.8 36.6 6.4 37.4 2.4 20.8 35.1 45.9 21.0 39.0 16.5 18.8 18.2 31.6 26.1 46.5 22.0 22.2 34.2 37.8 30.4 18.8 10.8 11.5 38.8 39.6 25.8 15.5 24.4 29.7 9.8 37.8 22.1 17.2 21.5 15.7 20.5 10.3 24.9 10.9 12.1 40.9 8.0 26.1 46.3 38.4 13.0 26.4 10.8 13.8 18.9 19.4 40.6 26.8 9.9 29.4 0.0 19.3 35.0 0.2 14.3 17.1 18.3 19.3 20.8 28.8 11.1 16.7 16.0 29.3 18.5 13.4 17.4 38.6 0.0 10.5 5.8 28.0 24.6 21.9 6.3 0.1 30.1 23.5 16.3 9.5 25.0 7.6 11.6 18.8 12.3 18.4 0.0 21.4 0.1 16.3 0.0 8.7 22.6 30.9 0.5 29.4 25.8 21.4 25.1 16.3 15.1 21.3 24.2 70.3 2.7 7.8 17.2 9.2 9.3 15.1 20.0 9.7 0.4 28.6 0.0 8.0 2.0 0.3 0.9 8.1 1.3 11.7 9.3 9.1 10.4 3.1 8.5 12.0 10.4 0.5 15.4 0.9 5.1 9.4 3.4 36.6 37.4 35.1 45.9 34.2 37.8 38.8 39.6 37.8 40.9 38.4 40.6 17.7 16.0 19.5 89.5 10.7 42.3 46.6 82.8 22.8 47.6 38.0 45.6 67.5 74.4 73.6 40.5 95.9 50.6 7.5 17.1 76.3 44.0 243.1 207.0 31.3 18.5 38.2 9.0 205.9 24.9 20.8 30.8 32.1 30.3 10.1 34.0 12.8 16.9 11.7 40.4 273.7 37.8 101.7 4.6 9.6 86.2 41.3 5.9 23.2 42.2 29.2 82.7 8.2 92.0 74.9 27.3 18.8 44.8 9.4 25.4 9.4 94.9 330.0 69.0 13.1 30.8 36.1 167.9 31.0 64.6 56.4 23.5 12.9 55.3 39.8 53.8 SPAG17 "CT143, FLJ34497, PF6, RP4-776P7.2" ENSG00000155761 "Sperm associated antigen 17" Q6Q759 1 117953590-118185228 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 26.7;testis: 14.9" "Group enriched" "Detected in many" 5 "Early spermatids: 263.7;Endometrial ciliated cells: 180.7;Late spermatids: 370.9;Respiratory ciliated cells: 300.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 8.9" "HPA028597, HPA028666" Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA028597: AB_10600221, HPA028666: AB_10602281" "unprognostic (3.67e-2)" "unprognostic (4.86e-3)" "unprognostic (3.42e-1)" "unprognostic (1.50e-2)" "unprognostic (1.56e-2)" "unprognostic (6.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.20e-2)" "unprognostic (3.19e-2)" "unprognostic (2.89e-2)" "unprognostic (1.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.76e-5)" "unprognostic (4.81e-1)" "unprognostic (9.90e-2)" "unprognostic (8.23e-2)" "unprognostic (9.67e-2)" 0.5 0.1 2.3 0.0 1.6 0.0 0.7 0.9 0.3 1.2 26.7 0.0 0.0 0.3 4.5 6.1 8.4 0.3 0.0 1.9 2.3 2.5 0.0 1.8 0.0 7.3 8.9 0.1 0.4 0.0 3.8 0.1 5.1 0.1 0.0 0.4 0.3 0.1 0.2 0.2 0.0 0.0 5.1 0.0 0.5 14.9 2.6 0.0 0.9 0.0 0.5 1.0 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.6 0.9 0.3 1.9 2.3 7.3 8.9 5.1 5.1 2.6 3.0 0.1 6.4 3.9 0.7 0.0 0.4 0.2 2.8 0.6 0.5 1.2 0.6 0.6 0.0 45.3 11.0 33.3 2.3 0.1 0.1 1.9 0.6 263.7 180.7 1.1 0.6 0.0 0.0 2.7 0.7 0.5 4.6 0.0 4.0 1.3 0.2 0.0 0.0 0.2 0.0 2.2 0.0 4.1 0.0 0.4 370.9 1.5 0.7 0.0 1.0 0.1 1.1 0.0 0.5 0.9 0.2 0.0 1.2 0.0 0.1 0.0 1.0 300.1 0.1 0.0 0.4 1.1 48.2 6.2 16.1 0.3 0.7 0.4 1.5 0.0 0.9 SPAG5 "DEEPEST, hMAP126, MAP126" ENSG00000076382 "Sperm associated antigen 5" Q96R06 17 28577565-28599025 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.9;kidney: 37.8;testis: 74.0" "Cell type enhanced" "Detected in many" "Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 11.7;T-reg: 4.9" "Group enriched" "Detected in many" 6 "granulocytes: 11.7;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA022008, HPA022479, HPA024418" Approved Supported "Nuclear bodies,Mitotic spindle,Cytosol" Yes Yes "Cluster 34: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies, Mitotic spindle" Cytosol "HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: " "unprognostic (4.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.31e-3)" "unprognostic (2.32e-3)" "unprognostic (3.50e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (5.43e-5)" "unprognostic (3.37e-3)" "unprognostic (4.84e-3)" "unprognostic (5.97e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.49e-2)" "prognostic unfavorable (5.43e-13)" "unprognostic (2.64e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-2)" "unprognostic (2.01e-1)" 2.2 3.3 7.8 7.8 7.6 37.9 2.4 5.8 9.1 2.6 3.4 8.3 7.9 1.9 2.4 8.3 1.7 1.8 1.4 7.6 7.7 37.8 14.8 3.4 14.5 6.7 6.8 2.7 1.5 1.1 4.3 5.7 6.7 2.2 10.7 10.8 2.4 0.8 1.0 5.5 9.1 3.4 5.0 7.4 3.6 74.0 7.7 22.4 8.7 0.7 17.3 2.6 3.6 7.5 84.7 87.7 103.3 78.4 5.2 8.6 42.4 65.9 42.4 98.1 78.3 69.2 25.5 59.8 34.2 46.8 91.7 70.2 114.5 42.7 103.8 108.6 72.9 62.9 87.9 80.2 0.6 83.1 76.1 2.9 3.8 78.6 40.4 14.5 52.1 90.6 69.7 101.5 80.7 52.6 109.4 92.9 54.2 68.3 44.5 72.1 144.4 70.9 29.0 43.0 78.6 45.8 96.4 114.9 31.6 84.9 82.2 70.6 25.7 56.4 91.3 46.6 114.6 46.7 72.9 87.3 37.8 60.6 91.8 11.7 0.0 0.0 0.4 0.4 0.7 0.6 1.2 0.9 0.1 1.4 1.1 0.9 0.2 0.8 0.3 0.3 4.9 0.9 7.8 7.6 5.8 9.1 7.6 7.7 6.7 6.8 6.7 5.0 7.7 7.5 0.5 3.2 1.7 0.7 3.3 2.0 0.9 1.3 1.2 5.0 1.1 1.0 0.7 0.0 1.9 0.0 0.0 9.0 1.3 4.7 1.9 0.5 126.0 6.0 1.1 1.5 13.1 37.2 5.2 0.4 12.2 2.6 5.1 1.8 1.3 12.6 3.3 6.3 6.5 3.3 6.0 4.6 4.1 2.7 4.0 25.2 0.9 6.1 0.0 1.9 0.9 0.7 0.0 2.0 1.7 0.4 4.7 0.0 13.1 0.8 8.1 12.5 7.7 3.9 6.6 2.0 2.2 72.6 21.0 5.2 1.0 3.8 2.8 0.9 5.1 1.1 SPAG6 "CFAP194, CT141, FAP194, PF16, Repro-SA-1" ENSG00000077327 "Sperm associated antigen 6" O75602 10 22345445-22454224 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 63.5;fallopian tube: 49.0;testis: 96.3" "Cell type enhanced" "Detected in some" "Early spermatids: 228.6;Endometrial ciliated cells: 73.2;Respiratory ciliated cells: 266.4;Spermatocytes: 372.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 29 "U-937: 105.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "midbrain: 11.1" HPA038440 Enhanced NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA038440: AB_10671742" "unprognostic (5.02e-2)" "unprognostic (9.52e-2)" "unprognostic (8.94e-6)" "unprognostic (2.21e-1)" "unprognostic (2.51e-2)" "unprognostic (4.91e-3)" "unprognostic (1.68e-1)" "unprognostic (2.38e-1)" "unprognostic (8.68e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-3)" "unprognostic (3.10e-2)" "unprognostic (2.78e-4)" 0.0 0.0 4.2 0.0 4.0 0.4 1.7 1.9 1.4 1.7 63.5 0.0 0.0 0.2 0.4 0.0 49.0 0.0 0.1 3.3 5.0 0.3 0.1 7.0 0.1 17.6 16.1 0.1 0.3 1.8 14.6 0.0 9.9 1.0 0.0 5.8 0.0 0.0 0.0 0.3 0.0 0.0 16.3 0.0 0.0 96.3 6.4 0.4 0.1 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.9 2.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 3.6 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.1 1.7 0.8 0.2 0.0 105.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 4.2 4.0 1.9 1.4 3.3 5.0 17.6 16.1 9.9 16.3 6.4 10.1 0.0 0.0 4.8 0.0 0.1 0.1 0.1 14.0 0.0 0.2 0.5 0.3 0.6 0.0 24.5 0.0 0.0 0.1 0.2 0.1 1.9 0.3 228.6 73.2 0.4 0.2 0.0 0.0 7.1 0.0 0.0 0.7 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 3.1 0.0 16.2 0.0 0.2 51.4 5.0 0.5 1.8 4.7 0.0 0.3 0.0 0.5 6.0 0.4 0.0 4.9 0.3 1.8 0.0 1.4 266.4 1.2 0.0 0.0 3.7 372.6 4.8 0.0 0.1 0.0 0.5 0.1 0.0 0.1 SPAG8 "BS-84, CT142, HSD-1, hSMP-1, SPAG3" ENSG00000137098 "Sperm associated antigen 8" Q99932 9 35808045-35812272 "Predicted intracellular proteins" "Cell cycle, Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 5.6;choroid plexus: 16.4;fallopian tube: 14.2;testis: 10.3" "Cell type enhanced" "Detected in many" "Early spermatids: 51.2;Endometrial ciliated cells: 75.7;Late spermatids: 26.5;Respiratory ciliated cells: 123.3;Spermatocytes: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "ASC diff: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068012 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA068012: AB_2685941" "unprognostic (1.01e-4)" "unprognostic (3.52e-3)" "unprognostic (6.36e-3)" "prognostic favorable (2.15e-4)" "unprognostic (2.62e-1)" "unprognostic (5.04e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-2)" "unprognostic (1.59e-1)" "unprognostic (4.65e-2)" "unprognostic (1.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.22e-2)" "unprognostic (5.41e-2)" "unprognostic (1.33e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-3)" 0.3 0.5 0.9 0.2 0.8 0.3 0.3 0.9 1.1 1.7 16.4 0.8 0.4 0.7 1.0 0.2 14.2 0.6 1.7 1.4 0.8 0.7 0.1 1.3 0.4 3.8 5.6 1.3 0.3 1.0 2.5 0.2 2.9 0.7 0.1 0.2 0.3 0.4 0.4 0.2 0.3 0.2 2.0 0.6 0.4 10.3 1.0 0.7 1.4 0.8 0.3 0.5 0.3 1.3 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.3 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.3 0.1 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.4 0.2 0.6 0.3 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.3 0.2 1.4 0.7 0.0 0.6 0.4 0.2 0.0 0.4 0.6 1.1 0.4 0.3 0.8 0.0 0.9 0.0 0.0 1.0 0.4 0.9 0.8 0.9 1.1 1.4 0.8 3.8 5.6 2.9 2.0 1.0 1.3 1.0 0.0 1.5 8.1 1.0 0.4 1.0 6.3 0.0 4.9 0.8 1.8 3.6 0.0 10.4 5.5 8.4 0.3 1.0 0.0 1.9 0.4 51.2 75.7 1.1 1.0 3.0 0.4 4.4 0.0 0.1 1.4 0.5 1.4 1.3 0.7 1.1 0.1 1.0 3.3 4.7 0.0 8.2 0.3 0.9 26.5 1.5 1.9 0.0 1.0 1.9 5.7 0.0 3.0 7.0 0.1 0.0 1.2 0.9 0.6 0.1 1.6 123.3 8.5 0.0 1.5 4.5 58.8 3.1 0.0 0.6 0.1 1.1 1.4 0.1 0.3 SPATA17 "CFAP305, FAP305, IQCH, MOT17" ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 10.3" "Cell type enhanced" "Detected in many" "Early spermatids: 770.1;Endometrial ciliated cells: 117.8;Late spermatids: 518.2;Respiratory ciliated cells: 150.1;Spermatocytes: 284.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.1 0.2 0.5 0.2 0.5 1.6 0.5 0.9 0.6 0.4 2.0 0.2 0.4 0.4 3.4 0.3 4.1 0.3 0.2 0.7 0.5 0.8 0.1 0.5 0.2 1.4 1.3 0.3 0.3 2.6 0.4 0.2 1.5 0.3 0.2 1.7 0.3 0.3 2.1 0.6 0.4 0.1 0.7 0.2 0.3 10.3 0.7 0.1 0.7 0.1 0.1 0.1 0.0 0.9 0.1 0.3 0.4 0.3 0.1 0.5 0.3 0.1 0.2 0.1 0.0 0.2 0.9 0.1 0.3 0.1 0.1 0.8 0.2 0.3 0.1 0.1 0.3 0.1 0.5 0.2 0.1 0.1 0.1 0.1 0.6 0.3 0.3 0.4 0.0 0.2 0.2 0.3 0.1 0.7 0.1 0.3 0.6 0.4 0.3 0.1 0.1 0.1 0.6 0.3 1.4 0.6 0.2 0.2 0.2 0.5 0.4 0.1 0.1 0.2 0.2 0.3 0.1 0.3 0.2 0.1 0.6 0.1 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.5 0.5 0.9 0.6 0.7 0.5 1.4 1.3 1.5 0.7 0.7 0.9 0.2 3.2 0.0 10.7 0.1 0.6 0.9 6.6 0.0 0.4 2.1 1.9 2.1 0.0 18.4 3.7 20.9 0.9 0.0 0.4 5.9 2.4 770.1 117.8 3.4 0.6 1.8 0.0 5.1 0.7 0.6 1.6 0.5 3.2 0.0 2.0 0.0 0.0 0.2 0.0 3.3 1.3 12.2 0.0 0.3 518.2 8.7 0.5 1.8 2.8 0.0 4.4 0.0 5.0 1.3 0.3 0.2 6.8 0.3 1.0 0.2 10.6 150.1 18.5 0.0 2.0 2.3 284.7 8.4 0.4 1.0 0.3 0.3 2.8 0.9 0.4 SPATA18 FLJ32906 ENSG00000163071 "Spermatogenesis associated 18" Q8TC71 4 52051304-52097299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 68.3;testis: 28.8" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2341.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036854, HPA036855" Enhanced Supported Mitochondria NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria "HPA036854: AB_10670927, HPA036855: AB_2675352" "unprognostic (6.54e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.27e-2)" "unprognostic (4.49e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-1)" "unprognostic (3.13e-1)" "unprognostic (3.13e-2)" "prognostic favorable (3.73e-9)" "unprognostic (4.38e-1)" "unprognostic (1.39e-1)" "unprognostic (1.01e-2)" "unprognostic (4.00e-2)" 2.1 5.0 2.4 0.7 2.2 0.0 6.3 1.3 1.0 10.7 15.6 4.1 2.1 4.2 2.0 4.6 68.3 6.7 1.8 2.5 2.7 5.3 5.4 8.0 0.3 6.8 8.3 1.8 2.0 4.5 4.9 1.9 5.5 4.2 5.6 0.1 10.1 5.6 0.8 6.6 2.2 3.1 6.0 0.6 4.9 28.8 2.6 3.2 1.2 1.3 0.9 2.8 3.4 3.8 0.0 3.8 1.8 0.0 12.7 31.5 24.4 9.3 15.9 0.6 0.7 0.0 1.5 0.0 0.0 12.3 0.2 0.3 0.1 7.1 0.3 0.0 1.1 0.0 0.0 8.0 11.2 0.0 0.0 29.3 28.7 1.0 4.5 5.1 6.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.9 2.0 1.0 0.0 0.0 9.7 0.0 0.2 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 1.3 1.0 2.5 2.7 6.8 8.3 5.5 6.0 2.6 3.8 0.3 9.6 3.0 0.3 0.0 5.2 8.5 9.4 8.6 0.0 6.0 6.7 2.2 8.6 15.1 0.0 0.0 1.7 0.3 1.8 1.9 1.2 561.1 124.6 1.8 1.2 1.8 0.0 1.7 2.6 1.8 4.3 11.2 4.7 2.5 1.9 1.4 3.4 0.3 0.0 0.5 1.6 6.1 0.6 1.6 2341.5 10.8 1.1 0.0 2.8 0.1 0.0 0.0 0.5 0.1 2.0 2.7 10.9 0.0 5.1 1.9 7.4 141.4 0.0 0.0 1.8 3.9 13.9 7.1 7.1 7.5 0.8 0.2 2.5 4.3 6.8 SPATA4 "CFAP178, FAP178, SPEF1B, TSARG2" ENSG00000150628 "Spermatogenesis associated 4" Q8NEY3 4 176184579-176195585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 139.5" "Group enriched" "Detected in some" 12 "Early spermatids: 1074.2;Late spermatids: 496.7;Spermatocytes: 460.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 9 "basophil: 1.2" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "GAMG: 1.4;U-87 MG: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019220 Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA019220: AB_1857420" "unprognostic (1.97e-3)" "unprognostic (6.08e-2)" "unprognostic (2.83e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-2)" "unprognostic (1.87e-2)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (3.09e-3)" "unprognostic (9.77e-2)" "unprognostic (4.38e-6)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.59e-1)" 0.0 0.4 0.8 0.0 0.9 0.1 0.6 0.9 1.0 0.3 1.4 0.4 0.0 0.3 3.6 0.1 8.7 0.2 0.4 0.8 1.0 2.2 0.0 1.2 0.0 1.6 1.9 0.2 0.4 0.4 1.0 0.0 1.1 0.2 0.0 2.3 0.3 0.5 1.1 0.1 0.1 0.2 1.2 0.0 0.1 139.5 1.1 0.0 1.7 0.4 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.2 0.3 0.1 0.3 0.2 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.9 0.3 0.3 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 2.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.9 0.9 1.0 0.8 1.0 1.6 1.9 1.1 1.2 1.1 0.8 0.0 0.0 0.5 0.3 0.0 0.0 0.1 2.2 0.0 0.5 1.0 1.4 0.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 5.9 0.5 1074.2 20.0 0.3 0.7 0.0 0.0 1.1 0.0 0.0 0.2 2.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.0 2.0 0.0 0.0 496.7 11.5 1.3 0.0 0.0 0.0 1.9 0.0 1.0 0.5 1.5 0.0 8.2 0.0 0.1 0.0 10.7 52.3 3.1 0.0 0.5 1.3 460.1 11.3 0.0 0.0 0.0 0.1 0.5 0.1 0.1 SPATS1 "FLJ25442, SPATA8, SRSP1" ENSG00000249481 "Spermatogenesis associated serine rich 1" Q496A3 6 44342650-44380179 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 5.9;fallopian tube: 7.6;testis: 22.1" "Group enriched" "Detected in some" 13 "Early spermatids: 30.9;Late spermatids: 12.1;Respiratory ciliated cells: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SK-MEL-30: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030897, HPA049722" Approved Approved Nucleoplasm NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA030897: AB_2673647, HPA049722: AB_2680861" "unprognostic (2.30e-3)" 0.0 0.1 0.7 0.0 0.7 0.2 0.0 0.6 0.8 0.2 0.7 0.0 0.0 0.2 5.9 0.0 7.6 0.0 0.1 0.8 0.8 0.0 0.0 0.6 0.1 1.4 2.1 0.0 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.1 22.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.4 0.1 0.0 0.1 7.9 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.7 0.7 0.6 0.8 0.8 0.8 1.4 2.1 1.2 1.3 0.7 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24 component of NDC80 kinetochore complex" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.0;lymphoid tissue: 14.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA051234 Approved Supported Nucleoplasm,Nucleoli NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA051234: AB_2681397" "unprognostic (1.57e-1)" "prognostic favorable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 1.9 1.7 1.3 4.8 1.5 26.0 1.2 3.9 2.1 2.1 1.7 4.7 4.5 2.7 0.8 5.0 1.3 2.3 2.7 1.6 1.5 0.8 1.6 1.6 6.3 1.1 0.8 1.3 1.1 0.4 0.4 3.2 1.3 1.6 4.3 1.2 1.3 2.0 4.0 3.9 4.1 8.1 0.5 3.1 2.9 4.3 1.4 14.7 0.9 1.1 6.5 2.5 2.0 2.4 73.6 26.9 36.9 30.1 5.0 9.7 16.6 42.3 15.7 38.6 43.6 28.4 24.6 58.2 46.0 18.5 22.8 38.8 29.0 30.3 28.7 30.9 24.9 78.5 68.9 43.2 1.1 55.5 33.7 1.9 1.1 27.8 12.8 10.0 34.7 62.3 42.8 118.3 27.6 48.7 76.4 32.9 25.5 19.8 43.9 59.8 56.7 18.6 11.2 23.8 38.4 27.2 37.0 22.4 9.6 17.5 22.0 19.8 33.2 36.8 38.3 49.6 51.2 70.5 39.8 55.6 26.9 53.9 30.5 1.9 0.4 0.4 0.5 0.5 0.4 0.8 0.9 1.5 0.2 0.7 0.9 0.6 2.2 2.0 0.5 0.5 1.7 0.3 1.3 1.5 3.9 2.1 1.6 1.5 1.1 0.8 1.3 0.5 1.4 2.4 0.2 0.0 0.5 0.3 1.5 1.1 1.2 1.3 0.0 0.0 1.0 0.4 9.0 1.5 0.8 5.5 6.2 10.0 0.9 2.8 0.0 0.2 0.3 1.0 2.2 2.2 2.4 35.0 0.3 0.0 15.5 3.5 3.6 1.8 5.7 6.5 4.6 0.7 14.0 0.0 0.3 2.6 0.0 3.0 2.5 3.0 0.6 1.0 0.0 1.0 0.0 2.1 2.1 0.5 0.3 0.3 0.0 0.4 6.3 0.3 0.7 0.6 0.2 0.6 0.0 1.3 2.4 6.9 10.8 2.1 0.3 2.1 2.2 0.5 6.6 1.2 SPEF1 "C20orf28, CLAMP, DKFZP434I114, SPEF1A" ENSG00000101222 "Sperm flagellar 1" Q9Y4P9 20 3777504-3781448 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.6;choroid plexus: 15.9;fallopian tube: 11.5;testis: 12.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 104.7;Respiratory ciliated cells: 66.5;Rod photoreceptor cells: 22.4;Spermatocytes: 24.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.2;hTEC/SVTERT24-B: 1.1;MCF7: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050786 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA050786: AB_2681238" "unprognostic (2.41e-2)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (4.91e-3)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.08e-3)" "unprognostic (8.12e-3)" "unprognostic (5.95e-2)" "unprognostic (8.41e-2)" "unprognostic (8.88e-3)" "unprognostic (1.69e-1)" "unprognostic (3.81e-3)" "unprognostic (1.83e-1)" "unprognostic (6.60e-2)" "prognostic unfavorable (9.87e-4)" "unprognostic (7.49e-2)" 0.1 0.2 3.6 0.0 9.6 0.0 0.1 2.4 4.5 1.7 15.9 0.2 0.0 0.3 0.5 0.0 11.5 0.0 0.2 5.5 4.0 2.1 0.1 2.8 0.0 7.6 9.1 0.3 0.6 0.3 2.9 0.0 5.8 0.2 0.0 2.1 0.1 0.1 0.0 0.1 0.0 0.0 6.9 0.0 0.1 12.4 4.2 0.0 1.7 0.0 0.0 0.1 0.0 3.9 0.9 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.4 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.4 0.3 0.0 0.4 0.6 0.0 0.5 0.0 0.0 0.3 0.1 0.4 0.1 0.1 0.0 0.1 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 9.6 2.4 4.5 5.5 4.0 7.6 9.1 5.8 6.9 4.2 3.9 0.3 0.0 0.0 2.3 0.1 0.4 0.1 3.5 0.0 1.5 1.5 1.1 0.4 0.0 9.9 3.7 16.7 0.1 0.1 0.1 5.9 1.2 5.5 104.7 1.0 0.4 0.0 0.0 16.7 0.2 0.2 0.3 0.0 1.7 0.0 0.2 0.7 0.2 0.2 0.0 6.6 0.0 4.1 0.0 0.0 4.1 0.3 0.3 0.0 1.9 0.0 2.6 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 7.3 66.5 22.4 0.0 0.3 1.5 24.9 2.8 0.0 0.1 0.1 0.3 0.2 0.3 0.1 SPEF2 "CT122, FLJ23577, KPL2" ENSG00000152582 "Sperm flagellar 2" Q9C093 5 35617844-35814611 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 104.6;Endometrial ciliated cells: 143.9;Excitatory neurons: 62.9;Respiratory ciliated cells: 238.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 3.2;MAIT T-cell: 3.9;memory CD4 T-cell: 1.9;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.1;naive CD8 T-cell: 2.6;NK-cell: 3.0" "Group enriched" "Detected in many" 8 "NK-cells: 3.0;T-cells: 3.9" "Cell line enhanced" "Detected in many" "HDLM-2: 13.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039606, HPA040343" Enhanced NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 44: HDLM-2 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA039606: AB_10671044, HPA040343: AB_2676930" "unprognostic (3.81e-2)" "unprognostic (3.17e-1)" "unprognostic (6.23e-2)" "unprognostic (8.71e-2)" "unprognostic (4.55e-2)" "unprognostic (8.23e-2)" "unprognostic (8.11e-4)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (9.96e-2)" "unprognostic (1.01e-4)" "unprognostic (4.50e-2)" "unprognostic (6.34e-3)" "unprognostic (1.53e-2)" "unprognostic (1.63e-1)" "unprognostic (2.52e-2)" "unprognostic (2.12e-2)" 1.5 3.7 2.9 1.1 3.6 1.5 5.4 1.4 3.1 13.2 20.7 1.8 0.9 11.1 7.6 1.1 15.8 3.1 1.8 2.8 3.6 7.7 1.4 4.6 1.6 5.5 6.3 5.6 4.4 8.6 6.4 4.8 4.6 4.0 2.0 10.2 3.3 4.5 0.4 1.2 1.5 4.3 4.4 2.4 2.2 7.0 4.6 2.1 8.6 0.5 0.9 2.4 5.0 2.8 0.8 1.3 1.6 4.2 1.0 1.2 0.1 2.1 1.2 4.7 3.1 0.0 2.2 0.0 1.1 2.8 5.2 0.1 1.3 1.9 4.6 13.3 0.4 0.0 6.2 0.4 1.3 3.5 0.0 1.8 3.4 2.6 1.4 5.7 0.1 0.8 1.6 0.8 0.8 2.3 0.0 0.0 0.1 3.1 1.2 3.1 0.0 0.0 3.3 0.4 0.1 1.2 0.0 2.4 0.4 0.9 7.5 6.7 0.0 1.3 1.8 2.7 0.7 0.0 0.0 0.3 3.8 0.1 0.0 0.0 0.3 0.0 3.2 0.3 3.9 0.2 1.9 3.4 0.4 0.3 2.1 2.6 0.3 3.0 0.1 0.1 0.5 0.8 2.9 3.6 1.4 3.1 2.8 3.6 5.5 6.3 4.6 4.4 4.6 2.8 2.4 9.6 6.4 36.9 1.1 1.7 2.4 4.7 3.4 15.6 9.2 10.0 6.7 11.5 28.8 5.5 37.5 1.7 3.1 1.5 5.9 4.7 104.6 143.9 23.3 5.2 2.4 6.5 62.9 1.7 0.8 9.7 1.1 9.1 5.7 6.7 5.3 1.3 1.2 20.2 27.6 3.5 8.2 0.8 1.4 25.2 10.2 2.3 1.8 6.5 21.7 13.7 4.1 16.1 11.5 1.2 1.5 7.2 0.7 1.6 0.5 14.2 238.4 41.9 0.0 9.4 5.6 36.1 11.9 0.7 1.0 0.8 9.2 9.0 3.1 0.2 SPOCK1 "SPOCK, testican-1, TIC1" ENSG00000152377 "SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1" Q08629 5 136975298-137598379 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 172.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 252.8;Inhibitory neurons: 349.9;Muller glia cells: 243.8;Oligodendrocyte precursor cells: 273.4;Oligodendrocytes: 913.1;Peritubular cells: 150.1" "Cancer enriched" "Detected in all" 7 "prostate cancer: 83.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 573.1;hTERT-RPE1: 1112.8;HUVEC TERT2: 594.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007450, HPA026770" Uncertain Approved Vesicles "Secreted to blood" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA007450: AB_10603116, HPA026770: " "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (5.83e-3)" "prognostic unfavorable (9.08e-4)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.72e-4)" "unprognostic (9.09e-3)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.77e-5)" "prognostic unfavorable (9.40e-4)" "unprognostic (1.26e-1)" "unprognostic (2.21e-1)" "unprognostic (1.90e-2)" 29.7 41.4 67.9 4.1 116.3 0.3 19.0 129.2 99.5 25.6 9.9 24.9 1.2 44.2 34.3 6.1 18.6 18.6 54.2 100.5 50.9 24.3 0.2 2.9 0.6 80.7 84.5 4.8 5.5 13.7 9.9 9.3 89.8 65.6 3.2 48.7 7.6 25.5 17.5 9.3 4.6 30.7 78.4 8.5 9.1 21.7 102.6 7.5 9.4 7.1 0.4 11.4 21.7 172.9 4.6 0.9 299.4 0.4 573.1 116.0 0.4 100.6 90.0 207.7 115.9 0.0 0.6 0.4 0.2 206.7 53.3 4.4 1.4 70.3 65.3 17.8 0.6 0.2 16.7 0.0 4.0 0.0 0.4 203.8 28.5 128.6 23.2 1112.8 594.4 0.2 0.0 0.4 60.5 0.5 0.0 0.2 19.1 0.0 28.4 0.0 0.2 0.0 140.3 9.4 3.7 14.4 49.9 0.8 0.1 35.6 0.4 1.2 98.9 294.0 10.6 102.1 28.5 0.1 0.1 0.1 159.4 4.4 136.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 67.9 116.3 129.2 99.5 100.5 50.9 80.7 84.5 89.8 78.4 102.6 172.9 2.0 0.0 0.0 91.7 0.0 1.8 1.6 5.8 0.0 9.7 0.4 0.4 58.8 1.5 0.4 22.0 2.1 0.4 0.0 0.2 1.9 0.6 12.0 4.2 37.9 8.4 35.0 0.0 252.8 1.4 0.3 58.8 0.0 2.9 0.0 0.1 1.1 0.0 0.9 8.4 349.9 0.1 16.2 1.2 3.0 9.5 17.4 1.6 7.2 17.8 2.3 243.8 0.0 273.4 913.1 2.0 0.1 150.1 0.1 40.9 0.0 3.1 0.9 7.3 13.1 11.6 16.4 7.4 7.1 0.7 1.4 0.1 0.4 0.0 0.3 3.2 SPOCK2 "KIAA0275, testican-2" ENSG00000107742 "SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2" Q92563 10 72059034-72089032 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 220.1;lymphoid tissue: 114.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 288.4;Bipolar cells: 116.5;dendritic cells: 86.4;Inhibitory neurons: 81.1;Microglial cells: 75.9;NK-cells: 90.6;T-cells: 195.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 117.5;MAIT T-cell: 198.8;memory CD4 T-cell: 115.9;memory CD8 T-cell: 93.5;naive CD4 T-cell: 87.8;naive CD8 T-cell: 89.4;T-reg: 174.3" "Lineage enriched" "Detected in all" 8 "T-cells: 198.8" "Group enriched" "Detected in some" 7 "Hep G2: 50.2;SCLC-21H: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044605 Enhanced "Secreted to blood" NA NA 34000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 24: Non-specific - Transcription regulation" "HPA044605: AB_10965991" "prognostic favorable (4.05e-4)" "unprognostic (3.11e-3)" "unprognostic (2.92e-2)" "unprognostic (2.29e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.18e-2)" "unprognostic (9.04e-2)" "prognostic favorable (4.72e-4)" "prognostic unfavorable (7.19e-4)" "unprognostic (4.53e-3)" "unprognostic (2.29e-1)" "unprognostic (1.46e-3)" "unprognostic (5.59e-2)" "unprognostic (5.49e-2)" "unprognostic (3.19e-3)" "unprognostic (2.24e-2)" 9.4 46.6 152.6 44.5 108.0 58.1 3.8 160.4 143.2 4.2 2.8 7.6 9.2 4.0 3.1 3.3 6.2 15.3 10.0 117.4 150.1 68.0 2.7 86.5 67.3 212.1 157.7 7.1 1.6 2.0 44.0 3.4 220.1 4.7 5.4 33.4 3.3 5.6 5.1 1.8 32.3 4.4 127.9 29.1 13.6 25.1 207.3 114.4 10.4 6.7 45.3 9.9 3.8 95.6 0.2 0.4 0.3 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 8.2 0.3 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.8 0.2 1.4 50.2 1.6 0.4 1.2 0.1 0.4 0.0 0.0 0.2 0.1 2.7 0.1 0.8 0.0 0.3 0.9 0.3 0.1 0.0 0.2 0.2 0.3 0.1 0.0 0.3 68.2 4.1 0.1 1.5 0.4 0.3 0.0 1.9 0.2 0.0 0.3 0.3 0.1 0.7 1.7 7.3 0.3 0.1 0.2 0.6 0.4 0.2 117.5 1.2 198.8 23.6 115.9 93.5 0.3 18.3 87.8 89.4 13.5 14.4 0.4 3.5 174.3 48.4 152.6 108.0 160.4 143.2 117.4 150.1 212.1 157.7 220.1 127.9 207.3 95.6 17.3 288.4 10.0 51.9 54.6 3.8 0.4 2.1 0.0 116.5 1.9 2.0 3.1 1.5 4.1 14.7 6.2 0.1 86.4 2.4 0.0 3.6 8.1 2.5 1.0 29.9 4.9 3.6 39.6 0.8 0.1 8.4 3.6 1.0 3.8 0.2 7.9 0.4 0.2 3.3 81.1 1.3 2.0 1.6 7.9 10.5 5.3 5.5 5.4 75.9 4.1 5.0 90.6 28.6 8.3 0.0 4.4 6.0 34.2 0.5 0.1 0.5 2.4 17.6 0.0 17.9 2.4 6.3 1.1 0.5 4.4 0.4 195.1 0.8 0.7 0.3 SRCIN1 "KIAA1684, p140Cap, SNIP" ENSG00000277363 "SRC kinase signaling inhibitor 1" Q9C0H9 17 38530031-38605952 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 66.3;Horizontal cells: 102.6;Inhibitory neurons: 58.5;Oligodendrocytes: 261.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009701, HPA063795" Enhanced Approved "Cell Junctions" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Cell Junctions" "HPA009701: AB_1857324, HPA063795: AB_2685124" "unprognostic (4.53e-1)" "unprognostic (4.05e-1)" "unprognostic (2.45e-2)" "unprognostic (3.24e-4)" "unprognostic (4.10e-2)" "unprognostic (3.72e-3)" "unprognostic (1.53e-1)" "unprognostic (2.84e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.16e-4)" "unprognostic (1.00e-1)" "unprognostic (5.07e-3)" "unprognostic (9.51e-2)" "unprognostic (6.50e-2)" "unprognostic (2.67e-2)" "prognostic favorable (1.76e-4)" 1.9 1.3 11.1 0.1 32.1 0.2 3.1 22.1 29.9 2.1 0.0 4.2 0.6 1.0 0.6 2.2 3.0 0.0 2.1 13.6 14.1 1.6 13.9 1.2 0.2 36.4 28.8 0.5 6.6 2.4 15.5 0.2 33.7 2.3 0.2 0.4 7.8 0.8 0.5 6.1 1.4 0.1 13.8 0.6 2.1 1.4 29.9 0.1 0.7 0.0 0.0 1.7 1.1 66.2 0.4 0.4 0.6 2.7 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.4 1.1 0.9 0.0 0.7 1.0 1.2 0.2 0.1 1.1 1.2 0.0 0.5 1.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.5 0.1 3.9 0.0 2.4 0.0 0.0 1.5 0.5 0.0 0.1 0.0 0.1 0.4 1.7 18.0 2.0 0.0 1.0 0.7 0.6 1.8 0.4 0.0 0.0 1.2 0.0 0.0 0.8 0.2 0.0 0.1 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 32.1 22.1 29.9 13.6 14.1 36.4 28.8 33.7 13.8 29.9 66.2 0.4 0.0 1.1 5.5 0.3 0.8 1.0 0.3 0.6 31.5 6.1 5.1 2.9 21.5 0.3 3.7 0.0 0.1 0.3 0.7 0.0 2.7 0.2 9.0 1.0 0.6 9.7 0.0 66.3 0.2 0.1 0.9 0.0 0.9 0.0 2.7 0.4 12.6 0.4 102.6 58.5 1.8 2.0 0.0 0.4 0.6 0.6 0.1 0.0 3.7 0.0 1.8 0.0 6.6 261.8 0.3 0.3 0.4 0.1 1.4 0.6 0.2 5.3 3.4 0.0 0.4 0.5 0.9 2.1 0.8 0.9 0.1 0.2 0.0 1.5 1.6 SRD5A2 ENSG00000277893 "Steroid 5 alpha-reductase 2" P31213 2 31522480-31580938 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "epididymis: 23.5;fallopian tube: 20.4;liver: 60.8;prostate: 16.8;seminal vesicle: 18.0" "Group enriched" "Detected in some" 5 "Early spermatids: 71.7;Endometrial ciliated cells: 29.6;Hepatocytes: 20.0;Late spermatids: 59.9" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2" "Region enriched" "Detected in single" 11 "midbrain: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 85: Liver - Metabolism" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" "unprognostic (6.75e-3)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-3)" "unprognostic (5.92e-3)" "unprognostic (3.37e-2)" "unprognostic (2.79e-3)" "unprognostic (6.56e-2)" "unprognostic (9.10e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-3)" "unprognostic (6.61e-6)" "unprognostic (4.37e-2)" "unprognostic (2.04e-1)" "unprognostic (3.85e-1)" "unprognostic (3.48e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 23.5 0.0 20.4 0.0 0.0 0.0 0.0 0.3 60.8 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.1 0.0 18.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.2 0.0 0.0 0.0 1.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.7 29.6 0.2 0.2 0.0 0.0 0.9 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.4 20.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 59.9 0.6 0.1 0.0 3.7 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.2 0.0 0.7 0.0 0.3 7.3 0.0 0.0 0.0 0.2 1.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 8.6 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1;retina: 14.8" "Cell type enhanced" "Detected in many" "Astrocytes: 201.8;Bipolar cells: 217.5;Cone photoreceptor cells: 273.1;Endometrial ciliated cells: 166.0;Excitatory neurons: 223.1;Horizontal cells: 228.8;Inhibitory neurons: 281.2;Oligodendrocyte precursor cells: 159.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.3;HBEC3-KT: 8.2;hTCEpi: 7.8;RT4: 10.9;T-47d: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Approved Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 0.7 3.3 12.3 0.7 13.9 0.3 1.5 22.1 16.9 5.2 0.3 1.0 0.7 2.2 1.5 2.3 10.9 1.0 1.8 14.5 9.1 3.2 0.5 1.0 1.1 5.1 9.8 3.7 1.1 0.6 6.1 0.7 7.4 4.5 1.1 14.8 4.2 1.4 1.3 3.7 0.9 0.7 5.6 0.7 1.5 3.5 11.9 1.8 2.6 2.1 0.9 4.1 1.7 10.0 0.5 0.5 9.3 0.4 0.6 1.2 1.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.1 4.8 0.2 8.2 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.0 0.7 7.8 0.6 0.8 0.2 0.0 2.1 0.0 0.0 0.0 0.1 0.2 2.0 0.9 1.6 0.7 1.1 0.0 0.0 3.8 10.9 1.0 1.2 0.2 2.8 0.1 2.2 10.5 0.0 0.0 0.0 0.3 0.1 0.1 2.7 0.1 0.0 0.8 1.7 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 12.3 13.9 22.1 16.9 14.5 9.1 5.1 9.8 7.4 5.6 11.9 10.0 1.0 3.2 5.6 201.8 2.3 4.1 28.7 36.3 23.3 217.5 7.9 9.8 9.6 0.0 40.6 77.3 273.1 2.4 3.5 1.4 5.9 3.2 24.1 166.0 6.0 4.2 3.0 0.8 223.1 0.5 0.8 4.9 8.2 93.8 1.3 5.4 0.7 2.1 13.2 228.8 281.2 6.2 12.2 18.6 6.0 20.2 2.5 9.4 1.8 37.5 3.3 80.6 1.0 159.8 132.2 0.6 0.5 1.2 1.4 12.3 0.5 1.4 59.4 94.8 0.0 2.9 3.9 6.1 7.1 17.2 5.8 1.4 14.7 12.0 3.1 31.2 STIL "MCPH7, SIL" ENSG00000123473 "STIL centriolar assembly protein" Q15468 1 47250139-47314147 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.8;lymphoid tissue: 9.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Glandular and luminal cells: 12.4;Spermatocytes: 17.8;Spermatogonia: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046543 Approved "Plasma membrane,Cytosol" NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Cytosol" "HPA046543: AB_2679692" "unprognostic (2.07e-1)" "unprognostic (6.29e-2)" "unprognostic (5.54e-3)" "unprognostic (2.67e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-2)" "unprognostic (2.90e-5)" "unprognostic (7.35e-3)" "unprognostic (4.04e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.81e-2)" "unprognostic (3.36e-14)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" 1.0 0.5 0.8 3.0 0.8 10.8 2.9 0.7 1.2 1.1 0.2 4.1 2.9 1.4 1.4 2.5 0.9 1.4 0.6 0.8 0.6 0.7 1.0 0.9 4.9 0.7 0.6 0.8 0.7 0.9 0.4 1.9 0.8 1.3 5.6 1.2 1.7 0.5 0.6 3.1 2.7 1.4 0.4 1.4 1.8 6.6 0.8 9.9 0.9 0.7 5.7 1.1 1.0 1.0 33.7 17.4 24.7 22.1 1.8 3.8 15.7 29.3 14.0 32.0 33.2 18.5 16.1 39.4 13.3 14.4 32.7 21.4 29.4 15.3 33.7 29.6 12.9 44.5 20.9 16.6 0.8 35.7 21.5 1.6 2.1 27.2 17.5 3.8 21.5 29.5 31.7 35.9 24.1 14.3 35.6 10.9 30.0 18.6 14.2 23.0 40.3 19.0 9.0 20.0 22.0 13.2 31.4 22.2 14.6 29.6 14.5 20.6 12.2 29.6 29.9 21.2 40.0 11.9 26.4 38.1 13.8 27.0 28.0 0.3 0.1 0.2 0.2 0.0 0.0 0.4 0.2 0.2 0.1 0.2 0.0 0.1 0.3 0.7 0.0 0.3 0.3 0.1 0.8 0.8 0.7 1.2 0.8 0.6 0.7 0.6 0.8 0.4 0.8 1.0 1.6 3.2 0.5 2.0 2.4 0.9 0.6 2.0 1.2 1.1 2.8 3.0 0.5 0.0 2.3 0.0 4.2 2.5 1.6 5.4 0.0 1.6 1.6 7.8 3.2 2.2 1.8 12.8 5.1 0.4 4.4 1.6 3.1 12.4 2.5 8.2 1.4 0.5 2.9 0.0 3.9 6.1 0.0 2.4 1.2 1.1 0.3 2.7 0.0 0.0 3.0 0.8 1.0 2.0 4.8 1.9 1.8 0.7 10.2 1.1 1.4 0.4 7.6 0.6 0.0 1.7 2.0 17.8 14.4 5.3 2.4 0.8 3.3 2.6 5.5 1.4 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 49.3;testis: 51.8" "Cell type enhanced" "Detected in many" "Astrocytes: 213.8;Early spermatids: 98.8;Endometrial ciliated cells: 220.9;Late spermatids: 157.0;Oligodendrocyte precursor cells: 117.6;Respiratory ciliated cells: 155.3;Spermatocytes: 148.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.1;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 5 "B-cells: 4.1" "Cell line enhanced" "Detected in many" "Daudi: 23.0;hTERT-RPE1: 22.0;Karpas-707: 21.2;SCLC-21H: 22.9;U-251 MG: 24.3;U-266/84: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 1.3 8.1 6.7 2.0 6.6 1.3 0.5 8.5 4.9 5.6 49.3 8.3 3.3 12.0 11.3 2.7 42.3 5.1 16.2 6.1 10.1 10.2 0.4 7.1 2.0 14.7 15.6 13.4 6.5 23.1 24.1 0.1 13.3 6.4 1.5 15.6 2.1 11.5 3.9 0.2 3.4 9.3 12.0 1.5 6.0 51.8 12.8 3.8 20.0 6.0 2.2 3.4 1.7 8.3 0.0 3.4 15.4 0.0 0.0 0.0 0.0 3.0 3.1 7.0 6.2 2.2 0.0 23.0 11.5 0.6 8.7 0.0 6.9 2.5 6.0 0.0 18.9 0.0 4.2 5.6 2.5 13.4 0.0 1.1 0.0 0.2 0.0 22.0 0.5 11.2 0.0 21.2 0.3 0.0 0.4 0.0 11.2 0.0 0.0 8.8 2.2 14.3 6.1 0.0 22.9 6.2 0.0 0.0 0.1 4.3 0.0 1.3 0.0 0.0 10.6 0.2 24.3 5.1 21.2 0.3 6.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 0.7 0.0 2.2 0.0 0.6 0.0 0.1 0.0 0.4 0.1 0.2 6.7 6.6 8.5 4.9 6.1 10.1 14.7 15.6 13.3 12.0 12.8 8.3 0.1 19.2 14.5 213.8 6.2 0.0 1.3 1.9 0.0 20.7 0.1 0.3 37.8 8.6 27.5 20.2 70.9 0.1 1.4 0.2 3.9 9.5 98.8 220.9 5.5 1.8 9.1 1.7 12.0 4.9 3.3 5.0 6.1 17.8 1.3 29.3 0.4 0.0 0.3 1.7 15.4 1.6 6.1 0.0 0.0 157.0 4.4 0.6 0.0 23.4 0.0 31.0 0.0 117.6 19.7 4.4 0.4 17.0 5.2 0.5 3.6 13.5 155.3 77.4 0.0 0.2 2.7 148.3 26.8 0.2 0.0 0.0 1.3 6.3 3.5 0.0 STMND1 FLJ23152 ENSG00000230873 "Stathmin domain containing 1" H3BQB6 6 17102050-17131378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 17.8;gallbladder: 5.3;testis: 5.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 93.8;Respiratory ciliated cells: 72.8;Spermatocytes: 18.7;Spermatogonia: 23.8" "Group enriched" "Detected in some" 6 "breast cancer: 4.1;endometrial cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 2.4;SCLC-21H: 6.0;T-47d: 7.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA067970 Enhanced Approved "Actin filaments" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" "HPA067970: AB_2685934" "unprognostic (7.70e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-2)" "unprognostic (2.09e-3)" "unprognostic (6.88e-2)" "unprognostic (6.64e-2)" "unprognostic (4.29e-2)" "unprognostic (4.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.72e-2)" "unprognostic (5.29e-4)" "unprognostic (7.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" 0.0 0.0 0.2 0.1 0.2 0.0 3.0 0.3 0.4 0.8 2.2 0.9 0.1 0.5 0.3 0.0 17.8 5.3 0.0 0.3 0.2 0.0 0.1 2.4 0.0 0.5 0.5 0.0 3.5 0.0 0.5 0.1 0.3 0.0 0.8 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 5.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 0.0 0.0 0.0 0.0 0.5 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.2 0.0 0.0 0.2 0.2 0.3 0.4 0.3 0.2 0.5 0.5 0.3 0.5 0.2 0.6 0.0 0.0 1.3 0.0 0.0 0.0 1.7 2.9 0.0 0.1 5.0 1.4 0.7 2.8 8.3 0.0 0.0 0.0 0.0 1.2 0.0 0.6 1.3 93.8 0.9 0.5 1.8 0.0 0.5 0.2 0.0 0.4 0.0 2.3 0.0 0.7 0.0 0.3 0.0 0.0 0.2 0.7 2.0 0.0 0.4 2.8 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.6 0.3 0.4 0.0 0.7 0.0 0.0 72.8 0.0 6.6 1.3 2.7 18.7 23.8 0.0 0.9 0.0 0.3 0.0 1.8 0.6 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38990859 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 34.9" "Group enriched" "Detected in some" 19 "Endometrial ciliated cells: 75.5;Respiratory ciliated cells: 109.2" "Group enriched" "Detected in some" 4 "endometrial cancer: 2.4;lung cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "AF22: 17.5" "Region enriched" "Detected in many" 6 "olfactory bulb: 23.6" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "HPA012892: AB_1857610, HPA071011: AB_2732169" "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favorable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.5 0.0 0.7 1.3 0.1 0.0 0.6 0.0 0.0 34.9 0.0 0.0 1.1 1.8 0.0 0.0 2.1 0.0 4.7 5.1 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.5 0.0 1.1 1.8 4.7 5.1 5.0 2.0 0.9 1.3 0.0 0.0 1.5 0.0 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.4 0.1 0.0 4.8 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.4 75.5 0.4 0.3 0.0 0.0 0.1 0.0 1.1 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.0 0.0 0.0 1.5 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 109.2 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.1 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827531-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;choroid plexus: 30.8" "Group enriched" "Detected in many" 5 "Astrocytes: 85.2;Endometrial ciliated cells: 67.4;Respiratory ciliated cells: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.6;HAP1: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" No NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: AB_2675700, HPA037845: AB_10671369" "prognostic favorable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 6.3 5.1 26.4 0.5 23.6 0.2 4.2 14.9 33.2 1.9 30.8 1.6 1.1 1.6 7.4 1.4 12.5 0.9 0.4 23.9 22.4 2.8 0.3 1.3 1.2 16.5 24.9 1.1 1.4 6.5 7.2 0.8 17.4 1.2 1.6 0.7 1.6 1.1 1.3 0.9 2.1 0.8 16.3 0.4 3.4 2.5 26.2 6.7 3.1 0.8 1.0 2.5 0.7 20.5 1.8 2.0 4.2 8.6 1.8 0.0 2.5 0.2 0.1 1.2 1.3 1.8 2.6 1.7 2.4 0.0 3.3 0.5 8.1 0.0 0.6 2.0 3.4 0.1 0.4 2.6 0.2 2.3 3.1 0.2 0.1 0.2 0.0 0.2 0.1 4.5 0.4 0.2 0.1 1.8 3.9 2.8 1.4 0.4 1.2 2.8 0.1 0.0 2.6 4.6 1.3 3.9 3.1 0.8 0.6 2.7 1.9 1.8 0.0 0.0 0.2 0.0 1.3 0.7 1.6 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.8 0.4 0.0 0.0 0.0 1.0 0.0 0.0 26.4 23.6 14.9 33.2 23.9 22.4 16.5 24.9 17.4 16.3 26.2 20.5 0.3 0.0 0.5 85.2 0.3 1.5 4.5 0.9 1.2 0.7 5.1 4.1 0.5 0.0 5.6 1.8 0.0 1.6 3.1 0.4 3.9 0.1 0.3 67.4 1.7 0.4 0.0 1.7 11.4 0.4 0.5 0.6 0.5 4.2 2.5 0.8 0.0 0.2 0.1 0.0 9.9 2.5 2.0 0.3 0.7 0.7 1.2 0.2 0.0 1.9 0.1 1.9 2.1 6.0 2.1 0.1 0.3 0.0 0.6 1.7 0.8 1.8 42.8 0.4 6.6 1.5 5.0 1.4 8.8 0.4 0.4 1.2 0.7 6.9 5.3 1.8 STPG1 "C1orf201, FLJ33340, MAPO2" ENSG00000001460 "Sperm tail PG-rich repeat containing 1" Q5TH74 1 24356999-24416934 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.5" "Group enriched" "Detected in many" 8 "Early spermatids: 282.7;Late spermatids: 660.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024301 Approved Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA024301: AB_1845634" "unprognostic (2.63e-2)" "unprognostic (3.35e-1)" "unprognostic (1.36e-2)" "prognostic favorable (1.33e-4)" "unprognostic (6.06e-4)" "unprognostic (5.14e-2)" "unprognostic (2.91e-3)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (1.08e-1)" "unprognostic (3.48e-2)" "prognostic favorable (2.31e-4)" "unprognostic (9.14e-2)" "unprognostic (3.93e-2)" "unprognostic (5.21e-2)" "unprognostic (1.42e-1)" 4.6 4.1 10.0 2.1 9.2 1.1 4.0 9.2 11.5 3.3 15.7 6.4 3.5 3.8 5.4 5.0 16.8 3.2 3.2 8.6 10.5 5.5 1.6 4.9 2.1 9.9 11.2 4.2 3.9 9.2 8.8 1.0 10.0 4.3 5.3 14.6 3.4 3.2 1.3 4.5 4.4 4.9 9.4 1.8 4.0 27.5 11.6 2.7 4.5 2.5 2.7 4.0 4.2 11.1 7.9 4.7 0.6 8.5 5.9 8.5 4.5 11.5 10.8 10.6 11.0 2.1 11.6 1.0 7.6 11.9 8.9 3.3 7.3 8.0 12.2 9.4 7.2 1.4 2.4 2.2 12.2 3.9 1.9 5.1 15.9 15.4 20.2 11.2 8.5 0.0 2.9 0.0 8.1 2.9 0.0 3.3 6.9 8.3 7.7 2.1 0.0 0.3 14.3 2.6 6.9 4.6 6.2 2.5 18.1 7.0 6.2 6.9 5.8 4.0 4.5 1.6 3.4 4.9 5.0 2.8 4.3 0.4 6.3 0.0 0.0 0.5 0.6 0.6 0.1 2.2 0.5 1.9 0.3 1.7 0.5 0.7 0.0 0.0 0.1 1.3 1.2 0.8 10.0 9.2 9.2 11.5 8.6 10.5 9.9 11.2 10.0 9.4 11.6 11.1 7.6 9.6 9.6 3.9 4.1 4.6 13.0 12.0 7.4 14.9 5.5 6.0 5.3 0.0 13.5 11.0 14.6 3.9 1.6 22.9 15.6 7.5 282.7 32.1 2.3 5.0 4.8 5.7 11.0 7.1 7.8 4.1 4.1 8.5 12.0 3.2 6.8 1.7 3.7 10.1 5.9 5.9 8.2 1.6 6.7 660.7 6.5 2.4 16.0 4.7 3.0 7.1 0.0 4.0 16.1 11.3 14.0 4.5 5.0 6.2 21.0 8.4 55.9 20.0 6.6 2.4 4.8 37.0 11.3 13.0 5.5 4.5 3.7 3.1 6.3 54.2 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552172-48599425 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 286.0;skin 1: 186.5;vagina: 145.9" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041724, HPA043539, HPA076510" Enhanced Enhanced Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" Vesicles Cytosol "HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: " "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.3 0.2 0.5 0.4 0.4 0.1 11.5 0.6 0.8 74.4 0.4 0.8 9.3 0.5 6.8 286.0 1.2 2.7 0.2 0.5 0.5 13.0 0.3 9.4 0.0 0.5 0.7 0.1 0.7 7.9 0.4 1.5 0.5 22.6 0.2 0.0 53.6 3.7 0.4 186.5 18.2 0.1 0.4 0.1 3.5 0.5 0.9 0.4 1.9 0.0 28.3 0.7 145.9 0.5 12.6 15.8 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.9 74.2 0.1 0.1 0.0 0.7 3.9 0.1 0.3 0.0 0.5 0.4 0.0 0.5 0.5 0.0 0.0 7.2 0.2 2.1 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.0 46.8 0.0 0.5 0.0 122.9 0.0 0.1 0.0 0.1 0.0 3.5 0.2 0.1 0.0 6.2 0.3 0.0 36.7 0.1 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.5 0.1 0.0 0.3 0.2 0.6 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.5 0.4 0.6 0.8 0.5 0.5 0.5 0.7 0.5 0.4 0.9 0.5 0.4 19.2 0.5 1.0 0.0 24.1 30.5 11.6 0.0 0.0 16.8 12.4 0.6 5.7 40.2 9.2 0.0 3.2 0.0 4.4 0.0 12.2 0.0 15.7 1.4 0.9 4.8 0.0 1.0 1.2 3.1 1.2 2.6 17.5 0.0 0.1 0.0 0.3 0.7 0.0 0.9 12.6 24.4 0.0 4.8 0.9 0.3 0.4 12.4 1.0 0.0 1.6 0.0 0.5 0.8 18.5 7.9 0.0 0.0 62.3 75.9 1.3 6.7 0.6 0.0 0.1 2.2 0.2 11.1 56.0 137.4 1.9 0.6 2.0 9.2 114.6 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364233 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.0;esophagus: 51.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 83.7;Inhibitory neurons: 89.7;Oligodendrocyte precursor cells: 101.6;Squamous epithelial cells: 68.3;Theca cells: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 6.8;naive CD4 T-cell: 10.2" "Lineage enriched" "Detected in single" 40 "T-cells: 10.2" "Cell line enhanced" "Detected in some" "HaCaT: 9.7;RPTEC TERT1: 11.1;SCLC-21H: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA058296: AB_2683672" "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.4 6.0 28.4 0.8 21.7 0.4 8.7 5.4 63.7 9.5 0.0 1.3 1.0 0.3 25.1 51.1 3.5 0.7 23.0 69.0 26.8 19.5 3.8 2.8 1.6 9.4 10.4 45.3 10.7 14.9 26.0 0.5 15.9 6.0 0.2 12.2 17.0 4.3 3.5 7.8 0.6 0.4 5.0 0.4 11.0 6.6 21.4 3.4 1.0 2.2 15.0 3.6 25.3 16.2 5.9 0.5 0.2 0.0 0.0 0.0 0.1 0.8 0.4 1.0 0.5 5.8 1.8 0.0 1.8 0.2 0.0 9.7 0.2 1.5 0.9 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.2 0.0 6.6 0.5 0.0 0.5 3.9 3.8 0.0 0.2 3.0 1.3 0.0 0.2 0.1 11.1 2.8 36.3 0.4 0.0 3.2 0.0 0.8 2.1 0.2 0.0 1.7 6.2 0.0 2.9 0.7 0.1 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.3 0.1 5.5 0.0 6.8 1.7 0.0 0.0 10.2 1.9 0.0 0.2 0.0 0.0 0.9 1.4 28.4 21.7 5.4 63.7 69.0 26.8 9.4 10.4 15.9 5.0 21.4 16.2 0.2 0.0 4.8 6.2 0.0 0.6 8.6 8.4 10.2 17.9 9.7 5.0 9.5 5.7 14.8 16.5 10.4 0.1 0.3 0.1 31.3 0.6 3.1 4.0 0.4 0.6 1.2 0.0 83.7 6.9 0.0 3.8 2.6 6.1 0.0 9.1 0.4 1.8 2.8 21.9 89.7 0.1 2.0 0.6 0.3 3.4 20.5 0.3 5.4 8.4 0.0 1.6 0.0 101.6 2.5 2.6 0.0 12.4 0.1 4.6 0.0 0.3 5.4 6.2 0.0 1.4 2.8 1.3 10.7 68.3 1.7 0.0 1.7 65.5 0.3 25.7 SYT8 DKFZp434K0322 ENSG00000149043 "Synaptotagmin 8" Q8NBV8 11 1828307-1837521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.2;skin 1: 65.5;urinary bladder: 40.5" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 184.7;Basal squamous epithelial cells: 520.2;Breast myoepithelial cells: 192.9;Cholangiocytes: 183.0;Extravillous trophoblasts: 201.8;Respiratory ciliated cells: 163.8;Squamous epithelial cells: 132.5" "Group enriched" "Detected in many" 5 "cervical cancer: 10.5;pancreatic cancer: 21.7;urothelial cancer: 33.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CAPAN-2: 32.2;hTCEpi: 50.2;T-47d: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047239, HPA052700" Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA047239: , HPA052700: AB_2681920" "unprognostic (1.66e-3)" "unprognostic (2.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.14e-1)" "unprognostic (6.31e-2)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (1.36e-2)" "unprognostic (1.02e-1)" "unprognostic (8.25e-2)" "unprognostic (7.09e-2)" "unprognostic (2.48e-1)" "unprognostic (2.33e-6)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (5.52e-2)" "unprognostic (2.77e-2)" 0.1 0.2 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.3 0.1 0.4 0.5 0.0 0.5 29.2 1.0 8.6 0.0 0.0 0.0 0.3 0.6 4.7 0.0 0.0 0.0 0.0 14.9 0.0 0.2 1.6 0.0 2.5 0.0 0.0 20.9 2.9 0.0 65.5 2.5 0.0 0.0 0.1 2.3 0.2 0.0 0.0 0.0 0.0 0.1 40.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 32.2 0.0 0.0 0.0 0.6 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 50.2 0.0 5.8 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.0 0.3 0.0 0.1 1.0 0.0 0.3 0.0 2.7 0.0 0.0 13.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 16.0 3.9 0.0 0.3 184.7 5.6 24.9 520.2 0.0 3.2 192.9 0.6 183.0 39.1 5.5 0.0 28.7 0.7 3.4 0.0 31.1 0.0 15.6 0.1 1.7 0.0 0.0 0.0 9.7 201.8 1.6 12.2 0.6 1.3 0.0 0.0 0.1 7.1 0.0 0.0 1.3 16.2 0.0 14.7 0.0 0.0 1.3 10.6 0.0 0.0 0.0 0.0 0.0 0.0 28.3 3.5 0.0 6.2 1.3 18.3 0.0 163.8 0.0 0.0 0.0 7.0 0.0 0.0 132.5 47.2 36.8 0.6 0.1 1.7 31.5 TAGLN "DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10" ENSG00000149591 Transgelin Q01995 11 117199370-117207464 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 9628.1;intestine: 11712.2" "Group enriched" "Detected in many" 4 "Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9" "Cancer enhanced" "Detected in all" "prostate cancer: 279.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 41.6;non-classical monocyte: 63.1" "Lineage enriched" "Detected in many" 12 "monocytes: 63.1" "Cell line enhanced" "Detected in all" "BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001447, HPA019467" Enhanced Approved Microtubules,Mitochondria,Cytosol No No 6300000 "Cluster 51: Monocytes - Innate immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Microtubules, Mitochondria" Cytosol "CAB001447: AB_564012, HPA019467: AB_1857245" "unprognostic (1.36e-2)" "unprognostic (1.06e-1)" "unprognostic (3.57e-3)" "unprognostic (1.91e-1)" "unprognostic (6.58e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (9.58e-3)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" "unprognostic (2.52e-3)" 2235.7 512.7 118.5 963.9 144.4 12.1 1680.5 126.1 215.9 3611.3 172.5 11712.2 451.2 9628.1 693.9 1954.6 4610.6 893.8 1583.5 119.6 120.4 774.5 302.8 1258.6 245.5 137.0 127.0 1643.4 218.6 65.3 254.6 348.0 129.2 4624.1 1154.6 22.9 461.8 6383.6 356.4 619.8 1948.4 7108.7 127.2 532.0 3148.4 202.5 138.2 52.2 723.2 152.4 59.9 5521.7 2331.2 130.0 17.5 5.5 293.3 8.2 140.0 123.8 226.7 1913.4 788.1 1641.8 609.0 1531.4 28.4 3.2 2145.6 2094.4 1.7 46.1 4.4 16.8 543.3 6.8 4.4 5.0 66.9 130.2 708.7 1.7 5.2 304.6 57.5 267.1 36.1 1499.7 3.3 4.5 3.3 6.7 1377.1 4.5 1.7 15.8 84.6 18.8 2.1 2.7 23.1 12.0 4.4 25.8 1.9 9.6 29.9 11.0 1.5 807.6 9.2 5.1 182.0 1598.8 276.9 14.4 86.6 8.9 8.8 21.7 9.1 7.7 6.2 1.8 2.7 0.1 0.3 41.6 0.5 3.6 0.1 0.0 3.2 5.1 0.2 0.1 0.3 0.0 63.1 1.6 0.5 2.1 118.5 144.4 126.1 215.9 119.6 120.4 137.0 127.0 129.2 127.2 138.2 130.0 264.8 38.5 6.1 4.6 10.3 63.9 453.4 248.6 10.8 9.9 74.0 2508.6 1.3 4.3 22.5 40.5 18.8 57.0 8.6 3.1 0.0 577.8 3.3 14.6 455.5 260.3 3.0 2.7 4.5 74.5 35.3 464.4 41.3 12.8 1.3 32.4 639.7 8.9 41.5 1.7 6.5 18.3 24.4 23.1 91.8 23.9 48.4 33.8 96.0 37.5 8.1 4.9 2.1 3.0 11.9 38.4 4.5 2306.4 3.2 414.0 12.1 2.2 23.0 9.9 2866.2 177.6 4563.9 6.0 13.7 8.6 60.9 32.2 15.1 8.3 3.1 62.0 TAGLN3 "NP22, NP25" ENSG00000144834 "Transgelin 3" Q9UI15 3 111998739-112013887 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 442.4;choroid plexus: 172.3;pituitary gland: 100.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7" "Cancer enriched" "Detected in many" 4 "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062620 Enhanced NA NA 9000000 "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA062620: AB_2684810" "unprognostic (1.55e-2)" "unprognostic (2.28e-1)" "unprognostic (1.81e-1)" "unprognostic (1.36e-3)" "unprognostic (4.28e-1)" "unprognostic (4.07e-1)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (8.92e-2)" "unprognostic (6.82e-3)" "unprognostic (2.51e-1)" "unprognostic (5.49e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (8.60e-2)" "unprognostic (7.67e-3)" 0.3 33.5 291.3 1.5 313.2 0.0 0.1 250.3 442.4 0.0 172.3 11.4 0.6 0.0 0.0 0.2 0.0 0.2 0.6 318.0 310.2 4.5 0.3 0.5 0.2 300.5 235.8 0.3 5.6 0.0 100.9 0.0 292.8 0.5 2.3 74.3 0.2 0.2 0.2 0.6 2.4 1.1 212.3 0.1 3.3 0.3 254.2 1.3 0.4 0.0 0.2 0.2 1.1 309.3 0.0 0.0 104.1 0.2 0.0 0.0 0.1 2.6 1.9 0.1 0.1 0.4 0.2 0.0 3.8 0.0 0.1 0.7 0.1 7.2 1.4 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.5 0.0 0.0 0.8 0.4 0.0 0.1 0.0 4.0 0.0 9.0 15.1 2.8 0.0 41.6 0.0 55.5 94.5 0.0 0.1 0.0 2.1 0.1 0.3 0.0 0.3 0.3 0.0 0.3 0.1 0.1 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 291.3 313.2 250.3 442.4 318.0 310.2 300.5 235.8 292.8 212.3 254.2 309.3 0.1 0.0 0.0 16.6 0.0 0.8 1.2 1.0 0.0 104.3 0.2 0.3 0.7 0.0 1.8 5.5 8.4 0.0 0.1 0.0 0.0 0.1 2.6 0.2 0.0 1.1 5.3 0.0 78.1 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 297.8 49.3 0.0 30.5 0.0 0.0 0.9 0.0 0.4 0.0 15.0 0.0 16.3 0.0 32.2 18.8 2.3 0.0 0.0 0.0 1.1 0.0 31.9 12.8 50.7 0.0 0.4 0.5 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.9 TAT ENSG00000198650 "Tyrosine aminotransferase" P17735 16 71565660-71577092 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Aminotransferase, Transferase" "Disease variant, Mental retardation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "liver: 1272.2" "Cell type enriched" "Detected in some" 43 "Hepatocytes: 4164.8" "Cancer enriched" "Detected in some" 10 "liver cancer: 152.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (3.66e-3)" "unprognostic (1.29e-1)" "unprognostic (8.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.01e-2)" "prognostic favorable (6.51e-4)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-3)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.1 58.9 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.4 1272.2 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.6 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.8 0.1 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.7 6.7 0.0 0.1 0.0 0.0 0.6 95.3 18.7 0.5 72.9 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.3 1.0 0.3 0.0 3.1 0.0 45.5 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.1 49.6 4164.8 0.0 0.0 0.0 0.0 0.0 72.3 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 2.7 0.2 0.3 1.0 0.0 0.0 0.1 1.3 1.3 0.0 0.0 0.0 3.9 0.0 0.1 0.0 TCF21 "bHLHa23, POD1" ENSG00000118526 "Transcription factor 21" O43680 6 133889113-133895553 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 100.4;ovary: 88.3;placenta: 137.2" "Group enriched" "Detected in some" 5 "Fibroblasts: 123.8;Leydig cells: 102.2;Peritubular cells: 116.9;Sertoli cells: 118.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 1.7;hippocampal formation: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HHSteC: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA013189 Uncertain NA NA "Cluster 19: Lung - Lung function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 33: Fibroblasts - ECM organization" "HPA013189: AB_10601215" "unprognostic (2.43e-2)" "unprognostic (8.45e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "unprognostic (4.78e-5)" "unprognostic (2.58e-2)" "unprognostic (6.66e-2)" "unprognostic (9.74e-2)" "unprognostic (2.88e-2)" "unprognostic (2.91e-3)" "unprognostic (2.01e-2)" "unprognostic (8.48e-2)" "unprognostic (5.37e-2)" "unprognostic (2.95e-1)" 8.9 10.7 0.1 11.0 0.0 0.0 0.3 0.4 1.7 3.3 2.7 24.6 23.4 9.4 13.1 19.4 3.5 20.2 22.6 1.6 0.0 38.3 5.1 58.5 0.3 0.2 0.0 88.3 10.4 1.3 3.5 137.2 0.1 37.0 21.2 0.0 0.1 42.2 1.1 0.1 26.7 14.3 0.0 100.4 21.0 3.4 0.1 0.1 0.3 0.7 0.0 40.3 8.5 0.1 0.0 1.3 0.0 0.2 0.2 0.0 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 51.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.0 2.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.7 1.6 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 3.2 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 5.5 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.6 1.3 0.0 0.0 0.0 0.0 1.9 123.8 0.5 0.0 0.0 0.5 0.7 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 102.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.9 0.1 0.3 0.0 0.0 0.0 0.0 118.3 0.3 20.8 0.3 0.4 1.4 0.0 5.7 0.1 14.5 0.0 0.4 TCF24 bHLHa25 ENSG00000261787 "Transcription factor 24" Q7RTU0 8 66946501-66962591 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 1.0;kidney: 1.1;testis: 1.5" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 5.1;Spermatocytes: 4.7;Spermatogonia: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.2;HEK 293: 5.5;HMC-1: 4.7;K-562: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (1.07e-1)" "unprognostic (9.14e-3)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (8.30e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (2.25e-1)" "unprognostic (9.38e-3)" "unprognostic (9.36e-2)" "unprognostic (1.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.0 0.3 0.1 1.1 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.2 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.5 0.2 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.2 0.9 0.4 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.3 0.1 0.7 0.7 0.6 0.5 0.3 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCP11 "D6S230E, FPPR, KIAA0229" ENSG00000124678 "T-complex 11" Q8WWU5 6 35118071-35148610 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 338 "testis: 340.8" "Group enriched" "Detected in some" 11 "Early spermatids: 1921.3;Late spermatids: 6899.4" "Cancer enhanced" "Detected in some" "cervical cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.6;WM-115: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048311 Supported NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "HPA048311: AB_2680351" "unprognostic (1.35e-1)" "prognostic favorable (5.02e-4)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (6.43e-4)" "unprognostic (8.09e-7)" "unprognostic (4.06e-3)" "unprognostic (1.25e-1)" "unprognostic (9.98e-2)" "unprognostic (9.53e-2)" "unprognostic (2.95e-1)" "unprognostic (1.61e-1)" "unprognostic (5.54e-4)" "unprognostic (9.41e-2)" "unprognostic (4.56e-2)" "unprognostic (2.77e-2)" "unprognostic (2.49e-1)" 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.7 0.1 1.0 0.1 0.2 0.0 0.1 0.6 0.2 0.2 0.1 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.4 0.1 0.2 0.4 0.1 0.1 0.0 0.0 0.2 340.8 0.0 0.1 0.2 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.6 0.1 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.3 0.4 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.0 0.1 0.1 0.4 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1921.3 0.3 0.1 1.7 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 6899.4 30.1 2.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 29.0 0.0 0.1 0.0 0.1 3.6 0.0 13.1 0.0 0.1 375.1 26.2 0.0 0.1 0.0 0.0 0.2 0.0 0.2 TCP11X1 ENSG00000268235 "T-complex 11 family, X-linked 1" X 102215301-102229532 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048311 Uncertain NA NA "HPA048311: AB_2680351" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCP11X2 ENSG00000215029 "T-complex 11 family, X-linked 2" X 102456862-102471842 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "Early spermatids: 4.6;Late spermatids: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048311 Supported NA NA "Cluster 25: Spermatids - Spermatogenesis" "HPA048311: AB_2680351" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCTE1 "D6S46, DRC5, FAP155, MGC33600" ENSG00000146221 "T-complex-associated-testis-expressed 1" Q5JU00 6 44278734-44297698 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 14.4;testis: 30.0" "Group enriched" "Detected in some" 10 "Early spermatids: 161.8;Late spermatids: 359.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;U-266/84: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031739 Uncertain Vesicles NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "HPA031739: AB_10601269" "unprognostic (3.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (7.06e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.49e-2)" "unprognostic (1.17e-2)" "unprognostic (7.05e-2)" "unprognostic (2.23e-5)" "unprognostic (7.68e-2)" "unprognostic (3.13e-2)" "unprognostic (1.37e-3)" "unprognostic (2.68e-1)" 0.2 0.2 1.4 0.0 1.3 0.9 0.2 6.2 1.3 0.9 1.3 0.2 0.0 0.4 0.2 0.1 14.4 0.1 0.1 1.4 1.0 0.1 0.1 1.4 0.0 3.0 3.3 0.5 0.1 0.0 0.5 1.9 1.5 0.2 0.1 1.0 0.2 0.1 0.1 0.5 0.2 0.1 2.6 0.2 0.1 30.0 1.2 0.1 0.1 0.2 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.7 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 6.2 1.3 1.4 1.0 3.0 3.3 1.5 2.6 1.2 1.0 0.1 0.0 0.0 1.0 0.0 0.1 0.1 0.7 0.0 1.1 0.1 0.1 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 161.8 7.3 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 359.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 16.0 0.2 0.0 0.4 0.3 23.9 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TCTEX1D1 FLJ40873 ENSG00000152760 "Tctex1 domain containing 1" Q8N7M0 1 66752459-66779047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 8.9;liver: 7.1" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 55.7;granulocytes: 25.9;Inhibitory neurons: 21.6;Respiratory ciliated cells: 104.2" "Cancer enriched" "Detected in single" 10 "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEL: 14.6;HUVEC TERT2: 13.4;THP-1: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA028420 Uncertain NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "HPA028420: AB_10603995" "unprognostic (3.54e-2)" "unprognostic (2.32e-2)" "unprognostic (3.72e-4)" "unprognostic (1.22e-1)" "unprognostic (9.65e-3)" "unprognostic (1.81e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-2)" "unprognostic (1.01e-1)" "unprognostic (2.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.53e-6)" "unprognostic (9.28e-4)" "unprognostic (2.78e-2)" "unprognostic (6.13e-3)" "unprognostic (3.65e-2)" 1.1 0.3 2.5 0.4 2.2 4.4 1.0 2.8 2.2 1.1 6.6 0.8 0.2 0.4 0.1 0.3 8.9 0.3 3.0 2.3 2.7 3.3 7.1 2.5 0.0 6.3 5.5 0.0 0.2 0.0 0.7 5.7 5.0 0.6 0.3 0.9 0.5 0.6 0.7 0.5 0.5 0.4 4.6 0.2 0.4 0.0 3.5 0.1 0.5 0.2 0.1 0.7 0.7 4.9 0.0 0.0 0.2 0.0 0.2 2.3 0.0 0.3 0.7 0.3 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 13.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.2 2.8 2.2 2.3 2.7 6.3 5.5 5.0 4.6 3.5 4.9 7.5 0.0 3.2 2.9 0.3 1.3 0.0 4.5 0.0 0.3 0.1 0.0 0.6 0.0 11.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 55.7 0.5 12.5 0.0 0.8 13.2 0.0 0.0 0.5 0.0 0.5 25.9 0.0 0.7 3.5 2.7 0.0 21.6 0.0 0.0 0.6 0.8 0.1 0.0 3.0 0.0 1.9 0.3 6.1 0.0 0.5 0.5 0.0 0.0 0.4 1.2 0.5 0.0 0.0 104.2 0.6 0.0 0.4 1.3 0.0 0.1 0.0 0.6 0.0 3.1 0.1 0.0 0.1 TCTEX1D4 ENSG00000188396 "Tctex1 domain containing 4" Q5JR98 1 44805893-44807351 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 21.6;fallopian tube: 10.2" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 94.5;Respiratory ciliated cells: 129.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 12 "neutrophil: 7.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.9" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.7;TIME: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA062652 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA062652: AB_2684818" "unprognostic (3.12e-1)" "unprognostic (3.13e-1)" "unprognostic (1.81e-1)" "prognostic favorable (1.58e-4)" "unprognostic (5.28e-2)" "unprognostic (3.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.26e-1)" "unprognostic (3.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.26e-2)" "unprognostic (4.92e-2)" "unprognostic (4.70e-3)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.83e-3)" 1.1 2.0 0.7 1.2 1.0 2.4 0.4 1.1 2.1 1.1 21.6 0.4 0.4 1.3 2.2 0.7 10.2 1.8 0.6 0.9 1.4 0.6 0.6 2.8 0.3 5.1 4.0 0.4 0.9 0.4 0.8 0.1 3.0 0.3 0.1 0.0 1.1 0.3 0.4 0.6 0.5 0.1 2.6 0.4 1.0 0.4 3.9 0.0 0.9 0.2 0.0 0.4 0.3 3.0 0.5 0.9 0.3 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.4 0.7 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 1.1 0.0 0.1 0.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.2 0.5 0.9 0.0 0.0 1.8 0.1 0.7 0.2 0.3 0.7 0.4 0.0 0.2 0.2 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.2 0.7 1.0 1.1 2.1 0.9 1.4 5.1 4.0 3.0 2.6 3.9 3.0 0.2 0.0 0.5 0.0 0.3 0.3 0.4 11.4 0.0 0.0 0.6 0.8 0.2 1.5 10.6 1.8 0.0 0.2 0.1 0.9 0.0 1.2 0.0 94.5 0.9 0.4 0.0 0.0 0.0 4.0 0.2 0.4 0.0 1.5 0.0 0.2 0.0 1.2 0.8 0.0 0.0 1.7 10.2 1.2 0.9 0.1 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 2.4 0.0 0.0 0.4 2.3 1.3 129.4 0.0 0.0 0.8 3.8 0.1 0.6 0.0 0.0 0.3 0.3 0.5 0.6 0.5 TCTN2 "C12orf38, FLJ12975, JBTS24, MKS8, TECT2" ENSG00000168778 "Tectonic family member 2" Q96GX1 12 123671110-123708399 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 27.6;Respiratory ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039900 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus, Vesicles" "HPA039900: AB_10673366" "unprognostic (3.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-2)" "unprognostic (1.63e-3)" "unprognostic (1.32e-1)" "unprognostic (3.09e-3)" "unprognostic (3.14e-2)" "unprognostic (7.05e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-3)" "unprognostic (2.23e-1)" "unprognostic (1.69e-1)" "unprognostic (2.79e-1)" "unprognostic (2.46e-1)" "unprognostic (7.86e-2)" "unprognostic (2.68e-1)" 5.3 4.4 5.5 2.6 6.4 1.9 7.2 5.8 5.3 10.0 30.4 5.7 2.1 11.0 11.0 3.4 28.5 6.4 4.8 4.9 9.5 10.0 1.4 8.3 3.3 8.4 11.5 14.7 6.9 14.1 16.3 4.6 6.5 9.6 4.0 17.6 9.1 8.6 1.7 8.3 3.8 6.0 7.1 4.1 5.4 11.1 8.7 2.5 12.4 2.1 3.0 5.2 6.7 4.1 14.9 15.1 10.7 15.6 15.0 16.5 13.1 5.4 10.9 11.5 8.7 7.9 14.5 0.5 9.2 8.9 10.0 19.6 6.2 4.9 11.2 2.5 7.6 1.2 10.6 7.2 5.0 3.7 4.8 8.0 8.8 16.3 4.8 34.9 15.7 5.1 7.1 0.3 7.1 7.9 4.5 7.4 6.8 5.9 9.1 4.0 10.8 1.5 13.7 11.1 6.5 8.3 18.2 6.0 8.4 11.0 25.5 5.6 9.8 16.0 8.2 14.7 7.1 4.3 8.9 1.4 20.9 0.4 9.7 1.7 0.2 1.2 1.9 0.6 2.7 1.9 2.2 2.0 0.4 2.1 2.4 2.4 0.3 0.8 0.5 2.5 1.4 0.2 5.5 6.4 5.8 5.3 4.9 9.5 8.4 11.5 6.5 7.1 8.7 4.1 2.7 3.2 5.3 6.5 1.8 4.1 2.3 2.6 1.2 4.4 4.8 2.3 3.8 5.7 3.9 7.3 12.5 2.8 2.1 1.2 0.0 2.9 6.1 27.6 5.0 1.7 1.2 2.5 10.4 2.1 3.0 4.6 2.6 4.3 3.8 5.0 2.9 0.4 1.3 0.0 14.4 1.8 2.0 0.3 1.2 2.8 2.5 1.0 5.4 2.8 1.4 4.6 1.0 2.5 1.3 2.0 0.8 4.9 1.1 1.4 0.2 1.9 32.1 14.5 0.0 6.0 2.7 11.5 10.9 0.6 2.3 1.1 2.4 2.3 3.0 1.0 TEKT1 ENSG00000167858 "Tektin 1" Q969V4 17 6789133-6831761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "fallopian tube: 50.4" "Group enriched" "Detected in some" 6 "Early spermatids: 412.2;Endometrial ciliated cells: 173.1;Late spermatids: 146.2;Respiratory ciliated cells: 288.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 7.8" "HPA044444, HPA062285" Approved NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "HPA044444: AB_10961038, HPA062285: AB_2684737" "unprognostic (7.28e-3)" "unprognostic (7.24e-3)" "prognostic favorable (6.08e-4)" "unprognostic (2.88e-2)" "unprognostic (8.04e-2)" "unprognostic (3.73e-2)" "unprognostic (1.91e-1)" "unprognostic (4.22e-1)" "unprognostic (2.88e-2)" "unprognostic (1.62e-1)" "unprognostic (7.63e-6)" "unprognostic (6.28e-2)" "unprognostic (2.78e-2)" "unprognostic (9.53e-3)" "unprognostic (3.13e-1)" 0.0 0.0 1.6 0.0 1.8 0.5 0.0 1.2 1.2 1.5 9.5 0.0 0.0 1.2 0.3 0.9 50.4 0.9 0.5 1.8 2.2 0.0 0.2 4.6 0.3 5.9 6.5 0.3 0.0 0.0 0.8 0.0 4.2 0.0 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.1 4.8 0.1 0.1 9.9 2.0 0.1 0.3 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.8 1.2 1.2 1.8 2.2 5.9 6.5 4.2 4.8 2.0 4.0 0.1 0.0 1.5 2.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.5 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 412.2 173.1 1.5 0.2 0.0 0.0 1.9 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 18.3 0.0 0.0 146.2 2.8 0.3 0.0 0.0 0.0 1.0 0.0 1.5 1.1 0.0 0.0 0.7 0.0 0.2 0.0 0.1 288.1 0.0 0.0 0.0 5.3 38.2 3.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 TEKT2 TEKTB1 ENSG00000092850 "Tektin 2" Q9UIF3 1 36084094-36088275 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 62.8;testis: 71.2" "Group enriched" "Detected in some" 4 "Early spermatids: 523.7;Late spermatids: 306.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enriched" "Detected in some" 8 "NB-4: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA027248, HPA027461" Approved Approved Microtubules NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Microtubules "HPA027248: AB_1857884, HPA027461: AB_10600912" "unprognostic (1.02e-3)" "unprognostic (1.21e-2)" "unprognostic (2.96e-2)" "unprognostic (2.12e-3)" "unprognostic (2.64e-1)" "unprognostic (1.78e-2)" "unprognostic (1.98e-2)" "unprognostic (3.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-3)" "unprognostic (5.28e-4)" "unprognostic (6.11e-2)" "prognostic favorable (1.98e-4)" "unprognostic (9.78e-2)" "unprognostic (8.35e-2)" "unprognostic (5.29e-2)" "unprognostic (7.68e-2)" 0.2 0.5 2.2 0.1 2.4 1.5 0.9 1.9 2.6 3.5 12.2 0.6 0.1 1.5 0.1 0.2 62.8 0.1 0.1 2.3 3.0 3.1 0.1 6.3 0.1 4.6 6.3 0.5 2.4 0.7 4.3 0.0 3.7 0.7 0.0 0.1 0.4 0.5 0.0 0.2 0.2 0.3 4.4 0.0 0.4 71.2 3.1 1.1 2.7 0.0 0.0 0.1 0.3 3.3 0.0 0.0 4.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 37.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.2 2.4 1.9 2.6 2.3 3.0 4.6 6.3 3.7 4.4 3.1 3.3 0.2 0.0 0.0 0.0 0.2 0.1 0.6 9.4 0.0 0.0 0.8 0.6 0.6 0.0 8.0 1.8 0.0 0.2 0.0 0.0 0.0 0.9 523.7 81.2 0.8 0.4 1.8 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.1 12.2 0.0 0.0 306.1 5.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.1 0.0 3.8 0.0 0.4 0.0 2.5 84.7 0.1 0.0 0.0 2.6 27.6 4.0 0.0 0.0 0.0 0.2 0.4 0.1 0.5 TEKT3 FLJ32828 ENSG00000125409 "Tektin 3" Q9BXF9 17 15303811-15341632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 31.0" "Group enriched" "Detected in some" 10 "Early spermatids: 413.1;Late spermatids: 408.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "basophil: 1.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;SuSa: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027293, HPA044354, HPA073565" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 12: NES - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Plasma membrane" Nucleoplasm "HPA027293: , HPA044354: AB_10962623, HPA073565: " "unprognostic (1.85e-1)" "unprognostic (6.64e-3)" "unprognostic (9.73e-2)" "unprognostic (5.38e-4)" "unprognostic (4.59e-2)" "unprognostic (3.09e-2)" "unprognostic (9.07e-2)" "unprognostic (8.63e-3)" "unprognostic (4.91e-2)" "unprognostic (1.23e-1)" "unprognostic (9.67e-4)" "unprognostic (1.29e-1)" "unprognostic (1.09e-4)" "unprognostic (1.69e-2)" "unprognostic (3.00e-1)" "unprognostic (2.90e-3)" "unprognostic (7.85e-2)" 0.3 0.2 0.7 0.3 0.6 0.1 0.5 1.4 0.9 1.2 0.6 0.3 0.3 0.5 0.6 0.1 4.9 0.4 0.2 0.4 0.4 0.3 0.2 0.8 0.1 0.9 1.0 0.9 0.7 0.2 1.0 0.3 0.5 0.4 0.2 0.6 0.5 0.1 0.1 0.7 0.4 0.2 0.5 0.2 0.2 31.0 0.4 0.1 0.7 0.0 0.1 0.2 0.4 1.1 0.0 0.0 0.4 0.5 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.1 0.1 0.1 1.5 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.7 0.3 0.0 0.1 0.0 0.0 0.7 0.6 1.4 0.9 0.4 0.4 0.9 1.0 0.5 0.5 0.4 1.1 0.7 3.2 0.5 0.7 0.1 0.3 0.1 0.7 0.0 0.7 0.5 0.5 0.7 1.5 4.7 0.0 0.0 0.3 0.2 0.5 0.0 0.1 413.1 16.3 1.7 0.7 1.8 0.0 1.2 0.0 0.5 3.9 0.0 0.5 0.0 0.7 0.4 0.1 3.8 0.0 1.1 0.0 0.0 0.0 1.4 408.9 11.1 0.3 0.0 1.0 0.0 1.7 0.0 2.0 0.8 0.0 0.1 6.4 0.0 0.2 0.7 0.1 39.1 0.2 6.6 3.2 1.4 25.9 2.6 0.0 0.1 0.0 0.1 3.4 0.0 0.2 TEKT4 MGC27019 ENSG00000163060 "Tektin 4" Q8WW24 2 94871430-94876823 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.4" "Group enriched" "Detected in many" 7 "Early spermatids: 137.1;Endometrial ciliated cells: 49.0;Late spermatids: 129.3;Respiratory ciliated cells: 51.6" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 2.7" "Region enhanced" "Detected in single" "midbrain: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 2.9" "HPA048600, HPA053929, HPA069872" Enhanced Uncertain "Intermediate filaments" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "Intermediate filaments" "HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: " "unprognostic (1.49e-2)" "unprognostic (4.00e-1)" "prognostic favorable (1.29e-4)" "unprognostic (9.95e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (2.82e-3)" "unprognostic (2.15e-1)" "unprognostic (5.25e-2)" "unprognostic (5.00e-2)" "unprognostic (9.01e-2)" "unprognostic (5.25e-3)" "unprognostic (5.45e-3)" "unprognostic (2.33e-1)" "unprognostic (3.27e-2)" "unprognostic (7.56e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.7 1.6 0.5 0.3 0.1 0.2 3.6 0.0 1.5 2.9 0.4 1.5 0.1 1.9 0.0 0.0 0.7 0.6 0.5 7.2 4.7 1.8 0.0 0.5 0.1 0.3 1.9 1.9 137.1 49.0 1.3 1.3 0.0 0.0 1.3 0.4 0.5 1.1 0.0 0.9 1.3 0.1 1.8 1.5 0.2 0.0 0.9 0.2 0.0 1.6 0.5 129.3 2.8 0.8 0.0 1.0 2.6 0.0 0.0 2.0 2.3 0.8 0.0 1.2 0.0 0.4 0.0 8.3 51.6 0.0 6.6 0.6 0.9 12.4 2.4 0.0 1.3 0.5 0.5 0.0 0.2 0.4 TEX26 "C13orf26, MGC40178" ENSG00000175664 "Testis expressed 26" Q8N6G2 13 30932656-30975500 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 21.5" "Group enriched" "Detected in some" 19 "Early spermatids: 847.1;Late spermatids: 1640.3" "Cancer enriched" "Detected in single" 7 "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA079709 Approved "Golgi apparatus" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA079709: " "unprognostic (2.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (1.53e-2)" "unprognostic (9.27e-2)" 0.1 0.4 1.2 0.0 1.3 0.0 0.0 0.9 1.2 0.8 4.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 1.1 4.5 0.0 0.1 0.2 0.0 2.3 2.3 0.0 0.0 0.0 1.3 0.0 2.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 21.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.9 1.2 1.1 4.5 2.3 2.3 2.1 2.0 4.6 1.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 28.6 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 847.1 19.0 0.1 0.4 0.0 0.0 4.3 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.0 6.1 0.0 0.0 1640.3 8.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 7.9 0.0 0.0 0.0 0.0 65.4 0.0 0.0 1.1 1.1 15.5 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TEX9 ENSG00000151575 "Testis expressed 9" Q8N6V9 15 56244009-56445997 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 89.1;Endometrial ciliated cells: 86.2;Respiratory ciliated cells: 125.6;Spermatocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "basophil: 4.3;memory B-cell: 14.4;naive B-cell: 11.4" "Group enriched" "Detected in many" 12 "B-cells: 14.4;granulocytes: 4.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039415 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Plasma membrane" "HPA039415: AB_10672775" "unprognostic (3.27e-1)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (4.71e-3)" "unprognostic (2.34e-1)" "unprognostic (5.13e-2)" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "unprognostic (8.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" 1.8 6.1 4.1 4.6 3.9 3.4 10.1 7.4 3.9 8.8 17.0 3.6 11.6 5.2 8.4 4.4 28.0 5.2 1.1 3.2 4.2 10.8 1.5 4.4 6.0 9.4 8.6 5.4 5.4 14.2 9.9 1.6 4.5 4.5 4.8 18.0 10.5 3.4 1.2 5.6 8.0 2.2 5.3 3.2 12.2 16.4 6.6 3.7 17.4 1.5 10.6 2.7 1.6 5.7 7.8 7.1 15.3 13.7 3.7 10.8 2.0 1.7 6.3 4.8 5.7 1.7 6.9 15.5 7.0 1.2 8.2 6.6 6.6 7.4 5.5 1.7 7.8 9.1 6.7 5.2 1.1 3.3 1.3 5.9 13.3 5.4 4.1 6.9 0.2 11.1 5.2 1.4 2.6 4.5 6.5 1.2 7.2 13.2 3.0 2.6 7.1 5.5 15.9 4.4 24.3 9.8 8.7 4.9 5.5 11.2 14.6 3.0 0.7 20.3 5.8 6.5 6.4 2.1 16.5 11.7 8.0 1.7 3.9 4.3 0.1 0.1 0.4 0.6 0.1 14.4 0.4 0.3 0.2 11.4 0.2 0.8 0.3 0.4 0.4 0.4 0.6 0.7 4.1 3.9 7.4 3.9 3.2 4.2 9.4 8.6 4.5 5.3 6.6 5.7 1.5 6.4 7.5 38.8 21.0 4.2 7.3 13.2 20.5 6.4 11.3 11.7 0.8 5.7 23.5 11.0 12.5 1.8 0.3 2.3 21.5 15.6 89.1 86.2 5.1 3.2 7.7 5.9 14.3 7.0 0.5 5.0 17.3 4.8 1.3 5.1 1.8 0.4 1.3 1.7 20.4 3.7 16.2 0.0 2.1 40.9 4.7 2.7 3.6 4.7 1.2 6.8 1.0 14.6 15.1 4.5 5.4 3.8 15.8 3.7 12.3 21.7 125.6 37.5 0.0 4.6 6.0 74.6 36.6 6.9 2.3 0.3 1.0 6.2 6.7 4.9 TFAP2A "AP-2, AP2TF, TFAP2" ENSG00000137203 "Transcription factor AP-2 alpha" P05549 6 10393186-10419659 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 32.8;skin 1: 66.7" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 167.9;Cytotrophoblasts: 285.8;Extravillous trophoblasts: 260.6;Squamous epithelial cells: 147.7;Syncytiotrophoblasts: 700.1" "Cancer enhanced" "Detected in many" "melanoma: 45.6" "Group enriched" "Detected in many" 4 "cerebellum: 4.1;medulla oblongata: 3.0;midbrain: 1.3;pons: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 104.7;hTCEpi: 97.3;SuSa: 97.3" "Group enriched" "Detected in some" 4 "cerebellum: 3.9;pons and medulla: 1.0" "Low region specificity" "Detected in many" "CAB000326, HPA056871" Enhanced Enhanced Nucleoplasm NA NA "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "CAB000326: AB_667767, HPA056871: AB_2683262" "unprognostic (5.97e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-2)" "unprognostic (1.27e-1)" "unprognostic (7.62e-5)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.45e-1)" "unprognostic (2.76e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-11)" "unprognostic (1.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-4)" "unprognostic (2.25e-2)" 0.5 0.4 0.4 0.1 0.3 0.1 32.8 4.1 0.4 7.5 0.2 1.1 0.5 0.3 21.8 29.9 0.4 0.2 0.9 0.3 0.1 7.4 0.1 0.5 0.4 3.0 1.3 0.4 0.2 0.6 0.4 29.6 2.1 9.8 0.5 8.1 23.5 9.3 0.5 66.7 0.8 0.1 0.5 0.1 1.4 2.2 0.5 0.2 0.5 0.1 5.1 3.5 16.6 0.6 51.8 17.8 0.1 87.9 0.4 0.0 19.7 40.2 30.3 31.7 31.4 2.1 19.3 3.2 4.9 12.0 17.5 53.2 4.3 66.1 30.9 104.7 45.2 0.4 44.5 0.0 0.0 1.7 1.5 0.0 97.3 0.1 66.6 18.3 0.0 0.9 3.3 0.1 0.3 12.2 0.0 17.2 0.5 3.3 24.7 5.9 5.0 2.2 18.8 21.8 12.5 0.3 44.1 82.7 82.3 97.3 56.0 1.7 0.0 9.9 2.7 7.1 25.3 0.1 5.1 0.8 5.1 1.7 59.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 4.1 0.4 0.3 0.1 3.0 1.3 2.1 0.5 0.5 0.6 0.5 0.0 0.0 0.0 0.4 130.6 45.5 50.3 167.9 25.9 98.2 65.7 2.7 0.0 30.5 31.3 2.1 285.8 0.5 1.0 7.9 2.2 5.3 1.2 0.7 2.1 1.2 0.0 0.0 0.4 260.6 4.2 0.0 1.5 0.0 0.1 0.0 0.0 20.4 80.8 0.0 0.5 46.8 0.0 6.1 3.8 0.6 0.5 124.5 0.0 0.0 4.3 0.0 0.0 0.1 3.7 0.5 0.0 1.2 58.2 0.1 0.3 21.5 4.6 0.0 0.3 4.1 6.5 16.8 147.7 138.4 700.1 0.3 0.3 0.5 46.7 TGM3 TGE ENSG00000125780 "Transglutaminase 3" Q08188 20 2296001-2341079 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "esophagus: 1838.1" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 46.2;Squamous epithelial cells: 22.5" "Cancer enriched" "Detected in many" 9 "head and neck cancer: 81.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 295 "neutrophil: 30.3" "Lineage enriched" "Detected in single" 303 "granulocytes: 30.3" "Cell line enriched" "Detected in single" 14 "EFO-21: 5.2" HPA004728 Approved NA NA 14000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 38: EFO-21 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA004728: AB_1080360" "unprognostic (7.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.18e-2)" "unprognostic (3.23e-3)" "unprognostic (4.27e-2)" "unprognostic (4.20e-2)" "unprognostic (8.62e-2)" "unprognostic (4.21e-2)" "unprognostic (1.50e-1)" "unprognostic (8.00e-2)" "unprognostic (4.88e-3)" "unprognostic (1.35e-1)" "unprognostic (7.78e-8)" "unprognostic (1.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.45e-2)" "unprognostic (9.67e-2)" 0.6 0.3 0.2 0.2 0.0 1.4 3.9 0.0 0.1 54.3 0.0 0.3 0.0 0.2 0.8 1838.1 1.4 2.2 0.4 0.2 0.0 0.2 0.8 0.5 0.0 0.1 0.3 0.3 1.1 0.0 1.6 0.1 0.1 0.6 0.8 0.0 229.3 0.0 0.4 83.1 0.4 0.0 0.1 0.4 2.2 2.0 0.0 0.1 0.1 0.0 142.9 0.3 31.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.9 4.0 0.1 0.1 46.2 0.0 0.4 0.0 0.0 0.3 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.3 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.2 0.5 22.5 8.2 0.0 0.0 0.1 0.3 0.2 TIGD4 ENSG00000169989 "Tigger transposable element derived 4" Q8IY51 4 152769354-152779730 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 22.1" "Group enriched" "Detected in many" 4 "Early spermatids: 107.6;Rod photoreceptor cells: 30.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.1;U-266/70: 4.5;U-266/84: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035649, HPA073768" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 16: U-266 - Nucleosome" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol Nucleoplasm "HPA035649: AB_10670956, HPA073768: " "unprognostic (1.71e-1)" "unprognostic (5.97e-2)" "unprognostic (4.01e-2)" "unprognostic (1.23e-4)" "unprognostic (6.19e-3)" "unprognostic (1.82e-2)" "unprognostic (1.61e-5)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (3.89e-3)" "unprognostic (1.16e-2)" "unprognostic (3.36e-2)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-2)" "unprognostic (4.47e-2)" 0.2 0.3 0.6 0.2 0.7 0.0 0.4 0.6 0.7 0.8 1.3 0.2 0.3 0.7 1.2 0.1 2.0 0.2 0.3 0.5 0.9 0.7 0.1 0.4 0.1 1.1 1.2 0.5 0.2 1.5 1.2 0.1 0.8 0.4 0.2 22.1 0.7 0.3 0.4 0.4 0.2 0.2 1.0 0.2 0.3 4.9 0.8 0.3 0.7 0.8 0.1 0.2 0.1 0.8 0.4 0.4 2.0 0.8 0.1 0.2 0.2 0.0 0.4 0.2 0.4 0.3 0.9 0.7 0.1 0.1 0.9 0.4 0.8 0.3 0.3 0.7 0.1 1.0 0.6 0.2 0.1 0.4 0.2 0.0 0.3 0.3 0.2 0.4 0.1 1.5 0.3 3.1 0.2 0.2 2.0 0.2 0.9 0.3 0.3 0.3 0.4 0.0 1.3 0.1 0.9 1.0 0.1 0.2 1.9 0.9 0.5 0.1 0.0 0.2 0.4 0.3 0.4 4.5 9.4 0.4 0.6 1.1 1.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.7 0.6 0.7 0.5 0.9 1.1 1.2 0.8 1.0 0.8 0.8 0.4 0.0 1.5 8.5 0.6 0.0 0.4 0.6 0.6 7.9 0.8 0.8 0.1 0.0 0.3 1.8 12.5 0.2 0.8 0.2 0.0 0.7 107.6 6.9 0.6 0.7 1.2 0.4 6.5 1.1 0.2 0.4 1.1 1.4 0.0 0.2 0.0 0.1 0.5 1.7 6.3 0.4 0.0 0.3 0.0 14.0 0.3 0.5 0.0 5.6 0.0 14.1 0.0 5.5 2.1 0.4 1.1 0.4 0.0 0.4 0.4 2.0 9.3 30.3 0.0 1.0 0.5 8.3 3.2 0.0 0.0 0.3 0.6 0.1 0.4 0.3 TINCR "FLJ90734, LINC00036, NCRNA00036, onco-lncRNA-16, PLAC2" ENSG00000223573 "TINCR ubiquitin domain containing" 19 5558167-5578349 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "skin 1: 119.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.4;Cytotrophoblasts: 61.0;Extravillous trophoblasts: 116.9;Squamous epithelial cells: 53.3;Suprabasal keratinocytes: 92.2;Syncytiotrophoblasts: 204.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 53.3;HaCaT: 35.9;MCF7: 14.9;SK-BR-3: 56.1" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "unprognostic (4.75e-2)" "unprognostic (2.99e-2)" "unprognostic (7.78e-2)" "unprognostic (1.78e-3)" "unprognostic (3.69e-1)" "unprognostic (2.54e-3)" "unprognostic (3.38e-2)" "unprognostic (3.95e-1)" "unprognostic (3.07e-1)" "unprognostic (1.66e-2)" "unprognostic (8.87e-2)" "unprognostic (1.24e-1)" "unprognostic (0.00e+0)" "unprognostic (4.22e-2)" "unprognostic (1.16e-1)" "unprognostic (3.63e-2)" "unprognostic (7.32e-2)" 0.9 1.9 6.6 0.7 6.6 2.9 3.6 4.7 8.0 5.7 1.0 2.0 0.5 0.6 1.5 21.2 0.7 0.5 0.5 4.9 4.8 1.1 0.1 2.9 0.9 4.1 7.3 0.6 0.3 0.3 2.9 17.8 7.2 4.7 2.5 2.8 4.3 0.8 0.9 119.1 0.8 0.4 0.6 0.9 0.3 1.7 11.7 0.2 0.5 0.0 4.9 1.4 13.7 4.4 2.0 1.6 0.2 0.6 0.5 1.0 53.3 0.2 0.1 0.1 0.2 0.9 6.3 0.3 0.5 0.2 0.5 35.9 0.6 0.1 0.4 0.6 1.2 0.4 1.9 0.5 0.1 0.7 0.5 0.0 11.5 0.3 0.3 0.3 0.0 2.9 0.3 0.8 0.1 14.9 0.2 0.8 1.0 1.4 2.5 1.2 0.4 1.3 0.0 3.8 0.7 0.1 3.9 56.1 5.6 5.0 6.7 0.5 0.0 0.6 0.5 1.0 0.1 1.4 0.4 1.0 0.3 0.7 1.1 3.2 0.4 0.5 0.4 0.3 0.3 0.9 0.3 0.3 0.1 0.9 0.3 0.4 2.3 0.6 0.4 1.3 0.4 0.2 6.6 6.6 4.7 8.0 4.9 4.8 4.1 7.3 7.2 0.6 11.7 4.4 2.1 12.8 1.7 0.3 0.6 46.4 5.2 2.9 21.1 4.2 6.1 3.2 1.3 4.3 2.6 1.8 0.0 61.0 1.4 3.3 11.7 0.0 0.4 1.2 1.8 2.4 1.8 0.0 0.8 0.5 116.9 1.7 0.0 2.6 0.0 0.5 2.9 0.3 6.6 0.0 1.2 3.0 4.1 1.4 4.6 0.2 0.6 1.2 7.2 0.0 0.5 3.5 1.0 0.0 0.2 0.1 7.5 0.7 0.1 5.9 0.1 0.4 1.9 2.1 0.0 3.6 1.3 1.0 3.1 53.3 92.2 204.5 1.1 0.2 0.9 10.1 TK1 ENSG00000167900 "Thymidine kinase 1" P04183 17 78174091-78187233 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA synthesis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 77.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 92.8;Erythroid cells: 108.6;Extravillous trophoblasts: 210.4;Hofbauer cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 34.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Region enhanced" "Detected in some" "white matter: 3.6" "Low region specificity" "Detected in many" CAB004683 Enhanced NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "CAB004683: AB_437067" "unprognostic (7.09e-2)" "unprognostic (1.17e-3)" "unprognostic (1.82e-1)" "unprognostic (2.14e-3)" "unprognostic (3.22e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.87e-4)" "prognostic unfavorable (3.03e-5)" "unprognostic (4.05e-2)" "unprognostic (3.18e-3)" "unprognostic (6.64e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (6.50e-11)" "unprognostic (5.55e-3)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (4.94e-2)" 3.7 2.7 2.5 20.4 3.4 77.9 5.9 3.6 3.4 5.9 1.3 24.4 18.0 3.0 0.2 27.2 4.9 3.4 2.8 2.7 2.4 11.0 9.2 9.1 34.8 3.4 3.3 1.3 5.6 0.6 0.6 14.8 3.3 3.4 15.7 0.1 6.3 1.5 5.5 14.2 18.3 10.1 2.6 12.4 17.9 3.1 3.8 25.1 2.0 1.6 30.6 5.5 9.0 4.4 443.9 357.7 68.2 92.5 7.6 28.0 47.3 207.6 113.2 323.1 442.3 324.2 178.7 144.1 72.9 131.7 133.9 204.2 63.4 187.1 158.0 51.2 230.4 252.5 119.9 213.3 2.2 107.1 162.9 13.8 7.1 166.1 22.5 22.3 137.9 49.4 156.7 311.9 130.8 352.0 56.0 68.6 36.7 259.1 240.9 152.6 276.4 324.1 90.6 138.5 33.6 94.2 162.0 481.2 59.7 59.4 303.9 156.1 57.8 302.3 305.7 219.9 292.1 132.5 71.4 181.9 149.0 71.9 142.1 0.0 1.1 0.0 1.8 2.1 0.7 5.8 7.9 4.0 3.4 1.7 0.4 2.2 1.8 10.8 1.7 1.1 34.0 5.5 2.5 3.4 3.6 3.4 2.7 2.4 3.4 3.3 3.3 2.6 3.8 4.4 1.6 0.0 2.7 0.0 17.1 28.4 13.3 17.8 2.2 0.0 10.6 9.4 0.9 2.8 8.3 12.9 0.0 92.8 3.6 35.0 7.9 7.7 3.0 9.2 3.3 10.6 5.4 108.6 0.3 11.2 210.4 15.7 19.4 7.0 0.0 15.9 7.5 10.5 65.2 0.0 0.2 32.7 8.2 15.5 19.1 6.8 0.6 10.9 3.6 0.0 5.7 0.0 3.1 0.0 1.0 9.6 7.5 0.7 53.6 4.9 3.1 17.5 5.8 0.0 0.0 1.7 20.1 3.8 16.8 24.7 11.2 51.0 8.7 1.7 60.8 24.0 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 141 "testis: 90.7" "Group enriched" "Detected in some" 104 "Early spermatids: 1153.9;Late spermatids: 3910.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA056530, HPA064017" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA056530: AB_2683167, HPA064017: " "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 90.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1153.9 0.2 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3910.6 13.4 1.1 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 1.1 0.0 6.6 0.0 0.0 24.2 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TMEM190 MDAC1 ENSG00000160472 "Transmembrane protein 190" Q8WZ59 19 55376826-55378246 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 138.1;testis: 57.6" "Cell type enhanced" "Detected in some" "Early spermatids: 556.2;Endometrial ciliated cells: 307.5;Late spermatids: 179.0;Respiratory ciliated cells: 1386.5" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 11.5" "Region enhanced" "Detected in many" "cerebellum: 6.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 10.6;SCLC-21H: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (5.00e-2)" "unprognostic (6.58e-2)" "unprognostic (6.24e-3)" "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (5.02e-1)" "unprognostic (2.08e-1)" "unprognostic (4.95e-2)" "unprognostic (1.03e-1)" "unprognostic (5.38e-5)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.93e-1)" 0.2 1.5 0.3 0.2 0.2 0.2 0.0 6.5 0.8 7.6 0.0 0.3 0.2 0.4 0.0 0.1 138.1 0.2 0.0 0.4 0.1 1.4 0.0 18.2 0.1 1.5 2.8 0.2 0.1 0.0 7.4 0.6 1.4 0.5 0.0 0.2 0.1 0.5 0.0 1.3 0.1 0.1 0.0 0.1 1.0 57.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 1.8 0.0 0.4 0.0 0.0 0.2 0.5 0.2 0.4 0.1 1.3 1.1 1.8 0.1 0.5 0.2 3.3 0.0 0.0 0.0 3.2 0.1 0.0 2.2 10.6 0.6 0.0 0.0 0.2 0.0 0.1 0.0 3.4 0.0 0.1 0.0 2.5 0.0 1.5 0.2 0.0 0.4 1.3 0.5 0.1 1.2 1.1 0.0 0.9 5.0 0.9 1.0 1.3 0.4 0.9 0.5 0.0 0.0 0.1 0.8 0.1 0.5 0.3 2.5 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 6.5 0.8 0.4 0.1 1.5 2.8 1.4 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 63.5 0.0 0.6 0.0 0.0 0.0 0.0 66.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 556.2 307.5 1.8 0.4 8.9 0.0 0.0 0.0 0.1 1.8 0.0 3.7 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 91.6 0.0 0.0 179.0 5.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.2 0.0 0.0 1386.5 0.1 0.0 0.0 28.6 3.4 1.8 0.0 0.0 0.4 0.2 0.0 0.0 0.3 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.8;fallopian tube: 30.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 30.9;Club cells: 25.8;granulocytes: 15.2;Respiratory ciliated cells: 102.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: AB_2679436" "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 1.0 0.9 2.6 1.5 5.7 3.8 0.9 15.8 12.9 0.9 0.8 1.9 1.0 1.7 1.6 0.6 30.2 1.1 0.9 4.9 0.6 0.8 6.5 4.2 1.6 0.6 1.7 1.4 0.9 0.8 0.0 1.2 1.3 1.1 1.9 7.9 1.4 0.6 2.6 2.7 1.4 0.5 0.0 1.5 1.2 2.8 3.1 0.6 1.3 0.3 1.0 0.6 0.0 10.8 2.1 1.5 1.5 1.5 0.4 0.1 3.0 1.2 0.5 0.6 0.6 1.3 1.7 3.0 1.5 0.9 1.4 1.4 1.0 0.8 1.4 4.3 1.4 2.7 4.5 1.5 0.2 2.4 2.2 0.7 0.6 0.8 0.6 0.7 0.8 1.8 2.2 4.5 0.5 1.7 1.7 2.2 2.4 0.9 1.3 1.4 2.1 2.2 0.6 2.2 1.9 1.6 2.1 1.6 1.1 1.4 1.6 1.6 3.6 2.0 2.4 3.4 1.5 2.7 2.3 1.8 1.1 1.4 1.1 3.2 0.7 0.6 0.8 0.6 0.6 0.5 0.5 0.5 0.3 1.1 0.6 0.7 1.5 1.2 0.7 1.1 0.4 0.2 2.6 5.7 15.8 12.9 4.9 0.6 0.6 1.7 1.3 0.0 3.1 10.8 0.0 35.3 30.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 25.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 9.2 0.2 3.6 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.1 15.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.5 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.7 0.0 0.0 0.3 0.3 0.7 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.1 TMEM231 "ALYE870, FLJ22167, JBTS20, MKS11, PRO1886" ENSG00000205084 "Transmembrane protein 231" Q9H6L2 16 75536741-75556268 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "fallopian tube: 48.5" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 121.2;Respiratory ciliated cells: 132.2;Rod photoreceptor cells: 33.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042081 Enhanced Approved Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA042081: AB_10795391" "unprognostic (4.29e-2)" "unprognostic (9.84e-2)" "unprognostic (8.07e-2)" "unprognostic (2.71e-3)" "unprognostic (1.03e-1)" "unprognostic (9.34e-2)" "unprognostic (2.90e-2)" "unprognostic (2.81e-1)" "unprognostic (2.92e-1)" "unprognostic (1.69e-2)" "unprognostic (3.34e-3)" "unprognostic (7.84e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (1.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 2.4 3.3 5.1 1.4 5.1 1.4 2.5 5.0 5.2 3.6 11.9 2.5 2.4 4.2 3.6 1.7 48.5 3.2 6.0 5.3 6.5 2.9 1.1 4.6 1.6 8.8 10.3 4.7 3.1 7.0 4.9 2.2 7.1 3.5 1.9 5.2 1.5 3.5 1.0 2.3 2.6 5.5 8.5 1.5 1.9 4.5 7.3 0.9 5.8 1.2 1.0 2.6 1.7 5.1 4.0 2.6 7.1 12.0 6.8 16.6 3.8 5.0 6.3 6.1 7.3 1.4 7.0 5.0 6.7 6.9 5.1 10.3 0.8 5.3 3.9 0.9 2.9 0.3 3.6 1.6 5.9 2.9 2.1 3.7 7.0 6.2 15.1 11.0 3.3 4.5 4.8 0.2 1.8 11.5 1.8 5.2 4.0 0.8 2.1 0.9 1.0 11.5 7.4 1.6 5.7 3.8 8.8 2.5 4.4 2.3 2.3 3.0 5.1 4.7 3.7 3.0 2.6 9.1 8.4 1.6 11.9 1.3 4.6 1.8 0.3 0.2 0.6 0.4 1.5 2.2 0.7 1.2 1.0 1.0 0.6 1.0 2.5 0.4 0.2 1.3 0.2 0.6 5.1 5.1 5.0 5.2 5.3 6.5 8.8 10.3 7.1 8.5 7.3 5.1 6.4 3.2 6.3 9.4 3.0 1.0 4.7 5.5 1.8 18.3 5.3 6.1 5.2 1.5 14.0 7.3 52.1 1.1 1.1 3.7 0.0 3.0 17.6 121.2 8.1 6.3 3.0 1.7 11.6 2.3 1.2 5.2 3.6 10.6 1.3 6.1 4.2 1.5 0.9 13.5 11.4 5.0 18.3 1.2 0.8 5.3 1.8 1.5 0.0 1.0 2.8 6.0 0.0 9.5 7.6 1.5 3.8 3.8 2.0 5.0 16.8 2.1 132.2 33.1 0.0 6.6 6.1 15.3 9.8 1.8 1.0 0.3 2.3 6.0 4.2 2.5 TMEM232 FLJ43080 ENSG00000186952 "Transmembrane protein 232" C9JQI7 5 110289233-110738956 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.4;testis: 16.9" "Cell type enhanced" "Detected in many" "Astrocytes: 154.8;Early spermatids: 130.7;Endometrial ciliated cells: 80.5;Excitatory neurons: 258.9;Inhibitory neurons: 175.0;Respiratory ciliated cells: 114.0;Spermatocytes: 83.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049386 Uncertain NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA049386: AB_2680739" "unprognostic (1.12e-2)" "unprognostic (1.43e-1)" "unprognostic (7.27e-2)" "unprognostic (1.47e-2)" "unprognostic (1.20e-1)" "unprognostic (4.40e-1)" "unprognostic (8.49e-2)" "unprognostic (9.88e-2)" "unprognostic (1.91e-1)" "unprognostic (1.22e-1)" "unprognostic (6.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.32e-5)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (3.14e-4)" "unprognostic (8.96e-2)" 0.6 1.2 2.7 0.2 2.4 0.1 1.1 1.1 1.8 1.1 8.3 0.4 0.5 0.8 1.7 0.6 14.4 1.8 0.7 1.8 2.3 3.7 0.7 1.7 0.4 6.6 7.9 0.7 0.4 2.1 1.3 0.4 6.0 0.9 0.4 3.6 0.6 0.7 0.0 0.4 0.3 0.4 5.1 0.2 0.9 16.9 2.8 0.4 3.8 0.3 0.3 0.3 0.1 5.3 0.4 0.1 1.0 0.3 0.8 1.5 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.5 0.3 0.0 1.6 0.3 0.2 0.8 0.2 1.0 0.1 0.1 0.0 0.0 0.7 0.3 0.1 0.4 0.1 0.2 0.4 1.4 0.0 1.2 0.3 0.3 0.5 0.1 0.5 0.3 0.1 0.1 0.0 0.2 0.1 0.2 1.0 0.0 0.8 1.0 0.1 0.0 0.9 1.6 0.4 0.1 0.0 1.1 0.1 0.0 0.0 2.5 0.9 0.4 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.4 1.1 1.8 1.8 2.3 6.6 7.9 6.0 5.1 2.8 5.3 0.6 0.0 5.4 154.8 0.4 0.4 0.9 4.8 1.2 5.0 1.2 0.8 2.4 1.5 11.7 7.3 27.1 0.3 0.0 0.4 9.8 1.3 130.7 80.5 1.4 0.7 1.2 0.8 258.9 0.5 0.1 0.8 0.0 2.3 0.0 0.7 1.1 0.6 0.1 3.3 175.0 0.6 8.2 1.3 0.0 68.0 1.2 0.7 0.0 32.8 0.0 4.5 0.0 54.8 66.1 0.2 0.1 0.7 0.5 0.7 0.4 5.5 114.0 16.9 0.0 1.6 1.8 83.9 4.3 0.1 0.4 0.3 0.2 1.6 0.3 0.6 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865890 "Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 215 "testis: 77.6" "Cell type enriched" "Detected in single" 7 "Endometrial ciliated cells: 2.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA077196: AB_2732334" "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM52 ENSG00000178821 "Transmembrane protein 52" Q8NDY8 1 1917590-1919279 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "pancreas: 216.2;skeletal muscle: 298.9;tongue: 207.8" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 22.3;Hepatocytes: 25.9;Spermatocytes: 34.6;Spermatogonia: 39.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 20.5;OE19: 18.2;RPMI-8226: 37.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA079372 Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane" Nucleoplasm "HPA079372: " "unprognostic (4.39e-2)" "unprognostic (2.60e-1)" "unprognostic (3.76e-2)" "unprognostic (7.35e-3)" "unprognostic (1.04e-5)" "unprognostic (1.46e-1)" "unprognostic (6.71e-3)" "unprognostic (3.68e-2)" "unprognostic (9.49e-2)" "unprognostic (1.69e-1)" "unprognostic (3.83e-3)" "unprognostic (5.80e-2)" "unprognostic (8.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" 1.9 52.6 1.9 0.2 2.1 0.5 2.0 2.1 3.7 1.1 3.0 2.5 3.6 0.6 0.4 6.9 3.3 0.4 1.8 1.8 1.9 2.4 13.5 1.9 0.4 1.8 2.1 2.2 216.2 3.1 1.7 0.2 1.7 1.8 1.3 0.2 19.8 0.4 298.9 3.5 2.3 0.3 1.5 2.8 6.9 29.2 1.8 0.4 0.8 207.8 0.3 0.6 2.1 1.7 3.4 0.3 0.9 1.8 0.3 0.1 7.5 0.5 0.2 2.2 1.3 5.6 2.3 0.8 2.2 3.5 0.8 1.1 5.5 1.5 0.4 0.4 4.0 0.0 0.9 20.5 1.1 0.0 1.3 0.1 3.1 0.7 0.3 0.1 0.1 3.9 5.1 1.9 0.0 6.4 0.5 1.5 2.9 18.2 10.6 1.5 0.0 37.1 1.2 0.2 3.7 2.6 0.0 3.1 0.4 1.3 2.1 0.4 0.0 0.0 1.4 1.0 0.0 2.4 0.8 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 2.1 2.1 3.7 1.8 1.9 1.8 2.1 1.7 1.5 1.8 1.7 0.4 0.0 0.0 0.0 1.2 4.5 2.9 1.2 2.8 0.4 3.9 5.2 0.8 8.6 2.4 0.0 0.0 1.9 0.8 6.8 1.9 1.8 3.9 3.8 0.3 0.8 0.0 0.4 0.6 22.3 7.0 1.6 5.1 0.8 0.0 5.1 0.7 25.9 0.6 0.0 0.5 11.1 8.2 0.8 2.2 5.8 14.9 0.7 8.8 0.0 0.6 1.8 0.0 0.0 0.1 6.7 2.5 9.8 4.3 14.2 15.4 11.5 8.7 1.0 0.0 15.4 1.6 34.6 39.4 2.5 2.8 3.7 1.2 15.5 7.1 3.1 TMEM67 "JBTS6, MGC26979, MKS3, NPHP11" ENSG00000164953 "Transmembrane protein 67" Q5HYA8 8 93754844-93819234 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Deafness, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 66.7;Excitatory neurons: 59.8;Respiratory ciliated cells: 95.8;Rod photoreceptor cells: 83.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.57e-3)" "unprognostic (1.22e-1)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (3.08e-1)" "unprognostic (2.25e-5)" "unprognostic (2.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.22e-2)" "unprognostic (2.51e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (8.41e-2)" "unprognostic (2.21e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" 2.4 2.5 1.7 1.3 2.7 1.4 3.5 2.8 2.7 3.6 10.3 2.1 1.4 4.2 6.3 1.8 13.3 2.8 5.0 2.5 3.0 3.1 1.2 3.6 1.4 6.5 6.8 4.2 2.6 4.7 5.8 2.1 3.1 2.8 2.2 6.1 1.9 3.2 1.2 3.7 1.3 2.4 3.5 1.9 2.0 6.8 3.1 1.4 6.0 0.6 1.7 2.5 2.2 3.9 5.8 3.7 5.2 4.1 4.4 9.8 3.1 3.3 5.4 3.8 7.5 2.1 13.0 1.5 6.9 3.6 6.9 5.9 1.9 3.3 5.6 1.1 4.3 3.6 4.8 1.8 4.0 2.7 1.5 4.2 3.0 6.8 3.0 7.1 4.0 6.1 2.5 0.9 4.0 1.4 4.5 2.0 4.3 2.3 3.4 1.6 1.7 0.0 4.7 2.5 3.4 5.7 3.3 0.9 5.6 4.6 6.8 1.4 2.1 4.1 1.7 5.7 3.0 1.8 5.5 1.6 7.4 0.8 3.9 1.7 0.5 0.2 1.5 0.2 1.2 0.7 1.3 1.3 1.0 1.5 1.5 1.5 0.5 1.8 0.2 1.1 0.3 0.5 1.7 2.7 2.8 2.7 2.5 3.0 6.5 6.8 3.1 3.5 3.1 3.9 5.0 12.8 8.7 27.4 6.3 2.8 5.6 12.2 2.2 14.6 6.0 5.6 31.9 5.7 12.5 20.2 66.7 3.4 5.6 1.2 0.0 6.4 24.5 50.9 15.1 6.8 9.0 4.6 59.8 2.7 5.6 9.8 4.1 4.9 5.1 16.1 10.0 1.6 2.2 23.5 34.2 2.4 8.2 2.9 2.6 7.7 16.1 1.8 1.8 13.1 1.5 9.3 3.1 17.6 3.4 2.1 0.5 10.5 2.7 2.1 0.4 3.9 95.8 83.2 6.6 18.9 6.9 47.6 16.5 2.6 1.4 2.3 5.6 13.7 2.8 1.6 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 108.7;intestine: 43.5;urinary bladder: 74.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 101.7;Club cells: 103.5;Distal enterocytes: 187.9;Squamous epithelial cells: 119.2;Urothelial cells: 258.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 1.8" "Immune cell enriched" "Detected in single" 7 "basophil: 2.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.1" "Group enriched" "Detected in some" 5 "CAPAN-2: 103.7;HaCaT: 39.2;OE19: 141.6;RPTEC TERT1: 70.6;RT4: 95.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain "Secreted in other tissues" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.2 0.0 0.1 6.1 0.1 0.8 0.3 1.8 0.3 16.6 0.3 43.5 25.4 2.1 3.2 108.7 1.0 14.3 0.2 0.1 0.0 21.1 0.2 1.4 0.2 0.1 0.0 0.1 0.3 0.0 0.2 0.1 0.2 7.8 42.9 0.4 6.5 0.2 0.2 4.1 22.4 1.5 0.0 0.2 31.4 1.1 0.2 1.1 0.2 0.1 14.9 74.6 16.7 0.3 18.5 0.1 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.7 103.7 0.1 3.5 0.0 0.1 39.2 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 3.4 0.3 0.0 1.3 0.3 4.5 0.1 141.6 0.0 0.1 0.1 0.2 70.6 95.9 0.1 0.1 0.0 8.4 0.1 0.2 0.5 0.1 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.8 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.1 0.0 1.7 0.0 0.4 1.1 35.2 101.7 38.1 0.0 0.0 0.0 0.7 0.0 103.5 11.0 0.0 0.2 0.0 187.9 0.0 1.5 3.0 45.3 4.6 0.8 4.2 0.0 0.2 7.3 3.0 0.5 53.5 66.4 5.7 0.0 0.0 0.1 0.2 0.0 0.2 55.3 34.6 0.3 0.3 2.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 52.6 67.5 0.0 2.7 17.5 55.2 2.4 69.4 0.0 0.0 0.0 4.7 0.0 0.1 119.2 6.3 0.3 0.5 0.0 71.2 258.6 TNFRSF13C "BAFFR, CD268" ENSG00000159958 "TNF receptor superfamily member 13C" Q96RJ3 22 41922032-41926806 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 33.8;lymphoid tissue: 58.1" "Cell type enriched" "Detected in some" 10 "B-cells: 194.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "memory B-cell: 22.5;naive B-cell: 29.1" "Lineage enriched" "Detected in single" 40 "B-cells: 29.1" "Group enriched" "Detected in some" 6 "REH: 21.0;U-698: 10.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA003246, CAB008380" Enhanced NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 14: REH - Unknown function" "Cluster 57: B-cells - Immune response" "CAB008380: AB_590602, HPA003246: AB_1078264" "unprognostic (3.43e-4)" "prognostic favorable (4.44e-7)" "unprognostic (6.52e-2)" "unprognostic (9.10e-2)" "unprognostic (7.64e-3)" "unprognostic (4.83e-3)" "unprognostic (2.89e-2)" "unprognostic (3.78e-3)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (2.51e-2)" "unprognostic (1.66e-1)" "unprognostic (4.79e-8)" "unprognostic (2.21e-1)" "unprognostic (1.89e-1)" "unprognostic (1.77e-1)" "unprognostic (9.44e-2)" 0.8 0.8 2.1 17.7 1.3 6.0 0.5 1.6 1.9 0.2 0.6 2.1 1.2 0.3 0.3 1.5 0.4 1.0 0.4 1.9 2.0 0.8 0.3 1.0 39.0 3.6 2.1 0.1 0.1 0.1 0.2 0.3 2.2 0.5 1.1 0.4 1.7 0.1 2.3 3.3 33.8 0.1 2.7 58.1 2.5 0.7 2.1 3.4 1.1 0.5 54.6 1.8 0.5 2.0 0.3 0.2 1.1 2.3 0.0 0.0 0.4 0.2 0.1 0.2 0.8 0.9 0.5 1.9 0.4 0.2 0.2 0.4 0.7 0.0 0.3 0.4 2.3 0.2 0.4 0.2 0.1 1.7 0.4 0.1 0.0 0.4 0.1 0.1 0.0 0.7 0.4 1.9 0.2 0.7 1.6 1.8 0.7 0.1 0.1 21.0 2.4 1.6 0.0 0.2 1.3 0.3 0.1 0.4 0.3 0.2 0.4 2.2 0.2 0.5 2.5 0.9 0.3 2.0 1.1 10.9 0.1 1.8 0.5 0.7 0.1 0.2 0.2 0.2 0.3 22.5 0.3 0.2 0.1 29.1 0.4 0.4 0.3 0.3 0.3 0.4 0.2 1.1 2.1 1.3 1.6 1.9 1.9 2.0 3.6 2.1 2.2 2.7 2.1 2.0 0.1 0.0 1.1 0.0 194.5 0.1 0.4 0.0 1.2 1.0 1.6 1.3 1.4 0.0 0.0 0.0 0.0 0.2 2.6 0.3 0.0 0.0 0.1 2.6 0.5 0.3 1.2 0.4 0.0 0.0 0.2 0.7 0.5 4.3 0.0 1.5 0.0 0.2 0.1 8.4 0.1 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.0 6.5 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 18.0 0.3 0.1 0.2 0.0 0.4 0.0 0.5 0.4 1.5 1.4 0.3 0.0 0.1 3.4 0.2 0.4 0.2 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451100-52454041 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 36 "heart muscle: 8734.3;skeletal muscle: 21081.1;tongue: 12403.9" "Cell type enriched" "Detected in many" 10 "Cardiomyocytes: 3550.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 27.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 6 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7" "Region enriched" "Detected in all" 4 "cerebral cortex: 87.0" "Group enriched" "Detected in some" 6 "midbrain: 7.6;spinal cord: 7.1" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" NA NA 990000 "Cluster 13: T-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 9: U-2 OS - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 8.4 10.9 0.7 0.8 0.8 0.7 19.1 2.7 1.1 7.7 7.3 4.0 1.1 2.8 41.7 387.3 2.8 3.3 8734.3 1.2 0.7 19.2 4.0 78.5 3.9 0.8 0.9 2.4 6.8 1.6 17.6 5.2 1.0 170.1 4.1 0.4 120.8 2.2 21081.1 18.9 3.3 0.8 0.8 2.8 5.7 10.6 0.8 4.3 14.4 12403.9 1.6 5.3 5.4 0.7 0.7 5.2 3.6 0.6 0.2 0.5 8.0 0.4 0.3 0.3 0.4 68.2 33.5 0.5 65.2 9.9 0.1 0.4 0.1 0.3 0.0 1.2 1.6 0.5 49.1 46.1 0.3 0.3 0.1 67.2 1.2 0.0 0.7 0.6 0.0 2.0 0.2 5.1 2.0 0.1 0.2 0.8 0.5 15.1 0.7 0.1 2.9 2.3 3.3 13.0 0.2 0.0 0.5 6.7 0.1 3.9 26.7 0.5 0.0 0.1 97.7 0.8 0.2 2.8 1.3 0.9 0.3 0.7 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.7 0.8 2.7 1.1 1.2 0.7 0.8 0.9 1.0 0.8 0.8 0.7 0.2 125.0 12.6 0.0 0.3 1.5 1.7 4.0 0.6 0.2 0.5 0.3 3550.1 5.7 7.9 3.7 2.1 59.0 0.1 1.6 27.4 11.8 0.7 66.4 6.7 39.8 330.7 0.4 0.0 13.0 5.1 52.7 0.5 98.8 0.0 0.8 0.7 0.7 4.9 0.0 0.0 1.7 2.0 0.0 1.4 5.8 22.4 2.6 5.4 0.0 0.1 1.2 0.0 0.0 0.0 6.5 0.3 177.6 0.1 0.8 0.5 1.3 2.8 0.1 0.0 241.8 36.0 2.1 1.0 0.1 0.9 31.1 2.8 1.3 2.0 6.8 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 622 "heart muscle: 10813.5" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 12618.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6" "Region enhanced" "Detected in many" "olfactory bulb: 10.9" "Low region specificity" "Detected in many" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol NA NA 2400000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol Vesicles "CAB009349: AB_793465, HPA046428: AB_2679661" "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 1.1 3.0 0.3 0.0 0.5 0.0 17.3 0.2 0.4 0.7 0.7 0.7 0.0 0.3 0.1 0.8 6.2 0.9 10813.5 0.6 0.2 1.0 1.1 7.3 1.6 0.5 2.8 1.4 2.3 0.2 0.6 1.0 1.3 2.4 0.0 0.2 1.3 0.0 6.5 1.2 0.6 0.0 0.6 0.4 0.7 3.7 0.3 0.1 1.5 2.4 0.0 0.4 0.6 0.3 1.2 0.6 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 0.0 0.3 1.8 6.3 0.0 1.1 1.1 1.2 0.3 0.0 0.0 13.0 3.0 0.0 1.9 0.5 0.0 20.3 0.0 0.6 0.1 0.3 0.1 0.1 0.8 39.1 0.8 0.0 0.6 0.2 0.0 0.7 54.6 0.5 1.9 0.4 0.1 1.8 0.0 0.1 2.2 0.0 0.0 0.2 0.0 2.8 9.5 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.6 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.4 0.6 0.2 0.5 2.8 1.3 0.6 0.3 0.3 0.1 0.0 0.0 0.0 0.2 6.9 0.0 0.8 13.6 0.0 1.0 0.9 12618.4 8.6 1.8 5.5 0.0 1.4 0.1 0.4 0.0 0.7 56.2 3.5 0.1 131.3 1.8 0.0 0.0 0.2 0.5 202.7 0.0 1.3 0.0 996.2 0.0 0.0 2.2 1.7 0.2 0.4 2.0 0.3 0.7 222.9 0.3 4.6 1.8 1.9 0.0 4.2 0.0 0.0 0.1 1.0 0.0 1.9 0.0 0.0 0.0 0.1 11.2 0.5 0.0 0.4 123.6 6.4 16.1 0.7 2.8 2.5 0.6 1.2 1.0 0.1 TNS4 CTEN ENSG00000131746 "Tensin 4" Q8IZW8 17 40475828-40501623 "Predicted intracellular proteins" Apoptosis Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 205.0;vagina: 74.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 133.4;Basal prostatic cells: 117.7;Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 77.4;Suprabasal keratinocytes: 65.5;Urothelial cells: 50.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 77.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 136.2;HBEC3-KT: 613.4;hTCEpi: 435.3;hTERT-HME1: 138.8;OE19: 125.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "unprognostic (4.16e-2)" "unprognostic (9.83e-2)" "unprognostic (1.01e-1)" "unprognostic (3.40e-2)" "unprognostic (3.68e-4)" "unprognostic (7.88e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.89e-1)" "unprognostic (8.02e-3)" "unprognostic (2.01e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-2)" "unprognostic (3.72e-1)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (7.08e-2)" 0.9 0.1 0.0 1.1 0.0 0.1 16.5 0.0 0.0 28.6 0.1 3.2 0.8 0.7 3.5 46.1 0.9 0.3 0.1 0.0 0.0 1.0 0.1 0.5 0.2 0.0 0.0 0.1 0.1 0.0 0.9 9.7 0.0 35.6 5.9 0.0 58.8 19.6 0.2 205.0 0.8 0.1 0.0 0.0 1.8 0.0 0.0 1.4 14.3 0.0 6.9 14.8 74.7 0.2 7.7 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 18.6 0.1 3.9 0.0 0.0 136.2 0.0 613.4 0.0 0.0 0.0 0.0 57.5 9.3 0.0 0.0 0.4 0.0 435.3 0.0 138.8 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.2 0.0 125.9 70.2 0.0 0.0 0.0 0.0 32.3 0.0 0.0 79.4 14.4 0.0 0.7 16.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 133.4 117.7 39.8 287.4 0.0 1.6 25.5 0.9 0.0 18.2 0.0 0.0 4.7 0.5 7.5 1.9 0.2 0.0 4.6 0.7 1.3 0.0 0.0 0.1 0.2 0.5 1.0 2.0 3.9 0.0 0.0 0.0 0.0 0.3 0.0 0.2 3.5 2.0 0.0 8.8 0.0 0.0 1.1 5.4 0.0 0.6 0.0 0.0 0.0 0.1 25.2 0.3 0.0 0.0 18.9 0.1 0.0 7.3 0.0 0.0 0.1 1.6 0.0 0.0 77.4 65.5 4.4 2.1 0.0 2.6 50.2 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29052230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 34.9;choroid plexus: 25.2;fallopian tube: 20.1" "Group enriched" "Detected in some" 4 "dendritic cells: 20.1;Endometrial ciliated cells: 65.4;Respiratory ciliated cells: 30.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 2.3;JURKAT: 1.2;NB-4: 1.3" "Low region specificity" "Detected in many" "HPA037561, HPA037562, HPA075216" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Plasma membrane" "HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.1 1.2 4.5 0.6 11.5 1.9 0.2 10.6 2.3 0.5 25.2 0.3 0.5 0.6 0.1 0.4 20.1 0.3 2.8 4.5 7.6 0.1 0.2 2.8 0.8 19.2 34.9 0.5 0.3 0.0 1.1 0.3 17.3 0.2 0.2 0.2 0.2 0.1 1.2 0.3 0.4 0.5 12.5 2.0 1.0 1.3 10.6 0.2 0.1 3.0 0.7 0.2 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.0 0.6 0.1 0.2 0.6 2.3 0.1 0.0 0.0 0.0 0.2 0.1 1.2 0.0 0.3 0.3 0.0 0.3 1.3 1.0 0.4 0.1 0.0 0.3 0.6 0.3 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.6 0.5 4.5 11.5 10.6 2.3 4.5 7.6 19.2 34.9 17.3 12.5 10.6 5.3 0.3 0.0 3.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.6 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 65.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.2 30.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 3.6 0.5 0.0 0.0 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388525-40417896 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 127.8;testis: 65.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 4.2;white matter: 8.0" "Low region specificity" "Detected in some" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.2 2.5 0.2 20.0 0.2 42.0 5.4 0.1 0.7 5.0 1.1 17.8 18.1 3.9 0.3 29.0 1.5 2.6 1.2 0.2 0.2 1.2 2.8 4.1 40.3 0.2 0.8 1.0 0.9 0.3 0.3 15.9 0.5 1.4 19.8 0.1 4.3 0.5 0.3 15.3 17.0 7.6 0.2 9.9 8.9 65.7 1.1 127.8 1.9 0.2 42.5 6.0 9.6 0.4 212.6 275.6 343.1 158.0 16.8 33.9 76.3 283.3 151.5 255.0 224.2 130.5 157.6 339.4 140.1 96.7 152.7 326.5 266.8 113.5 339.5 182.7 177.8 224.8 167.9 216.7 1.6 318.4 228.6 7.4 9.2 179.8 181.4 55.1 136.3 216.5 247.5 225.8 279.2 72.6 372.3 209.6 143.0 152.4 108.3 310.7 531.9 141.3 61.6 133.3 201.6 144.6 229.3 281.4 89.4 198.2 236.9 143.2 90.3 167.0 233.2 195.5 276.7 128.4 154.9 290.7 94.3 214.9 285.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.3 0.1 0.1 0.0 0.0 0.1 1.4 0.1 0.0 2.4 0.4 0.2 0.2 0.1 0.7 0.2 0.2 0.2 0.8 0.5 0.2 1.1 0.4 1.0 0.0 2.0 0.3 17.4 11.7 3.7 15.0 2.2 0.0 18.7 17.1 1.3 2.8 5.8 0.0 0.0 72.9 6.1 19.8 0.0 0.8 20.3 12.7 15.8 9.3 0.0 216.8 0.2 0.0 92.4 23.3 23.0 10.0 0.0 117.5 20.7 5.4 83.5 0.0 0.1 34.2 18.3 33.9 13.2 19.1 4.7 14.1 1.8 0.0 2.6 0.0 3.1 0.0 0.1 0.3 3.5 1.9 31.3 3.1 3.4 0.1 1.8 0.0 72.3 0.5 19.5 621.2 269.6 45.1 6.1 8.9 14.8 4.3 61.0 6.9 TP53AIP1 p53AIP1 ENSG00000120471 "Tumor protein p53 regulated apoptosis inducing protein 1" Q9HCN2 11 128934731-128943399 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.5;lymphoid tissue: 29.5;skin 1: 20.4;vagina: 13.6" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 45.5;Basal respiratory cells: 42.4;Basal squamous epithelial cells: 179.2;Endometrial ciliated cells: 38.7;Respiratory ciliated cells: 27.3;Squamous epithelial cells: 72.1;Suprabasal keratinocytes: 32.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044300, HPA048797" Uncertain NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA044300: AB_2678888, HPA048797: AB_2680524" "unprognostic (4.12e-7)" "unprognostic (3.00e-2)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-2)" "unprognostic (1.18e-1)" "unprognostic (4.66e-2)" "unprognostic (1.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.94e-1)" "unprognostic (6.57e-6)" "unprognostic (1.10e-2)" "unprognostic (3.71e-1)" "unprognostic (7.75e-2)" "unprognostic (1.78e-2)" 0.0 0.6 0.9 0.0 0.8 0.0 1.3 1.1 1.3 5.6 0.6 0.1 0.0 0.1 2.5 24.5 2.7 0.0 0.0 0.8 0.6 0.8 0.1 0.2 0.0 1.0 1.0 0.0 0.2 0.0 1.8 0.0 0.9 2.0 0.0 0.5 3.9 0.8 0.1 20.4 0.1 0.0 0.5 0.0 0.0 1.6 1.0 29.5 0.0 0.0 1.1 0.0 13.6 0.8 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.1 1.3 0.8 0.6 1.0 1.0 0.9 0.5 1.0 0.8 0.2 0.0 0.5 1.0 0.0 45.5 11.4 42.4 179.2 0.7 1.5 23.9 0.3 0.0 5.3 0.0 0.0 0.1 0.0 0.3 7.9 0.0 0.9 38.7 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 1.8 1.1 0.0 0.4 1.8 1.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.2 27.3 0.4 0.0 0.6 1.6 0.2 0.3 72.1 32.7 0.3 0.3 0.0 0.3 2.6 TP63 "EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L" ENSG00000073282 "Tumor protein p63" Q9H3D4 3 189631389-189897276 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.6;skin 1: 137.3" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1" "Group enriched" "Detected in many" 11 "cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000083, HPA006288, HPA006289, HPA007009, HPA007010" Enhanced Enhanced Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 15: RT4 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336" "prognostic favorable (1.07e-4)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "unprognostic (3.02e-1)" "unprognostic (4.38e-2)" "unprognostic (3.50e-1)" "unprognostic (1.29e-1)" "unprognostic (5.17e-2)" "unprognostic (2.78e-1)" "unprognostic (5.37e-2)" "unprognostic (2.09e-3)" "unprognostic (1.54e-1)" "unprognostic (1.87e-5)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (2.74e-3)" 0.5 0.3 0.3 0.6 0.3 0.4 18.0 0.9 0.5 23.5 0.3 0.3 0.1 0.3 10.5 69.6 1.0 0.3 0.6 0.5 0.5 0.3 0.4 1.9 1.0 0.4 0.6 0.1 0.3 0.0 0.5 10.8 0.7 17.4 0.2 0.0 20.8 18.0 42.4 137.3 0.2 0.3 0.2 0.2 0.4 3.4 0.4 23.1 0.3 12.4 17.7 18.6 54.4 0.4 2.3 4.6 0.0 0.1 0.2 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 16.6 0.6 0.1 0.2 87.1 0.0 167.3 0.0 1.4 0.0 1.9 1.3 0.4 0.0 0.0 0.3 0.2 124.0 0.2 117.3 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.3 0.2 0.0 1.0 0.3 0.0 0.2 185.1 0.2 0.1 0.2 0.0 0.0 2.5 0.9 0.2 0.3 0.2 0.1 0.2 0.0 25.3 0.3 1.1 0.5 0.1 0.8 0.6 0.0 0.2 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.3 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.0 0.3 0.3 0.9 0.5 0.5 0.5 0.4 0.6 0.7 0.2 0.4 0.4 0.2 0.0 5.3 1.0 0.9 275.4 26.8 61.9 335.2 0.0 0.9 30.1 0.7 0.0 8.5 0.0 0.0 24.9 0.1 0.1 0.0 0.2 1.8 0.0 0.1 1.1 0.0 0.0 1.3 0.2 2.8 1.4 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.0 4.8 0.0 2.0 0.0 11.9 0.4 0.3 0.7 8.8 14.0 0.6 0.0 0.0 0.5 1.4 1.6 0.0 1.2 1.6 5.6 0.0 0.0 2.8 0.0 0.0 5.3 0.9 0.5 2.4 173.4 283.1 8.9 0.6 0.2 0.0 15.2 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652516-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971" "unprognostic (5.71e-3)" "prognostic favorable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favorable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favorable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.0 0.0 0.7 0.7 0.5 0.5 0.8 4.2 0.5 1.4 8.0 0.2 0.0 0.1 0.1 3.7 6.7 0.0 0.1 0.8 0.7 0.1 0.2 0.9 1.0 2.4 2.9 0.1 0.8 0.1 0.3 0.0 1.4 2.6 0.1 0.2 2.9 0.3 0.2 6.6 0.2 0.0 1.4 0.7 0.3 0.7 0.7 1.6 0.2 0.0 1.4 0.1 2.9 1.0 2.6 0.1 0.3 7.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.9 4.0 2.6 2.0 0.0 0.9 4.3 2.7 0.9 0.0 0.8 8.7 0.2 3.9 2.6 0.0 0.0 2.9 0.0 1.7 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.8 1.9 15.0 2.0 0.5 0.0 0.1 0.0 11.6 0.1 0.3 3.8 18.0 8.4 0.4 0.0 0.8 0.0 10.9 9.2 0.0 2.9 7.5 0.0 5.8 3.3 0.7 18.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 4.2 0.5 0.8 0.7 2.4 2.9 1.4 1.4 0.7 1.0 0.0 0.0 1.5 0.0 1.2 3.1 3.8 13.0 16.5 0.5 0.2 2.5 1.5 0.0 7.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 21.8 31.0 0.3 0.3 2.4 3.2 0.1 0.2 0.4 0.4 0.0 0.7 0.0 0.1 0.4 0.2 0.3 0.0 0.1 0.5 2.0 0.0 1.3 15.7 0.6 0.1 1.8 0.0 0.0 0.2 0.0 2.5 0.1 0.2 0.0 0.0 6.8 0.2 0.0 0.1 35.8 0.1 0.0 0.0 2.6 0.1 0.4 1.6 2.3 0.3 0.4 0.1 0.3 0.2 TPM1 "C15orf13, CMH3" ENSG00000140416 "Tropomyosin 1" P09493 15 63042632-63071915 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6" "Cell type enriched" "Detected in all" 4 "Cardiomyocytes: 13012.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 48.7" "Group enriched" "Detected in all" 4 "dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 3141.3;SuSa: 3810.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, CAB017698, HPA047089, HPA053624" Supported Approved "Actin filaments,Cytosol" NA NA 120000000 "Cluster 38: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "Actin filaments" Cytosol "CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.00e-2)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.20e-1)" "unprognostic (1.66e-3)" "unprognostic (3.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (7.30e-4)" 372.0 103.6 49.8 232.9 53.2 21.6 348.8 52.4 53.9 577.4 59.3 2947.3 289.6 1566.9 250.5 639.0 823.8 288.0 10621.0 53.3 42.2 215.5 94.8 247.1 48.1 42.5 44.3 320.3 383.4 37.5 70.6 206.4 43.7 809.6 523.1 83.9 258.2 1545.5 12678.0 150.7 680.8 1754.9 44.8 134.3 976.5 52.3 50.0 21.1 156.8 5183.6 29.4 1511.0 425.8 42.2 554.5 357.3 418.1 20.9 143.1 89.9 1335.5 1509.1 552.8 905.9 669.2 253.9 107.6 1.7 677.7 1517.1 602.7 295.9 361.8 243.4 597.0 14.5 50.9 81.2 376.3 124.5 403.3 3.8 17.9 125.7 138.0 742.1 198.2 3141.3 243.2 14.7 8.7 20.4 695.3 286.4 25.6 7.1 496.0 129.0 61.1 9.0 146.5 15.8 1308.7 298.8 101.1 71.7 180.9 284.4 65.1 3810.3 204.8 15.3 1095.8 1178.8 572.0 181.6 1094.8 5.9 4.3 7.8 335.9 22.4 842.1 48.7 9.9 4.8 4.0 19.2 3.1 5.5 3.6 4.3 14.1 5.6 4.0 3.6 10.7 1.9 14.3 2.4 6.3 15.6 49.8 53.2 52.4 53.9 53.3 42.2 42.5 44.3 43.7 44.8 50.0 42.2 542.3 57.7 86.3 19.9 12.1 71.9 202.0 344.1 18.2 49.0 450.1 953.1 13012.4 346.0 147.0 318.2 383.7 212.1 20.6 561.3 187.9 2502.6 6.5 147.2 614.4 294.3 267.7 137.0 44.2 1671.1 3094.8 557.1 279.3 211.2 52.0 85.3 175.6 138.1 201.5 52.2 53.2 964.7 183.1 42.5 72.1 27.3 205.0 114.3 81.8 111.5 47.5 47.4 28.8 36.2 6.0 2372.3 623.4 1130.3 8.8 244.3 724.7 361.1 104.2 447.5 1038.7 484.0 1685.9 27.4 82.2 29.4 50.4 103.0 29.0 130.7 385.3 198.2 TPM2 "AMCD1, DA1, NEM4" ENSG00000198467 "Tropomyosin 2" P07951 9 35681992-35690056 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "skeletal muscle: 39012.3;tongue: 16773.7" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 1066.2;Peritubular cells: 2072.1;Sertoli cells: 2222.0;Smooth muscle cells: 2341.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 812 "plasmacytoid DC: 398.6" "Lineage enriched" "Detected in single" 920 "dendritic cells: 398.6" "Cell line enhanced" "Detected in many" "BJ: 2309.6;fHDF/TERT166: 1289.0;hTERT-RPE1: 1399.1" "HPA047089, HPA053624" Approved NA NA 140000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (5.56e-2)" "unprognostic (5.37e-2)" "prognostic unfavorable (2.64e-4)" "unprognostic (3.34e-2)" "unprognostic (2.70e-1)" "unprognostic (1.75e-2)" "unprognostic (1.18e-3)" "unprognostic (6.56e-3)" "unprognostic (2.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.51e-10)" "unprognostic (1.43e-2)" "unprognostic (8.33e-2)" "unprognostic (5.52e-2)" "unprognostic (1.41e-2)" 331.1 285.0 88.0 411.0 89.8 16.7 260.8 92.5 117.3 651.3 127.3 3498.4 217.7 1928.1 201.9 1018.0 849.7 442.4 788.5 84.8 81.1 144.0 41.0 283.1 62.2 86.1 79.2 388.4 73.7 24.1 82.6 142.3 80.5 1219.0 238.0 8.0 393.6 1988.7 39012.3 148.5 636.2 2340.8 78.6 140.1 1252.6 82.9 83.3 26.3 138.9 16773.7 21.2 1630.1 454.9 79.8 375.4 291.2 213.9 33.6 335.4 893.3 129.3 2309.6 934.4 983.0 667.9 12.2 24.2 0.4 213.0 1289.0 144.6 9.2 3.7 291.2 457.0 716.2 10.8 9.1 1054.1 11.8 540.2 2.3 102.7 1067.7 44.9 738.8 0.4 1399.1 235.7 25.3 5.6 0.8 1052.1 15.3 2.7 29.1 269.6 1.5 17.0 18.5 391.5 3.0 31.1 7.2 3.8 13.3 470.0 7.9 18.2 273.8 6.8 27.7 30.0 16.5 585.7 11.6 730.6 0.6 2.7 2.9 34.0 6.5 29.2 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.3 0.4 0.0 0.1 0.0 0.4 0.2 0.0 398.6 0.0 2.1 88.0 89.8 92.5 117.3 84.8 81.1 86.1 79.2 80.5 78.6 83.3 79.8 110.0 3.2 4.1 10.4 5.9 57.1 81.2 274.1 24.5 0.8 29.9 1066.2 619.5 4.3 42.1 7.3 0.0 12.1 116.7 1.4 0.0 21.4 4.3 20.3 488.3 80.3 2.4 4.0 2.5 5.7 104.8 332.6 99.4 18.7 2.5 142.0 181.3 1.4 32.4 1.7 4.6 1.9 48.8 3.1 77.9 32.4 283.0 24.2 67.6 9.4 6.5 11.7 1.0 3.0 0.4 8.4 0.1 2072.1 2.9 169.8 0.4 1.3 23.5 0.9 2222.0 594.8 2341.4 2.5 27.3 6.7 42.8 14.6 16.0 106.7 2.8 28.7 TPPP3 "CGI-38, p20, p25gamma" ENSG00000159713 "Tubulin polymerization promoting protein family member 3" Q9BW30 16 67389809-67393518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 858.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3" "Cancer enhanced" "Detected in all" "endometrial cancer: 61.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 65.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047629, HPA061691" Enhanced Approved "Nucleoli fibrillar center" NA NA 43000 "Cluster 7: Monocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center" "HPA047629: AB_2680108, HPA061691: " "unprognostic (1.63e-1)" "unprognostic (6.62e-3)" "unprognostic (1.35e-1)" "unprognostic (7.28e-3)" "unprognostic (4.48e-3)" "unprognostic (1.59e-3)" "unprognostic (9.22e-2)" "unprognostic (3.23e-1)" "unprognostic (1.46e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-3)" "unprognostic (7.98e-2)" "prognostic unfavorable (8.84e-4)" "unprognostic (3.51e-2)" "unprognostic (9.44e-2)" "unprognostic (9.46e-2)" "unprognostic (1.86e-3)" 44.3 27.1 199.2 8.0 200.1 1.0 81.0 186.0 225.7 50.3 168.7 96.4 23.7 29.3 9.7 99.3 858.4 21.9 81.4 188.1 222.0 60.7 4.4 148.0 4.4 258.7 291.6 8.6 23.9 13.6 40.7 78.5 231.2 18.9 14.1 9.6 39.5 13.3 72.2 170.5 38.0 21.4 223.6 17.7 43.6 15.4 228.3 4.7 18.4 55.8 9.1 32.8 36.4 296.2 0.4 59.9 0.6 0.4 0.4 9.4 0.2 1.7 0.4 0.4 0.9 3.9 12.0 0.0 0.9 0.8 0.2 11.3 9.2 0.0 0.1 0.0 3.5 0.0 1.5 1.7 0.1 0.0 0.0 2.4 0.3 3.6 0.0 1.8 0.6 0.0 0.1 0.0 5.4 0.3 0.0 0.2 1.9 40.8 0.0 0.0 31.1 0.2 0.0 0.0 47.8 20.7 0.0 0.1 2.4 1.5 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.1 0.0 0.0 2.9 0.0 0.9 0.0 25.4 12.4 0.0 37.6 0.2 0.0 0.0 0.0 33.1 0.1 0.0 0.0 5.8 0.0 65.8 0.3 0.0 9.4 199.2 200.1 186.0 225.7 188.1 222.0 258.7 291.6 231.2 223.6 228.3 296.2 14.7 16.0 129.8 17.0 0.2 303.9 8.8 92.5 5.7 3.8 5.9 5.0 4.1 30.0 160.4 18.4 4.2 8.3 0.2 28.4 5.9 166.8 60.1 962.0 30.9 31.6 177.9 0.0 0.5 1.8 4.3 141.9 7.1 14.7 25.4 1.0 5.0 0.1 2.9 0.0 0.7 65.1 132.2 3.8 82.5 23.7 29.2 13.7 501.6 1.0 10.7 68.7 1.0 1.0 30.0 8.4 39.7 3.4 0.0 5.6 29.8 0.9 1825.2 8.9 236.7 259.3 163.7 8.1 5.8 1.6 495.3 80.0 5.5 0.8 27.3 10.1 TPSAB1 "TPS1, TPS2, TPSB1" ENSG00000172236 "Tryptase alpha/beta 1" Q15661 16 1240379-1242554 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 13 "granulocytes: 5873.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 893 "basophil: 89.3" "Lineage enriched" "Detected in single" 893 "granulocytes: 89.3" "Cell line enriched" "Detected in some" 166 "HMC-1: 3813.2" "CAB016369, CAB022175, HPA049153, HPA049554" Supported "Secreted to blood" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815" "unprognostic (2.06e-2)" "unprognostic (5.14e-2)" "unprognostic (2.02e-3)" "unprognostic (1.64e-2)" "unprognostic (9.31e-3)" "prognostic favorable (9.62e-6)" "unprognostic (1.02e-1)" "unprognostic (4.08e-2)" "unprognostic (1.80e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (2.83e-2)" "unprognostic (4.13e-2)" "unprognostic (2.23e-1)" "unprognostic (2.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.36e-2)" 96.6 2.9 0.3 23.6 0.5 2.4 47.2 0.3 0.9 53.7 0.9 83.0 71.6 73.3 6.0 64.3 26.6 129.7 14.7 0.4 0.4 13.9 12.2 128.5 21.3 0.4 0.3 3.2 18.9 2.3 3.5 1.2 0.6 65.9 34.6 0.0 60.2 22.5 10.1 122.7 148.7 17.9 0.4 5.9 104.0 8.9 0.4 14.2 4.7 13.0 13.2 113.5 52.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 1.3 3813.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.3 2.1 6.1 0.5 0.4 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 1.1 0.0 0.0 2.8 22.9 2.0 89.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.5 0.3 0.9 0.4 0.4 0.4 0.3 0.6 0.4 0.4 0.3 0.0 25.6 135.5 0.0 2.9 18.6 5.1 0.0 1.2 0.0 0.9 0.1 0.3 0.0 8.1 0.0 0.0 0.0 0.2 0.9 0.0 1.2 0.3 0.0 0.0 4.1 0.0 3.8 0.0 0.0 0.2 7.6 0.5 0.0 5873.9 0.0 0.0 0.3 5.2 0.0 0.0 0.0 0.0 0.3 25.6 0.2 0.0 7.7 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 11.7 4.0 0.4 0.1 5.1 0.0 0.0 0.3 3.2 0.0 0.1 0.1 9.9 0.3 440.9 0.0 0.5 5.6 TPSB2 ENSG00000197253 "Tryptase beta 2" P20231 16 1227272-1230184 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 25 "granulocytes: 8966.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 50 "basophil: 5.0" "Lineage enriched" "Detected in single" 50 "granulocytes: 5.0" "Cell line enriched" "Detected in some" 7 "HMC-1: 297.5" "HPA049153, HPA049554" Supported "Secreted to blood" NA NA 16000000 "Cluster 10: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "HPA049153: AB_2680656, HPA049554: AB_2680815" "unprognostic (9.05e-2)" "unprognostic (8.46e-3)" "unprognostic (2.42e-3)" "unprognostic (2.27e-2)" "unprognostic (4.97e-3)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (8.55e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (1.95e-1)" "unprognostic (8.30e-3)" "unprognostic (1.91e-2)" "unprognostic (5.76e-2)" "unprognostic (2.41e-2)" "unprognostic (4.65e-2)" "unprognostic (3.17e-2)" 95.1 2.5 0.3 20.2 0.6 4.3 47.8 0.3 0.9 53.2 1.0 77.8 35.5 71.8 9.8 64.6 30.4 103.9 15.0 0.5 0.5 15.5 12.2 127.8 26.2 0.5 0.4 3.5 18.9 1.5 3.9 1.3 0.5 67.0 19.8 0.0 64.5 13.3 10.0 122.5 146.1 22.0 0.5 5.2 102.1 9.9 0.5 4.9 4.7 10.4 9.9 118.6 53.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.2 0.4 297.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 4.7 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.7 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 0.9 0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.3 0.1 38.5 275.3 0.0 2.8 0.0 4.4 0.0 0.0 0.0 1.5 0.0 1.5 0.0 16.7 0.0 0.0 0.1 0.6 0.7 0.0 2.4 0.6 0.0 0.0 3.2 0.0 18.9 0.0 0.0 0.2 6.0 2.0 0.0 8966.1 0.0 0.0 0.0 3.8 0.0 0.1 0.7 0.0 0.0 0.0 1.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.8 5.4 0.7 0.1 3.6 0.0 0.0 0.4 1.1 0.0 0.7 0.0 0.0 0.1 345.1 0.0 1.0 6.1 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2 microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 8.1" "Group enriched" "Detected in many" 5 "granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes Yes "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (8.07e-7)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.9 1.4 0.9 13.0 0.9 48.0 2.7 0.8 1.0 2.3 0.5 11.6 9.4 2.4 0.2 13.2 0.9 1.8 0.8 1.1 0.6 0.7 4.2 1.9 26.6 0.6 1.0 0.5 0.4 0.4 0.2 8.3 0.7 0.7 14.2 0.5 2.0 0.5 1.4 9.8 9.4 6.8 0.6 5.2 6.2 30.7 1.3 70.3 1.0 0.8 32.3 3.4 4.1 0.9 455.1 149.1 176.4 139.1 13.8 25.2 169.8 186.1 104.5 264.0 197.7 319.1 190.4 212.4 106.7 104.5 196.8 232.7 203.7 169.0 298.8 92.3 78.8 416.3 139.7 219.6 4.2 161.9 102.8 8.7 9.1 166.0 120.0 37.9 144.6 157.1 313.8 187.8 209.7 186.2 272.2 125.3 197.1 174.0 159.3 152.5 475.5 128.2 71.2 72.8 127.5 85.7 284.6 106.3 82.0 120.9 185.1 97.3 98.3 294.1 179.7 136.5 290.0 74.4 138.6 187.3 92.2 565.1 195.8 5.1 0.0 0.4 0.4 0.0 0.2 0.6 1.4 1.7 0.5 0.2 0.3 0.5 0.2 3.6 0.1 1.0 8.1 1.0 0.9 0.9 0.8 1.0 1.1 0.6 0.6 1.0 0.7 0.6 1.3 0.9 1.0 0.0 4.2 0.0 5.9 6.9 1.5 4.3 1.2 0.9 3.0 3.4 0.9 4.3 3.8 0.0 0.0 23.3 3.8 6.4 0.0 1.2 9.3 7.3 6.6 3.9 1.2 90.7 2.9 0.4 68.5 9.2 16.3 8.4 0.0 46.6 8.9 3.0 19.5 1.7 0.9 9.8 10.2 8.0 5.5 13.1 0.9 7.6 0.0 1.0 2.1 0.4 3.1 0.5 0.5 1.8 1.4 0.0 30.8 2.5 0.9 0.0 0.7 0.4 0.0 1.1 15.4 114.5 63.1 31.2 6.1 4.7 8.2 4.2 18.4 2.9 TRAC ENSG00000277734 "T cell receptor alpha constant" 14 22547506-22552156 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 7 "lymphoid tissue: 787.9" "Cell type enhanced" "Detected in many" "dendritic cells: 166.3;Rod photoreceptor cells: 75.9;T-cells: 428.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "MAIT T-cell: 2123.1;memory CD4 T-cell: 2939.7;memory CD8 T-cell: 2508.6;naive CD4 T-cell: 2671.8;naive CD8 T-cell: 2388.0;T-reg: 4379.2" "Lineage enriched" "Detected in all" 41 "T-cells: 4379.2" "Cell line enhanced" "Detected in many" "HDLM-2: 127.0;JURKAT: 294.7;NB-4: 83.1;U-266/84: 126.2;U-698: 62.1" "Low region specificity" "Detected in all" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "prognostic favorable (3.21e-4)" "prognostic favorable (4.87e-6)" "unprognostic (9.92e-3)" "prognostic favorable (4.15e-6)" "unprognostic (3.71e-2)" "prognostic favorable (5.25e-5)" "unprognostic (2.83e-2)" "unprognostic (9.81e-3)" "unprognostic (2.51e-3)" "unprognostic (1.00e-2)" "unprognostic (1.01e-1)" "unprognostic (4.99e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (2.13e-1)" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (2.75e-2)" 17.5 7.7 5.4 157.5 14.8 29.5 16.9 6.9 3.9 12.0 2.4 33.6 46.6 9.3 39.3 17.2 10.0 42.2 45.3 2.0 2.0 10.5 16.5 47.0 394.3 3.4 8.2 7.3 3.3 1.9 11.4 2.3 4.0 15.3 43.4 112.7 25.8 5.5 3.3 19.5 78.3 10.4 2.5 134.1 54.9 7.2 2.2 787.9 12.2 2.7 287.6 58.4 9.7 2.3 0.3 0.0 11.6 0.0 0.0 0.0 0.2 0.1 0.4 0.3 0.4 1.8 0.0 11.4 1.5 0.0 0.2 0.0 0.2 0.1 1.1 127.0 0.0 0.2 0.0 0.0 0.0 16.4 0.8 0.0 0.0 4.3 0.2 0.0 3.1 294.7 0.4 0.1 1.2 0.0 45.7 83.1 3.1 0.1 0.6 22.9 2.8 0.2 0.7 0.0 0.0 0.2 0.0 0.0 1.1 1.7 0.0 1.6 8.3 3.4 0.7 0.3 1.0 2.7 126.2 62.1 1.0 0.5 0.1 24.5 10.2 9.8 520.5 6.7 2123.1 105.6 2939.7 2508.6 7.9 94.6 2671.8 2388.0 57.7 89.7 11.0 11.8 4379.2 2965.8 5.4 14.8 6.9 3.9 2.0 2.0 3.4 8.2 4.0 2.5 2.2 2.3 9.0 3.2 25.6 0.0 46.3 0.0 1.0 0.0 5.7 9.0 4.9 8.5 35.7 0.0 6.2 0.0 12.5 0.2 166.3 0.9 17.6 0.7 46.2 0.9 0.6 3.3 0.0 16.4 0.0 0.0 0.2 15.9 4.1 0.5 10.1 0.0 9.3 1.4 1.3 0.0 0.0 0.9 0.0 8.1 0.0 4.8 1.8 12.2 0.0 0.0 20.2 11.8 44.3 0.0 0.0 0.1 1.2 5.3 25.4 0.2 0.5 4.6 0.0 75.9 0.0 2.6 4.7 2.2 0.8 5.4 0.0 0.3 428.0 0.0 0.7 0.2 TRAV12-1 ENSG00000211785 "T cell receptor alpha variable 12-1" A0A0B4J245 14 21841240-21841774 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 21.1" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 4.1;Plasma cells: 1.4;T-cells: 6.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 72 "MAIT T-cell: 128.5;memory CD4 T-cell: 205.2;memory CD8 T-cell: 199.7;naive CD4 T-cell: 138.6;naive CD8 T-cell: 251.7;T-reg: 193.9" "Lineage enriched" "Detected in many" 97 "T-cells: 251.7" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (4.83e-3)" "unprognostic (9.56e-5)" "unprognostic (2.18e-2)" "unprognostic (3.33e-3)" "unprognostic (8.05e-2)" "unprognostic (2.99e-4)" "unprognostic (3.16e-4)" "unprognostic (3.23e-2)" "unprognostic (1.77e-3)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" "unprognostic (3.97e-4)" "unprognostic (1.39e-1)" "unprognostic (7.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.92e-2)" 0.5 0.0 0.0 6.5 0.0 1.2 1.3 0.0 0.2 0.6 0.0 1.3 2.8 0.4 0.8 0.7 0.4 2.5 0.1 0.0 0.0 0.1 0.5 1.3 13.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.2 0.0 0.4 0.0 2.3 1.2 0.0 4.9 1.9 0.1 0.0 21.1 0.2 0.2 14.3 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.9 1.9 0.4 128.5 0.2 205.2 199.7 0.3 0.6 138.6 251.7 2.6 0.3 1.0 0.2 193.9 100.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 TREML2 "C6orf76, dJ238O23.1, FLJ13693, TLT2" ENSG00000112195 "Triggering receptor expressed on myeloid cells like 2" Q5T2D2 6 41189749-41201149 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 14.4;lymphoid tissue: 9.5" "Cell type enhanced" "Detected in some" "B-cells: 5.3;Early spermatids: 19.1;Late spermatids: 37.3;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive B-cell: 23.3;neutrophil: 33.3" "Group enriched" "Detected in many" 15 "B-cells: 23.3;dendritic cells: 9.3;granulocytes: 33.3" "Cell line enhanced" "Detected in some" "HEL: 27.9;HL-60: 6.9;JURKAT: 7.9;SuSa: 4.5;U-698: 8.0;U-937: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 3400000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 36: HEL - Hemostasis" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (3.76e-3)" "unprognostic (2.39e-1)" "unprognostic (9.05e-3)" "unprognostic (1.30e-3)" "unprognostic (3.22e-3)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-1)" "unprognostic (7.46e-2)" "unprognostic (2.51e-1)" "unprognostic (2.40e-3)" "unprognostic (2.46e-1)" "unprognostic (2.02e-2)" "unprognostic (7.45e-2)" "unprognostic (1.54e-2)" "unprognostic (6.23e-2)" "unprognostic (6.71e-2)" 1.7 0.0 0.1 6.4 0.1 14.4 0.1 0.2 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.3 0.5 0.1 0.1 0.5 0.0 0.1 0.7 9.5 0.1 0.1 0.0 0.2 0.4 0.0 3.0 0.2 0.0 0.3 0.1 0.3 0.0 0.8 0.1 1.1 0.3 0.0 6.6 0.3 3.7 0.1 6.9 0.1 0.8 7.5 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.1 0.4 0.0 0.0 1.5 2.2 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 5.2 0.0 2.6 0.6 13.4 0.4 1.2 0.5 6.0 1.0 0.2 2.2 23.3 1.3 0.4 33.3 0.7 1.4 9.3 0.7 2.0 0.1 0.1 0.2 0.3 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 1.1 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.4 37.3 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 8.8 0.2 0.0 0.0 0.0 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111286-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 600.1;skin 1: 551.2;vagina: 269.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "spinal cord: 4.0" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 2.5 1.0 0.1 0.4 0.2 0.4 41.7 0.0 0.4 133.8 1.6 3.0 1.7 2.6 4.8 600.1 17.4 3.5 0.4 0.3 0.0 1.7 1.8 3.7 0.0 1.8 0.6 0.4 1.0 0.0 8.1 30.7 1.8 31.4 2.6 0.3 131.5 23.7 2.2 551.2 1.0 1.5 2.6 0.3 1.4 2.7 0.0 19.9 0.4 0.2 107.2 55.8 269.1 0.6 34.4 2.5 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.2 0.1 0.8 25.6 0.2 3.9 0.2 0.5 399.9 0.0 107.5 0.0 0.1 0.0 0.2 25.4 0.4 0.0 0.2 0.5 0.0 476.0 0.0 2.6 0.0 0.0 0.0 0.2 0.7 0.0 4.4 0.0 0.0 0.1 11.4 0.1 0.0 0.3 0.0 0.3 190.5 1.3 5.9 268.3 35.2 0.1 0.2 1.9 0.0 0.4 0.1 2.1 0.2 0.1 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.3 0.0 1.8 0.6 1.8 2.6 0.0 0.6 0.5 0.0 1.5 3.3 0.2 272.0 106.1 76.4 250.4 0.0 9.5 58.8 1.2 1.5 39.2 0.0 0.0 41.0 0.2 11.3 0.0 5.0 28.1 8.7 0.8 3.4 2.4 0.0 0.5 4.3 7.1 5.6 1.1 3.6 1.3 0.0 0.0 0.4 5.0 0.0 0.1 2.1 12.2 0.0 30.3 150.3 0.6 1.4 23.2 1.0 0.0 0.0 0.0 0.0 0.1 57.1 11.3 0.0 0.0 66.0 0.2 0.6 64.6 0.0 0.0 0.1 4.9 0.8 2.6 552.9 460.6 24.8 2.4 0.1 3.7 159.3 TRIM31 "C6orf13, HCG1, HCGI, RNF" ENSG00000204616 "Tripartite motif containing 31" Q9BZY9 6 30102897-30113090 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 22.1;stomach 1: 6.0;urinary bladder: 8.6" "Group enriched" "Detected in some" 4 "Distal enterocytes: 409.1;Paneth cells: 404.9;Proximal enterocytes: 193.3;Urothelial cells: 227.9" "Group enriched" "Detected in many" 5 "cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 726 "RT4: 294.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA074175 Enhanced NA NA "Cluster 37: Intestine - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA074175: " "unprognostic (1.37e-1)" "unprognostic (7.78e-3)" "unprognostic (1.83e-1)" "unprognostic (7.05e-3)" "unprognostic (1.75e-1)" "unprognostic (9.37e-2)" "unprognostic (6.13e-2)" "unprognostic (1.32e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-2)" "unprognostic (1.97e-2)" "unprognostic (1.92e-1)" "unprognostic (1.43e-3)" "unprognostic (5.84e-3)" "unprognostic (6.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.50e-3)" 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 22.1 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.4 12.1 0.1 0.0 0.0 6.0 3.3 0.0 0.0 0.0 0.0 0.0 8.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 294.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.6 0.1 12.3 2.5 0.0 0.0 0.4 0.3 5.7 4.3 3.0 0.0 0.0 0.0 0.2 409.1 0.0 2.7 0.2 25.7 0.2 0.4 5.4 2.7 0.0 1.7 0.0 0.3 73.9 1.1 4.5 0.0 0.0 0.0 0.1 0.0 0.0 52.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 404.9 0.0 0.2 2.7 193.3 0.6 14.2 0.0 0.0 0.2 0.5 1.8 0.2 0.0 0.0 0.0 0.8 0.0 25.6 227.9 TRIM55 "MURF-2, RNF29" ENSG00000147573 "Tripartite motif containing 55" Q9BYV6 8 66126896-66175485 "Predicted intracellular proteins, Predicted membrane proteins" "Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 61.8;liver: 37.9;skeletal muscle: 29.6;tongue: 33.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 108.9;Endometrial ciliated cells: 64.7;Hepatocytes: 30.4;Skeletal myocytes: 31.0;Spermatocytes: 23.8" "Group enriched" "Detected in some" 10 "liver cancer: 12.3;renal cancer: 5.8" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "LHCN-M2: 426.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038793, HPA053691" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 39: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" Cytosol "HPA038793: AB_10673289, HPA053691: AB_2682231" "unprognostic (5.44e-3)" "unprognostic (1.25e-2)" "unprognostic (5.93e-3)" "unprognostic (4.07e-2)" "unprognostic (6.83e-3)" "unprognostic (3.77e-3)" "unprognostic (8.31e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.50e-1)" "unprognostic (5.18e-2)" "unprognostic (2.10e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-2)" "unprognostic (1.77e-3)" 1.4 0.0 0.1 0.1 0.0 0.0 0.2 1.5 0.1 0.3 0.0 0.0 0.1 0.1 3.5 0.8 5.3 0.1 61.8 0.0 0.0 4.8 37.9 0.2 0.0 0.1 0.6 0.0 0.2 0.2 0.4 0.0 0.3 0.7 0.1 0.0 1.3 0.2 29.6 0.4 0.1 0.1 0.0 0.1 0.0 7.3 0.0 0.2 0.3 33.7 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 7.2 0.1 0.3 0.1 0.0 0.4 0.5 0.6 0.0 60.5 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 4.2 426.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.7 1.5 27.6 0.0 2.4 0.0 0.0 0.1 0.0 91.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.6 0.0 0.1 2.8 0.0 0.0 0.1 0.0 108.9 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.8 64.7 0.2 1.2 0.0 0.0 0.2 0.0 0.1 3.8 0.0 3.5 0.0 0.0 0.7 30.4 0.1 0.0 1.5 0.0 0.0 1.3 0.0 6.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 7.4 15.4 0.0 6.6 31.0 2.9 23.8 1.2 0.0 0.0 3.8 0.3 0.0 0.0 0.3 TROAP TASTIN ENSG00000135451 "Trophinin associated protein" Q12815 12 49323236-49331731 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.0;lymphoid tissue: 36.7;testis: 29.1" "Cell type enhanced" "Detected in many" "Early spermatids: 71.5;Erythroid cells: 75.6;Late spermatids: 70.2;Spermatocytes: 29.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 8.6" "Lineage enriched" "Detected in many" 4 "T-cells: 8.6" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA044102 Uncertain NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 21: OE19 - Mitochondria" "Cluster 12: Non-specific - Cell cycle regulation" "HPA044102: AB_10963691" "unprognostic (1.47e-1)" "unprognostic (2.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.92e-3)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (3.43e-3)" "unprognostic (2.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.08e-3)" "unprognostic (3.51e-2)" "unprognostic (0.00e+0)" "unprognostic (1.80e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (5.17e-2)" 1.3 1.5 0.2 7.3 0.3 51.0 1.4 0.2 0.7 2.8 0.2 6.7 9.0 1.2 0.5 13.5 0.7 0.8 0.8 0.2 0.2 0.9 1.6 2.4 11.2 0.4 0.2 0.8 0.8 0.7 0.4 5.1 0.3 0.9 9.2 0.6 2.5 0.4 0.3 7.7 7.6 2.8 0.1 7.0 5.4 29.1 0.5 36.7 0.8 0.3 14.5 1.9 5.3 0.3 95.9 73.9 92.4 69.7 2.8 6.2 71.2 45.4 43.4 129.5 73.1 163.7 73.5 64.6 21.9 33.7 70.7 74.6 70.4 44.0 75.7 51.9 101.8 90.9 120.4 53.7 1.9 66.5 93.8 1.5 6.0 86.9 59.8 21.1 75.1 68.0 57.2 108.9 52.7 123.0 122.9 101.8 43.4 269.3 110.2 62.5 78.6 83.9 31.7 35.0 59.9 41.0 56.0 107.4 32.7 53.6 88.2 50.1 25.0 33.5 91.2 69.4 124.8 58.3 68.8 83.0 32.3 73.8 38.4 0.2 0.0 0.1 0.1 0.0 0.2 1.4 2.1 2.3 0.3 1.4 0.1 0.5 0.0 2.0 0.1 0.0 8.6 0.5 0.2 0.3 0.2 0.7 0.2 0.2 0.4 0.2 0.3 0.1 0.5 0.3 0.1 0.0 0.0 0.0 4.6 3.8 1.5 2.8 1.2 0.6 2.1 2.8 0.5 0.0 1.8 0.0 0.0 14.1 1.0 3.7 0.0 0.7 71.5 1.9 1.3 1.9 1.2 75.6 0.0 0.7 23.6 3.3 10.2 2.7 0.0 16.0 5.7 1.1 15.7 0.0 0.0 7.9 10.2 6.7 3.7 70.2 1.8 4.0 1.8 0.0 0.9 0.0 6.2 0.0 0.0 0.8 1.8 0.4 17.0 1.1 0.7 0.1 0.2 0.4 0.0 0.7 3.5 29.1 9.3 15.6 2.0 4.0 2.5 0.9 12.7 3.6 TRPV4 "CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC" ENSG00000111199 "Transient receptor potential cation channel subfamily V member 4" Q9HBA0 12 109783087-109833406 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Charcot-Marie-Tooth disease, Disease variant, Dwarfism, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 50.8;salivary gland: 19.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 17.1;Cholangiocytes: 20.0;Cytotrophoblasts: 20.0;Kupffer cells: 19.6;Respiratory ciliated cells: 28.2;Syncytiotrophoblasts: 21.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 5 "hippocampal formation: 4.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 7.9;BJ hTERT+: 9.5;EFO-21: 7.2;HaCaT: 14.2;HUVEC TERT2: 8.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA007150 Uncertain NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA007150: AB_1080393" "unprognostic (2.98e-2)" "unprognostic (1.12e-2)" "unprognostic (2.33e-2)" "unprognostic (4.20e-3)" "unprognostic (6.25e-3)" "unprognostic (1.09e-2)" "unprognostic (7.95e-2)" "unprognostic (2.03e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "prognostic favorable (4.12e-5)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.73e-2)" 1.0 0.8 0.2 0.9 0.3 0.1 1.9 0.7 0.5 2.0 50.8 0.4 0.7 0.6 0.4 10.3 4.7 1.4 0.8 4.2 0.2 14.7 8.6 2.2 0.8 0.5 0.4 0.3 4.4 0.3 2.1 5.2 0.3 6.8 0.3 0.0 19.2 0.8 0.1 7.5 0.4 0.7 0.2 2.8 0.7 0.8 0.8 0.1 0.9 0.0 0.9 1.8 2.2 0.4 2.4 0.2 0.0 0.0 2.0 1.2 7.9 4.2 9.5 1.2 0.3 0.0 6.4 0.0 7.2 5.8 0.0 14.2 1.0 0.0 0.4 0.0 1.8 0.0 0.1 3.7 0.6 0.0 0.0 3.4 2.0 2.7 0.0 0.6 8.7 0.0 0.5 0.0 0.4 5.3 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 4.9 0.0 0.0 0.3 0.6 2.6 3.5 1.1 0.2 4.5 0.0 2.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.5 4.2 0.2 0.5 0.4 0.3 0.2 0.8 0.4 0.1 0.0 0.0 0.0 0.7 3.3 8.1 17.1 7.4 0.0 5.1 5.5 1.0 20.0 12.0 11.0 0.0 20.0 0.4 0.0 3.9 2.5 0.2 3.2 1.0 1.4 0.0 0.0 0.3 9.3 5.3 1.2 2.0 1.2 0.0 0.9 0.7 7.7 4.0 0.0 0.4 0.0 6.1 19.6 0.7 0.2 0.9 2.6 7.2 1.9 0.8 0.0 0.0 1.0 0.3 2.0 0.0 0.0 0.0 4.6 0.0 12.5 28.2 0.0 0.0 0.1 1.1 0.3 1.1 4.5 3.8 21.1 0.3 0.2 0.0 3.3 TSGA10 "CEP4L, CT79" ENSG00000135951 "Testis specific 10" Q9BZW7 2 98997261-99154964 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 51.5" "Cell type enhanced" "Detected in all" "Early spermatids: 458.9;Late spermatids: 294.2;Oligodendrocytes: 144.9;Spermatocytes: 206.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036879 Approved Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA036879: AB_10671715" "unprognostic (1.71e-3)" "unprognostic (6.68e-2)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (3.69e-2)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-5)" "unprognostic (2.32e-1)" "unprognostic (2.82e-6)" "unprognostic (1.06e-2)" "unprognostic (9.91e-3)" "unprognostic (9.79e-2)" "unprognostic (8.37e-4)" 1.1 1.0 1.8 0.6 1.6 0.7 1.4 1.6 1.9 1.3 3.7 0.9 1.0 1.1 1.6 0.6 12.6 1.1 0.2 1.8 1.6 3.0 0.5 1.6 1.0 3.4 3.5 0.5 1.7 1.6 2.5 0.4 2.5 1.0 1.3 2.6 1.1 0.6 0.1 1.9 0.6 0.3 2.7 0.8 1.4 51.5 1.5 1.1 3.1 0.2 0.8 0.6 0.4 3.7 0.8 0.2 1.2 0.5 0.6 0.7 0.9 0.0 0.1 0.3 0.2 0.2 0.8 0.7 0.2 0.0 0.5 0.2 0.2 0.2 0.3 1.0 0.8 0.1 0.0 0.3 0.0 0.5 1.7 0.9 1.0 0.1 0.1 0.7 0.0 0.9 0.0 0.0 0.6 0.2 0.2 0.4 0.1 0.3 0.2 0.3 0.1 0.2 4.2 0.7 1.7 0.2 0.9 0.7 0.2 1.3 0.2 0.3 0.4 0.2 0.4 0.0 0.1 0.6 0.3 0.3 0.3 1.0 0.4 0.1 0.2 0.2 0.6 0.0 0.7 0.7 0.7 0.8 0.0 0.8 1.1 0.7 0.0 1.0 0.0 0.4 0.7 0.3 1.8 1.6 1.6 1.9 1.8 1.6 3.4 3.5 2.5 2.7 1.5 3.7 3.1 3.2 9.2 35.3 13.3 3.6 10.3 8.6 6.2 19.3 13.9 15.4 7.1 17.2 14.5 23.9 29.2 9.7 5.6 4.7 25.4 8.4 458.9 80.6 4.5 4.0 15.5 8.6 73.4 10.5 4.3 5.8 8.6 10.9 5.1 5.3 4.2 7.1 4.6 20.2 57.9 6.7 12.2 3.1 1.4 294.2 11.1 5.1 1.8 23.4 4.5 21.1 15.5 27.6 144.9 4.7 12.2 9.8 8.1 7.8 8.0 12.9 107.9 36.6 6.6 5.7 6.2 206.8 36.6 5.6 4.4 9.3 8.9 5.9 8.4 7.9 TSNAXIP1 TXI1 ENSG00000102904 "Translin associated factor X interacting protein 1" Q2TAA8 16 67806765-67832148 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 8.6;testis: 21.5" "Cell type enhanced" "Detected in many" "Early spermatids: 99.9;Endometrial ciliated cells: 41.1;Late spermatids: 178.6;Respiratory ciliated cells: 51.9;Spermatocytes: 53.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.0;SiHa: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA053516 Approved Nucleoplasm,Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA053516: AB_2682175" "unprognostic (9.78e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "prognostic favorable (2.22e-4)" "unprognostic (1.92e-1)" "unprognostic (2.82e-3)" "unprognostic (2.73e-1)" "unprognostic (7.09e-2)" "unprognostic (2.93e-1)" "unprognostic (6.66e-2)" "unprognostic (1.81e-3)" "unprognostic (1.94e-1)" "unprognostic (4.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-3)" "unprognostic (1.59e-3)" 0.5 1.0 1.1 0.4 1.3 0.1 0.5 0.8 1.8 1.4 2.8 1.0 0.0 0.9 0.9 0.2 8.6 0.4 0.3 1.3 1.2 1.2 0.8 1.3 0.1 1.8 2.2 1.5 1.2 1.3 6.4 0.1 1.7 0.9 0.1 3.5 0.3 0.4 0.2 0.3 0.3 0.4 1.2 0.3 0.5 21.5 1.3 0.2 0.7 0.0 0.1 0.6 0.5 1.0 0.5 0.1 1.1 3.0 1.4 0.4 0.4 0.1 0.7 0.2 1.0 0.3 0.3 0.4 0.4 0.1 0.3 0.6 0.3 0.4 0.6 0.1 0.4 0.0 0.4 0.0 0.4 0.7 0.0 0.3 0.4 1.4 0.2 0.2 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.3 0.3 0.0 0.1 0.8 0.3 0.0 1.3 0.3 0.8 1.0 2.0 0.0 0.2 0.3 0.8 0.0 0.3 0.1 0.0 0.3 0.1 0.5 1.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 0.8 1.8 1.3 1.2 1.8 2.2 1.7 1.2 1.3 1.0 0.6 0.0 2.7 9.1 0.2 0.1 0.4 2.5 0.6 2.9 1.0 1.1 12.0 0.0 4.8 5.5 4.2 0.4 0.2 0.2 0.0 0.7 99.9 41.1 2.0 1.1 0.0 0.4 7.9 0.0 0.2 1.6 0.0 1.3 0.0 1.3 0.7 0.7 0.3 3.3 4.9 0.0 10.2 0.0 0.2 178.6 2.8 0.3 0.0 3.7 0.0 3.7 0.0 3.0 1.3 0.1 0.0 1.9 0.0 0.3 0.0 2.5 51.9 10.2 6.6 0.6 1.7 53.3 8.9 0.1 0.3 0.5 0.2 1.4 0.0 0.2 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185962 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 593.8;kidney: 244.3" "Cell type enhanced" "Detected in many" "Club cells: 723.5;Distal enterocytes: 1983.8;Late spermatids: 838.1;Paneth cells: 1127.7;Respiratory ciliated cells: 1817.6" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 57 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 57 "dendritic cells: 5.6" "Cell line enhanced" "Detected in many" "A-431: 129.6;CAPAN-2: 216.7;HaCaT: 151.4;hTCEpi: 173.6;OE19: 257.9;RPTEC TERT1: 628.4;RT4: 308.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA011909 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.9 4.3 0.5 53.2 0.7 0.0 6.2 1.7 1.1 78.2 1.4 523.3 25.4 17.7 34.7 5.5 122.4 28.9 0.9 0.5 0.5 244.3 3.9 32.1 0.4 1.2 0.6 0.4 3.1 72.0 17.3 1.1 1.1 194.7 593.8 0.0 101.0 65.9 0.8 2.5 96.7 20.8 1.0 0.7 213.1 27.3 0.6 1.9 121.9 0.1 4.9 104.9 9.9 1.8 129.6 2.0 0.0 0.0 0.2 0.0 1.8 0.1 2.7 0.1 0.0 0.0 216.7 0.0 40.2 0.3 0.2 151.4 0.0 111.2 0.1 0.0 0.0 0.0 1.1 7.6 0.0 0.0 0.2 0.0 173.6 0.7 60.9 3.6 0.3 1.3 0.0 0.0 1.6 4.9 0.0 0.5 0.1 257.9 8.1 0.1 0.1 1.6 628.4 308.2 1.9 0.0 0.3 13.0 0.5 0.5 9.0 0.1 1.4 0.0 0.7 0.4 0.7 1.5 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.5 0.7 1.7 1.1 0.5 0.5 1.2 0.6 1.1 1.0 0.6 1.8 2.5 25.6 29.5 0.3 7.4 1.0 194.4 499.9 4.0 0.0 14.5 11.0 0.7 11.5 723.5 579.4 0.0 0.3 0.2 1983.8 46.9 61.3 141.3 268.3 14.1 4.5 201.8 0.0 1.2 525.1 0.1 6.0 223.3 144.3 11.4 0.0 1.4 3.6 0.3 0.0 1.3 648.1 242.1 0.3 0.3 838.1 5.0 5.3 5.4 1.0 1.6 0.0 0.0 0.5 1.6 484.4 1127.7 1.9 0.7 211.7 505.4 477.8 1817.6 0.0 0.0 0.4 54.1 4.7 2.6 2.9 1.3 0.0 7.4 0.0 275.9 517.0 TSPAN13 "NET-6, TM4SF13" ENSG00000106537 "Tetraspanin 13" O95857 7 16753755-16784536 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 303.4;Alveolar cells type 1: 496.8;Cytotrophoblasts: 293.7;Intestinal goblet cells: 404.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 99.6;plasmacytoid DC: 231.7" "Group enriched" "Detected in many" 42 "B-cells: 99.6;dendritic cells: 231.7" "Cell line enhanced" "Detected in many" "OE19: 484.5;SCLC-21H: 215.3;SK-BR-3: 314.0;T-47d: 587.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007426 Uncertain Uncertain Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 6: T47d - Mammary gland" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm "HPA007426: AB_10603137" "unprognostic (3.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.56e-5)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (5.69e-2)" "unprognostic (6.63e-2)" "prognostic favorable (2.20e-4)" "unprognostic (1.50e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" 65.6 81.1 32.1 29.1 37.2 26.1 76.3 20.5 95.8 60.7 17.0 83.5 88.9 20.0 36.9 19.7 19.9 55.5 23.9 36.2 67.1 7.8 47.4 185.5 56.2 24.1 28.3 3.1 95.8 14.1 83.6 67.1 28.7 51.1 99.9 19.4 168.0 35.8 9.3 16.6 77.3 20.3 19.8 26.3 108.0 8.9 27.1 20.4 35.1 13.7 47.2 41.0 16.1 29.3 47.4 38.6 47.8 50.9 6.0 0.2 13.2 99.0 16.1 2.6 4.9 137.4 70.9 1.4 24.7 35.8 12.3 71.2 56.2 83.2 21.6 1.4 60.3 20.3 15.3 14.8 13.3 1.9 4.0 5.6 35.4 5.2 5.9 27.4 30.1 20.7 67.0 0.4 2.9 135.4 2.8 2.6 33.4 484.5 46.5 54.0 0.2 48.5 153.1 90.1 215.3 32.5 18.0 314.0 4.8 68.1 587.9 5.2 2.9 1.4 17.0 1.5 33.1 28.4 0.8 1.0 44.2 0.8 69.1 0.6 0.0 0.2 0.0 0.0 0.1 47.9 0.1 0.0 1.1 99.6 0.0 0.1 3.9 3.6 0.1 231.7 0.0 5.6 32.1 37.2 20.5 95.8 36.2 67.1 24.1 28.3 28.7 19.8 27.1 29.3 303.4 496.8 82.5 10.1 94.0 42.6 84.9 96.0 31.9 78.2 141.7 46.7 19.1 41.5 137.6 29.5 8.4 293.7 131.6 95.4 7.9 68.0 1.6 27.8 6.5 97.9 107.7 60.2 79.3 203.9 109.3 22.5 89.2 67.1 9.5 1.0 7.5 26.3 40.8 15.2 56.8 404.6 122.1 18.9 22.6 2.5 0.6 9.4 32.0 9.4 61.3 3.5 2.1 23.6 7.6 109.1 88.8 0.7 49.9 127.4 99.8 0.9 63.2 8.1 32.9 2.2 22.0 1.7 19.5 39.4 39.6 201.1 8.9 6.1 125.3 173.6 TSPAN19 ENSG00000231738 "Tetraspanin 19" P0C672 12 85014311-85036277 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 4.3;testis: 4.5" "Cell type enriched" "Detected in some" 5 "Respiratory ciliated cells: 382.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.5;SK-BR-3: 1.7;U-266/70: 1.6" "Low region specificity" "Detected in many" HPA057066 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 77: Retina - Visual perception" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "HPA057066: AB_2683325" "unprognostic (1.94e-1)" "unprognostic (9.81e-4)" "unprognostic (8.57e-2)" "unprognostic (8.37e-2)" "unprognostic (2.33e-1)" "unprognostic (6.57e-2)" "unprognostic (2.26e-3)" "unprognostic (9.52e-2)" "unprognostic (5.09e-3)" "unprognostic (2.22e-1)" "unprognostic (3.78e-2)" 0.1 0.3 0.7 0.3 0.6 1.1 0.0 2.3 1.1 0.2 1.3 0.2 0.4 0.3 0.9 0.1 0.9 0.3 0.1 0.4 0.6 0.4 0.0 2.7 0.3 1.0 0.3 0.2 0.8 0.1 2.0 0.1 0.9 0.5 0.1 4.3 0.0 0.0 0.9 1.3 0.2 0.0 0.2 0.3 0.1 4.5 0.6 0.0 1.8 0.5 0.2 0.1 0.0 1.2 0.3 0.0 0.6 0.2 0.3 0.5 0.8 0.4 0.0 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.4 0.5 0.0 0.3 0.3 0.9 0.6 0.7 0.4 0.4 0.4 0.2 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.5 1.1 0.0 1.7 0.4 0.2 0.4 0.0 0.5 1.0 0.3 0.5 0.3 1.6 0.0 0.2 1.3 0.0 0.5 0.3 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.2 0.2 1.4 0.2 0.1 0.2 0.0 0.0 0.7 0.6 2.3 1.1 0.4 0.6 1.0 0.3 0.9 0.2 0.6 1.2 0.1 3.2 2.0 0.7 0.0 0.1 0.0 18.2 0.0 3.5 0.1 0.1 1.1 0.0 30.3 0.0 8.4 0.0 0.0 0.0 0.0 0.0 72.7 0.6 0.0 0.5 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 14.2 0.0 0.3 6.9 0.0 0.1 0.0 1.0 0.0 5.1 0.0 0.0 3.1 0.0 0.0 0.4 0.1 0.6 0.0 0.1 382.1 9.1 6.6 0.4 5.2 7.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TTC16 FLJ32780 ENSG00000167094 "Tetratricopeptide repeat domain 16" Q8NEE8 9 127716079-127731590 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "fallopian tube: 6.9;testis: 16.0" "Group enriched" "Detected in some" 4 "Early spermatids: 103.1;Late spermatids: 258.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (3.10e-3)" "unprognostic (1.63e-3)" "unprognostic (3.86e-3)" "unprognostic (2.02e-4)" "unprognostic (4.08e-3)" "unprognostic (2.25e-3)" "unprognostic (8.87e-4)" "unprognostic (2.91e-2)" "unprognostic (2.25e-2)" "unprognostic (2.36e-1)" "unprognostic (1.96e-3)" "unprognostic (7.32e-2)" "unprognostic (9.14e-3)" "unprognostic (6.35e-3)" "unprognostic (5.29e-2)" "unprognostic (1.17e-1)" "unprognostic (5.54e-3)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.2 0.0 6.9 0.1 0.0 0.1 0.1 0.1 0.0 0.7 0.4 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.5 1.1 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.2 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.4 0.1 0.1 1.0 0.0 0.0 0.2 0.1 0.8 1.5 5.7 0.0 0.0 0.0 13.7 0.0 0.0 0.0 103.1 6.0 0.1 0.5 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.3 0.0 258.3 1.2 0.3 1.8 0.0 0.3 0.2 9.2 4.5 0.1 0.0 0.0 3.8 2.6 0.0 0.0 0.4 41.8 0.5 0.0 0.1 0.4 17.9 1.6 0.0 0.0 0.0 7.4 3.8 0.0 0.1 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 21.2" "Cell type enhanced" "Detected in many" "Early spermatids: 82.3;Late spermatids: 84.7;Respiratory ciliated cells: 56.0;Spermatocytes: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA035510: AB_2674659, HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favorable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.1 0.1 0.6 0.4 0.6 0.1 0.2 0.4 1.1 0.2 1.8 0.1 0.2 0.3 0.0 0.1 1.0 0.1 0.1 0.5 0.6 0.1 0.1 0.2 0.3 0.7 0.9 0.3 1.1 0.2 0.1 0.1 0.6 0.2 0.1 0.4 0.3 0.1 0.1 0.2 0.1 0.0 0.5 0.2 0.1 21.2 0.5 0.2 0.2 0.1 0.3 0.1 0.1 0.6 0.1 0.3 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.3 0.1 0.0 0.3 0.0 0.3 0.3 0.2 0.2 0.2 0.0 0.4 0.2 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.8 0.3 0.0 0.8 0.0 0.2 0.0 0.1 0.7 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.4 1.1 0.5 0.6 0.7 0.9 0.6 0.5 0.5 0.6 3.7 0.0 3.0 20.2 10.4 0.6 4.4 4.0 0.6 5.3 2.6 2.4 6.4 4.3 5.4 1.8 8.4 1.7 1.8 2.5 0.0 2.1 82.3 24.0 3.6 3.0 4.2 0.4 15.0 1.8 1.7 2.1 4.1 5.2 1.3 3.2 5.0 1.3 1.6 5.0 13.3 2.5 0.0 2.2 0.9 84.7 7.2 1.6 3.6 4.7 2.6 3.4 0.0 5.0 3.2 1.7 2.0 6.0 3.7 2.1 2.3 1.2 56.0 15.3 6.6 7.8 2.7 59.8 3.4 0.1 0.6 3.7 1.3 2.1 2.4 2.3 TTC23L FLJ25439 ENSG00000205838 "Tetratricopeptide repeat domain 23 like" Q6PF05 5 34838833-34899456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 24.7" "Group enriched" "Detected in some" 12 "Early spermatids: 373.9;Late spermatids: 218.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037807 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 34: Spermatids - Unknown function" "HPA037807: AB_10672466" "unprognostic (7.87e-2)" "unprognostic (6.80e-3)" "unprognostic (1.36e-1)" "unprognostic (1.78e-3)" "unprognostic (8.92e-3)" "unprognostic (9.89e-3)" "unprognostic (3.48e-2)" "unprognostic (9.93e-4)" "unprognostic (1.36e-1)" "unprognostic (2.20e-2)" "unprognostic (2.30e-3)" "unprognostic (1.30e-1)" "unprognostic (3.06e-3)" "unprognostic (4.16e-1)" "unprognostic (9.90e-2)" "unprognostic (2.53e-3)" "unprognostic (4.69e-4)" 0.0 0.9 0.9 0.1 1.3 0.0 0.7 0.8 1.1 0.4 3.6 0.0 0.0 0.4 0.7 0.0 3.6 0.2 0.1 0.8 1.8 0.3 0.1 0.3 0.2 2.2 2.1 0.1 0.7 0.8 0.9 0.1 1.6 0.2 0.0 1.2 0.4 0.6 0.0 0.6 0.1 0.1 2.2 0.0 0.2 24.7 1.4 0.2 0.5 0.0 0.1 0.1 0.0 2.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.8 1.1 0.8 1.8 2.2 2.1 1.6 2.2 1.4 2.3 0.0 0.0 1.1 14.7 0.0 0.0 0.2 0.5 0.0 0.0 5.4 0.5 0.4 0.0 2.7 0.0 10.4 0.2 0.1 0.0 0.0 0.1 373.9 8.1 0.3 0.4 0.0 0.0 13.1 0.0 0.1 0.4 0.0 0.3 1.3 0.1 0.0 0.0 0.1 0.0 11.9 0.0 0.0 0.0 0.0 218.7 3.1 0.0 0.0 1.9 0.0 0.7 0.0 4.5 15.3 0.0 0.0 3.0 0.0 0.0 0.0 0.1 23.3 0.5 0.0 0.1 0.1 11.0 2.0 0.0 0.0 0.4 0.0 0.3 0.1 0.1 TTC25 DKFZP434H0115 ENSG00000204815 "Tetratricopeptide repeat domain 25" Q96NG3 17 41930617-41966503 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 17.0;testis: 44.9" "Cell type enhanced" "Detected in many" "Early spermatids: 227.2;Endometrial ciliated cells: 65.3;Late spermatids: 43.5;Respiratory ciliated cells: 79.4;Spermatocytes: 98.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.0;U-87 MG: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023908 Enhanced Uncertain Vesicles,Centrosome NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Vesicles "HPA023908: AB_2241243" "unprognostic (3.08e-3)" "unprognostic (4.51e-2)" "unprognostic (6.96e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (4.57e-2)" "unprognostic (4.11e-2)" "unprognostic (1.41e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-4)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (2.10e-2)" "unprognostic (9.21e-3)" "unprognostic (3.76e-1)" "unprognostic (2.71e-1)" 0.6 0.6 1.8 0.0 1.8 2.7 0.8 1.6 1.8 2.6 6.8 1.1 0.1 1.5 1.3 0.1 17.0 0.5 0.7 1.8 2.4 2.0 0.4 2.8 0.1 3.1 3.3 1.3 0.7 1.9 5.6 0.3 2.4 0.9 0.1 1.7 0.3 0.4 0.5 0.4 0.3 0.5 2.2 0.2 0.5 44.9 2.6 0.3 2.0 0.2 0.0 0.8 0.5 1.7 0.1 1.2 1.4 1.4 0.3 0.3 0.2 0.0 0.6 0.2 0.3 0.2 1.0 0.1 0.5 0.2 0.4 0.3 0.2 0.1 0.3 0.2 0.3 0.3 0.3 0.0 0.4 0.0 0.7 0.2 0.2 0.6 0.0 0.8 0.0 0.7 0.1 0.8 0.2 0.8 0.8 0.1 0.4 0.0 0.1 0.0 0.1 1.0 1.3 0.1 3.0 2.0 0.1 0.4 1.1 0.4 0.5 0.3 0.0 0.1 0.6 0.5 0.3 1.0 0.9 0.1 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 1.8 1.6 1.8 1.8 2.4 3.1 3.3 2.4 2.2 2.6 1.7 0.4 3.2 4.8 2.9 0.0 0.0 0.5 0.0 0.0 2.7 0.5 1.1 1.6 1.5 14.9 3.7 8.4 0.5 0.0 0.3 1.9 2.3 227.2 65.3 2.6 0.9 0.0 18.7 5.2 0.8 0.7 3.0 0.5 3.1 3.8 0.6 0.7 0.2 0.4 3.3 4.6 0.2 0.0 0.0 0.0 43.5 3.4 0.4 0.0 1.0 0.2 2.8 0.0 1.0 0.7 0.4 0.1 1.9 0.0 0.2 0.0 3.4 79.4 5.2 13.1 4.1 0.6 98.4 3.5 0.0 0.0 0.1 0.2 1.5 0.2 0.3 TTC26 "dyf-13, DYF13, FLJ12571, IFT56" ENSG00000105948 "Tetratricopeptide repeat domain 26" A0AVF1 7 139133744-139191986 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 45.4;Endometrial ciliated cells: 52.6;Respiratory ciliated cells: 82.5;Spermatocytes: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036338 Enhanced NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA036338: AB_10673351" "unprognostic (3.40e-2)" "unprognostic (8.88e-2)" "unprognostic (5.01e-2)" "unprognostic (6.72e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" "unprognostic (2.46e-7)" "unprognostic (1.72e-1)" "unprognostic (4.96e-2)" "unprognostic (5.27e-2)" "unprognostic (7.12e-2)" "unprognostic (2.75e-1)" "unprognostic (5.18e-2)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" 2.0 3.1 2.2 1.6 2.2 2.5 3.6 2.4 2.1 3.6 9.0 1.6 0.7 4.2 3.6 1.9 14.1 2.9 1.6 1.9 2.4 4.6 1.1 3.3 1.9 3.1 4.0 4.8 1.7 8.2 3.7 2.5 2.5 2.7 1.6 4.7 1.8 3.4 1.1 1.9 1.0 2.9 2.9 1.7 1.5 12.2 3.0 2.4 4.8 1.6 2.0 2.5 1.9 2.4 13.2 9.8 8.5 10.1 10.3 11.9 4.2 6.3 6.5 10.1 10.3 6.3 9.3 2.9 10.3 4.9 16.5 6.4 9.5 7.4 14.6 8.3 8.2 3.5 7.5 5.5 5.2 10.3 2.4 6.8 6.5 15.1 6.8 6.3 7.5 6.8 8.1 1.8 8.1 12.9 17.6 12.0 8.4 3.9 8.6 6.1 10.0 4.6 8.8 3.9 12.4 8.9 15.5 6.5 8.9 2.5 7.9 5.5 5.3 9.4 8.1 8.6 11.8 4.0 5.6 2.2 16.3 5.0 11.2 0.6 0.1 0.4 0.6 0.1 0.3 1.2 0.4 0.4 0.4 0.7 0.7 0.5 1.8 0.5 0.5 0.9 0.3 0.3 2.2 2.2 2.4 2.1 1.9 2.4 3.1 4.0 2.5 2.9 3.0 2.4 2.3 0.0 4.1 13.7 2.3 1.1 2.3 5.5 1.8 6.8 3.3 2.3 2.6 5.7 13.4 5.5 12.5 1.4 0.4 0.7 0.0 5.3 45.4 52.6 8.0 2.3 1.2 6.5 26.9 2.8 3.3 5.9 1.1 11.5 5.7 7.4 4.6 1.8 2.2 0.0 20.3 1.0 12.2 0.8 1.2 17.7 4.1 1.9 3.6 7.5 1.6 4.2 1.0 9.0 6.5 2.2 2.7 5.3 0.3 0.9 0.1 5.5 82.5 18.3 0.0 5.0 4.1 57.5 11.1 2.0 1.7 0.4 1.4 11.0 0.9 0.8 TTC29 NYD-SP14 ENSG00000137473 "Tetratricopeptide repeat domain 29" Q8NA56 4 146706617-146945882 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "fallopian tube: 20.0;testis: 71.8" "Cell type enhanced" "Detected in some" "Early spermatids: 697.9;Late spermatids: 445.9;Respiratory ciliated cells: 97.7;Spermatocytes: 157.6" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;hTERT-HME1: 1.4;U-266/70: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037006, HPA061473" Uncertain NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA037006: AB_10670379, HPA061473: AB_2684534" "unprognostic (1.28e-3)" "unprognostic (1.52e-2)" "unprognostic (8.21e-2)" "unprognostic (1.70e-1)" "unprognostic (6.70e-2)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (1.32e-1)" "unprognostic (5.67e-4)" "unprognostic (9.81e-4)" "unprognostic (7.30e-2)" "unprognostic (6.88e-4)" 0.1 0.0 1.1 0.0 0.8 0.0 0.1 0.5 0.5 0.5 4.6 0.0 0.0 0.2 2.2 0.0 20.0 0.0 0.0 0.9 1.3 0.2 0.0 2.0 0.0 3.8 4.2 0.0 0.0 0.7 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 71.8 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 1.4 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.5 0.5 0.9 1.3 3.8 4.2 2.9 3.4 1.1 2.1 0.2 0.0 1.8 7.8 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.4 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 697.9 48.9 0.3 0.7 0.0 0.0 5.3 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 2.0 0.0 0.0 445.9 7.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 4.9 0.0 0.1 0.0 0.1 97.7 0.0 0.0 0.0 1.4 157.6 8.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TTK "CT96, MPH1, MPS1, MPS1L1" ENSG00000112742 "TTK protein kinase" P33981 6 80003887-80042527 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 25.3;lymphoid tissue: 46.6;testis: 34.3" "Cell type enhanced" "Detected in many" "Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010166, CAB013229" Enhanced Approved Nucleoli,Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Cytosol" "CAB010166: AB_632567, CAB013229: AB_2533230" "unprognostic (4.27e-2)" "unprognostic (8.71e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.97e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.84e-10)" "unprognostic (1.56e-3)" "unprognostic (7.95e-2)" "unprognostic (2.02e-3)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.54e-1)" "unprognostic (0.00e+0)" "unprognostic (3.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" 0.7 0.8 0.0 4.2 0.1 25.3 2.2 0.1 0.3 0.7 0.0 4.8 4.0 1.0 0.1 4.8 0.6 0.5 0.1 0.1 0.1 0.2 0.5 0.8 8.1 0.2 0.1 0.2 0.2 0.3 0.0 3.9 0.2 0.8 5.9 1.8 0.7 0.1 0.0 3.6 4.1 1.7 0.1 1.4 3.3 34.3 0.2 46.6 0.4 0.1 9.0 1.2 1.4 0.2 39.9 23.4 68.2 56.4 3.1 9.5 38.5 44.9 27.4 64.2 77.8 32.1 29.6 58.5 34.1 19.5 66.9 50.0 60.7 27.6 88.6 53.4 49.3 54.1 29.4 26.5 0.2 64.4 33.9 1.2 2.8 45.0 28.6 9.6 36.9 80.6 60.2 58.5 55.2 29.5 37.0 46.4 40.4 35.4 27.9 32.7 124.4 24.4 16.3 25.2 46.8 27.4 26.6 28.3 16.3 36.6 26.6 48.3 15.4 28.8 28.5 18.8 72.9 13.1 47.1 32.4 10.3 58.9 25.1 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.4 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.3 3.2 1.1 0.0 1.4 1.3 0.6 2.6 0.0 0.2 0.9 0.5 0.6 0.0 2.3 0.0 2.1 9.8 0.8 2.2 3.9 0.4 43.3 3.1 1.6 1.1 1.8 23.1 0.2 0.2 15.0 2.1 2.6 2.3 1.3 13.9 0.7 0.2 6.5 0.0 0.2 3.0 4.1 2.6 1.2 21.4 0.9 1.9 0.0 0.0 5.2 0.2 1.0 0.0 0.1 0.6 0.2 0.7 5.1 0.4 0.3 0.1 3.0 1.6 6.6 0.1 1.7 130.5 33.0 8.5 0.3 3.7 1.1 0.5 5.6 1.6 TTLL10 "FLJ36119, TTLL5" ENSG00000162571 "Tubulin tyrosine ligase like 10" Q6ZVT0 1 1173880-1197936 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "choroid plexus: 13.1;fallopian tube: 10.7;testis: 41.9" "Group enriched" "Detected in many" 6 "Early spermatids: 244.1;Late spermatids: 768.4" "Cancer enhanced" "Detected in some" "cervical cancer: 1.5;endometrial cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 32 "SCLC-21H: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA042712 Uncertain NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" "HPA042712: AB_10797019" "unprognostic (1.74e-1)" "unprognostic (7.95e-2)" "unprognostic (2.66e-3)" "prognostic favorable (1.61e-5)" "unprognostic (5.33e-2)" "unprognostic (2.68e-3)" "unprognostic (4.93e-3)" "unprognostic (2.14e-3)" "unprognostic (4.50e-1)" "unprognostic (3.69e-2)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "unprognostic (6.00e-4)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (1.12e-1)" "unprognostic (4.39e-2)" 1.3 0.0 0.6 0.1 0.4 0.0 1.1 0.2 0.4 1.7 13.1 0.2 0.1 0.2 0.4 0.3 10.7 0.3 0.2 0.8 0.9 0.4 0.0 2.8 0.1 2.6 3.7 0.0 0.3 0.0 2.1 1.5 1.8 0.3 0.1 0.0 0.3 0.1 0.4 0.2 0.2 0.0 2.0 0.1 0.5 41.9 0.9 0.0 0.2 0.0 0.0 0.2 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.4 0.8 0.9 2.6 3.7 1.8 2.0 0.9 0.6 14.4 0.0 0.5 0.0 0.3 1.8 0.7 3.0 0.0 0.1 1.4 1.0 0.8 1.5 3.4 0.0 2.1 0.0 0.9 0.9 0.0 0.5 244.1 52.2 0.6 2.1 0.0 0.0 0.2 1.3 1.0 0.3 3.6 6.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 3.1 0.0 0.0 1.1 768.4 5.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.5 1.0 4.5 0.0 1.5 0.4 0.1 72.5 0.1 6.6 0.9 1.0 9.3 2.1 1.0 2.0 0.1 0.9 0.0 3.6 1.3 TTLL13P "FLJ46079, MGC33417, TTLL13" ENSG00000213471 "Tubulin tyrosine ligase like 13, pseudogene" A6NNM8 15 90249530-90265482 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "testis: 8.9" "Cell type enhanced" "Detected in single" "Inhibitory neurons: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041305 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA041305: AB_2732492" "unprognostic (6.23e-3)" "unprognostic (2.19e-2)" "unprognostic (6.49e-4)" "unprognostic (6.09e-4)" "unprognostic (2.46e-1)" "unprognostic (1.43e-1)" "unprognostic (8.58e-2)" "unprognostic (5.17e-3)" "unprognostic (3.61e-3)" "unprognostic (9.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.79e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-2)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.88e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TTLL6 FLJ35808 ENSG00000170703 "Tubulin tyrosine ligase like 6" Q8N841 17 48762235-48817214 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.9" "Group enriched" "Detected in some" 4 "Early spermatids: 49.7;Late spermatids: 176.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HDLM-2: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA052397 Enhanced Approved Vesicles,Microtubules NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Microtubules Vesicles "HPA052397: AB_2681812" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-1)" "unprognostic (8.04e-2)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.21e-5)" "unprognostic (1.10e-2)" "unprognostic (6.01e-5)" "unprognostic (1.17e-1)" "unprognostic (3.28e-1)" "unprognostic (6.68e-2)" "unprognostic (2.09e-3)" 0.1 0.0 0.6 0.1 0.6 0.0 0.1 0.5 1.0 0.2 1.6 2.8 1.3 0.1 0.0 0.0 3.6 0.5 0.0 0.7 0.6 2.5 0.0 0.6 0.0 0.8 0.9 0.0 0.6 0.0 0.4 0.0 0.6 0.1 3.9 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.6 0.0 0.2 18.9 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 1.0 0.7 0.6 0.8 0.9 0.6 0.6 0.8 0.6 0.1 3.2 2.6 5.2 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.6 0.0 3.8 1.8 0.0 0.0 0.0 7.4 1.9 0.3 49.7 2.6 0.1 0.5 4.2 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.1 0.1 0.0 1.0 2.6 0.0 0.0 0.0 176.1 1.2 0.1 0.0 0.0 0.0 0.4 0.0 13.0 0.7 0.0 2.2 0.0 0.0 0.4 4.1 3.2 23.8 0.7 0.0 0.0 0.0 11.2 0.4 0.0 0.0 0.0 0.0 0.4 3.5 0.1 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.4;choroid plexus: 10.3;epididymis: 2.6;fallopian tube: 6.2;testis: 5.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 20.8;Early spermatids: 39.3;Endometrial ciliated cells: 25.8;Late spermatids: 69.8;Oligodendrocytes: 28.0;Respiratory ciliated cells: 50.2" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: AB_2682881" "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.1 0.1 2.0 0.0 2.1 0.0 0.2 2.2 2.2 0.9 10.3 0.0 0.0 0.1 2.6 0.0 6.2 0.1 0.0 2.5 2.3 0.7 0.0 1.1 0.1 3.8 4.4 0.1 0.2 0.6 0.9 0.0 3.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 3.0 0.2 0.0 5.0 2.4 0.0 0.6 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.1 2.2 2.2 2.5 2.3 3.8 4.4 3.0 3.0 2.4 2.6 0.2 12.8 20.8 13.1 0.1 0.1 1.1 1.1 0.0 1.8 0.4 0.6 0.9 0.0 8.1 0.0 4.2 0.1 0.1 0.0 0.0 0.2 39.3 25.8 0.7 1.1 0.0 0.0 5.6 0.0 0.0 1.6 0.0 0.8 7.6 0.8 0.4 0.1 0.0 5.0 7.8 0.2 2.0 0.6 0.5 69.8 1.5 3.5 0.0 1.0 0.8 0.4 0.0 15.1 28.0 0.1 0.0 1.2 0.0 0.5 0.0 0.2 50.2 0.8 0.0 0.8 0.7 13.8 1.2 0.0 0.1 0.0 2.7 0.4 0.0 0.4 TUBA4B "FLJ13940, TUBA4" ENSG00000243910 "Tubulin alpha 4b" Q9H853 2 219253243-219272197 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "fallopian tube: 40.0" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 148.9;Respiratory ciliated cells: 83.1" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 8.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.20e-5)" "unprognostic (1.47e-4)" "unprognostic (1.85e-1)" "unprognostic (3.70e-3)" "unprognostic (9.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.18e-3)" "unprognostic (7.32e-2)" "unprognostic (9.50e-2)" "unprognostic (6.56e-2)" "unprognostic (2.50e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-3)" "unprognostic (3.78e-2)" "unprognostic (9.57e-2)" "unprognostic (3.91e-2)" "unprognostic (4.08e-1)" 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.2 0.1 1.5 4.7 0.0 0.1 0.5 0.7 0.0 40.0 0.0 0.0 0.4 0.8 1.5 0.2 3.5 0.1 1.9 3.6 0.1 0.0 0.0 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.2 0.2 0.3 0.3 0.0 0.2 0.3 0.3 0.6 0.1 0.1 0.0 0.3 1.4 0.8 0.6 0.2 0.1 0.4 0.8 1.9 3.6 1.8 1.8 0.7 1.4 0.0 0.0 3.2 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 4.3 1.8 0.0 0.0 0.0 0.0 1.9 0.0 1.8 148.9 0.9 0.1 1.8 0.0 0.3 0.2 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 27.9 83.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 TYMS "HsT422, TMS, TS, Tsase" ENSG00000176890 "Thymidylate synthetase" P04818 18 657653-673578 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Methyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 88.5;lymphoid tissue: 113.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 105.8;Erythroid cells: 189.3;Extravillous trophoblasts: 115.3;Plasma cells: 112.7;Spermatocytes: 180.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 14.1" "Group enriched" "Detected in many" 6 "NK-cells: 6.7;T-cells: 14.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002784, HPA074922" Enhanced NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "CAB002784: , HPA074922: " "unprognostic (7.58e-2)" "unprognostic (2.06e-3)" "unprognostic (9.31e-2)" "unprognostic (2.34e-2)" "unprognostic (7.35e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.10e-6)" "unprognostic (1.62e-3)" "unprognostic (1.68e-2)" "unprognostic (9.82e-2)" "unprognostic (1.07e-3)" "unprognostic (3.28e-2)" "unprognostic (1.23e-2)" "unprognostic (6.34e-2)" "unprognostic (1.66e-1)" "unprognostic (5.65e-3)" "unprognostic (2.47e-1)" 4.5 3.1 4.3 24.2 7.5 88.5 6.7 4.1 6.5 4.8 2.7 22.9 10.5 5.1 1.3 14.8 5.6 3.8 2.2 5.0 4.9 6.5 11.8 4.9 36.1 4.9 5.2 2.1 3.6 1.8 1.6 22.3 4.4 3.1 27.1 4.2 3.9 2.0 0.4 6.2 14.8 12.7 4.8 10.6 8.8 34.3 6.1 113.6 2.1 0.4 44.5 8.4 5.5 10.3 102.7 156.6 320.4 154.9 35.1 57.9 159.9 238.9 141.1 251.7 299.9 132.8 80.1 160.0 91.5 129.9 143.2 45.1 225.3 89.7 216.1 152.3 244.9 273.1 135.8 229.4 8.2 564.8 286.5 51.5 20.7 159.6 49.6 48.4 214.4 334.0 222.0 249.6 321.8 118.1 687.7 311.4 114.7 124.3 114.0 446.8 287.0 191.3 95.6 88.9 106.0 175.7 201.4 91.6 61.1 197.3 63.5 253.5 85.0 289.7 569.5 267.3 474.2 305.9 405.2 367.3 75.2 240.6 339.2 0.0 0.0 1.3 1.1 0.1 0.0 1.1 2.8 2.2 1.8 0.0 0.0 0.6 0.7 6.7 0.1 0.3 14.1 2.9 4.3 7.5 4.1 6.5 5.0 4.9 4.9 5.2 4.4 4.8 6.1 10.3 2.1 0.0 2.3 1.6 15.7 14.4 15.9 13.0 27.9 0.5 7.8 11.7 3.6 2.8 6.7 0.0 0.0 105.8 14.5 15.5 1.9 2.3 34.4 5.6 8.4 12.5 1.2 189.3 0.4 0.8 115.3 28.3 14.3 7.4 7.0 76.2 6.8 4.3 71.4 0.0 0.6 20.9 10.2 15.6 19.4 31.9 6.2 10.7 10.6 1.0 3.9 45.0 5.2 0.5 15.6 1.5 8.9 3.8 112.7 5.0 13.8 36.6 1.0 2.4 13.1 1.3 32.6 180.8 30.7 48.0 7.2 27.0 21.3 10.5 54.9 18.7 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 78.5;lymphoid tissue: 113.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 129.6;Erythroid cells: 182.1;Extravillous trophoblasts: 449.1;Granulosa cells: 119.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 8.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.1;NK-cells: 2.1;T-cells: 8.2" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 4.3;white matter: 11.4" "Low region specificity" "Detected in some" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Approved "Plasma membrane,Cytosol" Yes Yes "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658" "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 2.6 2.9 0.3 21.5 0.3 78.5 4.3 0.9 0.6 6.1 0.7 26.7 21.4 5.7 0.6 37.2 1.9 2.7 1.4 0.2 0.3 1.9 2.9 5.4 45.3 0.3 0.7 1.3 1.0 0.4 0.4 20.4 0.7 1.5 30.9 0.2 5.0 0.9 0.9 18.5 20.6 10.5 0.2 15.8 13.0 16.4 1.6 113.5 1.1 0.2 69.5 6.9 12.3 0.4 312.8 223.9 390.9 188.3 10.4 24.0 225.2 238.5 121.6 390.7 278.4 743.8 345.4 327.6 233.2 115.5 475.6 294.9 2.2 260.5 395.8 141.7 213.7 101.5 168.5 196.0 3.0 145.4 241.6 7.6 27.8 265.7 257.3 57.4 193.4 206.4 1.8 261.6 325.4 516.2 243.5 41.1 237.1 350.8 529.4 256.0 354.8 1.4 134.9 105.9 226.1 188.7 378.3 271.7 154.4 196.2 276.6 209.4 70.1 341.2 298.4 236.2 473.4 84.3 2.9 369.4 208.0 103.4 328.6 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.8 1.7 0.6 0.1 0.1 0.1 2.1 2.1 0.5 0.3 8.2 3.2 0.3 0.3 0.9 0.6 0.2 0.3 0.3 0.7 0.7 0.2 1.6 0.4 0.9 0.0 3.7 0.0 17.9 17.3 7.8 39.0 5.7 0.0 8.6 14.6 0.0 1.5 9.3 0.0 0.0 129.6 3.6 27.4 0.0 1.3 12.0 5.8 5.9 9.5 1.2 182.1 0.0 0.5 449.1 28.5 25.5 9.6 5.7 119.0 18.2 3.6 92.6 0.0 0.1 41.1 50.8 20.8 18.1 6.4 0.9 24.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 7.2 0.0 37.0 12.6 6.2 0.6 1.8 0.0 0.0 0.5 19.2 52.2 50.7 83.2 11.6 31.2 13.7 2.5 68.4 18.4 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.5;Erythroid cells: 134.3;Extravillous trophoblasts: 103.4;Spermatocytes: 114.1;Spermatogonia: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favorable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 2.3 3.7 6.6 10.4 6.5 28.7 4.5 5.8 13.7 4.1 5.0 13.1 8.7 4.5 4.4 10.6 3.3 2.5 11.3 6.8 7.4 3.5 3.2 3.0 19.0 6.5 6.6 1.0 0.7 4.4 3.0 10.1 6.9 2.1 15.5 2.5 2.7 3.1 17.2 5.3 8.2 9.4 6.0 6.2 4.7 19.3 6.7 47.1 2.9 13.0 18.6 6.3 5.0 6.1 123.3 111.6 167.1 79.8 15.4 27.9 94.2 130.2 72.8 146.0 102.6 79.9 147.1 140.4 50.0 47.0 108.4 98.6 154.1 76.7 131.2 128.1 87.2 85.6 54.0 93.8 6.9 105.2 102.0 9.8 18.1 114.0 47.2 34.3 85.8 157.4 111.0 114.0 116.4 113.3 190.8 135.1 65.4 126.9 57.4 145.0 176.2 122.9 57.1 58.1 131.3 132.8 90.2 112.1 44.8 49.8 117.1 64.6 41.8 65.7 104.6 116.1 159.6 57.8 120.1 182.9 64.5 107.0 139.1 0.0 0.7 1.7 3.3 2.3 2.5 8.5 4.5 3.3 1.7 6.6 6.4 7.1 0.0 1.2 8.9 3.4 10.8 2.4 6.6 6.5 5.8 13.7 6.8 7.4 6.5 6.6 6.9 6.0 6.7 6.1 1.9 0.0 2.2 1.3 13.3 14.3 10.4 29.9 2.8 6.4 6.3 8.6 12.8 0.0 12.1 5.5 0.0 74.5 5.4 10.1 5.9 10.9 24.4 15.7 7.6 5.3 1.2 134.3 8.3 7.5 103.4 11.8 10.7 6.7 8.8 32.2 3.9 2.4 27.7 10.1 6.1 14.4 32.6 1.9 5.4 8.2 3.1 5.8 3.6 1.9 2.6 1.6 0.0 1.0 1.4 10.3 2.9 4.1 32.1 5.2 3.3 12.2 16.2 1.2 6.6 0.8 11.3 114.1 113.1 15.5 10.9 22.4 9.3 12.1 30.5 11.3 UBL3 "DKFZP434K151, FLJ32018, HCG-1, PNSC1" ENSG00000122042 "Ubiquitin like 3" O95164 13 29764371-29850617 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 350.5;Late spermatids: 316.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBF TERT88: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053772, HPA058781" Uncertain Approved Centrosome NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 22: Non-specific - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 34: Spermatids - Unknown function" Centrosome "HPA053772: AB_2682258, HPA058781: AB_2683818" "unprognostic (2.83e-2)" "unprognostic (5.48e-2)" "unprognostic (3.20e-1)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.20e-1)" "unprognostic (3.22e-1)" "unprognostic (3.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "prognostic favorable (4.23e-4)" "unprognostic (8.49e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.84e-1)" 23.3 20.7 39.6 17.8 49.6 22.2 29.3 58.0 47.1 38.3 25.9 28.6 27.7 42.4 25.6 42.9 27.1 31.5 20.5 38.5 52.3 35.1 41.7 36.9 19.3 51.5 54.8 30.7 55.8 30.0 17.1 22.6 49.0 22.5 27.7 47.2 29.2 22.7 29.7 24.1 29.0 30.7 53.8 25.2 72.8 22.4 47.3 21.5 40.4 35.5 19.0 19.5 23.6 61.3 12.5 7.8 23.9 14.5 33.0 31.7 25.3 101.2 59.2 42.5 34.0 18.6 27.7 10.9 22.3 101.3 19.7 12.2 11.0 15.1 121.0 17.3 13.5 11.5 9.9 15.0 10.4 17.0 14.8 18.8 48.2 22.4 14.3 36.7 15.5 12.9 5.8 7.7 18.1 84.5 12.8 14.3 14.3 29.3 11.1 14.5 30.8 12.5 28.2 14.7 27.8 13.9 14.3 49.0 106.8 50.6 26.4 28.6 13.4 54.7 13.6 30.3 13.8 17.7 7.4 8.2 19.4 14.4 37.0 10.4 11.2 10.0 10.7 11.4 5.0 2.9 13.5 10.5 10.9 4.1 7.6 9.5 11.2 6.9 13.0 5.1 34.7 9.1 39.6 49.6 58.0 47.1 38.5 52.3 51.5 54.8 49.0 53.8 47.3 61.3 60.7 192.3 46.2 58.4 47.0 77.0 99.6 30.6 57.5 166.8 47.3 29.6 35.6 70.1 63.3 36.8 77.2 17.2 55.2 81.8 92.0 36.7 350.5 113.7 66.4 44.0 60.6 8.6 77.2 37.3 87.9 73.0 154.5 103.6 14.5 16.4 35.0 58.0 39.1 95.9 95.1 58.8 42.7 60.0 92.1 316.1 34.8 69.4 97.8 91.8 56.6 174.9 38.1 97.0 214.1 60.9 34.8 33.1 58.3 65.9 45.1 50.8 80.4 67.9 19.7 91.0 49.6 72.5 24.5 55.2 80.0 29.6 56.8 76.5 43.8 104.0 UBXN10 "FLJ25429, UBXD3" ENSG00000162543 "UBX domain protein 10" Q96LJ8 1 20186096-20196050 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 49.7" "Group enriched" "Detected in many" 7 "Early spermatids: 117.5;Endometrial ciliated cells: 72.6;Late spermatids: 146.8;Respiratory ciliated cells: 117.8;Spermatocytes: 48.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 2.9;HMC-1: 7.1;K-562: 8.5;SCLC-21H: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028555, HPA028564" Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" "HPA028555: AB_10600417, HPA028564: AB_10601897" "unprognostic (3.00e-3)" "unprognostic (3.30e-2)" "unprognostic (4.31e-2)" "prognostic favorable (2.02e-4)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.43e-1)" "unprognostic (3.43e-2)" "unprognostic (2.37e-1)" "unprognostic (6.76e-2)" "unprognostic (4.60e-1)" "unprognostic (8.79e-2)" "unprognostic (5.78e-2)" "unprognostic (1.65e-3)" "unprognostic (7.11e-2)" "unprognostic (4.47e-2)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" 0.6 1.3 2.5 0.5 2.8 2.0 2.9 2.1 2.9 7.1 15.3 9.7 0.8 6.2 4.7 4.1 49.7 2.0 3.5 3.3 3.3 2.1 5.9 5.3 0.3 5.2 5.6 0.4 1.5 4.8 3.0 1.0 4.5 2.4 4.8 2.2 0.9 2.7 0.2 0.5 2.0 3.4 4.8 0.1 2.3 14.1 3.7 0.3 5.4 0.2 0.5 2.6 0.3 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 1.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 8.5 0.0 0.0 0.0 0.3 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.6 0.4 5.6 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.0 2.7 0.4 0.7 0.9 0.8 0.1 0.5 0.8 0.4 4.1 0.0 0.0 0.4 0.5 2.5 2.8 2.1 2.9 3.3 3.3 5.2 5.6 4.5 4.8 3.7 4.3 0.1 0.0 6.1 0.7 0.2 0.1 0.0 5.5 0.0 0.5 1.2 1.5 5.3 1.5 13.0 3.7 0.0 0.1 0.4 5.1 5.9 3.7 117.5 72.6 2.0 0.8 1.2 2.1 1.8 1.7 0.6 2.0 0.0 7.4 13.9 0.4 1.1 4.2 0.9 0.0 1.6 10.6 10.2 1.2 0.0 146.8 2.8 0.8 0.0 0.0 0.6 1.9 0.0 0.0 0.1 1.4 1.4 1.2 0.0 0.1 0.6 2.9 117.8 3.1 0.0 0.4 4.1 48.9 2.2 0.0 0.0 0.3 1.2 0.0 3.2 0.3 UBXN11 "SOC, SOCI, UBXD5" ENSG00000158062 "UBX domain protein 11" Q5T124 1 26281328-26318363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 131.1;Late spermatids: 327.4;Respiratory ciliated cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 93.2;intermediate monocyte: 82.6;myeloid DC: 48.4;non-classical monocyte: 72.2" "Group enriched" "Detected in all" 4 "dendritic cells: 48.4;monocytes: 93.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028600, HPA031357" Approved Approved Nucleoli,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli, Cytosol" "HPA028600: AB_10604001, HPA031357: AB_2673840" "unprognostic (1.78e-3)" "prognostic favorable (2.54e-5)" "unprognostic (8.18e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.53e-1)" "prognostic favorable (4.90e-4)" "prognostic unfavorable (5.90e-6)" "unprognostic (8.41e-2)" "unprognostic (2.70e-1)" "unprognostic (4.41e-2)" "unprognostic (1.79e-3)" "unprognostic (1.89e-2)" "unprognostic (5.59e-3)" "unprognostic (5.00e-2)" "unprognostic (2.20e-1)" "unprognostic (3.25e-1)" "unprognostic (1.31e-2)" 10.5 10.8 23.2 9.5 25.2 19.3 10.6 17.8 35.1 11.6 45.1 8.4 3.4 9.5 14.7 6.2 31.2 5.1 11.0 26.8 23.9 19.1 7.8 17.7 8.0 25.3 27.9 13.4 11.1 8.0 31.3 4.3 22.0 11.5 2.7 15.0 9.4 6.5 5.6 7.6 8.0 4.1 24.3 21.8 8.8 48.4 25.0 6.8 25.1 3.4 3.9 8.5 7.5 20.1 26.4 11.7 5.7 11.6 4.1 3.1 19.7 5.7 8.8 15.6 11.3 4.6 22.8 15.3 8.5 3.6 10.3 14.0 3.5 9.3 3.9 7.7 13.6 2.6 18.1 11.5 7.2 11.2 5.0 4.7 9.9 26.3 6.7 4.9 4.3 11.1 10.2 10.3 5.4 11.8 6.4 5.4 11.5 7.4 8.8 13.1 4.2 13.8 8.7 3.8 26.9 6.3 14.1 13.1 10.2 2.9 10.3 10.7 4.2 8.9 13.4 13.4 8.7 9.7 29.8 17.7 11.0 15.4 7.5 2.2 93.2 4.6 9.0 82.6 11.4 12.7 13.6 10.8 48.4 16.2 15.2 9.7 6.8 6.1 72.2 7.5 12.5 41.7 23.2 25.2 17.8 35.1 26.8 23.9 25.3 27.9 22.0 24.3 25.0 20.1 4.3 0.0 1.1 5.5 18.8 21.4 15.7 23.4 5.2 11.9 13.2 15.5 1.3 5.7 16.2 23.9 22.9 9.9 10.0 5.5 13.7 14.7 131.1 78.6 9.2 5.1 9.0 6.7 7.0 8.7 20.8 10.0 17.9 8.3 10.2 11.9 6.1 3.0 20.9 23.5 5.1 5.9 18.3 62.4 35.3 327.4 12.8 59.9 10.6 2.8 41.9 24.2 12.3 2.0 1.6 7.6 2.5 10.1 9.5 9.8 1.2 26.7 121.2 54.9 19.7 6.6 11.5 26.1 24.0 5.1 13.4 7.3 23.7 8.7 8.3 12.1 UBXN2B p37 ENSG00000215114 "UBX domain protein 2B" Q14CS0 8 58411359-58451501 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 42.8" "Group enriched" "Detected in all" 5 "granulocytes: 42.8;monocytes: 12.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045278 Uncertain Approved Nucleoplasm No No "Cluster 9: Neutrophils - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 2: Karpas-707 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "HPA045278: AB_10963578" "unprognostic (1.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (2.15e-3)" "unprognostic (1.63e-1)" "unprognostic (2.22e-1)" "unprognostic (2.46e-1)" "unprognostic (8.71e-2)" "unprognostic (3.36e-1)" "unprognostic (5.97e-2)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (6.48e-3)" "unprognostic (1.26e-1)" "unprognostic (8.22e-2)" "unprognostic (2.00e-1)" "unprognostic (1.42e-2)" 7.9 9.1 10.3 12.0 11.4 15.4 11.0 14.0 12.5 6.6 9.2 8.7 7.7 8.1 10.8 5.8 8.5 8.6 9.8 11.9 9.0 15.7 18.8 9.7 9.1 11.2 8.9 9.0 8.8 16.1 7.9 7.6 11.2 9.5 9.2 13.4 12.9 8.5 9.0 6.4 7.8 9.8 9.6 10.1 8.2 9.5 9.8 11.9 14.2 11.0 9.4 8.9 4.3 12.8 11.1 20.2 16.9 20.9 3.0 1.5 11.7 6.7 12.3 8.2 10.6 8.8 20.4 13.0 13.4 8.3 22.2 9.9 25.1 12.1 11.5 10.0 12.7 16.2 17.0 11.0 12.6 14.5 15.1 5.4 19.0 3.8 18.9 19.5 10.2 19.7 11.4 23.8 7.4 11.3 26.0 16.0 22.1 38.6 4.8 14.5 7.5 8.9 26.4 16.8 6.2 25.4 11.6 11.7 19.7 16.5 23.7 17.3 2.3 6.3 13.4 13.7 14.0 12.4 13.3 18.0 20.6 13.6 8.5 15.8 11.9 18.0 4.3 11.0 4.2 3.4 4.1 3.6 5.9 3.3 4.9 4.3 42.8 5.4 12.9 2.9 5.3 5.3 10.3 11.4 14.0 12.5 11.9 9.0 11.2 8.9 11.2 9.6 9.8 12.8 4.0 9.6 8.7 27.7 11.4 5.7 10.6 10.3 4.0 16.0 13.7 11.7 18.4 10.0 9.0 11.0 22.9 15.9 10.4 15.9 9.8 11.2 35.8 8.6 9.3 4.7 12.0 13.5 55.3 11.1 17.6 9.5 10.7 11.8 23.5 13.3 4.6 17.1 23.0 11.8 62.4 9.6 14.2 32.4 12.4 61.8 10.5 27.5 8.8 21.5 26.0 13.6 15.5 43.2 41.4 10.8 8.2 14.7 8.4 10.4 15.5 29.7 8.9 25.6 0.0 13.9 8.5 20.4 17.8 9.3 6.7 8.6 10.9 8.6 9.1 10.4 UGT1A1 "GNT1, UGT1, UGT1A" ENSG00000241635 "UDP glucuronosyltransferase family 1 member A1" P22309 2 233760270-233773300 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "intestine: 201.2;liver: 322.4" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 105.0" "Cancer enriched" "Detected in some" 19 "liver cancer: 16.4" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "HaCaT: 14.0;OE19: 64.5;RT4: 34.7" "Not detected" "Not detected" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (3.60e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-3)" "unprognostic (6.31e-3)" "unprognostic (1.94e-5)" "unprognostic (2.78e-3)" "unprognostic (2.99e-4)" 0.1 0.1 0.6 0.2 0.5 0.5 0.2 1.5 0.8 0.1 0.2 3.0 201.2 0.2 0.4 3.5 0.1 1.0 0.2 0.4 0.8 4.0 322.4 0.2 0.3 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.2 2.4 0.9 0.5 0.3 0.1 1.8 79.2 0.1 0.0 0.2 2.4 0.6 0.3 0.1 0.2 0.1 0.3 10.0 0.9 0.6 0.3 1.1 0.2 0.2 0.1 0.1 0.6 0.0 0.0 0.0 0.1 5.4 0.3 0.2 2.5 0.1 0.1 14.0 0.0 0.2 0.0 0.2 0.1 0.1 0.6 1.6 0.0 0.5 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.8 0.1 0.3 0.5 64.5 6.5 0.1 0.1 0.6 0.0 34.7 0.2 0.4 2.6 0.4 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.3 0.0 0.2 0.2 0.1 0.7 0.4 0.2 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 1.4 0.3 0.1 0.1 0.1 0.0 0.6 0.5 1.5 0.8 0.4 0.8 0.2 0.2 0.2 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.7 1.8 0.0 0.0 0.0 1.8 0.0 0.1 2.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.1 105.0 0.0 0.0 0.0 0.4 0.0 2.4 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.1 6.9 14.6 2.2 1.5 0.0 0.0 0.4 0.1 0.2 0.1 1.5 0.0 0.0 0.1 0.0 0.7 7.3 UGT1A6 "GNT1, HLUGP, UGT1F" ENSG00000167165 "UDP glucuronosyltransferase family 1 member A6" P19224 2 233691607-233773300 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 71.3;liver: 143.3;urinary bladder: 88.8" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 12.5;Early spermatids: 52.4;Gastric mucus-secreting cells: 14.3;Late spermatids: 23.3;Squamous epithelial cells: 17.3" "Group enriched" "Detected in many" 5 "liver cancer: 7.2;lung cancer: 3.1;renal cancer: 7.6;urothelial cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 1194.0" "Not detected" "Not detected" "CAB009819, HPA054065, HPA056023" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" Vesicles "Endoplasmic reticulum" "CAB009819: AB_2241481, HPA054065: AB_2682367, HPA056023: " "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (5.43e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.79e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-3)" "unprognostic (9.97e-2)" "unprognostic (2.16e-2)" "unprognostic (3.52e-1)" "unprognostic (7.50e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 1.8 0.0 1.8 5.8 0.1 2.6 16.1 0.0 3.5 0.0 0.0 0.0 71.3 143.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 1.3 0.0 2.6 3.6 0.0 11.1 2.6 0.0 0.0 0.0 17.4 0.4 0.0 1.2 0.5 0.0 5.8 88.8 5.5 0.0 4.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 53.8 1.6 0.0 80.2 0.1 0.8 294.5 0.1 4.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.3 0.0 31.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.0 1194.0 0.0 0.1 0.2 0.1 3.2 149.0 0.0 0.0 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 1.2 12.5 0.0 0.0 0.0 0.3 0.0 2.9 1.8 0.0 0.0 0.0 0.4 0.0 0.0 52.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.5 0.0 0.0 0.4 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 23.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.5 1.8 0.1 0.0 0.0 0.0 0.0 1.2 0.2 17.3 1.1 0.0 0.0 0.0 0.1 3.0 UGT1A7 UGT1G ENSG00000244122 "UDP glucuronosyltransferase family 1 member A7" Q9HAW7 2 233681938-233773299 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "esophagus: 83.8" "Cell type enriched" "Detected in some" 4 "Squamous epithelial cells: 40.7" "Group enriched" "Detected in some" 10 "cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "SiHa: 112.2" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 20: HeLa - Mitochondria" "Cluster 61: Squamous epithelial cells - Keratinization" "unprognostic (6.27e-2)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.09e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-7)" "unprognostic (2.14e-1)" "unprognostic (4.57e-2)" 0.1 1.3 0.2 0.0 0.2 0.0 0.4 0.5 0.8 1.2 0.4 0.3 0.2 0.0 0.0 83.8 0.0 0.0 0.0 0.3 0.2 0.7 4.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 5.6 0.0 0.0 3.6 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 5.2 0.4 7.1 1.0 0.0 1.8 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 112.2 7.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.8 0.3 0.2 0.2 0.5 0.2 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.4 2.3 1.3 4.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.7 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 40.7 1.7 0.0 0.0 0.0 0.5 8.5 UHRF1 "FLJ21925, ICBP90, Np95, RNF106, TDRD22" ENSG00000276043 "Ubiquitin like with PHD and ring finger domains 1" Q96T88 19 4903080-4962154 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "bone marrow: 27.0;lymphoid tissue: 67.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.8" "Group enriched" "Detected in many" 4 "dendritic cells: 4.8;T-cells: 2.3" "Cell line enhanced" "Detected in all" "MOLT-4: 450.9;REH: 1004.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049408, HPA055446" Enhanced Supported Nucleoplasm No Yes "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA049408: AB_2756317, HPA055446: AB_2732597" "unprognostic (3.83e-2)" "unprognostic (6.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.52e-5)" "unprognostic (2.33e-3)" "unprognostic (0.00e+0)" "unprognostic (3.75e-3)" "unprognostic (2.45e-1)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" 1.0 0.9 2.1 9.6 2.7 27.0 1.7 2.1 2.3 1.6 1.8 2.9 3.7 1.0 0.1 6.5 0.4 0.8 0.5 2.0 2.2 0.6 0.9 1.3 15.8 2.8 2.8 0.3 0.6 0.2 0.2 2.1 2.7 0.6 2.6 0.4 1.5 0.2 1.2 3.4 3.9 1.9 1.9 3.7 3.3 5.2 3.5 67.2 0.3 0.3 10.3 1.6 2.5 4.6 111.3 78.7 116.6 83.4 3.3 13.3 18.5 88.3 42.0 89.9 86.8 94.6 54.9 62.7 21.1 39.4 32.7 54.1 81.2 47.7 63.0 102.7 92.2 54.3 74.3 102.4 1.3 135.1 78.9 6.5 3.5 48.9 12.6 14.1 27.2 97.2 79.3 70.5 54.5 86.7 450.9 82.5 52.5 40.0 84.3 1004.5 259.7 45.4 24.9 80.1 86.0 68.5 69.2 37.7 12.1 18.8 68.2 127.6 34.2 94.6 76.7 124.3 108.3 29.8 33.1 183.5 54.8 129.7 123.3 0.3 0.2 0.1 0.6 0.0 0.0 0.2 0.8 1.0 1.3 0.1 0.2 0.8 0.8 0.5 0.2 4.8 2.3 0.6 2.1 2.7 2.1 2.3 2.0 2.2 2.8 2.8 2.7 1.9 3.5 4.6 0.2 0.0 0.0 1.6 2.1 0.0 0.8 0.0 3.4 2.5 4.4 2.8 4.3 1.5 0.6 0.0 0.0 6.6 6.9 2.6 0.0 2.2 2.9 1.3 1.8 2.2 0.0 49.7 0.4 0.4 7.8 4.7 8.6 2.4 0.0 10.4 0.4 0.7 8.9 3.3 0.4 2.3 0.0 1.9 0.0 1.8 0.6 3.8 0.0 0.0 2.0 0.6 1.0 3.0 1.3 4.2 1.9 0.4 21.0 0.6 1.4 0.2 0.7 0.7 0.0 1.2 6.1 6.1 11.9 15.8 0.0 1.4 3.7 1.5 8.3 1.3 UPK3B "FLJ32198, MGC10902, p35, UPIIIb" ENSG00000243566 "Uroplakin 3B" Q9BT76 7 76510525-76516522 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 120.6;esophagus: 64.8;lung: 50.0;urinary bladder: 42.2" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 121.8" "Group enriched" "Detected in many" 12 "ovarian cancer: 64.6;urothelial cancer: 78.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 13.2;CAPAN-2: 48.2;HaCaT: 10.0;RT4: 34.7;T-47d: 27.1" "Not detected" "Not detected" HPA010506 Approved NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA010506: AB_1080479" "unprognostic (8.33e-2)" "unprognostic (1.30e-1)" "unprognostic (3.62e-3)" "unprognostic (2.26e-3)" "unprognostic (7.87e-2)" "unprognostic (8.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.63e-1)" "unprognostic (4.03e-1)" "unprognostic (5.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.06e-2)" "unprognostic (8.37e-9)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-1)" "unprognostic (6.34e-2)" 120.6 0.7 0.1 0.1 0.4 0.1 1.4 0.0 0.4 8.0 1.0 1.2 0.0 0.7 0.2 64.8 10.0 0.1 10.6 0.0 0.2 0.6 1.0 50.0 0.1 0.1 0.2 6.9 1.3 0.0 1.7 0.0 0.2 2.7 0.0 0.2 8.3 0.0 0.5 4.1 0.9 0.0 0.0 2.1 2.9 4.2 0.7 0.0 1.4 0.0 1.8 42.2 12.1 0.1 1.1 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 48.2 0.0 0.4 0.0 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 2.9 0.1 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.3 3.9 0.0 0.1 27.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.2 0.1 0.2 0.2 0.0 0.7 0.1 0.3 121.8 3.3 0.0 0.3 1.7 0.4 18.3 4.6 0.4 0.2 0.0 0.3 20.0 20.4 3.7 4.2 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 13.9 1.1 0.5 1.3 0.1 0.7 0.1 0.1 1.7 0.0 0.0 6.1 0.3 2.5 0.0 12.2 0.3 3.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.1 0.0 11.1 0.2 0.0 0.0 1.1 0.0 0.1 2.1 2.8 0.1 0.4 0.0 0.2 14.2 UROC1 "FLJ31300, HMFN0320" ENSG00000159650 "Urocanate hydratase 1" Q96N76 3 126481166-126517773 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 336 "liver: 116.6" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 62.2" "Cancer enriched" "Detected in single" 100 "liver cancer: 12.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NB-4: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069863 Enhanced NA NA 670000 "Cluster 62: Liver - Hemostasis" "Cluster 24: NB-4 - Immune response" "Cluster 15: Hepatocytes - Hemostasis" "HPA069863: AB_2732143" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-2)" "unprognostic (6.43e-2)" "unprognostic (1.43e-1)" "unprognostic (2.23e-3)" "unprognostic (2.95e-1)" "unprognostic (2.57e-2)" "unprognostic (7.71e-2)" "unprognostic (9.97e-2)" "unprognostic (3.04e-1)" "unprognostic (3.65e-5)" "unprognostic (3.97e-2)" "unprognostic (2.66e-1)" "unprognostic (5.52e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 116.6 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.1 3.3 62.2 0.3 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 USP43 FLJ30626 ENSG00000154914 "Ubiquitin specific peptidase 43" Q70EL4 17 9644698-9729687 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 37.9;Excitatory neurons: 35.5;Glandular and luminal cells: 52.5;Oligodendrocyte precursor cells: 73.4;Syncytiotrophoblasts: 73.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 11.7;SK-BR-3: 8.1;T-47d: 9.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA023389, HPA027762, HPA027763" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear speckles" "HPA023389: AB_1858691, HPA027762: AB_10603001, HPA027763: " "unprognostic (1.39e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-3)" "unprognostic (1.08e-1)" "unprognostic (5.24e-2)" "unprognostic (2.04e-1)" "unprognostic (6.40e-3)" "unprognostic (2.26e-1)" "unprognostic (3.05e-3)" "unprognostic (2.41e-2)" "unprognostic (7.49e-2)" "unprognostic (5.95e-2)" "prognostic favorable (5.39e-4)" "unprognostic (3.24e-1)" "unprognostic (2.06e-1)" "unprognostic (3.28e-1)" 0.3 0.2 2.6 0.6 3.4 0.7 1.9 0.8 4.1 2.9 2.9 3.5 4.2 1.9 1.0 6.5 4.2 1.2 0.0 3.3 1.4 4.0 9.1 3.2 0.1 2.5 4.6 0.1 5.0 1.1 3.5 8.3 2.5 9.8 3.2 1.4 4.3 2.2 0.0 2.2 3.5 0.2 2.1 0.3 2.1 3.2 2.3 0.3 1.7 0.0 0.7 1.1 2.4 2.5 5.6 1.4 0.0 0.5 0.0 0.0 11.7 0.1 0.2 0.6 1.6 2.8 4.5 0.0 1.8 0.2 2.5 6.8 0.6 5.3 0.6 3.6 1.8 0.3 3.0 1.0 0.1 0.5 0.0 0.0 6.8 0.3 2.8 0.3 0.0 0.8 0.0 0.0 0.0 2.6 0.9 4.6 0.7 4.8 0.3 3.6 0.0 0.8 4.1 3.0 0.7 0.0 2.4 8.1 1.0 3.7 9.9 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 3.4 0.8 4.1 3.3 1.4 2.5 4.6 2.5 2.1 2.3 2.5 0.0 3.2 3.1 1.6 0.3 4.7 7.8 4.6 5.2 0.5 7.0 2.4 0.6 4.3 7.4 11.0 6.2 26.2 0.6 14.3 1.9 4.4 1.1 37.9 4.2 0.5 2.4 3.2 35.5 4.7 23.7 0.8 7.7 52.5 0.0 0.9 0.4 15.6 2.7 0.0 4.0 8.3 2.0 0.9 0.3 1.1 0.0 0.6 5.4 0.0 0.3 8.4 0.0 73.4 1.2 11.3 3.5 0.0 0.2 10.6 8.7 1.8 30.2 1.5 0.0 0.0 1.0 1.5 0.3 12.3 3.3 73.2 0.7 0.0 9.7 11.8 VNN1 Tiff66 ENSG00000112299 "Vanin 1" O95497 6 132680849-132714055 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "gallbladder: 89.2;intestine: 136.3;liver: 218.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7" "Cancer enhanced" "Detected in many" "liver cancer: 41.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "classical monocyte: 13.7;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 80 "dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7" "Cell line enhanced" "Detected in some" "A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5" "Region enhanced" "Detected in single" "white matter: 2.4" "Not detected" "Not detected" "HPA046103, HPA064145" Approved Approved Vesicles "Intracellular and membrane" NA NA 980000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Vesicles "HPA046103: , HPA064145: AB_2685197" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (9.95e-2)" "unprognostic (1.35e-3)" "unprognostic (6.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.20e-1)" "unprognostic (4.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (4.62e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (2.26e-2)" "unprognostic (4.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.34e-1)" 2.7 0.6 0.3 3.1 0.6 9.4 1.1 0.5 1.5 1.0 0.0 6.2 136.3 8.9 0.2 0.6 2.6 89.2 0.6 0.2 0.3 21.7 218.7 4.7 2.5 0.6 0.3 0.3 1.4 0.1 0.1 2.7 1.2 0.3 1.8 1.0 2.3 0.2 0.3 0.9 79.5 0.9 0.2 10.1 1.5 0.5 0.5 0.6 0.4 1.1 2.5 1.6 0.7 0.9 2.5 0.0 0.3 0.1 0.0 0.7 0.5 0.2 0.2 0.0 0.0 0.0 2.5 0.1 8.7 0.0 0.4 0.0 0.0 2.3 0.6 0.0 0.0 0.1 0.1 1.4 1.3 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.1 0.5 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.3 3.0 13.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 8.5 0.0 11.9 0.2 0.0 3.8 0.3 0.6 0.5 1.5 0.2 0.3 0.6 0.3 1.2 0.2 0.5 0.9 0.0 0.0 3.0 0.0 0.3 1.3 0.2 14.9 0.0 0.0 1.2 0.4 0.2 50.1 11.4 1.8 0.0 0.1 0.2 12.5 0.0 244.2 0.0 7.6 4.1 0.2 0.0 0.0 0.0 19.4 0.1 0.3 4.6 39.6 0.0 0.0 1.1 70.6 18.1 0.0 0.0 11.2 22.4 12.0 3.9 0.0 0.0 23.1 0.0 0.0 17.6 0.0 0.0 0.0 0.0 98.0 1.6 0.0 0.5 6.6 61.7 21.9 16.0 0.0 0.0 0.4 1.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 2.0 14.7 VNN2 "FOAP-4, GPI-80" ENSG00000112303 "Vanin 2" O95498 6 132743870-132763459 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.6;lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" "Ductal cells: 63.6;Ionocytes: 22.4;Macrophages: 41.1;monocytes: 57.5;Respiratory ciliated cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 7 "neutrophil: 477.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 477.4" "Cell line enriched" "Detected in some" 7 "Daudi: 59.7" "Low region specificity" "Detected in some" NA NA 240000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "unprognostic (2.13e-1)" "unprognostic (1.15e-1)" "unprognostic (9.60e-3)" "unprognostic (5.71e-2)" "unprognostic (2.14e-1)" "unprognostic (5.61e-3)" "unprognostic (1.98e-3)" "unprognostic (4.38e-1)" "unprognostic (3.07e-1)" "unprognostic (3.46e-1)" "unprognostic (2.84e-1)" "unprognostic (8.30e-2)" "prognostic unfavorable (2.72e-7)" "unprognostic (1.62e-1)" "unprognostic (8.17e-2)" "unprognostic (2.01e-1)" "unprognostic (5.45e-2)" 21.7 2.7 0.6 23.9 0.9 31.6 1.3 0.7 2.8 4.3 1.4 3.8 2.4 1.3 0.4 4.1 5.3 22.5 2.3 0.5 0.7 2.4 10.1 22.5 39.0 1.5 1.0 1.5 4.3 0.7 0.9 20.7 1.7 1.8 3.0 0.1 1.5 0.9 0.6 0.3 4.6 6.3 0.8 56.6 7.3 0.6 1.0 11.7 1.2 7.9 42.0 17.8 1.2 1.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 59.7 1.1 0.0 1.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.1 1.4 0.0 0.0 11.6 65.2 0.3 24.6 14.5 10.3 40.3 8.4 29.0 14.1 32.2 27.0 39.4 477.4 36.1 9.9 2.6 6.1 40.4 0.6 0.9 0.7 2.8 0.5 0.7 1.5 1.0 1.7 0.8 1.0 1.0 0.2 0.0 6.7 0.0 11.0 0.0 0.5 4.3 0.0 0.0 0.2 0.0 1.5 7.2 11.8 0.0 0.0 0.8 10.9 0.1 0.0 63.6 0.0 0.3 0.0 1.4 0.0 1.3 0.2 0.4 0.2 1.9 13.3 0.2 5.1 0.1 3.3 1.0 13.9 0.0 0.0 0.0 22.4 18.6 1.0 0.0 0.0 41.1 0.0 1.9 57.5 0.3 20.6 0.0 0.1 3.6 0.0 0.0 2.7 8.0 0.0 0.6 25.4 0.1 6.6 2.5 1.2 0.1 0.0 0.1 0.0 1.4 10.9 6.5 0.2 14.5 VPREB1 "CD179A, VpreB" ENSG00000169575 "V-set pre-B cell surrogate light chain 1" P12018 22 22244780-22245515 "CD markers, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "bone marrow: 29.8" "Cell type enhanced" "Detected in single" "NK-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 5.7;naive B-cell: 5.3" "Lineage enriched" "Detected in many" 4 "B-cells: 5.7" "Group enriched" "Detected in some" 11 "Daudi: 9.4;MOLT-4: 19.8;RPMI-8226: 5.4" "Not detected" "Not detected" HPA055886 Approved "Intracellular and membrane" NA NA 62000 "Cluster 37: B-cells - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 33: Fibroblasts - ECM organization" "HPA055886: AB_2682956" 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 VTCN1 "B7-H4, B7H4, B7S1, B7x, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 100.9;fallopian tube: 32.7;pancreas: 30.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 244.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" No NA "Cluster 5: Breast - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: AB_2682415" "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 100.9 0.0 0.0 15.3 0.0 0.0 0.4 4.5 5.0 0.4 32.7 5.0 0.2 0.0 0.0 17.3 1.1 0.7 0.0 0.0 0.0 0.1 30.1 0.0 0.1 0.8 0.0 3.0 0.0 0.0 22.1 7.8 0.2 2.8 0.0 0.1 0.0 0.0 3.6 1.1 0.1 0.1 0.0 0.0 0.0 3.2 0.1 0.0 1.0 0.1 1.7 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 7.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 4.2 0.1 1.2 0.0 0.0 244.8 0.1 29.9 14.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 2.5 6.9 0.0 0.0 62.3 18.4 1.1 0.0 22.6 55.2 0.0 3.4 1.1 0.0 0.0 83.6 2.5 42.7 4.4 0.6 0.0 0.0 0.8 34.2 1.4 0.4 0.0 79.1 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 6.1 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.3 11.3 0.0 0.0 0.0 1.6 0.0 0.3 8.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 3.0 0.5 0.0 0.0 4.8 VWA3A "FLJ40941, FLJ46765" ENSG00000175267 "Von Willebrand factor A domain containing 3A" A6NCI4 16 22092538-22156964 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 28.2;choroid plexus: 53.0;fallopian tube: 39.7" "Cell type enhanced" "Detected in some" "Astrocytes: 25.5;Club cells: 16.7;Endometrial ciliated cells: 45.6;Excitatory neurons: 33.8;Late spermatids: 15.2;Respiratory ciliated cells: 88.0" "Group enriched" "Detected in some" 4 "endometrial cancer: 3.2;glioma: 1.4;ovarian cancer: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041696, HPA042044" Uncertain "Secreted - unknown location" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 16: U-266 - Nucleosome" "Cluster 49: Ciliated cells - Cilium organization" "HPA041696: AB_10964202, HPA042044: AB_10968997" "unprognostic (2.69e-2)" "unprognostic (1.54e-1)" "unprognostic (9.75e-4)" "prognostic favorable (8.15e-4)" "unprognostic (2.70e-1)" "unprognostic (4.46e-2)" "unprognostic (1.65e-2)" "unprognostic (6.79e-3)" "unprognostic (5.55e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (1.40e-1)" "unprognostic (2.16e-5)" "unprognostic (1.08e-1)" "unprognostic (2.97e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-4)" 0.3 0.3 9.6 0.0 11.9 0.4 0.3 4.1 13.2 11.0 53.0 0.3 0.1 2.5 0.1 0.1 39.7 0.0 0.8 7.8 6.5 0.5 0.1 8.8 0.1 21.0 28.2 0.5 0.3 0.1 16.6 0.1 13.3 0.4 0.1 0.3 0.1 0.1 0.1 1.9 0.3 0.1 15.1 0.3 0.2 8.2 10.1 0.1 0.5 0.2 0.2 0.1 0.1 10.9 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.2 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 11.9 4.1 13.2 7.8 6.5 21.0 28.2 13.3 15.1 10.1 10.9 0.3 0.0 1.1 25.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 45.6 0.3 0.0 0.0 0.0 33.8 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 15.2 0.3 0.2 0.0 3.7 0.0 0.0 0.0 4.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 88.0 0.0 0.0 0.0 1.2 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 VWA3B "DKFZp686F2227, MGC26733" ENSG00000168658 "Von Willebrand factor A domain containing 3B" Q502W6 2 98087116-98313299 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 22.3;testis: 30.0" "Group enriched" "Detected in many" 5 "Early spermatids: 467.1;Late spermatids: 995.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "hippocampal formation: 7.1" "Low region specificity" "Detected in all" "HPA036700, HPA036701" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA036700: AB_2675261, HPA036701: AB_10673505" "unprognostic (2.36e-2)" "unprognostic (4.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.01e-3)" "unprognostic (5.16e-2)" "unprognostic (3.27e-1)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (1.44e-2)" "unprognostic (4.53e-2)" "unprognostic (6.41e-2)" "unprognostic (2.63e-7)" "unprognostic (2.57e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (4.96e-2)" 0.0 0.0 1.4 0.0 1.1 0.0 0.0 0.9 0.7 0.6 5.0 0.1 0.0 0.2 0.0 0.0 22.3 0.0 0.0 1.3 1.5 0.1 0.0 2.5 0.0 7.0 5.8 0.2 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.1 30.0 1.2 0.7 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.9 0.7 1.3 1.5 7.0 5.8 3.7 4.8 1.2 2.7 0.3 0.0 1.1 11.8 0.1 0.3 1.7 2.2 0.0 1.0 0.1 0.3 0.9 0.0 12.1 1.8 31.3 0.0 0.0 0.8 0.0 0.0 467.1 53.8 0.6 0.6 1.8 0.0 1.9 0.4 0.2 0.8 4.6 1.6 0.0 0.1 1.1 0.0 0.2 0.0 1.0 2.8 6.1 0.0 0.8 995.9 4.7 0.7 0.0 3.7 0.6 0.7 0.0 1.5 0.7 0.2 2.7 5.7 0.2 0.4 0.2 0.0 124.5 0.5 0.0 0.5 1.0 17.6 6.0 0.0 0.4 0.0 0.1 0.2 1.0 0.8 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 40.7;brain: 16.4" "Group enriched" "Detected in some" 7 "Enteroendocrine cells: 112.4;Excitatory neurons: 39.2;Inhibitory neurons: 29.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9;pancreatic cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 31.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 22.9" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507" "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.0 40.7 7.8 0.0 1.7 0.1 0.0 0.7 16.4 0.5 0.0 0.4 1.8 0.2 0.1 0.0 1.3 0.0 0.0 6.5 0.7 0.2 0.0 0.1 0.0 7.4 0.5 0.4 5.6 1.4 8.3 0.0 5.0 0.5 0.3 0.2 0.6 2.4 0.0 0.0 1.1 0.0 0.0 0.0 2.8 1.0 2.6 0.0 0.3 0.0 0.0 0.1 0.1 2.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.9 0.3 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.7 0.4 0.3 0.0 0.0 31.7 2.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.1 0.1 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 1.7 0.7 16.4 6.5 0.7 7.4 0.5 5.0 0.0 2.6 2.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 7.6 0.1 0.1 112.4 0.0 39.2 0.2 0.0 0.0 6.1 0.8 0.0 0.2 1.1 0.0 0.2 3.3 29.2 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 1.7 0.2 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 VWA7 "C6orf27, G7c, NG37" ENSG00000204396 "Von Willebrand factor A domain containing 7" Q9Y334 6 31765590-31777328 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 21.3" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 4.2;Gastric mucus-secreting cells: 8.2;Proximal enterocytes: 5.0;Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 2.9;hypothalamus: 8.2;medulla oblongata: 5.9;pons: 5.5;thalamus: 7.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;HMC-1: 1.3;Karpas-707: 1.1;U-266/84: 1.6" "Group enriched" "Detected in some" 5 "cerebellum: 7.0;pons and medulla: 3.9" "Low region specificity" "Detected in many" "HPA046954, HPA054262" Approved Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA 9200 "Cluster 10: Basophils - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 45: Enterocytes - Digestion" "Plasma membrane, Cytosol" "HPA046954: AB_2679875, HPA054262: AB_2682430" "unprognostic (9.13e-2)" "unprognostic (8.60e-4)" "unprognostic (9.99e-2)" "unprognostic (2.43e-1)" "unprognostic (2.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.38e-2)" "unprognostic (4.40e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-2)" "unprognostic (1.65e-2)" "unprognostic (9.25e-2)" "prognostic favorable (4.35e-8)" "unprognostic (3.75e-2)" "unprognostic (2.37e-1)" "unprognostic (9.48e-2)" "unprognostic (7.66e-2)" 0.4 0.3 0.5 0.1 0.3 0.0 0.7 0.1 2.9 0.8 0.0 1.3 1.0 4.6 0.0 0.4 7.2 0.7 5.2 0.8 8.2 5.7 1.4 1.4 0.1 5.9 1.0 0.5 2.6 1.7 21.3 0.0 5.5 0.8 0.4 0.2 1.4 1.3 6.6 0.8 2.3 0.0 0.0 0.5 3.0 0.7 7.5 0.0 1.8 0.0 0.1 0.6 0.7 1.0 0.8 1.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.7 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.1 0.0 0.9 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.1 2.9 0.8 8.2 5.9 1.0 5.5 0.0 7.5 1.0 0.0 0.0 1.1 0.0 0.6 0.1 0.4 0.5 1.2 0.5 0.1 0.3 0.8 0.0 0.3 1.8 0.0 0.0 0.2 1.4 1.9 0.6 0.0 1.5 0.1 0.1 4.2 0.0 1.5 0.5 0.0 0.1 8.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 2.1 0.0 0.4 0.3 5.0 2.4 1.6 0.8 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.4 0.0 0.5 0.4 WDHD1 "AND-1, CHTF4, CTF4" ENSG00000198554 "WD repeat and HMG-box DNA binding protein 1" O75717 14 54938949-55027105 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3" "Cancer enhanced" "Detected in all" "testis cancer: 23.5" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000632, HPA001122" Enhanced Enhanced Nucleoplasm NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA000632: , HPA001122: AB_1080589" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (6.85e-3)" "unprognostic (2.33e-4)" "unprognostic (5.52e-3)" "unprognostic (7.28e-3)" "unprognostic (8.05e-3)" "prognostic unfavorable (9.24e-4)" "unprognostic (5.11e-2)" "unprognostic (2.67e-4)" "unprognostic (8.31e-3)" "unprognostic (1.50e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" 1.3 0.8 0.5 3.8 1.0 7.2 2.2 0.9 0.9 1.2 0.1 2.8 1.8 2.1 0.6 2.4 1.6 1.3 0.9 0.7 0.2 1.1 1.2 1.3 5.5 0.2 0.2 1.4 0.9 1.5 0.3 2.8 0.2 1.0 4.0 1.8 0.7 0.8 0.6 2.0 1.7 2.6 0.3 1.7 1.6 5.3 0.4 8.0 0.9 0.8 6.7 1.7 1.1 0.9 39.6 24.7 48.4 21.4 4.6 11.2 28.1 37.5 16.1 29.6 36.0 16.6 25.9 44.9 18.6 10.8 21.4 32.8 72.9 21.5 61.7 30.0 12.7 29.8 23.7 16.2 1.9 56.7 21.8 5.9 3.8 36.6 14.3 7.1 19.6 28.8 37.8 22.0 28.7 21.7 53.5 11.1 38.6 21.1 25.7 49.5 69.7 17.3 8.4 26.0 28.1 19.8 39.8 10.0 12.8 35.1 26.8 11.3 12.8 37.3 43.9 27.5 32.1 6.5 14.4 58.8 17.1 27.4 30.0 1.7 0.3 0.6 0.9 0.2 1.2 1.2 1.0 1.3 0.5 1.8 1.3 1.8 0.4 2.0 0.4 0.7 1.6 0.6 0.5 1.0 0.9 0.9 0.7 0.2 0.2 0.2 0.2 0.3 0.4 0.9 2.3 0.0 2.0 3.9 5.1 3.8 2.2 3.5 3.4 2.9 1.8 1.9 1.7 0.0 4.0 3.7 0.0 8.7 3.6 1.8 0.0 1.8 0.8 1.9 3.1 2.0 0.0 15.5 10.3 1.0 8.4 3.4 2.6 2.5 0.0 12.4 0.7 0.9 4.1 3.3 6.5 2.4 6.1 2.1 1.2 1.1 0.0 2.4 1.8 5.6 1.4 1.4 2.1 4.5 10.1 1.1 0.3 3.0 7.8 0.6 0.5 6.2 3.5 3.1 0.0 2.4 3.0 15.0 19.3 6.1 2.4 2.6 3.6 2.8 5.2 1.7 WDR38 ENSG00000136918 "WD repeat domain 38" Q5JTN6 9 124853417-124857890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "fallopian tube: 77.7" "Cell type enhanced" "Detected in some" "Early spermatids: 26.9;Endometrial ciliated cells: 93.3;Late spermatids: 92.6;Respiratory ciliated cells: 127.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 12.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA056607 Approved Vesicles NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA056607: AB_2683188" "unprognostic (5.66e-3)" "unprognostic (2.15e-3)" "unprognostic (1.51e-2)" "prognostic favorable (3.97e-4)" "unprognostic (1.14e-1)" "unprognostic (2.17e-3)" "unprognostic (4.29e-3)" "unprognostic (7.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.82e-1)" "unprognostic (1.38e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-5)" "unprognostic (1.01e-1)" "unprognostic (3.25e-2)" "unprognostic (6.36e-2)" "unprognostic (4.42e-2)" 0.0 0.0 2.1 0.0 2.0 0.0 0.0 2.3 1.3 2.4 16.3 0.0 0.0 0.7 0.0 0.0 77.7 0.0 0.1 2.2 4.0 0.1 0.0 5.2 0.0 8.2 9.8 0.0 0.0 0.0 0.3 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 7.2 0.0 0.0 7.6 3.3 0.1 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.0 2.3 1.3 2.2 4.0 8.2 9.8 6.5 7.2 3.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.2 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 26.9 93.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 0.0 92.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 127.9 0.0 0.0 0.0 2.8 1.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 31.3;choroid plexus: 29.3;fallopian tube: 10.0" "Group enriched" "Detected in some" 5 "Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 24 "dendritic cells: 2.9;monocytes: 2.7" "Cell line enhanced" "Detected in some" "AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 9.5" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.1 0.1 10.2 0.4 8.2 2.0 0.1 16.6 3.4 0.3 29.3 0.1 2.0 0.4 0.0 0.9 10.0 0.2 2.1 7.0 15.6 0.3 0.0 1.9 0.3 30.1 27.0 0.1 0.3 0.0 0.5 0.0 23.8 0.2 0.1 0.0 0.2 0.0 0.0 0.1 4.6 0.1 31.3 0.4 0.2 0.6 15.5 0.4 0.0 0.2 0.3 0.2 0.2 23.4 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 2.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.5 10.2 8.2 16.6 3.4 7.0 15.6 30.1 27.0 23.8 31.3 15.5 23.4 0.2 0.0 0.6 79.0 0.1 0.0 0.9 1.7 9.1 0.0 0.1 0.1 1.1 0.0 10.9 0.0 0.0 0.0 1.6 0.1 0.0 0.1 2.4 43.4 0.3 0.2 0.0 1.7 4.5 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 4.1 1.6 2.5 0.8 0.0 1.8 0.0 0.0 4.0 0.0 0.0 2.5 3.0 0.0 0.0 0.0 0.1 0.4 3.3 0.0 47.7 0.0 6.6 0.3 0.6 0.1 0.2 1.0 0.1 0.0 0.1 0.0 0.2 0.8 WDR54 FLJ12953 ENSG00000005448 "WD repeat domain 54" Q9H977 2 74421678-74425755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 70.2" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 207.0;Late spermatids: 124.6;Respiratory ciliated cells: 395.9;Spermatocytes: 147.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043257, HPA053558" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Cytosol" "HPA043257: AB_10795981, HPA053558: AB_2682189" "unprognostic (1.12e-1)" "unprognostic (3.68e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (2.62e-1)" "unprognostic (3.06e-3)" "unprognostic (4.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (7.25e-3)" "unprognostic (3.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.85e-2)" 8.2 8.5 11.0 6.5 11.7 6.7 7.7 8.5 11.2 11.8 17.6 6.7 3.2 10.4 5.6 3.4 70.2 8.4 4.3 11.8 14.2 12.1 1.9 10.7 11.6 10.3 12.5 10.8 6.3 30.0 24.4 6.3 11.2 7.4 4.0 28.0 5.2 9.9 1.3 4.9 7.0 7.7 10.8 12.2 7.0 38.0 11.7 18.5 7.8 1.7 11.2 8.6 6.3 9.9 44.9 78.3 37.9 32.5 14.0 25.7 11.8 22.5 45.8 56.8 52.8 6.9 34.4 39.3 22.5 25.1 34.5 37.6 27.8 100.6 49.8 30.3 16.8 19.4 42.4 4.7 14.3 30.6 15.3 11.6 27.6 58.1 30.3 67.5 30.6 61.6 7.7 45.8 32.4 69.8 48.6 32.3 30.3 10.9 29.8 41.2 44.1 84.4 51.3 22.4 66.4 52.1 17.6 15.9 27.0 11.2 25.6 14.7 15.3 29.2 50.9 32.1 50.7 49.2 26.7 10.1 86.5 18.8 21.6 6.6 8.5 0.6 31.1 11.5 31.4 24.2 35.5 33.7 28.6 22.0 25.1 23.8 0.7 29.1 10.1 46.7 36.8 21.6 11.0 11.7 8.5 11.2 11.8 14.2 10.3 12.5 11.2 10.8 11.7 9.9 20.0 3.2 12.8 1.3 23.1 7.0 20.1 64.1 10.2 48.3 9.4 10.9 1.7 20.0 39.4 23.9 83.4 9.8 30.1 1.5 19.6 28.5 77.8 207.0 18.5 25.1 28.9 5.5 5.6 6.0 14.6 14.3 7.1 9.2 12.7 23.8 30.0 1.9 8.6 32.0 4.1 6.0 38.7 6.9 17.4 124.6 17.1 7.4 12.4 0.0 29.8 51.9 26.8 3.0 2.4 13.6 4.4 22.2 17.5 9.4 0.8 28.4 395.9 112.5 0.0 8.4 30.6 147.9 19.3 1.7 4.8 2.9 30.5 37.2 3.8 13.3 WDR62 "C19orf14, DKFZP434J046, FLJ33298, MCPH2" ENSG00000075702 "WD repeat domain 62" O43379 19 36054649-36105108 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 110.3;testis: 63.7;tongue: 63.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6" "Cancer enhanced" "Detected in many" "testis cancer: 10.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.7" "Lineage enriched" "Detected in single" 4 "monocytes: 2.7" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043255, HPA043639" Enhanced Enhanced "Centriolar satellite,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "Centriolar satellite" "HPA043255: AB_2678393, HPA043639: AB_2678593" "unprognostic (1.77e-1)" "unprognostic (2.79e-3)" "unprognostic (3.16e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-1)" "unprognostic (4.22e-3)" "unprognostic (1.78e-4)" "unprognostic (2.00e-1)" "unprognostic (4.00e-2)" "unprognostic (5.82e-3)" "unprognostic (4.72e-2)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.73e-3)" "unprognostic (2.72e-1)" "unprognostic (1.50e-1)" "unprognostic (2.67e-1)" 0.4 0.4 0.3 2.1 0.5 5.4 0.4 0.9 0.7 0.9 0.2 0.9 1.1 0.6 0.2 3.7 0.7 0.2 22.1 0.4 0.2 0.4 0.7 0.7 2.9 0.5 0.5 0.3 0.2 0.1 0.4 0.5 0.5 0.7 0.5 6.7 1.3 0.2 110.3 2.7 1.2 0.7 0.2 2.0 0.9 63.7 0.4 5.0 0.4 63.1 1.8 0.3 1.4 0.8 19.9 37.8 12.3 12.6 1.1 0.3 7.8 18.0 7.6 24.1 20.8 20.0 6.7 24.7 10.9 9.3 11.3 6.1 18.6 6.8 13.5 16.1 8.8 16.9 20.5 13.5 0.8 16.8 19.6 0.3 0.7 17.7 5.2 1.7 6.0 17.3 21.7 26.8 11.3 20.6 33.1 9.0 7.3 16.0 7.4 23.3 12.5 11.7 3.3 7.5 15.3 8.6 12.1 16.7 2.8 7.6 9.6 14.3 4.1 20.8 19.9 16.7 29.6 14.0 22.1 32.0 9.1 13.0 24.6 0.5 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.6 0.2 2.7 0.1 0.5 0.1 0.3 0.5 0.9 0.7 0.4 0.2 0.5 0.5 0.5 0.2 0.4 0.8 1.8 0.0 5.5 0.3 1.0 2.2 1.3 0.5 0.6 1.6 0.9 0.6 43.4 0.0 0.8 0.0 85.5 1.9 1.2 2.5 1.9 0.4 42.5 0.8 0.8 2.0 0.0 11.0 1.4 0.9 1.9 1.8 5.6 0.8 0.0 4.3 1.1 0.8 2.2 3.3 1.0 2.2 2.0 1.3 1.6 46.2 1.2 1.9 1.8 1.0 0.8 2.1 0.0 1.0 1.0 0.5 0.2 0.4 7.1 0.8 0.3 0.3 0.2 41.7 6.6 2.8 1.9 67.6 15.4 2.0 3.7 0.3 2.2 1.2 3.0 0.7 WDR90 "C16orf15, C16orf16, C16orf17, C16orf18, C16orf19, FLJ36483, KIAA1924, POC16" ENSG00000161996 "WD repeat domain 90" Q96KV7 16 649311-667833 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.2" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 32.3;Respiratory ciliated cells: 57.6;Rod photoreceptor cells: 34.7;Spermatocytes: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA049362, HPA061785" Approved Approved "Nuclear speckles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "HPA049362: AB_2680728, HPA061785: AB_2684606" "unprognostic (1.97e-2)" "unprognostic (1.50e-2)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.89e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.67e-2)" "unprognostic (8.28e-2)" "unprognostic (5.23e-2)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (9.96e-3)" "unprognostic (2.84e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-1)" "unprognostic (4.25e-2)" "unprognostic (4.48e-2)" 8.1 16.3 8.7 3.4 8.8 11.5 10.9 9.5 12.3 17.0 9.9 11.4 5.9 13.3 3.2 10.5 22.1 3.6 9.7 8.9 8.7 16.4 10.9 10.0 4.0 9.2 9.3 21.5 15.7 4.4 25.9 2.5 8.9 15.1 2.2 4.6 9.5 5.5 4.6 9.9 9.3 2.2 8.5 7.4 11.7 61.2 9.1 5.1 22.2 1.4 2.0 10.0 10.5 9.4 10.2 14.1 7.8 18.8 2.9 1.9 0.5 7.4 2.8 5.4 6.3 18.2 14.0 8.8 5.7 2.3 0.1 22.0 3.8 6.0 1.2 15.0 13.7 2.9 57.2 16.9 0.8 15.7 13.4 3.8 4.7 10.8 2.5 2.0 4.0 13.7 1.0 21.9 2.4 7.4 12.5 15.0 7.6 8.4 4.4 34.7 3.1 14.6 6.0 9.4 14.6 15.3 6.8 13.9 1.6 0.5 28.7 12.9 4.3 13.0 13.1 14.3 9.8 22.0 10.4 9.7 3.8 8.5 8.6 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 8.7 8.8 9.5 12.3 8.9 8.7 9.2 9.3 8.9 8.5 9.1 9.4 4.5 0.0 9.1 10.4 1.1 3.4 2.8 4.5 3.4 9.4 9.7 10.4 4.9 14.3 6.9 9.2 14.6 2.8 0.7 10.1 0.0 5.4 5.6 32.3 6.5 4.3 1.2 2.5 5.0 3.8 2.6 5.9 12.2 9.9 0.0 15.1 1.8 4.5 2.7 11.8 5.5 6.9 0.0 0.8 2.5 4.0 6.2 2.2 3.6 5.6 0.3 5.6 0.0 1.5 2.6 4.5 3.1 4.5 1.3 2.7 3.0 2.1 57.6 34.7 6.6 8.3 5.1 34.2 20.7 3.0 2.3 2.5 1.5 8.3 10.8 2.0 WDR93 "C1d-87, CFAP297, FAP297" ENSG00000140527 "WD repeat domain 93" Q6P2C0 15 89690811-89743638 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.9;testis: 11.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Early spermatids: 49.1;Endometrial ciliated cells: 28.1;Late spermatids: 42.4;Respiratory ciliated cells: 47.7;Spermatocytes: 30.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA046196, HPA048112" Uncertain Uncertain "Actin filaments" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" "HPA046196: AB_2679582, HPA048112: AB_2680267" "unprognostic (2.56e-3)" "unprognostic (3.21e-3)" "unprognostic (7.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.90e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-2)" "unprognostic (2.08e-2)" "unprognostic (1.22e-2)" "unprognostic (7.40e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.40e-2)" "unprognostic (4.73e-2)" "unprognostic (9.84e-2)" "unprognostic (4.44e-2)" 0.4 0.2 0.6 0.0 0.6 0.4 0.7 1.6 0.6 0.6 3.5 0.1 0.0 0.4 4.9 0.0 8.9 0.2 1.2 0.8 1.0 1.0 0.1 1.0 0.2 2.4 2.9 0.4 0.6 0.5 0.8 0.1 1.1 0.6 0.1 2.8 0.3 0.5 0.3 0.2 0.1 0.0 1.6 0.1 0.1 11.6 0.9 0.1 1.8 0.0 0.1 0.0 0.0 1.0 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.5 0.2 0.7 0.2 1.0 0.1 0.1 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.6 1.6 0.6 0.8 1.0 2.4 2.9 1.1 1.6 0.9 1.0 0.1 3.2 0.5 2.9 0.0 0.3 0.7 1.8 0.0 2.7 0.8 0.6 0.5 0.0 4.2 9.2 20.9 0.4 0.1 0.1 3.9 0.8 49.1 28.1 0.6 0.7 0.0 0.0 2.7 0.2 0.3 0.4 0.0 0.8 0.0 0.4 0.4 0.0 0.2 3.3 2.1 0.1 0.0 0.3 0.8 42.4 1.5 0.3 1.8 0.0 0.6 0.6 0.0 0.5 1.0 0.3 1.1 0.7 0.1 0.7 0.0 2.1 47.7 14.8 0.0 0.9 0.6 30.4 5.7 0.0 0.1 0.3 0.6 2.9 0.2 0.4 WFDC6 "C20orf171, dJ461P17.11, WAP6" ENSG00000243543 "WAP four-disulfide core domain 6" Q9BQY6 20 45534196-45539482 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 250.9" "Cell type enriched" "Detected in some" 4 "Respiratory ciliated cells: 34.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.9;testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-87 MG: 2.6" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.68e-3)" "unprognostic (2.21e-3)" "unprognostic (1.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.91e-2)" 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.4 1.0 0.0 0.0 0.0 0.2 250.9 0.1 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.5 0.1 0.0 0.0 0.0 0.0 37.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 WIF1 ENSG00000156076 "WNT inhibitory factor 1" Q9Y5W5 12 65050626-65121305 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 599.7" "Cell type enriched" "Detected in many" 13 "Muller glia cells: 2736.1" "Group enriched" "Detected in many" 5 "endometrial cancer: 16.9;lung cancer: 14.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.2;LHCN-M2: 1.0;NTERA-2: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" "Cluster 5: Muller glia cells - Visual perception" "unprognostic (5.96e-3)" "unprognostic (2.00e-1)" "unprognostic (4.29e-3)" "unprognostic (3.26e-3)" "unprognostic (9.66e-2)" "unprognostic (1.91e-1)" "unprognostic (1.26e-2)" "unprognostic (7.94e-2)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (3.17e-1)" "unprognostic (2.30e-5)" "unprognostic (3.02e-1)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (7.24e-3)" 1.3 2.7 22.4 0.3 34.3 0.0 22.9 16.3 44.6 1.6 15.0 0.3 0.0 8.6 23.8 4.7 1.5 0.0 0.5 24.8 35.4 0.7 0.0 117.4 0.1 16.6 16.5 1.2 0.3 0.0 46.5 0.0 16.2 14.2 0.3 599.7 45.1 2.8 0.1 6.6 2.2 0.9 16.5 0.1 1.4 0.7 23.4 0.2 0.0 0.7 0.0 1.7 2.2 18.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 34.3 16.3 44.6 24.8 35.4 16.6 16.5 16.2 16.5 23.4 18.4 0.0 35.3 197.8 186.1 0.0 12.6 34.5 0.0 2.2 25.0 0.7 13.7 1.6 0.0 26.6 1.8 8.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 4.7 0.0 0.0 0.6 0.0 0.0 27.8 0.5 0.1 7.6 1.0 0.0 0.0 0.0 15.2 46.5 0.0 0.0 0.0 20.4 0.0 0.0 0.8 23.2 12.2 0.0 2736.1 0.0 1.5 0.9 0.0 0.0 0.4 0.2 25.5 0.0 1.2 34.2 80.8 0.0 1.8 1.5 2.5 2.0 0.4 10.5 0.0 1.2 0.0 0.0 0.8 WNK2 "KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43" ENSG00000165238 "WNK lysine deficient protein kinase 2" Q9Y3S1 9 93184916-93320572 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 83.1;skeletal muscle: 62.3" "Cell type enhanced" "Detected in many" "Astrocytes: 76.4;Cone photoreceptor cells: 160.6;Excitatory neurons: 128.5;Inhibitory neurons: 98.8;Intestinal goblet cells: 77.3;Rod photoreceptor cells: 106.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 18.8;Hep G2: 31.0;SCLC-21H: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015555, HPA016519, CAB017813" Enhanced Approved Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 38: Heart - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380" "unprognostic (5.02e-2)" "unprognostic (1.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.04e-1)" "unprognostic (1.79e-3)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.31e-3)" "unprognostic (2.23e-1)" "unprognostic (4.48e-3)" "unprognostic (6.51e-2)" "unprognostic (1.44e-1)" "unprognostic (4.38e-4)" "unprognostic (1.62e-1)" 2.0 3.0 14.9 3.3 14.8 0.0 4.9 4.6 39.1 4.7 0.3 36.0 17.9 5.8 4.2 5.7 15.4 1.3 83.1 18.3 7.7 0.8 1.3 0.9 0.5 13.8 6.0 1.1 42.8 2.3 29.6 3.0 8.8 16.7 11.9 28.8 47.3 12.3 62.3 15.8 21.5 4.5 1.9 2.7 14.7 6.6 14.2 7.1 1.8 31.0 1.0 5.5 3.4 10.5 7.4 6.6 4.6 13.2 0.0 0.0 8.8 0.0 0.0 0.1 0.0 2.7 0.2 18.8 2.4 0.0 1.3 0.3 10.4 0.0 0.0 0.0 12.1 0.0 5.8 31.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.2 0.0 0.0 9.8 0.2 0.2 11.5 7.2 0.4 0.0 0.0 15.3 0.0 1.1 37.6 14.8 2.4 10.2 0.9 1.3 1.3 2.2 0.1 0.0 4.8 0.2 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 14.8 4.6 39.1 18.3 7.7 13.8 6.0 8.8 1.9 14.2 10.5 0.3 0.0 0.0 76.4 0.3 1.3 8.5 3.1 0.0 62.0 19.4 18.7 58.1 31.5 14.1 0.0 160.6 15.5 0.2 34.3 0.0 17.1 1.2 7.7 9.2 1.3 32.4 0.0 128.5 9.1 6.7 2.7 3.6 15.8 0.0 8.6 0.4 0.2 3.4 1.7 98.8 77.3 6.1 1.3 2.2 2.6 0.9 0.1 1.8 29.0 0.6 60.3 0.0 9.0 3.2 3.2 57.0 6.0 0.2 11.1 47.7 1.1 6.6 106.8 13.1 3.5 5.0 0.7 7.7 1.1 5.5 15.6 0.4 0.1 59.0 8.9 WNK4 PRKWNK4 ENSG00000126562 "WNK lysine deficient protein kinase 4" Q96J92 17 42780610-42797066 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 11.0;kidney: 37.6;prostate: 11.6" "Cell type enriched" "Detected in some" 4 "Distal tubular cells: 160.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016500 Approved NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "HPA016500: AB_10962984" "unprognostic (6.34e-3)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (2.48e-1)" "unprognostic (1.69e-1)" "unprognostic (5.84e-2)" "unprognostic (3.94e-1)" "unprognostic (2.08e-3)" "unprognostic (4.33e-3)" "unprognostic (7.70e-3)" "unprognostic (1.62e-1)" "unprognostic (6.11e-2)" "unprognostic (1.43e-1)" "unprognostic (7.99e-2)" 1.3 0.0 0.7 1.1 0.9 0.0 2.8 0.8 3.3 0.6 0.3 9.8 1.9 0.2 0.7 8.9 0.4 0.0 0.1 1.7 1.1 37.6 0.2 0.1 0.1 1.1 0.7 4.3 0.2 0.0 1.2 0.0 0.7 11.6 11.0 0.6 1.8 1.1 0.0 0.5 3.7 0.4 0.6 0.1 3.4 0.2 1.0 0.0 0.0 0.3 0.1 0.2 0.4 1.0 2.1 1.2 0.6 0.0 0.7 0.2 4.8 11.9 4.8 4.5 1.3 0.7 1.0 0.6 6.8 32.6 1.2 0.0 0.2 0.3 8.6 0.6 1.8 0.1 0.0 4.7 7.4 0.3 0.7 3.9 1.4 6.4 2.1 2.1 0.3 0.4 36.8 1.3 0.0 1.0 0.0 1.1 0.3 2.0 8.2 0.6 1.2 0.0 0.0 0.5 0.0 0.2 0.1 0.2 1.7 4.1 2.4 2.7 34.1 0.3 3.1 0.5 0.4 6.2 5.3 1.2 0.0 2.1 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.8 3.3 1.7 1.1 1.1 0.7 0.7 0.6 1.0 1.0 0.2 0.0 0.6 0.0 0.5 0.0 0.2 0.0 0.6 0.2 7.1 4.1 1.0 1.5 0.6 7.3 0.0 0.0 0.3 8.0 160.4 0.0 0.0 5.1 1.1 0.2 13.1 0.0 0.2 0.2 0.2 0.1 3.1 6.7 4.5 0.1 0.7 0.0 0.0 0.0 0.2 40.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.2 0.4 0.0 3.6 0.9 1.0 2.9 0.5 0.0 0.2 0.5 0.8 0.8 12.1 0.4 0.0 0.2 0.0 13.1 0.3 WNT7A Wnt-7a ENSG00000154764 "Wnt family member 7A" O00755 3 13816258-13880071 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;gallbladder: 2.3;placenta: 2.7" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2;ovarian cancer: 11.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015719, CAB025894" Approved "Secreted to extracellular matrix" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 38: Extravillous trophoblasts - Unknown function" "CAB025894: , HPA015719: AB_1858856" "unprognostic (1.26e-2)" "unprognostic (4.60e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (3.02e-1)" "unprognostic (1.14e-3)" "unprognostic (2.49e-1)" "unprognostic (3.32e-4)" "unprognostic (2.20e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (7.89e-2)" "unprognostic (3.78e-2)" "unprognostic (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (3.74e-1)" "unprognostic (8.88e-3)" 0.0 0.0 3.6 0.1 3.1 0.1 0.0 1.0 3.7 0.2 0.3 0.0 0.0 1.1 0.2 0.4 0.1 2.3 0.0 2.4 2.1 0.2 0.0 2.0 0.2 5.1 1.9 0.0 0.1 0.0 0.0 2.7 2.5 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 3.4 1.3 0.0 1.3 2.5 0.0 0.0 0.0 0.1 0.3 0.1 2.8 8.6 0.0 0.8 0.0 0.0 0.0 59.8 0.0 0.0 0.0 0.0 0.0 7.6 0.0 56.0 0.0 0.1 11.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 1.7 100.3 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.6 3.1 1.0 3.7 2.4 2.1 5.1 1.9 2.5 3.4 2.5 2.8 0.0 12.8 0.0 8.5 0.0 5.9 2.8 2.6 0.0 0.0 0.0 0.0 0.7 8.6 1.4 0.0 0.0 68.7 0.0 0.0 0.0 13.8 17.3 14.5 0.4 0.6 0.0 0.0 4.0 9.1 147.5 0.4 0.0 17.9 0.0 0.0 0.0 0.0 7.4 0.0 2.4 0.0 0.0 0.0 0.0 5.6 0.0 0.1 0.0 1.0 0.0 0.0 0.0 4.5 0.3 98.8 0.0 0.0 0.0 3.3 0.0 0.1 0.2 0.0 0.0 0.0 0.2 6.0 2.3 0.0 1.3 185.7 1.5 0.0 0.0 6.0 WNT9A WNT14 ENSG00000143816 "Wnt family member 9A" O14904 1 227918656-227947932 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.7;skeletal muscle: 26.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 5.1;Ionocytes: 6.1;Respiratory ciliated cells: 12.5;Urothelial cells: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 16.2;PC-3: 10.8;RH-30: 16.4;SCLC-21H: 14.9;SiHa: 14.7;U-2197: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (2.27e-2)" "unprognostic (3.24e-1)" "unprognostic (3.77e-3)" "unprognostic (4.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.48e-1)" "unprognostic (1.38e-2)" "unprognostic (1.70e-2)" "unprognostic (3.72e-2)" "unprognostic (8.71e-2)" "unprognostic (5.04e-2)" "unprognostic (9.93e-2)" 3.3 1.4 0.4 1.1 0.6 0.1 3.0 0.6 0.8 4.1 7.7 18.7 1.3 5.3 0.4 5.8 5.5 2.1 10.1 0.7 0.9 0.9 0.2 3.9 0.3 1.2 0.9 9.8 2.8 1.2 2.8 2.1 2.1 2.5 1.1 0.0 2.4 1.0 26.3 1.1 6.0 4.3 0.5 1.0 5.9 1.5 0.7 1.1 2.0 2.8 0.3 4.9 3.4 0.5 1.0 3.3 0.4 0.1 0.4 0.7 8.1 1.1 0.9 0.1 0.0 0.0 8.8 0.0 4.7 1.5 3.3 16.2 0.4 0.8 0.0 1.6 0.6 0.0 6.0 0.2 0.4 0.0 0.5 0.1 4.0 0.1 0.1 0.3 1.0 0.0 0.0 0.1 1.8 2.2 0.0 0.0 1.0 0.0 10.8 0.2 16.4 1.7 4.6 1.1 14.9 0.0 14.7 6.6 0.0 5.2 8.4 1.8 0.6 2.1 1.3 10.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.6 0.8 0.7 0.9 1.2 0.9 2.1 0.5 0.7 0.5 0.3 3.2 0.6 0.3 0.0 0.9 1.3 3.6 0.0 0.0 3.1 1.3 1.4 0.0 4.3 1.8 0.0 0.3 0.2 0.8 0.0 0.7 0.1 2.1 2.1 0.4 3.0 0.0 0.7 1.3 0.2 5.1 1.5 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 2.9 6.1 0.0 0.4 0.1 4.4 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.9 1.1 0.0 4.5 0.1 1.8 0.1 0.1 12.5 0.0 0.0 1.3 1.1 0.0 1.8 3.9 0.3 0.0 0.2 0.1 0.1 5.3 WWC2 "BOMB, FLJ22029" ENSG00000151718 "WW and C2 domain containing 2" Q6AWC2 4 183099257-183320777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 262.8;Microglial cells: 129.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 84.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044005 Uncertain Approved Microtubules NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 39: CACO-2 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Microtubules "HPA044005: AB_10960552" "unprognostic (1.07e-1)" "prognostic unfavorable (8.61e-4)" "unprognostic (7.16e-4)" "unprognostic (1.70e-1)" "unprognostic (2.00e-2)" "unprognostic (4.48e-3)" "unprognostic (2.05e-1)" "unprognostic (3.93e-2)" "unprognostic (4.42e-2)" "unprognostic (1.97e-1)" "unprognostic (9.52e-3)" "unprognostic (2.22e-1)" "prognostic favorable (9.29e-4)" "unprognostic (3.27e-2)" "unprognostic (3.44e-1)" "unprognostic (3.23e-1)" "unprognostic (2.52e-2)" 9.0 5.5 4.7 4.6 5.9 0.6 7.8 5.5 4.4 7.7 10.0 5.0 2.0 8.9 3.3 5.2 6.9 6.9 12.1 4.4 4.4 18.8 19.2 28.2 2.3 7.3 5.8 11.5 12.6 9.7 1.8 14.5 6.3 7.9 2.9 21.3 6.1 8.8 4.2 4.1 2.1 9.9 6.6 6.3 6.8 15.5 5.4 1.0 15.9 5.5 2.2 6.2 3.8 7.7 26.0 10.9 23.1 20.7 16.9 18.8 26.7 34.5 27.1 37.2 26.6 48.2 24.7 0.0 16.9 55.7 13.0 9.2 35.7 14.3 46.9 0.0 11.0 26.3 25.4 24.9 17.5 12.5 27.6 14.3 10.7 24.6 22.9 30.8 25.1 3.7 18.9 1.4 28.6 7.5 0.0 8.3 22.0 0.7 9.3 0.0 21.1 14.0 52.7 6.9 1.5 11.7 84.2 72.7 11.1 36.5 17.6 4.2 37.8 13.8 38.2 8.2 25.1 0.0 0.0 0.3 13.5 5.7 24.7 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 4.7 5.9 5.5 4.4 4.4 4.4 7.3 5.8 6.3 6.6 5.4 7.7 27.8 262.8 65.4 23.2 0.4 24.0 9.3 6.3 8.6 5.4 15.0 11.4 30.0 37.1 24.0 7.3 64.6 15.4 1.4 0.7 27.4 16.3 36.9 26.7 26.6 27.4 1.2 3.6 62.1 14.6 9.8 25.0 9.2 35.4 19.0 39.5 17.2 39.0 10.5 0.0 98.1 0.2 4.1 15.6 7.7 26.9 17.7 9.0 12.4 129.3 7.6 11.7 0.0 52.3 44.0 30.3 0.1 21.1 0.8 29.3 0.0 24.7 11.5 58.6 26.3 34.2 24.2 41.8 19.7 7.7 15.3 6.6 3.2 19.9 0.4 12.2 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644776-152676141 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 14.1;Extravillous trophoblasts: 21.2;Granulosa cells: 20.2;Spermatocytes: 31.3;Spermatogonia: 19.1;Syncytiotrophoblasts: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Vesicles" "HPA065153: AB_2685422" "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 0.2 0.2 0.9 2.3 0.6 5.3 1.5 1.6 2.8 0.3 0.0 1.1 1.7 1.1 0.9 1.0 0.5 0.4 1.0 0.6 1.9 0.4 0.4 0.5 2.9 0.6 0.6 1.0 0.0 0.6 0.0 2.1 1.4 0.7 1.7 1.9 0.2 0.4 0.1 1.9 1.5 0.5 1.1 1.0 1.0 3.0 1.0 3.6 0.6 0.0 2.5 0.5 0.1 1.9 16.5 10.4 18.3 15.8 1.1 1.8 15.0 11.8 3.9 8.2 10.3 14.7 12.8 24.8 9.5 3.5 13.7 13.7 12.8 7.1 19.3 8.9 17.3 16.8 15.5 10.0 0.3 27.3 9.3 0.9 1.1 15.6 3.6 2.0 3.8 15.5 34.2 22.8 8.3 12.6 32.4 21.2 21.6 10.8 12.9 22.8 19.3 15.3 3.1 10.3 16.7 18.1 11.7 7.6 5.0 11.3 5.4 8.3 4.2 17.2 6.9 13.3 23.0 8.8 14.5 19.0 11.0 20.9 20.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.6 1.6 2.8 0.6 1.9 0.6 0.6 1.4 1.1 1.0 1.9 0.2 0.0 1.1 1.6 1.9 1.3 1.0 1.0 0.0 4.9 0.8 0.4 2.9 0.0 1.4 1.8 0.0 11.2 0.4 0.9 0.0 1.1 11.7 0.9 1.9 1.1 0.0 14.1 2.3 0.2 21.2 2.5 3.1 1.4 0.0 20.2 1.1 0.2 2.4 0.0 2.0 1.7 2.0 0.6 0.8 4.9 0.9 0.8 0.0 0.0 0.6 1.1 3.1 4.5 2.0 0.5 0.1 1.2 6.1 0.6 0.3 0.3 0.1 2.3 0.0 1.9 1.8 31.3 19.1 2.7 1.4 12.6 2.2 1.2 2.3 1.0 ZBBX FLJ23049 ENSG00000169064 "Zinc finger B-box domain containing" A8MT70 3 167239843-167407874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 13.5;choroid plexus: 28.9;fallopian tube: 23.2;testis: 35.9" "Cell type enhanced" "Detected in some" "Early spermatids: 423.4;Endometrial ciliated cells: 107.4;Excitatory neurons: 80.1;Late spermatids: 232.4;Respiratory ciliated cells: 226.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036327, HPA036328" Enhanced Approved "Golgi apparatus" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA036327: AB_10672240, HPA036328: AB_2675063" "unprognostic (2.68e-3)" "unprognostic (4.49e-2)" "unprognostic (6.94e-2)" "unprognostic (3.99e-1)" "unprognostic (4.08e-2)" "unprognostic (7.61e-2)" "unprognostic (1.24e-1)" "unprognostic (1.75e-3)" "unprognostic (1.29e-1)" "unprognostic (2.30e-3)" "unprognostic (1.15e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" 0.0 0.2 3.7 0.0 2.6 0.0 0.0 0.7 1.5 0.7 28.9 0.0 0.0 0.8 0.1 0.0 23.2 0.0 0.0 2.4 2.7 0.2 0.0 3.5 0.0 13.5 11.1 0.0 0.0 0.3 2.0 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 35.9 3.5 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.6 0.7 1.5 2.4 2.7 13.5 11.1 6.6 10.5 3.5 6.1 0.0 0.0 1.1 7.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 423.4 107.4 0.6 0.6 0.0 0.0 80.1 0.0 0.0 0.5 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 23.8 0.0 6.1 0.0 0.0 232.4 1.5 0.4 0.0 1.9 0.0 0.0 0.0 4.5 1.1 0.1 0.0 1.5 0.0 0.1 0.0 0.2 226.2 0.0 0.0 0.0 1.2 37.4 11.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520857-23556192 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.9;testis: 7.3" "Cell type enhanced" "Detected in many" "Astrocytes: 22.5;Early spermatids: 38.9;Excitatory neurons: 31.0;Inhibitory neurons: 20.0;Late spermatids: 19.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 20.8;Spermatocytes: 16.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.8;SuSa: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 21: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 0.5 0.7 1.8 0.5 6.3 0.1 0.4 11.9 5.3 0.4 0.0 0.7 0.1 0.7 0.4 0.2 2.2 0.4 0.3 3.2 0.0 1.3 0.2 0.5 0.3 1.5 0.1 0.5 0.4 1.7 3.4 0.2 0.2 0.6 0.2 3.1 0.4 1.2 0.7 0.5 0.3 0.6 0.0 0.2 0.4 7.3 0.9 0.2 0.7 0.5 0.2 0.3 0.2 2.3 0.1 3.1 2.4 4.8 1.6 0.2 0.1 0.7 0.2 0.3 1.2 0.3 0.2 0.2 0.3 0.0 0.3 0.1 1.2 0.1 0.5 2.2 0.8 2.5 0.0 0.6 0.2 0.4 1.7 0.3 0.1 0.5 0.1 1.3 0.3 2.1 0.4 0.4 0.1 0.8 0.3 0.3 2.9 0.3 0.7 1.4 0.0 0.0 1.3 1.2 2.7 1.7 0.4 0.6 0.1 3.6 1.0 0.6 0.1 0.0 1.2 0.7 0.3 0.3 1.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 6.3 11.9 5.3 3.2 0.0 1.5 0.1 0.2 0.0 0.9 2.3 0.5 0.0 1.1 22.5 0.7 0.1 0.6 1.1 0.0 9.0 2.2 2.3 2.5 0.0 2.4 1.8 0.0 0.3 0.1 0.6 1.9 2.8 38.9 12.2 0.6 1.1 6.7 0.0 31.0 2.4 0.0 1.4 2.0 2.5 0.0 3.2 0.7 0.2 1.0 8.4 20.0 0.7 2.0 1.0 1.9 19.1 0.6 0.8 0.0 4.7 1.0 2.7 0.0 27.2 20.8 1.2 1.2 0.4 0.1 1.4 0.4 1.4 9.8 3.8 0.0 2.5 1.3 16.5 1.2 0.7 0.0 0.3 0.4 0.2 0.6 0.3 ZFR2 KIAA1086 ENSG00000105278 "Zinc finger RNA binding protein 2" Q9UPR6 19 3804024-3869038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 17.0;pituitary gland: 26.1;retina: 10.9;testis: 13.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.7;Cone photoreceptor cells: 27.1;Early spermatids: 25.3;Excitatory neurons: 39.3;Horizontal cells: 32.0;Inhibitory neurons: 42.7;Rod photoreceptor cells: 38.5;Spermatocytes: 29.4" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 16.3;NTERA-2: 31.7;SiHa: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043275, HPA055678" Uncertain Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 5: NTERA-2 - Transcription" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA043275: , HPA055678: AB_2682883" "unprognostic (1.74e-3)" "unprognostic (2.32e-3)" "unprognostic (4.05e-3)" "unprognostic (1.51e-2)" "unprognostic (6.60e-3)" "unprognostic (5.47e-4)" "unprognostic (9.12e-2)" "unprognostic (3.87e-2)" "unprognostic (1.18e-2)" "unprognostic (4.92e-2)" "unprognostic (1.97e-3)" "unprognostic (4.29e-2)" "unprognostic (3.58e-1)" "unprognostic (3.58e-1)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (2.18e-2)" 0.2 2.5 9.6 0.4 9.5 0.2 0.1 0.3 17.0 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.7 0.1 0.3 7.9 10.9 0.2 0.1 0.3 0.2 3.9 3.0 0.1 0.4 2.5 26.1 0.0 4.0 0.4 0.1 10.9 0.1 0.1 0.1 0.2 0.3 0.0 1.3 0.3 0.3 13.4 8.0 0.0 0.3 0.0 0.2 0.1 0.2 5.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 31.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.1 0.5 6.9 0.0 0.4 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 1.1 0.0 1.2 0.0 0.7 0.5 0.0 0.2 1.0 0.8 0.2 0.4 0.0 0.0 0.2 0.3 9.6 9.5 0.3 17.0 7.9 10.9 3.9 3.0 4.0 1.3 8.0 5.3 0.2 0.0 1.1 2.9 0.2 1.0 0.5 0.1 0.0 33.7 0.2 1.0 1.6 0.0 0.0 0.0 27.1 0.0 1.1 0.0 0.0 0.5 25.3 0.7 0.2 0.5 0.0 0.0 39.3 0.2 0.1 0.2 1.1 0.2 1.3 0.3 0.0 0.1 0.1 32.0 42.7 0.2 0.0 0.0 0.4 11.0 0.9 0.2 1.8 1.9 0.1 4.4 1.0 16.1 4.5 0.2 0.0 0.0 0.3 0.4 0.0 0.3 1.5 38.5 0.0 0.6 0.2 29.4 15.9 0.0 0.1 0.0 1.5 0.1 0.0 0.4 ZMYND10 "BLU, CILD22, DNAAF7" ENSG00000004838 "Zinc finger MYND-type containing 10" O75800 3 50341110-50345732 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "fallopian tube: 120.2;testis: 258.5" "Group enriched" "Detected in many" 11 "Early spermatids: 309.4;Endometrial ciliated cells: 221.8;Late spermatids: 415.3;Respiratory ciliated cells: 390.8;Spermatocytes: 529.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "T-47d: 5.6;U-87 MG: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035255 Approved "Plasma membrane,Cytosol" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" Cytosol "HPA035255: AB_10601928" "unprognostic (2.93e-3)" "unprognostic (2.98e-3)" "unprognostic (1.15e-2)" "unprognostic (3.85e-3)" "unprognostic (4.44e-1)" "unprognostic (7.78e-3)" "unprognostic (4.71e-2)" "unprognostic (6.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (6.73e-2)" "prognostic favorable (6.75e-5)" "unprognostic (8.25e-2)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" 0.3 0.1 5.0 0.2 5.0 0.7 1.1 3.5 2.8 4.3 29.2 0.2 0.2 1.7 1.6 0.2 120.2 0.5 0.2 4.3 6.7 2.1 0.9 11.1 0.2 12.5 15.6 0.6 1.1 3.7 5.9 0.1 9.4 0.7 0.1 3.2 0.3 0.4 0.4 0.5 0.4 0.5 10.4 0.6 0.3 258.5 7.3 0.5 1.9 0.2 0.1 0.2 0.3 9.2 1.6 0.6 0.2 0.5 0.6 0.9 0.3 0.2 0.9 1.6 0.5 0.0 1.0 0.7 0.6 1.0 0.2 0.2 1.5 0.0 0.1 0.4 0.6 1.5 1.2 0.0 0.0 0.5 0.8 0.0 0.1 2.0 0.1 1.5 0.1 1.3 0.5 0.1 0.2 1.0 0.3 2.7 0.0 0.2 0.7 0.7 0.0 0.5 2.0 0.0 1.8 0.5 0.1 0.5 0.0 0.0 5.6 0.6 0.0 0.3 0.4 0.9 0.1 1.0 0.4 0.1 3.9 2.2 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.1 5.0 5.0 3.5 2.8 4.3 6.7 12.5 15.6 9.4 10.4 7.3 9.2 0.5 3.2 5.1 1.3 0.7 0.5 0.4 24.2 1.2 1.2 2.3 1.7 0.8 0.0 33.1 1.8 4.2 0.1 1.7 0.2 0.0 1.1 309.4 221.8 2.4 1.2 0.0 3.2 0.5 0.0 0.2 1.1 0.0 3.6 0.0 0.3 0.7 0.4 0.6 0.0 0.3 0.7 22.4 0.0 0.4 415.3 9.0 1.3 1.8 1.0 0.9 1.2 2.1 0.5 1.3 0.1 0.0 5.7 0.9 0.6 0.0 1.0 390.8 7.6 0.0 0.9 9.8 529.7 9.1 1.1 0.4 0.1 1.7 0.2 0.3 0.1 ZMYND12 DKFZp434N2435 ENSG00000066185 "Zinc finger MYND-type containing 12" Q9H0C1 1 42430329-42456253 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.1;testis: 28.8" "Cell type enhanced" "Detected in many" "Early spermatids: 164.2;Late spermatids: 71.4;Respiratory ciliated cells: 40.0;Spermatocytes: 95.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 2.6;SK-MEL-30: 2.2;WM-115: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (4.54e-2)" "unprognostic (1.57e-1)" "unprognostic (2.20e-1)" "unprognostic (6.43e-3)" "unprognostic (2.53e-3)" "unprognostic (8.13e-2)" "unprognostic (4.89e-2)" "unprognostic (2.79e-3)" "unprognostic (7.23e-2)" "unprognostic (2.17e-1)" "unprognostic (2.51e-1)" "unprognostic (1.87e-2)" "prognostic favorable (1.11e-5)" "unprognostic (1.76e-1)" "unprognostic (2.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" 1.0 2.3 4.6 0.2 4.4 0.2 2.2 4.3 5.6 2.0 5.7 1.2 1.0 1.3 9.4 0.3 17.1 1.8 2.3 4.2 5.1 9.3 6.9 1.9 0.4 5.6 7.1 1.9 3.3 2.3 3.4 0.5 5.4 2.3 1.1 4.1 1.0 2.1 1.8 0.7 0.4 0.9 5.0 0.9 1.6 28.8 4.9 0.6 5.0 2.5 0.3 0.9 0.3 5.0 0.0 0.0 0.2 0.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.5 2.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.4 1.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.3 4.6 4.4 4.3 5.6 4.2 5.1 5.6 7.1 5.4 5.0 4.9 5.0 0.4 3.2 2.7 4.6 0.5 0.0 0.8 2.6 0.0 0.9 2.5 1.8 3.7 7.2 4.3 7.3 0.0 1.5 0.3 0.6 15.6 1.0 164.2 26.3 1.0 0.5 0.0 1.3 1.6 0.5 1.3 1.3 4.1 1.8 0.0 1.1 0.4 3.8 2.6 0.0 1.7 1.5 6.1 2.6 0.0 71.4 2.5 3.7 3.6 2.8 0.8 3.5 1.0 1.0 1.6 0.1 0.3 2.2 0.8 0.5 0.9 18.4 40.0 2.8 0.0 1.0 0.5 95.9 5.4 0.8 0.3 0.7 0.4 1.9 0.7 1.1 ZNF165 "CT53, ZSCAN7" ENSG00000197279 "Zinc finger protein 165" P49910 6 28080568-28089563 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 94.6;Early spermatids: 152.7;Glandular and luminal cells: 75.8;Paneth cells: 120.3;Syncytiotrophoblasts: 79.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 14.4;BEWO: 22.9;GAMG: 16.9" "Low region specificity" "Detected in all" HPA007247 Approved "Nuclear speckles,Microtubules" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear speckles, Microtubules" "HPA007247: AB_2797217" "unprognostic (1.85e-1)" "unprognostic (2.01e-3)" "unprognostic (1.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.45e-1)" "unprognostic (4.32e-3)" "unprognostic (3.42e-1)" "unprognostic (2.09e-1)" "unprognostic (1.93e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.18e-3)" "unprognostic (1.29e-2)" "prognostic favorable (1.19e-5)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (2.18e-1)" "prognostic favorable (9.82e-5)" 0.4 0.8 0.4 1.0 0.5 1.4 2.1 0.6 0.8 1.4 2.1 2.4 2.2 1.1 5.1 2.2 1.8 0.9 0.5 0.5 0.5 4.5 2.4 1.9 1.3 0.9 0.7 0.7 4.6 4.8 3.8 3.1 1.0 1.0 3.3 1.7 2.0 1.2 0.7 1.0 1.8 0.5 0.4 0.9 2.5 17.2 0.4 0.5 2.9 0.1 1.7 2.5 1.1 0.7 14.4 0.9 0.8 1.1 0.3 0.5 22.9 0.5 0.5 0.9 0.8 9.0 10.3 1.2 3.9 0.2 16.9 5.4 2.0 6.2 0.6 0.4 3.6 0.7 1.5 9.7 0.3 2.3 2.0 0.3 3.2 0.7 8.8 0.6 0.3 0.8 2.3 1.1 0.5 3.9 0.6 2.7 1.9 12.2 1.4 1.9 0.8 7.7 4.7 6.5 9.6 0.7 1.2 11.1 1.3 2.5 5.5 0.5 0.4 0.8 1.1 0.4 1.0 3.4 9.6 3.6 0.5 2.6 0.4 5.8 1.7 3.4 1.3 1.4 1.6 7.0 1.5 1.0 1.8 8.6 2.5 2.0 2.5 1.4 1.7 5.5 0.7 0.9 0.4 0.5 0.6 0.8 0.5 0.5 0.9 0.7 1.0 0.4 0.4 0.7 0.8 6.4 7.0 0.0 23.2 8.5 16.5 2.3 2.8 0.8 24.5 9.4 0.4 4.3 5.0 3.7 0.0 9.4 4.2 94.6 3.9 18.2 152.7 55.4 5.9 1.3 53.9 0.0 1.2 12.3 9.0 0.6 13.7 75.8 0.0 0.6 0.0 0.4 1.5 0.0 0.9 53.7 6.1 0.6 3.2 19.5 0.9 2.8 5.4 0.0 1.6 1.5 0.0 0.0 0.1 17.5 120.3 2.2 12.4 6.5 9.0 2.0 12.0 2.6 0.0 0.6 1.5 33.6 4.4 8.5 11.8 79.6 8.5 0.3 34.9 40.8 ZNF19 "KOX12, MGC51021" ENSG00000157429 "Zinc finger protein 19" P17023 16 71464555-71565089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.9;Spermatocytes: 15.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA063685 Approved Approved Mitochondria NA NA "Cluster 24: B-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 46: Photoreceptor cells - Phototransduction" Mitochondria "HPA063685: AB_2685090" "unprognostic (5.59e-4)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-4)" "unprognostic (6.02e-3)" "unprognostic (4.92e-2)" "unprognostic (3.34e-2)" "unprognostic (6.97e-3)" "unprognostic (2.23e-1)" "unprognostic (4.84e-2)" "unprognostic (8.90e-4)" "unprognostic (1.31e-1)" "unprognostic (3.04e-6)" "unprognostic (3.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.83e-2)" "unprognostic (4.87e-2)" 3.3 3.2 1.7 2.4 3.1 2.6 3.5 2.5 6.0 2.0 3.1 2.4 3.7 3.9 8.3 4.4 8.3 6.5 4.3 4.3 0.6 3.5 2.3 4.3 3.1 0.4 0.1 4.2 6.2 4.3 5.3 1.8 0.0 3.2 2.1 11.3 3.4 2.0 9.7 6.5 3.1 1.5 0.0 2.7 2.9 16.2 1.6 1.1 8.2 1.7 1.4 1.7 0.6 5.7 1.2 1.0 2.9 2.8 1.3 0.9 2.0 1.9 0.9 1.1 1.2 2.1 3.9 1.7 2.1 0.9 2.0 1.4 1.4 1.7 0.4 1.3 1.3 2.3 2.2 3.2 0.8 2.3 1.9 2.1 1.8 1.5 3.2 2.5 0.5 3.0 1.3 2.1 1.4 1.8 1.6 1.5 1.5 0.7 2.5 1.0 2.5 0.6 1.6 2.2 4.0 3.0 3.3 1.1 2.6 1.9 2.2 1.8 1.0 3.3 1.7 2.1 1.8 1.9 1.9 0.4 2.7 1.3 1.8 2.3 0.9 0.8 1.1 0.8 0.3 2.1 1.2 1.1 0.7 2.4 1.5 1.4 1.7 0.9 1.0 1.3 0.5 0.6 1.7 3.1 2.5 6.0 4.3 0.6 0.4 0.1 0.0 0.0 1.6 5.7 1.4 0.0 3.2 3.9 3.7 0.3 2.0 2.1 1.2 3.8 3.1 1.8 1.2 1.5 2.3 1.8 10.4 1.4 2.3 1.8 5.9 4.4 7.3 6.3 1.3 1.6 1.2 3.6 1.7 1.4 0.8 2.1 0.5 1.2 0.0 5.0 2.2 4.1 1.4 10.1 1.6 2.0 2.0 1.0 1.6 4.4 0.6 0.9 0.0 2.8 1.3 3.5 0.0 2.0 2.1 2.2 1.7 1.9 0.8 1.3 3.6 3.3 10.0 25.9 6.6 2.2 2.0 15.3 7.6 0.8 0.6 0.5 1.8 3.4 1.5 1.0 ZNF273 HZF9 ENSG00000198039 "Zinc finger protein 273" Q14593 7 64870172-64930966 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 4.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 44.0;Inhibitory neurons: 51.2;Respiratory ciliated cells: 82.0" "Cancer enhanced" "Detected in many" "testis cancer: 4.9" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA077549 Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA077549: AB_2732352" "unprognostic (7.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.80e-2)" "unprognostic (5.87e-4)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-2)" "unprognostic (1.65e-2)" "unprognostic (2.02e-5)" "unprognostic (2.54e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (1.04e-2)" "unprognostic (3.14e-1)" "unprognostic (9.48e-2)" "unprognostic (1.85e-2)" 0.4 0.1 0.2 0.2 0.2 2.4 1.2 1.0 0.7 0.8 0.1 0.2 0.3 0.6 0.1 0.5 0.8 0.1 0.2 0.2 0.2 0.2 0.1 0.4 1.1 0.5 0.4 0.9 0.3 0.2 0.0 0.5 0.3 0.4 0.4 0.4 0.4 0.3 0.3 4.0 0.1 0.2 0.3 0.4 0.2 2.1 0.2 1.2 1.5 0.3 1.0 0.4 0.6 0.3 1.8 1.3 2.8 4.1 0.4 0.9 2.3 0.8 0.5 1.2 2.2 2.0 1.6 4.7 2.4 0.4 2.2 0.6 5.6 1.1 1.0 2.3 2.1 2.5 0.6 0.7 0.2 2.4 1.7 0.7 0.7 2.0 1.8 0.8 1.1 6.9 6.7 1.8 1.4 1.6 5.3 2.7 5.7 1.0 2.0 5.5 4.2 2.8 0.6 1.1 2.6 2.7 2.2 1.1 1.3 5.4 2.1 3.5 0.5 1.4 1.5 1.0 1.7 1.7 2.4 6.8 0.3 2.4 1.0 2.0 0.2 1.2 0.3 0.3 0.6 1.2 0.7 0.5 0.6 1.0 0.5 0.9 0.4 0.2 0.2 0.6 0.8 0.3 0.2 0.2 1.0 0.7 0.2 0.2 0.5 0.4 0.3 0.3 0.2 0.3 8.2 3.2 2.3 22.5 12.9 25.0 6.2 8.8 6.8 5.5 7.6 4.7 4.3 1.5 11.1 1.8 0.0 6.8 4.9 0.5 7.9 3.4 25.0 27.1 4.7 7.1 0.0 30.7 44.0 2.9 13.1 7.8 3.6 4.4 3.8 13.4 6.4 1.1 3.6 5.0 51.2 2.0 8.2 3.1 3.5 13.5 6.2 4.1 5.4 15.0 3.9 3.6 7.2 20.1 11.6 2.6 6.1 3.4 2.8 3.6 0.6 1.6 82.0 3.2 0.0 4.8 4.4 21.6 11.4 9.7 18.9 2.9 7.2 5.2 3.5 3.1 ZNF367 FLJ33970 ENSG00000165244 "Zinc finger protein 367" Q7RTV3 9 96385941-96418370 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA015319, HPA015785" Uncertain Supported Nucleoplasm NA Yes "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "HPA015319: AB_2669185, HPA015785: AB_2217750" "unprognostic (5.91e-2)" "unprognostic (2.78e-3)" "unprognostic (2.17e-2)" "unprognostic (1.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.57e-3)" "unprognostic (7.76e-3)" "unprognostic (1.60e-3)" "unprognostic (4.35e-2)" "unprognostic (3.01e-1)" "unprognostic (3.78e-3)" "unprognostic (2.71e-2)" "unprognostic (4.88e-3)" "unprognostic (3.23e-3)" "unprognostic (1.72e-1)" "prognostic favorable (2.34e-4)" "unprognostic (2.28e-1)" 1.4 0.6 0.7 3.7 1.3 26.1 1.7 1.4 1.3 1.1 0.2 3.0 2.9 1.1 0.1 2.4 0.7 1.0 2.1 0.7 1.0 3.0 10.8 1.1 4.6 1.5 1.4 1.0 1.4 1.6 0.3 1.9 1.4 1.2 3.3 1.3 0.7 0.4 1.5 3.5 3.0 2.4 0.9 1.3 2.1 6.1 1.3 8.7 1.1 2.7 4.7 1.5 1.2 2.7 25.4 10.3 9.9 8.9 3.8 5.3 13.4 34.6 20.4 16.9 20.0 6.4 17.5 19.2 14.4 16.5 12.6 30.5 11.6 12.6 19.9 21.2 10.0 14.0 19.1 5.3 0.0 19.8 16.5 0.9 0.8 13.7 6.9 3.7 6.3 13.3 13.0 45.4 21.7 16.9 30.4 16.1 6.7 27.9 16.7 15.3 49.9 11.7 4.9 16.8 17.4 12.0 15.3 18.1 10.6 8.0 9.4 17.3 5.7 27.6 15.8 25.6 26.6 17.6 32.0 7.8 16.7 17.0 23.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.7 1.3 1.4 1.3 0.7 1.0 1.5 1.4 1.4 0.9 1.3 2.7 1.1 0.0 0.0 2.9 3.8 9.9 1.3 0.4 10.8 0.7 2.2 2.3 2.6 0.0 0.9 0.0 0.0 3.2 2.5 2.4 0.0 0.5 0.7 0.6 1.1 2.0 0.0 22.3 5.1 1.2 4.2 1.7 2.6 1.8 0.0 4.7 1.1 3.8 1.9 0.0 5.3 3.6 0.0 2.1 2.6 0.8 0.6 8.3 3.6 2.8 0.1 0.6 1.0 3.0 7.9 0.7 0.5 0.7 9.6 0.6 0.9 2.5 0.0 1.5 6.6 2.0 3.6 10.3 1.7 10.9 6.5 0.8 5.0 0.3 5.6 1.1 ZNF440 FLJ37933 ENSG00000171295 "Zinc finger protein 440" Q8IYI8 19 11814273-11835216 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 44.8;Respiratory ciliated cells: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 12.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 12.6" "Cell line enhanced" "Detected in many" "RT4: 25.5" HPA047845 Approved Approved Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 31: Skin - Epidermis development" "Cluster 15: RT4 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.48e-1)" "unprognostic (8.96e-3)" "unprognostic (1.34e-1)" "unprognostic (4.40e-2)" "unprognostic (2.45e-3)" "unprognostic (1.24e-3)" "unprognostic (1.03e-1)" "unprognostic (3.13e-2)" "unprognostic (9.05e-2)" "unprognostic (4.64e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.57e-4)" "prognostic favorable (1.18e-4)" "unprognostic (9.81e-3)" "unprognostic (2.22e-1)" "unprognostic (3.80e-2)" "prognostic favorable (9.88e-4)" 3.8 3.9 2.8 3.4 2.5 6.9 6.8 6.3 3.6 6.1 7.4 10.0 5.6 4.4 4.8 9.8 14.5 4.3 3.3 5.0 1.8 4.7 3.7 6.9 4.2 3.7 5.3 3.8 5.5 16.4 2.8 9.7 3.1 6.3 11.1 7.1 7.1 4.3 4.3 15.6 7.1 3.5 1.2 4.3 8.6 6.4 2.4 8.0 4.1 2.2 5.2 11.6 7.1 4.8 6.7 0.0 7.3 8.9 5.4 4.8 19.4 4.6 3.8 5.5 4.7 7.0 5.7 3.7 4.4 4.2 2.7 8.2 3.8 8.9 7.6 0.3 2.5 5.2 4.8 5.6 2.7 0.1 11.5 2.7 5.8 3.4 0.9 3.9 3.1 5.0 19.9 0.3 6.4 2.8 4.7 6.9 5.6 2.3 5.8 3.9 9.5 1.6 4.0 25.5 4.2 3.3 7.2 3.0 5.3 7.8 12.9 10.3 3.3 12.5 2.6 9.2 4.1 6.7 5.2 4.9 5.8 3.3 4.6 12.6 1.4 1.9 1.1 0.9 1.4 1.0 1.4 1.3 1.8 1.1 1.0 1.6 2.5 3.0 2.9 1.1 1.8 0.8 2.8 2.5 6.3 3.6 5.0 1.8 3.7 5.3 3.1 1.2 2.4 4.8 3.9 16.0 7.9 7.2 2.5 2.9 7.6 5.2 8.0 5.5 3.4 2.7 3.0 1.5 14.6 9.2 35.5 31.1 5.8 25.1 3.9 3.6 16.7 44.8 3.8 4.2 6.7 2.1 10.4 3.6 20.7 3.1 15.3 11.9 10.8 3.3 4.2 1.7 4.5 6.7 6.7 12.7 2.0 5.0 2.8 5.7 2.8 3.0 3.6 2.8 2.2 2.0 4.1 10.6 5.8 5.8 15.9 1.9 2.5 5.7 20.8 2.1 74.1 13.1 0.0 3.9 4.1 9.7 3.5 9.0 4.8 29.8 4.6 1.1 12.1 9.8 ZNF473 "DKFZP434N043, HZFP100, KIAA1141" ENSG00000142528 "Zinc finger protein 473" Q8WTR7 19 50025714-50053414 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 42.4" "Cell type enhanced" "Detected in many" "Early spermatids: 88.9;Late spermatids: 23.3;Spermatocytes: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA004191, HPA073309" Approved Supported Nucleoplasm NA NA "Cluster 30: Non-specific - Translation" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA004191: AB_2667168, HPA073309: AB_2686594" "unprognostic (7.47e-3)" "unprognostic (3.57e-2)" "unprognostic (2.47e-1)" "unprognostic (3.40e-1)" "unprognostic (4.27e-1)" "unprognostic (8.00e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.31e-3)" "unprognostic (6.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.70e-2)" "unprognostic (3.22e-3)" "unprognostic (8.49e-2)" "unprognostic (1.60e-1)" "unprognostic (3.93e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" 3.8 2.9 4.0 2.9 4.9 4.2 4.6 5.7 7.6 3.6 9.0 3.1 2.8 3.7 4.0 3.6 7.3 3.2 2.9 4.4 5.0 3.5 3.3 3.5 3.5 5.2 5.8 4.4 4.6 4.3 5.4 3.0 4.8 4.7 3.0 6.2 2.4 3.9 4.1 3.7 2.4 4.9 4.7 6.7 3.1 42.4 5.4 4.1 4.5 4.6 4.5 3.2 2.4 6.8 14.4 9.6 14.7 12.4 5.7 6.6 8.3 13.2 7.9 18.4 17.2 18.4 9.5 22.2 5.0 7.7 6.8 10.8 18.4 8.8 23.4 15.6 18.0 22.5 8.8 9.3 6.6 16.3 13.1 6.8 16.1 19.3 25.2 7.6 6.2 13.1 32.1 19.3 9.4 6.2 13.0 7.8 10.4 22.4 15.1 15.8 20.5 9.8 6.1 15.6 12.1 13.9 18.6 10.1 8.9 10.0 9.4 14.7 3.0 25.7 13.1 5.2 13.4 8.9 22.8 18.4 6.1 12.7 21.0 2.0 5.0 2.9 6.3 7.3 6.6 11.7 6.3 7.7 5.0 10.0 7.8 10.0 4.4 2.5 3.4 5.3 3.9 4.2 4.0 4.9 5.7 7.6 4.4 5.0 5.2 5.8 4.8 4.7 5.4 6.8 2.8 0.0 1.7 0.3 4.6 4.6 2.9 1.9 6.8 0.7 2.9 2.8 2.2 0.0 1.7 0.0 0.0 2.3 1.5 2.3 3.9 2.4 88.9 5.6 5.1 3.8 1.8 5.2 3.1 3.2 3.2 3.5 7.7 4.0 0.0 3.8 6.8 1.7 2.2 0.0 3.1 3.7 2.0 1.3 1.7 23.3 3.7 2.0 1.8 1.9 3.2 1.7 2.1 1.5 2.8 3.4 3.0 3.8 4.1 4.1 1.6 1.7 10.4 4.3 13.1 3.5 2.7 64.7 20.5 4.8 4.7 1.9 3.5 3.5 2.4 2.1 ZNF474 "4933409D10Rik, FLJ32921" ENSG00000164185 "Zinc finger protein 474" Q6S9Z5 5 122129546-122153569 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.2;choroid plexus: 7.1;fallopian tube: 17.1;testis: 7.6" "Group enriched" "Detected in some" 5 "Early spermatids: 23.0;Endometrial ciliated cells: 23.2;Late spermatids: 12.4;Respiratory ciliated cells: 22.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.0;CAPAN-2: 1.1;GAMG: 1.3;TIME: 1.2" "Low region specificity" "Detected in many" HPA036594 Approved "Nuclear membrane,Plasma membrane" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane" "Plasma membrane" "HPA036594: " "unprognostic (9.98e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (5.90e-3)" "unprognostic (7.82e-2)" "unprognostic (2.49e-2)" "unprognostic (3.94e-2)" "unprognostic (7.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (1.51e-3)" "unprognostic (1.12e-3)" "unprognostic (9.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.09e-4)" 0.2 0.1 0.6 0.1 0.7 0.0 0.2 0.5 0.3 0.6 7.1 0.3 0.1 0.7 0.0 0.4 17.1 0.5 0.1 0.6 1.2 0.3 0.1 1.7 0.0 2.2 4.2 0.2 0.1 0.0 0.2 0.0 2.0 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 1.7 0.1 0.1 7.6 1.2 0.3 0.9 0.1 0.1 0.1 0.1 1.9 0.0 0.4 0.1 0.0 0.2 0.1 0.0 1.0 0.2 0.1 0.0 0.0 1.1 0.0 0.0 0.7 1.3 0.2 0.0 0.0 0.4 0.1 0.1 0.4 0.2 0.0 0.2 0.3 0.0 0.1 0.5 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.1 0.1 1.2 0.3 0.2 0.7 0.2 0.1 0.2 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.5 0.3 0.6 1.2 2.2 4.2 2.0 1.7 1.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.0 23.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.0 0.0 0.0 0.1 0.6 2.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" 10 43436841-43483181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.2" "Cell type enhanced" "Detected in many" "Early spermatids: 191.2;Endometrial ciliated cells: 65.7;Late spermatids: 289.9;Respiratory ciliated cells: 73.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Cluster 5: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 2.9 2.1 2.1 2.0 2.1 4.3 2.8 2.0 6.3 3.2 4.5 2.6 2.4 3.8 2.1 2.1 6.0 3.7 2.1 2.3 1.9 2.3 2.2 3.0 2.4 7.5 6.0 4.2 1.6 3.6 2.4 1.9 5.0 2.3 1.9 8.9 1.5 2.7 1.2 2.1 2.5 3.0 4.7 2.4 2.3 28.2 2.2 3.6 3.3 1.6 2.2 3.3 2.1 3.8 1.7 1.6 2.0 2.1 2.4 4.8 0.6 2.7 4.7 2.5 2.7 2.6 4.7 4.3 0.4 3.4 2.4 2.7 0.6 1.0 2.4 0.5 0.9 1.4 0.4 1.5 3.1 1.4 1.7 5.0 2.3 4.2 3.0 5.2 0.9 0.9 0.7 0.6 1.9 3.0 2.9 1.1 0.4 0.8 0.9 1.5 0.7 1.8 5.7 1.9 1.7 1.3 2.4 1.3 1.1 1.2 2.2 1.6 1.5 2.4 1.5 1.4 0.7 0.3 1.1 4.7 5.6 2.0 0.9 1.8 3.0 4.5 3.3 2.2 2.6 1.9 2.4 2.9 3.9 2.5 1.9 2.3 10.4 2.9 1.2 2.9 1.6 2.1 2.1 2.1 2.0 6.3 2.3 1.9 7.5 6.0 5.0 4.7 2.2 3.8 4.0 22.4 4.8 11.8 6.2 1.8 6.3 6.6 3.4 5.4 6.6 7.7 3.3 7.2 8.3 5.5 8.4 1.4 9.8 6.1 11.7 4.5 191.2 65.7 6.5 5.3 7.8 1.3 19.4 2.1 4.0 5.4 5.6 6.3 0.0 3.4 3.3 2.7 3.3 6.7 21.1 4.4 10.2 5.6 3.1 289.9 4.7 6.3 1.8 0.0 7.3 12.6 2.1 6.0 7.1 2.1 3.9 6.8 3.6 3.2 13.0 12.7 73.5 18.7 0.0 6.3 5.1 16.7 7.5 1.9 2.8 1.6 5.6 3.8 3.5 6.1 ZNF497 FLJ44773 ENSG00000174586 "Zinc finger protein 497" Q6ZNH5 19 58354357-58362848 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Respiratory ciliated cells: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 20.2" HPA047872 Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA "Cluster 30: Non-specific - Translation" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Cell Junctions" "HPA047872: AB_2680196" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (2.17e-1)" "unprognostic (1.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.42e-2)" "unprognostic (2.30e-2)" "unprognostic (8.53e-2)" "unprognostic (9.45e-2)" "unprognostic (9.29e-2)" "unprognostic (4.16e-3)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (4.58e-2)" "unprognostic (7.28e-2)" "unprognostic (1.24e-1)" 0.7 1.4 2.3 1.8 3.3 1.6 1.8 6.4 3.2 2.6 3.7 1.0 1.3 2.3 1.9 2.1 5.7 1.2 1.4 2.7 0.9 3.5 3.1 1.8 2.5 1.6 1.7 2.5 2.5 1.4 4.5 0.9 0.9 2.4 0.8 1.8 2.7 1.1 0.7 2.7 1.2 0.4 0.8 2.3 1.6 1.6 1.6 0.5 3.7 0.0 0.4 0.9 1.7 3.9 2.0 6.8 6.0 5.8 0.2 0.1 7.9 3.7 0.0 0.0 0.0 0.5 2.2 4.0 1.9 0.0 3.3 0.9 0.7 0.4 0.0 4.2 20.2 3.6 2.2 1.2 0.3 1.5 9.2 0.5 0.9 0.1 0.7 6.6 0.0 9.8 3.1 0.6 0.1 7.1 5.1 5.1 3.7 1.7 2.1 12.6 4.4 2.1 0.6 1.6 4.6 6.6 2.0 5.9 3.3 3.0 8.1 4.1 0.6 6.6 3.4 0.6 1.2 8.7 11.1 3.5 1.8 4.1 3.6 1.3 1.1 0.3 0.8 0.4 0.9 1.3 1.0 1.0 1.0 1.5 0.9 1.7 0.3 0.8 0.3 1.8 1.2 0.7 2.3 3.3 6.4 3.2 2.7 0.9 1.6 1.7 0.9 0.8 1.6 3.9 0.3 6.4 0.5 3.9 0.9 0.3 0.4 1.0 1.2 1.4 2.1 1.3 0.7 0.0 1.0 0.0 0.0 2.0 0.1 0.5 1.9 1.4 1.7 3.6 0.6 0.6 0.0 1.3 3.1 0.2 0.5 0.5 1.5 1.2 0.0 1.9 0.0 1.9 0.5 0.0 3.0 1.4 0.0 0.0 0.4 0.9 0.0 0.2 0.0 1.9 0.1 1.3 0.0 3.0 3.5 0.3 1.2 0.0 0.7 0.3 0.4 0.7 5.2 1.6 0.0 0.4 0.4 0.3 1.7 0.8 0.3 0.3 0.5 0.3 1.2 0.1 ZSCAN1 "FLJ33779, ZNF915" ENSG00000152467 "Zinc finger and SCAN domain containing 1" Q8NBB4 19 58034025-58054631 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.8;pituitary gland: 15.9;testis: 8.7" "Cell type enhanced" "Detected in many" "Distal tubular cells: 11.7;Early spermatids: 28.2;Endometrial ciliated cells: 21.8;Late spermatids: 19.6;Spermatocytes: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.0;HMC-1: 2.1;NTERA-2: 2.1;T-47d: 3.1" HPA007938 Uncertain Approved Nucleoli NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Nucleoli "HPA007938: AB_1080768" "unprognostic (1.60e-3)" "unprognostic (2.44e-1)" "unprognostic (2.21e-1)" "unprognostic (3.58e-1)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (1.97e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-1)" "prognostic favorable (7.36e-4)" "unprognostic (1.41e-2)" "unprognostic (3.81e-2)" "unprognostic (1.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.32e-1)" "unprognostic (2.47e-2)" "unprognostic (3.60e-1)" 0.1 0.9 3.7 0.0 2.7 0.1 0.9 4.1 4.6 1.2 1.4 0.3 0.0 0.6 6.1 0.1 2.1 0.2 0.5 3.6 7.8 2.6 0.1 0.5 0.0 4.0 5.3 0.6 1.0 2.6 15.9 0.2 3.1 2.4 0.0 2.3 0.4 0.8 0.0 0.2 0.1 0.1 2.1 0.2 0.1 8.7 5.1 0.6 5.9 0.0 0.0 0.5 0.3 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.6 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.7 4.1 4.6 3.6 7.8 4.0 5.3 3.1 2.1 5.1 1.6 0.1 0.0 0.0 3.6 0.0 0.0 0.4 0.2 0.0 3.4 1.8 2.2 1.1 1.5 0.2 1.8 2.1 0.0 0.0 0.0 11.7 1.7 28.2 21.8 3.1 0.5 0.0 0.0 3.8 0.0 0.0 0.8 0.0 1.7 0.0 3.2 0.4 0.0 0.1 3.3 5.4 0.0 0.0 0.0 0.0 19.6 0.9 0.1 1.8 2.8 0.0 8.1 0.0 4.0 1.8 0.3 0.0 0.0 0.0 0.9 0.0 0.2 4.3 2.6 0.0 0.0 0.6 13.7 2.7 0.0 0.0 0.0 0.1 6.7 0.0 0.5 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357227-56361273 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.6;lymphoid tissue: 43.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 17.0" "Lineage enriched" "Detected in many" 5 "T-cells: 17.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 2.6 2.5 1.2 15.7 1.3 41.6 6.5 1.1 1.8 3.9 1.0 18.8 13.7 3.2 1.7 12.4 2.8 2.4 1.5 1.5 1.2 4.4 4.8 2.9 26.5 1.2 1.3 1.5 2.4 5.4 0.8 10.8 1.2 2.5 22.4 0.5 3.3 1.4 0.3 10.8 14.8 6.8 1.2 5.0 12.5 26.1 1.6 43.5 3.9 0.7 33.0 5.0 4.3 1.4 199.8 154.8 107.9 120.9 7.5 10.8 88.1 143.1 108.0 169.6 153.4 275.4 116.1 102.0 53.2 49.6 79.1 99.9 153.2 108.3 156.7 259.9 80.2 101.6 120.8 129.4 0.7 169.6 131.0 5.1 6.8 157.7 64.9 20.8 86.8 134.2 140.2 121.4 151.1 160.1 150.7 108.3 77.0 135.9 188.7 151.7 209.5 54.0 53.5 87.5 99.8 61.2 135.2 304.2 35.3 62.2 197.3 163.4 47.4 73.6 189.4 76.9 223.2 105.8 55.3 176.0 103.8 210.0 94.7 0.0 0.8 0.7 2.4 3.0 0.3 1.6 5.3 3.6 1.4 0.3 6.3 3.6 0.0 3.5 2.3 1.1 17.0 3.1 1.2 1.3 1.1 1.8 1.5 1.2 1.2 1.3 1.2 1.2 1.6 1.4 0.9 3.2 1.7 0.3 11.1 18.4 6.0 20.2 4.6 2.0 9.4 5.5 1.4 2.8 7.3 5.5 0.0 73.7 3.3 17.9 0.0 9.7 74.0 7.0 4.3 5.7 0.0 133.0 1.3 13.3 108.6 10.3 16.8 8.0 0.0 27.6 7.9 3.5 49.4 0.0 0.3 22.8 14.2 8.5 8.8 208.8 5.0 9.2 7.2 0.0 2.6 1.3 0.0 0.0 0.6 8.6 16.4 2.6 42.4 1.9 8.7 6.0 2.5 0.9 0.0 1.4 10.6 121.0 100.3 24.5 8.2 23.1 7.9 6.5 39.4 8.4